FN Clarivate Analytics Web of Science
VR 1.0
PT S
AU Violin, KB
   Ribeiro, C
   Goia, TS
   Bressiani, JC
   Bressiani, AHD
AF Violin, Kalan Bastos
   Ribeiro, Christiane
   Goia, Tamiye Simone
   Bressiani, Jose Carlos
   de Almeida Bressiani, Ana Helena
BE Ishikawa, K
   Iwamoto, Y
TI Lectinhistochemistry Evaluation of Rabbit's Tibia Implanted with
   Macroporous Biphasic Ceramic Implants
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE Lectinhistochemistry; Hydroxyapatite; Beta-Tricalcium Phosphate;
   Ceramic; Bone; Implant; Macroporous; Lectin
ID BINDING; LECTINS; DESIGN; BONE
AB Many techniques are used to assess biomaterials implants, always intending to measure osseointegration success and tissue response facing the implanted material. Calcium phosphates are widely used as biomaterial and a major component of bone. Many processing methods have been used to achieve porous materials to allow bone ingrowth with an osteoconductive scaffold for bone. To obtain the macroporous BCP implant it was processed by direct consolidation using the protein-action technique, a globular protein based consolidation with ovalbumin. The samples were sintered at 1250 degrees C for 30 minutes, after sintering samples were cut in 4mm diameter cylinders, with 73% volume of porosity and mean pore size ranging about 100 mu m. In the present work the macroporous BCP of HAp:beta-TCP is assessed after bone implantation in rabbit's tibia by lectinhistochemistry (LHC) technique. Lectins are proteins from non-imune origin which binds with strong specificity carbohydrates, LHC is a technique which mark histologically carbohydrates present in glycoproteins of cells. The macroporous BCP cylindrical samples were implanted in male rabbits tibia to the evaluation of biocompatibility and osseointegration in a period of 2 weeks to 4 weeks. After euthanasia of rabbits, tibia samples from the surgery site were taken and fixed with formalin, decalcified, dehydrated and embedded with paraffin to perform histological slides for both morphological and molecular evaluation. The morphological evaluation were performed on histological slides stained with Haematoxilin and Eosin (HE), while for molecular evaluation LHC was performed on histological slides using the lectins PNA, UEA-1, WGA, sWGA and RCA-1 (Vector Labs). All samples osseointegrated well with the bone and the neoformed bone surrounding the implant took the shape of its surface. The implants also allowed bone ingrowth inside the pores towards the center of implant, characterized by islets of round bone present in the HE stained slides.
C1 [Violin, Kalan Bastos; Goia, Tamiye Simone; Bressiani, Jose Carlos; de Almeida Bressiani, Ana Helena] Mat Sci & Technol Ctr IPEN, Av Prof Lineu Prestes,2242 Cidade Univ, Sao Paulo, Brazil.
   [Ribeiro, Christiane] UFABC, Ctr Engn, Appl Social Sci Ctr, Santo Andre sp, Brazil.
RP Violin, KB (reprint author), Mat Sci & Technol Ctr IPEN, Av Prof Lineu Prestes,2242 Cidade Univ, Sao Paulo, Brazil.
EM kbviolin@ipen.br; cribeiro@ipen.br; tsgoia@ipen.br; jbressia@ipen.br;
   abressia@ipen.br
RI Bressiani, Ana/I-1402-2012
FU "lNCT em Biofabricacao", FAPESP [2010/20698-4]; CNPq
FX The authors are thankful for the financial support "lNCT em
   Biofabricacao", FAPESP 2010/20698-4 and CNPq.
CR ALROY J, 1991, CARBOHYD RES, V213, P229, DOI 10.1016/S0008-6215(00)90611-6
   Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1593, DOI 10.1039/b414350g
   Bilyy R, 2007, AUTOIMMUNITY, V40, P249, DOI 10.1080/08916930701358867
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Doernberg M C, 2006, BIOMATERIALS, V27, P5186
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Mahal LK, 2008, ANTI-CANCER AGENT ME, V8, P37, DOI 10.2174/187152008783330806
   NIIKAWA S, 1992, ACTA NEUROPATHOL, V83, P347, DOI 10.1007/BF00713524
   Ribeiro C., 2010, ADV SCI TECHN, V76, P66
   Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122
   Taraszewska A, 2007, FOLIA NEUROPATHOL, V45, P9
   Violin K.B., 2012, ADV SCI TEC IN PRESS
NR 15
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 331
EP +
DI 10.4028/www.scientific.net/KEM.529-530.331
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800069
DA 2018-10-19
ER

PT S
AU Keuer, H
   Ganz, C
   Xu, W
   Schubert, A
   Frerich, B
   Gerber, T
AF Keuer, H.
   Ganz, C.
   Xu, W.
   Schubert, A.
   Frerich, B.
   Gerber, Th.
BE Ishikawa, K
   Iwamoto, Y
TI Osteoinductive coating on PEEK surfaces by using nanocrystalline
   biomaterial and in vivo test
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE polyetheretherketone; biomaterial coating; synthetic hydroxyapatite; in
   vivo experiment
AB A surface coating on the polymer polyetheretherketone (PEEK) was developed to improve the osteointegration of an implantation model for cages (implant for spinal fusion). In a process of induction heating the polymer surface was coated with a synthetic biomaterial. The polymer surface melts during the coating process and crawls into the nanoporous structure of the biomaterial. After heat dissipation, a strong connection is reached between polymer and biomaterial. Finally, the model was implanted into New Zealand rabbit femur as control and coated group for 2, 4 and 6 weeks. The evaluation offers a ca. 10% higher bone-to-implant-contact value for the coated group.
C1 [Keuer, H.; Ganz, C.; Xu, W.; Gerber, Th.] Univ Rostock, Inst Phys, D-18055 Rostock, Germany.
   [Schubert, A.; Frerich, B.] Univ Rostock, Dept Oral, Maxillofacial & Plast Surg, Rostock, Germany.
RP Keuer, H (reprint author), Univ Rostock, Inst Phys, D-18055 Rostock, Germany.
EM holger.keuer@uni-rostock.de; thomas.gerber@uni-rostock.de
CR Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Han CM, 2010, BIOMATERIALS, V31, P3465, DOI 10.1016/j.biomaterials.2009.12.030
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   SKINNER HB, 1988, CLIN ORTHOP RELAT R, P224
   Xu WG, 2009, J BIOMED MATER RES B, V91B, P692, DOI 10.1002/jbm.b.31445
NR 6
TC 0
Z9 0
U1 1
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 345
EP +
DI 10.4028/www.scientific.net/KEM.529-530.345
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800072
DA 2018-10-19
ER

PT S
AU David, M
   Guenaelle, B
   Aline, L
   Maria, Z
   Luc, M
   Stephanie, S
   Nicolas, D
   Didier, BA
   Jerome, C
AF David, Marchat
   Guenaelle, Bouet
   Aline, Lueckgen
   Maria, Zymelka
   Luc, Malaval
   Stephanie, Szenknect
   Nicolas, Dacheux
   Didier, Bernache-Assollant
   Jerome, Chevalier
BE Ishikawa, K
   Iwamoto, Y
TI Physico-chemical characterization and in vitro biological evaluation of
   pure SiHA for bone tissue engineering application
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE silicon-substituted hydroxyapatite; bioceramics; dissolution; in vitro
   biocompatibility
ID SILICON-SUBSTITUTED HYDROXYAPATITE; BIOCERAMICS
AB Studies about silicon-substituted hydroxyapatites exhibit several shortcomings that leave unanswered questions regarding the properties and subsequent biological outcomes generated by this biomaterial. Firstly, samples characterization is often incomplete, meaning that phase purity on the pellet surface is not assured. In fact, ceramic materials used in literature that are claimed to be pure are actually polluted through second phase as superficial polymerized silicate.
   In this study, we have successfully synthesized a phase-pure silicon hydroxyapatite powder Ca-10(PO4)(5.5)(SiO4)(0.5)(OH)(1.5) (Si(0.5)HA) compressed this powder into pellets, sintered them, and evaluated the biological response of osteoblast cells (C3H10 line) seeded on the pellet surface. Besides, the solubility in aqueous media of HA and Si(0.5)HA pellets were determined through "static" experiments. These tests attempt to provide a comprehensive picture of the cellular response to the SiHA material, in order to determine the mechanism by which Si evokes the improved in vitro biological outcomes described in the literature. Results revealed first an equivalent solubility of Si(0.5)HA and HA pellets, and second that cells do not react favourably to the pure SiHA surface.
C1 [David, Marchat; Aline, Lueckgen; Maria, Zymelka; Didier, Bernache-Assollant] Ecole Natl Super Mines, CIS EMSE, CNRS FRE3312, 158 Cours Fauriel, F-42023 St Etienne, France.
   [Guenaelle, Bouet; Luc, Malaval] Univ Jean Monnet, Fac Med St Etienne, LBTO, INSERM, F-42023 St Etienne, France.
   [Stephanie, Szenknect; Nicolas, Dacheux] Univ Montpellier, Inst Chinnie Separat Marcoule UMR 5257, Lab Interfaces Mat Evolut LIME, F-30207 Bagnols Sur Ceze 30207, France.
   [Jerome, Chevalier] Univ Lyon, MATEIS Lab UMR CNRS 5510, INSA Lyon, F-69621 Villeurbanne, France.
RP David, M (reprint author), Ecole Natl Super Mines, CIS EMSE, CNRS FRE3312, 158 Cours Fauriel, F-42023 St Etienne, France.
EM marchat@emse.fr
CR Best SM, 2008, KEY ENG MATER, V361-363, P985, DOI 10.4028/www.scientific.net/KEM.361-363.985
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Dacheux N, 2010, J NUCL MATER, V404, P33, DOI 10.1016/j.jnucmat.2010.06.023
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Jillavenkatesa A, 1998, SPECTROSC LETT, V31, P1619, DOI 10.1080/00387019808007439
   Marchat D, 2012, ACTA BIOMATERI UNPUB
   Marchat D, 2011, J HAZARDOUS MA UNPUB
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Porter AE, 2006, J BIOMED MATER RES A, V78A, P25, DOI 10.1002/jbm.a.30690
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   Zymelka M, 2012, ACTA BIOMATERI UNPUB
NR 13
TC 3
Z9 3
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 351
EP +
DI 10.4028/www.scientific.net/KEM.529-530.351
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800073
DA 2018-10-19
ER

PT S
AU Nakamura, M
   Nagai, A
   Yamashita, K
AF Nakamura, Miho
   Nagai, Akiko
   Yamashita, Kimihiro
BE Ishikawa, K
   Iwamoto, Y
TI Surface Electric Fields of Apatite Electret Promote Osteoblastic
   Responses
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE osteoblast; differentiation; polarization; hydroxyapatite
ID HYDROXYAPATITE CERAMICS; POLARIZATION
AB The osteoblast behaviors on the biomaterial substrates are recognized to play a fundamental role in osteoconduction process. The purpose of this study was to evaluate the in vitro behaviors of osteoblasts cultured on electrically polarized hydroxyapatite (HA), having the enhanced osteobonding abilities. Osteoblasts derived from mouse bone marrow were seeded onto the polarized HA and investigated the proliferation and differentiation. The polarization had effects on the proliferation of osteoblast precursor cells based on the MTT assay. The acceleration was emerged as the early achievement to the confluence on the N-HA and P-HA. The quantitative analysis of the results of ALP and AR-S staining, the charges induced on the HA surface accelerated the differentiation from the osteoblast precursor cells to mature osteoblasts.
C1 [Nakamura, Miho; Nagai, Akiko; Yamashita, Kimihiro] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Nakamura, M (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM miho.bcr@tmd.ac.jp; nagai.bcr@tmd.ac.jp; yama-k.bcr@tmd.ac.jp
CR Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Itoh S, 2006, CALCIFIED TISSUE INT, V78, P133, DOI 10.1007/s00223-005-0213-6
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   Nakamura M, 2009, ACS APPL MATER INTER, V1, P2181, DOI 10.1021/am900341v
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Valta MP, 2006, ENDOCRINOLOGY, V147, P2171, DOI 10.1210/en.2005-1502
   Yamashita K, 2005, J CERAM SOC JPN, V113, P1, DOI 10.2109/jcersj.113.1
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
NR 9
TC 4
Z9 4
U1 1
U2 13
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 357
EP 360
DI 10.4028/www.scientific.net/KEM.529-530.357
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800074
DA 2018-10-19
ER

PT S
AU Miyazaki, T
   Kuramoto, A
AF Miyazaki, Toshiki
   Kuramoto, Akimasa
BE Ishikawa, K
   Iwamoto, Y
TI Fabrication of Composites from Apatite and Chemically Synthesized
   collagen
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE Chemically synthesized collagen; Apatite; Organic-inorganic hybrid;
   Simulated body fluid (SBF)
AB Chemically synthesized collagen with triple helix structure similar to natural collagen has been developed as a safe biomaterial. If the chemically synthesized collagen is deposited with apatite, they are expected for novel bone substitutes having bioactivity and bioresorbability. Although apatite formation on the chemically synthesized collagen has been examined, highly supersaturated condition such as 1.5SBF with ion concentration 1.5 times those of simulated body fluid (SBF) is needed to achieve apatite formation. In the present study, we intended acceleration on the apatite formation on the chemically synthesized collagen by immobilization with polyglutamic acid (PGA). PGA is known as biodegradable and biocompatible polypeptide having excellent apatite-forming ability. We examined effects of the immobilization procedure on mineralization behavior in SBF. At first, PGA was immobilized on porous sponges of chemically synthesized collagen in aqueous solutions containing PGA and CaCl2. As a result, not only apatite but also calcite-type CaCO3 was deposited on the specimens in SBF. The calcite formation was occurred during the treatment with PGA solution. pH of the solution was adjusted to 7 by NaOH solution in order to avoid dissolution of the collagen. During this procedure, Ca(OH)(2) would be precipitated by locally increase in pH of the solution and converted into the calcite. When the PGA solution treatment was shortened so as to prevent the calcite formation, single phase of the apatite was formed in SBF. The present results indicate that crystalline phase deposited on the chemically synthesized collagen can be controlled by fabrication procedure, and provide fundamental design of composites containing apatite and chemically synthesized collagen useful for bone regeneration.
C1 [Miyazaki, Toshiki; Kuramoto, Akimasa] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan.
RP Miyazaki, T (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.
EM tmiya@life.kyutech.ac.jp
CR GIRIJA EK, 2002, CHEM LETT 0705, P702
   KAMITAKAHARA M, 2005, ARCH BIOCERAMICS RES, V5, P210
   Kishimoto T, 2005, BIOPOLYMERS, V79, P163, DOI 10.1002/bip.20348
   Sugino A, 2008, J MATER SCI-MATER M, V19, P2269, DOI 10.1007/s10856-007-3327-8
NR 4
TC 1
Z9 1
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 426
EP 429
DI 10.4028/www.scientific.net/KEM.529-530.426
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800088
DA 2018-10-19
ER

PT S
AU Yoshida, Y
   Okihara, T
   Nakamura, M
   Matsumoto, T
AF Yoshida, Yasuhiro
   Okihara, Takumi
   Nakamura, Mariko
   Matsumoto, Takuya
BE Ishikawa, K
   Iwamoto, Y
TI Phosphorylated Pullulan Bioadhesive for Regeneration and Reconstruction
   of Bone and Tooth
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE phosphorylated pullulan; bioadhesive; regeneration; reconstruction;
   bone; tooth
ID PERCUTANEOUS VERTEBROPLASTY; HIP-ARTHROPLASTY; TISSUE ADHESIVE; CEMENT;
   SURGERY; INTERFACE; COLLAPSE; DENTIN; DEATH
AB A biodegradable material that bonds to hard tissues such as bones and teeth is urgently needed for medical and dental applications. However, such materials are not available in today's clinical practice of orthopedics and dentistry. Therefore, we synthesized biodegradable phosphorylated pullulan to develop a biomaterial that combines primary properties such as high biocompatibility, good bonding potential to hard tissue, high strength, biodegradability, and osteoconductivity. The pharmacopoeial polysaccharide pullulan was chemically functionalized with dihydrogen phosphate groups. Phosphorylated pullulan was formed network by adding calcium ion, making the composite less soluble in water. Adhesive force measurement revealed that adhesiveness of the pastes before setting can be controlled through optimization of additives. In addition, histological evaluation revealed that phosphorylated pullulan-based composite possesses high biocompatibility. These results indicate that phosphorylated pullulan can be used as a key material for regeneration and reconstruction of bone and tooth.
C1 [Yoshida, Yasuhiro; Matsumoto, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
   [Okihara, Takumi] Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biochem, Kita Ku, Okayama 7008530, Japan.
   [Nakamura, Mariko] Kibi Int Univ Jr Coll, Dept Hlth & Welf Program, Okayama 7168508, Japan.
RP Yoshida, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
EM yasuhiro@md.okayama-u.ac.jp; okihara@cc.okayama-u.ac.jp;
   marin@kiui.ac.jp; tmatsu@md.okayama-u.ac.jp
CR Amar AP, 2001, NEUROSURGERY, V49, P1105, DOI 10.1097/00006123-200111000-00017
   Ambard Alberto J, 2006, J Prosthodont, V15, P321, DOI 10.1111/j.1532-849X.2006.00129.x
   Byrick RJ, 1997, CAN J ANAESTH, V44, P107, DOI 10.1007/BF03012996
   BYRICK RJ, 1986, ANESTHESIOLOGY, V65, P213, DOI 10.1097/00000542-198608000-00016
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Chen HL, 2002, ANESTH ANALG, V95, P1060, DOI 10.1213/01.ANE.0000025591.86476.F2
   DUNCAN JAT, 1989, ANAESTHESIA, V44, P149, DOI 10.1111/j.1365-2044.1989.tb11168.x
   Dunn CJ, 1999, DRUGS, V58, P863, DOI 10.2165/00003495-199958050-00010
   Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308
   Herget GW, 2001, EUR J CARDIO-THORAC, V19, P4, DOI 10.1016/S1010-7940(00)00613-8
   Inoue S, 2005, J DENT RES, V84, P1160, DOI 10.1177/154405910508401213
   Leathers TD, 2003, APPL MICROBIOL BIOT, V62, P468, DOI 10.1007/s00253-003-1386-4
   MAYER JM, 1990, POLYM MAT SCI ENG, V63, P732
   Parvizi J, 1999, CLIN ORTHOP RELAT R, P39
   Ries MD, 2006, BIOMATERIALS, V27, P256, DOI 10.1016/j.biomaterials.2005.05.103
   Singer AJ, 1998, ACAD EMERG MED, V5, P94, DOI 10.1111/j.1553-2712.1998.tb02590.x
   Stanczyk M, 2004, J BIOMECH, V37, P1803, DOI [10.1016/j.jbiomech.2004.03.002, 10.1016/j.biomech.2004.03.002]
   Vasconcelos C, 2001, J VASC INTERV RADIOL, V12, P1001, DOI 10.1016/S1051-0443(07)61584-X
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
   Yoshida Y, 2012, J DENT RES, V91, P376, DOI 10.1177/0022034512437375
   Yoshihara K, 2011, ACTA BIOMATER, V7, P3187, DOI 10.1016/j.actbio.2011.04.026
   Yoshihara K, 2010, ACTA BIOMATER, V6, P3573, DOI 10.1016/j.actbio.2010.03.024
NR 24
TC 2
Z9 2
U1 1
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 516
EP +
DI 10.4028/www.scientific.net/KEM.529-530.516
PG 3
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800106
DA 2018-10-19
ER

PT S
AU Yamamoto, E
   Kato, N
   Nishikawa, H
   Kusunoki, M
   Hayami, T
   Yoshikawa, K
   Hontsu, S
AF Yamamoto, E.
   Kato, N.
   Nishikawa, H.
   Kusunoki, M.
   Hayami, T.
   Yoshikawa, K.
   Hontsu, S.
BE Ishikawa, K
   Iwamoto, Y
TI Adhesive Strength between Flexible Hydroxyapatite Sheet and Tooth Enamel
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE Hydroxyapatite sheet; Tricalcium phosphate; Pulsed laser deposition;
   Artificial enamel; Adhesive strength
ID BONE
AB Tooth enamel cannot be reconstructed once it is destroyed immoderately. Hydroxyapatite (HAp) thin sheet can potentially be used for a novel dental biomaterial to repair the enamel. Using a pulsed laser deposition (PLD) method, we have successfully created a flexible HAp sheet of less than a few micrometers in thickness. Due to its flexibility, the HAp sheet is tightly adhered on curved surfaces at the target site. In the present study, we newly developed double-layered sheets composed of HAp film coated with tricalcium phosphate (TCP) thin layer. The HAp/TCP sheet was adhered to the extracted human teeth using a calcium phosphate solution for 3 days. The adhesive strength between the HAp/TCP sheet and tooth enamel was evaluated by quasi-static tensile tests. Moreover, the interface structure between them was observed by a scanning electron microscopy. As a result of the mechanical evaluation, the adhesive strength was greater than approximately 2.5 MPa. The electron microscopic observation revealed that the sheet was partially fused with the enamel. These findings suggest the possibility that enamel defects are repaired using the HAp/TCP sheet for a short duration.
C1 [Yamamoto, E.; Kato, N.; Nishikawa, H.; Kusunoki, M.; Hayami, T.; Hontsu, S.] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan.
   [Yoshikawa, K.] Osaka Dent Univ, Dept Operat Dent, Osaka, Japan.
RP Yamamoto, E (reprint author), Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan.
EM ei@waka.kindai.ac.jp; nkato@waka.kindai.ac.jp;
   nishik32@waka.kindai.ac.jp; kusu@waka.kindai.ac.jp;
   hayami@waka.kindai.ac.jp; kazushi@cc.osaka-dent.ac.jp;
   hontsu@waka.kindai.ac.jp
OI Nishikawa, Hiroaki/0000-0001-7753-3866; Kato,
   Nobuhiro/0000-0002-8210-6305
CR Hayami T, 2011, CLIN ORAL IMPLAN RES, V22, P774, DOI 10.1111/j.1600-0501.2010.02057.x
   Hontsu S, 1998, JPN J APPL PHYS 2, V37, pL1169, DOI 10.1143/JJAP.37.L1169
   Hontsu S, 1997, THIN SOLID FILMS, V295, P214, DOI 10.1016/S0040-6090(96)09146-8
   Hontsu S., 2010, MEMORIES FACULTY BIO, V26, P87
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Nishikawa H., 2010, APPL PHYS EXPRESS, V1
   Ozeki K, 2001, BIO-MED MATER ENG, V11, P63
   Schroeder JE, 2011, INJURY, V42, P609, DOI 10.1016/j.injury.2011.03.029
NR 8
TC 0
Z9 0
U1 1
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 522
EP +
DI 10.4028/www.scientific.net/KEM.529-530.522
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800107
DA 2018-10-19
ER

PT S
AU Cavalu, S
   Simon, V
   Ratiu, C
   Rus, V
   Akin, I
   Goller, G
AF Cavalu, Simona
   Simon, Viorica
   Ratiu, Cristian
   Rus, Vasile
   Akin, Ipek
   Goller, Gultekin
BE Ishikawa, K
   Iwamoto, Y
TI Titania versus Ceria alumina/zirconia composites: structural aspects and
   biological tolerance
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE alumina/zirconia composites; structure; biocompatibility
ID ZIRCONIA; CERAMICS; DENSIFICATION; BIOMATERIAL; ALUMINA; SURFACE; BONE
AB The aim of our study is to compare the structural and biological tolerance of novel Al2O3/3Y-TZP composites with ceria respectively titania addition (5 wt%). Scanning electron microscopy, X-ray diffraction, infrared spectroscopy and XPS results are reported for structural characteristics and surface modifications upon different fluoride treatments. The biocompatibility of the samples was evaluated using an animal model (rabbit). The explants were analyzed at a specific period (6 weeks).The sections of implanted bone area were subjected to histological evaluation. Upon correlating the structural properties and in vivo evaluation, we concluded that the addition of both TiO2 and CeO2 to Al2O3/3Y-TZP implies similar properties and satisfactory biological tolerance. With respect to the surface treatment, qualitative and quantitative results show that the alumina/zirconia with titania addition are more sensitive to fluoride treatment.
C1 [Cavalu, Simona; Ratiu, Cristian] Univ Oradea, Fac Med & Pharm, Oradea, Romania.
   [Simon, Viorica] Univ Babes Bolyai, Fac Phys Inst Interdisciplinary Res Bio Nano Sci, Cluj Napoca, Romania.
   [Rus, Vasile] USAMV, Fac Vet Med, Cluj Napoca, Romania.
   [Akin, Ipek; Goller, Gultekin] Istanbul Tech Univ, Dept Mat Sci, Istanbul, Turkey.
RP Cavalu, S (reprint author), Univ Oradea, Fac Med & Pharm, Oradea, Romania.
EM scavalu@rdslink.ro; viorica.simon@phys.ubbcluj.ro;
   ratiu_cristian@yahoo.com; vasilerus2002@yahoo.com; akinipe@itu.edu.tr;
   goller@itu.edu.tr
RI Akin, Ipek/B-6012-2014
OI Goller, Gultekin/0000-0003-4680-3936
FU CNCS-UEFISCDI [nr. PNE-1D-PCE 2011-3-0441]; Bilateral Cooperation
   between Romania and Turkey [2012-2013]
FX This work was accomplished in the framework of CNCS-UEFISCDI, project
   nr. PNE-1D-PCE 2011-3-0441 and Bilateral Cooperation between Romania and
   Turkey 2012-2013.
CR Akin I, 2011, CERAM INT, V37, P3273, DOI 10.1016/j.ceramint.2011.05.123
   Casellas D, 2003, J MATER PROCESS TECH, V143, P148, DOI [10.1016/S0924-0136(03)00396-0, 10.1016/S0924-0136(03)000396-0]
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   Duan K, 2006, J MATER CHEM, V16, P2309, DOI 10.1039/b517634d
   HATTAB FN, 1989, J DENT, V17, P47, DOI 10.1016/0300-5712(89)90129-2
   Macauro G., 2004, J BONE JOINT SURG BR, V86, P1192
   Meng FC, 2012, J ALLOY COMPD, V512, P63, DOI 10.1016/j.jallcom.2011.09.015
   Mustafa K, 2008, CLIN ORAL IMPLAN RES, V19, P1178, DOI 10.1111/j.1600-0501.2008.01560.x
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Silva NRFA, 2010, MATERIALS, V3, P863, DOI 10.3390/ma3020863
   Simon V, 2007, J OPTOELECTRON ADV M, V9, P3368
   Simon V., 2011, STUDIA UBB PHYS, V1, P67
   Tsukuma K, 2000, J AM CERAM SOC, V83, P3219, DOI 10.1111/j.1151-2916.2000.tb01711.x
NR 16
TC 1
Z9 1
U1 0
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 595
EP +
DI 10.4028/www.scientific.net/KEM.529-530.595
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800121
DA 2018-10-19
ER

PT S
AU Oktar, FN
   Agathopoulos, S
   Ozyegin, LS
   Turner, IG
   Gunduz, O
   Demirkol, N
   Bruck, S
   Ben-Nissan, B
   Samur, R
   Kayali, ES
   Aktas, C
AF Oktar, F. N.
   Agathopoulos, S.
   Ozyegin, L. S.
   Turner, I. G.
   Gunduz, O.
   Demirkol, N.
   Brueck, S.
   Ben-Nissan, B.
   Samur, R.
   Kayali, E. S.
   Aktas, C.
BE Ishikawa, K
   Iwamoto, Y
TI Nano-Bioceramic Production via Mechano-Chemical Conversion
   (Ultrasonication)
SO BIOCERAMICS 24
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 24th Symposium and Annual Meeting of International Society for Ceramics
   in Medicine (ISCM 2012)
CY OCT 21-24, 2012
CL Fukuoka, JAPAN
DE Local sea snail; ultrasonication; natural nano-bioceramics;
   hydroxyapatite
ID MECHANICAL-PROPERTIES; HYDROXYAPATITE COATINGS; BONE; FABRICATION;
   SCAFFOLDS; DENTIN
AB The production of nano-calcium phosphate powders, such as HA (hydroxyapatite), from synthetic chemicals can be expensive and time consuming. The skeleton or shells of sea creatures (e.g. sea urchins, shells, corals) could be an alternative source of materials to produce very fine and even nano-structured calcium phosphate biomaterial powders. Hydrothermal conversion under very high pressures or methods such as hot-plating (chemical) or ultrasonication (mechano-chemical), have been proposed to transform naturally derived CaCO3, e.g. aragonite, into apatite based materials. The aim of the present work was to prepare inexpensive nano-sized HA and TCP bioceramics powders from a local sea snail shells as a possible raw material for HA/TCP bioceramics.
   Empty shells of a local sea snail (Nassarius hinia reticulatus) from Marmara Sea, Turkey were collected from a beach near Istanbul. The collected shells were ground to a particle size <75 mu m. Thermal analyses (DTA/TGA) were performed to determine the exact CaCO3 content and thermal behavior. The raw powder was suspended in an aqueous media which was placed in an ultrasonic bath. The temperature was set at 80 degrees C for 15min. Then, an equivalent (to CaO content) amount of H3PO4 was added drop by drop very gently into the solution. The reaction continued for 8h, following which the liquid component was evaporated off in an incubator at 100 degrees C for 24h. The dried sediment was collected and heat treated at two different temperatures, 400 and 800 degrees C. The morphology of the powders produced was examined using SEM. The crystalline phases were indentified using X-ray analysis.
C1 [Oktar, F. N.] Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.
   Marmara Univ, Sch Hlth Related Profess, Dept Med Imaging Tech, Istanbul, Turkey.
   [Gunduz, O.] Marmara Univ, Nanotechnol Biomaterials Applicat Res Ctr, Istanbul, Turkey.
   [Oktar, F. N.; Turner, I. G.] Univ Bath, Dept Mech Engn, Ctr Orthopaed Biomechan, Bath BA2 7AY, Avon, England.
   [Agathopoulos, S.] Univ Ioannina, Dept Mat Sci & Engn, Ioannina, Greece.
   [Ozyegin, L. S.] Marmara Univ, Istanbul, Turkey.
   [Gunduz, O.] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Gunduz, O.; Samur, R.] Marmara Univ, Fac Tech Educ, Dept Met Educ, Istanbul, Turkey.
   [Demirkol, N.] Kocaeli Univ, Degirmendere Ali Ozbay Vocat Sch, Dept Tech Programmes, Kocaeli, Turkey.
   [Brueck, S.; Aktas, C.] Leibniz Inst New Mat, Saarbrucken, Germany.
   [Ben-Nissan, B.; Samur, R.] Univ Technol, Dept Chem, Mat & Forens Sci, Sydney, NSW, Australia.
   [Kayali, E. S.] Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Fac Engn, Dept Bioengn, Istanbul, Turkey.
EM foktar@marmara.edu.tr; sagat@cc.uoi.gr; sevgiozyegin@yahoo.com;
   I.G.Turner@bath.ac.uk; oguzhan.gunduz.09@ucl.ac.uk;
   nermin.demirkol@kocaeli.edu.tr; Stefan.Brueck@inm-gnnbh.de;
   Besim.Ben-Nissan@uts.edu.au; rsamur@marmara.edu.tr; kayali@itu.edu.tr;
   Cenk.Aktas@inm-gmbh.de
OI Gunduz, Oguzhan/0000-0002-9427-7574
CR Adak M. D., 2011, TRENDS BIOMATER ARTI, V25, P101
   Agaogullari D, 2012, ACTA PHYS POL A, V121, P23
   Agathopoulos S., 2012, Key Engineering Materials, V493-494, P775, DOI 10.4028/www.scientific.net/KEM.493-494.775
   Akyurt N., 2011, EURO PM 2011 C BARC
   Ben-Nissan B., 2008, [US Patent, Processes for treating coral and coating an object], Patent No. [2008/0063683 A1, 20080063683]
   Boutinguiza M, 2012, MAT SCI ENG C-MATER, V32, P478, DOI 10.1016/j.msec.2011.11.021
   Carvalho Alexandre L, 2007, J Oral Implantol, V33, P267, DOI 10.1563/1548-1336(2007)33[267:EOGSOT]2.0.CO;2
   Chou J., 2007, J AUST CERAM SOC, V43, P44
   Demir Muzaffer, 2003, Turkish Journal of Zoology, V27, P101
   Demirkol Nermin, 2012, Key Engineering Materials, V493-494, P588, DOI 10.4028/www.scientific.net/KEM.493-494.588
   Demirkol N, 2010, INT J ARTIF ORGANS, V33, P468
   Goller G, 2004, MATER LETT, V58, P2599, DOI 10.1016/j.matlet.2004.03.032
   Goller G, 2002, MATER LETT, V56, P142
   Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033
   JARCHO M, 1979, J MATER SCI, V14, P142, DOI 10.1007/BF01028337
   Jenis L.G., 2006, MUSCULOSKELETAL REV, P48
   Karthikeyan S, 2008, J AM CHEM SOC, V130, P14968, DOI 10.1021/ja806887k
   Kel D., 2012, Key Engineering Materials, V493-494, P287, DOI 10.4028/www.scientific.net/KEM.493-494.287
   KEL D, 2011, INT J ARTIF ORGANS, V34, P700
   Lemos AF, 2006, J EUR CERAM SOC, V26, P3639, DOI 10.1016/j.jeurceramsoc.2005.12.011
   Lewis K, 2006, KEY ENG MAT, V309-311, P15, DOI 10.4028/www.scientific.net/KEM.309-311.15
   Macchetta A, 2009, ACTA BIOMATER, V5, P1319, DOI 10.1016/j.actbio.2008.11.009
   Moharamzadeh K, 2008, BRIT J ORAL MAX SURG, V46, P110, DOI 10.1016/j.bjoms.2007.07.209
   Oktar FN, 2007, CERAM INT, V33, P1309, DOI 10.1016/j.ceramint.2006.05.022
   Ozyegin L. S., 2012, Key Engineering Materials, V493-494, P781, DOI 10.4028/www.scientific.net/KEM.493-494.781
   Ozyegin LS, 2004, MATER LETT, V58, P2605, DOI 10.1016/j.matlet.2004.03.033
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Skolka M., 2004, SPECII INVAZIVE MARE
   Supova M, 2011, CERAM-SILIKATY, V55, P256
   Tuyel U., 2008, THESIS
NR 30
TC 5
Z9 5
U1 0
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2013
VL 529-530
BP 609
EP +
DI 10.4028/www.scientific.net/KEM.529-530.609
PG 2
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BDT66
UT WOS:000314795800124
DA 2018-10-19
ER

PT J
AU Ciambelli, GS
   Perez, MO
   Siqueira, GV
   Candella, MA
   Motta, AC
   Duarte, MAT
   Alberto-Rincon, MD
   Duek, EAD
AF Ciambelli, Giuliano Serafino
   Perez, Mariana Ortega
   Siqueira, Guilherme Vasconcelos
   Candella, Marco Aurelio
   Motta, Adriana Cristina
   Duarte, Marcia Adriana Tomaz
   Alberto-Rincon, Maria do Carmo
   de Rezende Duek, Eliana Aparecida
TI Characterization of Poly (L-co-D,L Lactic Acid) and a Study of
   Polymer-tissue Interaction in Subcutaneous Implants in Wistar Rats
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE PLDLA; degradation in vitro; tissue
ID IN-VIVO; DEGRADATION; MORPHOLOGY; COPOLYMER; MEMBRANES; VITRO
AB Poly (L-co-D,L lactic acid) (PLDLA) is an important biomaterial because of its biocompatibility properties that promote cellular regeneration and growth. The aim of this study was to evaluate the polymer-tissue interaction of PLDLA implants in the dorsal subcutaneous tissue of male Wistar rats at various intervals (2, 7, 15, 30, 60 and 90 days) after implantation. Physical properties such as the glass transition point (Tg), degradation behavior and other mechanical properties were characterized by differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), gel permeation chromatography (GPC), scanning electron microscopy (SEM) and tension tests. Analysis of the degradation of PLDLA membranes in vitro showed that the polymer became crystalline as a function of the degradation time. Mechanical tension tests showed that the polymer behaved like a ductile material: when subjected to constant tension it initially suffered deformation, then elongation and finally ruptured. TGA/MEV provided evidence of PLDLA membrane degradation. For histological analysis, samples from each group were processed in xylol/paraffin, except for the 60 - and 90 - day samples. Each of the latter samples was divided in two: one half was treated with xylol/paraffin and the other with historesin. Light microscopy showed the adhesion of cells to the biomaterial, the formation of a conjunctive capsule around the implant, the presence of epithelioid cells, the formation of foreign body giant cells and angiogenesis. During degradation, the polymer showed a 'lace' - like appearance when processed in xylol/paraffin compared to the formation of "centripetal cracks in the form of glove fingers" when embedded in historesin.
C1 [Ciambelli, Giuliano Serafino; Perez, Mariana Ortega; Siqueira, Guilherme Vasconcelos; Candella, Marco Aurelio; Motta, Adriana Cristina; Duarte, Marcia Adriana Tomaz] Pontifical Catholic Univ Sao Paulo PUC SP, Fac Med Sci, BR-18030095 Sorocaba, SP, Brazil.
   [Alberto-Rincon, Maria do Carmo] Pontifical Catholic Univ Sao Paulo PUC SP, Fac Med Sci, Dept Physiol Sci, BR-18030095 Sorocaba, SP, Brazil.
   [de Rezende Duek, Eliana Aparecida] Univ Estadual Campinas, Dept Mat Engn, Fac Mech Engn, BR-13083970 Campinas, SP, Brazil.
RP Ciambelli, GS (reprint author), Pontifical Catholic Univ Sao Paulo PUC SP, Fac Med Sci, BR-18030095 Sorocaba, SP, Brazil.
EM eliduek@fem.unicamp.br
RI Biofabris, Inct/I-2418-2013
OI Serafino Ciambelli, Giuliano/0000-0002-3271-4185
FU PIBIC/CEPE (Programa Institucional de Bolsas de Iniciacao Cientifica -
   Conselho de Ensino Pesquisa e Extensao)
FX The authors thank. Debora Regina Machado Silva, Carolina Lucchesi,
   Grazielle dos Santos Barauna and Katia Fernanda Silva (Laboratory of
   Biomaterials, PUC-SP) for help during this work and Elizabeth Almeida
   (Laboratory of Histology, PUC-SP) for technical assistance. This work
   was supported by grants from PIBIC/CEPE (Programa Institucional de
   Bolsas de Iniciacao Cientifica - Conselho de Ensino Pesquisa e
   Extensao).
CR Alberto-Rincon MC, 2001, BRAZILIAN J MORPHOLO, V18, P7
   Barauna G, 2007, THESIS U ESTADUAL CA
   BARBANTI SH, 2002, ACTA MICROSCOPICA, V11, P85
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Duck EAR, 1999, POLYMER, V40, P6465
   Duek EAR, 2005, POLIMEROS, V15, P13
   Gorna K, 2006, J BIOMED MATER RES A, V79A, P128, DOI 10.1002/jbm.a.30708
   Huang MH, 2004, J BIOMED MATER RES A, V69A, P417, DOI 10.1002/jbm.a.30008
   Jagur-Grodzinski J, 2006, POLYM ADVAN TECHNOL, V17, P395, DOI 10.1002/pat.729
   Jiang SC, 2004, MACROMOL CHEM PHYSIC, V205, P2229, DOI 10.1002/macp.200400204
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Khouw IMSL, 1999, BIOMATERIALS, V20, P1815, DOI 10.1016/S0142-9612(99)00077-0
   LAM KH, 1993, J BIOMED MATER RES, V27, P1569, DOI 10.1002/jbm.820271214
   Lehle K, 2004, BIOMATERIALS, V25, P5457, DOI 10.1016/j.biomaterials.2003.12.055
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Li Suming, 1990, J MATER SCI-MATER M, V1, P198
   Luciano RM, 2003, J MATER SCI-MATER M, V14, P87, DOI 10.1023/A:1021509722296
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Marucci DD, 2002, J CRANIO MAXILL SURG, V30, P208, DOI 10.1054/jcms.2002.0289
   Middeleton JC, 2000, BIOMATERIALS, V20, P2335
   Motta Adriana C., 2006, Polímeros, V16, P26, DOI 10.1590/S0104-14282006000100008
   Motta AC, 2007, POLIMEROS, V17, P123, DOI 10.1590/S0104-14282007000200011
   Padera RF, 1996, BIOMATERIALS, V17, P277, DOI 10.1016/0142-9612(96)85565-7
   PEZZIN APT, 2001, THESIS U ESTADUAL CA
   PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403
   Rezende Camila A., 2005, Polímeros, V15, P232, DOI 10.1590/S0104-14282005000300015
   Shannon C, 1997, J BIOMED MATER RES, V34, P401, DOI 10.1002/(SICI)1097-4636(19970305)34:3<401::AID-JBM15>3.0.CO;2-I
   Silva DRM, 2002, THESIS STATE U CAMPI
   SILVA DRM, 2007, THESIS U ESTADUAL CA
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 32
TC 5
Z9 5
U1 0
U2 13
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD JAN-FEB
PY 2013
VL 16
IS 1
BP 28
EP 37
DI 10.1590/S1516-14392012005000146
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 087VC
UT WOS:000314791100004
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Chuah, JA
   Yamada, M
   Taguchi, S
   Sudesh, K
   Doi, Y
   Numata, K
AF Chuah, Jo-Ann
   Yamada, Miwa
   Taguchi, Seiichi
   Sudesh, Kumar
   Doi, Yoshiharu
   Numata, Keiji
TI Biosynthesis and characterization of polyhydroxyalkanoate containing
   5-hydroxyvalerate units: Effects of 5HV units on biodegradability,
   cytotoxicity, mechanical and thermal properties
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Polyhydroxyalkanoate (PHA); 5-hydroxyvalerate (5HV); Biomaterial;
   Lipase-mediated degradation
ID SUBSTRATE SPECIFICITIES; COMAMONAS-ACIDOVORANS; ALCALIGENES-EUTROPHUS;
   MICROBIAL SYNTHESIS; GENETIC-ANALYSIS; BACTERIAL; ACIDS; POLYESTERS;
   COPOLYMERS; SYNTHASE
AB This study describes the biosynthesis of polyhydroxyalkanoate (PHA) containing 5-hydroxyvalerate (5HV) units. Monomer units like 5HV, with variation in length of the backbone segment of the repeat unit, are known to more greatly impact mechanical properties of polymers. Introduction of 5HV units was also aimed at enhancing biodegradability of the material, as it had been found previously that a homopolymer of 5HV could be degraded by lipase. The produced poly[(R)-3-hydroxybutyrate-co-3-hydroxypropionate-co-5-hydroxyvalerate]s [P(3HB-co-3HP-co-5HV)s] with 5HV content ranging from 1 to 32 mol% by the choice of strain, type and concentration of carbon substrate, exhibited low melting temperature (T-m), reduced crystallinity and elastomeric behavior. Enzymatic degradation test confirmed the role of 5HV unit in enabling lipase-mediated degradation of P(3HB-co-3HP-co-5HV)s, as poly[(R)-3-hydroxybutyrate] and poly[(R)-3-hydroxypropionatel films were not hydrolyzed by porcine pancreas lipase. Additionally, viability assay of human mesenchymal stem cells revealed that the P(3HB-co-3HP-co-5HV) films were less cytotoxic and supported cell proliferation, highlighting the potential of P(3HB-co-3HP-co-5HV)s as biomaterials. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Chuah, Jo-Ann; Yamada, Miwa; Numata, Keiji] RIKEN, Biomass Engn Program, Enzyme Res Team, Wako, Saitama 3510198, Japan.
   [Chuah, Jo-Ann; Sudesh, Kumar] Univ Sains Malaysia, Sch Biol Sci, Ecobiomat Res Lab, George Town 11800, Malaysia.
   [Taguchi, Seiichi] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan.
   [Doi, Yoshiharu] RIKEN, RIKEN Res Cluster Innovat, Wako, Saitama 3510198, Japan.
RP Numata, K (reprint author), RIKEN, Biomass Engn Program, Enzyme Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM keiji.numata@riken.jp
RI Numata, Keiji/H-9751-2012; Sudesh, Kumar/C-2942-2011
OI Numata, Keiji/0000-0003-2199-7420; Sudesh, Kumar/0000-0003-4756-9192
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [23760757]; RIKEN Biomass Engineering Program; USM fellowship scheme;
   RIKEN International Program Associate
FX The work described here was supported by a Research Fellowship for Young
   Scientists (B) (no. 23760757) (to M.Y.) from the Ministry of Education,
   Culture, Sports, Science and Technology, Japan and RIKEN Biomass
   Engineering Program. J.C. is grateful to the USM fellowship scheme and
   RIKEN International Program Associate for financial support.
CR ABE H, 1995, MACROMOLECULES, V28, P7630, DOI 10.1021/ma00127a007
   Abe H, 1999, INT J BIOL MACROMOL, V25, P177, DOI 10.1016/S0141-8130(99)00032-X
   Abe H, 1998, MACROMOLECULES, V31, P1791, DOI 10.1021/ma971559v
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   DOI Y, 1990, NATO ADV SCI I E-APP, V186, P37
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   Doi Y, 1987, MAKROMOL CHEM-RAPID, V8, P631
   Doi Y., 1990, MICROBIAL POLYESTERS
   Gorenflo V, 2001, BIOMACROMOLECULES, V2, P45, DOI 10.1021/bm0000992
   HAYWOOD GW, 1991, INT J BIOL MACROMOL, V13, P83, DOI 10.1016/0141-8130(91)90053-W
   Hocking PJ, 1994, BLACKIE ACAD PROFESS, P48
   JAEGER KE, 1995, APPL ENVIRON MICROB, V61, P3113
   KUNIOKA M, 1988, POLYM COMMUN, V29, P174
   Labuzek S, 2001, J APPL MICROBIOL, V90, P353, DOI 10.1046/j.1365-2672.2001.01253.x
   MUKAI K, 1993, BIOTECHNOL LETT, V15, P601, DOI 10.1007/BF00138548
   NAKAMURA S, 1991, J MACROMOL SCI CHEM, VA28, P15, DOI 10.1080/00222339108054378
   Numata K, 2011, BIOMACROMOLECULES, V12, P2137, DOI 10.1021/bm200221u
   Peplinski K, 2010, MICROBIOL-SGM, V156, P2136, DOI 10.1099/mic.0.038380-0
   Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9
   Rehm BHA, 1999, INT J BIOL MACROMOL, V25, P3, DOI 10.1016/S0141-8130(99)00010-0
   SAITO Y, 1994, INT J BIOL MACROMOL, V16, P99, DOI 10.1016/0141-8130(94)90022-1
   SCHUBERT P, 1988, J BACTERIOL, V170, P5837, DOI 10.1128/jb.170.12.5837-5847.1988
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Sudesh K, 1998, APPL ENVIRON MICROB, V64, P3437
   Sun J, 2007, BIOMATERIALS, V28, P3896, DOI 10.1016/j.biomaterials.2007.05.011
   Taguchi S, 2002, POLYM INT, V51, P899, DOI 10.1002/pi.878
   Taguchi S, 2002, J BIOCHEM, V131, P801, DOI 10.1093/oxfordjournals.jbchem.a003168
   Taguchi S, 2001, FEMS MICROBIOL LETT, V198, P65, DOI 10.1111/j.1574-6968.2001.tb10620.x
   Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105
   Tajima K, 2003, J BIOSCI BIOENG, V95, P77, DOI 10.1016/S1389-1723(03)80152-4
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Tsuge T, 2004, MACROMOL BIOSCI, V4, P238, DOI 10.1002/mabi.200300077
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   WILLIAMS SF, 2002, BIOPOLYMERS POLYESTE, V3, P91
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   YASIN M, 1992, BIOMATERIALS, V13, P9, DOI 10.1016/0142-9612(92)90087-5
NR 39
TC 30
Z9 35
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JAN
PY 2013
VL 98
IS 1
BP 331
EP 338
DI 10.1016/j.polymdegradstab.2012.09.008
PG 8
WC Polymer Science
SC Polymer Science
GA 093DD
UT WOS:000315171000041
DA 2018-10-19
ER

PT J
AU Zheng, WF
   Zhang, W
   Jiang, XY
AF Zheng, Wenfu
   Zhang, Wei
   Jiang, Xingyu
TI Precise Control of Cell Adhesion by Combination of Surface Chemistry and
   Soft Lithography
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Review
ID SELF-ASSEMBLED MONOLAYERS; CIRCULATING TUMOR-CELLS; MESENCHYMAL
   STEM-CELLS; PATTERNING MULTIPLE TYPES; EXTRACELLULAR-MATRIX; IN-VITRO;
   SUBSTRATE STIFFNESS; POLYSTYRENE SURFACES; PROTEIN ADSORPTION;
   ENDOTHELIAL-CELLS
AB The adhesion of cells on an extracellular matrix (ECM) (in vivo) or the surfaces of materials (in vitro) is a prerequisite for most cells to survive. The rapid growth of nano/microfabrication and biomaterial technologies has provided new materials with excellent surfaces with specific, desirable biological interactions with their surroundings. On one hand, the chemical and physical properties of material surfaces exert an extensive influence on cell adhesion, proliferation, migration, and differentiation. On the other hand, material surfaces are useful for fundamental cell biology research and tissue engineering. In this Review, an overview will be given of the chemical and physical properties of newly developed material surfaces and their biological effects, as well as soft lithographic techniques and their applications in cell biology research. Recent advances in the manipulation of cell adhesion by the combination of surface chemistry and soft lithography will also be highlighted.
C1 [Zheng, Wenfu; Zhang, Wei; Jiang, Xingyu] Natl Ctr NanoSci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
RP Jiang, XY (reprint author), Natl Ctr NanoSci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, 11 ZhongGuanCun BeiYiTiao, Beijing 100190, Peoples R China.
EM xingyujiang@nanoctr.cn
OI Jiang, Xingyu/0000-0002-5008-4703
FU Ministry of Science and Technology [2009CB930001, 2011CB933201];
   National Science Foundation of China [31170905, 90813032, 20890020,
   50902025]; Chinese Academy of Sciences [KJCX2-YW-M15]
FX This research was supported by the Ministry of Science and Technology
   (grant no. 2009CB930001 and 2011CB933201), the National Science
   Foundation of China (grant no. 31170905, 90813032, 20890020, and
   50902025), and the Chinese Academy of Sciences (grant no. KJCX2-YW-M15).
CR Agudelo-Garcia PA, 2011, NEOPLASIA, V13, P831, DOI 10.1593/neo.11612
   Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Auernheimer J, 2005, J AM CHEM SOC, V127, P16107, DOI 10.1021/ja053648q
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445
   Belizna C, 2012, STROKE, V43, P1129, DOI 10.1161/STROKEAHA.111.635383
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen ZL, 2010, LANGMUIR, V26, P17790, DOI 10.1021/la103132m
   Chen ZL, 2009, ANGEW CHEM INT EDIT, V48, P8303, DOI 10.1002/anie.200902708
   Co CC, 2005, J AM CHEM SOC, V127, P1598, DOI 10.1021/ja044382a
   Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI [10.1038/ncb, 10.1038/ncb2074]
   Corey JM, 2003, EXP NEUROL, V184, pS89, DOI 10.1016/S0014-4886(03)00392-3
   Cox JD, 2002, BIOMATERIALS, V23, P929, DOI 10.1016/S0142-9612(01)00205-8
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Da Silva RMP, 2007, TRENDS BIOTECHNOL, V25, P577, DOI 10.1016/j.tibtech.2007.08.014
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Danova M, 2011, EXPERT REV MOL DIAGN, V11, P473, DOI 10.1586/ERM.11.33
   Davidson PM, 2010, J MATER SCI-MATER M, V21, P939, DOI 10.1007/s10856-009-3950-7
   den Toonder J, 2011, LAB CHIP, V11, P375, DOI 10.1039/c0lc90100h
   Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j
   Douville NJ, 2011, LAB CHIP, V11, P609, DOI 10.1039/c0lc00251h
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Ehrlicher A, 2011, NAT MATER, V10, P12, DOI 10.1038/nmat2928
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Felder M, 2012, LAB CHIP, V12, P640, DOI 10.1039/c1lc20879a
   Ferber D, 1999, SCIENCE, V284, P422, DOI 10.1126/science.284.5413.422
   Ferber D, 1999, SCIENCE, V286, P2051
   Fioretta ES, 2012, J BIOMECH, V45, P736, DOI 10.1016/j.jbiomech.2011.11.013
   Fu JP, 2011, NAT METHODS, V8, P184, DOI 10.1038/nmeth0211-184a
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Fukumori K, 2009, ACTA BIOMATER, V5, P470, DOI 10.1016/j.actbio.2008.06.018
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghassemi S, 2008, J VAC SCI TECHNOL B, V26, P2549, DOI 10.1116/1.3013424
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170
   Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c
   Green JV, 2009, LAB CHIP, V9, P677, DOI 10.1039/b813516a
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a
   Gunther A, 2010, LAB CHIP, V10, P2341, DOI 10.1039/c004675b
   Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Iiizumi M, 2007, MICROVASC RES, V74, P114, DOI 10.1016/j.mvr.2007.04.002
   IRIE M, 1990, ADV POLYM SCI, V94, P27
   IRIE M, 1990, PURE APPL CHEM, V62, P1495, DOI 10.1351/pac199062081495
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Jiang XY, 2003, J AM CHEM SOC, V125, P2366, DOI 10.1021/ja029485c
   Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002
   Kaji H, 2006, ANAL CHEM, V78, P5469, DOI 10.1021/ac060304p
   Kaji H, 2009, LAB CHIP, V9, P427, DOI 10.1039/b812510d
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kawaguchi T, 2000, LANGMUIR, V16, P9830, DOI 10.1021/la000756b
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim H. N., 2012, ANN BIOMED ENG
   Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j
   Kirmizidis G, 2009, TISSUE ENG PT A, V15, P1427, DOI 10.1089/ten.tea.2008.0137
   Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g
   Kushiro K, 2010, ADV MATER, V22, P4516, DOI 10.1002/adma.201001619
   Lai T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061907
   Lamb BM, 2010, LANGMUIR, V26, P12817, DOI 10.1021/la1022642
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   le Digabel J, 2010, MED BIOL ENG COMPUT, V48, P965, DOI 10.1007/s11517-010-0619-9
   Lee CJ, 2004, LANGMUIR, V20, P4155, DOI 10.1021/la035467c
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Li Y, 2007, ANGEW CHEM INT EDIT, V46, P1094, DOI 10.1002/anie.200603844
   Liu DB, 2009, ANGEW CHEM INT EDIT, V48, P4406, DOI 10.1002/anie.200901130
   Liu YY, 2012, SMALL, V8, P676, DOI 10.1002/smll.201101199
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McGlohorn JB, 2004, TISSUE ENG, V10, P505, DOI 10.1089/107632704323061861
   McUsic AC, 2012, BIOMATERIALS, V33, P1396, DOI 10.1016/j.biomaterials.2011.10.083
   Mizutani A, 2008, BIOMATERIALS, V29, P2073, DOI 10.1016/j.biomaterials.2009.01.004
   Mrksich M, 2009, ACTA BIOMATER, V5, P832, DOI 10.1016/j.actbio.2009.01.016
   Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Nuttelman CR, 2006, BIOMATERIALS, V27, P1377, DOI 10.1016/j.biomaterials.2005.08.014
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Oliveira SM, 2011, SOFT MATTER, V7, P8932, DOI 10.1039/c1sm05943b
   Owatverot TB, 2005, J BIOMECH ENG-T ASME, V127, P374, DOI 10.1115/1.1894180
   Papenburg BJ, 2009, BIOMATERIALS, V30, P6228, DOI 10.1016/j.biomaterials.2009.07.057
   Pearson D, 2007, J AM CHEM SOC, V129, P14862, DOI 10.1021/ja0766674
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peng XL, 2012, J BIOMECH, V45, P116, DOI 10.1016/j.jbiomech.2011.09.013
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Pulsipher A, 2011, ADV POLYM SCI, V240, P103, DOI 10.1007/12_2010_87
   Qian F, 2004, REV SCI INSTRUM, V75, P2937, DOI 10.1063/1.1781382
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   Robertus J, 2010, CHEM SOC REV, V39, P354, DOI 10.1039/b906608j
   Rosenhahn A, 2010, PHYS CHEM CHEM PHYS, V12, P4275, DOI 10.1039/c001968m
   Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125
   Su WT, 2011, BIOMED MICRODEVICES, V13, P11, DOI 10.1007/s10544-010-9466-6
   Su WT, 2010, J BIOMED MATER RES A, V93A, P1463, DOI 10.1002/jbm.a.32643
   Sun K, 2011, LANGMUIR, V27, P5709, DOI 10.1021/la2012099
   Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028156
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126
   Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103
   Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001
   Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002
   Uttayarat P, 2008, AM J PHYSIOL-HEART C, V294, pH1027, DOI 10.1152/ajpheart.00816.2007
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wan PB, 2009, ADV MATER, V21, P4362, DOI 10.1002/adma.200901237
   Wang D, 2010, INTEGR BIOL-UK, V2, P288, DOI 10.1039/b920644b
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wang PY, 2012, ACTA BIOMATER, V8, P519, DOI 10.1016/j.actbio.2011.09.030
   Wang ST, 2011, ANGEW CHEM INT EDIT, V50, P3084, DOI 10.1002/anie.201005853
   Wang ST, 2009, ANGEW CHEM INT EDIT, V48, P8970, DOI 10.1002/anie.200901668
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wischerhoff E, 2008, ANGEW CHEM INT EDIT, V47, P5666, DOI 10.1002/anie.200801202
   Wischerhoff E, 2011, ADV POLYM SCI, V240, P1, DOI 10.1007/12_2010_88
   Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571
   Xie YY, 2011, LAB CHIP, V11, P2819, DOI 10.1039/c0lc00562b
   Xing SG, 2010, ELECTROPHORESIS, V31, P3144, DOI 10.1002/elps.201000133
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yuan B, 2012, ADV MATER, V24, P890, DOI 10.1002/adma.201104589
   Yuan B, 2010, ADV FUNCT MATER, V20, P3715, DOI 10.1002/adfm.201001298
   Zhao C, 2006, ANGEW CHEM INT EDIT, V45, P5469, DOI 10.1002/anie.200601151
   Zhao H, 2002, MICROVASC RES, V63, P218, DOI 10.1006/mvre.2001.2390
   Zheng XJ, 2011, LAB CHIP, V11, P3269, DOI 10.1039/c1lc20331b
NR 165
TC 49
Z9 50
U1 8
U2 210
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JAN
PY 2013
VL 2
IS 1
SI SI
BP 95
EP 108
DI 10.1002/adhm.201200104
PG 14
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092LC
UT WOS:000315121900007
PM 23184447
DA 2018-10-19
ER

PT J
AU Gil, ES
   Panilaitis, B
   Bellas, E
   Kaplan, DL
AF Gil, Eun Seok
   Panilaitis, Bruce
   Bellas, Evangelia
   Kaplan, David L.
TI Functionalized Silk Biomaterials for Wound Healing
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID EPIDERMAL-GROWTH-FACTOR; IN-VIVO; FACTOR RECEPTOR; FIBROIN FILMS; MOUSE
   SKIN; CELL FATE; MODEL; COLLAGEN; RELEASE; OXYGEN
AB Silk protein-biomaterial wound dressings with epidermal growth factor (EGF) and silver sulfadiazine were studied with a cutaneous excisional mouse wound model. Three different material designs and two different drug incorporation techniques were studied to compare wound healing responses. Material formats included silk films, lamellar porous silk films and electrospun silk nanofibers, each studied with the silk matrix alone and with drug loading or drug coatings on the silk matrices. Changes in wound size and histological assessments of wound tissues showed that the functionalized silk biomaterial wound dressings increased wound healing rate, including reepithelialization, dermis proliferation, collagen synthesis and reduced scar formation, when compared to air-permeable Tegaderm tape (3M) (-control) and a commercial wound dressing, Tegaderm Hydrocolloid dressing (3M) (+control). All silk biomaterials were effective for wound healing, while the lamellar porous films and electrospun nanofibers and the incorporation of EGF/silver sulfadiazine, via drug loading or coating, provided the most rapid wound healing responses. This systematic approach to evaluating functionalized silk biomaterial wound dressings demonstrates a useful strategy to select formulations for further study towards new treatment options for chronic wounds.
C1 [Gil, Eun Seok; Panilaitis, Bruce; Bellas, Evangelia; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH/NIBIB via the Tissue Engineering Resource Center [EB002520]
FX This study was supported by NIH/NIBIB (EB002520) via the Tissue
   Engineering Resource Center.
CR Adelson DL, 1997, REPROD FERT DEVELOP, V9, P493, DOI 10.1071/R96118
   AFILALO M, 1992, BURNS, V18, P313, DOI 10.1016/0305-4179(92)90153-L
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205
   BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6
   BUCKLEY A, 1985, P NATL ACAD SCI USA, V82, P7340, DOI 10.1073/pnas.82.21.7340
   CHAPMAN RE, 1988, AUST J BIOL SCI, V41, P261, DOI 10.1071/BI9880261
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   FRANKLIN JD, 1979, PLAST RECONSTR SURG, V64, P766, DOI 10.1097/00006534-197912000-00003
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   HUNT TK, 1969, AM J SURG, V118, P521, DOI 10.1016/0002-9610(69)90174-3
   HUNT TK, 1969, BRIT J SURG, V56, P705
   Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   KNAUER DJ, 1984, J BIOL CHEM, V259, P5623
   Konrad D, 2002, J EXP ANIM SCI, V42, P31, DOI 10.1016/S0939-8600(02)80004-9
   Koster MI, 2002, J INVEST DERM SYMP P, V7, P41, DOI 10.1046/j.1523-1747.2002.19639.x
   LAATO M, 1987, BIOCHEM J, V247, P385, DOI 10.1042/bj2470385
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Ligouri PA, 2009, J WOUND OSTOMY CONT, V36, pS46, DOI 10.1097/01.WON.0000352024.71082.2b
   Lim HJ, 2010, POLYM-KOREA, V34, P363, DOI 10.7317/pk.2010.34.4.363
   Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   MADDEN MR, 1989, J TRAUMA, V29, P924, DOI 10.1097/00005373-198907000-00004
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   OKEEFE E, 1982, J INVEST DERMATOL, V78, P482, DOI 10.1111/1523-1747.ep12510246
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Padol Amol R, 2011, Toxicol Int, V18, P17, DOI 10.4103/0971-6580.75847
   Panchal H, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-105
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   PROCKOP DJ, 1979, NEW ENGL J MED, V301, P77, DOI 10.1056/NEJM197907123010204
   Richardson GD, 2009, DEVELOPMENT, V136, P2153, DOI 10.1242/dev.031427
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Strehin IA, 2011, WOUND REPAIR REGEN, V19, pA54
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x
   Uppal R, 2011, J BIOMED MATER RES B, V97B, P20, DOI 10.1002/jbm.b.31776
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Wittmer CR, 2011, ADV FUNCT MATER, V21, P4232, DOI 10.1002/adfm.201100755
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   WYATT D, 1990, J TRAUMA, V30, P857, DOI 10.1097/00005373-199007000-00016
NR 54
TC 103
Z9 107
U1 14
U2 194
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JAN
PY 2013
VL 2
IS 1
SI SI
BP 206
EP 217
DI 10.1002/adhm.201200192
PG 12
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092LC
UT WOS:000315121900019
PM 23184644
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ikonen, L
   Kerkela, E
   Metselaar, G
   Stuart, MCA
   de Jong, MR
   Aalto-Setala, K
AF Ikonen, Liisa
   Kerkela, Erja
   Metselaar, Gerald
   Stuart, Marc C. A.
   de Jong, Menno R.
   Aalto-Setala, Katriina
TI 2D and 3D Self-Assembling Nanofiber Hydrogels for Cardiomyocyte Culture
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID CELL-DERIVED CARDIOMYOCYTES; ACUTE MYOCARDIAL-INFARCTION; EMBRYONIC
   STEM-CELLS; CARDIAC DIFFERENTIATION; TISSUE; TRANSPLANTATION;
   BIOMATERIALS; REGENERATION; SCAFFOLDS; MYOCYTES
AB Collagen is a widely used biomaterial in cardiac tissue engineering studies. However, as a natural material, it suffers from variability between batches that can complicate the standardization of culture conditions. In contrast, synthetic materials are modifiable, have well-defined structures and more homogeneous batches can be produced. In this study, several collagen-like synthetic self-assembling nanofiber hydrogels were examined for their suitability for cardiomyocyte culture in 2D and 3D. Six different nanofiber coatings were used in the 2D format with neonatal rat cardiomyocytes (NRCs) and human embryonic stem-cell-derived cardiomyocytes (hESC-CMs). The viability, growth, and functionality of the 2D-cultured cardiomyocytes were evaluated. The best-performing nanofiber coatings were selected for 3D experiments. Hydrophilic pH-sensitive nanofiber hydrogel coassembled with hyaluronic acid performed best with both NRCs and hESC-CMs. Hydrophilic non-pH-sensitive nanofiber hydrogels supported the growth of NRCs; however, their ability to promote attachment and growth of hESC-CMs was limited. NRCs also grew on hydrophobic nanofiber hydrogels; however, the cell-supporting capacity of these hydrogels was inferior to that of the hydrophilic hydrogel materials. This is the first study demonstrating that hydrophilic self-assembling nanofiber hydrogels support the culture of both NRCs and hESC-CMs, which suggests that these biomaterials hold promise for cardiac tissue engineering.
C1 [Ikonen, Liisa; Kerkela, Erja; Aalto-Setala, Katriina] Univ Tampere, IBT, Tampere 33520, Finland.
   [Ikonen, Liisa; Aalto-Setala, Katriina] BioMediTech, Tampere 33520, Finland.
   [Kerkela, Erja] Finnish Red Cross Blood Serv, Helsinki 00310, Finland.
   [Metselaar, Gerald; Stuart, Marc C. A.; de Jong, Menno R.] Nano Fiber Matrices BV, NL-9747 AG Groningen, Netherlands.
   [Metselaar, Gerald] BASF Nederland BV, NL-8466 SN Heerenveen, Netherlands.
   [Stuart, Marc C. A.] Univ Groningen, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands.
   [Aalto-Setala, Katriina] Tampere Univ Hosp, Ctr Heart, Tampere 33521, Finland.
RP Ikonen, L (reprint author), Univ Tampere, IBT, Biokatu 12, Tampere 33520, Finland.
EM liisaikonen@hotmail.com
RI Kerkela, Erja/P-9459-2016
OI Kerkela, Erja/0000-0002-2923-5300; Stuart, Marc/0000-0003-0667-6338
FU Finnish Cultural Foundation-Pirkanmaa Regional Fund; Pirkanmaa Hospital
   District; Tekes-the Finnish Funding Agency for Technology and
   Innovation; Finnish Foundation for Cardiovascular Research; NanoNextNL;
   micro- and nanotechnology consortium of the Government of The
   Netherlands
FX This study was funded by the Finnish Cultural Foundation-Pirkanmaa
   Regional Fund, Competitive Research Funding of the Pirkanmaa Hospital
   District, Tekes-the Finnish Funding Agency for Technology and Innovation
   and Finnish Foundation for Cardiovascular Research. This work is
   supported by NanoNextNL, a micro- and nanotechnology consortium of the
   Government of The Netherlands and 130 partners. The authors would like
   to thank Ms. Henna Venalainen and Mr. Markus Haponen for technical
   assistance, and Ms. Annemarie Tuin for fruitful discussions and Ms.
   Heini Huhtala for statistical analysis. They would also like to
   acknowledge the animal facilities of the University of Tampere.
CR Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Bettiol E, 2007, REV PHYSIOL BIOCH P, V157, P1, DOI 10.1007/s112_0508
   Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004
   Brizard A, 2008, ANGEW CHEM INT EDIT, V47, P2063, DOI 10.1002/anie.200704609
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280
   Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   deJong M. R., 2008, J CONTROL RELEASE, V132, pe19
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Ikonen L., J CLIN EXPT IN PRESS
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349
   Kusters I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020435
   Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Li F, 2010, CHEMPHYSCHEM, V11, P1956, DOI 10.1002/cphc.200900946
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pekkanen-Mattila M, 2009, ANN MED, V41, P360, DOI 10.1080/07853890802609542
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918
   Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Traverse JH, 2009, AM HEART J, V158, P356, DOI 10.1016/j.ahj.2009.06.009
   Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109
   UUSIMAA PA, 1992, ENDOCRINOLOGY, V130, P2455, DOI 10.1210/en.130.5.2455
   van Bommel KJC, 2005, ORG BIOMOL CHEM, V3, P2917, DOI 10.1039/b507157g
   van Bommel KJC, 2004, ANGEW CHEM INT EDIT, V43, P1663, DOI 10.1002/anie.200352396
   Widimsky P, 2006, EUR HEART J SUPPL, V8, pH16, DOI 10.1093/eurheartj/sul067
   Yousef M, 2009, J AM COLL CARDIOL, V53, P2262, DOI 10.1016/j.jacc.2009.02.051
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
NR 44
TC 12
Z9 12
U1 1
U2 32
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 285678
DI 10.1155/2013/285678
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 089UX
UT WOS:000314936600001
PM 23573513
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Lenarz, T
   Pau, HW
   Paasche, G
AF Lenarz, Thomas
   Pau, Hans-Wilhelm
   Paasche, Gerrit
TI Cochlear Implants
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Article
DE Biomaterial; cochlear implant; drug delivery; electrode-neural
   interface; inner ear; neurotrophic factor; surface pattern
ID SPIRAL-GANGLION NEURONS; SENSORINEURAL HEARING-LOSS; DEAFENED
   GUINEA-PIG; CHRONIC ELECTRICAL-STIMULATION; DORSAL-ROOT GANGLION;
   MODIFIED ELECTRODE SURFACES; FABRICATED SPIKE STRUCTURES;
   FIBROBLAST-GROWTH-FACTOR; ROUND WINDOW MEMBRANE; DRUG-ELUTING STENTS
AB Cochlear implants have evolved to become the treatment of choice for severely hearing-impaired patients. Speech signals are picked up by a microphone, processed and then delivered to the stimulating electrodes (the current maximum number being 22) that are placed on an electrode array implanted into the scala tympani of the cochlea. The target cells of electrical stimulation, the spiral ganglion cells (SGCs), are located some distance away in the central axis of the cochlea. SGCs start to degenerate after the onset of deafness. Additionally, fibrous tissue is formed around the electrode array after implantation. If cochlear implants are to deliver sound that is closer to natural hearing, the number of independent stimulation channels has to be increased. Optimization of the interface between the electrode array and the surrounding tissue is, therefore, the focus of current research. Promising approaches relating to cells, micro- and nanosystems will be reviewed.
C1 [Lenarz, Thomas; Paasche, Gerrit] Hannover Med Sch, Dept Otolaryngol, D-30625 Hannover, Germany.
   [Pau, Hans-Wilhelm] Univ Rostock, Dept Otolaryngol, D-18055 Rostock, Germany.
RP Lenarz, T (reprint author), Hannover Med Sch, Dept Otolaryngol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Lenarz.Thomas@mh-hannover.de
CR Abizaid A, 2007, VASC HEALTH RISK MAN, V3, P191, DOI 10.2147/vhrm.2007.3.2.191
   Adunka O, 2004, LARYNGOSCOPE, V114, P1237, DOI 10.1097/00005537-200407000-00018
   AGNEW WF, 1977, J NEUROPATH EXP NEUR, V36, P533, DOI 10.1097/00005072-197705000-00010
   Anastasiadis S. H., 2009, APS M, P19013
   Antonelli PJ, 2004, OTOL NEUROTOL, V25, P953, DOI 10.1097/00129492-200411000-00015
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arnoldner C, 2010, ADV OTO-RHINO-LARYNG, V67, P116, DOI 10.1159/000262603
   Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20
   Baudonck N, 2010, INT J PEDIATR OTORHI, V74, P416, DOI 10.1016/j.ijporl.2010.01.017
   Besch D, 2008, BRIT J OPHTHALMOL, V92, P1361, DOI 10.1136/bjo.2007.131961
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   BILLINGER M, 2006, J INVASIVE CARDIOL, V18, P427
   Billinger Michael, 2006, J Invasive Cardiol, V18, P423
   Briggs Robert J S, 2006, Audiol Neurootol, V11 Suppl 1, P42, DOI 10.1159/000095613
   Bromberg LE, 2000, J CONTROL RELEASE, V68, P63, DOI 10.1016/S0168-3659(00)00233-9
   BROWN JN, 1993, HEARING RES, V70, P167, DOI 10.1016/0378-5955(93)90155-T
   BRUMMER SB, 1975, BIOELECTROCH BIOENER, V2, P13, DOI 10.1016/0302-4598(75)80002-X
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   Buchner A, 2009, AUDIOL NEURO-OTOL, V14, P8, DOI 10.1159/000206490
   Busby P A, 2002, Cochlear Implants Int, V3, P87, DOI 10.1179/cim.2002.3.2.87
   Busby PA, 2008, EAR HEARING, V29, P853, DOI 10.1097/AUD.0b013e318181a878
   Chikar JA, 2008, HEARING RES, V245, P24, DOI 10.1016/j.heares.2008.08.005
   Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071
   Clark G.M., 2003, COCHLEAR IMPLANTS FU
   Cogan SF, 2004, J NEUROSCI METH, V137, P141, DOI 10.1016/j.jneumeth.2004.02.019
   Cohen LT, 2006, HEARING RES, V212, P160, DOI 10.1016/j.heares.2005.11.005
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Damm C, 2008, MATER CHEM PHYS, V108, P61, DOI 10.1016/j.matchemphys.2007.09.002
   De Ceulaer G, 2003, OTOL NEUROTOL, V24, P769, DOI 10.1097/00129492-200309000-00014
   DEBOER RW, 1978, MED BIOL ENG COMPUT, V16, P1
   Dinh C, 2008, OTOL NEUROTOL, V29, P1012, DOI 10.1097/MAO.0b013e3181859a1f
   Dittrich B, 2009, BIOMATERIALIEN MUNCH, V10, P61
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   Durkaya G., 2009, APS M, pC6
   Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Emerich DF, 1996, BRAIN RES, V736, P99, DOI 10.1016/S0006-8993(96)00683-X
   Evans AJ, 2009, J BIOMED MATER RES A, V91A, P241, DOI 10.1002/jbm.a.32228
   Fadeeva E, 2009, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 6, P163
   Fadeeva E, 2009, PHYS STATUS SOLIDI A, V206, P1348, DOI 10.1002/pssa.200881063
   Fan YW, 2002, APPL SURF SCI, V187, P313, DOI 10.1016/S0169-4332(01)01046-7
   Ferrari A, 2010, BIOMATERIALS, V31, P4682, DOI 10.1016/j.biomaterials.2010.02.032
   Fransson A, 2009, J NEUROSCI RES, V87, P1712, DOI 10.1002/jnr.21969
   FRANZ B, 1984, ACTA OTO-LARYNGOL, P17
   FRANZ BKH, 1987, ANN OTO RHINOL LARYN, V96, P174, DOI 10.1177/000348948709600207
   Fraysse B, 2006, OTOL NEUROTOL, V27, P624, DOI 10.1097/01.mao.0000226289.04048.0f
   Gantz BJ, 2004, ACTA OTO-LARYNGOL, V124, P344, DOI 10.1080/00016480410016423
   GANTZ BJ, 1993, ANN OTO RHINOL LARYN, V102, P909, DOI 10.1177/000348949310201201
   Gillespie LN, 2005, EUR J NEUROSCI, V22, P2123, DOI 10.1111/j.1460-9568.2005.04430.x
   Glueckert R, 2008, J COMP NEUROL, V507, P1602, DOI 10.1002/cne.21619
   Gomez N, 2007, J R SOC INTERFACE, V4, P223, DOI 10.1098/rsif.2006.0171
   GREATBATCH W, 1969, ANN NY ACAD SCI, V167, P722, DOI 10.1111/j.1749-6632.1969.tb34133.x
   Gref R, 2003, BIOMATERIALS, V24, P4529, DOI 10.1016/S0142-9612(03)00348-X
   Gstoettner WG, 2009, ACTA OTO-LARYNGOL, V129, P372, DOI 10.1080/00016480802552568
   Gstoettner Wolfgang K, 2006, Audiol Neurootol, V11 Suppl 1, P49, DOI 10.1159/000095614
   Hahn A, 2010, ADV ENG MATER, V12, pB156, DOI 10.1002/adem.200980071
   Hang T, 2010, APPL SURF SCI, V256, P2400, DOI 10.1016/j.apsusc.2009.10.074
   HARTSHORN DO, 1991, OTOLARYNG HEAD NECK, V104, P311, DOI 10.1177/019459989110400305
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Herr BD, 2005, OTOLARYNG HEAD NECK, V132, P527, DOI 10.1016/j.otohns.2004.09.138
   Ho M., 2004, APS M, p9012P
   Hu ZQ, 2009, OTOL NEUROTOL, V30, P551, DOI 10.1097/MAO.0b013e31819fe70a
   Hu ZQ, 2005, NEUROBIOL DIS, V18, P184, DOI 10.1016/j.nbd.2004.09.010
   Hu ZQ, 2004, BRAIN RES, V1026, P68, DOI 10.1016/j.brainres.2004.08.013
   Huang Christie Qi, 2007, Cochlear Implants Int, V8, P123, DOI 10.1002/cii.336
   Huang CQ, 2000, HEARING RES, V146, P57, DOI 10.1016/S0378-5955(00)00100-3
   Hyland M., 2000, P 5 ANN C INT FUNCT
   Incesulu A, 1998, ANN OTO RHINOL LARYN, V107, P906, DOI 10.1177/000348949810701102
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jain P, 2005, BIOTECHNOL BIOENG, V90, P59, DOI 10.1002/bit.20368
   Johnson TA, 2007, OTOLARYNG HEAD NECK, V136, P577, DOI 10.1016/j.otohns.2006.11.006
   JOHNSSON LG, 1982, ANN OTO RHINOL LARYN, V91, P74
   Jolly C, 2010, ADV OTO-RHINO-LARYNG, V67, P28, DOI 10.1159/000262594
   Kanzaki S, 2002, J COMP NEUROL, V454, P350, DOI 10.1002/cne.10480
   Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Lamprecht A, 2002, J CONTROL RELEASE, V84, P59, DOI 10.1016/S0168-3659(02)00258-4
   Lasala John M, 2006, J Interv Cardiol, V19, P422, DOI 10.1111/j.1540-8183.2006.00183.x
   LEAKE PA, 1991, HEARING RES, V54, P251, DOI 10.1016/0378-5955(91)90120-X
   Lee KK, 2004, J MICROMECH MICROENG, V14, P32, DOI 10.1088/0960-1317/14/1/305
   Lenarz Thomas, 2006, Audiol Neurootol, V11 Suppl 1, P34, DOI 10.1159/000095612
   Lenarz T, 2009, AUDIOL NEURO-OTOL, V14, P22, DOI 10.1159/000206492
   Levy Y, 2009, J BIOMED MATER RES B, V91B, P441, DOI 10.1002/jbm.b.31420
   Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925
   Li PMMC, 2007, ANN OTO RHINOL LARYN, V116, P731, DOI 10.1177/000348940711601004
   LOUSTEAU RJ, 1987, LARYNGOSCOPE, V97, P836
   LUCIDIPHILLIPI CA, 1995, J COMP NEUROL, V354, P361, DOI 10.1002/cne.903540306
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Malgrange B, 1996, NEUROREPORT, V7, P2495, DOI 10.1097/00001756-199611040-00019
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Marletta G, 2010, TOP APPL PHYS, V116, P345, DOI 10.1007/978-3-540-88789-8_12
   Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616
   Maruyama J, 2007, NEUROBIOL DIS, V25, P309, DOI 10.1016/j.nbd.2006.09.012
   Marzella PL, 1997, NEUROREPORT, V8, P1641, DOI 10.1097/00001756-199705060-00017
   Marzella PL, 1999, ACTA OTO-LARYNGOL, V119, P407
   McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50
   Miller JM, 1997, INT J DEV NEUROSCI, V15, P631, DOI 10.1016/S0736-5748(96)00117-7
   Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320
   Mitchell A, 1997, HEARING RES, V105, P30, DOI 10.1016/S0378-5955(96)00202-X
   Munoz-Baell IM, 2000, J EPIDEMIOL COMMUN H, V54, P40, DOI 10.1136/jech.54.1.40
   NADOL JB, 1989, ANN OTO RHINOL LARYN, V98, P411, DOI 10.1177/000348948909800602
   Newbold C, 2004, J NEURAL ENG, V1, P218, DOI 10.1088/1741-2560/1/4/005
   Nopp P, 2010, ADV OTO-RHINO-LARYNG, V67, P88, DOI 10.1159/000262600
   Okano T, 2006, MOL THER, V14, P866, DOI 10.1016/j.ymthe.2006.06.012
   Olivius P, 2003, BRAIN RES, V979, P1, DOI 10.1016/S0006-8993(03)02802-6
   Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3
   OTTE J, 1978, LARYNGOSCOPE, V88, P1231
   Paasche G, 2006, HEARING RES, V212, P74, DOI 10.1016/j.heares.2005.10.013
   Paasche G, 2003, OTOL NEUROTOL, V24, P222, DOI 10.1097/00129492-200303000-00016
   Paasche G., 2009, TAG THUR GRENZ OB TH, P267
   Paasche G, 2006, OTOL NEUROTOL, V27, P639, DOI 10.1097/01.mao.0000227662.88840.61
   Paasche G, 2009, OTOL NEUROTOL, V30, P592, DOI 10.1097/MAO.0b013e3181ab8fba
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Parker Alan L., 2003, Expert Reviews in Molecular Medicine, V5, P1
   Pawlowski KS, 2005, OTOL NEUROTOL, V26, P972, DOI 10.1097/01.mao.0000169047.38759.8b
   Peeters S, 1998, Acta Otorhinolaryngol Belg, V52, P115
   Pettingill LN, 2008, NEUROSCIENCE, V152, P821, DOI 10.1016/j.neuroscience.2007.11.057
   Pettingill LN, 2007, IEEE T BIO-MED ENG, V54, P1138, DOI 10.1109/TBME.2007.895375
   PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915
   Praetorius M, 2007, ACTA OTO-LARYNGOL, V127, P486, DOI 10.1080/00016480600895102
   Prieskorn DM, 2000, HEARING RES, V140, P212, DOI 10.1016/S0378-5955(99)00193-8
   QUARANTA N, 2004, ACTA OTO-LARYNGOL, V552, P68
   Rainicek A.M., 1997, J CELL SCI, V<IT>110</IT>, P2905
   Rask-Andersen H, 2005, HEARING RES, V203, P180, DOI 10.1016/j.heares.2004.12.005
   Regala C, 2005, EXP NEUROL, V193, P326, DOI 10.1016/j.expneurol.2004.12.027
   Reich U, 2008, J BIOMED MATER RES B, V87B, P146, DOI 10.1002/jbm.b.31084
   Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010
   Richardson RT, 2006, AUDIOL NEURO-OTOL, V11, P343, DOI 10.1159/000095896
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015
   Riggs PD, 1997, BIOMATERIALS, V18, P721, DOI 10.1016/S0142-9612(96)00195-0
   ROBBLEE LS, 1990, NEURAL PROSTHESES FU, P25
   Roehm Pamela C, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P294, DOI 10.1097/01.moo.0000180919.68812.b9
   Rohm H.W., 2009, WORLD C MED PHYS BIO
   Roland JT, 2008, OTOL NEUROTOL, V29, P482, DOI 10.1097/MAO.0b013e31816845eb
   Rubinstein Jay T, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P444, DOI 10.1097/01.moo.0000134452.24819.c0
   RUDDY HA, 1995, MED BIOL ENG COMPUT, V33, P793, DOI 10.1007/BF02523011
   Ryan AF, 2006, AUDIOL NEURO-OTOL, V11, P134, DOI 10.1159/000090686
   Salt AN, 2009, AUDIOL NEURO-OTOL, V14, P350, DOI 10.1159/000241892
   Salt AN, 2006, J NEUROSCI METH, V153, P121, DOI 10.1016/j.jneumeth.2005.10.008
   Samuel U, 2004, INT J ANTIMICROB AG, V23, pS75, DOI 10.1016/j.ijantimicag.2003.12.004
   Saoji AA, 2009, EAR HEARING, V30, P559, DOI 10.1097/AUD.0b013e3181ab2b6f
   Saunders E, 2002, EAR HEARING, V23, p28S, DOI 10.1097/00003446-200202001-00004
   Scheper V, 2009, NANOMEDICINE-UK, V4, P623, DOI [10.2217/nnm.09.41, 10.2217/NNM.09.41]
   Scheper V, 2009, J NEUROSCI RES, V87, P1389, DOI 10.1002/jnr.21964
   Schlie S, 2010, J BIOMATER APPL, V25, P217, DOI 10.1177/0885328209345553
   Shepherd R K, 1983, Acta Otolaryngol Suppl, V399, P19
   Shepherd RK, 2005, J COMP NEUROL, V486, P145, DOI 10.1002/cne.20564
   SHEPHERD RK, 1984, ACTA OTO-LARYNGOL, P71
   Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011
   Shoji F, 2000, HEARING RES, V142, P41, DOI 10.1016/S0378-5955(00)00007-1
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Somdas MA, 2007, AUDIOL NEURO-OTOL, V12, P277, DOI 10.1159/000103208
   Sousa JE, 2003, CIRCULATION, V107, P2274, DOI 10.1161/01.CIR.0000069330.41022.90
   SPOENDLIN H, 1984, ANN OTO RHINOL LARYN, V93, P76
   STAECKER H, 1995, NEUROREPORT, V6, P1533, DOI 10.1097/00001756-199507310-00017
   Stover T, 2007, Cochlear Implants Int, V8, P38, DOI 10.1002/cii.329
   Stover T, 2005, OTOL NEUROTOL, V26, P1161
   Stover T, 2009, Laryngorhinootologie, V88 Suppl 1, pS12, DOI 10.1055/s-0028-1119552
   Sutton D, 1983, Ann Otol Rhinol Laryngol, V92, P316
   Swan EEL, 2008, ADV DRUG DELIVER REV, V60, P1583, DOI 10.1016/j.addr.2008.08.001
   Tamura T, 2005, LARYNGOSCOPE, V115, P2000, DOI 10.1097/01.mlg.00001800174.81036.5a
   Thompson BC, 2006, J CONTROL RELEASE, V116, P285, DOI 10.1016/j.jconrel.2006.09.004
   Thompson BC, 2010, J CONTROL RELEASE, V141, P161, DOI 10.1016/j.jconrel.2009.09.016
   Tsai I., 2003, APS M, P18007
   Tykocinski M, 2005, OTOL NEUROTOL, V26, P948, DOI 10.1097/01.mao.0000185056.99888.f3
   Tykocinski M, 2000, AM J OTOL, V21, P205, DOI 10.1016/S0196-0709(00)80010-1
   Tykocinski M, 2001, HEARING RES, V159, P53, DOI 10.1016/S0378-5955(01)00320-3
   Van Weert S, 2005, ACTA OTO-LARYNGOL, V125, P725, DOI 10.1080/00016480510028492
   Vieira M, 2007, HEARING RES, V230, P17, DOI 10.1016/j.heares.2007.03.005
   Vonarbourg A, 2006, J BIOMED MATER RES A, V78A, P620, DOI 10.1002/jbm.a.30711
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7
   Warnecke A, 2010, NEUROREPORT, V21, P517, DOI 10.1097/WNR.0b013e328339045b
   WEBSTER M, 1981, BRAIN RES, V212, P17, DOI 10.1016/0006-8993(81)90028-7
   Weiland JD, 2000, IEEE T BIO-MED ENG, V47, P911, DOI 10.1109/10.846685
   Wenzel GI, 2010, EUR ARCH OTO-RHINO-L, V267, P691, DOI 10.1007/s00405-009-1126-1
   White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849
   Wissel K, 2008, OTOL NEUROTOL, V29, P475, DOI 10.1097/MAO.0b013e318164d110
   Wright CG, 2005, LARYNGOSCOPE, V115, P2041, DOI 10.1097/01.MLG.0000181461.63392.49
   Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yang FC, 2009, MATER CHEM PHYS, V113, P474, DOI 10.1016/j.matchemphys.2008.07.126
   Yeager JD, 2008, J NEUROSCI METH, V173, P279, DOI 10.1016/j.jneumeth.2008.06.024
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Zenner H.P., 2000, PHYSL MENSCHEN, V28
   Zou J, 2008, J BIOMED MATER RES B, V87B, P10, DOI 10.1002/jbm.b.31058
NR 189
TC 20
Z9 20
U1 0
U2 28
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PD JAN
PY 2013
VL 14
IS 1
BP 112
EP 123
PG 12
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 087SW
UT WOS:000314784100014
PM 23092261
DA 2018-10-19
ER

PT J
AU Silini, A
   Parolini, O
   Huppertz, B
   Lang, I
AF Silini, Antonietta
   Parolini, Ornella
   Huppertz, Berthold
   Lang, Ingrid
TI Soluble Factors of Amnion-Derived Cells in Treatment of Inflammatory and
   Fibrotic Pathologies
SO CURRENT STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Amnion; fibrosis; inflammation; placenta; soluble factors; wound healing
ID MESENCHYMAL STEM-CELLS; TRANSFORMING-GROWTH-FACTOR; MEMBRANE STROMAL
   MATRIX; INDUCED LUNG FIBROSIS; HUMAN TERM PLACENTA; VENOUS LEG ULCERS;
   EPITHELIAL-CELLS; UMBILICAL-CORD; ENDOTHELIAL-CELLS; HEPATIC-FIBROSIS
AB Inflammation is a complex defense mechanism characterized by leukocyte migration from the vasculature into damaged tissues and subsequent deposition of extracellular matrix resulting in tissue repair. The inflammatory process is generally categorized into an acute, rapid response, and a persistent but slowly evolving chronic condition, which may progress into inflammatory diseases. An excessive deposition of extracellular matrix leads to overgrowth, hardening, and/or scarring of tissues, defined as fibrosis.
   The amnion has been used as biomaterial in medicine for over 100 years and has been proven valuable for the treatment of different pathological conditions including wound healing. In light of recent reports, this article will review the effects of the amnion and its cellular components within the inflammatory-fibrotic scenario and the factors described so far that could be involved in these immunomodulatory actions. As proof of principles, we will also discuss pre-clinical and clinical applications of the amnion where advantage has been taken of its anti-inflammatory and anti-fibrotic properties. It is conceivable that the local host environment in which the amnion is placed may have a profound role in influencing the production and function of soluble factors and the shift towards different steps in triggering healing. The healing effect depends on time, dosage, and location of cytokine/growth factor production by the amnion, together with the influence of the host microenvironment. Indeed, determining the specific cascade of events that may define the role of the amnion in a given clinical situation remains a challenge.
C1 [Silini, Antonietta; Parolini, Ornella] Fdn Poliambulanza, Ctr Ric E Menni, Brescia, Italy.
   [Huppertz, Berthold; Lang, Ingrid] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria.
RP Lang, I (reprint author), Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria.
EM ingrid.lang@medunigraz.at
RI Silini, Antonietta/K-7638-2016
OI Silini, Antonietta/0000-0001-6208-3583; Huppertz,
   Berthold/0000-0003-4814-2158
FU Fondazione Cariplo, Italy; MIUR Progetto Firb, Italy
FX Fondazione Cariplo and MIUR Progetto Firb, Italy.
CR Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11
   Anzalone R, 2011, STEM CELL REV REP, V7, P342, DOI 10.1007/s12015-010-9196-4
   Anzalone R, 2010, STEM CELLS DEV, V19, P423, DOI 10.1089/scd.2009.0299
   Apte RS, 1998, J IMMUNOL, V160, P5693
   Arai N, 2012, J ORAL MAXIL SURG, V70, P2221, DOI 10.1016/j.joms.2011.09.033
   Baradaran-Rafii A, 2007, J OPHTHALMIC VISION, V2, P58
   Branski LK, 2008, BURNS, V34, P393, DOI 10.1016/j.burns.2007.06.007
   Cargnoni A, 2012, CYTOTHERAPY, V14, P153, DOI 10.3109/14653249.2011.613930
   Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857
   Ching Yiu-Hei, 2011, Eplasty, V11, pe41
   Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   DAVIS JW, 1910, J HOPKINS MED J, V15, P307
   Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90
   Dinarello CA, 1994, CYTOKINE HDB, P31
   Escorcio-Correia M, 2010, CANCER DRUG DISCOV D, P371, DOI 10.1007/978-1-4419-6615-5_18
   FIDEL PL, 1994, AM J REPROD IMMUNOL, V32, P1
   Fortunato SJ, 1997, AM J OBSTET GYNECOL, V177, P803, DOI 10.1016/S0002-9378(97)70272-2
   Fortunato SJ, 1998, AM J OBSTET GYNECOL, V179, P794, DOI 10.1016/S0002-9378(98)70085-7
   Franz Michael G, 2008, Eplasty, V8, pe21
   Gajiwala A. Lobo, 2003, Cell and Tissue Banking, V4, P147
   Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513
   Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881
   Higa K, 2005, CORNEA, V24, P206, DOI 10.1097/01.ico.0000133999.45262.83
   Hollweck T, 2011, OPEN TISSUE ENG REGE, V4, P95
   Huang SY, 1996, CLIN CANCER RES, V2, P1969
   Huang YC, 2012, STEM CELLS DEV, V21, P2900, DOI 10.1089/scd.2012.0216
   Huppertz BKJ, 2012, DEWHURSTS TXB OBSTET
   Hurme M, 1998, ANN MED, V30, P469, DOI 10.3109/07853899809002488
   Jeschke MG, 2011, OPEN TISSUE ENG REGE, V4, P21
   Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530
   Kamiya K, 2005, EXP EYE RES, V80, P671, DOI 10.1016/j.exer.2004.11.018
   Kang JW, 2012, J VET SCI, V13, P23, DOI 10.4142/jvs.2012.13.1.23
   Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286
   Kelekci Sefa, 2007, Archives of Gynecology and Obstetrics, V276, P355, DOI 10.1007/s00404-007-0376-7
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Kita K, 2010, STEM CELLS DEV, V19, P491, DOI 10.1089/scd.2009.0192
   Konig J, 2012, STEM CELLS DEV, V21, P1309, DOI 10.1089/scd.2011.0223
   Koziak Andrzej, 2004, Ann Transplant, V9, P21
   Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012
   La Rocca G, 2009, SCAND J IMMUNOL, V70, P161, DOI 10.1111/j.1365-3083.2009.02283.x
   Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.013909.105812
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Lee SB, 2000, CURR EYE RES, V20, P325, DOI 10.1076/0271-3683(200004)20:4;1-5;FT325
   Letendre S, 2009, ADV SKIN WOUND CARE, V22, P161, DOI 10.1097/01.ASW.0000305463.32800.32
   Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495
   Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737
   Li W, 2008, J CELL PHYSIOL, V215, P657, DOI 10.1002/jcp.21345
   Liu JB, 2010, EXPERT REV OPHTHALMO, V5, P645, DOI 10.1586/EOP.10.63
   Lo V, 2009, INT J DERMATOL, V48, P935, DOI 10.1111/j.1365-4632.2009.04173.x
   Lu LL, 2006, HAEMATOL-HEMATOL J, V91, P1017
   Magatti M, 2009, CELL TRANSPLANT, V18, P899, DOI 10.3727/096368909X471314
   Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010
   Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496
   Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.0243
   Mermet I, 2007, WOUND REPAIR REGEN, V15, P459, DOI 10.1111/j.1524-475X.2007.00252.x
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC
   Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385
   Najar M, 2012, IMMUNOL LETT, V146, P50, DOI 10.1016/j.imlet.2012.04.017
   Najar M, 2010, CELL IMMUNOL, V264, P171, DOI 10.1016/j.cellimm.2010.06.006
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Nores JER, 1999, EUR J IMMUNOL, V29, P265, DOI 10.1002/(SICI)1521-4141(199901)29:01<265::AID-IMMU265>3.0.CO;2-G
   Parolini O, 2011, PLACENTA, V32, pS186, DOI 10.1016/j.placenta.2010.12.016
   Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594
   Parolini O, 2010, PREG INFANTS-MED PSY, P1, DOI 10.1109/ITAB.2010.5687674
   Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404
   Payne WG, 2010, WORLD J SURG, V34, P1663, DOI 10.1007/s00268-010-0420-9
   Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727
   Petter-Puchner AH, 2011, SURG ENDOSC, V25, P2125, DOI 10.1007/s00464-010-1507-y
   Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006
   Remick DG, 2009, CRIT CARE MED, V37, P1809, DOI 10.1097/CCM.0b013e3181a1a12b
   Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034
   Rossi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046956
   Sant'Anna LB, 2011, CELL TRANSPLANT, V20, P441, DOI 10.3727/096368910X522252
   Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270
   SATOH K, 1981, PROSTAG LEUKOTR ESS, V6, P359, DOI 10.1016/0161-4630(81)90067-7
   Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590
   Sippel KC, 2001, CURR OPIN OPHTHALMOL, V12, P269, DOI 10.1097/00055735-200108000-00006
   SMITH RE, 1994, J IMMUNOL, V153, P4704
   SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Solomon A, 2005, CLIN EXP ALLERGY, V35, P941, DOI 10.1111/j.1365-2222.2005.02285.x
   Steed David L, 2008, Eplasty, V8, pe18
   Tosi GM, 2005, J CELL PHYSIOL, V202, P849, DOI 10.1002/jcp.20181
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Tseng Scheffer C G, 2004, Ocul Surf, V2, P177
   Uberti MG, 2010, ANN PLAST SURG, V66, P575
   WARD DJ, 1989, BRIT J PLAST SURG, V42, P463, DOI 10.1016/0007-1226(89)90015-5
   Warrier S, 2012, PLACENTA, V33, P850, DOI 10.1016/j.placenta.2012.07.001
   Wu KH, 2007, J CELL BIOCHEM, V100, P608, DOI 10.1002/jcb.21078
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008
   Yetkin G, 2009, INT J SURG, V7, P561, DOI 10.1016/j.ijsu.2009.09.007
NR 98
TC 42
Z9 45
U1 4
U2 23
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-888X
J9 CURR STEM CELL RES T
JI Curr. Stem Cell Res. Ther.
PD JAN
PY 2013
VL 8
IS 1
BP 6
EP 14
DI 10.2174/1574888X11308010003
PG 9
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA 088DO
UT WOS:000314814200003
PM 23270631
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Yang, J
AF Zhang, Yi
   Yang, Jian
TI Design strategies for fluorescent biodegradable polymeric biomaterials
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID SEMICONDUCTOR QUANTUM DOTS; IN-VIVO; DRUG-DELIVERY; CANCER-THERAPY;
   LIVING CELLS; POLY(LACTIDE-CO-GLYCOLIDE) NANOPARTICLES; TRANSFECTION
   EFFICIENCY; 2-PHOTON ABSORPTION; HPMA COPOLYMERS; PAMAM DENDRIMER
AB The combination of biodegradable polymer and fluorescent imaging has resulted in an important area of polymeric biomaterials: biodegradable fluorescent polymers. Researchers have made significant efforts in developing versatile fluorescent biomaterials due to their promising applications in biological/biomedical labeling, tracking, monitoring, imaging, and diagnostics, especially in drug delivery, tissue engineering, and cancer imaging. Biodegradable fluorescent polymers can function not only as implant biomaterials but also as imaging probes. Currently, there are two major classes of biodegradable polymers, which are used as fluorescent materials. The first class is the combination of non-fluorescent biodegradable polymers and fluorescent agents such as organic dyes and quantum dots. Another class of polymers shows intrinsic photoluminescence as polymers by themselves carrying integral fluorescent chemical structures in or pendent to their polymer backbone, such as Green Fluorescent protein (GFP), and the recently developed biodegradable photoluminescent polymer (BPLP). Thus there is no need to conjugate or encapsulate additional fluorescent materials for the latter. In the present review, we will review the fluorescent biodegradable polymers with emphases on material fluorescence mechanism, design criteria for fluorescence, and their cutting-edge applications in biomedical engineering. We expect that this review will provide an insightful discussion on the fluorescent biomaterial design and lead to innovations for the next generation of fluorescent biomaterials and fluorescence-based biomedical technology.
C1 [Zhang, Yi] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Zhang, Yi] Univ Texas SW Med Ctr Dallas, Joint Biomed Engn Program, Dallas, TX 75390 USA.
   [Zhang, Yi] Univ Texas Arlington, Dallas, TX 75390 USA.
   [Yang, Jian] Penn State Univ, Huck Inst Life Sci, Mat Res Inst, Dept Bioengn, University Pk, PA 16802 USA.
RP Zhang, Y (reprint author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
EM jxy30@psu.edu
RI Yang, Jian/N-1291-2014; Zhang, Yi/K-3340-2016
OI Yang, Jian/0000-0003-0695-828X; Zhang, Yi/0000-0001-8667-7829
FU National Institute of Biomedical Imaging and Bioengineering (NIBIB)
   [EB012575]; National Science Foundation (NSF) [0954109]
FX This work was supported in part by a R01 award (EB012575) from the
   National Institute of Biomedical Imaging and Bioengineering (NIBIB), and
   a National Science Foundation (NSF) CAREER award 0954109.
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Bagalkot V, 2007, NANO LETT, V7, P3065, DOI 10.1021/nl071546n
   Benninger RKP, 2008, REV PHYSIOL BIOCH P, V160, P71, DOI 10.1007/112_2008_801
   Bhadra D, 2003, INT J PHARM, V257, P111, DOI 10.1016/S0378-5173(03)00132-7
   Bharali DJ, 2009, INT J NANOMED, V4, P1
   Brenier A, 1996, J LUMIN, V69, P131, DOI 10.1016/0022-2313(96)00086-5
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Cao J, 2012, J BIOMED MATER RES A, V100A, P958, DOI 10.1002/jbm.a.34043
   Chang K, 2008, J NUCL CARDIOL, V15, P417, DOI 10.1016/j.nuclcard.2008.03.001
   Cheng FY, 2008, BIOMATERIALS, V29, P2104, DOI [10.1016/j.biomaterials.2008.01.010, 10.1016/j.biomaterials.2008.01.01]
   Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c
   Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbt1340, 10.1038/nbtl340]
   Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/nnano.2009.314, 10.1038/NNANO.2009.314]
   Chu CC, 2009, MACROMOL RAPID COMM, V30, P89, DOI 10.1002/marc.200800571
   Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009
   Chung L. W. K., 2004, NAT BIOTECHNOL, V22, P969
   Chung YI, 2010, J CONTROL RELEASE, V143, P374, DOI 10.1016/j.jconrel.2010.01.017
   Crouch D, 2003, PHILOS T R SOC A, V361, P297, DOI 10.1098/rsta.2002.1129
   CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4
   Demchenko AP, 2002, LUMINESCENCE, V17, P19, DOI 10.1002/bio.671
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Di Corato R, 2008, J MATER CHEM, V18, P1991, DOI 10.1039/b717801h
   Donaldson L, 2011, MATER TODAY, V14, P131, DOI 10.1016/S1369-7021(11)70079-7
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Escobedo JO, 2010, CURR OPIN CHEM BIOL, V14, P64, DOI 10.1016/j.cbpa.2009.10.022
   Farokhzad OC, 2005, ANAL CHEM, V77, P5453, DOI 10.1021/ac050312q
   Finn MG, 2010, CHEM SOC REV, V39, P1231, DOI 10.1039/c003740k
   Gaylord BS, 2001, J AM CHEM SOC, V123, P6417, DOI 10.1021/ja010373f
   Ghandehari H, 2008, ADV DRUG DELIVER REV, V60, P956, DOI 10.1016/j.addr.2008.04.001
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008
   Gong YJ, 2005, CHEM MATER, V17, P2648, DOI 10.1021/cm047932c
   Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990
   Han DW, 2008, BIOORGAN MED CHEM, V16, P9652, DOI 10.1016/j.bmc.2008.10.009
   He GS, 2008, CHEM REV, V108, P1245, DOI 10.1021/cr050054x
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818
   Hezinger AFE, 2008, EUR J PHARM BIOPHARM, V68, P138, DOI 10.1016/j.ejpb.2007.05.013
   Hild WA, 2008, EUR J PHARM BIOPHARM, V68, P153, DOI 10.1016/j.cejpb.2007.06.009
   Hirsch A, 2000, ANGEW CHEM INT EDIT, V39, P3915, DOI 10.1002/1521-3773(20001103)39:21<3915::AID-ANIE3915>3.0.CO;2-O
   Hong J, 2012, BIOMACROMOLECULES, V13, P261, DOI 10.1021/bm201554x
   Hong X, 2004, J MAGN MAGN MATER, V269, P95, DOI 10.1016/S0304-8853(03)00566-3
   Hong YN, 2009, CHEM COMMUN, P4332, DOI 10.1039/b904665h
   Hou XD, 2009, MACROMOL BIOSCI, V9, P551, DOI 10.1002/mabi.200800312
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Janib SM, 2010, ADV DRUG DELIVER REV, V62, P1052, DOI 10.1016/j.addr.2010.08.004
   Jensen KD, 2001, AAPS PHARMSCI, V3
   Kang Y, 2006, J BIOMED MATER RES A, V77A, P331, DOI 10.1002/jbm.a.30607
   Kim BYS, 2008, NANO LETT, V8, P3887, DOI 10.1021/nl802311t
   Kim JS, 2011, J COLLOID INTERF SCI, V353, P363, DOI 10.1016/j.jcis.2010.08.053
   Kim JH, 2007, PROG POLYM SCI, V32, P1031, DOI 10.1016/j.progpolymsci.2007.05.016
   Kim SH, 2005, LANGMUIR, V21, P8852, DOI 10.1021/la0502084
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Knyazhanskii K., 1975, J APPL SPECTROSC, V23, P3
   Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012
   Kogej T, 1998, CHEM PHYS LETT, V298, P1, DOI 10.1016/S0009-2614(98)01196-8
   Kumar N, 2001, ADV DRUG DELIVER REV, V53, P23, DOI 10.1016/S0169-409X(01)00219-8
   Larson N, 2012, CHEM MATER, V24, P840, DOI 10.1021/cm2031569
   Le Droumaguet B, 2011, INT J PHARMACEUT, V416, P453, DOI 10.1016/j.ijpharm.2011.01.015
   Lee WI, 2004, J AM CHEM SOC, V126, P8358, DOI 10.1021/ja0475914
   Lee Young-Ran, 2011, Immune Netw, V11, P163, DOI 10.4110/in.2011.11.3.163
   Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954
   Liu Q, 2012, INT J PHARMACEUT, V430, P350, DOI 10.1016/j.ijpharm.2012.04.008
   Lu ZR, 2010, ADV DRUG DELIVER REV, V62, P246, DOI 10.1016/j.addr.2009.12.007
   Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024
   Majoros IJ, 2006, BIOMACROMOLECULES, V7, P572, DOI 10.1021/bm0506142
   Martinez-Palau M, 2006, ACTA CRYSTALLOGR C, V62, pO262, DOI 10.1107/S0108270106010079
   Mattoussi H, 2012, ADV DRUG DELIVER REV, V64, P138, DOI 10.1016/j.addr.2011.09.011
   Melancon MP, 2007, PHARM RES-DORDR, V24, P1217, DOI 10.1007/s11095-007-9253-0
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264
   Murcia MJ, 2008, OPT COMMUN, V281, P1771, DOI 10.1016/j.optcom.2007.07.069
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nam HY, 2009, BIOMATERIALS, V30, P665, DOI 10.1016/j.biomaterials.2008.10.013
   Nam T, 2010, BIOCONJUGATE CHEM, V21, P578, DOI 10.1021/bc900408z
   Nehilla BJ, 2008, ACS NANO, V2, P538, DOI 10.1021/nn700281b
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Paganin-Gioanni A, 2010, RADIOL ONCOL, V44, P142, DOI 10.2478/v10019-010-0031-y
   Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003
   Pridgen EM, 2007, NANOMEDICINE-UK, V2, P669, DOI 10.2217/17435889.2.5.669
   Qi LF, 2008, EXPERT OPIN DRUG DEL, V5, P263, DOI 10.1517/17425247.5.3.263 
   Qin A, 2012, PROG POLYM SCI, V37, P182, DOI 10.1016/j.progpolymsci.2011.08.002
   Rajeshwar K, 2001, CHEM MATER, V13, P2765, DOI 10.1021/cm010254z
   Rautio J, 2008, NAT REV DRUG DISCOV, V7, P255, DOI 10.1038/nrd2468
   Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI 10.1038/NMETH.1248
   Santra S, 2011, WIRES NANOMED NANOBI, V3, P501, DOI 10.1002/wnan.134
   Schipper ML, 2009, SMALL, V5, P126, DOI 10.1002/smll.200800003
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Smyder J., 2011, MATER TODAY, V14, P16
   Sokolova V, 2010, J MATER SCI, V45, P4952, DOI 10.1007/s10853-009-4159-3
   Sumer B, 2008, NANOMEDICINE-UK, V3, P137, DOI 10.2217/17435889.3.2.137
   Tavare JM, 2001, J ENDOCRINOL, V170, P297, DOI 10.1677/joe.0.1700297
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tomczak N, 2009, PROG POLYM SCI, V34, P393, DOI 10.1016/j.progpolymsci.2008.11.004
   Trindade T, 2001, CHEM MATER, V13, P3843, DOI 10.1021/cm000843p
   Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Walling MA, 2009, INT J MOL SCI, V10, P441, DOI 10.3390/ijms10020441
   Wang DJ, 2004, J AM CHEM SOC, V126, P13204, DOI 10.1021/ja0454992
   Wang D, 2007, J COLLOID INTERF SCI, V306, P222, DOI 10.1016/j.jcis.2006.10.025
   Wang F, 2006, NANOTECHNOLOGY, V17, pR1, DOI 10.1088/0957-4484/17/1/R01
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wu CL, 2009, MACROMOL BIOSCI, V9, P1185, DOI 10.1002/mabi.200900232
   Xu YL, 2007, POLYMER, V48, P1711, DOI 10.1016/j.polymer.2007.01.022
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2009, P NATL ACAD SCI USA, V106, P10086, DOI 10.1073/pnas.0900004106
   Zanetti-Ramos BG, 2006, POLYMER, V47, P8080, DOI 10.1016/j.polymer.2006.09.057
   Zhang YJ, 2011, SENSORS-BASEL, V11, P11036, DOI 10.3390/s111211036
   Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI 10.1021/b6700333s
NR 111
TC 66
Z9 69
U1 3
U2 139
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 2
BP 132
EP 148
DI 10.1039/c2tb00071g
PG 17
WC Materials Science, Biomaterials
SC Materials Science
GA 087TN
UT WOS:000314786200001
PM 23710326
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhou, PY
   Xia, Y
   Wang, J
   Liang, C
   Yu, L
   Tang, W
   Gu, S
   Xu, SG
AF Zhou, Panyu
   Xia, Yan
   Wang, Jing
   Liang, Chong
   Yu, Long
   Tang, Wei
   Gu, Shen
   Xu, Shuogui
TI Antibacterial properties and bioactivity of HACC- and HACC-Zein-modified
   mesoporous bioactive glass scaffolds
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID PROSTHETIC-JOINT INFECTIONS; IN-VITRO BIOACTIVITY;
   ANTIMICROBIAL-PROPHYLAXIS; ANTIBIOTIC-RESISTANCE; BIOFILM FORMATION;
   DELIVERY-SYSTEM; DRUG-DELIVERY; CHITOSAN; BONE; BIOMATERIALS
AB Infection and its complications are one of the greatest threats to the health of orthopedic patients. Mesoporous bioglass (MBG) scaffolds are characterized by well-ordered, three-dimensional, nanometer-sized mesoporous structures, which facilitate the adhesion of hydroxyapatite and the loading of drugs. MBG has been widely used as a new-generation biomaterial in bone tissue engineering. However, MBG is very brittle and lacks antibacterial activity. This limits its applications in the treatment of bone defects, especially large bone defects complicated by infection. In order to dispel these disadvantages, a novel hydroxypropyltrimethyl ammonium chloride chitosan (HACC) and a class of prolamine proteins found in maize, Zeins, were here used to modify the traditional MBG scaffolds. Two new types of scaffold, MBG-HACC scaffolds and MBG-HACC-Zein scaffolds, were made. Transmission electron microscopy (TEM), small angle X-ray diffraction (SAXRD), and Barrett-Joyner-Halenda (BJH) were used to analyze the surface properties of these MBG scaffolds. Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), mechanical experiments, and synchrotron radiation microcomputer tomography (SR mu CT) were used to compare the features of the traditional and modified scaffolds and to analyze the mineralization of the scaffold after being soaked in simulated body fluid (SBF). Confocal laser scanning microscopy (CLSM) was used to compare the antibacterial properties and biocompatibility of the scaffolds at various points in time. The current study demonstrates that all these prepared MBG scaffolds possessed well-ordered, three-dimensional, nanometer-sized mesoporous structures and that HACC-Zein-modified MBG scaffolds are characterized by strong bioactivity and by effective, prolonged antibacterial activity. Finally, biocompatibility was demonstrated by studying the in vitro proliferation and viability of human mesenchymal stem cells (hMSCs).
C1 [Zhou, Panyu; Xia, Yan; Xu, Shuogui] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai 200433, Peoples R China.
   [Wang, Jing; Tang, Wei; Xu, Shuogui] E China Univ Sci & Technol, Minist Educ, Engn Res Ctr Biomed Mat, Shanghai 200237, Peoples R China.
   [Liang, Chong; Xu, Shuogui] 81 Hosp Peoples Liberat Army China, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.
   [Yu, Long; Xu, Shuogui] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped, Xian 710033, Peoples R China.
   [Gu, Shen; Xu, Shuogui] Second Mil Med Univ, Acad Nursing, Shanghai 200433, Peoples R China.
RP Zhou, PY (reprint author), Second Mil Med Univ, Changhai Hosp, Dept Orthoped, 168 Changhai Rd, Shanghai 200433, Peoples R China.
EM summer520m@163.com; wjbiomat@yahoo.com.cn; liangchong1984@163.com;
   Bonexu@yahoo.cn
FU Nano Project of Science and Technology Commission of Shanghai
   Municipality [1052nm03100]; Key Projects for Basic Research Shanghai
   Committee of Science and Technology [11JC1415700]; National Natural
   Science Foundation of China [81171794]
FX This work received support from the Nano Project of Science and
   Technology Commission of Shanghai Municipality (no. 1052nm03100), Key
   Projects for Basic Research Shanghai Committee of Science and Technology
   (no. 11JC1415700), and National Natural Science Foundation of China (no.
   81171794).
CR Alcantara ACS, 2010, J MATER CHEM, V20, P9495, DOI 10.1039/c0jm01211d
   Auschill TM, 2005, J CLIN PERIODONTOL, V32, P147, DOI 10.1111/j.1600-051X.2005.00650.x
   Bai J, 2003, POSTHARVEST BIOL TEC, V28, P259, DOI 10.1016/S0925-5214(02)00182-5
   Berendt T, 2004, CLIN MED, V4, P510, DOI 10.7861/clinmedicine.4-6-510
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Cataldo MA, 2010, J INFECTION, V61, P443, DOI 10.1016/j.jinf.2010.09.033
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Costa EM, 2012, ANAEROBE, V18, P305, DOI 10.1016/j.anaerobe.2012.04.009
   Duan B, 2010, ACTA BIOMATER, V6, P4495, DOI 10.1016/j.actbio.2010.06.024
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   Enzler MJ, 2011, MAYO CLIN PROC, V86, P686, DOI 10.4065/mcp.2011.0012
   Gao ZB, 2007, INT J PHARM, V328, P57, DOI 10.1016/j.ijpharm.2006.07.048
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Kim YB, 2012, J MATER CHEM, V22, P16880, DOI 10.1039/c2jm33036a
   Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012
   Li XN, 2010, J COLLOID INTERF SCI, V345, P46, DOI 10.1016/j.jcis.2010.01.029
   Liu LS, 2006, DRUG DELIV, V13, P417, DOI 10.1080/10717540500394935
   Lonn-Stensrud J, 2009, J ANTIMICROB CHEMOTH, V63, P309, DOI 10.1093/jac/dkn501
   Martinez LR, 2010, J INFECT DIS, V201, P1436, DOI 10.1086/651558
   Martinez-Pastor JC, 2010, EUR J CLIN MICROBIOL, V29, P1039, DOI 10.1007/s10096-010-0950-y
   Moroni L, 2008, MATER TODAY, V11, P44, DOI 10.1016/S1369-7021(08)70089-0
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Ostomel TA, 2006, SMALL, V2, P1261, DOI 10.1002/smll.200600177
   Peng ZX, 2010, CARBOHYD POLYM, V81, P275, DOI 10.1016/j.carbpol.2010.02.008
   Steinberg JP, 2009, ANN SURG, V250, P10, DOI 10.1097/SLA.0b013e3181ad5fca
   Subramanian S, 2007, BIOMACROMOLECULES, V8, P2120, DOI 10.1021/bm0701999
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   WARREN LD, 1989, J BIOMED MATER RES-A, V23, P201
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu TY, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045003
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 41
TC 19
Z9 19
U1 3
U2 97
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 5
BP 685
EP 692
DI 10.1039/c2tb00102k
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 087YF
UT WOS:000314799900012
DA 2018-10-19
ER

PT J
AU Hasebe, T
   Kobayashi, E
   Tezuka, H
   Sato, T
AF Hasebe, Tatsuya
   Kobayashi, Equo
   Tezuka, Hiroyasu
   Sato, Tatsuo
TI Effects of Sintering Conditions on Mechanical Properties of Biomedical
   Porous Ti Produced by Spark Plasma Sintering
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID BIOACTIVE TITANIUM; YOUNGS MODULUS; ALLOYS; METAL; IMPLANTS
AB Because of its excellent biocompatibility, good corrosion resistance and relatively lower Young's modulus, Ti was suitable for biomaterial. It, however, showed still bigger Young's modulus comparing to the living bone. It was necessary to decrease the Young's modulus in order to avoid adversely affect to the bone, such as stress sheilding. In this study, porous Ti were fablicated to decrease the Young's modulus by space holder method from Ti/NaCl composites sintered using spark plasma sintering (SPS) method. The sintering condition and the size of NaCl affected to the porous structure and mechanical properties. According to the scanning electron microscope (SEM) observation and the relative density measurement of specimens sintered with several sintering conditions, the desirable sintering condition was concluded as 973 K of sintering temperature and 1.2 ks of sintering time. The specimens made from NaCl powder whose size were from 106 to 214 mu m showed almost opened and connected pores. The Young's modulus was decreased with increasing the porosity. (C) 2013 The Japan Society of Applied Physics
C1 [Hasebe, Tatsuya] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan.
   [Kobayashi, Equo; Tezuka, Hiroyasu] Tokyo Inst Technol, Dept Met & Ceram Sci, Meguro Ku, Tokyo 1528552, Japan.
   [Sato, Tatsuo] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Hasebe, T (reprint author), Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan.
RI Sato, Tatsuo/F-4407-2014
CR Banerjee R, 2004, BIOMATERIALS, V25, P3413, DOI 10.1016/j.biomaterials.2003.10.041
   Feng HB, 2005, COMPOS PART A-APPL S, V36, P558, DOI 10.1016/j.compositesa.2004.09.003
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   Hisashi S., 2007, MATER SCI FORUM, V539-543, P3201
   Li Y, 2008, POWDER METALL, V51, P231, DOI 10.1179/174329007X223965
   Majumdar P, 2008, MAT SCI ENG A-STRUCT, V489, P419, DOI 10.1016/j.msea.2007.12.029
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Pattanayak DK, 2009, MAT SCI ENG C-MATER, V29, P1974, DOI 10.1016/j.msec.2009.03.014
   Rak ZS, 2006, J MATER PROCESS TECH, V175, P358, DOI 10.1016/j.jmatprotec.2005.04.006
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Traini T, 2008, DENT MATER, V24, P1525, DOI 10.1016/j.dental.2008.03.029
   Velten D., 2003, Z METALLKD, V6, P667
   Watanabe Y, 2011, J MATER PROCESS TECH, V211, P1919, DOI 10.1016/j.jmatprotec.2011.05.024
   Zhu K, 2007, J MATER SCI, V42, P7348, DOI 10.1007/s10853-007-1532-y
NR 15
TC 4
Z9 4
U1 0
U2 27
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0021-4922
EI 1347-4065
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD JAN
PY 2013
VL 52
IS 1
SI SI
AR 01AE03
DI 10.7567/JJAP.52.01AE03
PN 2
PG 4
WC Physics, Applied
SC Physics
GA 083LV
UT WOS:000314466500028
DA 2018-10-19
ER

PT J
AU San Martin, S
   Alaminos, M
   Zorn, TMT
   Sanchez-Quevedo, MC
   Garzon, I
   Rodriguez, IA
   Campos, A
AF San Martin, S.
   Alaminos, M.
   Zorn, T. M. T.
   Sanchez-Quevedo, M. C.
   Garzon, I.
   Rodriguez, I. A.
   Campos, A.
TI The effects of fibrin and fibrin-agarose on the extracellular matrix
   profile of bioengineered oral mucosa
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE extracellular matrix; fibrin; agarose; constructs; tissue engineering;
   oral mucosa
ID IN-VITRO; COLLAGEN FIBRILLOGENESIS; DECORIN DEFICIENCY; SMALL
   PROTEOGLYCAN; BIGLYCAN; SKIN; RECONSTRUCTION; SUBSTITUTE; EXPRESSION;
   SCAFFOLDS
AB Several studies have developed efficient oral mucosa constructs using different types of scaffold. However, the changes in the morphology and gene and protein expression profile that could occur in these artificial constructs remain unknown. This study compared the histology and expression of several extracellular matrix molecules in human artificial oral mucosa developed using two different types of scaffolds: fibrin and fibrin-agarose. To that end, bioengineered oral mucosa stromas were constructed from biopsy samples of human oral mucosa and the substitute generated was analyzed at different periods of time in culture. Histological analysis was carried out by light and transmission electron microscopy and the expression of collagen types I, III, and VI, the proteoglycans decorin and biglycan, and the different chains of laminin, were assessed by immunoperoxidase technique. This study found that fibrin scaffolds accelerated fibroblast growth and remodeling of the scaffold, thus enhancing collagen fibrillogenesis. In the fibrin-agarose scaffold, themorphology and organization of the fibroblasts did not change during the culture period. All extracellular matrix proteins analyzed were expressed in both scaffolds. However, in fibrin scaffolds, these proteins were widely distributed and replaced the scaffold during the follow-up period. These results show that the substitutes generated showed histological and molecular similarities with native human oral mucosa stroma. In addition, it was observed that the nature of the biomaterial influenced the behaviour of the oral stromal fibroblasts, thereby modulating their growth, protein synthesis, and collagen fibrillogenesis. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [San Martin, S.] Univ Valparaiso, Biomed Res Ctr, Sch Med, Valparaiso, Chile.
   [San Martin, S.] CREAS, Valparaiso, Chile.
   [Alaminos, M.; Sanchez-Quevedo, M. C.; Garzon, I.; Rodriguez, I. A.; Campos, A.] Univ Granada, Dept Histol, Granada, Spain.
   [Zorn, T. M. T.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Rodriguez, I. A.] Natl Univ Cordoba, Fac Odontol, Histol Dept B, Cordoba, Argentina.
RP San Martin, S (reprint author), Univ Valparaiso, Dept Biomed Sci, Biomed Res Ctr, Sch Med, Calle Hontaneda 2664,Casilla 92-V, Valparaiso, Chile.
EM sebastian.sanmartin@uv.cl
RI Zorn, Telma/C-4065-2008; ALAMINOS, MIGUEL/N-9960-2016
OI ALAMINOS, MIGUEL/0000-0003-4876-2672
FU National R + D + i; Institute of Health Carlos III; Biomedical Research
   Centre at Universidad de Valparaiso, Valparaiso, Chile [05/2006]
FX This study was supported by the National R + D + i 2004-2007, the
   Institute of Health Carlos III, and the Biomedical Research Centre at
   Universidad de Valparaiso, Valparaiso, Chile; grant no 05/2006). The
   authors offer thanks to Victor Carriel, Makarena Gonzalez, and Fernanda
   Barrence for their technical assistance.
CR Alaminos M, 2007, J TISSUE ENG REGEN M, V1, P350, DOI 10.1002/term.38
   Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003
   Aufderheide AC, 2005, TISSUE ENG, V11, P1095, DOI 10.1089/ten.2005.11.1095
   Birk DE, 1997, DEV DYNAM, V208, P291
   BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401
   Buckley CT, 2009, J MECH BEHAV BIOMED, V2, P512, DOI 10.1016/j.jmbbm.2008.12.007
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180
   Feinberg SE, 2005, J ORAL MAXIL SURG, V63, P1418, DOI 10.1016/j.joms.2005.07.004
   Ferdous Z, 2008, BIOMATERIALS, V29, P2740, DOI 10.1016/j.biomaterials.2008.03.018
   Garzon I, 2009, J PERIODONTAL RES, V44, P588, DOI 10.1111/j.1600-0765.2008.01159.x
   Garzon I, 2009, INT J ARTIF ORGANS, V32, P711
   Gonzalez-Andrades M, 2009, J TISSUE ENG REGEN M, V3, P442, DOI 10.1002/term.178
   Hernandez Rosa, 2009, V470, P105, DOI 10.1007/978-1-59745-204-5_10
   Ionescu AM, 2010, CORNEA, V29, P895, DOI 10.1097/ICO.0b013e3181ca3650
   Izumi K, 1999, J ORAL MAXIL SURG, V57, P571, DOI 10.1016/S0278-2391(99)90077-0
   Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6
   Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6
   Llames Sara, 2006, Cell and Tissue Banking, V7, P47, DOI 10.1007/s10561-004-7253-4
   Llames SG, 2004, TRANSPLANTATION, V77, P350, DOI 10.1097/01.TP.0000112381.80964.85
   Meana A, 1998, BURNS, V24, P621, DOI 10.1016/S0305-4179(98)00107-7
   Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949
   Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203
   Moioli EK, 2007, ADV DRUG DELIVER REV, V59, P308, DOI 10.1016/j.addr.2007.03.019
   Munoz-Corcuera M, 2009, CLIN EXP DERMATOL, V34, P456, DOI 10.1111/j.1365-2230.2009.03219.x
   Nieto-Aguilar R, 2010, J BIOMATER APPL, V25, P743
   Porter SR, 2005, ALIMENT PHARM THERAP, V21, P295, DOI 10.1111/j.1365-2036.2005.02333.x
   Reichl S, 2003, INT J PHARM, V250, P191, DOI 10.1016/S0378-5173(02)00541-0
   San Martin S, 2003, CELL MOL BIOL, V49, P673
   Sanchez-Quevedo MC, 2007, HISTOL HISTOPATHOL, V22, P631, DOI 10.14670/HH-22.631
   Scheller EL, 2009, J ORAL REHABIL, V36, P368, DOI 10.1111/j.1365-2842.2009.01939.x
   SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776
   Serrato D, 2009, HISTOL HISTOPATHOL, V24, P1531, DOI 10.14670/HH-24.1531
   SLOAN P, 1991, J DENT, V19, P107, DOI 10.1016/0300-5712(91)90100-D
   Starborg T, 2008, METHOD CELL BIOL, V88, P319, DOI 10.1016/S0091-679X(08)00417-2
   Trelstad RL, 1981, CELL BIOL EXTRACELLU, P179
   Vacanti CA, 2006, J CELL MOL MED, V10, P569, DOI 10.2755/jcmm010.003.20
   VOGEL KG, 1987, COLLAGEN REL RES, V7, P105
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200
NR 42
TC 10
Z9 10
U1 1
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2013
VL 7
IS 1
BP 10
EP 19
DI 10.1002/term.490
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 086AZ
UT WOS:000314656700002
PM 22052862
DA 2018-10-19
ER

PT J
AU Cunha-Reis, C
   El Haj, AJ
   Yang, XB
   Yang, Y
AF Cunha-Reis, Cassilda
   El Haj, Alicia J.
   Yang, Xuebin
   Yang, Ying
TI Fluorescent labeling of chitosan for use in non-invasive monitoring of
   degradation in tissue engineering
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE chitosan; fluorescence; degradation; scaffold; tissue engineering;
   non-invasive monitoring
ID CHEMICALLY-MODIFIED CHITOSAN; LASER-SCANNING MICROSCOPY; IN-VITRO;
   HYDROLYTIC DEGRADATION; SURFACE MODIFICATION; SWELLING BEHAVIOR;
   CELL-ADHESION; N-ACETYLATION; QUANTIFICATION; MEMBRANE
AB The establishment of non-invasive analytical tools for assessing the in-situ use of biomaterials for surgical implants or scaffolds in tissue engineering and polymer-based therapies is fundamental. This study established a method for fluorescent tracking of the degradation of a chitosan membrane scaffold for use in vitro in bioreactors and ultimately in vivo. The basis of this tracking system is a fluorescence emitting biomaterial obtained by covalent binding of the fluorophore tetramethylrhodamine isothiocyanate (TRITC) onto the backbone of chitosan. Using confocal microscopy, this study quantitated the reductions in fluorescence intensity of the membrane and correlated these decreases with weight loss during polymer breakdown, thereby providing a technique for non-destructively assessing the extent of degradation of chitosan materials over time in vitro. Using multispectral imaging in a mouse model, the study assessed the degradation profile of the fluorophore-labeled biomaterial in vivo in real time and identified the dispersing pathway of the chitosan membrane degradation products in vivo. The results revealed that TRITC conjugated chitosan was biocompatible and supported bone cell growth. The changes in fluorescence intensity correlated well with weight loss up to 16 weeks of in vitro culture and could be monitored over two weeks in vivo. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Cunha-Reis, Cassilda; El Haj, Alicia J.; Yang, Ying] Keele Univ, Sch Med, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.
   [Yang, Xuebin] Univ Leeds, Dept Oral Biol, Leeds LS2 9LU, W Yorkshire, England.
RP El Haj, AJ (reprint author), Keele Univ, Sch Med, Inst Sci & Technol Med, Thornburrow Dr, Stoke On Trent ST4 7QB, Staffs, England.
EM a.j.el.haj@bemp.keele.ac.uk
OI Cunha Reis, Cassilda/0000-0001-6886-3900; Yang, Ying/0000-0002-1362-6040
FU Marie Curie Actions; Alea Jacta; EXPERTISSUES Network of Excellence
   (NoE) [NMP3-CT-2004-500283];  [EST-MEST-CT-2004-008104]; Engineering and
   Physical Sciences Research Council [EP/H028277/1]
FX The authors would like to acknowledge Marie Curie Actions, Alea Jacta,
   EST-MEST-CT-2004-008104 and EXPERTISSUES Network of Excellence (NoE),
   NMP3-CT-2004-500283 for funding and Miss Yamuna Mohanram for technical
   support with animal experiments.
CR Agnihotri SA, 2006, J APPL POLYM SCI, V102, P3255, DOI 10.1002/app.24663
   Bingaman S, 2003, MICROCIRCULATION, V10, P221, DOI 10.1038/sj.mn.7800186
   Bohmer RM, 1996, MOL BIOL CELL, V7, P101
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Capek M, 2006, MICROSC RES TECHNIQ, V69, P624, DOI 10.1002/jemt.20330
   Cesaro SN, 1998, VIB SPECTROSC, V16, P5
   Cho HJ, 2006, BIOMATERIALS, V27, P544, DOI 10.1016/j.biomaterials.2005.06.026
   Dhanasingh S, 2010, INT J ENG APPL SCI, V6, P5
   DUNN KW, 1994, FASEB J, V8, P573
   Feng J, 2004, BIOCHEM BIOPH RES CO, V317, P414, DOI 10.1016/j.bbrc.2004.03.048
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Gareau DS, 2004, J BIOMED OPT, V9, P254, DOI 10.1117/1.1645798
   Giunchedi P, 1998, J CONTROL RELEASE, V56, P53, DOI 10.1016/S0168-3659(98)00068-6
   Graves EE, 2004, CURR MOL MED, V4, P419, DOI 10.2174/1566524043360555
   Han XX, 2009, BIOMATERIALS, V30, P423, DOI 10.1016/j.biomaterials.2008.10.001
   HANSEN LK, 1994, MOL BIOL CELL, V5, P967
   HEINRICHS M, 1994, ANAL QUANT CYTOL, V16, P233
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Jung C, 2006, J AM CHEM SOC, V128, P5283, DOI 10.1021/ja0588104
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Loo JSC, 2005, BIOMATERIALS, V26, P1359, DOI 10.1016/j.biomaterials.2004.05.001
   Lopez-Perez PM, 2007, J MATER CHEM, V17, P4064, DOI 10.1039/b707326g
   Luedtke MA, 2009, SKIN RES TECHNOL, V15, P482, DOI 10.1111/j.1600-0846.2009.00394.x
   Luna SM, 2011, J BIOMATER APPL, V26, P101, DOI 10.1177/0885328210362924
   Marois Y, 2000, J BIOMED MATER RES, V49, P216, DOI 10.1002/(SICI)1097-4636(200002)49:2<216::AID-JBM9>3.0.CO;2-X
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Meyer LE, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337294
   Model MA, 2000, J BIOMED MATER RES, V50, P90, DOI 10.1002/(SICI)1097-4636(200004)50:1<90::AID-JBM13>3.0.CO;2-3
   Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065
   Murphy CL, 2002, EXP PHYSIOL, V87, P163, DOI 10.1113/eph8702332
   MUZZARELLI RAA, 1995, ENZYME MICROB TECH, V17, P541, DOI 10.1016/0141-0229(94)00015-J
   Nagata M, 1999, MACROMOLECULES, V32, P7762, DOI 10.1021/ma990907l
   Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104
   Ntziachristos V, 2004, P NATL ACAD SCI USA, V101, P12294, DOI 10.1073/pnas.0401137101
   Ntziachristos Vasilis, 2002, Nature Medicine, V8, P757, DOI 10.1038/nm729
   Ntziachristos V, 2002, MOL IMAGING, V1, P82, DOI 10.1162/153535002320162732
   Park H, 2006, J BIOMED MATER RES A, V76A, P144, DOI 10.1002/jbm.a.30533
   Picart C, 2005, ADV FUNCT MATER, V15, P1771, DOI 10.1002/adfm.200400588
   Qiu YZ, 2009, J BIOMED MATER RES B, V90B, P668, DOI 10.1002/jbm.b.31333
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Renouf-Glauser AC, 2006, BIOMACROMOLECULES, V7, P612, DOI 10.1021/bm050746v
   ROMIJN HJ, 1994, BRAIN RES, V657, P245, DOI 10.1016/0006-8993(94)90974-1
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
   Wang JW, 2003, J MATER SCI-MATER M, V14, P1079, DOI 10.1023/B:JMSM.0000004005.52762.ea
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Wolbank S, 2008, 8 WORLD BIOM C AMST
   Wolf M, 2008, PHARMAZIE, V63, P43, DOI 10.1691/ph.2008.6711
   Yang J, 2009, P NATL ACAD SCI USA, V106, P10086, DOI 10.1073/pnas.0900004106
   Yang Y, 2005, ANALYST, V130, P1502, DOI 10.1039/b506911d
   Zhang QQ, 2000, ARTIF CELL BLOOD SUB, V28, P255, DOI 10.3109/10731190009119356
   Zhao W., 2005, ANGEW CHEM, V117, P1705
   Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899
   Zucker RM, 2006, CYTOM PART A, V69A, P930, DOI 10.1002/cyto.a.20315
NR 56
TC 21
Z9 21
U1 2
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2013
VL 7
IS 1
BP 39
EP 50
DI 10.1002/term.494
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 086AZ
UT WOS:000314656700005
PM 22125289
DA 2018-10-19
ER

PT J
AU Kuner, R
   Brase, JC
   Sultmann, H
   Wuttig, D
AF Kuner, Ruprecht
   Brase, Jan C.
   Sueltmann, Holger
   Wuttig, Daniela
TI microRNA biomarkers in body fluids of prostate cancer patients
SO METHODS
LA English
DT Review
DE miRNA; Body fluids; Prostate cancer; Biomarker
ID MESSENGER-RNA; CIRCULATING MICRORNAS; EXPRESSION SIGNATURE; LUNG-CANCER;
   SERUM; CELLS; CARCINOMA; PROFILES; PROTEIN; METHYLATION
AB The abundance of miRNAs - small non-coding RNAs involved in posttranscriptional regulation of gene expression - in tissues and body fluids of cancer patients hold great promise to identify specific biomarkers, which may be useful for early diagnosis as well as to predict the clinical outcome and treatment response. For the extraction and quantification of miRNAs from cells and tissues, present technologies for transcriptome analyses like microarrays, quantitative real-time PCR or next generation sequencing can be applied. However, the analyses of miRNAs in body fluids like serum or urine is still a challenge with respect to the nucleic acid recovery from very limited sources of biomaterial, normalization strategies and validation using independent technologies. The presence of specific miRNA patterns in body fluids like serum of cancer patients suggests a promising role of these molecules as surrogate markers. However, the majority of miRNA studies were addressed in relatively small patient cohorts limiting the validity and the clinical application of potential miRNA biomarkers or signatures. We reflect the critical steps to translate miRNA biomarker into clinical routine diagnostics and present future aspects for the fast, robust and standardized quantification of miRNAs in body fluids. (C) 2012 Elsevier Inc. All rights reserved.
C1 German Canc Res Ctr, Unit Canc Genome Res, Div Mol Genet, D-69120 Heidelberg, Germany.
   Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany.
RP Kuner, R (reprint author), German Canc Res Ctr, Unit Canc Genome Res, Neuenheimer Feld 460, D-69120 Heidelberg, Germany.
EM r.kuner@dkfz.de; jcbrase@gmx.de; h.sueltmann@dkfz.de; d.wuttig@dkfz.de
RI Sultmann, Holger/E-4534-2013
OI Sultmann, Holger/0000-0002-5257-8600
FU German Federal Ministry of Education and Science [FKZ: 01GS0890]
FX This review is linked to experimental studies, which were funded by the
   German Federal Ministry of Education and Science in the framework of the
   program for medical genome research (FKZ: 01GS0890). The authors thank
   Maria Falth and Stephan Gade for the stimulating discussion about miRNA
   research in cancer.
CR Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9
   Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144
   Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696
   Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108
   Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79
   Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154
   Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880
   Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306
   Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376
   Brett AS, 2011, NEW ENGL J MED, V365, P1949, DOI 10.1056/NEJMp1112191
   Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595
   Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370
   Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282
   Chen Z.H., 2012, PROSTATE
   Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822
   Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127
   Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023
   Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76
   Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3
   Debey-Pascher Svenja, 2012, Methods Mol Biol, V822, P307, DOI 10.1007/978-1-61779-427-8_22
   Driskell JD, 2010, CHEM COMMUN, V46, P3298, DOI 10.1039/c002059a
   Gary B, 2004, AM J PATHOL, V164, P1607, DOI 10.1016/S0002-9440(10)63719-4
   Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179
   Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241
   Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342
   Kirschner M.B., 2011, PLOS ONE, V6
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032
   Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x
   Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001
   Lodes M.J., 2009, PLOS ONE, V4, pe6229
   Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Lusi EA, 2009, ANAL CHEM, V81, P2819, DOI 10.1021/ac8026788
   Mahn L.C., 2011, UROLOGY, V77
   Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304
   Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815
   McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198
   Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105
   Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229
   Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809
   Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726
   Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421
   Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533
   Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001
   Rani S, 2011, METHODS MOL BIOL, V784, P181, DOI 10.1007/978-1-61779-289-2_13
   Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467
   Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827
   Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084
   Selth LA, 2012, INT J CANCER, V131, P652, DOI 10.1002/ijc.26405
   Shen J., 2012, PROSTATE
   Sieuwerts AM, 2011, CLIN CANCER RES, V17, P3600, DOI 10.1158/1078-0432.CCR-11-0255
   Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715
   Streichert T, 2011, METHODS MOL BIOL, V676, P253, DOI 10.1007/978-1-60761-863-8_18
   Suh SO, 2011, CARCINOGENESIS, V32, P772, DOI 10.1093/carcin/bgr036
   Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573
   Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443
   Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026
   Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918
   Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103
   Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276
   Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183
   Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405
   Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099
   White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173
   Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117
   Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246
NR 69
TC 29
Z9 31
U1 1
U2 60
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD JAN
PY 2013
VL 59
IS 1
BP 132
EP 137
DI 10.1016/j.ymeth.2012.05.004
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 084RB
UT WOS:000314555700015
PM 22652624
DA 2018-10-19
ER

PT J
AU De Rita, F
   Marchi, D
   Lucchese, G
   Barozzi, L
   Dissegna, R
   Menon, T
   Faggian, G
   Mazzucco, A
   Luciani, GB
AF De Rita, Fabrizio
   Marchi, Diego
   Lucchese, Gianluca
   Barozzi, Luca
   Dissegna, Roberta
   Menon, Tiziano
   Faggian, Giuseppe
   Mazzucco, Alessandro
   Luciani, Giovanni Battista
TI Comparison Between D901 Lilliput 1 and Kids D100 Neonatal Oxygenators:
   Toward Bypass Circuit Miniaturization
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Pediatric Mechanical Circulatory Support
   Systems and Pediatric Cardiopulmonary Perfusion
CY JUN 13-16, 2012
CL Istanbul, TURKEY
DE Oxygenators; Neonatal; Cardiopulmonary bypass; Biomaterial;
   Miniaturization
ID HYPOTHERMIC CARDIOPULMONARY BYPASS; BLOOD-TRANSFUSION; HEART-SURGERY;
   INFLAMMATORY RESPONSE; RANDOMIZED-TRIAL; PERFUSION; PRIME; INFANTS
AB Progress in biomaterial technology and improvements in surgical and perfusion strategy ameliorated morbidity and mortality in pediatric cardiac surgery. In this study, we describe our clinical experience comparing performance of two neonatal oxygenators. From January 2002 to March 2011, 159 infants with less than 5kg body weight underwent heart surgery. Ninety-four patients received a D901 Lilliput 1 oxygenator with standard bypass circuit (group A), while 65 received a D100 Kids with miniaturized bypass circuit (group B). Miniaturization consisted in shortened arterial, venous, cardioplegia, and pump-master lines. Priming composition consisted in Ringer's acetate solution with addition of albumin and blood, with target hematocrit of 24% or greater. In group B cardiopulmonary bypass (CPB) was vacuum-assisted and started with an empty venous line. Modified ultrafiltration and Cell-Saver blood infusion was routinely applied in both groups. Average+/-standard deviation (SD) age at repair was 37+/-38 days in group A and 59+/-60 days in group B (P=0.005). Average+/-SD weight, height, and body surface area were 3.5+/-0.7kg, 52+/-4cm, and 0.22+/-0.03m2, respectively, in group A, and 3.7+/-1kg, 53+/-5cm, and 0.23+/-0.02m2, respectively, in group B (P=not significant [NS]). Male sex was predominant (55 vs. 58%, P=NS). Priming volume was 524+/-67mL (group A) and 337+/-53mL (group B) (P=0.001). There were no statistical differences in hemoglobin at the start, during, and at the end of CPB, but group A required higher blood volume added to the prime (111+/-33 vs. 93+/-31mL, P=0.001). In group B, two surgical procedures were completed in total hemodilution. In group B, CPB time and aortic cross-clamp time were shorter than in group A (106+/-52 vs. 142+/-78min and 44+/-31 vs. 64+/-31min, respectively, P=0.001). There were 16 hospital deaths in group A and 4 in group B (P=0.04). Durations of mechanical ventilation and intensive care unit stay were 5.3+/-3.2 vs. 4.1+/-3.2 days (P=0.02) and 6.5+/-4.9 vs. 5.1+/-3 days (P=0.03), respectively. There were significant differences in inotropic score (1083+/-1175 vs. 682+/-938, P=0.04) and blood postoperative transfusion (153+/-226 vs. 90+/-61mL, P=0.04). Twenty-seven patients in group A and 10 in group B presented with major adverse postoperative complications (P=0.04). Use of neonatal oxygenators with low priming volume, associated with a miniaturized bypass circuit, seems to be a favorable strategy to decrease postoperative morbidity after cardiac surgery in neonates and infants.
C1 [De Rita, Fabrizio; Marchi, Diego; Lucchese, Gianluca; Barozzi, Luca; Dissegna, Roberta; Menon, Tiziano; Faggian, Giuseppe; Mazzucco, Alessandro; Luciani, Giovanni Battista] Univ Verona, Div Cardiac Surg, I-37126 Verona, Italy.
RP Luciani, GB (reprint author), Univ Verona, Div Cardiac Surg, OCM Piazzale Stefani 1, I-37126 Verona, Italy.
EM giovanni.luciani@univr.it
RI Faggian, Giuseppe/J-4590-2018
OI Faggian, Giuseppe/0000-0001-5371-5761; Luciani, Giovanni
   Battista/0000-0003-0931-018X
FU Cariverona Project
FX Supported by Institutional Funds from Cariverona Project.
CR Ando M, 2004, ANN THORAC SURG, V78, P1717, DOI 10.1016/j.athorascur.2004.05.006
   De Rita F, 2011, ARTIF ORGANS, V35, P1029, DOI 10.1111/j.1525-1594.2011.01355.x
   Durandy Y, 2007, ASAIO J, V53, P659, DOI 10.1097/MAT.0b013e31815b0cee
   Durandy Yves, 2010, Asian Cardiovasc Thorac Ann, V18, P386, DOI 10.1177/0218492310376675
   Durandy Y, 2009, ASAIO J, V55, P117, DOI 10.1097/MAT.0b013e31819142f1
   Golab HD, 2009, PERFUSION-UK, V24, P239, DOI 10.1177/0267659109348722
   GROOM RC, 1994, ANN THORAC SURG, V58, P573, DOI 10.1016/0003-4975(94)92267-5
   Hickey E, 2006, ANN THORAC SURG, V81, pS2367, DOI 10.1016/j.athoracsur.2006.02.071
   Jacobs JRP, 2005, ANN THORAC SURG, V80, P2278, DOI 10.1016/j.athoracsur.2005.05.107
   Jonas RA, 2003, J THORAC CARDIOV SUR, V126, P1765, DOI 10.1016/j.jtcvs.2003.04.003
   Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027
   Lawson DS, 2008, PERFUSION-UK, V23, P39, DOI 10.1177/0267659108092470
   McElhinney DB, 2001, CURR OPIN PEDIATR, V13, P104, DOI 10.1097/00008480-200104000-00003
   Merkle F, 2004, PERFUSION-UK, V19, P229, DOI 10.1191/0267659104pf744oa
   Molicki JS, 2001, J THORAC CARDIOV SUR, V122, P449, DOI 10.1067/mtc.2001.1115422
   Napoleone CP, 2008, J CARDIOVASC MED, V9, P716, DOI 10.2459/JCM.0b013e3282f3a1ca
   Newburger JW, 2008, J THORAC CARDIOV SUR, V135, P347, DOI 10.1016/j.jtcvs.2007.01.051
   Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676
NR 18
TC 3
Z9 3
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD JAN
PY 2013
VL 37
IS 1
BP E24
EP E28
DI 10.1111/aor.12017
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 072XG
UT WOS:000313706400008
PM 23305583
DA 2018-10-19
ER

PT J
AU Wang, HY
   Li, Y
   Qin, LX
   Heyman, A
   Shoseyov, O
   Willner, I
   Long, YT
   Tian, H
AF Wang, Hai-Yan
   Li, Yang
   Qin, Li-Xia
   Heyman, Arnon
   Shoseyov, Oded
   Willner, Itamar
   Long, Yi-Tao
   Tian, He
TI Single-molecule DNA detection using a novel SP1 protein nanopore
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID ALPHA-HEMOLYSIN NANOPORE; POLYNUCLEOTIDE MOLECULES; MEMBRANE-CHANNEL;
   DISCRIMINATION; TRANSLOCATION; PORE
AB SP1 protein as a new type of biological nanopore is described and is utilized to distinguish single-stranded DNA at the single-molecule level. Using the SP1 nanopore to investigate single molecule detection broadens the existing research areas of pore-forming biomaterials from unsymmetrical biological nanopores to symmetrical biological nanopores. This novel nanopore could provide a good candidate for single-molecule detection and characterization of biomaterial applications.
C1 [Wang, Hai-Yan; Li, Yang; Qin, Li-Xia; Long, Yi-Tao; Tian, He] E China Univ Sci & Technol, Key Lab Adv Mat, Shanghai 200237, Peoples R China.
   [Wang, Hai-Yan; Li, Yang; Qin, Li-Xia; Long, Yi-Tao; Tian, He] E China Univ Sci & Technol, Inst Fine Chem, Shanghai 200237, Peoples R China.
   [Wang, Hai-Yan; Li, Yang; Qin, Li-Xia; Long, Yi-Tao; Tian, He] E China Univ Sci & Technol, Dept Chem, Shanghai 200237, Peoples R China.
   [Heyman, Arnon; Shoseyov, Oded] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Fac Agr Food & Environm Qual Sci, Jerusalem, Israel.
   [Willner, Itamar] Hebrew Univ Jerusalem, Inst Chem, Ctr Nanosci & Nanotechnol, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, Ctr Nanosci & Nanotechnol, IL-91904 Jerusalem, Israel.
EM willnea@vms.huji.ac.il; yitaolong@ecust.edu.cn; tianhe@ecust.edu.cn
RI Long, Yitao/P-4089-2014
OI Long, Yitao/0000-0002-4466-3119; Long, Yitao/0000-0003-2571-7457
FU National Science Fund for Distinguished Young Scholars [21125522]; 973
   Program [2013CB733700]; National Natural Science Foundation of China
   [91027035, 21105028]; Science and Technology Commission of Shanghai
   Municipality Natural Science Foundation of Shanghai [11ZR1408900];
   Fundamental Research Funds for the Central Universities [WK1013002]
FX This research was supported by the National Science Fund for
   Distinguished Young Scholars (21125522), 973 Program (2013CB733700), the
   National Natural Science Foundation of China (91027035, 21105028),
   Science and Technology Commission of Shanghai Municipality Natural
   Science Foundation of Shanghai (11ZR1408900), and the Fundamental
   Research Funds for the Central Universities (WK1013002).
CR ADLER A, 1967, P NATL ACAD SCI USA, V57, P423, DOI 10.1073/pnas.57.2.423
   Butler TZ, 2007, BIOPHYS J, V93, P3229, DOI 10.1529/biophysj.107.107003
   Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106
   Dgany O, 2004, J BIOL CHEM, V279, P51516, DOI 10.1074/jbc.M409952200
   Gao C, 2008, ANAL CHEM, V81, P80
   Henrickson SE, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3328875
   Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770
   Mathe J, 2004, BIOPHYS J, V87, P3205, DOI 10.1529/biophysj.104.047274
   Medalsy I, 2008, NANO LETT, V8, P473, DOI 10.1021/nl072455t
   Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079
   Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406
   Muthukumar M, 2001, PHYS REV LETT, V86, P3188, DOI 10.1103/PhysRevLett.86.3188
   PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0
   Pastoriza-Gallego M., 2011, J AM CHEM SOC, P663
   Qin LX, 2012, ANGEW CHEM INT EDIT, V51, P140, DOI 10.1002/anie.201106482
   Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859
   Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106
   Wang HY, 2011, ANAL CHEM, V83, P1746, DOI 10.1021/ac1029874
   Wang WX, 2002, PLANT PHYSIOL, V130, P865, DOI 10.1104/pp.002436
   Wang Y., 2011, NAT NANOTECHNOL, V147, P1
   Ying YL, 2011, CHEM COMMUN, V47, P5690, DOI 10.1039/c0cc05787h
NR 21
TC 28
Z9 29
U1 4
U2 122
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
J9 CHEM COMMUN
JI Chem. Commun.
PY 2013
VL 49
IS 17
BP 1741
EP 1743
DI 10.1039/c3cc38939a
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 082WS
UT WOS:000314424700017
PM 23340583
DA 2018-10-19
ER

PT J
AU Mhuka, V
   Dube, S
   Nindi, MM
AF Mhuka, Vimbai
   Dube, Simiso
   Nindi, Mathew Muzi
TI Chemical, structural and thermal properties of Gonometa postica silk
   fibroin, a potential biomaterial
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Biopolymer; Fibroin; Gonometa species
ID BOMBYX-MORI SILK; SPIDER SILK; IN-VITRO; PHYSICAL-PROPERTIES;
   HEAT-TREATMENT; FIBERS; ACID; SEQUENCE; REGENERATION; CONFORMATION
AB In the present study, chemical, structural and thermal properties of fibroin from Gonometa postica, a wild silkmoth species were investigated. Silk from Gonometa rufobrunnea and Bombyx mori species were included in this study for comparison. The results indicated that G. postica and G. rufobrunnea silk exhibited similar properties whereas distinct differences were observed with B. mori silk. Amino acid analysis showed that glycine, alanine and serine accounted for more than 70% of the total amino acid content in all species. The amount of polar amino acids in Gonometa fibroin was significantly higher than for B. mori fibroin suggesting increased chemical reactivity of the former. The abundance of basic amino acids in Gonometa fibroin makes it a promising biomaterial in cell and tissue culture. Structural analysis revealed a unique beta-sheet structure of Gonometa fibroin which is comprised of both poly-alanine and poly-glycine-alanine sequences. The maximum decomposition temperatures for Gonometa and B. mori fibroin were 350 degrees C and 320 degrees C respectively. The influence of amino acid composition on structural and thermal properties of the silks is also discussed. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Mhuka, Vimbai; Dube, Simiso; Nindi, Mathew Muzi] Univ S Africa, Coll Sci Engn & Technol, Dept Chem, ZA-0003 Pretoria, South Africa.
RP Dube, S (reprint author), Univ S Africa, Coll Sci Engn & Technol, Dept Chem, POB 392, ZA-0003 Pretoria, South Africa.
EM dubes@unisa.ac.za
OI Dube, Simiso/0000-0003-1225-5812
FU National Research Foundation (NRF) [69081]; University of South Africa
   (UNISA); Organization for Women in Science for the Developing World
   (OWSD)
FX The authors gratefully acknowledge the National Research Foundation
   (NRF) (Grant number 69081) and the University of South Africa (UNISA)
   for financially supporting this project. We are also indebted to the
   Organization for Women in Science for the Developing World (OWSD) for
   awarding Ms. Mhuka with a postgraduate fellowship. We would also like to
   acknowledge Mr. J. A. Nyati, University of Pretoria (Department of
   Zoology & Entomology) and Elster Vermeulen for their assistance in
   sourcing varieties of silkworm cocoons. Special thanks to Dr. S.
   Chigome, Mr. H. Steyn, Ms. N. Baloyi and Mr. S. Radzirani for SEM
   analysis.
CR Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   Chang JC, 2005, POLYMER, V46, P7909, DOI 10.1016/j.polymer.2005.06.077
   Chattopadhyay R, 2008, J TEXTILE ENG, V54, P179
   Devi D, 2011, J TEXT I, V102, P527, DOI 10.1080/00405000.2010.498172
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   FREDDI G, 1994, J APPL POLYM SCI, V52, P775, DOI 10.1002/app.1994.070520608
   FREDDI G, 1993, J APPL POLYM SCI, V48, P99, DOI 10.1002/app.1993.070480110
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Gheysens T, 2011, BIOMACROMOLECULES, V12, P2257, DOI 10.1021/bm2003362
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Holland C, 2012, BIOPOLYMERS, V97, P362, DOI 10.1002/bip.22011
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   IIZUKA EISAKU, 1965, BIORHEOLOGY, V3, P1
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Kweon H, 2001, J APPL POLYM SCI, V82, P750, DOI 10.1002/app.1901
   Lee KH, 2005, FIBER POLYM, V6, P181, DOI 10.1007/BF02875641
   LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Reddy N, 2010, INT J BIOL MACROMOL, V46, P419, DOI 10.1016/j.ijbiomac.2010.02.013
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Teshome A, 2012, INT J BIOL MACROMOL, V50, P63, DOI 10.1016/j.ijbiomac.2011.09.025
   TSUKADA M, 1992, J APPL POLYM SCI, V46, P1945, DOI 10.1002/app.1992.070461107
   TSUKADA M, 1987, J POLYM SCI POL PHYS, V25, P1325, DOI 10.1002/polb.1987.090250610
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Valluzzi R, 2004, BIOMACROMOLECULES, V5, P696, DOI 10.1021/bm0343085
   Veldtman R, 2002, AFR ENTOMOL, V10, P127
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0
   Yuan QQ, 2010, POLYMER, V51, P6278, DOI 10.1016/j.polymer.2010.10.046
   Zahou E, 2000, ANAL BIOCHEM, V281, P115, DOI 10.1006/abio.2000.4549
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 39
TC 13
Z9 13
U1 0
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JAN
PY 2013
VL 52
BP 305
EP 311
DI 10.1016/j.ijbiomac.2012.09.010
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 076CO
UT WOS:000313934300045
PM 23000253
DA 2018-10-19
ER

PT J
AU Lai, JY
AF Lai, Jui-Yang
TI Corneal Stromal Cell Growth on Gelatin/Chondroitin Sulfate Scaffolds
   Modified at Different NHS/EDC Molar Ratios
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE gelatin; chondroitin sulfate; carbodiimide chemistry; scaffold; corneal
   keratocyte
ID TISSUE ENGINEERING APPLICATIONS; HYALURONIC-ACID HYDROGELS; LINKED
   GELATIN MEMBRANES; PIGMENT EPITHELIAL-CELLS; CHONDROITIN-SULFATE;
   CROSS-LINKING; IN-VITRO; SHEET TRANSPLANTATION; EXTRACELLULAR-MATRIX;
   CHITOSAN MATERIALS
AB A nanoscale modification strategy that can incorporate chondroitin sulfate (CS) into the cross-linked porous gelatin materials has previously been proposed to give superior performance for designed corneal keratocyte scaffolds. The purpose of this work was to further investigate the influence of carbodiimide chemistry on the characteristics and biofunctionalities of gelatin/CS scaffolds treated with varying N-hydroxysuccinimide (NHS)/1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride (EDC) molar ratios (0-1) at a constant EDC concentration of 10 mM. Results of Fourier transform infrared spectroscopy and dimethylmethylene blue assays consistently indicated that when the NHS to EDC molar ratio exceeds a critical level (i.e., 0.5), the efficiency of carbodiimide-mediated biomaterial modification is significantly reduced. With the optimum NHS/EDC molar ratio of 0.5, chemical treatment could achieve relatively high CS content in the gelatin scaffolds, thereby enhancing the water content, glucose permeation, and fibronectin adsorption. Live/Dead assays and interleukin-6 mRNA expression analyses demonstrated that all the test samples have good cytocompatibility without causing toxicity and inflammation. In the molar ratio range of NHS to EDC from 0 to 0.5, the cell adhesion ratio and proliferation activity on the chemically modified samples significantly increased, which is attributed to the increasing CS content. Additionally, the materials with highest CS content (0.143 +/- 0.007 nmol/10 mg scaffold) showed the greatest stimulatory effect on the biosynthetic activity of cultivated keratocytes. These findings suggest that a positive correlation is noticed between the NHS to EDC molar ratio and the CS content in the biopolymer matrices, thereby greatly affecting the corneal stromal cell growth.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC100-2628-E-182-004-MY3]; Chang Gung Memorial Hospital [CMRPD1B0451]
FX This work was supported by grant NSC100-2628-E-182-004-MY3 from the
   National Science Council of Republic of China and grant CMRPD1B0451 from
   Chang Gung Memorial Hospital. The author is grateful to Ya-Ting Li
   (Institute of Biochemical and Biomedical Engineering, Chang Gung
   University) for technical assistance.
CR Bassleer CT, 1998, OSTEOARTHR CARTILAGE, V6, P196, DOI 10.1053/joca.1998.0112
   Cao H, 2008, J MATER SCI-MATER M, V19, P567, DOI [10.1007/s10856-007-3281-5, 10.1007/S10856-007-3281-5]
   CHAYAKUL V, 1982, GRAEF ARCH CLIN EXP, V218, P145, DOI 10.1007/BF02215652
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c
   Hsiue GH, 2002, J BIOMED MATER RES, V61, P19, DOI 10.1002/jbm.2000
   Jayasuriya AC, 2003, J BIOMED MATER RES A, V66A, P260, DOI 10.1002/jbm.a.10536
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2012, MATERIALS, V5, P1986, DOI 10.3390/ma5101986
   Lai JY, 2012, INT J MOL SCI, V13, P10970, DOI 10.3390/ijms130910970
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leonard DW, 1997, BIOPHYS J, V72, P1382, DOI 10.1016/S0006-3495(97)78784-8
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liu YW, 2006, INVEST OPHTH VIS SCI, V47, P1869, DOI 10.1167/iovs.05-1339
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439
   Monti D, 2002, INT J PHARM, V232, P139, DOI 10.1016/S0378-5173(01)00907-3
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Smith SML, 2007, MATRIX BIOL, V26, P175, DOI 10.1016/j.matbio.2006.10.012
   Strehin I, 2010, BIOMATERIALS, V31, P2788, DOI 10.1016/j.biomaterials.2009.12.033
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599
   Wang HJ, 2009, ADV ATMOS SCI, V26, P613, DOI 10.1007/s00376-009-0613-z
   Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000
   YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zou XH, 2009, ACTA BIOMATER, V5, P1588, DOI 10.1016/j.actbio.2008.12.001
NR 48
TC 20
Z9 20
U1 5
U2 87
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2013
VL 14
IS 1
BP 2036
EP 2055
DI 10.3390/ijms14012036
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 077SS
UT WOS:000314048800118
PM 23337203
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Li, X
   He, JK
   Liu, YX
   Zhao, Q
   Wu, WQ
   Li, DC
   Jin, ZM
AF Li, Xiao
   He, Jiankang
   Liu, Yaxiong
   Zhao, Qian
   Wu, Wanquan
   Li, Dichen
   Jin, Zhongmin
TI Biomaterial Scaffolds with Biomimetic Fluidic Channels for Hepatocyte
   Culture
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE liver tissue engineering; scaffold; biomimetic vascular tree; dynamic
   culture; hepatocyte
ID 3-DIMENSIONAL SCAFFOLDS; TISSUE; FABRICATION; DESIGN
AB Biomaterial scaffolds play an important role in maintaining the viability and biological functions of highly metabolic hepatocytes in liver tissue engineering. One of the major challenges involves building a complex microchannel network inside three-dimensional (3D) scaffolds for efficient mass transportation. Here we presented a biomimetic strategy to generate a microchannel network within porous biomaterial scaffolds by mimicking the vascular tree of rat liver. The typical parameters of the blood vessels were incorporated into the biomimetic design of the microchannel network such as branching angle and diameter. Silk fibroin-gelatin scaffolds with biomimetic vascular tree were fabricated by combining micromolding, freeze drying and 3D rolling techniques. The relationship between the micro-channeled design and flow pattern was revealed by a flow experiment, which indicated that the scaffolds with biomimetic vascular tree exhibited unique capability in improving mass transportation inside the 3D scaffold. The 3D scaffolds, preseeded with primary hepatocytes, were dynamically cultured in a bioreactor system. The results confirmed that the pre-designed biomimetic microchannel network facilitated the generation and expansion of hepatocytes.
C1 [Li, Xiao; He, Jiankang; Liu, Yaxiong; Zhao, Qian; Wu, Wanquan; Li, Dichen; Jin, Zhongmin] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710054, Peoples R China.
RP Liu, YX (reprint author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710054, Peoples R China.
EM yaxiongliu@mail.xjtu.edu.cn
RI Li, Xiao/H-3014-2012
OI Li, Xiao/0000-0002-1200-8590
FU National High Technology Research and Development Program
   [2009AA043801]; Natural Science Foundation of China [51275386]
FX This work was funded by the National High Technology Research and
   Development Program (2009AA043801) and the Natural Science Foundation of
   China (51275386).
CR Bhandari RNB, 2001, TISSUE ENG, V7, P345, DOI 10.1089/10763270152044206
   Bhatia SN, 1999, BIOMED MICRODEVICES, V2, P131, DOI 10.1023/A:1009949704750
   Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156
   Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Gibson L J, 2001, PROGR MAT SCI, V46, P273
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guillotin B, 2011, TRENDS BIOTECHNOL, V29, P183, DOI 10.1016/j.tibtech.2010.12.008
   He JK, 2007, POLYMER, V48, P4578, DOI 10.1016/j.polymer.2007.05.048
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   Hoganson DM, 2010, TISSUE ENG PT A, V16, P1469, DOI [10.1089/ten.tea.2009.0118, 10.1089/ten.TEA.2009.0118]
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005
   Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liu YM, 1999, BIOMED CHROMATOGR, V13, P75, DOI 10.1002/(SICI)1099-0801(199902)13:1<75::AID-BMC817>3.0.CO;2-6
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Olivares AL, 2009, BIOMATERIALS, V30, P6142, DOI 10.1016/j.biomaterials.2009.07.041
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   Papenburg BJ, 2009, BIOMATERIALS, V30, P6228, DOI 10.1016/j.biomaterials.2009.07.057
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Song YS, 2009, ANAL BIOANAL CHEM, V395, P185, DOI 10.1007/s00216-009-2935-1
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Wang XH, 2007, TRENDS BIOTECHNOL, V25, P505, DOI 10.1016/j.tibtech.2007.08.010
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Yan YN, 2005, BIOMATERIALS, V26, P5864, DOI 10.1016/j.biomaterials.2005.02.027
NR 28
TC 4
Z9 7
U1 1
U2 67
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD JAN
PY 2013
VL 10
IS 1
BP 57
EP 64
DI 10.1016/S1672-6529(13)60199-7
PG 8
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 083AV
UT WOS:000314436000007
DA 2018-10-19
ER

PT J
AU Mandal, BB
   Gil, ES
   Panilaitis, B
   Kaplan, DL
AF Mandal, Biman B.
   Gil, Eun Seok
   Panilaitis, Bruce
   Kaplan, David L.
TI Laminar Silk Scaffolds for Aligned Tissue Fabrication
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE alignment; freeze drying; laminar scaffolds; silk
ID FIBROIN 3D SCAFFOLDS; IN-VIVO; OPTICAL INTERFEROMETRY; BIOMATERIALS;
   FIBERS; GROWTH; REPAIR; CELLS; VITRO; ACID)
AB 3D-biomaterial scaffolds with aligned architecture are of vital importance in tissue regeneration. A generic method is demonstrated to produce aligned biomaterial scaffolds using the physics of directional ice freezing. Homogeneously aligned 3D silk scaffolds with high porosity and alignment are prepared. The method can be adapted to a wide range of polymers and is devoid of any chemical reactions, thus avoiding potential complications associated with by-products. Mechanical properties and cellular responses with chondrocytes and bone-marrow-derived hMSCs are studied, assessing survival, proliferation, and differentiation. In vivo tests suggest biocompatibility of the matrices for future tissue engineering applications, specifically in areas where high cellular alignment is needed.
C1 [Mandal, Biman B.] Indian Inst Technol, Dept Biotechnol, Gauhati 781039, India.
   [Mandal, Biman B.; Gil, Eun Seok; Panilaitis, Bruce; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [EB002520, DE017207]; DARPA [W911NF-11-1-0079]
FX We thank the NIH (EB002520, DE017207) and DARPA (W911NF-11-1-0079) for
   support of these studies.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Butler MF, 2002, CRYST GROWTH DES, V2, P541, DOI 10.1021/cg02559le
   Butler MF, 2001, CRYST GROWTH DES, V1, P213, DOI 10.1021/cg005534q
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Ferrer ML, 2006, CHEM MATER, V18, P554, DOI 10.1021/cm052087z
   Fukasawa T, 2001, J AM CERAM SOC, V84, P230, DOI 10.1111/j.1151-2916.2001.tb00638.x
   Gutierrez MC, 2006, ADV MATER, V18, P1137, DOI 10.1002/adma.200502550
   Kenar H, 2011, BIOMATERIALS, V32, P5320, DOI 10.1016/j.biomaterials.2011.04.025
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   MAHLER W, 1980, NATURE, V285, P27, DOI 10.1038/285027a0
   Mandal BB, 2011, TISSUE ENG PT A, V17, P2749, DOI [10.1089/ten.tea.2011.0031, 10.1089/ten.TEA.2011.0031]
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   McCann JT, 2006, J AM CHEM SOC, V128, P1436, DOI 10.1021/ja056810y
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mukai SR, 2004, CHEM MATER, V16, P4987, DOI 10.1021/cm0491328
   Mukai SR, 2004, CHEM COMMUN, P874, DOI 10.1039/b316597c
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Yang F, 2006, BIOMATERIALS, V27, P4923, DOI 10.1016/j.biomaterials.2006.05.028
   Zhang H, 2007, ADV MATER, V19, P1529, DOI 10.1002/adma.200700154
   Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487
NR 44
TC 25
Z9 27
U1 3
U2 62
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JAN
PY 2013
VL 13
IS 1
BP 48
EP 58
DI 10.1002/mabi.201200230
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 075UT
UT WOS:000313913100007
PM 23161731
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hsiao, MH
   Lin, KH
   Liu, DM
AF Hsiao, Meng-Hsuan
   Lin, Kuan-Hui
   Liu, Dean-Mo
TI Improved pH-responsive amphiphilic carboxymethyl-hexanoyl
   chitosan-poly(acrylic acid) macromolecules for biomedical applications
SO SOFT MATTER
LA English
DT Article
ID SELF-ASSEMBLED NANOPARTICLES; DRUG-DELIVERY; POLY(ACRYLIC ACID);
   POLYMERIC MICELLES; CHITOSAN NANOPARTICLES; ANTITUMOR-ACTIVITY;
   BLOCK-COPOLYMER; DOXORUBICIN; CARRIERS; RELEASE
AB In this communication, we report a new type of amphiphilic carboxymethyl-hexanoyl chitosan (CHC)-poly(acrylic acid) (PAA) hybrid macromolecule, which was successfully prepared through polymerization of acrylic acid (AA) in the presence of amphiphilic CHC. The chemical structure of the hybrid was characterized by FT-IR and H-1 NMR, which confirmed a chemical linkage between the amine groups of CHC and hydroxyl groups of AA. This CHC-PAA hybrid exhibited amphiphilic property as the original CHC rendering the self-assembling capability to be tunable in terms of AA concentration. Compared with the existing pristine chitosan-PAA co-polymers, this CHC-PAA hybrid exhibited a relatively high pH-responsive volumetric change by 10-100 times compared with the existing alternatives reported in the literature. The hybrid nanoparticles showed excellent encapsulation efficiency greater than 90% for a hydrophobic anti-cancer substance, (S)-(+)-camptothecin. A pH-responsive drug release behavior was systematically evaluated. Besides, this hybrid also revealed excellent cytocompatibility towards the MCF-7 and BCE cell lines, which, associated with its structural stability, suggests this new type of CHC-PAA hybrid to be a promising biomaterial for oral drug delivery application.
C1 [Hsiao, Meng-Hsuan; Lin, Kuan-Hui; Liu, Dean-Mo] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 300, Taiwan.
RP Liu, DM (reprint author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, 1001 Ta Hsueh Rd, Hsinchu 300, Taiwan.
EM deanmo_liu@yahoo.ca
FU National Science Council, Taiwan, Republic of China
   [NSC-100-2622-M-009-002-CC3]
FX The authors would like to thank the National Science Council, Taiwan,
   Republic of China, for the financial support under a project contract of
   NSC-100-2622-M-009-002-CC3.
CR Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653
   Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166
   Barbani N, 1999, J APPL POLYM SCI, V72, P971, DOI 10.1002/(SICI)1097-4628(19990516)72:7<971::AID-APP13>3.0.CO;2-N
   Chae SY, 2005, J CONTROL RELEASE, V109, P330, DOI 10.1016/j.jconrel.2005.09.040
   Chuang CY, 2009, J POLYM SCI POL CHEM, V47, P2798, DOI 10.1002/pola.23369
   CUROTTO E, 1993, ANAL BIOCHEM, V211, P240, DOI 10.1006/abio.1993.1263
   Friedman M, 2004, J AGR FOOD CHEM, V52, P385, DOI 10.1021/jf030490p
   Fu LS, 2004, CHEM MATER, V16, P1507, DOI 10.1021/cm035028z
   Hu FQ, 2009, BIOMATERIALS, V30, P6955, DOI 10.1016/j.biomaterials.2009.09.008
   Hu Y, 2002, BIOMATERIALS, V23, P3193, DOI 10.1016/S0142-9612(02)00071-6
   Jin YH, 2012, COLLOID SURFACE B, V94, P184, DOI 10.1016/j.colsurfb.2012.01.032
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kim K, 2010, J CONTROL RELEASE, V146, P219, DOI 10.1016/j.jconrel.2010.04.004
   Kurkuri MD, 2004, J CONTROL RELEASE, V96, P9, DOI 10.1016/j.jconrel.2003.12.025
   Lee CM, 2011, BIOCONJUGATE CHEM, V22, P186, DOI 10.1021/bc100241a
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Lee SJ, 2011, J CONTROL RELEASE, V152, P21, DOI 10.1016/j.jconrel.2011.03.027
   Lin CL, 2005, J COLLOID INTERF SCI, V291, P411, DOI 10.1016/j.jcis.2005.05.023
   Liu JH, 2011, POLYM ADVAN TECHNOL, V22, P627, DOI 10.1002/pat.1558
   Liu KH, 2008, MACROMOLECULES, V41, P6511, DOI 10.1021/ma8002399
   Liu TY, 2006, LANGMUIR, V22, P9740, DOI 10.1021/la061471n
   Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001
   Nakanishi T, 2001, J CONTROL RELEASE, V74, P295, DOI 10.1016/S0168-3659(01)00341-8
   Nasongkla N., 2004, ANGEW CHEM, V116, P6483
   Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006
   Oerlemans C, 2010, PHARM RES-DORDR, V27, P2569, DOI 10.1007/s11095-010-0233-4
   Park JH, 2006, BIOMATERIALS, V27, P119, DOI 10.1016/j.biomaterials.2005.05.028
   Park JS, 2006, J CONTROL RELEASE, V115, P37, DOI 10.1016/j.jconrel.2006.07.011
   Saravanakumar G, 2009, J CONTROL RELEASE, V140, P210, DOI 10.1016/j.jconrel.2009.06.015
   Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9
   Wang JJ, 2011, INT J NANOMED, V6, P765, DOI 10.2147/IJN.S17296
   Wang WW, 2012, ADV MATER, V24, P115, DOI 10.1002/adma.201104066
   Wu WT, 2010, BIOMATERIALS, V31, P3023, DOI 10.1016/j.biomaterials.2010.01.011
   Yoo HS, 2001, J CONTROL RELEASE, V70, P63, DOI 10.1016/S0168-3659(00)00340-0
   Zhang SS, 2011, J APPL POLYM SCI, V121, P3359, DOI 10.1002/app.33977
   Zheng C, 2011, J COLLOID INTERF SCI, V355, P374, DOI 10.1016/j.jcis.2010.12.004
   Zheng H, 2011, CARBOHYD POLYM, V83, P1952, DOI 10.1016/j.carbpol.2010.10.069
   Zhou HF, 2010, BIOMACROMOLECULES, V11, P3480, DOI 10.1021/bm100989x
   Zhu HY, 2011, CARBOHYD POLYM, V86, P1118, DOI 10.1016/j.carbpol.2011.05.061
NR 39
TC 18
Z9 20
U1 1
U2 74
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2013
VL 9
IS 8
BP 2458
EP 2466
DI 10.1039/c2sm27610k
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 080UE
UT WOS:000314268200015
DA 2018-10-19
ER

PT J
AU Sethi, A
   Slack, JM
   Kovaleva, ES
   Buchman, GW
   Scharf, ME
AF Sethi, Amit
   Slack, Jeffrey M.
   Kovaleva, Elena S.
   Buchman, George W.
   Scharf, Michael E.
TI Lignin-associated metagene expression in a lignocellulose-digesting
   termite
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Reticulitermes flavipes; Recombinant enzymes; Lignin; Cellulose;
   Hemicellulose; Biofuel
ID RETICULITERMES-FLAVIPES; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE;
   PROTEIN-PRODUCTION; INSECT LARVAE; GUT; ISOPTERA; PROTOZOA; HOST
AB Lignin is a component of plant biomass that presents a significant obstacle to biofuel production. It is composed of a highly stable phenylpropanoid matrix that upon degradation, releases toxic metabolites. Termites have specialized digestive systems that overcome the lignin barrier in wood lignocellulose to efficiently release fermentable simple sugars; however, how termites specifically degrade lignin and tolerate its toxic byproducts remains unknown. Here, using the termite Reticulitermes flavipes and its symbiotic (protozoan) gut fauna as a model system, we used high throughput Roche 454-titanium pyrosequencing and proteomics approaches to (i) experimentally compare the effects of diets containing varying degrees of lignin complexity on host-symbiont digestome composition, (ii) deeply sample host and symbiont lignocellulase diversity, and (iii) identify promising lignocellulase candidates for functional characterization. In addition to revealing over 9500 differentially expressed transcripts related to a wide range of physiological processes, our findings reveal two detoxification enzyme families not generally considered in connection with lignocellulose digestion: aldo-keto reductases and catalases. Recombinant versions of two host enzymes from these enzyme families, which apparently play no roles in cellulose or hemicellulose digestion, significantly enhance lignocellulose saccharification by cocktails of host and symbiont cellulases. These hypothesis-driven results provide important new insights into (i) dietary lignin as a xenobiotic challenge, (ii) the complex mechanisms used by termites to cope with their lignin-rich diets, and (iii) novel lignin-targeted enzymatic approaches to enhance biofuel and biomaterial production. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Sethi, Amit; Scharf, Michael E.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.
   [Slack, Jeffrey M.; Kovaleva, Elena S.; Buchman, George W.] Chesapeake PERL Inc, Savage, MD USA.
RP Scharf, ME (reprint author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.
EM mscharf@purdue.edu
FU USDA-NIFA-AFRI [2009-05245]; Phase I and II DOE-SBIR [DE-FG02-08ER85063,
   DE-85538 S08-II]
FX We thank Philip San Miguel, Rick Westerman, and Samuel Martin of the
   Purdue University Genomics Core for pyrosequencing sequencing and
   first-pass analysis, Marjorie Chow, Carolyn Diaz and Jin Koh of the
   University of Florida ICBR Proteomics Core Facility for assistance with
   proteomics, Drion Boucias, Rhitoban Raychoudhury, Ruchira Sen and
   Zachary Karl for helpful discussions; Andres Sandoval for help with
   Genbank data submission and discussions; and Jesse Hoteling for termite
   rearing. This work was supported by USDA-NIFA-AFRI grant no. 2009-05245
   to MES, and Phase I and II DOE-SBIR grant nos. DE-FG02-08ER85063 and
   DE-85538 S08-II to Chesapeake-PERL Inc. (Savage, MD) and MES. Contig
   sequences are deposited under the accession numbers KA650619-KA659892.
CR Blumberg B., 2009, METHOD MOL BIOL, V461, P555
   BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672
   BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321
   BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   Cleveland L.R., 1924, BIOL BULL, V46, P177
   Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424
   Coy MR, 2010, INSECT BIOCHEM MOLEC, V40, P723, DOI 10.1016/j.ibmb.2010.07.004
   Ford G, 2001, CHEM-BIOL INTERACT, V130, P685, DOI 10.1016/S0009-2797(00)00259-3
   Friedman DB, 2004, PROTEOMICS, V4, P793, DOI 10.1002/pmic.200300635
   Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105
   Hamilton C., 2011, J INSECT PHYSL, V57, P259
   Hungate RE, 1938, ECOLOGY, V19, P1, DOI 10.2307/1930363
   Ke J, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-17
   Kovaleva ES, 2009, BIOTECHNOL LETT, V31, P381, DOI 10.1007/s10529-008-9883-2
   KUHN A, 1995, APPL ENVIRON MICROB, V61, P1580
   KUPFER D, 1972, BIOCHEM BIOPH RES CO, V47, P611, DOI 10.1016/0006-291X(72)90922-9
   Leidy J., 1881, J ACAD NAT SCI-PHILA, V8, P425
   Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1
   Liu Yi, 2007, V388, P267
   NEWSHOLME EA, 1978, BIOCHEM J, V172, P533, DOI 10.1042/bj1720533
   Nutting W.L., 1990, SOIL BIOL GUIDE, V33, P997
   O'Connell KP, 2007, MOL BIOTECHNOL, V36, P44, DOI 10.1007/s12033-007-0014-4
   Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z
   Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15
   Pettersen RC, 1984, CHEM SOLID WOOD, V207, P57, DOI DOI 10.1021/BA-1984-0207.CH002
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Raychoudhury R., 2012, INSECT MOL IN PRESS
   REID ID, 1994, APPL ENVIRON MICROB, V60, P1395
   Ritter S, 2008, PLANT BIOCH, V86, P15
   Roche Inc, 2010, 454 SEQ SYST SOFTW M
   Roche Inc, 2010, EMPCR METH MAN LIB L
   Roche Inc, 2010, RAP LIB PREP METH MA
   Roche Inc, 2010, GS FLX TIT SER
   Scharf ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021709
   Scharf ME, 2010, INSECT BIOCHEM MOLEC, V40, P611, DOI 10.1016/j.ibmb.2010.06.002
   Scharf ME, 2010, INSECT SCI, V17, P166, DOI 10.1111/j.1744-7917.2009.01309.x
   Scharf ME, 2008, BIOFUEL BIOPROD BIOR, V2, P540, DOI 10.1002/bbb.107
   Scharf Michael E., 2008, V442, P205, DOI 10.1007/978-1-59745-191-8_15
   Sethi A, 2011, COMP BIOCHEM PHYS A, V159, P261, DOI 10.1016/j.cbpa.2011.03.012
   Shim SY, 2009, FOOD CHEM TOXICOL, V47, P555, DOI 10.1016/j.fct.2008.12.012
   Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108
   Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007
   Szalanski AL, 2003, J ECON ENTOMOL, V96, P1514, DOI 10.1603/0022-0493-96.5.1514
   Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25
   Tarver MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-28
   Todaka N, 2007, FEMS MICROBIOL ECOL, V59, P592, DOI 10.1111/j.1574-6941.2006.00237.x
   Todaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008636
   Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269
   Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260
   Wheeler MM, 2010, ARCH INSECT BIOCHEM, V73, P30, DOI 10.1002/arch.20333
   Wilson E. O., 1971, INSECT SOC
   Zhou X, 2006, INSECT MOL BIOL, V15, P749, DOI 10.1111/j.1365-2583.2006.00675.x
   Zhou XG, 2007, GENE, V395, P29, DOI 10.1016/j.gene.2007.01.004
   Zhou XG, 2010, ARCH INSECT BIOCHEM, V74, P147, DOI 10.1002/arch.20368
NR 55
TC 36
Z9 38
U1 0
U2 80
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD JAN
PY 2013
VL 43
IS 1
BP 91
EP 101
DI 10.1016/j.ibmb.2012.10.001
PG 11
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA 076CT
UT WOS:000313934800010
PM 23108206
DA 2018-10-19
ER

PT J
AU de Cogan, F
   Booth, A
   Gough, JE
   Webb, SJ
AF de Cogan, Felicity
   Booth, Andrew
   Gough, Julie E.
   Webb, Simon J.
TI Spatially controlled apoptosis induced by released nickel(II) within a
   magnetically responsive nanostructured biomaterial
SO SOFT MATTER
LA English
DT Article
ID ALGINATE HYDROGELS; HYBRIDOMA CELLS; DRUG-DELIVERY; CALCEIN-BLUE;
   LIPOSOMES; NANOPARTICLES; FIBRONECTIN; VESICLES; THERAPY; REPAIR
AB Magnetically patterned and responsive biomaterials have been shown to produce spatially controlled cell death in response to a magnetic signal. The responsive elements in these nano-structured biomaterials are magnetic nanoparticle-vesicle assemblies (MNPVs), which are thermally sensitive vesicles crosslinked by magnetic nanoparticles. MNPVs are nano-sized drug delivery platforms that are responsive to magnetic fields in two ways: they can be spatially manipulated by static magnetic fields, and upon exposure to an alternating magnetic field (AMF) they can release chemical messengers stored within the vesicles. Magnetically initiated release of nickel(II) from MNPVs immobilised in an alginate hydrogel was used to produce remotely triggered and spatially controlled apoptosis of fibroblasts cultured in the hydrogel. The ability to manipulate MNPVs with static magnetic fields was used to immobilise the MNPVs in only one region of the biomaterial; subsequent AMF-induced release of nickel(II) caused a wave of cellular apoptosis through the biomaterial as the nickel(II) slowly diffused through the hydrogel.
C1 [de Cogan, Felicity; Booth, Andrew; Webb, Simon J.] Univ Manchester, MIB, Manchester M1 7DN, Lancs, England.
   [de Cogan, Felicity; Booth, Andrew; Webb, Simon J.] Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England.
   [de Cogan, Felicity; Booth, Andrew; Gough, Julie E.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.
RP Gough, JE (reprint author), Univ Manchester, Sch Mat, Grosvenor St, Manchester M13 9PL, Lancs, England.
EM J.Gough@manchester.ac.uk; S.Webb@manchester.ac.uk
OI Webb, Simon/0000-0001-9793-8748; Booth, Andrew/0000-0001-6210-2115
FU BBSRC; Biotechnology and Biological Sciences Research Council
   [BB/F011547/1, 996810]
FX The authors gratefully acknowledge the BBSRC for financial support and
   FdC thanks Mr M. Faulkner for ESEM.
CR Aili D, 2011, NANO LETT, V11, P1401, DOI 10.1021/nl1024062
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Barbucci R, 2012, ACTA BIOMATER, V8, P4244, DOI 10.1016/j.actbio.2012.09.006
   Barton P, 2002, ANGEW CHEM INT EDIT, V41, P3878, DOI 10.1002/1521-3773(20021018)41:20<3878::AID-ANIE3878>3.0.CO;2-F
   Bealle G, 2012, LANGMUIR, V28, P11843, DOI 10.1021/la3024716
   Beaune G, 2011, SOFT MATTER, V7, P6248, DOI 10.1039/c1sm05279a
   Bhosale S, 2006, SCIENCE, V313, P84, DOI 10.1126/science.1126524
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Bisby RH, 2000, BIOCHEM BIOPH RES CO, V276, P169, DOI 10.1006/bbrc.2000.3456
   Bothun GD, 2011, NANOMED-NANOTECHNOL, V7, P797, DOI 10.1016/j.nano.2011.02.007
   Brizard A, 2008, ANGEW CHEM INT EDIT, V47, P2063, DOI 10.1002/anie.200704609
   Brouckaert P, 2004, INT J CANCER, V109, P442, DOI 10.1002/ijc.11703
   Brule S, 2011, ADV MATER, V23, P787, DOI 10.1002/adma.201003763
   Dally H, 1997, CARCINOGENESIS, V18, P1021, DOI 10.1093/carcin/18.5.1021
   de Cogan F, 2011, ANGEW CHEM INT EDIT, V50, P12290, DOI 10.1002/anie.201103469
   de Cogan F, 2011, J MATER SCI-MATER M, V22, P1045, DOI 10.1007/s10856-011-4271-1
   Drake P, 2007, J MATER CHEM, V17, P4914, DOI 10.1039/b711962c
   Galie PA, 2011, CARDIOVASC PATHOL, V20, P325, DOI 10.1016/j.carpath.2010.10.001
   Galloway JM, 2012, SMALL, V8, P204, DOI 10.1002/smll.201101627
   Gu HW, 2005, J AM CHEM SOC, V127, P34, DOI 10.1021/ja045220h
   Guan FQ, 2007, TOXICOL APPL PHARM, V221, P86, DOI 10.1016/j.taap.2007.01.029
   Heath MD, 2010, LANGMUIR, V26, P5304, DOI 10.1021/la100678n
   Heywood HK, 2004, TISSUE ENG, V10, P1467, DOI 10.1089/ten.2004.10.1467
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   HUITINK GM, 1974, TALANTA, V21, P1221, DOI 10.1016/0039-9140(74)80143-8
   IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Karanth H, 2007, J PHARM PHARMACOL, V59, P469, DOI 10.1211/jpp.59.4.0001
   Kim K, 2002, TOXICOL APPL PHARM, V185, P41, DOI 10.1006/taap.2002.9513
   Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/NNANO.2011.95, 10.1038/nnano.2011.95]
   Leng F., 2010, MATER RES SOC S P, V1272, P1272
   Liem KP, 2007, J AM CHEM SOC, V129, P12080, DOI 10.1021/ja075000e
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Liu XX, 2003, POLYMER, V44, P407, DOI 10.1016/S0032-3861(02)00771-1
   Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lynn S, 1997, ENVIRON MOL MUTAGEN, V29, P208
   Ma MM, 2009, J AM CHEM SOC, V131, P16919, DOI 10.1021/ja9072657
   Mart RJ, 2009, CHEM COMMUN, P2287, DOI 10.1039/b901472a
   Mart RJ, 2009, PHARM RES-DORD, V26, P1701, DOI 10.1007/s11095-009-9880-8
   Menger FM, 1998, ACCOUNTS CHEM RES, V31, P789, DOI 10.1021/ar970103v
   Mishra D, 2011, MAT SCI ENG C-MATER, V31, P1295, DOI 10.1016/j.msec.2011.04.007
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Mourtas S, 2007, COLLOID SURFACE B, V55, P212, DOI 10.1016/j.colsurfb.2006.12.005
   Nappini S, 2011, J PHYS CHEM LETT, V2, P713, DOI 10.1021/jz2000936
   Noble GT, 2012, J AM CHEM SOC, V134, P13010, DOI 10.1021/ja302506t
   Ong W, 2008, J AM CHEM SOC, V130, P14739, DOI 10.1021/ja8050469
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Patel E, 2012, TOXICOL APPL PHARM, V258, P367, DOI 10.1016/j.taap.2011.11.019
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   PHILLIPS D, 1971, ANAL LETT, V4, P867
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pradhan P, 2010, J CONTROL RELEASE, V142, P108, DOI 10.1016/j.jconrel.2009.10.002
   Preiss MR, 2011, EXPERT OPIN DRUG DEL, V8, P1025, DOI 10.1517/17425247.2011.584868
   Pulido MD, 2003, MUTAT RES-FUND MOL M, V533, P227, DOI 10.1016/j.mrfmmm.2003.07.015
   Rodriguez-Llansola F, 2011, CHEM COMMUN, V47, P4706, DOI 10.1039/c1cc10640f
   Samanta B, 2008, J MATER CHEM, V18, P1204, DOI 10.1039/b718745a
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   Satarkar N. S., 2010, SOFT MATTER, V6, P2364
   SCOTT BJ, 1983, CLIN CHEM, V29, P629
   Stano P, 2011, J MATER CHEM, V21, P18887, DOI 10.1039/c1jm12298c
   Stupp SI, 2010, NANO LETT, V10, P4783, DOI 10.1021/nl103567y
   Taktak S, 2007, ANAL CHEM, V79, P8863, DOI 10.1021/ac701976p
   Tejada-Berges T, 2002, Expert Rev Anticancer Ther, V2, P143, DOI 10.1586/14737140.2.2.143
   Tian YF, 2011, SOFT MATTER, V7, P6005, DOI 10.1039/c1sm05504f
   TOONEY NM, 1983, J CELL BIOL, V97, P1686, DOI 10.1083/jcb.97.6.1686
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Webber RE, 2004, MACROMOLECULES, V37, P6153, DOI 10.1021/ma049274n
   Woolfson DN, 2010, CHEM SOC REV, V39, P3464, DOI 10.1039/c0cs00032a
   Wu GH, 2008, J AM CHEM SOC, V130, P8175, DOI 10.1021/ja802656d
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
NR 74
TC 10
Z9 10
U1 0
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2013
VL 9
IS 7
BP 2245
EP 2253
DI 10.1039/c2sm27379a
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 075OR
UT WOS:000313896900018
DA 2018-10-19
ER

PT J
AU Azagarsamy, MA
   Anseth, KS
AF Azagarsamy, Malar A.
   Anseth, Kristi S.
TI Bioorthogonal Click Chemistry: An Indispensable Tool to Create
   Multifaceted Cell Culture Scaffolds
SO ACS MACRO LETTERS
LA English
DT Article
ID 3-DIMENSIONAL HYDROGELS; PEG HYDROGELS; DESIGN; GROWTH;
   PHOTOPOLYMERIZATIONS; FUNCTIONALITY; ENCAPSULATION; SELECTIVITY;
   MOLECULES; MECHANISM
AB Over the past decade, bioorthogonal click chemistry has led the field of biomaterial science into a new era of diversity and complexity by its extremely selective, versatile, and biocompatible nature. In this viewpoint, we seek to emphasize recent endeavors of exploiting this versatile chemistry toward the development of poly(ethylene glycol) hydrogels as cell culture scaffolds. In these cell-laden materials, the orthogonality of these reactions has played an effective role in allowing the creation of diverse biochemical patterns in complex biological environments that provide new found opportunities for researchers to delineate and control cellular phenotypes more precisely than ever.
C1 [Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Dept Chem & Biol Engn, Boulder, CO 80303 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.
RP Anseth, KS (reprint author), Univ Colorado, BioFrontiers Inst, Dept Chem & Biol Engn, 596 UCB Boulder, Boulder, CO 80303 USA.
EM kristi.anseth@colorado.edu
FU National Science Foundation [DM 1006711D]; Howard Hughes Medical
   Institute
FX The authors would like to thank the National Science Foundation (DM
   1006711D) and the Howard Hughes Medical Institute for their financial
   support.
CR Adzima BJ, 2011, NAT CHEM, V3, P256, DOI 10.1038/NCHEM.980
   Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja0449981
   Aimetti AA, 2010, CHEM COMMUN, V46, P5781, DOI 10.1039/c0cc01292k
   Baldwin A. D., 2011, BIOCONJUGATE CHEM, V22, P1946
   Barner-Kowollik C, 2011, ANGEW CHEM INT EDIT, V50, P60, DOI 10.1002/anie.201003707
   Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104
   Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726
   Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Brantley JN, 2011, SCIENCE, V333, P1606, DOI 10.1126/science.1207934
   Codelli JA, 2008, J AM CHEM SOC, V130, P11486, DOI 10.1021/ja803086r
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Devaraj NK, 2008, BIOCONJUGATE CHEM, V19, P2297, DOI 10.1021/bc8004446
   Dondoni A, 2008, ANGEW CHEM INT EDIT, V47, P8995, DOI 10.1002/anie.200802516
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Fairbanks BD, 2009, MACROMOLECULES, V42, P211, DOI 10.1021/ma801903w
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Golas PL, 2010, CHEM SOC REV, V39, P1338, DOI 10.1039/b901978m
   Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269
   Gupta N, 2010, NAT CHEM, V2, P138, DOI [10.1038/NCHEM.478, 10.1038/nchem.478]
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEE J, 1989, J AM CHEM SOC, V111, P1522, DOI 10.1021/ja00186a070
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083
   Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Lowe AB, 2010, J MATER CHEM, V20, P4745, DOI 10.1039/b917102a
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001
   McCall JD, 2012, BIOMACROMOLECULES, V13, P2410, DOI 10.1021/bm300671s
   Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Seitchik JL, 2012, J AM CHEM SOC, V134, P2898, DOI 10.1021/ja2109745
   Shikanov A, 2011, BIOMATERIALS, V32, P2524, DOI 10.1016/j.biomaterials.2010.12.027
   Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Wiggins KM, 2012, ACS MACRO LETT, V1, P623, DOI 10.1021/mz300167y
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 62
TC 104
Z9 104
U1 3
U2 115
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2161-1653
J9 ACS MACRO LETT
JI ACS Macro Lett.
PD JAN
PY 2013
VL 2
IS 1
BP 5
EP 9
DI 10.1021/mz300585q
PG 5
WC Polymer Science
SC Polymer Science
GA 071PF
UT WOS:000313606000002
PM 23336091
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Calvie, E
   Joly-Pottuz, L
   Esnouf, C
   Douillard, T
   Gremillard, L
   Malchere, A
   Chevalier, J
   Masenelli-Varlot, K
AF Calvie, E.
   Joly-Pottuz, L.
   Esnouf, C.
   Douillard, T.
   Gremillard, L.
   Malchere, A.
   Chevalier, J.
   Masenelli-Varlot, K.
TI Evidence for the formation of distorted nanodomains involved in the
   phase transformation of stabilized zirconia by coupling convergent beam
   electron diffraction and in situ TEM nanoindentation
SO ACTA MATERIALIA
LA English
DT Article
DE Transmission electron microscopy; In situ; CBED; Zirconia
ID ARC-MELTED ZRO2-2MOL-PERCENT-Y2O3; MONOCLINIC TRANSFORMATION; CBED
   PATTERNS; SPECIMEN PREPARATION; GRAIN-BOUNDARY; SIMULATION; ZRO2-Y2O3;
   STRESS; VIEW; MG
AB The transformation of zirconia from its tetragonal to its monoclinic phase is an important feature of the zirconia system. First found to be an advantage due to its important toughening effect, it can also be very detrimental when it occurs in the framework of low-temperature degradation, particularly in the case of biomaterial applications. One way to avoid or to control this phase transformation is to understand how it initiates and more particularly the stress states that can trigger it. A new technique available inside a transmission electron microscope seems to be particularly well suited for that type of study: convergent beam electron diffraction, a well-known technique to reveal stresses, was coupled to in situ transmission electron microscopy mechanical nanoindentation. The experiments reveal the presence of sheared nanoregions at grain boundaries. These could act as embryos for tetragonal-to-monoclinic phase transformations. This is an important first step in the understanding of the earliest stage of zirconia phase transformation. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Calvie, E.; Joly-Pottuz, L.; Esnouf, C.; Douillard, T.; Gremillard, L.; Malchere, A.; Chevalier, J.; Masenelli-Varlot, K.] INSA Lyon, MATEIS UMR5510, F-69621 Villeurbanne, France.
RP Joly-Pottuz, L (reprint author), INSA Lyon, MATEIS UMR5510, 7 Ave J Capelle, F-69621 Villeurbanne, France.
EM Lucile.Joly-Pottuz@insa-lyon.fr
RI Douillard, Thierry/G-9808-2014
OI Douillard, Thierry/0000-0001-7113-889X; JOLY-POTTUZ,
   Lucile/0000-0001-8970-5960; Gremillard, Laurent/0000-0001-7258-6483
FU Region Rhone-Alpes (Cluster MACODEV); Institut Universitaire de France
FX The authors would like to acknowledge the CLYM (Centre Lyonnais de
   Microscopie, http://www.clym.fr) for the access to the JEOL 2010F and A.
   Schertel (Carl Zeiss NTS company GMBH) for the preparation of the thin
   foil by the "lift-out" technique. Financial support was provided by the
   Region Rhone-Alpes (Cluster MACODEV) and the Institut Universitaire de
   France.
CR BATEMAN CA, 1990, J MATER SCI LETT, V9, P803, DOI 10.1007/BF00720164
   Beaber A, 2010, NAT MATER, V9, P698, DOI 10.1038/nmat2840
   Boudias C., 1989, CARINE CRYSTALLOGRAP
   Calvie E, 2012, J EUR CERAM SOC
   Calvie E, UNPUB
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Chuvilin A, 2005, J ELECTRON MICROSC, V54, P515, DOI 10.1093/jmicro/dfi069
   Deneen J, 2006, J MATER SCI, V41, P4477, DOI 10.1007/s10853-006-0085-9
   Deville S, 2004, ACTA MATER, V52, P5709, DOI 10.1016/j.actamat.2004.08.036
   Esnouf C., 2011, CARACTERISATION MICR
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0
   HAYAKAWA M, 1989, ACTA METALL MATER, V37, P2229, DOI 10.1016/0001-6160(89)90149-1
   HAYAKAWA M, 1989, ACTA METALL MATER, V37, P2223, DOI 10.1016/0001-6160(89)90148-X
   HIRSCH PB, 1969, ELECT MICROSCOPY THI
   Houdellier F, 2008, ULTRAMICROSCOPY, V108, P426, DOI 10.1016/j.ultramic.2007.06.002
   Houdellier F, 2008, ULTRAMICROSCOPY, V108, P295, DOI 10.1016/j.ultramic.2007.04.003
   IGAWA N, 1993, J AM CERAM SOC, V76, P2673, DOI 10.1111/j.1151-2916.1993.tb03999.x
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   Lee JH, 2010, ACTA MATER, V58, P4891, DOI 10.1016/j.actamat.2010.05.027
   Li J, 2006, MATER CHARACT, V57, P64, DOI 10.1016/j.matchar.2005.12.007
   Minor AM, 2006, NAT MATER, V5, P697, DOI [10.1038/nmat1714, 10.1038/NMAT1714]
   Morniroli J. P., 1998, ELECT DIFFRACTION SO
   Morniroli JP, 1997, INTERFACE SCI, V4, P273
   RUHLE M, 1988, PHYSICA B & C, V150, P86, DOI 10.1016/0378-4363(88)90110-6
   Shan ZW, 2008, NAT MATER, V7, P947, DOI 10.1038/nmat2295
   SHIBATA M, 1987, J MATER SCI, V22, P1432, DOI 10.1007/BF01233144
   Soer WA, 2004, ACTA MATER, V52, P5783, DOI 10.1016/j.actamat.2004.08.032
   Stadelman P, 1987, ULTRAMICROSCOPY
NR 29
TC 2
Z9 2
U1 1
U2 43
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6454
J9 ACTA MATER
JI Acta Mater.
PD JAN
PY 2013
VL 61
IS 1
BP 174
EP 182
DI 10.1016/j.actamat.2012.09.047
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 071OP
UT WOS:000313604400016
DA 2018-10-19
ER

PT J
AU Calcaterra, J
   Van Cott, KE
   Butler, SP
   Gil, GC
   Germano, M
   van Veen, HA
   Nelson, K
   Forsberg, EJ
   Carlson, MA
   Velander, WH
AF Calcaterra, Jennifer
   Van Cott, Kevin E.
   Butler, Stephen P.
   Gil, Geun Cheol
   Germano, Marta
   van Veen, Harrie A.
   Nelson, Kay
   Forsberg, Erik J.
   Carlson, Mark A.
   Velander, William H.
TI Recombinant Human Fibrinogen That Produces Thick Fibrin Fibers with
   Increased Wound Adhesion and Clot Density
SO BIOMACROMOLECULES
LA English
DT Article
ID V LIVER-INJURIES; HYPOTHERMIC COAGULOPATHIC SWINE; REDUCE BLOOD-LOSS;
   RESUSCITATION VOLUME; SEALANT DRESSINGS; PLASMA-FIBRINOGEN; TRANSGENIC
   MICE; MAMMARY-GLAND; GAMMA-CHAIN; FACTOR-XIII
AB Human fibrinogen is a biomaterial used in surgical tissue sealants, scaffolding for tissue engineering, and wound healing. Here we report on the post-translational structure and functionality of recombinant human FL (rFI) made at commodity levels in the milk of transgenic dairy cows. Relative to plasma-derived fibrinogen (pdFI), rFI predominately contained a simplified, neutral carbohydrate structure and >4 fold higher levels of the gamma'-chain transcriptional variant that has been reported to bind thrombin and Factor XIII. In spite of these differences, rFI and pdFI were kinetically similar with respect to the thrombin-catalyzed formation of protofibrils and Factor XIIIa-mediated formation of cross-linked fibrin polymer. However, electron microscopy showed rFI produced fibrin with much thicker fibers with less branching than pdFI. In vivo studies in a swine liver transection model showed that, relative to pdFI, rFI made a denser, more strongly wound adherent fibrin clot that more rapidly established hemostasis.
C1 [Calcaterra, Jennifer; Van Cott, Kevin E.; Gil, Geun Cheol; Velander, William H.] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.
   [Butler, Stephen P.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.
   [Germano, Marta; van Veen, Harrie A.; Nelson, Kay] Pharming Grp NV, NL-2300 AL Leiden, Netherlands.
   [Forsberg, Erik J.] WiCell Res Inst, Madison, WI 53707 USA.
   [Carlson, Mark A.] Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68105 USA.
   [Carlson, Mark A.] Omaha VA Med Ctr, Omaha, NE 68105 USA.
RP Velander, WH (reprint author), Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.
EM wvelander2@unl.edu
FU U.S.A. Medical Material Development Activity of the Army Grant
   [W81XWH-05-1-0527]; American Red Cross; Pharming Group NV
FX We are grateful to Dr. Jason Johanning and Dr. Iraklis Pipinos for their
   assistance in the surgical procedures. Thanks to Dr. Mehmet Inan for the
   production of rFXIIIa and L. Smoyer of the University of Nebraska for
   technical assistance. We would like to acknowledge Dr. Roman Drews and
   the late Dr. William Drohan and Dr. Henryk Lubon for their contributions
   while at the American Red Cross Jerome Holland Laboratory. This research
   was primarily supported by a U.S.A. Medical Material Development
   Activity of the Army Grant (W81XWH-05-1-0527) to W.H.V, the American Red
   Cross and Pharming Group NV. This study is the result of work supported
   in part with resources and the use of facilities at the Omaha VA Medical
   Center.
CR Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca
   Adiguzel C, 2009, CLIN APPL THROMB-HEM, V15, P645, DOI 10.1177/1076029609339748
   Anumula KR, 1998, GLYCOBIOLOGY, V8, P685, DOI 10.1093/glycob/8.7.685
   Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743
   BINGHAM EW, 1974, J BIOL CHEM, V249, P3647
   Burnouf T, 2006, VOX SANG, V91, P56, DOI 10.1111/j.1423-0410.2006.00772.x
   Butler SP, 2004, TRANSGENIC RES, V13, P437, DOI 10.1007/s11248-004-9589-8
   Butler SP, 1997, THROMB HAEMOSTASIS, V78, P537
   Ceroni A, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-3
   Chandler W. L., 1995, SEMIN THROMB HEMO S4, V<IT>21</IT>, P1
   Cheung EYL, 2008, STROKE, V39, P1033, DOI 10.1161/STROKEAHA.107.495499
   CHUNG DW, 1984, BIOCHEMISTRY-US, V23, P4232, DOI 10.1021/bi00313a033
   Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150
   Dainiak M. B., 2009, BIOMATERIALS, V31, P67
   de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180
   Delgado AV, 2008, J TRAUMA, V64, P75, DOI 10.1097/TA.0b013e31815b843c
   DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211
   Echelard Y., 2006, BIOPHARM INT, V<IT>19</IT>, P46
   Echelard Y., 2006, BIOPHARM INT, V<IT>19</IT>, P44
   Echelard Y., 2006, BIOPHARM INT, V<IT>19</IT>, P42
   Echelard Y, 2006, BIOPHARM INT, V19, P36
   Edmunds T, 1998, BLOOD, V91, P4561
   Elvin CM, 2009, BIOMATERIALS, V30, P2059, DOI 10.1016/j.biomaterials.2008.12.059
   FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P9414, DOI 10.1021/bi00103a004
   Fenger-Eriksen C, 2008, BRIT J ANAESTH, V101, P769, DOI 10.1093/bja/aen270
   FERRY JD, 1952, P NATL ACAD SCI USA, V38, P566, DOI 10.1073/pnas.38.7.566
   FORNACE AJ, 1984, J BIOL CHEM, V259, P2826
   Forsberg EJ, 2002, BIOL REPROD, V67, P327, DOI 10.1095/biolreprod67.1.327
   Gersh KC, 2009, THROMB RES, V124, P356, DOI 10.1016/j.thromres.2008.11.016
   Gorkun OV, 1997, BLOOD, V89, P4407
   GRAY JL, 1994, J SURG RES, V57, P596, DOI 10.1006/jsre.1994.1189
   Holcomb JB, 1999, J TRAUMA, V47, P233, DOI 10.1097/00005373-199908000-00002
   Holcomb JB, 1999, J TRAUMA, V46, P49, DOI 10.1097/00005373-199901000-00009
   Horowitz B, 2008, TRANSFUSION, V48, P1739, DOI 10.1111/j.1537-2995.2008.01717
   Howells G, 1999, J TRAUMA, V47, P240
   LANGER BG, 1988, J BIOL CHEM, V263, P15056
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26
   Lubon H, 1996, TRANSFUS MED REV, V10, P131, DOI 10.1016/S0887-7963(96)80089-7
   Marchi R, 2004, J THROMB HAEMOST, V2, P940, DOI 10.1111/j.1538-7836.2004.00730.x
   MARTIN SC, 1992, THROMB RES, V68, P467, DOI 10.1016/0049-3848(92)90059-J
   MCDONAGH RP, 1971, FEBS LETT, V14, P33, DOI 10.1016/0014-5793(71)80268-5
   MORCOL T, 1994, ANN NY ACAD SCI, V721, P218, DOI 10.1111/j.1749-6632.1994.tb47394.x
   MORELL AG, 1971, J BIOL CHEM, V246, P1461
   Mosesson MW, 2009, J THROMB HAEMOST, V7, P102, DOI 10.1111/j.1538-7836.2008.03213.x
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Park DS, 2002, BIOTECHNOL LETT, V24, P97, DOI 10.1023/A:1013810912609
   Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021
   PLATENBURG GJ, 1994, TRANSGENIC RES, V3, P99, DOI 10.1007/BF01974087
   Powell K, 2003, NAT BIOTECHNOL, V21, P965, DOI 10.1038/nbt0903-965
   Prasad S, 2008, BLOOD, V111, P672, DOI 10.1182/blood-2007-07-098913
   Prunkard D, 1996, NAT BIOTECHNOL, V14, P867, DOI 10.1038/nbt0796-867
   Pusateri AE, 2003, J TRAUMA, V55, P518, DOI 10.1097/01.TA.0000075336.92129.27
   Siebenlist KR, 2005, BLOOD, V106, P2730, DOI 10.1182/blood-2005-01-0240
   Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206
   SPIK G, 1994, ADV EXP MED BIOL, V357, P21
   Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x
   Spotnitz William D, 2005, J Long Term Eff Med Implants, V15, P245, DOI 10.1615/JLongTermEffMedImplants.v15.i3.20
   Thiel KA, 2004, NAT BIOTECHNOL, V22, P1365, DOI 10.1038/nbt1104-1365
   TOWNSEND RR, 1982, J BIOL CHEM, V257, P9704
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026
NR 63
TC 10
Z9 10
U1 1
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2013
VL 14
IS 1
BP 169
EP 178
DI 10.1021/bm301579p
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 071PD
UT WOS:000313605800020
PM 23215461
DA 2018-10-19
ER

PT J
AU Saito, T
   Kuramae, R
   Wohlert, J
   Berglund, LA
   Isogai, A
AF Saito, Tsuguyuki
   Kuramae, Ryota
   Wohlert, Jakob
   Berglund, Lars A.
   Isogai, Akira
TI An Ultrastrong Nanofibrillar Biomaterial: The Strength of Single
   Cellulose Nanofibrils Revealed via Sonication-Induced Fragmentation
SO BIOMACROMOLECULES
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; TRANSMISSION ELECTRON-MICROSCOPY;
   TEMPO-OXIDIZED CELLULOSE; ELASTIC-MODULUS; CRYSTALLINE REGIONS; CARBON
   NANOTUBES; NATIVE CELLULOSE; INDUCED SCISSION; MECHANISM; BACTERIAL
AB We report the mechanical strength of native cellulose nanofibrils. Native cellulose nanofibrils, purified from wood and sea tunicate, were fully dispersed in water via a topochemical modification of cellulose nanofibrils using 2,2,6,6-tetramethylpiperidinyl-1-oxyl (TEMPO) as a catalyst. The strength of individual nanofibrils was estimated based on a model for the sonication-induced fragmentation of filamentous nanostructures. The resulting strength parameters were then analyzed based on fracture statistics. The mean strength of the wood cellulose nanofibrils ranged from 1.6 to 3 GPa, depending on the method used to measure the nanofibril width. The highly crystalline, thick tunicate cellulose nanofibrils exhibited higher mean strength of 3-6 GPa. The strength values estimated for the cellulose nanofibrils in the present study are comparable with those of commercially available multiwalled carbon nanotubes.
C1 [Saito, Tsuguyuki; Kuramae, Ryota; Isogai, Akira] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan.
   [Saito, Tsuguyuki; Wohlert, Jakob; Berglund, Lars A.] Royal Inst Technol, Wallenberg Wood Sci Ctr, SE-10044 Stockholm, Sweden.
   [Berglund, Lars A.] Royal Inst Technol, Dept Fibre & Polymer Technol, SE-10044 Stockholm, Sweden.
RP Berglund, LA (reprint author), Royal Inst Technol, Wallenberg Wood Sci Ctr, SE-10044 Stockholm, Sweden.
EM blund@kth.se; aisogai@mail.ecc.u-tokyo.ac.jp
RI Berglund, Lars/A-6971-2010; Saito, Tsuguyuki/J-7954-2014
OI Berglund, Lars/0000-0001-5818-2378; Saito, Tsuguyuki/0000-0003-1073-6663
FU Japan Society for the Promotion of Science (JSPS) [21228007, 23688020,
   24-390]; Wallenberg Wood Science Center (WWSC)
FX This study was financially supported by Scientific Research S
   (21228007), Encouragement of Young Scientists A (23688020), and
   Postdoctoral Fellowships for Research Abroad (24-390) from the Japan
   Society for the Promotion of Science (JSPS), and the Wallenberg Wood
   Science Center (WWSC).
CR Ahir SV, 2008, POLYMER, V49, P3841, DOI 10.1016/j.polymer.2008.05.005
   Aulin C, 2010, CELLULOSE, V17, P559, DOI 10.1007/s10570-009-9393-y
   Bulota M, 2012, J MATER SCI, V47, P5517, DOI 10.1007/s10853-012-6443-x
   Capadona JR, 2007, NAT NANOTECHNOL, V2, P765, DOI 10.1038/nnano.2007.379
   Elazzouzi-Hafraoui S, 2008, BIOMACROMOLECULES, V9, P57, DOI 10.1021/bm700769p
   Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   HANLEY SJ, 1992, POLYMER, V33, P4639, DOI 10.1016/0032-3861(92)90426-W
   Helbert W, 1998, J STRUCT BIOL, V124, P42, DOI 10.1006/jsbi.1998.4045
   Hennrich F, 2007, J PHYS CHEM B, V111, P1932, DOI 10.1021/jp065262n
   Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n
   Hori R, 2005, CELLULOSE, V12, P479, DOI 10.1007/s10570-005-5967-5
   Huang YY, 2009, ADV MATER, V21, P3945, DOI 10.1002/adma.200900498
   Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e
   Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n
   Jakob HF, 1995, MACROMOLECULES, V28, P8782, DOI 10.1021/ma00130a010
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Koga H, 2010, CHEM COMMUN, V46, P8567, DOI 10.1039/c0cc02754e
   Kuijpers MWA, 2004, POLYMER, V45, P6461, DOI 10.1016/j.polymer.2004.06.051
   Lahiji RR, 2010, LANGMUIR, V26, P4480, DOI 10.1021/la903111j
   Li QQ, 2011, BIOMACROMOLECULES, V12, P650, DOI 10.1021/bm101315y
   Li X, 2007, J POLYM ENVIRON, V15, P25, DOI 10.1007/s10924-006-0042-3
   NISHINO T, 1995, J POLYM SCI POL PHYS, V33, P1647, DOI 10.1002/polb.1995.090331110
   Nishiyama Y, 2009, J WOOD SCI, V55, P241, DOI 10.1007/s10086-009-1029-1
   Nystrom G, 2009, NANO LETT, V9, P3635, DOI 10.1021/nl901852h
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/NNANO.2010.155, 10.1038/nnano.2010.155]
   Olszewska A, 2011, CELLULOSE, V18, P1213, DOI 10.1007/s10570-011-9577-0
   Quintanilla J, 1999, POLYM ENG SCI, V39, P559, DOI 10.1002/pen.11446
   Rooze J, 2011, J PHYS CHEM B, V115, P11038, DOI 10.1021/jp203780a
   Roylance D., 1996, MECH MATER, P251
   Rusli R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2963491
   Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s
   SAKURADA I, 1962, J POLYM SCI, V57, P651, DOI 10.1002/pol.1962.1205716551
   Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155
   Sehaqui H, 2012, ACS APPL MATER INTER, V4, P1043, DOI 10.1021/am2016766
   Sehaqui H, 2010, SOFT MATTER, V6, P1824, DOI 10.1039/b927505c
   Shinoda R, 2012, BIOMACROMOLECULES, V13, P842, DOI 10.1021/bm2017542
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Sturcova A, 2005, BIOMACROMOLECULES, V6, P1055, DOI 10.1021/bm049291k
   Syverud K, 2009, CELLULOSE, V16, P75, DOI 10.1007/s10570-008-9244-2
   Tanpichai S, 2012, BIOMACROMOLECULES, V13, P1340, DOI 10.1021/bm300042t
   Xie SS, 2000, J PHYS CHEM SOLIDS, V61, P1153, DOI 10.1016/S0022-3697(99)00376-5
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Young R J, 1981, INTRO POLYM, P319
NR 44
TC 185
Z9 187
U1 14
U2 239
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2013
VL 14
IS 1
BP 248
EP 253
DI 10.1021/bm301674e
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 071PD
UT WOS:000313605800030
PM 23215584
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Thalla, PK
   Contreras-Garcia, A
   Fadlallah, H
   Barrette, J
   De Crescenzo, G
   Merhi, Y
   Lerouge, S
AF Thalla, Pradeep Kumar
   Contreras-Garcia, Angel
   Fadlallah, Hicham
   Barrette, Jeremie
   De Crescenzo, Gregory
   Merhi, Yahye
   Lerouge, Sophie
TI A Versatile Star PEG Grafting Method for the Generation of Nonfouling
   and Nonthrombogenic Surfaces
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; POLY(ETHYLENE GLYCOL); PROTEIN ADSORPTION;
   PLATELET ACTIVATION; SILICON SURFACES; RESISTANCE; STABILITY; ADHESION;
   OXIDE); THROMBOSIS
AB Polyethylene glycol (PEG) grafting has a great potential to create nonfouling and nonthrombogenic surfaces, but present techniques lack versatility and stability. The present work aimed to develop a versatile PEG grafting method applicable to most biomaterial surfaces, by taking advantage of novel primary amine-rich plasma-polymerized coatings. Star-shaped PEG covalent binding was studied using static contact angle, X-ray photoelectron spectroscopy (XPS), and quartz crystal microbalance with dissipation monitoring (QCM-D). Fluorescence and QCM-D both confirmed strong reduction of protein adsorption when compared to plasma-polymerized coatings and pristine poly(ethyleneterephthalate) (PET). Moreover, almost no platelet adhesion was observed after 15 min perfusion in whole blood. Altogether, our results suggest that primary amine-rich plasma-polymerized coatings offer a promising stable and versatile method for PEG grafting in order to create nonfouling and nonthrombogenic surfaces and micropatterns.
C1 [Thalla, Pradeep Kumar; Fadlallah, Hicham; Barrette, Jeremie; Lerouge, Sophie] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Lab Endovasc Biomat LBeV, Montreal, PQ H2L 2W5, Canada.
   [Thalla, Pradeep Kumar; Barrette, Jeremie; Lerouge, Sophie] Ecole Technol Super ETS, Dept Mech Engn, Montreal, PQ H3C 1K3, Canada.
   [Contreras-Garcia, Angel] Ecole Polytech Montreal, Dept Engn Phys, Montreal, PQ H3C 3A7, Canada.
   [Fadlallah, Hicham; Merhi, Yahye] Montreal Heart Inst, Lab Thrombosis & Haemostasis, Res Ctr, Montreal, PQ H1T 1C8, Canada.
   [De Crescenzo, Gregory] Ecole Polytech Montreal, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada.
RP Lerouge, S (reprint author), Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Lab Endovasc Biomat LBeV, 2099 Alexandre de Seve, Montreal, PQ H2L 2W5, Canada.
EM sophie.lerouge@etsmtl.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Canadian Institutes of Health Research (CIHR)
FX This study was jointly funded by the Natural Sciences and Engineering
   Research Council of Canada (NSERC) and the Canadian Institutes of Health
   Research (CIHR). The authors would like to thank M. Ahmed Hachem and
   Younes Zaid for human blood sampling and platelet labeling. The authors
   are grateful to Professor Michael R. Wertheimer for his expertise in
   plasma polymerization. The authors would also like to thank Marion Maire
   (CRCHUM), Suzie Poulin (Ecole Polytechnique de Montreal), and Houman
   Savoji for their help regarding SEM, XPS analysis, and plasma
   deposition, respectively.
CR Cao L, 2006, J BIOMED MATER RES A, V79A, P788, DOI 10.1002/jbm.a.30908
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   DAVIS SS, 1988, BIOMATERIALS, V9, P111, DOI 10.1016/0142-9612(88)90081-6
   Demming S, 2011, PHYS STATUS SOLIDI A, V208, P1301, DOI 10.1002/pssa.201000967
   Diener JL, 2009, J THROMB HAEMOST, V7, P1155, DOI 10.1111/j.1538-7836.2009.03459.x
   Dimitrievska S, 2011, MACROMOL BIOSCI, V11, P493, DOI 10.1002/mabi.201000390
   FUERTGES F, 1990, J CONTROL RELEASE, V11, P139, DOI 10.1016/0168-3659(90)90127-F
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRAHAM NB, 1984, BIOMATERIALS, V5, P27, DOI 10.1016/0142-9612(84)90063-2
   Groll J, 2010, METHOD ENZYMOL, V472, P1, DOI 10.1016/S0076-6879(10)72019-X
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Huang H, 2011, CHEMPHYSCHEM, V12, P3642, DOI 10.1002/cphc.201100398
   Hubbell J, 1993, CARDIOVASC PATHOL, V2, P121
   Irvine DJ, 1996, MACROMOLECULES, V29, P6037, DOI 10.1021/ma951903t
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Knetsch MLW, 2010, J BIOMED MATER RES A, V93A, P77, DOI 10.1002/jbm.a.32538
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Lerouge S, 2007, BIOMATERIALS, V28, P1209, DOI 10.1016/j.biomaterials.2006.10.033
   Li S, 2011, ANNU REV BIOMED ENG, V13, P451, DOI 10.1146/annurev-bioeng-071910-124733
   Merhi Y, 1997, J BIOMED MATER RES, V34, P477
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Ruiz JC, 2010, PLASMA PROCESS POLYM, V7, P737, DOI 10.1002/ppap.201000042
   Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Shin HS, 2009, J BIOACT COMPAT POL, V24, P316, DOI 10.1177/0883911509104273
   Sofia SJ, 1997, ACS SYM SER, V680, P342
   Truica-Marasescu F., 2008, THIN SOLID FILMS, V516, P7406
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Wagner C. D., 1979, HDB XRAY ULTRAVIOLET
   Weber N, 2005, J BIOMED MATER RES A, V72A, P420, DOI 10.1002/jbm.a.30272
   Weber N, 2007, LANGMUIR, V23, P3298, DOI 10.1021/la060500r
   Yang ZH, 1999, LANGMUIR, V15, P8405, DOI 10.1021/la990260y
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   Zhao X, 1998, J PHARM SCI, V87, P1450, DOI 10.1021/js980065o
   Zhao YH, 2007, LANGMUIR, V23, P5779, DOI 10.1021/la070139o
   Zhou GY, 2011, POLYM CHEM-UK, V2, P1409, DOI 10.1039/c1py00016k
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
NR 44
TC 4
Z9 4
U1 1
U2 30
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2013
AR 962376
DI 10.1155/2013/962376
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 072VZ
UT WOS:000313702800001
PM 23509823
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wang, H
   Liu, XY
   Chuah, YJ
   Goh, JCH
   Li, JL
   Xu, HY
AF Wang, Hui
   Liu, Xiang Yang
   Chuah, Yon Jin
   Goh, James C. H.
   Li, Jing Liang
   Xu, Hongyao
TI Design and engineering of silk fibroin scaffolds with biomimetic
   hierarchical structures
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID SPECTROSCOPY; BIOMATERIAL; NUCLEATION; MIGRATION
AB Silk scaffolds having biomimetic hierarchical porous structures were achieved by carefully tuning liquid-liquid separation in regenerated silk fibroin solutions. Such scaffolds show greatly enhanced cellular responses.
C1 [Wang, Hui; Liu, Xiang Yang; Li, Jing Liang] Xiamen Univ, Coll Mat, Xiamen 361005, Peoples R China.
   [Wang, Hui; Liu, Xiang Yang; Li, Jing Liang] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore.
   [Wang, Hui; Liu, Xiang Yang; Li, Jing Liang] Natl Univ Singapore, Dept Chem, Singapore 117542, Singapore.
   [Wang, Hui] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Chuah, Yon Jin; Goh, James C. H.] Natl Univ Singapore, Dept Orthopaed Surg, Singapore 119074, Singapore.
   [Liu, Xiang Yang; Xu, Hongyao] Donghua Univ, Coll Mat Sci & Engn, Shanghai, Peoples R China.
   [Liu, Xiang Yang; Xu, Hongyao] Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China.
RP Liu, XY (reprint author), Xiamen Univ, Coll Mat, Xiamen 361005, Peoples R China.
EM phyliuxy@nus.edu.sg
RI Zhou, Weiqian/B-8991-2011; li, jingliang/E-5075-2010; Liu,
   XY/E-5090-2010
OI li, jingliang/0000-0003-0709-2246; Chuah, Yon Jin/0000-0003-0579-6370
FU Singapore ARF Project [T206B1114]; National Natural Science Foundation
   of China [50928301, 51203108]; China MOE Chang Jiang Scholars Program
FX This work was supported by the Singapore ARF Project (Grant T206B1114),
   the National Natural Science Foundation of China (50928301, 51203108)
   and the China MOE Chang Jiang Scholars Program.
CR De Cock LJ, 2012, CHEM COMMUN, V48, P3512, DOI 10.1039/c2cc17006j
   Diao YY, 2012, ADV FUNCT MATER, V22, P1354, DOI 10.1002/adfm.201102288
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Liu XY, 2004, J BIOL CHEM, V279, P6124, DOI 10.1074/jbc.M310487200
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ning D, 2002, APPL PHYS LETT, V81, P445, DOI 10.1063/1.1492849
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Schenning APHJ, 1996, J AM CHEM SOC, V118, P8549, DOI 10.1021/ja961234e
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Sun W, 2007, ADV MATER, V19, P921, DOI 10.1002/adma.200600319
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zhang KQ, 2004, NATURE, V429, P739, DOI 10.1038/nature02630
   Zhang TH, 2009, ANGEW CHEM INT EDIT, V48, P1308, DOI 10.1002/anie.200804743
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
NR 24
TC 17
Z9 18
U1 4
U2 130
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2013
VL 49
IS 14
BP 1431
EP 1433
DI 10.1039/c2cc38779d
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 074II
UT WOS:000313805700019
PM 23321676
DA 2018-10-19
ER

PT J
AU Wright, B
   Mi, SL
   Connon, CJ
AF Wright, Bernice
   Mi, Shengli
   Connon, Che J.
TI Towards the use of hydrogels in the Treatment of limbal stem cell
   deficiency
SO DRUG DISCOVERY TODAY
LA English
DT Review
ID CORNEAL EPITHELIAL-CELLS; OCULAR DRUG-DELIVERY; EX-VIVO EXPANSION;
   AMNIOTIC MEMBRANE; RABBIT CORNEA; IN-VIVO; SURFACE RECONSTRUCTION;
   EXTRACELLULAR-MATRIX; COMPRESSED COLLAGEN; CONTROLLED-RELEASE
AB Corneal blindness caused by limbal stem cell deficiency (LSCD) is a prevailing disorder worldwide. Clinical outcomes for LSCD therapy using amniotic membrane (AM) are unpredictable. Hydrogels can eliminate limitations of standard therapy for LSCD, because they present all the advantages of AM (i.e. biocompatibility, inertness and a biodegradable structure) but unlike AM, they are structurally uniform and can be easily manipulated to alter mechanical and physical properties. Hydrogels can be delivered with minimum trauma to the ocular surface and do not require extensive serological screening before clinical application. The hydrogel structure is also amenable to modifications which direct stem cell fate. In this focussed review we highlight hydrogels as biomaterial substrates which may replace and/or complement AM in the treatment of LSCD.
C1 [Wright, Bernice; Connon, Che J.] Univ Reading, Sch Pharm, Reading RG6 6UB, Berks, England.
   [Mi, Shengli] Tsinghua Univ, Grad Sch, Shenzhen 518057, Peoples R China.
RP Connon, CJ (reprint author), Univ Reading, Sch Pharm, Reading RG6 6UB, Berks, England.
EM c.j.connon@rdg.ac.uk
RI Connon, Che/B-3128-2012
OI Connon, Che/0000-0001-8264-6531
FU Medical Research Council; Medical Research Council [G0900877]
FX We would like to thank the Medical Research Council for funding and Dr
   Ricardo Gouveia for editing assistance. Dr Bernice Wright and Dr Shengli
   Mi contributed equally to compiling the manuscript.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Blackmore SJ, 2010, CONTACT LENS ANTERIO, V33, P239, DOI 10.1016/j.clae.2010.06.004
   Branch M.J., 2012, INVEST OPHTHALMOL VI
   Builles N, 2010, BIOMATERIALS, V31, P8313, DOI 10.1016/j.biomaterials.2010.07.066
   Cao YX, 2007, J CONTROL RELEASE, V120, P186, DOI 10.1016/j.jconrel.2007.05.009
   Chayosumrit M, 2010, BIOMATERIALS, V31, P505, DOI 10.1016/j.biomaterials.2009.09.071
   Chen B, 2012, SOFT MATTER, V8, P8379, DOI 10.1039/c2sm26175h
   CHEN JJY, 1990, INVEST OPHTH VIS SCI, V31, P1301
   Choi JA, 2011, EYE CONTACT LENS, V37, P370, DOI 10.1097/ICL.0b013e318233c9bb
   Crawford GJ, 1996, J REFRACT SURG, V12, P525
   CRAWFORD GJ, 1993, CORNEA, V12, P348, DOI 10.1097/00003226-199307000-00012
   DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0
   De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8
   Deshpande P, 2010, REGEN MED, V5, P395, DOI 10.2217/RME.10.16
   Di Colo G, 2002, INT J PHARM, V248, P115, DOI 10.1016/S0378-5173(02)00421-0
   Di Girolamo N, 2007, BRIT J OPHTHALMOL, V91, P459, DOI 10.1136/bjo.2006.103895
   Du LQ, 2008, OPHTHALMIC RES, V40, P282, DOI 10.1159/000131503
   Evans MDM, 1999, J BIOMED MATER RES, V46, P485, DOI 10.1002/(SICI)1097-4636(19990915)46:4<485::AID-JBM6>3.0.CO;2-F
   Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022
   Felt O, 2000, J OCUL PHARMACOL TH, V16, P261, DOI 10.1089/jop.2000.16.261
   Fiorica C, 2011, INT J PHARMACEUT, V414, P104, DOI 10.1016/j.ijpharm.2011.05.002
   Francis D, 2009, EXP EYE RES, V88, P339, DOI 10.1016/j.exer.2008.06.016
   Gomes JAP, 2003, OPHTHALMOLOGY, V110, P466, DOI 10.1016/S0161-6420(02)01888-2
   Gorle AP, 2010, PHARM DEV TECHNOL, V15, P46, DOI 10.3109/10837450902967947
   Gu SF, 2009, MOL VIS, V15, P99
   Hackett JM, 2011, INVEST OPHTH VIS SCI, V52, P651, DOI 10.1167/iovs.10-5224
   Higa K., 2010, J BIOMATER SCI POLYM
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Hunt Nicola C., 2009, Biotechnology Journal, V4, P730, DOI 10.1002/biot.200800292
   Jain D, 2011, DRUG DEV IND PHARM, V37, P167, DOI 10.3109/03639045.2010.502533
   Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001
   KENYON KR, 1989, OPHTHALMOLOGY, V96, P709
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lee SB, 2000, CURR EYE RES, V20, P325, DOI 10.1076/0271-3683(200004)20:4;1-5;FT325
   Lee YC, 1999, INT J PHARM, V182, P121, DOI 10.1016/S0378-5173(99)00072-1
   Lee YC, 1999, INT J PHARM, V181, P71, DOI 10.1016/S0378-5173(98)00418-9
   Levis HJ, 2010, BIOMATERIALS, V31, P7726, DOI 10.1016/j.biomaterials.2010.07.012
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liang Y, 2011, COLLOID SURFACE B, V82, P1, DOI [10.1016/j.colsurfb.2010.07.043, 10.1016/j.colsurfb.2010.07043]
   Liu WG, 2008, J MATER SCI-MATER M, V19, P3365, DOI 10.1007/s10856-008-3486-2
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Mathurm M, 2011, DRUG DELIV, V18, P54, DOI 10.3109/10717544.2010.509366
   Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109
   Mi SL, 2010, TISSUE ENG PT A, V16, P2091, DOI [10.1089/ten.tea.2009.0748, 10.1089/ten.TEA.2009.0748]
   Mi SL, 2011, J BIOMED MATER RES A, V99A, P1, DOI 10.1002/jbm.a.33152
   Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861
   Mimura T, 2008, MOL VIS, V14, P1819
   Mundada AS, 2008, CURR EYE RES, V33, P469, DOI 10.1080/02713680802023104
   Natu MV, 2007, BIOMED MATER, V2, P241, DOI 10.1088/1748-6041/2/4/006
   Ozturk E, 2006, INT J ARTIF ORGANS, V29, P228
   Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0
   Pritchard N, 2000, OPTOMETRY VISION SCI, V77, P68, DOI 10.1097/00006324-200002000-00010
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   SALL KN, 1987, ANN OPHTHALMOL, V19, P31
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020
   Sitalakshmi G, 2009, TISSUE ENG PT A, V15, P407, DOI 10.1089/ten.tea.2008.0041
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Stapleton F, 2006, OCUL SURF, V4, P24, DOI 10.1016/S1542-0124(12)70262-8
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Sudha B, 2006, INDIAN J MED RES, V124, P655
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Talbot M, 2006, MOL VIS, V12, P65
   TAMPONNET C, 1990, APPL MICROBIOL BIOT, V33, P442
   TRINKAUSRANDALL V, 1988, INVEST OPHTH VIS SCI, V29, P393
   TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003
   Tseng SCG, 2010, CURR MOL MED, V10, P841
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   Vijayasekaran S, 2000, J BIOMAT SCI-POLYM E, V11, P599, DOI 10.1163/156856200743896
   Wang N, 2009, J BIOTECHNOL, V144, P304, DOI 10.1016/j.jbiotec.2009.08.008
   Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.tea.2010.0568, 10.1089/ten.TEA.2010.0568]
   Wikstrom J, 2008, BIOMATERIALS, V29, P869, DOI 10.1016/j.biomaterials.2007.10.056
   Wright B, 2012, REGEN MED, V7, P295, DOI [10.2217/RME.12.7, 10.2217/rme.12.7]
   Wu XY, 1997, J BIOMED MATER RES, V37, P166, DOI 10.1002/(SICI)1097-4636(199711)37:2<166::AID-JBM4>3.3.CO;2-2
   Xu FL, 2007, J MATER SCI-MATER M, V18, P635, DOI 10.1007/s10856-007-2313-5
   Yang CF, 2000, OPHTHALMIC RES, V32, P19, DOI 10.1159/000055582
   Yeh LK, 2009, J BIOMED MATER RES A, V90A, P18, DOI 10.1002/jbm.a.32077
   Zajicova A, 2010, CELL TRANSPLANT, V19, P1281, DOI 10.3727/096368910X509040
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
NR 83
TC 26
Z9 26
U1 0
U2 76
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6446
EI 1878-5832
J9 DRUG DISCOV TODAY
JI Drug Discov. Today
PD JAN
PY 2013
VL 18
IS 1-2
BP 79
EP 86
DI 10.1016/j.drudis.2012.07.012
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 071QG
UT WOS:000313608700010
PM 22846850
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Perez, ER
   Cruz, DMG
   Monros, MCA
   Gomez-Pinedo, U
   Pradas, MM
   Ivirico, JLE
AF Rodriguez Perez, Eduard
   Garcia Cruz, Dunia M.
   Araque Monros, Maria C.
   Gomez-Pinedo, U.
   Monleon Pradas, Manuel
   Escobar Ivirico, Jorge L.
TI Polymer chains incorporating caprolactone and arginine-glycine-aspartic
   acid functionalities: Synthesis, characterization and biological
   response in vitro of the Schwann cell
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Itaconic acid; arginine-glycine-aspartic acid; polymeric networks;
   Schwann cells; Bungner bands
ID HYALURONIC-ACID; HYDROGELS; PEPTIDES; ADHESION; PROLIFERATION;
   REGENERATION; SCAFFOLDS; SURFACE; REPAIR; BRAIN
AB This study describes a strategy for the covalent immobilization of active adhesion peptide moieties onto polymers through the intermediacy of itaconic acid. The arginine-glycine-aspartic acid peptide was grafted to a novel poly(caprolactone 2-(methacryloyloxy) ethyl ester)-co-itaconic acid bulk biomaterial, in order to improve the cell adhesion of the polymer. First, the arginine-glycine-aspartic acid sequence was grafted onto itaconic acid via an amidation reaction using N(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride/N-hydroxysuccinimide as activation complex. The itaconic acid-arginine-glycine-aspartic acid macromer was characterized by Fourier transform infrared spectroscopy and H-1-NMR, yielding a functionalization degree of 85%. In a second step, poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid-arginine-glycine-aspartic acid) (with a feed mixture of 90 wt% of caprolactone 2-(methacryloyloxy) ethyl ester and 10 wt% of itaconic acid-arginine-glycine-aspartic acid macromer) and a series of copolymers of caprolactone 2-(methacryloyloxy) ethyl ester and itaconic acid with different compositions (weight fractions of itaconic acid up to 20 wt%) were synthesized by radical copolymerization. The microstructure and network architecture of the new polymer systems were investigated. Mechanical moduli of poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid), evaluated by dynamic-mechanical analysis, increase with the itaconic acid content. In poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid-arginine-glycine-aspartic acid), the glass transition temperature and the mechanical moduli of the system are smaller than in the nonfunctionalized poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid) copolymers, and the polymer is less hydrophilic. The results indicate that arginine-glycine-aspartic acid grafting of poly(caprolactone 2-(methacryloyloxy) ethyl ester-co-itaconic acid) copolymer networks can be useful for tissue engineering applications, because regenerative processes in the nervous system can be promoted and accelerated, thus, opening a possibility to generate materials with a high potential for clinical applicability.
C1 [Rodriguez Perez, Eduard; Garcia Cruz, Dunia M.; Araque Monros, Maria C.; Monleon Pradas, Manuel; Escobar Ivirico, Jorge L.] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia 46022, Spain.
   [Gomez-Pinedo, U.] Hosp Clin San Carlos, IdISSC, Lab Med Regenerat Neurol & Neurocirugia, Madrid, Spain.
   [Monleon Pradas, Manuel] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valencia, Spain.
RP Ivirico, JLE (reprint author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia 46022, Spain.
EM joresciv@ter.upv.es
RI Rodriguez-Perez, Eduard/S-9666-2017; Escobar Ivirico, Jorge/G-9649-2012;
   Escobar ivirico, Jorge/J-1203-2016; Escobar Ivirico, Jorge
   Luis/M-1947-2013
OI Rodriguez-Perez, Eduard/0000-0002-3636-4469; Escobar ivirico,
   Jorge/0000-0002-1077-2333; Escobar Ivirico, Jorge
   Luis/0000-0002-1077-2333; , ulises.gomez-pinedo/0000-0003-3097-5557;
   MONLEON PRADAS, MANUEL/0000-0001-6457-0414
FU Spanish Science and Innovation Ministry [MAT2011-28791-C03]
FX This study was supported by the Spanish Science and Innovation Ministry
   through project MAT2011-28791-C03
CR Baron-Van Evercooren A, 1982, J CELL BIOL, V93, P211
   Behravesh E, 2003, BIOMATERIALS, V24, P4365, DOI 10.1016/S0142-9612(03)00338-7
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   CHI H, 1993, J NEUROSCI RES, V35, P183, DOI 10.1002/jnr.490350208
   Martinez EC, 2008, TISSUE ENG PT A, V14, P1751, DOI 10.1089/ten.tea.2007.0270
   Cui FZ, 2003, J BIOACT COMPAT POL, V18, P413, DOI 10.1177/0883911503040470
   Ivirico JLE, 2007, J BIOMED MATER RES B, V83B, P266, DOI 10.1002/jbm.b.30792
   Ivirico JLE, 2009, J BIOMED MATER RES B, V91B, P277, DOI 10.1002/jbm.b.31400
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Gugutkov D, 2011, J BIOACT COMPAT POL, V26, P375, DOI 10.1177/0883911511409020
   Hu M, 2000, TISSUE ENG, V6, P585, DOI 10.1089/10763270050199532
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Kirsebom H, 2007, J BIOACT COMPAT POL, V22, P621, DOI 10.1177/0883911507084293
   Krusic MK, 2004, EUR POLYM J, V40, P793, DOI 10.1016/j.europolymj.2003.11.016
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   MARK JE, 1985, ACCOUNTS CHEM RES, V18, P202, DOI 10.1021/ar00115a002
   Mei Y, 2010, BIOMATERIALS, V31, P8989, DOI 10.1016/j.biomaterials.2010.08.029
   Min SK, 2010, BIOMATERIALS, V31, P4725, DOI 10.1016/j.biomaterials.2010.02.045
   Niu XF, 2005, J MATER SCI TECHNOL, V21, P571
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Patel A, 2011, J BIOACT COMPAT POL, V26, P114, DOI 10.1177/0883911511398713
   Rao S. S., 2009, FRONT NEUROENG, V2, P1, DOI 10.3389/neuro.16.006.2009
   Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007
   Hernandez JCR, 2009, MACROMOL BIOSCI, V9, P766, DOI 10.1002/mabi.200800332
   RUEGG UT, 1984, NEUROSCI LETT, V49, P319, DOI 10.1016/0304-3940(84)90309-4
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Vleggeert-Lankamp CLAM, 2004, BIOMATERIALS, V25, P2741, DOI 10.1016/j.biomaterials.2003.09.067
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Willke T, 2001, APPL MICROBIOL BIOT, V56, P289, DOI 10.1007/s002530100685
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
NR 34
TC 2
Z9 2
U1 1
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2013
VL 28
IS 1
BP 50
EP 65
DI 10.1177/0883911512469710
PG 16
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 071LG
UT WOS:000313593600004
DA 2018-10-19
ER

PT J
AU Rasmussen, J
   Nielsen, OW
   Lund, AM
   Kober, L
   Djurhuus, H
AF Rasmussen, Jan
   Nielsen, Olav W.
   Lund, Allan M.
   Kober, Lars
   Djurhuus, Hogni
TI Primary carnitine deficiency and pivalic acid exposure causing
   encephalopathy and fatal cardiac events
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID CEREBRAL EDEMA; FATTY-ACID; TRANSPORTER; METABOLISM; CARDIOMYOPATHY;
   PREGNANCY; PIVALOYLCARNITINE; HYPERAMMONEMIA; PIVAMPICILLIN; MUTATIONS
AB Several episodes of sudden death among young Faroese individuals have been associated with primary carnitine deficiency (PCD). Patients suffering from PCD have low carnitine levels and can present with metabolic and/or cardiac complications. Pivalic acid exposure decreases carnitine levels. The purpose of this study was to investigate and describe the association and pathophysiology of exposure to antibiotics containing pivalic acid and severe neurological and cardiac complications in six identified subjects suffering from PCD.
   Six cases of PCD were identified and studied through medical records and family interview. Stored biomaterial was analyzed for mutations causing PCD.
   Five patients (two children, three adults) died suddenly while one adult patient survived sudden cardiac arrest. Lethal cardiac arrhythmia was documented in five patients, while one patient was not monitored at time of death, but had signs of cardiac arrhythmia a few days earlier. All patients suffered encephalopathy before cardiac arrhythmia. Autopsy showed severe hepatic steatosis and signs of cerebral edema in four out of five. One subject had a dilated heart. All patients were homozygous for the c.95A > G (p.N32S) mutation in SLC22A5 causing PCD. All patients had been treated with antibiotics containing pivalic acid prior to the episode.
   Exposure to antibiotics containing pivalic acid was associated with encephalopathy and progression to lethal cardiac arrhythmia in patients suffering from PCD.
C1 [Rasmussen, Jan] Natl Hosp, Dept Internal Med, FR-100 Torshavn, Faroe Islands, Denmark.
   [Nielsen, Olav W.] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark.
   [Lund, Allan M.] Univ Copenhagen Hosp, Dept Clin Genet, Rigshosp, DK-2100 Copenhagen, Denmark.
   [Kober, Lars] Univ Copenhagen Hosp, Dept Cardiol, Rigshosp, DK-2100 Copenhagen, Denmark.
   [Djurhuus, Hogni] Natl Hosp, Dept Anesthesia, FR-100 Torshavn, Faroe Islands, Denmark.
RP Rasmussen, J (reprint author), Natl Hosp, Dept Internal Med, FR-100 Torshavn, Faroe Islands, Denmark.
EM lsjanra@ls.fo
RI Nielsen, Olav/S-4390-2016
OI Nielsen, Olav/0000-0003-3532-9431
FU Department of Clinical Genetics in Rigshospitalet, Copenhagen;
   Department of Pathology in the National Hospital of the Faroe Islands;
   Faroese Research Council
FX The authors would like to thank Anne Vesterby from Retsmedicinsk
   Institute, Aarhus University, and Ulrike Steuerwald for their
   contribution. And the Department of Clinical Genetics in Rigshospitalet,
   Copenhagen, the Department of Pathology in the National Hospital of the
   Faroe Islands and the Faroese Research Council for their assistance and
   support.
CR BARGENLOCKNER C, 1981, AM J OBSTET GYNECOL, V140, P412, DOI 10.1016/0002-9378(81)90035-1
   Bjerring PN, 2009, METAB BRAIN DIS, V24, P5, DOI 10.1007/s11011-008-9116-3
   Brass EP, 2002, PHARMACOL REV, V54, P589, DOI 10.1124/pr.54.4.589
   BRODERICK TL, 1995, METABOLISM, V44, P499, DOI 10.1016/0026-0495(95)90058-6
   Calvani M, 2000, BASIC RES CARDIOL, V95, P75, DOI 10.1007/s003950050167
   Christensen E, 2000, J INHERIT METAB D S1, V23
   Chung Mina K, 2004, Cardiol Rev, V12, P73, DOI 10.1097/01.crd.0000091839.22076.f4
   El-Hattab AW, 2010, GENET MED, V12, P19, DOI [10.1097/GIM.0b013c3181c5e6f7, 10.1097/GIM.0b013e3181c5e6f7]
   ERIKSSON BO, 1988, EUR J PEDIATR, V147, P662, DOI 10.1007/BF00442488
   GENGER H, 1988, Z GEBURTSH PERINATOL, V192, P134
   Haberle J, 2011, EUR J PEDIATR, V170, P21, DOI 10.1007/s00431-010-1369-2
   Heins J, 2010, METAB BRAIN DIS, V25, P81, DOI 10.1007/s11011-010-9170-5
   HOLME E, 1989, LANCET, V2, P469
   Hou Jia-Woei, 2002, Chang Gung Med J, V25, P832
   HUANG JMC, 1992, P NATL ACAD SCI USA, V89, P6452, DOI 10.1073/pnas.89.14.6452
   ITO T, 1995, TOHOKU J EXP MED, V175, P43, DOI 10.1620/tjem.175.43
   KATO M, 1992, HEPATOLOGY, V15, P1060, DOI 10.1002/hep.1840150615
   Lamhonwah AM, 2002, AM J MED GENET, V111, P271, DOI 10.1002/ajmg.10585
   Lango R, 2001, CARDIOVASC RES, V51, P21, DOI 10.1016/S0008-6363(01)00313-3
   Limketkai BN, 2008, J GEN INTERN MED, V23, P210, DOI 10.1007/s11606-007-0473-0
   LOMBARD KA, 1989, AM J CLIN NUTR, V50, P301
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Lund AM, 2007, J INHERIT METAB DIS, V30, P341, DOI 10.1007/s10545-007-0527-9
   MELEGH B, 1987, BIOCHEM PHARMACOL, V36, P3405, DOI 10.1016/0006-2952(87)90318-2
   Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030
   Ohnishi S, 2008, DRUG METAB PHARMACOK, V23, P293, DOI 10.2133/dmpk.23.293
   Opalka JR, 2001, CLIN CHEM, V47, P2150
   Osa Elmar, 2004, Ugeskr Laeger, V166, P4612
   Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003
   REBOUCHE CJ, 1992, FASEB J, V6, P3379
   REBOUCHE CJ, 1989, J NUTR, V119, P1907
   REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6
   Rijlaarsdam RS, 2004, PACE, V27, P675, DOI 10.1111/j.1540-8159.2004.00507.x
   Scaglia F, 1998, GENET MED, V1, P34
   Schoderbeck M, 1995, J PERINAT MED, V23, P477, DOI 10.1515/jpme.1995.23.6.477
   Shoji Y, 1998, AM J HUM GENET, V63, P101, DOI 10.1086/301911
   STANLEY CA, 1991, ANN NEUROL, V30, P709, DOI 10.1002/ana.410300512
   Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006
   SUZUKI Y, 1982, JPN HEART J, V23, P349
   Tadros TM, 2009, CIRCULATION, V120, pS747
   Takiyama N, 1998, J AM COLL NUTR, V17, P71, DOI 10.1080/07315724.1998.10720458
   Tein I, 2003, J INHERIT METAB DIS, V26, P147, DOI 10.1023/A:1024481016187
   Thumburu KK, 2012, NEUROCHEM INT, V60, P672, DOI 10.1016/j.neuint.2011.10.013
   Todesco L, 2009, CHEM-BIOL INTERACT, V180, P472, DOI 10.1016/j.cbi.2009.02.014
NR 44
TC 18
Z9 22
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JAN
PY 2013
VL 36
IS 1
BP 35
EP 41
DI 10.1007/s10545-012-9488-8
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 070GL
UT WOS:000313494500006
PM 22566287
DA 2018-10-19
ER

PT J
AU Hwang, JY
   Shin, US
   Jang, WC
   Hyun, JK
   Wall, IB
   Kim, HW
AF Hwang, Ji-Young
   Shin, Ueon Sang
   Jang, Won-Cheoul
   Hyun, Jung Keun
   Wall, Ivan B.
   Kim, Hae-Won
TI Biofunctionalized carbon nanotubes in neural regeneration: a mini-review
SO NANOSCALE
LA English
DT Review
ID EMBRYONIC STEM-CELLS; NEURITE OUTGROWTH; NEURONAL GROWTH; DRUG-DELIVERY;
   NERVE REGENERATION; IN-VITRO; CYTOTOXICITY; STIMULATION; POLYMER;
   DIFFERENTIATION
AB Carbon nanotubes (CNTs) have become an intriguing and promising biomaterial platform for the regeneration and functional recovery of damaged nerve tissues. The unique electrical, structural and mechanical properties, diversity of available surface chemistry and cell-penetrating ability of CNTs have made them useful implantable matrices or carriers for the delivery of therapeutic molecules. Although there are still challenges being faced in the clinical applications of CNTs mainly due to their toxicity, many studies to overcome this issue have been published. Modification of CNTs with chemical groups to ensure their dissolution in aqueous media is one possible solution. Functionalization of CNTs with biologically relevant and effective molecules (biofunctionalization) is also a promising strategy to provide better biocompatibility and selectivity for neural regeneration. Here, we review recent advances in the use of CNTs to promote neural regeneration.
C1 [Hwang, Ji-Young; Shin, Ueon Sang; Jang, Won-Cheoul; Hyun, Jung Keun; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat & Engn, Cheonan 330714, South Korea.
   [Shin, Ueon Sang; Hyun, Jung Keun; Wall, Ivan B.; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Shin, Ueon Sang; Hyun, Jung Keun; Wall, Ivan B.; Kim, Hae-Won] Dankook Univ, WCU Res Ctr, Cheonan 330714, South Korea.
   [Jang, Won-Cheoul] Dankook Univ, Dept Chem, Cheonan 330714, South Korea.
   [Wall, Ivan B.] UCL, Dept Biochem Engn, London WC1E 6BT, England.
   [Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan 330714, South Korea.
RP Kim, HW (reprint author), Dankook Univ, Inst Tissue Regenerat & Engn, Cheonan 330714, South Korea.
EM kimhw@dku.edu
OI Hwang, Ji-Young/0000-0001-8044-1989; Hyun, Jung Keun/0000-0001-9254-4424
FU Priority Research Centers Program [2009-0093829]; World Class University
   (WCU) Program [R31-10069]; National Research Foundation (NRF), the
   Ministry of Education, Science and Technology
FX This work was supported by Priority Research Centers Program (Grant no.
   2009-0093829) and World Class University (WCU) Program (Grant no.
   R31-10069) funded by the National Research Foundation (NRF), the
   Ministry of Education, Science and Technology.
CR Agarwal S, 2010, LANGMUIR, V26, P2244, DOI 10.1021/la9048743
   Al-Jamal KT, 2010, METHODS MOL BIOL, V625, P123, DOI 10.1007/978-1-60761-579-8_11
   Ali-Boucetta H, 2011, METHODS MOL BIOL, V726, P299, DOI 10.1007/978-1-61779-052-2_19
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bhirde AA, 2010, NANOMEDICINE-UK, V5, P1535, DOI 10.2217/NNM.10.90
   Bianco Alberto, 2004, Expert Opin Drug Deliv, V1, P57, DOI 10.1517/17425247.1.1.57
   Biazar E, 2010, INT J NANOMED, V5, P839, DOI 10.2147/IJN.S11883
   Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/nnano.2008.374, 10.1038/NNANO.2008.374]
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   CHIQUET M, 1987, J EXP BIOL, V132, P191
   Cho YN, 2010, J BIOMED MATER RES A, V95A, P510, DOI 10.1002/jbm.a.32841
   Coccini T, 2010, TOXICOLOGY, V269, P41, DOI 10.1016/j.tox.2010.01.005
   Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640
   Detriche S, 2008, J NANOSCI NANOTECHNO, V8, P6082, DOI 10.1166/jnn.2008.SW16
   Foldvari M, 2008, NANOMED-NANOTECHNOL, V4, P183, DOI 10.1016/j.nano.2008.04.003
   Gilmore JL, 2008, J NEUROIMMUNE PHARM, V3, P83, DOI 10.1007/s11481-007-9099-6
   Graham BP, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S9
   Hadlock T, 2006, EXPERT OPIN BIOL TH, V6, P1105, DOI 10.1517/14712598.6.11.1105
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jacobsen NR, 2008, ENVIRON MOL MUTAGEN, V49, P476, DOI 10.1002/em.20406
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Jin GZ, 2011, CELL BIOL INT, V35, P741, DOI 10.1042/CBI20100705
   Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kateb B, 2007, NEUROIMAGE, V37, pS9, DOI 10.1016/j.neuroimage.2007.03.078
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   Kiddie G, 2005, PROG BRAIN RES, V147, P67, DOI 10.1016/S0079-6123(04)47006-X
   Lee HJ, 2011, NAT NANOTECHNOL, V6, P120, DOI 10.1038/nnano.2010.281
   Li J, 2007, ACTA NEUROCHIR SUPPL, V97, P537
   Lin CM, 2009, BIOSENS BIOELECTRON, V24, P2791, DOI 10.1016/j.bios.2009.02.005
   Liopo AV, 2006, J NANOSCI NANOTECHNO, V6, P1365, DOI 10.1166/jnn.2006.155
   Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146
   Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8
   Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899
   Lu Y, 2010, BIOMATERIALS, V31, P5169, DOI 10.1016/j.biomaterials.2010.03.022
   Malarkey EB, 2008, NANO LETT, V8, P3538, DOI 10.1021/nl8017912
   Malarkey EB, 2010, ACTA NEUROCHIR SUPPL, V106, P337, DOI 10.1007/978-3-211-98811-4_62
   Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c
   Matsumoto K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/11/115101
   Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078
   Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x
   Ni YC, 2005, J NANOSCI NANOTECHNO, V5, P1707, DOI 10.1166/jnn.2005.189
   Nunes A, 2010, SMALL, V6, P2281, DOI 10.1002/smll.201000864
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Pancrazio JJ, 2008, NANOMEDICINE-UK, V3, P823, DOI 10.2217/17435889.3.6.823
   Porter AE, 2007, NAT NANOTECHNOL, V2, P713, DOI 10.1038/nnano.2007.347
   Roman JA, 2011, J NEUROTRAUM, V28, P2349, DOI 10.1089/neu.2010.1409
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shin US, 2011, J TISSUE ENG
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   SISKEN BF, 1989, BRAIN RES, V485, P309, DOI 10.1016/0006-8993(89)90575-1
   Sucapane A, 2008, J NANONEUROSCI, V1, P10
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t
   Wick P, 2007, TOXICOL LETT, V168, P121, DOI 10.1016/j.toxlet.2006.08.019
   Woolley Adam T., 2004, V283, P305
   Xu FM, 2008, COLLOID SURFACE B, V67, P67, DOI 10.1016/j.colsurfb.2008.07.016
   Xu HF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285102
   Zakharenko S, 2000, NEUROSCIENCE, V97, P185, DOI 10.1016/S0306-4522(00)00022-1
   Zhang YB, 2011, ACS NANO, V5, P7020, DOI 10.1021/nn2016259
   Zhou H, 2007, INT J MOL SCI, V8, P884, DOI 10.3390/i8080884
   Zhu L, 2007, NANO LETT, V7, P3592, DOI 10.1021/nl071303v
NR 71
TC 32
Z9 32
U1 2
U2 94
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
J9 NANOSCALE
JI Nanoscale
PY 2013
VL 5
IS 2
BP 487
EP 497
DI 10.1039/c2nr31581e
PG 11
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 069HP
UT WOS:000313426200003
PM 23223857
DA 2018-10-19
ER

PT J
AU Raimondi, MT
   Eaton, SM
   Lagana, M
   Aprile, V
   Nava, MM
   Cerullo, G
   Osellame, R
AF Raimondi, Manuela T.
   Eaton, Shane M.
   Lagana, Matteo
   Aprile, Veronica
   Nava, Michele M.
   Cerullo, Giulio
   Osellame, Roberto
TI Three-dimensional structural niches engineered via two-photon laser
   polymerization promote stem cell homing
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Two-photon polymerization; Femtosecond laser; Mesenchymal stem cell;
   Niche; Scaffold
ID HIGH-THROUGHPUT; FATE
AB A strategy to modulate the behavior of stem cells in culture is to mimic structural aspects of the native cell/extracellular matrix interaction. We applied femtosecond laser two-photon polymerization (2PP) to fabricate three-dimensional (3-D) microscaffolds, or "niches", using a hybrid organic-inorganic photoresist called SZ2080. The niches, of sizes fitting in a volume of 100 x 100 x 100 mu m(3), were made by an external containment grid of horizontal parallel elements and by an internal 3-D lattice. We developed two niche heights, 20 and 80-100 mu m, and four lattice pore dimensions (10, 20, 30 mu m and graded). We used primary rat mesenchymal stem cells (MSCs) to study cell viability, migration and proliferation in the niches, up to 6 culture days. MSCs preferentially stayed on/in the structures once they ran into them through random migration from the surrounding flat surface, invaded those with a lattice pore dimension greater than 10 mu m, and adhered to the internal lattice while the cell nuclei acquired a roundish morphology. In the niches, the highest MSC density was found in those areas where proliferation was observed, corresponding to the regions where the scaffold surface density available for cell adhesion was highest. The microgeometry inducing the highest cell density was 20 mu m high with graded pores, in which cell invasion was favored in the central region of large porosity and cell adhesion was favored in the lateral regions of high scaffold surface density. Cell density in the niches, 17 +/- 6 cells/(100 x 100 mu m(2)), did not significantly differ from that of the flat surface colonies. This implies that MSCs spontaneously homed and established colonies within the 3-D niches. This study brings to light the crucial role played by the niche 3-D geometry on MSC colonization in culture, with potential implications for the design of biomaterial scaffolds for synthetic niche engineering. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Raimondi, Manuela T.; Lagana, Matteo; Aprile, Veronica; Nava, Michele M.] Politecn Milan, Dept Struct Engn, LaBS, I-20133 Milan, Italy.
   [Eaton, Shane M.; Osellame, Roberto] IFN CNR, I-20133 Milan, Italy.
   [Cerullo, Giulio] Politecn Milan, Dept Phys, I-20133 Milan, Italy.
RP Raimondi, MT (reprint author), Politecn Milan, Dept Struct Engn, LaBS, I-20133 Milan, Italy.
EM manuela.raimondi@polimi.it
RI Nava, Michele/L-8939-2017; Osellame, Roberto/E-6076-2012; Eaton,
   Shane/A-2084-2008; Raimondi, Manuela Teresa/F-6606-2013
OI Nava, Michele/0000-0001-8733-6364; Osellame,
   Roberto/0000-0002-4457-9902; Eaton, Shane/0000-0003-0805-011X; Raimondi,
   Manuela Teresa/0000-0003-2585-7206; Cerullo, Giulio/0000-0002-9534-2702
FU Politecnico di Milano [CUPD41J10000490001]; "Biosensors and Artificial
   Bio-systems" (Italian Institute of Technology- IIT, Genova); Fondazione
   Cariplo, Milano
FX We acknowledge the following funding grants: "5 per Mille Junior 2009
   CUPD41J10000490001" (Politecnico di Milano), "Biosensors and Artificial
   Bio-systems" (Italian Institute of Technology- IIT, Genova), Cariplo
   2010 "3-D Micro structuring and Functionalisation of Polymeric Materials
   for Scaffolds in Regenerative Medicine" (Fondazione Cariplo, Milano).
   The funding sources had no involvement in the study design, collection,
   analysis, interpretation of data, paper writing and in the decision to
   submit it for publication. We thank Prof. A. Remuzzi for critically
   reviewing the manuscript.
CR Amato L, 2012, LAB CHIP, V12, P1135, DOI 10.1039/c2lc21116e
   Becerra J, 2011, STEM CELL REV REP, V7, P248, DOI 10.1007/s12015-010-9195-5
   Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Haske W, 2007, OPT EXPRESS, V15, P3426, DOI 10.1364/OE.15.003426
   Huang NF, 2010, ACTA BIOMATER, V6, P4614, DOI 10.1016/j.actbio.2010.06.033
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Melissinaki V, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045005
   Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602
   Ovsianikov A, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014104
   Ovsianikov A, 2008, ACS NANO, V2, P2257, DOI 10.1021/nn800451w
   Park SH, 2009, LASER PHOTONICS REV, V3, P1, DOI 10.1002/lpor.200810027
   Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158
   Psycharakis S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045008
   Schade R, 2010, INT J ARTIF ORGANS, V33, P219
   Tayalia P, 2008, ADV MATER, V20, P4494, DOI 10.1002/adma.200801319
   Vazin T, 2010, TRENDS BIOTECHNOL, V28, P117, DOI 10.1016/j.tibtech.2009.11.008
   Wan LQ, 2010, INTEGR BIOL-UK, V2, P346, DOI 10.1039/c0ib00016g
   Zangi L, 2006, TISSUE ENG, V12, P2343, DOI 10.1089/ten.2006.12.2343
NR 19
TC 63
Z9 64
U1 1
U2 98
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2013
VL 9
IS 1
BP 4579
EP 4584
DI 10.1016/j.actbio.2012.08.022
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068OV
UT WOS:000313376900011
PM 22922332
DA 2018-10-19
ER

PT J
AU Kang, TY
   Hong, JM
   Kim, BJ
   Cha, HJ
   Cho, DW
AF Kang, Tae-Yun
   Hong, Jung Min
   Kim, Bum Jin
   Cha, Hyung Joon
   Cho, Dong-Woo
TI Enhanced endothelialization for developing artificial vascular networks
   with a natural vessel mimicking the luminal surface in scaffolds
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tissue engineering; Scaffold with artificial vascular networks; Shear
   stress precondition; Surface coating; Endothelialization
ID FLOW-CHANNEL NETWORK; CELL-ADHESION; IN-VITRO; PLATELET-ADHESION;
   SHEAR-STRESS; PERFUSION CULTURE; RGD-PEPTIDES; GRAFT; FABRICATION;
   MICROSTEREOLITHOGRAPHY
AB Large tissue regeneration remains problematic because of a lack of oxygen and nutrient supply. An attempt to meet the metabolic needs of cells has been made by preforming branched vascular networks within a scaffold to act as channels for mass transport. When constructing functional vascular networks with channel patency, emphasis should be placed on anti-thrombogenic surface issues. The aim of this study was to develop a rapid endothelialization method for creating an anti-thrombogenic surface mimicking the natural vessel wall in the artificial vascular networks. Shear stress preconditioning and scaffold surface modification were investigated as effective approaches for promoting biomaterial endothelialization. We found that a transient increase in shear stress at the appropriate time is key to enhancing endothelialization. Moreover, surface modification with bioactive materials such as collagen and recombinant mussel adhesive protein fused with arginine-glycine-aspartic acid peptide (MAP-RGD) showed a synergetic effect with shear stress preconditioning. Platelet adhesion tests demonstrated the anti-thrombogenic potential of MAP-RGD itself without endothelialization. The rapid endothelialization method established in this study can be easily applied to preformed artificial vascular networks in porous scaffolds. Development of artificial vascular networks with an anti-thrombogenic luminal surface will open up a new chapter in tissue engineering and regenerative medicine. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kang, Tae-Yun; Hong, Jung Min; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang 790784, Gyungbuk, South Korea.
   [Kim, Bum Jin; Cha, Hyung Joon] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Gyungbuk, South Korea.
   [Cha, Hyung Joon] Pohang Univ Sci & Technol POSTECH, Dept Chem Engn, Pohang 790784, Gyungbuk, South Korea.
   [Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, Gyungbuk, South Korea.
RP Cho, DW (reprint author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31 Hyoja Dong, Pohang 790784, Gyungbuk, South Korea.
EM dwcho@postech.ac.kr
FU National Research Foundation of Korea (NRF); Korea government (MEST)
   [2012-0001235]
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grant funded by the Korea government (MEST) (No. 2012-0001235).
CR Akimoto S, 2000, CIRC RES, V86, P185, DOI 10.1161/01.RES.86.2.185
   Aldenhoff Y., 2003, EUR CELLS MATER, V5, P67
   Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   Barber RW, 2008, MICROFLUID NANOFLUID, V4, P179, DOI 10.1007/s10404-007-0163-6
   Blit PH, 2011, BIOMATERIALS, V32, P5790, DOI 10.1016/j.biomaterials.2011.04.067
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Choi WS, 2009, MACROMOL RES, V17, P458, DOI 10.1007/BF03218892
   Chung TW, 2003, ARTIF ORGANS, V27, P155, DOI 10.1046/j.1525-1594.2003.07045.x
   Dimitrievska S, 2011, MACROMOL BIOSCI, V11, P493, DOI 10.1002/mabi.201000390
   Farrar DJ, 2000, HEART SURG FORUM, V3, P36
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   Golanski J, 2011, ARCH MED SCI, V7, P34, DOI 10.5114/aoms.2011.20601
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HARKER LA, 1994, NEW ENGL J MED, V330, P1006, DOI 10.1056/NEJM199404073301411
   Hashi CK, 2010, ARTERIOSCL THROM VAS, V30, P1621, DOI 10.1161/ATVBAHA.110.208348
   He JK, 2007, POLYMER, V48, P4578, DOI 10.1016/j.polymer.2007.05.048
   Hoganson DM, 2010, TISSUE ENG PT A, V16, P1469, DOI [10.1089/ten.tea.2009.0118, 10.1089/ten.TEA.2009.0118]
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   Hsu SH, 2003, ARTIF ORGANS, V27, P1068, DOI 10.1111/j.1525-1594.2003.07141.x
   Huang H, 2007, BIOMATERIALS, V28, P3815, DOI 10.1016/j.biomaterials.2007.05.004
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039
   Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020
   Ishii Y, 2007, ANN THORAC SURG, V83, P517, DOI 10.1016/j.athoracsur.2006.09.053
   Jung JW, 2012, INT J PRECIS ENG MAN, V13, P445, DOI 10.1007/s12541-012-0057-8
   Kammerer PW, 2011, EUR CELLS MATER, V21, P364
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Kang HW, 2012, TISSUE ENG PART C-ME, V18, P719, DOI [10.1089/ten.tec.2011.0621, 10.1089/ten.TEC.2011.0621]
   Kang HW, 2009, MICROELECTRON ENG, V86, P941, DOI 10.1016/j.mee.2008.11.054
   Kang TY, 2011, ACTA BIOMATER, V7, P3345, DOI 10.1016/j.actbio.2011.05.015
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Knetsch MLW, 2004, J BIOMED MATER RES A, V71A, P615, DOI 10.1002/jbm.a.30195
   Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925
   Lee JH, 2004, J MATER SCI-MATER M, V15, P155, DOI 10.1023/B:JMSM.0000011817.47636.59
   Li JH, 2008, J MATER SCI-MATER M, V19, P2595, DOI 10.1007/s10856-007-3354-5
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lin JC, 1999, BIOMATERIALS, V20, P1439, DOI 10.1016/S0142-9612(98)00200-2
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Luo XL, 2006, MACROMOL BIOSCI, V6, P373, DOI 10.1002/mabi.200500236
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Motlagh D, 2007, J BIOMED MATER RES A, V82A, P907, DOI 10.1002/jbm.a.31211
   Mukhopadhyay R, 2007, ANAL CHEM, V79, P7249, DOI 10.1021/ac071972t
   OTT MJ, 1995, SURGERY, V117, P334, DOI 10.1016/S0039-6060(05)80210-7
   Paguirigan AL, 2009, INTEGR BIOL, V1, P182, DOI 10.1039/b814565b
   Park IB, 2012, INT J PRECIS ENG MAN, V13, P291, DOI 10.1007/s12541-012-0036-0
   Phaneuf MD, 1998, ASAIO J, V44, pM653, DOI 10.1097/00002480-199809000-00071
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Rouleau L, 2010, ANN BIOMED ENG, V38, P1451, DOI 10.1007/s10439-010-9934-4
   Sakai Y, 2004, MAT SCI ENG C-BIO S, V24, P379, DOI 10.1016/j.msec.2003.12.007
   Shin HS, 2009, J BIOACT COMPAT POL, V24, P316, DOI 10.1177/0883911509104273
   Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wong G, 2008, J VASC SURG, V47, P608, DOI 10.1016/j.jvs.2007.11.025
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Yin M, 2009, BIOMATERIALS, V30, P2764, DOI 10.1016/j.biomaterials.2009.01.039
   Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047
   Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109
NR 62
TC 19
Z9 19
U1 2
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2013
VL 9
IS 1
BP 4716
EP 4725
DI 10.1016/j.actbio.2012.08.042
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068OV
UT WOS:000313376900027
PM 22947325
DA 2018-10-19
ER

PT J
AU Heinemann, S
   Heinemann, C
   Wenisch, S
   Alt, V
   Worch, H
   Hanke, T
AF Heinemann, S.
   Heinemann, C.
   Wenisch, S.
   Alt, V.
   Worch, H.
   Hanke, T.
TI Calcium phosphate phases integrated in silica/collagen nanocomposite
   xerogels enhance the bioactivity and ultimately manipulate the
   osteoblast/osteoclast ratio in a human co-culture model
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Human osteoblasts; Human osteoclasts; Co-culture; Nanocomposites;
   Bioactivity
ID RESISTANT ACID-PHOSPHATASE; IN-VITRO; SUBSTITUTED HYDROXYAPATITE;
   OSTEOCLAST DIFFERENTIATION; CELL-DIFFERENTIATION; COMPOSITE XEROGELS;
   BONE-REPLACEMENT; STROMAL CELLS; OSTEOBLASTS; COLLAGEN
AB A human co-culture model of osteoblasts and osteoclasts, derived from bone marrow stromal cells and monocytes respectively, was used to characterize the influence of biomaterial modification on the bioactivity and ultimately the ratio of bone-forming to bone-resorbing cells cultivated directly on the surface. Nanocomposites of silica and collagen have been shown to function as skeletal structures in nature and were reproduced in vitro by using a sol gel approach. The resulting xerogels exhibit a number of features that make it a valuable system for the development of innovative materials for bone substitution applications. In the present study, the incorporation of different calcium phosphate phases in silica/collagen-based gels was demonstrated to enhance the bioactivity of these samples. This ability of the biomaterial to precipitate calcium phosphate on the surface when incubated in simulated body fluids or cell culture medium is generally considered to an advantageous property for bone substitution materials. By co-cultivating human osteoblasts and osteoclasts up to 42 days on the xerogels, we demonstrate that the long-term ratio of these cell types depends on the level of bioactivity of the substrate samples. Biphasic silica/collagen xerogels exhibited comparably low bioactivity but encouraged proliferation of osteoblasts in comparison to osteoclast formation. A balanced ratio of both cell types was detected for moderately bioactive triphasic xerogels with 5% calcium phosphate. However, enhancing the bioactivity of the xerogel samples by increasing the calcium phosphate phase percentage to 20% resulted in a diminished number of osteoblasts in favor of osteoclast formation. Quantitative evaluation was carried out by biochemical methods (calcium, DNA, ALP, TRAP 5b) as well as RT-PCR (ALP, BSP II, OC, RANKL, TRAP, CALCR, VTNR, CTSK), and was supported by confocal laser scanning microscopy (cell nuclei, actin, CD68, TRAP) as well as scanning electron microscopy. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Heinemann, S.; Heinemann, C.; Worch, H.; Hanke, T.] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Heinemann, S.; Heinemann, C.; Worch, H.; Hanke, T.] Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
   [Wenisch, S.] Univ Giessen, Inst Vet Anat, D-35392 Giessen, Germany.
   [Alt, V.] Univ Giessen, Dept Trauma Surg, D-35385 Giessen, Germany.
RP Heinemann, S (reprint author), Tech Univ Dresden, Max Bergmann Ctr Biomat, Budapester Str 27, D-01069 Dresden, Germany.
EM sascha.heinemann@tu-dresden.de
FU Deutsche Forschungsgemeinschaft [HA5284/2-1, TRR79-TP-M03]
FX We gratefully acknowledge the Deutsche Forschungsgemeinschaft Grants
   HA5284/2-1 and TRR79-TP-M03 for partial financial support.
CR Alt V, 2011, ACTA BIOMATER, V7, P3773, DOI 10.1016/j.actbio.2011.06.024
   [Anonymous], 2010, TRACP 5B ASS
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806
   Botelho CM, 2006, J BIOMED MATER RES A, V78A, P709, DOI 10.1002/jbm.a.30726
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Donahue HJ, 2000, BONE, V26, P417, DOI 10.1016/S8756-3282(00)00245-3
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Guo H, 2007, BIOMED MATER, V2, pS153, DOI 10.1088/1748-6041/2/3/S13
   Halleen JM, 2002, CALCIFIED TISSUE INT, V71, P20, DOI 10.1007/s00223-001-2122-7
   Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667
   Heinemann C, 2011, EUR CELLS MATER, V21, P80, DOI 10.22203/eCM.v021a07
   Heinemann S, 2011, COMPOS SCI TECHNOL, V71, P1873, DOI 10.1016/j.compscitech.2011.08.023
   Heinemann S, 2011, ORTHOPADE, V40, P761, DOI 10.1007/s00132-011-1748-z
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Heinemann S, 2007, ADV ENG MATER, V9, P1061, DOI 10.1002/adem.200700219
   Hempel U, 2004, J BIOMED MATER RES B, V71B, P130, DOI 10.1002/jbm.b.30082
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Itoh K, 2000, J BONE MINER RES, V15, P1766, DOI 10.1359/jbmr.2000.15.9.1766
   Janckila AJ, 2001, J BONE MINER RES, V16, P788, DOI 10.1359/jbmr.2001.16.4.788
   Karpov M, 2008, J BIOMED MATER RES A, V84A, P718, DOI 10.1002/jbm.a.31386
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)00096-3
   Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200
   Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   Miyamoto T, 2001, BLOOD, V98, P2544, DOI 10.1182/blood.V98.8.2544
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Narducci P, 2009, ANN ANAT, V191, P349, DOI 10.1016/j.aanat.2009.02.009
   Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Quarles LD, 1997, J BONE MINER RES, V12, P1971, DOI 10.1359/jbmr.1997.12.12.1971
   Quarles LD, 1997, J BONE MINER RES, V12, P393, DOI 10.1359/jbmr.1997.12.3.393
   REINHOLT FP, 1990, J BONE MINER RES, V5, P1055
   Romanello M, 2001, J BONE MINER RES, V16, P1465, DOI 10.1359/jbmr.2001.16.8.1465
   Sakai H, 2010, AM J PHYSIOL-CELL PH, V299, pC570, DOI 10.1152/ajpcell.00486.2009
   Schilling AF, 2008, J CELL MOL MED, V12, P2497, DOI 10.1111/j.1582-4934.2008.00275.x
   SCHWARZ K, 1978, P207
   Sheu TJ, 2003, J BIOL CHEM, V278, P438, DOI 10.1074/jbc.M208292200
   Spence G, 2009, J BIOMED MATER RES A, V90A, P217, DOI 10.1002/jbm.a.32083
   Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345
   Thimm BW, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015007
   TONG HS, 1994, J BONE MINER RES, V9, P577
   Travaglione S, 2002, TOXICOL IN VITRO, V16, P405, DOI 10.1016/S0887-2333(02)00028-0
   Traykova T, 2004, KEY ENG MAT, V254-2, P679, DOI 10.4028/www.scientific.net/KEM.254-256.679
   Valles G, 2008, BIOMATERIALS, V29, P2326, DOI 10.1016/j.biomaterials.2008.02.011
   Yam LT, 2003, J BONE MINER RES, V18, P1894, DOI 10.1359/jbmr.2003.18.10.1894
   Yamaguchi T, 2008, J BONE MINER METAB, V26, P301, DOI 10.1007/s00774-008-0843-7
   Zhou HJ, 2010, J MATER SCI-MATER M, V21, P2175, DOI 10.1007/s10856-010-4083-8
NR 58
TC 36
Z9 36
U1 2
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2013
VL 9
IS 1
BP 4878
EP 4888
DI 10.1016/j.actbio.2012.10.010
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068OV
UT WOS:000313376900044
PM 23072829
DA 2018-10-19
ER

PT J
AU Vidal, G
   Blanchi, T
   Mieszawska, AJ
   Calabrese, R
   Rossi, C
   Vigneron, P
   Duval, JL
   Kaplan, DL
   Egles, C
AF Vidal, Guillaume
   Blanchi, Thomas
   Mieszawska, Aneta J.
   Calabrese, Rossella
   Rossi, Claire
   Vigneron, Pascale
   Duval, Jean-Luc
   Kaplan, David L.
   Egles, Christophe
TI Enhanced cellular adhesion on titanium by silk functionalized with
   titanium binding and RGD peptides
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk protein; Titanium-binding peptide; Peptide grafting; Cell adhesion;
   Surface modification
ID QUARTZ-CRYSTAL MICROBALANCE; SURFACE; BIOMATERIALS; ADSORPTION;
   ATTACHMENT; TIO2; BONE; FIBRONECTIN; PARTICLES; RESPONSES
AB Soft tissue adhesion on titanium represents a challenge for implantable materials. In order to improve adhesion at the cell/material interface we used a new approach based on the molecular recognition of titanium by specific peptides. Silk fibroin protein was chemically grafted with titanium binding peptide (TiBP) to increase adsorption of these chimeric proteins to the metal surface. A quartz crystal microbalance was used to quantify the specific adsorption of TiBP-functionalized silk and an increase in protein deposition by more than 35% was demonstrated due to the presence of the binding peptide. A silk protein grafted with TiBP and fibronectin-derived arginine glycine aspartic acid (RGD) peptide was then prepared. The adherence of fibroblasts on the titanium surface modified with the multifunctional silk coating demonstrated an increase in the number of adhering cells by 60%. The improved adhesion was demonstrated by scanning electron microscopy and immunocytochemical staining of focal contact points. Chick embryo organotypic culture also revealed strong adhesion of endothelial cells expanding on the Multifunctional silk peptide coating. These results demonstrated that silk functionalized with TiBP and RGD represents a promising approach to modify cell biomaterial interfaces, opening new perspectives for implantable medical devices, especially when reendothelialization is required. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Vidal, Guillaume; Vigneron, Pascale; Duval, Jean-Luc; Egles, Christophe] Ctr Rech Royallieu, UMR CNRS Biomecan & BioIngn 7338, F-60205 Compiegne, France.
   [Blanchi, Thomas] Tufts Univ, Sch Dent Med, Dept Periodontol, Boston, MA 02111 USA.
   [Mieszawska, Aneta J.; Calabrese, Rossella; Kaplan, David L.] Tufts Univ, Biomed Engn Sci & Technol Ctr, Medford, MA 02155 USA.
   [Rossi, Claire] Ctr Rech Royallieu, UMR CNRS Genie Enzymat & Cellulaire 6022, F-60205 Compiegne, France.
   [Egles, Christophe] Tufts Univ, Sch Dent Med, Dept Oral & Maxillofacial Pathol, Boston, MA 02111 USA.
RP Egles, C (reprint author), Univ Technol Compiegne, Bur G212, Ctr Rech, BP 20529,Rue Personne Roberval, F-60205 Compiegne, France.
EM christophe.egles@utc.fr
OI EGLES, Christophe/0000-0003-0982-7752
FU European Union within the CPER; NIH [EB002520, AFIRM R01NS058780-01]
FX We thank the European Union for co-funding of equipment within the CPER
   2007-2013. We thank Rajesh Naik, AFOSR, for the titanium-binding peptide
   sequence and Kader Bamouni, Fanny Chapelin and Audrey Jousse for
   technical assistance. We thank the NIH (EB002520, AFIRM R01NS058780-01)
   (DLK) for support of this work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Baneyx F, 2007, CURR OPIN BIOTECH, V18, P312, DOI 10.1016/j.copbio.2007.04.008
   Becker B, 2011, J MOL RECOGNIT, V24, P754, DOI 10.1002/jmr.1117
   Chen HB, 2006, ANAL CHEM, V78, P4872, DOI 10.1021/ac0603025
   Chen HB, 2009, LANGMUIR, V25, P1588, DOI 10.1021/la8030304
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Delvat E, 2008, J MECH BEHAV BIOMED, V1, P345, DOI 10.1016/j.jmbbm.2008.01.006
   Dickerson MB, 2008, CHEM MATER, V20, P1578, DOI 10.1021/cm071515t
   do Serro APVA, 2000, J BIOMED MATER RES, V49, P345
   Duval JL, 2006, J CONTROL RELEASE, V116, pE50, DOI 10.1016/j.jconrel.2006.09.045
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kriplani K, 2005, CURR OPIN BIOTECH, V16, P470, DOI DOI 10.1016/J.COPBIO.2005.07.001
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Rezania A, 1996, J BIOMED MATER RES, V37, P9
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ronold HJ, 2003, J BIOMED MATER RES A, V67A, P524, DOI 10.1002/jbm.a.10580
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040
   Vockenroth IK, 2009, BIOINTERPHASES, V4, P19, DOI 10.1116/1.3122019
   Yang CL, 2009, J MATER SCI-MATER M, V20, P2349, DOI 10.1007/s10856-009-3794-1
   Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004
NR 34
TC 39
Z9 41
U1 5
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2013
VL 9
IS 1
BP 4935
EP 4943
DI 10.1016/j.actbio.2012.09.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068OV
UT WOS:000313376900050
PM 22975628
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Nilsson, PH
   Ekdahl, KN
   Magnusson, PU
   Qu, HC
   Iwata, H
   Ricklin, D
   Hong, J
   Lambris, JD
   Nilsson, B
   Teramura, Y
AF Nilsson, Per H.
   Ekdahl, Kristina N.
   Magnusson, Peetra U.
   Qu, Hongchang
   Iwata, Hiroo
   Ricklin, Daniel
   Hong, Jaan
   Lambris, John D.
   Nilsson, Bo
   Teramura, Yuji
TI Autoregulation of thromboinflammation on biomaterial surfaces by a
   multicomponent therapeutic coating
SO BIOMATERIALS
LA English
DT Article
DE Surface modification; poly(ethylene glycol) (PEG); Factor H-binding
   peptide; Apyrase; Complement; Coagulation
ID INDUCED LUNG INJURY; COMPLEMENT ACTIVATION; FACTOR-H; ISLET
   TRANSPLANTATION; ALTERNATIVE PATHWAY; POLYMER SURFACE; WHOLE-BLOOD;
   ADENOSINE; MODEL; BINDING
AB Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact We have created a surface which is auto-protective to human innate immunity by combining three fundamentally different strategies, all developed by us previously, which have been shown to induce substantial, but incomplete hemocompatibility when used separately. In summary, we have conjugated a factor H-binding peptide; and an ADP-degrading enzyme; using a PEG linker on both material and cellular surfaces. When exposed to human whole blood, factor H was specifically recruited to the modified surfaces and inhibited complement attack. In addition, activation of platelets and coagulation was efficiently attenuated, by degrading ADP. Thus, by inhibiting thromboinflammation using a multicomponent approach, we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Nilsson, Per H.; Ekdahl, Kristina N.] Linnaeus Univ, Sch Nat Sci, Vaxjo, Sweden.
   [Ekdahl, Kristina N.; Magnusson, Peetra U.; Hong, Jaan; Nilsson, Bo; Teramura, Yuji] Uppsala Univ, Rudbeck Lab C5, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden.
   [Qu, Hongchang; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Iwata, Hiroo; Teramura, Yuji] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068501, Japan.
RP Nilsson, B (reprint author), Uppsala Univ, Rudbeck Lab C5, Dept Immunol Genet & Pathol, Dag Hammarskolds Vag 20, SE-75185 Uppsala, Sweden.
EM bo.nilsson@igp.uu.se
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012; Ricklin,
   Daniel/F-5104-2011
OI Nilsson, Bo/0000-0003-0057-2730; Ricklin, Daniel/0000-0001-6140-0233;
   Lambris, John/0000-0002-9370-5776
FU Swedish Research Council (VR) [2009-4675, 2009-4462, 90293501, A0290401,
   A0290402]; Stem Therapy; Swedish Research Council; Swedish Research
   Council/SSF/Vinnova [60761701]; Japan Society for the Promotion of
   Science grant [442-H22]; Novo Nordisk Foundation; National Institutes of
   Health [EB003968, AI068730, GM062134, AI030040]; Linnaeus University,
   Sweden
FX This work was supported by grants from the Swedish Research Council (VR)
   2009-4675, 2009-4462, 90293501, A0290401, and A0290402 and Stem Therapy;
   the Swedish Research Council; and the Swedish Research
   Council/SSF/Vinnova contract grant number 60761701; the Japan Society
   for the Promotion of Science grant number 442-H22; the Novo Nordisk
   Foundation; National Institutes of Health grants EB003968, AI068730,
   GM062134, and AI030040; and faculty grants from the Linnaeus University,
   Sweden.
CR Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Cattaneo M, 1999, ARTERIOSCL THROM VAS, V19, P2281, DOI 10.1161/01.ATV.19.10.2281
   Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45
   Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066
   Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132
   Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137
   Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   HESSING M, 1990, J IMMUNOL, V144, P204
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   JACKSON R W, 1970, Infection and Immunity, V1, P142
   Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783
   Luan N.M., 2011, BIOMATERIALS
   Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Murakami Y, 2005, J BIOMAT SCI-POLYM E, V16, P381, DOI 10.1163/1568562053654095
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   NILSSON UR, 1984, J IMMUNOL METHODS, V72, P49, DOI 10.1016/0022-1759(84)90432-0
   NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L
   PLATTSMI.TA, 1974, J IMMUNOL, V113, P348
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254
   Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x
   Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Teramura Y, 2007, BIOMATERIALS, V28, P4818, DOI 10.1016/j.biomaterials.2007.07.050
   Teramura Y, 2011, TRANSPLANTATION, V91, P271, DOI 10.1097/TP.0b013e3182034fa4
   Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e
   Van Linden A, 2007, EXPERT OPIN BIOL TH, V7, P1437, DOI 10.1517/14712598.7.9.1437
   Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449
   Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
NR 42
TC 32
Z9 32
U1 1
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 4
BP 985
EP 994
DI 10.1016/j.biomaterials.2012.10.040
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 065NS
UT WOS:000313155800014
PM 23137394
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kim, HT
   Lee, KI
   Kim, DW
   Hwang, DY
AF Kim, Hyeong-Taek
   Lee, Kang-In
   Kim, Dong-Wook
   Hwang, Dong-Youn
TI An ECM-based culture system for the generation and maintenance of
   xeno-free human iPS cells
SO BIOMATERIALS
LA English
DT Article
DE Extracellular matrix protein; Vitronectin biomaterial-based culture;
   Human induced pluripotent stem cells; Human embryonic stem cells
ID EMBRYONIC STEM-CELLS; PROLONGED UNDIFFERENTIATED GROWTH; BOVINE
   APOLIPOPROTEIN B-100; NONHUMAN SIALIC-ACID; HUMAN FEEDER CELLS;
   RECOMBINANT VITRONECTIN; HUMAN FIBROBLASTS; SELF-RENEWAL; INDUCTION;
   SERUM
AB Pluripotent stem cells (PSCs) including induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) have emerged as a promising source for treating incurable diseases. Problems that urgently need to be resolved before the clinical application include avoiding potential xenopathogenic transmission and immune rejection that may be caused by the exposure of PSCs to animal-derived products. In addition, an efficient feeder cell-free culture condition would be required for reducing batch-to-batch variation and facilitating scale-up. Therefore, establishing an efficient xeno-free and extracelluar matrix-based culture system is a prerequisite for the clinical application of PSCs. In this study, by blocking protein kinase C and histone deacetylase activities, we formulated a medium that, in combination with vitronectin as an extracellular matrix, not only allows the long-term culture of hESCs and iPSCs but also efficiently generates xeno-free iPSCs. This xeno-free and feeder cell-free culture system would facilitate the clinical applications of both iPSC- and ESC-based cell therapies in the future. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Kim, Hyeong-Taek; Lee, Kang-In; Hwang, Dong-Youn] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul 463840, South Korea.
   [Kim, Dong-Wook] Yonsei Univ, Sch Med, Dept Physiol, Seoul 120749, South Korea.
RP Hwang, DY (reprint author), CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul 463840, South Korea.
EM hdy@cha.ac.kr
FU Stem Cell Research Center of the 21st Frontier Research Program and Stem
   Cell Research Program [SC5170, 2010-0020350]; MEST, Korea
FX This work is supported by grants from the Stem Cell Research Center
   (SC5170) of the 21st Frontier Research Program and Stem Cell Research
   Program (2010-0020350), funded by the MEST, Korea.
CR Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583
   Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291
   Cerdan C, 2006, NAT MED, V12, P1113, DOI 10.1038/nm1006-1113
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502
   Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605
   Feng XZ, 2012, STEM CELLS, V30, P461, DOI 10.1002/stem.1018
   Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444
   Hisamatsu-Sakamoto M, 2008, STEM CELLS, V26, P72, DOI 10.1634/stemcells.2007-0744
   Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418
   Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]
   Kim HT, 2012, TISSUE ENG REGEN MED, V9, P55
   Lee JB, 2005, BIOL REPROD, V72, P42, DOI 10.1095/biolrepod.104.033480
   Lee JB, 2004, REPRODUCTION, V128, P727, DOI 10.1530/rep.1.00415
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]
   Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546
   Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248
   Rowland TJ, 2010, STEM CELLS DEV, V19, P1231, DOI 10.1089/scd.2009.0328
   Sakamoto N, 2007, BLOOD, V110, P501, DOI 10.1182/blood-2007-07-066522
   Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106
   Unger C, 2009, HUM REPROD, V24, P2567, DOI 10.1093/humrep/dep232
   Wang Q, 2005, STEM CELLS, V23, P1221, DOI 10.1634/stemcells.2004-0347
   Wang QH, 2012, PROTEIN CELL, V3, P51, DOI 10.1007/s13238-012-2002-0
   Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Yoon TM, 2010, STEM CELL REV REP, V6, P425, DOI 10.1007/s12015-010-9158-x
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
NR 33
TC 18
Z9 18
U1 4
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 4
BP 1041
EP 1050
DI 10.1016/j.biomaterials.2012.10.064
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 065NS
UT WOS:000313155800020
PM 23153417
DA 2018-10-19
ER

PT J
AU Myllymaa, K
   Levon, J
   Tiainen, VM
   Myllymaa, S
   Soininen, A
   Korhonen, H
   Kaivosoja, E
   Lappalainen, R
   Konttinen, YT
AF Myllymaa, Katja
   Levon, Jaakko
   Tiainen, Veli-Matti
   Myllymaa, Sami
   Soininen, Antti
   Korhonen, Hannu
   Kaivosoja, Emilia
   Lappalainen, Reijo
   Konttinen, Yrjo Tapio
TI Formation and retention of staphylococcal biofilms on DLC and its
   hybrids compared to metals used as biomaterials
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biofilm; Staphylococci; Physical vapour deposition; Diamond-like carbon;
   Polytetrafluoroethylene
ID SURFACE FREE-ENERGY; DIAMOND-LIKE CARBON; BACTERIAL ADHESION;
   EPIDERMIDIS BIOFILMS; STAINLESS-STEEL; ROUGHNESS; CHEMISTRY; POLYMERS;
   COATINGS; COLONIZATION
AB Staphylococcus epidermidis and Staphylococcus aureus cause most of the implant-related infections.Antibiotic treatment often fails and cure requires surgical intervention. It was hypothesized that biomaterial coatings resistant to biofilms offer a preventive option. Physical vapour deposited diamond-like carbon (DLC) and its polytetrafluoroethylene (DLC-PTFE-h) and polydimethylsiloxane (DLC-PDMS-h) hybrids were compared to titanium (Ti), tantalum (Ta) and chromium (Cr) thin films on silicon wafers for their resistance against formation and/or retention of biofilms produced by S. epidermidis and S. aureus in vitro. Sample surfaces were characterized for surface topography, contact angle and zeta-potential, because such properties might affect the biofilm. Biofilm was stained using calcofluor white and analysed in fluorescence microscopy using morphometry. Sixteen hour incubation was selected in pilot tests; at this checkpoint Ti, Ta, Cr and DLC-PDMS-h were almost fully covered by biofilm, but DLC and DLC-PTFE-h were only partially biofilm coated by S. epidermidis (88 +/- 26%, p < 0.001 and 56 +/- 39%, p < 0.001, respectively) or S. aureus (81 +/- 24%, p<0.001 and 51 +/- 26%, p < 0.001, respectively). DLC and its PTFE hybrid offer a potential biofilm hostile surface coating for implants and medical devices. This ability to resist biofilm formation and attachment could not be explained by only one factor, but it seems to be related to a combination of various properties, with electrokinetic streaming potential and protein coating being particularly important for its outcome. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Myllymaa, Katja; Myllymaa, Sami; Korhonen, Hannu; Lappalainen, Reijo] Univ Kuopio, Dept Phys, FI-70211 Kuopio, Finland.
   [Myllymaa, Katja] Savonia Univ Appl Sci, Sch Engn & Technol, Microsensor Lab, FI-70201 Kuopio, Finland.
   [Levon, Jaakko] Univ Helsinki, Inst Biomed, Dept Anat, FI-00014 Hy, Finland.
   [Tiainen, Veli-Matti; Soininen, Antti; Konttinen, Yrjo Tapio] ORTON Fdn, ORTON Orthopaed Hosp, FI-00281 Helsinki, Finland.
   [Kaivosoja, Emilia; Konttinen, Yrjo Tapio] Univ Helsinki, Cent Hosp, Dept Med, Inst Clin Med, FI-00029 Helsinki, Finland.
   [Konttinen, Yrjo Tapio] COXA Hosp Joint Replacement, FI-33101 Tampere, Finland.
RP Konttinen, YT (reprint author), Univ Helsinki, Cent Hosp, Dept Med, Inst Clin Med, POB 700,Haartmaninkatu 8, FI-00029 Helsinki, Finland.
EM katja.myllymaa@uku.fi; jhlevo@utu.fi; vmt@sci.fi; sami.myllymaa@uku.fi;
   antti.soininen@invalidisaatio.fi; hannu.korhonen@uku.fi;
   emilia.kaivosoja@helsinki.fi; reijo.lappalainen@uku.fi;
   yrjo.konttinen@helsinki.fi
RI Peltola, Emilia/L-9969-2013
OI Peltola, Emilia/0000-0002-8868-9273
FU Sigrid Juselius Foundation; Finska Lakaresallskapet; evo-grants;
   Orion-Farmos Foundation; ORION Foundation; Danish Council for Strategic
   research on "Individualized Musculoskeletal Medicine"; Otto A. Maim
   Foundation; Orion-Farmos Research Foundation; PhD-programme in
   Musculoskeletal Diseases and Biomaterials (TBGS); TEKES (a Finnish
   national public funding organisation for technical research and
   development) [40270/06]
FX This research work has been supported by Sigrid Juselius Foundation,
   Finska Lakaresallskapet, evo-grants, Orion-Farmos Foundation, ORION
   Foundation, Danish Council for Strategic research on "Individualized
   Musculoskeletal Medicine", Otto A. Maim Foundation, Orion-Farmos
   Research Foundation, PhD-programme in Musculoskeletal Diseases and
   Biomaterials (TBGS) and TEKES (a Finnish national public funding
   organisation for technical research and development) project 40270/06 "A
   New Generation of Titanium Biomaterials". The authors acknowledge the
   personnel of Microsensor laboratory of Savonia University of Applied
   Sciences. Montserrat Espanol Pons and Maria-Pau Ginebra from the
   Department of Materials Science and Metallurgy, Technical University of
   Catalonia, Barcelona, Spain, are gratefully acknowledged for acting as
   hosts to Katja Myllymaa and Emilia Kaivosoja during their ESF
   Regenerative Medicine RNP-sponsored stay to learn to measure zeta
   potentials.
CR Auschill TM, 2005, J CLIN PERIODONTOL, V32, P147, DOI 10.1111/j.1600-051X.2005.00650.x
   Azeredo J, 1997, J I BREWING, V103, P359, DOI 10.1002/j.2050-0416.1997.tb00964.x
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1980, ADSORPTION MICROORGA, P59
   Baier RE, 1971, MANAGEMENT OCCLUSIVE, V147- 163
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Buchanan LA, 2010, J BIOMED MATER RES A, V93A, P537, DOI 10.1002/jbm.a.32561
   Calzado-Martin A, 2010, ACTA BIOMATER, V6, P3325, DOI 10.1016/j.actbio.2010.02.048
   Campos E, 2008, J MICROENCAPSUL, V25, P154, DOI [10.1080/02652040701806476, 10.1080/02652040701806476 ]
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chandra J, 2005, APPL ENVIRON MICROB, V71, P8795, DOI 10.1128/AEM.71.12.8795-8801.2005
   Chapin K.C., 2007, MANUAL CLIN MICROBIO, V1, P334
   Colas A., 2004, BIOMATERIALS SCI INT, P80
   Costerton J W, 2007, BIOFILM PRIMER
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Galdbart JO, 1999, J CLIN MICROBIOL, V37, P1306
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Kaivosoja E., 2011, J BIOMATER APPL
   Kaivosoja E., 2011, ANN MED
   Kaivosoja E, 2010, EUR CELLS MATER, V19, P147, DOI 10.22203/eCM.v019a15
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kinnari TJ, 2009, J MED MICROBIOL, V58, P132, DOI 10.1099/jmm.0.002758-0
   Konttinen YT, 2008, WOODHEAD PUBL MATER, P115, DOI 10.1533/9781845694807.2.115
   Lappalainen R, 2003, J BIOMED MATER RES B, V66B, P410, DOI 10.1002/jbm.b.10026
   Lappalainen R, 1998, DIAM RELAT MATER, V7, P482, DOI 10.1016/S0925-9635(98)80003-4
   Levon J, 2010, J BIOMED MATER RES A, V92A, P1606, DOI 10.1002/jbm.a.32486
   Litzler PY, 2007, J THORAC CARDIOV SUR, V134, P1025, DOI 10.1016/j.jtcvs.2007.06.013
   Lyklema J. J, 1995, FUNDAMENTALS INTERFA, V2, P1
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   MEURMAN JH, 1989, ORAL MICROBIOL IMMUN, V4, P117, DOI 10.1111/j.1399-302X.1989.tb00109.x
   Munoz OLS, 2003, ELECTROPHORESIS, V24, P390, DOI 10.1002/elps.200390049
   Myllymaa S, 2010, J MATER SCI-MATER M, V21, P329, DOI 10.1007/s10856-009-3836-8
   Nayak N, 2011, J HOSP INFECT, V77, P153, DOI 10.1016/j.jhin.2010.09.023
   Neut D, 2007, ACTA ORTHOP, V78, P299, DOI 10.1080/17453670710013843
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Pereni CI, 2006, COLLOID SURFACE B, V48, P143, DOI 10.1016/j.colsurfb.2006.02.004
   Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169
   Quirynen M., 1995, J CLIN PERIODONTOL, V22, P1
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   Amarante ES, 2008, AM J DENT, V21, P318
   Soininen A, 2009, J BIOMED MATER RES B, V90B, P882, DOI 10.1002/jbm.b.31359
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Teoh S.H., 1998, HDB BIOMATERIAL PROP, P275
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Vadyvaloo V, 2005, INT J ARTIF ORGANS, V28, P1069
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022
   Zambon J J, 1990, Am J Dent, V3 Spec No, pS27
   Zhao Q, 2008, MED ENG PHYS, V30, P341, DOI 10.1016/j.medengphy.2007.04.004
   Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012
NR 63
TC 16
Z9 17
U1 3
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2013
VL 101
BP 290
EP 297
DI 10.1016/j.colsurfb.2012.07.012
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 068ZS
UT WOS:000313405300044
PM 23010032
DA 2018-10-19
ER

PT J
AU Amna, T
   Hassan, MS
   Shin, WS
   Ba, HV
   Lee, HK
   Khil, MS
   Hwang, IH
AF Amna, Touseef
   Hassan, M. Shamshi
   Shin, Woon-Seob
   Ba, Hoa Van
   Lee, Hak-Kyo
   Khil, Myung-Seob
   Hwang, I. H.
TI TiO2 nanorods via one-step electrospinning technique: A novel nanomatrix
   for mouse myoblasts adhesion and propagation
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE TiO2 nanorods; Cytotoxicity; Scaffolds; Myoblast cells; Electrospinning
ID ZINC-OXIDE NANORODS; THIN-FILMS; CELLS; CONVERSION; ANATASE
AB This study was aimed at the synthesis and characterization of novel Titania nanorods by sol gel electrospinning technique. The physicochemical properties of the synthesized nanorods were determined by field emission scanning electron microscopy (FE-SEM), energy dispersive X-ray spectroscopy (EDX), transmission electron microscopy (TEM), and X-ray diffraction (XRD) pattern. To examine the in vitro cytotoxicity, mouse myoblast C2C12 cells were treated with different concentrations of as prepared TiO2 nanorods and the viability of cells was analyzed by Cell Counting Kit-8 assay at regular time intervals. The morphological features of the cells attached with nanorods were examined by Bio-SEM. Cytotoxicity experiments indicated that the mouse myoblast cells could attach to the TiO2 nanorods after being cultured. We observed that TiO2 nanorods could support cell adhesion and growth and guide spreading behavior of myoblasts. We conclude that the electrospun TiO2 nanorods scaffolds with unique morphology had excellent biocompatibility. Thus, the current work demonstrates that the as-synthesized TiO2 nanorods represent a promising biomaterial to be exploited for various tissue engineering applications. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Amna, Touseef; Ba, Hoa Van; Hwang, I. H.] Chonbuk Natl Univ, Dept Anim Sci, Inst Rare Earth Biol Applicat, Jeonju 561756, South Korea.
   [Hassan, M. Shamshi; Khil, Myung-Seob] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
   [Shin, Woon-Seob] Kwandong Univ, Dept Microbiol, Coll Med, Kangnung 210701, South Korea.
   [Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea.
RP Lee, HK (reprint author), Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea.
EM breedlee@empas.com; inho.hwang@jbnu.ac.kr
FU Next-Generation BioGreen 21 Program [PJ008191]; Rural Development
   Administration, Republic of Korea [PJ907055]
FX This work has been conducted and partly supported by a grant from
   Next-Generation BioGreen 21 Program (No. PJ008191) and a fund for FTA
   issues (No. PJ907055), Rural Development Administration, Republic of
   Korea.
CR Brown G. L., 1979, EuropeanPatent, Patent No. 0004966
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607
   Jenkins R., 1996, INTRO XRAY POWDER DI
   Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k
   Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029
   Liu Y., 2000, J ELECT MAT, V29, P60
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Madhugiri S, 2003, J AM CHEM SOC, V125, P14531, DOI 10.1021/ja030326i
   Maiyalagan T, 2008, APPL CATAL A-GEN, V340, P191, DOI 10.1016/j.apcata.2008.02.016
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   Moon WT, 2006, SENSOR ACTUAT B-CHEM, V115, P123, DOI 10.1016/j.snb.2005.08.024
   More AM, 2008, SENSOR ACTUAT B-CHEM, V129, P671, DOI 10.1016/j.snb.2007.09.026
   NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0
   Pathan H.M., 2005, MATER CHEM PHYS, V97, P5
   Saito Y, 2004, SOL ENERG MAT SOL C, V83, P1, DOI 10.1016/j.solomat.2004.02.010
   Sankapal BR, 2006, CR CHIM, V9, P702, DOI 10.1016/j.crci.2005.06.035
   Sankapal BR, 2005, APPL SURF SCI, V239, P165, DOI 10.1016/j.apsusc.2004.05.142
   Shimizu K, 1999, THIN SOLID FILMS, V351, P220, DOI 10.1016/S0040-6090(99)00084-X
   Shin YJ, 2007, CURR EYE RES, V32, P1, DOI 10.1080/02713680601077061
   Sorapong P., 2005, J SOLID STATE CHEM, V178, P3110
   Yoo KC, 2012, INT J NANOMED, V7, P1203, DOI 10.2147/IJN.S28647
   Yoon YI, 2009, CARBOHYD POLYM, V5, P246
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
NR 28
TC 16
Z9 16
U1 1
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2013
VL 101
BP 424
EP 429
DI 10.1016/j.colsurfb.2012.06.012
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 068ZS
UT WOS:000313405300062
PM 23010050
DA 2018-10-19
ER

PT J
AU Forni, MF
   Loureiro, RR
   Cristovam, PC
   Bonatti, JA
   Sogayar, MC
   Gomes, JAP
AF Forni, Maria Fernanda
   Loureiro, Renata Ruoco
   Cristovam, Priscila Cristina
   Bonatti, Jose Americo
   Sogayar, Mari Cleide
   Pereira Gomes, Jose Alvaro
TI Comparison Between Different Biomaterial Scaffolds for Limbal-Derived
   Stem Cells Growth and Enrichment
SO CURRENT EYE RESEARCH
LA English
DT Article
DE Biomaterial scaffolds; Collagen gel; Extracellular matrix; Fibrin glue;
   Limbal-derived corneal stem cell
ID SIDE POPULATION CELLS; OCULAR SURFACE RECONSTRUCTION; CORNEAL
   REGENERATION; EPITHELIAL-CELLS; FIBRIN; THERAPY; MARKERS; P63;
   PHENOTYPE; LOCATION
AB Purpose/Aim: Corneal epithelial stem cells have been used for the treatment of total limbal deficiency with corneal conjunctivalization and decreased vision secondary to a variety of ocular surface diseases. We set to compare the ability of different extracellular components in promoting growth and migration of these cells.
   Materials and Methods: Growth parameters were evaluated, including cell migration and proliferation (by wound healing) and mRNA gene expression (by quantitative RT-PCR).
   Results: The growth of corneal epithelial cells plated onto different matrix has shown that all treatments were efficient in supporting exponential growth, with a small increase in the puramatrix and collagen I groups when compared with fibrin treatment, which displayed the best doubling time rate and saturation density. The mRNA relative levels for c-myc, a proliferation marker, were considerably higher in the fibrin-coated group. In a smaller extent, the same could be observed for the puramatrix and collagen I groups. The same pattern could be observed for beta-1 and alpha-6-integrin mRNA relative levels. The levels of CD71 mRNA, a LESC negative marker, were decreased in all groups, with a greater decrease in the fibrin group. We also found that the relative mRNA levels of the efflux pump ABCG2 and Delta Np63 transcripts were significantly higher in the fibrin group but not for collagen and puramatrix groups. Moreover, a diminished capacity of wound repair was observed for the uncoated control while the coated biomaterial groups were able to restore the cell-covered surface at some extent.
   Conclusion: All components tested were effective in promoting growth of corneal epithelial cells and maintenance of stem cell putative markers when compared with the uncoated surface group. Fibrin was far superior than collagen I and puramatrix in promoting survival, growth and migration of these cells.
C1 [Forni, Maria Fernanda; Sogayar, Mari Cleide] Univ Sao Paulo, NUCEL, Sao Paulo, Brazil.
   [Forni, Maria Fernanda; Sogayar, Mari Cleide] Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil.
   [Loureiro, Renata Ruoco; Cristovam, Priscila Cristina; Pereira Gomes, Jose Alvaro] Univ Fed Sao Paulo, BR-01239010 Sao Paulo, Brazil.
   [Bonatti, Jose Americo] Univ Sao Paulo, Med Sch Ophthalm Clin, Sao Paulo, Brazil.
RP Gomes, JAP (reprint author), Univ Fed Sao Paulo, Rua Sabara 566,Conjunto 43, BR-01239010 Sao Paulo, Brazil.
EM mcsoga@iq.usp.br; japgomes@uol.com.br
RI CRISTOVAM, PRISCILA/E-8481-2012; Loureiro, Renata/I-5669-2013; Gomes,
   Jose Alvaro Pereira/P-4798-2018
OI Gomes, Jose Alvaro Pereira/0000-0001-7329-9531; Forni, Maria
   Fernanda/0000-0002-3335-9023
FU FAPESP; CNPq; FINEP; BNDES-FUNTEC; MS-DECIT; MCT
FX The excellent technical support of Zizi de Mendoncca, Sandra Regina de
   Souza, Debora Cristina da Costa, Ricardo Krett de Oliveira and Marluce
   Cunha Mantovani is deeply appreciated. This work was supported by
   FAPESP, CNPq, FINEP, BNDES-FUNTEC, MS-DECIT, MCT.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003
   Bonatti JA, 1997, ARQUIVOS BRASILEIROS, V60, P60
   Bonatti José Américo, 2007, Arq. Bras. Oftalmol., V70, P884, DOI 10.1590/S0004-27492007000500029
   Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674
   Chee KYH, 2006, CLIN EXP OPHTHALMOL, V34, P64, DOI 10.1111/j.1442-9071.2006.1147.x
   Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355
   Cristovam PC, 2008, ARQ BRAS OFTALMOL, V71, P689, DOI 10.1590/S0004-27492008000500015
   Ricardo JRD, 2010, ARQ BRAS OFTALMOL, V73, P541, DOI 10.1590/S0004-27492010000600017
   Daniels JT, 2007, EXPERT OPIN BIOL TH, V7, P1, DOI 10.1517/14712598.7.1.1
   De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093
   Dua HS, 1996, EYE, V10, P447, DOI 10.1038/eye.1996.98
   [顾国贞 GU Guozhen], 2008, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V34, P814
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Haug K, 2012, ACTA OPHTHALMOL
   Hayashi R, 2008, BIOCHEM BIOPH RES CO, V367, P256, DOI 10.1016/j.bbrc.2007.12.077
   LAGOUTTE FM, 1989, BRIT J OPHTHALMOL, V73, P757, DOI 10.1136/bjo.73.9.757
   Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406
   Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861
   MORANDINI W, 1992, ACTA CIR BRAS, V7, P80
   Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114
   Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769
   Pellegrini G, 2009, J PATHOL, V217, P217, DOI 10.1002/path.2441
   Raeder S, 2007, INVEST OPHTH VIS SCI, V48, P5484, DOI 10.1167/iovs.07-0494
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020
   Secker GA, 2008, STEM CELL REV, V4, P159, DOI 10.1007/s12015-008-9029-x
   Sonmez B, 2011, CORNEA, V30, P296, DOI 10.1097/ICO.0b013e3181eeb2af
   Sun TT, 2010, NATURE, V463, pE10, DOI 10.1038/nature08805
   Takacs L, 2009, CYTOM PART A, V75A, P54, DOI 10.1002/cyto.a.20671
   Talbot M, 2006, MOL VIS, V12, P65
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Tuori A, 1996, CORNEA, V15, P286, DOI 10.1097/00003226-199605000-00010
   Unno K, 2012, CIRC RES, V110, P1355, DOI 10.1161/CIRCRESAHA.111.243014
   Vinciguerra P, 2008, J REFRACT SURG, V24, P323
   Watanabe K, 2004, FEBS LETT, V565, P6, DOI 10.1016/j.febslet.2004.03.064
   Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0
   Yano S, 2005, STEM CELLS, V23, P834, DOI 10.1634/stemcells.2004-0226
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028
NR 42
TC 4
Z9 5
U1 0
U2 18
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0271-3683
J9 CURR EYE RES
JI Curr. Eye Res.
PD JAN-FEB
PY 2013
VL 38
IS 1
BP 27
EP 34
DI 10.3109/02713683.2012.733053
PG 8
WC Ophthalmology
SC Ophthalmology
GA 067IV
UT WOS:000313288400004
PM 23051105
DA 2018-10-19
ER

PT J
AU Huang, XD
   Li, HY
   Lin, L
   Yao, K
AF Huang, Xiao-Dan
   Li, He-Yi
   Lin, Lin
   Yao, Ke
TI Reduced Silicone Oil Adherence to Silicone Intraocular Lens by Surface
   Modification with 2-Methacryloyloxyethyl Phosphoryl-Choline
SO CURRENT EYE RESEARCH
LA English
DT Article
DE Intraocular lens; Silicone oil; Bioadhesives; Surface modification;
   Phosphoryl-choline
ID BIOCOMPATIBILITY; ADHESION
AB Purpose: to evaluate and compare the interaction of silicone oil-intraocular lens (IOLs) biomaterial in 2-methacryloyloxyethyl phosphoryl-choline (MPC) -modified IOLs and various widely used IOLs in vitro.
   Methods: Five groups of foldable IOLs, including 3-piece hydrophobic silicone IOLs, MPC-modified silicone IOLs, 3-piece hydrophilic hydrogel IOLs, one-piece hydrophilic acrylic IOLs and one-piece hydrophobic acrylic IOLs were photographed after immersion in silicone oil. The silicone oil coverage of the anterior and posterior surfaces of each IOL was measured using EPCO Image-analysis software. The hydrophilicity of the IOL surface was characterized by the water contact angle.
   Results: hydrophilic IOLs, such as MPC-modified silicone IOLs, hydrophilic acrylic IOLs and hydrogel IOLs having a lower contact angle exhibited less silicone oil adherence than hydrophobic IOLs, including both silicone IOLs and hydrophobic acrylic IOLs (p = 0.000, p < 0.05).
   Conclusions: MPC-modified hydrophilic silicone IOLs reduce silicone oil adherence, and thus may meet the need of a foldable IOL suitable for vitreoretinal patients.
C1 [Huang, Xiao-Dan; Li, He-Yi; Lin, Lin; Yao, Ke] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310009, Zhejiang, Peoples R China.
   [Huang, Xiao-Dan; Li, He-Yi; Lin, Lin; Yao, Ke] Zhejiang Univ, Coll Med, Inst Ophthalmol, Hangzhou 310009, Zhejiang, Peoples R China.
RP Yao, K (reprint author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310009, Zhejiang, Peoples R China.
EM xlren@zju.edu.cn
FU National Natural Science Foundation of China [81000372]; Zhejiang Key
   Innovation Team Project of China [2009R50039]; Zhejiang Key Laboratory
   Fund of China [2011E10006]
FX This work was supported by National Natural Science Foundation of China
   (grant no. 81000372), and Zhejiang Key Innovation Team Project of China
   (grant no. 2009R50039), and Zhejiang Key Laboratory Fund of China
   (No.2011E10006). Pacific Edit reviewed the manuscript prior to
   submission.
CR Apple DJ, 1996, OPHTHALMOLOGY, V103, P1555, DOI 10.1016/S0161-6420(96)30463-6
   Apple DJ, 1997, J CATARACT REFR SURG, V23, P536, DOI 10.1016/S0886-3350(97)80210-6
   Arthur SN, 2001, J CATARACT REFR SURG, V27, P1662, DOI 10.1016/S0886-3350(01)00891-4
   Arthur SN, 2001, INT OPHTHALMOL CLIN, V41, P33, DOI 10.1097/00004397-200107000-00005
   BATTERBURY M, 1994, EYE, V8, P547, DOI 10.1038/eye.1994.135
   Dick B, 1997, KLIN MONATSBL AUGENH, V211, P192, DOI 10.1055/s-2008-1035121
   Drimtzias EG, 2011, AM J OPHTHALMOL, V152, P824, DOI 10.1016/j.ajo.2011.04.009
   Huang XD, 2007, CLIN EXP OPHTHALMOL, V35, P462, DOI 10.1111/j.1442-9071.2007.01516.x
   Huang XD, 2010, J CATARACT REFR SURG, V36, P290, DOI 10.1016/j.jcrs.2009.09.027
   Ishihara K, 2000, SCI TECHNOL ADV MAT, V1, P131, DOI 10.1016/S1468-6996(00)00012-7
   Leaming DV, 2004, J CATARACT REFR SURG, V30, P892, DOI 10.1016/j.jcrs.2004.02.064
   Little U, 2009, ACTA BIOMATER, V5, P2025, DOI 10.1016/j.actbio.2009.01.042
   Maddula S, 2011, J CATARACT REFR SURG, V37, P740, DOI 10.1016/j.jcrs.2010.10.058
   Monge S, 2011, BIOMACROMOLECULES, V12, P1973, DOI 10.1021/bm2004803
   Oner FH, 2003, OPHTHALMOLOGICA, V217, P124, DOI 10.1159/000068561
   Sarra-Bournet C, 2006, J PHYS D APPL PHYS, V39, P3461, DOI 10.1088/0022-3727/39/16/S03
   Yao K, <IT>China patent</IT>, Patent No. [<IT>ZL200510050022.X</IT>, 200510050022]
   Yao K, 2006, J BIOMED MATER RES A, V78A, P684, DOI 10.1002/jbm.a.30741
NR 18
TC 5
Z9 5
U1 2
U2 23
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0271-3683
J9 CURR EYE RES
JI Curr. Eye Res.
PD JAN-FEB
PY 2013
VL 38
IS 1
BP 91
EP 96
DI 10.3109/02713683.2012.704477
PG 6
WC Ophthalmology
SC Ophthalmology
GA 067IV
UT WOS:000313288400013
PM 22742824
DA 2018-10-19
ER

PT J
AU Guterl, CC
   See, EY
   Blanquer, SBG
   Pandit, A
   Ferguson, SJ
   Benneker, LM
   Grijpma, DW
   Sakai, D
   Eglin, D
   Alini, M
   Iatridis, JC
   Grad, S
AF Guterl, Clare C.
   See, Eugene Y.
   Blanquer, Sebastien B. G.
   Pandit, Abhay
   Ferguson, Stephen J.
   Benneker, Lorin M.
   Grijpma, Dirk W.
   Sakai, Daisuke
   Eglin, David
   Alini, Mauro
   Iatridis, James C.
   Grad, Sibylle
TI CHALLENGES AND STRATEGIES IN THE REPAIR OF RUPTURED ANNULUS FIBROSUS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Annulus fibrosus rupture; disc herniation; disc biomechanics;
   biomaterial scaffold; pre-clinical model; interdisciplinary approach;
   annulus fibrosus tissue engineering; annulus fibrosus regeneration
ID INTERVERTEBRAL DISC DEGENERATION; LOW-BACK-PAIN; MESENCHYMAL STEM-CELLS;
   FINITE-ELEMENT-ANALYSIS; ISSLS PRIZE WINNER; NUCLEUS PULPOSUS CELLS;
   HUMAN ANULUS FIBROSUS; RESEARCH TRIAL SPORT; LUMBAR DISC; IN-VIVO
AB Lumbar discectomy is the surgical procedure most frequently performed for patients suffering from low back pain and sciatica. Disc herniation as a consequence of degenerative or traumatic processes is commonly encountered as the underlying cause for the painful condition. While discectomy provides favourable outcome in a majority of cases, there are conditions where unmet requirements exist in terms of treatment, such as large disc protrusions with minimal disc degeneration; in these cases, the high rate of recurrent disc herniation after discectomy is a prevalent problem. An effective biological annular repair could improve the surgical outcome in patients with contained disc herniations but otherwise minor degenerative changes. An attractive approach is a tissue-engineered implant that will enable/stimulate the repair of the ruptured annulus. The strategy is to develop three-dimensional scaffolds and activate them by seeding cells or by incorporating molecular signals that enable new matrix synthesis at the defect site, while the biomaterial provides immediate closure of the defect and maintains the mechanical properties of the disc. This review is structured into (1) introduction, (2) clinical problems, current treatment options and needs, (3) biomechanical demands, (4) cellular and extracellular components, (5) biomaterials for delivery, scaffolding and support, (6) pre-clinical models for evaluation of newly developed cell- and material-based therapies, and (7) conclusions. This article highlights that an interdisciplinary approach is necessary for successful development of new clinical methods for annulus fibrosus repair. This will benefit from a close collaboration between research groups with expertise in all areas addressed in this review.
C1 [Guterl, Clare C.; Iatridis, James C.] Mt Sinai Med Ctr, Dept Orthopaed, New York, NY 10029 USA.
   [See, Eugene Y.; Pandit, Abhay] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
   [Blanquer, Sebastien B. G.; Grijpma, Dirk W.] Univ Twente, Dept Biomat Sci & Technol, NL-7500 AE Enschede, Netherlands.
   [Ferguson, Stephen J.] ETH, Inst Biomech, Zurich, Switzerland.
   [Benneker, Lorin M.] Univ Bern, Dept Orthopaed Surg, Bern, Switzerland.
   [Sakai, Daisuke] Tokai Univ, Sch Med, Dept Orthopaed Surg, Isehara, Kanagawa 25911, Japan.
   [Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Grijpma, Dirk W.] Univ Groningen, Groningen, Netherlands.
   [Eglin, David; Alini, Mauro; Grad, Sibylle] AO Res Inst Davos, CH-7270 Davos, Switzerland.
   [Guterl, Clare C.; See, Eugene Y.; Blanquer, Sebastien B. G.; Pandit, Abhay; Ferguson, Stephen J.; Benneker, Lorin M.; Grijpma, Dirk W.; Sakai, Daisuke; Eglin, David; Alini, Mauro; Iatridis, James C.; Grad, Sibylle] AO Fdn, Collaborat Res Partner Annulus Fibrosus Rupture P, Davos, Switzerland.
RP Grad, S (reprint author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM sibylle.grad@aofoundation.org
RI Ferguson, Stephen/A-4118-2012; Pandit, Abhay/B-6187-2008
OI Ferguson, Stephen/0000-0003-0650-5889; Pandit, Abhay/0000-0002-6292-4933
FU AO Exploratory Research Board; NIAMS/NIH [R01 AR057397, F32 AR062455]
FX The authors are supported by a consortium grant from AO Exploratory
   Research Board. J. C. Iatridis receives funding from NIAMS/NIH R01
   AR057397 and C. C. Guterl from NIAMS/NIH F32 AR062455. We wish to
   confirm that there are no known conflicts of interest associated with
   this publication and there has been no significant financial support for
   this work that could have influenced its outcome.
CR Acaroglu ER, 1995, SPINE, V20, P2690, DOI 10.1097/00007632-199512150-00010
   Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287
   Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Alini M, 2002, EUR SPINE J, V11, pS215, DOI 10.1007/s00586-002-0485-8
   Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y
   Andersson GBJ, 1996, SPINE, V21, pS10, DOI 10.1097/00007632-199612151-00003
   Aoki Y, 2006, SPINE, V31, pE774, DOI 10.1097/01.brs.0000238681.71537.41
   Atlas SJ, 1996, SPINE, V21, P2885, DOI 10.1097/00007632-199612150-00020
   Attia M, 2011, BIOMATERIALS, V32, P450, DOI 10.1016/j.biomaterials.2010.09.010
   Bailey A, 2010, 10 ANN GLOB S MOT PR
   Bajanes G, 2007, ONE YEAR FOLLOW DISC, V7
   Barth M, 2008, SPINE, V33, P273, DOI 10.1097/BRS.0b013e31816201a6
   Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313
   Bergknut N, 2012, SPINE, V37, P351, DOI 10.1097/BRS.0b013e31821e5665
   BERNEY J, 1990, NEUROCHIRURGIE, V36, P354
   Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Blanco JF, 2010, SPINE, V35, P2259, DOI 10.1097/BRS.0b013e3181cb8828
   Blankenbaker DG, 2006, AM J ROENTGENOL, V186, P795, DOI 10.2214/AJR.04.1629
   Bourgeault C, 2007, BIOMECHANICAL ASSESS, V7
   Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI 10.1089/ten.TEA.2009.0442
   Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108
   Boyd LM, 2008, ARTHRITIS RHEUM, V58, P164, DOI 10.1002/art.23231
   Bron JL, 2011, J MECH BEHAV BIOMED, V4, P1196, DOI 10.1016/j.jmbbm.2011.04.002
   Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x
   Carragee E J, 2001, Spine J, V1, P364, DOI 10.1016/S1529-9430(01)00051-1
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Carrino JA, 2009, RADIOLOGY, V250, P161, DOI 10.1148/radiol.2493071999
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chen IR, 2009, SPINE, V34, P1402, DOI 10.1097/BRS.0b013e31817b8fbd
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f
   Chiang YF, 2012, CLIN BIOMECH, V27, P241, DOI 10.1016/j.clinbiomech.2011.09.008
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   Choi JH, 2009, TISSUE ENG REGEN MED, V6, P83
   Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86
   Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262
   COLE TC, 1985, BIOCHIM BIOPHYS ACTA, V839, P127, DOI 10.1016/0304-4165(85)90029-7
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Coombes AGA, 2002, BIOMATERIALS, V23, P2113, DOI 10.1016/S0142-9612(01)00341-6
   Costi JJ, 2007, J BIOMECH, V40, P2457, DOI 10.1016/j.jbiomech.2006.11.006
   Cs-Szabo G, 2002, SPINE, V27, P2212, DOI 10.1097/01.BRS.0000029249.02864.5B
   Dash BC, 2011, J CONTROL RELEASE, V152, P382, DOI 10.1016/j.jconrel.2011.03.006
   DePalma MJ, 2012, PAIN PHYSICIAN, V15, pE53
   Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508
   Ekman P, 2009, EUR SPINE J, V18, P1175, DOI 10.1007/s00586-009-0947-3
   Ercelen O, 2003, SPINE, V28, P1922, DOI 10.1097/01.BRS.0000083326.39944.73
   Fazzalari NL, 2001, SPINE, V26, P2575, DOI 10.1097/00007632-200112010-00010
   Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freeman BJC, 2005, SPINE, V30, P2369, DOI 10.1097/01.brs.0000186587.43373.f2
   Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1
   Fujiwara A, 2000, SPINE, V25, P3036, DOI 10.1097/00007632-200012010-00011
   Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006
   GOEL VK, 1995, SPINE, V20, P689, DOI 10.1097/00007632-199503150-00010
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de
   Grad S, 2010, CELLS BIOMATERIALS I
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Gruber HE, 2006, BIOMATERIALS, V27, P371, DOI 10.1016/j.biomaterials.2005.06.032
   Gruber HE, 2007, SPINE, V32, P1181, DOI 10.1097/BRS.0b013e318053ec89
   Gruber HE, 2007, SPINE, V32, P1287, DOI 10.1097/BRS.0b013e31805931d8
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   Gruber HE, 2011, SPINE J, V11, P782, DOI 10.1016/j.spinee.2011.06.012
   Gruber HE, 2010, SPINE J, V10, P721, DOI 10.1016/j.spinee.2010.05.014
   Guilfoyle MR, 2007, BRIT J NEUROSURG, V21, P389, DOI 10.1080/02688690701477310
   Guyot L, 2010, 10 ANN GLOB S MOT PR
   Haglund L, 2011, TISSUE ENG PART C-ME, V17, P1011, DOI [10.1089/ten.tec.2011.0025, 10.1089/ten.TEC.2011.0025]
   Haughton VM, 2002, AM J NEURORADIOL, V23, P1110
   Hegewald AA, 2012, SPINE, V37, P101, DOI 10.1097/BRS.0b013e318210ed55
   Helen W, 2007, BIOMATERIALS, V28, P2010, DOI 10.1016/j.biomaterials.2007.01.011
   Henriksson HB, 2009, SPINE, V34, P2278, DOI 10.1097/BRS.0b013e3181a95ad2
   Henriksson HB, 2012, SPINE, V37, P722, DOI 10.1097/BRS.0b013e318231c2f7
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Heuer F, 2008, J BIOMECH, V41, P1953, DOI 10.1016/j.jbiomech.2008.03.023
   Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468
   Hoppe S, 2012, EUR RADIOL, V22, P2013, DOI 10.1007/s00330-012-2448-8
   Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4
   Iatridis JC, 1998, J BIOMECH, V31, P535, DOI 10.1016/S0021-9290(98)00046-3
   Iatridis JC, 1999, J ORTHOPAED RES, V17, P732, DOI 10.1002/jor.1100170517
   Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407
   Iatridis JC, 2004, J BIOMECH, V37, P1165, DOI 10.1016/j.jbiomech.2003.12.026
   Illien-Junger S, 2012, SPINE, V37, P1865, DOI 10.1097/BRS.0b013e3182544a8a
   Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019
   Jackson AR, 2008, SPINE, V33, P1, DOI 10.1097/BRS.0b013e31815e4136
   JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201
   JENSEN MC, 1994, MAGN RESON QUART, V10, P173
   Johnson WE, 2006, EUR SPINE J, V15, pS389, DOI 10.1007/s00586-006-0125-9
   Johnson WEB, 2007, SPINE, V32, P1295, DOI 10.1097/BRS.0b013e31805b835d
   Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d
   KAMBIN P, 1995, SPINE, V20, P599, DOI 10.1097/00007632-199503010-00018
   Kang CH, 2009, SKELETAL RADIOL, V38, P877, DOI 10.1007/s00256-009-0709-7
   Kim KS, 2005, SPINE, V30, P33, DOI 10.1097/01.brs.0000149191.02304.9b
   Koepsell L, 2011, MACROMOL BIOSCI, V11, P391, DOI 10.1002/mabi.201000352
   Kong QQ, 2011, SPINE, V36, P1030, DOI [10.1097/BRS.0b013e3181e80507, 10.1097/BRS.0b013e3181d10401]
   Kuh SU, 2009, JOINT BONE SPINE, V76, P70, DOI 10.1016/j.jbspin.2008.02.021
   Kvarstein G, 2009, PAIN, V145, P279, DOI 10.1016/j.pain.2009.05.001
   Le Visage C, 2006, SPINE, V31, P2036, DOI 10.1097/01.brs.0000231442.05245.87
   Lebow RL, 2011, SPINE, V36, P2147, DOI 10.1097/BRS.0b013e3182054595
   Ledet EH, 2009, SPINE, V34, P1457, DOI 10.1097/BRS.0b013e3181a48554
   Ledic D, 2007, SPINE J, V7, p123S
   Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y
   Li XD, 2004, SPINE, V29, P2229, DOI 10.1097/01.brs.0000142427.82605.fb
   Liang HX, 2010, SPINE J, V10, P32, DOI 10.1016/j.spinee.2009.10.006
   Little JP, 2007, J BIOMECH, V40, P2744, DOI 10.1016/j.jbiomech.2007.01.007
   Liu LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026285
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Loupasis GA, 1999, SPINE, V24, P2313, DOI 10.1097/00007632-199911150-00005
   Maestretti G, 2012, P 30 INT S MIN INV S
   Mahor S, 2011, CURR DRUG DELIV, V8, P354, DOI 10.2174/156720111795768031
   Malandrino A, 2012, COMPUT METH IN PRESS
   MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510
   MAROUDAS A, 1975, Journal of Anatomy, V120, P113
   Masuda K, 2006, SPINE, V31, P742, DOI 10.1097/01.brs.0000206358.66412.7b
   McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a
   Mehra M, 2012, J MED ECON, V15, P245, DOI 10.3111/13696998.2011.642090
   Melrose J, 2002, SPINE, V27, P1278, DOI 10.1097/00007632-200206150-00007
   Melrose J, 2008, EUR SPINE J, V17, P1131, DOI 10.1007/s00586-008-0712-z
   Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5
   Melrose J, 2012, SPINE, V37, P18, DOI 10.1097/BRS.0b013e31820cd8d5
   Michalek AJ, 2012, SPINE J, V12, P425, DOI 10.1016/j.spinee.2012.04.001
   Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   MOORE AJ, 1994, BRIT J NEUROSURG, V8, P319, DOI 10.3109/02688699409029620
   MOORE RJ, 1994, SPINE, V19, P2787, DOI 10.1097/00007632-199412150-00010
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Mwale F, 2004, Eur Cell Mater, V8, P58
   Mwale F, 2011, SPINE, V36, pE131, DOI 10.1097/BRS.0b013e3181d52b9e
   NACHEMSON A., 1966, CLIN ORTHO RELAT RES, V45, P107
   Nasto LA, 2012, SPINE, V37, P1819, DOI 10.1097/BRS.0b013e31824ee8f7
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Nerurkar NL, 2011, BIOMECH MODEL MECHAN, V10, P973, DOI 10.1007/s10237-011-0288-0
   Nerurkar NL, 2011, BIOMATERIALS, V32, P461, DOI 10.1016/j.biomaterials.2010.09.015
   Nerurkar NL, 2010, J BIOMECH, V43, P1017, DOI 10.1016/j.jbiomech.2009.12.001
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Noailly J, 2012, EUR SPINE J, V21, pS675, DOI 10.1007/s00586-011-1716-7
   O'Connell GD, 2007, SPINE, V32, P328, DOI 10.1097/01.brs.0000253961.40910.c1
   Orozco L, 2011, TRANSPLANTATION, V92, P822, DOI 10.1097/TP.0b013e3182298a15
   ORTOLANI F, 1988, BASIC APPL HISTOCHEM, V32, P443
   OSTI OL, 1990, SPINE, V15, P762, DOI 10.1097/00007632-199008010-00005
   PANJABI M, 1988, SPINE, V13, P913, DOI 10.1097/00007632-198808000-00008
   Parker SL, 2010, J NEUROSURG-SPINE, V12, P178, DOI 10.3171/2009.9.SPINE09410
   Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147
   Pauza Kevin J, 2004, Spine J, V4, P27, DOI 10.1016/j.spinee.2003.07.001
   Pope MH, 1998, CLIN ORTHOP RELAT R, P241
   Power KA, 2011, ARTHRITIS RHEUM-US, V63, P3876, DOI 10.1002/art.30607
   Rethore G, 2009, TISSUE ENG PART C-ME, V15, P605, DOI [10.1089/ten.tec.2008.0581, 10.1089/ten.TEC.2008.0581]
   Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6
   Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009
   Saad L, 2004, J BIOMED MATER RES A, V71A, P233, DOI 10.1002/jbm.a.30150
   SACHS BL, 1987, SPINE, V12, P287, DOI 10.1097/00007632-198704000-00018
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sato M, 2003, MED BIOL ENG COMPUT, V41, P365, DOI 10.1007/BF02348444
   Sato M, 2003, J BIOMED MATER RES A, V64A, P249
   Schmidt H, 2006, CLIN BIOMECH, V21, P337, DOI 10.1016/j.clinbiomech.2005.12.001
   Schmidt H, 2007, CLIN BIOMECH, V22, P988, DOI 10.1016/j.clinbiomech.2007.07.008
   Schneider TO, 1999, J ORTHOPAED RES, V17, P192, DOI 10.1002/jor.1100170207
   Schoenfeld AJ, 2010, INT J GEN MED, V3, P209
   Schollum ML, 2010, J ANAT, V216, P310, DOI 10.1111/j.1469-7580.2009.01197.x
   See EYS, 2011, SPINE, V36, P1744, DOI 10.1097/BRS.0b013e31821986b3
   Sha'ban Munirah, 2008, J Orthop Surg Res, V3, P17, DOI 10.1186/1749-799X-3-17
   Sha'ban M, 2008, J BIOMAT SCI-POLYM E, V19, P1219, DOI 10.1163/156856208785540163
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   SHIRAZIADL A, 1989, SPINE, V14, P96, DOI 10.1097/00007632-198901000-00019
   Showalter BL, 2012, SPINE, V37, pE900, DOI 10.1097/BRS.0b013e31824d911c
   Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd
   Sobajima S, 2005, SPINE, V30, P15, DOI 10.1097/01.brs.0000148048.15348.9b
   SPENGLER DM, 1990, J BONE JOINT SURG AM, V72A, P230, DOI 10.2106/00004623-199072020-00010
   Stadnik TW, 1998, RADIOLOGY, V206, P49, DOI 10.1148/radiology.206.1.9423651
   Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da
   Suk KS, 2001, SPINE, V26, P672, DOI 10.1097/00007632-200103150-00024
   Takahashi K, 2008, EUR SPINE J, V17, pS428, DOI 10.1007/s00586-008-0752-4
   Thompson RE, 2000, SPINE, V25, P3026, DOI 10.1097/00007632-200012010-00010
   Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52
   Vadala G, 2012, J TISSUE ENG REGEN M, V6, P348, DOI 10.1002/term.433
   Veres SP, 2008, SPINE, V33, P2711, DOI 10.1097/BRS.0b013e31817bb906
   Vernon-Roberts B, 2007, SPINE, V32, P2797, DOI 10.1097/BRS.0b013e31815b64d2
   Vucetic N, 1997, ACTA ORTHOP SCAND, V68, P116, DOI 10.3109/17453679709003991
   Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031
   Wan YQ, 2007, MACROMOL BIOSCI, V7, P1217, DOI 10.1002/mabi.200700053
   Wang YH, 2007, EUR SPINE J, V16, P1021, DOI 10.1007/s00586-007-0306-1
   Wang Z, 2005, P ANN INT IEEE EMBS, P3202
   Watanabe A, 2007, AM J ROENTGENOL, V189, P936, DOI 10.2214/AJR.07.2142
   WEBER H, 1994, SPINE, V19, P2234, DOI 10.1097/00007632-199410000-00022
   WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003
   Wei A, 2009, INT J BIOL SCI, V5, P388
   Wei AQ, 2009, J ORTHOP RES, V27, P374, DOI 10.1002/jor.20567
   Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451
   Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe
   Weinstein JN, 2008, SPINE, V33, P2789, DOI 10.1097/BRS.0b013e31818ed8f4
   Wilda H, 2006, BIOMATERIALS, V27, P5220, DOI 10.1016/j.biomaterials.2006.06.008
   Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005
   Williams FMK, 2011, BEST PRACT RES CL RH, V25, P69, DOI 10.1016/j.berh.2011.01.007
   Wuertz K, 2012, EUR CELLS MATER, V23, P103
   Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867
   Yang L, 2009, J BIOMED MATER RES A, V91A, P1089, DOI 10.1002/jbm.a.32331
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yoon SH, 2008, J NEUROSURG-SPINE, V8, P450, DOI 10.3171/SPI/2008/8/5/450
   Yoon ST, 2004, SPINE, V29, P2603, DOI 10.1097/01.brs.0000146103.94600.85
   Yorimitsu E, 2001, SPINE, V26, P652, DOI 10.1097/00007632-200103150-00019
   Yu J, 2007, J ANAT, V210, P460, DOI 10.1111/j.1469-7580.2007.00707.x
   YU SW, 1988, AM J NEURORADIOL, V9, P367
   Yurube T, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3764
   Zhang HN, 2011, J NEUROSURG-SPINE, V15, P404, DOI 10.3171/2011.5.SPINE10811
   Zhang Y, 2007, SPINE, V32, P2515, DOI 10.1097/BRS.0b013e318158cc09
   Zhang YJ, 2011, SPINE, V36, P1519, DOI 10.1097/BRS.0b013e3181f60b39
   Zhang YJ, 2009, AM J PHYS MED REHAB, V88, P455, DOI 10.1097/PHM.0b013e3181a5f0aa
   Zhang YH, 2011, APOPTOSIS, V16, P594, DOI 10.1007/s10495-011-0596-y
   Zobel BB, 2012, SPINE, V37, P1224, DOI 10.1097/BRS.0b013e31824b2450
NR 218
TC 88
Z9 92
U1 2
U2 41
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2013
VL 25
BP 1
EP 21
PG 21
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 069FH
UT WOS:000313420200001
PM 23283636
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Tamimi, F
   Comeau, P
   Le Nihouannen, D
   Zhang, YL
   Bassett, DC
   Khalili, S
   Gbureck, U
   Tran, SD
   Komarova, S
   Barralet, JE
AF Tamimi, F.
   Comeau, P.
   Le Nihouannen, D.
   Zhang, Y. L.
   Bassett, D. C.
   Khalili, S.
   Gbureck, U.
   Tran, S. D.
   Komarova, S.
   Barralet, J. E.
TI PERFLUORODECALIN AND BONE REGENERATION
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Perfluorocarbons; bone regeneration; bone marrow; bone; biomaterials;
   radiopacity
ID MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE CEMENT; IN-VIVO; BLOOD
   SUBSTITUTES; PROGENITOR CELLS; TISSUE OXYGEN; STROMAL CELLS; MARROW;
   HYPOXIA; REPAIR
AB Perfluorodecalin (PFD) is a chemically and biologically inert biomaterial and, as many perfluorocarbons, is also hydrophobic, radiopaque and has a high solute capacity for gases such as oxygen. In this article we have demonstrated, both in vitro and in vivo, that PFD may significantly enhance bone regeneration. Firstly, the potential benefit of PFD was demonstrated by prolonging the survival of bone marrow cells cultured in anaerobic conditions. These findings translated in vivo, where PFD incorporated into bone-marrow-loaded 3D-printed scaffolds substantially improved their capacity to regenerate bone. Secondly, in addition to biological applications, we have also shown that PFD improves the radiopacity of bone regeneration biomaterials, a key feature required for the visualisation of biomaterials during and after surgical implantation. Finally, we have shown how the extreme hydrophobicity of PFD enables the fabrication of highly cohesive self-setting injectable biomaterials for bone regeneration. In conclusion, perfluorocarbons would appear to be highly beneficial additives to a number of regenerative biomaterials, especially those for bone regeneration.
C1 [Tamimi, F.; Comeau, P.; Zhang, Y. L.; Bassett, D. C.; Khalili, S.; Tran, S. D.; Komarova, S.; Barralet, J. E.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Le Nihouannen, D.] Univ Bordeaux, Bordeaux, France.
   [Gbureck, U.] Univ Wurzburg, D-97070 Wurzburg, Germany.
RP Tamimi, F (reprint author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.
EM faleh.tamimimarino@mcgill.ca
RI Bassett, David/B-2489-2009; Gbureck, Uwe/G-1430-2012; barralet,
   jake/A-5820-2008
OI Bassett, David/0000-0001-7167-2566; barralet, jake/0000-0003-3543-6042
CR Alkhraisat MH, 2008, BIOMATERIALS, V29, P4691, DOI 10.1016/j.biomaterials.2008.08.026
   Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534
   Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321
   ARO H, 1984, J SURG RES, V37, P202, DOI 10.1016/0022-4804(84)90181-1
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Bohner M, 2006, EUR CELLS MATER, V12, P26, DOI 10.22203/eCM.v012a03
   Brown MF, 2007, AM J PHYSIOL-REG I, V292, pR2115, DOI 10.1152/ajpregu.00568.2006
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Carey LE, 2005, BIOMATERIALS, V26, P5002, DOI 10.1016/j.biomaterials.2005.01.015
   CARMICHAEL J, 1987, CANCER RES, V47, P936
   Cheema U, 2008, CELL MOL LIFE SCI, V65, P177, DOI 10.1007/s00018-007-7356-8
   Chen FP, 2010, ACTA BIOMATER, V6, P3199, DOI 10.1016/j.actbio.2010.02.049
   CONNOLLY JF, 1995, CLIN ORTHOP RELAT R, P8
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gbureck U, 2007, J CONTROL RELEASE, V122, P173, DOI 10.1016/j.jconrel.2007.06.022
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054
   Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571
   Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11
   Huibregtse BA, 2000, J ORTHOPAED RES, V18, P18, DOI 10.1002/jor.1100180104
   Jeng MJ, 2003, PEDIATR RES, V53, P81, DOI 10.1203/01.PDR.0000041520.50792.0A
   Jewitt N, 1999, ENZYME MICROB TECH, V25, P349, DOI 10.1016/S0141-0229(99)00052-6
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   KIVISAARI J, 1975, ACTA ORTHOP SCAND, V46, P269, DOI 10.3109/17453677508989217
   Knowles HJ, 2009, J PATHOL, V218, P256, DOI 10.1002/path.2534
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kruyt MC, 2009, J ORTHOP RES, V27, P1055, DOI 10.1002/jor.20830
   Kurdy NMG, 1996, INJURY, V27, P143, DOI 10.1016/0020-1383(95)00169-7
   LANE TA, 1995, TRANSFUS SCI, V16, P19, DOI 10.1016/0955-3886(94)00067-T
   Lochner K, 2011, INT J MOL MED, V28, P1055, DOI 10.3892/ijmm.2011.778
   Long D M, 1975, Bull Soc Int Chir, V34, P137
   LONG D M, 1971, Surgical Forum (Chicago), V22, P207
   LOWE KC, 1991, ADV MATER, V3, P87, DOI 10.1002/adma.19910030203
   Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI [10.1021/bp.128, 10.1002/btpr.128]
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   MATTREY RF, 1987, RADIOLOGY, V163, P339, DOI 10.1148/radiology.163.2.3550878
   MCFARLAND E, 1985, J COMPUT ASSIST TOMO, V9, P8, DOI 10.1097/00004728-198501000-00002
   Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Otto William R, 2005, Methods Mol Biol, V289, P251
   Pilarek M, 2008, BIOCHEM ENG J, V41, P38, DOI 10.1016/j.bej.2008.03.004
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PUTYATINA TK, 1994, ARTIF CELL BLOOD SUB, V22, P1281, DOI 10.3109/10731199409138827
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   RIESS JG, 1988, BIOMATER ARTIF CELL, V16, P421, DOI 10.3109/10731198809132592
   Riess JG, 1998, BIOMATERIALS, V19, P1529, DOI 10.1016/S0142-9612(98)00071-4
   Roser BJ, 1999, US patent, Patent No. [6'190'701, 6190701]
   Sengupta S, 2010, TISSUE ENG PT A, V16, P3623, DOI [10.1089/ten.tea.2010.0302, 10.1089/ten.TEA.2010.0302]
   Soman N, 2003, BIO-MED MATER ENG, V13, P59
   Song-Ling L, 1975, US Patent, Patent No. [3'996'355, 3996355]
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tamimi F, 2009, BIOMATERIALS, V30, P208, DOI 10.1016/j.biomaterials.2008.09.032
   Tan Q, 2009, TISSUE ENG PT A, V15, P2471, DOI 10.1089/ten.tea.2008.0461
   Xu HHK, 2007, DENT MATER, V23, P433, DOI 10.1016/j.dental.2006.02.014
   Yu T, 2009, ACTA BIOMATER, V5, P2717, DOI 10.1016/j.actbio.2009.03.015
NR 60
TC 10
Z9 10
U1 0
U2 33
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2013
VL 25
BP 22
EP 36
DI 10.22203/eCM.v025a02
PG 15
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 069FH
UT WOS:000313420200002
PM 23283637
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Kramer, ER
   Morey, AM
   Staruch, M
   Suib, SL
   Jain, M
   Budnick, JI
   Wei, M
AF Kramer, Erica R.
   Morey, Aimee M.
   Staruch, Margo
   Suib, Steven L.
   Jain, Menka
   Budnick, Joseph I.
   Wei, Mei
TI Synthesis and characterization of iron-substituted hydroxyapatite via a
   simple ion-exchange procedure
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID MAGNETIC NANOPARTICLES; OXIDE NANOPARTICLES
AB Hydroxyapatite (HA), the main inorganic component of natural bones, is widely studied as a biomaterial due to its excellent biocompatibility and osteoinductivity. The crystal structure of HA lends itself to a wide variety of substitutions and ion doping, which allows for tailoring of material properties. In this study, iron-doped HA was synthesized via a simple ion-exchange procedure and characterized thoroughly for crystal structure and phase purity using X-ray diffraction, energy-dispersive X-ray spectroscopy, inductively coupled plasma atomic emission spectroscopy, and Fourier transform infrared spectroscopy. Magnetic properties were studied using vibrating sample magnetometer and superconducting quantum interference device analysis. Ion-exchange was attempted using both ferric and ferrous chloride iron solutions, but a substitution was only achieved using ferric chloride solution. The results showed that after iron substitution the powder retained characteristic apatite crystal structure and functional groups, but the iron-doped samples displayed paramagnetic properties, as opposed to the diamagnetism of pure HA. The effect of soaking time on iron content was also examined, and collectively X-ray diffraction and inductively coupled plasma atomic emission spectroscopy results suggested that an increase in soaking time led to an increase in iron content in the sample powder. Iron-substituted HA nanoparticles, a biomaterial with magnetic properties, could be a promising biomaterial to be used in a variety of biomedical fields, including magnetic imaging, drug delivery, or hyperthermia-based cancer treatments.
C1 [Kramer, Erica R.; Wei, Mei] Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Morey, Aimee M.; Suib, Steven L.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA.
   [Staruch, Margo; Jain, Menka; Budnick, Joseph I.] Univ Connecticut, Dept Phys, Storrs, CT 06269 USA.
RP Wei, M (reprint author), Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, 97 N Eagleville Rd, Storrs, CT 06269 USA.
EM m.wei@ims.uconn.edu
RI Staruch, Margo/M-9260-2015
OI Staruch, Margo/0000-0003-3088-2553; Jain, Menka/0000-0002-2264-6895
FU U.S. Department of Education Graduate Assistance In Areas of National
   Need (GAANN) Fellowship Program [P200A09315]; National Science
   Foundation [BES 0503315, CBET-1133883]; US Department of Energy Office
   of Basic Energy Sciences Division of Chemical, Geological, and
   Biological Science [DE-FG02-86ER13622.A000]
FX The authors would like to thank the U.S. Department of Education
   Graduate Assistance In Areas of National Need (GAANN) Fellowship Program
   (P200A09315) and National Science Foundation (BES 0503315 and
   CBET-1133883) for their support of the research. AM and SS thank the US
   Department of Energy Office of Basic Energy Sciences Division of
   Chemical, Geological, and Biological Science under grant
   DE-FG02-86ER13622.A000 for support of this work. They would also like to
   thank Dr. Bill Hines for his assistance with the SQUID equipment, and
   Dr. Heng Zhang for his assistance with the XPS facility.
CR Biji A., 2007, INORG CHIM ACTA, V360, P1009
   Bowden V, 2010, CHILDREN THEIR FAMIL
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Duguet E, 2006, NANOMEDICINE-UK, V1, P157, DOI 10.2217/17435889.1.2.157
   Ennas G, 1998, CHEM MATER, V10, P495, DOI 10.1021/cm970400u
   GOLDFARB D, 1994, J AM CHEM SOC, V116, P6344, DOI 10.1021/ja00093a039
   Gross K.A., 2002, EUR CELLS MATER, V3, P114
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Jain TK, 2008, BIOMATERIALS, V29, P4012, DOI 10.1016/j.biomaterials.2008.07.004
   Jiang M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224107
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Li Y, 2009, J PHYS CONF SER, V187, DOI 10.1088/1742-6596/187/1/012024
   Low HR, 2008, INORG CHEM, V47, P11774, DOI 10.1021/ic801491t
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   Martini F, 2006, FUNDAMENTALS ANATOMY
   Morrissey R, 2005, J MATER SCI-MATER M, V16, P387, DOI 10.1007/s10856-005-6976-5
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Park J. B., 2003, BIOMATERIALS PRINCIP
   Patel N., 2005, Journal of the Australasian Ceramic Society, V41, P1
   Pon-On W, 2008, MATER RES BULL, V43, P2137, DOI 10.1016/j.materresbull.2007.09.004
   Prakash K. H., 2006, Molecular & Cellular Biomechanics, V3, P177
   Qu H, 2005, J MATER SCI-MATER M, V16, P447, DOI 10.1007/s10856-005-6985-4
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Wang J, 2008, J MATER SCI-MATER M, V19, P2663, DOI 10.1007/s10856-007-3365-2
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wu H.-C., 2007, NONOTECHNOLOGY, V18, P9
NR 28
TC 24
Z9 25
U1 1
U2 72
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN
PY 2013
VL 48
IS 2
BP 665
EP 673
DI 10.1007/s10853-012-6779-2
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 062FA
UT WOS:000312903400012
DA 2018-10-19
ER

PT J
AU Nicoletti, A
   Fiorini, M
   Paolillo, J
   Dolcini, L
   Sandri, M
   Pressato, D
AF Nicoletti, A.
   Fiorini, M.
   Paolillo, J.
   Dolcini, L.
   Sandri, M.
   Pressato, D.
TI Effects of different crosslinking conditions on the chemical-physical
   properties of a novel bio-inspired composite scaffold stabilised with
   1,4-butanediol diglycidyl ether (BDDGE)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DERMAL SHEEP COLLAGEN; OSTEOCHONDRAL DEFECTS; TRICALCIUM PHOSPHATE;
   FABRICATED SCAFFOLDS; HUMAN CHONDROCYTES; CARTILAGE REPAIR;
   DRUG-DELIVERY; BONE; HYDROXYAPATITE; BIOMATERIAL
AB Serious cartilage lesions (Outerbridge III, IV) may be successfully treated with a three-layered gradient scaffold made by magnesium-doped hydroxyapatite and type I collagen, manufactured through a bio-inspired process and stabilised by a reactive bis-epoxy (1,4-butanediol diglycidyl ether, BDDGE). Each layer was analysed to elucidate the effects of crosslinking variables (concentration, temperature and pH). The chemical stabilisation led to an homogeneous and aligned collagenous matrix: the fibrous structures switched to a laminar foils-based arrangement and organic phases acquired an highly coordinated 3D-organization. These morphological features were strongly evident when crosslinking occurred in alkaline solution, with BDDGE concentration of at least 1 wt%. The optimised crosslinking conditions did not affect the apatite nano-crystals nucleated into self-assembling collagen fibres. The present work allowed to demonstrate that acting on BDDGE reaction parameters might be an useful tool to control the chemical-physical properties of bio-inspired scaffold suitable to heal wide osteochondral defects, even through arthroscopic procedure.
C1 [Nicoletti, A.; Fiorini, M.; Paolillo, J.; Dolcini, L.; Pressato, D.] Fin Ceram Faenza SpA, I-48018 Faenza, RA, Italy.
   [Sandri, M.] CNR, Inst Sci & Technol Ceram ISTEC, I-48018 Faenza, RA, Italy.
RP Nicoletti, A (reprint author), Fin Ceram Faenza SpA, Via Ravegnana 186, I-48018 Faenza, RA, Italy.
EM anicoletti@finceramica.it
OI Sandri, Monica/0000-0001-5782-3137
CR BELL LC, 1978, ARCH ORAL BIOL, V23, P329, DOI 10.1016/0003-9969(78)90089-4
   Bigi A, 2004, CHEM MATER, V16, P3740, DOI 10.1021/cm049363e
   Chang MC, 2004, J MATER SCI, V39, P5547, DOI 10.1023/B:JMSC.0000039284.70028.fa
   Chang MC, 2002, J MATER SCI-MATER M, V13, P993, DOI 10.1023/A:1019825132610
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GARCIACASTINEIRAS S, 1983, INVEST OPHTH VIS SCI, V24, P1181
   Gavenis K, 2006, IN VITRO CELL DEV-AN, V42, P159
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Gratzer PF, 2007, J BIOMED MATER RES B, V81B, P1, DOI 10.1002/jbm.b.30629
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Iwasaki N, 2009, AM J SPORT MED, V37, P2349, DOI 10.1177/0363546509341793
   Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Lowenstam A.H., 1989, BIOMINERALIZATION
   Mauli C, 2001, J BIOMED MATER RES, V55, P141
   Metsaranta M, 1996, MATRIX BIOL, V15, P39, DOI 10.1016/S0945-053X(96)90125-0
   MORGAN K, 1980, ANN RHEUM DIS, V39, P285, DOI 10.1136/ard.39.3.285
   Nebelung S, 2011, BIORHEOLOGY, V48, P247, DOI 10.3233/BIR-2012-0597
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   QUELCH KJ, 1983, ARCH ORAL BIOL, V28, P665, DOI 10.1016/0003-9969(83)90100-0
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   STEFFEN C, 1964, J IMMUNOL, V93, P656
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Tampieri A, 2008, KEY ENG MATER, V361- 363, P543
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tampieri A, 2008, KEY ENG MATER, V361-363, P927, DOI 10.4028/www.scientific.net/KEM.361-363.927
   Tang B, 1999, CLIN IMMUNOL, V92, P256, DOI 10.1006/clim.1999.4755
   Teixeira CC, 2006, TISSUE ENG, V12, P2283, DOI 10.1089/ten.2006.12.2283
   TODHUNTER RJ, 1994, AM J VET RES, V55, P425
   Vinther MU, 2003, J AM ACAD ORTHOP SUR, V11, P421
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P555, DOI 10.1016/0304-4165(78)90330-6
   Wang YJ, 2006, ADV ENG MATER, V8, P97, DOI 10.1002/adem.200500220
   Westman E, 2006, CLIN EXP IMMUNOL, V145, P339, DOI 10.1111/j.1365-2249.2006.03129.x
   Yao B, 2009, MATER SCI-POLAND, V27, P319
   Zeeman R, 1999, J BIOMED MATER RES, V46, P424, DOI 10.1002/(SICI)1097-4636(19990905)46:3<424::AID-JBM16>3.0.CO;2-R
   Zeeman R, 2000, J BIOMED MATER RES, V51, P541, DOI 10.1002/1097-4636(20000915)51:4<541::AID-JBM1>3.0.CO;2-P
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
   Zizak I, 2003, J STRUCT BIOL, V141, P208, DOI 10.1016/S1047-8477(02)00635-4
NR 51
TC 13
Z9 14
U1 2
U2 34
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2013
VL 24
IS 1
BP 17
EP 35
DI 10.1007/s10856-012-4782-4
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 068LT
UT WOS:000313368900003
PM 23053811
DA 2018-10-19
ER

PT J
AU Peng, QM
   Ma, N
   Fang, DQ
   Li, H
   Liu, RP
   Tian, YJ
AF Peng, Qiuming
   Ma, Ning
   Fang, Daqing
   Li, Hui
   Liu, Riping
   Tian, Yongjun
TI Microstructures, aging behaviour and mechanical properties in hydrogen
   and chloride media of backward extruded Mg-Y based biomaterials
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Mg biomaterials; Microstructure; Age hardening behaviour; Mechanical
   properties; Hydrogen and chloride media
ID STRESS-CORROSION CRACKING; MAGNESIUM ALLOYS; ZN; PERFORMANCE; EXTRUSION;
   BONE
AB Microstructures, aging behaviour from room temperature to 300 degrees C and mechanical properties in different media of backward extruded (BE) Mg-Y based biomaterial have been investigated. The results reveal that BE-Mg-Y based alloy is mainly composed of polygon-shaped grains and fine precipitates. The results of aging response show that BE-Mg-Y based alloy exhibits remarkable age hardening behaviour when the aging temperature is 200 degrees C and higher. The high mechanical properties of aged BE-Mg-Y based alloy are mostly associated with fine microstructure, solid solution strengthening and the existence of homogeneous precipitates. The hydrogen embrittlement dependence on the aging time is confirmed in BE-Mg-Y based alloy. Additionally, the strength and elongation of BE-Mg-Y based alloy are significantly influenced by the ion concentration in media. These results offer some implications for understanding the reduced strength of Mg based implants in body environment. It is demonstrated that the temporary high mechanical strength in air of BE-Mg-Y based biomaterials is insufficient to evaluate the in vivo mechanical integrity. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Peng, Qiuming; Ma, Ning; Li, Hui; Liu, Riping; Tian, Yongjun] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.
   [Fang, Daqing] Taiyuan Univ Sci & Technol, Sch Mat Sci & Engn, Taiyuan 030024, Shanxi, Peoples R China.
RP Peng, QM (reprint author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.
EM pengqiuming@gmail.com
RI Tian, Yongjun/A-1693-2010
OI Tian, Yongjun/0000-0002-4594-4879
FU National Natural Science Foundation of China [51101142, 50821001]; China
   Postdoctoral Science Foundation [2012M510766]
FX This research is financially supported by the National Natural Science
   Foundation of China (Grant Nos. 51101142 and 50821001) and the China
   Postdoctoral Science Foundation funded project (Grant No. 2012M510766).
   The authors also thank Dr. Guangli Bi for stimulating discussion.
CR Abe E, 2002, ACTA MATER, V50, P3845, DOI 10.1016/S1359-6454(02)00191-X
   Abidin NIZ, 2011, CORROS SCI, V53, P3542, DOI 10.1016/j.corsci.2011.06.030
   Ambat R, 2000, CORROS SCI, V42, P1433, DOI 10.1016/S0010-938X(99)00143-2
   ARSENAULT RJ, 1989, METALL TRANS A, V20, P1411, DOI 10.1007/BF02665498
   Atrens A, 2006, ADV ENG MATER, V8, P749, DOI 10.1002/adem.200600050
   Bender S, 2007, MATER CORROS, V58, P977, DOI 10.1002/maco.200704091
   Berman E, 1980, TOXIC METALS THEIR A
   BUXBAUM RE, 1985, IND ENG CHEM FUND, V24, P180, DOI 10.1021/i100018a007
   Dhanapal A, 2012, J ALLOY COMPD, V523, P49, DOI 10.1016/j.jallcom.2012.01.070
   Emley E. F., 1966, PRINCIPLES MAGNESIUM
   Friedman LH, 1998, PHYS REV LETT, V81, P2715, DOI 10.1103/PhysRevLett.81.2715
   Gao Y, 2009, J ALLOY COMPD, V477, P374, DOI 10.1016/j.jallcom.2008.10.003
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Honma T, 2005, MAT SCI ENG A-STRUCT, V395, P301, DOI 10.1016/j.msea.2004.12.035
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Kim YD, 2008, J MATER SCI TECHNOL, V24, P80
   KIMURA H, 1962, ACTA METALL MATER, V10, P607, DOI 10.1016/0001-6160(62)90050-0
   Koleini S, 2012, MATER DESIGN, V33, P20, DOI 10.1016/j.matdes.2011.06.063
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Nayeb-Hashemi A., 1988, PHASE DIAGRAMS BINAR
   Peng QM, 2008, MAT SCI ENG A-STRUCT, V477, P193, DOI 10.1016/j.msea.2007.05.081
   Peng QM, 2012, J MECH BEHAV BIOMED, V10, P128, DOI 10.1016/j.jmbbm.2012.02.024
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Qu Q, 2011, CORROS SCI, V53, P1186, DOI 10.1016/j.corsci.2010.12.014
   Raynor R, 1959, PHYS METALLURGY MAGN
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song RG, 2004, ACTA MATER, V52, P4727, DOI 10.1016/j.actamat.2004.06.023
   Wu Q, 2012, J MECH BEHAV BIOMED, V8, P1, DOI 10.1016/j.jmbbm.2011.12.011
   Yamasaki M, 2007, CORROS SCI, V49, P255, DOI 10.1016/j.corsci.2006.05.017
   Yang L, 2012, J MECH BEHAV BIOMED, V13, P36, DOI 10.1016/j.jmbbm.2012.04.007
   Zhang E, 2008, MAT SCI ENG A-STRUCT, V488, P102, DOI 10.1016/j.msea.2007.10.056
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 38
TC 10
Z9 14
U1 2
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JAN
PY 2013
VL 17
BP 176
EP 185
DI 10.1016/j.jmbbm.2012.08.017
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 066OP
UT WOS:000313230400016
PM 23127631
DA 2018-10-19
ER

PT J
AU Skardal, A
   Mack, D
   Atala, A
   Soker, S
AF Skardal, Aleksander
   Mack, David
   Atala, Anthony
   Soker, Shay
TI Substrate elasticity controls cell proliferation, surface marker
   expression and motile phenotype in amniotic fluid-derived stem cells
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Elastic modulus; Amniotic fluid-derived stem cells; Biomaterial; Cell
   therapy; Cell mobility
ID IN-VIVO; REGENERATIVE MEDICINE; MIGRATION; MUSCLE; EXPANSION; ADHESION;
   TISSUES; NICHES; THY-1
AB The physical cues presented to stem cells by the substrate on or in which they exist have been shown to play a crucial role in regulation of their behavior. Until recently, most research has focused on the effects of substrate elasticity on differentiation capability rather than maintenance of long-term proliferation and plasticity. The main goal of the present study is to study the interaction of amniotic fluid-derived stem (AFS) cells with growth substrata of different elasticity, which may extend their application potentials. Here, we investigate the effects of elastic modulus (E'), on AFS cell proliferation, morphology, cell surface marker expression, and autocrine stimulation of cell migration. AFS cells cultured on substrates of different E' exhibited significant changes in proliferation and morphology. Immunohistochemistry revealed increased expression of cell surface markers associated with mesenchymal stem cells (MSCs) (CD44, CD90, CD105, and N-cadherin) in cells cultured on softer substrates. Additionally, AFS cells cultured on softer substrates induced autocrine stimulation of migration. Therefore, tailoring the elastic modulus of biomaterials to specific stiffness values is an effective method to control stem cell properties, which may modulate the effectiveness of their therapeutic applications. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Skardal, Aleksander; Mack, David; Atala, Anthony; Soker, Shay] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Soker, S (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
EM ssoker@wakehealth.edu
OI Atala, Anthony/0000-0001-8186-2160
FU NIH NIBIB Grant [R01EB008009]
FX This research was supported by an NIH NIBIB Grant (R01EB008009).
CR Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Augello A, 2010, EUR CELLS MATER, V20, P121
   Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611
   Benetti A, 2008, CANCER RES, V68, P8626, DOI 10.1158/0008-5472.CAN-08-1218
   Cananzi M, 2009, REPROD BIOMED ONLINE, V18, P17, DOI 10.1016/S1472-6483(10)60111-3
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chaudhuri T, 2010, METHODS MOL BIOL, V621, P185, DOI 10.1007/978-1-60761-063-2_13
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010
   Delo DM, 2006, METHOD ENZYMOL, V419, P426, DOI 10.1016/S0076-6879(06)19017-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fong CY, 2012, J CELL BIOCHEM, V113, P658, DOI 10.1002/jcb.23395
   Ghionzoli M, 2010, PEDIATR SURG INT, V26, P79, DOI 10.1007/s00383-009-2504-x
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Hoist J, 2010, NAT BIOTECHNOL, V28, P1123
   Keung AJ, 2010, WIRES SYST BIOL MED, V2, P49, DOI 10.1002/wsbm.46
   Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187
   Kolambkar YM, 2007, J MOL HISTOL, V38, P405, DOI 10.1007/s10735-007-9118-1
   Lee EJ, 2012, MOL THER, V20, P155, DOI 10.1038/mt.2011.202
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x
   Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008
   Pozzobon M, 2010, PEDIATR SURG INT, V26, P3, DOI 10.1007/s00383-009-2478-8
   Raab M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt38
   Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008
   Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev
   Valli A, 2010, ONCOGENE, V29, P966, DOI 10.1038/onc.2009.405
   Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141
NR 30
TC 20
Z9 22
U1 2
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JAN
PY 2013
VL 17
BP 307
EP 316
DI 10.1016/j.jmbbm.2012.10.001
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 066OP
UT WOS:000313230400028
PM 23122714
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Polak, R
   Rodas, ACD
   Chicoma, DL
   Giudici, R
   Beppu, MM
   Higa, OZ
   Pitombo, RNM
AF Polak, Roberta
   Rodas, Andrea C. D.
   Chicoma, Dennis L.
   Giudici, Reinaldo
   Beppu, Marisa M.
   Higa, Olga Z.
   Pitombo, Ronaldo N. M.
TI Inhibition of calcification of bovine pericardium after treatment with
   biopolymers, E-beam irradiation and in vitro endothelization
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bovine pericardium; Electron beam irradiation; Endothelial cell;
   Calcification; Silk fibroin; Chitosan
ID TISSUE ENGINEERING APPLICATIONS; BIOPROSTHETIC HEART-VALVES; SILK
   FIBROIN; CHITOSAN MEMBRANES; RAMAN-SPECTROSCOPY; AORTIC VALVES; CELL
   ADHESION; GLUTARALDEHYDE; MATRIX; BIOMATERIALS
AB This work has investigated the in vitro calcification of bovine pericardium (BP) treated with chitosan (C), silk fibroin (SF) and electron beam irradiation after its endothelization in vitro. For this purpose, freeze-dried BP membranes treated with mixtures of C and SF (1:3, 1:1 and 3:1) and then irradiated by electron beam irradiation were seeded with human umbilical vein endothelial cells (HUVEC) in vitro. After 3 weeks of cultivation these membranes were submitted to in vitro calcification tests using simulated body fluid as the calcifying agent. Control membranes were also studied (without endothelial cells exposure). The results have shown that the membrane compatibility with HUVECs in vitro prevent such biomaterial from calcifying, showing a potential application in biomaterial area, such as cardiac valves and repair patches. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Polak, Roberta; Pitombo, Ronaldo N. M.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, BR-05508900 Sao Paulo, Brazil.
   [Rodas, Andrea C. D.; Higa, Olga Z.] IPEN CNEN SP, Energy & Nucl Res Inst, Ctr Biotechnol, Sao Paulo, Brazil.
   [Chicoma, Dennis L.; Giudici, Reinaldo] Univ Sao Paulo, Polytech Sch, Dept Chem Engn, BR-05508900 Sao Paulo, Brazil.
   [Beppu, Marisa M.] Univ Estadual Campinas, Sch Chem Engn, Campinas, SP, Brazil.
RP Pitombo, RNM (reprint author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Av Prof Lineu Prestes 580, BR-05508900 Sao Paulo, Brazil.
EM pitombo@usp.br
RI Rodas, Andrea/E-1130-2012; Polak, Roberta/E-1479-2014; BEPPU,
   MARISA/E-1057-2012; Giudici, Reinaldo/C-3467-2012
OI Giudici, Reinaldo/0000-0001-6544-7098
CR Abolhoda A, 1996, ANN THORAC SURG, V62, P169, DOI 10.1016/0003-4975(96)00277-9
   Aimoli CG, 2007, ARTIF ORGANS, V31, P278, DOI 10.1111/j.1525-1594.2007.00376.x
   Aimoli CG, 2006, COLLOID SURFACE B, V53, P15, DOI 10.1016/j.colsurfb.2006.07.012
   Aimoli CG, 2006, MAT SCI ENG C-BIO S, V26, P78, DOI 10.1016/j.msec.2005.06.037
   Altman AM, 2010, ACTA BIOMATER, V6, P1388, DOI 10.1016/j.actbio.2009.10.034
   Arcidiacono G, 2005, J BIOMECH, V38, P1483, DOI 10.1016/j.jbiomech.2004.07.007
   Beppu MM, 2004, KEY ENG MAT, V254-2, P311, DOI 10.4028/www.scientific.net/KEM.254-256.311
   Beppu MM, 2003, MAT SCI ENG C-BIO S, V23, P651, DOI 10.1016/j.msec.2003.08.002
   Borgognoni CF, 2009, BRAZ ARCH BIOL TECHN, V52, P1493, DOI 10.1590/S1516-89132009000600021
   Chester AH, 2011, ASWAN HEART CTR SCI, V4
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   da Costa FDA, 2004, ARTIF ORGANS, V28, P366, DOI 10.1111/j.1525-1594.2004.47357.x
   Daar E, 2010, NUCL INSTRUM METH A, V619, P356, DOI 10.1016/j.nima.2009.11.007
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   de Mel Achala, 2008, Expert Rev Cardiovasc Ther, V6, P1259, DOI 10.1586/14779072.6.9.1259
   Dye JF, 2004, ENDOTHELIUM-J ENDOTH, V11, P151, DOI 10.1080/10623320490512093
   Feugier P, 2005, BIOMATERIALS, V26, P1457, DOI 10.1016/j.biomaterials.2004.04.050
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Gross J. M., 2003, J THORAC CARDIOVASC, V125, pS6
   Gulbins H, 2006, ANN THORAC SURG, V81, P1472, DOI 10.1016/j.athoracsur.2005.11.011
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hung HS, 2011, CELL TRANSPLANT, V20, P63, DOI 10.3727/096368910X532864
   Jastrzebska M, 2005, J MOL STRUCT, V744, P789, DOI 10.1016/j.molstruc.2004.11.040
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Ki CS, 2009, MACROMOL RES, V17, P935, DOI 10.1007/BF03218639
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kubisz L, 2007, SPECTROCHIM ACTA A, V66, P616, DOI 10.1016/j.saa.2006.04.003
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Maizato MJS, 2003, ARTIF ORGANS, V27, P692, DOI 10.1046/j.1525-1594.2003.07275.x
   Mikroulis D, 2002, J MATER SCI-MATER M, V13, P885, DOI 10.1023/A:1016556514203
   Nina Vinicius José da Silva, 2004, Braz. J. Cardiovasc. Surg., V19, P144, DOI 10.1590/S0102-76382004000200008
   Nogueira GM, 2010, BIORESOURCE TECHNOL, V101, P8446, DOI 10.1016/j.biortech.2010.06.064
   Nogueira GM, 2010, MAT SCI ENG C-MATER, V30, P575, DOI 10.1016/j.msec.2010.02.011
   Ohri R, 2004, J BIOMED MATER RES A, V70A, P328, DOI 10.1002/jbm.a.30088
   Orefice RL, 2006, BIOMATERIAIS FUNDAME
   Orrego CE, 2010, CARBOHYD POLYM, V79, P9, DOI 10.1016/j.carbpol.2009.06.015
   Otero EU, 2004, SPECTROSC-INT J, V18, P75, DOI 10.1155/2004/975105
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Polak R, 2011, CRYOBIOLOGY, V63, P61, DOI 10.1016/j.cryobiol.2011.05.001
   Popp J., 2011, OPT PHOTONIK, V6, P24
   Rodas ACD, 2011, ARTIF ORGANS, V35, P502, DOI 10.1111/j.1525-1594.2011.01255.x
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schrader B, 1995, INFRARED RAMAN SPECT
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Shao JZ, 2005, J APPL POLYM SCI, V96, P1999, DOI 10.1002/app.21346
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Starr A, 2002, CLIN EXP PHARMACOL P, V29, P735, DOI 10.1046/j.1440-1681.1999.03710.x
   Trantina-Yates AE, 2001, BIOMATERIALS, V22, P1837, DOI 10.1016/S0142-9612(00)00365-3
   Unger R.E., 2010, BIOMATERIALS, V27, P959
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238
NR 64
TC 4
Z9 4
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2013
VL 33
IS 1
BP 85
EP 90
DI 10.1016/j.msec.2012.08.009
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 065NP
UT WOS:000313155500013
PM 25428047
DA 2018-10-19
ER

PT J
AU Hamza, S
   Bouchemi, M
   Slimane, N
   Azari, Z
AF Hamza, Samir
   Bouchemi, Meryem
   Slimane, Noureddine
   Azari, Zitouni
TI Physical and chemical characterization of adsorbed protein onto gold
   electrode functionalized with Tunisian coral and nacre
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Electrochemical impedance spectroscopy; Protein; Adsorption
ID BOVINE SERUM-ALBUMIN; IMPEDANCE SPECTROSCOPY; ELECTROCHEMICAL IMPEDANCE;
   TITANIUM SURFACES; CALCIUM-PHOSPHATE; CELL ATTACHMENT; ADSORPTION;
   POLYPYRROLE; INTERFACE; HYDROXYAPATITE
AB Bone substitutes are more and more used in bone surgery because of their biologic safety, clinic efficiency and facility to synthesize. Bone substitutes with active osteogenic properties, associating biomaterials with organic macromolecule components of the extracellular matrix (protein, GAG) are recommended. Nevertheless, we should have a simple technique to control interactions between proteins and the material. Natural coral and nacre have been found to be impressive bone graft substitutes. In this work, we characterize nacre and coral powder using energy dispersive X-ray analysis (EDX). We used electrochemical impedance spectroscopy (EIS) and attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy to evaluate bovine serum albumin (BSA) as model protein, adsorbed to these biomaterial surfaces. In order to understand the nacre/coral-protein interfacial compatibility, it is necessary to investigate the wettability. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Hamza, Samir; Slimane, Noureddine] Natl Inst MT Kassab Orthoped, Biomat & Biomech Lab, Tunis 2010, Tunisia.
   [Azari, Zitouni] Natl Sch Engineers Metz, Lab Biomech Polymer & Struct Mech, F-57078 Metz 03, France.
   [Hamza, Samir; Bouchemi, Meryem] Natl Inst Appl Sci & Technol, Ctr Urbain Nord, Tunis 1080, Tunisia.
RP Hamza, S (reprint author), Natl Inst Appl Sci & Technol, Ctr Urbain Nord, BP 676, Tunis 1080, Tunisia.
EM samir.hamza@insat.rnu.tn; bouchemimeryem@yahoo.fr;
   labiomecanique@yahoo.fr; azari@univ-metz.fr
FU French Institute of Cooperation
FX We are grateful to Professors M. Boussaid, L. Sedel, R. M'Rabet, A.
   Abdelghani, and N. Marzouki for their help. We are greatly thankful for
   the financial support from the French Institute of Cooperation.
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bren L, 2004, J ADHES SCI TECHNOL, V18, P1711, DOI 10.1163/1568561042708403
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Ehrenbeck C, 1998, ELECTROCHIM ACTA, V43, P2781, DOI 10.1016/S0013-4686(98)00019-X
   Feng B, 2002, BIOMATERIALS, V23, P2499, DOI 10.1016/S0142-9612(01)00384-2
   Freng B., 2002, BIOMATERIALS, V23, P2499
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   Hafaid I, 2010, SENSOR ACTUAT B-CHEM, V144, P323, DOI 10.1016/j.snb.2009.08.058
   Hallik A, 2006, SYNTHETIC MET, V156, P488, DOI 10.1016/j.synthmet.2006.02.004
   Hubner W, 1998, CHEM PHYS LIPIDS, V96, P99, DOI 10.1016/S0009-3084(98)00083-8
   Irigaray JL, 1996, J BIOMAT SCI-POLYM E, V7, P741, DOI 10.1163/156856296X00507
   IRIGARAY JL, 1995, J MATER SCI-MATER M, V6, P230, DOI 10.1007/BF00146861
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Kania R. E., 1997, INNOVATION TECHNOLOG, V18, P233
   KELLER H, 1992, THIN SOLID FILMS, V210, P799, DOI 10.1016/0040-6090(92)90408-4
   Kobayashi M, 1999, J DENT RES, V78, P1624, DOI 10.1177/00220345990780100701
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 1995, B I OCEANOGR MONACO, V143, P49
   Love C. J., 2005, CHEM REV, V105, P1103
   Macdonald DD, 2006, ELECTROCHIM ACTA, V51, P1376, DOI 10.1016/j.electacta.2005.02.107
   McClellan SJ, 2005, COLLOID SURFACE A, V260, P265, DOI 10.1016/j.colsurfa.2005.03.017
   Meiron TS, 2004, J COLLOID INTERF SCI, V274, P637, DOI 10.1016/j.jcis.2004.02.036
   Mejri MB, 2010, BIOSENS BIOELECTRON, V26, P1261, DOI 10.1016/j.bios.2010.06.054
   Pei RJ, 2001, BIOSENS BIOELECTRON, V16, P355, DOI 10.1016/S0956-5663(01)00150-6
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   ROUX FX, 1995, ACTA NEUROCHIR, V133, P201, DOI 10.1007/BF01420075
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Shahgaldi BF, 1998, BIOMATERIALS, V19, P205, DOI 10.1016/S0142-9612(98)80002-1
   Soost F, 1996, CHIRURG, V67, P1193, DOI 10.1007/s001040050125
   Tlili A, 2006, MAT SCI ENG C-BIO S, V26, P546, DOI 10.1016/j.msec.2005.10.007
   Verma D, 2006, SPECTROCHIM ACTA A, V64, P1051, DOI 10.1016/j.saa.2005.09.014
   Vermette P, 2003, COLLOID SURFACE B, V29, P285, DOI 10.1016/S0927-7765(03)00017-1
   Wang MJ, 2004, BIOSENS BIOELECTRON, V19, P575, DOI 10.1016/S0956-5663(03)00252-5
   Yang YZ, 2003, COLLOID SURFACE B, V30, P291, DOI 10.1016/S0927-7765(03)00116-4
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
NR 41
TC 1
Z9 2
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2013
VL 33
IS 1
BP 537
EP 542
DI 10.1016/j.msec.2012.09.028
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 065NP
UT WOS:000313155500074
PM 25428107
DA 2018-10-19
ER

PT J
AU Nakashima, Y
   Mashima, N
   Imai, H
   Mitsugi, N
   Taki, N
   Mochida, Y
   Owan, I
   Arakaki, K
   Yamamoto, T
   Mawatari, T
   Motomura, G
   Ohishi, M
   Doi, T
   Kanazawa, M
   Iwamoto, Y
AF Nakashima, Yasuharu
   Mashima, Naohiko
   Imai, Hiroshi
   Mitsugi, Naoto
   Taki, Naoya
   Mochida, Yuichi
   Owan, Ichiro
   Arakaki, Kaoru
   Yamamoto, Takuaki
   Mawatari, Taro
   Motomura, Goro
   Ohishi, Masanobu
   Doi, Toshio
   Kanazawa, Masayuki
   Iwamoto, Yukihide
TI Clinical and radiographic evaluation of total hip arthroplasties using
   porous tantalum modular acetabular components: 5-year follow-up of
   clinical trial
SO MODERN RHEUMATOLOGY
LA English
DT Article
DE Clinical trial; Loosening; Porous tantalum; Radiolucency; Total hip
   arthroplasty
ID TRABECULAR METAL IMPLANTS; POLYETHYLENE WEAR; SCREW FIXATION;
   RADIOLOGICAL EVALUATION; BONE INGROWTH; CUPS; REPLACEMENTS; MULTICENTER;
   INTERFACE; NECROSIS
AB Porous tantalum is a biomaterial newly applied for artificial joints. We present here 5-years follow-up report of a multicenter clinical trial of total hip arthroplasties (THA) with porous tantalum modular acetabular component (modular PTC).
   Study participants received 82 hips in 79 cases, with 61.2 months follow-up on average. Age at operation was 60.9 years. Clinical results were evaluated using Merle d'Aubigne Postel score. Presence of implant loosening, periacetabular radiolucency, osteolysis, and gap filling were examined for radiographic results.
   Merle d'Aubigne Postel score improved from 10.0 to 16.4 points. All PTC were radiographically stable, with no evidence of progressive radiolucencies. Average polyethylene wear rate was 0.004 mm/year, with no periacetabular osteolysis. Fifteen hips (18.3%) showed a gap > 1 mm; however, all showed bone filling within 12 months. PTC with oversized reaming was significantly less likely to have a gap. No implant failure was noted related to modularity. Resulting survival rate of modular PTC was 100% at 5 years.
   Modular PTC showed excellent results at 5-years of follow-up. Some hips showed periacetabular gaps, which were filled with bone within 1 year. Further follow-up was needed to determine long-term efficacy.
C1 [Nakashima, Yasuharu; Yamamoto, Takuaki; Mawatari, Taro; Motomura, Goro; Ohishi, Masanobu; Doi, Toshio; Kanazawa, Masayuki; Iwamoto, Yukihide] Kyushu Univ, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan.
   [Mashima, Naohiko; Imai, Hiroshi] Ehime Univ, Dept Bone & Joint Surg, Shizugawa, Toon 7910295, Japan.
   [Mitsugi, Naoto; Taki, Naoya; Mochida, Yuichi] Yokohama City Univ, Med Ctr, Dept Orthopaed Surg, Minami Ku, Yokohama, Kanagawa 2320024, Japan.
   [Owan, Ichiro; Arakaki, Kaoru] Univ Ryukyus, Dept Orthoped Surg, Nishihara, Okinawa 9030215, Japan.
RP Nakashima, Y (reprint author), Kyushu Univ, Dept Orthopaed Surg, Higashi Ku, 1-3-3 Maidashi, Fukuoka 8128582, Japan.
EM yasunaka@ortho.med.kyushu-u.ac.jp
RI U-ID, Kyushu/C-5291-2016
FU Zimmer
FX Y. N. received lecture fees from Zimmer. All other authors have declared
   no conflicts of interest.
CR Archibeck MJ, 2001, J BONE JOINT SURG AM, V83A, P1666, DOI 10.2106/00004623-200111000-00008
   Baad-Hansen T, 2011, ACTA ORTHOP, V82, P155, DOI 10.3109/17453674.2011.572251
   BOBYN JD, 1988, J BONE JOINT SURG BR, V70, P302
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bono J V, 1994, J Arthroplasty, V9, P119, DOI 10.1016/0883-5403(94)90059-0
   CROWE JF, 1979, J BONE JOINT SURG AM, V61, P15, DOI 10.2106/00004623-197961010-00004
   DAntonio JA, 1997, CLIN ORTHOP RELAT R, P124
   Deglurkar M, 2007, J BIOMED MATER RES B, V80B, P528, DOI 10.1002/jbm.b.30627
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Ebramzadeh E, 2003, J BONE JOINT SURG AM, V85A, P2378, DOI 10.2106/00004623-200312000-00016
   Fisher D A, 1990, Semin Arthroplasty, V1, P35
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P459, DOI 10.1007/s11999-009-1090-5
   KERBOUL M, 1974, J BONE JOINT SURG BR, VB 56, P291
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4
   Latimer HA, 1996, J BONE JOINT SURG AM, V78A, P975, DOI 10.2106/00004623-199607000-00001
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Malizos KN, 2008, CLIN ORTHOP RELAT R, V466, P159, DOI 10.1007/s11999-007-0008-3
   Nakashima Y, 1997, J BIOMED MATER RES, V35, P287
   Periasamy K, 2011, J BONE JOINT SURG BR, V93B, P1033, DOI 10.1302/0301-620X.93B8.26233
   Rahbek O, 2005, INT ORTHOP, V29, P368, DOI 10.1007/s00264-005-0008-4
   Schmalzried T P, 1994, J Arthroplasty, V9, P235, DOI 10.1016/0883-5403(94)90077-9
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P1130, DOI 10.2106/00004623-199274080-00002
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Shiraza-Adl A, 2003, J BIOMED MATER RES, V27, P167
   Simon JP, 2009, ACTA ORTHOP BELG, V75, P623
   Xenakis TA, 2009, INT ORTHOP, V33, P911, DOI 10.1007/s00264-008-0581-4
NR 31
TC 13
Z9 15
U1 1
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1439-7595
EI 1439-7609
J9 MOD RHEUMATOL
JI Mod. Rheumatol.
PD JAN
PY 2013
VL 23
IS 1
BP 112
EP 118
DI 10.1007/s10165-012-0618-9
PG 7
WC Rheumatology
SC Rheumatology
GA 068ML
UT WOS:000313370700014
PM 22395477
DA 2018-10-19
ER

PT J
AU Chang, J
   Liu, WS
   Han, BQ
   Peng, SK
   He, B
   Gu, ZW
AF Chang, Jing
   Liu, Wanshun
   Han, Baoqin
   Peng, Sikai
   He, Bin
   Gu, Zhongwei
TI Investigation of the skin repair and healing mechanism of
   N-carboxymethyl chitosan in second-degree burn wounds
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID TISSUE GROWTH-FACTOR; INDUCED APOPTOSIS; MOLECULAR-MECHANISMS;
   HYPERTROPHIC SCARS; EXPRESSION; FIBROBLASTS; KELOIDS; KERATINOCYTES;
   SURVIVIN; DEXAMETHASONE
AB N-carboxymethyl chitosan (NCMC) was synthesized with the modification of chitosan; the substitution degree was measured by titration. The biocompatibility and degradability of the NCMC were studied in vivo and the results showed that the NCMC was nontoxic and biocompatible. The in vivo degradation rate of NCMC in musculature was faster than that in subcutaneous tissue due to the relatively high lysozyme concentration. The NCMC was used as biomaterial to heal deep second-degree burn wounds. The wound size reduction, histological examination, and the quantification of transforming growth factor-beta(1), tumor necrosis factor-alpha and interleukin-8 protein levels, and Smad3 gene expression were measured to evaluate the healing effects. The results demonstrated that the NCMC was efficient in accelerating wound healing via activating transforming growth factor-beta(1)/Smad3 signaling pathway.
C1 [Chang, Jing; He, Bin; Gu, Zhongwei] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Chang, Jing; Liu, Wanshun; Han, Baoqin; Peng, Sikai] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.
RP Gu, ZW (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM zwgu@scu.edu.cn
FU National Basic Research Program of China (National 973 Program)
   [2011CB606206]; National Science Foundation of China [31100676,
   50830105]; Natural Science Foundation of Shandong Province
   [ZR2011CQ032]; National Science and Technology Support Program
   [2012BAI17B06]; China Postdoctoral Science Foundation Funded Project
   [2012T50777, 20110491724]
FX This work was funded by National Basic Research Program of China
   (National 973 Program, No. 2011CB606206), National Science Foundation of
   China (NO. 31100676, 50830105), Natural Science Foundation of Shandong
   Province (No. ZR2011CQ032), National Science and Technology Support
   Program (No. 2012BAI17B06), China Postdoctoral Science Foundation Funded
   Project (No. 2012T50777, 20110491724). Particular thanks are extended to
   the participants of this study and to Doctor Lin Cong of the Department
   of Pathology of the Affiliated Hospital of Medical College Qingdao
   University.
CR Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440
   BERRY RB, 1985, BRIT J PLAST SURG, V38, P163, DOI 10.1016/0007-1226(85)90045-1
   Dammeier J, 1998, J BIOL CHEM, V273, P18185, DOI 10.1074/jbc.273.29.18185
   Diem R, 2003, J NEUROSCI, V23, P6993, DOI 10.1523/JNEUROSCI.23-18-06993.2003
   Funayama E, 2003, J INVEST DERMATOL, V121, P1326, DOI 10.1111/j.1523-1747.2003.12572.x
   GOLLADAY ES, 1988, SOUTHERN MED J, V81, P736, DOI 10.1097/00007611-198806000-00013
   Greenstein S, 2002, CLIN CANCER RES, V8, P1681
   Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345
   Gupta BBP, 2002, CURR SCI INDIA, V83, P1103
   Hammer S, 2004, J CELL BIOCHEM, V91, P840, DOI 10.1002/jcb.10766
   He L, 2006, CHINESE J CONT PEDIA, V8, P173
   Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771
   Jiang Du-yin, 2004, Zhonghua Zheng Xing Wai Ke Za Zhi, V20, P128
   KISCHER CW, 1982, HUM PATHOL, V13, P819, DOI 10.1016/S0046-8177(82)80078-6
   Leventhal D, 2006, ARCH FACIAL PLAST S, V8, P362, DOI 10.1001/archfaci.8.6.362
   MASTURZO A, 1960, Riforma Med, V74, P633
   Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746
   Ohtsuru Akira, 2000, Endocrine Journal, V47, pS41, DOI 10.1507/endocrj.47.SupplMarch_S41
   Ottolini MG, 2002, ANTIMICROB AGENTS CH, V46, P2299, DOI 10.1128/AAC.46.7.2299-2302.2002
   RAUSCHER GE, 1986, CUTIS, V37, P67
   Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123
   Rippo MR, 2010, INT J IMMUNOPATH PH, V23, P1153, DOI 10.1177/039463201002300419
   Roques Claude, 2008, Int J Low Extrem Wounds, V7, P137, DOI 10.1177/1534734608320786
   Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456
   Scoltock AB, 2006, CELL DEATH DIFFER, V14, P840
   Shaker SA, 2011, APPL IMMUNOHISTO M M, V19, P153, DOI 10.1097/PAI.0b013e3181efa2ef
   Shih B, 2010, WOUND REPAIR REGEN, V18, P139, DOI 10.1111/j.1524-475X.2009.00553.x
   Sloka JS, 2005, MULT SCLER, V11, P425, DOI 10.1191/1352458505ms1190oa
   Smith J. C., 2007, J INVEST DERMATOL, V128, P1298
   Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200
   Studdiford J, 2008, J AM BOARD FAM MED, V21, P149, DOI 10.3122/jabfm.2008.02.070011
   Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x
   SYED F, 2010, BRIT J DERMATOL, V164, P83
   Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430
   VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787
   Vincent AS, 2007, J INVEST DERMATOL, V128, P702
   Wu WS, 2006, J INVEST DERMATOL, V126, P1264, DOI 10.1038/sj.jid.5700274
   Xu HX, 2010, PHOTODERMATOL PHOTO, V26, P198, DOI 10.1111/j.1600-0781.2010.00522.x
   Yoshimoto H, 1999, AM J PATHOL, V154, P883, DOI 10.1016/S0002-9440(10)65335-7
   Zhu HY, 2011, HEPATOL RES, V41, P795, DOI 10.1111/j.1872-034X.2011.00830.x
NR 40
TC 13
Z9 15
U1 5
U2 51
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD JAN-FEB
PY 2013
VL 21
IS 1
BP 113
EP 121
DI 10.1111/j.1524-475X.2012.00859.x
PG 9
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 068EQ
UT WOS:000313348500050
PM 23126571
DA 2018-10-19
ER

PT J
AU Filardo, G
   Kon, E
   Roffi, A
   Di Martino, A
   Marcacci, M
AF Filardo, Giuseppe
   Kon, Elizaveta
   Roffi, Alice
   Di Martino, Alessandro
   Marcacci, Maurilio
TI Scaffold-Based Repair for Cartilage Healing: A Systematic Review and
   Technical Note
SO ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE MULTILAYERED BIOMATERIAL;
   CLINICAL SAFETY TRIAL; TERM-FOLLOW-UP; ARTICULAR-CARTILAGE; CHONDRAL
   DEFECTS; OSTEOCHONDRAL REGENERATION; PROSPECTIVE MULTICENTER;
   KNEE-JOINT; MATRIX
AB Purpose: The aim of this systematic review was to address the treatment of chondral and osteochondral knee lesions through the use of scaffolds, by showing surgical options and results of this scaffold-based repair approach for the healing of the articular surface. Methods: All studies published in English addressing cartilage scaffold-based treatment were identified, including those that fulfilled the following criteria: (1) Levels I to IV evidence addressing the outlined areas of interest, (2) measures of functional or clinical outcome, (3) knee cartilage lesions, and (4) minimum of 2 years of follow-up. Results: The analysis showed a progressively increasing number of articles per year from 1995 to February 2012. The number of selected articles was 51, with 40 focusing on 2-step procedures and 11 focusing on 1-step procedures. The evaluation of evidence level showed 3 randomized studies, 10 comparative studies, 33 case series, and 5 case reports. Conclusions: Regenerative scaffold-based procedures are emerging as a therapeutic option for the treatment of chondral lesions, but well-designed studies are lacking. Systematic long-term evaluation of these techniques and randomized studies are necessary to confirm the potential of this treatment approach, especially compared with the available traditional treatments. Different 1-step scaffold-based strategies are emerging to simplify the procedure and reduce costs. Level of Evidence: Level IV, systematic review of Level I to IV studies.
C1 [Filardo, Giuseppe; Kon, Elizaveta; Roffi, Alice; Di Martino, Alessandro; Marcacci, Maurilio] Rizzoli Orthopaed Inst, Biomech Lab, I-40136 Bologna, Italy.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Biomech Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
OI Roffi, Alice/0000-0002-2683-3743; Filardo, Giuseppe/0000-0002-8136-0977
CR Adachi N, 2007, J BONE JOINT SURG AM, V89A, P2752, DOI 10.2106/JBJS.F00983
   Almqvist KF, 2009, AM J SPORT MED, V37, P1920, DOI 10.1177/0363546509335463
   Basad E, 2010, KNEE SURG SPORT TR A, V18, P519, DOI 10.1007/s00167-009-1028-1
   Bauer S, 2011, KNEE
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Choi NY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-103
   Clar H, 2010, KNEE, V17, P255, DOI 10.1016/j.knee.2009.09.004
   Cole BJ, 2011, AM J SPORT MED, V39, P1170, DOI 10.1177/0363546511399382
   Crawford DC, 2009, AM J SPORT MED, V37, P1334, DOI 10.1177/0363546509333011
   Della Villa S, 2010, AM J SPORT MED, V38, P68, DOI 10.1177/0363546509348490
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Ebert JR, 2011, AM J SPORT MED, V39, P753, DOI 10.1177/0363546510390476
   Erggelet C, 2003, ARTHROSCOPY, V19, P108, DOI 10.1053/jars.2003.50025
   Erggelet C, 2010, ARCH ORTHOP TRAUM SU, V130, P957, DOI 10.1007/s00402-009-0957-y
   Ferruzi A, 2008, J BONE JOINT SURG AM, V90A, P90, DOI 10.2106/JBJS.H.00633
   Filardo G, 2011, KNEE
   Filardo G, 2011, KNEE SURG SPORTS TRA
   Filardo G, 2011, AM J SPORT MED, V39, P2153, DOI 10.1177/0363546511415658
   Gigante A, 2009, KNEE SURG SPORT TR A, V17, P2, DOI 10.1007/s00167-008-0635-6
   Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3
   Gobbi A, 2006, AM J SPORT MED, V34, P1763, DOI 10.1177/0363546506288853
   Gobbi A, 2011, CARTILAGE, V2, P286, DOI 10.1177/1947603510392023
   Gobbi Alberto, 2009, J Knee Surg, V22, P36
   Gobbi A, 2009, AM J SPORT MED, V37, P1083, DOI 10.1177/0363546509331419
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Gross AE, 2005, CLIN ORTHOP RELAT R, P79, DOI 10.1097/01.blo.0000165845.21735.05
   Kim MK, 2010, KNEE SURG SPORT TR A, V18, P528, DOI 10.1007/s00167-009-0905-y
   Kon E, 2011, EUR J RADIOL, V79, P382, DOI 10.1016/j.ejrad.2010.04.002
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2011, AM J SPORT MED, V39, P2549, DOI 10.1177/0363546511420688
   Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, AM J SPORT MED, V37, p156S, DOI 10.1177/0363546509351649
   Kon E, 2008, SPORTS MED ARTHROSC, V16, P221, DOI 10.1097/JSA.0b013e31818cdbc5
   Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256
   Kreuz PC, 2011, AM J SPORT MED, V39, P1697, DOI 10.1177/0363546511403279
   Kreuz PC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2638
   Kusano T, 2011, KNEE SURG SPORTS TRA
   Macmull S, 2012, INT ORTHOP
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marcacci M, 2002, KNEE SURG SPORT TR A, V10, P154, DOI 10.1007/s00167-001-0275-6
   Marcacci M, 2007, AM J SPORT MED, V35, P2014, DOI 10.1177/0363546507305455
   Marcacci M, 2007, KNEE SURG SPORT TR A, V15, P610, DOI 10.1007/s00167-006-0265-9
   Nehrer S, 1999, CLIN ORTHOP RELAT R, P149
   Nehrer S, 2006, EUR J RADIOL, V57, P3, DOI 10.1016/j.ejrad.2005.08.005
   Nehrer S, 2009, AM J SPORT MED, V37, p81S, DOI 10.1177/0363546509350704
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Panagopoulos A, 2012, ORTHOPEDICS, V35, pE6, DOI 10.3928/01477447-20111122-07
   Panni AS, 2011, INT J IMMUNOPATH PH, V24, P149, DOI 10.1177/03946320110241S228
   Pascarella A, 2010, KNEE SURG SPORT TR A, V18, P509, DOI 10.1007/s00167-009-1007-6
   Patrascu JM, 2010, J BONE JOINT SURG BR, V92B, P1160, DOI 10.1302/0301-620X.92B8.24341
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Ronga M, 2006, ARTHROSCOPY, V22, p576e1
   Salzmanni GM, 2009, OSTEOARTHR CARTILAGE, V17, P1576, DOI 10.1016/j.joca.2009.07.010
   Saris DBF, 2009, AM J SPORT MED, V37, p10S, DOI 10.1177/0363546509350694
   Schneider U, 2011, AM J SPORT MED, V39, P2558, DOI 10.1177/0363546511423369
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Tohyama H, 2009, J ORTHOP SCI, V14, P579, DOI 10.1007/s00776-009-1384-1
   Ventura A, 2012, KNEE SURG SPORT TR A, V20, P121, DOI 10.1007/s00167-011-1575-0
   Welsch GH, 2010, AM J SPORT MED, V38, P934, DOI 10.1177/0363546509354971
   Wondrasch B, 2009, AM J SPORT MED, V37, p88S, DOI 10.1177/0363546509351272
   Zeifang F, 2010, AM J SPORT MED, V38, P924, DOI 10.1177/0363546509351499
NR 68
TC 79
Z9 83
U1 1
U2 49
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-8063
J9 ARTHROSCOPY
JI Arthroscopy
PD JAN
PY 2013
VL 29
IS 1
BP 174
EP 186
DI 10.1016/j.arthro.2012.05.891
PG 13
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 063HL
UT WOS:000312986800021
PM 23159494
DA 2018-10-19
ER

PT J
AU Kurosaki, T
   Uematsu, M
   Shimoda, K
   Suzuma, K
   Nakai, M
   Nakamura, T
   Kitahara, T
   Kitaoka, T
   Sasaki, H
AF Kurosaki, Tomoaki
   Uematsu, Masafumi
   Shimoda, Kenichiro
   Suzuma, Kiyoshi
   Nakai, Masato
   Nakamura, Tadahiro
   Kitahara, Takashi
   Kitaoka, Takashi
   Sasaki, Hitoshi
TI Ocular Gene Delivery Systems Using Ternary Complexes of Plasmid DNA,
   Polyethylenimine, and Anionic Polymers
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE non-viral gene delivery; biomaterial; gene vector; nanoparticle; DNA
ID IN-VIVO; EPITHELIAL-CELLS; CATIONIC POLYMERS; THERAPY; VECTORS; RETINA;
   SERUM; NEOVASCULARIZATION; TRANSFECTION; BARRIER
AB In this experiment, we developed anionic ternary complexes for effective and safe ocular gene delivery. Ternary complexes were constructed by coating plasmid DNA (pDNA)/polyethylenimine (PEI) complex with anionic polymers such as gamma-polyglutamic acid (gamma-PGA) and chondroitin sulfate (CS). The cationic pDNA/PEI complex showed high gene expression on the human retinal pigment epithelial cell line, ARPE-19 cells. The pDNA/PEI complexes, however, also showed high cytotoxicity on the cells and aggregated strongly in the vitreous body. On the other hand, the anionic ternary complexes showed high gene expression on ARPE-19 cells without such cytotoxicity and aggregation. After intravitreous administration of the complexes, the anionic ternary complexes showed high gene expression in the retina. These results strongly indicate that anionic ternary complexes are suitable for effective and safe ocular gene therapy.
C1 [Shimoda, Kenichiro; Nakai, Masato; Nakamura, Tadahiro; Kitahara, Takashi; Sasaki, Hitoshi] Nagasaki Univ Hosp, Dept Hosp Pharm, Nagasaki 8528501, Japan.
   [Kurosaki, Tomoaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan.
   [Kurosaki, Tomoaki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028471, Japan.
   [Sasaki, Hitoshi] Nagasaki Univ, Global COE Program, Nagasaki 8528523, Japan.
   [Uematsu, Masafumi; Suzuma, Kiyoshi; Kitaoka, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Nagasaki 8528501, Japan.
RP Sasaki, H (reprint author), Nagasaki Univ Hosp, Dept Hosp Pharm, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
EM sasaki@nagasaki-u.ac.jp
OI Kurosaki, Tomoaki/0000-0003-4234-6934
FU Global COE Program, Nagasaki University, Japan; Ministry of Education,
   Culture, Sports, Science and Technology of Japan
FX This study was supported in part by the Global COE Program, Nagasaki
   University, Japan and a Grant-in-Aid for Scientific Research from the
   Ministry of Education, Culture, Sports, Science and Technology of Japan.
CR Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327
   Ahn HH, 2008, BIOMATERIALS, V29, P2415, DOI 10.1016/j.biomaterials.2008.02.006
   Bainbridge JWB, 2002, GENE THER, V9, P320, DOI 10.1038/sj/gt/3301680
   Binley K, 2012, HUM GENE THER, V23, P980, DOI 10.1089/hum.2012.008
   Bishop P, 1996, EYE, V10, P664, DOI 10.1038/eye.1996.159
   Bloquel C, 2006, ADV DRUG DELIVER REV, V58, P1224, DOI 10.1016/j.addr.2006.07.023
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Cai X, 2008, VISION RES, V48, P319, DOI 10.1016/j.visres.2007.07.012
   Campochiaro PA, 2012, GENE THER, V19, P121, DOI 10.1038/gt.2011.164
   Carrabino S, 2005, J GENE MED, V7, P1555, DOI 10.1002/jgm.799
   Colella P, 2009, TRENDS MOL MED, V15, P23, DOI 10.1016/j.molmed.2008.11.003
   Finsinger D, 2000, GENE THER, V7, P1183, DOI 10.1038/sj.gt.3301227
   Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5
   Hornof M, 2008, J GENE MED, V10, P70, DOI 10.1002/jgm.1125
   Itaka K, 2004, J GENE MED, V6, P76, DOI 10.1002/jbm.470
   Kawakami S, 2004, INT J PHARM, V278, P255, DOI 10.1016/j.ijpharm.2004.03.013
   Kichler A, 2001, J GENE MED, V3, P135, DOI 10.1002/jgm.173
   Kim H, 2009, PHARM RES-DORDR, V26, P329, DOI 10.1007/s11095-008-9745-6
   Kircheis R, 2001, ADV DRUG DELIVER REV, V53, P341, DOI 10.1016/S0169-409X(01)00202-2
   Kurosaki T, 2009, BIOMATERIALS, V30, P4427, DOI 10.1016/j.biomaterials.2009.04.041
   Kurosaki T, 2009, BIOMATERIALS, V30, P2846, DOI 10.1016/j.biomaterials.2009.01.055
   Lee JH, 2008, J TISSUE ENG REGEN M, V2, P288, DOI 10.1002/term.94
   Liao HW, 2007, BIOTECHNIQUES, V42, P285, DOI 10.2144/000112404
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   MARIO CF, 1998, INT J PHARMACEUT, V162, P159
   Naik R, 2009, DRUG DISCOV TODAY, V14, P306, DOI 10.1016/j.drudis.2008.09.012
   Pathak A, 2009, Nucleic Acids Symp Ser (Oxf), P57, DOI 10.1093/nass/nrp029
   Peeters L, 2007, BIOCHEM SOC T, V35, P47, DOI 10.1042/BST0350047
   Peeters L, 2005, INVEST OPHTH VIS SCI, V46, P3553, DOI 10.1167/iovs.05-0165
   Pitkanen L, 2003, PHARMACEUT RES, V20, P576, DOI 10.1023/A:1023238530504
   Ralph GS, 2006, CLIN SCI, V110, P37, DOI 10.1042/CS20050158
   Ruponen M, 1999, BBA-BIOMEMBRANES, V1415, P331, DOI 10.1016/S0005-2736(98)00199-0
   Sakurai E, 2001, OPHTHALMIC RES, V33, P31, DOI 10.1159/000055638
   Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Trubetskoy VS, 2003, GENE THER, V10, P261, DOI 10.1038/sj.gt.3301888
   Urtti A, 2000, J DRUG TARGET, V7, P413, DOI 10.3109/10611860009102216
NR 37
TC 10
Z9 10
U1 1
U2 25
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD JAN
PY 2013
VL 36
IS 1
BP 96
EP 101
DI 10.1248/bpb.b12-00728
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 063UK
UT WOS:000313027300016
PM 23302641
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Rokstad, AM
   Brekke, OL
   Steinkjer, B
   Ryan, L
   Kollarikova, G
   Strand, BL
   Skjak-Braek, G
   Lambris, JD
   Lacik, I
   Mollnes, TE
   Espevik, T
AF Rokstad, Anne Mari
   Brekke, Ole-Lars
   Steinkjer, Bjorg
   Ryan, Liv
   Kollarikova, Gabriela
   Strand, Berit L.
   Skjak-Braek, Gudmund
   Lambris, John D.
   Lacik, Igor
   Mollnes, Tom Eirik
   Espevik, Terje
TI The induction of cytokines by polycation containing microspheres by a
   complement dependent mechanism
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Inflammation; Complement; Biocompatibility; Microspheres;
   Alginate
ID FOREIGN-BODY REACTION; HUMAN WHOLE-BLOOD; IN-VIVO; ALGINATE
   MICROCAPSULES; INFLAMMATORY RESPONSES; ANAPHYLATOXINS C5A;
   SURFACE-CHEMISTRY; ENDOTHELIAL-CELLS; GIANT-CELLS; BIOMATERIALS
AB The cytokine-inducing potential of various microspheres were evaluated in a short-time screening assay of lepirudin-anticoagulated human whole blood utilizing the Bio-Plex Human cytokine 27-plex system. The inflammatory cytokines IL-1 beta, TNF and IL-6; the anti-inflammatory mediators IL-1ra and IL-10; the chemokines IL-8, MIP-1 alpha and MCP-1; and the growth factor VEGF were induced by polycation (poly-L-lysine or poly(methylene-co-guanidine)) containing microspheres. Alginate microspheres without polycations did not induce the corresponding cytokine panel, nor did soluble alginate. By inhibiting complement C3 using compstatin analog CP20, a total inhibition of complement activation as well as the inflammatory mediators was achieved, indicating that complement activation alone was responsible for the induced cytokines. A strong deposition of C3c on the poly-L-lysine containing surface, while not on the microspheres lacking polycations, also points to the formation of C3 convertase as involved in the biomaterial-induced cytokine induction. These results show that complement is responsible for the induction of cytokines by polycation containing microspheres. We point to complement as an important initiator of inflammatory responses to biomaterials and the lepirudin anticoagulated whole blood assay as an important tool to identify the most tolerable and safe materials for implantation to humans. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Rokstad, Anne Mari; Steinkjer, Bjorg; Ryan, Liv; Strand, Berit L.; Espevik, Terje] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway.
   [Brekke, Ole-Lars; Mollnes, Tom Eirik] Nordland Hosp, Dept Lab Med, Bodo, Norway.
   [Brekke, Ole-Lars; Mollnes, Tom Eirik] Univ Tromso, N-9001 Tromso, Norway.
   [Kollarikova, Gabriela; Lacik, Igor] Slovak Acad Sci, Inst Polymer, Dept Biomat Res, Bratislava, Slovakia.
   [Strand, Berit L.; Skjak-Braek, Gudmund] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7489 Trondheim, Norway.
   [Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Mollnes, Tom Eirik] Univ Oslo, Rikshosp, Dept Immunol, N-0027 Oslo, Norway.
RP Rokstad, AM (reprint author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway.
EM anne.m.rokstad@ntnu.no
RI Strand, Berit Lokensgard/O-3999-2015
OI Strand, Berit Lokensgard/0000-0002-9951-0355; Lacik,
   Igor/0000-0001-6037-3747; Lambris, John/0000-0002-9370-5776
FU Central Norway Regional Health Authority; European Commission; Slovak
   Research and Development Agency [APVV-0486-10]; EFDS New Horizons grant;
   National Institutes of Health [A1068730]; Chicago Diabetes Project
FX This work has been financially supported by grant from the Central
   Norway Regional Health Authority, grant from the European Commission
   EP-7 BetaCellTherapy, grant from the Slovak Research and Development
   Agency under the contract No. APVV-0486-10, an EFDS New Horizons grant
   and by National Institutes of Health grants A1068730. The Chicago
   Diabetes Project (hap://www.chicagodiabetesproject.org/) is acknowledged
   for grant support and discussions during this work. A specific thank to
   David Hunkeler as critical discussion partner. The confocal imaging was
   performed at the Cellular & Molecular Imaging Core Facility, Norwegian
   University of Science and Technology (NTNU) by Kine Samset Hoem and
   Pontus Orning. Dr. Hongchang Qu is thanked for the peptide synthesis. In
   addition Dorte Christiansen and Grethe Bergseth at Department of
   Laboratory Medicine, Nordland Hospital are thanked for skillful
   technical support.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   Belperio JA, 2005, J CLIN INVEST, V115, P1150, DOI 10.1172/JCI200524233
   Bergseth G, 2011, ANN THORAC SURG, V91, P527, DOI 10.1016/j.athoracsur.2010.10.084
   Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343
   Brekke OL, 2008, MOL IMMUNOL, V45, P3804, DOI 10.1016/j.molimm.2008.05.017
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835
   Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027
   KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554
   Lacik I, 1998, J BIOMED MATER RES, V39, P52, DOI 10.1002/(SICI)1097-4636(199801)39:1<52::AID-JBM7>3.0.CO;2-H
   Lappegard KT, 2008, J BIOMED MATER RES A, V87A, P129, DOI 10.1002/jbm.a.31750
   Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106
   Lappegard KT, 2004, ANN THORAC SURG, V78, P38, DOI 10.1016/j.athorascur.2004.02.005
   Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962
   Le YY, 2004, CELL MOL IMMUNOL, V1, P95
   Luttikhuizen DT, 2007, J BIOMED MATER RES A, V83A, P879, DOI 10.1002/jbm.a.31420
   Luttikhuizen DT, 2007, J TISSUE ENG REGEN M, V1, P398, DOI 10.1002/term.50
   Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004
   Mangsbo SM, 2009, J IMMUNOL, V183, P6724, DOI 10.4049/jimmunol.0902374
   MOLLNES TE, 1993, CLIN EXP IMMUNOL, V91, P295
   MOLLNES TE, 1984, SCAND J IMMUNOL, V20, P157, DOI 10.1111/j.1365-3083.1984.tb00989.x
   Mollnes TE, 2002, BLOOD, V100, P1869
   Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Pan ZXK, 1998, BBA-GENE STRUCT EXPR, V1443, P90, DOI 10.1016/S0167-4781(98)00198-5
   Qi M, 2008, ARTIF CELL BLOOD SUB, V36, P403, DOI 10.1080/10731190802369755
   Qu H., 2012, IMMUNOBIOLOGY
   Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1
   Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753
   Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011
   Safley Susan A, 2008, J Diabetes Sci Technol, V2, P760
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Sokolov A, 2012, J BIOMED MATER RES A, V100A, P1142, DOI 10.1002/jbm.a.34054
   Sokolov Andrey, 2011, J Diabetes Sci Technol, V5, P1490
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577
   Takeda Y, 2012, CLIN EXP IMMUNOL, V167, P149, DOI 10.1111/j.1365-2249.2011.04490.x
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51
   VANDENBOSSCHE GMR, 1993, J PHARM PHARMACOL, V45, P115, DOI 10.1111/j.2042-7158.1993.tb03694.x
   Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636
NR 52
TC 24
Z9 25
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 3
BP 621
EP 630
DI 10.1016/j.biomaterials.2012.10.012
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 060ER
UT WOS:000312759800002
PM 23103159
DA 2018-10-19
ER

PT J
AU van Noort, JM
   Bsibsi, M
   Nacken, PJ
   Gerritsen, WH
   Amor, S
   Holtman, IR
   Boddeke, E
   van Ark, I
   Leusink-Muis, T
   Folkerts, G
   Hennink, WE
   Amidi, M
AF van Noort, Johannes M.
   Bsibsi, Malika
   Nacken, Peter J.
   Gerritsen, Wouter H.
   Amor, Sandra
   Holtman, Inge R.
   Boddeke, Erik
   van Ark, Ingrid
   Leusink-Muis, Thea
   Folkerts, Gert
   Hennink, Wim E.
   Amidi, Maryam
TI Activation of an immune-regulatory macrophage response and inhibition of
   lung inflammation in a mouse model of COPD using heat-shock protein
   alpha B-crystallin-loaded PLGA microparticles
SO BIOMATERIALS
LA English
DT Article
DE PLGA microparticles; Heat-shock proteins; Immunomodulation; Macrophage;
   Toll-like receptors; COPD
ID MULTIPLE-SCLEROSIS; CANDIDATE AUTOANTIGEN; DENDRITIC CELLS; MICROARRAY
   DATA; T-CELL; TOLERANCE; DIFFERENTIATION; AUTOIMMUNITY; EXPRESSION;
   APOPTOSIS
AB As an extracellular protein, the small heat-shock protein alpha B-crystallin (HSPB5) has anti-inflammatory effects in several mouse models of inflammation. Here, we show that these effects are associated with the ability of HSPB5 to activate an immune-regulatory response in macrophages via endosomal/phagosomal CD14 and Toll-like receptors 1 and 2. Humans, however, possess natural antibodies against HSPB5 that block receptor binding. To protect it from these antibodies, we encapsulated HSPB5 in porous PLGA microparticles. We document here size, morphology, protein loading and release characteristics of such microparticles. Apart from effectively protecting HSPB5 from neutralization, PLGA microparticles also strongly promoted macrophage targeting of HSPB via phagocytosis. As a result, HSPB5 in porous PLGA microparticles was more than 100-fold more effective in activating macrophages than free soluble protein. Yet, the immune-regulatory nature of the macrophage response, as documented here by microarray transcript profiling, remained the same. In mice developing cigarette smoke-induced COPD, HSPB5-loaded PLGA microparticles were selectively taken up by alveolar macrophages upon intratracheal administration, and significantly suppressed lung infiltration by lymphocytes and neutrophils. In contrast, 30-fold higher doses of free soluble HSPB5 remained ineffective. Our data indicate that porous HSPB5-PLGA microparticles hold considerable promise as an anti-inflammatory biomaterial for humans. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [van Noort, Johannes M.; Bsibsi, Malika; Nacken, Peter J.] Delta Crystallon By, NL-2333 CK Leiden, Netherlands.
   [Gerritsen, Wouter H.; Amor, Sandra] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands.
   [Amor, Sandra] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Dept Neurosci & Trauma, London E1 2AT, England.
   [Holtman, Inge R.; Boddeke, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Med Physiol, NL-9713 AV Groningen, Netherlands.
   [van Ark, Ingrid; Leusink-Muis, Thea; Folkerts, Gert] Univ Utrecht, Inst Pharmaceut Sci, Div Pharmacol, NL-3508 TB Utrecht, Netherlands.
   [Hennink, Wim E.; Amidi, Maryam] Univ Utrecht, Inst Pharmaceut Sci, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands.
RP van Noort, JM (reprint author), Delta Crystallon By, Zernikedreef 9, NL-2333 CK Leiden, Netherlands.
EM hans@deltacrystallon.com
RI Amor, Sandra/A-1812-2013
OI van Noort, Johannes/0000-0002-9060-5921; Holtman, Inge
   R./0000-0001-9752-4756
FU Delta Crystal Ion BV
FX We are grateful to the microarray core facility of the VUmc, Amsterdam
   for their assistance in performing the microarray experiments. This
   study was sponsored by Delta Crystal Ion BV.
CR Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108
   Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108
   Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044
   Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063
   Computing RF for S.R Development Core Team, 2011, R LANG ENV STAT COMP
   Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854
   Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x
   Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717
   Geiser M, 2010, J AEROSOL MED PULM D, V23, P207, DOI 10.1089/jamp.2009.0797
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6
   Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669
   Kalinski P, 1997, J IMMUNOL, V159, P28
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Masilamoni JG, 2006, BBA-MOL BASIS DIS, V1762, P284, DOI 10.1016/j.bbadis.2005.11.007
   Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45
   Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825
   Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935
   Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42
   Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412
   Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/261
   Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002
   Sarmiento J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027967
   Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294
   Smyth GK, 2005, STAT BIOL HEALTH, P397
   van Noort JM, 2006, MULT SCLER, V12, P287, DOI 10.1191/135248506ms1271oa
   van Noort JM, 2000, J NEUROIMMUNOL, V105, P46, DOI 10.1016/S0165-5728(00)00181-8
   van Noort JM, 2010, J NEUROPATH EXP NEUR, V69, P694, DOI 10.1097/NEN.0b013e3181e4939c
   van Sechel AC, 1999, J IMMUNOL, V162, P129
   van Stipdonk MJB, 2000, J NEUROIMMUNOL, V103, P103, DOI 10.1016/S0165-5728(99)00171-X
   van Stipdonk MJB, 2000, CELL IMMUNOL, V204, P128, DOI 10.1006/cimm.2000.1698
   VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0
   Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072
   Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009
   Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x
   Zaja-Milatovic S, 2008, HISTOL HISTOPATHOL, V23, P1399, DOI 10.14670/HH-23.1399
NR 41
TC 21
Z9 21
U1 1
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 3
BP 831
EP 839
DI 10.1016/j.biomaterials.2012.10.028
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 060ER
UT WOS:000312759800023
PM 23117214
DA 2018-10-19
ER

PT J
AU Barone, A
   Ricci, M
   Grassi, RF
   Nannmark, U
   Quaranta, A
   Covani, U
AF Barone, A.
   Ricci, M.
   Grassi, R. F.
   Nannmark, U.
   Quaranta, A.
   Covani, U.
TI A 6-month histological analysis on maxillary sinus augmentation with and
   without use of collagen membranes over the osteotomy window: randomized
   clinical trial
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; collagen membrane; sinus augmentation
ID HUMAN OSTEOGENIC PROTEIN-1; FLOOR ELEVATION; DEPROTEINIZED BOVINE;
   IMPLANT PLACEMENT; AUTOGENOUS BONE; FOLLOW-UP; SURVIVAL; COMBINATION;
   SUCCESS; MIXTURE
AB Introduction Over the years, several modifications have been made to the sinus augmentation technique and to the materials used. However, there is still controversy about the need for using a barrier concurrently with a graft in sinus augmentation procedures. On this basis, the aim of this randomized clinical study was to investigate the effect of resorbable collagen membrane over the osteotomy window on maxillary sinus augmentation healing. Materials and methods Patients who required maxillary sinus augmentation were evaluated and selected to enter the study. After maxillary sinus grafting, each patient was randomly assigned to control (membrane over the osteotomy window) or test (no membrane) group. After 6 months, one bone biopsy was harvested from the lateral window and sent to the histology laboratory. The MannWhitney nonparametric test was used for comparing the two groups. P-value was set at 5%. Results Eighteen patients entered the study and were randomly allocated in control (nine patients) or test group (nine patients). The histomorphometric measurements revealed that newly formed bone was 30.7% +/- 15.5% of the total volume from the membrane group (control). The average percentage of connective tissue was 50.6% +/- 18.7% and residual graft percentage was 18.4% +/- 20.3%. On the other hand, data regarding the nonmembrane group (test) showed that the percentage of newly formed bone was 28.1% +/- 19.4%. The mean percentage of connective tissues was 59.3% +/- 15.4% and 12.6% +/- 12.4% for the residual graft particles. No significant difference was detected in the histomorphometrical evaluation between the two groups. Discussion Our results showed that, compared with sites not covered, the use of the membrane did not substantially increase the amount of vital bone over a period of 6 months. On the other hand, the use of membrane seems to reduce the proliferation of the connective tissue and the graft re-absorption rate. It is plausible that blood supply of maxillary sinus can play a role in such a result. Further studies are needed to explore whether the use of membrane could really be advantageous for the sinus augmentation procedure and to evaluate what influence this method can have on the amount and quality of reconstructed bone.
C1 [Barone, A.; Ricci, M.; Covani, U.] Univ Pisa, Dept Surg, Tirrenian Stomatol Inst, Versilia Hosp, Lido Di Camaiore, Italy.
   [Grassi, R. F.] Univ Bari, Dept Surg & Dent, Bari, Italy.
   [Quaranta, A.] Univ Roma La Sapienza, Dept Dent, Rome, Italy.
   [Nannmark, U.] Gothenburg Univ, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.
RP Barone, A (reprint author), Piazza Diaz 10, I-55041 Camaiore, LU, Italy.
EM barosurg@gmail.com
RI Barone, Antonio/O-2738-2013
OI Barone, Antonio/0000-0003-1226-7565; Grassi, Felice
   Roberto/0000-0002-4427-4180; QUARANTA, ALESSANDRO/0000-0002-4225-9374
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   BOYNE P. J., 1962, ORAL SURG ORAL MED AND ORAL PATHOL, V15, P265, DOI 10.1016/0030-4220(62)90105-6
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Boyne PJ, 1997, INT J PERIODONT REST, V17, P10
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x
   Cordaro L, 2002, CLIN ORAL IMPLAN RES, V13, P103, DOI 10.1034/j.1600-0501.2002.130113.x
   Del Fabbro M, 2008, EUR J ORAL SCI, V116, P497, DOI 10.1111/j.1600-0722.2008.00571.x
   Emtiaz Shahram, 2006, Implant Dent, V15, P171, DOI 10.1097/01.id.0000220550.27164.74
   Esposito M., 2008, COCHRANE DB SYST REV, V16
   Galindo-Moreno P, 2007, CLIN ORAL IMPLAN RES, V18, P376, DOI 10.1111/j.1600-0501.2007.01337.x
   Hallman M, 2005, INT J ORAL MAX SURG, V34, P273, DOI 10.1016/j.ijom.2004.09.009
   Jensen O T, 1995, Int J Oral Maxillofac Implants, V10, P335
   Maiorana C, 2006, INT J ORAL MAX IMPL, V21, P426
   Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911
   McAllister BS, 1998, INT J PERIODONT REST, V18, P227
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Misch C. E., 1991, J ORAL IMPLANTOL, V8, P13
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Nevins M, 1998, IMPLANT THERAPY CLIN, P171
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Scala A, 2010, CLIN ORAL IMPLAN RES, V21, P1320, DOI 10.1111/j.1600-0501.2010.01964.x
   Schlegel KA, 2002, BIOMATERIALS, V23, P2939, DOI 10.1016/S0142-9612(01)00423-9
   Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18
   Soltan Muna, 2005, J Oral Implantol, V31, P85, DOI 10.1563/0-773.1
   Tan WC, 2008, J CLIN PERIODONTOL, V35, P241, DOI 10.1111/j.1600-051X.2008.01273.x
   Tarnow DP, 2000, INT J PERIODONT REST, V20, P117
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Vercellotti T, 2001, INT J PERIODONT REST, V21, P561
   WAGNER J R, 1991, Journal of Oral Implantology, V17, P152
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   Widmark G, 1997, INT J ORAL MAX SURG, V26, P106, DOI 10.1016/S0901-5027(05)80827-6
NR 34
TC 21
Z9 21
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JAN
PY 2013
VL 24
IS 1
BP 1
EP 6
DI 10.1111/j.1600-0501.2011.02340.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 060YR
UT WOS:000312814800001
PM 22151577
DA 2018-10-19
ER

PT J
AU Johnson, TD
   Christman, KL
AF Johnson, Todd D.
   Christman, Karen L.
TI Injectable hydrogel therapies and their delivery strategies for treating
   myocardial infarction
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE cardiac repair; catheter; heart failure; hydrogel; injectable;
   myocardial infarction; naturally derived; polymer
ID TISSUE ENGINEERING APPLICATIONS; VENTRICULAR SEPTAL RUPTURE; CARDIAC
   REPAIR; HEART-DISEASE; CHITOSAN HYDROGEL; IN-SITU; INJECTION; ALGINATE;
   BIOMATERIALS; COLLAGEN
AB Introduction: Heart failure following myocardial infarction (MI) impacts millions of people each year in the US. The field of tissue engineering has developed several potential therapies for treating MI including injectable acellular hydrogels. These injectable biomaterials can either be synthetic or naturally derived, and have the potential to be delivered minimally invasively.
   Areas covered: This review covers the different methods of delivery and presents the initial work on the use of injectable biomaterial scaffolds alone to improve cardiac function post-MI. Several naturally derived materials including alginate, collagen, chitosan, decellularized tissues, fibrin, hyaluronic acid, keratin, and Matrigel, as well as a few synthetic materials have shown promise on their own without the addition of therapeutics such as cells or growth factors. These biomaterials can be potentially delivered via endocardial, epicardial, or intracoronary injections and some can even utilize current catheter technology, indicating a potential for avoiding invasive surgical procedures. Once injected into the wall of the heart, these hydrogels create a scaffold that provides biochemical and structural cues, and the ability for cellular infiltration and remodeling of the local environment.
   Expert opinion: Injectable biomaterials have several crucial challenges that should be over come to design optimal therapies for MI and heart failure, including optimizing material properties, methods of injection and understanding the mechanisms of action. But, studies in both small and large animals have shown significant improvement in important parameters including wall thickness, vascularization of the ischemic region, left ventricular volumes, and cardiac function. Thus, the application of injectable biomaterials shows promise for developing into new therapies to treat MI, potentially improving millions of lives.
C1 [Johnson, Todd D.; Christman, Karen L.] Univ Calif San Diego, Sanford Consortium Regenerat Med, Dept Bioengn, La Jolla, CA 92037 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Sanford Consortium Regenerat Med, Dept Bioengn, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
FU NSF; NIH [DP20D004309]
FX TD Johnson receives funding from the NSF as a graduate student fellow.
   KL Christman receives funding from the NIH (DP20D004309). KLC has an
   equity interest in Ventrix, Inc., and serves on the company's board.
CR Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   BioLineRX Ltd, 2007, SAF FEAS INJ BL 1040, Patent No. NCT00557531
   Birnbaum Y, 2002, NEW ENGL J MED, V347, P1426, DOI 10.1056/NEJMra020228
   Cabrales P, 2005, AM J PHYSIOL-HEART C, V288, pH1708, DOI 10.1152/ajpheart.00911.2004
   Chachques Juan C, 2007, J Interv Cardiol, V20, P188, DOI 10.1111/j.1540-8183.2007.00255.x
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dib N, 2010, JACC-CARDIOVASC INTE, V3, P265, DOI 10.1016/j.jcin.2009.12.013
   Dib Nabil, 2006, Journal of Pharmacological and Toxicological Methods, V54, P71, DOI 10.1016/j.vascn.2005.12.002
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   EDWARDS BS, 1984, AM J CARDIOL, V54, P1201, DOI 10.1016/S0002-9149(84)80067-3
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gyongyosi M, 2011, NAT REV CARDIOL, V8, P393, DOI 10.1038/nrcardio.2011.64
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Ikara Holdings Inc, 2010, IK 5001 PREV REM VEN, Patent No. NCT01226563
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Laham RJ, 2005, DRUG METAB DISPOS, V33, P1101, DOI 10.1124/dmd.104.002774
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   LEMERY R, 1992, AM J CARDIOL, V70, P147, DOI 10.1016/0002-9149(92)91266-7
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Li ZQ, 2011, POLYMERS-BASEL, V3, P740, DOI 10.3390/polym3020740
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   McManus DD, 2009, J AM SOC ECHOCARDIOG, V22, P190, DOI 10.1016/j.echo.2008.11.005
   Menon V, 2000, J AM COLL CARDIOL, V36, P1110, DOI 10.1016/S0735-1097(00)00878-0
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   NA GC, 1986, J BIOL CHEM, V261, P2290
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ou LL, 2011, J CELL MOL MED, V15, P1310, DOI 10.1111/j.1582-4934.2010.01086.x
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   POHJOLASINTONEN S, 1989, AM HEART J, V117, P809, DOI 10.1016/0002-8703(89)90617-0
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Seif-Naraghi SB, 2011, J CARDIOVASC TRANSL, V4, P545, DOI 10.1007/s12265-011-9293-z
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Shen DL, 2011, BIOMATERIALS, V32, P9290, DOI 10.1016/j.biomaterials.2011.08.057
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Stamm C, 2009, HEART LUNG CIRC, V18, P245, DOI 10.1016/j.hlc.2008.10.014
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Yang TL, 2011, INT J MOL SCI, V12, P1936, DOI 10.3390/ijms12031936
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
NR 83
TC 87
Z9 89
U1 4
U2 201
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5247
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD JAN
PY 2013
VL 10
IS 1
BP 59
EP 72
DI 10.1517/17425247.2013.739156
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 059JP
UT WOS:000312701500006
PM 23140533
DA 2018-10-19
ER

PT J
AU Pathare, PB
   Opara, UL
   Al-Said, FA
AF Pathare, Pankaj B.
   Opara, Umezuruike Linus
   Al-Said, Fahad Al-Julanda
TI Colour Measurement and Analysis in Fresh and Processed Foods: A Review
SO FOOD AND BIOPROCESS TECHNOLOGY
LA English
DT Review
DE Colour; Non-destructive measurement; Colorimeter; CIELAB; Colour index;
   Browning index; Colour kinetics; Food quality
ID RESPONSE-SURFACE METHODOLOGY; THERMAL-DEGRADATION KINETICS; JUICE
   QUALITY PARAMETERS; ASTERISK-B-ASTERISK; IMAGE-ANALYSIS; POTATO-CHIPS;
   HIGH-TEMPERATURES; ORANGE JUICE; BIOLOGICAL VARIATION; COMPUTER VISION
AB Colour is an important quality attribute in the food and bioprocess industries, and it influences consumer's choice and preferences. Food colour is governed by the chemical, biochemical, microbial and physical changes which occur during growth, maturation, postharvest handling and processing. Colour measurement of food products has been used as an indirect measure of other quality attributes such as flavour and contents of pigments because it is simpler, faster and correlates well with other physicochemical properties. This review discusses the techniques and procedures for the measurement and analysis of colour in food and other biomaterial materials. It focuses on the instrumental (objective) and visual (subjective) measurements for quantifying colour attributes and highlights the range of primary and derived objective colour indices used to characterise the maturity and quality of a wide range of food products and beverages. Different approaches applied to model food colour are described, including reaction mechanisms, response surface methodology and others based on probabilistic and non-isothermal kinetics. Colour is one of the most widely measured product quality attributes in postharvest handling and in the food processing research and industry. Apart from differences in instrumentation, colour measurements are often reported based on different colour indices even for the same product, making it difficult to compare results in the literature. There is a need for standardisation to improve the traceability and transferability of measurements. The correlation between colour and other sensory quality attributes is well established, but future prospects exist in the application of objective non-destructive colour measurement in predictive modelling of the nutritional quality of fresh and processed food products.
C1 [Pathare, Pankaj B.; Opara, Umezuruike Linus] Univ Stellenbosch, S African Res Chair Postharvest Technol, Postharvest Technol Res Lab, ZA-7600 Stellenbosch, South Africa.
   [Al-Said, Fahad Al-Julanda] Sultan Qaboos Univ, Coll Agr & Marine Sci, Dept Crop Sci, Muscat, Oman.
RP Opara, UL (reprint author), Univ Stellenbosch, S African Res Chair Postharvest Technol, Postharvest Technol Res Lab, ZA-7600 Stellenbosch, South Africa.
EM opara@sun.ac.za
RI Opara, Umezuruike/J-3978-2013; Pathare, Pankaj/C-4983-2009
OI Opara, Umezuruike/0000-0001-8056-7215; Pathare,
   Pankaj/0000-0001-5140-0272
FU South African Research Chairs Initiative of the Department of Science
   and Technology; National Research Foundation
FX This work is based upon research supported by the South African Research
   Chairs Initiative of the Department of Science and Technology and
   National Research Foundation.
CR Abe S., 2011, American Journal of Food Technology, V6, P63
   Adam E, 2000, NAHRUNG, V44, P32, DOI 10.1002/(SICI)1521-3803(20000101)44:1<32::AID-FOOD32>3.0.CO;2-F
   Adekunte AO, 2010, FOOD CHEM, V122, P500, DOI 10.1016/j.foodchem.2010.01.026
   Ahmed J, 2000, J FOOD ENG, V44, P239, DOI 10.1016/S0260-8774(00)00034-0
   Ahmed J, 2002, J FOOD SCI, V67, P1088, DOI 10.1111/j.1365-2621.2002.tb09457.x
   Ahmed J, 2002, J FOOD SCI, V67, P2692, DOI 10.1111/j.1365-2621.2002.tb08800.x
   Ahmed J, 2002, INT J FOOD PROP, V5, P359, DOI 10.1081/JFP-120005791
   ALMELA L, 1995, FOOD CHEM, V53, P321, DOI 10.1016/0308-8146(95)93940-S
   Ameur LA, 2006, FOOD CHEM, V98, P790, DOI 10.1016/j.foodchem.2005.07.038
   Ameur LA, 2007, FOOD CHEM, V101, P1407, DOI 10.1016/j.foodchem.2006.03.049
   Arabhosseini A, 2011, FOOD BIOPROCESS TECH, V4, P1281, DOI 10.1007/s11947-009-0305-9
   Arslan D., 2010, FOOD BIOPROD PROCESS, V89, P504
   Arzate-Vazquez I, 2011, FOOD BIOPROCESS TECH, V4, P1307, DOI 10.1007/s11947-011-0595-6
   Assawarachan Rittichai, 2010, International Journal of Agricultural and Biological Engineering, V3, P74, DOI 10.3965/j.issn.1934-6344.2010.01.074-084
   Avila IMLB, 1999, J FOOD ENG, V39, P161, DOI 10.1016/S0260-8774(98)00157-5
   Baini R, 2009, J FOOD ENG, V93, P177, DOI 10.1016/j.jfoodeng.2009.01.012
   Barreiro JA, 1997, J FOOD ENG, V33, P359, DOI 10.1016/S0260-8774(97)00035-6
   Barrett DM, 2010, CRIT REV FOOD SCI, V50, P369, DOI 10.1080/10408391003626322
   Bayarri S, 2001, FOOD SCI TECHNOL INT, V7, P399, DOI 10.1106/JJWN-FFRQ-JBMC-LQ5R
   BeMiller J. N., 1996, FOOD CHEM, P157
   Benlloch-Tinoco M, 2012, FOOD BIOPROCESS TECH, V5, P3021, DOI 10.1007/s11947-011-0652-1
   Boudhrioua N, 2003, LEBENSM-WISS TECHNOL, V36, P633, DOI 10.1016/S0023-6438(03)00083-5
   Brandt S, 2006, J SCI FOOD AGR, V86, P568, DOI 10.1002/jsfa.2390
   Brites C, 2010, FOOD BIOPROCESS TECH, V3, P707, DOI 10.1007/s11947-008-0108-4
   Brosnan T, 2004, J FOOD ENG, V61, P3, DOI 10.1016/S0260-8774(03)00183-3
   Buera M. P., 1986, FARBE, V32, P318
   BUSLIG BS, 1987, P FLA STATE HORT SOC, V100, P47
   CAMPBELL CA, 1989, HORTSCIENCE, V24, P472
   Carcel JA, 2010, LWT-FOOD SCI TECHNOL, V43, P1191, DOI 10.1016/j.lwt.2010.04.011
   CARRENO J, 1995, FOOD RES INT, V28, P373, DOI 10.1016/0963-9969(95)00008-A
   Chen HH, 1997, J FOOD SCI, V62, P985, DOI 10.1111/j.1365-2621.1997.tb15021.x
   Chutintrasri B, 2007, LWT-FOOD SCI TECHNOL, V40, P300, DOI 10.1016/j.lwt.2005.11.003
   CLYDESDALE FM, 1993, CRIT REV FOOD SCI, V33, P83, DOI 10.1080/10408399309527614
   CLYDESDALE FM, 1978, CRC CR REV FOOD SCI, V10, P243, DOI 10.1080/10408397809527252
   Corzo O, 2006, J FOOD ENG, V75, P21, DOI 10.1016/j.jfoodeng.2005.03.046
   Costa C, 2011, FOOD BIOPROCESS TECH, V4, P673, DOI 10.1007/s11947-011-0556-0
   Crisosto CH, 2003, POSTHARVEST BIOL TEC, V28, P159, DOI 10.1016/S0925-5214(02)00173-4
   Cubero S, 2011, FOOD BIOPROCESS TECH, V4, P487, DOI 10.1007/s11947-010-0411-8
   Dadali G, 2007, DRY TECHNOL, V25, P1703, DOI 10.1080/07373930701590954
   Dadali G, 2007, DRY TECHNOL, V25, P925, DOI 10.1080/07373930701372296
   Dana W, 2008, COMPUT ELECTRON AGR, V61, P126, DOI 10.1016/j.compag.2007.10.001
   Das I, 2004, J FOOD ENG, V62, P9, DOI 10.1016/S0260-8774(03)00164-X
   Dede S, 2007, J SCI FOOD AGR, V87, P773, DOI 10.1002/jsfa.2758
   Demirhan E, 2009, DRY TECHNOL, V27, P156, DOI 10.1080/07373930802566101
   Alvarez MD, 2010, FOOD BIOPROCESS TECH, V3, P55, DOI 10.1007/s11947-007-0051-9
   Drogoudi PD, 2008, SCI HORTIC-AMSTERDAM, V115, P149, DOI 10.1016/j.scienta.2007.08.010
   Du CJ, 2004, TRENDS FOOD SCI TECH, V15, P230, DOI 10.1016/j.tifs.2003.10.006
   Ekpong A, 2006, FOOD QUAL PREFER, V17, P622, DOI 10.1016/j.foodqual.2006.06.001
   Eksteen G. J., 1987, International Journal of Refrigeration, V10, P14, DOI 10.1016/0140-7007(87)90091-0
   Emmambux NM, 2003, J SCI FOOD AGR, V83, P1065, DOI 10.1002/jsfa.1509
   Erkan N, 2011, FOOD BIOPROCESS TECH, V4, P1322, DOI 10.1007/s11947-010-0415-4
   Esti M, 2002, FOOD CHEM, V76, P399, DOI 10.1016/S0308-8146(01)00231-X
   Fathi M, 2011, FOOD BIOPROCESS TECH, V4, P1357, DOI 10.1007/s11947-009-0222-y
   Fennema OR, 1996, FOOD CHEM
   Fernandez-Artigas P, 1999, J AGR FOOD CHEM, V47, P2872, DOI 10.1021/jf9808729
   Figura L. O., 2007, FOOD PHYS PHYS PROPE
   Francis F.J., 1980, HORTSCIENCE, V15, P14
   Francis F. J., 1975, FOOD COLORIMETRY THE
   FRANCIS FJ, 1995, FOOD QUAL PREFER, V6, P149, DOI 10.1016/0950-3293(94)00026-R
   Ganjloo A, 2011, FOOD BIOPROCESS TECH, V4, P1442, DOI 10.1007/s11947-009-0245-4
   Garcia JAL, 2000, INT J FOOD SCI TECH, V35, P385
   Garza S, 1999, FOOD RES INT, V32, P335, DOI 10.1016/S0963-9969(99)00094-0
   Geel L, 2005, FOOD QUAL PREFER, V16, P237, DOI 10.1016/j.foodqual.2004.04.014
   Giannou V, 2008, FOOD BIOPROCESS TECH, V1, P276, DOI 10.1007/s11947-007-0008-z
   Gomez-Sanchis J, 2008, J FOOD ENG, V89, P80, DOI 10.1016/j.jfoodeng.2008.04.009
   Granato D, 2010, CIENCIA TECNOL ALIME, V30, P1090, DOI 10.1590/S0101-20612010000400039
   Grossman R. P., 1999, J MARK PRACT APPL MA, V5, P78, DOI DOI 10.1108/EUM0000000004565
   Hertog MLATM, 2007, POSTHARVEST BIOL TEC, V43, P183, DOI 10.1016/j.postharvbio.2006.09.014
   Hertog MLATM, 2004, POSTHARVEST BIOL TEC, V34, P271, DOI 10.1016/j.postharvbio.2004.05.014
   Hertog MLATM, 2002, POSTHARVEST BIOL TEC, V26, P253, DOI 10.1016/S0925-5214(02)00044-3
   HOBSON GE, 1987, J HORTIC SCI, V62, P55, DOI 10.1080/14620316.1987.11515748
   Hosoda H, 2005, J JPN SOC FOOD SCI, V52, P120, DOI 10.3136/nskkk.52.120
   Hsu CL, 2003, FOOD CHEM, V83, P85, DOI 10.1016/S0308-8146(03)00053-0
   Hunter R. S., 1987, MEASUREMENT APPEARAN
   HunterLab, 1995, INSIGHT COLOR, V5, P1
   Hur SJ, 2008, FOOD BIOPROCESS TECH, V1, P196, DOI 10.1007/s11947-008-0061-2
   Hutchings JB, 1994, FOOD COLOUR APPEARAN
   Ibanoglu E, 2002, J FOOD ENG, V51, P209, DOI 10.1016/S0260-8774(01)00057-7
   Ibarz A, 1999, J FOOD ENG, V39, P415, DOI 10.1016/S0260-8774(99)00032-1
   IWAHORI S, 1986, SCI HORTIC-AMSTERDAM, V28, P243, DOI 10.1016/0304-4238(86)90006-3
   Jackman P, 2011, TRENDS FOOD SCI TECH, V22, P185, DOI 10.1016/j.tifs.2011.01.008
   Jain A. K, 1989, FUNDAMENTALS DIGITAL
   Jha SN, 2007, J FOOD ENG, V78, P22, DOI 10.1016/j.jfoodeng.2005.08.048
   Jimenez-Cuesta M., 1981, P INT SOC CITRICULTU
   Jin SK, 2011, FOOD BIOPROCESS TECH, V4, P1407, DOI 10.1007/s11947-010-0392-7
   Jing H, 2011, FOOD BIOPROCESS TECH, V4, P1489, DOI 10.1007/s11947-009-0279-7
   K MINOLTA., 1994, PRECISE COLOR COMMUN
   Kang KJ, 2004, FOOD SCI BIOTECHNOL, V13, P119
   Kaya A, 2011, FOOD BIOPROCESS TECH, V4, P241, DOI 10.1007/s11947-008-0169-4
   Kaymak-Ertekin F, 2005, J FOOD ENG, V68, P443, DOI 10.1016/j.jfoodeng.2004.06.022
   Kotwaliwale N, 2007, J FOOD ENG, V78, P1207, DOI 10.1016/j.jfoodeng.2005.12.033
   Kramer A., 1976, FOOD TECHNOLOGY, V30, P68
   Kramer A., 1976, FOOD TECHNOLOGY, V30, P70
   Kramer A., 1976, FOOD TECHNOLOGY, V30, P66
   Krokida MK, 2001, INT J FOOD SCI TECH, V36, P53, DOI 10.1046/j.1365-2621.2001.00426.x
   Krokida MK, 1999, DRY TECHNOL, V17, P449, DOI 10.1080/07373939908917545
   Krokida MK, 2000, DRY TECHNOL, V18, P937, DOI 10.1080/07373930008917745
   Krokida MK, 1998, DRY TECHNOL, V16, P667, DOI 10.1080/07373939808917429
   Kuhn BF, 2001, FOOD QUAL PREFER, V12, P543, DOI 10.1016/S0950-3293(01)00050-7
   LaBell F., 1993, Food Processing, USA, V54, P66
   LAMBRECHT HS, 1995, ACS SYM SER, V600, P313
   Lang C, 2012, FOOD BIOPROCESS TECH, V5, P3244, DOI 10.1007/s11947-011-0694-4
   Lebesi DM, 2011, FOOD BIOPROCESS TECH, V4, P710, DOI 10.1007/s11947-009-0181-3
   Lee HS, 2000, J AGR FOOD CHEM, V48, P1507, DOI 10.1021/jf9907236
   Leemans V, 1998, COMPUT ELECTRON AGR, V20, P117, DOI 10.1016/S0168-1699(98)00012-X
   Leon K, 2006, FOOD RES INT, V39, P1084, DOI 10.1016/j.foodres.2006.03.006
   Lin LY, 2009, FOOD CHEM, V112, P987, DOI 10.1016/j.foodchem.2008.07.022
   LITTLE AC, 1975, J FOOD SCI, V40, P410, DOI 10.1111/j.1365-2621.1975.tb02213.x
   Liu YL, 2003, MEAT SCI, V63, P301, DOI 10.1016/S0309-1740(02)00086-4
   Lopez A, 1997, DRY TECHNOL, V15, P989, DOI 10.1080/07373939708917273
   Lozano JE, 1997, J FOOD ENG, V31, P365, DOI 10.1016/S0260-8774(96)00079-9
   Lu SM, 2007, FOOD CHEM, V104, P824, DOI 10.1016/j.foodchem.2006.12.050
   Lunadei L, 2011, POSTHARVEST BIOL TEC, V60, P225, DOI 10.1016/j.postharvbio.2011.02.001
   Lurie S, 2009, OPTICAL MONITORING F, P2
   Lv B, 2009, J CEREAL SCI, V50, P262, DOI 10.1016/j.jcs.2009.06.004
   MacDougall DB, 2002, COLOUR FOOD IMPROVIN
   Maharaj R, 1999, POSTHARVEST BIOL TEC, V15, P13, DOI 10.1016/S0925-5214(98)00064-7
   Mangaraj S, 2011, FOOD BIOPROCESS TECH, V4, P272, DOI 10.1007/s11947-008-0145-z
   Manickavasagan A, 2010, FOOD BIOPROCESS TECH, V3, P450, DOI 10.1007/s11947-008-0110-x
   MARQUEZ G, 1986, J FOOD SCI, V51, P157, DOI 10.1111/j.1365-2621.1986.tb10859.x
   Martins RC, 2002, INT J REFRIG, V25, P966, DOI 10.1016/S0140-7007(01)00050-0
   Maskan A, 2002, J FOOD ENG, V54, P75, DOI 10.1016/S0260-8774(01)00187-X
   Maskan M, 2001, J FOOD ENG, V48, P169, DOI 10.1016/S0260-8774(00)00154-0
   MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6
   McMinn WAM, 1997, FOOD BIOPROD PROCESS, V75, P223, DOI 10.1205/096030897531621
   MEDLICOTT AP, 1992, TROP AGR, V69, P161
   Melendez-Martinez A., 2012, J FOOD COMPOS ANAL, V26, P837
   Melendez-Martinez AJ, 2005, J SCI FOOD AGR, V85, P894, DOI 10.1002/jsfa.2115
   Mendoza F, 2004, J FOOD SCI, V69, pE471
   Mendoza F, 2006, POSTHARVEST BIOL TEC, V41, P285, DOI 10.1016/j.postharvbio.2006.04.004
   Mitcham B., 1996, PERISHABLES HANDL NE, V85, P1
   Mohapatra D, 2010, J FOOD SCI, V75, pE146, DOI 10.1111/j.1750-3841.2010.01518.x
   MOTTUR GP, 1989, CEREAL FOOD WORLD, V34, P620
   Nevares I, 2009, FOOD BIOPROCESS TECH, V2, P328, DOI 10.1007/s11947-008-0109-3
   Nieto-Sandoval JM, 1999, COLOR RES APPL, V24, P93, DOI 10.1002/(SICI)1520-6378(199904)24:2<93::AID-COL4>3.0.CO;2-W
   Nisha P, 2011, FOOD BIOPROCESS TECH, V4, P781, DOI 10.1007/s11947-009-0300-1
   North M., 2006, 27 INT HORT C IHC200, P772
   O'Leary E, 2000, LEBENSM-WISS TECHNOL, V33, P217, DOI 10.1006/fstl.2000.0645
   Obenland D, 2009, POSTHARVEST BIOL TEC, V52, P156, DOI 10.1016/j.postharvbio.2009.01.005
   Ochoa MR, 2001, J FOOD ENG, V49, P55, DOI 10.1016/S0260-8774(00)00184-9
   OLIVER JR, 1992, CEREAL CHEM, V69, P546
   Opara L. U., 2010, BRIT FOOD J, V112, P797
   Opara L. U., 2010, BRIT FOOD J, V112, P811
   Opara LU, 2009, FOOD BIOPROCESS TECH, V2, P315, DOI 10.1007/s11947-008-0095-5
   Osanai Y, 2003, J JPN SOC FOOD SCI, V50, P254
   Ozdemir M, 2000, J FOOD ENG, V44, P31, DOI 10.1016/S0260-8774(99)00162-4
   Ozdemir M, 2000, J FOOD ENG, V45, P17, DOI 10.1016/S0260-8774(00)00036-4
   Palacios VM, 2002, J FOOD ENG, V54, P95, DOI 10.1016/S0260-8774(01)00189-3
   Papadakis SE, 2000, FOOD TECHNOL-CHICAGO, V54, P48
   Park C. R., 1975, KOREAN J NUTR, V8, P33
   Parker R, 2001, INTRO FOOD SCI
   Patras A, 2011, FOOD BIOPROCESS TECH, V4, P1245, DOI 10.1007/s11947-009-0226-7
   Patras A, 2009, INNOV FOOD SCI EMERG, V10, P308, DOI 10.1016/j.ifset.2008.12.004
   Pedreschi F, 2004, J FOOD SCI, V69, pE264
   Pedreschi F, 2007, J FOOD ENG, V79, P989, DOI 10.1016/j.jfoodeng.2006.03.020
   Pedreschi F, 2012, FOOD BIOPROCESS TECH, V5, P2401, DOI 10.1007/s11947-011-0559-x
   Pek Z, 2010, HORTSCIENCE, V45, P466
   Pereira AC, 2009, IND ENG CHEM RES, V48, P988, DOI 10.1021/ie071610b
   Pott I, 2005, INNOV FOOD SCI EMERG, V6, P412, DOI 10.1016/j.ifset.2005.05.004
   Pristijono P, 2006, POSTHARVEST BIOL TEC, V42, P256, DOI 10.1016/j.postharvbio.2006.07.006
   Purlis E, 2010, J FOOD ENG, V99, P239, DOI 10.1016/j.jfoodeng.2010.03.008
   Purlis E, 2009, FOOD RES INT, V42, P865, DOI 10.1016/j.foodres.2009.03.007
   Qin PY, 2010, INT J FOOD SCI TECH, V45, P951, DOI 10.1111/j.1365-2621.2010.02231.x
   Quevedo RA, 2010, FOOD BIOPROCESS TECH, V3, P637, DOI 10.1007/s11947-008-0106-6
   Quintas MAC, 2007, J FOOD ENG, V83, P483, DOI 10.1016/j.jfoodeng.2007.03.036
   Quitao-Teixeira LJ, 2008, FOOD BIOPROCESS TECH, V1, P364, DOI 10.1007/s11947-007-0018-x
   Raju PN, 2009, FOOD BIOPROCESS TECH, V2, P101, DOI 10.1007/s11947-008-0137-z
   Ramirez-Jimenez A, 2000, J AGR FOOD CHEM, V48, P4176, DOI 10.1021/jf9907687
   Rattanathanalerk M, 2005, J FOOD ENG, V66, P259, DOI 10.1016/j.jfoodeng.2004.03.016
   Rekha MN, 2010, FOOD BIOPROCESS TECH, V3, P441, DOI 10.1007/s11947-008-0123-5
   RESMINI P, 1993, ITALIAN J FOOD SCI, V4, P341
   Rhim JW, 2011, FOOD SCI BIOTECHNOL, V20, P215, DOI 10.1007/s10068-011-0029-2
   Rhim JW, 1999, J FOOD SCI, V64, P149, DOI 10.1111/j.1365-2621.1999.tb09880.x
   RHIM JW, 1989, J FOOD SCI, V54, P776, DOI 10.1111/j.1365-2621.1989.tb04710.x
   Ribotta PD, 2010, FOOD BIOPROCESS TECH, V3, P395, DOI 10.1007/s11947-008-0080-z
   Rodriguez-Aguilera R, 2011, LWT-FOOD SCI TECHNOL, V44, P337, DOI 10.1016/j.lwt.2010.06.014
   Rosales-Juarez M, 2008, FOOD BIOPROCESS TECH, V1, P152, DOI 10.1007/s11947-007-0004-3
   Sabanis D, 2008, FOOD BIOPROCESS TECH, V1, P374, DOI 10.1007/s11947-007-0027-9
   Sabanis D, 2009, FOOD BIOPROCESS TECH, V2, P68, DOI 10.1007/s11947-007-0037-7
   Sacks EJ, 2001, J AM SOC HORTIC SCI, V126, P221
   SAHIN S., 2006, PHYS PROPERTIES FOOD
   SAPERS GM, 1987, J FOOD SCI, V52, P1258, DOI 10.1111/j.1365-2621.1987.tb14057.x
   Saricoban C., 2010, World Applied Sciences Journal, V9, P14
   Saxena A., 2010, FOOD BIOPROCESS TECH, V5, P672
   SCANLON MG, 1994, AM POTATO J, V71, P717, DOI 10.1007/BF02849210
   Schouten RE, 2004, POSTHARVEST BIOL TEC, V32, P299, DOI 10.1016/j.postharvbio.2003.12.005
   Schouten RE, 2007, POSTHARVEST BIOL TEC, V45, P298, DOI 10.1016/j.postharvbio.2007.03.011
   Sciarini LS, 2010, FOOD BIOPROCESS TECH, V3, P577, DOI 10.1007/s11947-008-0098-2
   Segnini S, 1999, FOOD SCI TECHNOL-LEB, V32, P216
   Sharma R, 2008, INT J FOOD PROP, V11, P439, DOI 10.1080/10942910701530826
   SHEWFELT RL, 1984, J FOOD SCI, V49, P1612, DOI 10.1111/j.1365-2621.1984.tb12857.x
   SHEWFELT RL, 1993, POSTHARVEST HANDLING, P99, DOI DOI 10.1016/B978-0-08-092576-9.50011-2
   SHEWFELT RL, 2003, POSTHARVEST PHYSL PA, P287
   SHEWFELT RL, 2000, FRUIT VEGETABLE QUAL, P144
   Shi J, 1999, FOOD RES INT, V32, P15, DOI 10.1016/S0963-9969(99)00059-9
   SHIN SG, 1995, J FOOD ENG, V24, P77, DOI 10.1016/0260-8774(94)P1609-2
   Silva FM, 1999, INT J FOOD SCI TECH, V34, P87, DOI 10.1046/j.1365-2621.1999.00246.x
   Sinesio F, 1997, FOOD QUAL PREFER, V8, P35, DOI 10.1016/S0950-3293(96)00005-5
   Singh KK, 2006, J FOOD ENG, V73, P112, DOI 10.1016/j.jfoodeng.2005.01.010
   SKREDE G, 1985, J FOOD SCI, V50, P514
   Soysal Y, 2004, BIOSYST ENG, V89, P167, DOI 10.1016/j.biosystemseng.2004.07.008
   STAMP JA, 1983, J FOOD SCI, V48, P543, DOI 10.1111/j.1365-2621.1983.tb10785.x
   Stewart I., 1971, P FLORIDA STATE HORT
   Suh HJ, 2003, NAHRUNG, V47, P132, DOI 10.1002/food.200390024
   Sumnu G, 2005, LWT-FOOD SCI TECHNOL, V38, P549, DOI 10.1016/j.lwt.2004.07.006
   Sun DW, 2004, J FOOD ENG, V61, P1, DOI 10.1016/S0260-8774(03)00182-1
   TAO Y, 1995, T ASAE, V38, P1555
   Tijskens L., 2005, INT C POSTH UNL DOWN, P687
   Tijskens L. M. M., 1994, Postharvest Biology and Technology, V4, P85, DOI 10.1016/0925-5214(94)90010-8
   Tijskens L. M. M., 2001, Innovative Food Science and Emerging Technologies, V2, P303, DOI 10.1016/S1466-8564(01)00045-5
   Tijskens L. M. M., 2011, Journal of Fruit and Ornamental Plant Research, V19, P113
   Tijskens LMM, 2003, POSTHARVEST BIOL TEC, V27, P15, DOI 10.1016/S0925-5214(02)00191-6
   Tiwari BK, 2008, J FOOD ENG, V88, P553, DOI 10.1016/j.jfoodeng.2008.03.021
   Tiwari BK, 2008, J AGR FOOD CHEM, V56, P2423, DOI 10.1021/jf073503y
   Tiwari BK, 2009, FOOD BIOPROCESS TECH, V2, P109, DOI 10.1007/s11947-008-0156-9
   Toivonen PMA, 2004, HORTSCIENCE, V39, P1066
   Tsami E, 2000, DRY TECHNOL, V18, P1559, DOI 10.1080/07373930008917793
   Turabi E, 2008, FOOD BIOPROCESS TECH, V1, P64, DOI 10.1007/s11947-007-0003-4
   Usenik V, 2008, FOOD CHEM, V107, P185, DOI 10.1016/j.foodchem.2007.08.004
   VAMOSVIGYAZO L, 1981, CRC CR REV FOOD SCI, V15, P49, DOI 10.1080/10408398109527312
   Van Zeebroeck M, 2007, POSTHARVEST BIOL TEC, V45, P157, DOI 10.1016/j.postharvbio.2007.01.015
   vanBoekel MAJS, 1996, J FOOD SCI, V61, P477
   Vandekinderen I, 2008, J AGR FOOD CHEM, V56, P5723, DOI 10.1021/jf800681a
   Vardin H, 2003, NAHRUNG, V47, P300, DOI 10.1002/food.200390070
   Vasquez-Caicedo AL, 2005, J AGR FOOD CHEM, V53, P4827, DOI 10.1021/jf048168h
   VoegelTurenne C, 1997, DRY TECHNOL, V15, P2587, DOI 10.1080/07373939708917379
   WALKER JRL, 1975, ENZYME TECHNOL DIG, V4, P89
   Walker P., 1990, P AUSTR SOC ANIMAL P
   Walkling-Ribeiro M, 2009, FOOD BIOPROCESS TECH, V2, P422, DOI 10.1007/s11947-007-0045-7
   Walkling-Ribeiro M, 2010, LWT-FOOD SCI TECHNOL, V43, P1067, DOI 10.1016/j.lwt.2010.02.010
   Wambura P, 2011, FOOD BIOPROCESS TECH, V4, P107, DOI 10.1007/s11947-008-0150-2
   Wand SJE, 2006, SCI HORTIC-AMSTERDAM, V107, P271, DOI 10.1016/j.scienta.2005.11.002
   WOLF G, 1984, PHYSIOL REV, V64, P873
   Yam KL, 2004, J FOOD ENG, V61, P137, DOI 10.1016/S0260-8774(03)00195-X
   Yu HL, 2003, IND ENG CHEM RES, V42, P3036, DOI 10.1021/ie020941f
   Zanoni B, 1995, FOOD SCI TECHNOL-LEB, V28, P604
   Zepka LQ, 2009, J AGR FOOD CHEM, V57, P7841, DOI 10.1021/jf900558a
NR 237
TC 177
Z9 192
U1 12
U2 225
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1935-5130
J9 FOOD BIOPROCESS TECH
JI Food Bioprocess Technol.
PD JAN
PY 2013
VL 6
IS 1
BP 36
EP 60
DI 10.1007/s11947-012-0867-9
PG 25
WC Food Science & Technology
SC Food Science & Technology
GA 061VO
UT WOS:000312878500003
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Moreira, PD
   Genari, SC
   Goissis, G
   Galembeck, F
   An, YHH
   Santos, AR
AF Moreira, Patricia da Luz
   Genari, Selma Candelaria
   Goissis, Gilberto
   Galembeck, Fernando
   An, Yuehuei H.
   Santos, Arnaldo Rodrigues, Jr.
TI Bovine osteoblasts cultured on polyanionic collagen scaffolds: An
   ultrastructural and immunocytochemical study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE anionic collagen; cell culture; osteoblasts; biomaterials; tissue
   engineering; cell differentiation
ID ANIONIC COLLAGEN; BONE REPAIR; IN-VITRO; RAT CALVARIA; ELASTIN MATRICES;
   DRUG-DELIVERY; CELL-ADHESION; MINERALIZATION; BIOMATERIALS;
   DIFFERENTIATION
AB Collagen is the most abundant protein in the body and is also the most important component of the extracellular matrix. Collagen has several advantages as a biomaterial such as lack of toxicity, biocompatibility, biodegradability, and easy reabsorption. In this study, we examined bovine osteoblasts cultured on native or anionic collagen scaffolds prepared from bovine pericardium after selective hydrolysis of glutamine and asparagine side chain amides for periods from 24 (BP24) and 48 h (BP48). The cells were cultured in control and mineralization medium at 37 degrees C in the presence of 5% CO2. Transmission and scanning electron microscopy, energy dispersive spectroscopy, and an immunocytochemical marker were used for analysis. Cells with an irregular morphology forming a confluent multilayer were observed on matrices kept in control medium. Most of these cells presented a polygonal or elongated flattened morphology. Several spherical deposits of calcium crystal associated with phosphorus were observed on the native and BP48 matrices. Similar results were observed in samples kept in control medium except with lower calcium/phosphorus ratio. Vesicles actively expelled from the cell membrane were also seen (do this vesicles corresponds to calcium/phosphorus deposits). Osteocalcin was clearly visible on matrices kept in mineralization medium and was more expression on the surface of BP48 matrices. The results showed that anionic collagen is able to support osteoblastic differentiation, regardless of the medium used. Finally, the BP48 matrix promoted better osteoblast differentiation than the native matrix. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 101B: 1827, 2013.
C1 [Santos, Arnaldo Rodrigues, Jr.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.
   [Moreira, Patricia da Luz; Genari, Selma Candelaria] Univ Estadual Campinas, Dept Biol Celular, Inst Biol, Sao Paulo, Brazil.
   [Genari, Selma Candelaria] Fac Tecnol Bauru, Ctr Estadual Educ Tecnol Paula Souza, Sao Paulo, Brazil.
   [Goissis, Gilberto] Biotech Biomed Prod Med & Odontol Ltda ME Prod, Sao Paulo, Brazil.
   [Galembeck, Fernando] Univ Estadual Campinas, Inst Quim, Dept Fis Quim, Sao Paulo, Brazil.
   [An, Yuehuei H.] Med Univ S Carolina, Orthopaed Res Lab, Charleston, SC 29425 USA.
RP Santos, AR (reprint author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.
EM arnaldo.santos@ufabc.edu.br
RI Galembeck, Fernando/D-9509-2012; Santos, Jr, Arnaldo/I-4813-2012
OI Galembeck, Fernando/0000-0003-4778-5442; 
CR Alberts B, 2008, MOL BIOL CELL
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   Bet MR, 2003, BIOMATERIALS, V24, P131, DOI 10.1016/S0142-9612(02)00270-3
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, P250
   Chao Edmund Y S, 2003, Eur Cell Mater, V6, P72
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Chierico A, 1999, CLIN ORAL IMPLAN RES, V10, P415, DOI 10.1034/j.1600-0501.1999.100508.x
   Cobos JA, 1998, J BIOMED MATER RES, V39, P458, DOI 10.1002/(SICI)1097-4636(19980305)39:3<458::AID-JBM16>3.3.CO;2-Q
   Cunha MR, 2008, J MATER SCI-MATER M, V19, P1341, DOI 10.1007/s10856-006-0105-y
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Goissis G, 2003, ARTIF ORGANS, V27, P437, DOI 10.1046/j.1525-1594.2003.07252.x
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   Gundberg CM, 2003, OSTEOPOROSIS INT, V14, pS37, DOI 10.1007/s00198-003-1471-7
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Haralson M. A., 1995, EXTRACELLULAR MATRIX, P1
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kimura M, 2000, SCAND J PLAST RECONS, V34, P289, DOI 10.1080/028443100750059057
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   KRUKOWSKI M, 1994, CLIN ORTHOP RELAT R, P266
   KRUKOWSKI M, 1990, J ORAL MAXIL SURG, V48, P468, DOI 10.1016/0278-2391(90)90233-R
   Kryszewski M, 2004, ACTA PHYS POL A, V105, P389, DOI 10.12693/APhysPolA.105.389
   Lacerda C, 1998, QUIM NOVA, V21, P267, DOI 10.1590/S0100-40421998000300006
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LEFEBVRE F, 1992, BIOMATERIALS, V13, P28, DOI 10.1016/0142-9612(92)90091-2
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   Moreira PL, 2004, J BIOMED MATER RES B, V71B, P229, DOI 10.1002/jbm.b.30026
   Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402
   NIMNI ME, 1988, CALCIFIED TISSUE INT, V42, P313, DOI 10.1007/BF02556366
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Pasteris JD, 2008, ELEMENTS, V4, P97, DOI 10.2113/GSELEMENTS.4.2.97
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Rocha LB, 2004, J BIOMED MATER RES B, V71B, P355, DOI 10.1002/jbm.b.30102
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Rocha LB, 2006, J BIOMED MATER RES A, V79A, P237, DOI 10.1002/jbm.a.30782
   Rosa FP, 2003, BIOMATERIALS, V24, P207, DOI 10.1016/S0142-9612(02)00292-2
   Santos Jr AR, 2012, TISSUE REGENERATION, P339
   SAUTIER JM, 1992, CALCIFIED TISSUE INT, V50, P527, DOI 10.1007/BF00582168
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   SINGH MP, 1995, PHARMACEUT RES, V12, P1205, DOI 10.1023/A:1016272212833
   Skinner HCW, 2005, MINERAL MAG, V69, P621, DOI 10.1180/0026461056950275
   Suh H, 2001, ARTIF ORGANS, V25, P14, DOI 10.1046/j.1525-1594.2001.025001014.x
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   WERKMEISTER J A, 1992, Clinical Materials, V9, P137
   WHITSON SW, 1992, J BONE MINER RES, V7, P727
   Zellin G, 1996, CONNECT TISSUE RES, V35, P279, DOI 10.3109/03008209609029202
NR 55
TC 3
Z9 3
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2013
VL 101B
IS 1
BP 18
EP 27
DI 10.1002/jbm.b.32804
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 057CS
UT WOS:000312540100003
PM 22987821
DA 2018-10-19
ER

PT J
AU Brown, EM
   Latona, RJ
   Taylor, MM
AF Brown, Eleanor M.
   Latona, Renee J.
   Taylor, Maryann M.
TI EFFECTS OF PRETANNING PROCESSES ON COLLAGEN STRUCTURE AND REACTIVITY
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
ID HIDE; MICROFIBRIL; STABILITY
AB The cattle hide, a major byproduct of the US meat industry, is the tanner's substrate, and also the source of collagen for the food and biomaterials industries. Conversion of animal hides into leather is a multistep process that continually evolves in response to economic and environmental concerns. Processing changes are generally evaluated in terms of impact on tannery costs and quality of leather produced. Because the basis for tanning and other biomaterial applications is the stabilization of the collagen matrix, changes to the molecular characteristics of hide collagen may be expected to impact these applications. In previous studies, we began the development of protocols for production and utilization of powdered hide from specific steps in beam-house processing. In this study, the effects of pretanning processes on the structure, stability and reactivity of hide collagen with tanning materials are evaluated. The results are anticipated to assist the tanner as well as the manufacturers of collagen-based biomaterials and gelatin to better understand their substrate and changes to it that may occur when beam-house processes are altered.
C1 [Brown, Eleanor M.; Latona, Renee J.; Taylor, Maryann M.] USDA ARS, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.
RP Brown, EM (reprint author), USDA ARS, Eastern Reg Res Ctr, 600 E Mermaid Lane, Wyndmoor, PA 19038 USA.
EM eleanor.brown@ars.usda.gov
CR Brown EM, 2006, J AM LEATHER CHEM AS, V101, P274
   Brown EM, 2012, J AM LEATHER CHEM AS, V107, P1
   Brown EM, 2011, J AM LEATHER CHEM AS, V106, P145
   Brown EM, 2010, J AM LEATHER CHEM AS, V105, P116
   Brown EM, 2009, J AM LEATHER CHEM AS, V104, P275
   Brown EM, 2005, J AM LEATHER CHEM AS, V100, P401
   BROWN EM, 1993, J AM LEATHER CHEM AS, V88, P2
   Brown EM, 1997, J AM LEATHER CHEM AS, V92, P225
   Brown EM, 2000, J PROTEIN CHEM, V19, P85, DOI 10.1023/A:1007074314686
   Cabeza LF, 1998, J AM LEATHER CHEM AS, V93, P83
   Ding K, 2006, J AM LEATHER CHEM AS, V101, P362
   Marmer WN, 2005, J AM LEATHER CHEM AS, V100, P427
   TAYLOR MM, 2004, JALCA, V99, P129
NR 13
TC 4
Z9 4
U1 0
U2 11
PU AMER LEATHER CHEMISTS ASSOC
PI LUBBOCK
PA 1314 50 ST, STE 103, LUBBOCK, TX 79412 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD JAN
PY 2013
VL 108
IS 1
BP 23
EP 29
PG 7
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA 063TE
UT WOS:000313023400004
DA 2018-10-19
ER

PT J
AU Fornell, J
   Pellicer, E
   Van Steenberge, N
   Gonzalez, S
   Gebert, A
   Surinach, S
   Baro, MD
   Sort, J
AF Fornell, J.
   Pellicer, E.
   Van Steenberge, N.
   Gonzalez, S.
   Gebert, A.
   Surinach, S.
   Baro, M. D.
   Sort, J.
TI Improved plasticity and corrosion behavior in Ti-Zr-Cu-Pd metallic glass
   with minor additions of Nb: An alloy composition intended for biomedical
   applications
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Biomaterial; Corrosion; Ti-based bulk glassy alloy; Elastic properties;
   Plasticity
ID MECHANICAL-PROPERTIES; MATRIX-COMPOSITES; AMORPHOUS-ALLOYS; FORMING
   ABILITY; DEFORMATION; MEDIA
AB The effects of minor additions of Nb (2, 3 and 4 at%) to the Ti40Zr10Cu38Pd12 alloy are discussed in terms of microstructure, thermal behavior, mechanical properties and corrosion resistance. The addition of Nb promotes the formation of nanocrystals, i.e., from a completely amorphous structure (when no Nb is added) to a mainly crystalline structure (for a 4% of Nb addition). The glassy alloy exhibits large hardness, relatively low Young's modulus and excellent corrosion behavior, although the plasticity is rather limited. A significant increase in compressive plasticity (total strain over 13%) is achieved in the sample with 3% of Nb without compromising the strength. Young's modulus of the as-cast alloy (around 100 GPa, as determined from acoustic measurements) increases only slightly when disperse nanocrystallites are embedded in the amorphous matrix. Improvement of the corrosion performance, with delayed pitting corrosion, is also observed for 3% Nb addition. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Fornell, J.; Pellicer, E.; Gonzalez, S.; Surinach, S.; Baro, M. D.; Sort, J.] Univ Autonoma Barcelona, Dept Fis, Bellaterra 08193, Spain.
   [Van Steenberge, N.] OCAS NV, BE-9060 Zelzate, Belgium.
   [Gebert, A.] IFW Dresden, Inst Metall Mat, D-01171 Dresden, Germany.
   [Sort, J.] Univ Autonoma Barcelona, Inst Catalana Recerca & Estudis Avancats, Bellaterra 08193, Spain.
RP Fornell, J (reprint author), Univ Autonoma Barcelona, Dept Fis, Bellaterra 08193, Spain.
EM Jordinafornell@gmail.com
RI Baro, Maria Dolors/A-2096-2009; Pellicer, Eva/G-2917-2014; BAI,
   JIE/D-7448-2016; Sort, Jordi/F-6582-2014; Surinach, Santiago/A-1749-2009
OI Baro, Maria Dolors/0000-0002-8636-1063; Pellicer,
   Eva/0000-0002-8901-0998; Sort, Jordi/0000-0003-1213-3639; Surinach,
   Santiago/0000-0001-8125-0594; Gonzalez Sanchez,
   Sergio/0000-0002-0211-7822; Gebert, Annett/0000-0003-2748-3850
FU Spanish Ministry of Science and Innovation; ICREA Academia; 
   [2009-SGR-1292];  [MAT2011-27380-C02-01]; 
   [FP7-PEO-PLE-2010-ITN-264635]; ICREA
FX This work has been partially financed by the 2009-SGR-1292 and
   MAT2011-27380-C02-01 research projects and the
   FP7-PEO-PLE-2010-ITN-264635 research training network. We also thank C.
   Deroover and K. Van Brussel for their technical assistance. J. F. and S.
   G. acknowledge the PhD Fellowship and the Juan de la Cierva contract
   from the Spanish Ministry of Science and Innovation, respectively.
   M.D.B. was partially supported by an ICREA Academia award.
CR Anand L, 2005, J MECH PHYS SOLIDS, V53, P1362, DOI 10.1016/j.jmps.2004.12.006
   Choe H, 2005, MAT SCI ENG A-STRUCT, V396, P99, DOI 10.1016/j.msea.2005.01.051
   Davis J. R., CORROSION UNDERSTAND
   Donachie M.J., 2000, TITANIUM TECHNICAL G, P44073
   Egami T, 2006, INTERMETALLICS, V14, P882, DOI 10.1016/j.intermet.2006.01.004
   Fornell J, 2009, INTERMETALLICS, V17, P1090, DOI 10.1016/j.intermet.2009.05.015
   Fornell J, 2009, INT J PLASTICITY, V25, P1540, DOI 10.1016/j.ijplas.2008.11.002
   Gebert A, 2010, CORROS SCI, V52, P1711, DOI 10.1016/j.corsci.2010.01.027
   He G, 2003, NAT MATER, V2, P33, DOI 10.1038/nmat792
   Huang L, 2011, ACTA BIOMATER, V7, P395, DOI 10.1016/j.actbio.2010.08.002
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Jiang WH, 2008, INT J PLASTICITY, V24, P1, DOI 10.1016/j.ijplas.2007.01.015
   Kuhn U, 2006, INTERMETALLICS, V14, P978, DOI 10.1016/j.intermet.2006.01.016
   Kusy M, 2006, INTERMETALLICS, V14, P982, DOI 10.1016/j.intermet.2006.01.017
   LAMPARTER P, 1988, J NON-CRYST SOLIDS, V106, P137, DOI 10.1016/0022-3093(88)90247-5
   LEE HP, 1986, J ELECTROCHEM SOC, V133, P2035, DOI 10.1149/1.2108335
   Oak JJ, 2009, MAT SCI ENG C-BIO S, V29, P322, DOI 10.1016/j.msec.2008.07.009
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Otmacic H, 2003, ELECTROCHIM ACTA, V48, P985, DOI 10.1016/S0013-4686(02)00811-3
   Ott RT, 2003, J NON-CRYST SOLIDS, V317, P158, DOI 10.1016/S0022-3093(02)01996-8
   Park JM, 2010, PHILOS MAG, V90, P2619, DOI 10.1080/14786431003662556
   Qin F., J MECH BEHAV BIOMED
   Qin FX, 2008, INTERMETALLICS, V16, P1026, DOI 10.1016/j.intermet.2008.05.004
   Qin FX, 2007, INTERMETALLICS, V15, P1337, DOI 10.1016/j.intermet.2007.04.005
   Qiu CL, 2005, J BIOMED MATER RES A, V75A, P950, DOI 10.1002/jbm.a.30502
   Raju VR, 2002, MATER LETT, V57, P173, DOI 10.1016/S0167-577X(02)00725-5
   Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052
   Wang WH, 2000, PHYS REV B, V62, P25, DOI 10.1103/PhysRevB.62.25
   WU TW, 1990, PHILOS MAG B, V61, P739, DOI 10.1080/13642819008219307
   Zhang ZF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.045505
   Zhu SL, 2008, INTERMETALLICS, V16, P1031, DOI 10.1016/j.intermet.2008.05.006
   Zhu SL, 2007, MATER TRANS, V48, P163, DOI 10.2320/matertrans.48.163
NR 32
TC 23
Z9 23
U1 4
U2 93
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JAN 1
PY 2013
VL 559
BP 159
EP 164
DI 10.1016/j.msea.2012.08.058
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 058HB
UT WOS:000312623600019
DA 2018-10-19
ER

PT J
AU Baiguera, S
   Ribatti, D
AF Baiguera, Silvia
   Ribatti, Domenico
TI Endothelialization approaches for viable engineered tissues
SO ANGIOGENESIS
LA English
DT Review
DE Angiogenesis; Endothelial cells; Growth factors; Scaffold properties;
   Tissue engineered construct; Vascularization
ID ANGIOGENIC GROWTH-FACTORS; MESENCHYMAL STEM-CELLS; COLONY-STIMULATING
   FACTOR; BLOOD-VESSEL MATURATION; MORPHOGENESIS IN-VITRO; CAPILLARY-LIKE
   NETWORK; HUMAN PERIPHERAL-BLOOD; FLUID SHEAR-STRESS; OF-THE-ART;
   PROGENITOR CELLS
AB One of the main limitation in obtaining thick, 3-dimensional viable engineered constructs is the inability to provide a sufficient and functional blood vessel system essential for the in vitro survival and the in vivo integration of the construct. Different strategies have been proposed to simulate the ingrowth of new blood vessels into engineered tissue, such as the use of growth factors, fabrication scaffold technologies, in vivo prevascularization and cell-based strategies, and it has been demonstrated that endothelial cells play a central role in the neovascularization process and in the control of blood vessel function. In particular, different "environmental" settings (origin, presence of supporting cells, biomaterial surface, presence of hemodynamic forces) strongly influence endothelial cell function, angiogenic potential and the in vivo formation of durable vessels. This review provides an overview of the different techniques developed so far for the vascularization of tissue-engineered constructs (with their advantages and pitfalls), focusing the attention on the recent development in the cell-based vascularization strategy and the in vivo applications.
C1 [Baiguera, Silvia] Univ Hosp Careggi, BIOAIRLab, European Ctr Thorac Surg CERT, I-50134 Florence, Italy.
   [Ribatti, Domenico] Univ Bari, Dept Basic Med Sci, Sect Human Anat & Histol, Sch Med, Bari, Italy.
RP Baiguera, S (reprint author), Univ Hosp Careggi, BIOAIRLab, European Ctr Thorac Surg CERT, Largo Brambilla 3, I-50134 Florence, Italy.
EM sbaiguer@libero.it
FU European Union Seventh Framework Programme [278570]
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no 278570.
CR Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Ando J, 1999, MECH FORCES ENDOTHEL, P111
   Ando J, 2011, ANTIOXID REDOX SIGN, V15, P1389, DOI 10.1089/ars.2010.3361
   Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583
   Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   ANTONOV AS, 1992, THROMB RES, V67, P135, DOI 10.1016/0049-3848(92)90133-U
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318
   Berglund JD, 2003, BRIT J PHARMACOL, V140, P627, DOI 10.1038/sj.bjp.0705457
   Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398
   Black AF, 1998, FASEB J, V12, P1331
   Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332
   Brey EM, 2005, LANCET, V365, P2068, DOI 10.1016/S0140-6736(05)66715-3
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Cassell OCS, 2001, ANN NY ACAD SCI, V944, P429
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chennazhy KP, 2005, BIOMATERIALS, V26, P5658, DOI 10.1016/j.biomaterials.2005.02.024
   Chiquet M, 1996, BIOCHEM CELL BIOL, V74, P737, DOI 10.1139/o96-080
   Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521
   Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Curcio E, 2010, BIOMATERIALS, V31, P5131, DOI 10.1016/j.biomaterials.2010.03.013
   D'Amore P A, 1992, Semin Cancer Biol, V3, P49
   d'Angelo I., 2010, MOL PHARM
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   Darland DC, 2001, CURR TOP DEV BIOL, V52, P107, DOI 10.1016/S0070-2153(01)52010-4
   de Boer R, 2010, J BIOMED MATER RES A, V95A, P1067, DOI 10.1002/jbm.a.32900
   Demirdogen B, 2010, GROWTH FACTORS, V28, P426, DOI 10.3109/08977194.2010.508456
   Ding RB, 2004, STEM CELLS DEV, V13, P509, DOI 10.1089/scd.2004.13.509
   Dye JF, 2004, ENDOTHELIUM-J ENDOTH, V11, P151, DOI 10.1080/10623320490512093
   Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102
   Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004
   Finkenzeller G, 2009, CELL PROLIFERAT, V42, P498, DOI 10.1111/j.1365-2184.2009.00610.x
   Finkenzeller G, 2007, TISSUE ENG, V13, P1413, DOI 10.1089/ten.2006.0369
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Gassman AA, 2011, J TISSUE ENG REGEN M, V5, P375, DOI 10.1002/term.323
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Gibot L, 2010, TISSUE ENG PT A, V16, P3199, DOI 10.1089/ten.TEA.2010.0189
   GRABOWSKI EF, 1995, THROMB HAEMOSTASIS, V74, P123
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Gulino D, 1998, J BIOL CHEM, V273, P29786, DOI 10.1074/jbc.273.45.29786
   Helm CLE, 2007, BIOTECHNOL BIOENG, V96, P167, DOI 10.1002/bit.21185
   Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102
   HEWETT PW, 1993, IN VITRO CELL DEV-AN, V29A, P823
   Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x
   Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hordijk PL, 1999, J CELL SCI, V112, P1915
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5
   Huang NF, 2010, ACTA BIOMATER, V6, P3947, DOI 10.1016/j.actbio.2010.05.020
   Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   HYAKUSOKU H, 1993, BRIT J PLAST SURG, V46, P45, DOI 10.1016/0007-1226(93)90064-I
   Imbert E, 1998, BIOMATERIALS, V19, P2285, DOI 10.1016/S0142-9612(98)00137-9
   Ishizawa K, 2004, BIOCHEM BIOPH RES CO, V324, P276, DOI 10.1016/j.bbrc.2004.09.049
   IVES CL, 1986, IN VITRO CELL DEV B, V22, P500
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Joung IS, 2006, MICROVASC RES, V71, P1, DOI 10.1016/j.mvr.2005.10.005
   Kakisis JD, 2004, ENDOTHELIUM-J ENDOTH, V11, P17, DOI 10.1080/10623320490432452
   Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483
   Karal-Yilmaz O, 2011, J MICROENCAPSUL, V28, P46, DOI 10.3109/02652048.2010.523795
   Kelm JM, 2006, TISSUE ENG, V12, P2541, DOI 10.1089/ten.2006.12.2541
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009
   Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721
   KO C, 1995, ARTIF CELL BLOOD SUB, V23, P143, DOI 10.3109/10731199509117934
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Korbling M, 2006, TRANSFUSION, V46, P1795, DOI 10.1111/j.1537-2995.2006.00985.x
   Kosaki K, 1998, CIRC RES, V82, P794, DOI 10.1161/01.RES.82.7.794
   KUMAR S, 1987, DIFFERENTIATION, V36, P57, DOI 10.1111/j.1432-0436.1987.tb00181.x
   Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5
   Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306
   Layman H, 2012, J BIOMAT SCI-POLYM E, V23, P185, DOI 10.1163/092050610X546417
   le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   Ley CD, 2004, MICROVASC RES, V68, P161, DOI 10.1016/j.mvr.2004.06.002
   Liu H, 2008, ANGIOGENESIS, V11, P223, DOI 10.1007/s10456-008-9102-8
   Liu SY, 2011, TISSUE ENG PT A, V17, P725, DOI [10.1089/ten.tea.2010.0331, 10.1089/ten.TEA.2010.0331]
   Lokmic Z, 2007, FASEB J, V21, P511, DOI 10.1096/fj.06-6614com
   Matsumoto T, 2007, TISSUE ENG, V13, P207, DOI 10.1089/ten.2006.0058
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   MOONEY DJ, 1994, MOL BIOL CELL, V5, P1281
   Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002
   Nguyen LL, 2001, INT REV CYTOL, V204, P1, DOI 10.1016/S0074-7696(01)04002-5
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Ogawa R, 2007, REGEN MED, V2, P831, DOI 10.2217/17460751.2.5.831
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Perez-Castillejos R, 2010, MATER TODAY, V13, P32, DOI 10.1016/S1369-7021(10)70015-8
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Pinney E, 2000, J CELL PHYSIOL, V183, P74, DOI 10.1002/(SICI)1097-4652(200004)183:1<74::AID-JCP9>3.0.CO;2-G
   Poh M, 2005, LANCET, V365, P2122, DOI 10.1016/S0140-6736(05)66735-9
   Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083
   Polykandriotis E, 2007, PLAST RECONSTR SURG, V120, P855, DOI 10.1097/01.prs.0000277664.89467.14
   Prokop A, 2001, Diabetes Technol Ther, V3, P245, DOI 10.1089/152091501300209624
   Raimondi Manuela Teresa, 2006, Curr Drug Discov Technol, V3, P245
   Ribatti D, 2002, J HEMATOTH STEM CELL, V11, P81, DOI 10.1089/152581602753448559
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   Rophael JA, 2007, AM J PATHOL, V171, P2048, DOI 10.2353/ajpath.2007.070066
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   Sahar DE, 2012, J CRANIOFAC SURG, V23, P913, DOI 10.1097/SCS.0b013e31824e5cd8
   Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928
   SAMPATH R, 1995, ANN BIOMED ENG, V23, P247, DOI 10.1007/BF02584426
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Schantz JT, 2007, TISSUE ENG, V13, P2615, DOI 10.1089/ten.2006.0438
   Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   SCHNAPER HW, 1993, PEDIATR NEPHROL, V7, P96, DOI 10.1007/BF00861587
   Schultheiss D, 2005, J UROLOGY, V173, P276, DOI 10.1097/01.ju.0000145882.80339.18
   Schumann P, 2009, MICROVASC RES, V78, P180, DOI 10.1016/j.mvr.2009.06.003
   Shepherd BR, 2006, FASEB J, V20, P1739, DOI 10.1096/fj.05-5682fje
   Shi Q, 1998, BLOOD, V92, P362
   Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002
   SPEISER W, 1987, BLOOD, V69, P964
   Sun G, 2011, BIOMATERIALS, V32, P95, DOI 10.1016/j.biomaterials.2010.08.091
   Sweeney NV, 2005, BIOCHEM BIOPH RES CO, V329, P573, DOI 10.1016/j.bbrc.2005.02.013
   Tanaka Y, 2000, BRIT J PLAST SURG, V53, P51, DOI 10.1054/bjps.1999.3186
   Tavassol F, 2010, TISSUE ENG PT A, V16, P2265, DOI [10.1089/ten.tea.2008.0457, 10.1089/ten.TEA.2008.0457]
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   THOUMINE O, 1995, LAB INVEST, V73, P565
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   UNDERWOOD PA, 1993, EXP CELL RES, V205, P311, DOI 10.1006/excr.1993.1091
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Vacanti JP, 1999, LANCET, V354, pSI32
   Velazquez OC, 2002, FASEB J, V16, P1316, DOI 10.1096/fj.01-1011fje
   Verseijden F, 2012, J TISSUE ENG REGEN M, V6, P169, DOI 10.1002/term.410
   Verseijden F, 2010, CELL TRANSPLANT, V19, P1007, DOI 10.3727/09636890X492571
   Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287
   Westmuckett AD, 2000, ARTERIOSCL THROM VAS, V20, P2474, DOI 10.1161/01.ATV.20.11.2474
   Wisser D, 2003, BURNS, V29, P375, DOI 10.1016/S0305-4179(03)00013-5
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Yang JF, 2007, CARDIOLOGY, V107, P17, DOI 10.1159/000093609
   YOSHIZUMI M, 1989, BIOCHEM BIOPH RES CO, V161, P859, DOI 10.1016/0006-291X(89)92679-X
   Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609
   Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047
   Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081
   Zheng L, 2000, J IMMUNOL, V164, P4665, DOI 10.4049/jimmunol.164.9.4665
   Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 163
TC 54
Z9 54
U1 2
U2 93
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-6970
EI 1573-7209
J9 ANGIOGENESIS
JI Angiogenesis
PD JAN
PY 2013
VL 16
IS 1
BP 1
EP 14
DI 10.1007/s10456-012-9307-8
PG 14
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 058UA
UT WOS:000312658800001
PM 23010872
DA 2018-10-19
ER

PT J
AU Ko, YG
   Co, CC
   Ho, CC
AF Ko, Young-Gwang
   Co, Carlos C.
   Ho, Chia-Chi
TI Directing cell migration in continuous microchannels by topographical
   amplification of natural directional persistence
SO BIOMATERIALS
LA English
DT Article
DE Cell migration; Microchannel; Gelatin; Directional movement
ID MOTILITY; BIOMATERIALS; SUBSTRATUM; HYDROGELS; MOVEMENT; ADHESION;
   DEPEND
AB Discrete micropatterns on biomaterial surfaces can be used to guide the direction of mammalian cell movement by orienting cell morphology. However, guiding cell assembly in three-dimensional scaffolds remains a challenge. Here we demonstrate that the random motions of motile cells can be rectified within continuous microchannels without chemotactic gradients or fluid flow. Our results show that uniform width microchannels with an overhanging zigzag design can induce polarization of NIH3T3 fibroblasts and human umbilical vein endothelial cells by expanding the cell front at each turn. These continuous zigzag microchannels can guide the direction of cell movement even for cells with altered intracellular signals that promote random movement. This approach for directing cell migration within microchannels has important potential implications in the design of scaffolds for tissue engineering. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Ko, Young-Gwang; Co, Carlos C.; Ho, Chia-Chi] Univ Cincinnati, Dept Chem & Mat Engn, Cincinnati, OH 45220 USA.
RP Ho, CC (reprint author), Univ Cincinnati, Dept Chem & Mat Engn, Cincinnati, OH 45220 USA.
EM hocc@ucmail.uc.edu
FU National Institutes of Health [R01EB010043]; National Science Foundation
   [CBET0928219]
FX This research was supported by the National Institutes of Health
   (R01EB010043) and the National Science Foundation (CBET0928219). We
   thank Ross Andrews for synthesizing the cell resistant poly(OEGMA-MA),
   Dr. Girish Kumar for helpful discussions, and Rebecca Moore for
   performing some preliminary studies.
CR Baran ET, 2011, J TISSUE ENG REGEN M, V5, pE108, DOI 10.1002/term.368
   Cicha K, 2011, J APPL PHYS, V110
   Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a
   De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kumar G, 2003, LANGMUIR, V19, P10550, DOI 10.1021/la035309l
   Kumar G, 2007, ADV MATER, V19, P1084, DOI 10.1002/adma.200601629
   Kumar G, 2011, LANGMUIR, V27, P3803, DOI 10.1021/la2000206
   Kushiro K, 2010, ADV MATER, V22, P4516, DOI 10.1002/adma.201001619
   Leclair AM, 2011, BIOMATERIALS, V32, P1351, DOI 10.1016/j.biomaterials.2010.10.051
   Li R, 1999, J BIOL CHEM, V274, P29648, DOI 10.1074/jbc.274.42.29648
   Lin XF, 2008, BIOPHYS J, V95, P3066, DOI 10.1529/biophysj.107.127761
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Mader CC, 2007, SOFT MATTER, V3, P357, DOI 10.1039/b606590b
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306
   Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235
   Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152
   Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849
   Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Wang YC, 2004, FASEB J, V18, P525, DOI 10.1096/fj.03-0490fje
   Ware MF, 1998, J CELL SCI, V111, P2423
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 28
TC 16
Z9 16
U1 1
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 2
BP 353
EP 360
DI 10.1016/j.biomaterials.2012.09.071
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056UD
UT WOS:000312516000004
PM 23099064
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Marsano, A
   Maidhof, R
   Luo, JW
   Fujikara, K
   Konofagou, EE
   Banfi, A
   Vunjak-Novakovic, G
AF Marsano, Anna
   Maidhof, Robert
   Luo, Jianwen
   Fujikara, Kana
   Konofagou, Efisa E.
   Banfi, Andrea
   Vunjak-Novakovic, Gordana
TI The effect of controlled expression of VEGF by transduced myoblasts in a
   cardiac patch on vascularization in a mouse model of myocardial
   infarction
SO BIOMATERIALS
LA English
DT Article
DE Cardiac tissue engineering; Elastomer; Bioreactor; Cardiac ischemia;
   Angiogenesis; VEGF
ID ENDOTHELIAL GROWTH-FACTOR; GENE-THERAPY; STEM-CELLS; IN-VIVO;
   HEART-MUSCLE; TISSUE; ANGIOGENESIS; TRANSPLANTATION; SCAFFOLDS; DELIVERY
AB Key requirements for cardiac tissue engineering include the maintenance of cell viability and function and the establishment of a perfusable vascular network in millimeters thick and compact cardiac constructs upon implantation. We investigated if these requirements can be met by providing an intrinsic vascularization stimulus (via sustained action of VEGF secreted at a controlled rate by transduced myoblasts) to a cardiac patch engineered under conditions of effective oxygen supply (via medium flow through channeled elastomeric scaffolds seeded with neonatal cardiomyocytes). We demonstrate that this combined approach resulted in increased viability, vascularization and functionality of the cardiac patch. After implantation in a mouse model of myocardial infarction, VEGF-expressing patches displayed significantly improved engraftment, survival and differentiation of cardiomyocytes, leading to greatly enhanced contractility as compared to controls not expressing VEGF. Controlled VEGF expression also mediated the formation of mature vascular networks, both within the engineered patches and in the underlying ischemic myocardium. We propose that this combined cell-biomaterial approach can be a promising strategy to engineer cardiac patches with intrinsic and extrinsic vascularization potential. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Marsano, Anna; Maidhof, Robert; Luo, Jianwen; Fujikara, Kana; Konofagou, Efisa E.; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.
   [Marsano, Anna; Banfi, Andrea] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Marsano, Anna; Banfi, Andrea] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Biomed Engn, 622 W 168th St,VC12-234, New York, NY 10032 USA.
EM abanfi@uhbs.ch; gv2131@columbia.edu
RI Banfi, Andrea/B-8720-2008; Luo, Jianwen/D-5612-2011; vunjak-novakovic,
   gordana/J-9279-2012
OI Banfi, Andrea/0000-0001-5737-8811; Luo, Jianwen/0000-0001-9215-5568;
   Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIH [HL088913, HL076485, EB002520]; Swiss National Science Foundation
   [310030-127426]
FX The authors gratefully acknowledge funding of this research provided by
   NIH (HL088913, HL076485, and EB002520 to GVN) and the Swiss National
   Science Foundation (310030-127426 to AB), and for the technical
   assistance of T. Martens, G. Eng, and J. Shin in performing the
   experiments.
CR Banfi A, 2002, METHOD ENZYMOL, V346, P145
   Banfi A.vonDG, 2012, FASEB J
   Banfi Andrea, 2005, Curr Atheroscler Rep, V7, P227, DOI 10.1007/s11883-005-0011-7
   Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chiu LLY, 2010, MACROMOL BIOSCI, V10, P1286, DOI 10.1002/mabi.201000202
   Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Helmrich U, 2012, TISSUE ENG PART C-ME, V18, P283, DOI [10.1089/ten.tec.2011.0413, 10.1089/ten.TEC.2011.0413]
   Houtgraaf JH, 2012, J AM COLL CARDIOL, V59, P539, DOI 10.1016/j.jacc.2011.09.065
   Kondoh H, 2006, CARDIOVASC RES, V69, P466, DOI 10.1016/j.cardiores.2005.11.005
   Kreutziger KL, 2011, TISSUE ENG PT A, V17, P1219, DOI [10.1089/ten.tea.2010.0557, 10.1089/ten.TEA.2010.0557]
   Lee EJ, 2009, CELL TRANSPLANT, V18, P731, DOI 10.3727/096368909X470919
   Lee RJ, 2000, CIRCULATION, V102, P898
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Luo JW, 2008, IEEE T ULTRASON FERR, V55, P240, DOI 10.1109/TUFFC.2008.633
   Luo JW, 2007, ULTRASOUND MED BIOL, V33, P1206, DOI 10.1016/j.ultrasmedbio.2007.01.019
   Luo JW, 2010, IEEE T ULTRASON FERR, V57, P1347, DOI 10.1109/TUFFC.2010.1554
   Luo JW, 2004, IEEE T ULTRASON FERR, V51, P1119, DOI 10.1109/TUFFC.2004.1334844
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Maidhof R, 2010, BIOTECHNOL PROGR, V26, P565, DOI 10.1002/btpr.337
   Marsano A, 2010, BIOTECHNOL PROGR, V26, P1382, DOI 10.1002/btpr.435
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Menasche P, 2008, J CARDIOVASC TRANSL, V1, P201, DOI 10.1007/s12265-008-9017-1
   Misteli H, 2010, STEM CELLS, V28, P611, DOI 10.1002/stem.291
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392
   Perin EC, 2010, CIRCULATION, V122
   Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Sanchez PL, 2010, EUR HEART J, V31, P394, DOI 10.1093/eurheartj/ehp403
   Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9
   Springer ML, 1997, SOMAT CELL MOLEC GEN, V23, P203, DOI 10.1007/BF02721371
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182
   von Degenfeld G, 2006, FASEB J, V20, P2657, DOI 10.1096/fj.06-6568fje
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Vunjak-Novakovic G, 2011, CELL STEM CELL, V8, P252, DOI 10.1016/j.stem.2011.02.014
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wolff T, 2012, J CELL MOL MED, V16, P107, DOI 10.1111/j.1582-4934.2011.01308.x
   Zhang CW, 2011, ANN THORAC SURG, V92, P1435, DOI 10.1016/j.athoracsur.2011.05.054
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5
NR 56
TC 37
Z9 40
U1 6
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 2
BP 393
EP 401
DI 10.1016/j.biomaterials.2012.09.038
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056UD
UT WOS:000312516000008
PM 23083931
OA Green Accepted
DA 2018-10-19
ER

PT J
AU An, B
   DesRochers, TM
   Qin, GK
   Xia, XX
   Thiagarajan, G
   Brodsky, B
   Kaplan, DL
AF An, Bo
   DesRochers, Teresa M.
   Qin, Guokui
   Xia, Xiaoxia
   Thiagarajan, Geetha
   Brodsky, Barbara
   Kaplan, David L.
TI The influence of specific binding of collagen-silk chimeras to silk
   biomaterials on hMSC behavior
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Silk; Stem cells; Chimera
ID TRIPLE-HELIX; I COLLAGEN; OSTEOGENIC-DIFFERENTIATION; NANOFIBROUS
   SCAFFOLDS; STREPTOCOCCAL SCL1; SELF-ASSOCIATION; FIBROIN FILMS; DRAGLINE
   SILK; SPIDER SILK; PROTEIN
AB Collagen-like proteins in the bacteria Streptococcus pyogenes adopt a triple-helix structure with a thermal stability similar to that of animal collagens, can be expressed in high yield in Escherichia coli and can be easily modified through molecular biology techniques. However, potential applications for such recombinant collagens are limited by their lack of higher order structure to achieve the physical properties needed for most biomaterials. To overcome this problem, the S. pyogenes collagen domain was fused to a repetitive Bombyx mori silk consensus sequence, as a strategy to direct specific non-covalent binding onto solid silk materials whose superior stability, mechanical and material properties have been previously established. This approach resulted in the successful binding of these new collagen silk chimeric proteins to silk films and porous scaffolds, and the binding affinity could be controlled by varying the number of repeats in the silk sequence. To explore the potential of collagen silk chimera for regulating biological activity, integrin (Int) and fibronectin (Fn) binding sequences from mammalian collagens were introduced into the bacterial collagen domain. The attachment of bioactive collagen silk chimeras to solid silk biomaterials promoted hMSC spreading and proliferation substantially in comparison to the controls. The ability to combine the biomaterial features of silk with the biological activities of collagen allowed more rapid cell interactions with silk-based biomaterials, improved regulation of stem cell growth and differentiation, as well as the formation of artificial extracellular matrices useful for tissue engineering applications. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [An, Bo; DesRochers, Teresa M.; Qin, Guokui; Xia, Xiaoxia; Thiagarajan, Geetha; Brodsky, Barbara; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Brodsky, B (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM Barbara.Brodsky@tufts.edu; David.Kaplan@tufts.edu
RI Qin, Guokui/B-1520-2012; Xia, Xiaoxia/C-6614-2013; An, Bo/N-3466-2014
OI Qin, Guokui/0000-0002-2212-1597; Xia, Xiaoxia/0000-0001-8375-1616; An,
   Bo/0000-0002-1031-3380
FU NIH [EB011620]
FX This work is supported by NIH (grant# EB011620 to BB and DK). The
   authors would like to thank Dr. Randolph Lewis from Utah State
   University for the spider silk proteins used in this study, and Dr.
   David Wilbur and the Tufts Chemistry Department for allowing us to use
   the MALDI-TOF MS equipment. Any opinions, findings, and conclusions or
   recommendations expressed in this publication are those of the author(s)
   and do not necessarily reflect the views of the NIH.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Canabady-Rochelle LLS, 2012, BIOMACROMOLECULES, V13, P683, DOI 10.1021/bm201555c
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Cho SY, 2011, J NANOSCI NANOTECHNO, V11, P801, DOI 10.1166/jnn.2011.3181
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Ding S, 2012, BIOMACROMOLECULES, V13, P1035, DOI 10.1021/bm2017367
   Drummy LF, 2005, BIOMACROMOLECULES, V6, P3328, DOI 10.1021/bm0503524
   Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106
   Fallas JA, 2010, CHEM SOC REV, V39, P3510, DOI 10.1039/b919455j
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Fraser R., 1973, CONFORMATION FIBROUS
   FRW Lisman T, 2008, BIOCH SOC T, V36, P241
   Gomes SC, 2011, BIOMATERIALS, V32, P4255, DOI 10.1016/j.biomaterials.2011.02.040
   Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Krishna OD, 2011, BIOMATERIALS, V32, P6412, DOI 10.1016/j.biomaterials.2011.05.034
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Li Y, 2011, BIOPOLYMERS, V95, P94, DOI 10.1002/bip.21536
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Myllyharju J., 2009, METHODS MOL BIOL, V522
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nomura Y, 2011, BIOTECHNOL LETT, V33, P1067
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/nchem.1123, 10.1038/NCHEM.1123]
   Pakkanen O, 2006, J BIOTECHNOL, V123, P248, DOI 10.1016/j.jbiotec.2005.11.012
   Papanikolopoulou K, 2005, J BIOL CHEM, V280, P2481, DOI 10.1074/jbc.M406282200
   Peng YY, 2010, BIOMATERIALS, V31, P2755, DOI 10.1016/j.biomaterials.2009.12.040
   Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704
   Pinkas DM, 2011, ACS CHEM BIOL, V6, P320, DOI 10.1021/cb100298r
   Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2011, MACROMOL BIOSCI, V11, P100, DOI 10.1002/mabi.201000173
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
   Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979
   Yu ZX, 2011, J BIOL CHEM, V286, P18960, DOI 10.1074/jbc.M110.217422
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 63
TC 36
Z9 37
U1 2
U2 94
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 2
BP 402
EP 412
DI 10.1016/j.biomaterials.2012.09.085
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056UD
UT WOS:000312516000009
PM 23088839
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lee, SS
   Huang, BJ
   Kaltz, SR
   Sur, S
   Newcomb, CJ
   Stock, SR
   Shah, RN
   Stupp, SI
AF Lee, Sungsoo S.
   Huang, Brian J.
   Kaltz, Stuart R.
   Sur, Shantanu
   Newcomb, Christina J.
   Stock, Stuart R.
   Shah, Ramille N.
   Stupp, Samuel I.
TI Bone regeneration with low dose BMP-2 amplified by biomimetic
   supramolecular nanofibers within collagen scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Peptide amphiphile; Heparin; Heparan sulfate; BMP-2 (bone morphogenetic
   protein-2); Regenerative medicine; Bone regeneration
ID PEPTIDE-AMPHIPHILE NANOFIBERS; MORPHOGENETIC PROTEIN; GROWTH-FACTOR;
   INFLAMMATORY RESPONSE; ORTHOPEDIC TRAUMA; TIBIAL FRACTURES;
   DRUG-RELEASE; DELIVERY; HEPARIN; REPAIR
AB Bone morphogenetic protein-2 (BMP-2) is a potent osteoinductive cytokine that plays a critical role during bone regeneration and repair. In the extracellular environment, sulfated polysaccharides anchored covalently to glycoproteins such as syndecan and also non-covalently to fibronectin fibers have been shown to bind BMP-2 through a heparin-binding domain and regulate its bioactivity. We report here on a synthetic biomimetic strategy that emulates biological BMP-2 signaling through the use of peptide amphiphile nanofibers designed to bind heparin. The supramolecular nanofibers, which integrate the biological role of syndecan and fibronectin, were allowed to form gel networks within the pores of an absorbable collagen scaffold by simply infiltrating dilute solutions of the peptide amphiphile, heparan sulfate, and BMP-2. The hybrid biomaterial enhanced significantly bone regeneration in a rat critical-size femoral defect model using BMP-2 amounts that are one order of magnitude lower than required for healing in this animal model. Using micro-computed tomography, we also showed that the hybrid scaffold was more effective at bridging within the gap relative to a conventional scaffold of the type used clinically based on collagen and BMP-2. Histological evaluation also revealed the presence of more mature bone in the new ossified tissue when the low dose of BMP-2 was delivered using the biomimetic supramolecular system. These results demonstrate how molecularly designed materials that mimic features of the extracellular environment can amplify the regenerative capacity of growth factors. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Sur, Shantanu; Shah, Ramille N.; Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
   [Lee, Sungsoo S.; Kaltz, Stuart R.; Newcomb, Christina J.; Shah, Ramille N.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Huang, Brian J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Stock, Stuart R.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.
   [Shah, Ramille N.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.
RP Stupp, SI (reprint author), Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
EM s-stupp@northwestern.edu
RI Stupp, Samuel/B-6737-2009; Shah, Ramille/E-3737-2010
OI Sur, Shantanu/0000-0001-6371-5466
FU NIH/NIDCR [2R01DE015920-06]; DARPA [W911NF-09-1-0044]; Samsung
   Scholarship
FX This work was supported by NIH/NIDCR grant 2R01DE015920-06 and DARPA
   grant W911NF-09-1-0044. Sungsoo Lee acknowledges fellowship support from
   the Samsung Scholarship. Experiments made use of the following
   facilities at Northwestern University: EPIC of the NUANCE Center, Center
   for Comparative Medicine, Pathology Core Facility, Mouse Histology &
   Phenotyping Laboratory, Cell Imaging Facility, and the Peptide Synthesis
   Core and Equipment Core at the Institute for BioNanotechnology in
   Medicine. The authors thank Mark Seniw for molecular graphics, Dr.
   Melina Kibbe for help with tissue embedding, and Dr. Malcolm Snead, Dr.
   Liam Palmer, Dr. Wellington Hsu, Dr. Erin Hsu, and Dr. Matthew Webber
   for useful discussions.
CR Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Aro HT, 2011, J BONE JOINT SURG AM, V93A, P801, DOI 10.2106/JBJS.I.01763
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Benoit DSW, 2007, ADV FUNCT MATER, V17, P2085, DOI 10.1002/adfm.200700012
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Crouzier T, 2010, SMALL, V6, P651, DOI 10.1002/smll.200901728
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1825, DOI 10.1007/s10529-009-0100-8
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hsu WK, 2008, SPINE J, V8, P419, DOI 10.1016/j.spinee.2008.01.008
   Huang Z, 2010, BIOMATERIALS, V31, P9202, DOI 10.1016/j.biomaterials.2010.08.013
   Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381
   Jongpoiboonkit L, 2009, ADV MATER, V21, P1960, DOI 10.1002/adma.200801808
   Julka A, 2012, J SHOULDER ELB SURG, V21, pE12, DOI 10.1016/j.jse.2011.06.006
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010
   Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MacDonald KM, 2010, J PEDIATR ORTHOPED, V30, P199, DOI 10.1097/BPO.0b013e3181cec35b
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Mata A, 2010, BIOMATERIALS, V31, P6004, DOI 10.1016/j.biomaterials.2010.04.013
   Matson JB, 2012, SOFT MATTER, V8, P3586, DOI 10.1039/c2sm07420f
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Matson JB, 2011, CHEM COMMUN, V47, P7962, DOI 10.1039/c1cc12570b
   McCarthy I, 2006, J BONE JOINT SURG AM, V88A, P4, DOI 10.2106/JBJS.F.00890
   Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   MULLERMAI CM, 1995, J BIOMED MATER RES, V29, P9, DOI 10.1002/jbm.820290103
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Rajangam K, 2008, BIOMATERIALS, V29, P3298, DOI 10.1016/j.biomaterials.2008.04.008
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stendahl JC, 2006, ADV FUNCT MATER, V16, P499, DOI 10.1002/adfm.200500161
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   STUPP SI, 1992, J BIOMED MATER RES, V26, P169, DOI 10.1002/jbm.820260204
   Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200
   Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   Xu X, 2011, ACTA BIOMATER, V7, P3050, DOI 10.1016/j.actbio.2011.04.018
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200
NR 63
TC 123
Z9 129
U1 7
U2 197
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2013
VL 34
IS 2
BP 452
EP 459
DI 10.1016/j.biomaterials.2012.10.005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056UD
UT WOS:000312516000014
PM 23099062
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Reitinger, S
   Lepperdinger, G
AF Reitinger, Stephan
   Lepperdinger, Guenter
TI Hyaluronan, a Ready Choice to Fuel Regeneration: A Mini-Review
SO GERONTOLOGY
LA English
DT Review
DE Extracellular matrix; Regeneration; Wound healing; Mesenchymal stem
   cells; Biomaterial
ID POSTSURGICAL ADHESION; DOWN-REGULATION; ACID HYDROGELS; STEM-CELLS;
   REPAIR; ACTIVATION; CARTILAGE; SYSTEM; FILM
AB Background: Hyaluronan (HA) is present in extracellular spaces and interstitia of many tissue types. As it is capable of binding high amounts of water, HA provides ideal conditions for cell migration and proliferation. Under conditions of cellular crowding, it also permits lineage-specific differentiation and thus promotes many aspects of healing and tissue remodeling. Methods: The simplicity of its structure makes it amenable to chemical modifications and/or combined formulations with other bioactive substances. Thus a wide variety of clinical applications have been proposed, several of which are currently being implemented in advanced therapies. Results: Known features of HA biology, in particular regarding synthesis and processes related to signaling and control, have been adopted to elaborate specific products in order to support progress in regenerative medicine. Purified HA, HA-based hydrogels or special HA composites have been formulated together with other well-characterized biomaterials and bioactive factors. HA is currently employed in a variety of therapeutic applications both in its pure form and in a biofunctionalized form. Conclusions: HA plays an essential role in regenerative processes. Owing to the growing scientific knowledge in this field, medicinal products based on HA have been devised and are being routinely applied in ophthalmology or in trauma and transplantation surgery. Further areas of application are contemplated, such as the use of HA composite scaffold material in tissue engineering, or refined HA hydrogels enabling controlled release of medication. Copyright (c) 2012 S. Karger AG, Basel
C1 [Reitinger, Stephan; Lepperdinger, Guenter] Austrian Acad Sci, Inst Biomed Aging Res, AT-6020 Innsbruck, Austria.
RP Lepperdinger, G (reprint author), Austrian Acad Sci, Inst Biomed Aging Res, Rennweg 10, AT-6020 Innsbruck, Austria.
EM guenter.lepperdinger@oeaw.ac.at
CR Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004
   Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Itakura H, 2009, OPHTHALMOLOGICA, V223, P32, DOI 10.1159/000165682
   Jha AK, 2009, BIOMATERIALS, V30, P6964, DOI 10.1016/j.biomaterials.2009.09.009
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Johnsson C, 2006, J HEART LUNG TRANSPL, V25, P544, DOI 10.1016/j.healun.2005.06.029
   Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200
   Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002
   Labat-Robert J, 2012, MED LONGEVITE, V4, P3
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   Matsumoto Y, 2010, J BIOMAT SCI-POLYM E, V21, P715, DOI 10.1163/156856209X435844
   Park JS, 2011, J SURG RES, V168, P49, DOI 10.1016/j.jss.2009.09.025
   Park WS, 2010, ASIAN J SURG, V33, P25, DOI 10.1016/S1015-9584(10)60005-X
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Rajapaksa S, 2005, AM J RHINOL, V19, P251, DOI 10.1177/194589240501900307
   Seidlits SK, 2011, ACTA BIOMATER, V7, P2401, DOI 10.1016/j.actbio.2011.03.024
   Shirali AC, 2008, CURR OPIN ORGAN TRAN, V13, P20, DOI 10.1097/MOT.0b013e3282f3df04
   Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017
   Su WY, 2011, J BIOMAT SCI-POLYM E, V22, P1777, DOI 10.1163/092050610X522729
   Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Tsai SW, 2005, J INT MED RES, V33, P68, DOI 10.1177/147323000503300106
   Turley EA, 2012, FRONT BIOSCI-LANDMRK, V17, P1775, DOI 10.2741/4018
   Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141
   Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656
   Voigt J, 2012, WOUND REPAIR REGEN, V20, P317, DOI 10.1111/j.1524-475X.2012.00777.x
   Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200
   Xie Y, 2011, J CONTROL RELEASE, V153, P225, DOI 10.1016/j.jconrel.2011.03.021
   Zhao J, 2008, MACROMOL BIOSCI, V8, P836, DOI 10.1002/mabi.200700334
NR 39
TC 22
Z9 23
U1 5
U2 50
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PY 2013
VL 59
IS 1
BP 71
EP 76
DI 10.1159/000342200
PG 6
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 057UN
UT WOS:000312589600010
PM 23006468
DA 2018-10-19
ER

PT J
AU Jiang, B
   Waller, TM
   Larson, JC
   Appel, AA
   Brey, EM
AF Jiang, Bin
   Waller, Thomas M.
   Larson, Jeffery C.
   Appel, Alyssa A.
   Brey, Eric M.
TI Fibrin-Loaded Porous Poly(Ethylene Glycol) Hydrogels as Scaffold
   Materials for Vascularized Tissue Formation
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MECHANICAL-PROPERTIES; MOLECULAR-MECHANISMS; PEG HYDROGELS;
   GROWTH-FACTOR; IN-VITRO; NEOVASCULARIZATION; RELEASE; GELS
AB Vascular network formation within biomaterial scaffolds is essential for the generation of properly functioning engineered tissues. In this study, a method is described for generating composite hydrogels in which porous poly(ethylene glycol) (PEG) hydrogels serve as scaffolds for mechanical and structural support, and fibrin is loaded within the pores to induce vascularized tissue formation. Porous PEG hydrogels were generated by a salt leaching technique with 100-150-mu m pore size and thrombin (Tb) preloaded within the scaffold. Fibrinogen (Fg) was loaded into pores with varying concentrations and polymerized into fibrin due to the presence of Tb, with loading efficiencies ranging from 79.9% to 82.4%. Fibrin was distributed throughout the entire porous hydrogels, lasted for greater than 20 days, and increased hydrogel mechanical stiffness. A rodent subcutaneous implant model was used to evaluate the influence of fibrin loading on in vivo response. At weeks 1, 2, and 3, all hydrogels had significant tissue invasion, but no difference in the depth of invasion was found with the Fg concentration. Hydrogels with fibrin loading induced more vascularization, with a significantly higher vascular density at 20mg/mL (week 1) and 40mg/mL (weeks 2 and 3) Fg concentration compared to hydrogels without fibrin. In conclusion, we have developed a composite hydrogel that supports rapid vascularized tissue ingrowth, and thus holds great potential for tissue engineering applications.
C1 [Jiang, Bin; Waller, Thomas M.; Larson, Jeffery C.; Appel, Alyssa A.; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Jiang, Bin; Waller, Thomas M.; Larson, Jeffery C.; Appel, Alyssa A.; Brey, Eric M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA.
RP Brey, EM (reprint author), IIT, Dept Biomed Engn, 3255 S Dearborn St,Wishnick Hall,Room 314, Chicago, IL 60616 USA.
EM brey@iit.edu
RI Jiang, Bin/Q-4150-2017
OI Jiang, Bin/0000-0003-2390-4312
FU Veterans Administration and National Science Foundation [IIS-1125412]
FX The authors would like to acknowledge Dr. David C. Venerus (Department
   of Chemical and Biological Engineering, Illinois Institute of
   Technology) for assistance with the compression testing. We thank Dr.
   William Wolf for providing guidance in perfusion fixation technique. We
   would also like to thank Yinghui-Lee for assistance in thrombin activity
   assay and Dr. Sanja Turturro for help in isolectin injection. This work
   was supported by grants from the Veterans Administration and National
   Science Foundation (IIS-1125412).
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Brey EA, 2004, ANN BIOMED ENG, V32, P1100, DOI 10.1114/B:ABME.0000036646.17362.c4
   Brey EM, 2005, TISSUE ENG, V11, P567, DOI 10.1089/ten.2005.11.567
   Cheng MH, 2009, PLAST RECONSTR SURG, V124, P787, DOI 10.1097/PRS.0b013e3181b17a91
   Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   Coughlin SR, 1998, ARTERIOSCL THROM VAS, V18, P514, DOI 10.1161/01.ATV.18.4.514
   Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229
   Drinnan CT, 2010, J CONTROL RELEASE, V147, P180, DOI 10.1016/j.jconrel.2010.03.026
   Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jiang B, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P477
   Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883
   Kretlow JD, 2010, TISSUE ENG PT A, V16, P3555, DOI 10.1089/ten.TEA.2010.0471
   Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003
   Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389
   Mason MN, 2010, J BIOMED MATER RES A, V95A, P283, DOI 10.1002/jbm.a.32825
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
   Zhao HG, 2009, J MATER SCI-MATER M, V20, P135, DOI 10.1007/s10856-008-3543-x
NR 30
TC 30
Z9 30
U1 1
U2 45
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2013
VL 19
IS 1-2
BP 224
EP 234
DI 10.1089/ten.tea.2012.0120
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 057XS
UT WOS:000312598400022
PM 23003671
OA Green Published
DA 2018-10-19
ER

PT J
AU Lawrence, B
   Alagumanikumaran, N
   Prithivikumaran, N
   Jeyakumaran, N
   Ramadas, V
   Natarajan, B
AF Lawrence, B.
   Alagumanikumaran, N.
   Prithivikumaran, N.
   Jeyakumaran, N.
   Ramadas, V.
   Natarajan, B.
TI Effect of surface modification on the porous silicon infiltrated with
   biomolecules
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Nanostructured porous silicon; Chicken blood plasma; Chicken blood
   serum; Biofunctionalized porous silicon surface; Biosensor
ID FABRICATION; BIOSENSOR
AB Nanostructured porous silicon was prepared by electrochemical etching method. The porous silicon has advantages over planar platforms in biosensor development due to its increased surface area. The high surface area in the porous silicon biosensors will allow for higher biosensor sensitivity while using as a smaller device. The porous silicon optical sensing device works on the basis of changes in its physical properties especially photoluminescence or reflectance, on exposure to the surrounding environment. In the present investigation, porous silicon was bio-functionalized through the deposition of functional groups on its surface by adsorption of chicken blood plasma and serum. SEM, FTIR and photoluminescence studies were carried out for bio-functionalized porous silicon surfaces to study the possibility for utilizing porous silicon as a biomaterial for biosensor applications instead of utilizing porous silicon as a biosensor and biomaterial. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Natarajan, B.] RD Govt Arts Coll, Res Dept Phys, Sivagangai 630561, India.
   [Ramadas, V.] RD Govt Arts Coll, Dept Zool Res, Sivagangai 630561, India.
   [Alagumanikumaran, N.] VHNSN Coll, Dept Zool Res, Virudunagar 626001, India.
   [Lawrence, B.; Prithivikumaran, N.; Jeyakumaran, N.] VHNSN Coll, Res Dept Phys, Virudunagar 626001, India.
RP Natarajan, B (reprint author), RD Govt Arts Coll, Res Dept Phys, Sivagangai 630561, India.
EM b_natraj_b@rediffmail.com
FU UGC, New Delhi, India [39-463/2010 (SR)]
FX The authors also express their sincere thanks to the UGC (Major Research
   Project-[F.No.39-463/2010 (SR)], New Delhi, India.
CR Bonanno LM, 2007, BIOSENS BIOELECTRON, V23, P444, DOI 10.1016/j.bios.2007.05.008
   Canham L., 1997, PROPERTIES POROUS SI
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Han HM, 2011, THIN SOLID FILMS, V519, P3325, DOI 10.1016/j.tsf.2010.12.015
   Hart BR, 2003, CHEM COMMUN, P322, DOI 10.1039/b209453c
   Hiraoui M, 2011, MATER CHEM PHYS, V128, P151, DOI 10.1016/j.matchemphys.2011.02.052
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   LEHMANN V, 1991, APPL PHYS LETT, V58, P856, DOI 10.1063/1.104512
   Massad-Ivanir N, 2011, ANAL CHEM, V83, P3282, DOI 10.1021/ac200407w
   Meskini O, 2007, TALANTA, V71, P1430, DOI 10.1016/j.talanta.2006.05.089
   Palma R. J. M., 2009, SENSORS, V9, P5149
   Rossi AM, 2007, BIOSENS BIOELECTRON, V23, P741, DOI 10.1016/j.bios.2007.06.004
   Salcedo W. J., 1997, Brazilian Journal of Physics, V27A, P158
   Salman KA, 2012, INT J ELECTROCHEM SC, V7, P376
   Sook P.J., 2006, J MICROBIOL BIOTECHN, V16, P1968
   Stefano L D, 2006, J OPT A-PURE APPL OP, V8, P540
   Stefano L.D., 2004, APPL OPTICS, V43, P167
   Stefano L.D., 2006, BIOSENS BIOELECTRON, V21, P1664
   Theiss W, 1996, THIN SOLID FILMS, V276, P7, DOI 10.1016/0040-6090(95)08036-8
   Tsargorodskaya A, 2004, NANOTECHNOLOGY, V15, P703, DOI 10.1088/0957-4484/15/5/051
   Xue T, 2008, OPTOELECTRON LETT, V4, P328, DOI 10.1007/s11801-008-8037-z
   Yin HB, 2004, MICROELECTRON ENG, V73-4, P830, DOI 10.1016/j.mee.2004.03.060
   ZHANG XG, 1991, J ELECTROCHEM SOC, V138, P3750, DOI 10.1149/1.2085494
NR 24
TC 8
Z9 8
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 1
PY 2013
VL 264
BP 767
EP 771
DI 10.1016/j.apsusc.2012.10.118
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 049SX
UT WOS:000312004800119
DA 2018-10-19
ER

PT J
AU Noriega, S
   Hasanova, G
   Subramanian, A
AF Noriega, Sandra
   Hasanova, Gulnara
   Subramanian, Anuradha
TI The Effect of Ultrasound Stimulation on the Cytoskeletal Organization of
   Chondrocytes Seeded in Three-Dimensional Matrices
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Actin cytoskeleton; Biomaterial; Cartilage, articular; Cartilage
   research; Cell-cell and cell-matrix interactions; Cytoskeleton;
   Cytoskeleton interaction; Tissue engineering, cartilage and bone
ID LOW-INTENSITY ULTRASOUND; INTERMITTENT PHYSIOLOGICAL PRESSURE;
   GENE-EXPRESSION; ARTICULAR CHONDROCYTES; INTERMEDIATE-FILAMENTS;
   REGENERATING CARTILAGE; HYDROSTATIC-PRESSURE; SELF-ORGANIZATION; ACTIN;
   PROLIFERATION
AB The impact of low-intensity diffuse ultrasound (LIDUS) stimulation on the cytoskeletal organization of chondrocytes seeded in three-dimensional (3D) scaffolds was evaluated. Chondrocytes seeded on 3D chitosan matrices were exposed to LIDUS at 5.0 MHz (approx. 15 kPa, 51 s, 4 applications/day) in order to study the organization of actin, tubulin and vimentin. The results showed that actin presented a punctate cytosolic distribution and tubulin presented a quasiparallel organization of microtubules, whereas vimentin distribution was unaffected. Chondrocytes seeded on 3D scaffolds responded to US stimulation by the disruption of actin stress fibers and were sensitive to the presence of Rho-activated kinase (ROCK) inhibitor (Y27632). The gene expression of ROCK-I, a key element in the formation of stress fibers and mDia1, was significantly upregulated under the application of US. We conclude that the results of both the cytoskeletal analyses and gene expression support the argument that the presence of punctate actin upon US stimulation was accompanied by the upregulation of the RhoA/ROCK pathway. Copyright (C) 2012 S. Karger AG, Basel
C1 [Noriega, Sandra; Hasanova, Gulnara; Subramanian, Anuradha] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68516 USA.
RP Subramanian, A (reprint author), Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68516 USA.
EM asubramanian2@unl.edu
FU UNL-Tobacco Settlement Funds; NIH [R21EB006046]; Department of Health
   and Human Services [1R21RR024437-01A1]
FX We are especially thankful to Ms. Terry Fangman and the microscopy
   facility at the University of Nebraska, Lincoln, for their help with the
   confocal microscopy, image acquisition and processing. This research
   work was partially supported by UNL-Tobacco Settlement Funds, NIH grant
   R21EB006046, and in part by the American Recovery and Reinvestment Act
   of 2009 research grant 1R21RR024437-01A1 from the Department of Health
   and Human Services.
CR BENJAMIN M, 1994, MICROSC RES TECHNIQ, V28, P372, DOI 10.1002/jemt.1070280503
   Blain EJ, 2009, INT J EXP PATHOL, V90, P1, DOI 10.1111/j.1365-2613.2008.00625.x
   Campbell JJ, 2007, BIOCHEM BIOPH RES CO, V361, P329, DOI 10.1016/j.bbrc.2007.06.185
   Carver SE, 1999, BIOTECHNOL BIOENG, V62, P166, DOI 10.1002/(SICI)1097-0290(19990120)62:2<166::AID-BIT6>3.3.CO;2-B
   Carver SE, 1999, TISSUE ENG, V5, P1, DOI 10.1089/ten.1999.5.1
   Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168
   Durrant LA, 1999, J ANAT, V194, P343, DOI 10.1046/j.1469-7580.1999.19430343.x
   Fioravanti A, 2005, CLIN EXP RHEUMATOL, V23, P847
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003
   Hasanova G., 2007, EUR CELLS MATER, V14, P108
   Hasanova GI, 2011, J TISSUE ENG REGEN M, V5, P815, DOI 10.1002/term.384
   Haudenschild DR, 2008, BIORHEOLOGY, V45, P219, DOI 10.3233/BIR-2008-0499
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Idowu BD, 2000, HISTOCHEM J, V32, P165, DOI 10.1023/A:1004095207330
   Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147
   Knight MM, 2006, J BIOMECH, V39, P1547, DOI 10.1016/j.jbiomech.2005.04.006
   Langelier E, 2000, J HISTOCHEM CYTOCHEM, V48, P1307, DOI 10.1177/002215540004801002
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Mobasheri A, 2002, CELL BIOL INT, V26, P1, DOI 10.1006/cbir.2001.0826
   Needleman DJ, 2004, P NATL ACAD SCI USA, V101, P16099, DOI 10.1073/pnas.0406076101
   Ng L, 2007, J BIOMECH, V40, P1011, DOI 10.1016/j.jbiomech.2006.04.004
   Nishikori T, 2002, J BIOMED MATER RES, V59, P201, DOI 10.1002/jbm.1226.abs
   Noriega S, 2007, TISSUE ENG, V13, P611, DOI 10.1089/ten.2006.0130
   Papaseit C, 2000, P NATL ACAD SCI USA, V97, P8364, DOI 10.1073/pnas.140029597
   Parvizi J, 1999, J ORTHOPAED RES, V17, P488, DOI 10.1002/jor.1100170405
   Pinot M, 2009, CURR BIOL, V19, P954, DOI 10.1016/j.cub.2009.04.027
   Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175
   Tabony J, 2002, LANGMUIR, V18, P7196, DOI 10.1021/la0255875
   Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
   Zhang ZJ, 2003, ULTRASOUND MED BIOL, V29, P1645, DOI 10.1016/j.ultrasmedbio.2003.08.011
   Zhang ZJ, 2002, ULTRASOUND MED BIOL, V28, P1547, DOI 10.1016/S0301-5629(02)00659-2
   Zhou S., 2004, J BIOL CHEM, V279, P54563
NR 36
TC 8
Z9 11
U1 0
U2 12
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2013
VL 197
IS 1
BP 14
EP 26
DI 10.1159/000339772
PG 13
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 055UG
UT WOS:000312442700002
PM 22987069
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Saracino, GAA
   Cigognini, D
   Silva, D
   Caprini, A
   Gelain, F
AF Saracino, Gloria A. A.
   Cigognini, Daniela
   Silva, Diego
   Caprini, Andrea
   Gelain, Fabrizio
TI Nanomaterials design and tests for neural tissue engineering
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID SPINAL-CORD-INJURY; MOLECULAR-DYNAMICS SIMULATIONS; PEPTIDE NANOFIBER
   SCAFFOLD; AMYLOID FIBRIL FORMATION; ATOMIC-FORCE MICROSCOPY; EMBRYONIC
   STEM-CELLS; INTERPENETRATING POLYMER NETWORKS; TRANSMISSION
   ELECTRON-MICROSCOPY; DISSIPATIVE PARTICLE DYNAMICS; PERIPHERAL-NERVE
   REGENERATION
AB Nanostructured scaffolds recently showed great promise in tissue engineering: nanomaterials can be tailored at the molecular level and scaffold morphology may more closely resemble features of extracellular matrix components in terms of porosity, framing and biofunctionalities. As a consequence, both biomechanical properties of scaffold microenvironments and biomaterial-protein interactions can be tuned, allowing for improved transplanted cell engraftment and better controlled diffusion of drugs. Easier said than done, a nanotech-based regenerative approach encompasses different fields of know-how, ranging from in silico simulations, nanomaterial synthesis and characterization at the nano-, micro-and mesoscales to random library screening methods (e. g. phage display), in vitro cellular-based experiments and validation in animal models of the target injury. All of these steps of the "assembly line'' of nanostructured scaffolds are tightly interconnected both in their standard analysis techniques and in their most recent breakthroughs: indeed their efforts have to jointly provide the deepest possible analyses of the diverse facets of the challenging field of neural tissue engineering. The purpose of this review is therefore to provide a critical overview of the recent advances in and drawbacks and potential of each mentioned field, contributing to the realization of effective nanotech-based therapies for the regeneration of peripheral nerve transections, spinal cord injuries and brain traumatic injuries. Far from being the ultimate overview of such a number of topics, the reader will acknowledge the intrinsic complexity of the goal of nanotech tissue engineering for a conscious approach to the development of a regenerative therapy and, by deciphering the thread connecting all steps of the research, will gain the necessary view of its tremendous potential if each piece of stone is correctly placed to work synergically in this impressive mosaic.
C1 [Saracino, Gloria A. A.; Cigognini, Daniela; Silva, Diego; Caprini, Andrea; Gelain, Fabrizio] AO Osped Niguarda Ca Granda, Ctr Nanomed & Tissue Engn, I-20162 Milan, Italy.
   [Saracino, Gloria A. A.; Cigognini, Daniela; Silva, Diego; Caprini, Andrea] Univ Milano Bicocca, Biotechnol & Biosci Dept, I-20126 Milan, Italy.
   [Gelain, Fabrizio] IRCCS Casa Sollievo Sofferenza Opera San Pio Piet, I-71013 San Giovanni Rotondo, Italy.
RP Gelain, F (reprint author), AO Osped Niguarda Ca Granda, Ctr Nanomed & Tissue Engn, I-20162 Milan, Italy.
EM gelain@mit.edu
RI Gelain, Fabrizio/K-5069-2012
OI Gelain, Fabrizio/0000-0002-2624-5853
CR Abu-Rub M, 2010, DRUG DISCOV TODAY, V15, P436, DOI 10.1016/j.drudis.2010.03.008
   Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Ahmed I, 2007, MOL CELL BIOCHEM, V301, P241, DOI 10.1007/s11010-007-9417-6
   ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376
   Allison DP, 2010, WIRES NANOMED NANOBI, V2, P618, DOI 10.1002/wnan.104
   Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121
   Auer S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.258101
   Auer S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000222
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Bagatolli LA, 2010, PROG LIPID RES, V49, P378, DOI 10.1016/j.plipres.2010.05.001
   Bahney CS, 2011, EUR CELLS MATER, V22, P43, DOI 10.22203/eCM.v022a04
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P82, DOI 10.1021/bm1010195
   Balestrieri ML, 2007, EUR J CANCER, V43, P1242, DOI 10.1016/j.ejca.2007.02.006
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Barattin R, 2008, CHEM COMMUN, P1513, DOI 10.1039/b614328h
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Bareyre FM, 2011, P NATL ACAD SCI USA, V108, P6282, DOI 10.1073/pnas.1015239108
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592
   Baumketner A, 2005, BIOPHYS J, V89, P1493, DOI 10.1529/biophysj.105.059196
   Baumketner A, 2006, J MOL BIOL, V362, P567, DOI 10.1016/j.jmb.2006.07.032
   Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695
   Bellesia G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3108461
   Bellesia G, 2009, BIOPHYS J, V96, P875, DOI 10.1016/j.bpj.2008.10.040
   Bhattarai N, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455601
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Bjugstad KB, 2010, J BIOMED MATER RES A, V95A, P79, DOI 10.1002/jbm.a.32809
   BROWN S, 1992, P NATL ACAD SCI USA, V89, P8651, DOI 10.1073/pnas.89.18.8651
   Bull SR, 2008, J AM CHEM SOC, V130, P2742, DOI 10.1021/ja710749q
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686
   Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009
   Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653
   CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030
   Carrillo JMY, 2011, MACROMOLECULES, V44, P5798, DOI 10.1021/ma2007943
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chen C, 2006, POLYMER, V47, P6322, DOI 10.1016/j.polymer.2006.07.009
   Chen JP, 2011, COLLOID SURFACE B, V86, P169, DOI 10.1016/j.colsurfb.2011.03.038
   Chen L, 2010, CHEM COMMUN, V46, P4267, DOI 10.1039/c003052j
   Cheon M, 2010, PROTEINS, V78, P2950, DOI 10.1002/prot.22817
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chiessi E, 2010, J PHYS CHEM B, V114, P8301, DOI 10.1021/jp912209z
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162
   Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782
   Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938
   Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321
   Cranford S, 2010, NANOTECHNOL SCI APPL, V3, P127, DOI 10.2147/NSA.S9037
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Cui H, 2007, SOFT MATTER, V3, P945, DOI 10.1039/b704194b
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   Daidone I, 2004, PROTEINS, V57, P198, DOI 10.1002/prot.20178
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   de la Paz ML, 2005, J MOL BIOL, V349, P583, DOI 10.1016/j.jmb.2005.03.081
   De Simone A, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3385470
   Derreumaux P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408414
   DIETZ MH, 1971, CANCER RES, V31, P1206
   DiMarco RL, 2012, ADV MATER, V24, P3923, DOI 10.1002/adma.201200051
   Ding F, 2005, J BIOL CHEM, V280, P40235, DOI 10.1074/jbc.M506372200
   Dobrynin AV, 2008, CURR OPIN COLLOID IN, V13, P376, DOI 10.1016/j.cocis.2008.03.006
   Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006
   Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015
   Edgecombe S, 2008, POLYMER, V49, P1981, DOI 10.1016/j.polymer.2008.02.018
   Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Escobedo FA, 1999, PHYS REP, V318, P86, DOI 10.1016/S0370-1573(99)00012-5
   Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103
   Evans HJ, 2003, AM J PHYSIOL-HEART C, V285, pH570, DOI 10.1152/ajpheart.01027.2002
   Fallas JA, 2012, J BIOL CHEM, V287, P8039, DOI 10.1074/jbc.M111.296574
   Fang P. A., 2011, CELLS TISSUES ORGANS
   Favrin G, 2004, BIOPHYS J, V87, P3657, DOI 10.1529/biophysj.104.046839
   Feng Y, 2011, CHEM COMMUN, V47, P10455, DOI 10.1039/c1cc13943f
   Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012
   Flory P. J., 1953, PRINCIPLE POLYM CHEM
   Ford MD, 2001, CLIN TOXICOLOGY
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Friedrich H, 2010, ANGEW CHEM INT EDIT, V49, P7850, DOI 10.1002/anie.201001493
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Gao Y, 2009, J AM CHEM SOC, V131, P13576, DOI 10.1021/ja904411z
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u
   Gelain F, 2012, NANOSCALE, V4, P2946, DOI 10.1039/c2nr30220a
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gelain F, 2011, ACS NANO, V5, P1845, DOI 10.1021/nn102663a
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Gennes PG, 1979, SCALING CONCEPTS POL
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005
   Giudice S, 2007, TOXICOL IN VITRO, V21, P240, DOI 10.1016/j.tiv.2006.09.023
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Guilbaud JB, 2011, CHEM SOC REV, V40, P1200, DOI 10.1039/c0cs00105h
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hoess RH, 2001, CHEM REV, V101, P3205, DOI 10.1021/cr000056b
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong HY, 2008, J CONTROL RELEASE, V131, P167, DOI 10.1016/j.jconrel.2008.07.020
   Hoogenboom HR, 1997, TRENDS BIOTECHNOL, V15, P62, DOI 10.1016/S0167-7799(97)84205-9
   HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001
   Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hou ST, 2004, J NEUROSCI METH, V138, P39, DOI 10.1016/j.jneumeth.2004.03.013
   Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101
   Hyland LL, 2012, BIOPOLYMERS, V97, P177, DOI 10.1002/bip.21722
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jejurikar A, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025010
   Jeon O, 2012, BIOMATERIALS, V33, P3503, DOI 10.1016/j.biomaterials.2012.01.041
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Kamada T, 2011, NEUROPATHOLOGY, V31, P48, DOI 10.1111/j.1440-1789.2010.01130.x
   Kanki S, 2011, J MOL CELL CARDIOL, V50, P841, DOI 10.1016/j.yjmcc.2011.02.003
   Kessick R, 2004, POLYMER, V45, P2981, DOI 10.1016/j.polymer.2004.02.056
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066
   Khoe U, 2009, LANGMUIR, V25, P4111, DOI 10.1021/la8025232
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   King VR, 2010, NEUROSCIENCE, V168, P523, DOI 10.1016/j.neuroscience.2010.03.040
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Kolonin MG, 2006, CANCER RES, V66, P34, DOI 10.1158/0008-5471CAN-05-2748
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601
   LaNasa SM, 2011, J BIOMED MATER RES B, V96B, P294, DOI 10.1002/jbm.b.31765
   Leach AR, 2001, MOL MODELLING PRINCI
   Lee H, 2009, J PHYS CHEM B, V113, P13186, DOI 10.1021/jp9058966
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Lee SG, 2009, BIOMATERIALS, V30, P6130, DOI 10.1016/j.biomaterials.2009.07.035
   Lee SH, 2009, NEUROL RES, V31, P996, DOI 10.1179/174313209X385626
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li MS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2989981
   Li Song, 2003, FASEB Journal, V17, P97
   Li XM, 2010, CHEM COMMUN, V46, P5364, DOI 10.1039/c0cc00163e
   Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   LIESI P, 1989, FEBS LETT, V244, P141, DOI 10.1016/0014-5793(89)81180-9
   Lin EI, 2010, J PHYS CHEM B, V114, P11899, DOI 10.1021/jp104114n
   Lin SL, 2011, PHYS CHEM CHEM PHYS, V13, P17323, DOI 10.1039/c1cp20186g
   Liu JK, 2005, NEUROBIOL DIS, V19, P407, DOI 10.1016/j.nbd.2005.01.022
   Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692
   Longo GS, 2012, SOFT MATTER, V8, P1344, DOI 10.1039/c1sm06708g
   Longo GS, 2011, MACROMOLECULES, V44, P147, DOI 10.1021/ma102312y
   Lowery J, 2009, NANOTECHNOL SCI TECH, P1
   Lu Y, 2009, PROTEINS, V75, P954, DOI 10.1002/prot.22305
   Lu ZY, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061807
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mann BA, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1882275
   Mann BAF, 2011, MACROMOL THEOR SIMUL, V20, P721, DOI 10.1002/mats.201100050
   Manoutcharian K, 2001, CURR PHARM BIOTECHNO, V2, P217, DOI [10.2174/1389201013378671, DOI 10.2174/1389201013378671]
   Massi F, 2002, PROTEIN SCI, V11, P1639, DOI 10.1110/ps.3150102
   Mathur AM, 1996, BIOMATERIALS, V17, P547, DOI 10.1016/0142-9612(96)88705-9
   Matsumura S, 2005, MOL BIOSYST, V1, P146, DOI 10.1039/b504516a
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   Meiners S, 2007, POLYM INT, V56, P1340, DOI 10.1002/pi.2383
   Merzlyak A, 2009, NANO LETT, V9, P846, DOI 10.1021/nl8036728
   METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232
   METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114
   Micklitsch CM, 2011, ANGEW CHEM INT EDIT, V50, P1577, DOI 10.1002/anie.201006652
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Mousseau N, 2008, FRONT BIOSCI-LANDMRK, V13, P4495, DOI 10.2741/3019
   Murray MM, 2009, J PHYS CHEM B, V113, P6041, DOI 10.1021/jp808384x
   Nagaprashantha LD, 2011, INT J CANCER, V128, P743, DOI 10.1002/ijc.25725
   Nagy KJ, 2011, J AM CHEM SOC, V133, P14975, DOI 10.1021/ja206742m
   Nam HB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3415372
   Nasica-Labouze J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002051
   Negureanu L, 2009, J MOL BIOL, V389, P921, DOI 10.1016/j.jmb.2009.04.058
   Nguyen HD, 2006, J AM CHEM SOC, V128, P1890, DOI 10.1021/ja0539140
   Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r
   Nikolov S, 2010, ADV MATER, V22, P519, DOI 10.1002/adma.200902019
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030
   Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/nchem.1123, 10.1038/NCHEM.1123]
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Olsen BD, 2010, MACROMOLECULES, V43, P9094, DOI 10.1021/ma101434a
   Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m
   Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221
   Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Paparcone R, 2010, J BIOMECH, V43, P1196, DOI 10.1016/j.jbiomech.2009.11.026
   Paradossi G, 2011, POLYMERS-BASEL, V3, P1805, DOI 10.3390/polym3041805
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Park J, 2006, BIOPHYS J, V90, P2510, DOI 10.1529/biophysj.105.074906
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Pellarin R, 2007, J MOL BIOL, V374, P917, DOI 10.1016/j.jmb.2007.09.090
   Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Phillips MJ, 2011, INVEST OPHTH VIS SCI, V52, P1439, DOI 10.1167/iovs.10-6400
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Reddy G, 2009, P NATL ACAD SCI USA, V106, P11948, DOI 10.1073/pnas.0902473106
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Richert L, 2002, TOXICOL IN VITRO, V16, P89, DOI 10.1016/S0887-2333(01)00099-6
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4
   Rockwood DN, 2004, ABSTR PAP AM CHEM S, V228, pU364
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986
   Santini S, 2004, STRUCTURE, V12, P1245, DOI 10.1016/j.str.2004.04.018
   Saracino GAA, 2009, PROTEINS, V75, P964, DOI 10.1002/prot.22306
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Schor M, 2011, PHYS CHEM CHEM PHYS, V13, P10457, DOI 10.1039/c0cp02842h
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Sharpe S, 2011, BIOMACROMOLECULES, V12, P1546, DOI 10.1021/bm101486s
   SHENOY AV, 1983, RHEOL ACTA, V22, P209, DOI 10.1007/BF01332373
   Shoichet MS, 2007, PROG BRAIN RES, V161, P385, DOI 10.1016/S0079-6123(06)61027-3
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh G, 2008, BIOPHYS J, V95, P3208, DOI [10.1529/biophysj.108.136226, 10.1529/biophysj.108.13622]
   Skovstrup S, 2010, BIOMACROMOLECULES, V11, P3196, DOI 10.1021/bm100736w
   SKUBITZ APN, 1990, CANCER RES, V50, P7612
   Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216
   Sokic S, 2012, ACTA BIOMATER, V8, P2213, DOI 10.1016/j.actbio.2012.03.017
   Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106
   Stedall TP, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11005-0
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526
   Stulz E, 2011, CHEM SOC REV, V40, P5633, DOI 10.1039/c1cs90048j
   Stupp S. I., 2009, US, Patent No. [7 544 661 B2, 7544661]
   Stupp S. I., 2010, NAT MATER, V9, P594
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   SUSI H, 1986, METHOD ENZYMOL, V130, P290
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Tang C, 2011, LANGMUIR, V27, P14438, DOI 10.1021/la202113j
   Tang H, 2009, ANN BIOMED ENG, V37, P1117, DOI 10.1007/s10439-009-9679-0
   Tang QW, 2009, J COLLOID INTERF SCI, V339, P45, DOI 10.1016/j.jcis.2009.07.026
   Taraballi Francesca, 2010, Front Neuroeng, V3, P1, DOI 10.3389/neuro.16.001.2010
   Taraballi F, 2009, SOFT MATTER, V5, P660, DOI 10.1039/b809236b
   Taraban MB, 2011, SOFT MATTER, V7, P2624, DOI 10.1039/c0sm00919a
   Taras John S, 2005, J Hand Ther, V18, P191, DOI 10.1197/j.jht.2005.02.012
   Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013
   Tarus B, 2005, J MOL BIOL, V345, P1141, DOI 10.1016/j.jmb.2004.11.022
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005
   Tran H, 2011, JOVE-J VIS EXP, DOI 10.3791/3373
   Trepel M, 2002, CURR OPIN CHEM BIOL, V6, P399, DOI 10.1016/S1367-5931(02)00336-8
   Truong WT, 2011, CHEM-ASIAN J, V6, P30, DOI 10.1002/asia.201000592
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tsonchev S, 2008, J PHYS CHEM B, V112, P441, DOI 10.1021/jp076273z
   Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Ueberberg S, 2010, REGUL PEPTIDES, V160, P1, DOI 10.1016/j.regpep.2009.11.017
   Vanlandingham MR, 1997, J MATER SCI LETT, V16, P117, DOI 10.1023/A:1018533708655
   Vegners R, 1995, J Pept Sci, V1, P371, DOI 10.1002/psc.310010604
   Velichko YS, 2008, J PHYS CHEM B, V112, P2326, DOI 10.1021/jp074420n
   VENSTROM KA, 1993, FASEB J, V7, P996
   Walker PA, 2009, STEM CELL REV REP, V5, P283, DOI 10.1007/s12015-009-9081-1
   Wallmersperger T, 2011, COLLOID POLYM SCI, V289, P535, DOI 10.1007/s00396-011-2404-1
   Walter J, 2010, FLUID PHASE EQUILIBR, V296, P164, DOI 10.1016/j.fluid.2010.03.025
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang W, 2008, J BIOMED MATER RES A, V85A, P919, DOI 10.1002/jbm.a.31522
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   Wang W, 2009, J BIOMED MATER RES A, V91A, P994, DOI 10.1002/jbm.a.32329
   Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   Whaley SR, 2000, NATURE, V405, P665
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Woerly S, 2000, NEUROSURG REV, V23, P59
   Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715
   Woolfson D. N., 2005, ANGEW CHEM INT EDIT, V44, P325
   Wu RL, 2012, MACROMOL THEOR SIMUL, V21, P250, DOI 10.1002/mats.201100088
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xing BG, 2002, J AM CHEM SOC, V124, P14846, DOI 10.1021/ja028539f
   Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032
   Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yan CQ, 2012, LANGMUIR, V28, P6076, DOI 10.1021/la2041746
   Yan CQ, 2010, SOFT MATTER, V6, P5143, DOI 10.1039/c0sm00642d
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
   Young TJ, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/12/125703
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yucel T, 2008, MACROMOLECULES, V41, P5763, DOI 10.1021/ma702840q
   Zahid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012252
   Zhang JN, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050295
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P976, DOI 10.1002/jbm.a.32497
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   Zhang Y, 2012, LANGMUIR, V28, P3063, DOI 10.1021/la203923d
   Zhao F, 2011, LANGMUIR, V27, P1510, DOI 10.1021/la103982e
   Zhao WX, 2010, J BIOMOL SCREEN, V15, P687, DOI 10.1177/1087057110370997
   Zhong S, 2010, POLYM REV, V50, P287, DOI 10.1080/15583724.2010.493254
   Zitzmann S, 2005, CLIN CANCER RES, V11, P139
   Zuckermann RN, 2009, CURR OPIN MOL THER, V11, P299
NR 325
TC 81
Z9 88
U1 7
U2 303
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2013
VL 42
IS 1
BP 225
EP 262
DI 10.1039/c2cs35065c
PG 38
WC Chemistry, Multidisciplinary
SC Chemistry
GA 049FV
UT WOS:000311968700015
PM 22990473
DA 2018-10-19
ER

PT J
AU Ferrero-Gutierrez, A
   Menendez-Menendez, Y
   Alvarez-Viejo, M
   Meana, A
   Otero, J
AF Ferrero-Gutierrez, Amaia
   Menendez-Menendez, Yolanda
   Alvarez-Viejo, Maria
   Meana, Alvaro
   Otero, Jesus
TI New serum-derived albumin scaffold seeded with adipose-derived stem
   cells and olfactory ensheathing cells used to treat spinal cord injured
   rats
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE Spinal cord injury; Cell transplantation; Albumin scaffold;
   Adipose-derived stem cells (ADSCs); Olfactory ensheathing cells (OECs)
ID MARROW STROMAL CELLS; CHRONIC PARAPLEGIC RATS; CENTRAL-NERVOUS-SYSTEM;
   FUNCTIONAL RECOVERY; AXONAL REGENERATION; EXTRACELLULAR-MATRIX; COLLAGEN
   SCAFFOLDS; CNS REGENERATION; GLIA TRANSPLANTS; MYELIN
AB Recent advances in spinal cord injury (SCI) research and cell culture techniques and biomaterials predict promising new treatments for patients with SCI or other nerve injuries. Biomaterial scaffolds form a substrate within which cells are instructed to form a tissue in a controlled manner. This study was designed to assess axon regeneration and locomotor recovery in rats with spinal cord injury treated with a novel serum-derived albumin scaffold seeded with adipose derived stem cells (ADSCs) and olfactory ensheathing cells (OECs). OECs are considered promising candidates for the treatment of SCI, and ADSCs have the ability to differentiate into neural lineages. In vitro experiments revealed that ADSCs and OECs adhered to the scaffold, remained viable and expressed specific markers of their cell types when cultured in the scaffold. Rats treated with scaffold plus cells showed locomotor skills at several time points from 45 days post-injury that were improved over those recorded in control injured, untreated animals. Astrocytic scars and tissue regeneration, identified using histological and immunohistochemical techniques, revealed that although the scaffold itself appeared to play a significant role in reducing glial scar formation and filling of the lesion cavity with cells, the presence of ADSCs and OECs in the scaffold led to the appearance of cells expressing markers of neurons and axons at the injury site. Our findings point to the clinical feasibility of an albumin scaffold seeded with ADSCs and OECs as a treatment candidate for use in spinal cord injury repair studies.
C1 [Ferrero-Gutierrez, Amaia] HUCA, Lab Trasplantes & Terapia Celular, Transplant & Cell Therapy Unit, Oviedo 33006, Asturias, Spain.
   [Meana, Alvaro] Ctr Comunitario Sangre & Tejidos Asturias, Tissue Engn Res Unit, Oviedo, Spain.
RP Ferrero-Gutierrez, A (reprint author), HUCA, Lab Trasplantes & Terapia Celular, Transplant & Cell Therapy Unit, C Celestino Villamil S-N,Edificio Polivalente A,1, Oviedo 33006, Asturias, Spain.
EM amaya.ferrero@sespa.princast.es
RI Ferrero-Gutierrez, Amaia/H-9341-2017; Alvarez-Viejo, Maria/H-9289-2017;
   Otero, Jesus/J-1858-2017
OI Otero, Jesus/0000-0003-4097-3846
FU FICYT [PEST 08-12]; Obra Social y Cultural Cajastur
FX This work was supported by FICYT PEST 08-12 and Obra Social y Cultural
   Cajastur. The authors acknowledge the assistance of: Dra. Aurora
   Astudillo and the staff of pathology unit of the HUCA, Dr. M.
   Nieto-Sampedro and E. Martin-Lopez, Dra. Ana Martin-Villalba.
CR Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3
   BALENTINE JD, 1978, LAB INVEST, V39, P254
   Barnett SC, 2004, J ANAT, V204, P57, DOI 10.1111/j.1469-7580.2004.00257.x
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   CADELLI DS, 1992, EXP NEUROL, V115, P189, DOI 10.1016/0014-4886(92)90246-M
   Caroni P, 2008, NEURON, V60, P404, DOI 10.1016/j.neuron.2008.10.028
   Ceccatelli S, 2004, TOXICOL LETT, V149, P59, DOI 10.1016/j.toxlet.2003.12.060
   Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6
   Collazos-Castro JE, 2005, J NEUROSURG-SPINE, V3, P308, DOI 10.3171/spi.2005.3.4.0308
   Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007
   Deng YB, 2008, CYTOTHERAPY, V10, P551, DOI 10.1080/14653240802165673
   Deng YB, 2006, CYTOTHERAPY, V8, P210, DOI 10.1080/14653240600760808
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Gallego L., 2009, J BIOMATER APPL, V25, P367
   Gallego L, 2010, TISSUE ENG PT A, V16, P1179, DOI [10.1089/ten.tea.2009.0517, 10.1089/ten.TEA.2009.0517]
   Garcia-Alias G, 2004, J NEUROSCI RES, V75, P632, DOI 10.1002/jnr.20029
   GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0
   GudinoCabrera G, 1996, RESTOR NEUROL NEUROS, V10, P25, DOI 10.3233/RNN-1996-10104
   Jin KL, 2003, EXP NEUROL, V184, P78, DOI 10.1016/S0014-4886(03)00133-X
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X
   Li C, 2004, BRAIN, V127, P535
   Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   McDonald JW, 2003, AM J PHYS MED REHAB, V82, pS38, DOI 10.1097/01.PHM.0000086994.53716.17
   McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6
   Meana A, 2008, Spanish patent, Patent No. [WO 2008/119855, 2008119855]
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Radtke C, 2009, BRAIN RES, V1254, P10, DOI 10.1016/j.brainres.2008.11.036
   RAISMAN G, 1985, NEUROSCIENCE, V14, P237, DOI 10.1016/0306-4522(85)90176-9
   Raisman G, 2001, NAT REV NEUROSCI, V2, P369, DOI 10.1038/35072576
   Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099
   Resnick DK, 2003, J NEUROTRAUM, V20, P279, DOI 10.1089/089771503321532860
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Tatard VM, 2007, BONE, V40, P360, DOI 10.1016/j.bone.2006.09.013
   Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072
   Verdu E, 2003, GLIA, V42, P275, DOI 10.1002/glia.10217
   Verdu E, 2001, NEUROREPORT, V12, P2303, DOI 10.1097/00001756-200108080-00005
   Wang B, 2006, NEUROSCI LETT, V401, P65, DOI 10.1016/j.neulet.2006.02.085
   Wang B, 2007, NEUROSCI LETT, V421, P191, DOI 10.1016/j.neulet.2007.04.081
   Yarak S, 2010, AN BRAS DERMATOL, V85, P647, DOI 10.1590/S0365-05962010000500008
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang LQ, 2009, GLIA, V57, P1178, DOI 10.1002/glia.20840
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069
   Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f
NR 50
TC 14
Z9 16
U1 0
U2 26
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD JAN
PY 2013
VL 28
IS 1
BP 89
EP 100
PG 12
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA 054ZK
UT WOS:000312384000008
PM 23233062
DA 2018-10-19
ER

PT J
AU Fogaca, R
   Catalani, LH
AF Fogaca, Renata
   Catalani, Luiz H.
TI PVP Hydrogel Membranes Produced by Electrospinning for Protein Release
   Devices
SO SOFT MATERIALS
LA English
DT Article
DE Collagenase; Electrospinning; Hydrogels; Porosity; PVP
ID OXIDE)/POLY(VINYL PYRROLIDONE)-IODINE COMPLEX; BIOMEDICAL APPLICATIONS;
   CROSS-LINKING; NANOFIBERS; MORPHOLOGIES; DESIGN; BLENDS
AB Hydrogels are materials of interest in the biomedical field due to their potential application in wound dressing as well as in drug delivery devices. This work describes the production of a novel poly(N-vinyl-2-pyrrolidone) (PVP) hydrogel membrane produced by electrospinning with a gel fraction up to 90% and a high swelling degree. PVP electrospun nanofiber, cross-linking with UV-C radiation and Fenton reactions, were used to obtain a highly porous membrane. By a 23 experimental design the control of the nanofiber diameter was achieved and proven to exert significant influence on the BSA release profile. Collagenase release behavior and its enzymatic activity were also evaluated in order to estimate the ability of this biomaterial to be used as an enzymatic debriding wound dressing.
C1 [Fogaca, Renata; Catalani, Luiz H.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, BR-05508900 Sao Paulo, Brazil.
RP Catalani, LH (reprint author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, CP 26077, BR-05508900 Sao Paulo, Brazil.
EM catalani@usp.br
RI Catalani, Luiz/E-2841-2010; Institute of Chemistry - USP, Dept. of
   Chemistry/B-8988-2012
OI Catalani, Luiz/0000-0003-3689-1792; 
FU FAPESP; CNPq
FX The authors would like to thank FAPESP and CNPq for financial support
   and the Laboratorio Nacional de Luz Sincroton - LNLS for the use of
   their facilities.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Barros JAG, 2006, POLYMER, V47, P8414, DOI 10.1016/j.polymer.2006.10.033
   Beachley V, 2009, MAT SCI ENG C-BIO S, V29, P663, DOI 10.1016/j.msec.2008.10.037
   Bognitzki M, 2001, POLYM ENG SCI, V41, P982, DOI 10.1002/pen.10799
   Bueno VB, 2009, COLLOID POLYM SCI, V287, P705, DOI 10.1007/s00396-009-2017-0
   Chiu CT, 2008, J MATER SCI-MATER M, V19, P2503, DOI 10.1007/s10856-008-3389-2
   Cunha F, 2004, MAT RES, V7, P539
   Fechine GJM, 2004, POLYMER, V45, P4705, DOI 10.1016/j.polymer.2004.05.006
   Forte MMD, 2003, POLYMER, V44, P1377
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Harrington DJ, 1996, INFECT IMMUN, V64, P1885
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ignatova M, 2008, J BIOMAT SCI-POLYM E, V19, P373, DOI 10.1163/156856208783721056
   Ignatova M, 2007, EUR POLYM J, V43, P1609, DOI 10.1016/j.eurpolymj.2007.02.020
   Lopergolo LC, 2003, POLYMER, V44, P6217, DOI 10.1016/S0032-3861(03)00686-4
   MANDL I, 1953, J CLIN INVEST, V32, P1323, DOI 10.1172/JCI102861
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Molina I, 2001, BIOMATERIALS, V22, P363, DOI 10.1016/S0142-9612(00)00192-7
   MOORE S, 1948, J BIOL CHEM, V176, P367
   Moura M, 2009, MAT SCI ENG C, V29, P2319
   Ozcon C., 2002, BURNS, V28, P791
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Sajeev US, 2008, B MATER SCI, V31, P343, DOI 10.1007/s12034-008-0054-9
   Shi L., 2009, WOUND OSTOMY CONTINE, V36, P12
   Tan S, 2007, POLYM INT, V56, P1330, DOI 10.1002/pi.2354
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Xin Y, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2236382
   Xu CY, 2007, POLYM BULL, V58, P53, DOI 10.1007/s00289-006-0597-0
   Yang QB, 2004, J POLYM SCI POL PHYS, V42, P3721, DOI 10.1002/polb.20222
NR 30
TC 9
Z9 9
U1 5
U2 92
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1539-445X
J9 SOFT MATER
JI Soft Mater.
PD JAN 1
PY 2013
VL 11
IS 1
BP 61
EP 68
DI 10.1080/1539445X.2011.580411
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 055TP
UT WOS:000312440900009
DA 2018-10-19
ER

PT J
AU Ferreira, MSV
   Schneider, RK
   Wagner, W
   Jahnen-Dechent, W
   Labude, N
   Bovi, M
   Piroth, D
   Knuchel, R
   Hieronymus, T
   Muller, AM
   Zenke, M
   Neuss, S
AF Ferreira, Monica Sofia Ventura
   Schneider, Rebekka Kramann
   Wagner, Wolfgang
   Jahnen-Dechent, Willi
   Labude, Norina
   Bovi, Manfred
   Piroth, Daniela
   Knuechel, Ruth
   Hieronymus, Thomas
   Mueller, Albrecht M.
   Zenke, Martin
   Neuss, Sabine
TI Two-Dimensional Polymer-Based Cultures Expand Cord Blood-Derived
   Hematopoietic Stem Cells and Support Engraftment of NSG Mice
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID EX-VIVO EXPANSION; PROGENITOR CELLS; BONE-MARROW; 3-DIMENSIONAL
   SCAFFOLDS; STEM/PROGENITOR CELLS; SELF-RENEWAL; IN-VITRO;
   TRANSPLANTATION; ADHESION; MATRIX
AB Currently, ex vivo expansion of hematopoietic stem cells (HSC) is still insufficient. Traditional approaches for HSC expansion include the use of stromal cultures, growth factors, and/or bioreactors. Biomaterial-based strategies provide new perspectives. We focus on identifying promising two-dimensional (2D) polymer candidates for HSC expansion. After a 7-day culture period with cytokine supplementation, 2D fibrin, poly(D, L-lacticco-glycolic acid; Resomer (R) RG503), and Poly(epsilon-caprolactone; PCL) substrates supported expansion of cord blood (CB)-derived CD34(+) cells ex vivo. Fibrin cultures achieved the highest proliferation rates (>8700-fold increase of total nuclear cells, p < 0.001), high total colony-forming units (3.6-fold increase, p < 0.001), and highest engraftment in NSG mice (7.69-fold more donor cells compared with tissue culture polysterene, p < 0.001). In addition, the presence of multiple human hematopoietic lineages such as myeloid (CD13(+)), erythroid (GypC(+)), and lymphoid (CD20(+)/CD56(+)) in murine transplant recipients confirmed the multilineage engraftment potential of fibrin-based cultures. Filopodia development in fibrin-expanded cells was a further indicator for superior cell adhesion capacities. We propose application of fibrin, Resomer (R) RG503, and PCL for future strategies of CB-CD34(+) cell expansion. Suitable polymers for HSC expansion might also be appropriate for future drug discovery applications or for studies aimed to develop hematological therapies.
C1 [Ferreira, Monica Sofia Ventura; Schneider, Rebekka Kramann; Labude, Norina; Knuechel, Ruth; Neuss, Sabine] Rhein Westfal TH Aachen, Inst Pathol, D-52074 Aachen, Germany.
   [Wagner, Wolfgang] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Stem Cell Biol & Cellular Engn Grp, D-52074 Aachen, Germany.
   [Jahnen-Dechent, Willi; Neuss, Sabine] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Biointerface Grp, D-52074 Aachen, Germany.
   [Bovi, Manfred] Univ Hosp Aachen, Electron Microscop Facil, Aachen, Germany.
   [Piroth, Daniela] Rhein Westfal TH Aachen, Dept Gynecol, D-52074 Aachen, Germany.
   [Hieronymus, Thomas; Zenke, Martin] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Dept Cell Biol, D-52074 Aachen, Germany.
   [Mueller, Albrecht M.] Univ Wurzburg, Inst Med Radiat & Cell Res, Wurzburg, Germany.
RP Ferreira, MSV (reprint author), Rhein Westfal TH Aachen, Inst Pathol, Pauwelsstr 30, D-52074 Aachen, Germany.
EM mventuraferreira@ukaachen.de; sabine.neuss@post.rwth-aachen.de
RI Ventura Ferreira, Monica/P-5910-2017; Jahnen-Dechent, Willi/A-7608-2011
OI Ventura Ferreira, Monica/0000-0002-1437-1342; Jahnen-Dechent,
   Willi/0000-0003-1315-4407; Wagner, Wolfgang/0000-0002-1971-3217
FU Federal Ministry of Education and Research (BMBF), Germany; "Cell-based
   Regenerative Medicine" program [01GN0931]
FX We thank the financial support from the Federal Ministry of Education
   and Research (BMBF), Germany. This project (Grant-Number: 01GN0931) is
   part of the CB-HERMES consortium working on a "Cell-based Regenerative
   Medicine" program. We thank the Department of Gynecology and
   Obstetrics-University Clinics RWTH Aachen for the cooperation related to
   CB collection. We thank the DWI e.V. and Institute of Technical and
   Macromolecular Chemistry, RWTH Aachen University, Dr. Anandhan
   Dhanasingh, Dr. Jochen Salber, Dr. Xiaomin Zhu, and Mareike Hoss (IZKF
   Aachen) for the cooperation related to polymer production. We thank
   Thomas Walenda and Gudrun Walenda for sharing their expertise on CFSE
   analysis and NSG transplantation.
CR Araki H, 2006, EXP HEMATOL, V34, P140, DOI 10.1016/j.exphem.2005.10.002
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979
   Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080
   Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829
   Ferreira MSV, 2013, J TISSUE ENG REGEN M, V7, P944, DOI 10.1002/term.1486
   Ferreira MV, 2012, J MATER SCI-MATER M, V23, P109, DOI 10.1007/s10856-011-4483-4
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Franke K, 2007, BIOMATERIALS, V28, P836, DOI 10.1016/j.biomaterials.2006.09.031
   GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707
   Gluckman E, 2009, HAEMATOL-HEMATOL J, V94, P451, DOI 10.3324/haematol.2009.005694
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225
   Jiang XS, 2006, BIOMATERIALS, V27, P2723, DOI 10.1016/j.biomaterials.2005.12.001
   Koch S, 2010, BIOMATERIALS, V31, P4731, DOI 10.1016/j.biomaterials.2010.02.051
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034
   Li Y, 2001, J HEMATOTH STEM CELL, V10, P355, DOI 10.1089/152581601750288966
   Liao YL, 2011, EXP HEMATOL, V39, P393, DOI 10.1016/j.exphem.2011.01.002
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4
   Mantalaris A, 1998, BIOTECHNOL PROGR, V14, P126, DOI 10.1021/bp970136+
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Mortera-Blanco T, 2011, BIOMATERIALS, V32, P9263, DOI 10.1016/j.biomaterials.2011.08.051
   NAUGHTON BA, 1990, PROG CLIN BIOL RES, V333, P435
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Oswald J, 2006, STEM CELLS, V24, P494, DOI 10.1634/stemcells.2005-0276
   Pierres A, 2008, BIOPHYS J, V94, P4114, DOI 10.1529/biophysj.107.125278
   Purton LE, 2008, STEMBOOK, P1
   Rocha V, 2010, BEST PRACT RES CL HA, V23, P223, DOI 10.1016/j.beha.2010.07.005
   Rosenzweig M, 1997, GENE THER, V4, P928, DOI 10.1038/sj.gt.3300480
   Sagar BMM, 2006, BIOCHEM BIOPH RES CO, V350, P1000, DOI 10.1016/j.bbrc.2006.09.140
   Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Singbrant S, 2011, J CELL BIOCHEM, V112, P1486, DOI 10.1002/jcb.23085
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Verfaillie CM, 1998, BLOOD, V92, P2609
   Walenda T, 2011, EXP HEMATOL, V39, P617, DOI 10.1016/j.exphem.2011.02.011
   Wang JCY, 1997, BLOOD, V89, P3919
   WANG TY, 1995, EXP HEMATOL, V23, P26
   Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119
NR 46
TC 1
Z9 1
U1 0
U2 26
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JAN
PY 2013
VL 19
IS 1
DI 10.1089/ten.tec.2011.0706
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 054MM
UT WOS:000312347900003
PM 22712684
OA Green Published
DA 2018-10-19
ER

PT J
AU Cameron, K
   Travers, P
   Chander, C
   Buckland, T
   Campion, C
   Noble, B
AF Cameron, Kate
   Travers, Paul
   Chander, Chaman
   Buckland, Tom
   Campion, Charlie
   Noble, Brendon
TI Directed osteogenic differentiation of human mesenchymal stem/precursor
   cells on silicate substituted calcium phosphate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mesenchymal stem cells; biomaterial; osteogenic differentiation; calcium
   phosphate
ID MARROW STROMAL CELLS; DENTIN MATRIX PROTEIN-1; OSTEOBLASTIC
   DIFFERENTIATION; STEM-CELLS; IN-VITRO; BIOLOGICAL RESPONSE;
   GENE-EXPRESSION; BONE; RUNX2; HYDROXYAPATITE
AB Insufficient, underactive, or inappropriate osteoblast function results in serious clinical conditions such as osteoporosis, osteogenesis imperfecta and fracture nonunion and therefore the control of osteogenesis is a medical priority. In vitro mesenchymal stem cells (MSCs) can be directed to form osteoblasts through the addition of soluble factors such as beta-glycerophosphate, ascorbic acid, and dexamethasone; however this is unlikely to be practical in the clinical setting. An alternative approach would be to use a scaffold or matrix engineered to provide cues for differentiation without the need for soluble factors. Here we describe studies using Silicate-substituted calcium phosphate (Si-CaP) and unmodified hydroxyapatite (HA) to test whether these materials are capable of promoting osteogenic differentiation of MSCs in the absence of soluble factors. Si-CaP supported attachment and proliferation of MSCs and induced osteogenesis to a greater extent than HA, as evidenced through upregulation of the osteoblast-related genes: Runx2 (1.2 fold), Col1a1 (2 fold), Pth1r (1.5 fold), and Bglap (1.7 fold) Dmp1 (1.1 fold), respectively. Osteogenic-associated proteins, alkaline phosphatase (1.4 fold), RUNX2, COL1A1, and BGLAP, were also upregulated and there was an increased production of mineralized bone matrix (1.75 fold), as detected by the Von Kossa Assay. These data indicate that inorganic substrates are capable of directing the differentiation programme of stem cells in the absence of known chemical drivers and therefore may provide the basis for bone repair in the clinical setting. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:1322, 2013.
C1 [Cameron, Kate; Travers, Paul] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland.
   [Chander, Chaman; Buckland, Tom; Campion, Charlie] ApaTech Ltd, Elstree WD6 3TJ, Herts, England.
   [Noble, Brendon] Univ Campus Suffolk, Sch Sci Technol & Hlth, Ipswich IP4 1QJ, Suffolk, England.
RP Cameron, K (reprint author), Univ Edinburgh, MRC Ctr Regenerat Med, SCRM Bldg,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.
EM k.r.cameron@sms.ed.ac.uk
FU Chief Scientist Office [CZB/4/656]; Medical Research Council [G0700711B]
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alonso V, 2011, J BONE MINER RES, V26, P143, DOI 10.1002/jbmr.167
   Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chen PY, 2007, BIOCHEM BIOPH RES CO, V360, P1, DOI 10.1016/j.bbrc.2007.04.211
   Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246
   Gargiulo C, 2010, 3 INT C DEV BIOM ENG
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Guth K, 2006, KEY ENG MATER, V309-311, P117, DOI 10.4028/www.scientific.net/KEM.309-311.117
   Hing K, 2004, T 50 A M ORTH RES SO, V9
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kaur G, 2010, BIOMATERIALS, V31, P1732, DOI 10.1016/j.biomaterials.2009.11.041
   Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303
   Koh AJ, 1999, ENDOCRINOLOGY, V140, P3154, DOI 10.1210/en.140.7.3154
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3
   Lavery K, 2009, BONE, V45, P27, DOI 10.1016/j.bone.2009.03.656
   Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41
   Makita N, 2008, GENE, V413, P8, DOI 10.1016/j.gene.2007.12.025
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   Mareddy S, 2007, TISSUE ENG, V13, P819, DOI 10.1089/ten.2006.0180
   Marinucci L, 2010, ANN BIOMED ENG, V38, P640, DOI 10.1007/s10439-009-9898-4
   McCauley LK, 1996, J CELL BIOCHEM, V61, P638, DOI 10.1002/(SICI)1097-4644(19960616)61:4<638::AID-JCB18>3.3.CO;2-9
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Owen M, 1988, J CELL SCI S
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pockwinse SM, 2006, J CELL PHYSIOL, V206, P354, DOI 10.1002/jcp.20469
   Porter AE, 2006, J BIOMED MATER RES A, V78A, P25, DOI 10.1002/jbm.a.30690
   Ramaswamy Y, 2008, ACTA BIOMATER, V4, P1487, DOI 10.1016/j.actbio.2008.04.014
   Rashid N, 2004, T 7 WORLD BIOM C SYD
   Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot4050, 10.1101/pdb.prot4027, 10.1101/pdb.prot4044, 10.1101/pdb.prot4056, 10.1101/pdb.prot3871, 10.1101/pdb.prot4022, 10.1101/pdb.prot4455]
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213
   STEIN GS, 1990, FASEB J, V4, P3111
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737
   Tortelli F, 2009, TISSUE ENG PT A, V15, P2373, DOI 10.1089/ten.tea.2008.0501
   Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017
   Tremoleda FL, 2008, CLONING STEM CELLS, V10, P119, DOI [10.1089/clo.2007.OR36, 10.1089/clo.2007.0R36]
   Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024
   Zou S, 2009, J BIOMED MATER RES B, V90B, P123, DOI 10.1002/jbm.b.31262
NR 54
TC 19
Z9 22
U1 1
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 13
EP 22
DI 10.1002/jbm.a.34261
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900002
PM 22733430
DA 2018-10-19
ER

PT J
AU Uzarski, JS
   Van de Walle, AB
   McFetridge, PS
AF Uzarski, Joseph S.
   Van de Walle, Aurore B.
   McFetridge, Peter S.
TI Preimplantation processing of ex vivo-derived vascular biomaterials:
   Effects on peripheral cell adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE allograft; cell adhesion; decellularization; endothelialization;
   extracellular matrix
ID HUMAN UMBILICAL VEIN; EXTRACELLULAR-MATRIX; BYPASS GRAFTS;
   BLOOD-VESSELS; DECELLULARIZED MATRIX; PROSTHETIC BYPASS; SAPHENOUS-VEIN;
   SCAFFOLD; REVASCULARIZATION; THROMBOGENICITY
AB The use of ex vivo-derived scaffolds as vascular conduits has shown to be a clinically valid approach to repair or bypass occluded vessels. Implantation of allogeneic tissue grafts requires careful processing to lower immunogenicity and prevent bacterial infection. However, the mechanical/chemical treatments used to prepare biological scaffolds can result in significant alterations to the native structure and surface chemistry, which can affect in vivo performance. Of particular importance for vascular grafts are binding interactions between the implanted biomaterial and host cells from the circulation and adjacent vasculature. Here we present a comparison of four strategies used to decellularize allogeneic human umbilical vein (HUV) scaffolds: ethanol/acetone, sodium chloride, sodium dodecyl sulfate (SDS), or Triton X-100. Scanning electron microscopy revealed that all four techniques achieved removal of native cells from both the lumenal and ablumenal surfaces of HUV grafts. Platelets and promyelocytic HL-60 cells showed preferential binding on the more loosely structured ablumenal surface, although low surface coverage was observed overall by peripheral blood cells. Vascular endothelial cell adhesion was highest on HUV decellularized using ethanol/acetone, and significantly higher than on SDS-processed grafts (p = 0.016). Primary cells showed high viability on the lumenal surface regardless of decellularization technique (over 95% in all cases). These results demonstrate the critical effects of various chemical processing strategies on the adhesive properties of ex vivo-derived vascular grafts. Careful application-specific consideration is warranted when selecting a processing strategy that minimizes innate responses (e.g. thrombosis, inflammation) that are often deleterious to graft survival. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:123131, 2013.
C1 [Uzarski, Joseph S.; Van de Walle, Aurore B.; McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP McFetridge, PS (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, 1275 Ctr Dr, Gainesville, FL 32611 USA.
EM pmcfetridge@bme.ufl.edu
RI Mcfetridge, Peter/A-2802-2010
OI Van de Walle, Aurore/0000-0003-1579-9145
FU NHLBI NIH HHS [R01 HL088207]
CR Abousleiman RI, 2008, ARTIF ORGANS, V32, P735, DOI 10.1111/j.1525-1594.2008.00598.x
   Afshar-Kharghan V, 2006, CURR OPIN HEMATOL, V13, P34, DOI 10.1097/01.moh.0000190107.54790.de
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Chan RW, 2009, TISSUE ENG PT A, V15, P3537, DOI [10.1089/ten.tea.2009.0064, 10.1089/ten.TEA.2009.0064]
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Crouzier T, 2009, J BIOMED MATER RES A, V89A, P818, DOI 10.1002/jbm.a.32103
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   Dardik H, 2002, J VASC SURG, V35, P64, DOI 10.1067/mva.2002.121053
   Dardik H, 2006, J AM COLL SURGEONS, V203, P582, DOI 10.1016/j.jamcollsurg.2006.07.003
   Eble JA, 2009, CURR PHARM DESIGN, V15, P1385, DOI 10.2174/138161209787846757
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goktas S, 2010, TISSUE ENG PT A, V16, P769, DOI [10.1089/ten.tea.2009.0101, 10.1089/ten.TEA.2009.0101]
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x
   Hoh BL, 2011, CIRCULATION, V124, P2243, DOI 10.1161/CIRCULATIONAHA.111.036061
   Issa RI, 2011, TISSUE ENG PT A, V17, P1479, DOI [10.1089/ten.tea.2010.0484, 10.1089/ten.TEA.2010.0484]
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Johnson TR, 2000, J VASC SURG, V31, P994, DOI 10.1067/mva.2000.105676
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Montoya CV, 2009, TISSUE ENG PART C-ME, V15, P191, DOI 10.1089/ten.tec.2008.0372
   Moriyama S, 2001, ASAIO J, V47, P202, DOI 10.1097/00002480-200105000-00007
   Neufang A, 2007, J VASC SURG, V46, P280, DOI 10.1016/j.jvs.2007.03.054
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Parang P, 2009, CAN J CARDIOL, V25, pE57, DOI 10.1016/S0828-282X(09)70486-6
   Randon C, 2010, J VASC SURG, V51, P869, DOI 10.1016/j.jvs.2009.11.062
   Roger LV, 2012, CIRCULATION, V125, P188
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Stehbens WE, 2005, FETAL PEDIATR PATHOL, V24, P297, DOI 10.1080/15227950500503660
   Tosun Z, 2011, J VASC SURG, V54, P1451, DOI 10.1016/j.jvs.2011.05.050
   Twine CP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001487.pub2
   Vollmar B, 2003, MICROCIRCULATION, V10, P143, DOI 10.1038/sj.mn.7800179
   Watson SP, 2009, CURR PHARM DESIGN, V15, P1358, DOI 10.2174/138161209787846702
NR 40
TC 14
Z9 15
U1 1
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 123
EP 131
DI 10.1002/jbm.a.34308
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900013
PM 22825780
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Peng, YJ
   Lu, YT
   Liu, KS
   Liu, SJ
   Fan, L
   Huang, WC
AF Peng, Yi-Jie
   Lu, Yu-Ting
   Liu, Kuo-Sheng
   Liu, Shih-Jung
   Fan, Ling
   Huang, Wen-Cheng
TI Biodegradable balloon-expandable self-locking polycaprolactone stents as
   buckling explants for the treatment of retinal detachment: An in vitro
   and in vivo study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biodegradable balloon-expandable stents; scleral buckle;
   polycaprolactone
ID SCLERAL BUCKLE; REATTACHMENT SURGERY; EPISCLERAL IMPLANTS;
   COMPLICATIONS; SILICONE; INTRUSION; PTFE; PCL
AB The purpose of this report was to develop biodegradable balloon-expandable self-locking poly(e-caprolactone) (PCL) stents for the treatment of retinal detachment. To create the biodegradable stents, polycaprolactone components were first fabricated by a laboratory-scale microinjection molding machine. The components were then assembled into mesh-like stents of 6 and 8 mm in diameter. A special geometry of the components was designed to self-lock the assembled stents after being expanded by balloons. Characterization of the biodegradable PCL stents was carried out. PCL stents exhibited comparable mechanical properties with that of silicone sponge. Neither significant amount of collapse pressure reduction nor weight loss of the stents was observed after being submerged in phosphate buffered saline for 30 days. In addition, the stents were also implanted in the episcleral space of 10 New Zealand white rabbits. The stents were placed in radial direction and left unsutured after balloon expansion. The stents achieved an efficient buckling effect in echographic and fundus photographic examinations. The ocular pressure was significantly elevated after stent implantation and gradually normalized after the second week. The computed tomography studies verified the hypothesis of minimal migration of the PCL stents. The in vivo result suggests that balloon-expandable biodegradable stents can potentially serve as an ideal indenting biomaterial in retinal detachment surgery. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:167175, 2013.
C1 [Lu, Yu-Ting; Liu, Kuo-Sheng; Liu, Shih-Jung] Chang Gung Univ, Dept Mech Engn, Tao Yuan, Taiwan.
   [Peng, Yi-Jie] Buddhist Tzu Chi Gen Hosp, Dept Ophthalmol, Taipei Branch, Taipei, Taiwan.
   [Liu, Kuo-Sheng] Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Tao Yuan, Taiwan.
   [Fan, Ling; Huang, Wen-Cheng] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan, Taiwan.
   [Fan, Ling; Huang, Wen-Cheng] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan.
RP Liu, SJ (reprint author), Chang Gung Univ, Dept Mech Engn, Tao Yuan, Taiwan.
EM shihjung@mail.cgu.edu.tw
OI Liu, Shih-Jung/0000-0003-2083-4865
CR Barile GR, 1998, AM J OPHTHALMOL, V126, P379, DOI 10.1016/S0002-9394(98)00093-2
   BARR CC, 1990, RETINA-J RET VIT DIS, V10, P189, DOI 10.1097/00006982-199010030-00007
   BINDER S, 1986, RETINA-J RET VIT DIS, V6, P210, DOI 10.1097/00006982-198606040-00003
   Chen H, 2010, J MATER SCI-MATER M, V21, P2887, DOI 10.1007/s10856-010-4141-2
   Ciulla TA, 1998, SURV OPHTHALMOL, V43, P134, DOI 10.1016/S0039-6257(98)00014-9
   DAMICO DJ, 1994, NEW ENGL J MED, V331, P95, DOI 10.1056/NEJM199407143310207
   Deokule S, 2003, EYE, V17, P697, DOI 10.1038/sj.eye.6700491
   DHERMIES F, 1995, RETINA-J RET VIT DIS, V15, P62, DOI 10.1097/00006982-199515010-00012
   Doi N, 1999, JPN J OPHTHALMOL, V43, P232, DOI 10.1016/S0021-5155(99)00009-X
   Jiang SC, 2001, POLYMER, V42, P3901, DOI 10.1016/S0032-3861(00)00565-6
   KORNBLUETH W, 1964, AM J OPHTHALMOL, V57, P261, DOI 10.1016/0002-9394(64)91831-8
   Korobelnik JF, 1999, J BIOMED MATER RES, V48, P807, DOI 10.1002/(SICI)1097-4636(1999)48:6<807::AID-JBM7>3.3.CO;2-Z
   KREISSIG I, 1989, AM J OPHTHALMOL, V107, P381, DOI 10.1016/0002-9394(89)90661-2
   Lansman SM, 2005, RETINA-J RET VIT DIS, V25, P581
   Li XX, 2003, OPHTHALMOLOGY, V110, P2413, DOI 10.1016/S0161-6420(03)00867-4
   Liu KS, 2011, J THORAC CARDIOV SUR, V141, P463, DOI 10.1016/j.jtcvs.2010.08.008
   Liu SJ, 2010, ANN BIOMED ENG, V38, P3185, DOI 10.1007/s10439-010-0075-6
   Mortemousque B, 2002, J BIOMED MATER RES, V63, P686, DOI 10.1002/jbm.10393
   Natu MV, 2011, INT J PHARMACEUT, V415, P73, DOI 10.1016/j.ijpharm.2011.05.047
   Nguyen QD, 2001, RETINA-J RET VIT DIS, V21, P214
   Roldan-Pallares M, 1999, ARCH OPHTHALMOL-CHIC, V117, P197
   RUBSAMEN PE, 1994, AM J OPHTHALMOL, V118, P299, DOI 10.1016/S0002-9394(14)72952-6
   SCHEPENS CL, 1991, SURV OPHTHALMOL, V35, P447, DOI 10.1016/0039-6257(91)90108-R
   Shami MJ, 2001, RETINA-J RET VIT DIS, V21, P195, DOI 10.1097/00006982-200104000-00027
   SMIDDY WE, 1991, RETINA-J RET VIT DIS, V11, P394, DOI 10.1097/00006982-199111040-00005
   SPENCER AF, 1993, EYE, V7, P751, DOI 10.1038/eye.1993.175
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Wu WC, 2008, INVEST OPHTH VIS SCI, V49, P2673, DOI 10.1167/iovs.07-1594
   YOSHIZUMI MO, 1980, OPHTHALMOLOGY, V87, P1150
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 30
TC 3
Z9 3
U1 2
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 167
EP 175
DI 10.1002/jbm.a.34315
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900018
PM 22829533
DA 2018-10-19
ER

PT J
AU Lee, HS
   Stachelek, SJ
   Tomczyk, N
   Finley, MJ
   Composto, RJ
   Eckmann, DM
AF Lee, Hyun-Su
   Stachelek, Stanley J.
   Tomczyk, Nancy
   Finley, Matthew J.
   Composto, Russell J.
   Eckmann, David M.
TI Correlating macrophage morphology and cytokine production resulting from
   biomaterial contact
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophage; biocompatibility; cell morphology; biomaterials;
   inflammation
ID TITANIUM SURFACE-TOPOGRAPHY; FOREIGN-BODY REACTION; MONOCYTE-DERIVED
   MACROPHAGES; IN-VITRO; CELLS; DIFFERENTIATION; RESPONSES;
   BIOCOMPATIBILITY; BIODEGRADATION; ATTACHMENT
AB The morphological and inflammatory responses of adherent macrophages are correlated to evaluate the biocompatibility of surfaces. Monocyte-derived macrophage (MDM), THP-1, and THP-1 cells expressing GFP-actin chimeric protein were seeded onto glass, polyurethane (PU), and glass surface modified with quaternary ammonium salt functionalized chitosan (CH-Q) and hyaluronic acid (HA). Using confocal microscopy, the surface area, volume and 3D shape factor of adherent macrophages was quantified. For comparison, functional consequences of cell-surface interactions that activate macrophages and thereby elicit secretion of a proinflammatory cytokine were evaluated. Using an enzyme linked immune sorbent assay, tumor necrosis factor-alpha (TNF-alpha) was measured. On glass, macrophages exhibited mainly an amoeboid shape, exhibited the largest surface area, volume, and 3D shape factor and produced the most TNF-alpha. On PU, macrophages displayed mainly a hemispherical shape, exhibited an intermediate volume, surface area and 3D shape factor, and produced moderate TNF-alpha. In contrast, on CH-Q and HA surfaces, macrophages were spherical, exhibited the smallest volume, surface area, and 3D shape factor, and produced the least TNF-alpha. These studies begin to validate the use of GFP-actin-modified MDM as a novel tool to correlate cell morphology with inflammatory cell response. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:203212, 2013.
C1 [Lee, Hyun-Su; Tomczyk, Nancy; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Lee, Hyun-Su; Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Lee, Hyun-Su; Composto, Russell J.; Eckmann, David M.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.
   [Stachelek, Stanley J.; Finley, Matthew J.] Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Philadelphia, PA 19104 USA.
RP Eckmann, DM (reprint author), 331 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.
EM David.Eckmann@uphs.upenn.edu
OI Lee, Hyun-Su/0000-0002-5245-8430
FU National Institutes of Health [R01 HL60230]; Nano/Bio Interface Center
   at the University of Pennsylvania [NSF/DMR08-32802]
FX Contract grant sponsor: National Institutes of Health; contract grant
   number: R01 HL60230; Contract grant sponsor: Nano/Bio Interface Center
   at the University of Pennsylvania; contract grant number:
   NSF/DMR08-32802
CR AMATO PA, 1983, J CELL BIOL, V96, P750, DOI 10.1083/jcb.96.3.750
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Baba T, 1992, VIRCHOWS ARCH, V61, P39
   Baddour LM, 2003, CIRCULATION, V108, P2015, DOI 10.1161/01.CIR.0000093201.57771.47
   BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Chang CC, 1999, BIOMATERIALS, V20, P273, DOI 10.1016/S0142-9612(98)00171-9
   Christenson EM, 2005, J BIOMED MATER RES A, V74A, P141, DOI 10.1002/jbm.a.30317
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   Endo M, 2007, MOL THER, V15, P579, DOI 10.1038/sj.mt.6300092
   Ferrer MCC, 2010, LANGMUIR, V26, P14126, DOI 10.1021/la102315j
   Jang JY, 2004, BIOMATERIALS, V25, P3663, DOI 10.1016/j.biomaterials.2003.10.062
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Labow RS, 2005, J BIOMAT SCI-POLYM E, V16, P1167, DOI 10.1163/1568562054798563
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee H, 2011, PMSE PREPRINTS, V104, P41
   Lee HS, 2011, LANGMUIR, V27, P12458, DOI 10.1021/la202616u
   Li C, 2012, POLYMER, V53, P1138, DOI 10.1016/j.polymer.2012.01.019
   Lin DT, 2001, BIOMATERIALS, V22, P1521, DOI 10.1016/S0142-9612(00)00308-2
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Markowicz P, 2000, AM J RESP CRIT CARE, V161, P1942, DOI 10.1164/ajrccm.161.6.9909122
   Martin DC, 2010, J ORAL MAXIL SURG, V68, P508, DOI 10.1016/j.joms.2009.09.055
   MURAO S, 1983, CANCER RES, V43, P4989
   Ombelli M, 2011, BIOFOULING, V27, P505, DOI 10.1080/08927014.2011.585711
   Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020
   Schubert MA, 1997, J BIOMED MATER RES, V34, P493, DOI 10.1002/(SICI)1097-4636(19970315)34:4<493::AID-JBM10>3.0.CO;2-E
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017
   Solheim E, 2000, J BIOMED MATER RES, V49, P257, DOI 10.1002/(SICI)1097-4636(200002)49:2<257::AID-JBM15>3.0.CO;2-5
   Stachelek SJ, 2007, J BIOMED MATER RES A, V82A, P1004, DOI 10.1002/jbm.a.31215
   Stachelek SJ, 2011, BIOMATERIALS, V32, P4317, DOI 10.1016/j.biomaterials.2011.02.053
   STENDAHL OI, 1980, J CELL BIOL, V84, P215, DOI 10.1083/jcb.84.2.215
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tsai IY, 2011, SOFT MATTER, V7, P3599, DOI 10.1039/c0sm01353f
   Tsai IY, 2011, COLLOID SURFACE B, V84, P241, DOI 10.1016/j.colsurfb.2011.01.006
   Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043
   Wan LS, 2007, ACTA BIOMATER, V3, P183, DOI 10.1016/j.actbio.2006.09.007
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
NR 50
TC 38
Z9 38
U1 3
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 203
EP 212
DI 10.1002/jbm.a.34309
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900022
PM 22847892
OA Green Accepted, Green Published
DA 2018-10-19
ER

PT J
AU Voge, CM
   Johns, J
   Raghavan, M
   Morris, MD
   Stegemann, JP
AF Voge, Christopher M.
   Johns, Jeremy
   Raghavan, Mekhala
   Morris, Michael D.
   Stegemann, Jan P.
TI Wrapping and dispersion of multiwalled carbon nanotubes improves
   electrical conductivity of protein-nanotube composite biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE carbon nanotubes; composite; collagen; fibroblast; nanoparticle;
   pluronic
ID PERCOLATION-THRESHOLD; SURFACE-CHEMISTRY; IN-VITRO; SWNT;
   FUNCTIONALIZATION; NEURONS; RAMAN
AB Composites of extracellular matrix proteins reinforced with carbon nanotubes have the potential to be used as conductive biopolymers in a variety of biomaterial applications. In this study, the effect of functionalization and polymer wrapping on the dispersion of multiwalled carbon nanotubes (MWCNT) in aqueous media was examined. Carboxylated MWCNT were wrapped in either Pluronic (R) F127 or gelatin. Raman spectroscopy and X-ray photoelectron spectroscopy showed that covalent functionalization of the pristine nanotubes disrupted the carbon lattice and added carboxyl groups. Polymer and gelatin wrapping resulted in increased surface adsorbed oxygen and nitrogen, respectively. Wrapping also markedly increased the stability of MWCNT suspensions in water as measured by settling time and zeta potential, with Pluronic (R)-wrapped nanotubes showing the greatest effect. Treated MWCNT were used to make 3D collagenfibrinMWCNT composite materials. Carboxylated MWCNT resulted in a decrease in construct impedance by an order of magnitude, and wrapping with Pluronic (R) resulted in a further order of magnitude decrease. Functionalization and wrapping also were associated with maintenance of fibroblast function within proteinMWCNT materials. These data show that increased dispersion of nanotubes in proteinMWCNT composites leads to higher conductivity and improved cytocompatibility. Understanding how nanotubes interact with biological systems is important in enabling the development of new biomedical technologies. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:231238, 2013.
C1 [Voge, Christopher M.; Johns, Jeremy; Raghavan, Mekhala; Stegemann, Jan P.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Raghavan, Mekhala; Morris, Michael D.] Univ Michigan, Dept Chem, Ann Arbor, MI 48108 USA.
RP Stegemann, JP (reprint author), Univ Michigan, Dept Biomed Engn, 1101 Beal Ave, Ann Arbor, MI 48109 USA.
EM jpsteg@umich.edu
CR Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340
   Bardi G, 2009, NANOMED-NANOTECHNOL, V5, P96, DOI 10.1016/j.nano.2008.06.008
   Behler K, 2006, J NANOPART RES, V8, P615, DOI 10.1007/s11051-006-9113-6
   Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005
   Ciofani G, 2009, FULLER NANOTUB CAR N, V17, P11, DOI 10.1080/15363830802515840
   Coleman JN, 2006, ADV MATER, V18, P689, DOI 10.1002/adma.200501851
   Crouzier T, 2008, LANGMUIR, V24, P13173, DOI 10.1021/la801999n
   Dong H, 2009, ACS APPL MATER INTER, V1, P1599, DOI 10.1021/am900267e
   Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   George JJ, 2008, J NANOSCI NANOTECHNO, V8, P1913, DOI 10.1166/jnn.2008.024
   HIURA H, 1993, CHEM PHYS LETT, V202, P509, DOI 10.1016/0009-2614(93)90040-8
   Hu H, 2005, J PHYS CHEM B, V109, P11520, DOI 10.1021/jp050781w
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   Li J, 2007, ADV FUNCT MATER, V17, P3207, DOI 10.1002/adfm.200700065
   Luo SC, 2009, ACS APPL MATER INTER, V1, P1414, DOI 10.1021/am900117e
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   MAGNUSSON G, 1986, TOXICOL LETT, V30, P203, DOI 10.1016/0378-4274(86)90156-6
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p
   Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j
   Musumeci AW, 2007, POLYMER, V48, P1667, DOI 10.1016/j.polymer.2007.01.027
   Nativ-Roth E, 2007, MACROMOLECULES, V40, P3676, DOI 10.1021/ma0705366
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   Peng HQ, 2003, J AM CHEM SOC, V125, P15174, DOI 10.1021/ja037746s
   Quent VMC, 2010, J CELL MOL MED, V14, P1003, DOI 10.1111/j.1582-4934.2010.01013.x
   Sandler JKW, 2003, POLYMER, V44, P5893, DOI 10.1016/S0032-3861(03)00539-1
   Sangodkar H, 1996, ANAL CHEM, V68, P779, DOI 10.1021/ac950655w
   SCHMOLKA IR, 1972, J BIOMED MATER RES, V6, P571, DOI 10.1002/jbm.820060609
   Sinani VA, 2005, J AM CHEM SOC, V127, P3463, DOI 10.1021/ja045670+
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   Wenseleers W, 2004, ADV FUNCT MATER, V14, P1105, DOI 10.1002/adfm.200400130
   Wick P, 2007, TOXICOL LETT, V168, P121, DOI 10.1016/j.toxlet.2006.08.019
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Zhang J, 2003, J PHYS CHEM B, V107, P3712, DOI 10.1021/jp027500u
NR 36
TC 20
Z9 20
U1 1
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 231
EP 238
DI 10.1002/jbm.a.34310
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900025
PM 22865813
DA 2018-10-19
ER

PT J
AU Shen, CC
   Yang, YC
   Liu, BS
AF Shen, Chiung-Chyi
   Yang, Yi-Chin
   Liu, Bai-Shuan
TI Effects of large-area irradiated laser phototherapy on peripheral nerve
   regeneration across a large gap in a biomaterial conduit
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE low-level laser therapy; neural regeneration; peripheral nerve injury;
   sciatic nerve
ID HE-NE-LASER; SCHWANN-CELLS; SCIATIC-NERVE; REPAIR; RAT; GROWTH; ENERGY;
   RECONSTRUCTION; PERONEAL; CULTURES
AB This paper proposes a novel biodegradable nerve conduit comprising 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) cross-linked gelatin, annexed with beta-tricalcium phosphate (TCP) ceramic particles (EDC-Gelatin-TCP, EGT). In this study, the EGT-implant site in rats was irradiated using a large-area 660 nm AlGaInP diode laser (50 mW) to investigate the feasibility of laser stimulation in the regeneration of a 15-mm transected sciatic nerve. The animals were divided into three groups: a sham-irradiated group (EGT/sham); an experimental group undergoing low-level laser (LLL) therapy (EGT/laser); a control group undergoing autologous nerve grafts (autografts). Twelve weeks after implantation, walking track analysis showed a significantly higher sciatic functional index (p < 0.05) and improved toe spreading development in the EGT/laser and autograft groups than in the EGT/sham group. In electrophysiological measurement, both the mean peak amplitude and the area under the compound muscle action potential curves in the EGT/laser and autograft groups showed significantly improved functional recovery than the EGT/sham group (p < 0.05). Compared with the EGT/sham group, the EGT/laser and autograft groups displayed a reduction in muscular atrophy. Histomorphometric assessments revealed that the EGT/laser group had undergone more rapid nerve regeneration than the EGT/sham group. The laser-treated group also presented greater neural tissue area as well as larger axon diameter and thicker myelin sheath than the tube group without the laser treatment, indicating improved nerve regeneration. Thus, these assessments demonstrate that LLL therapy can accelerate the repair of a transected peripheral nerve in rats after being bridged with EGT conduit. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A:239252, 2013.
C1 [Liu, Bai-Shuan] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.
   [Shen, Chiung-Chyi] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.
   [Shen, Chiung-Chyi; Yang, Yi-Chin] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan.
RP Liu, BS (reprint author), Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.
EM bsliu@ctust.edu.tw
FU Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China
   [TCVGH-CTUST1017702]; Central Taiwan University of Science and
   Technology, Taichung, Taiwan, Republic of China [TCVGH-CTUST1017702];
   National Science Council of the Republic of China, Taiwan [NSC
   98-2320-B-166-002-MY3]
FX Contract grant sponsor: Taichung Veterans General Hospital and Central
   Taiwan University of Science and Technology, Taichung, Taiwan, Republic
   of China; contract grant number: TCVGH-CTUST1017702; Contract grant
   sponsor: National Science Council of the Republic of China, Taiwan;
   contract grant number: NSC 98-2320-B-166-002-MY3
CR ABERGEL RP, 1987, J DERMATOL SURG ONC, V13, P127, DOI 10.1111/j.1524-4725.1987.tb00510.x
   Amat A, 2006, J PHOTOCH PHOTOBIO B, V82, P152, DOI 10.1016/j.jphotobiol.2005.10.001
   Bagis S, 2002, LASER SURG MED, V30, P376, DOI 10.1002/lsm.10057
   BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Dahlin LB, 2001, SCAND J PLAST RECONS, V35, P29, DOI 10.1080/02844310151032510
   Dahlin LB, 2004, J AM SOC SURG HAND, V4, P143, DOI DOI 10.1016/J.JASSH.2004.06.006
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Ehrlicher A, 2002, P NATL ACAD SCI USA, V99, P16024, DOI 10.1073/pnas.252631899
   Elles JT, 2003, P NATL ACAD SCI USA, V100, P3439
   Evans PJ, 1998, MUSCLE NERVE, V21, P1507, DOI 10.1002/(SICI)1097-4598(199811)21:11<1507::AID-MUS21>3.0.CO;2-W
   Gigo-Benato D, 2005, MUSCLE NERVE, V31, P694, DOI 10.1002/mus.20305
   Gulsoy M, 2006, J PHOTOCH PHOTOBIO B, V82, P199, DOI 10.1016/j.jphotobiol.2005.11.004
   IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0
   Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z
   Joel A, 2005, PHYS MED REHABILITAT
   KARU T, 1992, Laser Therapy, V4, P5
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Mendonca AC, 2003, J NEUROSCI METH, V129, P183, DOI 10.1016/S0165-0270(03)00207-3
   Monte-Raso VV, 2008, J NEUROSCI METH, V170, P255, DOI 10.1016/j.jneumeth.2008.01.022
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   Plikk P, 2009, BIOMACROMOLECULES, V10, P1259, DOI 10.1021/bm900093r
   Raso VVM, 2005, J NEUROSCI METH, V142, P185, DOI 10.1016/j.jneumeth.2004.08.016
   Rochkind S, 2001, LASER SURG MED, V28, P216, DOI 10.1002/lsm.1041
   ROCHKIND S, 1992, Neurological Research, V14, P2
   RODRIGUEZ FJ, 2004, DRUG DISCOV TODAY DI, V1, P177, DOI DOI 10.1016/J.DDMOD.2004.09.008
   Santiago LY, 2009, CELL TRANSPLANT, V18, P145, DOI 10.3727/096368909788341289
   Schwartz F, 2002, J PHOTOCH PHOTOBIO B, V66, P195, DOI 10.1016/S1011-1344(02)00267-1
   Shin DH, 2003, NEUROSCI LETT, V344, P71, DOI 10.1016/S0304-3940(03)00354-9
   Snyder SK, 2002, LASER SURG MED, V31, P216, DOI 10.1002/lsm.10098
   Sufan W, 2001, J NEUROTRAUM, V18, P329, DOI 10.1089/08977150151070991
   VANBREUGEL HHFI, 1993, J NEUROCYTOL, V22, P185, DOI 10.1007/BF01246357
   Vladimirov YA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P81, DOI 10.1023/B:BIRY.0000016356.93968.7e
   Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168
   WALKER J, 1983, NEUROSCI LETT, V43, P339, DOI 10.1016/0304-3940(83)90211-2
   Wollman Y, 1996, NEUROL RES, V18, P467
   Yang YC, 2010, J BIOMED MATER RES B, V95B, P207, DOI 10.1002/jbm.b.31705
NR 39
TC 8
Z9 8
U1 3
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2013
VL 101
IS 1
BP 239
EP 252
DI 10.1002/jbm.a.34314
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041YU
UT WOS:000311438900026
PM 22887896
DA 2018-10-19
ER

PT J
AU Wang, HY
   Zhang, YQ
AF Wang, Hai-Yan
   Zhang, Yu-Qing
TI Effect of regeneration of liquid silk fibroin on its structure and
   characterization
SO SOFT MATTER
LA English
DT Article
ID BOMBYX-MORI; L-ASPARAGINASE; IMMOBILIZATION; BIOMATERIAL; COCOON; FTIR
AB Silk derived from cocoons of the female silkworm (Bombyx mori) was made into three kinds of test material, degummed fiber, liquid fibroin and regenerated silk fibroin membrane (RSFM). The effect of the silk degumming and fiber dissolution system (SD-FDS) on the molecular structure and properties of silk fibroin were studied in detail. Degumming with Na2CO3 solution had the greatest impact on silk fibroin fiber, resulting in significant reduction of the thermal stability and crystallinity, and the fiber tensile property was only half of that degummed with urea buffer. The moderate degumming solution was urea buffer, followed by strongly alkaline electrolyzed water (SAEW). SDS-PAGE showed that the silk fibroin degummed with 8.0 M urea at 80 degrees C and dissolved in 9.3 M LiBr at 25 degrees C was similar to the natural silk fibroin in vivo, but boiling in Na2CO3 solution leads to serious breakage of the silk fibroin peptide chain. The degree of breakage of the peptide chain is positively correlated with the storage time of liquid silk fibroin. DSC showed the more nearly intact the silk fibroin peptide chain, the higher the thermal decomposition temperature. The regenerated condition of the silk protein is often overlooked during the research process, while our study showed that different silk degumming and fiber dissolution systems will have different influences. The results of this test help us gain a deeper understanding of the effect of silk degumming and fiber dissolution on the molecular structure and properties of silk fibroin and provide important experimental data for screening and using silk protein as advanced functional biomaterials, such as medical tissue engineering materials.
C1 [Wang, Hai-Yan; Zhang, Yu-Qing] Soochow Univ, Sch Biol & Basic Med Sci, Silk Biotechnol Lab, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Zhang, YQ (reprint author), Soochow Univ, Sch Biol & Basic Med Sci, Silk Biotechnol Lab, Natl Engn Lab Modern Silk, 702-2303 Room,199 Renai Rd, Suzhou 215123, Peoples R China.
EM sericult@suda.edu.cn
OI Zhang, Yu-Qing/0000-0001-7670-386X
FU earmarked fund for China Agriculture Research System (CARS); Priority
   Academic Program Development of Jiangsu Higher Education Institutions,
   P. R. China
FX The authors gratefully acknowledge the earmarked fund for China
   Agriculture Research System (CARS) and a project funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions,
   P. R. China.
CR Ajisawa A., 1968, SEN-I GAKKAISHI, V24, P61
   Asakura T, 2004, MAGN RESON CHEM, V42, P258, DOI 10.1002/mrc.1337
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Fraser R. D. B., 1973, CONFORMATIONS FIBROU
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Haggag K., 2007, J NATURAL FIBERS, V4
   Karve KA, 2011, J MEMBRANE SCI, V383, P44, DOI 10.1016/j.memsci.2011.08.032
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   Majibur M., 2010, BIORESOURCE TECHNOL, V101, P8439
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Matsumoto A, 2008, MACROMOL BIOSCI, V8, P1006, DOI 10.1002/mabi.200800020
   Matsumoto K., 1995, Japan Patent, Patent No. [JP7173192, 7173192]
   MITA K, 1994, J MOL EVOL, V38, P583
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Shimizu Y., 1978, J SERICULT SCI JPN, V47, P417
   Takahashi Y, 1999, INT J BIOL MACROMOL, V24, P127, DOI 10.1016/S0141-8130(98)00080-4
   Takasu Y., 2006, Sanshi Konchuu Biotec (Journal of Insect Biotechnology and Sericology), V75, P133
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   WALTERS RH, 1934, TEXT RES J, V5, P92
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YJ, 2011, ADV MATER RES-SWITZ, V175-176, P158, DOI 10.4028/www.scientific.net/AMR.175-176.158
   Wen D. J., 2005, ACTA SERICOL SIN, V26, P110
   Wu H. Y., 1993, ACTA SERICOL SIN, V19, P105
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Zhang Y. Q., 1997, ACTA SERICOL SIN, V28, P75
   Zhang Y.Q., 2012, China Patent, Patent No. [201210082082.X, 201210082082, CN 201210082082 X]
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zhang YQ, 2010, SCI CHINA LIFE SCI, V53, P1330, DOI 10.1007/s11427-010-4084-3
NR 35
TC 50
Z9 56
U1 4
U2 128
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2013
VL 9
IS 1
BP 138
EP 145
DI 10.1039/c2sm26945g
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 049EF
UT WOS:000311964200015
DA 2018-10-19
ER

PT S
AU Pavaloiu, RD
   Dobre, T
   Hlevca, C
AF Pavaloiu, Ramona-Daniela
   Dobre, Tanase
   Hlevca, Cristina
GP IEEE
TI Use of Bacterial Cellulose-Glycerol-Poly(vinyl alcohol) Composites in
   Drug Release
SO 2013 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB)
SE E-Health and Bioengineering Conference
LA English
DT Proceedings Paper
CT 4th IEEE International Conference on E-Health and Bioengineering (EHB)
CY NOV 21-23, 2013
CL Iasi, ROMANIA
SP IEEE, IEEE EMB Romania Chapter, Romanian Acad Iasi Branch, Inst Comp Sci
DE bacterial cellulose; drug release; biomaterial
ID BIOMEDICAL APPLICATIONS; CELLULOSE; NANOCOMPOSITES; MEMBRANES
AB Bacterial cellulose (BC) is a biomaterial suited for various biomedical applications, due to its unique nanostructure, that confers remarkable physical and chemical properties, such as: excellent elasticity, biocompatibility, high purity, high tensile strength and high elastic modulus. The article describes the mechanism and amoxicillin release profiles from bacterial cellulose-glycerol-poly(vinyl alcohol) composites, in the aim to use such systems in controlled drug delivery field. Obtained data from these composites were slightly smaller than BC-Glycerol, probably due to the fact that PVA layers provide an additional barrier for drug release. The presented data are of interest for the biomaterials community.
C1 [Pavaloiu, Ramona-Daniela; Dobre, Tanase] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest, Romania.
   [Hlevca, Cristina] ICCF Bucharest, Natl Inst Chem Pharmaceut Res & Dev, Bucharest, Romania.
RP Pavaloiu, RD (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest, Romania.
EM pavaloiu_daniella@yahoo.com
FU European Social Fund [POSDRU/107/1.5/S/76903]
FX We gratefully thank European Social Fund for their financial support
   (POSDRU/107/1.5/S/76903).
CR Chatri A, 2011, BIOMATTER, V1, P189
   Chiaoprakobkij N, 2011, CARBOHYD POLYM, V85, P548, DOI 10.1016/j.carbpol.2011.03.011
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Fu LN, 2013, CARBOHYD POLYM, V92, P1432, DOI 10.1016/j.carbpol.2012.10.071
   Gea S, 2010, MATER LETT, V64, P901, DOI 10.1016/j.matlet.2010.01.042
   Grande CJ, 2009, MAT SCI ENG C-BIO S, V29, P1098, DOI 10.1016/j.msec.2008.09.024
   Halib N, 2010, J APPL POLYM SCI, V116, P2920, DOI 10.1002/app.31857
   Kim J, 2011, J POLYM RES, V18, P739, DOI 10.1007/s10965-010-9470-9
   Kurniawan H, 2013, BIOCHEM ENG J, V78, P138, DOI 10.1016/j.bej.2013.03.021
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Pavaloiu R.D., CONTROLLED REL UNPUB
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Phisalaphong M, 2008, CARBOHYD POLYM, V74, P482, DOI 10.1016/j.carbpol.2008.04.004
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Trovatti E, 2011, BIOMACROMOLECULES, V12, P4162, DOI 10.1021/bm201303r
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wan YZ, 2009, COMPOS SCI TECHNOL, V69, P1212, DOI 10.1016/j.compscitech.2009.02.024
   Yin N, 2011, PROG NAT SCI-MATER, V21, P472, DOI 10.1016/S1002-0071(12)60085-9
NR 19
TC 0
Z9 0
U1 1
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2575-5137
EI 2575-5145
BN 978-1-4799-2372-4
J9 E-HEALTH BIOENG CONF
PY 2013
PG 4
WC Health Care Sciences & Services; Engineering, Biomedical; Medical
   Informatics
SC Health Care Sciences & Services; Engineering; Medical Informatics
GA BB8IU
UT WOS:000346672900080
DA 2018-10-19
ER

PT S
AU Wattanutchariya, W
AF Wattanutchariya, W.
GP IEEE
TI Relationship between Polymeric Foam Characteristics and Properties of
   Porous Bone Substitute Fabricated by Polymeric Foam Replication
SO 2013 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND
   ENGINEERING MANAGEMENT (IEEM 2013)
SE International Conference on Industrial Engineering and Engineering
   Management IEEM
LA English
DT Proceedings Paper
CT IEEE International Conference on Industrial Engineering and Engineering
   Management (IEEM)
CY DEC 10-13, 2013
CL Bangkok, THAILAND
SP IEEE, IEEE TMC Thailand Chapter, IEEE TMC Singapore Chapter, IEEE TMC Hong Kong Chapter, IEEE SMC Thailand Chapter
DE Polymeric foam replication; Porous Bone substitution; Bone scaffold;
   Trabecular bone; Biomaterial
AB Polymeric foam replication is one technique used to produce bone scaffold for porous bone substitution or bone grafting in the human body. This method provides scaffolds similar to trabecular bone, as well as producing a controllable pore size and porosity scaffold. Preliminary studies illustrated that the characteristics of polymeric foam such as pore size and porosity could affect both physical and mechanical properties of the resulting scaffold. Therefore, the objective of this study is to evaluate the relationship of polymeric foam characteristics with the properties of the porous bone scaffold. In this study, 5 different types of polymeric foam were evaluated, and the phosphate glass was implemented as the biomaterial slurry. Scaffold forming took place by immersing the foam types into the slurry and then sintering them at 750 degrees C for 3 hours. Porosity and compression testings were then used to analyze the physical and mechanical properties of the specimens. Results indicate that the optimal condition of both physical and mechanical properties was found when the polymeric foam with the highest pore density (99.5%) and approximately 300 mu m pore size range was used. However, the highest compression strength obtained was only 3.48 MPa, which is at the lower range of the trabecular bone's mechanical properties. Future study will therefore focus on producing stronger porous bone scaffold for porous bone substitution.
C1 [Wattanutchariya, W.] Chiang Mai Univ, Dept Ind Engn, Fac Engn, Design & Dev Adv Mfg Res Unit, Chiang Mai, Thailand.
RP Wattanutchariya, W (reprint author), Chiang Mai Univ, Dept Ind Engn, Fac Engn, Design & Dev Adv Mfg Res Unit, Chiang Mai, Thailand.
EM wattanwa@gmail.com
FU Thai Stimulus Package 2; Department of Industrial Engineering and the
   Biomedical Engineering Center, Faculty of Engineering, Chiang Mai
   University, Thailand
FX The authors acknowledge support from Thai Stimulus Package 2. Special
   thanks to the Department of Industrial Engineering and the Biomedical
   Engineering Center, Faculty of Engineering, Chiang Mai University,
   Thailand for facility and laboratory support.
CR Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033
   Masoud M., 2010, APPL SURF SCI, V257, P1740
   Patrick J. P., 2004, TOPICS BIOMECHANICAL, P147
   Qiang F., 2007, PREPARATION BIOACTIV, P222
   Schwartzwalder K., 1963, Patent US, Patent No. [3090094 A, 3090094, 3,090,094]
   Wang X, 2010, FUNDAMENTAL BIOMECHA
   Wattanutchariya W., 2012, P JOINT S MECH IND E
   Yenbut P., 2013, BANGK INT C BIOL ENG
NR 9
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2157-3611
BN 978-1-4799-0986-5
J9 IN C IND ENG ENG MAN
PY 2013
BP 1072
EP 1076
PG 5
WC Engineering, Industrial; Operations Research & Management Science
SC Engineering; Operations Research & Management Science
GA BH0NG
UT WOS:000395631500213
DA 2018-10-19
ER

PT S
AU Goktas, H
   Zaghloul, M
AF Goktas, Hasan
   Zaghloul, Mona
GP IEEE
TI HIGH SENSITIVITY CMOS PORTABLE BIOSENSOR WITH FLEXIBLE MICROFLUIDIC
   INTEGRATION
SO 2013 IEEE SENSORS
SE IEEE Sensors
LA English
DT Proceedings Paper
CT 12th IEEE Sensors Conference
CY NOV 03-06, 2013
CL Baltimore, MD
SP IEEE, IEEE Sensors Council
ID QUALITY-FACTOR; AIR
AB In this work, a portable biosensor that has 60% effective surface area on the chip with 1fg sensitivity by using novel array configuration is designed, and sent for fabrication. High frequency shift, quality factor, capacitance ratio, and small response time during the AC actuation are the critical parameters for the biosensor design. By using a beam structure in contrast to the more common cantilever, the effective surface area increases from 41% to 71%. Flexible microfluidic channels are integrated with the CMOS chip to deliver the biomaterial and are used for the packaging.
C1 [Goktas, Hasan; Zaghloul, Mona] George Washington Univ, Elect & Comp Engn, Washington, DC 20052 USA.
RP Goktas, H (reprint author), George Washington Univ, Elect & Comp Engn, Washington, DC 20052 USA.
EM hgoktas.gwu@gmail.com; mona.zaghloul@gmail.com
CR Ikehara T, 2007, J MICROMECH MICROENG, V17, P2491, DOI 10.1088/0960-1317/17/12/015
   Lee JH, 2007, J MICROMECH MICROENG, V17, P139, DOI 10.1088/0960-1317/17/1/018
   Li YC, 2006, J MICROMECH MICROENG, V16, P2659, DOI 10.1088/0960-1317/16/12/019
   Liu Chan, FDN MEMS, P130
   Naeli K, 2009, J APPL PHYS, V105, DOI 10.1063/1.3062204
   Rebeiz Gabriel M., 2003, RF MEMS THEORY DESIG, P30
   Verd J., 2007, APPL PHYS LETT, V91
   YOON JY, 2012, REV SENSORS, V12, P10713, DOI DOI 10.3390/S120810713
   Zhang BW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01098
NR 9
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1930-0395
BN 978-1-4673-4642-9
J9 IEEE SENSOR
PY 2013
BP 314
EP 317
PG 4
WC Engineering, Electrical & Electronic; Remote Sensing
SC Engineering; Remote Sensing
GA BF0XP
UT WOS:000379846100079
DA 2018-10-19
ER

PT S
AU Feng, NC
   Zhang, FY
AF Feng, Ningchuan
   Zhang, Fengyuan
BE Quan, X
TI Untreated Chinese ephedra residue as biosorbents for the removal of Pb2+
   ions from aqueous solutions
SO 2013 INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL SCIENCE AND TECHNOLOGY
   (2013 ISEST)
SE Procedia Environmental Sciences
LA English
DT Proceedings Paper
CT 4th International Symposium on Environmental Science and Technology
   (ISEST)
CY JUN 04-07, 2013
CL Dalian, PEOPLES R CHINA
SP Chinese Soc Environm Sci, Beijing Inst Technol, Dalian Univ Technol, Dalian Assoc Sci & Technol, ENVR Div Amer Chem Soc, Dalian Soc Environm Sci, Profess Comm Pollut Prevent & Control Heavy Metals CSES, Dalian Univ Technol, Key Lab Ind Ecol & Environm Engn, Dalian Univ Technol, Sch Environm Sci & Technol, Beijing Inst Technol, State Key Lab Explos Sci & Technol
DE Ephedria residue; Pb2+ ions; Biosorption; Isotherms; Kinetics
ID LOW-COST BIOSORBENT; HEAVY-METALS; ADSORPTION; BIOSORPTION; EQUILIBRIUM;
   KINETICS; PB(II); CARBON
AB The objective of this work was to propose an alternative use for ephedra residue (ER) as untreated biosorbents for the removal of Pb2+ ions from aqueous solutions. Biosorption studies were conducted as a function of the solution pH, contact time and initial metal ion concentration. The biosorption kinetics was determined by fitting second-order kinetic models to the experimental data, being described by the pseudo-second-order model (R-2 > 0.99). Both Langmuir and Freundlich sorption models fit the experimental sorption equilibrium data, with Langmuir providing the best fit (R-2 > 0.97). According to the Langmuir equation, the maximum uptake capacity for Pb2+ ions was 1.0 mmol/g at 298K. A comparison of the maximum sorption capacity of several untreated biomaterial-based residues showed that the ER is a suitable candidate for use as biosorbents in the removal of Pb2+ ions from aqueous solutions. (C) 2013 The Authors. Published by Elsevier B.V.
C1 [Feng, Ningchuan; Zhang, Fengyuan] Ningxia Med Univ, Sch Basic Med Sci, Yinchuan 750004, Peoples R China.
RP Feng, NC (reprint author), Ningxia Med Univ, Sch Basic Med Sci, Yinchuan 750004, Peoples R China.
EM ncfeng@sina.com
CR Amarasinghe BMWPK, 2007, CHEM ENG J, V132, P299, DOI 10.1016/j.cej.2007.01.016
   Azouaou N, 2010, J HAZARD MATER, V184, P126, DOI 10.1016/j.jhazmat.2010.08.014
   Chen JP, 2000, SEP PURIF TECHNOL, V19, P157, DOI 10.1016/S1383-5866(99)00069-6
   Farajzadeh MA, 2004, SEP PURIF TECHNOL, V38, P197, DOI 10.1016/j.seppur.2003.11.005
   Feng NC, 2011, J HAZARD MATER, V185, P49, DOI 10.1016/j.jhazmat.2010.08.114
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   Huang LH, 2011, DESALINATION, V268, P12, DOI 10.1016/j.desal.2010.09.044
   Li QZ, 2009, APPL SURF SCI, V255, P4298, DOI 10.1016/j.apsusc.2008.11.024
   Qi BC, 2008, BIORESOURCE TECHNOL, V99, P5595, DOI 10.1016/j.biortech.2007.10.042
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Sari A, 2007, BIOCHEM ENG J, V37, P151, DOI 10.1016/j.bej.2007.04.007
   Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009
   Witek-Krowiak A, 2011, DESALINATION, V265, P126, DOI 10.1016/j.desal.2010.07.042
   Yao YJ, 2010, BIORESOURCE TECHNOL, V101, P3040, DOI 10.1016/j.biortech.2009.12.042
   Zouboulis AI, 2004, PROCESS BIOCHEM, V39, P909, DOI 10.1016/S0032-9592(03)00200-0
NR 15
TC 2
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1878-0296
J9 PROCEDIA ENVIRON SCI
PY 2013
VL 18
BP 794
EP 799
DI 10.1016/j.proenv.2013.04.107
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA BD4NK
UT WOS:000360928700105
OA Other Gold
DA 2018-10-19
ER

PT J
AU Freischmidt, A
   Muller, K
   Ludolph, AC
   Weishaupt, JH
AF Freischmidt, Axel
   Mueller, Kathrin
   Ludolph, Albert C.
   Weishaupt, Jochen H.
TI Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic
   lateral sclerosis
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
AB Background: A pathological hallmark of most amyotrophic lateral sclerosis (ALS) cases are intracellular aggregates of the protein TDP-43. The pathophysiological relevance of TDP-43 is underlined by familial ALS cases caused by TDP-43 mutations. TDP-43 is involved in processing of both coding RNAs and microRNAs, which are key epigenetic regulators of transcriptome plasticity and suspected to contribute to neurological diseases. We therefore asked whether the TDP-43 binding microRNAs recently identified in cell lines are also dysregulated in ALS patients. We compared their abundance in cerebrospinal fluid (CSF), serum and immortalized lymphoblast cell lines (LCLs) derived from ALS patients and healthy controls.
   Results: We found that expression levels of 5 out of 9 TDP-43 binding microRNAs were altered in the CSF and serum of sporadic ALS cases. The differentially regulated serum microRNAs together with a poor correlation between CSF and serum levels indicate a systemic dysregulation of microRNA abundance independent from the CSF compartment, in line with the ubiquitous expression of TDP-43. The most strongly regulated microRNAs could be confirmed in LCLs from genetically defined ALS patients. While dysregulation of miR-143-5p/3p seems to be a common feature of ALS pathology, downregulation of miR-132-5p/3p and miR-574-5p/3p was evident in sporadic, TARDBP, FUS and C9ORF72, but not SOD1 mutant patients. This parallels the TDP-43 pathology found in most ALS cases, but usually not in patients with SOD1 mutation.
   Conclusions: We thus report a systemic and genotype-dependent dysregulation of TDP-43 binding microRNAs in human biomaterial that might reflect an easily accessible biological measure of TDP-43 dysfunction. Furthermore we suggest an independent regulation of TDP-43 binding microRNAs in the serum and CSF compartment as well as a generally low transition of microRNAs across the blood-cerebrospinal fluid barrier.
C1 [Freischmidt, Axel; Mueller, Kathrin; Ludolph, Albert C.; Weishaupt, Jochen H.] Ulm Univ, Dept Neurol, Albert Einstein Allee 113, D-89081 Ulm, Germany.
RP Weishaupt, JH (reprint author), Ulm Univ, Dept Neurol, Albert Einstein Allee 113, D-89081 Ulm, Germany.
EM jochen.weishaupt@uni-ulm.de
FU German Federal Ministry of Education and Research [01GI0704]; Charcot
   Foundation for ALS Research (ACL, JHW); virtual Helmholtz Institute;
   BMBF
FX Antje Knehr is gratefully acknowledged. Work was supported whole or in
   parts by grants from the German Federal Ministry of Education and
   Research (01GI0704; network for ALS research (MND-NET)), the Charcot
   Foundation for ALS Research (ACL, JHW), the virtual Helmholtz Institute
   "RNA-Dysmetabolismus bei ALS und FTD" and the BMBF funded Swabian ALS
   Registry.
CR Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4
   Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150
   Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110
   Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x
   Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x
   Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5
   Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009
   Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012
   De Felice B, 2012, GENE, V508, P35, DOI 10.1016/j.gene.2012.07.058
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101
   Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577
   Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120
   Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0
   Ingre C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.009
   Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264
   Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4
   Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106
   Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Kolde G, 1996, LANCET, V347, P1226, DOI 10.1016/S0140-6736(96)90737-0
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Lawton KA, 2012, AMYOTROPH LATERAL SC, V13, P110, DOI 10.3109/17482968.2011.619197
   Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10
   Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147
   Morlando M, 2012, EMBO J, V31, P4502, DOI 10.1038/emboj.2012.319
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107
   Soreq H, 2011, TRENDS MOL MED, V17, P548, DOI 10.1016/j.molmed.2011.06.009
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151
   Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106
   Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107
   Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280
   Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409
   Xu JH, 2012, J MOL MED, V90, P865, DOI 10.1007/s00109-011-0840-5
NR 41
TC 59
Z9 59
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2051-5960
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PY 2013
VL 1
AR 42
DI 10.1186/2051-5960-1-42
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA V9K2F
UT WOS:000422387200032
PM 24252274
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Goffard, R
   Sforza, T
   Clarinval, A
   Dormal, T
   Boilet, L
   Hocquet, S
   Cambier, F
AF Goffard, R.
   Sforza, T.
   Clarinval, A.
   Dormal, T.
   Boilet, L.
   Hocquet, S.
   Cambier, F.
TI Additive manufacturing of biocompatible ceramics
SO ADVANCES IN PRODUCTION ENGINEERING & MANAGEMENT
LA English
DT Article
DE Biomaterial; Ceramic; Rapid Manufacturing
AB Considering that the ageing of the population is not going to stop, the need for biocompatible materials is continuously increasing, especially in the field of bone substitutes as well as in the fabrication of surgery tools. The Optoform process is an additive manufacturing technology able to shape most of the common biocompatible ceramic materials such as hydroxyapatite (HA) and tricalcium phosphate (TCP). Those ceramic materials are largely studied to substitute bone defects or as voids fillers while stronger bioinert materials like alumina and zirconia can find applications in surgery tools or in dentistry. The Optoform process allows building a component, layer by layer, from CAD data, leading to significant advantages: 1) the manufacturing of elements with a complex geometry and with a controlled porosity that would be impossible to demold or to machine; and 2) short delays of production for customized part with the desired characteristics and design. The quality control of these parts is essential for medical use and is certified by the control of each step of the manufacturing process: synthesis of biocompatible ceramic powders, preparation of photo-curable resin based paste, shaping of the part by Optoform and subsequent thermal treatment for debinding and sintering. (C) 2013 PEI, University of Maribor. All rights reserved.
C1 [Goffard, R.] CRIG, B-4030 Angleur, Belgium.
   [Sforza, T.; Clarinval, A.; Dormal, T.] Sirris, Addit Mfg Dept, Seraing 4102, Belgium.
   [Boilet, L.; Hocquet, S.; Cambier, F.] BCRC, B-7000 Mons, Belgium.
RP Goffard, R (reprint author), CRIG, 27 Quai Condroz, B-4030 Angleur, Belgium.
EM raphael.goffard@sirris.be
FU Walloon region
FX We would like to thanks the Walloon region for its financial supports in
   the project OPTOBIO. In addition we thanks Dr. D. Nimal for the cell
   culture, the rats implanted and the STL file of a cranial flap. Thanks
   to Centis, Medsys and Dr ph. Docquier for their case studies and STL
   files.
CR Allanic A.-L., 2000, Patent, Patent No. [US6110409, 6110409]
   Becker ST, 2009, ORAL ONCOL, V45, pE181, DOI 10.1016/j.oraloncology.2009.07.004
   Benaqqa C., 2003, THESIS U LYON LYON
   Boilet L, 2013, CERAM INT, V39, P283, DOI 10.1016/j.ceramint.2012.06.023
   Charlier T., 1997, Patent, Patent No. [W00042471, 0042471]
   Clarinval A.M., 2010, P NANT MAT 2010 S NA
   DORMAL T, 2004, IND TECHNOLOGIES JUI, P64
   Greco A, 2001, J MATER SCI, V36, P99, DOI 10.1023/A:1004899027360
   Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   Kundribskaja S., 2010, J FUNCTIONAL BIOMATE, V1, P22, DOI [10.3390/jfb1010022, DOI 10.3390/JFB1010022]
   Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Rose FR, 2004, BIOMATERIALS, V25, P5507, DOI 10.1016/j.biomaterials.2004.01.012
   Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291
   Tan KH, 2005, P I MECH ENG H, V219, P183, DOI 10.1243/095441105X9345
   Tommasini SM, 2008, J BONE MINER RES, V23, P236, DOI 10.1359/JBMR.071014
   Vorndran E, 2008, ADV ENG MATER, V10, pB67, DOI 10.1002/adem.200800179
   YUKITOSHI K, 2000, Patent No. 0059972
NR 19
TC 3
Z9 3
U1 3
U2 21
PU UNIV MARIBOR, FAC MECHANICAL ENGINEERING
PI MARIBOR
PA SMETANOVA ULICA 17, MARIBOR, SI-2000, SLOVENIA
SN 1854-6250
EI 1855-6531
J9 ADV PROD ENG MANAG
JI Adv. Prod. Eng. Manag.
PY 2013
VL 8
IS 2
BP 96
EP 106
DI 10.14743/apem2013.2.157
PG 11
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA V41VA
UT WOS:000209572500004
OA Bronze
DA 2018-10-19
ER

PT J
AU Brown, SR
   Wadhawan, H
   Nelson, RL
AF Brown, Steven R.
   Wadhawan, Himanshu
   Nelson, Richard L.
TI Surgery for faecal incontinence in adults
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Anal Canal [surgery]; Electric Stimulation Therapy [methods]; Fecal
   Incontinence [surgery; therapy]; Pelvic Floor [surgery]; Randomized
   Controlled Trials as Topic; Adult; Humans
ID ANAL-SPHINCTER REPAIR; PELVIC FLOOR REPAIR; RANDOMIZED-CONTROLLED-TRIAL;
   SACRAL NERVE-STIMULATION; INJECTABLE SILICONE BIOMATERIAL; ARTIFICIAL
   BOWEL SPHINCTER; DOUBLE-BLIND CROSSOVER; COMPARING 3 FORMS; TO-END
   REPAIR; CLINICAL-TRIAL
AB Background
   Faecal incontinence is a debilitating problem with significant medical, social and economic implications. Treatment options include conservative, non-operative interventions (for example pelvic floor muscle training, biofeedback, drugs) and surgical procedures. A surgical procedure may be aimed at correcting an obvious mechanical defect, or augmenting a functionally deficient but structurally intact sphincter complex.
   Objectives
   To assess the effects of surgical techniques for the treatment of faecal incontinence in adults who do not have rectal prolapse. Our aim was firstly to compare surgical management with non-surgical management and secondly, to compare the various surgical techniques.
   Search methods
   Electronic searches of the Cochrane Incontinence Group Specialised Register (searched 6 March 2013), the Cochrane Colorectal Cancer Group Specialised Register (searched 6 March 2013), CENTRAL (2013, issue 1) and EMBASE (1 January 1998 to 6 March 2013) were undertaken. The British Journal of Surgery (1 January 1995 to 6 March 2013), Colorectal Diseases (1 January 2000 to 6 March 2013) and the Diseases of the Colon and Rectum (1 January 1995 to 6 March 2013) were specifically handsearched. The proceedings of the Association of Coloproctology of Great Britain and Ireland annual meetings held from 1999 to 2012 were perused. Reference lists of all relevant articles were searched for further trials.
   Selection criteria
   All randomised or quasi-randomised trials of surgery in the management of adult faecal incontinence (other than surgery for rectal prolapse).
   Data collection and analysis
   Three review authors independently selected studies from the literature, assessed the methodological quality of eligible trials and extracted data. The three primary outcome measures were change or deterioration in incontinence, failure to achieve full continence, and the presence of faecal urgency.
   Main results
   Nine trials were included with a total sample size of 264 participants. Two trials included a group managed non-surgically. One trial compared levatorplasty with anal plug electrostimulation and one compared an artificial bowel sphincter with best supportive care. The artificial bowel sphincter resulted in significant improvements in at least one primary outcome but the numbers were small. The other trial showed no difference in the primary outcome measures.
   Seven trials compared different surgical interventions. These included anterior levatorplasty versus postanal repair, anterior levatorplasty versus total pelvic floor repair, total pelvic floor versus postanal repair, end to end versus overlap sphincter repair, overlap repair with or without a defunctioning stoma or with or without biofeedback, and total pelvic floor repair versus repair plus internal sphincter plication and neosphincter formation versus total pelvic floor repair. Sacral nerve stimulation and injectables are considered in separate Cochrane reviews. Only one comparison had more than one trial (total pelvic floor versus postanal repair, 44 participants) and no trial showed any difference in primary outcome measures.
   Authors' conclusions
   The review is striking for the lack of high quality randomised controlled trials on faecal incontinence surgery that have been carried out in the last 10 years. Those trials that have been carried out have focused on sacral neuromodulation and injectable bulking agents, both reported in separate reviews. The continued small number of relevant trials identified together with their small sample sizes and other methodological weaknesses limit the usefulness of this review for guiding practice. It was impossible to identify or refute clinically important differences between the alternative surgical procedures. Larger rigorous trials are still needed. However, it should be recognised that the optimal treatment regime may be a complex combination of various surgical and non-surgical therapies.
C1 [Brown, Steven R.] Sheffield Teaching Hosp, Sheffield S7, S Yorkshire, England.
   [Wadhawan, Himanshu] Sheffield Teaching Hosp, Dept Surg, Sheffield, S Yorkshire, England.
   [Nelson, Richard L.] No Gen Hosp, Dept Gen Surg, Sheffield S7 S5 7AU, S Yorkshire, England.
RP Brown, SR (reprint author), No Gen Hosp, Sheffield Teaching Hosp, Dept Surg, Herried Rd, Sheffield S7 S5 7AU, S Yorkshire, England.
EM stevebrown@doctors.org.uk
FU NHS National R&D Programme for People with Physical and Complex
   Disabilities, UK; Chief Scientist Office, Scottish Executive Health
   Department, UK; The National Institute for Health Research, UK; The
   National Institute for Health Research (NIHR)
FX External sources; NHS National R&D Programme for People with Physical
   and Complex Disabilities, UK.; Chief Scientist Office, Scottish
   Executive Health Department, UK.; The National Institute for Health
   Research, UK.; The National Institute for Health Research (NIHR) is the
   largest single funder of the Cochrane Incontinence Group.
CR ANDREW J, 1964, BRAIN, V87, P233, DOI 10.1093/brain/87.2.233
   *BLADD BOW FDN, 2000, MAK CAS INT CONT SER
   BURNSTOCK G, 1990, CIBA F SYMP, V151, P18
   BURNSTOCK G, 1990, CIBA F SYMP, V151, P2
   BYAR DP, 1976, NEW ENGL J MED, V295, P74, DOI 10.1056/NEJM197607082950204
   CARRARO PS, 1994, BRIT J SURG, V81, P140
   Chen ASH, 1998, DIS COLON RECTUM, V41, P1005, DOI 10.1007/BF02237391
   COUNIHAN TC, 2005, CURRENT THERAPY COLO, P105
   Davis KJ, 2004, ALIMENT PHARM THERAP, V20, P539, DOI 10.1111/j.1365-2036.2004.02119.x
   de Groat W.C., 1990, CIBA F SYMP, V151
   DEEN KI, 1993, BRIT J SURG, V80, P794, DOI 10.1002/bjs.1800800648
   DEEN KI, 1995, DIS COLON RECTUM, V38, P14, DOI 10.1007/BF02053851
   DEGROAT WC, 1990, CIBA F SYMP, V151, P27
   Delhi T, 2013, SCAND J GASTROENTERO, V48, P302
   Farrell SA, 2012, OBSTET GYNECOL, V120, P803, DOI 10.1097/AOG.0b013e31826ac4bb
   Farrell SA, 2010, OBSTET GYNECOL, V116, P16, DOI 10.1097/AOG.0b013e3181e366ef
   FeltBersma RJF, 1997, DIS COLON RECTUM, V40, P811, DOI 10.1007/BF02055438
   Fernando R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002866.pub2
   Fernando R, 2004, NEUROUROL URODYNAM, V23, P411
   Fernando RJ, 2006, OBSTET GYNECOL, V107, P1261, DOI 10.1097/01.AOG.0000218693.24144.bd
   Fitzpatrick M, 2000, AM J OBSTET GYNECOL, V183, P1220, DOI 10.1067/mob.2000.108880
   FITZPATRICK M, 1999, COLORECTAL DIS S1, V1, P10
   Garcia V, 2005, AM J OBSTET GYNECOL, V192, P1697, DOI 10.1016/j.ajog.2004.11.045
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Hasegawa H, 2000, DIS COLON RECTUM, V43, P961, DOI 10.1007/BF02237359
   Higgins JPT, 2008, COCHRANE HDB SYSTEMA
   Horrocks E, 2011, CONTROL FAECAL INCON
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Johanson JF, 1996, AM J GASTROENTEROL, V91, P33
   Kalantar JS, 2002, MED J AUSTRALIA, V176, P54
   Kamm MA, 1998, BRIT MED J, V316, P528, DOI 10.1136/bmj.316.7130.528
   Keating JP, 1997, DIS COLON RECTUM, V40, P896, DOI 10.1007/BF02051195
   Lam, 1999, Colorectal Dis, V1, P197, DOI 10.1046/j.1463-1318.1999.00044.x
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   LODER PB, 1993, BRIT J SURG, V80, P1352, DOI 10.1002/bjs.1800801053
   MacArthur C, 1997, BRIT J OBSTET GYNAEC, V104, P46, DOI 10.1111/j.1471-0528.1997.tb10648.x
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub3
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   Mellgren A, 1999, DIS COLON RECTUM, V42, P857, DOI 10.1007/BF02237089
   Michelsen HB, 2008, DIS COLON RECTUM, V51, P538, DOI 10.1007/s10350-008-9219-2
   Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2
   Nakayama H, 1997, STROKE, V28, P58, DOI 10.1161/01.STR.28.1.58
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Nordenstam J, 2008, BJOG-INT J OBSTET GY, V115, P857, DOI 10.1111/j.1471-0528.2008.01726.x
   O'Brien PE, 2004, DIS COLON RECTUM, V47, P1852, DOI 10.1007/s10350-004-0717-6
   Osterberg A, 2004, BRIT J SURG, V91, P1131, DOI 10.1002/bjs.4577
   Parellada CM, 1998, DIS COLON RECTUM, V41, P593, DOI 10.1007/BF02235265
   PARKS AG, 1975, P ROY SOC MED, V68, P681
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   Pfeifer J, 1997, DIS COLON RECTUM, V40, P79, DOI 10.1007/BF02055686
   Rainey J B, 1990, J R Coll Surg Edinb, V35, P101
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rygh AB, 2010, ACTA OBSTET GYN SCAN, V89, P1256, DOI 10.3109/00016349.2010.512073
   Ryhammer AM, 1997, DIS COLON RECTUM, V40, P287, DOI 10.1007/BF02050417
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Siproudhis L, 2006, DIS COLON RECTUM, V49, P219, DOI 10.1007/s10350-005-0249-8
   SUN WM, 1990, GUT, V31, P1056, DOI 10.1136/gut.31.9.1056
   Takahashi T, 2002, DIS COLON RECTUM, V45, P915, DOI 10.1007/s10350-004-6328-4
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P937, DOI 10.1097/01.DCR.0000074687.97942.92
   Tjandra JJ, 2008, DIS COLON RECTUM, V51, P494, DOI 10.1007/s10350-007-9103-5
   Tou S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001758.pub2
   TURNBERG L, 1995, INCONTINENCE CAUSES
   Uher EM, 1998, DIS COLON RECTUM, V41, P1165, DOI 10.1007/BF02239440
   Vaizey CJ, 2000, DIS COLON RECTUM, V43, P298, DOI 10.1007/BF02258292
   Vaizey CJ, 1998, BRIT J SURG, V85, P596
   van Tets WF, 1998, DIS COLON RECTUM, V41, P365, DOI 10.1007/BF02237493
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
   WILLIAMS A, 2004, P INT CONT SOC UK 11, P33
   Wong MTC, 2011, DIS COLON RECTUM, V54, P773, DOI 10.1007/DCR.0b013e3182182689
   Yoshioka K, 1999, DIS COLON RECTUM, V42, P252, DOI 10.1007/BF02237137
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 77
TC 11
Z9 12
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2013
IS 7
AR CD001757
DI 10.1002/14651858.CD001757.pub4
PG 70
WC Medicine, General & Internal
SC General & Internal Medicine
GA 193OB
UT WOS:000322568100006
PM 23821339
OA Bronze
DA 2018-10-19
ER

PT J
AU Maeda, Y
   Laurberg, S
   Norton, C
AF Maeda, Yasuko
   Laurberg, Soren
   Norton, Christine
TI Perianal injectable bulking agents as treatment for faecal incontinence
   in adults
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Acrylic Resins [administration & dosage]; Administration, Rectal;
   Biocompatible Materials [administration & dosage]; Collagen
   [administration & dosage]; Dimethylpolysiloxanes [administration &
   dosage]; Fecal Incontinence [therapy]; Glucans [administration &
   dosage]; Hydrogels [administration & dosage]; Palpation; Randomized
   Controlled Trials as Topic; Silicones [administration & dosage];
   Ultrasonography, Interventional; Zirconium [administration & dosage];
   Adult; Humans
ID INTERNAL ANAL-SPHINCTER; SILICONE BIOMATERIAL PTQ(TM); HYALURONIC-ACID;
   AUTOLOGOUS FAT; RISK-FACTORS; INJECTION; MANAGEMENT; IMPLANTS;
   DYSFUNCTION; DEXTRANOMER
AB Background
   Faecal incontinence is a complex and distressing condition with significant medical and social implications. Injection of perianal bulking agents has been used to treat the symptoms of passive faecal incontinence. However, various agents have been used without a standardised technique and the supposed benefit of the treatment is largely anecdotal with a limited clinical research base.
   Objectives
   To determine the effectiveness of perianal injection of bulking agents for the treatment of faecal incontinence in adults.
   Search methods
   We searched the Cochrane Incontinence Group Specialised Register of trials (25 May 2012), ZETOC (3 May 2012), clinical trials registries (3 May 2012) and the reference lists of relevant articles.
   Selection criteria
   All randomised or quasi-randomised controlled trials comparing the use of injectable bulking agents for faecal incontinence with any alternative treatments or placebo were reviewed to evaluate the therapeutic effects. Case-control and cohort studies were also reviewed to assess risks and complications associated with the treatments.
   Data collection and analysis
   Two review authors (YM and CN) assessed the methodological quality of eligible trials and independently extracted data from the included trials using a range of pre-specified outcome measures.
   Main results
   Five eligible randomised trials with a total of 382 patients were identified. Four of the trials were at an uncertain or high risk of bias.
   Most trials reported a short term benefit from injections regardless of the material used, including placebo saline injection. One study demonstrated dextranomer in stabilised hyaluronic acid (NASHA Dx) to be more effective than sham injection but with more adverse effects. Dextranomer in stabilised hyaluronic acid (NASHA Dx) was better than sham injections at six months (65/136, 48% versus 48/70, 69% participants not improved, defined as less than 50% reduction in incontinence episodes, RR 0.70, 95% CI 0.55 to 0.88; with more incontinence free days (3.1 days compared with 1.7 in the sham treatment group, MD 1.40 days, 95% CI 0.33 to 2.47). Another study comparing silicone material (PTQ (TM)) to saline injections was too small to demonstrate a clinical benefit compared to the control injection of normal saline.
   A silicone biomaterial (PTQ (TM)) was shown to provide some advantages and was safer in treating faecal incontinence than carbon-coated beads (Durasphere (R)) in the short term.
   Similarly, there were short term benefits from injections delivered under ultrasound guidance compared with digital guidance.
   No long term evidence on outcomes was available and further conclusions were not warranted from the available data. None of the studies reported patient evaluation of outcomes and thus it is difficult to gauge whether the improvement in incontinence scores matched practical symptom improvements that mattered to the patients.
   Authors' conclusions
   One large randomised controlled trial has shown that this form of treatment using dextranomer in stabilised hyaluronic acid (NASHA Dx) improves continence for a little over half of patients in the short term. However, the number of identified trials was limited and most had methodological weaknesses.
C1 [Maeda, Yasuko] St Marks Hosp, Sir Alan Parks Physiol Unit, Harrow, Middx, England.
   [Laurberg, Soren] Aarhus Univ Hosp, Dept Surg, DK-8000 Aarhus, Denmark.
   [Norton, Christine] Kings Coll London, London WC2R 2LS, England.
   [Norton, Christine] Imperial Coll Healthcare NHS Trust, London, England.
RP Maeda, Y (reprint author), St Marks Hosp, Sir Alan Parks Physiol Unit, Northwick Pk,Watford Rd, Harrow, Middx, England.
EM yazmaeda@gmail.com
RI Maeda, Yasuko/B-6123-2016
FU NIHR, UK
FX External sources; NIHR, UK.; The Cochrane Incontinence Review Group is
   supported by NIHR UK
CR Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   [Anonymous], 2011, EUCTR201002146332AT
   [Anonymous], 2009, NCT00762047 PROSP MU
   [Anonymous], 2009, NCT00605826 RAND BLI
   Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   Bharucha AE, 2010, GASTROENTEROLOGY, V139, P1559, DOI 10.1053/j.gastro.2010.07.056
   Brown SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001757.pub3
   Chan M., 2006, INJECTABLE SILICONE
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Cheetham M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002116
   Christiansen J, 1999, ANN SURG, V230, P45, DOI 10.1097/00000658-199907000-00007
   da Silva GM, 2003, DIS COLON RECTUM, V46, P1492, DOI 10.1097/01.DCR.0000093642.39267.67
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   Dehli T, 2009, RANDOMIZED CONTROLLE
   Dehli Trond, 2007, Tidsskr Nor Laegeforen, V127, P2934
   Deutekom M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005086.pub3
   Dodi G, 2010, GASTROENT RES PRACT, DOI 10.1155/2010/467136
   Draganic B, PTQ VERSUS DURASPHRE
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   Fader M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007408
   FeltBersma RJF, 1996, DIS COLON RECTUM, V39, P878, DOI 10.1007/BF02053986
   Feretis C, 2001, DIS COLON RECTUM, V44, P1605, DOI 10.1007/BF02234379
   Frudinger A, 2010, GUT, V59, P55, DOI 10.1136/gut.2009.181347
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   Gett RM, 2007, ANZ J SURG S1, V77, pA16
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Higgins J, COCHRANE HDB SYSTEMA
   Hosker G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001310.pub2
   Hussain ZI, 2011, BRIT J SURG, V98, P1526, DOI 10.1002/bjs.7645
   Kumar D, 1998, BRIT J SURG, V85, P978
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   Lindsey I, 2004, DIS COLON RECTUM, V47, P1643, DOI 10.1007/s10350-004-0651-7
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2
   National Collaborating Centre for Acute Care and NHS National Institute for Health and Clinical Excellence (NICE), 2007, CG49 ROYAL COLL SURG
   Norderval S, 2012, BLINDED RANDOMIZED C
   Norton C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub3
   Rao SSC, 2004, GASTROENTEROLOGY, V126, pS14, DOI 10.1053/j.gastro.2003.10.013
   Ratto C, 2011, BRIT J SURG, V98, P1644, DOI 10.1002/bjs.7699
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Smart N, 2008, COLORECTAL DIS, V10, P628, DOI 10.1111/j.1463-1318.2008.01475.x
   Smart N, 2005, COLORECTAL DIS, V7, P59
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2004, P AM SOC COL RECT SU, P178
   Ullah S, 2011, JCPSP-J COLL PHYSICI, V21, P227, DOI 04.2011/JCPSP.227229
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   van der Hagen SJ, 2007, BRIT J SURG, V94, P222, DOI 10.1002/bjs.5463
   van Wunnik B, 2012, TECH COLOPROCTOL, V16, P395, DOI 10.1007/s10151-011-0702-8
   Weiss EG, 2002, DIS COLON RECTUM, V45, pA46
   Wexner SD, 1996, DIS COLON RECTUM, V39, P957, DOI 10.1007/BF02054681
   Wheeler TL, 2007, CURR OPIN OBSTET GYN, V19, P474, DOI 10.1097/GCO.0b013e3282ef4142
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
NR 66
TC 27
Z9 28
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2013
IS 2
AR CD007959
DI 10.1002/14651858.CD007959.pub3
PG 45
WC Medicine, General & Internal
SC General & Internal Medicine
GA 097GE
UT WOS:000315461200015
PM 23450581
DA 2018-10-19
ER

PT S
AU Beisembayev, K
AF Beisembayev, Kanatzhan
GP SGEM
TI IMPROVEMENT OF METHODS OF BOVINE ANAPLASMOSIS DIAGNOSTICS
SO GEOCONFERENCE ON NANO, BIO AND GREEN - TECHNOLOGIES FOR A SUSTAINABLE
   FUTURE
SE International Multidisciplinary Scientific GeoConference-SGEM
LA English
DT Proceedings Paper
CT 13th International Multidisciplinary Scientific Geoconference, SGEM 2013
CY JUN 16-22, 2013
CL Albena, BULGARIA
DE anaplasma; animals; specific antiserum and antigens; reaction of
   indirect immunofluorescence; Vero; D. reticulates; D. silvarum;
   hemolymph-test; biomaterial
AB Specific antigens as well as RIDIF-active rabbit sera (1: 320) used for detecting Anaplasma in biomaterial of tick-transmitters and antibodies in serum of cattle, infected with anaplasmosis, have been received.
   Obtained serum can be used as indicator and identificator of bovine anaplasmosis causative agent in RIDIF and for studding antigenic and relative properties of bovine anaplasmosis causative agent and disease pathogenesis.
   High diagnostic value of RIDIF was confirmed practically, using this method (in combination with light microscopy) 14% infected animals as well as anaplasmosis - carriers have been detected.
C1 [Beisembayev, Kanatzhan] Kokshetau State Univ Ualihanov Shokan, Kokshetau, Kazakhstan.
RP Beisembayev, K (reprint author), Kokshetau State Univ Ualihanov Shokan, Kokshetau, Kazakhstan.
CR Krasikov A.P., 2000, CURRENT ISSUES VET M, P130
   Kuttler K., 1963, J AM VET MED ASS, V143
   Ristic M., 1962, J AM VET MED ASS, V141
   Schindler R., 1966, TROPENMED PARASITO B, V17, p337 
   Stepanova N.I., 1970, METHODS ANTIGEN PREP, V38, P90
NR 5
TC 0
Z9 0
U1 0
U2 1
PU STEF92 TECHNOLOGY LTD
PI SOFIA
PA 1 ANDREY LYAPCHEV BLVD, SOFIA, 1797, BULGARIA
SN 1314-2704
BN 978-619-7105-06-3
J9 INT MULTI SCI GEOCO
PY 2013
BP 163
EP 167
PG 5
WC Geosciences, Multidisciplinary; Nanoscience & Nanotechnology
SC Geology; Science & Technology - Other Topics
GA BE0GN
UT WOS:000365991700022
DA 2018-10-19
ER

PT J
AU Bellotti, C
   Stanco, D
   Ragazzini, S
   Romagnoli, L
   Martella, E
   Lazzati, S
   Marchetti, C
   Donati, D
   Lucarelli, E
AF Bellotti, C.
   Stanco, D.
   Ragazzini, S.
   Romagnoli, L.
   Martella, E.
   Lazzati, S.
   Marchetti, C.
   Donati, D.
   Lucarelli, E.
TI ANALYSIS OF THE KARYOTYPE OF EXPANDED HUMAN ADIPOSE-DERIVED STEM CELLS
   FOR BONE RECONSTRUCTION OF THE MAXILLO-FACIAL REGION
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE adipose-derived stem cells; maxillo-facial reconstruction; bone;
   cytogenetic analysis
AB Mesenchymal stem cells (MSC) and adipose-derived stem cells (ASC) were recently proposed for bone maxillofacial reconstruction in association with biomaterials. For this application MSC must be ex-vivo expanded in order to obtain, for a given volume of implanted biomaterial, a relevant number of bone forming cells. Previously conducted pre-clinical studies suggested that a concentration of 6 x 10(8) ASC associated with 900 mg of anorganic bovine bone (ABB) could be effective for human maxillary sinus floor elevation. A keystone issue to guarantee the quality and safety of Advanced Therapy Medicinal Products containing expanded MSC and ASC is their chromosome stability in culture: this topic has been widely investigated and conflicting results have been published. Abnormal karyotype of human ex-vivo expanded MSC and ASC was found by some authors, while, at the same time, several other studies showed the MSC and ASC karyotype to be normal. It is therefore important that all the results obtained on MSC and ASC karyotype analysis be published. Given this context, the aim of this manuscript, aim of this manuscript is to verify the karyotype stability of ASC in view of their applications in clinical trials. ASC obtained from the adipose tissue of 4 donors were expanded over extended culture time. Based on previous ASC expansions we hypothesized to be able to obtain 6 x 10(8) cells by passage 7. Karyotype analysis 30 metaphases was planned to be investigated at passage 2, 7, and 15 in all the cultures. No abnormalities were found in the karyotype of two donors at all the passages tested, while a translocation was found in 2 metaphases of a donor at passage 7, but not at passage 15, and in the fourth donor in 5 metaphases a trisomy was found at passage 15. Chromosomal abnormalities were detected only after extended ASC expansion. Whether these anomalies can be related to risk for the patient's safety will have to be demonstrated by in-vivo studies.
C1 [Bellotti, C.; Martella, E.; Donati, D.; Lucarelli, E.] Rizzoli Orthopaed Inst, Osteoarticular Regenerat Lab, I-40136 Bologna, Italy.
   [Stanco, D.] IRCCS Galeazzi Orthopaed Inst, Orthopaed Biotechnol Lab, Milan, Italy.
   [Ragazzini, S.; Marchetti, C.] Univ Bologna, Biomed & Neuromotor Sci, Via San Vitale 59, I-40125 Bologna, Italy.
   [Romagnoli, L.; Lazzati, S.] Areta Int Srl, I-21040 Gerenzano, VA, Italy.
RP Lucarelli, E (reprint author), Ist Ortoped Rizzoli, Lab Patol Ortoped & Rigeneraz Tissutale Osteoarti, Via Barbiano 1-10, I-40136 Bologna, BO, Italy.
EM enrico.lucarelli@ior.it
RI Lucarelli, Enrico/G-3588-2015
OI Lucarelli, Enrico/0000-0002-6681-6374; Martella,
   Elisa/0000-0003-3923-0906; DONATI, DAVIDE MARIA/0000-0002-9170-0576
FU Progetto di Ricerca [RF_EMR_2008-1216793]; FIRB-ACCORDI DI PROGRAMMA
   Anno [RBAP10447J]
FX The authors are grateful to Dr. Panagiota Dimopoulou for editorial
   assistance. The study was funded in part by Progetto di Ricerca
   RF_EMR_2008-1216793. and FIRB-ACCORDI DI PROGRAMMA Anno 2010 -
   Protocollo: RBAP10447J
CR Achille V, 2011, J CELL BIOCHEM, V112, P1817, DOI 10.1002/jcb.23100
   Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690
   Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002
   Bochkov NP, 2007, B EXP BIOL MED+, V143, P122, DOI 10.1007/s10517-007-0031-0
   Bochkov NP, 2009, B EXP BIOL MED+, V148, P677, DOI 10.1007/s10517-010-0793-7
   Bochkov NP, 2008, B EXP BIOL MED+, V146, P344, DOI 10.1007/s10517-008-0293-1
   Buyanovskaya OA, 2009, B EXP BIOL MED+, V148, P109, DOI 10.1007/s10517-009-0647-3
   Cavallo C, 2011, J CELL BIOCHEM, V112, P1418
   Choumerianou DM, 2008, CELL PROLIFERAT, V41, P909, DOI 10.1111/j.1365-2184.2008.00559.x
   Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376
   Dahl JA, 2008, INT J DEV BIOL, V52, P1033, DOI 10.1387/ijdb.082663jd
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Ferreira RJ, 2012, CURR STEM CELL RES T, V7, P356
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Grimes BR, 2009, STEM CELLS DEV, V18, P717, DOI 10.1089/scd.2008.0255
   Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272
   Kitoh H, 2007, BONE, V40, P522, DOI 10.1016/j.bone.2006.09.019
   Lucarelli E, 2012, CURR PHARM DES
   Mariani E, 2012, CURR PHARM DESIGN, V18, P1821, DOI 10.2174/138161212799859666
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Nikitina VA, 2011, B EXP BIOL MED+, V151, P550, DOI 10.1007/s10517-011-1379-8
   Nikitina VA, 2011, B EXP BIOL MED, V150, P627
   Pieri F, 2010, BIOMATERIALS, V31, P3527, DOI 10.1016/j.biomaterials.2010.01.066
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466
   Safwani WK, 2012, J TISSUE ENG REGEN M, P1
   Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001
   Spiropoulos A, 2011, J CELL MOL MED, V15, P1983, DOI 10.1111/j.1582-4934.2010.01157.x
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P258, DOI [10.1089/ten.teb.2011.0440, 10.1089/ten.TEB.2011.0440]
   Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907
   Zeng DL, 2012, TISSUE ENG PT A, V18, P871, DOI [10.1089/ten.TEA.2011.0379, 10.1089/ten.tea.2011.0379]
   Zou DR, 2012, TISSUE ENG PT A, V18, P1464, DOI [10.1089/ten.tea.2011.0501, 10.1089/ten.TEA.2011.0501]
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 36
TC 5
Z9 5
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JAN
PY 2013
VL 26
SU 1
BP 3
EP 9
DI 10.1177/03946320130260S102
PG 7
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA V43ZR
UT WOS:000209719800002
PM 24046944
DA 2018-10-19
ER

PT J
AU Chlapanidas, T
   Tosca, MC
   Farago, S
   Perteghella, S
   Galuzzi, M
   Lucconi, G
   Antonioli, B
   Ciancio, F
   Rapisarda, V
   Vigo, D
   Marazzi, M
   Faustini, M
   Torre, ML
AF Chlapanidas, T.
   Tosca, M. C.
   Farago, S.
   Perteghella, S.
   Galuzzi, M.
   Lucconi, G.
   Antonioli, B.
   Ciancio, F.
   Rapisarda, V.
   Vigo, D.
   Marazzi, M.
   Faustini, M.
   Torre, M. L.
TI FORMULATION AND CHARACTERIZATION OF SILK FIBROIN FILMS AS A SCAFFOLD FOR
   ADIPOSE-DERIVED STEM CELLS IN SKIN TISSUE ENGINEERING
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE Silk fibroin films; adipose-derived stem cells; bioengineered skin
AB Skin substitutes are epidermal, dermal or complete bilayered constructs, composed by natural or synthetic scaffolds and by adherent cells such as fibroblasts, keratinocytes or mesenchymal stem cells. Silk fibroin is a promising polymer to realize scaffolds, since it is biocompatible, biodegradable, and exhibits excellent mechanical properties in terms of tensile strength. Moreover, fibroin can be added of others components in order to modify the biomaterial properties for the purpose. The aim of this work is to prepare silk fibroin films for adipose-derived stem cell (ADSCs) culture as a novel feeder layer for skin tissue engineering. Pectin has been added to promote the protein conformational transition and construct strength, while glycerol as plasticizer, providing biomaterial flexibility. Eighteen formulations were prepared by casting method using fibroin, pectin (range 1-10% w/w), and glycerol (range 0-20% w/w); films were characterized by Fourier transform infrared spectroscopy and differential scanning calorimetry assay, to select the optimal composition. A stable fibroin conformation was obtained using 6% w/w pectin, and the best mechanical properties were obtained using 12% w/w glycerol. Films were sterilized, and human ADSCs were seeded and cultured for 15 days. Cells adhere to the support assuming a fibroblastic-like shape and reaching confluence. The ultrastructural analysis evidences typical active-cell features and adhesion structures that promote cell anchorage to the film, thus developing a multilayered cell structure. This construct could be advantageously employed in cutaneous wound healing or where the use of ADSCs scaffold is indicated either in human or veterinary field.
C1 [Chlapanidas, T.; Tosca, M. C.; Perteghella, S.; Galuzzi, M.; Lucconi, G.; Torre, M. L.] Univ Pavia, Dipartimento Sci Farmaco, Via Palestro 3, I-27100 Pavia, Italy.
   [Tosca, M. C.; Galuzzi, M.; Antonioli, B.; Marazzi, M.] Azienda Osped Osped Niguarda Ca Granda, Terapia Tissutale, Milan, Italy.
   [Farago, S.] Innovhub, Div Stn Sperimentale Seta, Milan, Italy.
   [Ciancio, F.] Univ Florence, Ist Chirurg Plast, Florence, Italy.
   [Rapisarda, V.] Azienda Osped Osped Niguarda Ca Granda, Chirurg Plast, Milan, Italy.
   [Rapisarda, V.] Azienda Osped Osped Niguarda Ca Granda, Ctr Grandi Ustionati, Milan, Italy.
   [Vigo, D.; Faustini, M.] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy.
RP Marazzi, M (reprint author), Azienda Osped Osped Niguarda Ca Granda, Struttura Semplice Terapia Tissutale, Piazza Osped Maggiore 3, I-20162 Milan, Italy.
EM mario.marazzi@ospedaleniguarda.it
RI faustini, massimo/K-6595-2017; Torre, Maria Luisa/N-4782-2015
OI faustini, massimo/0000-0003-2182-1003; Torre, Maria
   Luisa/0000-0001-8062-6836; Perteghella, Sara/0000-0003-1128-7636
FU Pavia University; Eurostars project FIBROSPHERE [E!5227]; Milan
   University
FX This work was supported by Pavia and Milan Universities, and Eurostars
   project E!5227 FIBROSPHERE. The authors thank Gammatom S.r.l. (Guanzate,
   Italy) for gamma sterilization and Dr Vittorio Necchi (Centro Grandi
   Strumenti, Pavia University) for the ultrastructural investigation.
CR Altman AM, 2008, BIOMATERIALS, V29, P1431, DOI 10.1016/j.biomaterials.2007.11.026
   Altman AM, 2010, ACTA BIOMATER, V6, P1388, DOI 10.1016/j.actbio.2009.10.034
   Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bussy C, 2008, J BIOMED MATER RES A, V86A, P597, DOI 10.1002/jbm.a.31729
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Chlapanidas T, 2011, TISSUE ENG PT A, V17, P1725, DOI 10.1089/ten.tea.2010.0636
   Dal Pra I, 2006, INT J MOL MED, V18, P241
   Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962
   Einhorn-Stoll U, 2009, FOOD HYDROCOLLOID, V23, P40, DOI 10.1016/j.foodhyd.2007.11.009
   Einhorn-Stoll U, 2007, FOOD HYDROCOLLOID, V21, P1101, DOI 10.1016/j.foodhyd.2006.08.004
   Farago S, IT2010MI2010A002081
   Faustini M, 2010, TISSUE ENG PART C-ME, V16, P1515, DOI [10.1089/ten.tec.2010.0214, 10.1089/ten.TEC.2010.0214]
   George KA, 2012, MAT SCI ENG C
   Guan GP, 2010, BIO-MED MATER ENG, V20, P295, DOI 10.3233/BME-2010-0643
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Kojthung A, 2008, INT BIODETER BIODEGR, V62, P487, DOI 10.1016/j.ibiod.2007.12.012
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Mizuno H, 2011, METHODS MOL BIOL, V702, P453, DOI 10.1007/978-1-61737-960-4_33
   Morra M, 2004, BIOMACROMOLECULES, V5, P2094, DOI 10.1021/bm049834q
   Munarin F, 2012, INT J BIOL MACROMOL, V51, P681, DOI 10.1016/j.ijbiomac.2012.07.002
   Munarin F, 2011, BIOMACROMOLECULES, V12, P568, DOI 10.1021/bm101110x
   Nagel MD, 2008, BBA-GEN SUBJECTS, V1780, P995, DOI 10.1016/j.bbagen.2008.04.002
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Sobajo Cassandra, 2008, Eplasty, V8, pe47
   Stacey GN, 2006, J BIOTECHNOL, V125, P583, DOI 10.1016/j.jbiotec.2006.03.011
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sugiyama H, 2008, J TISSUE ENG REGEN M, V2, P445, DOI 10.1002/term.111
   Suzuki K, 1997, J RADIAT RES, V38, P55, DOI 10.1269/jrr.38.55
   Takeuchi T, 2008, JPN J INFECT DIS, V61, P9
   Uebersax L, 2007, EUR CELLS MATER, V13, P15
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
NR 48
TC 11
Z9 12
U1 2
U2 19
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2058-7384
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JAN
PY 2013
VL 26
SU 1
BP 43
EP 49
DI 10.1177/03946320130260S106
PG 7
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA V43ZR
UT WOS:000209719800006
PM 24046948
OA Bronze
DA 2018-10-19
ER

PT B
AU Khoda, AKMB
   Koc, B
AF Khoda, A. K. M. B.
   Koc, Bahattin
GP ASME
TI FUNCTIONALLY HETEROGENEOUS POROUS SCAFFOLD DESIGN FOR TISSUE ENGINEERING
SO INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION - 2012, VOL
   2: BIOMEDICAL AND BIOTECHNOLOGY
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 09-15, 2012
CL Houston, TX
SP ASME
DE Deposition angle; Porosity function; variational filament distance
ID BONE; DENSITY
AB Most of the current tissue scaffolds are mainly designed with homogeneous porosity which does not represent the spatial heterogeneity found in actual tissues. Therefore engineering a realistic tissue scaffolds with properly graded properties to facilitate the mimicry of the complex elegance of native tissues are critical for the successful tissue regeneration. In this work, novel bio-mimetic heterogeneous porous scaffolds have been modeled. First, the geometry of the scaffold is extracted along with its internal regional heterogeneity. Then the model has been discretized with planner slices suitable for layer based fabrication. An optimum filament deposition angle has been determined for each slice based on the contour geometry and the internal heterogeneity. The internal region has been discritized considering the homogeneity factor along the deposition direction. Finally, an area weight based approach has been used to generate the spatial porosity function that determines the filament deposition location for desired bio-mimetic porosity. The proposed methodology has been implemented and illustrative examples are provided. The effective porosity has been compared between the proposed design and the conventional homogeneous scaffolds. The result shows a significant error reduction towards achieving the bio-mimetic porosity in the scaffold design and provides better control over the desired porosity level. Moreover, sample designed structures have also been fabricated with a NC motion controlled micro-nozzle biomaterial deposition system.
C1 [Khoda, A. K. M. B.] SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
   [Koc, Bahattin] Sabanci Univ, Fac Engn & Nat Sci, FENS G013, TR-34956 Istanbul, Turkey.
RP Khoda, AKMB (reprint author), SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
EM bkoc@buffalo.edu
FU Telemedicine and Advanced Technology Research Center (TATRC) at the US
   Army Medical Research; Material Command (USAMRMC) [W81XWH-05-1-0401]; EU
   FP7 Marie Curie Grant [PCIG09-GA-2011-294088]
FX The research was partially supported by the Telemedicine and Advanced
   Technology Research Center (TATRC) at the US Army Medical Research and
   Material Command (USAMRMC) through award W81XWH-05-1-0401 and by EU FP7
   Marie Curie Grant #: PCIG09-GA-2011-294088 awarded to Dr. Koc.
CR Chow HN, 2007, COMPUT AIDED DESIGN, V4, P321, DOI DOI 10.1080/16864360.2007.10738552.
   Coelho PG, 2009, J BIOMECH, V42, P830, DOI 10.1016/j.jbiomech.2009.01.020
   Fryazinov O., COMPUTER AIDED DESIG
   Geffre CP, 2009, J BIOMED MATER RES A, V91A, P795, DOI 10.1002/jbm.a.32251
   Holdstein Y., 2011, GEOMETRIC MODELING A, P91
   Hosokawa A, 2010, IEEE T ULTRASON FERR, V57, P1320, DOI 10.1109/TUFFC.2010.1552
   Khoda A., 2012, ASME T J ME IN PRESS
   Khoda A. B., 2012, CAD UNPUB
   Khoda AKM, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034106
   Kou XY, 2012, INT J COMPUT INTEG M, V25, P177, DOI 10.1080/0951192X.2011.627948
   Lal P, 2004, COMPUT AIDED DESIGN, V36, P487, DOI 10.1016/S0010-4485(03)00134-9
   Pasko A, 2011, GRAPH MODELS, V73, P165, DOI 10.1016/j.gmod.2011.03.001
   Pietruszczak S, 1999, J BIOMECH, V32, P1071, DOI 10.1016/S0021-9290(99)00096-2
   Schroeder C, 2005, COMPUT AIDED DESIGN, V37, P339, DOI 10.1016/j.cad.2004.03.008
   Wettergreen MA, 2005, COMPUT AIDED DESIGN, V37, P1141, DOI 10.1016/j.cad.2005.02.005
   Zioupos P, 2008, J BIOMECH, V41, P1961, DOI 10.1016/j.jbiomech.2008.03.025
NR 16
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4518-9
PY 2013
BP 579
EP +
PG 3
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA BC0XX
UT WOS:000349815500076
DA 2018-10-19
ER

PT B
AU Smith, C
   Xu, ZG
   Sankar, J
AF Smith, Christopher
   Xu, Zhigang
   Sankar, Jagannathan
GP ASME
TI THE EFFECTS OF T4 AND T6 HEAT TREATMENT ON THE CORROSION BEHAVIOR OF
   MGZNCA ALLOYS
SO INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION - 2012, VOL
   3, PTS A-C: DESIGN, MATERIALS, AND MANUFACTURING
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 09-15, 2012
CL Houston, TX
SP ASME
ID MECHANICAL-PROPERTIES; MAGNESIUM ALLOY; PURE MAGNESIUM; CHLORIDE
AB Some of the most important characteristics of a medical implant biomaterial are its corrosion resistance, cytotoxicity, mechanical property, and overall biological performance. Optimizing these characteristics is therefore vital to the success of creating effective medical biomaterials. It is well known that heat treatment processes affect the microstructure of metallic alloys which consequently can have favorable influences on the mechanical properties. The determination of the effects of heat treatment on the corrosion resistance of metallic alloys is another aspect that must be examined. That is the goal of this investigation. The corrosion characteristics of two MgZnCa alloy systems (MgZnCa-31 and MgZnCa-32) were studied to determine the correlation between T4 and T6 heat treatment and the corrosion rate on the alloys. The alloys were produced by melting and casting at 730 C and then heat treated. The corrosion performances of the alloys were examined by both immersion and electrochemical analysis, which were conduct in 0.9% NaCl physiological saline solution. In terms of the effects of the T4 heat treatment, the corrosion rate of the MgZnCa-31 decreases as the time period of the heat treatment increases, whereas the MgZnCa-32 alloys have an opposite effect meaning that the corrosion rate increases as the time period of the heat treatment increases. There was no significant change in corrosion with the introduction of T6 heat treatment to both alloy systems.
C1 [Smith, Christopher; Xu, Zhigang; Sankar, Jagannathan] N Carolina Agr & Tech State Univ, Greensboro, NC 27411 USA.
RP Smith, C (reprint author), N Carolina Agr & Tech State Univ, Greensboro, NC 27411 USA.
CR Akhter R, 2007, MAT SCI ENG A-STRUCT, V447, P192, DOI 10.1016/j.msea.2006.10.148
   [Anonymous], 2006, B661062003 ASTM, DOI [10.1520/B0661-06, DOI 10.1520/B0661-06]
   ASTM, 2010, E112 ASTM INT, P1, DOI DOI 10.1520/E0112-10
   AVEDESIAN M, 1998, MAGNESIUM MAGNESIUM
   Bajat J., CORROSION SCI, V53, P409
   DeGarmo E., 1998, MAT PROCESSES MANUFA
   Deshpande K. B., CORROSION SCI, V52, P2819
   Dezellus O., MAT SCI ENG A, V528, P2795
   Esmaeili S., 2010, TMS
   Feliu S, 2004, PROG ORG COAT, V50, P199, DOI 10.1016/j.porgcoat.2004.02.008
   Garcia KE, 2006, CORROS SCI, V48, P2813, DOI 10.1016/j.corsci.2005.09.002
   Liu M., 2011, MAT SCI E B IN PRESS
   Liu XB, 2010, T NONFERR METAL SOC, V20, P1345, DOI 10.1016/S1003-6326(09)60302-2
   Osorio WR, 2007, MATER CHEM PHYS, V106, P343, DOI 10.1016/j.matchemphys.2007.06.011
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Poorqasemi E, 2009, CORROS SCI, V51, P1043, DOI 10.1016/j.corsci.2009.03.001
   Shi Z., 2000, CORROS SCI, V52, P579
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Simbi D. J., 1997, CORROS SCI, V39, P1015
   Skar JI, 1999, MATER CORROS, V50, P2, DOI 10.1002/(SICI)1521-4176(199901)50:1<2::AID-MACO2>3.0.CO;2-N
   Song G, 1997, CORROS SCI, V39, P855, DOI 10.1016/S0010-938X(96)00172-2
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sudholz AD, 2011, CORROS SCI, V53, P2277, DOI 10.1016/j.corsci.2011.03.010
   Sulka G. D., INTERMETALLICS, V19, P974
   Wang Y, 2008, MATER LETT, V62, P2181, DOI 10.1016/j.matlet.2007.11.045
   Wasiur-Rahman S, 2009, INTERMETALLICS, V17, P847, DOI 10.1016/j.intermet.2009.03.014
   Xu Z., MAT SCI E B IN PRESS
   Yang L, 2009, MAT SCI ENG C-BIO S, V29, P1691, DOI 10.1016/j.msec.2009.01.014
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhao MC, 2008, CORROS SCI, V50, P3168, DOI 10.1016/j.corsci.2008.08.023
NR 31
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4519-6
PY 2013
BP 745
EP 759
PG 15
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BC1DQ
UT WOS:000350004500094
DA 2018-10-19
ER

PT J
AU Munoz-Guerra, S
   Garcia-Alvarez, M
   Portilla-Arias, JA
AF Munoz-Guerra, Sebastian
   Garcia-Alvarez, Montserrat
   Portilla-Arias, Jose A.
TI Chemical Modification of Microbial Poly(gamma-glutamic acid): Progress
   and Perspectives
SO JOURNAL OF RENEWABLE MATERIALS
LA English
DT Article
DE Microbial poly(glutamic acid); poly(gamma glutamic acid); polyglutamates
ID DRUG-DELIVERY SYSTEM; GAMMA-GLUTAMIC ACID; POLY(GLUTAMIC ACID); IONIC
   COMPLEXES; POLY(ALPHA-ALKYL GAMMA-GLUTAMATE)S; ACID)-POLY(LACTIDE)
   NANOPARTICLES; GAMMA-POLY(GLUTAMIC ACID); BIOMEDICAL APPLICATIONS;
   ENZYMATIC DEGRADATION; CATIONIC SURFACTANTS
AB Poly(gamma-glutamic acid) (PGGA) is an edible polypeptide excreted by certain bacteria that is presently accessible on a semi-industrial scale. Chemically, it is a nylon 4 derivative bearing a carboxylic side group attached to the fourth carbon of the repeating unit. Although this biopolymer is being exploited in the food, agriculture and cosmetic sectors, its use in massive applications as packaging or coating is still unknown mainly due to its instability in wet environments and unsuitability to be processed by common techniques. Chemical modification of PGGA involving esterification or amidation of the carboxylic group is the approach explored the most to obtain materials with potential interest as fibers, films or hydrogels. Electrostatic coupling of PGGA with hydrophobic cationic species may also be profited to generate non-water-soluble stable derivatives. On the other hand, the interest of modified PGGA as a functionalized biomaterial for scaffold and drug delivery has increased incredibly in the last years. This paper summarizes the progress in the methodology available for synthesizing PGGA derivatives, the relevant features of the new materials that are synthesized, and the most outstanding advances achieved in the biomedical field when modified PGGA is used.
C1 [Munoz-Guerra, Sebastian; Garcia-Alvarez, Montserrat; Portilla-Arias, Jose A.] Univ Politecn Cataluna, Dept Chem Engn, ETSEIB, Barcelona 08028, Spain.
RP Munoz-Guerra, S (reprint author), Univ Politecn Cataluna, Dept Chem Engn, ETSEIB, Diagonal 647, Barcelona 08028, Spain.
EM sebastian.munoz@upc.edu
FU MICINN (Spain) [MAT2009-14053-CO2-01]; AGAUR (Catalonia) [2009SGR1469]
FX Financial support for this work was provided by MICINN (Spain) with
   Grant MAT2009-14053-CO2-01, and by AGAUR (Catalonia) with Grant
   2009SGR1469.
CR Akagi T, 2006, BIOMACROMOLECULES, V7, P297, DOI 10.1021/bm050657i
   Akagi T, 2012, LANGMUIR, V28, P5249, DOI 10.1021/la205093j
   Akagi T, 2011, BIOMATERIALS, V32, P4959, DOI 10.1016/j.biomaterials.2011.03.049
   Akagi T, 2010, LANGMUIR, V26, P2406, DOI 10.1021/la902868g
   Akao T, 2010, J DRUG TARGET, V18, P550, DOI 10.3109/10611861003599453
   Bajaj I, 2011, BIORESOURCE TECHNOL, V102, P5551, DOI 10.1016/j.biortech.2011.02.047
   Block H., 1983, POLY GAMMA BENZYL L
   BORBELY M, 1994, POLYM BULL, V32, P127, DOI 10.1007/BF00306378
   Bovarnick M, 1942, J BIOL CHEM, V145, P415
   Bruckner V., 1935, HOPPESEYL Z, V247, P281
   Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458
   Chang KY, 2009, POLYMER, V50, P1755, DOI 10.1016/j.polymer.2009.01.057
   CHOI HJ, 1995, J APPL POLYM SCI, V58, P807, DOI 10.1002/app.1995.070580414
   Crescenzi V, 1996, ACS SYM SER, V627, P233
   de Ilarduya AM, 2002, BIOMACROMOLECULES, V3, P1078, DOI 10.1021/bm025568
   Fan KS, 1996, J ENVIRON POLYM DEGR, V4, P253, DOI 10.1007/BF02070694
   Fujii H., 1963, NIPPON NOGEIKAGAKU K, V37, P615
   Garcia-Alvarez M, 2005, MACROMOL BIOSCI, V5, P30, DOI 10.1002/mabi.200400146
   Gonzales D, 1996, J POLYM SCI POL CHEM, V34, P2019, DOI 10.1002/(SICI)1099-0518(19960730)34:10<2019::AID-POLA19>3.0.CO;2-K
   Gross R. A., 1998, BIOPOLYMERS RENEWABL
   Inagaki M., 1992, JP Patent, Patent No. [4298533-A, 4298533]
   Kang HS, 2007, J APPL POLYM SCI, V103, P386, DOI 10.1002/app.24623
   Kim H, 2009, MACROMOL BIOSCI, V9, P842, DOI 10.1002/mabi.200800367
   Kubota H, 1996, J POLYM SCI POL CHEM, V34, P1347, DOI 10.1002/(SICI)1099-0518(199605)34:7<1347::AID-POLA24>3.0.CO;2-8
   KUBOTA H, 1993, J POLYM SCI POL CHEM, V31, P2877, DOI 10.1002/pola.1993.080311127
   KUBOTA H, 1995, J POLYM SCI POL CHEM, V33, P85, DOI 10.1002/pola.1995.080330110
   Kunioka M, 1996, J ENVIRON POLYM DEGR, V4, P123, DOI 10.1007/BF02074873
   Kunioka M, 1997, J APPL POLYM SCI, V65, P1889, DOI 10.1002/(SICI)1097-4628(19970906)65:10<1889::AID-APP5>3.0.CO;2-B
   Kunioka M, 1998, POLYM DEGRAD STABIL, V59, P33, DOI 10.1016/S0141-3910(97)00181-X
   Liang HF, 2005, J CONTROL RELEASE, V105, P213, DOI 10.1016/j.jconrel.2005.03.021
   Liang HF, 2006, BIOCONJUGATE CHEM, V17, P291, DOI 10.1021/bc0502107
   Liang HF, 2006, BIOMATERIALS, V27, P2051, DOI 10.1016/j.biomaterials.2005.10.027
   Manocha B, 2010, J NANOMATER, DOI 10.1155/2010/780171
   Matsusaki M, 2002, BIOCONJUGATE CHEM, V13, P23, DOI 10.1021/bc010008d
   Melis J, 2002, MACROMOLECULES, V35, P8774, DOI 10.1021/ma020728v
   Melis J, 2001, POLYMER, V42, P9319, DOI 10.1016/S0032-3861(01)00484-0
   Mi FL, 2008, BIOCONJUGATE CHEM, V19, P1248, DOI 10.1021/bc800076n
   Morillo M, 2003, POLYMER, V44, P7557, DOI 10.1016/j.polymer.2003.10.001
   Morillo M, 2003, MACROMOLECULES, V36, P7567, DOI 10.1021/ma0345201
   Morillo M, 2001, MACROMOLECULES, V34, P7868, DOI 10.1021/ma010510t
   Okamoto S, 2009, VACCINE, V27, P5896, DOI 10.1016/j.vaccine.2009.07.037
   Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0
   Pacini A, 2012, J POLYM SCI POL CHEM, V50, P4790, DOI 10.1002/pola.26363
   Peng SF, 2011, BIOMATERIALS, V32, P239, DOI 10.1016/j.biomaterials.2010.08.081
   Peng SF, 2009, BIOMATERIALS, V30, P1797, DOI 10.1016/j.biomaterials.2008.12.019
   Perez-Camero G, 2004, BIOMACROMOLECULES, V5, P144, DOI 10.1021/bm034267c
   Perez-Camero G, 1999, BIOTECHNOL BIOENG, V63, P110, DOI 10.1002/(SICI)1097-0290(19990405)63:1<110::AID-BIT11>3.0.CO;2-T
   Perez-Camero G, 2001, J APPL POLYM SCI, V82, P2027, DOI 10.1002/app.2048
   Perez-Camero G., 1999, POLYM PREP-ACS, V40, P1142
   PFEFFER PE, 1976, J ORG CHEM, V41, P1373, DOI 10.1021/jo00870a018
   Portilla-Arias JA, 2007, POLYM DEGRAD STABIL, V92, P1916, DOI 10.1016/j.polymdegradstab.2007.06.011
   Portilla-Arias JA, 2007, MACROMOL BIOSCI, V7, P897, DOI 10.1002/mabi.200700025
   Portilla-Arias JA, 2009, J BIOMAT SCI-POLYM E, V20, P1065, DOI 10.1163/156856209X444420
   Prencipe G, 2009, J AM CHEM SOC, V131, P4783, DOI 10.1021/ja809086q
   Radu JEF, 2008, COLLOID POLYM SCI, V286, P365, DOI 10.1007/s00396-007-1776-8
   Richard A, 2001, CRIT REV BIOTECHNOL, V21, P219, DOI 10.1080/07388550108984171
   RYDON HN, 1964, J CHEM SOC, P1328, DOI 10.1039/jr9640001328
   Shah D.T., 1993, POLYM PREP AM CHEM S, V5, P488
   Shah D. T., 1995, Pat. Number US, Patent No. [5378807, 5378807-A]
   Sonaje K, 2010, BIOMATERIALS, V31, P3384, DOI 10.1016/j.biomaterials.2010.01.042
   Sung MH, 2005, CHEM REC, V5, P352, DOI 10.1002/tcr.20061
   Tachibana Y, 2003, BIOMACROMOLECULES, V4, P1132, DOI 10.1021/bm034123y
   Takeda H., 1995, Jpn. Kokai Tokyo Koho, Japan Patent, Patent No. [JP7138364, 7138364]
   Takeda H., 1997, Jpn. Kokai Tokyo Koho, Japan Patent, Patent No. [JP8319421, 8319421]
   Tang DW, 2010, BIOMATERIALS, V31, P9320, DOI 10.1016/j.biomaterials.2010.08.058
   Tolentino A, 2012, EUR POLYM J, V48, P1838, DOI 10.1016/j.eurpolymj.2012.08.007
   TSUBOKAWA N, 1993, J POLYM SCI POL CHEM, V31, P3193, DOI 10.1002/pola.1993.080311304
   TSUBOKAWA N, 1993, J POLYM SCI POL CHEM, V31, P563, DOI 10.1002/pola.1993.080310229
   Wang SG, 2012, COLLOID SURFACE B, V89, P254, DOI 10.1016/j.colsurfb.2011.09.029
   Yao B, 2009, MATER SCI-POLAND, V27, P319
   Yoshida H, 2009, MACROMOL BIOSCI, V9, P568, DOI 10.1002/mabi.200800334
   Yoshikawa T, 2008, VACCINE, V26, P1303, DOI 10.1016/j.vaccine.2007.12.037
   Zanuy D, 1998, INT J BIOL MACROMOL, V23, P175, DOI 10.1016/S0141-8130(98)00047-6
   Zanuy D, 2001, BIOMACROMOLECULES, V2, P651, DOI 10.1021/bm000122j
NR 74
TC 8
Z9 8
U1 0
U2 12
PU SCRIVENER PUBLISHING
PI BEVERLY
PA 100 CUMMINGS CENTER, SUITE 541J, BEVERLY, MA 01915-6106 USA
SN 2164-6325
EI 2164-6341
J9 J RENEW MATER
JI J. Renew. Mater.
PD JAN
PY 2013
VL 1
IS 1
BP 42
EP 60
DI 10.7569/JRM.2012.634105
PG 19
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Materials Science, Composites;
   Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA V41HB
UT WOS:000209536200004
DA 2018-10-19
ER

PT S
AU Darecki, A
   Saeid, A
   Chojnacka, K
AF Darecki, A.
   Saeid, A.
   Chojnacka, K.
BE Lekkas, TD
TI BIOSORPTION OF MICROELEMENTS BY SPIRULINA: TOWARDS TECHNOLOGY OF MINERAL
   FEED SUPPLEMENTS
SO PROCEEDINGS OF THE 13TH INTERNATIONAL CONFERENCE ON ENVIRONMENTAL
   SCIENCE AND TECHNOLOGY
SE Proceedings of the International Conference on Environmental Science and
   Technology
LA English
DT Proceedings Paper
CT 13th International Conference on Environmental Science and Technology
   (CEST)
CY SEP 05-07, 2013
CL Athens, GREECE
SP Univ Aegean, Global Network Environm Sci & Technol
DE biosorption; functional groups. Spirulina maxima; FTIR; SEM-EDX;
   ICP-OES; Cu(ll); Co(II); Mn(II); Zn(II)
ID BIOMASS
AB Surface characterization and metal ion adsorption properties of biomass of blue-green algae Spirulina sp. and Spirulina maxima has been carried out by various instrumental techniques. Ths approach is useful in elaboration of new applications of biosorption, e.g. the production of mineral feed additives for livestock from the biomass of algae enriched with microelement ions. Fourier transform infrared spectroscopy technique (FTIR) and potentiometric titration were used to determine functional groups responsible for metal ion-cells interactions and their concentration on algal biomass. In obtained FTIR spectra of Spirulina maxima grown under laboratory conditions and the cells enriched in copper ions, the characteristic peak shifting of amino, amide and carbonyl groups in Cu(ll)treated biomaterial was observed, while no presence of band corresponding to neither phosphoryl nor sulfone groups was found, proving their involvement in metal ions complexation by Spirulina. The potentiometric titration data were analyzed using three kinetic models, assuming the presence of one, two and three types of surface functional groups respectively. The best fit was obtained for three types of functional groups, where the major binding site was the carboxyl group. Comparison of the analytical results obtained by inductively coupled plasma optical emission spectroscopy (ICP-OES) and scanning electron microscopy with an energy dispersive X-ray analytical system (SEMEDX) was performed in order to investigate the mechanism of metal ions biosorption. The lyophilized Spirulina sp. was enriched with Cu(ll), Mn(II), Zn(II), and Co(II) ions via biosorption and the metal affinity relationships for single and multi-component analysis were determined. Obtained results showed that metal ion biosorption occured by replacing naturally bound ions: Na(I), K(I) or Ca(II) with a descending order of Mn(II)>Cu(II)>Zn(II)>Co(I I) for single-, and a descending order of Cu(II)>Mn(II)>Co(II)>Zn(II) for multi-compontent system respectively. The concentration of elements on the surface of natural and metal-loaded material was determined both by ICP-OES and SEM-EDX analysis, showing relatively high value of correlation coefficient between the concentration of Na(I) ions in algal biomass, confirming usefulness of SEM technique for biosorption processes analysis.
C1 [Darecki, A.; Saeid, A.; Chojnacka, K.] Wroclaw Univ Technol, Inst Inorgan Technol & Mineral Fertilizers, PL-50372 Wroclaw, Poland.
RP Darecki, A (reprint author), Wroclaw Univ Technol, Inst Inorgan Technol & Mineral Fertilizers, Smoluchowskiego 25, PL-50372 Wroclaw, Poland.
EM katarzyna.chojnacka@pwr.wroc.pl
RI Saeid, Agnieszka/F-5183-2015; Saeid, Agnieszka/A-1744-2016
OI Saeid, Agnieszka/0000-0002-1755-3002; Saeid,
   Agnieszka/0000-0002-1755-3002
CR Chojnacka K, 2006, TALANTA, V70, P966, DOI 10.1016/j.talanta.2006.05.063
   Chojnacka K, 2005, CHEMOSPHERE, V59, P75, DOI 10.1016/j.chemosphere.2004.10.005
   FOUREST E, 1994, FEMS MICROBIOL REV, V14, P325
   Gupta R, 2000, CURR SCI INDIA, V78, P967
   Liu Y., 2008, SEP PURIF TECHNOL, V63, P249
   Saeid A, 2013, J APPL PHYCOL, V25, P667, DOI 10.1007/s10811-012-9901-6
   Schiewer S, 1996, ENVIRON SCI TECHNOL, V30, P2921, DOI 10.1021/es950800n
   SCHLOSSER UG, 1982, BER DEUT BOT GES, V95, P181
   Zarrouk C., 1966, THESIS U PARIS FRANC
   Zielinska A, 2009, J SCI FOOD AGR, V89, P2292, DOI 10.1002/jsfa.3723
NR 10
TC 0
Z9 0
U1 2
U2 4
PU GLOBAL NEST, SECRETARIAT
PI ATHENS
PA UNIV, AEGEAN, 30, VOULGAROKTONOU STR, ATHENS, GR 114 72, GREECE
SN 1106-5516
BN 978-960-7475-51-0
J9 PROC INT CONF ENV SC
PY 2013
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA BB7WL
UT WOS:000346067900460
DA 2018-10-19
ER

PT B
AU Yu, Y
   Ozbolat, IT
AF Yu, Yin
   Ozbolat, Ibrahim T.
GP ASME
TI BIOPRINTING INDUCED CELL DAMAGE IN CELLULAR MICRO-FLUIDIC CHANNEL
   FABRICATION
SO PROCEEDINGS OF THE ASME 8TH INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE - 2013, VOL 1
LA English
DT Proceedings Paper
CT 8th International Manufacturing Science and Engineering Conference
CY JUN 10-14, 2013
CL Madison, WI
SP ASME, Mfg Engn Div
ID TISSUE; SCAFFOLDS
AB Bioprinting, or layer by layer additive tissue fabrication, is a revolutionary concept recently emerged as an interdisciplinary effort to produce three-dimensional living organ for clinical application. Among many challenges, it was agreed that inclusion of vascular system is critical for maintaining the viability and functionality of relatively thick 3D bioprinted tissue constructs. Our previous research addressed the printability of novel vessel-like micro-fluidic channels with alginate hydrogel and co-axial nozzles. Here, we further investigated the influence of bioprinting parameters on cartilage progenitor cells (CPCs) survival during and post printing. The results of this study revealed that quantifiable cell death could be induced by varying dispensing pressure, co-axial nozzle geometry, biomaterial concentration. However, damaged cells were able to recover during incubation, as well as undergo proliferation to certain extend. These findings may serve as a guideline for optimizing our system as well as predict cell damage in future studies.
C1 [Yu, Yin] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.
RP Yu, Y (reprint author), Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.
CR Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f
   Boland T, 2003, ANAT REC PART A, V272A, P497, DOI 10.1002/ar.a.10059
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004
   Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Lin YF, 2009, J APPL PHYS, V106, DOI 10.1063/1.3202388
   Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001
   Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004
   Xiang L, 2012, ANN PLAS SURG, V68, P229, DOI 10.1097/SAP.0b013e3182384068
   Yan YN, 2003, MATER LETT, V57, P2623, DOI 10.1016/S0167-577X(02)01339-3
   Yu Y., 2012, IDENTIFICATION CHARA, pix
   Zhang Yahui, 2013, CHARACTERIZATION PRI
NR 15
TC 0
Z9 0
U1 1
U2 8
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5545-4
PY 2013
AR V001T01A006
PG 6
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BC1BI
UT WOS:000349928300006
DA 2018-10-19
ER

PT J
AU Sutivisedsak, N
   Leathers, TD
   Price, NPJ
AF Sutivisedsak, Nongnuch
   Leathers, Timothy D.
   Price, Neil P. J.
TI Production of schizophyllan from distiller's dried grains with solubles
   by diverse strains of Schizophyllum commune
SO SPRINGERPLUS
LA English
DT Article
DE Distiller's dried grains with solubles; DDGS; Schizophyllum commune;
   Schizophyllan
AB Eleven diverse strains of Schizophyllan commune were examined for production of the biopolymer schizophyllan from agricultural biomass. Strains were grown in malt extract (ME) basal medium containing 1% (w/v) distiller's dried grains with solubles (DDGS), an abundant coproduct of fuel ethanol production by the dry grind process. Ten of 11 strains tested produced more than 2 g schizophyllan/L. Two strains, ATCC 20165 and CBS 266.60, produced more than 10 g schizophyllan/L. Schizophyllan from these strains was similar to commercial product in terms of solution viscosity, molecular weight, and surface tension properties, suggesting that they would be equivalent in biomaterial applications.
C1 [Sutivisedsak, Nongnuch; Leathers, Timothy D.; Price, Neil P. J.] ARS, Renewable Prod Technol Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 61604 USA.
RP Leathers, TD (reprint author), ARS, Renewable Prod Technol Res Unit, Natl Ctr Agr Utilizat Res, USDA, 1815 N Univ St, Peoria, IL 61604 USA.
EM Tim.Leathers@ars.usda.gov
FU Agriculture and Food Research Initiative Competitive Grant from the USDA
   National Institute of Food and Agriculture [2010-65504-20377]
FX Expert technical assistance was provided by Erika Hertenstein, Melinda
   S. Nunnally, Suzanne Unser, and Andrew J. Thomas. The authors sincerely
   thank Christopher Dunlap for surface tension measurements. This project
   was supported by Agriculture and Food Research Initiative Competitive
   Grant no. 2010-65504-20377 from the USDA National Institute of Food and
   Agriculture. Mention of any trade names or commercial products in this
   publication is solely for the purpose of providing specific information
   and does not imply recommendation or endorsement by the US Department of
   Agriculture. USDA is an equal opportunity provider and employer.
CR Dunlap CA, 2011, J MICROBIOL, V49, P603, DOI 10.1007/s12275-011-1044-y
   [高利忠 GAO Lizhong], 2008, [食品工业科技, Science & Technology of Food Industry], V29, P214
   Kumarl M, 2008, BIORESOURCE TECHNOL, V99, P1036, DOI 10.1016/j.biortech.2007.02.029
   Leathers TD, 2006, BIOTECHNOL LETT, V28, P623, DOI 10.1007/s10529-006-0028-1
   Leathers TD, 2010, CARBOHYD POLYM, V81, P732, DOI 10.1016/j.carbpol.2010.03.030
   Li WB, 2011, Z NATURFORSCH C, V66, P173, DOI 10.5560/ZNC.2011.66c0173
   PROKOP A, 1992, EXP MYCOL, V16, P197, DOI 10.1016/0147-5975(92)90028-P
   RAU U, 1992, J IND MICROBIOL, V9, P19, DOI 10.1007/BF01576364
   Rau U, 1999, METH BIOTEC, V10, P43
   RAU U, 1992, CHEM-ING-TECH, V64, P576, DOI 10.1002/cite.330640627
   Rau U., 2002, BIOPOLYMERS POLYSACC, V6, P61
   Rosentrater KA, 2012, DISTILLERS GRAINS: PRODUCTION, PROPERTIES, AND UTILIZATION, P73
   SANROMAN MA, 1993, AN ASOC QUIM ARGENT, V81, P15
   SCHULZ D, 1992, CARBOHYD POLYM, V18, P295, DOI 10.1016/0144-8617(92)90095-8
   Shu CH, 2011, J TAIWAN INST CHEM E, V42, P387, DOI 10.1016/j.jtice.2010.08.009
   STEINER W, 1987, BIOTECHNOL BIOENG, V30, P169, DOI 10.1002/bit.260300206
   Sutivisedsak N, 2013, J IND MICROBIOL BIOT, V40, P105, DOI 10.1007/s10295-012-1208-8
NR 17
TC 3
Z9 4
U1 0
U2 3
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2193-1801
J9 SPRINGERPLUS
JI SpringerPlus
PY 2013
VL 2
AR 476
DI 10.1186/2193-1801-2-476
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V40FS
UT WOS:000209465100048
PM 24102042
OA Green Published, Other Gold
DA 2018-10-19
ER

PT S
AU Muller, WD
   Nascimento, L
   Mele, M
AF Mueller, W. D.
   Nascimento, L.
   Mele, M.
BE Mendez, JF
   Rodriguez, TYA
   Vazquez, HV
   Marin, CFC
   Barreda, MC
   Rojas, RR
   Medina, JC
   Ruiz, SBL
TI Electrochemical Assessment of Biomaterial Surfaces Using the Mini-Cell
   System
SO 5TH LATIN AMERICAN CONGRESS ON BIOMEDICAL ENGINEERING (CLAIB 2011):
   SUSTAINABLE TECHNOLOGIES FOR THE HEALTH OF ALL, PTS 1 AND 2
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 5th Latin American Congress on Biomedical Engineering (CLAIB 2011)
CY MAY 16-21, 2011
CL Habana, CUBA
SP SOCBIO, CORAL, Acad Ciencias Cuba, AMECA CMA, CNSCS, Int Fed Med & Biol Engn, Minist Ciencia Tecnologia & Medio Ambiente, Minist Cultura, Minist Educ Superior, Minist Ind Ligera, Minist Informat & Commun, Minist Ind Sidero Mecan, Minist Salud Publ, Oficina Historiador Ciudad, Org Panamericana Salud, Org Mundial Salud, Sociedad Cubana Fis, Agencia Representaciones Artist Musicalia, Ctr Nacl Mus Concierto, SKAN AG, Materialise NV, Bavarian Enterprises, Bavarian Minist Econ Affairs Infrastructure Transport & Technol, Bavarian Bur Int Business Relat GmbH, AKUD Med Pharm GmbH, HAWO GmbH, HT Labor & Hospitaltechnik AG, MIPM GmbH, Nurnberger Business Club GmbH, Physiomed Elektromedizin AG, DEGA EXPOTEAM GmbH & Co
DE biomaterials; electrochemistry; corrosion; surface characterization
ID ORTHODONTIC WIRES; METALLIC BIOMATERIALS; CORROSION; ALLOYS
AB Local resolved electrochemical measurement setup, MCS, will present for demonstration of the power for a non-destructive assessment of metallic biomaterial interfaces under living near conditions. As an example the experiments on orthodontic wires are presented.
C1 [Mueller, W. D.; Nascimento, L.] Charite Univ Med Berlin, Berlin, Germany.
   [Nascimento, L.] Tech Univ Berlin, FB Mat Sci, Berlin, Germany.
   [Mele, M.] INIFTA, La Plata, Argentina.
RP Muller, WD (reprint author), Charite Univ Med Berlin, Berlin, Germany.
EM wolf-dieter.mueller@charite.de
CR BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139
   Ehrensberger M T, J BIOMED MAT RES A, V94, P781
   Es-Souni Martha, 2003, J Orofac Orthop, V64, P16, DOI 10.1007/s00056-003-0235-5
   Hiromoto S, 2002, CORROS SCI, V44, P955, DOI 10.1016/S0010-938X(01)00110-X
   Huang HH, 2003, BIOMATERIALS, V24, P3585, DOI 10.1016/S0142-9612(03)00188-1
   Katz E, 2003, ELECTROANAL, V15, P913, DOI 10.1002/elan.200390114
   Kim H, 1999, ANGLE ORTHOD, V69, P39
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Pust SE, 2007, J ELECTROCHEM SOC, V154, pC508, DOI 10.1149/1.2754080
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   Shettlemore MG, 2001, BIOMATERIALS, V22, P2215, DOI 10.1016/S0142-9612(00)00410-5
   Wataha JC, 2000, J PROSTHET DENT, V83, P223, DOI 10.1016/S0022-3913(00)80016-5
   Wirz Jakob, 2003, Schweiz Monatsschr Zahnmed, V113, P284
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
NR 14
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-21197-3
J9 IFMBE PROC
PY 2013
VL 33
IS 1-2
BP 180
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BCO94
UT WOS:000310929100046
DA 2018-10-19
ER

PT J
AU Gilmore, L
   Rimmer, S
   McArthur, SL
   Mittar, S
   Sun, DC
   MacNeil, S
AF Gilmore, Louisa
   Rimmer, Stephen
   McArthur, Sally L.
   Mittar, Shweta
   Sun, Dachau
   MacNeil, Sheila
TI Arginine functionalization of hydrogels for heparin bindingua
   supramolecular approach to developing a pro-angiogenic biomaterial
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE angiogenesis; heparin; hydrogels
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; COLLATERAL DEVELOPMENT; SUSTAINED
   DELIVERY; ACID) MICROGELS; CELL-SURFACE; ADHESION; RELEASE; SCAFFOLDS;
   MODEL
AB Our aim was to synthesize a biomaterial that stimulates angiogenesis for tissue engineering applications by exploiting the ability of heparin to bind and release vascular endothelial growth factor (VEGF). The approach adopted involved modification of a hydrogel with positively charged peptides (oligolysine or oligoarginine) to achieve heparin binding. Precursor hydrogels were produced from copolymerization of N-vinyl pyrolidone, diethylene glycol bis allyl carbonate and acrylic acid (PNDA) and functionalized after activation of the carboxylic acid groups with trilysine or triarginine peptides (PNDKKK and PNDRRR). Both hydrogels were shown to bind and release bioactive VEGF165 with arginine-modified hydrogel outperforming the lysine-modified hydrogel. Cytocompatibility of the hydrogels was confirmed in vitro with primary human dermal fibroblasts and human dermal microvascular endothelial cells (HUDMECs). Proliferation of HUDMECs was stimulated by triarginine-functionalized hydrogels, and to a lesser extent by lysine functionalized hydrogels once loaded with heparin and VEGF. The data suggests that heparin-binding hydrogels provide a promising approach to a pro-angiogenic biomaterial. Biotechnol. Bioeng. 2013; 110: 296317. (C) 2012 Wiley Periodicals, Inc.
C1 [Mittar, Shweta; MacNeil, Sheila] Univ Sheffield, Kroto Res Inst, Dept Mat Sci & Engn, Sheffield S3 7HQ, S Yorkshire, England.
   [Gilmore, Louisa; Rimmer, Stephen; Sun, Dachau] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.
   [McArthur, Sally L.] Swinburne Univ Technol, Fac Engn & Ind Sci, IRIS, Hawthorn, Vic 3122, Australia.
RP MacNeil, S (reprint author), Univ Sheffield, Kroto Res Inst, Dept Mat Sci & Engn, Sheffield S3 7HQ, S Yorkshire, England.
EM s.macneil@Sheffield.ac.uk
RI McArthur, Sally/B-6848-2008
OI McArthur, Sally/0000-0002-4914-6989
FU BBSRC; BBSRC (UK)
FX Contract grant sponsor: BBSRC; We thank BBSRC (UK) for funding a Ph.D.
   studentship for Louisa Gilmore and Dr. Tracy Whittle for XPS analysis.
CR Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Chen YM, 2007, BIOMATERIALS, V28, P1752, DOI 10.1016/j.biomaterials.2006.12.005
   Christensen K, 2005, THROMB RES, V115, P245, DOI 10.1016/j,thromres.2004.08.030
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   DVORAK HF, 1995, AM J PATHOL, V146, P1029
   Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179
   Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0
   Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115
   Gilmore L, 2009, CHEMBIOCHEM, V10, P2165, DOI 10.1002/cbic.200900383
   GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093
   Gu F, 2007, J CONTROL RELEASE, V117, P80, DOI 10.1016/j.jconrel.2006.09.077
   Haigh R, 2002, BIOMATERIALS, V23, P3509, DOI 10.1016/S0142-9612(02)00081-9
   Hamma-Kourbali Y, 2001, J BIOL CHEM, V276, P39748, DOI 10.1074/jbc.M101117200
   Haxhinasto KB, 2008, J MATER SCI-MATER M, V19, P1999, DOI 10.1007/s10856-007-3277-1
   HEYMAN PW, 1985, J BIOMED MATER RES, V19, P419, DOI 10.1002/jbm.820190407
   Hopkins SP, 1998, J VASC SURG, V27, P886, DOI 10.1016/S0741-5214(98)70269-1
   Jay SM, 2008, J CONTROL RELEASE, V134, P26
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030
   Johansson C, 2007, J COLLOID INTERF SCI, V316, P350, DOI 10.1016/j.jcis.2007.07.052
   Johansson C, 2010, J COLLOID INTERF SCI, V347, P241, DOI 10.1016/j.jcis.2010.03.072
   Kanczler JM, 2007, BIOCHEM BIOPH RES CO, V352, P135, DOI 10.1016/j.bbrc.2006.10.187
   Kavanagh CA, 2005, J BIOMED MATER RES A, V72A, P25, DOI 10.1002/jbm.a.30192
   Kiick KL, 2008, SOFT MATTER, V4, P29, DOI 10.1039/b711319f
   Kim S, 2009, ACTA BIOMATER, V5, P144, DOI 10.1016/j.actbio.2008.07.033
   Kim SW, 1996, BLOOD PURIFICAT, V14, P357
   Kipshidze N, 2000, TEX HEART I J, V27, P196
   Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e
   Lazarous DF, 1996, CIRCULATION, V94, P1074, DOI 10.1161/01.CIR.94.5.1074
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Norton LW, 2005, BIOMATERIALS, V26, P3285, DOI 10.1016/j.biomaterials.2004.07.069
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Rimmer S, 2007, BIOMATERIALS, V28, P5319, DOI 10.1016/j.biomaterials.2007.08.028
   Rouet V, 2005, J BIOL CHEM, V280, P32792, DOI 10.1074/jbc.M5044922200
   Schumacher B, 1998, CIRCULATION, V97, P645, DOI 10.1161/01.CIR.97.7.645
   Smith LE, 2006, BIOMATERIALS, V27, P2806, DOI 10.1016/j.biomaterials.2005.12.018
   SOKER S, 1994, BIOCHEM BIOPH RES CO, V203, P1339, DOI 10.1006/bbrc.1994.2329
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Sun QH, 2005, PHARM RES, V22, P1110, DOI 10.1007/s11095-005-5644-2
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Xu FJ, 2005, BIOMACROMOLECULES, V6, P1759, DOI 10.1021/bm050071w
   YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W
   Yoon JJ, 2007, J BIOMED MATER RES A, V83A, P597, DOI 10.1002/jbm.a.31271
NR 47
TC 12
Z9 12
U1 2
U2 50
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JAN
PY 2013
VL 110
IS 1
BP 296
EP 317
DI 10.1002/bit.24598
PG 22
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 041EP
UT WOS:000311380200027
PM 22753043
DA 2018-10-19
ER

PT J
AU Al-Abboodi, A
   Fu, J
   Doran, PM
   Chan, PPY
AF Al-Abboodi, Aswan
   Fu, Jing
   Doran, Pauline M.
   Chan, Peggy P. Y.
TI Three-dimensional nanocharacterization of porous hydrogel with ion and
   electron beams
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE porous hydrogel; focused ion beam (FIB); SEM; tomography; cell growth
ID CELLS; MICROSCOPY; SPECIMENS; BEHAVIOR; SYSTEM; SEM
AB Porous hydrogels provide an excellent environment for cell growth and tissue regeneration, with high permeability for oxygen, nutrients, and other water-soluble metabolites through their high water-content matrix. The ability to image three-dimensional (3D) cell growth is crucial for understanding and studying various cellular activities in 3D context, particularly for designing new tissue engineering scaffold, but it is still challenging to study cell-biomaterial interfaces with high resolution imaging. We demonstrate using focused ion beam (FIB) milling, electron imaging, and associated microanalysis techniques that novel 3D characterizations can be performed effectively on cells growing inside 3D hydrogel scaffold. With FIB-tomography, the porous microstructures were revealed at nanometer resolution, and the cells grown inside. The results provide a unique 3D measurement of hydrogel porosity, as compared with those from porosimetry, and offer crucial insights into material factors affecting cell proliferation at specific regions within the scaffold. We also proved that high throughput correlative imaging of cell growth is viable through a silicon membrane based environment. The proposed approaches, together with the protocols developed, provide a unique platform for analysis of the microstructures of novel biomaterials, and for exploration of their interactions with the cells as well. Biotechnol. Bioeng. 2013; 110: 318326. (C) 2012 Wiley Periodicals, Inc.
C1 [Fu, Jing] Monash Univ, Dept Mech & Aerosp Engn, Clayton, Vic 3800, Australia.
   [Al-Abboodi, Aswan] Monash Univ, Dept Chem Engn, Clayton, Vic 3800, Australia.
   [Doran, Pauline M.] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia.
   [Chan, Peggy P. Y.] RMIT Univ, Sch Appl Sci, Melbourne, Vic 3000, Australia.
   [Chan, Peggy P. Y.] RMIT Univ, Micro Nanophys Res Lab, Melbourne, Vic 3000, Australia.
RP Fu, J (reprint author), Monash Univ, Dept Mech & Aerosp Engn, Clayton, Vic 3800, Australia.
EM jing.fu@monash.edu; peggy.chan@rmit.edu.au
OI Fu, Jing/0000-0002-7752-5417
FU Faculty of Engineering, Monash University; Australian Research Council
   Discovery (ARC) Project Grant [DP 120102570, DP 120100583]; Commonwealth
   of Australia; Victorian Government
FX The authors would like to acknowledge support from the New Staff Member
   Research Fund from the Faculty of Engineering, Monash University.
   Funding for this work was partly provided through Australian Research
   Council Discovery (ARC) Project Grant DP 120102570 and DP 120100583.
   This work was performed in part at the Monash Centre of Electron
   Microscopy (MCEM) and the Melbourne Centre for Nanofabrication (MCN), an
   initiative partly funded by the Commonwealth of Australia and the
   Victorian Government. High performance computing was supported by
   Multi-modal Australian Sciences Imaging and Visualisation Environment
   (MASSIVE). The authors also thank Dr. Manoj Sridhar, Mr. David Vowles,
   and Monash Microimaging for experiment assistance.
CR Bennett AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000591
   Bittermann AG, 2009, ADV ENG MATER, V11, pB182, DOI 10.1002/adem.200900080
   da Silva J, 2010, BIOMATERIALS, V31, P2201, DOI 10.1016/j.biomaterials.2009.11.105
   Edwards HK, 2009, J MICROSC-OXFORD, V234, P16, DOI 10.1111/j.1365-2818.2009.03152.x
   Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Friedmann A, 2012, SCANNING, V34, P221, DOI 10.1002/sca.20297
   Friedmann A, 2011, ACTA BIOMATER, V7, P2499, DOI 10.1016/j.actbio.2011.02.024
   Fu J, 2008, J VAC SCI TECHNOL A, V26, P422, DOI 10.1116/1.2902962
   Fu J, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/9/095010
   Giannuzzi LA, 2005, INTRO FOCUSED ION BE, Vxiv, P357
   Greulich C, 2011, ACTA BIOMATER, V7, P347, DOI 10.1016/j.actbio.2010.08.003
   Hayles MF, 2007, J MICROSC-OXFORD, V226, P263, DOI 10.1111/j.1365-2818.2007.01775.x
   Hayles MF, 2010, J STRUCT BIOL, V172, P180, DOI 10.1016/j.jsb.2010.07.004
   Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006
   Heymann JAW, 2009, J STRUCT BIOL, V166, P1, DOI 10.1016/j.jsb.2008.11.005
   Hildebrand M, 2009, J STRUCT BIOL, V166, P316, DOI 10.1016/j.jsb.2009.02.014
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jin R, 2010, BIOMATERIALS, V31, P3103, DOI 10.1016/j.biomaterials.2010.01.013
   Keskar V, 2009, TISSUE ENG PT A, V15, P1695, DOI 10.1089/ten.tea.2008.0238
   Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008
   Lee BH, 2006, BIOMACROMOLECULES, V7, P2059, DOI 10.1021/bm060211h
   Lee F, 2008, SOFT MATTER, V4, P880, DOI 10.1039/b719557e
   Leser V, 2009, J MICROSC-OXFORD, V233, P309, DOI 10.1111/j.1365-2818.2009.03121.x
   Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037
   Lucille A, 2007, J ORAL MAXILLOFAC SU, V65, P737
   Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014
   Martinez E, 2008, MICRON, V39, P111, DOI 10.1016/j.micron.2006.12.003
   Mcgeoch JEM, 2007, J MICROSC-OXFORD, V227, P172, DOI 10.1111/j.1365-2818.2007.01798.x
   Murphy GE, 2011, J STRUCT BIOL, V176, P268, DOI 10.1016/j.jsb.2011.08.013
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Rigort A, 2010, J STRUCT BIOL, V172, P169, DOI 10.1016/j.jsb.2010.02.011
   Schroeder-Reiter E, 2009, J STRUCT BIOL, V165, P97, DOI 10.1016/j.jsb.2008.10.002
   Volkert CA, 2007, MRS BULL, V32, P389, DOI 10.1557/mrs2007.62
   Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042
NR 35
TC 21
Z9 21
U1 0
U2 58
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JAN
PY 2013
VL 110
IS 1
BP 318
EP 326
DI 10.1002/bit.24612
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 041EP
UT WOS:000311380200028
PM 22811278
DA 2018-10-19
ER

PT J
AU Rodriguez, R
   Loske, AM
   Estevez, M
   Vargas, S
   Salazar, R
   Pacheco, F
   Vazquez-Carpizo, J
   Gamboa, JM
AF Rodriguez, R.
   Loske, A. M.
   Estevez, M.
   Vargas, S.
   Salazar, R.
   Pacheco, F.
   Vazquez-Carpizo, J.
   Gamboa, J. M.
TI Bio-Packaged Transponder MEMS Implanted in Rats
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Bio-package; hybrid material; hydroxyapatite; MEMS; transponder;
   biomaterial; implant
ID POROUS HYDROXYAPATITE; BONE; POLYURETHANE; BIOMATERIALS; MATRIX
AB A novel hydroxyapatite-based hybrid material with controlled porosity was designed as a bio-package to implant micro-electro-mechanical systems (MEMS) in living organisms. The biomaterial was prepared using synthetic stoichiometric hydroxyapatite powder reacted with a chemical-active, solvent-free, alkyd-based polyurethane. This porous material has interconnected pores with sizes between 100 and 350 mu m and a pore volume fraction of 50%, fulfilling the requirements for implants. The biomaterial additionally has high wearing resistance and hydrolytic stability providing high endurance properties. The bio-package was characterized mechanically and morphologically using X-ray diffraction, scanning electron microscopy, densitometry, abrasion and mechanical tests. Twelve packaged micro-electro-mechanical systems were implanted subcutaneously into rats and tested for up to 9 months with good acceptance as revealed by the histological analysis performed on the soft tissue surrounding each implant. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Rodriguez, R.; Loske, A. M.; Estevez, M.; Vargas, S.] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro 76230, Qro, Mexico.
   [Rodriguez, R.] Univ Valle Mexico, Div Ciencias Salud, Queretaro 76230, Qro, Mexico.
   [Salazar, R.; Pacheco, F.] Univ Popular Autonoma Estado Puebla, Lab MEMS & CSAT, Puebla 72160, Pue, Mexico.
   [Vazquez-Carpizo, J.] Hosp Angeles Queretaro, Queretaro 76178, Qro, Mexico.
   [Gamboa, J. M.] Lab Anat Patol & Citol Queretaro, Queretaro 76020, Qro, Mexico.
RP Rodriguez, R (reprint author), Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro 76230, Qro, Mexico.
EM rogelior@unam.mx
RI Gamboa, Jose Manuel/D-5389-2014; Rodriguez Talavera, Jose
   Rogelio/L-1709-2018; Estevez, Miriam/F-8864-2018
OI Rodriguez Talavera, Jose Rogelio/0000-0002-7455-2276; Estevez,
   Miriam/0000-0003-4749-7715; VARGAS MUNOZ, SUSANA/0000-0001-9031-4182;
   Loske, Achim/0000-0002-9873-5165
CR Alves P, 2009, EUR POLYM J, V45, P1412, DOI 10.1016/j.eurpolymj.2009.02.011
   Barbic M, 2002, J MAGN MAGN MATER, V249, P357, DOI 10.1016/S0304-8853(02)00559-0
   BECHARD S, 1986, INT J PHARMACEUT, V32, P71, DOI 10.1016/0378-5173(86)90100-6
   Byun I, 2008, MICROELECTRON J, V39, P717, DOI 10.1016/j.mejo.2007.12.004
   Chen YC, 2004, J COLLOID INTERF SCI, V279, P370, DOI 10.1016/j.jcis.2004.06.074
   Cooley P., 2002, JALA, V7, P33, DOI 10.1016/S1535-5535(04)00214-X
   FANSKA CB, 1991, J CHROMATOGR, V537, P357, DOI 10.1016/S0021-9673(01)88908-1
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   Green JR, 1999, J ARTHROPLASTY, V14, P91, DOI 10.1016/S0883-5403(99)90208-5
   HOLMES R, 1988, J CRANIO MAXILL SURG, V16, P199, DOI 10.1016/S1010-5182(88)80047-7
   Horvath I, 2001, MICROELECTR J, V32, P1, DOI 10.1016/S0026-2692(00)00073-2
   Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x
   Ko YG, 2009, J COLLOID INTERF SCI, V330, P77, DOI 10.1016/j.jcis.2008.10.015
   Kumar P, 2010, J FOOD ENG, V100, P480, DOI 10.1016/j.jfoodeng.2010.04.035
   Laurienzo P, 2010, J FOOD ENG, V97, P491, DOI 10.1016/j.jfoodeng.2009.11.006
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   Li N., 2008, JALA, V13, P237
   Lie C., 2006, MICROELECTRON J, V37, P1347
   Niinomi M, 2007, INT J FATIGUE, V29, P992, DOI 10.1016/j.ijfatigue.2006.09.021
   RIPAMONTI U, 1991, J ORAL MAXIL SURG, V49, P817, DOI 10.1016/0278-2391(91)90010-J
   Rodriguez R, 2008, J MATER SCI-MATER EL, V19, P646, DOI 10.1007/s10854-007-9413-3
   Rodriguez R., 2010, J BIOMAT SCI-POLYM E, V22, P1799
   Rozenberg I., 2006, J MAGN MAGN MATER, V305
   Seramak T, 2010, J BIOMECH, V43, pS55
   Silva Marcelo Henrique Prado da, 2003, Mat. Res., V6, P321, DOI 10.1590/S1516-14392003000300004
   Singh A, 2005, J SOUND VIB, V286, P637, DOI 10.1016/j.jsv.2004.12.010
   Spector M, 1987, J Arthroplasty, V2, P163, DOI 10.1016/S0883-5403(87)80024-4
   Susuki S., 1999, THIN SOLID FILMS, V340, P194
   Tancret F, 2006, J EUR CERAM SOC, V26, P3647, DOI 10.1016/j.jeurceramsoc.2005.12.015
   Teissier J., 1985, J CRANIO MAXILLOFAC, V43, P1000
   Xiao SY, 2007, MICROELECTRON J, V38, P360, DOI 10.1016/j.mejo.2007.01.022
   Zhong ZW, 2006, MICROELECTRON J, V37, P295, DOI 10.1016/j.mejo.2005.05.016
NR 32
TC 0
Z9 0
U1 3
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2013
VL 24
IS 1
BP 31
EP 44
DI 10.1163/156856211X621097
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 043KW
UT WOS:000311543500003
PM 22304894
DA 2018-10-19
ER

PT J
AU Kumar, S
   Jain, SL
   Sain, B
AF Kumar, Subodh
   Jain, Suman L.
   Sain, Bir
TI Chemically modified expended starch grafted Ni-acetylacetonate/TBAB: An
   effective reusable catalytic combination for the cycloaddition of carbon
   dioxide to epoxides
SO CATALYSIS TODAY
LA English
DT Article
DE Carbon dioxide; Biomaterial; Heterogeneous catalyst; Cyclic carbonate
ID ZEOLITE-BASED CATALYSTS; CYCLIC CARBONATES; CO2 ACTIVATION; RENEWABLE
   RESOURCES; EFFICIENT SYNTHESIS; COUPLING REACTIONS; HIGHLY EFFICIENT;
   PHOSGENE-FREE; POLYCARBONATE; FIXATION
AB Starch is renewable, biodegradable and relatively inexpensive material that has been used for the grafting of nickel(II) acetylacetonate by covalent linkage. The prepared material in combination with tetrabutyl ammonium bromide is found to be a very active, selective and recyclable catalytic system for the cycloaddition of CO2 and epoxides without co-solvent under relatively mild reaction conditions. Importantly, the starch grafted nickel catalyst and TBAB are easily recovered after the reaction and reused many times without any loss in catalytic activity. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Kumar, Subodh; Jain, Suman L.; Sain, Bir] Indian Inst Petr, CSIR, Div Chem Sci, Dehra Dun 248005, Uttar Pradesh, India.
RP Jain, SL (reprint author), Indian Inst Petr, CSIR, Div Chem Sci, Dehra Dun 248005, Uttar Pradesh, India.
EM suman@iip.res.in
RI Sain, Bir/F-8603-2010
FU CSIR; DST, New Delhi
FX We acknowledge Director IIP for his kind permission to publish these
   results. SK thanks to CSIR for his research fellowship. DST, New Delhi
   is kindly acknowledged for the financial assistance. Analytical Sciences
   Division of the IIP is acknowledged for providing TGA, <SUP>1</SUP>H
   NMR, IR, SEM and ICP analysis of the samples.
CR Aresta M, 2001, ENERG FUEL, V15, P269, DOI 10.1021/ef000242k
   Aresta M., 2010, CARBON DIOXIDE CHEM
   Aresta M, 2007, DALTON T, P2975, DOI 10.1039/b700658f
   Benaglia M., 2009, RECOVERABLE RECYCLAB
   Biggadike K, 2000, J MED CHEM, V43, P19, DOI 10.1021/jm990436t
   Cokoja M, 2011, ANGEW CHEM INT EDIT, V50, P8510, DOI 10.1002/anie.201102010
   Darensbourg DJ, 1996, COORDIN CHEM REV, V153, P155, DOI 10.1016/0010-8545(95)01232-X
   Ding K., 2008, HDB ASYMMETRIC HETER
   Doi S, 2002, CHEM COMMUN, P2632, DOI 10.1039/b207780a
   Du Y, 2006, TETRAHEDRON LETT, V47, P1271, DOI 10.1016/j.tetlet.2005.12.077
   Ei-Hamshary H., 2004, J APPL POLYM SCI, V93, P630
   Gronnow MJ, 2005, GREEN CHEM, V7, P552, DOI 10.1039/b501130b
   Huang JW, 2003, J ORG CHEM, V68, P6705, DOI 10.1021/jo0348221
   Huang K, 2011, CHEM SOC REV, V40, P2435, DOI 10.1039/c0cs00129e
   Huang L, 2011, J HAZARD MATER, V192, P832, DOI 10.1016/j.jhazmat.2011.05.094
   Kandylis P, 2008, J AGR FOOD CHEM, V56, P12037, DOI 10.1021/jf802476w
   Kawanami H, 2003, CHEM COMMUN, P896, DOI 10.1039/b212823c
   Li FW, 2003, CHEM COMMUN, P2042, DOI 10.1039/b305617a
   Liang SG, 2011, CHEM COMMUN, V47, P2131, DOI 10.1039/c0cc04829a
   Liu C. J., 2003, UTILIZATION GREEN HO
   Lu XB, 2004, J CATAL, V227, P537, DOI 10.1016/j.jcat.2004.07.018
   Melendez J., 2007, EUROPEAN J INORGANIC, V21, P3323
   Miralda CM, 2012, ACS CATAL, V2, P180, DOI 10.1021/cs200638h
   Motokura K, 2009, GREEN CHEM, V11, P1876, DOI 10.1039/b916764c
   North M, 2009, ANGEW CHEM INT EDIT, V48, P2946, DOI 10.1002/anie.200805451
   Ratnasamy P., 2008, HDB HETEROGENEOUS CA, V7, P3717
   Shaabani A, 2008, CATAL COMMUN, V9, P13, DOI 10.1016/j.catcom.2007.05.021
   Shi F, 2005, J AM CHEM SOC, V127, P4182, DOI 10.1021/ja042207o
   Sit WN, 2005, J ORG CHEM, V70, P8583, DOI 10.1021/jo061077e
   Song JL, 2009, GREEN CHEM, V11, P1031, DOI 10.1039/b902550b
   Srivastava R, 2006, TETRAHEDRON LETT, V47, P4213, DOI 10.1016/j.tetlet.2006.04.057
   Srivastava R, 2004, STUD SURF SCI CATAL, V154, P2703
   Srivastava R, 2005, APPL CATAL A-GEN, V289, P128, DOI 10.1016/j.apcata.2005.04.055
   Srivastava R, 2005, J CATAL, V233, P1, DOI 10.1016/j.jcat.2005.03.023
   Srivastava R, 2004, CATAL LETT, V97, P41, DOI 10.1023/B:CATL.0000034285.05419.7e
   Srivastava R, 2006, MICROPOR MESOPOR MAT, V90, P314, DOI 10.1016/j.micromeso.2005.10.043
   Srivastava R, 2003, CATAL LETT, V89, P81, DOI 10.1023/A:1024723627087
   Srivastava R, 2003, CATAL LETT, V91, P133, DOI 10.1023/B:CATL.0000006329.37210.fd
   Verma S, 2011, CHEMCATCHEM, V3, P1329, DOI 10.1002/cctc.201100111
   Wang YH, 2010, BIORESOURCE TECHNOL, V101, P6170, DOI 10.1016/j.biortech.2010.02.102
   Wu RL, 2009, BIORESOURCE TECHNOL, V100, P2569, DOI 10.1016/j.biortech.2008.11.044
   Yasuda H, 2005, J CATAL, V233, P119, DOI 10.1016/j.jcat.2005.04.030
   Yasuda H, 2002, J CATAL, V209, P547, DOI 10.1006/jcat.2002.3662
   Yu L, 2006, PROG POLYM SCI, V31, P576, DOI 10.1016/j.progpolymsci.2006.03.002
   Zhang XL, 2009, CATAL COMMUN, V11, P43, DOI 10.1016/j.catcom.2009.08.007
   Zhao T., 1999, PHYS CHEM CHEM PHYS, V12, P3047
   Zhu AL, 2007, GREEN CHEM, V9, P169, DOI 10.1039/b612164k
NR 47
TC 10
Z9 10
U1 3
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0920-5861
EI 1873-4308
J9 CATAL TODAY
JI Catal. Today
PD DEC 30
PY 2012
VL 198
IS 1
SI SI
BP 204
EP 208
DI 10.1016/j.cattod.2012.05.028
PG 5
WC Chemistry, Applied; Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 040UO
UT WOS:000311350000027
DA 2018-10-19
ER

PT J
AU Londono, R
   Jobe, BA
   Hoppo, T
   Badylak, SF
AF Londono, Ricardo
   Jobe, Blair A.
   Hoppo, Toshitaka
   Badylak, Stephen F.
TI Esophagus and regenerative medicine
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Esophageal repair; Biomaterial mediated esophageal repair; Extracellular
   matrix; Extracellular matrix scaffold
ID ENDOSCOPIC SUBMUCOSAL DISSECTION; EXTRACELLULAR-MATRIX SCAFFOLD;
   TISSUE-ENGINEERED ESOPHAGUS; SMALL-INTESTINAL SUBMUCOSA; EPITHELIAL-CELL
   SHEETS; HIGH-GRADE DYSPLASIA; STEM-CELLS; BARRETTS-ESOPHAGUS; MACROPHAGE
   PHENOTYPE; DOG-MODEL
AB In addition to squamous cell carcinoma, the incidence of Barrett's esophagus with high-grade dysplasia and esophageal adenocarcinoma is rapidly increasing worldwide. Unfortunately, the current standard of care for esophageal pathology involves resection of the affected tissue, sometimes involving radical esophagectomy. Without exception, these procedures are associated with a high morbidity, compromised quality of life, and unacceptable mortality rates. Regenerative medicine approaches to functional tissue replacement include the use of biological and synthetic scaffolds to promote tissue remodeling and growth. In the case of esophageal repair, extracellular matrix (ECM) scaffolds have proven to be effective for the reconstruction of small patch defects, anastomosis reinforcement, and the prevention of stricture formation after endomucosal resection (EMR). More so, esophageal cancer patients treated with ECM scaffolds have shown complete restoration of a normal, functional, and disease-free epithelium after EMR. These studies provide evidence that a regenerative medicine approach may enable aggressive resection of neoplastic tissue without the need for radical esophagectomy and its associated complications. (C) 2012 Baishideng. All rights reserved.
C1 [Londono, Ricardo; Badylak, Stephen F.] McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Londono, Ricardo] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA.
   [Jobe, Blair A.; Hoppo, Toshitaka] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA 15232 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, 450 Technol Dr,Suite 300, Pittsburgh, PA 15213 USA.
EM badylaks@upmc.edu
OI Londono, Ricardo/0000-0001-5785-0645; Badylak,
   Stephen/0000-0003-3555-0689
FU National Institute of Biomedical Imaging and Bioengineering
   [T32EBO01026-08]
FX Supported by Award Number T32EBO01026-08, from the National Institute of
   Biomedical Imaging and Bioengineering, in part
CR Adamson R, 2009, J Wound Care, V18, P349
   Adolphe Christelle, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009890
   Agrawal V, 2011, TISSUE ENG PT A, V17, P2435, DOI [10.1089/ten.TEA.2011.0036, 10.1089/ten.tea.2011.0036]
   Alcantara PSM, 1997, INT SURG, V82, P249
   Allen S, 2008, ANN NY ACAD SCI, V1150, P260, DOI 10.1196/annals.1447.003
   Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234
   Aly Theresa, 2005, Am J Ther, V12, P481, DOI 10.1097/01.mjt.0000178782.97413.79
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739
   Baryan HK, 2012, INT J STROKE, V7, P150, DOI 10.1111/j.1747-4949.2011.00740.x
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   Bracken MB, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.00001046.PUB2
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Burns AS, 2012, J SPINAL CORD MED, V35, P3, DOI 10.1179/2045772311Y.0000000043
   Canto JG, 2011, JAMA-J AM MED ASSOC, V306, P2120, DOI 10.1001/jama.2011.1654
   Collard Jean-Marie, 2002, Chest Surg Clin N Am, V12, P77, DOI 10.1016/S1052-3359(03)00067-X
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Croagh D, 2008, STEM CELL REV, V4, P261, DOI 10.1007/s12015-008-9031-3
   Croagh D, 2007, STEM CELLS, V25, P313, DOI 10.1634/stemcells.2006-0421
   Devendra D, 2004, BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750
   DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dumot JA, 2009, GASTROINTEST ENDOSC, V70, P635, DOI 10.1016/j.gie.2009.02.006
   Dunn C D, 1971, Ser Haematol, V4, P1
   Ellis F H Jr, 1999, Surg Oncol Clin N Am, V8, P279
   Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010
   Falk GW, 1999, GASTROINTEST ENDOSC, V49, P170, DOI 10.1016/S0016-5107(99)70482-7
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185
   Gawad KA, 1999, AM J GASTROENTEROL, V94, P1490
   Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022
   Greenbaum CJ, 2002, CLIN IMMUNOL, V104, P97, DOI 10.1006/clim.2002.5234
   Grikscheit T, 2003, J THORAC CARDIOV SUR, V126, P537, DOI 10.1016/S0022-5223(03)00032-1
   Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007
   Grounds MD, 1999, CURR OPIN NEUROL, V12, P535, DOI 10.1097/00019052-199910000-00007
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   HAIGHT C, 1957, J THORAC SURG, V34, P141
   HALPRIN KM, 1972, BRIT J DERMATOL, V86, P14, DOI 10.1111/j.1365-2133.1972.tb01886.x
   Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003
   IIZUKA H, 1995, J DERMATOL SCI, V10, P220, DOI 10.1016/0923-1811(95)00407-J
   Jaffer H, 2011, DRUG DELIV TRANSL RE, V1, P409, DOI 10.1007/s13346-011-0046-y
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Katzka David A., 2001, Curr Treat Options Gastroenterol, V4, P59, DOI 10.1007/s11938-001-0047-x
   Keeley SB, 2007, ANN SURG ONCOL, V14, P2406, DOI 10.1245/s10434-007-9392-x
   Kohler BA, 2011, J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077
   LEBLOND C P, 1967, Proceedings of the Canadian Cancer Research Conference, V7, P3
   LEWIS JP, 1964, NATURE, V204, P589, DOI 10.1038/204589a0
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   LOUTIT JF, 1968, BRIT J HAEMATOL, V15, P333, DOI 10.1111/j.1365-2141.1968.tb01546.x
   Luostarinen M, 1997, Dis Esophagus, V10, P86
   Marzaro M, 2006, J BIOMED MATER RES A, V77A, P795, DOI 10.1002/jbm.a.30666
   May A, 2003, GASTROINTEST ENDOSC, V58, P167, DOI 10.1067/mge.2003.339
   Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675
   MILLIKAN CH, 1966, SCIENCE, V152, P803, DOI 10.1126/science.152.3723.803
   MOFFATT DJ, 1967, LANCET, V2, P547
   Morgan TH, 1901, REGENERATION, P170
   Nakase Y, 2008, J THORAC CARDIOV SUR, V136, P850, DOI 10.1016/j.jtcvs.2008.05.027
   Nieponice A, 2009, GASTROINTEST ENDOSC, V69, P289, DOI 10.1016/j.gie.2008.04.022
   Nieponice A, 2006, ANN THORAC SURG, V82, P2050, DOI 10.1016/j.athoracsur.2006.06.036
   O'Dowd JK, 2010, EUR SPINE J, V19, P18, DOI 10.1007/s00586-009-1118-2
   Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518
   Orringer MB, 2001, WORLD J SURG, V25, P196, DOI 10.1007/s002680020019
   POTTEN CS, 1984, INT J CELL CLONING, V2, P126, DOI 10.1002/stem.5530020206
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Rice TW, 1998, ANN THORAC SURG, V65, P787, DOI 10.1016/S0003-4975(97)01387-8
   Seery JP, 2002, J CELL SCI, V115, P1783
   Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4
   Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145
   Sharma VK, 2007, GASTROINTEST ENDOSC, V65, P185, DOI 10.1016/j.gie.2006.09.033
   Souza RF, 2011, ANN NY ACAD SCI, V1232, P316, DOI 10.1111/j.1749-6632.2011.06070.x
   Takagi R, 2011, PATHOBIOLOGY, V78, P311, DOI 10.1159/000322575
   Takagi R, 2010, GASTROINTEST ENDOSC, V72, P1253, DOI 10.1016/j.gie.2010.08.007
   Thelle DS, 2011, EUR J EPIDEMIOL, V26, P829, DOI 10.1007/s10654-011-9627-9
   Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   VRACKO R, 1974, AM J PATHOL, V77, P314
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Yamamoto H, 2007, NAT CLIN PRACT GASTR, V4, P511, DOI 10.1038/ncpgasthep0906
   YAU HC, 1979, RADIAT RES, V80, P92, DOI 10.2307/3575118
NR 87
TC 9
Z9 11
U1 0
U2 25
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD DEC 21
PY 2012
VL 18
IS 47
BP 6894
EP 6899
DI 10.3748/wjg.v18.i47.6894
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 064ZF
UT WOS:000313114100005
PM 23322986
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Geraths, C
   Christen, EH
   Weber, W
AF Geraths, Christian
   Christen, Erik H.
   Weber, Wilfried
TI A Hydrogel Sensing Pathological Urate Concentrations
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE biomaterial; DNA-protein interaction; gout; repressor protein;
   stimuli-sensitive polymers
ID DEINOCOCCUS-RADIODURANS; INDUCIBLE RELEASE; MAMMALIAN-CELLS; MICE;
   BIOPHARMACEUTICALS; BIOSENSORS; PROTEIN; SENSOR; FAMILY; GOUT
AB Metabolite-responsive hydrogels that detect pathological metabolite concentrations and react by releasing a therapeutic stimulus hold high promises in treating metabolic diseases. In this study, a hydrogel is described that discriminates between physiological and pathological concentrations of urate, the causative agent of gouty arthritis. The hydrogel is synthesized by coupling a dimeric variant of the Deinococcus radiodurans-derived urate repressor HucR to linear polyacrylamide. The protein-grafted polymer is crosslinked to form a hydrogel by a multimeric hucO DNA sequence [hucO]n specifically binding HucR. At elevated urate concentrations, HucR dissociates from [hucO]n thereby weakening the hydrogel structure and resulting in its dissolution.
C1 [Geraths, Christian; Christen, Erik H.; Weber, Wilfried] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.
   [Geraths, Christian; Christen, Erik H.; Weber, Wilfried] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany.
RP Weber, W (reprint author), Univ Freiburg, Fac Biol, Schanzlestr 18, D-79104 Freiburg, Germany.
EM wilfried.weber@biologie.uni-freiburg.de
RI Weber, Wilfried/B-4732-2012
FU European Research Council under the European Community
   [259043-CompBioMat]; Excellence Initiative of the German Federal
   Government [EXC 294]; Excellence Initiative of the State Government [EXC
   294]
FX We would like to thank Raphael Gubeli for critical comments on the
   manuscript and Prof. C. Friedrich (FMF, Freiburg, Germany) for his
   support in the mechanical hydrogel characterization. This work was
   supported by the European Research Council under the European
   Community's Seventh Framework Program (FP7/2007-2013)/ERC Grant
   agreement no 259043-CompBioMat and the Excellence Initiative of the
   German Federal and State Governments (EXC 294).
CR Alvarez-Lario B., 2010, RHEUMATOLOGY, V49, P2010
   Chen LX, 2008, JCR-J CLIN RHEUMATOL, V14, pS55, DOI 10.1097/RHU.0b013e3181896921
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   Ehrick JD, 2005, NAT MATER, V4, P298, DOI 10.1038/nmat1352
   Gitzinger M, 2009, P NATL ACAD SCI USA, V106, P10638, DOI 10.1073/pnas.0901501106
   Hartenbach S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm652
   Jakobus K, 2012, CHEM SOC REV, V41, P1000, DOI 10.1039/c1cs15176b
   Kampf MM, 2010, ADV FUNCT MATER, V20, P2534, DOI 10.1002/adfm.200902377
   Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617
   Liu JW, 2011, SOFT MATTER, V7, P6757, DOI 10.1039/c1sm05284e
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   Pittman JR, 1999, AM FAM PHYSICIAN, V59, P1799
   Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005
   Weber CC, 2005, BIOTECHNOL BIOENG, V89, P9, DOI 10.1002/bit.20224
   Weber W, 2006, METAB ENG, V8, P273, DOI 10.1016/j.ymben.2005.12.004
   Wilkinson SP, 2004, J BIOL CHEM, V279, P51442, DOI 10.1074/jbc.M405586200
   Wilkinson SP, 2005, J MOL BIOL, V350, P617, DOI 10.1016/j.jmb.2005.05.027
NR 17
TC 7
Z9 7
U1 2
U2 26
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD DEC 21
PY 2012
VL 33
IS 24
BP 2103
EP 2108
DI 10.1002/marc.201200563
PG 6
WC Polymer Science
SC Polymer Science
GA 056BP
UT WOS:000312462200006
PM 23079933
DA 2018-10-19
ER

PT J
AU Nan, JN
   Hu, XG
   Li, HX
   Zhang, XN
   Piao, RJ
AF Nan, Jinniang
   Hu, Xuguang
   Li, Hongxiu
   Zhang, Xiaonong
   Piao, Renjing
TI Use of nerve conduits for peripheral nerve injury repair A Web of
   Science-based literature analysis
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE nerve conduit; biomaterial; axon; neurotrophic factor; stem cell;
   extracellular matrix; peripheral nerve injury; peripheral nerve repair;
   degradation; biocompatibility; neural regeneration
ID SCHWANN-CELLS; SCIATIC-NERVE; GROWTH-FACTOR; IN-VITRO; ELECTROSPUN
   NANOFIBERS; NEUROTROPHIC FACTORS; SILK FIBROIN; STEM-CELLS;
   REGENERATION; DELIVERY
AB OBJECTIVE: To identify global research trends in the use of nerve conduits for peripheral nerve injury repair.
   DATA RETRIEVAL: Numerous basic and clinical studies on nerve conduits for peripheral nerve injury repair were performed between 2002-2011. We performed a bibliometric analysis of the institutions, authors, and hot topics in the field, from the Web of Science, using the key words peripheral nerve and conduit or tube.
   SELECTION CRITERIA: Inclusion criteria: peer-reviewed published articles on nerve conduits for peripheral nerve injury repair, indexed in the Web of Science; original research articles, reviews, meeting abstracts, proceedings papers, book chapters, editorial material, and news items. Exclusion criteria: articles requiring manual searching or telephone access; documents not published in the public domain; and several corrected papers.
   MAIN OUTCOME MEASURES: (a) Annual publication output; (b) publication type; (c) publication by research field; (d) publication by journal; (e) publication by funding agency; (f) publication by author; (g) publication by country and institution; (h) publications by institution in China; (i) most-cited papers.
   RESULTS: A total of 793 publications on the use of nerve conduits for peripheral nerve injury repair were retrieved from the Web of Science between 2002-2011. The number of publications gradually increased over the 10-year study period. Articles constituted the main type of publication. The most prolific journals were Biomaterials, Microsurgery, and Journal of Biomedical Materials Research Part A. The National Natural Science Foundation of China supported 27 papers, more than any other funding agency. Of the 793 publications, almost half came from American and Chinese authors and institutions.
   CONCLUSION: Nerve conduits have been studied extensively for peripheral nerve regeneration; however, many problems remain in this field, which are difficult for researchers to reach a consensus.
C1 [Nan, Jinniang; Hu, Xuguang; Li, Hongxiu; Zhang, Xiaonong; Piao, Renjing] Second Peoples Hosp Panjin, Dept Gen Surg, Panjin 124000, Liaoning Provin, Peoples R China.
RP Li, HX (reprint author), Second Peoples Hosp Panjin, Dept Gen Surg, Panjin 124000, Liaoning Provin, Peoples R China.
CR Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Biazar E, 2010, INT J NANOMED, V5, P839, DOI 10.2147/IJN.S11883
   Carlstedt T, 2011, J HAND SURG-EUR VOL, V36E, P726, DOI 10.1177/1753193411422329
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chhabra A, 2010, AM J NEURORADIOL, V31, P1363, DOI 10.3174/ajnr.A2002
   Coert JH, 2010, BURNS, V36, P593, DOI 10.1016/j.burns.2009.10.007
   Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004
   de Ruiter GCW, 2009, NEUROSURG CLIN N AM, V20, P91, DOI 10.1016/j.nec.2008.08.001
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Dornseifer U, 2007, ZBL NEUROCHIR, V68, P101, DOI 10.1055/s-2007-984453
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Grosheva M, 2008, BIOL CHEM, V389, P873, DOI 10.1515/BC.2008.100
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Hou SY, 2006, NEUROSCIENCE, V140, P101, DOI 10.1016/j.neuroscience.2006.01.066
   Hu J, 2007, EXP NEUROL, V204, P658, DOI 10.1016/j.expneurol.2006.11.018
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   Ishikawa N, 2009, J BIOMED MATER RES A, V89A, P1118, DOI 10.1002/jbm.a.32389
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Kemp SWP, 2008, NEUROL RES, V30, P1030, DOI 10.1179/174313208X362505
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Lavdas AA, 2011, CURR GENE THER, V11, P90
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192
   Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5
   Li ZY, 2011, NEURAL REGEN RES, V6, P988, DOI 10.3969/j.issn.1673-5374.2011.13.005
   Lu GY, 2007, EUR POLYM J, V43, P3807, DOI 10.1016/j.eurpolymj.2007.06.016
   Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905
   Olakowska E, 2010, FOLIA NEUROPATHOL, V48, P231
   Pabari A, 2011, J CONTROL RELEASE, V156, P2, DOI 10.1016/j.jconrel.2011.07.001
   Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010
   Lopes FRP, 2010, MICRON, V41, P783, DOI 10.1016/j.micron.2010.05.010
   Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x
   Pitcher GM, 2008, EXP NEUROL, V214, P219, DOI 10.1016/j.expneurol.2008.08.003
   Rodrigues F, 2011, CELL MOL LIFE SCI, V68, P55, DOI 10.1007/s00018-010-0512-6
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Sedaghati T, 2011, BIOTECHNOL APPL BIOC, V58, P288, DOI 10.1002/bab.51
   Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799
   Siemionow M, 2009, INT REV NEUROBIOL, V87, P141, DOI 10.1016/S0074-7742(09)87008-6
   Spassky N, 2002, J NEUROSCI, V22, P5992
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Toll EC, 2011, REGEN MED, V6, P635, DOI [10.2217/RME.11.43, 10.2217/rme.11.43]
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Yan H, 2009, INT REV NEUROBIOL, V87, P199, DOI 10.1016/S0074-7742(09)87010-4
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yannas IV, 2007, J BIOMAT SCI-POLYM E, V18, P943, DOI 10.1163/156856207781494386
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
NR 51
TC 1
Z9 1
U1 0
U2 49
PU SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES
PI SHENYANG
PA PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA
SN 1673-5374
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD DEC 15
PY 2012
VL 7
IS 35
BP 2826
EP 2833
DI 10.3969/j.issn.1673-5374.2012.35.011
PG 8
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 065KV
UT WOS:000313148100011
PM 25317133
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Hansson, A
   Di Francesco, T
   Falson, F
   Rousselle, P
   Jordan, O
   Borchard, G
AF Hansson, Annasara
   Di Francesco, Tiziana
   Falson, Francoise
   Rousselle, Patricia
   Jordan, Olivier
   Borchard, Gerrit
TI Preparation and evaluation of nanoparticles for directed tissue
   engineering
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Cell adhesion; Chitosan derivative; Human dermal fibroblast;
   Nanoparticle; RGD peptide; Wound healing
ID CHITOSAN NANOPARTICLES; CHONDROITIN SULFATE; CELL-ADHESION;
   POLYELECTROLYTE COMPLEXES; BIOMEDICAL APPLICATIONS; HYDROGELS;
   MICROSPHERES; DELIVERY
AB Herein we describe the preparation of a nanoparticulate system formed from an RGD-functionalized chitosan derivative by complexation with chondroitin sulfate. These bioactive complexes were developed to promote wound healing by inducing adhesion and subsequently migration of skin cells. The particles were characterized for their size, surface charge, stability and shape. Briefly, the nanoparticles were found to be stable up to 7 days in water at a diameter of 150-200 nm and a positive charge of 20 mV. In physiological media the particles swell significantly but remain intact. Tested in an in vitro cell model of human dermal fibroblasts, the particles were shown to promote cell adhesion and induce spreading in human dermal fibroblasts. The mean surface area per cell was found to be increased by three-fold (n = 3 assays, p < 0.01), for the cells plated on particles exposing RGD-peptides when compared to cells on control particles. This indicates a stimulation of the cells due to the exposure of the bioactive RGD-moieties and an enhanced cell-biomaterial interaction. Using nanoparticles is a novel approach to direct cellular behavior with numerous possible applications in tissue engineering such as substrate for dermal and epithelial cells, injectable suspensions or as building blocks to form scaffolds. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Hansson, Annasara; Di Francesco, Tiziana; Jordan, Olivier; Borchard, Gerrit] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva, Switzerland.
   [Hansson, Annasara; Rousselle, Patricia] Univ Lyon 1, SFR BioSci Gerland Lyon Sud, Inst Biol & Chim Prot, FRE 3310,CNRS, F-69367 Lyon, France.
   [Hansson, Annasara; Falson, Francoise] Univ Lyon 1, Fac Pharm, F-69373 Lyon, France.
RP Borchard, G (reprint author), Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.
EM gerrit.borchard@unige.ch
RI Borchard, Gerrit/A-2316-2010; Jordan, Olivier/B-5590-2009
OI Jordan, Olivier/0000-0003-3752-2198; Di Francesco,
   Tiziana/0000-0002-0029-1683; Rousselle, Patricia/0000-0003-0275-4562
FU Ministere de l'Education (France); Region Rhone-Alpes Explo'ra Doc grant
   (France)
FX Hansson was a recipient of a 3-years Ph.D. studentship from the
   Ministere de l'Education (France) and of a Region Rhone-Alpes Explo'ra
   Doc grant (France). The authors would like to thank Dr. Christoph Bauer
   and Jerome Bosset at the Bioimaging Platform (University of Geneva,
   Switzerland) for technical assistance and advise for microscopical
   images. We are grateful to Dr. Lee Ann Laurent-Applegate (CHUV,
   Lausanne, Switzerland) for the kind donation of human dermal
   fibroblasts.
CR Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Boddohi S, 2009, BIOMACROMOLECULES, V10, P1402, DOI 10.1021/bm801513e
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Dautzenberg H, 1997, MACROMOLECULES, V30, P7810, DOI 10.1021/ma970803f
   Drogoz A, 2007, LANGMUIR, V23, P10950, DOI 10.1021/la7008545
   Fan W, 2012, COLLOID SURFACE B, V90, P21, DOI 10.1016/j.colsurfb.2011.09.042
   Genta I, 1998, CARBOHYD POLYM, V36, P81, DOI 10.1016/S0144-8617(98)00022-8
   Grzesiak JJ, 1997, BIOMATERIALS, V18, P1625, DOI 10.1016/S0142-9612(97)00103-8
   Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Kumbar SG, 2002, J MICROENCAPSUL, V19, P173, DOI 10.1080/02652040110065422
   Learoyd TP, 2008, EUR J PHARM BIOPHARM, V68, P224, DOI 10.1016/j.ejpb.2007.04.017
   Li W, 2004, HISTOL HISTOPATHOL, V19, P1311, DOI 10.14670/HH-19.1311
   Liu YK, 1997, J BIOCHEM-TOKYO, V121, P961
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Miranda ES, 2011, TISSUE ENG PT A, V17, P2663, DOI 10.1089/ten.tea.2010.0635
   Mohajel N, 2012, INT J PHARMACEUT, V423, P577, DOI 10.1016/j.ijpharm.2011.11.014
   Parajo Y, 2010, DRUG DELIV, V17, P596, DOI 10.3109/10717544.2010.509357
   Piai JF, 2009, ACTA BIOMATER, V5, P2601, DOI 10.1016/j.actbio.2009.03.035
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Schatz C, 2004, BIOMACROMOLECULES, V5, P1882, DOI 10.1021/bm049786
   Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011
   Tavares IS, 2012, COLLOID SURFACE B, V90, P254, DOI 10.1016/j.colsurfb.2011.10.025
   Wang TW, 2006, BIOMATERIALS, V27, P5689, DOI 10.1016/j.biomaterials.2006.07.024
   Xu J, 2012, INT J BIOL MACROMOL, V50, P438, DOI 10.1016/j.ijbiomac.2011.12.034
   Yao Z. A., 2010, ADV MAT LETT, V1, P67
   Yeh MK, 2011, ACTA BIOMATER, V7, P3804, DOI 10.1016/j.actbio.2011.06.026
NR 33
TC 17
Z9 17
U1 0
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD DEC 15
PY 2012
VL 439
IS 1-2
BP 73
EP 80
DI 10.1016/j.ijpharm.2012.09.053
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 038BV
UT WOS:000311151100009
PM 23046666
DA 2018-10-19
ER

PT J
AU Iqbal, N
   Kadir, MRA
   Malek, NANN
   Mahmood, NH
   Murali, MR
   Kamarul, T
AF Iqbal, Nida
   Kadir, Mohammed Rafiq Abdul
   Malek, Nik Ahmad Nizam Nik
   Mahmood, Nasrul Humaimi
   Murali, Malliga Raman
   Kamarul, Tunku
TI Rapid microwave assisted synthesis and characterization of nanosized
   silver-doped hydroxyapatite with antibacterial properties
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Hydroxyapatite; Nano particles; Microwave irradiation;
   Antibacterial activity
ID SUBSTITUTED HYDROXYAPATITE
AB Synthesis of nanosized particles of silver-doped hydroxyapatite (Ag-HA) as an antibacterial agent is of potential importance in managing infections associated with surgical implants. However, the process of synthesizing this agent is time consuming and inefficient. To overcome this problem, a rapid method for synthesizing nano-sized Ag-doped hydroxyapatite (Ag-HA) [Ca10-xAgx(PO4)(6)(OH)(2)] (x=0.03-0.5) using microwave irradiation for 10 min at 800 W is proposed. The materials were characterized using XRD, FTIR, FESEM and EDX. Antibacterial behavior of the Ag-HA samples were evaluated using disc diffusion technique and results demonstrated good activity against Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa and Escherichia coli. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Iqbal, Nida; Kadir, Mohammed Rafiq Abdul; Mahmood, Nasrul Humaimi] Univ Teknol Malaysia, Med Implant Technol Grp MEDITEG, Fac Biomed Engn & Hlth Sci, Skudai 81310, Johor Darul Tak, Malaysia.
   [Malek, Nik Ahmad Nizam Nik] Univ Teknol Malaysia, Fac Biosci & Bioengn, Skudai 81310, Johor Darul Tak, Malaysia.
   [Malek, Nik Ahmad Nizam Nik] Univ Teknol Malaysia, Inst Ibnu Sina Fundamental Sci Studies, Skudai 81310, Johor Darul Tak, Malaysia.
   [Murali, Malliga Raman; Kamarul, Tunku] Univ Malaya, Tissue Engn Grp, Dept Orthopaed Surg, NOCERAL,Fac Med, Kuala Lumpur 50603, Malaysia.
RP Kadir, MRA (reprint author), Univ Teknol Malaysia, Med Implant Technol Grp MEDITEG, Fac Biomed Engn & Hlth Sci, Skudai 81310, Johor Darul Tak, Malaysia.
EM rafiq@biomedical.utm.my
RI iqbal, nida/F-8852-2014; Malliga Raman, Murali/A-6987-2012; Tunku Zainol
   Abidin, Tunku Kamarul Zaman/B-9633-2011; Mahmood, Nasrul
   Humaimi/G-7755-2016
OI iqbal, nida/0000-0002-8502-4954; Malliga Raman,
   Murali/0000-0002-5696-4541; Tunku Zainol Abidin, Tunku Kamarul
   Zaman/0000-0002-6028-1313; Mahmood, Nasrul Humaimi/0000-0002-0004-7613;
   Kamarul, Tunku/0000-0002-8226-6448
FU University of Malaya HIR-MOHE research grant
FX The authors would like to acknowledge Department of Chemical
   Engineering, Bioprocess Lab N19, UTM, for providing experimental
   facilities and Zeolite Lab, UTM, for the FTIR analysis and Faculty of
   Bioscience and Bioengineering, UTM, for antibacterial testing. More than
   one of the authors of this paper was supported under University of
   Malaya HIR-MOHE research grant.
CR Brajendra S., 2011, MATER SCI ENG, V31, P1320
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Cremet L, 2012, J INFECTION, V64, P169, DOI 10.1016/j.jinf.2011.11.010
   Fontenoy C., 2011, PHARMACIEN HOSP, V46, pe1
   Hu C, 2007, APPL CATAL B-ENVIRON, V73, P345, DOI 10.1016/j.apcatb.2007.01.006
   Hulbert S. F., 1982, Ceramics International, V8, P131, DOI 10.1016/0272-8842(82)90003-7
   Ipekoglu M, 2010, MATER TECHNOL, V25, P295, DOI 10.1179/175355510X12692596613648
   Iqbal N, 2012, CURR APPL PHYS, V12, P755, DOI 10.1016/j.cap.2011.11.003
   Kasimir V, 2010, NANO LETT, V10, P202
   Li Y, 2010, MAT SCI ENG C-MATER, V30, P1137, DOI 10.1016/j.msec.2010.06.011
   Ma YL, 2010, APPL CLAY SCI, V50, P348, DOI 10.1016/j.clay.2010.08.025
   Mahendra R., 2009, BIOTECHNOLOGY ADV, V27, P76, DOI DOI 10.1016/J.BIOTECHADV.2008.09.002
   Marcos D, 2009, J NANOMATER, V2009, P1
   Moriarty T. F., 2011, COMPREHENSIVE BIOMAT, V4, P75
   Murugan R, 2006, ACTA BIOMATER, V2, P201, DOI 10.1016/j.actbio.2005.09.005
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Sergey V.D, 2010, BIOMATERIALS, V31, P1465, DOI DOI 10.1016/J.BI0MATERIALS.2009.11.050
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   Wang PP, 2010, POWDER TECHNOL, V203, P315, DOI 10.1016/j.powtec.2010.05.023
NR 19
TC 34
Z9 35
U1 1
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD DEC 15
PY 2012
VL 89
BP 118
EP 122
DI 10.1016/j.matlet.2012.08.057
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 040MO
UT WOS:000311327200033
DA 2018-10-19
ER

PT J
AU Aslan, S
   Deneufchatel, M
   Hashmi, S
   Li, N
   Pfefferle, LD
   Elimelech, M
   Pauthe, E
   Van Tassel, PR
AF Aslan, Seyma
   Deneufchatel, Marie
   Hashmi, Sara
   Li, Nan
   Pfefferle, Lisa D.
   Elimelech, Menachem
   Pauthe, Emmanuel
   Van Tassel, Paul R.
TI Carbon nanotube-based antimicrobial biomaterials formed via
   layer-by-layer assembly with polypeptides
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Antimicrobial; Single walled carbon nanotubes; Biomaterial;
   Polyelectrolyte; Aqueous; Dispersibility; Layer-by-layer
ID POLYELECTROLYTE MULTILAYER FILMS; BIOMEDICAL APPLICATIONS; BACTERIAL
   CYTOTOXICITY; ANTIBACTERIAL SURFACES; STAPHYLOCOCCUS-AUREUS; CHEMISTRY;
   COATINGS; DELIVERY; RELEASE; FUNCTIONALIZATION
AB Biomaterials capable of suppressing microbial infection are of clear importance in various health care applications, e.g. implantable devices. In this study, we investigate the antimicrobial activity of single-walled carbon nanotubes (SWNT) layer-by-layer (LbL) assembled with the polyelectrolytes poly(L-lysine) (PLL) and poly(L-glutamic acid) (PGA). SWNT dispersion in aqueous solution is achieved through the biocompatible nonionic surfactant polyoxyethylene(20) sorbitan monolaurate (Tween 20), and the amphiphilic polymer phospholipid-poly(ethylene glycol) (PL-PEG). Absorbance spectroscopy and transmission electron microscopy (TEM) show SWNT with either Tween 20 or PL-PEG in aqueous solution to be well dispersed, at about the level of SWNT in chloroform. Quartz crystal microgravimetry with dissipation (QCMD) measurements show both SWNT-Tween and SWNT-PL-PEG to LbL assemble with PLL and PGA into multilayer films, with the PL-PEG system yielding the greater final SWNT content. Escherichia coli and Staphylococcus epidermidis inactivation rates are significantly higher (up to 90%) upon 24 h incubation with SWNT containing films, compared to control films (ca. 20%). This study demonstrates the potential usefulness of SWNT/PLL/PGA thin films as antimicrobial biomaterials. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Aslan, Seyma; Deneufchatel, Marie; Hashmi, Sara; Li, Nan; Pfefferle, Lisa D.; Elimelech, Menachem; Pauthe, Emmanuel; Van Tassel, Paul R.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
   [Deneufchatel, Marie; Pauthe, Emmanuel] Univ Cergy Pontoise, ERRMECe, F-95302 Cergy Pontoise, France.
RP Van Tassel, PR (reprint author), Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
EM paul.vantassel@yale.edu
RI Van Tassel, Paul/D-1087-2017; Li, Nan/B-6109-2011
OI Elimelech, Menachem/0000-0003-4186-1563
FU National Science Foundation [CBET-0756323]
FX We thank the National Science Foundation for financial support through
   CBET-0756323. We also thank Brian Holt for his helpful comments on
   absorbance spectra.
CR Agarwal A, 2011, ADV FUNCT MATER, V21, P1863, DOI 10.1002/adfm.201002662
   Ahmed F, 2012, ENVIRON SCI TECHNOL, V46, P1804, DOI 10.1021/es202374e
   Angione MD, 2011, MATER TODAY, V14, P424, DOI 10.1016/S1369-7021(11)70187-0
   Aslan S, 2010, NANOSCALE, V2, P1789, DOI 10.1039/c0nr00329h
   Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Brady-Estevez AS, 2010, LANGMUIR, V26, P19153, DOI 10.1021/la103776y
   Luz RAD, 2011, MATER CHEM PHYS, V130, P1072, DOI 10.1016/j.matchemphys.2011.08.038
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dong LF, 2009, NANOSCALE RES LETT, V4, P1517, DOI 10.1007/s11671-009-9429-0
   Dou WL, 2009, ACTA PHYS-CHIM SIN, V25, P382, DOI 10.3866/PKU.WHXB20090232
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Giuliani A, 2008, CELL MOL LIFE SCI, V65, P2450, DOI 10.1007/s00018-008-8188-x
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Gorczyca G, 2011, POLIMERY-W, V56, P709
   Guo YZ, 2002, PHYSICA B, V323, P235, DOI 10.1016/S0921-4526(02)00975-4
   Guyomard A, 2008, ADV FUNCT MATER, V18, P758, DOI 10.1002/adfm.200700793
   Halthur TJ, 2006, LANGMUIR, V22, P11065, DOI 10.1021/la0607712
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Haug BE, 2007, CURR MED CHEM, V14, P1, DOI 10.2174/092986707779313435
   He Q, 2008, J MATER CHEM, V18, P748, DOI 10.1039/b715770c
   He T, 2010, J BIOMED MATER RES A, V95A, P454, DOI 10.1002/jbm.a.32872
   Holt BD, 2011, SMALL, V7, P2348, DOI 10.1002/smll.201100437
   Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u
   Jia L., 2008, J APPL PHYS, V104, P6
   Jia L, 2008, J OPTOELECTRON ADV M, V10, P2743
   Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v
   Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r
   Kim JS, 2011, ARCH TOXICOL, V85, P1499, DOI 10.1007/s00204-011-0723-0
   Klibanov AM, 2007, J MATER CHEM, V17, P2479, DOI 10.1039/b702079a
   Kohnen W, 2003, BIOMATERIALS, V24, P4865, DOI 10.1016/S0142-9612(03)00379-X
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lee D, 2012, MICROELECTRON ENG, V93, P39, DOI 10.1016/j.mee.2011.10.017
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Lichter JA, 2009, LANGMUIR, V25, P7686, DOI 10.1021/la900349c
   Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253
   Liu SB, 2010, NANOSCALE, V2, P2744, DOI 10.1039/c0nr00441c
   Liu SB, 2009, ACS NANO, V3, P3891, DOI 10.1021/nn901252r
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t
   Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Moskowitz JS, 2010, BIOMATERIALS, V31, P6019, DOI 10.1016/j.biomaterials.2010.04.011
   Nepal D, 2008, NANO LETT, V8, P1896, DOI 10.1021/nl080522t
   O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631
   Ochs CJ, 2008, BIOMACROMOLECULES, V9, P3389, DOI 10.1021/bm800794w
   Orinakova R, 2011, FUEL, V90, P3123, DOI 10.1016/j.fuel.2011.06.051
   Pasquini LM, 2012, ENVIRON SCI TECHNOL, V46, P6297, DOI 10.1021/es300514s
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Saito A, 2012, ACTA BIOMATER, V8, P2932, DOI 10.1016/j.actbio.2012.04.019
   Saito R, 2000, PHYS REV B, V61, P2981, DOI 10.1103/PhysRevB.61.2981
   Schiffman JD, 2011, ACS APPL MATER INTER, V3, P462, DOI 10.1021/am101043y
   Shukla A, 2012, J CONTROL RELEASE, V157, P64, DOI 10.1016/j.jconrel.2011.09.062
   Sun P, 2011, SCI CHINA INFORM SCI, V54, P2680, DOI 10.1007/s11432-011-4279-7
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Taylor E, 2011, INT J NANOMED, V6, P1463, DOI 10.2147/IJN.S22021
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tiraferri A, 2011, ACS APPL MATER INTER, V3, P2869, DOI 10.1021/am200536p
   Tuncel D, 2011, NANOSCALE, V3, P3545, DOI 10.1039/c1nr10338e
   Vashist SK, 2011, CARBON, V49, P4077, DOI 10.1016/j.carbon.2011.05.049
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Vecitis CD, 2010, ACS NANO, V4, P5471, DOI 10.1021/nn101558x
   Vergaro V, 2011, ADV DRUG DELIVER REV, V63, P847, DOI 10.1016/j.addr.2011.05.007
   Wang H, 2009, CURR OPIN COLLOID IN, V14, P364, DOI 10.1016/j.cocis.2009.06.004
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Xiao YH, 2012, POLYM INT, V61, P190, DOI 10.1002/pi.3168
   Yilgor I, 2012, POLYMER, V53, P1180, DOI 10.1016/j.polymer.2012.01.053
   Yoshimura SH, 2011, BIOMACROMOLECULES, V12, P1200, DOI 10.1021/bm101491s
   Yuan SJ, 2011, LANGMUIR, V27, P2761, DOI 10.1021/la104442f
   Zardini HZ, 2012, COLLOID SURFACE B, V92, P196, DOI 10.1016/j.colsurfb.2011.11.045
   Zhou FF, 2011, SMALL, V7, P2727, DOI 10.1002/smll.201100669
   Zhu J, 2003, NANO LETT, V3, P1107, DOI 10.1021/nl0342489
NR 76
TC 31
Z9 32
U1 3
U2 106
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD DEC 15
PY 2012
VL 388
BP 268
EP 273
DI 10.1016/j.jcis.2012.08.025
PG 6
WC Chemistry, Physical
SC Chemistry
GA 029KX
UT WOS:000310495600035
PM 23006909
DA 2018-10-19
ER

PT J
AU Manno, D
   Carata, E
   Tenuzzo, BA
   Panzarini, E
   Buccolieri, A
   Filippo, E
   Rossi, M
   Serra, A
   Dini, L
AF Manno, Daniela
   Carata, Elisabetta
   Tenuzzo, Bernadetta A.
   Panzarini, Elisa
   Buccolieri, Alessandro
   Filippo, Emanuela
   Rossi, Marco
   Serra, Antonio
   Dini, Luciana
TI High ordered biomineralization induced by carbon nanoparticles in the
   sea urchin Paracentrotus lividus
SO NANOTECHNOLOGY
LA English
DT Article
ID BLACK CARBON; EMBRYO; GENE; NANORIBBONS; EXPRESSION; GROWTH; LAYER;
   FILMS; BULK; AREA
AB A surprising and unexpected biomineralization process was observed during toxicological assessment of carbon nanoparticles on Paracentrotus lividus (sea urchin) pluteus larvae. The larvae activate a process of defense against external material, by incorporating the nanoparticles into microstructures of aragonite similarly to pearl oysters. Aiming at a better understanding of this phenomenon, the larvae were exposed to increasing concentrations of carbon nanoparticles and the biomineralization products were analyzed by electron microscopy, x-ray diffraction and Raman spectroscopy. In order to evaluate the possible influence of Sp-CyP-1 expression on this biomineralization process by larvae, analyses of gene expression (Sp-CyP-1) and calcein labeling were performed. Overall, we report experimental evidence about the capability of carbon nanoparticles to induce an increment of Sp-CyP-1 expression with the consequent activation of a biomineralization process leading to the production of a new pearl-like biomaterial never previously observed in sea urchins.
C1 [Manno, Daniela; Carata, Elisabetta; Tenuzzo, Bernadetta A.; Panzarini, Elisa; Buccolieri, Alessandro; Dini, Luciana] Univ Salento, DiSTeBA, Lecce, Italy.
   [Filippo, Emanuela; Serra, Antonio] Univ Salento, Dip BBCC, Lecce, Italy.
   [Rossi, Marco] Univ Roma La Sapienza, Dipartimento Sci Base & Applicate Ingn, Rome, Italy.
   [Rossi, Marco] Univ Roma La Sapienza, Ctr Nanotecnol Applicate Ingn, Rome, Italy.
EM daniela.manno@unisalento.it
RI Rossi, Marco/G-1689-2012
OI Rossi, Marco/0000-0001-7603-1805; Serra, Antonio/0000-0003-3380-7751;
   Panzarini, Elisa/0000-0003-4219-4272; Filippo,
   Emanuela/0000-0002-8341-1846; Manno, Daniela/0000-0002-5843-8772;
   Buccolieri, Alessandro/0000-0002-8657-9468
CR Amore G, 2006, DEV BIOL, V293, P555, DOI 10.1016/j.ydbio.2006.02.024
   BAUMAN JW, 1993, FUND APPL TOXICOL, V21, P15, DOI 10.1006/faat.1993.1066
   Bisiaux MM, 2011, ENVIRON SCI TECHNOL, V45, P2065, DOI 10.1021/es103819v
   Campos-Delgado J, 2009, SMALL, V5, P2698, DOI 10.1002/smll.200901059
   Campos-Delgado J, 2008, NANO LETT, V8, P2773, DOI 10.1021/nl801316d
   Cancado LG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.047403
   Dini L, 2011, NANOMATER NANOTECHNO, V1, P58
   Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048
   Falugi C, 2011, MAR ENVIRON RES, V76, P114
   Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401
   Filippo E, 2010, J NON-CRYST SOLIDS, V356, P344, DOI 10.1016/j.jnoncrysol.2009.11.021
   Fu GD, 2011, PROG POLYM SCI, V36, P127, DOI 10.1016/j.progpolymsci.2010.07.011
   Fujimoto H, 2003, CARBON, V41, P1585, DOI 10.1016/S0008-6223(03)00116-7
   Gilbert P U P A, 2012, J ELECT SPECTROSC RE
   Guss KA, 1997, DEVELOPMENT, V124, P1899
   Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358
   Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047
   Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043
   Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657
   Oganesyan EA, 2010, PHARM CHEM J+, V44, P74, DOI 10.1007/s11094-010-0401-1
   Pinsino A, 2008, CELL BIOL TOXICOL, V24, P541, DOI 10.1007/s10565-008-9055-0
   Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v
   Serra A, 2012, SENSOR ACTUAT B-CHEM, V161, P359, DOI 10.1016/j.snb.2011.10.045
   Terranova ML, 2009, CRYST GROWTH DES, V9, P1245, DOI 10.1021/cg800352n
   URMOS J, 1991, AM MINERAL, V76, P641
   Veis A, 2011, FRONT BIOSCI-LANDMRK, V16, P2540, DOI 10.2741/3871
   Vishwakarma V., 2010, J MINERAL MAT CHAR E, V9, P455
   WALLACH DFH, 1959, ANAL CHEM, V31, P456, DOI 10.1021/ac60147a041
   Yamasu K, 1999, DEV GROWTH DIFFER, V41, P81
   Zito F, 2003, DEV BIOL, V264, P217, DOI 10.1016/j.ydbio.2003.07.015
   Zuo J M, 2004, MICROSC MICROANAL S2, V10, P84
NR 31
TC 7
Z9 7
U1 1
U2 26
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD DEC 14
PY 2012
VL 23
IS 49
AR 495104
DI 10.1088/0957-4484/23/49/495104
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 041WC
UT WOS:000311431400004
PM 23165288
DA 2018-10-19
ER

PT J
AU Peng, HJ
   Yin, Z
   Liu, HH
   Chen, X
   Feng, B
   Yuan, HH
   Su, B
   Ouyang, HW
   Zhang, YZ
AF Peng, Hongju
   Yin, Zi
   Liu, Huanhuan
   Chen, Xiao
   Feng, Bei
   Yuan, Huihua
   Su, Bo
   Ouyang, Hongwei
   Zhang, Yanzhong
TI Electrospun biomimetic scaffold of hydroxyapatite/chitosan supports
   enhanced osteogenic differentiation of mMSCs
SO NANOTECHNOLOGY
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS; IN-VITRO;
   OSTEOBLAST DIFFERENTIATION; COMPOSITE NANOFIBERS; STROMAL CELLS; BONE;
   GROWTH; DELIVERY; ACID)
AB Engaging functional biomaterial scaffolds to regulate stem cell differentiation has drawn a great deal of attention in the tissue engineering and regenerative medicine community. In this study, biomimetic composite nanofibrous scaffolds of hydroxyapatite/chitosan (HAp/CTS) were prepared to investigate their capacity for inducing murine mesenchymal stem cells (mMSCs) to differentiate into the osteogenic lineage, in the absence and presence of an osteogenic supplementation (i.e., ascorbic acid, beta-glycerol phosphate, and dexamethasone), respectively. Using electrospun chitosan (CTS) nanofibrous scaffolds as the control, cell morphology, growth, specific osteogenic genes expression, and quantified proteins secretion on the HAp/CTS scaffolds were sequentially examined and assessed. It appeared that the HAp/CTS scaffolds supported better attachment and proliferation of the mMSCs. Most noteworthy was that in the absence of the osteogenic supplementation, expression of osteogenic genes including collagen I (Col I), runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP), and osteocalcin (OCN) were significantly upregulated in mMSCs cultured on the HAp/CTS nanofibrous scaffolds. Also increased secretion of the osteogenesis protein markers of alkaline phosphatase and collagen confirmed that the HAp/CTS nanofibrous scaffold markedly promoted the osteogenic commitment in the mMSCs. Moreover, the presence of osteogenic supplementation proved an enhanced efficacy of mMSC osteogenesis on the HAp/CTS nanofibrous scaffolds. Collectively, this study demonstrated that the biomimetic nanofibrous HAp/CTS scaffolds could support and enhance the adhesion, proliferation, and particularly osteogenic differentiation of the mMSCs. It also substantiated the potential of using biomimetic nanofibrous scaffolds of HAp/CTS for functional bone repair and regeneration applications.
C1 [Peng, Hongju; Feng, Bei; Yuan, Huihua; Zhang, Yanzhong] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Dept Bioengn, Shanghai 201620, Peoples R China.
   [Yin, Zi; Liu, Huanhuan; Chen, Xiao; Ouyang, Hongwei] Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310058, Zhejiang, Peoples R China.
   [Su, Bo] Univ Bristol, Dept Oral & Dent Sci, Bristol BS2 8BS, Avon, England.
RP Zhang, YZ (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Dept Bioengn, Shanghai 201620, Peoples R China.
EM hwoy@zju.edu.cn; yzzhang@dhu.edu.cn
RI Yin, Zi/C-3371-2017; Yuan, Huihua/G-8590-2012; Zhang,
   Yanzhong/A-9865-2008; Chen, Xiao/A-4384-2009
OI Yin, Zi/0000-0002-9637-1169; Yuan, Huihua/0000-0001-8657-984X; Zhang,
   Yanzhong/0000-0002-2663-1279; Chen, Xiao/0000-0002-4438-5286; ouyang,
   hongwei/0000-0003-0627-2536
FU Pujiang Talent Programme; Science and Technology Commission of Shanghai
   Municipality [10PJ1400200]; National Natural Science Foundation of China
   [51073032]; Scientific Research Foundation for Returned Scholars
   [11W10523]; Fundamental Research Funds for the Central Universities
   [11D10540]; Ministry of Education of the People's Republic of China;
   Medical Research Council [G0701836]
FX This work was supported by the Pujiang Talent Programme funded by the
   Science and Technology Commission of Shanghai Municipality
   (10PJ1400200), the National Natural Science Foundation of China
   (51073032), the Scientific Research Foundation for Returned Scholars
   (11W10523) and the Fundamental Research Funds for the Central
   Universities (11D10540) funded by the Ministry of Education of the
   People's Republic of China.
CR Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chen JP, 2011, COLLOID SURFACE B, V86, P169, DOI 10.1016/j.colsurfb.2011.03.038
   Chew SY, 2011, J BIOMED MATER RES A, V97A, P355, DOI 10.1002/jbm.a.33064
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   GOTOH Y, 1990, BONE MINER, V8, P239, DOI 10.1016/0169-6009(90)90109-S
   Hamadouche M, 2000, J BONE JOINT SURG BR, V82B, P1095, DOI 10.1302/0301-620X.82B8.11744
   Heng BC, 2004, J BONE MINER RES, V19, P1379, DOI 10.1359/JBMR.040714
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hu J, 2008, BIOMATERIALS, V29, P3815, DOI 10.1016/j.biomaterials.2008.06.015
   HUSS R, 1995, BLOOD, V85, P2414
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Lee DA, 2011, J CELL BIOCHEM, V112, P1, DOI 10.1002/jcb.22758
   Lee JH, 2010, MACROMOL BIOSCI, V10, P173, DOI 10.1002/mabi.200900169
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Martins A, 2010, BIOMATERIALS, V31, P5875, DOI 10.1016/j.biomaterials.2010.04.010
   Mueller P, 2008, J CELL MOL MED, V12, P281
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Potier E, 2010, J BIOMECH, V43, P807, DOI 10.1016/j.jbiomech.2009.11.019
   Quaglia F, 2005, MACROMOL BIOSCI, V5, P945, DOI 10.1002/mabi.200500108
   REZNIKOFF CA, 1973, CANCER RES, V33, P3231
   Rim NG, 2009, MACROMOL BIOSCI, V9, P795, DOI 10.1002/mabi.200800358
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Schofer MD, 2009, THESCIENTIFICWORLDJO, V9, P118, DOI 10.1100/tsw.2009.13
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Singh A, 2010, J MATER CHEM, V20, P8832, DOI 10.1039/c0jm01613f
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   STEIN GS, 1990, FASEB J, V4, P3111
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
NR 50
TC 32
Z9 33
U1 4
U2 124
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD DEC 7
PY 2012
VL 23
IS 48
AR 485102
DI 10.1088/0957-4484/23/48/485102
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 037WV
UT WOS:000311138100002
PM 23128604
DA 2018-10-19
ER

PT J
AU Weng, L
   Webster, TJ
AF Weng, Lucy
   Webster, Thomas J.
TI Nanostructured magnesium increases bone cell density
SO NANOTECHNOLOGY
LA English
DT Article
ID ENHANCED OSTEOBLAST ADHESION; UNITED-STATES; HIP IMPLANTS; IN-VITRO;
   TITANIUM; STRENGTH; NANOPARTICLES; ARTHROPLASTY; COMPOSITES; NANOFIBERS
AB Magnesium has attracted some attention in orthopedics due to its biodegradability and mechanical properties. Since magnesium is an essential natural mineral for bone growth, it can be expected that as a biomaterial, it would support bone formation. However, upon degradation in the body, magnesium releases OH- which results in an alkaline pH that can be detrimental to cell density (for example, osteoblasts or bone forming cells). For this reason, modification of magnesium may be necessary to compensate for such detrimental effects to cells. This study created biologically inspired nanoscale surface features on magnesium by soaking magnesium in various concentrations of NaOH (from 1 to 10 N) and for various periods of time (from 10 to 30 min). The results provided the first evidence of increased roughness, surface energy, and consequently greater osteoblast adhesion, after 4 h as well as density up to 7 days on magnesium treated with any concentration of NaOH for any length of time compared to untreated controls. For these reasons, this study suggests that soaking magnesium in NaOH could be an inexpensive, simple and effective manner to promote osteoblast functions for numerous orthopedic applications and, thus, should be further studied.
C1 [Weng, Lucy] Brown Univ, Sch Engn, Providence, RI 02912 USA.
   Brown Univ, Dept Orthoped, Providence, RI 02912 USA.
RP Weng, L (reprint author), Brown Univ, Sch Engn, Providence, RI 02912 USA.
EM th.webster@nev.edu
FU Hermann Foundation
FX The authors would like to acknowledge the Hermann Foundation for funding
   and Dr Eric Darling for AFM usage.
CR Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Balasundaram G, 2007, NANOTECHNOLOGY REGEN, P53
   Belluci MM, 2011, CLIN ORAL IMPLAN RES, V22, P716, DOI 10.1111/j.1600-0501.2010.02046.x
   Bohler M, 2002, J BONE JOINT SURG BR, V84B, P128, DOI 10.1302/0301-620X.84B1.11324
   BONUCCI E, 1992, HISTOCHEMISTRY, V97, P323, DOI 10.1007/BF00270033
   Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Braddock M, 2001, NEWS PHYSIOL SCI, V16, P208
   Burns K, 2009, J BIOMED MATER RES A, V88A, P561, DOI 10.1002/jbm.a.31899
   Deng M, 2012, IEEE T NANOBIOSCI, V11, P3, DOI 10.1109/TNB.2011.2179554
   Gu XN, 2010, ACTA BIOMATER, V6, P4605, DOI 10.1016/j.actbio.2010.07.026
   Hristova K, 2011, J MATER SCI-MATER M, V22, P1891, DOI 10.1007/s10856-011-4357-9
   Hussain A, 2012, TISSUE ENG PT A, V18, P768, DOI [10.1089/ten.tea.2011.0310, 10.1089/ten.TEA.2011.0310]
   Iafisco M, 2012, ADV ENG MATER, V14, pB13, DOI 10.1002/adem.201180062
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Del Barrio RAL, 2010, INT J ORAL MAX IMPL, V25, P1125
   Liu H., 2007, NANOTECHNOLOGY REGEN, P1
   Liu HN, 2005, NANOTECHNOLOGY, V16, pS601, DOI 10.1088/0957-4484/16/7/038
   Lorenz C, 2009, ACTA BIOMATER, V5, P2783, DOI 10.1016/j.actbio.2009.04.018
   Mustafa K, 2005, BIOMATERIALS, V26, P373, DOI 10.1016/j.biomaterials.2004.02.037
   Nair LS, 2008, J BONE JOINT SURG AM, V90A, P128, DOI 10.2106/JBJS.G.01520
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   Padial-Molina M, 2011, ACTA BIOMATER, V7, P771, DOI 10.1016/j.actbio.2010.08.024
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Salunke P, 2011, MATER SCI ENG B-ADV, V176, P1711, DOI 10.1016/j.mseb.2011.07.002
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Seitz JM, 2011, ADV ENG MATER, V13, P1146, DOI 10.1002/adem.201100074
   Smith R., 2004, BONE HLTH OSTEOPOROS
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Toba Y, 2000, J NUTR, V130, P216
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Willumeit R, 2011, ACTA BIOMATER, V7, P2704, DOI 10.1016/j.actbio.2011.03.004
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Wolner C, 2006, MAT SCI ENG C-BIO S, V26, P34, DOI 10.1016/j.msec.2005.05.004
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Zhang LJ, 2008, INT J NANOMED, V3, P323
   Zhang LJ, 2008, TISSUE ENG PT A, V14, P1353, DOI 10.1089/ten.tea.2006.0436
   Zheng YF, 2010, ACTA BIOMATER, V6, P1783, DOI 10.1016/j.actbio.2009.10.009
NR 42
TC 11
Z9 11
U1 0
U2 21
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD DEC 7
PY 2012
VL 23
IS 48
AR 485105
DI 10.1088/0957-4484/23/48/485105
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 037WV
UT WOS:000311138100005
PM 23138136
DA 2018-10-19
ER

PT J
AU Tarakanova, A
   Buehler, MJ
AF Tarakanova, Anna
   Buehler, Markus J.
TI The role of capture spiral silk properties in the diversification of orb
   webs
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE spider web mechanics; evolution; viscid capture silk; cribellate capture
   silk; Deinopoidea; Araneoidea
ID SPIDER DRAGLINE SILK; WEAVING SPIDERS; MECHANICAL-PROPERTIES; BUILDING
   SPIDER; EVOLUTION; THREADS; BIOMATERIAL; ARANEAE; PERFORMANCE; BEHAVIOR
AB Among a myriad of spider web geometries, the orb web presents a fascinating, exquisite example in architecture and evolution. Orb webs can be divided into two categories according to the capture silk used in construction: cribellate orb webs (composed of pseudoflagelliform silk) coated with dry cribellate threads and ecribellate orb webs (composed of flagelliform silk fibres) coated by adhesive glue droplets. Cribellate capture silk is generally stronger but less-extensible than viscid capture silk, and a body of phylogenic evidence suggests that cribellate capture silk is more closely related to the ancestral form of capture spiral silk. Here, we use a coarse-grained web model to investigate how the mechanical properties of spiral capture silk affect the behaviour of the whole web, illustrating that more elastic capture spiral silk yields a decrease in web system energy absorption, suggesting that the function of the capture spiral shifted from prey capture to other structural roles. Additionally, we observe that in webs with more extensible capture silk, the effect of thread strength on web performance is reduced, indicating that thread elasticity is a dominant driving factor in web diversification.
C1 [Tarakanova, Anna; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, LAMM, Cambridge, MA 02139 USA.
   [Buehler, Markus J.] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA.
RP Buehler, MJ (reprint author), MIT, Dept Civil & Environm Engn, LAMM, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM mbuehler@mit.edu
RI Buehler, Markus/C-4580-2008
OI Buehler, Markus/0000-0002-4173-9659
FU Office of Naval Research (PECASE) [N000141010562]; National Science
   Foundation (CAREER) [CMMI-0642545]; Robert A. Brown Presidential
   Fellowship
FX This work was supported by the Office of Naval Research (PECASE, grant
   no. N000141010562), the National Science Foundation (CAREER, grant no.
   CMMI-0642545) and by a Robert A. Brown Presidential Fellowship. All
   simulations have been carried out at MIT's Laboratory for Atomistic and
   Molecular Mechanics (LAMM). We thank the reviewers for their helpful
   comments and suggestions.
CR Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005
   Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327
   Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Bond JE, 1998, EVOLUTION, V52, P403, DOI 10.1111/j.1558-5646.1998.tb01641.x
   CODDINGTON J, 1982, AM ZOOL, V22, P886
   Craig C., 2010, SPIDER SILK EVOLUTIO
   CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x
   Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739
   DENNY M, 1976, J EXP BIOL, V65, P483
   Dondale C. D., 2003, AGR AGRIFOOD CANADA
   EBERHARD W, 1993, J ARACHNOL, V21, P161
   Eberhard W.G., 1989, Bulletin of the British Arachnological Society, V8, P45
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Griswold CE, 1999, J ARACHNOL, V27, P53
   Harmer AMT, 2011, J R SOC INTERFACE, V8, P457, DOI 10.1098/rsif.2010.0454
   Heim M, 2010, CHEM SOC REV, V39, P156, DOI 10.1039/b813273a
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102
   Lin L, 1998, STRUCTURAL ENG, V76, P59
   LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Opell BD, 1999, EVOL ECOL RES, V1, P503
   OPELL BD, 1994, J MORPHOL, V221, P111, DOI 10.1002/jmor.1052210109
   Opell BD, 1998, FUNCT ECOL, V12, P613, DOI 10.1046/j.1365-2435.1998.00222.x
   Opell BD, 1996, AM NAT, V148, P630, DOI 10.1086/285944
   Opell BD, 2001, EVOL ECOL RES, V3, P567
   Opell BD, 1997, J ARACHNOL, V25, P295
   Opell BD, 2009, ZOOLOGY, V112, P16, DOI 10.1016/j.zool.2008.04.002
   PEAKALL DB, 1976, COMP BIOCHEM PHYS A, V54, P187, DOI 10.1016/S0300-9629(76)80094-1
   Penney D, 2006, BIOL LETTERS, V2, P447, DOI 10.1098/rsbl.2006.0506
   PETERS HM, 1995, NATURWISSENSCHAFTEN, V82, P380, DOI 10.1007/BF01134566
   SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Sensenig AT, 2012, J R SOC INTERFACE, V9, P1880, DOI 10.1098/rsif.2011.0851
   SHERMAN PM, 1994, ANIM BEHAV, V48, P19, DOI 10.1006/anbe.1994.1208
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013
   TANAKA K, 1989, OECOLOGIA, V81, P459, DOI 10.1007/BF00378952
   Tarakanova A, 2012, JOM-US, V64, P214, DOI 10.1007/s11837-012-0250-3
   TILLINGHAST EK, 1993, MATER RES SOC SYMP P, V292, P9
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0
   VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221
   Zschokke S, 2003, NATURE, V424, P636, DOI 10.1038/424636a
NR 53
TC 20
Z9 21
U1 0
U2 47
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD DEC 7
PY 2012
VL 9
IS 77
BP 3240
EP 3248
DI 10.1098/rsif.2012.0473
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 030LV
UT WOS:000310573100007
PM 22896566
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Regier, MC
   Taylor, JD
   Borcyk, T
   Yang, YQ
   Pannier, AK
AF Regier, Mary C.
   Taylor, Jessica D.
   Borcyk, Tyler
   Yang, Yiqi
   Pannier, Angela K.
TI Fabrication and characterization of DNA-loaded zein nanospheres
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Gene delivery; Nonviral; Zein; DNA; Nanoparticle; Oral delivery;
   Intramuscular injection
ID ORAL GENE DELIVERY; DRUG-DELIVERY; INTRAMUSCULAR INJECTION; NONVIRAL
   VECTORS; IN-VITRO; NANOPARTICLES; MICROSPHERES; PROTEIN; CARRIERS;
   TISSUE
AB Background: Particulates incorporating DNA are promising vehicles for gene delivery, with the ability to protect DNA and provide for controlled, localized, and sustained release and transfection. Zein, a hydrophobic protein from corn, is biocompatible and has properties that make it a promising candidate material for particulate delivery, including its ability to form nanospheres through coacervation and its insolubility under physiological conditions, making it capable of sustained release of encapsulated compounds. Due to the promise of this natural biomaterial for drug delivery, the objective of this study was to formulate zein nanospheres encapsulating DNA as the therapeutic compound, and to characterize size, charge, sustained release, cell cytotoxicity and cellular internalization of these particles.
   Results: Zein nanospheres encapsulating DNA were fabricated using a coacervation technique, without the use of harsh solvents or temperatures, resulting in the preservation of DNA integrity and particles with diameters that ranged from 157.8 +/- 3.9 nm to 396.8 +/- 16.1 nm, depending on zein to DNA ratio. DNA encapsulation efficiencies were maximized to 65.3 +/- 1.9% with a maximum loading of 6.1 +/- 0.2 mg DNA/g zein. The spheres protected encapsulated DNA from DNase I degradation and exhibited sustained plasmid release for at least 7 days, with minimal burst during the initial phase of release. Zein/DNA nanospheres demonstrated robust biocompatibility, cellular association, and internalization.
   Conclusions: This study represents the first report on the formation of zein particles encapsulating plasmid DNA, using simple fabrication techniques resulting in preservation of plasmid integrity and tunable sizes. DNA encapsulation efficiencies were maximized to acceptable levels at higher zein to DNA ratios, while loading was comparable to that of other hydrophilic compounds encapsulated in zein and that of DNA incorporated into PLGA nano- and microspheres. The hydrophobic nature of zein resulted in spheres capable of sustained release of plasmid DNA. Zein particles may be an excellent potential tool for the delivery of DNA with the ability to be fine-tuned for specific applications including oral gene delivery, intramuscular delivery, and in the fabrication of tissue engineering scaffolds.
C1 [Regier, Mary C.; Taylor, Jessica D.; Borcyk, Tyler; Yang, Yiqi; Pannier, Angela K.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA.
   [Yang, Yiqi] Univ Nebraska, Dept Text Clothing & Design, Lincoln, NE 68583 USA.
RP Pannier, AK (reprint author), Univ Nebraska, Dept Biol Syst Engn, 231 Chase Hall, Lincoln, NE 68583 USA.
EM apannier2@unl.edu
RI Yang, Yiqi/A-6900-2009
OI Yang, Yiqi/0000-0001-8153-4159
FU American Heart Association; University of Nebraska Foundation; Nebraska
   Research Initiative; USDA CSREES-Nebraska [NEB-21-146]; Institute of
   Agriculture and Natural Resources Seed Grant Program
FX Support for this research was provided in part by funds from the
   American Heart Association, the University of Nebraska Foundation
   (Layman Funds), the Nebraska Research Initiative, USDA CSREES-Nebraska
   (NEB-21-146), and the Institute of Agriculture and Natural Resources
   Seed Grant Program. Confocal and scanning electron microscopy were
   performed at the University of Nebraska-Lincoln's Center for
   Biotechnology Morrison Microscopy Core Research Facility and we thank
   Dr. You Zhou and Dr. Han Chen for assistance with imaging. We thank Dr.
   Shannon Bartelt-Hunt for the use of the Zetasizer, Dr. Curtis Weller for
   the use of the lyophilizer, Tadas Kasputis, Tim Martin, Sarah Plautz,
   and Dr. Qiuran Jiang for assistance with cell studies and Dr. Zhongji
   Han for imaging gels.
CR Agarwal A, 2008, CURR TOP MED CHEM, V8, P311
   ARSHADY R, 1990, POLYM ENG SCI, V30, P905, DOI 10.1002/pen.760301505
   Astete CE, 2006, J BIOMAT SCI-POLYM E, V17, P247, DOI 10.1163/156856206775997322
   Bhavsar MD, 2007, J CONTROL RELEASE, V119, P339, DOI 10.1016/j.jconrel.2007.03.006
   Bowman K, 2008, J CONTROL RELEASE, V132, P252, DOI 10.1016/j.jconrel.2008.06.019
   Cabra V, 2005, J AGR FOOD CHEM, V53
   Chen HM, 1998, ADV DRUG DELIVER REV, V34, P339, DOI 10.1016/S0169-409X(98)00047-7
   Clark MA, 2001, ADV DRUG DELIVER REV, V50, P81, DOI 10.1016/S0169-409X(01)00149-1
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Demetriades K, 1997, J FOOD SCI, V62, P342, DOI 10.1111/j.1365-2621.1997.tb03997.x
   Deo N, 2003, LANGMUIR, V19, P5083, DOI 10.1021/la020854s
   DiBiase MD, 1997, PROTEIN DELIVERY PHY, V10
   Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617
   ESEN A, 1987, J CEREAL SCI, V5, P117, DOI 10.1016/S0733-5210(87)80015-2
   Everett D. H., 1988, BASIC PRINCIPLES COL
   Fernandez-Carneado J, 2004, ANGEW CHEM INT EDIT, V43, P1811, DOI 10.1002/anie.200352540
   Fu JX, 2009, MAT SCI ENG C-BIO S, V29, P1161, DOI 10.1016/j.msec.2008.09.031
   Gan Q, 2005, COLLOID SURFACE B, V44, P65, DOI 10.1016/j.colsurfb.2005.06.001
   Gander B, 2006, ENCY PHARM TECHNOLOG, V1
   GENNADIOS A, 1994, T ASAE, V37, P535
   GERAGHTY D, 1981, NUCLEIC ACIDS RES, V9, P5163, DOI 10.1093/nar/9.19.5163
   Gong S-J, 2010, J BIOMATER APPL, P1
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   He XW, 2005, J GEN VIROL, V86, P601, DOI 10.1099/vir.0.80575-0
   Homback J., 2010, HDB EXP PHARM, V197, P251
   Hurtado-Lopez P, 2006, J MICROENCAPSUL, V23, P303, DOI 10.1080/026520400444149
   Hurtado-Lopez P, 2005, J DRUG DELIV SCI TEC, V15, P267, DOI 10.1016/S1773-2247(05)50048-0
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Jiang QR, 2011, J BIOMAT SCI-POLYM E, V22, P1393, DOI 10.1163/092050610X508437
   Jones DH, 1998, DEV BIOL STAND, V92, P149
   Jones DH, 1997, VACCINE, V15, P814, DOI 10.1016/S0264-410X(96)00266-6
   Lai LF, 2011, INT J PHARMACEUT, V404, P317, DOI 10.1016/j.ijpharm.2010.11.025
   Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1
   Li S, 2000, GENE THER, V7, P31, DOI 10.1038/sj.gt.3301110
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Loretz B, 2006, J DRUG TARGET, V14, P311, DOI 10.1080/10611860600823766
   Luo YC, 2011, COLLOID SURFACE B, V85, P145, DOI 10.1016/j.colsurfb.2011.02.020
   MADAN PL, 1978, DRUG DEV IND PHARM, V4, P95, DOI 10.3109/03639047809055641
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malafaya PB, 2006, J MATER SCI-MATER M, V17, P371, DOI 10.1007/s10856-006-8240-z
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Masotti A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/05/055302
   Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e
   Muthuselvi L, 2006, COLLOID SURFACE B, V51, P39, DOI [10.1016/j.colsurfb.2006.05.012, 10.1016/colsurfb.2006.05.012]
   Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923
   O'Hagan DT, 2004, IMMUNOL REV, V199, P191, DOI 10.1111/j.0105-2896.2004.00153.x
   OHagan DT, 1996, J ANAT, V189, P477
   PADUA G. W., 2009, MICRONANOENCAPSULATI, P143
   Page DT, 2001, DRUG DISCOV TODAY, V6, P92, DOI 10.1016/S1359-6446(00)01600-7
   Pannier AK, 2007, BIOTECHNOL BIOENG, V98, P486, DOI 10.1002/bit.21477
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Parris N, 2005, J AGR FOOD CHEM, V53, P4788, DOI 10.1021/jf040492p
   Podaralla S, 2010, J BIOMED NANOTECHNOL, V6, P312, DOI 10.1166/jbn.2010.1137
   Pomes A. F., 1971, ENCY POLYM SCI TECHN, V15, P125
   Reddy N, 2011, TRENDS BIOTECHNOL, V29, P490, DOI 10.1016/j.tibtech.2011.05.003
   Rothman Stephen, 2005, Diabetes Technol Ther, V7, P549, DOI 10.1089/dia.2005.7.549
   Roy K, 1999, NAT MED, V5, P387
   Schwaller K., 1993, EP, Patent No. [US5271961, 5271961]
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shyu KG, 1998, CIRCULATION, V98, P2081, DOI 10.1161/01.CIR.98.19.2081
   Sun QS, 2005, BIOPOLYMERS, V78, P268, DOI 10.1002/bip.20298
   SUZUKI T, 1989, CHEM PHARM BULL, V37, P1051
   Tripathy SK, 1996, P NATL ACAD SCI USA, V93, P10876, DOI 10.1073/pnas.93.20.10876
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang J, 2002, GENE THER, V9, P1254, DOI 10.1038/sj.gt.3301794
   Wang Q, 2004, BIOMACROMOLECULES, V5, P1356, DOI 10.1021/bm049965r
   Yannas IV, 2004, BIOMATERIAL SCI INTR
   Zhong QX, 2009, FOOD HYDROCOLLOID, V23, P2380, DOI 10.1016/j.foodhyd.2009.06.015
NR 69
TC 35
Z9 36
U1 2
U2 90
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD DEC 2
PY 2012
VL 10
AR 44
DI 10.1186/1477-3155-10-44
PG 13
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 055YN
UT WOS:000312454100001
PM 23199119
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Joseph, B
   Raj, SJ
AF Joseph, Baby
   Raj, S. Justin
TI Therapeutic applications and properties of silk proteins from Bombyx
   mori
SO FRONTIERS IN LIFE SCIENCE
LA English
DT Review
DE Bombyx mori; spinneret; bave; microfibrils; cocoon; tolylene
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; TRANSGENIC
   SILKWORMS; FIBROIN; SCAFFOLDS; GROWTH; SERICIN; BONE; GENE
AB Silk is a fibrous protein of animal origin. Organisms secrete silk, for anchorage, to entangle their prey, or form a protective sheath with or without other materials. Nearly 400-500 species of insects are known to produce silk but only few are commercially exploited. The Bombyx mori is a lepidopteron molecular model and an important economic insect that is emerging as an ideal molecular genetic resource for solving a broad range of biological problems. Silk proteins are usually produced within specialized glands after biosynthesis in epithelial cells, followed by secretion into the lumen of these glands where the proteins are stored prior to spinning. This is further converted into silk fibres. Silk is a high-molecular-weight natural protein polymer that has been approved as a biomaterial by the US Food and Drug Administration. The most important feature of the silk protein is that the dipeptides and tripeptides can easily permeate into the blood stream through the dermis layer of skin. Nowadays, Seri-waste products and Seri-by-products are used as value-added products. The need for new therapeutics for wound healing has encouraged the drive to examine the nature and value of silk products. Silk proteins have vast applications in medical field, cosmetics, textile industry, microbic field and also in the field of tissue engineering. Sericin protein is useful because of its special properties; it has antioxidant and antibacterial properties, is UV resistant, absorbs and releases moisture easily and it inhibits the activity of tyrosine kinase. The unique mechanical properties of these fibres have provided important clinical treatment options for many future scopes.
C1 [Joseph, Baby; Raj, S. Justin] Malankara Catholic Coll, Dept Biotechnol, Interdisciplinary Res Ctr, Kanyakumari, Tamil Nadu, India.
RP Raj, SJ (reprint author), Malankara Catholic Coll, Dept Biotechnol, Interdisciplinary Res Ctr, Kanyakumari, Tamil Nadu, India.
EM rajstephy6@gmail.com
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Basal G, 2010, FIBER POLYM, V11, P21, DOI [10.1007/s1221-010-0021-0, 10.1007/s12221-010-0021-0]
   Byun EB, 2010, CHEM-BIOL INTERACT, V186, P90, DOI 10.1016/j.cbi.2010.03.032
   CHEVILLARD M, 1986, NUCLEIC ACIDS RES, V14, P6341, DOI 10.1093/nar/14.15.6341
   Chevillard M, 1986, SERICOLOGIA, V26, P435
   Cook J G., 1964, HDB TEXTILE FIBRES N, V3, P154
   Gapurova G N., 1983, ZDRAVOOKHR TURKIN, V27, P15
   GOLDSMITH MR, 1984, ANNU REV GENET, V18, P443, DOI 10.1146/annurev.ge.18.120184.002303
   Gotoh K, 2000, BIOSCI BIOTECH BIOCH, V64, P1664, DOI 10.1271/bbb.64.1664
   Gulrajani M. L., 2005, SERICIN BIOMOLECULE, P21
   Henne W, 1986, CHEM ABSTR, V104, P39519
   Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028
   Hoppe U, 1984, CHEM ABSTR, V100
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kaewkorn W, 2012, BIOL RES, V45, P45, DOI 10.4067/S0716-97602012000100006
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kataoka K., 1977, NIPPON SANSHIGAKU ZA, V46, P227
   Kato M, 2000, J INVEST DERMATOL, V114, P599, DOI 10.1046/j.1523-1747.2000.02005.x
   Kirker H C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   KOMATSU K, 1975, Bulletin of the Sericultural Experiment Station (Tokyo), V26, P135
   Lesile M, 2003, USDA PUBLICATION, VCWS-0303, P1
   Lizuka E., 1996, SILK PHYSICOCHEMICAL
   Magoshi J., 1996, BIOSPINNING SILK FIB
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Mondal M., 2007, Caspian Journal of Environmental Sciences, V5, P63
   Morita Y, 2002, BIO-MED MATER ENG, V12, P291
   Natalia T C, 2011, ADV MATER, V23, P1463, DOI 10.1002/adma.201003860
   Padamwar Mahesh N, 2005, J Cosmet Dermatol, V4, P250, DOI 10.1111/j.1473-2165.2005.00200.x
   Padol A. R., 2012, INT J TOXICOL APPL P, V2, P31
   Padol Amol R, 2011, Toxicol Int, V18, P17, DOI 10.4103/0971-6580.75847
   PRUDHOMME JC, 1979, BIOCHIMIE, V61, P215, DOI 10.1016/S0300-9084(79)80068-1
   Qian J., 1997, SCI TECHNOL FOOD IND, V5, P42
   Sasaki M, 2000, ONCOL REP, V7, P1049
   Senakoon W, 2009, ASIAN J FOOD AGR IND, pS222
   SHAW JTB, 1951, NATURE, V168, P745, DOI 10.1038/168745a0
   Shimizu M., 2000, STRUCTURE SILK YARN, P7
   SHIMURA K, 1982, Journal of Sericultural Science of Japan, V51, P20
   SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008
   Suzuki Y., 1977, Results Probl Cell Differ, V8, P1
   Teramoto H, 2004, BIOMACROMOLECULES, V5, P1392, DOI 10.1021/bm034537r
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Voegeli R., 1993, COSMET TOILETRIES, V108, P101
   Vollrath F, 2000, J Biotechnol, V74, P67
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wu C, 1996, CHEM ABSTR, V130
   YAMAGUCHI K, 1989, J MOL BIOL, V210, P127, DOI 10.1016/0022-2836(89)90295-7
   Yang H X, 2002, B SERICULTURE, V3, P9
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhu L. J., 1996, NIPPON SANSHIGAKU ZA, V65, P270
NR 60
TC 3
Z9 3
U1 7
U2 53
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2155-3769
J9 FRONT LIFE SCI
JI Front. Life Sci.
PD DEC 1
PY 2012
VL 6
IS 3-4
BP 55
EP 60
DI 10.1080/21553769.2012.760491
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 201MR
UT WOS:000323146200002
DA 2018-10-19
ER

PT J
AU Faghihi, S
   Zia, S
   Taha, MF
AF Faghihi, Shahab
   Zia, Sonia
   Taha, Masoumeh Fakhr
TI Adipose tissue-derived stem cell response to the differently processed
   316L stainless steel substrates
SO TISSUE & CELL
LA English
DT Article
DE Stainless steel; Atomic structure; Adipose tissue-derived stem cells;
   Cardiac differentiation
ID TRANSCRIPTION FACTOR GATA-4; IN-VITRO; CRYSTAL-SURFACES; CARDIAC
   DEVELOPMENT; HEART TUBE; EXPRESSION; GENE; ADHESION; SPECIFICATION;
   ATTACHMENT
AB Stainless steel (SS) is one of the most applicable materials in fabrication of cardiac implants. The aim of this study is to investigate the effect of atomic structure of polycrystalline stainless steel on the response of adipose tissue-derived stem cells (ADSCs). Samples are prepared from differently processed extruded rod and rolled sheet of 316L SS having different crystallographic structure. X-ray diffraction analysis indicated (2 0 0) and (1 1 1) orientations with distinct volume fractions in the specimens. Morphology and ADSCs behavior including adhesion, proliferation and differentiation are assessed. The expression of cardiac specific protein (cardiac troponin I) and genes of differentiating cardiomyocytes is analyzed by immunofluorescence and RT-PCR. The number of attached and grown cells on the rod sample is higher than the sheet sample also the scanning electron microscopy (SEM) analysis of ADSCs grown on the samples demonstrates higher cell density and spreading pattern on the surface of rod sample. In differentiated ADSCs on the rod sample the expression of all genes except ANF are detectable, while on the sheet sample only the MEF2C and beta-MHC are expressed. This study shows that the cellular response is influenced by the crystal structure of the substrate therefore; the skill to alter the structure of substrate may lend itself to engineer a biomaterial which could be suitable for differentiation of stem cells into a definite lineage. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Faghihi, Shahab] NIGEB, Tissue Engn & Biomat Div, Tehran, Iran.
   [Zia, Sonia] Amirkabir Univ Technol, Dept Biomed Engn, Tehran, Iran.
   [Taha, Masoumeh Fakhr] NIGEB, Dept Med Genet, Tehran, Iran.
RP Faghihi, S (reprint author), NIGEB, Dept Med Genet, Shahrak-E Pajoohesh,Km 15,Tehran Karaj Highway,Te, Tehran, Iran.
EM sfaghihi@nigeb.ac.ir; mftaha@nigeb.ac.ir
OI Fakhr Taha, Masoumeh/0000-0002-7492-413X
CR ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ARREOLA J, 1993, J PHYSIOL-LONDON, V472, P289, DOI 10.1113/jphysiol.1993.sp019947
   Bai XW, 2010, BIOCHEM BIOPH RES CO, V401, P321, DOI 10.1016/j.bbrc.2010.09.012
   Biedermann A., 2001, PHYS REV LETT, V87, P86
   Di Lisi R, 1998, J BIOL CHEM, V273, P25371, DOI 10.1074/jbc.273.39.25371
   EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280
   Faghihi S, 2009, J BIOMED MATER RES A, V91A, P656, DOI 10.1002/jbm.a.32275
   Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67
   Gamsjager E, 2005, COMP MATER SCI, V32, P360, DOI 10.1016/j.commatsci.2004.09.031
   Giri J, 2008, J MAGN MAGN MATER, V320, P724, DOI 10.1016/j.jmmm.2007.08.010
   Gojo S, 2011, J ARTIF ORGANS, V14, P171, DOI 10.1007/s10047-011-0578-4
   GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115
   HANEIN D, 1993, J CELL SCI, V104, P275
   HANEIN D, 1994, SCIENCE, V263, P1413, DOI 10.1126/science.8128221
   He Q, 2002, AM J PHYSIOL-ENDOC M, V283, pE50, DOI 10.1152/ajpendo.00274.2001
   HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   IP HS, 1995, ADV EXP MED BIOL, V382, P117
   Lako M, 2001, MECH DEVELOP, V103, P49, DOI 10.1016/S0925-4773(01)00331-8
   Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Malheiro VN, 2011, BIOMATERIALS, V32, P6883, DOI 10.1016/j.biomaterials.2011.06.002
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Mayorga M, 2009, STEM CELL REV REP, V5, P51, DOI 10.1007/s12015-009-9050-8
   MILLERHANCE WC, 1993, J BIOL CHEM, V268, P25244
   Misra RDK, 2009, ACTA BIOMATER, V5, P1455, DOI 10.1016/j.actbio.2008.12.017
   MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947
   OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157
   Ozgowicz W., 2009, ARCH MAT SCI ENG, V38, P26
   Palmaz JC, 2002, J VASC SURG, V36, P1031, DOI 10.1067/MVA.2002.129113
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Purnama A, 2010, ACTA BIOMATER, V6, P1800, DOI 10.1016/j.actbio.2010.02.027
   Randle V., 2000, INTRO TEXTURE ANAL M, P13
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Schenke-Layland K, 2009, BIOMATERIALS, V30, P4665, DOI 10.1016/j.biomaterials.2009.05.033
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451
   Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3
   Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Tomitaka A, 2009, J MAGN MAGN MATER, V321, P1482, DOI 10.1016/j.jmmm.2009.02.058
   Vong L, 2006, DEV DYNAM, V235, P1809, DOI 10.1002/dvdy.20828
   Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   ZELLER R, 1987, GENE DEV, V1, P693, DOI 10.1101/gad.1.7.693
   Zhu YX, 2009, MOL CELL BIOCHEM, V324, P117, DOI 10.1007/s11010-008-9990-3
   Zimmerman E, 1999, J STRUCT BIOL, V125, P25, DOI 10.1006/jsbi.1998.4061
NR 49
TC 5
Z9 5
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0040-8166
J9 TISSUE CELL
JI Tissue Cell
PD DEC
PY 2012
VL 44
IS 6
BP 365
EP 372
DI 10.1016/j.tice.2012.06.002
PG 8
WC Anatomy & Morphology; Cell Biology
SC Anatomy & Morphology; Cell Biology
GA 179YY
UT WOS:000321560400003
PM 22770869
DA 2018-10-19
ER

PT J
AU Yuan, SM
AF Yuan, Shi-Min
TI The Contegra Valved Bovine Conduit: A Biomaterial for the Surgical
   Treatment of Congenital Heart Defects
SO ARQUIVOS BRASILEIROS DE CARDIOLOGIA
LA English
DT Review
DE Heart defects, congenital / surgery; bioprosthesis; vascular grafting;
   tetralogy of Fallot/surgery; transplantation, heterologous
ID RIGHT-VENTRICULAR OUTFLOW; JUGULAR-VEIN CONDUIT; PULMONARY-ARTERY
   CONNECTION; TRACT RECONSTRUCTION; RVOT RECONSTRUCTION; EXTRACARDIAC
   FONTAN; RISK-FACTORS; XENOGRAFT; REPAIR; HOMOGRAFT
AB Contegra, a bovine jugular vein graft, has been widely used as a preferable biomaterial in the surgical treatment of congenital heart defects, especially as a conduit for the right ventricular outflow tract reconstruction. This article aims to make a comprehensive review on the clinical outcomes of Contegra.
   Reports of Contegra published since 2002 were comprehensively retrieved, collected and analyzed.
   There were 1718 Contegra, applied in 1705 patients. The sizes of the conduits were 8-22 mm. The patients aged from newborn to 74.5 years, prevailed by pediatrics. The primary diagnosis was congenital heart defects in all cases, with Tetralogy of Fallot, truncus arteriosus and pulmonary atresia being the first three diagnoses, representing 25.6%, 16.7%, and 13.1%, respectively.
   Contegra was used as a tube graft in the pulmonary position in 1635 (95.9%) patients, as a monocuspid patch in 12 (0.7%), as a graft in the position of the pulmonary valve or a monocusps in 40 (2.3%), and as an inferior vena cava-pulmonary artery conduit in the Fontan procedure in 18 (1.1%) patients, respectively. Conduit reimplantation was performed in 141 (8.3%) patients 33.8 +/- 37 (8.6-106.8) months after the initial conduit insertion. Conduit plasty was necessary in 6 (0.4%), and reintervention in 83 (4.9%) patients. Indications for conduit reimplantation included severe stenosis of the distal anastomosis, pseudoaneurysm of the proximal anastomosis and severe conduit regurgitation.
   As for the good performance, availability and longevity, Contegra is a biomaterial suitable for the right ventricular outflow tract reconstruction and for patch repair for ventricular septal defect, but not apt for Fontan procedure.
C1 Fujian Med Univ, Teaching Hosp, Hosp Putian 1, Dept Cardiothorac Surg, Putian 351100, Fujian Province, Peoples R China.
RP Yuan, SM (reprint author), Fujian Med Univ, Teaching Hosp, Hosp Putian 1, Dept Cardiothorac Surg, 389 Longdejing St, Putian 351100, Fujian Province, Peoples R China.
EM shi_min_yuan@yahoo.com
CR Arenz C, 2008, THORAC CARDIOV SURG, V56, P401, DOI 10.1055/s-2008-1038736
   Bajraktari Gani, 2009, Cases J, V2, P57, DOI 10.1186/1757-1626-2-57
   Baslaim G, 2008, J CARDIAC SURG, V23, P528, DOI 10.1111/j.1540-8191.2007.00559.x
   Baslaim G, 2008, J CARDIAC SURG, V23, P146, DOI 10.1111/j.1540-8191.2007.00524.x
   Boethig D, 2005, EUR J CARDIO-THORAC, V27, P58, DOI 10.1016/j.ejcts.2004.09.009
   Boethig D, 2004, J CARDIAC SURG, V19, P420, DOI 10.1111/j.0886-0440.2004.04082.x
   Bove T, 2002, ANN THORAC SURG, V74, P536, DOI 10.1016/S0003-4975(02)03728-1
   Breymann T, 2002, EUR J CARDIO-THORAC, V21, P703, DOI 10.1016/S1010-7940(02)00049-0
   Brown JW, 2006, ANN THORAC SURG, V82, P909, DOI 10.1016/j.athoracsur.2006.03.008
   Carrel T, 2002, J HEART VALVE DIS, V11, P552
   Chatzis AC, 2003, HEART SURG FORUM, V6, P396
   Chiappini B, 2007, ANN THORAC SURG, V83, P185, DOI 10.1016/j.athoracsur.2006.07.071
   Christenson JT, 2010, ANN THORAC SURG, V90, P1287, DOI 10.1016/j.athoracsur.2010.06.078
   Corno AF, 2004, ANN THORAC SURG, V78, P1382, DOI 10.1016/j.athorscsur.2004.02.095
   Corno AF, 2002, J HEART VALVE DIS, V11, P242
   Dave H, 2011, ANN THORAC SURG, V91, P195, DOI 10.1016/j.athoracsur.2010.07.058
   Erek E, 2006, J HEART VALVE DIS, V15, P433
   Gober V, 2005, ANN THORAC SURG, V79, P625, DOI 10.1016/j.athoracsur.2004.07.085
   Hickey EJ, 2008, EUR J CARDIO-THORAC, V33, P890, DOI 10.1016/j.ejcts.2007.12.052
   Kadner A, 2004, J THORAC CARDIOV SUR, V127, P285, DOI 10.1016/j.jtcvs.2003.08.031
   Kalavrouziotis G, 2006, ANN THORAC SURG, V82, P2200, DOI 10.1016/j.athoracsur.2006.07.017
   Mert M, 2005, INT J ARTIF ORGANS, V28, P251
   Meyns B, 2004, J THORAC CARDIOV SUR, V128, P834, DOI 10.1016/j.jtcvs.2004.08.015
   Morales DLS, 2006, J THORAC CARDIOV SUR, V132, P665, DOI 10.1016/j.jtcvs.2006.03.061
   Neukamm C, 2011, SCAND CARDIOVASC J, V45, P41, DOI 10.3109/14017431.2010.519401
   Niclauss Lars, 2009, Interact Cardiovasc Thorac Surg, V9, P667, DOI 10.1510/icvts.2008.195248
   Niemantsverdriet Marieke B A, 2008, Congenit Heart Dis, V3, P176, DOI 10.1111/j.1747-0803.2008.00190.x
   Palma G, 2011, J CARDIOVASC SURG, V52, P285
   Purohit M, 2004, ANN THORAC SURG, V77, P1707, DOI 10.1016/j.athoracsur.2003.10.046
   Rastan AJ, 2006, ANN THORAC SURG, V82, P1308, DOI 10.1016/j.athoracsur.2006.04.071
   Schoenhoff FS, 2011, J THORAC CARDIOV SUR, V141, P654, DOI 10.1016/j.jtcvs.2010.06.068
   Schoof P, 2009, J THORAC CARDIOV SUR, V138, P258, DOI 10.1016/j.jtcvs.2009.02.051
   Sekarski N, 2007, ANN THORAC SURG, V84, P599, DOI 10.1016/j.athoracsur.2007.04.026
   Shebani SO, 2006, EUR J CARDIO-THORAC, V29, P397, DOI 10.1016/j.ejcts.2005.11.040
   Sierra J, 2007, ANN THORAC SURG, V84, P606, DOI 10.1016/j.athoracsur.2007.03.055
   Tiete AR, 2004, ANN THORAC SURG, V77, P2151, DOI 10.1016/j.athoracsur.2003.12.068
   Urso S, 2011, EUR J CARDIO-THORAC, V40, P603, DOI 10.1016/j.ejcts.2010.11.081
   Zureikat Y, 2005, JRMS, V12, P53
NR 38
TC 4
Z9 4
U1 0
U2 7
PU ARQUIVOS BRASILEIROS CARDIOLOGIA
PI RIO DE JANEIRO
PA AVENIDA MARECHAL CAMARA 160-330 CENTRO, RIO DE JANEIRO, RJ 20 020-907,
   BRAZIL
SN 0066-782X
J9 ARQ BRAS CARDIOL
JI Arq. Bras. Cardiol.
PD DEC
PY 2012
VL 99
IS 6
BP 1159
EP 1165
DI 10.1590/S0066-782X2012005000105
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 075EI
UT WOS:000313866200019
PM 23152287
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Wong, JY
   McDonald, J
   Taylor-Pinney, M
   Spivak, DI
   Kaplan, DL
   Buehler, MJ
AF Wong, Joyce Y.
   McDonald, John
   Taylor-Pinney, Micki
   Spivak, David I.
   Kaplan, David L.
   Buehler, Markus J.
TI Materials by design: Merging proteins and music
SO NANO TODAY
LA English
DT Editorial Material
DE Nanotechnology; Biology; Music; Theory; Experiment; Arts; Design;
   Manufacturing; Nanomechanics; Protein
ID SPIDER SILK; STRENGTH; WEBS
AB Tailored materials with tunable properties are crucial for applications as biomaterials, for drug delivery, as functional coatings, or as lightweight composites. An emerging paradigm in designing such materials is the construction of hierarchical assemblies of simple building blocks into complex architectures with superior properties. We review this approach in a case study of silk, a genetically programmable and processable biomaterial, which, in its natural role serves as a versatile protein fiber with hierarchical organization to provide structural support, prey procurement or protection of eggs. Through an abstraction of knowledge from the physical system, silk, to a mathematical model using category theory, we describe how the mechanism of spinning fibers from proteins can be translated into music through a process that assigns a set of rules that governs the construction of the system. This technique allows one to express the structure, mechanisms and properties of the 'material' in a very different domain, 'music'. The integration of science and art through categorization of structure-property relationships presents a novel paradigm to create new bioinspired materials, through the translation of structures and mechanisms from distinct hierarchical systems and in the context of the limited number of building blocks that universally governs these systems. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Wong, Joyce Y.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [McDonald, John] Tufts Univ, Dept Mus, Medford, MA 02155 USA.
   [Taylor-Pinney, Micki] Boston Univ, Coll Fine Arts, Boston, MA 02215 USA.
   [Spivak, David I.] MIT, Dept Math, Cambridge, MA 02139 USA.
   [Kaplan, David L.] Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Buehler, Markus J.] MIT, LAMM, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.
RP Wong, JY (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
EM jywong@bu.edu; David.Kaplan@tufts.edu; mbuehler@MIT.EDU
RI Buehler, Markus/C-4580-2008; Wong, Joyce/F-3732-2011
OI Buehler, Markus/0000-0002-4173-9659; Wong, Joyce/0000-0002-3526-6381
FU NIBIB NIH HHS [U01 EB014976]
CR Blackledge TA, 2012, J ARACHNOL, V40, P1
   Buehler MJ, 2010, NANO TODAY, V5, P379, DOI 10.1016/j.nantod.2010.08.001
   Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739
   Cranford SW, 2012, BIOMATERIOMICS
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Giesa T, 2012, ADV ENG MATER, V14, P810, DOI 10.1002/adem.201200109
   Giesa T, 2011, BIONANOSCIENCE, V1, P153, DOI 10.1007/s12668-011-0022-5
   Gronau G, 2012, BIOMATERIALS, V33, P8240, DOI 10.1016/j.biomaterials.2012.06.054
   Heim M, 2010, CHEM SOC REV, V39, P156, DOI 10.1039/b813273a
   Humenik M, 2011, PROG MOL BIOL TRANSL, V103, P131, DOI 10.1016/B978-0-12-415906-8.00007-8
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624
   Krishnaj S. T., 2012, ADV FUNCT MAT
   Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002
   Mac Lane S, 1998, CATEGORIES WORKING M
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Omenetto F, 2010, SCI AM, V303, P76, DOI 10.1038/scientificamerican1110-76
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Ryu S., UNPUB
   Spivak DI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024274
   Sutherland TD, 2012, BIOPOLYMERS, V97, P446, DOI 10.1002/bip.21702
   Takahashi R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-405
NR 24
TC 16
Z9 18
U1 3
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-0132
J9 NANO TODAY
JI Nano Today
PD DEC
PY 2012
VL 7
IS 6
BP 488
EP 495
DI 10.1016/j.nantod.2012.09.001
PG 8
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 075DU
UT WOS:000313864800005
PM 23997808
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hanawa, T
AF Hanawa, Takao
TI Research and development of metals for medical devices based on clinical
   needs
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Review
DE metal; alloy; biomaterial; implant; medical device; biofunction;
   biocompatibility
ID ELECTRODEPOSITED POLY(ETHYLENE GLYCOL); BONE MORPHOGENETIC PROTEIN-2;
   AUSTENITIC STAINLESS-STEELS; SUPERELASTIC NITINOL TUBE; SELF-ASSEMBLED
   MONOLAYERS; SHAPE-MEMORY ALLOYS; SURFACE OXIDE-FILM; ZR-NB ALLOYS; TI-V
   ALLOYS; MECHANICAL-PROPERTIES
AB The current research and development of metallic materials used for medicine and dentistry is reviewed. First, the general properties required of metals used in medical devices are summarized, followed by the needs for the development of alpha + beta type Ti alloys with large elongation and beta type Ti alloys with a low Young's modulus. In addition, nickel-free Ni-Ti alloys and austenitic stainless steels are described. As new topics, we review metals that are bioabsorbable and compatible with magnetic resonance imaging. Surface treatment and modification techniques to improve biofunctions and biocompatibility are categorized, and the related problems are presented at the end of this review. The metal surface may be biofunctionalized by various techniques, such as dry and wet processes. These techniques make it possible to apply metals to scaffolds in tissue engineering.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Metall Biomat, Chiyoda Ku, Tokyo 1010062, Japan.
RP Hanawa, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Metall Biomat, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM hanawa.met@tmd.ac.jp
CR Abe Y, 2005, DENT MATER J, V24, P536, DOI 10.4012/dmj.24.536
   Auernheimer J, 2005, CHEMBIOCHEM, V6, P2034, DOI 10.1002/cbic.200500031
   Baba H, 2002, CORROS SCI, V44, P2393, DOI 10.1016/S0010-938X(02)00040-9
   Bagno A, 2007, BONE, V40, P693, DOI 10.1016/j.bone.2006.10.007
   Bain CD, 1989, J AM CHEM SOC, V111, P437
   BALACHANDER N, 1990, LANGMUIR, V6, P1621, DOI 10.1021/la00101a001
   Balazic Matej, 2007, International Journal of Nano and Biomaterials, V1, P3, DOI 10.1504/IJNBM.2007.016517
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Brovelli D, 1999, LANGMUIR, V15, P4324, DOI 10.1021/la981758n
   Buenconsejo PJS, 2011, SCRIPTA MATER, V64, P1114, DOI 10.1016/j.scriptamat.2011.03.004
   Cadotte AJ, 2005, J NEURAL ENG, V2, P114, DOI 10.1088/1741-2560/2/4/007
   Chang WJ, 2008, DENT MATER J, V27, P340, DOI 10.4012/dmj.27.340
   Chauvel B, 1996, JMRI-J MAGN RESON IM, V6, P936, DOI 10.1002/jmri.1880060615
   Chowdhury PS, 2002, NEW ENGL J MED, V347, P581, DOI 10.1056/NEJMicm020259
   De Giglio E, 2001, J BIOMAT SCI-POLYM E, V12, P63, DOI 10.1163/156856201744452
   De Giglio E, 2009, J BIOMED MATER RES A, V88A, P1048, DOI 10.1002/jbm.a.31908
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Ernstberger T, 2007, EUR SPINE J, V16, P179, DOI 10.1007/s00586-006-0064-5
   Fang JL, 1991, LANGMUIR, V47, P169
   Fenelon AM, 2003, CORROS SCI, V45, P2837, DOI 10.1016/S0010-938X(03)00104-5
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Fontaine DD, 1988, METALL T A, V19, P169
   Gall K, 2008, MAT SCI ENG A-STRUCT, V486, P389, DOI 10.1016/j.msea.2007.11.033
   Gawalt ES, 2001, LANGMUIR, V17, P5736, DOI 10.1021/la010649x
   Gawalt ES, 2003, LANGMUIR, V19, P200, DOI 10.1021/la0203436
   Gebeau RC, 2001, ADV MATER PROCESS, V159, P46
   Guidoin R, 2000, J ENDOVASC THER, V7, P105, DOI 10.1583/1545-1550(2000)007<0105:FGAEAO>2.3.CO;2
   HANADA S, 1986, J MATER SCI, V21, P4131, DOI 10.1007/BF01106518
   HANADA S, 1982, T JPN I MET, V23, P507, DOI 10.2320/matertrans1960.23.507
   Hanawa T, 2010, WOODHEAD PUBL MATER, P3, DOI 10.1533/9781845699246.1.3
   Hanawa T, 2002, MATER TRANS, V43, P3000, DOI 10.2320/matertrans.43.3000
   HANAWA T, 1992, J JPN I MET, V56, P1168, DOI 10.2320/jinstmet1952.56.10_1168
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 2010, JPN DENT SCI REV, V46, P93, DOI 10.1016/j.jdsr.2009.11.001
   Hanawa T, 2009, J R SOC INTERFACE, V6, pS361, DOI 10.1098/rsif.2008.0427.focus
   Heintz C, 2001, J ENDOVASC THER, V8, P248, DOI 10.1583/1545-1550(2001)008<0248:CNWIEA>2.0.CO;2
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Huang NP, 2002, LANGMUIR, V18, P252, DOI 10.1021/la0109563
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ikarashi Y, 2005, MATER TRANS, V46, P2260, DOI 10.2320/matertrans.46.2260
   Indolfi L, 2009, J MATER SCI-MATER M, V20, P1541, DOI 10.1007/s10856-009-3699-z
   Kamata H, 2011, MATER TRANS, V52, P81, DOI 10.2320/matertrans.M2010311
   Kang WY, 2007, INT J CARDIOL, V120, P273, DOI 10.1016/j.ijcard.2006.07.192
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Kim JI, 2004, MAT T, V45, P852
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Kobayashi E, 2007, MATER TRANS, V48, P301, DOI 10.2320/matertrans.48.301
   Kondo R, 2011, ACTA BIOMATER, V7, P4278, DOI 10.1016/j.actbio.2011.07.020
   Kong HF, 2002, CARDIOL YOUNG, V12, P260, DOI 10.1017/S1047951102000562
   KUAN TS, 1975, METALL TRANS A, V6, P1767, DOI 10.1007/BF02642306
   Kuroda D, 2003, MATER TRANS, V44, P414, DOI 10.2320/matertrans.44.414
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lee YM, 2003, J PERIODONTOL, V74, P865, DOI 10.1902/jop.2003.74.6.865
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   MAHATO RI, 2005, BIOMATERIALS DELIVER
   Matsuura H, 2005, NEUROL MED-CHIR, V45, P395, DOI 10.2176/nmc.45.395
   Matsuura H, 2002, J NEUROSURG, V97, P1472, DOI 10.3171/jns.2002.97.6.1472
   MENGOLI G, 1979, ADV POLYM SCI, V33, P1
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   Nagai M, 2002, DENT MATER J, V21, P250, DOI 10.4012/dmj.21.250
   Nakai M, 2008, J JPN I MET, V72, P839, DOI 10.2320/jinstmet.72.839
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nomura N, 2007, MATER SCI FORUM, V539-543, P1033, DOI 10.4028/www.scientific.net/MSF.539-543.1033
   Nomura N, 2010, MATER TRANS, V51, P1449, DOI 10.2320/matertrans.M2010092
   Nomura N, 2009, MATER TRANS, V50, P2466, DOI 10.2320/matertrans.M2009187
   Nomura SN, 2010, ACTA BIOMATER, V6, P1033, DOI 10.1016/j.actbio.2009.09.013
   Olsrud J, 2005, J MAGN RESON IMAGING, V22, P433, DOI 10.1002/jmri.20391
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Oya K, 2009, BIOMATERIALS, V30, P1281, DOI 10.1016/j.biomaterials.2008.11.030
   Ozaki T, 2004, MATER TRANS, V45, P2776, DOI 10.2320/matertrans.45.2776
   Park JW, 2011, ACTA BIOMATER, V7, P3222, DOI 10.1016/j.actbio.2011.04.015
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Popowski Y, 2000, INT J RADIAT ONCOL, V47, P759, DOI 10.1016/S0360-3016(00)00488-0
   Possart W, 1998, METALS BIOMATERIALS, P197
   Pugdee K, 2007, DENT MATER J, V26, P647, DOI 10.4012/dmj.26.647
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Rammelt U, 2003, ELECTROCHIM ACTA, V48, P1257, DOI 10.1016/S0013-4686(02)00833-2
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Robertson SW, 2008, J BIOMED MATER RES B, V84B, P26, DOI 10.1002/jbm.b.30840
   Robertson SW, 2007, BIOMATERIALS, V28, P700, DOI 10.1016/j.biomaterials.2006.09.034
   Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026
   Schlager O, 2005, J ENDOVASC THER, V12, P676, DOI 10.1583/05-1672.1
   Schwartz J, 2003, MAT SCI ENG C-BIO S, V23, P395, DOI 10.1016/S0928-4931(02)00310-7
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Seol YJ, 2006, J BIOMED MATER RES A, V77A, P599, DOI 10.1002/jbm.a.30639
   Shafiei F, 2003, J DENT RES, V82, P602, DOI 10.1177/154405910308200806
   Sianos G, 2004, CATHETER CARDIO INTE, V61, P111, DOI 10.1002/ccd.10709
   SIKKA SK, 1982, PROG MATER SCI, V27, P245, DOI 10.1016/0079-6425(82)90002-0
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   Sumita M, 2004, MAT SCI ENG C-BIO S, V24, P753, DOI 10.1016/j.msec.2004.08.030
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   Tanaka Y, 2008, MATER TRANS, V49, P805, DOI 10.2320/matertrans.MRA20073171
   Tanaka Y, 2007, MAT SCI ENG C-BIO S, V27, P206, DOI 10.1016/j.msec.2006.03.007
   Tanaka Y, 2007, MATER TRANS, V48, P287, DOI 10.2320/matertrans.48.287
   Tanaka Y, 2010, J BIOMED MATER RES A, V95A, P1105, DOI 10.1002/jbm.a.32932
   Tanaka Y, 2010, J BIOMED MATER RES A, V92A, P350, DOI 10.1002/jbm.a.32375
   Tanaka Y, 2009, J COLLOID INTERF SCI, V330, P138, DOI 10.1016/j.jcis.2008.10.042
   Textor M, 2000, LANGMUIR, V16, P3257, DOI 10.1021/la990941t
   To Y, 2007, ACTA BIOMATER, V3, P1024, DOI 10.1016/j.actbio.2007.05.010
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Usami E, 2010, J JAPAN SOC DENT MAT, V29, P415
   Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4
   Viornery C, 2002, J BIOMED MATER RES, V62, P149, DOI 10.1002/jbm.10205
   Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727
   WANG K, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2697
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   WORCH H, 1998, METALS BIOMATERIALS, P177
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   XIAO SJ, 2001, TITANIUM MED, P417
   Yamamichi N, 2008, DENT MATER J, V27, P744, DOI 10.4012/dmj.27.744
   Zardiackas L. D., 1996, MED APPL TITANIUM IT, P60
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
NR 123
TC 23
Z9 23
U1 2
U2 133
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1468-6996
EI 1878-5514
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PD DEC
PY 2012
VL 13
IS 6
AR 064102
DI 10.1088/1468-6996/13/6/064102
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA 082XC
UT WOS:000314425900003
PM 27877526
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Modic, M
   Junkar, I
   Vesel, A
   Mozetic, M
AF Modic, Martina
   Junkar, Ita
   Vesel, Alenka
   Mozetic, Miran
TI Aging of plasma treated surfaces and their effects on platelet adhesion
   and activation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Plasma treatment; Aging effect; Platelet adhesion; ICP plasma; Surface
   modification
ID DIELECTRIC BARRIER DISCHARGES; IMMERSION ION-IMPLANTATION; LOW-PRESSURE
   PLASMA; POLYETHYLENE TEREPHTHALATE; OXYGEN-PLASMA; BLOOD COMPATIBILITY;
   PROTEIN ADSORPTION; VASCULAR GRAFTS; NITROGEN-PLASMA; PET SURFACES
AB Improving hemocompatibility of blood connecting devices is one of the key issues in biomaterial science. To prevent and study the effects of platelet adhesion and activation on polyethylene terephthalate (PET), a highly non-equilibrium oxygen plasma was used. Surface analyzing techniques confirmed that incorporation of oxygen functional groups, achieved by treatment with oxygen plasma, changed the surface character of PET from hydrophobic to hydrophilic. Moreover, plasma modifies the surface morphology and increases surface roughness of PET. It was shown that such surface modification has a significant effect on platelet adhesion and activation. Even a short exposure of PET surface to highly non-equilibrium plasma reduced adhesion and activation of platelets mainly through oxygen surface functionalization. However effects of plasma treatment diminish with time and many oxygen functional groups are lost from the surface within 3 h of aging. It was shown that aging of plasma treated PET is highly affected by the storage conditions. Thus the main objective of our work was to study these aging effects on platelet adhesion after storage of PET in the air, in deionized water and in phosphate buffered saline. According to the surface analysis, the samples stored in the air showed the least aging effects, as they contained the lowest number of adhered platelets. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Modic, Martina; Junkar, Ita; Vesel, Alenka; Mozetic, Miran] Jozef Stefan Inst, Dept Surface Engn, Ljubljana 1000, Slovenia.
RP Mozetic, M (reprint author), Jozef Stefan Inst, Dept Surface Engn, Jamova Cesta 39, Ljubljana 1000, Slovenia.
EM miran.mozetic@ijs.si
RI Mozetic, Miran/K-8784-2014; Vesel, Alenka/I-3934-2014
OI Vesel, Alenka/0000-0003-3782-6001
FU Slovenian Research Agency [L7-2139]
FX Financial support from the Slovenian Research Agency (grant number
   L7-2139) is gratefully acknowledged. Special thanks to the Blood
   Transfusion Centre of Slovenia for providing platelet-rich blood plasma.
CR Alves P, 2011, J APPL POLYM SCI, V122, P2302, DOI 10.1002/app.34348
   Barbucci R, 2002, BIOMATERIALS, V23, P1967, DOI 10.1016/S0142-9612(01)00323-4
   Belmonte T, 2002, J PHYS D APPL PHYS, V35, P1919, DOI 10.1088/0022-3727/35/16/304
   Belmonte T, 2001, SURF COAT TECH, V142, P306, DOI 10.1016/S0257-8972(01)01109-4
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Chen R, 2012, COLLOID SURFACE B, V96, P62, DOI 10.1016/j.colsurfb.2012.03.019
   Chu PK, 2007, SURF COAT TECH, V201, P5601, DOI 10.1016/j.surfcoat.2006.07.003
   De Geyter N, 2008, NUCL INSTRUM METH B, V266, P3086, DOI 10.1016/j.nimb.2008.03.167
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Doliska A., 2011, J BIOMATER SCI, P1
   Dorai R, 2003, J PHYS D APPL PHYS, V36, P1075, DOI 10.1088/0022-3727/36/9/305
   Fang Z, 2010, IEEE T PLASMA SCI, V38, P1615, DOI 10.1109/TPS.2010.2048342
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   Junkar I, 2009, PLASMA PROCESS POLYM, V6, P667, DOI 10.1002/ppap.200900034
   Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017
   KIAEI D, 1992, J BIOMED MATER RES, V26, P357, DOI 10.1002/jbm.820260307
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kostov KG, 2010, SURF COAT TECH, V204, P3064, DOI 10.1016/j.surfcoat.2010.02.008
   Larrieu J, 2005, SURF COAT TECH, V200, P2310, DOI 10.1016/j.surfcoat.2004.06.032
   Lee JH, 2009, APPL SURF SCI, V256, P876, DOI 10.1016/j.apsusc.2009.08.076
   Lehocky M, 2003, COLLOID SURFACE A, V222, P125, DOI 10.1016/S0927-7757(03)00242-5
   Loo CY, 2012, ACTA BIOMATER, V8, P1881, DOI 10.1016/j.actbio.2012.01.015
   Mirzadeh H, 2002, J APPL POLYM SCI, V86, P3191, DOI 10.1002/app.10775
   Morent R, 2008, EUR PHYS J-APPL PHYS, V43, P289, DOI 10.1051/epjap:2008076
   Morent R, 2007, SURF COAT TECH, V201, P7847, DOI 10.1016/j.surfcoat.2007.03.018
   Mrad O, 2011, EUR POLYM J, V47, P2403, DOI 10.1016/j.eurpolymj.2011.09.026
   Nagashima S, 2010, DIAM RELAT MATER, V19, P861, DOI 10.1016/j.diamond.2010.02.003
   NOISHIKI Y, 1987, VASCULAR SURG, V21, P401, DOI 10.1177/153857448702100605
   Ostrikov K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/17/174001
   Pascual M, 2008, J MATER SCI, V43, P4901, DOI 10.1007/s10853-008-2712-0
   Pinto S, 2010, COLLOID SURFACE B, V81, P20, DOI 10.1016/j.colsurfb.2010.06.014
   Ramires PA, 2000, J BIOMED MATER RES, V51, P535, DOI 10.1002/1097-4636(20000905)51:3<535::AID-JBM31>3.0.CO;2-P
   Ren JR, 2008, APPL SURF SCI, V255, P263, DOI 10.1016/j.apsusc.2008.06.181
   Rhodes NP, 2007, BIOMATERIALS, V28, P4561, DOI 10.1016/j.biomaterials.2007.07.008
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Solouk A, 2011, BIOTECHNOL APPL BIOC, V58, P311, DOI 10.1002/bab.50
   Vesel A, 2007, J PHYS D APPL PHYS, V40, P3689, DOI 10.1088/0022-3727/40/12/022
   Vesel A, 2008, SURF INTERFACE ANAL, V40, P661, DOI 10.1002/sia.2691
   Vesel A, 2007, VACUUM, V82, P248, DOI 10.1016/j.vacuum.2007.07.021
   Vesel A, 2010, VACUUM, V84, P969, DOI 10.1016/j.vacuum.2010.01.032
   Vesel A, 2008, SURF INTERFACE ANAL, V40, P1444, DOI 10.1002/sia.2923
   Vrlinic T, 2007, SURF INTERFACE ANAL, V39, P476, DOI 10.1002/sia.2548
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   Wang J, 2006, NUCL INSTRUM METH B, V242, P12, DOI 10.1016/j.nimb.2005.08.100
   Wang J, 2005, SURF COAT TECH, V196, P307, DOI 10.1016/j.surfcoat.2004.08.161
   Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046
   Williams RL, 2004, BIOMATERIALS, V25, P4659, DOI 10.1016/j.biomaterials.2003.12.010
   Wilson DJ, 2001, SURF INTERFACE ANAL, V31, P397, DOI 10.1002/sia.1066
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
NR 51
TC 28
Z9 28
U1 1
U2 40
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC
PY 2012
VL 213
BP 98
EP 104
DI 10.1016/j.surfcoat.2012.10.026
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 078EM
UT WOS:000314081200014
DA 2018-10-19
ER

PT J
AU Simka, W
   Mosialek, M
   Nawrat, G
   Nowak, P
   Zak, J
   Szade, J
   Winiarski, A
   Maciej, A
   Szyk-Warszynska, L
AF Simka, Wojciech
   Mosialek, Michal
   Nawrat, Ginter
   Nowak, Pawel
   Zak, Jerzy
   Szade, Jacek
   Winiarski, Antoni
   Maciej, Artur
   Szyk-Warszynska, Lilianna
TI Electrochemical polishing of Ti-13Nb-13Zr alloy
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Electropolishing; Vanadium free alloy; Ti-13Nb-13Zr; XPS; EIS
ID SHAPE-MEMORY ALLOYS; METHANOLIC SULFURIC-ACID; TITANIUM BIOMATERIAL;
   CORROSION-RESISTANCE; TI-6AL-4V; NITI; BEHAVIOR; PASSIVATION; OXIDATION;
   IMPLANTS
AB This work presents the results of the investigations on electropolishing of the Ti-13Nb-13Zr titanium alloy. The electropolishing was conducted in the solution containing ammonium fluoride and sulfuric acid. The influence of electropolishing process parameters on the texture (AFM, SEM) and chemical composition (EDX, XPS) of the surface layer was established. The Ti-13Nb-13Zr alloy after the electropolishing is covered with a thin layer composed mainly of titanium, niobium and zirconium oxides. Electrochemical impedance spectroscopy in 5% NaCl solution was used for the determination of the corrosion resistance of the alloy. The application of the electropolishing increases the corrosion resistance of the Ti-13Nb-13Zr alloy significantly. The increase of the corrosion resistance of the alloy is connected with the smoothing of the surface and with the formation of Ti, Nb and Zr oxides layer on the surface. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Simka, Wojciech; Nawrat, Ginter; Zak, Jerzy; Maciej, Artur] Silesian Tech Univ, Fac Chem, Gliwice, Poland.
   [Mosialek, Michal; Nowak, Pawel; Szyk-Warszynska, Lilianna] Jerzy Haber Inst Catalysis & Surface Chem PAS, Krakow, Poland.
   [Mosialek, Michal] August Chelkowski Inst Phys Chem PAS, Warsaw, Poland.
   [Szade, Jacek; Winiarski, Antoni] Univ Silesia, Inst Phys, Katowice, Poland.
RP Simka, W (reprint author), Silesian Tech Univ, Fac Chem, Gliwice, Poland.
EM wojciech.simka@polsl.pl
RI Mosialek, Michal/E-6370-2016
OI Mosialek, Michal/0000-0001-6891-881X; Simka,
   Wojciech/0000-0002-2648-5523
FU Polish Ministry of Science and Education [PBZ-MNiSW-01/I/2007]
FX This work was supported by the Polish Ministry of Science and Education
   under the research project no. PBZ-MNiSW-01/I/2007 during 2007-2010.
CR Armitage DA, 2003, MAT SCI ENG A-STRUCT, V349, P89, DOI 10.1016/S0921-5093(02)00818-3
   Assis SL, 2007, MATER CORROS, V58, P329, DOI 10.1002/maco.200604027
   Assis SL, 2005, J BIOMED MATER RES B, V73B, P109, DOI 10.1002/jbm.b.30205
   Baker MA, 2009, ACTA BIOMATER, V5, P63, DOI 10.1016/j.actbio.2008.08.008
   Barison S, 2004, ELECTROCHIM ACTA, V50, P11, DOI 10.1016/j.electacta.2004.07.007
   Chu CL, 2008, MAT SCI ENG C-BIO S, V28, P1430, DOI 10.1016/j.msec.2008.03.009
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Fushimi K, 2006, ELECTROCHIM ACTA, V52, P1290, DOI 10.1016/j.electacta.2006.07.030
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Habazaki H, 2007, ELECTROCHEM COMMUN, V9, P1222, DOI 10.1016/j.elecom.2006.12.023
   Hensel K. B., 2007, MET FINISH, V105, P365
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2012, SURF COAT TECH, V206, P4027, DOI 10.1016/j.surfcoat.2012.03.083
   Huang CA, 2011, CORROS SCI, V53, P589, DOI 10.1016/j.corsci.2010.10.002
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9
   Jurczyk M., 2008, BIONANOMATERIALS
   Kobayashi E, 1998, J MATER SCI-MATER M, V9, P567, DOI 10.1023/A:1008909408948
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Kuhn A., 2004, MET FINISH, V102, P80
   LANDSBERG JP, 1992, NATURE, V360, P65, DOI 10.1038/360065a0
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   Lee BG, 2011, APPL SURF SCI, V257, P7190, DOI 10.1016/j.apsusc.2011.03.089
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Marciniak J., 2002, BIOMATERIALS
   Nawrat G, 2003, PRZEM CHEM, V82, P851
   Nawrat G, 2006, PRZEM CHEM, V85, P1204
   Neelakantan L, 2007, ELECTROCHIM ACTA, V53, P915, DOI 10.1016/j.electacta.2007.08.007
   Neelakantan L, 2011, ELECTROCHIM ACTA, V56, P6678, DOI 10.1016/j.electacta.2011.05.049
   Oshida Y., 2006, BIOSCIENCE BIOENGINE
   Pohl M, 2004, MAT SCI ENG A-STRUCT, V378, P191, DOI 10.1016/j.msea.2003.11.080
   Poullou M, 2010, SCRIPTA MATER, V62, P411, DOI 10.1016/j.scriptamat.2009.12.003
   Przybyszewska-Doros I., 2005, ENG BIOMATERIALS, V43-44, P52
   Robin A, 2008, MATER CORROS, V59, P929, DOI 10.1002/maco.200805014
   Rokicki R., 1990, MET FINISH, V88, P65
   Rokicki R, 2012, J MATER SCI-MATER M, V23, P2127, DOI 10.1007/s10856-012-4696-1
   Shtanko V.M., 1981, Patent GB, Patent No. 2060700
   Shukla AK, 2006, CORROS SCI, V48, P1696, DOI 10.1016/j.corsci.2005.06.003
   Simka W, 2011, PRZEM CHEM, V90, P84
   Simka W, 2010, ELECTROCHIM ACTA, V55, P2437, DOI 10.1016/j.electacta.2009.11.097
   Szewczenko J, 2010, MATERIALWISS WERKST, V41, P360, DOI 10.1002/mawe.201000610
   Szewczenko J, 2012, LECT N BIOINFORMAT, V7339, P398
   Szewczenko J, 2011, PRZ ELEKTROTECHNICZN, V87, P177
   Takebe J, 2007, J BIOMED MATER RES A, V80A, P711, DOI 10.1002/jbm.a.30988
   Wennig R., 1988, HDB TOXICITY INORGAN
   Winship K.A., 1992, TOXICOL REV, V11, P123
NR 50
TC 28
Z9 28
U1 1
U2 73
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC
PY 2012
VL 213
BP 239
EP 246
DI 10.1016/j.surfcoat.2012.10.055
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 078EM
UT WOS:000314081200031
DA 2018-10-19
ER

PT J
AU Zhou, YZ
   Cao, Y
   Liu, W
   Chu, CH
   Li, QL
AF Zhou, Yun-Zhi
   Cao, Ying
   Liu, Wei
   Chu, Chun Hung
   Li, Quan-Li
TI Polydopamine-Induced Tooth Remineralization
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE mussel-adhesion; polydopamine; enamel; dentin; remineralization;
   hydroxyapatite
ID MUSSEL ADHESION; ENAMEL; CRYSTALLIZATION; MINERALIZATION; COLLAGEN;
   CALCIUM; DENTIN
AB Inspired by mussel bioadhesion in nature, dopamine is extensively used for biomaterial surface modification. In this study, we coated dopamine on demineralized enamel and dentin surfaces to evaluate the effect of polydopamine coating on dental remineralization. Dental slices containing enamel and dentin were first etched with 37% phosphoric acid for 2 min, followed by immersion in a 2 mg/mL freshly prepared solution of dopamine (10 mM Tris buffer, pH 8.5) for approximately 24 h at room temperature in the dark to obtain polydopamine coating. Then, the dental slices with and without polydopamine coating were immersed in the supersaturated solution of calcium and phosphate at 37 degrees C for 2 and 7 days. The supersaturated solution of calcium and phosphate was refreshed each day. The precipitates were characterized by SEM, XRD, FTIR, rnicrohardness, and nanoscratch analyses. No significant difference was observed in the remineralization of enamel whether it was coated with polydopamine or not However, a significant difference was found in dentin remineralization between dentin with and without polydopamine coating. Polydopamine coating remarkably promoted demineralized dentin remineralization, and all dentin tubules were occluded by densely packed hydroxyapatite crystals. Thus, coating polydopamine on dental tissue surface may be a simple universal technique to induce enamel and dentin remineralization simultaneously.
C1 [Zhou, Yun-Zhi; Cao, Ying; Liu, Wei; Li, Quan-Li] Anhui Med Univ, Stomatol Hosp & Collage, Hefei 230032, Peoples R China.
   [Cao, Ying; Chu, Chun Hung] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.
RP Chu, CH (reprint author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.
EM chchu@hku.hk; ql-li@126.com
RI Chu, Chun Hung/F-7838-2010
OI Chu, Chun Hung/0000-0002-3239-3051; Chu, Chun Hung/0000-0002-8167-0430
FU NSFC/RGC Joint Research Scheme [81061160511, N_HKU 776/10]; NSFC
   [30973352]; Board of education of Anhui Province [2011SQRL063]; Youth
   Foundation of Anhui Provincial Natural Science Foundation [1208085QH144]
FX This project was supported by NSFC/RGC Joint Research Scheme (Grant No.
   81061160511 and N_HKU 776/10, NSFC (Grant No. 30973352), the project of
   Outstanding Youth Fund from Board of education of Anhui Province (Grant
   No. 2011SQRL063), and Youth Foundation of Anhui Provincial Natural
   Science Foundation (Grant No. 1208085QH144).
CR Busch S, 2004, ANGEW CHEM INT EDIT, V43, P1428, DOI 10.1002/anie.200352183
   Cochrane NJ, 2010, J DENT RES, V89, P1187, DOI 10.1177/0022034510376046
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Fan YW, 2011, ACTA BIOMATER, V7, P2293, DOI 10.1016/j.actbio.2011.01.028
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Featherstone J D B, 2009, Adv Dent Res, V21, P4, DOI 10.1177/0895937409335590
   Hong Seong-Eui, 2008, Biotechnology Journal, V3, P648, DOI 10.1002/biot.200700250
   Kim J, 2010, J BIOMED MATER RES A, V93A, P1225, DOI 10.1002/jbm.a.32612
   Kim S, 2010, LANGMUIR, V26, P14730, DOI 10.1021/la1027509
   Kim YK, 2010, BIOMATERIALS, V31, P6618, DOI 10.1016/j.biomaterials.2010.04.060
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Liu Y, 2011, ACTA BIOMATER, V7, P1742, DOI 10.1016/j.actbio.2010.11.028
   Luz GM, 2010, COMPOS SCI TECHNOL, V70, P1777, DOI 10.1016/j.compscitech.2010.05.013
   Mitchell JC, 2011, DENT MATER, V27, P386, DOI 10.1016/j.dental.2010.11.019
   Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Pitts N B, 2009, Adv Dent Res, V21, P83, DOI 10.1177/0895937409335644
   Reynolds E C, 2008, Aust Dent J, V53, P268, DOI 10.1111/j.1834-7819.2008.00061.x
   Ryu J, 2010, ADV FUNCT MATER, V20, P2132, DOI 10.1002/adfm.200902347
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001
   Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j
NR 23
TC 63
Z9 65
U1 12
U2 123
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD DEC
PY 2012
VL 4
IS 12
BP 6900
EP 6909
DI 10.1021/am302041b
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 065LM
UT WOS:000313149800066
PM 23176019
DA 2018-10-19
ER

PT J
AU Park, SH
   Gil, ES
   Mandal, BB
   Cho, H
   Kluge, JA
   Min, BH
   Kaplan, DL
AF Park, Sang-Hyug
   Gil, Eun Seok
   Mandal, Biman B.
   Cho, Hongsik
   Kluge, Jonathan A.
   Min, Byoung-Hyun
   Kaplan, David L.
TI Annulus fibrosus tissue engineering using lamellar silk scaffolds
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE lamellar; silk; annulus fibrosus (AF); intervertebral disc (IVD)
ID INTERVERTEBRAL DISC; ANULUS FIBROSUS; ARTICULAR-CARTILAGE; NUCLEUS
   PULPOSUS; STEM-CELLS; DEGENERATION; REGENERATION; BIOMATERIAL; CULTURE;
   MATRIX
AB Degeneration of the intervertebral disc (IVD) represents a significant muscular skeletal disease. Recently, scaffolds composed of synthetic, natural and hybrid biomaterials have been investigated as options to restore the IVD; however, they lack the hallmark lamellar morphological features of annulus fibrosus (AF) tissue. The goal of regenerating the disc is to achieve anatomical morphology as well as restoration of mechanical and biological function. In this study, two types of scaffold morphology formed from silk fibroin were investigated towards the goal of AF tissue restoration. The first design mimics the lamellar features of the IVD that are associated with the AF region. The second is a porous spongy scaffold that serves as a control. Toroidal scaffolds were formed from the lamellar and porous silk material systems to generate structures with an outer diameter of 8?mm, inner diameter of 3.5?mm and a height of 3?mm. The inter-lamellar spacing in the lamellar scaffold was 150250 mu m and the average pore sizes in the porous scaffolds were 100250 mu m. The scaffolds were seeded with porcine AF cells and, after growth over defined time frames in vitro, histology, biochemical assays, mechanical testing and gene expression indicated that the lamellar scaffold generated results that were more favourable in terms of ECM expression and tissue function than the porous scaffold for AF tissue. Further, the seeded porcine AF cells supported the native shape of AF tissue in the lamellar silk scaffolds. The lamellar silk scaffolds were effective in the formation of AF-like tissue in vitro. Copyright (C) 2012 John Wiley & Sons, Ltd.
C1 [Park, Sang-Hyug; Gil, Eun Seok; Mandal, Biman B.; Kluge, Jonathan A.; Kaplan, David L.] Tufts Univ, Medford, MA 02155 USA.
   [Cho, Hongsik] Univ Tennessee, Ctr Hlth Sci, Dept Orthoped Surg, Memphis, TN 38163 USA.
   [Min, Byoung-Hyun] Ajou Univ, Sch Med, Dept Orthopaed Surg, Suwon 441749, South Korea.
   [Min, Byoung-Hyun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
RP Kaplan, DL (reprint author), Tufts Univ, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Min, Byoung-Hyun/0000-0001-8928-414X
FU National Institutes of Health (NIH) Tissue Engineering Resource Center
   [EB002520]
FX This study was supported by the National Institutes of Health (NIH)
   Tissue Engineering Resource Center (Grant No. EB002520).
CR Acaroglu ER, 1995, SPINE, V20, P2690, DOI 10.1097/00007632-199512150-00010
   ANDERSON JAD, 1986, J SOC OCCUP MED, V36, P90
   Aubin CE, 2004, MED BIOL ENG COMPUT, V42, P216, DOI 10.1007/BF02344634
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chang G, 2010, J BIOMED MATER RES A, V92A, P43, DOI 10.1002/jbm.a.32326
   Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Fujita Y, 1997, J ORTHOPAED RES, V15, P814, DOI 10.1002/jor.1100150605
   GHOSH P, 1980, SPINE, V5, P310, DOI 10.1097/00007632-198007000-00004
   Goins ML, 2005, SPINE J, V5, P317
   Green T P, 1993, Eur Spine J, V2, P209, DOI 10.1007/BF00299448
   Gruber HE, 2006, BIOMATERIALS, V27, P371, DOI 10.1016/j.biomaterials.2005.06.032
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Iatridis JC, 2005, J BIOMECH, V38, P557, DOI 10.1016/j.jbiomech.2004.03.038
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d
   MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011
   Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Park SH, 2005, ARTIF ORGANS, V29, P838, DOI 10.1111/j.1525-1594.2005.00137.x
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   Sato Masato, 2003, J Biomed Mater Res A, V64, P248, DOI 10.1002/jbm.a.10287
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031
   WHITLEY CB, 1989, CLIN CHEM, V35, P374
NR 36
TC 19
Z9 24
U1 3
U2 39
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD DEC
PY 2012
VL 6
SU 3
BP s24
EP s33
DI 10.1002/term.541
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 069JH
UT WOS:000313431100004
PM 22311816
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mayer, A
   Roch, T
   Kratz, K
   Lendlein, A
   Jung, F
AF Mayer, Anke
   Roch, Toralf
   Kratz, Karl
   Lendlein, Andreas
   Jung, Friedrich
TI Pro-angiogenic CD14(++) CD16(+) CD163(+) monocytes accelerate the in
   vitro endothelialization of soft hydrophobic poly(n-butyl acrylate)
   networks
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Multifunctional biomaterial; Endothelialization; Monocytes; Co-culture;
   Cellular cytokine release system
ID COMMON CAROTID-ARTERY; MATRIX METALLOPROTEINASES; CHEMICAL-COMPOSITION;
   DENDRITIC CELLS; STRESS FIBERS; GROWTH-FACTOR; SHEAR-STRESS; GRAFTS;
   IMMOBILIZATION; MACROPHAGES
AB As the majority of the polymers used as cardiovascular grafts so far do not match the elasticity of human arteries (100-1000 kPa) and the required endothelialization, a multifunctional material approach is needed to allow the adjustment of the mechanical properties while at the same time exhibiting a haemo-compatible surface. Recently soft poly(n-butyl acrylate) networks (cPnBA) with adjustable mechanical properties were introduced as candidate materials with a surface that can be endothelialized. In this study, angiogenically stimulated intermediate CD163(+) monocytes/macrophages (aMO2) were utilized as a cellular cytokine release system to realize the functional endothelialization of the hydrophobic cPnBA surface. We investigated the influence of co-cultured aMO2 on the morphology, density and cytokine secretion of human umbilical venous endothelial cells (HUVEC) seeded on cPnBA with an elastic modulus of around 250 kPa (cPnBA0250). A functional confluent HUVEC monolayer could be developed in the co-culture within 3 days. In contrast, the HUVEC in the monoculture exhibited stress fibres, broadened marginal filament bands and significantly more and larger cell-free areas in the monolayer, indicating incomplete cell-substrate binding. Remarkably, a functional confluent monolayer formation could only be achieved in co-cultures; it did not develop with the sole supplementation of recombinant VEGF-A(165) to the HUVEC monocultures (unpublished data). The study demonstrated the multifunctional potential of cPnBA in combination with aMO2 as a cellular cytokine release system, adapting their secretion to the demand of HUVEC. In this way, a functional confluent monolayer could be generated within 3 days. (c) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Teltow, Germany.
   Helmholtz Zentrum Geesthacht, Polymer Res Inst, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Roch, Toralf/K-9531-2013; Jung, Friedrich/L-1301-2013; Lendlein,
   Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU Helmholtz Association; Berlin-Brandenburg Center for Regenerative
   Therapies; Bundesministerium fur Bildung und Forschung through project
   Poly4BioBB [0315696A]; Impuls- und Vernetzungsfond [SO-036]
FX The study was financially supported by the Helmholtz Association,
   Impuls- und Vernetzungsfond: SO-036, Berlin-Brandenburg Center for
   Regenerative Therapies and the Bundesministerium fur Bildung und
   Forschung through project Poly4BioBB (Grant No. 0315696A).
CR Akeson A, 2010, MICROVASC RES, V80, P65, DOI 10.1016/j.mvr.2010.02.001
   Alikhani M, 2004, J CELL PHYSIOL, V201, P341, DOI 10.1002/jcp.20067
   Amsden BG, 2011, EXPERT OPIN DRUG DEL, V8, P873, DOI 10.1517/17425247.2011.577412
   Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557
   Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97
   Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Faries PL, 2000, J VASC SURG, V31, P1119, DOI 10.1016/S0741-5214(00)90101-0
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0
   FRANKE RP, 1986, KLIN WOCHENSCHR, V64, P989
   Gress TM, 1987, THESIS U MARBURG
   GRINNELL F, 1973, BIOCHEM MED METAB B, V7, P87, DOI 10.1016/0006-2944(73)90102-6
   GRINNELL F, 1972, ARCH BIOCHEM BIOPHYS, V153, P193, DOI 10.1016/0003-9861(72)90436-5
   Hao X, 2004, BIOCHEM BIOPH RES CO, V315, P1058, DOI 10.1016/j.bbrc.2004.01.165
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   LANFRANCONE L, 1992, BLOOD, V80, P2835
   Lee SR, 2004, J CEREBR BLOOD F MET, V24, P720, DOI 10.1097/01.WCB.0000122747.72175.47
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   Mayer A, 2010, CLIN HEMORHEOL MICRO, V46, P217, DOI 10.3233/CH-2010-1348
   Mayer A, 2012, ARTIF ORGANS, V36, pE28, DOI 10.1111/j.1525-1594.2011.01410.x
   McKenna KA, 2012, ACTA BIOMATER, V8, P225, DOI 10.1016/j.actbio.2011.08.001
   Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003
   Odedra D, 2011, ACTA BIOMATER, V7, P3027, DOI 10.1016/j.actbio.2011.05.002
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   PATEL DJ, 1970, CIRC RES, V27, P149, DOI 10.1161/01.RES.27.2.149
   RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952
   Roch T, 2012, CLIN HEMORHEOL MICRO, V50, P131, DOI 10.3233/CH-2010-1449
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Sharon JL, 2008, ACTA BIOMATER, V4, P1016, DOI 10.1016/j.actbio.2008.02.017
   Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x
   Song Y, 2011, CLIN HEMORHEOL MICRO, V49, P357, DOI 10.3233/CH-2011-1486
   Tiwari A, 2001, EUR J VASC ENDOVASC, V21, P193, DOI 10.1053/ejvs.2001.1316
   Worrall NK, 1997, AM J PHYSIOL-HEART C, V273, pH2565
   Ziegler-Heitbrock L, 2010, BLOOD, V116, pe74, DOI DOI 10.1182/BL00D-2010-02-258558
NR 39
TC 14
Z9 14
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2012
VL 8
IS 12
BP 4253
EP 4259
DI 10.1016/j.actbio.2012.08.011
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 060GR
UT WOS:000312765000008
PM 22902818
DA 2018-10-19
ER

PT J
AU Webster, TJ
   Patel, AA
   Rahaman, MN
   Bal, BS
AF Webster, T. J.
   Patel, A. A.
   Rahaman, M. N.
   Bal, B. Sonny
TI Anti-infective and osteointegration properties of silicon nitride,
   poly(ether ether ketone), and titanium implants
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silicon nitride; Poly(ether ether ketone); Titanium; Orthopedic implants
ID OSTEOBLAST-LIKE CELLS; BIOMATERIAL SURFACE-CHEMISTRY; EPIDERMIDIS
   BIOFILM FORMATION; ATOMIC-FORCE MICROSCOPY; IN-VITRO; SI3N4-BIOGLASS
   COMPOSITES; ORTHOPEDIC APPLICATIONS; ANTIBACTERIAL ACTIVITY; BACTERIAL
   ADHESION; GRINDING TECHNIQUE
AB Silicon nitride (Si3N4) is an industrial ceramic used in spinal fusion and maxillofacial reconstruction. Maximizing bone formation and minimizing bacterial infection are desirable attributes in orthopedic implants designed to adhere to living bone. This study has compared these attributes of Si3N4 implants with implants made from two other orthopedic biomaterials, i.e. poly(ether ether ketone) (PEEK) and titanium (Ti). Dense implants made of Si3N4, PEEK, or Ti were surgically implanted into matching rat calvarial defects. Bacterial infection was induced with an injection of 1 x 10(4) Staphylococcus epidermidis. Control animals received saline only. On 3, 7, and 14 days, and 3 months post-surgery four rats per time period and material were killed, and calvariae were examined to quantify new bone formation and the presence or absence of bacteria. Quantitative evaluation of osteointegration to adjacent bone was done by measuring the resistance to implant push-out (n = 8 rats each for Ti and PEEK, and n = 16 rats for Si3N4). Three months after surgery in the absence of bacterial injection new bone formation around Si3N4 was similar to 69%, compared with 24% and 36% for PEEK and Ti, respectively. In the presence of bacteria new bone formation for Si3N4, Ti, and PEEK was 41%, 26%, and 21%, respectively. Live bacteria were identified around PEEK (88%) and Ti (21%) implants, whereas none were present adjacent to Si3N4. Push-out strength testing demonstrated statistically superior bone growth onto Si3N4 compared with Ti and PEEK. Si3N4 bioceramic implants demonstrated superior new bone formation and resistance to bacterial infection compared with Ti and PEEK. (c) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bal, B. Sonny] Univ Missouri, Sch Med, Dept Orthopaed Surg, Columbia, MO 65211 USA.
   [Webster, T. J.] Brown Univ, Sch Engn, Providence, RI 02917 USA.
   [Webster, T. J.] Brown Univ, Dept Orthopaed, Providence, RI 02917 USA.
   [Patel, A. A.] Loyola Univ, Med Ctr, Dept Orthopaed Surg & Rehabil, Maywood, IL 60153 USA.
   [Rahaman, M. N.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO 65409 USA.
RP Bal, BS (reprint author), Univ Missouri, Sch Med, Dept Orthopaed Surg, Columbia, MO 65211 USA.
EM balb@health.missouri.edu
OI Bal, B. Sonny/0000-0002-9615-8632
CR Afanasiev SA, 2010, B EXP BIOL MED+, V150, P160, DOI 10.1007/s10517-010-1093-y
   Al-Ahmad A, 2010, J BIOMED MATER RES B, V95B, P101, DOI 10.1002/jbm.b.31688
   Amaral M, 2002, BIOMATERIALS, V23, P4897, DOI 10.1016/S0142-9612(02)00249-1
   Amaral M, 2002, BIOMATERIALS, V23, P4123, DOI 10.1016/S0142-9612(02)00155-2
   Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   [Anonymous], 2008, D733408 ASTM INT
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Arciola CR, 2011, INT J ARTIF ORGANS, V34, P771, DOI 10.5301/ijao.5000046
   Bal BS, 2012, ACTA BIOMATER, V8, P2889, DOI 10.1016/j.actbio.2012.04.031
   Bal BS, 2009, J ARTHROPLASTY, V24, P110, DOI 10.1016/j.arth.2008.01.300
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Boyan BD, 2003, J ORTHOPAED RES, V21, P638, DOI 10.1016/S0736-0266(02)00261-9
   Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3
   Collins I, 2008, EUR SPINE J, V17, P445, DOI 10.1007/s00586-007-0559-8
   Dabrowski B, 2010, J BIOMED MATER RES B, V95B, P53, DOI 10.1002/jbm.b.31682
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Diao JP, 2005, ANAL BIOCHEM, V343, P322, DOI 10.1016/j.ab.2005.05.010
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Eliaz N, 2011, J MATER SCI-MATER M, V22, P1741, DOI 10.1007/s10856-011-4355-y
   Fiedler J, 2011, INT J ARTIF ORGANS, V34, P882, DOI 10.5301/ijao.5000022
   Fogolari F, 2002, J MOL RECOGNIT, V15, P377, DOI 10.1002/jmr.577
   Silva CCGE, 2008, MATER CHARACT, V59, P1339, DOI 10.1016/j.matchar.2007.11.007
   Guedes e Silva CC, 2008, J BIOMED MATER RES A, V84, P337
   Silva CCGE, 2008, MATER RES-IBERO-AM J, V11, P47, DOI 10.1590/S1516-14392008000100009
   Hamilton V, 2007, POLYM INT, V56, P641, DOI 10.1002/pi.2181
   Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7
   Hernigou P, 2003, J BONE JOINT SURG BR, V85B, P504, DOI 10.1302/0301-620X.85B4.13397
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   IKEDA T, 1986, ANTIMICROB AGENTS CH, V30, P132, DOI 10.1128/AAC.30.1.132
   ITURRIZA I, 1989, J MATER SCI, V24, P2047, DOI 10.1007/BF02385420
   Jarman-Smith M, 2008, Med Device Technol, V19, P12
   Jou CH, 2007, J APPL POLYM SCI, V104, P220, DOI 10.1002/app.25549
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Matar WY, 2010, J BONE JOINT SURG AM, V92A, P36, DOI 10.2106/JBJS.J.01046
   Neumann A, 2006, OTOLARYNG HEAD NECK, V134, P923, DOI 10.1016/j.otohns.2006.01.022
   Neumann A, 2004, MATERIALWISS WERKST, V35, P569, DOI 10.1002/mawe.200400778
   Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92
   Olivares-Navarrete R, 2012, SPINE J, V12, P265, DOI 10.1016/j.spinee.2012.02.002
   Oosterbos CJM, 2002, J BIOMED MATER RES, V60, P339, DOI 10.1002/jbm.1288
   Park BJ, 2009, COLLOID SURFACE B, V73, P237, DOI 10.1016/j.colsurfb.2009.05.027
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Pohler O. E., 2000, INJURY S4, V1, P7
   Pokorny D, 2010, ACTA CHIR ORTHOP TR, V77, P470
   ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F
   Rupp F, 2012, J DENT RES, V91, P104, DOI 10.1177/0022034511424901
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Schoenfeld AJ, 2011, J BONE JOINT SURG AM, V93A, P1577, DOI 10.2106/JBJS.J.01048
   Schwartz Z, 2008, J BONE JOINT SURG AM, V90A, P2485, DOI 10.2106/JBJS.G.00499
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Shirshov YM, 2001, BIOSENS BIOELECTRON, V16, P381, DOI 10.1016/S0956-5663(01)00148-8
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   Smith JS, 2011, SPINE, V36, P556, DOI 10.1097/BRS.0b013e3181eadd41
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Tseng KH, 2011, J NANOSCI NANOTECHNO, V11, P10750, DOI 10.1166/jnn.2011.3943
   Umoh JU, 2009, PHYS MED BIOL, V54, P2147, DOI 10.1088/0031-9155/54/7/020
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   Vogely HC, 2000, J ORTHOPAED RES, V18, P485, DOI 10.1002/jor.1100180323
   Wang HY, 2010, BIOMATERIALS, V31, P8181, DOI 10.1016/j.biomaterials.2010.07.054
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Zhang W, 2010, J MATER SCI-MATER M, V21, P3049, DOI 10.1007/s10856-010-4144-z
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhou YS, 1997, MAT SCI ENG C-BIOMIM, V5, P125, DOI 10.1016/S0928-4931(97)00032-5
NR 70
TC 65
Z9 65
U1 4
U2 95
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2012
VL 8
IS 12
BP 4447
EP 4454
DI 10.1016/j.actbio.2012.07.038
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 060GR
UT WOS:000312765000030
PM 22863905
DA 2018-10-19
ER

PT J
AU Dhanalakshmi, CP
   Vijayalakshmi, L
   Narayanan, V
AF Dhanalakshmi, C. P.
   Vijayalakshmi, L.
   Narayanan, V.
TI In Situ Preparation and Characterization of Nano Carbonated
   Hydroxyapatite/Poly(4-Vinyl pyridine-co-styrene) Composite and Its
   Biomedical Application
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Carbonated Hydroxyapatite; Nanocrystalline; Nanocomposite; Poly(4-Vinyl
   pyridine-co-styrene)
ID MECHANICAL-PROPERTIES; POLY(VINYL ALCOHOL); BONE-RESORPTION;
   NANOCOMPOSITE; OSTEOCLASTS; BIOCOMPATIBILITY; MACROPHAGES; PARTICLES;
   IMPLANTS; APATITES
AB Carbonated hydroxyapatite/Poly(4-vinyl pyridine-co-styrene) nano composites of varying composition for biomaterial applications have been synthesized. The Carbonated hydroxyapatite/Poly(4-vinyl pyridine-co-styrene) nano composite materials were characterized by XRD, FTIR, 31 P NMR, TGA, DTA, FESEM and TEM. Carbonated Hydroxyapatite nano rod embedded composite was prepared using Poly(4-vinyl pyridine-co-styrene) as a matrix with different weight percentages (wt%). The results indicated that the size and crystallinity of Carbonated hydroxyapatite nano particles decreases with increase in Poly(4-vinyl pyridine-co-styrene) concentration in the composite. SEM confirms the presence of carbonated hydroxyapatite nano rod crystals in Poly (4-vinyl pyridine-co-styrene) matrix. Carbonated hydroxyapatite/Poly(4-vinyl pyridine-co-styrene) nano composites were screened for antimicrobial activity and anti inflammatory activity.
C1 [Dhanalakshmi, C. P.; Narayanan, V.] Univ Madras, Dept Inorgan Chem, Madras 600025, Tamil Nadu, India.
   [Vijayalakshmi, L.] SDNB Vaishnav Coll Women, Dept Chem, Madras 600044, Tamil Nadu, India.
RP Narayanan, V (reprint author), Univ Madras, Dept Inorgan Chem, Guindy Campus, Madras 600025, Tamil Nadu, India.
FU University Grants Commission; Council of Scientific and Industrial
   Research, New Delhi, India
FX The authors are grateful for the financial supports from the University
   Grants Commission and Council of Scientific and Industrial Research, New
   Delhi, India. The authors are grateful to Metha College of Pharmacy,
   Thuraipalckam, Chennai and Ramachandra University, Chennai, Tamil Nadu,
   India in extending facilities to do In vitro and In vivo anti
   inflammatory studies.
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   Boissiere M, 2006, J MATER CHEM, V16, P1178, DOI 10.1039/b515797h
   Chen CW, 2004, J MATER CHEM, V14, P2425, DOI 10.1039/b315095j
   Chen DZ, 2007, COMPOS SCI TECHNOL, V67, P1617, DOI 10.1016/j.compscitech.2006.07.034
   Choi D, 2006, J AM CERAM SOC, V89, P444, DOI 10.1111/j.1551-2916.2005.00738.x
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Darder M, 2006, CHEM MATER, V18, P1602, DOI 10.1021/cm0523642
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Elliot J., 1994, STRUCTURE CHEM APATI, V18
   Joseph R, 2005, BIOMACROMOLECULES, V6, P1021, DOI 10.1021/bm0493180
   Kannan S, 2006, CHEM MATER, V18, P2181, DOI 10.1021/cm052567q
   Kawagoe K, 2000, J BIOMED MATER RES, V53, P678, DOI 10.1002/1097-4636(2000)53:6<678::AID-JBM10>3.0.CO;2-E
   Komlev VS, 2003, J MATER SCI LETT, V22, P1215, DOI 10.1023/A:1025300617681
   Lak A, 2008, J AM CERAM SOC, V91, P3292, DOI 10.1111/j.1551-2916.2008.02600.x
   LeGeros R. Z., 1994, BIOL SYNTHETIC APATI, P3
   Legeros R. Z., 1991, MONOGRAPHS ORAL SCI
   Li JD, 2009, J MATER SCI-MATER M, V20, P1031, DOI 10.1007/s10856-008-3664-2
   Lowenstam HA, 1989, BIOMINERALIZATION
   Magaldi S, 2004, INT J INFECT DIS, V8, P39, DOI 10.1016/j.ijid.2003.03.002
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Pramanik N, 2008, POLYM COMPOSITE, V29, P429, DOI 10.1002/pc.20410
   Pramanik N, 2006, POLYM COMPOSITE, V27, P633, DOI 10.1002/pc.20246
   Rajendran V, 2002, BIOMATERIALS, V23, P4263, DOI 10.1016/S0142-9612(02)00189-8
   Rueger JM, 1998, ORTHOPADE, V27, P72
   Rueger JM, 1998, ORTHOPADE, V27, P89
   Shellis RP, 1999, J COLLOID INTERF SCI, V218, P351, DOI 10.1006/jcis.1999.6407
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Singh MK, 2008, ADV FUNCT MATER, V18, P694, DOI 10.1002/adfm.200700888
   STUPP SI, 1993, J BIOMED MATER RES, V27, P301, DOI 10.1002/jbm.820270304
   Sundaram NM, 2006, MATER LETT, V60, P761, DOI 10.1016/j.matlet.2005.10.034
   Teitelbaum SL, 1997, J LEUKOCYTE BIOL, V61, P381
   VAES G, 1988, CLIN ORTHOP RELAT R, P239
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wang MB, 2008, J BIOMED MATER RES A, V85A, P418, DOI 10.1002/jbm.a.31585
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wiria FE, 2008, J MATER SCI-MATER M, V19, P989, DOI 10.1007/s10856-007-3176-5
   Yang JM, 1997, J BIOMED MATER RES, V38, P143
   Zhang YJ, 2008, CRYST GROWTH DES, V8, P2101, DOI 10.1021/cg060880e
NR 43
TC 8
Z9 8
U1 2
U2 33
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD DEC
PY 2012
VL 2
IS 4
BP 314
EP 321
DI 10.1166/jbt.2012.1052
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 057NT
UT WOS:000312571000007
DA 2018-10-19
ER

PT J
AU Taddei, P
   Modena, E
   Traina, F
   Affatato, S
AF Taddei, Paola
   Modena, Enrico
   Traina, Francesco
   Affatato, Saverio
TI Raman and fluorescence investigations on retrieved Biolox (R) delta
   femoral heads
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE Biolox (R) delta; retrievals; wear; Raman spectroscopy; fluorescence
ID ZIRCONIA-TOUGHENED ALUMINA; RESIDUAL-STRESSES; SPECTROSCOPIC ANALYSIS;
   PHOTOLUMINESCENCE INVESTIGATIONS; PHASE-TRANSFORMATION; HIP JOINTS;
   CERAMICS; BIOMATERIAL; COMPOSITES; IMPLANTS
AB Since the introduction of ceramic-on-ceramic couplings in total hip arthroplasty, continuous efforts have been performed to improve the performance of the prosthetic components. To expand the applications of ceramics, in 2000 an innovative aluminazirconia composite was introduced in the market. The present study represents the first investigation aimed at characterising at the molecular level Biolox (R) delta retrievals implanted between 1999 and 2009. Fluorescence and Raman results showed that a progressive improvement of the material properties has occurred in the period between 1999 and 2009. Raman spectroscopy showed that wear was the main cause of the in vivo tetragonal-to-monoclinic zirconia transformation. Our findings validated the in vitro accelerated ageing protocols proposed in the literature to simulate the effects of the in vivo wear, because the mechanism operating in vivo was found to be the same active in vitro. The in vitro fracture of a new femoral head appeared to be an extreme wear condition that determined the most significant changes in the residual stress state and monoclinic content both in the section of the fragments and on their surface. The micro-Raman mapping of the fractured articulating surface showed that the tetragonal-to-monoclinic transformation involved a region much more extended than as reported in the literature. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Taddei, Paola; Modena, Enrico] Univ Bologna, Dipartimento Biochim G Moruzzi, Sez Chim & Propedeut Biochim, I-40126 Bologna, Italy.
   [Traina, Francesco; Affatato, Saverio] Ist Ortoped Rizzoli, Lab Tecnol Med, I-40136 Bologna, Italy.
RP Taddei, P (reprint author), Univ Bologna, Dipartimento Biochim G Moruzzi, Sez Chim & Propedeut Biochim, Via Belmeloro 8-2, I-40126 Bologna, Italy.
EM paola.taddei@unibo.it
RI traina, francesco/K-4112-2016
OI traina, francesco/0000-0002-0196-101X; TADDEI, PAOLA/0000-0001-8478-4508
CR BOUTIN P, 1972, REV CHIR ORTHOP, V58, P229
   Burger W., 2001, KEY ENG MATER, p[192, 545], DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.545
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chevalier J, 2011, J MECH BEHAV BIOMED, V4, P303, DOI 10.1016/j.jmbbm.2010.10.010
   Chevalier J, 2009, BIOMATERIALS, V30, P5279, DOI 10.1016/j.biomaterials.2009.06.022
   Christian J. W., 1965, THEORY TRANSFORMATIO
   CLARKE DR, 1982, J AM CERAM SOC, V65, P284, DOI 10.1111/j.1151-2916.1982.tb10445.x
   Clarke I. C., 2006, SEMIN ARTHROPLASTY, V17, P165
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   Clarke IC, 2003, KEY ENG MAT, V240-2, P777, DOI 10.4028/www.scientific.net/KEM.240-242.777
   DERBYSHIRE B, 1994, MED ENG PHYS, V16, P229, DOI 10.1016/1350-4533(94)90042-6
   Deville S, 2005, J AM CERAM SOC, V88, P1273, DOI 10.1111/j.1551-2916.2005.00221.x
   Dietrich B, 1999, J RAMAN SPECTROSC, V30, P893, DOI 10.1002/(SICI)1097-4555(199910)30:10<893::AID-JRS468>3.0.CO;2-3
   EVANS AG, 1986, ACTA METALL MATER, V34, P761, DOI 10.1016/0001-6160(86)90052-0
   Fagnano C, 2001, POLYMER, V42, P5871, DOI 10.1016/S0032-3861(00)00913-7
   Fruh HJ, 1997, BIOMATERIALS, V18, P873, DOI 10.1016/S0142-9612(97)00005-7
   Garcia MA, 2002, MAT SCI ENG A-STRUCT, V325, P302, DOI 10.1016/S0921-5093(01)01461-7
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GRABNER L, 1978, J APPL PHYS, V49, P580, DOI 10.1063/1.324682
   Gregori G, 1999, MAT SCI ENG A-STRUCT, V271, P401, DOI 10.1016/S0921-5093(99)00383-4
   HE J, 1995, J AM CERAM SOC, V78, P1347, DOI 10.1111/j.1151-2916.1995.tb08493.x
   Insley G. M., 2004, KEY ENG MATER, V192-195, P781
   ISHIGAME M, 1977, J AM CERAM SOC, V60, P367, DOI 10.1111/j.1151-2916.1977.tb15561.x
   Johnson WA, 1939, T AM I MIN MET ENG, V135, P416
   Katagiri G., 1988, SCI TECHNOLOGY ZIRCO, P537
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   Krishnan R, 2003, SCRIPTA MATER, V48, P1099, DOI 10.1016/S1359-6462(02)00631-0
   Li J, 1999, BIOMATERIAL PROPERTI, P341
   Lombardi AV, 2010, CLIN ORTHOP RELAT R, V468, P367, DOI 10.1007/s11999-009-1143-9
   Ma L, 2010, TRIBOL INT, V43, P1872, DOI 10.1016/j.triboint.2010.03.001
   MA Q, 1994, J AM CERAM SOC, V77, P298, DOI 10.1111/j.1151-2916.1994.tb06996.x
   MA Q, 1993, J AM CERAM SOC, V76, P1433, DOI 10.1111/j.1151-2916.1993.tb03922.x
   Morteza M., 2011, ORTHOPEDICS, V34, pe133
   Munoz Tabares JA, 2010, J AM CERAM SOC, V93, P1790
   ORTIZ M, 1993, J APPL MECH-T ASME, V60, P77, DOI 10.1115/1.2900782
   Pezzotti G, 2004, J BIOMED OPT, V9, P372, DOI 10.1117/1.1647547
   Pezzotti G, 2008, J AM CERAM SOC, V91, P1199, DOI 10.1111/j.1551-2916.2007.01507.x
   PHILLIPPI CM, 1971, J AM CERAM SOC, V54, P254, DOI 10.1111/j.1151-2916.1971.tb12283.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   PORTO SPS, 1967, J CHEM PHYS, V47, P1009, DOI 10.1063/1.1711980
   Pramanik S, 2005, TRENDS BIOMATER ARTI, V19, P15
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Sergo V, 1998, ACTA MATER, V46, P1701, DOI 10.1016/S1359-6454(97)00348-0
   Taddei P, 2006, J MATER SCI, V41, P5310, DOI 10.1007/s10853-006-0356-5
   Taddei P, 2006, J MATER SCI, V41, P399, DOI 10.1007/s10853-005-2515-5
   Willmann G, 1998, ORTHOPEDICS, V21, P173
   WILLMANN G, 2000, HIP INT, V10, P193
NR 49
TC 11
Z9 11
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD DEC
PY 2012
VL 43
IS 12
BP 1868
EP 1876
DI 10.1002/jrs.4105
PG 9
WC Spectroscopy
SC Spectroscopy
GA 056ZN
UT WOS:000312531400003
DA 2018-10-19
ER

PT J
AU Shirosaki, Y
AF Shirosaki, Yuki
TI Preparation of organic-inorganic hybrids with silicate network for the
   medical applications
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Organic-inorganic hybrid; Chitosan; Si(IV) species; Cell proliferation;
   Biodegradation; Biomedical application
ID GELATIN-SILOXANE HYBRIDS; IN-VITRO; DRUG-DELIVERY; CHITOSAN
   MICROSPHERES; SCAFFOLDS; MEMBRANES; CYTOCOMPATIBILITY; GLUTARALDEHYDE;
   REGENERATION; BIOMATERIAL
AB Novel strategies for regenerating or reconstructing damaged bone tissues are of urgent necessity, because of limitations in conventional therapies for trauma, congenital defects, cancer, and other bone diseases. The tissue engineering approach to repair and regeneration is founded upon the use of biodegradable polymer scaffolds, which may manipulate bone cell functions, encourage the migration of bone cells from border areas to the defect site, and provide a source of inductive factors to support bone cell differentiation. During the past decades, scaffolds from natural biodegradable polymers such as collagen, gelatin, fibrin, and alginates, or synthetic biodegradable polymers such as polyglycolide, polylactides, and copolymers of glycolide with lactides have been extensively explored. On the other hand, it has been confirmed that the bonelike apatite layer, deposited spontaneously on the biomaterial surfaces, can enhance osteoconductivity. The presence of such bone-like apatite layers is also believed to be a prerequisite to conduction of osteogenic cells into various porous scaffolds or onto the surface of bioactive glasses. The formation of such bone-like apatite is favored by the cooperative behavior of a hydrated silica or titania gel surface Si-OH or Ti-OH groups as well as calcium ions to be released into the body fluid when implanted. Thus, hybrid materials derived from the integration of biodegradable polymers with bioactive inorganic species may construct a new group of scaffolds appropriate for tissue engineering. Moreover, tissue engineering approach depends on the use of porous scaffolds that serve to support and reinforce the regenerating tissue. Controlled porous structures of these scaffolds allow cell attachment, and migration, tissue generation, or vascularization. The synthesis of novel chitosan-silicate hybrids derived from the integration of chitosan and gamma-glycidoxypropyltrimethoxysilane (GPTMS) has been studied. Some of the results on this hybrid for biomedical application are introduced. (C)2012 The Ceramic Society of Japan All rights reserved.
C1 Frontier Res Acad Young Researchers, Kyushu Inst Technol, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan.
RP Shirosaki, Y (reprint author), Frontier Res Acad Young Researchers, Kyushu Inst Technol, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.
EM yukis@lsse.kyutech.ac.jp
CR Amado S, 2008, BIOMATERIALS, V29, P4409, DOI 10.1016/j.biomaterials.2008.07.043
   Anredson S. I., 1998, J MATER SCI-MATER M, V9, P731
   Aubin Jane E., 1993, P1
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Hayakawa S, 1996, PHYS CHEM GLASSES, V37, P188
   HENCH LL, 1982, BIOMATERIALS INTERFA, P10
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Innocenzi P, 2000, J NON-CRYST SOLIDS, V265, P68, DOI 10.1016/S0022-3093(99)00898-4
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   KAWAMURA Y, 1993, IND ENG CHEM RES, V32, P386, DOI 10.1021/ie00014a015
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Lee Y. K, 2001, CHEM REV, V101, P1869
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Martin TJ, 1993, HDB EXPT PHARM, P149
   Ning SC, 1999, RADIOTHER ONCOL, V50, P215, DOI 10.1016/S0167-8140(98)00134-0
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Rashidova SS, 2004, J CHROMATOGR B, V800, P49, DOI 10.1016/j.jchromb.2003.10.015
   Ren L, 2001, J NON-CRYST SOLIDS, V285, P116, DOI 10.1016/S0022-3093(01)00441-0
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Shirosaki Y, 2008, KEY ENG MATER, V361-363, P1219, DOI 10.4028/www.scientific.net/KEM.361-363.1219
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   Shirosaki Y, 2008, CHEM ENG J, V137, P122, DOI 10.1016/j.cej.2007.10.012
   Shirosaki Y, 2010, J CERAM SOC JPN, V118, P989, DOI 10.2109/jcersj2.118.989
   Shirosaki Y, 2009, J NANOSCI NANOTECHNO, V9, P3714, DOI 10.1166/jnn.2009.NS56
   Shirosaki Y, 2009, ACTA BIOMATER, V5, P346, DOI 10.1016/j.actbio.2008.07.022
   Simoes MJ, 2011, ACTA MEDICA PORT, V24, P43
   Simoes Maria J., 2010, Italian Journal of Anatomy and Embryology, V115, P190
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   TATEISHI T, 2002, J ARTIF ORGANS, V5, P77, DOI DOI 10.1007/S100470200014
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
NR 38
TC 7
Z9 7
U1 0
U2 70
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD DEC
PY 2012
VL 120
IS 1408
BP 555
EP 559
DI 10.2109/jcersj2.120.555
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 063EG
UT WOS:000312978400001
OA Bronze
DA 2018-10-19
ER

PT J
AU Ozmen, M
   Akin, I
   Marsoglu, M
AF Ozmen, Melis
   Akin, Ipek
   Marsoglu, Muzeyyen
TI Production and Characterization of Hydroxyapatite-Zirconia Composites
SO HIGH TEMPERATURE MATERIALS AND PROCESSES
LA English
DT Article
DE Hydroxyapatite; zirconia; composite; sintering
ID CERAMICS
AB Hydroxyapatite (HA) ceramics are used extensively in different medical applications, such as biomaterial for repair or replacement of bone tissues since it resembles mineral component of bone and teeth. However, HA exhibits low fracture toughness due to its lack of strength and brittleness, thereby providing an obstacle to its application in implants that must withstand to high loads. In this study, HA was synthesized from human teeth by using a single calcinations method. Hydroxyapatite powders were mixed with different amounts of zirconia. The composites were sintered at different temperatures and characterized in terms of mechanical properties and the optimum sintering temperature was determined for good mechanical properties.
C1 [Ozmen, Melis; Marsoglu, Muzeyyen] Yildiz Tekn Univ, Dept Met & Mat Engn, TR-34210 Istanbul, Turkey.
   [Akin, Ipek] Istanbul Tech Univ, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
RP Marsoglu, M (reprint author), Yildiz Tekn Univ, Dept Met & Mat Engn, TR-34210 Istanbul, Turkey.
EM mmars@yildiz.edu.tr
RI Akin, Ipek/B-6012-2014
OI Akin, Ipek/0000-0002-3159-7650
CR Fu L., 2000, SURFACE COATINGS TEC, V127
   Genc Y., 2004, KEY ENG MATER, V264-268, P1961
   JARCHO M, 1979, J MATER SCI, V14, P142, DOI 10.1007/BF01028337
   Khalil MS, 2002, CERAM INT, V28, P451, DOI 10.1016/S0272-8842(01)00118-3
   Orlovskii V.P., 2002, IAN SSSR NEORG MATER, V38, P1159
   Osorio AG, 2011, REV ADV MATER SCI, V27, P58
   Prabakaran K., 2005, TRENDS BIOMATERIALS, V18
   Silva VV, 2001, COMPOS SCI TECHNOL, V61, P301, DOI 10.1016/S0266-3538(00)00222-0
   Suchanek V., 1998, J MAT RES SOC, V13, P94
   Suchanek W, 1997, BIOMATERIALS, V18, P923, DOI 10.1016/S0142-9612(97)00019-7
NR 10
TC 0
Z9 0
U1 1
U2 15
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-6455
J9 HIGH TEMP MAT PR-ISR
JI High Temp. Mater. Process.
PD DEC
PY 2012
VL 31
IS 6
BP 749
EP 753
DI 10.1515/htmp-2012-0006
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 056NY
UT WOS:000312498500012
DA 2018-10-19
ER

PT J
AU Kaneko, T
   Takahashi, S
   Hatakeyama, R
AF Kaneko, T.
   Takahashi, S.
   Hatakeyama, R.
TI Control of nanoparticle synthesis using physical and chemical dynamics
   of gas-liquid interfacial non-equilibrium plasmas
SO PLASMA PHYSICS AND CONTROLLED FUSION
LA English
DT Article; Proceedings Paper
CT 39th European-Physical-Society Conference on Plasma Physics
CY JUL 02-06, 2012
CL Stockholm, SWEDEN
ID GLOW-DISCHARGE ELECTROLYSIS; IONIC LIQUIDS; FUTURE
AB Plasmas generated in contact with liquids have attracted considerable attention as a novel reactive field in nano-biomaterial creation because the brand-new chemical and biological reactions are yielded at the gas-liquid interface, which are induced by the physical actions of the non-equilibrium plasmas. Highly ordered periodic structures of gold nanoparticles (AuNPs) are formed by transcribing the plasma structure to the surface of the liquid, where the spatially selective synthesis of the AuNPs is realized. Furthermore, the plasma structure is controlled using a ring or disk electrode under strong magnetic fields up to 4 T. The ring structure of the nanoparticles is found to be formed in accordance with the shadow region of the ring electrode. It is found that the AuNPs are synthesized by the reduction effect of the hydrogen radical via irradiation of neutral radicals of the plasma and are destroyed by the oxidation effect of the fluorine radical via high-energy plasma-ion irradiation.
C1 [Kaneko, T.; Takahashi, S.; Hatakeyama, R.] Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 9808579, Japan.
RP Kaneko, T (reprint author), Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 9808579, Japan.
EM kaneko@m.tohoku.ac.jp
RI Hatakeyama, Rikizo/P-1200-2014
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
FX The authors thank Professor K Tohji, K Motomiya, T Miyazaki and H Ishida
   for technical assistance. This work was supported by a Grant-in-Aid for
   Scientific Research from the Ministry of Education, Culture, Sports,
   Science and Technology, Japan.
CR Baba K, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2739327
   Baba K, 2006, JPN J APPL PHYS 1, V45, P8286, DOI 10.1143/JJAP.45.8286
   Baba K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.035006
   Bruggeman P, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/053001
   DENARO AR, 1958, J ELECTROCHEM SOC, V105, P265, DOI 10.1149/1.2428821
   Gubkin J., 1887, ANN PHYS, V32, P114
   HATAKEYAMA R, 1979, PHYS LETT A, V74, P215, DOI 10.1016/0375-9601(79)90774-6
   Hieda J, 2008, J VAC SCI TECHNOL A, V26, P854, DOI 10.1116/1.2919139
   Kaneko T, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034014
   Kaneko T, 2009, J APPL PHYS, V105, DOI 10.1063/1.3133213
   Kaneko T, 2009, PLASMA PROCESS POLYM, V6, P713, DOI 10.1002/ppap.200900029
   KANZAKI Y, 1986, J ELECTROCHEM SOC, V133, P2267, DOI 10.1149/1.2108392
   Koo IG, 2005, J MATER CHEM, V15, P4125, DOI 10.1039/b508420b
   Krenn JR, 2003, NAT MATER, V2, P210, DOI 10.1038/nmat865
   Meiss SA, 2007, CHEMPHYSCHEM, V8, P50, DOI 10.1002/cphc.200600582
   Nomura S, 2003, APPL PHYS LETT, V83, P4503, DOI 10.1063/1.1631062
   Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313
   Seddon KR, 2003, NAT MATER, V2, P363, DOI 10.1038/nmat907
   Sokolov V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.155001
   Torimoto T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2404975
   Wildgoose GG, 2006, SMALL, V2, P182, DOI 10.1002/smll.200500324
   Xie YB, 2008, PLASMA PROCESS POLYM, V5, P239, DOI 10.1002/ppap.200700094
NR 22
TC 10
Z9 10
U1 0
U2 28
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0741-3335
EI 1361-6587
J9 PLASMA PHYS CONTR F
JI Plasma Phys. Control. Fusion
PD DEC
PY 2012
VL 54
IS 12
AR 124027
DI 10.1088/0741-3335/54/12/124027
PN 1-2
PG 6
WC Physics, Fluids & Plasmas
SC Physics
GA 057QW
UT WOS:000312579500030
DA 2018-10-19
ER

PT J
AU Chung, H
   Kim, TY
   Lee, SY
AF Chung, Hannah
   Kim, Tae Yong
   Lee, Sang Yup
TI Recent advances in production of recombinant spider silk proteins
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID CLAVIPES DRAGLINE SILK; ESCHERICHIA-COLI; MAMMALIAN-CELLS;
   MECHANICAL-PROPERTIES; EXPRESSION; FIBER; BIOMATERIALS; FIBROIN; SYSTEM;
   GENES
AB Spider silk has been drawing much attention as a great biomaterial having many applications in biotechnology and biomedicine owing to its several desired material characteristics such as outstanding strength, toughness, and elasticity as well as biodegradability and biocompatibility. With various applications foreseeable in industry, there has been much effort to produce recombinant spider silk protein in large amounts. However, owing to the difficulties in its production using spiders, alternative host systems and engineering methods have been investigated to develop suitable production systems that can efficiently produce spider silk protein. Here, we review recent advances in production of spider silk proteins in various heterologous host systems with focus given on the development of metabolic and cellular engineering strategies.
C1 [Chung, Hannah; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Ctr Syst & Synthet Biotechnol, Inst BioCentury,Program BK21, Metab & Biomol Engn Natl Res Lab,Dept Chem & Biom, Taejon 305701, South Korea.
   [Kim, Tae Yong] Korea Adv Inst Sci & Technol, BioInformat Res Ctr, Taejon 305701, South Korea.
   [Lee, Sang Yup] Korea Adv Inst Sci & Technol, BioProc Engn Res Ctr, Dept Biol Sci, Dept Bio & Brain Engn, Taejon 305701, South Korea.
RP Lee, SY (reprint author), Korea Adv Inst Sci & Technol, Ctr Syst & Synthet Biotechnol, Inst BioCentury,Program BK21, Metab & Biomol Engn Natl Res Lab,Dept Chem & Biom, Taejon 305701, South Korea.
EM leesy@kaist.ac.kr
RI Lee, Sang Yup/C-1526-2011
OI Lee, Sang Yup/0000-0003-0599-3091
FU Converging Research Center Program of the Ministry of Education, Science
   and Technology (MEST) [2009-0082332]; Intelligent Synthetic Biology
   Center through the Global Frontier Research Program of MEST
   [2011-0031963]; World Class University Program of MEST through the
   National Research Foundation of Korea [R32-2009-000-10142-0]
FX This work was supported by the Converging Research Center Program
   (2009-0082332) of the Ministry of Education, Science and Technology
   (MEST) and Intelligent Synthetic Biology Center (2011-0031963) through
   the Global Frontier Research Program of MEST. Further support by the
   World Class University Program (R32-2009-000-10142-0) of MEST through
   the National Research Foundation of Korea is appreciated.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017
   Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P433, DOI 10.1007/s00114-008-0346-3
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Grip S, 2009, PROTEIN SCI, V18, P1012, DOI 10.1002/pro.111
   Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hofer M, 2012, BIOMATERIALS, V33, P1554, DOI 10.1016/j.biomaterials.2011.10.053
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kost TA, 1999, CURR OPIN BIOTECH, V10, P428, DOI 10.1016/S0958-1669(99)00005-1
   Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   ROSENBERG AH, 1993, J BACTERIOL, V175, P716
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Service RF, 2002, SCIENCE, V295, P419
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2
   Widmaier DM, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.62
   Williams David, 2003, Med Device Technol, V14, P9
   Winkler S, 2000, J Biotechnol, V74, P85
   Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xu HT, 2007, ANIM BIOTECHNOL, V18, P1, DOI 10.1080/10495390601091024
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zhang YS, 2008, MOL BIOL REP, V35, P329, DOI 10.1007/s11033-007-9090-6
NR 46
TC 30
Z9 32
U1 4
U2 143
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD DEC
PY 2012
VL 23
IS 6
BP 957
EP 964
DI 10.1016/j.copbio.2012.03.013
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 052FE
UT WOS:000312182300021
PM 22521455
DA 2018-10-19
ER

PT J
AU Kolk, A
   Handschel, J
   Drescher, W
   Rothamel, D
   Kloss, F
   Blessmann, M
   Heiland, M
   Wolff, KD
   Smeets, R
AF Kolk, Andreas
   Handschel, Joerg
   Drescher, Wolf
   Rothamel, Daniel
   Kloss, Frank
   Blessmann, Marco
   Heiland, Max
   Wolff, Klaus-Dietrich
   Smeets, Ralf
TI Current trends and future perspectives of bone substitute materials -
   From space holders to innovative biomaterials
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Bone replacement materials; Bone regeneration; Gene therapy; BMP
ID TRICALCIUM PHOSPHATE CYLINDERS; EMBRYONIC STEM-CELLS; GRAFT SUBSTITUTES;
   MORPHOGENETIC PROTEINS; IN-VIVO; POROUS HYDROXYAPATITE; RIDGE
   PRESERVATION; CANCELLOUS BONE; CLINICAL-TRIAL; DEFECT MODEL
AB An autologous bone graft is still the ideal material for the repair of craniofacial defects, but its availability is limited and harvesting can be associated with complications. Bone replacement materials as an alternative have a long history of success. With increasing technological advances the spectrum of grafting materials has broadened to allografts, xenografts, and synthetic materials, providing material specific advantages. A large number of bone-graft substitutes are available including allograft bone preparations such as demineralized bone matrix and calcium-based materials. More and more replacement materials consist of one or more components: an osteoconductive matrix, which supports the ingrowth of new bone; and osteoinductive proteins, which sustain mitogenesis of undifferentiated cells; and osteogenic cells (osteoblasts or osteoblast precursors), which are capable of forming bone in the proper environment. All substitutes can either replace autologous bone or expand an existing amount of autologous bone graft.
   Because an understanding of the properties of each material enables individual treatment concepts this review presents an overview of the principles of bone replacement, the types of graft materials available, and considers future perspectives. Bone substitutes are undergoing a change from a simple replacement material to an individually created composite biomaterial with osteoinductive properties to enable enhanced defect bridging. (C) 2012 European Association for Cranio-Maxillo-Facial Surgery.
C1 [Kolk, Andreas; Wolff, Klaus-Dietrich] Tech Univ Munich, Klinikum Rechts Isar, Dept Oral & Maxillofacial Surg, D-81675 Munich, Germany.
   [Handschel, Joerg] Univ Dusseldorf, Dept Cranio & Maxillofacial Surg, D-40225 Dusseldorf, Germany.
   [Drescher, Wolf] RWTH Univ Hosp, Dept Orthoped, Aachen, Germany.
   [Rothamel, Daniel] Univ Cologne, Dept Oral & Craniomaxillo & Facial Plast Surg, D-50931 Cologne, Germany.
   [Kloss, Frank] Med Univ Innsbruck, Dept Craniomaxillofacial & Oral Surg, Innsbruck, Austria.
   [Blessmann, Marco; Heiland, Max; Smeets, Ralf] Univ Med Ctr Hamburg Eppendorf, Dept Oral & Maxillofacial Surg, Hamburg, Germany.
RP Kolk, A (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Dept Oral & Maxillofacial Surg, Ismaninger Str 22, D-81675 Munich, Germany.
EM Kolk@mkg.med.tum.de
RI Heiland, Max/E-8400-2013
OI Heiland, Max/0000-0002-4987-2913
CR Abramovitch-Gottlib L, 2006, TISSUE ENG, V12, P729, DOI 10.1089/ten.2006.12.729
   Abshagen K, 2009, J BIOMED MATER RES A, V91A, P557, DOI 10.1002/jbm.a.32237
   AEBI M, 1991, SPINE, V16, pS38, DOI 10.1097/00007632-199103001-00008
   Ambard Alberto J, 2006, J Prosthodont, V15, P321, DOI 10.1111/j.1532-849X.2006.00129.x
   Asti Annalia, 2008, Technol Health Care, V16, P401
   BARTH A, 1895, BEITR PATH ANAT, V17, P65
   Bibbo C, 2006, FOOT ANKLE INT, V27, P487, DOI 10.1177/107110070602700702
   Bienengraeber V., 2006, Folia Morphologica, V65, P84
   Birk RZ, 2006, TISSUE ENG, V12, P21, DOI 10.1089/ten.2006.12.21
   Biswas A, 2010, BIOMACROMOLECULES, V11, P2545, DOI 10.1021/bm1009359
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   Bostrom Mathias P G, 2005, HSS J, V1, P9, DOI 10.1007/s11420-005-0111-5
   Brandoff Jared F, 2008, Am J Orthop (Belle Mead NJ), V37, P410
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   BUCHOLZ RW, 2002, CLIN ORTHOP FEBRUARY, V395, P44
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Chesnutt BM, 2009, J BIOMED MATER RES A, V88A, P491, DOI 10.1002/jbm.a.31878
   Chow L C, 2001, Monogr Oral Sci, V18, P94
   Claes L, 1997, J ORTHOP RES, V15, P577, DOI 10.1002/jor.1100150414
   CONRAD EU, 1995, J BONE JOINT SURG AM, V77A, P214, DOI 10.2106/00004623-199502000-00007
   COOK SD, 1994, CLIN ORTHOP RELAT R, P302
   Cornell CN, 1999, ORTHOP CLIN N AM, V30, P591, DOI 10.1016/S0030-5898(05)70112-7
   CORNELL CN, 1992, CLIN ORTHOP RELAT R, P297
   Costache AD, 2009, MOL PHARMACEUT, V6, P1620, DOI 10.1021/mp900114w
   Cunningham Larry L, 2005, J Long Term Eff Med Implants, V15, P609
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   Dai KR, 2005, CALCIFIED TISSUE INT, V77, P55, DOI 10.1007/s00223-004-0095-z
   Damien E, 2004, J Appl Biomater Biomech, V2, P65
   De Koker S, 2011, CHEM SOC REV, V40, P320, DOI 10.1039/b914943k
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   EHRLER DM, 2000, CLIN ORTHOPAEDICS, V371, P38
   Elhasid R, 2000, BONE MARROW TRANSPL, V26, P1221, DOI 10.1038/sj.bmt.1702701
   Ewers R, 2005, J ORAL MAXIL SURG, V63, P1712, DOI 10.1016/j.joms.2005.08.020
   Fernandes PG, 2011, J PERIODONTOL, V82, P72, DOI 10.1902/jop.2010.100241
   Fischer J, 2011, J CRANIO MAXILL SURG, V39, P54, DOI 10.1016/j.jcms.2010.03.016
   Fleming JE, 2000, ORTHOP CLIN N AM, V31, P357, DOI 10.1016/S0030-5898(05)70156-5
   Fujikawa K, 1995, Dent Mater J, V14, P45
   Fulmer MT, 2002, BIOMATERIALS, V23, P751, DOI 10.1016/S0142-9612(01)00180-6
   Gamradt SC, 2003, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000096814.78689.77
   Gerressen M, 2009, CLIN ORAL IMPLAN RES, V20, P109, DOI 10.1111/j.1600-0501.2008.01619.x
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Handschel J, 2002, BIOMATERIALS, V23, P1689, DOI 10.1016/S0142-9612(01)00296-4
   Handschel J, 2010, TISSUE ENG PT A, V16, P2475, DOI [10.1089/ten.tea.2009.0546, 10.1089/ten.TEA.2009.0546]
   Handschel J, 2009, J BIOMATER APPL, V23, P549, DOI 10.1177/0885328208094305
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   Hertz A, 2007, NANOMEDICINE-UK, V2, P899, DOI 10.2217/17435889.2.6.899
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Hollister S J, 2005, Orthod Craniofac Res, V8, P162, DOI 10.1111/j.1601-6343.2005.00329.x
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Hoshino M, 2006, BIOMATERIALS, V27, P4934, DOI 10.1016/j.biomaterials.2006.04.044
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   Joy A, 2011, LANGMUIR, V27, P1891, DOI 10.1021/la103722m
   Kahle M, 2010, BIO-MED MATER ENG, V20, P371, DOI 10.3233/BME-2010-0650
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kao Solon T, 2007, Oral Maxillofac Surg Clin North Am, V19, P513, DOI 10.1016/j.coms.2007.06.002
   Katz JM, 2009, J BIOMED MATER RES B, V89B, P127, DOI 10.1002/jbm.b.31195
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kirker-Head, 2000, ADV DRUG DELIV REV, V43, P65
   Kirmeier R, 2007, J ORAL MAXIL SURG, V65, P2235, DOI 10.1016/j.jams.2006.11.038
   Klawitter J J, 1974, Acta Orthop Belg, V40, P755
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Kolk A, 2011, BIOMATERIALS, V32, P6850, DOI 10.1016/j.biomaterials.2011.05.071
   KOSTER K, 1976, LANGENBECK ARCH CHIR, V341, P77, DOI 10.1007/BF01262779
   Kubler N, 1994, Fortschr Kiefer Gesichtschir, V39, P28
   Lane JM, 1999, CLIN ORTHOP RELAT R, pS107
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Mardas N, 2010, CLIN ORAL IMPLAN RES, V21, P688, DOI 10.1111/j.1600-0501.2010.01918.x
   Maus U, 2008, J BIOMATER APPL, V22, P559, DOI 10.1177/0885328207083311
   Maus U, 2008, J BIOMED MATER RES B, V85B, P87, DOI 10.1002/jbm.b.30920
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   McAndrew M P, 1988, J Orthop Trauma, V2, P333, DOI 10.1097/00005131-198802040-00011
   McKee Michael D, 2006, J Am Acad Orthop Surg, V14, pS163
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Misch C E, 1993, Implant Dent, V2, P158, DOI 10.1097/00008505-199309000-00003
   Mittelmeier H, 1998, ORTHOPADE, V27, P126
   Naujoks C, 2011, J BIOMATER APPL, V25, P497, DOI 10.1177/0885328209358631
   Nkenke E, 2004, INT J ORAL MAX SURG, V33, P157, DOI 10.1054/ijom.2003.0465
   Nomura T, 2005, J BIOMED MATER RES B, V73B, P29, DOI 10.1002/jbm.b.30201
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   Palmer SH, 1999, J BONE JOINT SURG BR, V81B, P333, DOI 10.1302/0301-620X.81B2.9320
   Parak WJ, 2011, ADV DRUG DELIV REV
   Park JK, 2009, ACTA BIOMATER, V5, P3394, DOI 10.1016/j.actbio.2009.05.019
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Ransford AO, 1998, J BONE JOINT SURG BR, V80B, P13, DOI 10.1302/0301-620X.80B1.7276
   Reddi A. Hari, 1992, Current Opinion in Cell Biology, V4, P850
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   RIPAMONTI U, 1994, J PERIODONTAL RES, V29, P225, DOI 10.1111/j.1600-0765.1994.tb01216.x
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Rupprecht S, 2007, J BIOMED MATER RES B, V83B, P314, DOI 10.1002/jbm.b.30797
   Sandhu HS, 2001, EUR SPINE J, V10, pS122, DOI 10.1007/s005860100303
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P505
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schmidmaier G, 2007, INJURY, V38, pS35, DOI 10.1016/S0020-1383(08)70007-X
   Schnurer SM, 2003, ORTHOPADE, V32, P2, DOI 10.1007/s00132-002-0407-9
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Smeets Ralf, 2009, Head Face Med, V5, P13, DOI 10.1186/1746-160X-5-13
   Smeets R, 2009, ORAL SURG ORAL MED O, V108, pE3, DOI 10.1016/j.tripleo.2009.05.025
   SPECTOR M, 1992, ORTHOP CLIN N AM, V23, P211
   Springer ING, 2004, CLIN ORAL IMPLAN RES, V15, P205, DOI 10.1111/j.1600-0501.2004.00976.x
   Swiontkowski M, 1999, LANCET S1, V353, pS128
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Takagi S, 2001, J BIOMED MATER RES, V58, P36, DOI 10.1002/1097-4636(2001)58:1<36::AID-JBM50>3.3.CO;2-R
   Tang ZB, 2011, J TISSUE ENG REGEN M
   TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017
   TULI SM, 1978, J BONE JOINT SURG BR, V60, P116
   URIST MR, 1981, CLIN ORTHOP RELAT R, P97
   Vaccaro Alexander R, 2002, Spine J, V2, P206, DOI 10.1016/S1529-9430(02)00180-8
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
   Wang W, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065009
   Warnke PH, 2009, TISSUE ENG PART C-ME, V15, P115, DOI 10.1089/ten.tec.2008.0288
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
   Xu HHK, 2009, DENT MATER, V25, P535, DOI 10.1016/j.dental.2008.10.009
NR 124
TC 155
Z9 165
U1 2
U2 103
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD DEC
PY 2012
VL 40
IS 8
BP 706
EP 718
DI 10.1016/j.jcms.2012.01.002
PG 13
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 054PG
UT WOS:000312355100014
PM 22297272
DA 2018-10-19
ER

PT J
AU Kvalem, HE
   Brantsaeter, AL
   Meltzer, HM
   Stigum, H
   Thomsen, C
   Haugen, M
   Alexander, J
   Knutsen, HK
AF Kvalem, Helen Engelstad
   Brantsaeter, Anne Lise
   Meltzer, Helle Margrete
   Stigum, Hein
   Thomsen, Cathrine
   Haugen, Margaretha
   Alexander, Jan
   Knutsen, Helle K.
TI Development and validation of prediction models for blood concentrations
   of dioxins and PCBs using dietary intakes
SO ENVIRONMENT INTERNATIONAL
LA English
DT Article
DE Dioxin; PCB; Blood concentrations; Prediction; Validation; Dietary
   exposure
ID POLYBROMINATED DIPHENYL ETHERS; TOXIC EQUIVALENCY FACTORS;
   POLYCHLORINATED-BIPHENYLS; CHEMICAL CONTAMINANTS; STATISTICAL-METHODS;
   ASSESSING AGREEMENT; FISH CONSUMPTION; SERUM DIOXIN; EXPOSURE; HEALTH
AB Background: Dioxins and PCBs accumulate in the food chain and might exert toxic effects in animals and humans. In large epidemiologic studies, exposure estimates of these compounds based on analyses of biological material might not be available or affordable.
   Objectives:To develop and then validate models for predicting concentrations of dioxins and PCBs in blood using a comprehensive food frequency questionnaire and blood concentrations.
   Methods: Prediction models were built on data from one study (n = 195), and validated in an independent study group (n = 66). We used linear regression to develop predictive models for dioxins and PCBs, both sums of congeners and 33 single congeners (7 and 10 polychlorinated dibenzo-p-dioxins and furans (PCDDs/PCDFs), 12 dioxin-like polychlorinated biphenyls (PCBs: 4 non-ortho and 8 mono-ortho), sum of all the 29 dioxin-like compounds (total TEQ) and sum of 4 non dioxin-like PCBs (Sigma CB-101, 138, 153, 183 = PCB4). We used the blood concentration and dietary intake of each of the above as dependent and independent variables, while sex, parity, age, place of living, smoking status, energy intake and education were covariates. We validated the models in a new study population comparing the predicted blood concentrations with the measured blood concentrations using correlation coefficients and Weighted Kappa (K-w) as measures of agreement, considering K-w > 0.40 as successful prediction.
   Results: The models explained 78% (sum dioxin-like compounds), 76% (PCDDs), 76% (PCDFs), 74% (no-PCBs), 69% (mo-PCBs), 68% (PCB4) and 63% (CB-153) of the variance. In addition to dietary intake, age and sex were the most important covariates. The predicted blood concentrations were highly correlated with the measured values, with r = 0.75 for dl-compounds 0.70 for PCB4, (p<0.001) and 0.66 (p<0.001) for CB-153. K-w was 0.68 for sum dl-compounds 0.65 for both PCB4 and CB-153. Out of 33 congeners 16 (13 dl-compounds and 3 ndl PCBs) had K-w > 0.40.
   Conclusions: The models developed had high power to predict blood levels of dioxins and PCBs and to correctly rank subjects according to high or low exposure based on dietary intake and demographic information. These models underline the value of dietary intake data for use in investigations of associations between dioxin and PCB exposure and health outcomes in large epidemiological studies with limited biomaterial for chemical analysis. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Kvalem, Helen Engelstad; Brantsaeter, Anne Lise; Meltzer, Helle Margrete; Stigum, Hein; Thomsen, Cathrine; Haugen, Margaretha; Alexander, Jan; Knutsen, Helle K.] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Kvalem, Helen Engelstad] Bjorknes Coll, Oslo, Norway.
RP Kvalem, HE (reprint author), Dept Food Safety & Nutr MIME, Div Environm Med, POB 4404 Nydalen, N-0403 Oslo, Norway.
EM helen.engelstad@fhi.no
RI Brantsaeter, Anne Lise/H-7014-2016
OI Brantsaeter, Anne Lise/0000-0001-6315-7134; Meltzer, Helle
   Margrete/0000-0002-3591-7017; Knutsen, Helle Katrine/0000-0003-2041-8917
FU European Commission [016320]
FX We express our thanks to the participants for answering extensive
   questionnaires and donating biological material, and to Bryndis Eva
   Birgisdottir for assistance with exposure assessments. This work was
   financially supported by the European Commission, 6th Framework
   Programme, Priority 5 on Food Quality and Safety (FOOD Contract No.
   016320 Integrated Project).
CR Altman DG, 1991, PRACTICAL STAT MED R
   Arrebola JP, 2010, ENVIRON INT, V36, P705, DOI 10.1016/j.envint.2010.05.004
   BLAND JM, 1986, LANCET, V1, P307
   Brantsaeter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x
   Committee Scientific, 2001, OP SCF RISK ASS DIOX
   EFSA, 2005, EFSA J, V284, P1, DOI DOI 10.2903/J.EFSA.2005.284
   Garabrant DH, 2009, ENVIRON HEALTH PERSP, V117, P818, DOI 10.1289/ehp.11779
   Giovannucci E, 2006, J NATL CANCER I, V98, P451, DOI 10.1093/jnei/djj101
   Grimvall E, 1997, ARCH ENVIRON CON TOX, V32, P329, DOI 10.1007/s002449900193
   Haug LS, 2010, ENVIRON INT, V36, P772, DOI 10.1016/j.envint.2010.05.016
   Humblet O, 2010, ENVIRON SCI TECHNOL, V44, P5633, DOI 10.1021/es100976j
   Jain RB, 2010, CHEMOSPHERE, V79, P243, DOI 10.1016/j.chemosphere.2010.02.013
   Jakobsson U, 2005, SCAND J CARING SCI, V19, P427, DOI 10.1111/j.1471-6712.2005.00368.x
   Johansson L, 1998, AM J CLIN NUTR, V68, P266
   Knutsen HK, 2011, MOL NUTR FOOD RES, V55, P772, DOI 10.1002/mnfr.201000243
   Kvalem HE, 2009, MOL NUTR FOOD RES, V53, P1438, DOI 10.1002/mnfr.200800462
   Landi MT, 1998, ENVIRON HEALTH PERSP, V106, P273
   Landrigan PJ, 2002, ENVIRON HEALTH PERSP, V110, pA313, DOI 10.1289/ehp.021100313
   Liem AKD, 2000, FOOD ADDIT CONTAM, V17, P241, DOI 10.1080/026520300283324
   Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441
   Llobet JM, 2008, TOXICOL LETT, V178, P117, DOI 10.1016/j.toxlet.2008.02.012
   Milbrath MO, 2009, ENVIRON HEALTH PERSP, V117, P417, DOI 10.1289/ehp.11781
   Perello G, 2012, FOOD CHEM TOXICOL, V50, P399, DOI 10.1016/j.fct.2011.06.077
   Safe S, 2001, TOXICOL LETT, V120, P1, DOI 10.1016/S0378-4274(01)00301-0
   Thomsen C, 2008, MOL NUTR FOOD RES, V52, P228, DOI 10.1002/mnfr.200700123
   Thomsen C, 2007, J CHROMATOGR B, V846, P252, DOI 10.1016/j.jchromb.2006.09.011
   Thomsen C, 2011, ENVIRON SCI TECHNOL, V45, P3192, DOI 10.1021/es200682w
   Turunen AW, 2010, EUR J CLIN NUTR, V64, P313, DOI 10.1038/ejcn.2009.147
   Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775
   Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055
   VKM, 2008, OP PAN CONT NORW SCI
   Wigle DT, 2008, J TOXICOL ENV HEAL B, V11, P373, DOI 10.1080/10937400801921320
NR 32
TC 10
Z9 11
U1 1
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0160-4120
J9 ENVIRON INT
JI Environ. Int.
PD DEC 1
PY 2012
VL 50
BP 15
EP 21
DI 10.1016/j.envint.2012.09.003
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 048PR
UT WOS:000311924900003
PM 23032644
DA 2018-10-19
ER

PT J
AU Lewis, R
   Lunniss, PJ
   Hammond, TM
AF Lewis, R.
   Lunniss, P. J.
   Hammond, T. M.
TI Novel biological strategies in the management of anal fistula
SO COLORECTAL DISEASE
LA English
DT Review
DE Anal fistula; fistula in ano; plug; glue; implant; biomaterial
ID ACELLULAR DERMAL MATRIX; STEM-CELL TRANSPLANTATION; ADVANCEMENT FLAP
   REPAIR; CORE-OUT FISTULECTOMY; PERIANAL FISTULAS; IN-ANO;
   EXTRACELLULAR-MATRIX; CROHNS-DISEASE; TISSUE RECONSTRUCTION;
   RECTOVAGINAL FISTULA
AB Background The mostly widely studied biomaterials for the sphincter sparing treatment of anal fistulas are fibrin glue and the anal fistula plug (AFP). However their overall mean clinical success is only 5060%. As the understanding of the pathology of anal fistula, wound healing and the host response to materials has improved, so new biological sphincter-sparing strategies have been developed. The aim of this review is to assess the safety and efficacy of these novel techniques. Method PubMed, the Cochrane database and EMBASE were independently searched. All studies that investigated the potential of a biomaterial (defined as any synthetic or biologically derived substance in contact with host tissue) to augment the healing of anal fistula without sphincter division were included. Studies solely describing the role of fibrin glue or an AFP were excluded. Data extraction included type of material, fistula aetiology, treatment of the primary tract, fistula healing, incontinence, duration of follow-up and any specific complications. Systematic quality assessment of the included articles was performed. Results Twenty-three articles were finally selected for review. These included a variety of biological and synthetic systems that were employed to deliver selected components of the extracellular matrix, growth factors, cytokines, stem cells or drugs to the fistula tract. Conclusion To date no study matches fistulotomy with regard to long-term fistula eradication rate. This is probably due to implant extrusion, inadequate track preparation or an unsuitable material. Future techniques need to address all these issues to ensure success. Success should be validated by MRI or long-term follow-up.
C1 [Hammond, T. M.] St Marks Hosp, Harrow HA1 3UJ, Middx, England.
   [Hammond, T. M.] Acad Inst, Harrow HA1 3UJ, Middx, England.
   [Lewis, R.; Lunniss, P. J.] Homerton Univ Hosp, Dept Surg, London, England.
   [Lunniss, P. J.] Univ London, Queen Mary Coll, Barts & London Med Sch, Acad Surg Unit, London WC1E 7HU, England.
RP Lewis, R (reprint author), St Marks Hosp, Level 4,Northwick Pk,Watford Rd, Harrow HA1 3UJ, Middx, England.
EM t.hammond@qmul.ac.uk
CR Abbas MA, 2008, DIS COLON RECTUM, V51, P1155, DOI 10.1007/s10350-008-9332-2
   Alexander SM, 2008, TECH COLOPROCTOL, V12, P225, DOI 10.1007/s10151-008-0425-7
   Amrani S, 2008, GASTROEN CLIN BIOL, V32, P946, DOI 10.1016/j.gcb.2008.09.003
   Ascanelli S, 2007, INT J COLORECTAL DIS, V22, P1135, DOI 10.1007/s00384-006-0141-6
   Ba-bai-ke-re MMTJA, 2010, WORLD J GASTROENTERO, V16, P3279, DOI 10.3748/wjg.v16.i26.3279
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Barillari P, 2006, INT J COLORECTAL DIS, V21, P791, DOI 10.1007/s00384-006-0090-0
   Bellows CF, 2006, EXPERT REV MED DEVIC, V3, P657, DOI 10.1586/17434440.3.5.657
   Blaker JJ, 2008, ALIMENT PHARM THER, V28, P614, DOI 10.1111/j.1365-2036.2008.03773.x
   Buchanan GN, 2003, DIS COLON RECTUM, V46, P1167, DOI 10.1097/01.DCR.0000084408.85802.A2
   Buchberg B, 2010, AM SURGEON, V76, P1150
   Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841
   Cirocchi R, 2010, ANN ITAL CHIR, V81, P349
   de la Portilla F, 2007, DIS COLON RECTUM, V50, P218, DOI 10.1007/s10350-006-0799-4
   de la Portilla F, 2011, DIS COLON RECTUM, V54, P1419, DOI 10.1097/DCR.0b013e31822c4d59
   de la Portilla F, 2010, DIS COLON RECTUM, V53, P1220, DOI 10.1007/DCR.0b013e3181e10dbf
   Dudukgian H, 2011, WORLD J GASTROENTERO, V17, P3292, DOI 10.3748/wjg.v17.i28.3292
   Ellis CN, 2008, DIS COLON RECTUM, V51, P1084, DOI 10.1007/s10350-008-9339-8
   Ellis CN, 2010, DIS COLON RECTUM, V53, P1652, DOI 10.1007/DCR.0b013e3181f2e9cd
   Ellis CN, 2010, DIS COLON RECTUM, V53, P1361, DOI 10.1007/DCR.0b013e3181ec4470
   Esmaeili M., 2012, Journal of Medical Engineering & Technology, V36, P67, DOI 10.3109/03091902.2011.638966
   Foong KS, 2010, TISSUE ENG PART C-ME, V16, P855, DOI [10.1089/ten.tec.2009.0599, 10.1089/ten.TEC.2009.0599]
   Fortelny RH, 2007, SURG ENDOSC, V21, P1781, DOI 10.1007/s00464-007-9243-7
   Garcia-Aguilar J, 2000, DIS COLON RECTUM, V43, P1206, DOI 10.1007/BF02237422
   Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-0052-6
   Garcia-Olmo D, 2003, INT J COLORECTAL DIS, V18, P451, DOI 10.1007/s00384-003-0490-3
   Garcia-Olmo D, 2010, CASE REP MED, DOI 10.1155/2010/961758
   Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487
   GarciaAguilar J, 1996, DIS COLON RECTUM, V39, P723, DOI 10.1007/BF02054434
   Garg P, 2010, COLORECTAL DIS, V12, P965, DOI 10.1111/j.1463-1318.2009.01933.x
   Ge Bu-jun, 2002, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V16, P345
   Ge LP, 2009, BURNS, V35, P46, DOI 10.1016/j.burns.2008.05.007
   Guadalajara H, 2012, INT J COLORECTAL DIS, V27, P595, DOI 10.1007/s00384-011-1350-1
   Hadorn DC, 1996, J CLIN EPIDEMIOL, V49, P749, DOI 10.1016/0895-4356(96)00019-4
   Hammond TM, 2008, BRIT J SURG, V95, P438, DOI 10.1002/bjs.5883
   Hammond T M, 2004, Colorectal Dis, V6, P308, DOI 10.1111/j.1463-1318.2004.00676.x
   Hammond TM, 2011, COLORECTAL DIS, V13, P94, DOI 10.1111/j.1463-1318.2009.02087.x
   Han JG, 2011, DIS COLON RECTUM, V54, P1412, DOI 10.1097/DCR.0b013e31822c5398
   Han JG, 2009, J AM COLL SURGEONS, V208, P1099, DOI 10.1016/j.jamcollsurg.2009.02.052
   Himpson RC, 2007, COMP CLIN PATHOL, V16, P9
   Himpson RC, 2009, DIS COLON RECTUM, V52, P602, DOI 10.1007/DCR.0b013e31819ece3e
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   Jacob TJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006319.pub2
   Jain SK, 2008, INT J COLORECTAL DIS, V23, P355, DOI 10.1007/s00384-007-0417-5
   KATZ AR, 1985, SURG GYNECOL OBSTET, V161, P213
   Keshaw H, 2010, INFLAMM BOWEL DIS, V16, P870, DOI 10.1002/ibd.21137
   Kubota M, 2010, PEDIATR SURG INT, V26, P1037, DOI 10.1007/s00383-010-2664-8
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   LUNNISS PJ, 1994, BRIT J SURG, V81, P1382, DOI 10.1002/bjs.1800810947
   Lunniss PJ, 1998, SEMIN COLON RECTAL S, V9, P192
   Meinero P, 2011, TECH COLOPROCTOL, V15, P417, DOI 10.1007/s10151-011-0769-2
   Miklos J R, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P405, DOI 10.1007/s001920050069
   Mitalas Litza E, 2010, Dis Colon Rectum, V53, P1713, DOI 10.1007/DCR.0b013e3181f569f8
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Queralto M, 2010, GASTROEN CLIN BIOL, V34, P477, DOI 10.1016/j.gcb.2009.12.010
   Ratto C, 2012, COLORECTAL DIS, V14, pe264, DOI 10.1111/j.1463-1318.2012.02964.x
   Schwandner O, 2009, TECH COLOPROCTOL, V13, P135, DOI 10.1007/s10151-009-0470-x
   Schwandner O, 2009, SURG INNOV, V16, P162, DOI 10.1177/1553350609338041
   Shawki S, 2011, WORLD J GASTROENTERO, V17, P3277, DOI 10.3748/wjg.v17.i28.3277
   Shelton AA, 2006, DIS COLON RECTUM, V49, P1454, DOI 10.1007/s10350-006-0619-x
   Shevchenko RV, 2008, WOUND REPAIR REGEN, V16, P198, DOI 10.1111/j.1524-475X.2008.00360.x
   Sileri P, 2011, INT J COLORECTAL DIS, V26, P345, DOI 10.1007/s00384-010-1066-7
   Silverman R P, 2004, Hernia, V8, P336, DOI 10.1007/s10029-004-0241-6
   Soiderer EE, 2004, J SURG RES, V118, P161, DOI 10.1016/S0022-4804(03)00352-4
   Soltani A, 2010, DIS COLON RECTUM, V53, P486, DOI 10.1007/DCR.0b013e3181ce8b01
   Song WL, 2008, WORLD J GASTROENTERO, V14, P4791, DOI 10.3748/wjg.14.4791
   Tasci I, 2003, DIS COLON RECTUM, V46, P1566, DOI 10.1097/01.DCR.0000093632.32408.53
   van Koperen PJ, 2008, INT J COLORECTAL DIS, V23, P697, DOI 10.1007/s00384-008-0460-x
   van Onkelen RS, 2012, DIS COLON RECTUM, V55, P163, DOI 10.1097/DCR.0b013e31823c0f74
NR 69
TC 16
Z9 17
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-8910
EI 1463-1318
J9 COLORECTAL DIS
JI Colorectal Dis.
PD DEC
PY 2012
VL 14
IS 12
BP 1445
EP 1455
DI 10.1111/j.1463-1318.2012.03192.x
PG 11
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 039NJ
UT WOS:000311253000010
PM 22882376
DA 2018-10-19
ER

PT J
AU de Viteri, VS
   Barandika, MG
   de Gopegui, UR
   Bayon, R
   Zubizarreta, C
   Fernandez, X
   Igartua, A
   Agullo-Rueda, F
AF Saenz de Viteri, V.
   Barandika, M. G.
   Ruiz de Gopegui, U.
   Bayon, R.
   Zubizarreta, C.
   Fernandez, X.
   Igartua, A.
   Agullo-Rueda, F.
TI Characterization of Ti-C-N coatings deposited on Ti6Al4V for biomedical
   applications
SO JOURNAL OF INORGANIC BIOCHEMISTRY
LA English
DT Article
DE Ti6Al4V; Biomaterials; Ti-C-N; Fretting; Friction coefficient
ID ION-IMPLANTATION; WEAR; TI-6AL-4V; ALUMINUM; FILMS
AB Ti6Al4V alloy is the most commonly employed implant material for orthopedic replacements due to its good mechanical properties close to those of bones, biocompatibility and its good corrosion resistance in biological media. Nevertheless, it does not exhibit good wear resistance, showing friction and wear even with soft tissues. This latter feature can lead to a premature failure of the implant with the subsequent component replacement. Therefore, a system with good tribological resistance is required for several medical applications. One possible alternative to solve tribological problems consists of protecting the alloy surface by means of biocompatible Ti-C-N coatings. In this work, five types of metallic Ti-C-N coatings deposited by physical vapor deposition (PVD) cathodic arc method on Ti6Al4V substrate have been studied. Different deposition conditions have been analyzed, and the superficial properties of films have been characterized. Additionally, tribological response of these films have been determined and compared with the substrate one under fretting conditions in simulated body fluid. The results indicate that Ti-C-N coatings improve the general response of the biomaterial. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Saenz de Viteri, V.; Ruiz de Gopegui, U.; Bayon, R.; Zubizarreta, C.; Fernandez, X.; Igartua, A.] IK4 Tekniker, Eibar 20600, Spain.
   [Barandika, M. G.] Univ Basque Country, Fac Farm, Dept Quim Inorgan, Vitoria 01006, Spain.
   [Agullo-Rueda, F.] Inst Ciencia Mat Madrid ICMM CSIC, Madrid 28049, Spain.
RP de Viteri, VS (reprint author), IK4 Tekniker, Calle Inaki Goenaga 5, Eibar 20600, Spain.
EM vsaenzdeviteri@tekniker.es
RI SGIKER, Cienciometria/A-5759-2012; Agullo-Rueda, Fernando/A-8889-2008;
   Barandika, Gotzone/N-2157-2014
OI Agullo-Rueda, Fernando/0000-0001-9211-1987; Barandika,
   Gotzone/0000-0002-6771-6586
FU Spanish Ministry of Science and Innovation [CSD2008-00023 FUNCOAT];
   Ministerio de Ciencia e Innovacion [MAT2010-15375]; "Gobierno Vasco"
   (Basque University) [IT-177-07]
FX The authors acknowledge financial support from the Spanish Ministry of
   Science and Innovation obtained in the project: CSD2008-00023 FUNCOAT
   (in frames of the CONSOLIDER INGENIO-2010 program).; G. B. thanks the
   "Ministerio de Ciencia e Innovacion" (MAT2010-15375) and the "Gobierno
   Vasco" (Basque University System Research Groups, IT-177-07) for their
   financial support. SGIker technical support (MEC, GV/EJ, European Social
   Fund) is also gratefully acknowledged.
CR [Anonymous], 2010, Patent number, Patent No. [WO2010072850 (A1), 2010072850]
   Chandra A, 2011, J MECH BEHAV BIOMED, V4, P1990, DOI 10.1016/j.jmbbm.2011.06.018
   Cheng YH, 2002, J APPL PHYS, V92, P1845, DOI 10.1063/1.1491588
   Dallmiglio M, 2008, J BIOMED MATER RES B, V86B, P407, DOI 10.1002/jbm.b.31034
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Everitt NM, 2009, WEAR, V267, P283, DOI 10.1016/j.wear.2008.12.032
   Farhat ZN, 1996, MAT SCI ENG A-STRUCT, V206, P302, DOI 10.1016/0921-5093(95)10016-4
   Ferrari AC, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155306
   Fukui H, 2004, SURF COAT TECH, V187, P70, DOI 10.1016/j.surfcoat.2004.01.014
   Guoqing L., 2005, THIN SOLID FILMS, V475, P279
   Klein J., 2009, SCIENCE, V232
   KLEIN MV, 1978, PHYS REV B, V17, P1546, DOI 10.1103/PhysRevB.17.1546
   Larry M., 2006, PROC BAYL UNIV MED C, V19, P232
   Lubet J.L., 1986, ASTM, P72
   Ma GJ, 2012, APPL SURF SCI, V258, P3045, DOI 10.1016/j.apsusc.2011.11.034
   Magaziner RS, 2009, WEAR, V267, P368, DOI 10.1016/j.wear.2008.12.083
   Osterle W, 2008, WEAR, V264, P505, DOI 10.1016/j.wear.2007.04.001
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Payling R, 2002, SURF INTERFACE ANAL, V33, P472, DOI 10.1002/sia.1233
   Raman Ganesh Sundara S, 2009, MECH ENG J J ENG, V223, P227
   Stuart B, 2008, J BIOMED MAT RES A
   Sylvestre M, 2010, SURF COAT TECH, V205, P1374, DOI 10.1016/j.surfcoat.2010.08.117
   Wendler BG, 2008, J ACHIEVEMENTS MAT M, V26, P207
   WILLIAMS JM, 1985, MATER SCI ENG, V69, P237, DOI 10.1016/0025-5416(85)90398-2
   Yetim AF, 2010, SURF COAT TECH, V205, P320, DOI 10.1016/j.surfcoat.2010.06.048
   Zhang L, 2008, DIAM RELAT MATER, V17, P1922, DOI 10.1016/j.diamond.2008.04.011
   Zheng Yufeng, 2008, BIOMED MATER, V3
NR 28
TC 21
Z9 21
U1 0
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0162-0134
EI 1873-3344
J9 J INORG BIOCHEM
JI J. Inorg. Biochem.
PD DEC
PY 2012
VL 117
BP 359
EP 366
DI 10.1016/j.jinorgbio.2012.09.012
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear
SC Biochemistry & Molecular Biology; Chemistry
GA 047EA
UT WOS:000311819300044
PM 23062699
DA 2018-10-19
ER

PT J
AU Bardajee, GR
   Hooshyar, Z
   Rezanezhad, H
AF Bardajee, Ghasem R.
   Hooshyar, Zari
   Rezanezhad, Habib
TI A novel and green biomaterial based silver nanocomposite hydrogel:
   Synthesis, characterization and antibacterial effect
SO JOURNAL OF INORGANIC BIOCHEMISTRY
LA English
DT Article
DE Silver nanoparticles; Drug delivery; Tetracycline hydrochloride;
   Hydrogel; Antibacterial effect
ID PALLADIUM NANOPARTICLES; IN-VITRO; TETRACYCLINE; SALEP; BIOSYNTHESIS
AB In the present study, we report a facile and eco-friendly method for the preparation of a novel silver nanocomposite hydrogel (SNH) based on poly(acrylic acid) (PM) grafted onto salep as a water soluble polysaccharide backbone. The presence of inorganic silver nanoparticles (nano-Ag) in the hydrogel was confirmed by thermo-gravimetric (TG) analysis. The TEM images illustrated the presence of embedded nano-Ag throughout the hydrogel matrix. In addition, the transmission electron microscopy (TEM) images showed that the formed nano-Ag had an average particle size of 5-10 nm. The potential of obtained SNH was examined for Tetracycline hydrochloride (TH) release in simulated colon conditions. Lastly, the in vitro antibacterial properties of the obtained optimum sample were successfully evaluated against gram-negative and gram-positive bacteria. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Bardajee, Ghasem R.; Hooshyar, Zari; Rezanezhad, Habib] Payame Noor Univ, Dept Chem, Tehran, Iran.
RP Bardajee, GR (reprint author), Payame Noor Univ, Dept Chem, POB 19395-3697, Tehran, Iran.
EM rezanejad@pnu.ac.ir
FU PNU; INSF
FX We are grateful to the PNU and INSF for funding this work.
CR Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016
   Dubas ST, 2011, COLLOID SURFACE A, V380, P25, DOI 10.1016/j.colsurfa.2011.01.037
   Farhoosh R, 2007, FOOD HYDROCOLLOID, V21, P660, DOI 10.1016/j.foodhyd.2006.07.021
   Figuerola A, 2010, PHARMACOL RES, V62, P126, DOI 10.1016/j.phrs.2009.12.012
   Fontenoy C., 2011, PHARMACIEN HOSP, V46, pe1
   Fritz JW, 2007, FOOD CHEM, V105, P1297, DOI 10.1016/j.foodchem.2007.03.047
   Galvez N, 2009, SOLID STATE SCI, V11, P754, DOI 10.1016/j.solidstatesciences.2008.04.026
   Gils PS, 2010, INT J BIOL MACROMOL, V46, P237, DOI 10.1016/j.ijbiomac.2009.12.014
   Guzman M, 2012, NANOMED-NANOTECHNOL, V8, P37, DOI 10.1016/j.nano.2011.05.007
   Hsieh CT, 2011, J POWER SOURCES, V196, P6055, DOI 10.1016/j.jpowsour.2011.03.087
   Jovanovic Z, 2011, RADIAT PHYS CHEM, V80, P1208, DOI 10.1016/j.radphyschem.2011.06.005
   Kaplan D.L., 1998, BIOPOLYMERS RENEWABL
   Khan A, 2011, COLLOID SURFACE A, V377, P356, DOI 10.1016/j.colsurfa.2011.01.042
   Kim SG, 2009, ADV POWDER TECHNOL, V20, P94, DOI 10.1016/j.apt.2008.10.006
   KTISTIS G, 1991, PHARMAZIE, V46, P55
   Madhumathi K, 2009, INT J BIOL MACROMOL, V45, P12, DOI 10.1016/j.ijbiomac.2009.03.011
   Omole MA, 2007, APPL CATAL B-ENVIRON, V76, P158, DOI 10.1016/j.apcatb.2007.05.018
   Park JH, 2007, CURR APPL PHYS, V7, P349, DOI 10.1016/j.cap.2006.09.006
   Pinto RJB, 2009, ACTA BIOMATER, V5, P2279, DOI 10.1016/j.actbio.2009.02.003
   Pinto VV, 2010, COLLOID SURFACE A, V364, P19, DOI 10.1016/j.colsurfa.2010.04.015
   Pourjavadi A., 2008, STARCH, V60, P468
   Pourjavadi A, 2009, J APPL POLYM SCI, V112, P2625, DOI 10.1002/app.29831
   Rao JP, 2011, PROG POLYM SCI, V36, P887, DOI 10.1016/j.progpolymsci.2011.01.001
   Reinhold C, 2006, NANO TODAY, V1, P15, DOI 10.1016/S1748-0132(06)70108-6
   Reis CP, 2006, NANOMED-NANOTECHNOL, V2, P8, DOI 10.1016/j.nano.2005.12.003
   Rieux A., 2006, J CONTROL RELEASE, V116, P1, DOI DOI 10.1016/J.JCONREL.2006.08.013
   Roberts MC, 1996, FEMS MICROBIOL REV, V19, P1, DOI 10.1111/j.1574-6976.1996.tb00251.x
   Tang B., 2010, J COLLOID INTERF SCI, V356, P513
   Vasiliev AN, 2009, SURF COAT TECH, V203, P2841, DOI 10.1016/j.surfcoat.2009.02.019
   Veerasamy R, 2011, J SAUDI CHEM SOC, V15, P113, DOI 10.1016/j.jscs.2010.06.004
   Vidal A, 2007, BIOORGAN MED CHEM, V15, P2368, DOI 10.1016/j.bmc.2007.01.026
   Vimala K, 2009, CARBOHYD POLYM, V75, P463, DOI 10.1016/j.carbpol.2008.08.009
   Vons VA, 2010, INT J HYDROGEN ENERG, V35, P5479, DOI 10.1016/j.ijhydene.2010.02.118
   Xiang DX, 2011, J VIROL METHODS, V178, P137, DOI 10.1016/j.jviromet.2011.09.003
   Yallapu MM, 2011, BIOMATERIALS, V32, P1890, DOI 10.1016/j.biomaterials.2010.11.028
   Zheng DY, 2010, SENSOR ACTUAT B-CHEM, V148, P247, DOI 10.1016/j.snb.2010.04.031
NR 36
TC 35
Z9 35
U1 6
U2 121
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0162-0134
J9 J INORG BIOCHEM
JI J. Inorg. Biochem.
PD DEC
PY 2012
VL 117
BP 367
EP 373
DI 10.1016/j.jinorgbio.2012.06.012
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear
SC Biochemistry & Molecular Biology; Chemistry
GA 047EA
UT WOS:000311819300045
PM 22818024
DA 2018-10-19
ER

PT J
AU Ozkaya, O
   Egemen, O
   Yesilada, A
   Sakiz, D
   Ugurlu, K
AF Ozkaya, Ozay
   Egemen, Onur
   Yesilada, Aysin
   Sakiz, Damlanur
   Ugurlu, Kemal
TI The effect of nonpreserved human amniotic membrane on the survival of
   ischaemic skin flaps in rats
SO JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY
LA English
DT Article
DE Ischaemic skin flaps; Human amniotic membrane; Flap survival
ID IMPROVES SURVIVAL; OCULAR SURFACE; FREE-RADICALS; TRANSPLANTATION;
   ENHANCEMENT; MODEL; RECONSTRUCTION; INVOLVEMENT; DEFECTS; SURGERY
AB Objective: Random-pattern skin flaps are used widely in plastic surgery, but necrosis resulting from ischaemia in the distal sections of the flap is a serious problem. Free oxygen radicals and the accumulation of increased neutrophil granulocytes play important roles in tissue injury and may lead to partial or complete necrosis of the flap. Amniotic membrane is a biomaterial used widely in clinical settings to prevent the infiltration and activation of leucocytes. The aim of this study was to test the effects of amniotic membrane on the survival of ischaemic skin flaps in rats.
   Methods: A total of 32 male rats were divided randomly into four groups of eight, according to the procedure to be tested: flap-only (F), flap-amniotic membrane (FA), flap-Tegaderm (R) (FT) and flap-amniotic membrane-Tegaderm (R) (FAT).
   Rectangular, random-pattern, caudally based modified McFarlane skin flaps were elevated at the dorsum of the rats in all four groups. The flap-only group was also the control group; in this group, the flaps were elevated and sutured to their native position. In the FA group, after the flaps were elevated, the amniotic membrane was inserted underneath the undersurface of the flap. In the FT group, after the flaps were elevated, a piece of Tegaderm (R) was inserted underneath the undersurface of the flap. In the FAT group, the amniotic membrane was inserted underneath the undersurface of the flap and the Tegaderm (R) was inserted in the flap donor area. The survival rate of the skin flaps was measured on day 7, and histologic assessments were performed.
   Results: The survival rate of the skin flaps was significantly improved in the FA and FAT groups (67-69%, p < 0.05) compared with the F and FT groups (46-48%, p < 0.05). Histologic analysis showed many more blood vessels and fewer neutrophils in the FA and FAT groups than in the F and FT groups.
   Conclusion: This study showed that amniotic membrane could improve the survival rate of ischaemic skin flaps. (c) 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Ozkaya, Ozay; Egemen, Onur] Okmeydani Training & Res Hosp, Dept Plast Reconstruct & Aesthet Surg, Istanbul, Turkey.
   [Yesilada, Aysin; Ugurlu, Kemal] Sisli Etfal Training & Res Hosp, Dept Plast Reconstruct & Aesthet Surg, Istanbul, Turkey.
   [Sakiz, Damlanur] Sisli Etfal Training & Res Hosp, Dept Pathol, Istanbul, Turkey.
RP Ozkaya, O (reprint author), Okmeydani Training & Res Hosp, Dept Plast Reconstruct & Aesthet Surg, Darulaceze Caddesi,Ana Bina Kat 2, Istanbul, Turkey.
EM oozozay@yahoo.com
CR Alizadeh N, 2004, J SURG RES, V122, P263, DOI 10.1016/j.jss.2004.06.014
   ANGEL MF, 1987, PLAST RECONSTR SURG, V79, P990, DOI 10.1097/00006534-198706000-00025
   ANGEL MF, 1988, PLAST RECONSTR SURG, V81, P233, DOI 10.1097/00006534-198802000-00017
   ANGEL MF, 1986, BRIT J PLAST SURG, V39, P469, DOI 10.1016/0007-1226(86)90115-3
   Cetinkale O, 1998, PLAST RECONSTR SURG, V102, P153, DOI 10.1097/00006534-199807000-00024
   Davis R E, 1999, Arch Facial Plast Surg, V1, P27, DOI 10.1001/archfaci.1.1.27
   de Rotth A, 1940, ARCH OPHTHALMOL-CHIC, V23, P522
   HAMMOND DC, 1993, PLAST RECONSTR SURG, V91, P316, DOI 10.1097/00006534-199302000-00017
   Hart K, 2006, LARYNGOSCOPE, V116, P522, DOI 10.1097/01.mlg.0000200792.67802.3b
   Hijjawi J, 2004, ARCH SURG-CHICAGO, V139, P142, DOI 10.1001/archsurg.139.2.142
   Hsu OK, 2004, PLAST RECONSTR SURG, V113, P2048, DOI 10.1097/01.prs.000121183.79676.de
   IM MJ, 1983, PLAST RECONSTR SURG, V71, P685, DOI 10.1097/00006534-198305000-00020
   Karacal N, 2005, J SURG RES, V124, P134, DOI 10.1016/j.jss.2004.08.035
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Kryger Z, 2000, BRIT J PLAST SURG, V53, P234, DOI 10.1054/bjps.1999.3315
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   Meller D, 2000, OPHTHALMOLOGY, V107, P908
   OKAMOTO Y, 1993, ANN PLAS SURG, V30, P154, DOI 10.1097/00000637-199302000-00010
   Qi Z, 2007, PLAST RECONSTR SURG, V120, P1148, DOI 10.1097/01.prs.0000279524.05541.5b
   Rinsch C, 2001, GENE THER, V8, P523, DOI 10.1038/sj.gt.3301436
   ROHRICH RJ, 1984, PLAST RECONSTR SURG, V73, P943, DOI 10.1097/00006534-198406000-00016
   Shimazaki J, 1997, OPHTHALMOLOGY, V104, P2068, DOI 10.1016/S0161-6420(97)30057-8
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
   Ucakhan OO, 2002, CORNEA, V21, P169, DOI 10.1097/00003226-200203000-00008
   VANHERENDAEL BJ, 1978, AM J OBSTET GYNECOL, V131, P872, DOI 10.1016/S0002-9378(16)33135-0
NR 26
TC 5
Z9 7
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-6815
J9 J PLAST RECONSTR AES
JI J. Plast. Reconstr. Aesthet. Surg.
PD DEC
PY 2012
VL 65
IS 12
BP 1700
EP 1705
DI 10.1016/j.bjps.2012.06.013
PG 6
WC Surgery
SC Surgery
GA 045GA
UT WOS:000311682200030
PM 22770572
DA 2018-10-19
ER

PT J
AU Unterman, SA
   Gibson, M
   Lee, JH
   Crist, J
   Chansakul, T
   Yang, EC
   Elisseeff, JH
AF Unterman, Shimon A.
   Gibson, Matthew
   Lee, Janice H.
   Crist, Joshua
   Chansakul, Thanissara
   Yang, Elaine C.
   Elisseeff, Jennifer H.
TI Hyaluronic Acid-Binding Scaffold for Articular Cartilage Repair
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; IN-SITU; CHONDROGENIC DIFFERENTIATION;
   NEOCARTILAGE FORMATION; LIMB BUD; HYDROGELS; VITRO; MORPHOGENESIS;
   NETWORKS; MATRIX
AB Hyaluronic acid (HA) is an extracellular matrix molecule with multiple physical and biological functions found in many tissues, including cartilage. HA has been incorporated in a number of biomaterial and scaffold systems. However, HA in the material may be difficult to control if it is not chemically modified and chemical modification of HA may negatively impact biological function. In this study, we developed a poly(ethylene glycol) hydrogel with noncovalent HA-binding capabilities and evaluated its ability to support cartilage formation in vitro and in an articular defect model. Chondrogenic differentiation of mesenchymal stem cells encapsulated in the HA-interactive scaffolds containing various amounts of exogenous HA was evaluated. The HA-binding hydrogel without exogenous HA produced the best cartilage as determined by biochemical content (glysocaminoglycan and collagen), histology (Safranin 0 and type II collagen staining), and gene expression analysis for aggrecan, type I collagen, type II collagen, and sox-9. This HA-binding formulation was then translated to an osteochondral defect model in the rat knee. After 6 weeks, histological analysis demonstrated improved cartilage tissue production in defects treated with the HA-interactive hydrogel compared to noninteractive control scaffolds and untreated defects. In addition to the tissue repair in the defect space, the Safranin 0 staining in cartilage tissue surrounding the defect was greater in treatment groups where the HA-binding scaffold was applied. In sum, incorporation of a noncovalent HA-binding functionality into biomaterials provides an ability to interact with local or exogenous HA, which can then impact tissue remodeling and ultimately new tissue production.
C1 [Unterman, Shimon A.; Gibson, Matthew; Lee, Janice H.; Crist, Joshua; Chansakul, Thanissara; Yang, Elaine C.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21231 USA.
   [Unterman, Shimon A.; Gibson, Matthew; Lee, Janice H.; Crist, Joshua; Chansakul, Thanissara; Yang, Elaine C.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Smith Bldg,Rm 5033,400 N Broadway, Baltimore, MD 21231 USA.
EM jhe@jhu.edu
FU National Institutes of Health under Ruth L. Kirschstein National
   Research Service [AG328232]
FX This investigation was supported by the National Institutes of Health
   under Ruth L. Kirschstein National Research Service Award #AG328232. We
   gratefully acknowledge Johns Hopkins A.B. Mass Spectrometry/Proteomic
   Facility for providing the MALDI-TOF spectrometer and the Johns Hopkins
   Department of Chemistry Instrumentation Facility for providing the
   peptide synthesizer.
CR BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Dong YX, 2012, J MATER SCI-MATER M, V23, P25, DOI 10.1007/s10856-011-4496-z
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Graff RD, 2003, BIOTECHNOL BIOENG, V82, P457, DOI 10.1002/bit.10593
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hwang NS, 2011, CELL TISSUE RES, V344, P499, DOI 10.1007/s00441-011-1153-2
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   KULYK WM, 1987, DEV BIOL, V120, P535, DOI 10.1016/0012-1606(87)90256-9
   Lee HJ, 2008, TISSUE ENG PT A, V14, P1843, DOI 10.1089/ten.tea.2007.0204
   Li YC, 2007, DEV BIOL, V305, P411, DOI 10.1016/j.ydbio.2007.02.023
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Modis L, 1990, ORG EXTRACELLULAR MA
   Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   TOOLE BP, 1972, P NATL ACAD SCI USA, V69, P1384, DOI 10.1073/pnas.69.6.1384
   Volpi N, 2009, CURR MED CHEM, V16, P1718, DOI 10.2174/092986709788186138
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Zmolik JM, 2005, J HISTOCHEM CYTOCHEM, V53, P745, DOI 10.1369/jhc.4A6491.2005
   Zustiak SP, 2010, ACTA BIOMATER, V6, P3404, DOI 10.1016/j.actbio.2010.03.040
NR 28
TC 36
Z9 38
U1 6
U2 38
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC
PY 2012
VL 18
IS 23-24
BP 2497
EP 2506
DI 10.1089/ten.tea.2011.0711
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 044DY
UT WOS:000311600800010
PM 22724901
OA Green Published
DA 2018-10-19
ER

PT J
AU Rochford, ETJ
   Richards, RG
   Moriarty, TF
AF Rochford, E. T. J.
   Richards, R. G.
   Moriarty, T. F.
TI Influence of material on the development of device-associated infections
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Review
DE Bacterial adhesion; biocompatibility; macrophage; preclinical testing;
   surface chemistry; surface topography
ID VASCULAR CATHETER MATERIAL; FOREIGN-BODY INFECTION; IN-VIVO;
   STAPHYLOCOCCUS-EPIDERMIDIS; LOCAL INFECTION; SURFACE-ROUGHNESS;
   STAINLESS-STEEL; FIXATION IMPLANTS; FRACTURE FIXATION; BIOFILM FORMATION
AB The use of implanted devices in modern orthopaedic surgery has greatly improved the quality of life for an increasing number of patients, by facilitating the rapid and effective healing of bone after traumatic fractures, and restoring mobility after joint replacement. However, the presence of an implanted device results in an increased susceptibility to infection for the patient, owing to the creation of an immunologically compromised zone adjacent to the implant. Within this zone, the ability of the host to clear contaminating bacteria may be compromised, and this can lead to biofilm formation on the surface of the biomaterial. Currently, there are only limited data on the mechanisms behind this increased risk of infection and the role of material choice. The impacts of implant material on bacterial adhesion, immune response and infection susceptibility have been investigated individually in numerous preclinical in vitro and in vivo studies. These data provide an indication that material choice does have an impact on infection susceptibility; however, the clinical implications remain to be clearly determined.
C1 [Rochford, E. T. J.; Richards, R. G.; Moriarty, T. F.] AO Fdn, AO Res Inst Davos, CH-7270 Davos, Switzerland.
RP Moriarty, TF (reprint author), AO Fdn, AO Res Inst Davos, Clavadelerstr 8,Davos Pl, CH-7270 Davos, Switzerland.
EM fintan.moriarty@aofoundation.org
RI Richards, Robert/I-8235-2015
OI Richards, Robert/0000-0002-7778-2480; Moriarty,
   Fintan/0000-0003-2307-0397
CR Anderson JM, 2000, INFECT ASS INDWELLIN, P89, DOI 10.1128/9781555818067.ch5
   ANDRIOLE VT, 1973, J BONE JOINT SURG AM, VA 55, P1511, DOI 10.2106/00004623-197355070-00019
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   Arens S, 1999, J ORTHOP TRAUMA, V13, P470, DOI 10.1097/00005131-199909000-00002
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051
   Boelens JJ, 2000, INFECT IMMUN, V68, P6924, DOI 10.1128/IAI.68.12.6924-6931.2000
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Broekhuizen CAN, 2008, J BIOMED MATER RES A, V85A, P498, DOI 10.1002/jbm.a.31528
   Brooks B, 2012, BIOMATERIAL IN PRESS
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   Edwards KJ, 1998, AM MINERAL, V83, P1444, DOI 10.2138/am-1998-11-1233
   Fernandez ICS, 2011, EUR CELLS MATER, V21, P73, DOI 10.22203/eCM.v021a06
   Gomez-Barrena E, 2012, J ORTHOP RES
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Hayes JS, 2010, EXPERT REV MED DEVIC, V7, P843, DOI 10.1586/ERD.10.53
   Hayes JS, 2010, EXPERT REV MED DEVIC, V7, P131, DOI [10.1586/erd.09.55, 10.1586/ERD.09.55]
   HENRY SL, 1990, J TRAUMA, V30, P1231, DOI 10.1097/00005373-199010000-00007
   Hetrick EM, 2007, BIOMATERIALS, V28, P1948, DOI 10.1016/j.biomaterials.2007.01.006
   Hosman AH, 2012, J ORTHOP RES, V30, P341, DOI 10.1002/jor.21526
   Hosman AH, 2009, J BIOMED MATER RES A, V88A, P711, DOI 10.1002/jbm.a.31922
   Hosoya N, 2003, J DENT, V31, P543, DOI 10.1016/S0300-5712(03)00109-X
   Hudetz D, 2008, CLIN MICROBIOL INFEC, V14, P1135, DOI 10.1111/j.1469-0691.2008.02096.x
   Jakobsen SS, 2007, EUR CELLS MATER, V14, P45, DOI 10.22203/eCM.v014a05
   Kinnari TJ, 2010, CLIN MICROBIOL INFEC, V16, P1036, DOI 10.1111/j.1469-0691.2009.02995.x
   Kollef MH, 2008, JAMA-J AM MED ASSOC, V300, P805, DOI 10.1001/jama.300.7.805
   Lacey DC, 2009, J ORTHOP RES, V27, P1481, DOI 10.1002/jor.20914
   Majumdar P, 2009, J COMB CHEM, V11, P1115, DOI 10.1021/cc900114e
   Marosok R, 1996, J BIOMED MATER RES, V30, P245
   Martinez-Gutierrez F, 2010, NANOMED-NANOTECHNOL, V6, P681, DOI 10.1016/j.nano.2010.02.001
   Montanaro L, 2008, INT J ARTIF ORGANS, V31, P771
   Moriarty TF, 2010, J MATER SCI-MATER M, V21, P1031, DOI 10.1007/s10856-009-3907-x
   Moriarty TF, 2009, INT J ARTIF ORGANS, V32, P663
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Patel JD, 2012, J BIOMED MAT RES A
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   Pieske O, 2008, J TRAUMA, V64, P1275, DOI 10.1097/TA.0b013e31815e40e0
   Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002
   Schlegel U, 2006, INJURY, V37, P67, DOI 10.1016/j.injury.2006.04.011
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SHERERTZ RJ, 1995, J BIOMED MATER RES, V29, P635, DOI 10.1002/jbm.820290511
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Soultanis Konstantinos C, 2008, J Surg Orthop Adv, V17, P193
   VERHEYEN CCPM, 1993, BIOMATERIALS, V14, P383, DOI 10.1016/0142-9612(93)90059-B
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 54
TC 36
Z9 37
U1 0
U2 44
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1198-743X
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD DEC
PY 2012
VL 18
IS 12
BP 1162
EP 1167
DI 10.1111/j.1469-0691.2012.04002.x
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 037MJ
UT WOS:000311109100014
PM 22925523
OA Bronze
DA 2018-10-19
ER

PT J
AU Iezzi, G
   Degidi, M
   Piattelli, A
   Mangano, C
   Scarano, A
   Shibli, JA
   Perrotti, V
AF Iezzi, Giovanna
   Degidi, Marco
   Piattelli, Adriano
   Mangano, Carlo
   Scarano, Antonio
   Shibli, Jamil A.
   Perrotti, Vittoria
TI Comparative histological results of different biomaterials used in sinus
   augmentation procedures: a human study at 6 months
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE anorganic bovine bone; biphasic calcium phosphate; calcium carbonate;
   phycogene hydroxyapatite; porcine bone; sinus augmentation procedures
ID ANORGANIC BOVINE BONE; BIPHASIC CALCIUM-PHOSPHATE; DIFFERENT GRAFTING
   MATERIALS; GUIDED TISSUE REGENERATION; MINERAL BIO-OSS; FLOOR
   AUGMENTATION; AUTOGENOUS BONE; IMPLANT PLACEMENT; DENTAL IMPLANTS;
   HISTOMORPHOMETRIC EVALUATION
AB Objectives Various grafts or combination of graft materials have been used in sinus floor augmentations, and human histological reports on their performance are available, although limited in number. Histological analysis of the regenerated tissues will provide useful information regarding the nature and amount of newly formed bone. Aim of the present study was a histological and histomorphometric evaluation, in humans, of specimens retrieved from sinuses augmented with phycogene hydroxyapatite, biphasic calcium phosphate ceramics, calcium carbonate, porcine bone and anorganic bovine bone, after a healing period of 6 months. Materials and methods A total of 15 patients, undergoing 30 sinus augmentation procedures with five different biomaterials, participated in this study. A total of 82 titanium dental implants were inserted in the augmented sinuses after a healing period of 6 months. A total of 60 bone cores, 2 for each augmented sinus, 12 for every biomaterial, were retrieved and all were stored immediately in 10% buffered formalin and processed to obtain thin ground sections. Results In all biomaterials, many grafted particles were lined and, sometimes, bridged by newly formed bone. Some biomaterials particles appeared to be partially resorbed and substituted by newly formed bone. Histomorphometry showed that, in all biomaterials, newly formed bone and residual grafted material particles represented about 30%. Conclusions Longer term histological and histomorphometric studies will be necessary to understand better the resorption times of all these biomaterials. The high interconnecting microporosity allowed, in all the present biomaterials, the ingrowth of newly formed bone and vessels in the pores of the partially resorbed particles. In conclusion, within the limitations of the present study, the data provided support the fact that all these biomaterials can be used, successfully, in sinus augmentation procedures.
C1 [Iezzi, Giovanna; Piattelli, Adriano; Scarano, Antonio; Perrotti, Vittoria] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Shibli, Jamil A.] Guarulhos Univ UnG, Dent Res Div, Dept Periodontol, Guarulhos, SP, Brazil.
RP Iezzi, G (reprint author), Via Vestini 31, I-66100 Chieti, Italy.
EM gio.iezzi@unich.it
RI Scarano, Antonio/F-6961-2017; Shibli, Jamil/A-1361-2014
OI Scarano, Antonio/0000-0003-1374-6146; Shibli, Jamil/0000-0003-1971-0195
FU Ministry of Education, University and Research (MIUR), Rome, Italy
FX The work was partially supported by the Ministry of Education,
   University and Research (MIUR), Rome, Italy.
CR Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Barone A, 2006, INT J ORAL MAX IMPL, V21, P81
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2008, CLIN ORAL IMPLAN RES, V19, P511, DOI 10.1111/j.1600-0501.2007.01498.x
   Barone A, 2011, J PERIODONTOL, V82, P219, DOI 10.1902/jop.2010.100177
   Barone A, 2012, CLIN IMPLANT DENT R, V14, P373, DOI 10.1111/j.1708-8208.2010.00274.x
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Calvo-Guirado J. L., 2011, CLIN IMPLANT DENT R, DOI [10.1111/j.1708-8208.2011.00337, DOI 10.1111/J.1708-8208.2011.00337]
   Campion CR, 2011, J BIOMED MATER RES B, V97B, P245, DOI 10.1002/jbm.b.31807
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Covani U, 2011, CLIN ORAL IMPLAN RES, V22, P481, DOI 10.1111/j.1600-0501.2010.02042.x
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   Ewers R, 2005, J ORAL MAXIL SURG, V63, P1712, DOI 10.1016/j.joms.2005.08.020
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Friedmann A, 2009, CLIN ORAL IMPLAN RES, V20, P708, DOI 10.1111/j.1600-0501.2009.01708.x
   Froum SJ, 2008, INT J PERIODONT REST, V28, P273
   Galindo-Moreno P, 2008, CLIN ORAL IMPLAN RES, V19, P755, DOI 10.1111/j.1600-0501.2008.01536.x
   Galindo-Moreno P, 2011, CLIN ORAL IMPLAN RES, V22, P857, DOI 10.1111/j.1600-0501.2010.02073.x
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Karabuda C, 2001, J PERIODONTOL, V72, P1436, DOI 10.1902/jop.2001.72.10.1436
   Kim YK, 2009, ORAL SURG ORAL MED O, V107, P204, DOI 10.1016/j.tripleo.2008.07.021
   Klongnoi B, 2006, J CLIN PERIODONTOL, V33, P500, DOI 10.1111/j.1600-051X.2006.00938.x
   Kuhl S, 2010, INT J ORAL MAX IMPL, V25, P930
   Lambert F, 2011, CLIN ORAL IMPLAN RES, V22, P538, DOI 10.1111/j.1600-0501.2010.02069.x
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   Lee JH, 2008, CLIN ORAL IMPLAN RES, V19, P767, DOI 10.1111/j.1600-0501.2008.01520.x
   Lee YM, 2006, INT J PERIODONT REST, V26, P471
   Lindgren C, 2009, INT J ORAL MAX IMPL, V24, P1093
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   Mangano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018721
   Mazor Z, 2009, J PERIODONTOL, V80, P2056, DOI 10.1902/jop.2009.090252
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Pagliani L, 2012, CLIN IMPLANT DENT R, V14, P746, DOI 10.1111/j.1708-8208.2010.00314.x
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Pikdoken L, 2011, J ORAL MAXIL SURG, V69, P160, DOI 10.1016/j.joms.2010.07.036
   Polyzois I, 2007, CLIN ORAL IMPLAN RES, V18, P304, DOI 10.1111/j.1600-0501.2007.01207.x
   Proussaefs P, 2003, INT J PERIODONT REST, V23, P185
   Ramirez Fernandez M. P., 2011, CLIN ORAL IMPLAN RES, V22, P767
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Ripamonti U., 2008, J CELLULAR MOL MED, V12, P1
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   Simunek A, 2005, CLIN ORAL IMPLAN RES, V16, P342, DOI 10.1111/j.1600-0501.2005.01097.x
   Soardi CM, 2011, CLIN ORAL IMPLAN RES, V22, P560, DOI 10.1111/j.1600-0501.2010.02034.x
   Stavropoulos A, 2003, J CLIN PERIODONTOL, V30, P636, DOI 10.1034/j.1600-051X.2003.00093.x
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   Traini T, 2008, J PERIODONTOL, V79, P1232, DOI [10.1902/jop.2008.070504, 10.1902/jop.2008.070504 ]
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wikesjo UME, 2003, J PERIODONTOL, V74, P957, DOI 10.1902/jop.2003.74.7.957
   Yamamichi N, 2008, INT J PERIODONT REST, V28, P163
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 65
TC 32
Z9 34
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD DEC
PY 2012
VL 23
IS 12
BP 1369
EP 1376
DI 10.1111/j.1600-0501.2011.02308.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 041LF
UT WOS:000311402600007
PM 22092377
DA 2018-10-19
ER

PT J
AU Ghalayini, SRA
   Helm, AT
   McLauchlan, GJ
AF Ghalayini, S. R. A.
   Helm, A. T.
   McLauchlan, G. J.
TI Minimum 6 year results of an uncemented trabecular metal tibial
   component in total knee arthroplasty
SO KNEE
LA English
DT Article
DE Knee; Arthroplasty; Clinical; Trabecular metal
ID POROUS TANTALUM BIOMATERIAL; FOLLOW-UP; PATIENTS YOUNGER; REPLACEMENT;
   14-YEAR; FIXATION; DESIGN; SCORES
AB Introduction: There are theoretical advantages of using a trabecular metal tibial component in total knee replacement (TKR) for long-term survival. We have previously reported outcomes at 3 years. We now report the clinical and radiological outcome of an unselected series of 109 knees at a minimum of 6 years follow up.
   Methods: Patient function was assessed in a research clinic using Oxford Knee Score (OKS), Clinical and Functional Knee Society Score (KSS) and SF-12 physical score. Up to date weight bearing radiographs were obtained.
   Results: Seventy-six knees in 72 patients were available for assessment OKS scores were maintained from the 3-year assessment with a mean of 36.1 (8.6). KSS and SF-12 scores declined slightly but only to a degree previously reported as normal age related change. The mean KSS at follow up was 87.2 (17.7). There was no radiographic evidence of loosening in any implant. There has been 1 revision for unexplained pain at 27 months.
   Conclusion: The uncemented TMT in an unselected group is performing as well as any TKR implant at this stage. Future follow up is required to ensure this is maintained. The theoretical advantages may make this the prosthesis of choice in younger patients.
   Level of evidence: IV. Case series (C) 2012 Elsevier B.V. All rights reserved.
RP McLauchlan, GJ (reprint author), 16 Miller Lane, Preston PR4 0ND, Lancs, England.
EM georgemclauchlan@hotmail.com
CR Benjamin J, 2003, J ARTHROPLASTY, V18, P867, DOI 10.1054/S0883-5403(03)00264-X
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Duffy GP, 1998, CLIN ORTHOP RELAT R, P66
   Dunbar MJ, 2009, J BONE JOINT SURG AM, V91A, P1578, DOI 10.2106/JBJS.H.00282
   Goldberg VM, 2004, CLIN ORTHOP RELAT R, P214, DOI 10.1097/01.blo.0000148572.95121.f0
   Graves SP, 2011, AUSTR ORTHOPAEDIC AS, P137
   Helm AT, 2009, J ARTHROPLASTY, V24, P941, DOI 10.1016/j.arth.2008.06.018
   Henricson A, 2008, J BONE JOINT SURG BR, V90B, P1585, DOI 10.1302/0301-620X.90B12.20797
   Kamath AF, 2011, J ARTHROPLASTY, V26, P1390, DOI 10.1016/j.arth.2011.06.030
   Marsh J, 2009, J BONE JOINT SURG AM, V91A, P2827, DOI 10.2106/JBJS.H.01415
   Minoda Y, 2010, J BONE JOINT SURG AM, V92A, P700, DOI 10.2106/JBJS.H.01349
   Park JW, 2011, J BONE JOINT SURG BR, V93B, P1479, DOI 10.1302/0301-620X.93B11.27507
   Ritter MA, 2001, CLIN ORTHOP RELAT R, P51
   Ritter MA, 2004, J BONE JOINT SURG BR, V86B, P438, DOI 10.1302/0301-620X.86B3.14243
   Rodricks DJ, 2007, J BONE JOINT SURG AM, V89A, P89, DOI 10.2106/JBJS.E.00492
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   Singh J, 2010, J AM ACAD ORTHOP SUR, V18, P72
   Sorrells RB, 2004, J BONE JOINT SURG AM, V86A, P2156, DOI 10.2106/00004623-200410000-00005
   Weir DJ, 1996, J BONE JOINT SURG BR, V78B, P907, DOI 10.1302/0301-620X78B6.6678
   Wilson DAJ, 2010, J ARTHROPLASTY, V25, P893, DOI 10.1016/j.arth.2009.06.015
NR 21
TC 9
Z9 9
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0968-0160
J9 KNEE
JI Knee
PD DEC
PY 2012
VL 19
IS 6
BP 872
EP 874
DI 10.1016/j.knee.2012.05.001
PG 3
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 040NJ
UT WOS:000311329300026
PM 22652203
DA 2018-10-19
ER

PT J
AU Georgieva, N
   Bryaskova, R
   Tzoneva, R
AF Georgieva, Nelly
   Bryaskova, Rayna
   Tzoneva, Rumiana
TI New Polyvinyl alcohol-based hybrid materials for biomedical application
SO MATERIALS LETTERS
LA English
DT Article
DE Polymeric composites; FTIR; Sol-gel preparation; Surface
   characterization; Cell adhesion; Biomaterials
ID CELL-ADHESION; POLY(VINYL ALCOHOL); POLYMER SURFACES; MEMBRANES;
   DEHYDRATION; BIOMATERIAL; HYDROGELS; ETHANOL
AB Polyvinyl alcohol (PVA), a hydrophilic, biodegradable and biocompatible synthetic polymer, has been widely used in different areas of the biotechnological and biomedical field. PVA is very sensitive towards moisture and as a result the film strength is reduced, which is strongly undesirable for biomedical applications. To overcome this problem, new hybrid materials based on PVA and gamma-aminopropyltriethoxyxilane (APTEOS), 3- mercaptopropyltriethoxysilane (MPTEOS) and tetraethoxysilane (TEOS) were prepared. Physisco-chemical surface characterization of the materials was done by measuring the water contact angle of the materials. The new materials were tested for potential use as matrices in tissue engineering application. Cytocompatibility and the cell adhesive behavior (actin cytoskeleton) of 3T3 cells as a function of surface functional groups were studied. The synthesized PVA/APTEOS materials proved efficient for use in tissue engineering applications. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Georgieva, Nelly; Bryaskova, Rayna] Univ Chem Technol & Met, BU-1756 Sofia, Bulgaria.
   [Tzoneva, Rumiana] Bulgarian Acad Sci, Inst Biophys & Biomed Engn, BU-1113 Sofia, Bulgaria.
RP Bryaskova, R (reprint author), Univ Chem Technol & Met, Kl Ohridski Str 8, BU-1756 Sofia, Bulgaria.
EM rbryaskova@uctm.edu
FU Bulgarian National Science Fund [DDVU 02-96/2010, DO 02/178, DO 02-326];
   European Social Fund [BG051PO001-3.3.04/42]
FX The present work is funded by the Project No DDVU 02-96/2010, Project DO
   02/178 and DO 02-326 from the Bulgarian National Science Fund and partly
   by the European Social Fund (BG051PO001-3.3.04/42).
CR Andrade G, 2006, BIOMED MATER, V1, P221, DOI 10.1088/1748-6041/1/4/008
   Bandyopadhyay A, 2005, J MATER SCI, V40, P5233, DOI 10.1007/s10853-005-4417-y
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   GEORGE JV, 1975, J CELL PHYSIOL, V85, P547, DOI 10.1002/jcp.1040850306
   GRINNELL F, 1978, EXP CELL RES, V115, P221, DOI 10.1016/0014-4827(78)90419-6
   Guo RL, 2007, POLYMER, V48, P2939, DOI 10.1016/j.polymer.2007.03.035
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024
   Kaneko S, 2011, PHYS CHEM CHEM PHYS, V13, P4051, DOI 10.1039/c0cp02013c
   Kariduraganavar MY, 2005, J MEMBRANE SCI, V246, P83, DOI 10.1016/j.memsci.2004.09.001
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Pereira MM, 2005, J MATER SCI-MATER M, V16, P1045, DOI 10.1007/s10856-005-4758-8
   Tzoneva R, 2007, BBA-GEN SUBJECTS, V1770, P1538, DOI 10.1016/j.bbagen.2007.07.008
   Uragami T, 2002, MACROMOLECULES, V35, P9156, DOI 10.1021/ma020850u
   Zhang QG, 2007, J MEMBRANE SCI, V287, P237, DOI 10.1016/j.memsci.2006.10.041
NR 20
TC 24
Z9 24
U1 1
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD DEC 1
PY 2012
VL 88
BP 19
EP 22
DI 10.1016/j.matlet.2012.07.111
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 028LL
UT WOS:000310423700006
DA 2018-10-19
ER

PT J
AU Demiroglu, SY
   Skrowny, D
   Quade, M
   Schwanke, J
   Budde, M
   Gullatz, V
   Reich-Erkelenz, D
   Jakob, JJ
   Falkai, P
   Rienhoff, O
   Helbing, K
   Heilbronner, U
   Schulze, TG
AF Demiroglu, S. Y.
   Skrowny, D.
   Quade, M.
   Schwanke, J.
   Budde, M.
   Gullatz, V.
   Reich-Erkelenz, D.
   Jakob, J. J.
   Falkai, P.
   Rienhoff, O.
   Helbing, K.
   Heilbronner, U.
   Schulze, T. G.
TI Managing sensitive phenotypic data and biomaterial in large-scale
   collaborative psychiatric genetic research projects: practical
   considerations
SO MOLECULAR PSYCHIATRY
LA English
DT Article
DE biobanking; data protection; GWAS; IT infrastructure; pseudonyms;
   sequencing
ID DEPRESSION
AB Large-scale collaborative research will be a hallmark of future psychiatric genetic research. Ideally, both academic and non-academic institutions should be able to participate in such collaborations to allow for the establishment of very large samples in a straightforward manner. Any such endeavor requires an easy-to-implement information technology (IT) framework. Here we present the requirements for a centralized framework and describe how they can be met through a modular IT toolbox. Molecular Psychiatry (2012) 17, 1180-1185; doi: 10.1038/mp.2012.11; published online 6 March 2012
C1 [Demiroglu, S. Y.; Skrowny, D.; Quade, M.; Schwanke, J.; Jakob, J. J.; Rienhoff, O.; Helbing, K.] Univ Med Ctr Gottingen, Dept Med Informat, D-37075 Gottingen, Germany.
   [Budde, M.; Gullatz, V.; Reich-Erkelenz, D.; Falkai, P.; Heilbronner, U.; Schulze, T. G.] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Sect Psychiat Genet, D-37075 Gottingen, Germany.
   [Falkai, P.] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany.
RP Demiroglu, SY (reprint author), Univ Med Ctr Gottingen, Dept Med Informat, Robert Koch Str 40, D-37075 Gottingen, Germany.
EM sara.demiroglu@med.uni-goettingen.de;
   thomas.schulze@med.uni-goettingen.de
RI Reich-Erkelenz, Daniela/D-9736-2018; Schulze, Thomas/H-2157-2013
OI Reich-Erkelenz, Daniela/0000-0001-7818-539X; Nussbeck,
   Sara/0000-0003-1223-6494; Heilbronner, Urs/0000-0001-7135-762X
FU Deutsche Forschungsgemeinschaft through the Clinical Research Group 241
   [SCHU 1603/5-1]
FX This work is supported by the Deutsche Forschungsgemeinschaft through
   the Clinical Research Group 241 'Genotype-phenotype relationships and
   neurobiology of the longitudinal course of psychosis'
   (http://www.kfo241.de; grant number SCHU 1603/5-1).
CR Almqvist C, 2011, EUR J EPIDEMIOL, V26, P67, DOI 10.1007/s10654-010-9521-x
   Dangl A, 2010, STUD HEALTH TECHNOL, V160, P1334, DOI 10.3233/978-1-60750-588-4-1334
   Faldum A, 2005, COMPUT METH PROG BIO, V79, P81, DOI 10.1016/j.cmpb.2005.03.004
   Heiman GA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-58
   Helbing K, 2010, METHOD INFORM MED, V49, P601, DOI 10.3414/ME09-02-0058
   Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891
   Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019
   Mailman MD, 2007, NAT GENET, V39, P1181
   Pommerening K, 2008, EHEALTH COMBINING HL, P5
   Schulze TG, 2010, PSYCHIAT CLIN N AM, V33, P67, DOI 10.1016/j.psc.2009.10.005
   Sullivan PF, 2010, NEURON, V68, P182, DOI 10.1016/j.neuron.2010.10.003
   Terdiman J, 2011, CLIN MED RES, V9, P168
   Thorisson GA, 2009, NAT REV GENET, V10, P9, DOI 10.1038/nrg2483
   Unutzer J, 2002, PSYCHIATR SERV, V53, P671, DOI 10.1176/appi.ps.53.6.671
   Warner V, 2008, PSYCHOL MED, V38, P1543, DOI 10.1017/S0033291708002894
   Webb AJ, 2011, HUM MUTAT, V32, P543, DOI 10.1002/humu.21469
   Weissman MM, 2011, ARCH GEN PSYCHIAT, V68, P600, DOI 10.1001/archgenpsychiatry.2011.47
   Zhang JJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar038
NR 18
TC 11
Z9 11
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD DEC
PY 2012
VL 17
IS 12
BP 1180
EP 1185
DI 10.1038/mp.2012.11
PG 6
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA 041UB
UT WOS:000311425600011
PM 22392033
DA 2018-10-19
ER

PT J
AU Nonoyama, T
   Kinoshita, T
   Higuchi, M
   Nagata, K
   Tanaka, M
   Kamada, M
   Sato, K
   Kato, K
AF Nonoyama, Takayuki
   Kinoshita, Takatoshi
   Higuchi, Masahiro
   Nagata, Kenji
   Tanaka, Masayoshi
   Kamada, Mari
   Sato, Kimiyasu
   Kato, Katsuya
TI Arrangement techniques of proteins and cells using amorphous calcium
   phosphate nanofiber scaffolds
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Arrangement technique; Osteoblast-like cell; Antibody protein;
   Mineralization; beta-Sheet peptide template; Amorphous calcium phosphate
ID ENZYME-BASED BIOSENSORS; CONTACT GUIDANCE; FIBRONECTIN CONFORMATION;
   SURFACE; ADHESION; ORIENTATION; ADSORPTION; SMOOTH; ACIDS
AB We demonstrate arrangement techniques of proteins and cells using an amorphous calcium phosphate (ACP) nanofiber scaffold. It is well known that protein andosteoblastic cell are preferably adsorbed onto ACP surface. The ACP nanofiber scaffold was prepared by calcium phosphate mineralization on a polypeptide monolayer-coated mica substrate, and ACP nanofibers were oriented unidirectionaly. In a protein system, the ACP nanofiber scaffold was soaked in a fluorescein isothiocyanate conjugated immunoglobulin G (IgG-FITC) aqueous solution. From fluorescence microscopic measurement, the adsorbed IgG-FITC was highly confined and arranged on the ACP nanofiber. In a cell system, a mouse osteoblast-like cell (MC3T3-E1) behavior on the ACP nanofiber scaffold was observed. The cell was elongated unidirectionaly, and its cytoskeletal shape showed high aspect ratio. These results are clearly different from an ACP bulk template or bare mica substrate, and the arrangement technique enable to fabricate a fine-tuned biomaterial template. Crown Copyright (c) 2011 Published by Elsevier B.V. All rights reserved.
C1 [Nonoyama, Takayuki; Kinoshita, Takatoshi; Tanaka, Masayoshi] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.
   [Higuchi, Masahiro; Nagata, Kenji] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
   [Kamada, Mari] Mie Univ, Grad Sch Engn, Div Chem Mat, Tsu, Mie 5148570, Japan.
   [Sato, Kimiyasu; Kato, Katsuya] Natl Inst Adv Ind Sci & Technol, Shimo Shidami Moriyama Ku, Nagoya, Aichi 4638560, Japan.
RP Kinoshita, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokisho Cho, Nagoya, Aichi 4668555, Japan.
EM takayuki.nonoyama@aist.go.jp; kinoshita.takatoshi@nitech.ac.jp;
   katsuya-kato@aist.go.jp
RI Kato, Katsuya/H-5074-2018; Sato, Kimiyasu/K-9284-2016
OI Sato, Kimiyasu/0000-0003-4696-3673
FU Japan Society for the Promotion of Science (JSPS) [23560925]; SER
   program from the Institute of Ceramics Research and Education (ICRE)
FX This work was partly supported by Grant-in-Aid for Scientific Research
   (C) no. 23560925 from Japan Society for the Promotion of Science (JSPS).
   We acknowledge the support of the SER program from the Institute of
   Ceramics Research and Education (ICRE) administered by Nagoya Institute
   of Technology (Prof. T. Kasuga and Prof. Y. Iwamoto).
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   BJORLING M, 1992, MACROMOLECULES, V25, P3956
   Chikae M, 2008, BIOELECTROCHEMISTRY, V74, P118, DOI 10.1016/j.bioelechem.2008.06.005
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Enander K, 2008, BIOCONJUGATE CHEM, V19, P1864, DOI 10.1021/bc800159d
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   GUIDO S, 1993, J CELL SCI, V105, P317
   Higuchi M, 2002, LANGMUIR, V18, P813, DOI 10.1021/la011305+
   Hock B, 2002, BIOSENS BIOELECTRON, V17, P239, DOI 10.1016/S0956-5663(01)00267-6
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   ISRAELS R, 1995, MACROMOLECULES, V28, P1626, DOI 10.1021/ma00109a040
   Jelinek R, 2004, CHEM REV, V104, P5987, DOI 10.1021/cr0300284
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Katz E, 2001, J AM CHEM SOC, V123, P10752, DOI 10.1021/ja0167102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Masahisa N., 1996, BIOMATERIALS, V17, P1771
   Mateo-Marti E, 2007, BIOSENS BIOELECTRON, V22, P1926, DOI 10.1016/j.bios.2006.08.012
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Nonoyama T, 2011, LANGMUIR, V27, P7077, DOI 10.1021/la2006953
   Nonoyama T, 2010, CHEM COMMUN, V46, P6983, DOI 10.1039/c0cc02012e
   Samoylov AM, 2002, J MOL RECOGNIT, V15, P197, DOI 10.1002/jmr.574
   Sun JR, 2010, BIOMACROMOLECULES, V11, P3067, DOI 10.1021/bm100883m
   Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   THOMANN JM, 1989, COLLOID SURFACE, V40, P293, DOI 10.1016/0166-6622(89)80027-7
   TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7
   Wilson GS, 2000, CHEM REV, V100, P2693, DOI 10.1021/cr990003y
   Yemini M, 2005, ANAL CHEM, V77, P5155, DOI 10.1021/ac050414g
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
NR 33
TC 4
Z9 4
U1 2
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 1
PY 2012
VL 262
BP 8
EP 12
DI 10.1016/j.apsusc.2011.12.009
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 037JA
UT WOS:000311098500003
DA 2018-10-19
ER

PT J
AU Nagai, A
   Ma, CF
   Kishi, S
   Inuzuka, M
   Nakamura, M
   Horiuchi, N
   Nishio, K
   Yamashita, K
AF Nagai, Akiko
   Ma, Chufan
   Kishi, Shigeki
   Inuzuka, Masahiro
   Nakamura, Miho
   Horiuchi, Naohiro
   Nishio, Keishi
   Yamashita, Kimihiro
TI Surface properties of Al2O3-YSZ ceramic composites modified by a
   combination of biomimetic coatings and electric polarization
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Al-YSZ; Electric polarization; Biomimetic coating; a.c. complex
   impedance
ID ZIRCONIA; HYDROXYAPATITE; ALUMINA; GROWTH
AB Alumina-containing yttria-stabilized zirconia composite (Al-YSZ) has a higher flexural strength than YSZ, although Al-YSZ cannot directly bond with bone tissues. To expand the biomedical applications of Al-YSZ, new surface modifications were investigated to improve the bioactivity in the present study. The combination of a biomimetic coatings method using an alternate soaking technique and electric polarization treatment was performed on Al-YSZ. The crystalline phases of the starting Al-YSZ sintered disks were assigned to tetragonal ZrO2 and alpha-Al2O3 phases. The analyses of the electrical properties were carried out using complex impedance and thermally stimulated depolarized current measurements for polarization treatments. Our results indicate that the stored charges in Al-YSZ via polarization decreased in YSZ, because of the added alumina, while the calcium phosphate film deposited by the biomimetic coatings method on polarized Al-YSZ was observed to be thicker than the non-polarized film. The coating method would be suitable for the complex geometry of biomaterials. As a result, polarized Al-YSZ fabricated using an alternate soaking process is expected to be useful as a biomaterial under load-bearing conditions. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Nagai, Akiko; Kishi, Shigeki; Inuzuka, Masahiro; Nakamura, Miho; Horiuchi, Naohiro; Yamashita, Kimihiro] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Ma, Chufan] Fourth Mil Med Univ, Xian 710032, Peoples R China.
   [Kishi, Shigeki; Nishio, Keishi] Tokyo Univ Sci, Noda, Chiba 2788510, Japan.
RP Nagai, A (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM nag-bcr@tmd.ac.jp
RI Nakamura, Miho/T-3166-2017
CR Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   BRAILSFORD AD, 1983, SOLID STATE IONICS, V11, P133, DOI 10.1016/0167-2738(83)90050-4
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   Feighery AJ, 1999, SOLID STATE IONICS, V121, P209, DOI 10.1016/S0167-2738(99)00015-6
   Guo X, 2003, ACTA MATER, V51, P2539, DOI 10.1016/S1359-6454(03)00052-1
   Miyazaki T, 2003, J MATER SCI-MATER M, V14, P569, DOI 10.1023/A:1024000821368
   Mutsuzaki H, 2005, BIOMATERIALS, V26, P1027, DOI 10.1016/j.biomaterials.2004.03.039
   Nagai A, 2011, J BIOMED MATER RES A, V99A, P116, DOI 10.1002/jbm.a.33131
   Nakamura M, 2011, J MATER SCI, V46, P7335, DOI 10.1007/s10853-011-5695-1
   Nakamura S, 2002, J BIOMED MATER RES, V61, P593, DOI 10.1002/jbm.10224
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sergo V., 1998, ACTA MAT, V46, P1702
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   Wang W, 2010, J AM CERAM SOC, V93, P2175, DOI 10.1111/j.1551-2916.2010.03710.x
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Yang F, 2010, SOLID STATE IONICS, V181, P783, DOI 10.1016/j.ssi.2010.04.036
NR 16
TC 0
Z9 0
U1 1
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 1
PY 2012
VL 262
BP 45
EP 50
DI 10.1016/j.apsusc.2012.01.038
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 037JA
UT WOS:000311098500010
DA 2018-10-19
ER

PT J
AU Ren, LM
   Todo, M
   Arahira, T
   Yoshikawa, H
   Myoui, A
AF Ren, Li-Mei
   Todo, Mitsugu
   Arahira, Takaaki
   Yoshikawa, Hideki
   Myoui, Akira
TI A comparative biomechanical study of bone ingrowth in two porous
   hydroxyapatite bioceramics
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Porous bioceramics; Microstructure; Finite element analysis; Mechanical
   properties; Bone ingrowth
ID IN-VIVO; ELEMENT; CERAMICS; SUBSTITUTES; PREDICTION; SCAFFOLDS; IMPLANT
AB Calcium phosphate-based bioceramics have been widely used as artificial bone substitute materials because of their superior biocompatibility and osteoconductivity. In the present study, mechanical properties changes of two hydroxyapatite (HA) ceramics induced by bone ingrowth were tested and evaluated in a rabbit model. Both materials (NEOBONE (R), Apaceram-AX (R)) have highly interconnected pores with a porosity of 75-85%. The major structural difference between them lies in that Apaceram-AX (R) has micropores smaller than 10 micrometers in diameter, whereas NEOBONE (R) does not contain such micropores. Both materials were implanted into the femoral condyles of rabbits for the specified observation period (1, 5, 12, 24, and 48 weeks) and then evaluated by experimental approach in combination with finite element method (FEM). Results indicate that two porous bioceramics exhibit different degradability in vivo, and remarkably different variation of total stiffness, elastic modulus distribution, as well as strain energy density distribution calculated by FE simulation. These results demonstrate how the internal microstructures affect the progress of bone regeneration and mechanical properties with the duration of implantation, emphasizing the importance of biomaterial design tailored to various clinic applications. Additionally, this study showed a potential for applying the computational method to monitor the time-dependent biomechanical changes of implanted porous bioceramics. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Ren, Li-Mei; Todo, Mitsugu; Arahira, Takaaki] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan.
   [Yoshikawa, Hideki; Myoui, Akira] Osaka Univ, Dept Orthopaed, Suita, Osaka 5650871, Japan.
RP Ren, LM (reprint author), Kyushu Univ, Appl Mech Res Inst, Kasuga Koen 6-1, Kasuga, Fukuoka 8168580, Japan.
EM lmren@riam.kyushu-u.ac.jp
RI Myoui, Akira/E-8296-2010; Kyushu, RIAM/F-4018-2015; U-ID,
   Kyushu/C-5291-2016
OI Kyushu, RIAM/0000-0002-3518-444X; 
FU Ministry of Education, Science, Sports, and Culture of Japan
FX This work was supported in part by The Grant-in-Aid for Highly
   Functional Interface Science: Innovation of Biomaterials with Highly
   Functional Interface to Host and Parasite from the Ministry of
   Education, Science, Sports, and Culture of Japan.
CR Bessho M, 2007, J BIOMECH, V40, P1745, DOI 10.1016/j.jbiomech.2006.08.003
   De Aza PN, 2003, BIOMATERIALS, V24, P1437, DOI 10.1016/S0142-9612(02)00530-6
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   He LH, 2008, ACTA BIOMATER, V4, P577, DOI 10.1016/j.actbio.2007.11.002
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Hing KA, 1999, J MATER SCI-MATER M, V10, P663, DOI 10.1023/A:1008900127475
   Keyak JH, 1998, J BIOMECH, V31, P125
   Kokubo T., 2008, BIOCERAMICS THEIR CL, P154
   Lacroix D, 2006, BIOMATERIALS, V27, P5326, DOI 10.1016/j.biomaterials.2006.06.009
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Okuda T, 2008, BIOMATERIALS, V29, P2719, DOI 10.1016/j.biomaterials.2008.03.028
   Ruimerman R, 2005, ANN BIOMED ENG, V33, P71, DOI 10.1007/s10439-005-8964-9
   Sanz-Herrera JA, 2009, ACTA BIOMATER, V5, P219, DOI 10.1016/j.actbio.2008.06.021
   Sepulveda P, 2000, J BIOMED MATER RES, V50, P27, DOI 10.1002/(SICI)1097-4636(200004)50:1<27::AID-JBM5>3.0.CO;2-6
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Sturm S, 2010, J BIOMECH, V43, P1738, DOI 10.1016/j.jbiomech.2010.02.020
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Tawara D, 2010, J MECH BEHAV BIOMED, V3, P31, DOI 10.1016/j.jmbbm.2009.03.001
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yamasaki N, 2009, J BIOMED MATER RES B, V91B, P788, DOI 10.1002/jbm.b.31457
   Yoshida Y, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-76
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Zhao J, 2008, MATER LETT, V62, P2921, DOI 10.1016/j.matlet.2008.01.075
NR 28
TC 3
Z9 3
U1 0
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 1
PY 2012
VL 262
BP 81
EP 88
DI 10.1016/j.apsusc.2012.02.060
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 037JA
UT WOS:000311098500017
DA 2018-10-19
ER

PT J
AU Mangindaan, D
   Chen, CT
   Wang, MJ
AF Mangindaan, Dave
   Chen, Chao-Ting
   Wang, Meng-Jiy
TI Integrating sol-gel with cold plasmas modified porous polycaprolactone
   membranes for the drug-release of silver-sulfadiazine and ketoprofen
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Polycaprolactone; Silver-sulfadiazine; Ketoprofen; Sol-gel; Plasma
   modifications; Control release
ID EPSILON-CAPROLACTONE; IN-VITRO; SKIN PERMEATION; DIFFUSION CELL;
   CHITOSAN; DELIVERY; VIVO; IMMOBILIZATION; FORMULATIONS; ABSORPTION
AB A controlled release system composed of surface modified porous polycaprolactone (PCL) membranes combined with a layer of tetraorthosilicate (TEOS)-chitosan sol-gel was reported in this study. PCL is a hydrophobic, semi-crystalline, and biodegradable polymer with a relatively slow degradation rate. The drugs chosen for release experiments were silver-sulfadiazine (AgSD) and ketoprofen which were impregnated in the TEOS-chitosan sol-gel. The surface modification was achieved by O-2 plasma and the surfaces were characterized by water contact angle (WCA) measurements, atomic force microscope (AFM), scanning electron microscope and electron spectroscopy for chemical analysis (ESCA). The results showed that the release of AgSD on O-2 plasma treated porous PCL membranes was prolonged when compared with the pristine sample. On the contrary, the release rate of ketoprofen revealed no significant difference on pristine and plasma treated PCL membranes. The prepared PCL membranes showed good biocompatibility for the wound dressing biomaterial applications. (c) 2012 Elsevier B. V. All rights reserved.
C1 [Mangindaan, Dave; Chen, Chao-Ting; Wang, Meng-Jiy] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 106, Taiwan.
RP Wang, MJ (reprint author), Natl Taiwan Univ Sci & Technol, Dept Chem Engn, 43 Keelung Rd,Sec 4, Taipei 106, Taiwan.
EM mjwang@mail.ntust.edu.tw
OI Mangindaan, Dave/0000-0001-8657-1709
FU National Science Council of Taiwan [NSC 99-2621-M-011-003]
FX The authors would like to demonstrate great appreciation to the
   financial supports from National Science Council of Taiwan (NSC
   99-2621-M-011-003).
CR Allen C, 2000, J CONTROL RELEASE, V63, P275, DOI 10.1016/S0168-3659(99)00200-X
   Bonferoni MC, 1999, PHARM DEV TECHNOL, V4, P45, DOI 10.1080/10837459908984223
   Bowen JL, 2006, INT J PHARM, V307, P251, DOI 10.1016/j.ijpharm.2005.10.014
   Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698
   CHI SC, 1991, J PHARM SCI, V80, P280, DOI 10.1002/jps.2600800318
   Chirkov SN, 2002, APPL BIOCHEM MICRO+, V38, P1, DOI 10.1023/A:1013206517442
   Fang JY, 2003, INT J PHARM, V255, P153, DOI 10.1016/S0378-5173(03)00086-3
   FRANZ TJ, 1975, J INVEST DERMATOL, V64, P190, DOI 10.1111/1523-1747.ep12533356
   Fujii M, 2000, INT J PHARM, V205, P117, DOI 10.1016/S0378-5173(00)00496-8
   Gallagher SJ, 2003, INT J PHARM, V268, P37, DOI 10.1016/j.ijpharm.20003.08.012
   Gurol Z, 1996, Pharm Acta Helv, V71, P205, DOI 10.1016/0031-6865(96)00011-8
   Haas KH, 2000, ADV ENG MATER, V2, P571, DOI 10.1002/1527-2648(200009)2:9<571::AID-ADEM571>3.0.CO;2-M
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HiljanenVainio M, 1996, J APPL POLYM SCI, V59, P1281, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1281::AID-APP11>3.0.CO;2-9
   HUBBELL DS, 1977, J APPL POLYM SCI, V21, P3035, DOI 10.1002/app.1977.070211117
   Jacobs T, 2011, SURF COAT TECH, V205, pS543, DOI 10.1016/j.surfcoat.2011.02.012
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Klimundova J, 2006, TALANTA, V69, P730, DOI 10.1016/j.talanta.2005.11.011
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lin WJ, 2002, J MEMBRANE SCI, V198, P109, DOI 10.1016/S0376-7388(01)00652-4
   Liu L, 2011, SOFT MATTER, V7, P4821, DOI 10.1039/c0sm01393e
   Mangindaan D, 2010, PLASMA PROCESS POLYM, V7, P754, DOI 10.1002/ppap.201000021
   Muller MJ, 2003, BURNS, V29, P834, DOI 10.1016/S0305-4179(03)00198-0
   Paolino D, 2002, INT J PHARMACEUT, V244, P21, DOI 10.1016/S0378-5173(02)00295-8
   Park SB, 2001, BIOMATERIALS, V22, P323, DOI 10.1016/S0142-9612(00)00187-3
   Piehler J, 2000, BIOSENS BIOELECTRON, V15, P473, DOI 10.1016/S0956-5663(00)00104-4
   Porzio S, 1998, PHARMACOL RES, V37, P41, DOI 10.1006/phrs.1997.0260
   SANO S, 1982, BURNS, V8, P278, DOI 10.1016/0305-4179(82)90010-9
   Sheu MT, 2002, INT J PHARM, V233, P257, DOI 10.1016/S0378-5173(01)00919-X
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tsai WB, 2009, ACTA BIOMATER, V5, P1442, DOI 10.1016/j.actbio.2009.01.002
   Wang SH, 2003, SENSOR ACTUAT B-CHEM, V94, P343, DOI 10.1016/S0925-4005(03)00383-6
   WEI H, 1995, ANAL CHIM ACTA, V397, P113
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yang YM, 2004, ENZYME MICROB TECH, V34, P126, DOI 10.1016/j.enzmictec.2003.09.007
   Yang ZH, 1999, LANGMUIR, V15, P8405, DOI 10.1021/la990260y
   Yu LM, 2006, INT J PHARM, V319, P107, DOI 10.1016/j.ijpharm.2006.03.039
   Zou Y., 2004, BIOSENS BIOELECTRON, V34, P126
NR 38
TC 5
Z9 5
U1 0
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 1
PY 2012
VL 262
BP 114
EP 119
DI 10.1016/j.apsusc.2012.03.003
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 037JA
UT WOS:000311098500023
DA 2018-10-19
ER

PT J
AU Dhanalakshmi, CP
   Vijayalakshmi, L
   Narayanan, V
AF Dhanalakshmi, C. P.
   Vijayalakshmi, L.
   Narayanan, V.
TI In vitro Antiinflammatory Study of Poly(vinyl alcohol)/Hydroxyapatite
   Nanocomposites: Synthesis and Characterization
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article; Proceedings Paper
CT International Conference on Global Trends in Pure and Applied Chemical
   Sciences (ICGTCS)
CY MAR 03-04, 2012
CL Udaipur, INDIA
SP Asian Journal Chem
DE Hydroxyapatite; Nanocrystalline; Nanocomposite; Poly(vinyl alcohol)
ID HYDROTHERMAL METHOD; HYDROXYAPATITE
AB nanocomposites of varying composition for biomaterial applications have been synthesized and characterized to XRD, FTIR, P-31 NMR, TGA, DTA and PESEM. Hydroxyapatite nano rod embedded composite was prepared using as a matrix with different weight percentages. The results indicated that the size and crystallinity of hydroxyapatite with increase in poly(vinyl alcohol) concentration in the composite SEM confirms the presence of hydroxyapatite poly(vinyl alcohol) matrix poly(vinyl alcohol) hydroxyapatite nano composites were screened for antimicrobial activity.
C1 [Dhanalakshmi, C. P.; Narayanan, V.] Univ Madras, Dept Inorgan Chem, Madras 600025, Tamil Nadu, India.
   [Vijayalakshmi, L.] SDNB Vaishnav Coll Women, Dept Chem, Madras 600044, Tamil Nadu, India.
RP Narayanan, V (reprint author), Univ Madras, Dept Inorgan Chem, Guindy Maraimalai Campus, Madras 600025, Tamil Nadu, India.
EM cpdhanlakshmi@yahoo.com; vnnara@yahoo.co.in
OI Narayanan, Vengidusamy/0000-0003-0653-8170
CR Bertinetti L, 2007, J PHYS CHEM C, V111, P4027, DOI 10.1021/jp066040s
   Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Ding YJ, 2007, BIOMATERIALS, V28, P2147, DOI 10.1016/j.biomaterials.2006.12.025
   Kannan S, 2006, CHEM MATER, V18, P2181, DOI 10.1021/cm052567q
   Komlev VS, 2003, J MATER SCI LETT, V22, P1215, DOI 10.1023/A:1025300617681
   Lak A, 2008, J AM CERAM SOC, V91, P3292, DOI 10.1111/j.1551-2916.2008.02600.x
   Li MO, 2008, J MATER SCI-MATER M, V19, P797, DOI 10.1007/s10856-007-3213-4
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Pramanik N, 2008, POLYM COMPOSITE, V29, P429, DOI 10.1002/pc.20410
   Rajendran V, 2002, BIOMATERIALS, V23, P4263, DOI 10.1016/S0142-9612(02)00189-8
   Sundaram NM, 2006, MATER LETT, V60, P761, DOI 10.1016/j.matlet.2005.10.034
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Zhan JH, 2005, ADV FUNCT MATER, V15, P2005, DOI 10.1002/adfm.200500274
NR 13
TC 3
Z9 3
U1 0
U2 3
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
J9 ASIAN J CHEM
JI Asian J. Chem.
PD DEC
PY 2012
VL 24
IS 12
BP 5497
EP 5499
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 033CT
UT WOS:000310771200020
DA 2018-10-19
ER

PT J
AU Wray, LS
   Rnjak-Kovacina, J
   Mandal, BB
   Schmidt, DF
   Gil, ES
   Kaplan, DL
AF Wray, Lindsay S.
   Rnjak-Kovacina, Jelena
   Mandal, Biman B.
   Schmidt, Daniel F.
   Gil, Eun Seok
   Kaplan, David L.
TI A silk-based scaffold platform with tunable architecture for engineering
   critically-sized tissue constructs
SO BIOMATERIALS
LA English
DT Article
DE Silk; Tissue engineering; Oxygen/nutrient delivery; Vascularization;
   Porous scaffold; Hollow channels
ID FIBROIN SCAFFOLDS; IN-VITRO; BIOMATERIALS; DEGRADATION; RESPONSES;
   FILMS; VASCULARIZATION; STABILIZATION; FABRICATION; HYDROGELS
AB In the field of tissue engineering and regenerative medicine there is significant unmet need for critically-sized, fully degradable biomaterial scaffold systems with tunable properties for optimizing tissue formation in vitro and tissue regeneration in vivo. To address this need, we have developed a silk-based scaffold platform that has tunable material properties, including localized and bioactive functionalization, degradation rate, and mechanical properties and that provides arrays of linear hollow channels for delivery of oxygen and nutrients throughout the scaffold bulk. The scaffolds can be assembled with dimensions that range from millimeters to centimeters, addressing the need for a critically-sized platform for tissue formation. We demonstrate that the hollow channel arrays support localized and confluent endothelialization. This new platform offers a unique and versatile tool for engineering 'tailored' scaffolds for a range of tissue engineering and regenerative medicine needs. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Wray, Lindsay S.; Rnjak-Kovacina, Jelena; Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Mandal, Biman B.] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati 781039, Assam, India.
   [Schmidt, Daniel F.] Univ Massachusetts Lowell, Dept Plast Engn, Lowell, MA 01854 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM David.kaplan@tufts.edu
RI Rnjak-Kovacina, Jelena/B-8928-2014
OI Schmidt, Daniel/0000-0003-2511-1906
FU NIH Tissue Engineering Resource Center (TERC) [NIH P41 EB002520];
   National Science Foundation Graduate Research Fellowship Program [NSF
   DGE 0806676]; National Science Foundation [ECS-0335765]
FX We thank the NIH Tissue Engineering Resource Center (TERC) (NIH P41
   EB002520) and the National Science Foundation Graduate Research
   Fellowship Program (NSF DGE 0806676) for support. We are grateful to G.
   Leisk and J. Trombetta for assistance in LWA assembly, and C. Preda for
   assistance in anisotropic scaffold construction. This work was performed
   in part at the Center for Nanoscale Systems (CNS), a member of the
   National Nanotechnology Infrastructure Network (NNIN), which is
   supported by the National Science Foundation under NSF award no.
   ECS-0335765. CNS is part of the Faculty of Arts and Sciences at Harvard
   University.
CR Altman Greg, 2002, FASEB Journal, V16, P270
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]
   Bagnaninchi PO, 2007, TISSUE ENG, V13, P323, DOI 10.1089/ten.2006.0168
   Carletti E, 2011, METHODS MOL BIOL, V695, P17, DOI 10.1007/978-1-60761-984-0_2
   Chin CD, 2008, BIOMED MICRODEVICES, V10, P459, DOI 10.1007/s10544-007-9155-2
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Ghaznavi AM, 2011, ANN PLAS SURG, V66, P273, DOI 10.1097/SAP.0b013e3181e6cff7
   Gil ES, 2011, J BIOMED MATER RES A, V99A, P16, DOI 10.1002/jbm.a.33158
   Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Lesman A., 2009, TISSUE ENG PART A, V16, P115
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Lokmic Z, 2008, TISSUE ENG PART B-RE, V14, P87, DOI 10.1089/teb.2007.0299
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Nazhat SN, 2007, BIOMACROMOLECULES, V8, P543, DOI 10.1021/bm060715f
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27
   Tsioris K., 2011, ADV FUNCT MATER, V22, P1
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
NR 42
TC 54
Z9 55
U1 2
U2 88
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2012
VL 33
IS 36
BP 9214
EP 9224
DI 10.1016/j.biomaterials.2012.09.017
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 035LB
UT WOS:000310947100006
PM 23036961
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Castells-Sala, C
   Semino, CE
AF Castells-Sala, Cristina
   Semino, Carlos E.
TI Biomaterials for stem cell culture and seeding for the generation and
   delivery of cardiac myocytes
SO CURRENT OPINION IN ORGAN TRANSPLANTATION
LA English
DT Review
DE cellular therapy; growth factors; myocardial infarct; scaffolds; tissue
   engineering
ID MYOCARDIAL-INFARCTION; HEART-DISEASE; REGENERATION; SCAFFOLDS; HYDROGEL;
   THERAPY; DIFFERENTIATION; TRANSPLANTATION; CARDIOMYOPLASTY;
   CARDIOMYOCYTES
AB Purpose of review
   Present an overview of last year's advances in stem cell delivery for cardiac tissue engineering.
   Recent findings
   Several promising novel biomaterial platforms to improve myocardial tissue repair/regeneration and local neovascularization using cellular therapy have been developed.
   Summary
   Still today, a clear statement on cellular therapy efficacy cannot be made but nonetheless, as we describe in this review, several improved in-vivo applications have already been initiated. The newest tissue engineering platforms have basically two main objectives: to improve low cell engraftment and viability into the hostile environment of the infarcted tissue; and to promote neoformation of functional myocardial tissue. With the idea to solve these issues many groups are presently working on the association of stem cells with novel biomaterials, providing an initial appropriate microenvironment (scaffold) for successful cell transplantation, proper differentiation and improved cardiac function.
C1 [Castells-Sala, Cristina; Semino, Carlos E.] Ramon Llull Univ IQS URL, Dept Bioengn, IQS Sch Engn, Barcelona 08017, Spain.
RP Semino, CE (reprint author), Ramon Llull Univ IQS URL, Dept Bioengn, IQS Sch Engn, Via Augusta 390, Barcelona 08017, Spain.
EM carlos.semino@iqs.url.edu
FU European Union [229239]
FX The authors of this work want to thank to the European Union, Seventh
   Framework Program (7FP/2007-2013) for the funding received with the
   project RECATABI to CES, under grant agreement no 229239.
CR Abdelli LS, 2012, CAN J PHYSIOL PHARM, V90, P307, DOI [10.1139/Y11-130, 10.1139/y11-130]
   Albanna MZ, 2012, J MECH BEHAV BIOMED, V5, P171, DOI 10.1016/j.jmbbm.2011.08.021
   Atala A, 2012, J PEDIATR SURG, V47, P17, DOI 10.1016/j.jpedsurg.2011.10.013
   Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049
   Binsalamah ZM, 2011, INT J NANOMED, V6, P2667, DOI 10.2147/IJN.S25175
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Cheng K, 2012, BIOMATERIALS, V33, P5317, DOI 10.1016/j.biomaterials.2012.04.006
   Cheng K, 2012, BIOMATERIALS, V33, P2872, DOI 10.1016/j.biomaterials.2011.12.040
   Cheng K, 2012, J AM COLL CARDIOL, V59, P256, DOI 10.1016/j.jacc.2011.10.858
   Chimenti I, 2011, BIOMATERIALS, V32, P9271, DOI 10.1016/j.biomaterials.2011.08.049
   Chong JJH, 2012, HEART LUNG CIRC, V21, P532, DOI 10.1016/j.hlc.2012.04.020
   Clifford DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037373
   Cortes-Morichetti M, 2007, TISSUE ENG, V13, P2681, DOI 10.1089/ten.2006.0447
   Demirbag B, 2011, BIOTECHNOL J, V6, P1437, DOI 10.1002/biot.201100261
   Dvir T, 2012, NAT NANOTECHNOL, V6
   Fernandes S, 2012, CELLS TISSUES ORGANS, V195, P48, DOI 10.1159/000331414
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Gallina C, 2012, J CELL BIOCHEM, V113, P800, DOI 10.1002/jcb.23407
   Giraud MN, 2012, CARDIOL RES PRACT, DOI 10.1155/2012/971614
   Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002
   Heydarkhan-Hagvall S, 2012, BIOMATERIALS, V33, P2032, DOI 10.1016/j.biomaterials.2011.11.065
   Hoover-Plow J., 2012, J VASCULAR HLTH RISK, V8, P99
   Huang CC, 2012, BIOMATERIALS, V33, P4069, DOI 10.1016/j.biomaterials.2012.02.024
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Kleger A, 2011, TRENDS CARDIOVAS MED, V21, P74, DOI 10.1016/j.tcm.2012.03.003
   Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078
   Li ZQ, 2012, BIOMACROMOLECULES, V13, P1956, DOI 10.1021/bm300574j
   Liau B, 2011, BIOMATERIALS, V32, P9180, DOI 10.1016/j.biomaterials.2011.08.050
   Liu JF, 2012, STEM CELLS DEV, V21, P2095, DOI 10.1089/scd.2012.0031
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lui KO, 2012, BIRTH DEFECTS RES C, V96, P98, DOI 10.1002/bdrc.21004
   Minato A, 2012, BIOMATERIALS, V33, P515, DOI 10.1016/j.biomaterials.2011.09.070
   Mullenix PS, 2012, J SURG ONCOL, V105, P475, DOI 10.1002/jso.23014
   Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946
   Oldroyd KG, 2012, MOL THER, V20, P1102, DOI 10.1038/mt.2012.99
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Polak DJ, 2010, J R SOC INTERFACE, V7, pS777, DOI 10.1098/rsif.2010.0362.focus
   Prabhakaran MP, 2012, BIOPOLYMERS, V97, P529, DOI 10.1002/bip.22035
   Qayyum AA, 2012, REGEN MED, V7, P421, DOI [10.2217/RME.12.17, 10.2217/rme.12.17]
   Qian L, 2012, TISSUE ENG PT A, V18, P1652, DOI [10.1089/ten.tea.2011.0591, 10.1089/ten.TEA.2011.0591]
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Sant S, 2010, CAN J CHEM ENG, V88, P899, DOI 10.1002/cjce.20411
   Smith AW, 2012, ACTA BIOMATER, V8, P31, DOI 10.1016/j.actbio.2011.08.021
   Stamm C, 2009, HEART LUNG CIRC, V18, P245, DOI 10.1016/j.hlc.2008.10.014
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Wang Y, 2012, MOL CELL BIOCHEM, V366, P139, DOI 10.1007/s11010-012-1291-1
   Weber B, 2011, PLACENTA, V32, pS316, DOI 10.1016/j.placenta.2011.04.001
NR 48
TC 12
Z9 12
U1 2
U2 30
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1087-2418
J9 CURR OPIN ORGAN TRAN
JI Curr. Opin. Organ Transpl.
PD DEC
PY 2012
VL 17
IS 6
BP 681
EP 687
DI 10.1097/MOT.0b013e32835a34a6
PG 7
WC Transplantation
SC Transplantation
GA 037LT
UT WOS:000311107100016
PM 23080064
DA 2018-10-19
ER

PT J
AU Nikkhah, M
   Eshak, N
   Zorlutuna, P
   Annabi, N
   Castello, M
   Kim, K
   Dolatshahi-Pirouz, A
   Edalat, F
   Bae, H
   Yang, YZ
   Khademhosseini, A
AF Nikkhah, Mehdi
   Eshak, Nouran
   Zorlutuna, Pinar
   Annabi, Nasim
   Castello, Marco
   Kim, Keekyoung
   Dolatshahi-Pirouz, Alireza
   Edalat, Faramarz
   Bae, Hojae
   Yang, Yunzhi
   Khademhosseini, Ali
TI Directed endothelial cell morphogenesis in micropatterned gelatin
   methacrylate hydrogels
SO BIOMATERIALS
LA English
DT Article
DE Microfabrication; Hydrogel; Gelatin methacrylate; Endothelial cells;
   Cords
ID GLYCOL) DIACRYLATE HYDROGELS; BLOOD-VESSEL FORMATION; IN-VITRO;
   CAPILLARY MORPHOGENESIS; TUBE FORMATION; MICROENGINEERED HYDROGELS;
   EXTRACELLULAR-MATRIX; ENGINEERED TISSUES; ADHESION MOLECULE; VE-CADHERIN
AB Engineering of organized vasculature is a crucial step in the development of functional and clinically relevant tissue constructs. A number of previous techniques have been proposed to spatially regulate the distribution of angiogenic biomolecules and vascular cells within biomaterial matrices to promote vascularization. Most of these approaches have been limited to two-dimensional (2D) micropatterned features or have resulted in formation of random vasculature within three-dimensional (3D) microenvironments. In this study, we investigate 3D endothelial cord formation within micropatterned gelatin methacrylate (GelMA) hydrogels with varying geometrical features (50-150 mu m height). We demonstrated the significant dependence of endothelial cells proliferation, alignment and cord formation on geometrical dimensions of the patterned features. The cells were able to align and organize within the micropatterned constructs and assemble to form cord structures with organized actin fibers and circular/elliptical cross-sections. The inner layer of the cord structure was filled with gel showing that the micropatterned hydrogel constructs guided the assembly of endothelial cells into cord structures. Notably, the endothelial cords were retained within the hydrogel microconstructs for all geometries after two weeks of culture; however, only the 100 mu m-high constructs provided the optimal microenvironment for the formation of circular and stable cord structures. Our findings suggest that endothelial cord formation is a preceding step to tubulogenesis and the proposed system can be used to develop organized vasculature for engineered tissue constructs. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Nikkhah, Mehdi; Eshak, Nouran; Zorlutuna, Pinar; Annabi, Nasim; Castello, Marco; Kim, Keekyoung; Dolatshahi-Pirouz, Alireza; Edalat, Faramarz; Khademhosseini, Ali] Harvard Univ, Ctr Biomed Engn, Dept Med, Brigham & Womens Hosp,Med Sch, Boston, MA 02139 USA.
   [Nikkhah, Mehdi; Eshak, Nouran; Zorlutuna, Pinar; Annabi, Nasim; Castello, Marco; Kim, Keekyoung; Dolatshahi-Pirouz, Alireza; Edalat, Faramarz; Khademhosseini, Ali] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Bae, Hojae] Kyung Hee Univ, Dept Maxillofacial Biomed Engn, Seoul 130701, South Korea.
   [Bae, Hojae] Kyung Hee Univ, Inst Oral Biol, Sch Dent, Seoul 130701, South Korea.
   [Yang, Yunzhi] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA.
   [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02139 USA.
RP Khademhosseini, A (reprint author), Harvard Univ, Ctr Biomed Engn, Dept Med, Brigham & Womens Hosp,Med Sch, Boston, MA 02139 USA.
EM alik@rics.bwh.harvard.edu
RI Zorlutuna, Pinar/A-7208-2015; Dolatshahi-Pirouz, Alireza/P-8179-2014;
   Khademhosseini, Ali/A-9435-2010
OI Zorlutuna, Pinar/0000-0002-3122-7553; Dolatshahi-Pirouz,
   Alireza/0000-0001-6326-0836; Khademhosseini, Ali/0000-0002-2692-1524;
   Khademhosseini, Ali/0000-0001-6322-8852
FU National Science Foundation CAREER Award [DMR 0847287]; office of Naval
   Research Young National Investigator Award; National Institutes of
   Health [HL092836, DE019024, EB012597, AR057837, DE021468, HL099073]
FX The authors acknowledge funding from the National Science Foundation
   CAREER Award (DMR 0847287), the office of Naval Research Young National
   Investigator Award, and the National Institutes of Health (HL092836,
   DE019024, EB012597, AR057837, DE021468, HL099073).
CR ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059
   Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389
   Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005
   Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   DeLisser HM, 1997, AM J PATHOL, V151, P671
   Dickinson LE, 2010, SOFT MATTER, V6, P5109, DOI 10.1039/c0sm00233j
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Huang JZ, 2003, P NATL ACAD SCI USA, V100, P7785, DOI 10.1073/pnas.1432908100
   Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7
   INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8
   Isner JM, 1996, LANCET, V348, P370, DOI 10.1016/S0140-6736(96)03361-2
   JACKSON CJ, 1991, EXP CELL RES, V192, P319, DOI 10.1016/0014-4827(91)90194-Y
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kniazeva E, 2009, AM J PHYSIOL-CELL PH, V297, pC179, DOI 10.1152/ajpcell.00018.2009
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee H, 2002, TRANSPLANTATION, V73, P1589, DOI 10.1097/00007890-200205270-00011
   Lee KY, 2000, NATURE, V408, P998
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI [10.1089/ten.tea.2010.0202, 10.1089/ten.TEA.2010.0202]
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153
   Manoussaki D, 1996, ACTA BIOTHEOR, V44, P271, DOI 10.1007/BF00046533
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Raghavan S, 2010, TISSUE ENG PT A, V16, P2255, DOI 10.1089/ten.TEA.2009.0584
   Sadr N, 2011, BIOMATERIALS, V32, P7479, DOI 10.1016/j.biomaterials.2011.06.034
   Shastri VP, 2009, ADV MATER, V21, P3246, DOI [10.1002/adma.200900608, 10.1002/adma.200990155]
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   VERNON RB, 1995, IN VITRO CELL DEV-AN, V31, P120
   VERNON RB, 1995, AM J PATHOL, V147, P873
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765
   Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109
   Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631
NR 55
TC 106
Z9 110
U1 9
U2 157
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2012
VL 33
IS 35
BP 9009
EP 9018
DI 10.1016/j.biomaterials.2012.08.068
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 032MC
UT WOS:000310721900011
PM 23018132
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lee, BK
   Ju, YM
   Cho, JG
   Jackson, JD
   Lee, SJ
   Atala, A
   Yoo, JJ
AF Lee, Bu-Kyu
   Ju, Young Min
   Cho, Jae-Gu
   Jackson, John D.
   Lee, Sang Jin
   Atala, Anthony
   Yoo, James J.
TI End-to-side neurorrhaphy using an electrospun PCL/collagen nerve conduit
   for complex peripheral motor nerve regeneration
SO BIOMATERIALS
LA English
DT Article
DE End to side neurorrhaphy; Nerve repair; Nerve guidance channel; Tissue
   engineering
ID WALKING TRACK ANALYSIS; OF-THE-LITERATURE; AUTOGENOUS VEIN; RAT MODEL;
   IN-VIVO; REPAIR; GRAFT; RECONSTRUCTION; DENERVATION; MUSCLES
AB In cases of complex neuromuscular defects, finding the proximal stump of a transected nerve in order to restore innervation to damaged muscle is often impossible. In this study we investigated whether a neighboring uninjured nerve could serve as a source of innervation of denervated damaged muscle through a biomaterial-based nerve conduit while preserving the uninjured nerve function. Tubular nerve conduits were fabricated by electrospinning a polymer blend consisting of poly(e-caprolactone) (PCL) and type I collagen. Using a rat model of common peroneal injury, the proximal end of the nerve conduit was connected to the side of the adjacent uninjured tibial branch (TB) of the sciatic nerve after partial axotomy, and the distal end of the conduit was connected to the distal stump of the common peroneal nerve (CPN). The axonal continuity recovered through the nerve conduit at 8 weeks after surgery. Recovery of denervated muscle function was achieved, and simultaneously, the donor muscle, which was innervated by the axotomized TB also recovered at 20 weeks after surgery. Therefore, this end-to-side neurorrhaphy (ETS) technique using the electrospun PCL/collagen conduit appears to be clinically feasible and would be a useful alternative in instances where autologous nerve grafts or an adequate proximal nerve stump is unavailable. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Lee, Bu-Kyu; Ju, Young Min; Cho, Jae-Gu; Jackson, John D.; Lee, Sang Jin; Atala, Anthony; Yoo, James J.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Lee, Bu-Kyu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oral & Maxillofacial Surg, Seoul, South Korea.
   [Cho, Jae-Gu] Korea Univ, Guro Hosp, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.
RP Yoo, JJ (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM jyoo@wakehealth.edu
RI Yoo, James/L-4850-2017
OI Atala, Anthony/0000-0001-8186-2160; Lee, Sang Jin/0000-0002-3899-1909
FU Department of Defense [Orthopaedic Trauma Research Program]
   [W81XWH-08-1-0333]
FX We would like to thank Dr. Jennifer Olson for editorial assistance and
   Ms. Tiffany Bledsoe and Ms. Cathy Mathis for technical assistance. This
   study was supported, in part, by a grant from the Department of Defense
   [Orthopaedic Trauma Research Program (W81XWH-08-1-0333)].
CR BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   Balik O, 2010, ANN PLAST SURG
   Bontioti E, 2009, INT REV NEUROBIOL, V87, P251, DOI 10.1016/S0074-7742(09)87012-8
   Brenner MJ, 2007, PLAST RECONSTR SURG, V120, P215, DOI 10.1097/01.prs.0000264094.06272.67
   Brenner MJ, 2006, LARYNGOSCOPE, V116, P1685, DOI 10.1097/01.mlg.0000229469.31749.91
   Bryan DJ, 1996, J RECONSTR MICROSURG, V12, P439, DOI 10.1055/s-2007-1006616
   Chaiyasate K, 2009, J INVEST SURG, V22, P401, DOI 10.3109/08941930903410775
   DEMEDINACELI L, 1989, MICROSURG, V10, P56, DOI 10.1002/micr.1920100111
   DENGLER R, 1989, NEUROSCI LETT, V97, P118, DOI 10.1016/0304-3940(89)90149-3
   Dijkstra JR, 2000, J NEUROSCI METH, V96, P89, DOI 10.1016/S0165-0270(99)00174-0
   Dong MM, 2010, FACIAL PLAST SURG, V26, P421, DOI 10.1055/s-0030-1265023
   Driscoll PJ, 2002, J ORTHOPAED RES, V20, P370, DOI 10.1016/S0736-0266(01)00104-8
   Dvali LT, 2008, HAND CLIN, V24, P455, DOI 10.1016/j.hcl.2008.04.006
   Frostick SP, 1995, INT ANGIOL, V14, P278
   GILLESPIE MJ, 1986, J PHYSIOL-LONDON, V372, P485, DOI 10.1113/jphysiol.1986.sp016021
   Goheen-Robillard B, 2002, LARYNGOSCOPE, V112, P899, DOI 10.1097/00005537-200205000-00022
   GOOCH JL, 1995, J TOXICOL-CLIN TOXIC, V33, P419, DOI 10.3109/15563659509013750
   Gramsbergen A, 1999, DEV BRAIN RES, V112, P217, DOI 10.1016/S0165-3806(98)00184-9
   HARE GMT, 1992, PLAST RECONSTR SURG, V89, P251, DOI 10.1097/00006534-199202000-00009
   Hayashi A, 2008, EXP NEUROL, V211, P539, DOI 10.1016/j.expneurol.2008.02.031
   Huilgol RL, 2006, ANZ J SURG, V76, P878, DOI 10.1111/j.1445-2197.2006.03830.x
   Kakibuchi M, 2004, ANN PLAS SURG, V53, P496, DOI 10.1097/01.sap.0000116283.76872.de
   Karacaoglu E, 2001, MICROSURG, V21, P196, DOI 10.1002/micr.1038
   Koenig J, 2009, NEUROCHIRURGIE, V55, pS104, DOI 10.1016/j.neuchi.2008.05.008
   Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Liu K, 1999, J ORTHOP RES, V17, P293, DOI 10.1002/jor.1100170220
   Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5
   Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165
   Matsuda K, 2008, J PLAST RECONSTR AES, V61, P1357, DOI 10.1016/j.bjps.2008.04.013
   Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3
   Noah EM, 1997, J RECONSTR MICROSURG, V13, P99, DOI 10.1055/s-2007-1000224
   Noah EM, 1999, J RECONSTR MICROSURG, V15, P449
   Ozmen S, 2002, PLAST RECONSTR SURG, V109, P1760
   Pabari A, 2010, J PLAST RECONSTR AES
   Pannucci C, 2007, RESTOR NEUROL NEUROS, V25, P45
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7
   Rafuse VF, 1996, J NEUROPHYSIOL, V75, P282
   Salpeter MM, 1999, SCIENCE, V286, P424, DOI 10.1126/science.286.5439.424
   SLACK JR, 1979, NATURE, V282, P506, DOI 10.1038/282506a0
   STANIFORTH P, 1978, HAND, V10, P187, DOI 10.1016/S0072-968X(78)80012-6
   Sundine MJ, 2003, PLAST RECONSTR SURG, V111, P2255, DOI 10.1097/01.PRS.0000060089.45869.59
   TANG JB, 1995, J RECONSTR MICROSURG, V11, P21, DOI 10.1055/s-2007-1006506
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Weber RV, 2005, CLIN PLAST SURG, V32, P605, DOI 10.1016/j.cps.2005.05.003
   Yamauchi Toru, 2000, Medical Electron Microscopy, V33, P151, DOI 10.1007/s007950000015
   Yampolsky P, 2010, EUR J NEUROSCI, V31, P646, DOI 10.1111/j.1460-9568.2010.07096.x
   Yan JG, 2002, J HAND SURG-AM, V27A, P484, DOI 10.1053/jhsu.2002.32953
   Zhao Juan, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P107
   Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922
NR 50
TC 35
Z9 37
U1 0
U2 70
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2012
VL 33
IS 35
BP 9027
EP 9036
DI 10.1016/j.biomaterials.2012.09.008
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 032MC
UT WOS:000310721900013
PM 22998812
DA 2018-10-19
ER

PT J
AU Song, BB
   Song, JS
   Zhang, SS
   Anderson, MA
   Ao, Y
   Yang, CY
   Deming, TJ
   Sofroniew, MV
AF Song, Bingbing
   Song, Jinsuk
   Zhang, Shanshan
   Anderson, Mark A.
   Ao, Yan
   Yang, Chu-Ya
   Deming, Timothy J.
   Sofroniew, Michael V.
TI Sustained local delivery of bioactive nerve growth factor in the central
   nervous system via tunable diblock copolypeptide hydrogel depots
SO BIOMATERIALS
LA English
DT Article
DE Depots; Scaffolds; Brain; Spinal cord; Drug delivery; Hydrogels
ID SEPTAL CHOLINERGIC NEURONS; SPINAL-CORD-INJURY; POLYPEPTIDE HYDROGELS;
   REACTIVE ASTROCYTES; AXON REGENERATION; BASAL FOREBRAIN; NEURAL REPAIR;
   TISSUE; NGF; IMPLANTATION
AB Biomaterial vehicles that can provide sustained, site-specific molecular delivery in the central nervous system (CNS) have potential for therapeutic and investigative applications. Here, we present in vitro and in vivo proof of principle tests of diblock copolypeptide hydrogels (DCH) to serve as depots for sustained local release of protein effector molecules. We tested two DCH, K180L20 and E180L20, previously shown to self-assemble into biocompatible, biodegradable deposits that persist four to eight weeks after injection into mouse forebrain. In vitro tests demonstrated sustained release from dialysis cassettes of the representative protein, lysozyme, dissolved in K180L20 or E180L20 hydrogels. Release time in vitro varied in relation to DCH charge and mechanical properties, and ionic strength of the media. To evaluate bioactive protein delivery in vivo, we used nerve growth factor (NGF) and measured the size of mouse forebrain cholinergic neurons, which respond to NGF with cellular hypertrophy. For in vivo tests, the storage modulus of DCH depots was tuned to just below that of CNS tissue. In comparison with NGF injected in buffer, depots of NGF dissolved in either K180L20 or E180L20 provided significantly longer delivery of NGF bioactivity, maintaining hypertrophy of local forebrain cholinergic neurons for at least 4 weeks and inducing hypertrophy a further distance away (up to 5 mm) from injection sites. These findings show that depots of DCH injected into CNS can provide sustained delivery within the blood brain barrier of a bioactive protein growth factor that exerts a predicted, quantifiable effect on local cells over a prolonged subacute time. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Song, Bingbing; Anderson, Mark A.; Ao, Yan; Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.
   [Song, Jinsuk; Zhang, Shanshan; Yang, Chu-Ya; Deming, Timothy J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Sofroniew, MV (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
EM sofroniew@mednet.ucla.edu
RI Deming, Timothy/I-5411-2013
OI Deming, Timothy/0000-0002-0594-5025
FU Adelson Medical Research Foundation (Adelson Program in Neural
   Rehabilitation and Repair); Wings for Life; Roman Reed Fund of
   California; Nanopacific Holdings
FX This study was supported by the Adelson Medical Research Foundation
   (Adelson Program in Neural Rehabilitation and Repair), Wings for Life
   and the Roman Reed Fund of California. Jinsuk Song was supported by
   Nanopacific Holdings. We thank Prof. Tom Mason for use of the rheometer
   to study DCH mechanical properties. We thank Ms. Rose Korsak for
   technical assistance.
CR Barrer R.M., 1941, DIFFUSION SOLIDS
   Breedveld V, 2004, MACROMOLECULES, V37, P3943, DOI 10.1021/ma049885f
   Busch NA, 2000, MACROMOLECULES, V33, P5932, DOI 10.1021/ma0005724
   Deming TJ, 2005, SOFT MATTER, V1, P28, DOI 10.1039/b500307e
   Deming TJ, 1999, MACROMOLECULES, V32, P4500, DOI 10.1021/ma9902899
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   ECKENSTEIN F, 1983, J NEUROSCI, V3, P2286
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.010
   Lampe KJ, 2011, J BIOMED MATER RES A, V96A, P595, DOI 10.1002/jbm.a.33011
   Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008
   McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714
   Menei P, 2000, EXP NEUROL, V161, P259, DOI 10.1006/exnr.1999.7253
   Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2
   Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165
   Nowak AP, 2003, J AM CHEM SOC, V125, P15666, DOI 10.1021/ja0381050
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1
   PHILLIES GDJ, 1985, BIOPOLYMERS, V24, P379, DOI 10.1002/bip.360240206
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Sirianni RW, 2010, BRAIN RES, V1321, P40, DOI 10.1016/j.brainres.2010.01.041
   SOFRONIEW MV, 1993, J NEUROSCI, V13, P5263
   Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217
   SOFRONIEW MV, 1990, SCIENCE, V247, P338, DOI 10.1126/science.1688664
   SOFRONIEW MV, 1987, BRAIN RES, V411, P310, DOI 10.1016/0006-8993(87)91084-5
   SVENDSEN CN, 1994, J NEUROSCI, V14, P75
   Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006
   TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012
   Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
NR 35
TC 47
Z9 48
U1 4
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2012
VL 33
IS 35
BP 9105
EP 9116
DI 10.1016/j.biomaterials.2012.08.060
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 032MC
UT WOS:000310721900021
PM 22985994
DA 2018-10-19
ER

PT J
AU Sileri, P
   Boehm, G
   Franceschilli, L
   Giorgi, F
   Perrone, F
   Stolfi, C
   Monteleone, G
   Gaspari, AL
AF Sileri, P.
   Boehm, G.
   Franceschilli, L.
   Giorgi, F.
   Perrone, F.
   Stolfi, C.
   Monteleone, G.
   Gaspari, A. L.
TI Collagen matrix injection combined with flap repair for complex anal
   fistula
SO COLORECTAL DISEASE
LA English
DT Article
DE Permacol; complex anal fistula; flap repair
ID ENDORECTAL ADVANCEMENT FLAP; IN-ANO; FIBRIN GLUE; MANAGEMENT; OUTCOMES;
   EFFICACY; PLUG
AB Several biomaterials have been proposed to treat anal fistula alone or in combination with other surgical procedures aiming to reduce recurrence rates while minimizing continence impairment. More recently a porcine dermal matrix injection has been proposed as infill biomaterial to treat fistulae. We propose an approach consisting of non-cutting seton positioning followed several weeks later by flap repair associated with dermal matrix injection into the fistula tracts. We report our experience with this two-staged procedure on 24 consecutive patients with complex anal fistulae with a median follow up of > 12 months. In our experience this two-stage approach seems to be safe and effective.
C1 [Sileri, P.; Franceschilli, L.; Giorgi, F.; Perrone, F.; Gaspari, A. L.] Univ Roma Tor Vergata, Policlin Tor Vergata, Dept Surg, I-00133 Rome, Italy.
   [Boehm, G.] Univ Hosp RWTH Aachen, Dept Gen Visceral & Transplant Surg, Aachen, Germany.
   [Stolfi, C.; Monteleone, G.] Univ Roma Tor Vergata, Policlin Tor Vergata, Dept Gastroenterol, I-00133 Rome, Italy.
RP Sileri, P (reprint author), Univ Roma Tor Vergata, Policlin Tor Vergata, Dept Surg, Viale Oxford 81, I-00133 Rome, Italy.
EM piersileri@yahoo.com
OI Stolfi, Carmine/0000-0002-6354-2443
CR Bohm G, 2011, J BIOMATER APPL, V25, P721, DOI 10.1177/0885328210361543
   Buchanan GN, 2003, DIS COLON RECTUM, V46, P1167, DOI 10.1097/01.DCR.0000084408.85802.A2
   Chung W, 2009, AM J SURG, V197, P604, DOI 10.1016/j.amjsurg.2008.12.013
   Davies M, 2008, INT J COLORECTAL DIS, V23, P833, DOI 10.1007/s00384-008-0444-x
   Ellis CN, 2010, DIS COLON RECTUM, V53, P798, DOI 10.1007/DCR.0b013e3181d43b7d
   Garg P, 2010, COLORECTAL DIS, V12, P965, DOI 10.1111/j.1463-1318.2009.01933.x
   Hammond T M, 2004, Colorectal Dis, V6, P308, DOI 10.1111/j.1463-1318.2004.00676.x
   Hammond TM, 2010, COLORECTAL DIS, V13, P94
   Himpson RC, 2009, DIS COLON RECTUM, V52, P602, DOI 10.1007/DCR.0b013e31819ece3e
   Hyman N, 2009, DIS COLON RECTUM, V52, P2022, DOI 10.1007/DCR.0b013e3181b72378
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Kimuli M, 2004, BJU INT, V94, P859, DOI 10.1111/j.1464-410X.2004.05047.x
   Lindsey I, 2002, COLORECTAL DIS, V4, P118
   Milito G, 2009, J AM COLL SURGEONS, V209, P542, DOI 10.1016/j.jamcollsurg.2009.07.012
   Ortiz H, 2008, BRIT J SURG, V95, P484, DOI 10.1002/bjs.6023
   Soltani A, 2010, DIS COLON RECTUM, V53, P486, DOI 10.1007/DCR.0b013e3181ce8b01
   Sonoda T, 2002, DIS COLON RECTUM, V45, P1622, DOI 10.1097/01.0000037653.68665.E8
   van Koperen PJ, 2008, INT J COLORECTAL DIS, V23, P697, DOI 10.1007/s00384-008-0460-x
   Zmora O, 2003, DIS COLON RECTUM, V46, P584, DOI 10.1097/01.DCR.0000064697.21308.37
NR 19
TC 7
Z9 7
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-8910
J9 COLORECTAL DIS
JI Colorectal Dis.
PD DEC
PY 2012
VL 14
SU 3
SI SI
BP 24
EP 28
DI 10.1111/codi.12046
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 034OH
UT WOS:000310882300006
PM 23136821
OA Bronze
DA 2018-10-19
ER

PT J
AU Watson, NFS
   Koshy, A
   Sagar, PM
AF Watson, N. F. S.
   Koshy, A.
   Sagar, P. M.
TI Anal bulking agents for faecal incontinence
SO COLORECTAL DISEASE
LA English
DT Review
DE Passive faecal seepage; internal anal sphincter dysfunction; collagen
   injections
ID INJECTABLE SILICONE BIOMATERIAL; SPHINCTER; IMPLANTS; EFFICACY; TRIAL
AB The aim of this review was to assess and evaluate reports of studies on the efficacy of anal bulking agents used in the treatment of faecal incontinence. A systematic review of the literature was carried out to identify studies that have reported on the use of anal bulking agents. A variety of biomaterials have been employed for anal bulking. These include autologous fat, bovine glutaraldehyde cross-linked collagen, carbon-coated zirconium oxide beads, dextranomer microspheres in a gel, hydrogel cross-linked with polyacrylamide, polydimethylsiloxane elastomer in a gel, porcine dermal collagen and synthetic calcium hydroxylapatitie ceramic microspheres. Although the ideal site of injection (submucosal or intramuscular) and the mechanism of action remain the subject of debate, most published studies report a significant improvement in continence in at least 50% of subjects with mild to moderate symptoms with little or no associated morbidity.We concluded that anal bulking agents may be used to alleviate symptoms of faecal seepage and soilage.
C1 [Watson, N. F. S.; Koshy, A.; Sagar, P. M.] St James Univ Hosp, John Goligher Colorectal Unit, Leeds LS9 7TF, W Yorkshire, England.
RP Sagar, PM (reprint author), St James Univ Hosp, John Goligher Colorectal Unit, Leeds LS9 7TF, W Yorkshire, England.
EM petersagar@aol.com
CR Brown SR, 2010, COCHRANE DA IN PRESS, V8
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Hussain ZI, 2011, BRIT J SURG, V98, P1526, DOI 10.1002/bjs.7645
   Kamm MA, 2003, BRIT MED J, V327, P1299, DOI 10.1136/bmj.327.7427.1299
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2010, COCHRANE DB SYST REV, V12
   Mercer-Jones M., 2010, PELVIC FLOOR DISORDE, P237
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Thekkinkattil DK, 2009, BRIT J SURG, V96, P680, DOI 10.1002/bjs.6597
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
NR 15
TC 26
Z9 26
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-8910
J9 COLORECTAL DIS
JI Colorectal Dis.
PD DEC
PY 2012
VL 14
SU 3
SI SI
BP 29
EP 33
DI 10.1111/codi.12047
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 034OH
UT WOS:000310882300007
PM 23136822
OA Bronze
DA 2018-10-19
ER

PT J
AU Chaves, MD
   Nunes, LSD
   de Oliveira, RV
   Holgado, LA
   Nary, H
   Matsumoto, MA
   Ribeiro, DA
AF Chaves, Marcelo Donizeti
   de Souza Nunes, Leandro Soeiro
   de Oliveira, Renato Victor
   Holgado, Leandro Andrade
   Nary Filho, Hugo
   Matsumoto, Mariza Akemi
   Ribeiro, Daniel Araki
TI Bovine hydroxyapatite (Bio-Oss (R)) induces osteocalcin, RANK-L and
   osteoprotegerin expression in sinus lift of rabbits
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Bovine hidroxiapatite; Sinus lift; eNOS; Osteocalcin; RANK-L;
   osteoprotegerin
AB Purpose: The aim of this study was to analyze and compare the expression of osteocalcin, RANK-L, osteoprotegerin, in sinus lift procedures using bovine hydroxyapatite (HA).
   Material and methods: Twenty four male rabbits underwent bilateral sinus lift procedures were distributed into two groups, according to the sinus filling material: Group 1) autogenous bone graft; and Group 2) bovine HA. All groups were sacrificed after 14 and 30 days, for microscopic and immunohistochemistry analysis.
   Results: At 14 days after surgery, discrete osteogenesis was observed in the highly vascularized granulation tissue surrounding HA particles, as well as woven bone deposition on the biomaterial surface. Following 30 days, well organized bone trabeculas were seen surrounding the HA granules presenting areas of osteogenic activity. Morphometric findings did not show remarkable differences between groups. Bovine HA induced similar osteocalcin, RANK-L, osteoprotegerin immunoexpressivity when compared to autogenous bone graft group for both periods evaluated in this setting.
   Conclusion: Taken together, these data are consistent with the notion that HA has a similar biological behavior to autogenous bone graft in sinus lift of rabbits. (C) 2012 European Association for Cranio-Maxillo-Facial Surgery.
C1 [Chaves, Marcelo Donizeti; Ribeiro, Daniel Araki] Univ Fed Sao Paulo, UNIFESP, Dept Biociencias, BR-10060001 Santos, SP, Brazil.
   [de Souza Nunes, Leandro Soeiro; de Oliveira, Renato Victor; Holgado, Leandro Andrade; Matsumoto, Mariza Akemi] Univ Sagrado Coracao, Sch Dent, Dept Hlth Sci, Discipline Oral & Maxillofacial Surg, Bauru, SP, Brazil.
RP Ribeiro, DA (reprint author), Univ Fed Sao Paulo, UNIFESP, Dept Biociencias, Av Ana Costa 95, BR-10060001 Santos, SP, Brazil.
EM daribeiro@unifesp.br
RI Matsumoto, Mariza/C-5183-2012
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
   [2007/04767-3]; CNPq
FX The authors are grateful to Maira Cristina Rondina Couto for histology
   assistance, Wilson Aparecido Orcini for morphometry assistance, Marcelo
   Souza e Silva for immunohistochemical procedures and Sergio Henrique
   Moura for animal care. This work was supported by FAPESP (Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo, Grant number 2007/04767-3).
   DAR is a recipient of the CNPq fellowship.
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Alcaide M, 2009, BIOMATERIALS, V30, P45, DOI 10.1016/j.biomaterials.2008.09.012
   Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   CAMARDA AJ, 1987, CALCIFIED TISSUE INT, V40, P349, DOI 10.1007/BF02556698
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x
   Cowan CM, 2005, CURR TOP DEV BIOL, V66, P239, DOI 10.1016/S0070-2153(05)66008-5
   Cricchio Giovanni, 2003, Clin Implant Dent Relat Res, V5, P161, DOI 10.1111/j.1708-8208.2003.tb00198.x
   de Resende M. Monterio, 2007, V180, P37
   Hammerle CHF, 2008, CLIN ORAL IMPLAN RES, V19, P19, DOI 10.1111/j.1600-0501.2007.01407.x
   Hench LL, 2004, BIOMATERIALS SCI INT, P153
   Kelly J, 2009, J PROSTHODONT, V18, P473, DOI 10.1111/j.1532-849X.2009.00446.x
   Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Park JW, 2009, CLIN ORAL IMPLAN RES, V20, P372, DOI 10.1111/j.1600-0501.2008.01602.x
   Robiony M, 2008, CLIN ORAL IMPLAN RES, V19, P1202, DOI 10.1111/j.1600-0501.2008.01568.x
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   SUGIMOTO T, 1993, J BONE MINER RES, V8, P1445
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   Weibel ER, 1970, PRACTICAL STEREOLOGI, P58
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P40, DOI 10.1016/j.bjoms.2004.10.004
NR 21
TC 11
Z9 11
U1 4
U2 12
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD DEC
PY 2012
VL 40
IS 8
BP E315
EP E320
DI 10.1016/j.jcms.2012.01.014
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA V35WJ
UT WOS:000209175700016
PM 22513050
DA 2018-10-19
ER

PT J
AU Draenert, GF
   Huetzen, DO
   Kammerer, PW
   Palarie, V
   Nacu, V
   Wagner, W
AF Draenert, G. F.
   Huetzen, D. O.
   Kaemmerer, P. W.
   Palarie, V.
   Nacu, V.
   Wagner, W.
TI Dexrazoxane shows cytoprotective effects in zoledronic acid-treated
   human cells in vitro and in the rabbit tibia model in vivo
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Osteonecrosis of the jaws; Bisphosphonates; Cytoprotectant
AB Introduction: Bisphosphonates are important and effective drugs in oncology and osteoporosis therapy. They accumulate in the bone matrix becoming released and active by bone resorption. This leads to effective inhibition of tumor cells and bone degradation. A side effect of bisphosphonates similar to other drugs like denosumab is osteonecrosis of the jaws (ONJ). This problem mostly occurs after tooth extraction. We studied the cytoprotectant dexrazoxane known from anthracycline chemotherapy for cytoprotection in nitrogen-containing bisphosphonate treated cells and in the rabbit tibia model to evaluate a possible value in ONJ management.
   Materials & methods: Human osteoblasts (HOB) P2 cells and Human ginigiva fibroblasts (HGF) P2 cells were treated with zoledronic acid (50 mu mol/L) and the cytoprotectant dexrazoxane (600 mmol/L). Analysis included cell viability testing with MTT assay and morphology analysis using CellTracker (TM) Green CMFDA. A biomaterial carrier (Bio-Oss Collagen) was implanted in the rabbit tibia of 6 female chinchilla bastard rabbits on both sides with drill hole defects (d: 3.2 mm). Implants were loaded with 25 nmol zoledronic acid, with and without 300 nmol dexrazoxane and unloaded in a control group. Analysis included histological examination of undecalcified samples with toloudine blue staining after 10 days.
   Results: In vitro experiments showed a significantly higher MTT activity in cells treated with zoledronic acid together with dexrazoxane compared to the same cells treated with the bisphosphonate alone in t-test (HOB: p = 0.0003; HGF: p below 0.0001) and one-way ANOVA. Cell morphology changes were consistent with these results. In vivo results showed newly formed bone trabeculae directly growing towards the implanted hydroxylapatite particles and cortical bone interface resorption activities in the control and the experimental group only.
   Conclusion: The study suggests a possible value of this patented technology for ONJ therapy and prevention with local or systemic application. (C) 2012 European Association for Cranio-Maxillo-Facial Surgery.
C1 [Draenert, G. F.] Univ Marburg, Clin Maxillofacial Surg, D-35039 Marburg, Germany.
   [Kaemmerer, P. W.; Wagner, W.] Johannes Gutenberg Univ Mainz, Clin Maxillofacial Surg, D-55131 Mainz, Germany.
   [Palarie, V.; Nacu, V.] State Med & Pharmaceut Univ Nicolae Testemitanu, Clin Oral & Maxillofacial Surg, Kishinev, Moldova.
RP Draenert, GF (reprint author), Univ Marburg, Clin Maxillofacial Surg, Georg Voigt Str 3, D-35039 Marburg, Germany.
EM draenert@draenert.net
OI Palarie, Victor/0000-0003-1420-7523; Kammerer, Peer
   Wolfgang/0000-0002-1671-3764
CR Acil Y, J CRANIOMAX IN PRESS
   Adornato MC, 2007, J AM DENT ASSOC, V138, P971, DOI 10.14219/jada.archive.2007.0294
   Bakheet SA, 2011, MUTAGENESIS, V26, P533, DOI 10.1093/mutage/ger013
   Baldwin JR, 1996, BIOPHARM DRUG DISPOS, V17, P541, DOI 10.1002/(SICI)1099-081X(199608)17:6<541::AID-BDD975>3.0.CO;2-5
   Barry EV, 2008, J CLIN ONCOL, V26, P1106, DOI 10.1200/JCO.2007.12.2481
   BASSER RL, 1994, J CLIN ONCOL, V12, P1659, DOI 10.1200/JCO.1994.12.8.1659
   Boanini E, 2012, BIOMATERIALS, V33, P722, DOI 10.1016/j.biomaterials.2011.09.092
   Boivin G., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P538
   Boivin G, 2002, CONNECT TISSUE RES, V43, P535, DOI 10.1080/03008200290000934
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Cuzick J, 2011, LANCET ONCOL, V12, P496, DOI 10.1016/S1470-2045(11)70030-4
   Della TP, 1996, TOXICOL PATHOL, V24, P398
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Elihu N, 1998, J CLIN PHARMACOL, V38, P101, DOI 10.1002/j.1552-4604.1998.tb04397.x
   Epstein MS, 2010, ORAL SURG ORAL MED O, V110, P593, DOI 10.1016/j.tripleo.2010.05.067
   Ferlito S, 2011, J ORAL MAXIL SURG, V69, pE1, DOI 10.1016/j.joms.2010.10.055
   Forsgren J, 2011, BIOTECHNOL LETT, V33, P1265, DOI 10.1007/s10529-011-0542-7
   Fusco V, 2011, J CLIN ONCOL, V29, pE521, DOI 10.1200/JCO.2011.35.1551
   Galetta F, 2010, BIOMED PHARMACOTHER, V64, P259, DOI 10.1016/j.biopha.2009.06.018
   George S, 2010, CURR ONCOL REP, V12, P80, DOI 10.1007/s11912-010-0088-1
   Goettsch WG, 2007, PHARMACOEPIDEM DR S, V16, P166, DOI 10.1002/pds.1245
   Green JR, 2004, ONCOLOGIST, V9, P3, DOI 10.1634/theoncologist.9-90004-3
   Handler RP, 2008, JCR-J CLIN RHEUMATOL, V14, P122, DOI 10.1097/RHU.0b013e31816d84b8
   Hasinoff BB, 1998, SEMIN ONCOL, V25, P3
   Hasinoff BB, 1998, ANTI-CANCER DRUG, V9, P465, DOI 10.1097/00001813-199806000-00014
   Hellmann K, 1998, SEMIN ONCOL, V25, P48
   Khosla S, 2008, J ORAL MAXIL SURG, V66, P1320, DOI [10.1016/j.joms.2008.01.054, 10.1016/j.jams.2008.01.054]
   Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ
   Kwon YD, 2009, QUINTESSENCE INT, V40, P277
   Kyle RA, 2004, CANCER-AM CANCER SOC, V101, P2667, DOI 10.1002/cncr.20652
   Kyrgidis A, 2011, J CRANIO MAXILL SURG, V39, P271, DOI 10.1016/j.jcms.2010.03.002
   Lipshultz SE, 2004, NEW ENGL J MED, V351, P145, DOI 10.1056/NEJMoa035153
   Lipshultz SE, 2010, LANCET ONCOL, V11, P950, DOI 10.1016/S1420-2045(10)70204-7
   Magliery T J, 1997, Met Based Drugs, V4, P199, DOI 10.1155/MBD.1997.199
   Marcuzzi A, 2011, ORAL ONCOL, V47, P436, DOI 10.1016/j.oraloncology.2011.02.017
   Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1
   Mast G, J CRANIOMAX IN PRESS
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   O'Marcaigh A S, 1997, J Pediatr Oncol Nurs, V14, P96
   Otto S, J CRANIOMAX IN PRESS
   Phekoo KJ, 2004, BRIT J HAEMATOL, V127, P299, DOI 10.1111/j.1365-2141.2004.05207.x
   Popelova O, 2009, BRIT J CANCER, V101, P792, DOI 10.1038/sj.bjc.6605192
   PR- Newswire- Europe- Ltd, 2008, GLOB OST THER MARK R
   Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5
   Rizzoli R, 2008, BONE, V42, P841, DOI 10.1016/j.bone.2008.01.003
   Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831
   Saad F, ANN ONCOL IN PRESS
   Sarasquete ME, 2008, BLOOD, V112, P2709, DOI 10.1182/blood-2008-04-147884
   Sedghizadeh PP, 2009, J AM DENT ASSOC, V140, P61, DOI 10.14219/jada.archive.2009.0019
   Simon MJK, 2010, CLIN ORAL INVEST, V14, P51, DOI 10.1007/s00784-009-0312-2
   Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101
   Surgeons AAoOaM, 2007, J ORAL MAXILLOFAC SU, V65, P369
   Swain SM, 1997, J CLIN ONCOL, V15, P1333, DOI 10.1200/JCO.1997.15.4.1333
   Tebbi CK, 2007, J CLIN ONCOL, V25, P493, DOI 10.1200/JCO.2005.02.3879
   Ural AU, 2007, CLIN CANCER RES, V13, P3432, DOI 10.1158/1078-0432.CCR-07-0079
   van Dalen EC, 2011, LANCET ONCOL, V12, P12, DOI 10.1016/S1470-2045(10)70301-6
   van Dalen EC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006647.pub2
   Vescovi P, MINERVA STOMATOL, V59, P181
   Vescovi P, 1959, MINERVA STOMATOL, V59, P204
   Visiongain Inc, 2010, OST BON MET DIS WORL
   Weiss G, 1997, BIOCHEM PHARMACOL, V53, P1419, DOI 10.1016/S0006-2952(96)00894-5
   Xiao WH, 2009, PAIN, V147, P202, DOI 10.1016/j.pain.2009.09.006
   Ziebart T, 2011, ORAL ONCOL, V47, P195, DOI 10.1016/j.oraloncology.2010.12.003
   Ziebart T, 2009, CLIN ORAL INVEST, V15, P105, DOI DOI 10.1007/S00784-009-0365-2
NR 64
TC 6
Z9 6
U1 0
U2 13
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD DEC
PY 2012
VL 40
IS 8
BP E369
EP E374
DI 10.1016/j.jcms.2012.01.028
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA V35WJ
UT WOS:000209175700027
PM 22429609
DA 2018-10-19
ER

PT J
AU Giobbe, GG
   Zagallo, M
   Riello, M
   Serena, E
   Masi, G
   Barzon, L
   Di Camillo, B
   Elvassore, N
AF Giobbe, Giovanni G.
   Zagallo, Monica
   Riello, Massimo
   Serena, Elena
   Masi, Giulia
   Barzon, Luisa
   Di Camillo, Barbara
   Elvassore, Nicola
TI Confined 3D microenvironment regulates early differentiation in human
   pluripotent stem cells
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE human embryonic stem cells; human induced pluripotent stem cells;
   differentiation; embryoid bodies; microenvironment; hydrogel microwells;
   endogenous factors
ID EMBRYOID BODY FORMATION; HUMAN BLASTOCYSTS; MEDIATED CONTROL; IN-VITRO;
   SIZE; LINES; BIOLOGY; SYSTEM; GROWTH; FATE
AB The therapeutic potential of human pluripotent stem (hPS) cells is threatened, among various problems, by the difficulty to homogenously direct cell differentiation into specific lineages. The transition from hPSC into committed differentiated cells is accompanied by secretome activity, remodeling of extracellular matrix and self-organization into germ layers. In this work, we aimed to investigate how different three-dimensional microenvironments regulate the early differentiation of the three germ layers in human embryonic stem (hES) cells derived embryoid bodies. In particular, a permeable, biocompatible, hydrogel microwell array was specifically designed for recreating a confined niche in which EB secreted molecules accumulate in accordance with hydrogel diffusional cut-off. Fluorescence recovery after photobleaching technique was performed to accurately evaluate hydrogel permeability, mesh size and diffusional cutoff for soluble molecules. Three different culture conditions of EB culture were analyzed: suspension, confinement in microwells of width/depth ratio 1:1 and 1:2. Results show that EBs cultured in microwells are viable and have comparable average size after 8 days culture. Whole genome microarrays show that significative differential gene expression was observed between suspension and confined EBs culture. In particular, EBs culture in microwells promotes the expression of genes involved in pattern specification processes, brain development, ectoderm and endoderm differentiation. On the contrary, suspension EBs express instead genes involved in mesoderm specification and heart development. These results suggest that local accumulation of EBs secreted molecules drives differentiation patterns, as confirmed by immunofluorescence of germ layer markers, in hydrogel confined EB culture from both hES cells and human induced pluripotent stem (hiPS) cells. Our findings highlight an additional potential role of biomaterial in controlling hPSC differentiation through secreted factor niche specification. Biotechnol. Bioeng. 2012; 109: 31193132. (C) 2012 Wiley Periodicals, Inc.
C1 [Giobbe, Giovanni G.; Zagallo, Monica; Riello, Massimo; Serena, Elena; Elvassore, Nicola] Univ Padua, Dept Ind Engn DII, I-35131 Padua, Italy.
   [Giobbe, Giovanni G.; Zagallo, Monica; Serena, Elena; Elvassore, Nicola] VIMM, I-35129 Padua, Italy.
   [Masi, Giulia; Barzon, Luisa] Dept Histol Microbiol & Med Biotechnol, I-35131 Padua, Italy.
   [Di Camillo, Barbara] Univ Padua, Dept Informat Engn DEI, I-35131 Padua, Italy.
RP Elvassore, N (reprint author), Univ Padua, Dept Ind Engn DII, Via Marzolo 9, I-35131 Padua, Italy.
EM nicola.elvassore@unipd.it
RI Di Camillo, Barbara/L-3202-2013; Barzon, Luisa/K-7961-2016; Masi,
   Giulia/K-1577-2016
OI Di Camillo, Barbara/0000-0001-8415-4688; Barzon,
   Luisa/0000-0003-0720-8456; Masi, Giulia/0000-0001-9138-9186; Giobbe,
   Giovanni/0000-0001-6958-7303
FU FSE "Fondo Sociale Europeo"; Progetti di Eccellenza Cariparo; Universita
   degli Studi di Padova
FX This research has been supported by the FSE "Fondo Sociale Europeo,"
   "Progetti di Eccellenza Cariparo," and the Universita degli Studi di
   Padova.
CR Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Bratt-Leal AM, 2009, BIOTECHNOL PROGR, V25, P43, DOI [10.1021/bp.139, 10.1002/btpr.139]
   Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115
   Cimetta E, 2009, BIOMED MICRODEVICES, V11, P389, DOI 10.1007/s10544-008-9245-9
   Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003
   Dennis G. J., 2003, GENOME BIOL, V4, pP3, DOI DOI 10.1186/GB-2003-4-5-P3
   Dvash T, 2004, BEST PRACT RES CL OB, V18, P929, DOI 10.1016/j.bpobgyn.2004.06.005
   GERMAIN EL, 1986, IN VITRO CELL DEV B, V22, P107
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605
   Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389
   Lee LH, 2009, STEM CELL RES, V2, P155, DOI 10.1016/j.scr.2008.11.004
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033
   Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193
   Park J, 2007, LAB CHIP, V7, P1018, DOI 10.1039/b704739h
   Park JY, 2009, LAB CHIP, V9, P2043, DOI 10.1039/b820955c
   Peerani R, 2009, PLOS ONE, V4
   Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896
   Pekkanen-Mattila M, 2010, HISTOCHEM CELL BIOL, V133, P595, DOI 10.1007/s00418-010-0689-7
   Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Stennard F, 1997, CURR OPIN GENET DEV, V7, P620, DOI 10.1016/S0959-437X(97)80009-3
   Tekin H, 2010, LAB CHIP, V10, P2411, DOI 10.1039/c004732e
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tian XH, 2004, EXP HEMATOL, V32, P1000, DOI 10.1016/j.exphem.2004.06.013
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006
   Williams JC, 1998, BIOPHYS J, V75, P493, DOI 10.1016/S0006-3495(98)77538-1
NR 35
TC 29
Z9 29
U1 0
U2 64
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD DEC
PY 2012
VL 109
IS 12
BP 3119
EP 3132
DI 10.1002/bit.24571
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 028ZU
UT WOS:000310465300024
PM 22674472
DA 2018-10-19
ER

PT J
AU Hammonds, RL
   Harrison, MS
   Cravanas, TC
   Gazzola, WH
   Stephens, CP
   Benson, RS
AF Hammonds, R. L.
   Harrison, M. S.
   Cravanas, T. C.
   Gazzola, W. H.
   Stephens, C. P.
   Benson, R. S.
TI Biomimetic hydroxyapatite powder from a bacterial cellulose scaffold
SO CELLULOSE
LA English
DT Article
DE Hydroxyapatite; Biomimetic; Bacterial cellulose; Cellulase; Degradation
ID CALCIUM-DEFICIENT HYDROXYAPATITE; IN-VIVO; HYDROLYSIS; TEMPERATURE;
   CHEMISTRY; HYDROGEL; BIOMASS; APATITE
AB In a persistent search to find affordable biomaterial sources, calcium deficient hydroxyapatite (CdHA) precipitated onto bacterial cellulose (BC) composites are excellent candidates. CdHA is resorbable in vivo and biomimetic to HA found in native bone due to its calcium deficiency. The shape of the starting BC scaffold limits BC/CdHA composite applications. In order to make greater use of these composites, this study aimed to investigate the feasibility in generating a CdHA powder from the original composite. The CdHA powder could be utilized at bone injury sites as stand-alone bone filler or as filler in an injectable system. This study selected thermal and enzymatic methods to investigate the effectiveness of BC removal from the original composite matrix. Scanning electron microscopy was used to examine the nanoscale hydroxyapatite rosettes. Energy dispersive x-ray spectroscopy was used to determine the calcium deficiency of hydroxyapatite. Thermogravimetric analysis was used to detect the presence of cellulose in the composites by mass. Fourier transform infrared spectroscopy was used to obtain chemical information of the degraded materials. Each degradation method successfully produced calcium deficient hydroxyapatite powders.
C1 [Hammonds, R. L.; Gazzola, W. H.; Benson, R. S.] Univ Tennessee, Knoxville, TN 37996 USA.
   [Harrison, M. S.; Cravanas, T. C.; Stephens, C. P.] Univ Tennessee, Dept Surg, Lab Regenerat Med, Knoxville, TN 37920 USA.
RP Benson, RS (reprint author), Univ Tennessee, 434 Dougherty Hall, Knoxville, TN 37996 USA.
EM rbenson1@utk.edu
RI S, C/A-3713-2012
CR Anthony JC, 1997, BIODEGRADATION CELLU
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HOWELL JA, 1975, BIOTECHNOL BIOENG, V17, P873, DOI 10.1002/bit.260170608
   Hutchens SA, 2007, THESIS U TENNESSEE
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Hutchens SA, 2009, CELLULOSE, V16, P887, DOI 10.1007/s10570-009-9300-6
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   LeGeros RZ, 2003, KEY ENG MAT, V240-2, P3, DOI 10.4028/www.scientific.net/KEM.240-242.3
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Mostafa NY, 2005, MATER CHEM PHYS, V94, P333, DOI 10.1016/j.matchemphys.2005.05.011
   Park JB, 1984, BIOMATERIALS SCI ENG
   POSNER AS, 1969, PHYSIOL REV, V49, P760
   Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+
   Schlufter K, 2006, MACROMOL RAPID COMM, V27, P1670, DOI 10.1002/marc.200600463
   SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sullivan AL, 2012, ATMOS ENVIRON, V47, P133, DOI 10.1016/j.atmosenv.2011.11.022
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Vallet-Regi M, 1997, SOLID STATE IONICS, V101, P1279, DOI 10.1016/S0167-2738(97)00213-0
   Williams PT, 1996, RENEW ENERG, V7, P233, DOI 10.1016/0960-1481(96)00006-7
   Yadav V, 2010, APPL ENVIRON MICROB, V76, P6257, DOI 10.1128/AEM.00698-10
   Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282
NR 24
TC 7
Z9 8
U1 1
U2 67
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
J9 CELLULOSE
JI Cellulose
PD DEC
PY 2012
VL 19
IS 6
BP 1923
EP 1932
DI 10.1007/s10570-012-9767-4
PG 10
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 029ZV
UT WOS:000310538300011
DA 2018-10-19
ER

PT J
AU Martinez-Ramos, C
   Valles-Lluch, A
   Verdugo, JMG
   Ribelles, JLG
   Barcia, JA
   Orts, AB
   Lopez, JMS
   Pradas, MM
AF Martinez-Ramos, Cristina
   Valles-Lluch, Ana
   Garcia Verdugo, Jose Manuel
   Gomez Ribelles, Jose Luis
   Antonio Barcia, Juan
   Baiget Orts, Amparo
   Soria Lopez, Jose Miguel
   Monleon Pradas, Manuel
TI Channeled scaffolds implanted in adult rat brain
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE scaffold; biocompatibility; brain; angiogenesis; neural regeneration
ID NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; CNS WHITE-MATTER;
   SUBVENTRICULAR ZONE; SPINAL-CORD; AXON REGENERATION; SCHWANN-CELLS;
   OLFACTORY NEURONS; ISCHEMIC-STROKE; DIFFERENTIATION
AB Scaffolds with aligned channels based on acrylate copolymers, which had previously demonstrated good compatibility with neural progenitor cells were studied as colonizable structures both in vitro with neural progenitor cells and in vivo, implanted without cells in two different locations, in the cortical plate of adult rat brains and close to the subventricular zone. In vitro, neuroprogenitors colonize the scaffold and differentiate into neurons and glia within its channels. When implanted in vivo immunohistochemical analysis by confocal microscopy for neural and endothelial cells markers demonstrated that the scaffolds maintained continuity with the surrounding neural tissue and were colonized by GFAP-positive cells and, in the case of scaffolds implanted in contact with the subventricular zone, by neurons. Local angiogenesis was evidenced in the interior of the scaffolds' pores. New axons and neural cells from the adult neural niche abundantly colonized the biomaterial's inner structure after 2 months, and minimal scar formation was manifest around the implant. These findings indicate the biocompatibility of the polymeric material with the brain tissue and open possibilities to further studies on the relevance of factors such as scaffold structure, scaffold seeding and scaffold placement for their possible use in regenerative strategies in the central nervous system. The development of neural interfaces with minimized glial scar and improved tissue compatibility of the implants may also benefit from these results. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A 100A:32763286, 2012.
C1 [Martinez-Ramos, Cristina; Valles-Lluch, Ana; Gomez Ribelles, Jose Luis; Baiget Orts, Amparo; Monleon Pradas, Manuel] Univ Politecn Valencia, Ctr Biomat, E-46071 Valencia, Spain.
   [Garcia Verdugo, Jose Manuel] Univ Valencia, Inst Cavanilles, E-46980 Valencia, Spain.
   [Garcia Verdugo, Jose Manuel; Soria Lopez, Jose Miguel] Inst Nacl Salud Carlos III, CIBER Enfermedades Neurodegenerat, Madrid, Spain.
   [Gomez Ribelles, Jose Luis; Monleon Pradas, Manuel] Inst Nacl Salud Carlos III, CIBER Bioingn Biomat & Nanomed, Madrid, Spain.
   [Antonio Barcia, Juan] Hosp Clin San Carlos, Madrid, Spain.
   [Soria Lopez, Jose Miguel] Univ CEU Cardenal Herrera, Fac Ciencias Salud, Valencia 46113, Spain.
RP Pradas, MM (reprint author), Univ Politecn Valencia, Ctr Biomat, POB 22012, E-46071 Valencia, Spain.
EM mmonleon@upvnet.upv.es
RI soria, jose/K-6722-2014; Valles-Lluch, Ana/D-1891-2010; MartiAnez-Ramos,
   Cristina/G-1591-2015; Martinez-Ramos, Cristina/B-8917-2015; Soria Lopez,
   Jose Miguel/M-5266-2017; Gomez Ribelles, Jose Luis/L-5629-2014
OI soria, jose/0000-0001-9144-5096; Valles-Lluch, Ana/0000-0002-7896-8666;
   MartiAnez-Ramos, Cristina/0000-0002-6540-4714; Martinez-Ramos,
   Cristina/0000-0001-7981-2324; Soria Lopez, Jose
   Miguel/0000-0001-9144-5096; Gomez Ribelles, Jose
   Luis/0000-0001-9099-0885; Barcia Albacar, Juan
   Antonio/0000-0001-6562-4568; MONLEON PRADAS, MANUEL/0000-0001-6457-0414
FU Spanish Fondo de Investigacion Sanitaria (Spanish Ministry of Health)
   [CP04/00036, PI05/075]; Spanish Ministry of Science and Innovation
   [MAT2008-06434]; Fundacion Ramon Areces; Copernicus Program of
   University CEU-Cardenal Herrera; Generalitat Valenciana; Spanish
   National Health Institute Carlos III
FX Contract grant sponsor: Spanish Fondo de Investigacion Sanitaria
   (Spanish Ministry of Health); contract grant numbers: CP04/00036 and
   PI05/075; Contract grant sponsor: Spanish Ministry of Science and
   Innovation; contract grant number: MAT2008-06434; Contract grant
   sponsors: Fundacion Ramon Areces; Copernicus Program of University
   CEU-Cardenal Herrera; Regenerative Medicine Program Agreement between
   the Generalitat Valenciana and the Spanish National Health Institute
   Carlos III
CR Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002
   Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4
   Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Bandtlow CE, 2003, EXP GERONTOL, V38, P79, DOI 10.1016/S0531-5565(02)00165-1
   CADELLI DS, 1992, EXP NEUROL, V115, P189, DOI 10.1016/0014-4886(92)90246-M
   Davies SJA, 1998, TRENDS NEUROSCI, V21, P515, DOI 10.1016/S0166-2236(98)01335-6
   De Marchis S, 2004, EUR J NEUROSCI, V20, P1307, DOI 10.1111/j.1460-9568.2004.03584.x
   Doetsch F, 2001, BRAIN BEHAV EVOLUT, V58, P306, DOI 10.1159/000057572
   Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E
   GARCIAVERDUGO JM, 1989, NEUROSCI LETT, V98, P247, DOI 10.1016/0304-3940(89)90408-4
   Gritti A., 2001, PROTOCOLS NEURAL CEL, P173, DOI [10.1385/1-59259-207-4:173, DOI 10.1385/1-59259-207-4:173]
   Hashimoto T, 2002, EXP BRAIN RES, V146, P356, DOI 10.1007/s00221-002-1173-y
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hsu SH, 2009, ARTIF ORGANS, V33, P26, DOI 10.1111/j.1525-1594.2008.00671.x
   Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6
   Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Kemp SWP, 2009, TISSUE ENG PT A, V15, P1975, DOI 10.1089/ten.tea.2008.0338
   Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998
   Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X
   Lindvall Olle, 2004, NeuroRx, V1, P379, DOI 10.1602/neurorx.1.4.379
   Lindvall Olle, 2004, NeuroRx, V1, P382
   Lluch AV, 2009, J BIOMED MATER RES B, V90B, P182, DOI 10.1002/jbm.b.31272
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec
   Martinez-Ramos C, 2008, TISSUE ENG PT A, V14, P1365, DOI 10.1089/ten.tea.2007.0295
   McKerracher L, 2001, NEUROBIOL DIS, V8, P11, DOI 10.1006/nbdi.2000.0359
   Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693
   Nieuwenhuys R, 2007, HUMAN CENTRAL NERVOU, P967
   Nishio T, 2009, J NEUROL, V256, pS306, DOI 10.1007/s00415-009-5244-x
   O'Keeffe FE, 2008, BRAIN, V131, P630, DOI 10.1093/brain/awm340
   Olakowska E, 2010, FOLIA NEUROPATHOL, V48, P231
   Osanai T, 2010, NEUROSURGERY, V66, P1140, DOI 10.1227/01.NEU.0000369610.76181.CF
   Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Hernandez JCR, 2008, J BIOMED MATER RES B, V84B, P541, DOI 10.1002/jbm.b.30902
   Soria JM, 2007, J BIOMED MATER RES A, V83A, P463, DOI 10.1002/jbm.a.31297
   Soria JM, 2006, J BIOMED MATER RES A, V79A, P495, DOI 10.1002/jbm.a.30803
   Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0
   Tabesh H, 2009, NEUROCHEM INT, V54, P73, DOI 10.1016/j.neuint.2008.11.002
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Vidaurre A, 2003, MACROMOL SYMP, V200, P283, DOI 10.1002/masy.200351030
   Walker PA, 2009, STEM CELL REV REP, V5, P283, DOI 10.1007/s12015-009-9081-1
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715
   Xu Q, 2003, CEREB CORTEX, V13, P670, DOI 10.1093/cercor/13.6.670
   Yu D, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E10
   Zhang HZ, 2007, BRAIN RES, V1132, P29, DOI 10.1016/j.brainres.2006.09.117
NR 53
TC 24
Z9 24
U1 2
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2012
VL 100A
IS 12
BP 3276
EP 3286
DI 10.1002/jbm.a.34273
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 027ZH
UT WOS:000310392100011
PM 22733596
DA 2018-10-19
ER

PT J
AU Shankarraman, V
   Davis-Gorman, G
   McDonagh, PF
   Caplan, MR
AF Shankarraman, Venkat
   Davis-Gorman, Grace
   McDonagh, Paul F.
   Caplan, Michael R.
TI Intracellular signaling controls endothelial cell prostacyclin secretion
   and regulation of blood clotting time
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatible materials; thrombosis; intracellular signaling; systems
   biology; extracellular matrix
ID NF-KAPPA-B; INDUCED APOPTOSIS; GENE-EXPRESSION; VASCULAR GRAFT;
   THROMBOGENICITY; BIOMATERIALS; ACTIVATION; THROMBOSIS; MEMBRANE;
   PATHWAYS
AB Blood is constantly in contact with a biological material, the blood vessel wall, without the need for anticoagulants to prevent clot formation on the vessel wall; however, man-made biomaterials require anticoagulants to prevent clot formation on the biomaterial. This study seeks to understand how some biomaterials elicit anticoagulant responses from endothelial cells (ECs), whereas others do not. Partial least squares regression analysis was used to correlate the activity of four relevant signaling molecules [extracellular signal-related kinase (ERK), c-Jun N-terminal kinase (JNK), Akt, and I?B kinase (IKK)] with human umbilical vein EC secretion of prostacyclin and clotting time of whole blood in contact with these cells. Prostacyclin secretion was increased when JNK activity (mean of all time-points) was elevated and IKK activity at 30 min was reduced. In addition, the clotting time, R-time measured by thromboelastography, was increased (reduced coagulability) when activity of both ERK and JNK (mean of all time-points) were increased and when Akt activity was increased at longer contact times (2472 h after cell contact with material). Inhibition of each signaling molecule with subsequent testing for prostacyclin secretion and R-time confirmed the interrelationship between EC intracellular signaling and prostacyclin secretion. Generally, JNK inhibition decreased and IKK inhibition increased prostacyclin secretion. Inhibition of ERK or JNK generally increased coagulability, and Akt inhibition decreased the R-time of samples normally eliciting reduced coagulability. These findings increase our understanding of the signaling pathways involved in endothelial prostacyclin release and suggest targets for developing EC-seeded biomaterial surfaces that can minimize coagulation. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A:33743383, 2012.
C1 [Shankarraman, Venkat; Caplan, Michael R.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.
   [Davis-Gorman, Grace; McDonagh, Paul F.] Univ Arizona, Hlth Sci Ctr, Dept Surg, Tucson, AZ USA.
   [Davis-Gorman, Grace; McDonagh, Paul F.] Univ Arizona, Hlth Sci Ctr, Sarver Heart Ctr, Tucson, AZ USA.
RP Caplan, MR (reprint author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.
EM Michael.Caplan@asu.edu
FU American Heart Association; Arizona Biomedical Research Commission;
   Sarver Heart Center Hudson/Lovaas Endowment Fund
FX Contract grant sponsors: American Heart Association, Arizona Biomedical
   Research Commission, Sarver Heart Center Hudson/Lovaas Endowment Fund
CR [Anonymous], 2009, EIG RES SOFTW DOC, V2009
   [Anonymous], 2009, HUM VITR PROD SPEC S, V2009
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   BRUCK SD, 1972, J BIOMED MATER RES, V6, P173, DOI 10.1002/jbm.820060306
   Clerk A, 2007, J CELL PHYSIOL, V212, P311, DOI 10.1002/jcp.21094
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598
   Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/cmb.2004.11.544
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kohlstedt K, 2005, HYPERTENSION, V45, P126, DOI 10.1161/01.HYP.0000150159.48992.11
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860
   Noe L, 2010, CURR MED CHEM, V17, P2897, DOI 10.2174/092986710792065018
   Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3
   Pauken CM, 2011, ACTA BIOMATER, V7, P3973, DOI 10.1016/j.actbio.2011.07.015
   Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153
   Qin HW, 2005, BLOOD, V106, P3114, DOI 10.1182/blood-2005-02-0759
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Shankarraman V, 2012, J BIOMED MATER RES B, V100B, P230, DOI 10.1002/jbm.b.31942
   Shankarraman V, 2010, CELL MOL BIOENG, V3, P229, DOI 10.1007/s12195-010-0122-2
   Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001
   Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538
   Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Yazdani S, 1998, AM HEART J, V136, P357, DOI 10.1053/hj.1998.v136.90408
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   ZILLA P, 1993, J CARDIAC SURG, V8, P32, DOI 10.1111/j.1540-8191.1993.tb00574.x
NR 30
TC 0
Z9 0
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2012
VL 100A
IS 12
BP 3374
EP 3383
DI 10.1002/jbm.a.34266
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 027ZH
UT WOS:000310392100021
PM 22767493
DA 2018-10-19
ER

PT J
AU Adamiak, K
   Anders, T
   Henze, M
   Keul, H
   Moller, M
   Elling, L
AF Adamiak, Kathrin
   Anders, Thorsten
   Henze, Manja
   Keul, Helmut
   Moeller, Martin
   Elling, Lothar
TI Chemo-enzymatic synthesis of functionalized oligomers of
   N-acetyllactosamine glycan derivatives and their immobilization on
   biomaterial surfaces
SO JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
LA English
DT Article; Proceedings Paper
CT 10th International Symposium on Biocatalysis and Biotransformations
   (BIOTRANS)
CY OCT 02-06, 2011
CL Giardini Naxos, ITALY
DE Poly-LacNAc; Glycosyltransferases; beta 1,4-galactosyltransferase; beta
   1,3-N-acetyl-glucosaminyltransferase; Galectin
ID ONE-POT SYNTHESIS; BINDING-PROTEINS; ENZYMATIC-SYNTHESIS;
   BETA-1,4-GALACTOSYLTRANSFERASE; GLYCOPROTEINS; SPECIFICITY; FABRICATION;
   GALACTOSE; GALECTINS; LIGANDS
AB Poly-N-acetyllactosamines (poly-LacNAc, [-3Gal(beta 1-4)GlcNAc(beta 1-](n)) are terminal glycan structures present in glycoproteins and glycolipids. Their biological functions as ligands for galectins and as carriers of glycan epitopes are well documented. In the present paper we have characterized six novel functionalized beta-D-GlcNAc derivatives, including aglyca of varying hydrophobicity and molecular weight, as substrates for recombinant human beta 1,4 galactosyltransferase 1 (beta 4GalT-1). The sugar derivatives carry short or long amino- or azide-terminated linker molecules for further modification or immobilization. The linker chemistry had an impact on enzyme kinetics and enzymatic syntheses of N-acetyllactosamine derivatives (LacNAc, Gal(beta 1-4)GlcNAc(beta 1-R). The combination of beta 4GaIT-1 with bacterial beta 1,3-N-acetylglucosaminyltransferase (beta 3GlcNAc-T) resulted in the preparative syntheses of LacNAc oligomers with up to three LacNAc repeating units. All products were characterized by NMR and MS. The obtained LacNAc glycans were immobilized onto microtiter plates and their efficiency of binding of fungal galectin CGL2 was determined. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Adamiak, Kathrin; Henze, Manja; Elling, Lothar] Rhein Westfal TH Aachen, Inst Biotechnol, Lab Biomat, D-52056 Aachen, Germany.
   [Adamiak, Kathrin; Henze, Manja; Elling, Lothar] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52056 Aachen, Germany.
   [Anders, Thorsten; Keul, Helmut; Moeller, Martin] Rhein Westfal TH Aachen, DWI, D-52056 Aachen, Germany.
   [Anders, Thorsten; Keul, Helmut; Moeller, Martin] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52056 Aachen, Germany.
RP Elling, L (reprint author), Rhein Westfal TH Aachen, Inst Biotechnol, Lab Biomat, Worringer Weg 1, D-52056 Aachen, Germany.
EM Keul@dwi.rwth-aachen.de; Moeller@dwi.rwth-aachen.de;
   l.elling@biotec.rwth-aachen.de
RI Moller, Martin/F-7860-2015
OI Moller, Martin/0000-0002-5955-4185
CR Anders T, 2011, MACROMOL BIOSCI, V11, P1201, DOI 10.1002/mabi.201100041
   Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200
   Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101
   Blixt O, 2001, J ORG CHEM, V66, P2442, DOI 10.1021/jo0057809
   Brewer FC, 2002, BIOCHIM BIOPHYS ACTA, V1572, P255
   Brinkmann N, 2001, BIOORG MED CHEM LETT, V11, P2503, DOI 10.1016/S0960-894X(01)00474-7
   Brockhausen I, 2006, GLYCOCONJUGATE J, V23, P525, DOI 10.1007/s10719-006-7153-x
   Drozdova A, 2011, CARBOHYD RES, V346, P1599, DOI 10.1016/j.carres.2011.04.043
   Drueckhammer D. G., 1991, SYNTHESIS-STUTTGART, V499, P525
   Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8
   Fazio F, 2004, TETRAHEDRON LETT, V45, P2689, DOI 10.1016/j.tetlet.2004.01.159
   Fazio F, 2002, J AM CHEM SOC, V124, P14397, DOI 10.1021/ja020887u
   Gasteier P, 2007, MACROMOL BIOSCI, V7, P1010, DOI 10.1002/mabi.200700064
   Grafahrend D., 2010, NAT MATER, V10, P67
   Groll J, 2004, J AM CHEM SOC, V126, P4234, DOI 10.1021/ja0318028
   Heyes CD, 2007, MOL BIOSYST, V3, P419, DOI 10.1039/b700055n
   HORTON D, 1966, ORG SYNTH, V46, P1, DOI DOI 10.15227/0RGSYN.046.0001
   Houseman BT, 2002, CHEM BIOL, V9, P443, DOI 10.1016/S1074-5521(02)00124-2
   Ibatullin FM, 2000, SYNTHETIC COMMUN, V30, P2819, DOI 10.1080/00397910008086908
   Koenigs W, 1901, BER DTSCH CHEM GES, V34, P957, DOI 10.1002/cber.190103401162
   Logan SM, 2005, GLYCOBIOLOGY, V15, P721, DOI 10.1093/glycob/cwi057
   Murata T, 2005, BBA-GEN SUBJECTS, V1722, P60, DOI 10.1016/j.bbagen.2004.11.008
   Namdjou DJ, 2007, ADV SYNTH CATAL, V349, P314, DOI 10.1002/adsc.200606169
   Park SJ, 2002, ANGEW CHEM INT EDIT, V41, P3180, DOI 10.1002/1521-3773(20020902)41:17<3180::AID-ANIE3180>3.0.CO;2-S
   Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785
   Rech C, 2011, ADV SYNTH CATAL, V353, P2492, DOI 10.1002/adsc.201100375
   Sauerzapfe B, 2008, J MOL CATAL B-ENZYM, V50, P128, DOI 10.1016/j.molcatb.2007.09.009
   Sauerzapfe B, 2009, GLYCOCONJUGATE J, V26, P141, DOI 10.1007/s10719-008-9172-2
   Seibel J, 2006, CHEMBIOCHEM, V7, P310, DOI 10.1002/cbic.200500350
   Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004
   Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068
   Ujita M, 1999, J BIOL CHEM, V274, P16717, DOI 10.1074/jbc.274.24.16717
   Vasiliu D, 2006, CARBOHYD RES, V341, P1447, DOI 10.1016/j.carres.2006.03.043
   Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062
   Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002
   Witten KG, 2011, SMALL, V7, P1954, DOI 10.1002/smll.201100492
   WONG CH, 1995, ANGEW CHEM INT EDIT, V34, P521, DOI 10.1002/anie.199505211
   WULFF G, 1972, CHEM BER-RECL, V105, P1122, DOI 10.1002/cber.19721050405
   Wulff G., 1974, ANGEW CHEM, V86, P173
   Zemplen G, 1929, BER DTSCH CHEM GES, V62, P1613, DOI 10.1002/cber.19290620640
   Zhou DP, 2003, CURR PROTEIN PEPT SC, V4, P1, DOI 10.2174/1389203033380304
NR 41
TC 11
Z9 11
U1 0
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-1177
J9 J MOL CATAL B-ENZYM
JI J. Mol. Catal. B-Enzym.
PD DEC
PY 2012
VL 84
SI SI
BP 108
EP 114
DI 10.1016/j.molcatb.2012.02.002
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA 017EO
UT WOS:000309573100019
DA 2018-10-19
ER

PT J
AU Wang, ZH
   Yan, J
   Zheng, Q
   Wang, ZG
AF Wang, Zhanhui
   Yan, Jun
   Zheng, Qi
   Wang, Zhigang
TI CyclinD1, CDK4, and P21 expression by IEC-6 cells in response to NiTi
   alloy and polymeric biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biocompatibility; Nickel-titanium alloy; Contact angle; Wettability;
   Carcinogenesis; In vitro
ID MESSENGER-RNA EXPRESSION; SUTURE MATERIALS; EXPERIMENTAL CARCINOGENESIS;
   COLORECTAL CARCINOGENESIS; EXTRACELLULAR-MATRIX; BIOLOGICAL RESPONSES;
   DEPENDENT KINASES; CANCER; TITANIUM; ADHESION
AB In order to investigate how cells recognize biomaterials, mRNA that was expressed in attached Intestinal epithelial cells (IEC-6) on various suture substrates was evaluated. The expressed cell cycle regulators (cyclin D1, CDK4 and p21) mRNA were then isolated and detected using the real time-polymerase chain reaction (PCR) method. As a result, cyclin D1 gene expression was affected by cell-polymer adhesion and was associated with cell proliferation. In addition, CDK4 gene expression was affected by cell proliferation rather than by cell-biomaterial interaction. The p21 mRNA gene expression was higher in cells on more hydrophilic surfaces than on hydrophobic surfaces. Further, the cyclin D1, CDK4 and p21 gene expression were also influenced by the surface chemistry of suture materials. We concluded that the expression of cyclin D1. CDK4 and p21 mRNA was a powerful method for studying cell-biomaterial interactions or the evaluation of the carcinogenic activity of biomaterials. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Wang, Zhanhui; Yan, Jun; Zheng, Qi; Wang, Zhigang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 6, Dept Gen Surg, Shanghai 200233, Peoples R China.
RP Zheng, Q (reprint author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 6, Dept Gen Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China.
EM greatzhengqi@gmail.com
FU Natural Science Foundation of China [30901422]
FX This work was supported by the Natural Science Foundation of China (No.
   30901422).
CR Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874
   Bagui TK, 2003, MOL CELL BIOL, V23, P7285, DOI 10.1128/MCB.23.20.7285-7290.2003
   BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812
   CALDERISI RN, 1984, CANCER RES, V44, P2827
   Chou LS, 1996, J BIOMED MATER RES, V31, P209
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   Dietrich C, 2010, CARCINOGENESIS, V31, P1319, DOI 10.1093/carcin/bgq028
   EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0
   ELDEIRY WS, 1994, CANCER RES, V54, P1169
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213
   Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138
   Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995
   GILBERTSEN VA, 1960, ANN SURG, V151, P340, DOI 10.1097/00000658-196003000-00007
   GILLETT C, 1994, CANCER RES, V54, P1812
   Goke M, 1996, AM J PHYSIOL-GASTR L, V271, pG729
   Hagerman EM, 2006, J BIOMED MATER RES A, V76A, P272, DOI 10.1002/jbm.a.30562
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   HARPER JW, 1993, CELL, V75, P805
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kato S, 2000, BIOMATERIALS, V21, P521, DOI 10.1016/S0142-9612(99)00214-8
   Kato S, 1998, BIOMATERIALS, V19, P821, DOI 10.1016/S0142-9612(97)00240-8
   Kim SY, 2009, CLIN ORAL IMPLAN RES, V20, P262, DOI 10.1111/j.1600-0501.2008.01652.x
   LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847
   LIN JC, 1994, J COLLOID INTERF SCI, V164, P99, DOI 10.1006/jcis.1994.1147
   Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065
   MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066
   MCCUE JL, 1992, DIS COLON RECTUM, V35, P902, DOI 10.1007/BF02047881
   MCGREGOR JR, 1991, DIS COLON RECTUM, V34, P987, DOI 10.1007/BF02049962
   Muftuoglu MAT, 2004, AM J SURG, V188, P200, DOI 10.1016/j.amjsurg.2003.12.068
   NAKAMURA A, 1992, J BIOMED MATER RES, V26, P631, DOI 10.1002/jbm.820260506
   Nakamura T, 1998, J BIOMED MATER RES, V42, P475, DOI 10.1002/(SICI)1097-4636(19981215)42:4<475::AID-JBM1>3.0.CO;2-B
   PHILLIPS RKS, 1986, BRIT J SURG, V73, P671, DOI 10.1002/bjs.1800730830
   QUARONI A, 1978, P NATL ACAD SCI USA, V75, P5548, DOI 10.1073/pnas.75.11.5548
   Santos MF, 1997, AM J PHYSIOL-GASTR L, V273, pG175
   Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Sun T, 2010, SURF COAT TECH, V205, P92, DOI 10.1016/j.surfcoat.2010.06.019
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   TOTH RW, 1985, J PROSTHET DENT, V54, P564, DOI 10.1016/0022-3913(85)90435-4
   UMPLEBY HC, 1987, BRIT J SURG, V74, P873, DOI 10.1002/bjs.1800741003
   WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
   Wang HY, 2010, BIOMATERIALS, V31, P413, DOI 10.1016/j.biomaterials.2009.09.066
   Wataha JC, 1997, J BIOMED MATER RES, V36, P145, DOI 10.1002/(SICI)1097-4636(199708)36:2<145::AID-JBM2>3.0.CO;2-K
   WILLIAMSON RCN, 1982, GUT, V23, P316, DOI 10.1136/gut.23.4.316
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wood SR, 2003, TISSUE CELL, V35, P47, DOI 10.1016/S0040-8166(02)00103-9
NR 51
TC 0
Z9 0
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2012
VL 32
IS 8
BP 2183
EP 2189
DI 10.1016/j.msec.2012.05.049
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 028BD
UT WOS:000310396900007
DA 2018-10-19
ER

PT J
AU Kim, JJ
   Jin, GZ
   Yu, HS
   Choi, SJ
   Kim, HW
   Wall, IB
AF Kim, Jung-Ju
   Jin, Guang-Zhen
   Yu, Hye-Sun
   Choi, Seong-Jun
   Kim, Hae-Won
   Wall, Ivan B.
TI Providing osteogenesis conditions to mesenchymal stem cells using
   bioactive nanocomposite bone scaffolds
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nanocomposite scaffolds; Bioactive glass; Mesenchymal stem cells;
   Osteogenic differentiation; Bone tissue engineering
ID IN-VITRO DEGRADATION; MECHANICAL-PROPERTIES; OSTEOBLAST RESPONSES;
   COMPOSITE SCAFFOLDS; POLY(LACTIC ACID); GLASS NANOFIBER; HYDROXYAPATITE;
   REGENERATION; BIOMATERIAL; NANOSCALE
AB Development of bone scaffolds with excellent osteogenic potential is highly important for stem cell-based bone engineering. Here we developed novel scaffolds made of poly( lactic acid) (PLA) biopolymer with bioactive glass nanocomponent. In vitro bone bioactivity and osteogenic potential of the nanocomposite scaffolds were determined using bone marrow mesenchymal stem cells. Glass nanocomponent was evenly embedded within the PLA matrix while preserving the scaffold pore structure. Simulated body fluid (SBF) test revealed rapid induction of bone mineral-like apatite over the surface of the nanocomposite scaffold, which was not readily observed in the PLA. Cells adhered well onto the nanocomposite scaffold and multiplied during culture period. Nanocomposite scaffold significantly stimulated alkaline phosphatase (ALP) activity and the expression of bone-associated genes (collagen I, ALP, osteopontin and osteocalcin) with respect to PLA. Western blot analysis confirmed the osteogenic protein level was also higher on the nanocomposite scaffold. Results suggest that the nanocomposite scaffolds provide favorable conditions for osteogenesis of MSCs and thus find potential uses in bone tissue engineering. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Kim, Jung-Ju; Yu, Hye-Sun; Kim, Hae-Won; Wall, Ivan B.] Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Kim, Jung-Ju; Yu, Hye-Sun; Kim, Hae-Won; Wall, Ivan B.] Dankook Univ, Grad Sch, WCU Res Ctr, Cheonan 330714, South Korea.
   [Kim, Jung-Ju; Jin, Guang-Zhen; Yu, Hye-Sun; Choi, Seong-Jun; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 330714, South Korea.
   [Kim, Hae-Won] Dankook Univ, Sch Dent, Dept Biomat Sci, Cheonan 330714, South Korea.
   [Wall, Ivan B.] UCL, Dept Biochem Engn, London WC1E 7JE, England.
RP Kim, HW (reprint author), Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
EM kimhw@dku.edu
FU Priority Research Centers Program [2009-0093829]; WCU (World Class
   University) Program through the National Research Foundation (NRF)
   [R31-10069]; Ministry of Education, Science and Technology
FX This work was supported by the Priority Research Centers Program (grant
   no.: 2009-0093829) and WCU (World Class University) Program (grant no.:
   R31-10069) through the National Research Foundation (NRF) funded by the
   Ministry of Education, Science and Technology.
CR Bang S.H., 2011, J MATER CHEM, V12, P4523
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Dalby M.J., 2007, NAT MATER, V6, P1997
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Ensanya A., 2010, J TISSUE ENG
   Freed L. E., 1994, NAT BIOTECHNOL, V12, P689
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Jo JH, 2009, J BIOMED MATER RES B, V91B, P213, DOI 10.1002/jbm.b.31392
   Kim HW, 2008, J BIOMED MATER RES A, V85A, P651, DOI 10.1002/jbm.a.31339
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P643, DOI 10.1002/jbm.a.30866
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   Kim HW, 2004, J BIOMED MATER RES A, V70A, P467, DOI 10.1002/j.jbm.a.30100
   Kim SH, 2011, MAT SCI ENG C-MATER, V31, P612, DOI 10.1016/j.msec.2010.11.028
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Loty C., 2001, J BONE MINER RES, V16, P23123
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P335, DOI 10.1002/jbm.a.10587
   McNamara L. E., 2010, J TISSUE ENG, V2010
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Navarro M, 2005, ACTA BIOMATER, V1, P411, DOI 10.1016/j.actbio.2005.03.004
   Noh KT, 2010, MATER LETT, V64, P802, DOI 10.1016/j.matlet.2010.01.014
   Oh CH, 2010, TISSUE ENG PART C-ME, V16, P561, DOI [10.1089/ten.tec.2009.0274, 10.1089/ten.TEC.2009.0274]
   Oh SA, 2010, J TISSUE ENG
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Shin S.H., 2011, J TISSUE ENG
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Yang XBB, 2006, BIOCHEM BIOPH RES CO, V342, P1098, DOI 10.1016/j.bbrc.2006.02.021
   Yao J, 2005, BIOMATERIALS, V26, P1935, DOI 10.1016/j.biomaterials.2004.06.027
NR 33
TC 7
Z9 7
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2012
VL 32
IS 8
BP 2545
EP 2551
DI 10.1016/j.msec.2012.07.038
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 028BD
UT WOS:000310396900060
DA 2018-10-19
ER

PT J
AU Lee, KS
   Kim, BY
   Kim, DH
   Jin, BR
AF Lee, Kwang Sik
   Kim, Bo Yeon
   Kim, Doh Hoon
   Jin, Byung Rae
TI Molecular cloning and characterization of the partial major ampullate
   silk protein gene from the spider Araneus ventricosus
SO JOURNAL OF ASIA-PACIFIC ENTOMOLOGY
LA English
DT Article
DE Araneus ventricosus; Baculovirus expression vector; cDNA cloning; Major
   ampullate silk protein; Spider
ID CLAVIPES DRAGLINE SILK; NEPHILA-CLAVIPES; MECHANICAL-PROPERTIES;
   ESCHERICHIA-COLI; C-TERMINUS; CONSERVATION; EXPRESSION; FIBROIN; FIBER;
   BIOMATERIALS
AB Spider silks have great potential as biomaterials with extraordinary properties. Here, we report the cloning and characterization of the major ampullate silk protein gene from the spider Araneus ventricosus. A cDNA encoding the partial major ampullate silk protein (AvMaSp) was cloned from A. ventricosus. An analysis of the cDNA sequence shows that AvMaSp consists of a 240 amino acid repetitive region and a 99 amino acid C-terminal non-repetitive domain. The peptide motifs that were found in the spider major ampullate silk proteins, (A)n, (GA)n, and (GGX)n, were conserved in the repetitive region of AvMaSp. Phylogenetic analysis further confirmed that AvMaSp belongs to the spider major ampullate spidroin family of proteins. The AvMaSp-R cDNA, which encodes the 240 amino acid repetitive domain, was expressed as a soluble 22 kDa polypeptide in baculovirus-infected insect cells. Recombinant AvMaSp-R was degraded abruptly by trypsin. However, AvMaSp-R was stable at 100 C for at least 30 min. Additionally, the AvMaSp-R was stable at pH values from 2 to 12 for at least 1 h. Taken together, our findings describe the molecular structure and biochemical properties of the A. ventricosus major ampullate silk protein and demonstrate its potential as a biomaterial. (C) Korean Society of Applied Entomology, Taiwan Entomological Society and Malaysian Plant Protection Society, 2012. Published by Elsevier B.V. All rights reserved.
C1 [Lee, Kwang Sik; Kim, Bo Yeon; Kim, Doh Hoon; Jin, Byung Rae] Dong A Univ, Coll Nat Resources & Life Sci, Pusan 604714, South Korea.
RP Jin, BR (reprint author), Dong A Univ, Coll Nat Resources & Life Sci, Pusan 604714, South Korea.
EM brjin@dau.ac.kr
FU Rural Development Administration; Republic of Korea
FX This work was supported by a grant from the Rural Development
   Administration (Next-Generation Biogreen 21 Program), Republic of Korea.
CR Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   BECKWITT R, 1994, J BIOL CHEM, V269, P6661
   Challis RJ, 2006, INSECT MOL BIOL, V15, P45, DOI 10.1111/j.1365-2583.2005.00606.x
   Futatsumori-Sugai M, 2010, BIOCHEM BIOPH RES CO, V391, P931, DOI 10.1016/j.bbrc.2009.11.167
   Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Je YH, 2001, BIOTECHNOL LETT, V23, P575
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee KS, 2003, COMP BIOCHEM PHYS B, V135, P117, DOI 10.1016/S1096-4959(03)00055-1
   Lee KS, 2007, J BIOSCIENCES, V32, P705, DOI 10.1007/s12038-007-0070-8
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
NR 30
TC 8
Z9 8
U1 0
U2 19
PU KOREAN SOC APPLIED ENTOMOLOGY
PI SUWON
PA NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA,
   249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA
SN 1226-8615
J9 J ASIA-PAC ENTOMOL
JI J. Asia-Pac. Entomol.
PD DEC
PY 2012
VL 15
IS 4
BP 641
EP 646
DI 10.1016/j.aspen.2012.08.004
PG 6
WC Entomology
SC Entomology
GA 023OE
UT WOS:000310043500019
DA 2018-10-19
ER

PT J
AU Ungureanu, C
   Pirvu, C
   Mindroiu, M
   Demetrescu, I
AF Ungureanu, Camelia
   Pirvu, Cristian
   Mindroiu, Mihaela
   Demetrescu, Ioana
TI Antibacterial polymeric coating based on polypyrrole and polyethylene
   glycol on a new alloy TiAlZr
SO PROGRESS IN ORGANIC COATINGS
LA English
DT Review
DE TiAlZr; Polymeric coating; Surface characterization; Electrochemical
   tests; Antibacterial effect
ID NANOPARTICLES; PARTICLES; SURFACES; FILM; TI
AB In order to enhance properties of the polymer composite films, composite coatings based on polypyrrole (PPy) and polyethylene glycol (PEG), using various percentages of PEG (0.5%, 2%, 4%), were electrodeposited on a new titanium alloy electrode as insulating material. The structure of the coatings was investigated via infrared (FTIR) analysis, and the surface features were studied using contact angle determination, atomic force microscopy (AFM) and scanning electronic microscopy (SEM). When testing the antibacterial properties of the coatings, the best effect was found for the coating with 2% PEG concentration, which has hydrophilic character and small roughness. Such results are in concordance with mechanism of biomaterial-bacteria interaction which involves as factors affecting bacterial adhesion and growth an initial physicochemical interaction stage, where roughness and wettabilitty are factors promoting bacterial adhesion and biofilm deposition.
   For the 2% PEG concentration in composite, electrochemical tests type cyclic voltammetry, Tafel plots, and electrochemical impedance spectroscopy (EIS) indicated an increase of stability in comparison with the polymeric coating with PPy. The effect of PEG on stability and antibacterial properties of polymeric coating PPy/PEG on TiAlZr was characterized by varying the PEG concentration. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Ungureanu, Camelia; Pirvu, Cristian; Mindroiu, Mihaela; Demetrescu, Ioana] Univ Polytehn Bucharest, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
RP Demetrescu, I (reprint author), Univ Polytehn Bucharest, Fac Appl Chem & Mat Sci, 1-7 Polizu, Bucharest 011061, Romania.
EM i_demetrescu@chim.upb.ro
RI Mindroiu, Mihaela/B-7608-2011
OI Pirvu, Cristian/0000-0003-0339-6146
FU CNCSIS - UEFISCSU [PNII - IDEI PCCE 248/2010]
FX This work was supported by CNCSIS - UEFISCSU, project number PNII - IDEI
   PCCE 248/2010. The authors acknowledge Roxana Trusca for SEM analysis.
CR Ansari M. A., 2011, Biology and Medicine, V3, P141
   Ballarre J, 2010, ACTA BIOMATER, V6, P1601, DOI 10.1016/j.actbio.2009.10.015
   CHIRIFE J, 1983, ANTIMICROB AGENTS CH, V24, P409, DOI 10.1128/AAC.24.3.409
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   Demetrescu I, 2006, MOL CRYST LIQ CRYST, V448, P61, DOI 10.1080/15421400500377412
   Dow Chemical U.S.A, 1974, POL GLYC HDB
   Ionita D, 2011, J BIOSCI BIOENG, V112, P630, DOI 10.1016/j.jbiosc.2011.07.022
   Jaiswal S, 2010, INT J ANTIMICROB AG, V36, P280, DOI 10.1016/j.ijantimicag.2010.05.006
   Kassim A., 2006, PAC J SCI TECHNOL, V7, P103
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Mindroiu M, 2010, ELECTROCHIM ACTA, V56, P193, DOI 10.1016/j.electacta.2010.08.100
   Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001
   Popa MV, 2011, SURF COAT TECH, V205, P4776, DOI 10.1016/j.surfcoat.2011.04.040
   Popescu S, 2010, MOL CRYST LIQ CRYST, V522, P425, DOI 10.1080/15421401003720066
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Sirivisoot S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/8/085101
   Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s
   Vishnuvardhan TK, 2006, B MATER SCI, V29, P77, DOI 10.1007/BF02709360
   Watari F, 2010, NANOBIOMEDICINE, V1, P2
   Xing YG, 2012, PROG ORG COAT, V73, P219, DOI 10.1016/j.porgcoat.2011.11.005
NR 20
TC 14
Z9 14
U1 1
U2 73
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0300-9440
J9 PROG ORG COAT
JI Prog. Org. Coat.
PD DEC
PY 2012
VL 75
IS 4
BP 349
EP 355
DI 10.1016/j.porgcoat.2012.07.015
PG 7
WC Chemistry, Applied; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA 018VV
UT WOS:000309695700010
DA 2018-10-19
ER

PT J
AU Kleinbeck, K
   Anderson, E
   Ogle, M
   Burmania, J
   Kao, WJ
AF Kleinbeck, Kyle
   Anderson, Edward
   Ogle, Matthew
   Burmania, Jeanine
   Kao, W. John
TI The New (Challenging) Role of Academia in Biomaterial Translational
   Research and Medical Device Development
SO BIOINTERPHASES
LA English
DT Article
AB With the ever-changing landscape of translational research, the medical device and pharmaceutical industries increasingly license technologies with the added value of clinical and/or pre-clinical data rather than those in earlier stages of development. Universities have the potential to fill the gap in product development from academic laboratories through enhanced student training and increased implementation of some development and manufacturing activities that are traditionally found only in the private sector. A development roadmap is described from initial product feasibility through commercialization in the context of efficient development practices. The specific challenges in the design and development of biomaterial-based medical devices are described in the context of this development path with an emphasis on unique challenges for academic laboratories.
C1 [Kleinbeck, Kyle; Kao, W. John] Univ Wisconsin Madison Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA.
   [Anderson, Edward; Ogle, Matthew] Vatrix Med Inc, Madison, WI 53719 USA.
   [Burmania, Jeanine] Wisconsin Alumni Res Fdn, Madison, WI 53726 USA.
   [Kao, W. John] Univ Wisconsin Madison Coll Engn, Dept Biomed Engn, Madison, WI 53706 USA.
   [Kao, W. John] Univ Wisconsin Madison Sch Med & Publ Hlth, Dept Gen Surg, Madison, WI 53729 USA.
RP Kao, WJ (reprint author), Univ Wisconsin Madison Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@wisc.edu
FU NIBIB NIH HHS [R01 EB006613]
CR Kucklick TR, 2006, MED DEVICE R D HDB
   Piezsch JB, 2009, J MED DEV, V3
   Tierce J, 2010, EVIDENCE BASED MED, P40
   [U.S. Food and Drug Administration U.S. Department of Health and Human Services], 2004, 1 US DEP HLTH HUM SE
   Zenios S, 2010, BIODESIGN PROCESS IN
NR 5
TC 5
Z9 5
U1 1
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1934-8630
J9 BIOINTERPHASES
JI Biointerphases
PD DEC
PY 2012
VL 7
IS 1-4
AR 12
DI 10.1007/s13758-011-0012-8
PG 4
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 987UD
UT WOS:000307442400012
PM 22589055
OA Green Published, Green Accepted, Other Gold
DA 2018-10-19
ER

PT J
AU Pegueroles, M
   Tonda-Turo, C
   Planell, JA
   Gil, FJ
   Aparicio, C
AF Pegueroles, Marta
   Tonda-Turo, Chiara
   Planell, Josep A.
   Gil, Francisco-Javier
   Aparicio, Conrado
TI Adsorption of Fibronectin, Fibrinogen, and Albumin on TiO2:
   Time-Resolved Kinetics, Structural Changes, and Competition Study
SO BIOINTERPHASES
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; HUMAN PLASMA FIBRONECTIN; INDUCED
   CONFORMATIONAL-CHANGES; VON-WILLEBRAND-FACTOR; BOVINE SERUM-ALBUMIN;
   PROTEIN ADSORPTION; POLYMER SURFACES; SOLID-SURFACES; VISCOELASTIC
   PROPERTIES; GLOBULAR-PROTEINS
AB An understanding of protein adsorption process is crucial for designing biomaterial surfaces. In this work, with the use of a quartz-crystal microbalance with dissipation monitoring, we researched the following: (a) the kinetics of adsorption on TiO2 surfaces of three extensively described proteins that are relevant for metallic implant integration [i.e., albumin (BSA), fibrinogen (Fbg), and fibronectin (Fn)]; and (b) the competition of those proteins for adsorbing on TiO2 in a two-step experiment consisted of sequentially exposing the surfaces to different monoprotein solutions. Each protein showed a different process of adsorption and properties of the adlayer-calculated using the Voigt model. The competition experiments showed that BSA displaced larger proteins such as Fn and Fbg when BSA was introduced as the second protein in the system, whereas the larger proteins laid on top of BSA forming an adsorbed protein bi-layer when those were introduced secondly in the system.
C1 [Pegueroles, Marta; Tonda-Turo, Chiara; Planell, Josep A.; Gil, Francisco-Javier; Aparicio, Conrado] Tech Univ Catalonia, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn Grp, Barcelona 08028, Spain.
   [Pegueroles, Marta; Planell, Josep A.; Gil, Francisco-Javier] Biomed Res Networking Ctr Bioengn Biomat & Nanome, E-50118 Zaragoza, Spain.
   [Planell, Josep A.] Inst Bioengn Catalonia IBEC, Barcelona 08028, Spain.
RP Aparicio, C (reprint author), Univ Minnesota, Sch Dent, Dept Restorat Sci, Minnesota Dent Res Ctr Biomat & Biomech MDRCBB, 16-212 Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.
EM marta.pegueroles@upc.edu; chiara.tondaturo@polito.it;
   japlanell@ibec.pcb.ub.es; francesc.xavier.gil@upc.edu; apari003@umn.edu
RI Aparicio, Conrado/J-9903-2012
OI Aparicio, Conrado/0000-0003-2969-6067; PEGUEROLES,
   MARTA/0000-0002-7895-8337
FU CICYT-Interministerial Comission of Science and Technology of the
   Ministry of Science and Technology of Spain [MAT2009-13547]; Universitat
   Politecnica de Catalunya (UPC)
FX This work was supported by the CICYT-Interministerial Comission of
   Science and Technology of the Ministry of Science and Technology of
   Spain, Grant MAT2009-13547. The authors thank Dr. Elisabeth Engel and
   Dr. George Altankov for experimental help with protein solution
   preparation. MP would like to thank the Universitat Politecnica de
   Catalunya (UPC) for funding through a fellowship Grant to complete her
   PhD graduate studies.
CR Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bai ZJ, 2009, SURF SCI, V603, P839, DOI 10.1016/j.susc.2009.01.040
   Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   do Serro APVA, 1999, J BIOMED MATER RES, V46, P376, DOI 10.1002/(SICI)1097-4636(19990905)46:3<376::AID-JBM10>3.3.CO;2-K
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   Godek ML, 2009, J BIOMED MATER RES A, V88A, P503, DOI 10.1002/jbm.a.31886
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   HAYNES CA, 1994, J COLLOID INTERF SCI, V164, P394, DOI 10.1006/jcis.1994.1182
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   Holgers KM, 2001, ENG MAT SER, P513
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   Hovgaard MB, 2008, J PHYS CHEM B, V112, P8241, DOI 10.1021/jp801103n
   ISO, 1996, 115621996 ISO
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   KUMAR R, 1994, THROMB HAEMOSTASIS, V72, P713
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   MILLER R, 1993, COLLOID SURFACE, V69, P203, DOI 10.1016/0166-6622(93)80001-V
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8
   Paine M, 2003, BIOIMPLANT INTERFACE
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Q-Sense, 2008, QCM D
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   RAMSDEN JJ, 1994, Q REV BIOPHYS, V27, P41, DOI 10.1017/S0033583500002900
   Renner L, 2005, LANGMUIR, V21, P4571, DOI 10.1021/la046801n
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Schmidt DR, 2009, BIOL INTERACTIONS MA, P2
   Scotchford CA, 2003, BIOMATERIALS, V24, P1147, DOI 10.1016/S0142-9612(02)00488-X
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Smith RA, 2000, J MATER SCI-MATER M, V11, P279, DOI 10.1023/A:1008953112683
   Sousa SR, 2005, J MATER SCI-MATER M, V16, P1173, DOI 10.1007/s10856-005-4725-4
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   TENGVALL P, 2001, ENG MAT SER, P457
   Textor M., 2001, TITANIUM MED, P172
   THOMPSON M, 1986, ANAL CHEM, V58, P1206, DOI 10.1021/ac00297a051
   Tzoneva R, 2002, J BIOMAT SCI-POLYM E, V13, P1033, DOI 10.1163/156856202760319171
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WARD MD, 1990, SCIENCE, V249, P1000, DOI 10.1126/science.249.4972.1000
   Wassell DTH, 1996, BIOMATERIALS, V17, P859, DOI 10.1016/0142-9612(96)83280-7
   Weber N, 2007, LANGMUIR, V23, P3298, DOI 10.1021/la060500r
   WILLIAMS DF, 1976, ANNU REV MATER SCI, V6, P237, DOI 10.1146/annurev.ms.06.080176.001321
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
NR 59
TC 21
Z9 22
U1 5
U2 60
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1934-8630
J9 BIOINTERPHASES
JI Biointerphases
PD DEC
PY 2012
VL 7
IS 1-4
AR 48
DI 10.1007/s13758-012-0048-4
PG 13
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 987UD
UT WOS:000307442400048
PM 22875482
OA Other Gold
DA 2018-10-19
ER

PT J
AU Ribeiro, AR
   Barbaglio, A
   Oliveira, MJ
   Santos, R
   Coelho, AV
   Ribeiro, CC
   Wilkie, IC
   Carnevali, MDC
   Barbosa, MA
AF Ribeiro, A. R.
   Barbaglio, A.
   Oliveira, M. J.
   Santos, R.
   Coelho, A. V.
   Ribeiro, C. C.
   Wilkie, I. C.
   Carnevali, M. D. Candia
   Barbosa, M. A.
TI Correlations Between the Biochemistry and Mechanical States of a
   Sea-Urchin Ligament: A Mutable Collagenous Structure
SO BIOINTERPHASES
LA English
DT Article
ID CONNECTIVE-TISSUE; EXTRACELLULAR-MATRIX; RAMAN-SPECTROSCOPY; CHONDROITIN
   SULFATE; CUCUMARIA-FRONDOSA; WATER-CONTENT; IN-VIVO; CARTILAGE; PROTEIN;
   PROTEOGLYCAN
AB Mutable collagenous tissues (MCTs) of echinoderms can be regarded as intelligent and dynamic biomaterials, due to their ability to reversibly change their mechanical properties in a short physiological time span. This mutability phenomenon is nervously mediated and involves secreted factors of the specialized 'juxtaligamental' cells, which, when released into the extracellular matrix (ECM), change the cohesive forces between collagen fibrils. MCTs exist in nature in several forms, including some associated with echinoderm autotomy mechanisms. Since the molecular mechanism of mutability is still incompletely understood, the aim of this work was to provide a detailed biochemical analysis of a typical mutable collagenous structure and to identify possible correlations between its biochemistry and mechanical states. A better understanding of the mutability phenomena is likely to provide a unique opportunity to develop new concepts that can be applied in the design of dynamic biomaterial for tissue regeneration, leading to new strategies in regenerative medicine. The MCT model used was the compass depressor ligament (CDL) of a sea urchin (Paracentrotus lividus), which was analyzed in different mechanical states, mimicking the mutability phenomenon. Spectroscopic techniques, namely Fourier transform infrared (FT-IR) and confocal Raman microscopy, were used to identify the specific molecular components that contribute to the CDL biochemical microenvironment and to investigate the possibility that remodelling/synthesis of new ECM components occurs during the mutability phenomenon by analogy with events during pregnancy in the uterine cervix of mammals (which also consists mainly of mechanically adaptable connective tissues). The results demonstrate that CDL ECM includes collagen with biochemical similarities to mammalian type I collagen, as well as sulphated glycosaminoglycans (GAGs). CDL mutability seems to involve a molecular rearrangement of the ECM, without synthesis of new ECM components. Although there were no significant biochemical differences between CDLs in the various mechanical states were observed. However, subtle adjustments in tissue hydration seemed to occur, particularly during stiffening.
C1 [Ribeiro, A. R.; Oliveira, M. J.; Ribeiro, C. C.; Barbosa, M. A.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Ribeiro, A. R.] Univ Porto, Fac Engn, P-4200645 Oporto, Portugal.
   [Barbaglio, A.; Carnevali, M. D. Candia] Univ Milan, UNIMI Dept Biol, I-20133 Milan, Italy.
   [Oliveira, M. J.] Univ Porto, Fac Med, P-4200319 Oporto, Portugal.
   [Santos, R.; Coelho, A. V.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780901 Oeiras, Portugal.
   [Santos, R.] Univ Lisbon, Fac Med Dent, Unidade Invest Ciencias Orais & Biomed, P-1649003 Lisbon, Portugal.
   [Ribeiro, C. C.] Inst Super Engn Porto, Dep Fis, P-4200072 Oporto, Portugal.
   [Wilkie, I. C.] Glasgow Caledonian Univ, Dept Biol & Biomed Sci, Glasgow G4 0BA, Lanark, Scotland.
   [Barbosa, M. A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal.
RP Barbosa, MA (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM mbarbosa@ineb.up.pt
RI Varela Coelho, Ana/O-3977-2014; PTMS, RNEM/C-1589-2014; Santos,
   Romana/J-3461-2012; Ribeiro, Cristina/O-1842-2017; Barbosa,
   Mario/F-5964-2011; Coelho, Ana/H-8885-2012; Candia Carnevali, M.
   Daniela/I-8048-2015
OI Varela Coelho, Ana/0000-0002-6143-4203; Santos,
   Romana/0000-0001-7720-6806; Ribeiro, Cristina/0000-0002-7802-7364;
   Barbosa, Mario/0000-0003-3568-7482; Candia Carnevali, M.
   Daniela/0000-0002-0215-8843; Barbaglio, Alice/0000-0003-0122-0331;
   Oliveira, Maria Jose/0000-0002-0724-0272
FU FEDER through Programa Operacional Factores de Competitividade-COMPETE;
   CARIPLO Foundation-Advanced Material projects (Mimesis-Marine
   Invertebrates Models and Engineered Substrates for Innovative
   bio-Scaffolds); Portuguese Foundation for Science and Technology (FCT)
   (SFRH Grant) [BD/40541/2007]
FX This work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade-COMPETE and received financial support from
   CARIPLO Foundation-Advanced Material projects 2009 (Mimesis-Marine
   Invertebrates Models and Engineered Substrates for Innovative
   bio-Scaffolds) and from the Portuguese Foundation for Science and
   Technology (FCT) (SFRH Grant BD/40541/2007). MJ Oliveira is Science
   2007/FCT fellow. The authors are grateful to Professor Cacilda Moura. We
   also acknowledge ELA (EstacaoLitoral da Aguda) for maintenance of the
   sea urchins.
CR Akins ML, 2011, BIOL REPROD, V84, P1053, DOI 10.1095/biolreprod.110.089599
   Barbaglio A, 2012, MAR ENVIRON RES, V76, P108, DOI 10.1016/j.marenvres.2011.07.006
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Belbachir K, 2009, ANAL BIOANAL CHEM, V395, P829, DOI 10.1007/s00216-009-3019-y
   Berberat JE, 2009, MAGN RESON IMAGING, V27, P727, DOI 10.1016/j.mri.2008.09.005
   Bjornsson S, 1998, ANAL BIOCHEM, V256, P229, DOI 10.1006/abio.1997.2494
   Brinckmann J., 2005, COLLAGEN PRIMER STRU
   Brooks JM, 2002, DEV BIOL, V245, P1, DOI 10.1006/dbio.2002.0611
   Bryan MA, 2007, J AM CHEM SOC, V129, P7877, DOI 10.1021/ja071154i
   Byler M. D., 1986, BIOPOLYMERS, V25, P469
   Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O
   Canty EG, 2002, COMP BIOCHEM PHYS A, V133, P979, DOI 10.1016/S1095-6433(02)00212-X
   Carnevali MDC, 2001, MICROSC RES TECHNIQ, V55, P403
   Carnevali MDC, 2001, MICROSC RES TECHNIQ, V55, P365
   Chen S, 2010, CARBOHYD POLYM, V83, P688
   Cheng WT, 2005, MICROSC RES TECHNIQ, V68, P75, DOI 10.1002/jemt.20229
   Cinelli LP, 2009, COMP BIOCHEM PHYS B, V154, P108, DOI 10.1016/j.cbpb.2009.05.004
   Cluzel C, 2000, MATRIX BIOL, V19, P545, DOI 10.1016/S0945-053X(00)00109-8
   Cluzel C, 2001, J BIOL CHEM, V276, P18108, DOI 10.1074/jbc.M009597200
   DALESSIO M, 1990, J BIOL CHEM, V265, P7050
   Ellis R, 2009, CONNECT TISSUE RES, V50, P29, DOI 10.1080/03008200802398422
   ERLINGER R, 1993, J ANAT, V183, P1
   Exposito JY, 2002, ANAT REC, V268, P302, DOI 10.1002/ar.10162
   Franco CF, 2011, PROTEOMICS, V11, P1359, DOI 10.1002/pmic.201000541
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Garnjanagoonchorn W, 2007, CHEM ENG PROCESS, V46, P465, DOI 10.1016/j.cep.2006.05.019
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   Haston JL, 2003, J BIOL CHEM, V278, P41189, DOI 10.1074/jbc.M212854200
   House M, 2009, SEMIN PERINATOL, V33, P300, DOI 10.1053/j.semperi.2009.06.002
   Ishwar AR, 2009, APPL SPECTROSC, V63, P636, DOI 10.1366/000370209788559656
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007
   Jastrzebska M, 2003, J BIOMAT SCI-POLYM E, V14, P185, DOI 10.1163/156856203321142605
   JUNQUEIRA LCU, 1983, ARCH HISTOL JAPON, V46, P589, DOI 10.1679/aohc.46.589
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KARIYA Y, 1990, J BIOL CHEM, V265, P5081
   Kittiphattanabawon P, 2010, LWT-FOOD SCI TECHNOL, V43, P792, DOI 10.1016/j.lwt.2010.01.006
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Koob TJ, 1999, J EXP BIOL, V202, P2291
   Larsen MR, 2002, PROTEOMICS, V2, P1277, DOI 10.1002/1615-9861(200209)2:9<1277::AID-PROT1277>3.0.CO;2-P
   Liess C, 2002, OSTEOARTHR CARTILAGE, V10, P907, DOI 10.1053/joca.2002.0847
   Mainreck N, 2010, J PHARM SCI, V100, P441
   Matsumura Y, 2009, J ORTHOP SCI, V14, P45, DOI 10.1007/s00776-008-1288-5
   Maul H, 2006, CLIN OBSTET GYNECOL, V49, P551, DOI 10.1097/00003081-200609000-00015
   Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9
   MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Myers K, 2009, EUR J OBSTET GYN R B, V144, P82
   Noll H, 2007, DEV BIOL, V310, P54, DOI 10.1016/j.ydbio.2007.07.016
   Noreen R, 2011, ANAL BIOANAL CHEM, V401, P845, DOI 10.1007/s00216-011-4899-1
   Osada M, 2004, EXP DERMATOL, V13, P391, DOI 10.1111/j.0906-6705.2004.00169.x
   Petibois C, 2006, ANAL BIOANAL CHEM, V386, P1961, DOI 10.1007/s00216-006-0828-0
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   Potter K, 2001, ARTHRITIS RHEUM, V44, P846, DOI 10.1002/1529-0131(200104)44:4<846::AID-ANR141>3.0.CO;2-E
   Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/RFP-07-0032
   Ribeiro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024822
   Santos R, 2009, MAR BIOTECHNOL, V11, P686, DOI 10.1007/s10126-009-9182-5
   Schlembach D, 2009, EUR J OBSTET GYN R B, V144, pS70, DOI 10.1016/j.ejogrb.2009.02.036
   Scott JE, 1998, J BIOCH, V252, P313
   Shapiro EM, 2001, OSTEOARTHR CARTILAGE, V9, P533, DOI 10.1053/joca.2001.0428
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Singh P, 2011, FOOD CHEM, V124, P97, DOI 10.1016/j.foodchem.2010.05.111
   Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609
   Sulea D, 2011, REV ROUM CHIM, V56, P129
   Tamori M, 2010, J EXP BIOL, V213, P1960, DOI 10.1242/jeb.038505
   Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011
   Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2
   TROTTER JA, 1994, CELL TISSUE RES, V275, P451, DOI 10.1007/BF00318814
   TROTTER JA, 1989, CELL TISSUE RES, V258, P527
   Trotter JA, 1995, COMP BIOCHEM PHYS A, V112, P463, DOI 10.1016/0300-9629(95)02015-2
   Tuma R, 2005, J RAMAN SPECTROSC, V36, P307, DOI 10.1002/jrs.1323
   Wehbe K, 2008, ANAL BIOANAL CHEM, V392, P129, DOI 10.1007/s00216-008-2230-6
   Wellen J, 2004, J MAGN RESON, V170, P49, DOI 10.1016/j.jmr.2004.04.021
   WILKIE IC, 1992, ZOOMORPHOLOGY, V112, P143, DOI 10.1007/BF01633105
   Wilkie IC, 2005, PROGR MOL SUBCELLULA, V39, P219
   Winkler M, 1999, J PERINAT MED, V27, P45, DOI 10.1515/JPM.1999.006
   Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547
NR 78
TC 7
Z9 7
U1 2
U2 44
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1934-8630
J9 BIOINTERPHASES
JI Biointerphases
PD DEC
PY 2012
VL 7
IS 1-4
AR 38
DI 10.1007/s13758-012-0038-6
PG 15
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 987UD
UT WOS:000307442400038
PM 22700358
OA Other Gold
DA 2018-10-19
ER

PT J
AU Rubert, M
   Alonso-Sande, M
   Monjo, M
   Ramis, JM
AF Rubert, M.
   Alonso-Sande, M.
   Monjo, M.
   Ramis, J. M.
TI Evaluation of Alginate and Hyaluronic Acid for Their Use in Bone Tissue
   Engineering
SO BIOINTERPHASES
LA English
DT Article
ID MARROW STROMAL CELLS; IN-VITRO; HYDROGELS; CHITOSAN; SCAFFOLDS;
   DIFFERENTIATION; REGENERATION; INFLAMMATION; DELIVERY; GELS
AB In this study, we compared the structural and physicochemical properties of different concentrations of alginate and high molecular weight hyaluronic acid (HA) hydrogels and their biocompatibility and bioactivity after long-term culture with MC3T3-E1 cells. Both hydrogels were biocompatible and supported long-term viability and cell proliferation. Alginate induced higher alkaline phosphatase (ALP) activity levels than HA. Calcium content was increased in concentration dependent manner in cells cultured with alginate compared to control. Culture with HA hydrogels reduced alkaline phosphatase (Alp), bone sialoprotein (Bsp) and osteocalcin (Oc), while alginate increased Oc mRNA levels. Unmodified alginate hydrogels supported osteoblast differentiation better than HA hydrogels, suggesting that alginates are more suitable for biomaterial applications in bone tissue engineering.
C1 [Rubert, M.; Alonso-Sande, M.; Monjo, M.; Ramis, J. M.] Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Grp Cell Therapy & Tissue Engn, Palma De Mallorca, Spain.
RP Ramis, JM (reprint author), Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Grp Cell Therapy & Tissue Engn, POB 07122, Palma De Mallorca, Spain.
EM joana.ramis@uib.es
RI Alonso-Sande, Maria/F-3131-2010
OI Monjo, Marta/0000-0002-2731-9527
FU Conselleria de Comerc, Industria i Energia de les Illes Balears
   [BA-2009-CALT-0001-PY]; Eureka-Eurostars Project Application [E!5069];
   Centre for the Development of Industrial Technology (CDTI)
   [CIIP20101024]; Ministerio de Ciencia e Innovacion del Gobierno de
   Espana
FX This work was supported by the Conselleria de Comerc, Industria i
   Energia de les Illes Balears (BA-2009-CALT-0001-PY), the
   Eureka-Eurostars Project Application E!5069 New-Bone, and Interempresas
   Internacional Program (CIIP20101024) from the Centre for the Development
   of Industrial Technology (CDTI) and the Ministerio de Ciencia e
   Innovacion del Gobierno de Espana (Torres Quevedo contract to MR and
   JMR, and Ramon y Cajal contract to MM). The authors are especially
   thankful for the excellent technical support of Ferran Hierro (Serveis
   Cientificotecnics, University of Balearic Islands).
CR Abbah SA, 2008, J MATER SCI-MATER M, V19, P2113, DOI 10.1007/s10856-006-0013-1
   Abbah SA, 2006, BIOCHEM BIOPH RES CO, V347, P185, DOI 10.1016/j.bbrc.2006.06.072
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Barbetta A, 2009, BIOMACROMOLECULES, V10, P2328, DOI 10.1021/bm900517q
   Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Florczyk SJ, 2011, J BIOMED MATER RES A, V98A, P614, DOI 10.1002/jbm.a.33153
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P678, DOI 10.1111/j.1600-051X.1997.tb00249.x
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hahn SK, 2007, INT J BIOL MACROMOL, V40, P374, DOI 10.1016/j.ijbiomac.2006.09.019
   Hall CL, 1995, J NEURO-ONCOL, V26, P221, DOI 10.1007/BF01052625
   Hong D, 2010, EXP CELL RES, V316, P2291, DOI 10.1016/j.yexcr.2010.05.011
   Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535
   IALENTI A, 1994, AGENTS ACTIONS, V43, P44, DOI 10.1007/BF02005763
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Lajeunesse D, 2003, BONE, V33, P703, DOI 10.1016/S8756-3282(03)00206-0
   Lee JY, 2007, BIOCHEM BIOPH RES CO, V357, P68, DOI 10.1016/j.bbrc.2007.03.106
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liew CV, 2006, INT J PHARM, V309, P25, DOI 10.1016/ijpharm.2005.10.040
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   Lum L, 2003, TOPICS TISSUE ENG, P25
   Mann BK, 2003, CLIN PLAST SURG, V30, P601, DOI 10.1016/S0094-1298(03)00078-6
   Martinez-Sanz E, 2011, J CONTROL RELEASE, V152, P232, DOI 10.1016/j.jconrel.2011.02.003
   Matsuno T, 2008, DENT MATER J, V27, P827, DOI 10.4012/dmj.27.827
   OLDBERG A, 1988, J BIOL CHEM, V263, P19430
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   Park K, 2011, J CONTROL RELEASE, V152, P207, DOI 10.1016/j.jconrel.2011.05.009
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Sila-Asna Monnipha, 2007, Kobe J Med Sci, V53, P25
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Varghese OP, 2010, MACROMOL RAPID COMM, V31, P1175, DOI 10.1002/marc.200900906
   WEIGEL PH, 1988, INT J TISSUE REACT, V10, P355
NR 43
TC 11
Z9 11
U1 0
U2 29
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD DEC
PY 2012
VL 7
IS 1-4
AR 44
DI 10.1007/s13758-012-0044-8
PG 11
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 987UD
UT WOS:000307442400044
DA 2018-10-19
ER

PT J
AU Lutisanova, G
   Palou, MT
   Mikula, M
   Kozankova, J
AF Lutisanova, Gabriela
   Palou, Martin T.
   Mikula, Milan
   Kozankova, Jana
TI Characterisation of the surface structure and bioactivity of glass and
   glass ceramics using surface topography
SO CENTRAL EUROPEAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Glass and glass ceramics; In vitro bioactivity; Surface chemistry;
   Surface morphology
ID ATOMIC-FORCE MICROSCOPY; IN-VITRO BIOACTIVITY; PIXE-RBS METHODS; SYSTEM;
   CRYSTALLIZATION; PHOSPHORUS; NUCLEATION; SILICATE; BEHAVIOR
AB The present paper reports the results of the relationship between the surface topography, microstructure and the in vitro bioactivity of samples with and without fluorapatite content in simulated body fluid. Glasses and glass ceramics belonging to the Li2O-SiO2-CaO-P2O5-CaF2 system were prepared by using conventional melting technique following by heat treatment to obtain glass ceramics. This current study demonstrates the benefits of combining two microscopic methods for better investigation of the surface structure. The formation of apatite layer on the surface and the increase in surface roughness proved that the glasses and glass ceramics with bioactive fluorapatite content could satisfy to the requirements for biomaterial applications. The results also showed that the roughness of apatite layer formed after immersion in body fluid on the surface of glasses with fluorapatite was more pronounced than that of equivalent glass ceramic samples cured under the same conditions.
C1 [Lutisanova, Gabriela; Palou, Martin T.; Kozankova, Jana] Slovak Univ Technol Bratislava, Inst Inorgan Chem Technol & Mat, Fac Chem & Food Technol, Bratislava 81237, Slovakia.
   [Mikula, Milan] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Polymer Mat, Bratislava 81237, Slovakia.
RP Lutisanova, G (reprint author), Slovak Univ Technol Bratislava, Inst Inorgan Chem Technol & Mat, Fac Chem & Food Technol, Bratislava 81237, Slovakia.
EM gabriela.lutisanova@stuba.sk
FU Slovak Academy of Sciences VEGA [1/0934/11]
FX This work was supported by the Slovak Academy of Sciences VEGA, grant
   No. 1/0934/11.
CR De Menezes F.C.H., 2009, BRAZ J ORAL SCI, V8, P9
   DURSCHANG BR, 1994, GLASTECH BER-GLASS, V67, P171
   DURSCHANG BR, 1995, GLASTECH BER, P172
   Ektessabi AM, 1995, THIN SOLID FILMS, V270, P335, DOI 10.1016/0040-6090(95)06714-0
   Guo XZ, 2005, J NON-CRYST SOLIDS, V351, P2133, DOI 10.1016/j.jnoncrysol.2005.04.071
   Hench L.L., 1996, THERMOCHIM ACTA, P280
   Hench L.L., 1971, J BIOMED MATER RES, V36, P41
   Hench L.L., 1991, J AM CHEM SOC, P74
   Holand W, 2003, PHILOS T ROY SOC A, V361, P575, DOI 10.1098/rsta.2002.1152
   Holand W, 2007, J EUR CERAM SOC, V27, P1521, DOI 10.1016/j.jeurceramsoc.2006.04.101
   Itala A, 2001, J BIOMED MATER RES, V56, P282, DOI 10.1002/1097-4636(200108)56:2<282::AID-JBM1096>3.0.CO;2-5
   James PF, 1997, J NON-CRYST SOLIDS, V219, P17, DOI 10.1016/S0022-3093(97)00247-0
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kuzielova E, 2006, CERAM-SILIKATY, V50, P159
   Lao J, 2008, NUCL INSTRUM METH B, V266, P2412, DOI 10.1016/j.nimb.2008.03.013
   Lao J, 2007, NUCL INSTRUM METH B, V261, P488, DOI 10.1016/j.nimb.2007.03.092
   Leonor IB, 2003, BIOMATERIALS, V24, P579, DOI 10.1016/S0142-9612(02)00371-X
   Mostafa NY, 2009, J ALLOY COMPD, V479, P692, DOI 10.1016/j.jallcom.2009.01.037
   Padilla S, 2005, BIOMATERIALS, V26, P475, DOI 10.1016/j.biomaterials.2004.02.054
   Palou M, 2009, CERAM-SILIKATY, V53, P161
   Palou M, 2009, CENT EUR J CHEM, V7, P228, DOI 10.2478/s11532-009-0002-6
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Radlein E, 1997, J NON-CRYST SOLIDS, V222, P69, DOI 10.1016/S0022-3093(97)90098-3
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Schmidt A., 1995, THESIS TU CLAUSTHAL
   Strnad J., 2007, J THERM ANAL CALORIM, V88, P1
   Takadama H, 2002, J AM CERAM SOC, V85, P1933, DOI 10.1111/j.1151-2916.2002.tb00383.x
   Xiao Z, 2011, OPEN MAT SCI J, V5, P45
   Zhang D., 2011, ADV MAT RES, V177, P447
NR 31
TC 0
Z9 0
U1 1
U2 17
PU VERSITA
PI WARSAW
PA SOLIPSKA 14A-1, 02-482 WARSAW, POLAND
SN 1895-1066
J9 CENT EUR J CHEM
JI Cent. Eur. J. Chem
PD DEC
PY 2012
VL 10
IS 6
BP 1890
EP 1898
DI 10.2478/s11532-012-0111-5
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 008IL
UT WOS:000308950500019
OA Other Gold
DA 2018-10-19
ER

PT J
AU Levis, HJ
   Peh, GSL
   Toh, KP
   Poh, R
   Shortt, AJ
   Drake, RAL
   Mehta, JS
   Daniels, JT
AF Levis, Hannah J.
   Peh, Gary S. L.
   Toh, Kah-Peng
   Poh, Rebekah
   Shortt, Alex J.
   Drake, Rosemary A. L.
   Mehta, Jodhbir S.
   Daniels, Julie T.
TI Plastic Compressed Collagen as a Novel Carrier for Expanded Human
   Corneal Endothelial Cells for Transplantation
SO PLOS ONE
LA English
DT Article
ID LIMBAL EPITHELIAL-CELLS; OCULAR SURFACE DISEASE; AMNIOTIC MEMBRANE;
   KERATOPLASTY; PRESERVATION; EXPANSION; MATRIX
AB Current treatments for reversible blindness caused by corneal endothelial cell failure involve replacing the failed endothelium with donor tissue using a one donor-one recipient strategy. Due to the increasing pressure of a worldwide donor cornea shortage there has been considerable interest in developing alternative strategies to treat endothelial disorders using expanded cell replacement therapy. Protocols have been developed which allow successful expansion of endothelial cells in vitro but this approach requires a supporting material that would allow easy transfer of cells to the recipient. We describe the first use of plastic compressed collagen as a highly effective, novel carrier for human corneal endothelial cells. A human corneal endothelial cell line and primary human corneal endothelial cells retained their characteristic cobblestone morphology and expression of tight junction protein ZO-1 and pump protein Na+/K+ ATPase alpha 1 after culture on collagen constructs for up to 14 days. Additionally, ultrastructural analysis suggested a well-integrated endothelial layer with tightly opposed cells and apical microvilli. Plastic compressed collagen is a superior biomaterial in terms of its speed and ease of production and its ability to be manipulated in a clinically relevant manner without breakage. This method provides expanded endothelial cells with a substrate that could be suitable for transplantation allowing one donor cornea to potentially treat multiple patients.
C1 [Levis, Hannah J.; Shortt, Alex J.; Daniels, Julie T.] UCL Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England.
   [Peh, Gary S. L.; Toh, Kah-Peng; Poh, Rebekah; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore.
   [Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore.
   [Drake, Rosemary A. L.] TAP Biosyst, Royston, Herts, England.
RP Levis, HJ (reprint author), UCL Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England.
EM h.levis@ucl.ac.uk
RI Mehta, Jodhbir/O-6192-2015
OI Levis, Hannah/0000-0002-3923-1178; Shortt, Alex/0000-0001-6576-3875;
   Peh, Gary/0000-0002-5387-4209
FU Technology Strategy Board; EPSRC; National Institute for the Health
   Research Biomedical Research Centre for Ophthalmology, Moorfields Eye
   Hospital; UCL Institute of Ophthalmology; National Research Foundation
   Translational and Clinical Research Programme Grant, Singapore
   [R621/42/2008]; Biomedical Research Council, Translational Clinical
   Research Partnership Grant, Singapore [TCR0101673]; National Institute
   for Health Research [848]
FX The study was supported by the Technology Strategy Board, the EPSRC
   (HL), the National Institute for the Health Research Biomedical Research
   Centre for Ophthalmology, Moorfields Eye Hospital and UCL Institute of
   Ophthalmology (JTD), the National Research Foundation Translational and
   Clinical Research Programme Grant, Singapore (R621/42/2008), and the
   Biomedical Research Council, Translational Clinical Research Partnership
   Grant, Singapore (TCR0101673) (GSP, RP, KPT, JSM). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Armitage WJ, 2011, TRANSFUS MED HEMOTH, V38, P143, DOI 10.1159/000326632
   Bayyoud T, 2012, CURR EYE RES, V37, P179, DOI 10.3109/02713683.2011.644382
   ENGELMANN K, 1989, IN VITRO CELL DEV B, V25, P1065
   ENGELMANN K, 1995, CORNEA, V14, P62
   Ham L, 2009, EYE, V23, P1990, DOI 10.1038/eye.2008.393
   Heindl LM, 2011, OPHTHALMOLOGY, V118, P294, DOI 10.1016/j.ophtha.2010.05.025
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645
   Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7
   Levis H, 2009, CURR OPIN BIOTECH, V20, P593, DOI 10.1016/j.copbio.2009.09.002
   Levis HJ, 2010, BIOMATERIALS
   Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126
   Madden PW, 2011, BIOMATERIALS, P1
   Mau K, 2009, OPTOMETRY, V80, P513, DOI 10.1016/j.optm.2008.11.010
   Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174
   Nakamura T, 2003, CORNEA, V22, P70, DOI 10.1097/00003226-200301000-00017
   Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310
   Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01
   Rose L, 2009, CAN J OPHTHALMOL, V44, P401, DOI 10.3129/i09-090
   Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003
   Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660
   Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8
   Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Watanabe R, 2011, TISSUE ENGINEERING P
   Yoeruek E, 2009, CORNEA, V28, P416, DOI 10.1097/ICO.0b013e31818c2c36
NR 26
TC 41
Z9 41
U1 1
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 30
PY 2012
VL 7
IS 11
AR e50993
DI 10.1371/journal.pone.0050993
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 054WM
UT WOS:000312376100254
PM 23226443
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Salimath, AS
   Phelps, EA
   Boopathy, AV
   Che, PL
   Brown, M
   Garcia, AJ
   Davis, ME
AF Salimath, Apoorva S.
   Phelps, Edward A.
   Boopathy, Archana V.
   Che, Pao-lin
   Brown, Milton
   Garcia, Andres J.
   Davis, Michael E.
TI Dual Delivery of Hepatocyte and Vascular Endothelial Growth Factors via
   a Protease-Degradable Hydrogel Improves Cardiac Function in Rats
SO PLOS ONE
LA English
DT Article
ID ACUTE MYOCARDIAL-INFARCTION; ENGINEERED PEG HYDROGELS; PEPTIDE
   NANOFIBERS; CELL THERAPY; STEM-CELLS; INTRAMYOCARDIAL INJECTION;
   ALGINATE BIOMATERIAL; PROGENITOR CELLS; IN-VITRO; ANGIOGENESIS
AB Acute myocardial infarction (MI) caused by ischemia and reperfusion (IR) is the most common cause of cardiac dysfunction due to local cell death and a temporally regulated inflammatory response. Current therapeutics are limited by delivery vehicles that do not address spatial and temporal aspects of healing. The aim of this study was to engineer biotherapeutic delivery materials to harness endogenous cell repair to enhance myocardial repair and function. We have previously engineered poly(ethylene glycol) (PEG)-based hydrogels to present cell adhesive motifs and deliver VEGF to promote vascularization in vivo. In the current study, bioactive hydrogels with a protease-degradable crosslinker were loaded with hepatocyte and vascular endothelial growth factors (HGF and VEGF, respectively) and delivered to the infarcted myocardium of rats. Release of both growth factors was accelerated in the presence of collagenase due to hydrogel degradation. When delivered to the border zones following ischemia-reperfusion injury, there was no acute effect on cardiac function as measured by echocardiography. Over time there was a significant increase in angiogenesis, stem cell recruitment, and a decrease in fibrosis in the dual growth factor delivery group that was significant compared with single growth factor therapy. This led to an improvement in chronic function as measured by both invasive hemodynamics and echocardiography. These data demonstrate that dual growth factor release of HGF and VEGF from a bioactive hydrogel has the capacity to significantly improve cardiac remodeling and function following IR injury.
C1 [Salimath, Apoorva S.; Phelps, Edward A.; Boopathy, Archana V.; Garcia, Andres J.; Davis, Michael E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Salimath, Apoorva S.; Phelps, Edward A.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Boopathy, Archana V.; Che, Pao-lin; Brown, Milton; Davis, Michael E.] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.
   [Boopathy, Archana V.; Che, Pao-lin; Brown, Milton; Davis, Michael E.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA USA.
RP Davis, ME (reprint author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM michael.davis@bme.emory.edu
RI Phelps, Edward/Q-1302-2016
OI Phelps, Edward/0000-0001-8666-805X
FU National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201000043C];
   American Heart Association (AHA) fellowship; National Science Foundation
   (NSF) Center Grant [CBET-0939511]; Georgia Tech/Emory Center for the
   Engineering of Living Tissues
FX This work was supported by a contract from the National Heart, Lung, and
   Blood Institute (NHLBI) (HHSN268201000043C) as part of a Program of
   Excellence in Nanotechnology. Additionally, funding was received in the
   form of an American Heart Association (AHA) fellowship, National Science
   Foundation (NSF) Center Grant (CBET-0939511), and Georgia Tech/Emory
   Center for the Engineering of Living Tissues. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Almeda FQ, 2001, CRIT CARE CLIN, V17, P411, DOI 10.1016/S0749-0704(05)70175-5
   Angoulvant D, 2011, J HEART LUNG TRANSPL, V30, P95, DOI 10.1016/j.healun.2010.08.023
   Anversa P, 2006, J AM COLL CARDIOL, V47, P1769, DOI 10.1016/j.jacc.2006.02,003
   Anversa P, 1995, Cardiologia, V40, P909
   Anversa P, 2000, CIRC RES, V86, P121, DOI 10.1161/01.RES.86.2.121
   Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chimenti I, 2011, BIOMATERIALS, V32, P9271, DOI 10.1016/j.biomaterials.2011.08.049
   Cho KR, 2008, EUR J CARDIO-THORAC, V34, P857, DOI 10.1016/j.ejcts.2008.05.045
   Danielsen CC, 1998, J MOL CELL CARDIOL, V30, P1431
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103
   Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115
   Fatma S, 2010, ANTIOXID REDOX SIGN, V13, P1857, DOI 10.1089/ars.2010.3104
   French KM, 2012, ACTA BIOMATER
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   Jacot JG, 2006, J BIOMED MATER RES A, V79A, P485, DOI 10.1002/jbm.a.30812
   Jacot JG, 2010, ANN NY ACAD SCI, V1188, P121, DOI 10.1111/j.1749-6632.2009.05091.x
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Kajstura J, 1996, LAB INVEST, V74, P86
   Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4
   Kloner RA, 2000, J THROMB THROMBOLYS, V10, P285, DOI 10.1023/A:1026507627097
   Leri A, 2001, Ital Heart J, V2 Suppl 3, p12S
   Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102
   Miyagawa S, 2006, TRANSPLANTATION, V81, P902, DOI 10.1097/01.tp.0000202843.86864.10
   Morishita R, 2004, CURR GENE THER, V4, P199
   Nakagawa K, 2000, SEMIN THROMB HEMOST, V26, P61, DOI 10.1055/s-2000-9805
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Patterson J, 2011, BIOMATERIALS, V32, P1301, DOI 10.1016/j.biomaterials.2010.10.016
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Perez-Ilzarbe M, 2008, EUR J HEART FAIL, V10, P1065, DOI 10.1016/j.ejheart.2008.08.002
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928
   Samuel SM, 2010, DIABETES, V59, P51, DOI 10.2337/db09-0336
   Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2
   Siltanen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019161
   Sun QH, 2010, PHARM RES-DORD, V27, P264, DOI 10.1007/s11095-009-0014-0
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Sy JC, 2010, J CARDIOVASC TRANSL, V3, P461, DOI 10.1007/s12265-010-9210-x
   Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026
   Vilahur G, 2011, J MOL CELL CARDIOL, V50, P522, DOI 10.1016/j.yjmcc.2010.12.021
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004
   Xaymardan M, 2009, STEM CELLS, V27, P1911, DOI 10.1002/stem.106
   Yamaguchi T, 2005, SURG TODAY, V35, P855, DOI 10.1007/s00595-005-3042-3
   Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180
   Zhu XY, 2009, BIOCHEM BIOPH RES CO, V379, P1084, DOI 10.1016/j.bbrc.2009.01.019
NR 54
TC 49
Z9 49
U1 2
U2 52
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 30
PY 2012
VL 7
IS 11
AR e50980
DI 10.1371/journal.pone.0050980
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 054WM
UT WOS:000312376100251
PM 23226440
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Tao, H
   Kainerstorfer, JM
   Siebert, SM
   Pritchard, EM
   Sassaroli, A
   Panilaitis, BJB
   Brenckle, MA
   Amsden, JJ
   Levitt, J
   Fantini, S
   Kaplan, DL
   Omenetto, FG
AF Tao, Hu
   Kainerstorfer, Jana M.
   Siebert, Sean M.
   Pritchard, Eleanor M.
   Sassaroli, Angelo
   Panilaitis, Bruce J. B.
   Brenckle, Mark A.
   Amsden, Jason J.
   Levitt, Jonathan
   Fantini, Sergio
   Kaplan, David L.
   Omenetto, Fiorenzo G.
TI Implantable, multifunctional, bioresorbable optics
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomedical optics; silk optics; biophotonics
ID VIVO BONE-FORMATION; SILK FIBROIN FILMS; IN-VIVO; DRUG-DELIVERY; GOLD
   NANOPARTICLES; ADENOSINE RELEASE; SCATTERING; BIOMATERIALS;
   SPECTROSCOPY; SCAFFOLDS
AB Advances in personalized medicine are symbiotic with the development of novel technologies for biomedical devices. We present an approach that combines enhanced imaging of malignancies, therapeutics, and feedback about therapeutics in a single implantable, biocompatible, and resorbable device. This confluence of form and function is accomplished by capitalizing on the unique properties of silk proteins as a mechanically robust, biocompatible, optically clear biomaterial matrix that can house, stabilize, and retain the function of therapeutic components. By developing a form of high-quality microstructured optical elements, improved imaging of malignancies and of treatment monitoring can be achieved. The results demonstrate a unique family of devices for in vitro and in vivo use that provide functional biomaterials with built-in optical signal and contrast enhancement, demonstrated here with simultaneous drug delivery and feedback about drug delivery with no adverse biological effects, all while slowly degrading to regenerate native tissue.
C1 [Tao, Hu; Kainerstorfer, Jana M.; Siebert, Sean M.; Pritchard, Eleanor M.; Sassaroli, Angelo; Panilaitis, Bruce J. B.; Brenckle, Mark A.; Amsden, Jason J.; Fantini, Sergio; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Levitt, Jonathan] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.
   [Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Omenetto, FG (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM fiorenzo.omenetto@tufts.edu
RI Tao, Hu/C-1528-2013; Brenckle, Mark/I-5931-2014
OI Brenckle, Mark/0000-0002-5535-1110
FU US Army Research Laboratory; US Army Research Office [W911
   NF-07-1-0618]; Defense Advanced Research Planning Agency-Defense
   Sciences Office; Air Force Office of Scientific Research; National
   Institutes of Health P41 Tissue Engineering Resource Center; National
   Science Foundation [ECS-0335765]
FX The authors thank Jason Bressner for SEM images and Miaomiao Yang for
   sample preparation. The Center for Nanoscale Systems (CNS) is part of
   the Faculty of Arts and Sciences at Harvard University. This material is
   based upon work supported in part by the US Army Research Laboratory and
   the US Army Research Office under Contract W911 NF-07-1-0618 and by the
   Defense Advanced Research Planning Agency-Defense Sciences Office, the
   Air Force Office of Scientific Research, and the National Institutes of
   Health P41 Tissue Engineering Resource Center. SEM images were obtained
   at the CNS, a member of the National Nanotechnology Infrastructure
   Network, which is supported by the National Science Foundation under
   Award ECS-0335765. F.G.O. acknowledges the John Simon Guggenheim
   Foundation.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amsden JJ, 2010, ADV MATER, V22, P1746, DOI 10.1002/adma.200903166
   Ardeshirpour Y, 2011, TECHNOL CANCER RES T, V10, P549, DOI 10.1177/153303461101000605
   Calabro K, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525565
   Domachuk P, 2009, APPL PHYS LETT, V95
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Howard D, 2002, BIOCHEM BIOPH RES CO, V299, P208, DOI 10.1016/S0006-291X(02)02561-5
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang WC, 2007, NANOMEDICINE-UK, V2, P777, DOI 10.2217/17435889.2.6.777
   ISHIMARU A, 1991, P IEEE, V79, P1359, DOI 10.1109/5.104210
   Jaeger GT, 2007, ACTA VET SCAND, V49, P31
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim M, 2012, TALANTA, V88, P631, DOI 10.1016/j.talanta.2011.11.049
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Liang ZQ, 2007, INT J MOL SCI, V8, P526, DOI 10.3390/i8060526
   Liu YY, 2007, INT J CANCER, V120, P2527, DOI 10.1002/ijc.22709
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Matcher SJ, 1997, APPL OPTICS, V36, P386, DOI 10.1364/AO.36.000386
   O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Partridge K, 2002, BIOCHEM BIOPH RES CO, V292, P144, DOI 10.1006/bbrc.2002.6623
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Weinstain R, 2010, CHEM COMMUN, V46, P553, DOI 10.1039/b919329d
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Zonios G, 2009, OPT EXPRESS, V17, P1256, DOI 10.1364/OE.17.001256
NR 32
TC 55
Z9 56
U1 4
U2 79
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 27
PY 2012
VL 109
IS 48
BP 19584
EP 19589
DI 10.1073/pnas.1209056109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 053ZN
UT WOS:000312313900024
PM 23150544
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Krishnan, R
   Arora, R
   Lamb, M
   Liang, O
   White, SM
   Storrs, R
   Dorian, R
   King, S
   Choi, B
   Lakey, JR
AF Krishnan, R.
   Arora, R.
   Lamb, M.
   Liang, O.
   White, S. M.
   Storrs, R.
   Dorian, R.
   King, S.
   Choi, B.
   Lakey, J. R.
TI A Comparison of the Host Response to Two Types of Biomaterial
   Encapsulated Islets Using the Dorsal Window Chamber Model
SO TRANSPLANTATION
LA English
DT Meeting Abstract
C1 [Krishnan, R.; Lamb, M.; Liang, O.; Lakey, J. R.] Univ Calif Irvine, Surg, Orange, CA 92668 USA.
   [Arora, R.] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Orange, CA 92668 USA.
   [White, S. M.; Choi, B.] Univ Calif Irvine, Biomed Engn, Orange, CA 92668 USA.
   [Storrs, R.; Dorian, R.; King, S.] Islet Sheet Med LLC, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD NOV 27
PY 2012
VL 94
IS 10
SU S
MA 2370
BP 350
EP 351
DI 10.1097/00007890-201211271-00650
PG 2
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA V45WJ
UT WOS:000209846401448
OA Bronze
DA 2018-10-19
ER

PT J
AU Chowdhury, RR
   Aachoui, Y
   Ghosh, SK
AF Chowdhury, Roshni Roy
   Aachoui, Youssef
   Ghosh, Swapan K.
TI Effects of Small Intestinal Submucosa (SIS) on the Murine Innate Immune
   Microenvironment Induced by Heat-Killed Staphylococcus aureus
SO PLOS ONE
LA English
DT Article
ID VERSUS-HOST-DISEASE; XENOGENEIC EXTRACELLULAR-MATRIX; COLONY-STIMULATING
   FACTOR; IN-VIVO; INFLAMMASOME ACTIVATION; IL-1-BETA SECRETION;
   TISSUE-RESPONSE; GRAFT; REPAIR; EXPRESSION
AB The use of biological scaffold materials for wound healing and tissue remodeling has profoundly impacted regenerative medicine and tissue engineering. The porcine-derived small intestinal submucosa (SIS) is a licensed bioscaffold material regularly used in wound and tissue repair, often in contaminated surgical fields. Complications and failures due to infection of this biomaterial have therefore been a major concern and challenge. SIS can be colonized and infected by wound-associated bacteria, particularly Staphylococcus aureus. In order to address this concern and develop novel intervention strategies, the immune microenvironment orchestrated by the combined action of S. aureus and SIS should be critically evaluated. Since the outcome of tissue remodeling is largely controlled by the local immune microenvironment, we assessed the innate immune profile in terms of cytokine/chemokine microenvironment and inflammasome-responsive genes. BALB/c mice were injected intra-peritoneally with heat-killed S. aureus in the presence or absence of SIS. Analyses of cytokines, chemokines and microarray profiling of inflammasome-related genes were done using peritoneal lavages collected 24 hours after injection. Results showed that unlike SIS, the S. aureus-SIS interactome was characterized by a Th1-biased immune profile with increased expressions of IFN-gamma, IL-12 and decreased expressions of IL-4, IL-13, IL-33 and IL-6. Such modulation of the Th1/Th2 axis can greatly facilitate graft rejections. The S. aureus-SIS exposure also augmented the expressions of pro-inflammatory cytokines like IL-1 beta, Tnf-alpha, CD30L, Eotaxin and Fractalkine. This heightened inflammatory response caused by S. aureus contamination could enormously affect the biocompatibility of SIS. However, the mRNA expressions of many inflammasome-related genes like Nlrp3, Aim2, Card6 and Pycard were down-regulated by heat-killed S. aureus with or without SIS. In summary, our study explored the innate immune microenvironment induced by the combined exposure of SIS and S. aureus. These results have practical implications in developing strategies to contain infection and promote successful tissue repair.
C1 [Chowdhury, Roshni Roy; Aachoui, Youssef; Ghosh, Swapan K.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.
RP Chowdhury, RR (reprint author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.
EM rroychowdhu@sycamores.indstate.edu; y_aachoui@yahoo.fr;
   Swapan.Ghosh@indstate.edu
FU Cook Biotech; Fraternal Order of Eagles Grant; School of graduate and
   professional studies, Indiana state university
FX The work was initiated under the sponsorship of Cook Biotech, the
   Fraternal Order of Eagles Grant, and the School of graduate and
   professional studies, Indiana state university. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aachoui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027083
   Aachoui Y, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-61
   Ahn HH, 2007, INT J BIOL MACROMOL, V41, P590, DOI 10.1016/j.ijbiomac.2007.07.019
   Allman AJ, 2002, TISSUE ENG, V8, P53, DOI 10.1089/107632702753503054
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bates BL, 2008, BIOFILM INHIBITING M
   Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028
   Bellows CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021228
   Blazar BR, 2004, J IMMUNOL, V173, P2933, DOI 10.4049/jimmunol.173.5.2933
   Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x
   Budde K, 1994, Transpl Int, V7 Suppl 1, pS97
   Carbonell AM, 2005, SURG ENDOSC, V19, P430, DOI 10.1007/s00464-004-8810-4
   Champagne BJ, 2006, DIS COLON RECTUM, V49, P1817, DOI 10.1007/s10350-006-0755-3
   Cimini M, 2005, J BIOMED MATER RES A, V75A, P895, DOI 10.1002/jbm.a.30493
   Crapo PM, 2010, ACTA BIOMATER, V6, P2091, DOI 10.1016/j.actbio.2009.10.048
   de la Fuente SG, 2003, J GASTROINTEST SURG, V7, P96, DOI 10.1016/S1091-255X(02)00050-1
   DIPIETRO LA, 1995, AM J PATHOL, V146, P868
   Dodge IL, 2003, J IMMUNOL, V170, P4457, DOI 10.4049/jimmunol.170.9.4457
   DONAHUE RE, 1988, SCIENCE, V241, P1820, DOI 10.1126/science.3051378
   Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720
   Faustin B, 2008, TRENDS CELL BIOL, V18, P4, DOI 10.1016/j.tcb.2007.10.004
   Fluit AC, 2001, EUR J CLIN MICROBIOL, V20, P188, DOI 10.1007/s10096-001-8078-8
   Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513
   GRAHAM MF, 1988, GASTROENTEROLOGY, V94, P257, DOI 10.1016/0016-5085(88)90411-8
   Graves DT, 2001, J IMMUNOL, V167, P5316, DOI 10.4049/jimmunol.167.9.5316
   Harth KC, 2009, SURG INNOV, V16, P324, DOI 10.1177/1553350609353609
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2007, AM J CLIN DERMATOL, V8, P61, DOI 10.2165/00128071-200708020-00001
   HOLDERBAUM D, 1986, INFECT IMMUN, V54, P359
   Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002
   Hutter G, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-29
   Hultgren OH, 2001, ARTHRITIS RES, V3, P41
   Hume EBH, 2006, INVEST OPHTH VIS SCI, V47, P4926, DOI 10.1167/iovs.06-0340
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Knoll LD, 2007, J UROLOGY, V178, P2474, DOI 10.1016/j.juro.2007.08.044
   Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547
   Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188
   LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503
   Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897
   Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   Liaskou E, 2012, HEPATOLOGY
   Loh SA, 2009, PLAST RECONSTR SURG, V123, p65S, DOI 10.1097/PRS.0b013e318191bdf4
   Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006
   Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137
   McGrory K, 2004, BIOCHEM BIOPH RES CO, V324, P317, DOI 10.1016/j.bbrc.2004.09.056
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933
   Murdoch C, 2000, BLOOD, V95, P3032
   Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3
   Nikolic B, 2000, J CLIN INVEST, V105, P1289, DOI 10.1172/JCI7894
   Perl TM, 2003, SURGERY, V134, pS10, DOI 10.1016/S0039-6060(03)00391-X
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009
   Sakata N, 2001, BONE MARROW TRANSPL, V27, P1153, DOI 10.1038/sj.bmt.1703060
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Shah BC, 2011, HERNIA, V15, P165, DOI 10.1007/s10029-010-0768-7
   Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008
   Shin Ok S, 2011, Korean J Hematol, V46, P69, DOI 10.5045/kjh.2011.46.2.69
   Suckow MA, 2008, ANTICANCER RES, V28, P2529
   Suckow MA, 2007, CANCER IMMUNOL IMMUN, V56, P1275, DOI 10.1007/s00262-006-0278-8
   Szeto CC, 2007, CLIN J AM SOC NEPHRO, V2, P245, DOI 10.2215/CJN.03180906
   Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161
   Ueha S, 2007, J LEUKOCYTE BIOL, V81, P176, DOI 10.1189/jlb.0306231
   Ueno T, 2007, J GASTROINTEST SURG, V11, P918, DOI 10.1007/s11605-007-0171-6
   van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130
   van den Brink MRM, 2000, TRANSPLANTATION, V70, P184
   Vegesna V, 1995, J SURG RES, V59, P699, DOI 10.1006/jsre.1995.1226
   Verdrengh M, 1998, INFECT IMMUN, V66, P853
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wu LC, 1997, J SURG RES, V72, P162, DOI 10.1006/jsre.1997.5178
   Xu J, 2003, J IMMUNOL, V171, P938, DOI 10.4049/jimmunol.171.2.938
   Zhao DXM, 2002, J IMMUNOL, V169, P1556, DOI 10.4049/jimmunol.169.3.1556
   Zhou HY, 2011, ANN SURG, V253, P1033, DOI 10.1097/SLA.0b013e31821260f3
NR 81
TC 1
Z9 1
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 26
PY 2012
VL 7
IS 11
AR e48724
DI 10.1371/journal.pone.0048724
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 048RI
UT WOS:000311929800013
PM 23189134
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Lawrence, BD
   Pan, Z
   Rosenblatt, MI
AF Lawrence, Brian D.
   Pan, Zhi
   Rosenblatt, Mark I.
TI Silk Film Topography Directs Collective Epithelial Cell Migration
SO PLOS ONE
LA English
DT Article
ID BASEMENT-MEMBRANE; CONTACT GUIDANCE; NANOSCALE TOPOGRAPHY; CORNEAL
   FIBROBLASTS; FIBROIN MEMBRANES; HYALURONIC-ACID; IN-VIVO; BIOMATERIAL;
   PATTERNS; ORGANIZATION
AB The following study provides new insight into how surface topography dictates directed collective epithelial cell sheet growth through the guidance of individual cell movement. Collective cell behavior of migrating human corneal limbal-epithelial cell sheets were studied on highly biocompatible flat and micro-patterned silk film surfaces. The silk film edge topography guided the migratory direction of individual cells making up the collective epithelial sheet, which resulted in a 75% increase in total culture elongation. This was due to a 3-fold decrease in cell sheet migration rate efficiency for movement perpendicular to the topography edge. Individual cell migration direction is preferred in the parallel approach to the edge topography where localization of cytoskeletal proteins to the topography's edge region is reduced, which results in the directed growth of the collective epithelial sheet. Findings indicate customized biomaterial surfaces may be created to direct both the migration rate and direction of tissue epithelialization.
C1 [Pan, Zhi; Rosenblatt, Mark I.] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA.
   [Lawrence, Brian D.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA.
RP Rosenblatt, MI (reprint author), Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA.
EM mar2058@med.cornell.edu
FU National Institutes of Health (NIH) [K08EY015829, NIH R21EY019561, NIH
   R24EY015656]; Research to Prevent Blindness Career Development Award;
   Tri-Institutional Stem Cell Initiative; NIH P41 Tissue Engineering
   Resource Center at Tufts University
FX Funding for this work was from National Institutes of Health (NIH)
   K08EY015829, NIH R21EY019561, and NIH R24EY015656, Research to Prevent
   Blindness Career Development Award, Tri-Institutional Stem Cell
   Initiative, and the NIH P41 Tissue Engineering Resource Center at Tufts
   University. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Boudreau N, 1996, P NATL ACAD SCI USA, V93, P3509, DOI 10.1073/pnas.93.8.3509
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]
   Crabb RAB, 2006, TISSUE ENG, V12, P1565, DOI 10.1089/ten.2006.12.1565
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851
   Gov NS, 2007, P NATL ACAD SCI USA, V104, P15970, DOI 10.1073/pnas.0708037104
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Jeon H, 2010, BIOMATERIALS, V31, P4286, DOI 10.1016/j.biomaterials.2010.01.103
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Kaplan D, 2012, ADV MAT
   Karuri NW, 2006, IEEE T NANOBIOSCI, V5, P273, DOI 10.1109/TNB.2006.886570
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2012, JOVE-J VIS EXP, DOI 10.3791/3646
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Lin CC, 2005, BIOMATERIALS, V26, P3655, DOI 10.1016/j.biomaterials.2004.09.051
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MEYLE J, 1994, J MATER SCI-MATER M, V5, P463, DOI 10.1007/BF00058984
   Mo C, 2009, VIBRATIONAL SPECTROS
   Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104
   Rockwood D., 2011, NATURE PROT IN PRESS
   Rolli CG, 2012, BIOMATERIALS, V33, P2409, DOI 10.1016/j.biomaterials.2011.12.012
   Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Tocce EJ, 2010, BIOMATERIALS, V31, P4064, DOI 10.1016/j.biomaterials.2010.01.101
   Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vrana E, 2008, J BIOMED MATER RES A, V84A, P454, DOI 10.1002/jbm.a.31442
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Whitesides G, 1998, SOFT LITHOGRAPHY
NR 52
TC 19
Z9 19
U1 2
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 21
PY 2012
VL 7
IS 11
AR e50190
DI 10.1371/journal.pone.0050190
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 047ER
UT WOS:000311821000197
PM 23185573
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Dai, WD
   Kloner, RA
AF Dai, Wangde
   Kloner, Robert A.
TI The Effect of Cell Therapy versus Noncellular Biomaterial Implantation
   on Cardiac Structure and Function Following Myocardial Infarction
SO CIRCULATION
LA English
DT Meeting Abstract
DE Myocardial infarction; Stem cells; Tissue engineering; Remodeling;
   Collagen
C1 [Dai, Wangde; Kloner, Robert A.] Hosp Good Samaritan, Inst Heart, Los Angeles, CA 90017 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD NOV 20
PY 2012
VL 126
IS 21
SU S
MA 11715
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA V31LL
UT WOS:000208885001403
DA 2018-10-19
ER

PT J
AU Ming, JF
   Zuo, BQ
AF Ming, Jinfa
   Zuo, Baoqi
TI A novel electrospun silk fibroin/hydroxyapatite hybrid nanofibers
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Composite materials; Electron microscopy; Fourier transform infrared
   spectroscopy; Crystal structure
ID SCAFFOLDS; FIBROIN; FIBERS
AB A novel electrospinning of silk fibroin/hydroxyapatite hybrid nanofibers with different composition ratios was performed with methanoic acid as a spinning solvent. The silk fibroin/hydroxyapatite hybrids containing up to 30% hydroxyapatite nanoparticles could be electrospun into the continuous fibrous structure. The electrospun silk fibroin/hydroxyapatite hybrid nanofibers showed bigger diameter and wider diameter distribution than pure silk fibroin nanofibers, and the average diameter gradually increased from 95 to 582 nm. At the same time, the secondary structure of silk fibroin/hydroxyapatite nanofibers was characterized by X-ray diffraction, Fourier transform infrared analysis, and DSC measurement. Comparing with the pure silk fibroin nanofibers, the crystal structure of silk fibroin was mainly amorphous structure in the hybrid nanofibers. X-ray diffraction results demonstrated the hydroxyapatite crystalline nature remained as evidenced from the diffraction planes (002), (211), (300), and (202) of the hydroxyapatite crystallites, which was also confirmed by Fourier transform infrared analysis. The thermal behavior of hybrid nanofibers exhibited the endothermic peak of moisture evaporation ranging from 86 to 113 degrees C, and the degradation peak at 286 degrees C appeared. The SF/HAp nanofibers mats containing 30% HAp nanoparticles showed higher breaking tenacity and extension at break for 1.1688 +/- 0.0398 MPa and 6.55 +/- 1.95%, respectively. Therefore, the electrospun silk fibroin/hydroxyapatite hybrid nanofibers should be provided potentially useful options for the fabrication of biomaterial scaffolds for bone tissue engineering. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Ming, Jinfa; Zuo, Baoqi] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Ming, Jinfa; Zuo, Baoqi] Soochow Univ, Coll Text & Clothing Engn, Suzhou 215021, Peoples R China.
RP Zuo, BQ (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM jinfa.ming@gmail.com; bqzuo@suda.edu.cn
FU Soochow University [5832003611]; Jiangsu Province Ordinary Universities
   and Colleges Graduate Scientific and Innovation Plan [CXLX12_0815];
   National Engineering Laboratory for Modern Silk
FX The support of the First Phase of Jiangsu Universities' Distinctive
   Discipline Development Program for Textile Science and Engineering of
   Soochow University, Doctoral Candidate Academic Award Project of Soochow
   University (No.5832003611), Jiangsu Province Ordinary Universities and
   Colleges Graduate Scientific and Innovation Plan (CXLX12_0815), and
   National Engineering Laboratory for Modern Silk are gratefully
   acknowledged.
CR Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Dror Y, 2003, LANGMUIR, V19, P7012, DOI 10.1021/la034234i
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Nuansing W, 2006, MAT SCI ENG B-SOLID, V131, P147, DOI 10.1016/j.mseb.2006.04.030
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
NR 20
TC 33
Z9 37
U1 2
U2 82
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD NOV 15
PY 2012
VL 137
IS 1
BP 421
EP 427
DI 10.1016/j.matchemphys.2012.10.001
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 058HG
UT WOS:000312624100061
DA 2018-10-19
ER

PT J
AU Yuan, WH
   Gu, YJ
   Li, L
AF Yuan, Wenhui
   Gu, Yejian
   Li, Li
TI Green synthesis of graphene/Ag nanocomposites
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Graphene; Graphene/Ag; Composites; Sodium citrate; Environment-friendly
ID GRAPHITE OXIDE; NANOPARTICLES; REDUCTION; DISPERSIONS; NANOSHEETS;
   SHEETS
AB Graphene/Ag nanocomposites (GNS/AgNPs) were fabricated via a green and facile method, employing graphite oxide (GO) as a precursor of graphene, AgNO3 as a precursor of Ag nanoparticles, and sodium citrate as an environmentally friendly reducing and stabilizing agent. The synthesized GNS/AgNPs were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FT-IR), X-ray photoelectron spectroscopy (XPS) and Raman spectra (RS), respectively. The results indicated that graphite oxide was completely reduced to graphene, and the silver ion was reduced by sodium citrate simultaneously. Under a suitable dosage of silver ions, well-dispersed AgNPs on the graphene sheets mostly centralized at 20-25 nm. The surface plasmon resonance property of AgNPs on graphene showed that there was a interaction between AgNPs and graphene supports. In addition, antibacterial activity of silver nanoparticles was retained in the nanocomposites, suggesting that they can be potentially used as a graphene-based biomaterial. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Yuan, Wenhui; Gu, Yejian] S China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510640, Guangdong, Peoples R China.
   [Li, Li] S China Univ Technol, Coll Environm Sci & Engn, Guangzhou 510640, Guangdong, Peoples R China.
RP Yuan, WH (reprint author), S China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510640, Guangdong, Peoples R China.
EM cewhyuan@scut.edu.cn
FU National Natural Science Foundation of China [20976057]; Joint Funds of
   NSFC-Guangdong [U0834004]; research fund of The Guangdong Provincial
   Engineering Research Center of Green Fine Chemicals, China
FX The authors gratefully acknowledge the financial support of the National
   Natural Science Foundation of China (No. 20976057) and Joint Funds of
   NSFC-Guangdong (U0834004) and research fund of The Guangdong Provincial
   Engineering Research Center of Green Fine Chemicals, China.
CR Akhavan O, 2009, J PHYS CHEM C, V113, P20214, DOI 10.1021/jp906325q
   Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109
   Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401
   Gao ZY, 2012, APPL SURF SCI, V258, P2473, DOI 10.1016/j.apsusc.2011.10.075
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Guo HL, 2009, ACS NANO, V3, P2653, DOI 10.1021/nn900227d
   Hranisavljevic J, 2002, J AM CHEM SOC, V124, P4536, DOI 10.1021/ja012263e
   Hull RV, 2006, CHEM MATER, V18, P1780, DOI 10.1021/cm0518978
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Li D, 2008, SCIENCE, V320, P1170, DOI 10.1126/science.1158180
   Li J, 2010, EUR J INORG CHEM, P1244, DOI 10.1002/ejic.200901048
   Liu JC, 2011, APPL CATAL B-ENVIRON, V106, P76, DOI 10.1016/j.apcatb.2011.05.007
   Liu S, 2011, J NANOPART RES, V13, P4539, DOI 10.1007/s11051-011-0410-3
   Nethravathi C, 2008, CARBON, V46, P1994, DOI 10.1016/j.carbon.2008.08.013
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Paredes JI, 2008, LANGMUIR, V24, P10560, DOI 10.1021/la801744a
   Pasricha R., 2009, SMALL, V20, P2253
   Pol VG, 2002, LANGMUIR, V18, P3352, DOI 10.1021/la0155552
   Qian Y, 2011, APPL SURF SCI, V257, P10758, DOI 10.1016/j.apsusc.2011.07.093
   Shen JF, 2010, NANO RES, V3, P339, DOI 10.1007/s12274-010-1037-x
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Sun XP, 2004, MACROMOLECULES, V37, P7105, DOI 10.1021/ma048847t
   Xu C, 2008, J PHYS CHEM C, V112, P19841, DOI 10.1021/jp807989b
   Yang J, 2011, MATER CHEM PHYS, V129, P270, DOI 10.1016/j.matchemphys.2011.04.002
   Yang Y, 2011, APPL SURF SCI, V257, P8950, DOI 10.1016/j.apsusc.2011.05.070
   Zhou GM, 2010, CHEM MATER, V22, P5306, DOI 10.1021/cm101532x
   Zhou Y, 2009, CHEM MATER, V21, P2950, DOI 10.1021/cm9006603
NR 28
TC 71
Z9 73
U1 4
U2 193
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2012
VL 261
BP 753
EP 758
DI 10.1016/j.apsusc.2012.08.094
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 028SJ
UT WOS:000310442500115
DA 2018-10-19
ER

PT J
AU Pashuck, ET
   Stevens, MM
AF Pashuck, E. Thomas
   Stevens, Molly M.
TI Designing Regenerative Biomaterial Therapies for the Clinic
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Review
ID SPINAL-CORD-INJURY; STEM-CELL FATE; EXTRACELLULAR-MATRIX; THERAPEUTIC
   ANGIOGENESIS; IN-VITRO; HYDROGELS; MEDICINE; SCAFFOLDS; DELIVERY;
   DIFFERENTIATION
AB The ability to regenerate damaged tissue is one of the great challenges in biomaterials and medicine. Successful treatments will require advances in areas ranging from basic cell biology to materials synthesis, but there have been major hurdles in translating the biomedical advances, such as scaffolds that direct stem cell differentiation, into marketed products. Careful consideration of the challenges going from bench to bedside is paramount in maximizing the chances that a good idea becomes a good treatment. We look at a variety of material-based platforms that have made it into the clinic, from biodegradable polymers for wound healing to organs grown ex vivo, and how they have been able to navigate the scientific, regulatory, and business hurdles into the market place.
C1 [Pashuck, E. Thomas; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Pashuck, E. Thomas; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England.
   [Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
RP Stevens, MM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
EM m.stevens@imperial.ac.uk
OI Pashuck III, Eugene/0000-0003-2881-4965
FU European Commission under the 7th Framework Program for Research and
   Development Marie Curie International Incoming Fellowships program; ERC
   SIG grant "Naturale"
FX We thank L. Chow and K. Nitiputri, of the authors' laboratory, for the
   SEM images in Fig. 3 and J. Hulvat for useful suggestions. Funding: The
   European Commission under the 7th Framework Program for Research and
   Development Marie Curie International Incoming Fellowships program for
   E.T.P. M.M.S. is funded by ERC SIG grant "Naturale." Competing
   interests: The authors declare that they have no competing interests.
CR Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   [Anonymous], INT TERM CHEM ACT DE
   [Anonymous], CLASS PROD DRUGS DEV
   [Anonymous], 2001, FED REG
   [Anonymous], 2011, MED TECHN INN SCOR
   Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674
   Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003
   Azevedo MM, 2010, J MATER CHEM, V20, P8854, DOI 10.1039/c0jm01111h
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005
   Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   BCC Research, TECHN ADV STRUCT CER
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013
   Brennan EP, 2008, J TISSUE ENG REGEN M, V2, P491, DOI 10.1002/term.123
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   De Bartolo L, 2012, CHEM ENG PROCESS, V51, P79, DOI 10.1016/j.cep.2011.09.009
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Dieckmann C, 2010, EXP DERMATOL, V19, P697, DOI 10.1111/j.1600-0625.2010.01087.x
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Haque A, 2012, BIOMATERIALS, V33, P5094, DOI 10.1016/j.biomaterials.2012.04.003
   Hillel AT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002331
   Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Institute of Medicine, 2011, MED DEV PUBL HLTH FD
   Jaklenec A, 2012, TISSUE ENG PART B-RE, V18, P155, DOI [10.1089/ten.teb.2011.0553, 10.1089/ten.TEB.2011.0553]
   Jung S, 2012, STEM CELLS INT, DOI 10.1155/2012/123030
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keyhani S, 2006, HEALTH AFFAIR, V25, P461, DOI 10.1377/hlthaff.25.2.461
   Kim M, 2011, BIOMATERIALS, V32, P7883, DOI 10.1016/j.biomaterials.2011.07.015
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Makower J., 2010, FDA IMPACT US MED TE
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Mason C, 2010, REGEN MED, V5, P307, DOI 10.2217/RME.10.37
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   O'Donnell MD, 2010, J MATER CHEM, V20, P8934, DOI 10.1039/c0jm01139h
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Orlando G, 2012, ANN SURG, V255, P867, DOI 10.1097/SLA.0b013e318243a4db
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Park HJ, 2012, ADV DRUG DELIVER REV, V64, P40, DOI 10.1016/j.addr.2011.09.005
   Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078
   Petrie T. A., 2010, SCI TRANSL MED, V2
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Prestwich GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004915
   Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044
   Ranga A, 2012, CURR OPIN CELL BIOL, V24, P236, DOI 10.1016/j.ceb.2012.01.006
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r
   Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Sreejalekshmi KG, 2011, J BIOMED MATER RES A, V96A, P477, DOI 10.1002/jbm.a.32980
   Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763
   Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tsou R, 2001, MOL CELL BIOCHEM, V224, P81, DOI 10.1023/A:1011947301849
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Valliant EM, 2011, SOFT MATTER, V7, P5083, DOI 10.1039/c0sm01348j
   Vanderploeg EJ, 2012, J ANAT, V221, P174, DOI 10.1111/j.1469-7580.2012.01523.x
   Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   Wei G, 2008, ADV FUNCT MATER, V18, P3566, DOI DOI 10.1002/ADFM.200800662
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Ye L, 2012, CELL STEM CELL, V11, P50, DOI 10.1016/j.stem.2012.04.009
   Yoo James J, 2011, Int Neurourol J, V15, P109, DOI 10.5213/inj.2011.15.3.109
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhou ZL, 2012, BIOMATERIALS, V33, P2473, DOI 10.1016/j.biomaterials.2011.12.005
NR 100
TC 95
Z9 96
U1 5
U2 146
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD NOV 14
PY 2012
VL 4
IS 160
AR 160sr4
DI 10.1126/scitranslmed.3002717
PG 12
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 037IQ
UT WOS:000311097100005
PM 23152328
DA 2018-10-19
ER

PT J
AU Qi, C
   Zhu, YJ
   Lu, BQ
   Zhao, XY
   Zhao, J
   Chen, F
AF Qi, Chao
   Zhu, Ying-Jie
   Lu, Bing-Qiang
   Zhao, Xin-Yu
   Zhao, Jing
   Chen, Feng
TI Hydroxyapatite nanosheet-assembled porous hollow microspheres:
   DNA-templated hydrothermal synthesis, drug delivery and protein
   adsorption
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID SPRAY-DRYING METHOD; ASSISTED SYNTHESIS; BOVINE HEMOGLOBIN; NANORODS;
   NANOPARTICLES; RELEASE; CARRIER; WATER; BONE
AB Porous hollow microspheres of hydroxyapatite (HAP) are an ideal biomaterial due to their excellent biocompatibility and hollow structure. Herein, we report a novel DNA-templated hydrothermal strategy for the synthesis of HAP nanosheet-assembled hollow microspheres with a nanoporous structure. The as-prepared HAP porous hollow microspheres consist of HAP nanosheets as the building blocks with an average thickness of about 20 nm, and the diameters of the HAP porous hollow microspheres are in the range 2.5-4.5 mu m, with an average pore size of about 21.8 nm. The as-prepared HAP porous hollow microspheres are explored for potential applications in drug delivery, and protein adsorption and release. The as-prepared HAP porous hollow microspheres show a relatively high drug loading capacity and protein adsorption ability, and sustained drug and protein release, using ibuprofen as a model drug and hemoglobin (Hb) as a model protein. The experiments indicate that the as-prepared HAP porous hollow microspheres are promising for applications in biomedical fields such as drug delivery and protein adsorption.
C1 [Qi, Chao; Zhu, Ying-Jie; Lu, Bing-Qiang; Zhao, Xin-Yu; Zhao, Jing; Chen, Feng] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Perfbrmance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Perfbrmance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
RI Qi, Chao/N-5957-2015; Chen, Feng/D-6406-2012; CHEN, Feng/E-4310-2016
OI Chen, Feng/0000-0002-1162-1684; CHEN, Feng/0000-0002-1162-1684
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [51172260, 51121064,
   51102258]; Science and Technology Commission of Shanghai [11nm0506600,
   1052nm06200]; CAS/SAFEA International Partnership Program for Creative
   Research Teams
FX Financial support from the National Basic Research Program of China (973
   Program, no. 2012CB933600), the National Natural Science Foundation of
   China (51172260, 51121064, 51102258), the Science and Technology
   Commission of Shanghai (11nm0506600, 1052nm06200) and CAS/SAFEA
   International Partnership Program for Creative Research Teams is
   gratefully acknowledged.
CR Andersson J, 2004, CHEM MATER, V16, P4160, DOI 10.1021/cm0401490
   Chen F, 2011, BIOMATERIALS, V32, P9031, DOI 10.1016/j.biomaterials.2011.08.032
   Chen F, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-67
   Chen F, 2011, CRYSTENGCOMM, V13, P1858, DOI 10.1039/c0ce00574f
   CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0
   Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Gao W, 2011, BIOMATERIALS, V32, P9425, DOI 10.1016/j.biomaterials.2011.08.046
   Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367
   Henzler K, 2007, BIOMACROMOLECULES, V8, P3674, DOI 10.1021/bm700953e
   Jevtic M, 2008, CRYST GROWTH DES, V8, P2217, DOI 10.1021/cg7007304
   Jiang SD, 2012, J PHYS CHEM C, V116, P4484, DOI 10.1021/jp211648x
   Jiao Y, 2012, POWDER TECHNOL, V217, P581, DOI 10.1016/j.powtec.2011.11.025
   Jongpoiboonkit L, 2009, ADV MATER, V21, P1960, DOI 10.1002/adma.200801808
   Kawai T, 2009, J CERAM SOC JPN, V117, P340, DOI 10.2109/jcersj2.117.340
   Ma MG, 2006, J PHYS CHEM B, V110, P14226, DOI 10.1021/jp061738r
   Ma MG, 2009, EUR J INORG CHEM, P5522, DOI 10.1002/ejic.200900839
   Ma MY, 2008, J MATER CHEM, V18, P2722, DOI 10.1039/b800389k
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Stephanopoulos N, 2010, NANO LETT, V10, P2714, DOI 10.1021/nl1018468
   Stulz E, 2012, CHEM-EUR J, V18, P4456, DOI 10.1002/chem.201102908
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun RX, 2009, MAT SCI ENG C-BIO S, V29, P1088, DOI 10.1016/j.msec.2008.08.010
   Tang QL, 2011, NANOMED-NANOTECHNOL, V7, P428, DOI 10.1016/j.nano.2010.12.005
   Tseng YH, 2009, MAT SCI ENG C-BIO S, V29, P819, DOI 10.1016/j.msec.2008.07.028
   Wang KW, 2011, MATER LETT, V65, P2361, DOI 10.1016/j.matlet.2011.04.104
   Wang KW, 2010, CHEM-ASIAN J, V5, P2477, DOI 10.1002/asia.201000463
   Wang KW, 2010, J MATER CHEM, V20, P1161, DOI 10.1039/b917441a
   Wang X, 2006, ADV MATER, V18, P2031, DOI 10.1002/adma.200600033
   Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998
   Wu GJ, 2010, J COLLOID INTERF SCI, V345, P427, DOI 10.1016/j.jcis.2010.01.048
   Xia W, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/30/305610
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Zhang C, 2012, ANGEW CHEM INT EDIT, V51, P3382, DOI 10.1002/anie.201108710
   Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011
   Zhang HB, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/031002
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 40
TC 82
Z9 85
U1 6
U2 148
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD NOV 14
PY 2012
VL 22
IS 42
BP 22642
EP 22650
DI 10.1039/c2jm35280j
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 032LW
UT WOS:000310721300044
DA 2018-10-19
ER

PT J
AU Aldana, AA
   Toselli, R
   Strumia, MC
   Martinelli, M
AF Agustina Aldana, Ana
   Toselli, Ricardo
   Strumia, Miriam C.
   Martinelli, Marisa
TI Chitosan films modified selectively on one side with dendritic molecules
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID BILAYER ARTIFICIAL SKIN; RELEASE; BIOCOMPATIBILITY; DERIVATIVES;
   DRESSINGS; BEADS
AB Novel chitosan films dendronized on one side were prepared by reaction between a cross-linked biopolymer and weisocyanate dendron. According to ATR-FTIR analysis, it can be concluded that the dendronization took place on only one of the faces of the films. The highlight of this work is that the modification grants different hydrophilic and hydrophobic properties on both sides of the system. Interactions between the dendron-polymer network and the hydrophobic characteristics of the dendron modify the physical properties of the films. As the thermal stability of the films increases, the degree of swelling and WVP values decrease, and the elastic modulus increases, turning the network more rigid. The dendronized films were swollen at pH 3.4 and 6.8 which are the pHs of the different wound healing stages. The films remained stable for an extended period. The films obtained can be potentially applied as wound dressings able to maintain a moist environment at the wound interface and act as a barrier to microorganisms, removing excess exudates. The product is made from a readily available biomaterial that requires minimal processing, possesses antimicrobial properties and could promote wound healing.
C1 [Agustina Aldana, Ana; Strumia, Miriam C.; Martinelli, Marisa] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Organ IMBIV, RA-5000 Cordoba, Argentina.
   [Toselli, Ricardo] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Quim Aplicada CEQUIMAP, RA-5000 Cordoba, Argentina.
RP Martinelli, M (reprint author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Organ IMBIV, RA-5000 Cordoba, Argentina.
EM aaldana@fcq.unc.edu.ar; rtoselli@fcq.unc.edu.ar; mcs@fcq.unc.edu.ar;
   mmartinelli@fcq.unc.edu.ar
OI Martinelli, Marisa/0000-0002-6780-9387; Aldana, Ana
   Agustina/0000-0003-4997-7982
FU FONCYT; CONICET; SECYT of UNC
FX The authors gratefully acknowledge the financial assistance of FONCYT,
   CONICET, and SECYT of UNC. Aldana AA thanks CONICET for the fellowship
   awarded. We thank Prof. Alicia Susana Lorenti of Buenos Aires University
   for discussions.
CR Aldana AA, 2012, MATER CHEM PHYS, V134, P317, DOI 10.1016/j.matchemphys.2012.02.071
   Appoh FE, 2009, J APPL POLYM SCI, V111, P709, DOI 10.1002/app.28980
   Balaji S, 2012, MAT SCI ENG C-MATER, V32, P975, DOI 10.1016/j.msec.2012.02.023
   Brown MA, 2009, J EMERG MED, V37, P1, DOI 10.1016/j.jemermed.2007.05.043
   BRUIN P, 1990, J BIOMED MATER RES, V24, P217, DOI 10.1002/jbm.820240208
   Dias AMA, 2011, INT J PHARMACEUT, V408, P9, DOI 10.1016/j.ijpharm.2011.01.063
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Enescu D, 2009, CARBOHYD POLYM, V76, P268, DOI 10.1016/j.carbpol.2008.10.026
   FUJIKAWA S, 1987, BIOTECHNOL LETT, V9, P697, DOI 10.1007/BF01024600
   Gethin G. T., 2007, WOUNDS UK, V3, P52
   Kamari A, 2009, J ENVIRON SCI-CHINA, V21, P296, DOI 10.1016/S1001-0742(08)62267-6
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Leane MM, 2004, INT J PHARM, V271, P241, DOI 10.1016/j.ijpharm.2003.11.023
   Lewandowska K, 2011, THERMOCHIM ACTA, V517, P90, DOI 10.1016/j.tca.2011.01.036
   Martinez-Camacho AP, 2010, CARBOHYD POLYM, V82, P305, DOI 10.1016/j.carbpol.2010.04.069
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   MATSUDA K, 1992, BIOMATERIALS, V13, P119, DOI 10.1016/0142-9612(92)90007-B
   Mi FL, 2000, J POLYM SCI POL CHEM, V38, P2804, DOI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.0.CO;2-Y
   Mi FL, 2002, CARBOHYD POLYM, V48, P61, DOI 10.1016/S0144-8617(01)00212-0
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Paez JI, 2009, ELECTROCHIM ACTA, V54, P4192, DOI 10.1016/j.electacta.2009.02.064
   PRABU SL, 2008, ARS PHARM, V49, P211
   Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x
   RAVIKUMAR MNV, 2000, REACT FUNCT POLYM, V46, P1
   Sezer A. D., 2007, PHARM SCI TECHNOL TO, V8, P1
   Shibata H, 1997, J BIOMAT SCI-POLYM E, V8, P601, DOI 10.1163/156856297X00209
   Silva CL, 2008, J MEMBRANE SCI, V320, P268, DOI 10.1016/j.memsci.2008.04.011
   SUZUKI S, 1990, BIOMATERIALS, V11, P356, DOI 10.1016/0142-9612(90)90114-6
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Williams AA, 2007, J ANTIMICROB CHEMOTH, V59, P451, DOI 10.1093/jac/dkl503
   Wu YB, 2004, CARBOHYD POLYM, V57, P435, DOI 10.1016/j.carbpol.2004.05.013
   Wyszogrodzka M, 2009, LANGMUIR, V25, P5703, DOI 10.1021/la803017b
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 34
TC 16
Z9 16
U1 0
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD NOV 14
PY 2012
VL 22
IS 42
BP 22670
EP 22677
DI 10.1039/c2jm33100d
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 032LW
UT WOS:000310721300048
DA 2018-10-19
ER

PT J
AU Nardecchia, S
   Gutierrez, MC
   Serrano, MC
   Dentini, M
   Barbetta, A
   Ferrer, ML
   del Monte, F
AF Nardecchia, Stefania
   Gutierrez, Maria C.
   Concepcion Serrano, M.
   Dentini, Mariella
   Barbetta, Andrea
   Luisa Ferrer, M.
   del Monte, Francisco
TI In Situ Precipitation of Amorphous Calcium Phosphate and Ciprofloxacin
   Crystals during the Formation of Chitosan Hydrogels and Its Application
   for Drug Delivery Purposes
SO LANGMUIR
LA English
DT Article
ID NANOPARTICLES; SCAFFOLDS; HYDROXYAPATITE; COMPOSITES; NMR; PROTEIN;
   CARBON; CRYSTALLIZATION; IMMOBILIZATION; TRANSFORMATION
AB The immobilization of more than one single substance within the structure of a biocompatible polymer provides multifunctional biomaterials with attractive and enhanced properties. In the context of bone tissue engineering, it could be of great interest to synthesize a biomaterial that simultaneously contains amorphous calcium phosphate (ACP), to favor calcium and phosphate precipitation. and promote Osteogenesis, and an antibiotic such as ciprofloxacin (CFX) that can, eventually, avoid infections resulting after surgical scaffold implantation. However, the co-immobilization of multiple substances is by no Means a trivial issue because of the enhanced number Of interactions that can take place. One of the main issues is controlling not only the diverse solid forms that individual substances can eventually adopt, but also the forces responsible for the self organization of the individual components The latter determines whether phase separated structures or conjugated architectures are obtained and, consequently, may dramatically affect their functionality. Herein, we have observed-by SEM, TEM, and solid-state NMR-that enzymatically assisted coprecipitation of ACP and CFX resulted in phase separated structures. Thus, CFX crystals showed identical morphology to that obtained in the absence of ACP, but the size was smaller. Neither the size nor the morphology of ACP exhibited significant differences whether precipitated with or without CFX, but, in the former case, ACP was stabilized over a wider range of pH and temperature. Finally, by Using this methodology and the ice segregation induced self assembly process (ISISA), we have successfully co-immobilized ACP and CFX in chitosan-based scaffolds Interestingly, the presence. of ACP exerted significant control on the CFX release from these materials.
C1 [Nardecchia, Stefania; Gutierrez, Maria C.; Concepcion Serrano, M.; Luisa Ferrer, M.; del Monte, Francisco] CSIC, ICMM, Madrid 28049, Spain.
   [Dentini, Mariella; Barbetta, Andrea] Univ Roma La Sapienza, Dipartimento Chim, I-00185 Rome, Italy.
RP Gutierrez, MC (reprint author), CSIC, ICMM, Campus Cantoblanco, Madrid 28049, Spain.
EM mcgutierrez@icmm.csic.es; delmonte@icmm.csic.es
RI Serrano, Maria Concepcion/D-7442-2014; Ferrer, Maria Luisa/C-5463-2011;
   del Monte, Francisco/A-5643-2011; Gutierrez, Maria/B-5386-2013; Dentini,
   Mariella/N-2653-2013
OI Serrano, Maria Concepcion/0000-0002-5010-644X; Ferrer, Maria
   Luisa/0000-0003-2284-8259; del Monte, Francisco/0000-0002-2868-0023;
   Gutierrez, Maria/0000-0001-8612-7974; Dentini,
   Mariella/0000-0003-0783-0982; Barbetta, Andrea/0000-0001-9292-4734
FU MINECO [MAT2009-10214, MAT2011-25329, MAT2012-34811, PIE2010601017];
   European Union Seventh Framework Programe [263289]; CSIC
FX This work was supported by grants from MINECO (Project Numbers
   MAT2009-10214, MAT2011-25329, MAT2012-34811 and PIE2010601017) and from
   the European Union Seventh Framework Programe (FP7/2007-2013) under
   grant agreement no 263289 (Green Nano Mesh). S.N. acknowledges CSIC for
   a JAE-Pre fellowship. M.C.S. acknowledges MINECO for a Juan de la Cierva
   research contract. Fernando Pinto (from the Instituto de Ciencias
   Agrarias-CSIC) and Maria Jose de la Mata (from SIdI-UAM) are
   acknowledged for their kind assistance with SEM and soli-state NMR
   studies, respectively.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Anton N, 2008, J CONTROL RELEASE, V128, P185, DOI 10.1016/j.jconrel.2008.02.007
   Aranaz I, 2009, J MATER CHEM, V19, P1576, DOI 10.1039/b813156b
   AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032
   Baeuerlein E., 2000, BIOMINERALIZATION BI
   Bandi S, 2006, MACROMOLECULES, V39, P6537, DOI 10.1021/ma0611826
   BOSKEY AL, 1973, J PHYS CHEM-US, V77, P2313, DOI 10.1021/j100638a011
   Bradley JV, 2010, CHEM MATER, V22, P6109, DOI 10.1021/cm101730f
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   Chou YF, 2004, BIOMATERIALS, V25, P5323, DOI 10.1016/j.biomaterials.2003.12.037
   Cohen S, 2012, BIOMATERIALS, V33, P614, DOI 10.1016/j.biomaterials.2011.09.085
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   des Rieux A, 2006, J CONTROL RELEASE, V116, P1, DOI 10.1016/j.jconrel.2006.08.013
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Ferrer ML, 2006, CHEM MATER, V18, P554, DOI 10.1021/cm052087z
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gutierrez MC, 2008, CHEM MATER, V20, P634, DOI 10.1021/cm702028z
   Gutierrez MC, 2008, CHEM MATER, V20, P11, DOI 10.1021/cm7020164
   Gutierrez MC, 2007, ADV FUNCT MATER, V17, P3505, DOI 10.1002/adfm.200700093
   Gutierrez MC, 2007, J MATER CHEM, V17, P2992, DOI 10.1039/b707504a
   Gutierrez MC, 2007, J PHYS CHEM C, V111, P5557, DOI 10.1021/jp0714365
   Gutierrez MC, 2007, CHEM MATER, V19, P1968, DOI 10.1021/cm062882s
   Hortiguela MJ, 2011, BIOMACROMOLECULES, V12, P179, DOI 10.1021/bm1010883
   Hortiguela MJ, 2008, J MATER CHEM, V18, P5933, DOI 10.1039/b815401e
   Jager C, 2006, MAGN RESON CHEM, V44, P573, DOI 10.1002/mrc.1774
   Kirsebom H, 2011, POLYM CHEM-UK, V2, P1059, DOI 10.1039/c1py00014d
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Li XW, 2007, INT J PHARM, V328, P177, DOI 10.1016/j.ijpharm.2006.08.012
   Liao JD, 2005, BIOMACROMOLECULES, V6, P392, DOI 10.1021/bm0494951
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t
   Lowenstam HA, 1989, BIOMINERALIZATION
   MANN S, 2000, ANGEW CHEM INT EDIT, V39, P3392, DOI DOI 10.1002/1521-3773(20001002)39:19<3392::AID-ANIE3392>3.0.CO;2-M
   Morissette SL, 2003, P NATL ACAD SCI USA, V100, P2180, DOI 10.1073/pnas.0437744100
   Moura MJ, 2007, BIOMACROMOLECULES, V8, P3823, DOI 10.1021/bm700762w
   Mukai SR, 2004, CHEM MATER, V16, P4987, DOI 10.1021/cm0491328
   Nardecchia S, 2012, ADV FUNCT MATER, V22, P4411, DOI 10.1002/adfm.201200684
   Nassif N, 2010, CHEM MATER, V22, P3653, DOI 10.1021/cm903596q
   Ozin GA, 1997, ACCOUNTS CHEM RES, V30, P17, DOI 10.1021/ar960021r
   Pan HH, 2010, CHEM COMMUN, V46, P7415, DOI 10.1039/c0cc00971g
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   Shan N, 2008, DRUG DISCOV TODAY, V13, P440, DOI 10.1016/j.drudis.2008.03.004
   Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152
   Shi QH, 2008, J AM CHEM SOC, V130, P5034, DOI 10.1021/ja800376t
   Shi QH, 2007, ADV MATER, V19, P4539, DOI 10.1002/adma.200700819
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   Skrtic D, 2000, J BIOMED MATER RES, V53, P381, DOI 10.1002/1097-4636(2000)53:4<381::AID-JBM12>3.3.CO;2-8
   Sumper M, 2006, ADV FUNCT MATER, V16, P17, DOI 10.1002/adfm.200500616
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   TROPP J, 1983, J AM CHEM SOC, V105, P22, DOI 10.1021/ja00339a006
   Vyalikh A, 2011, J PHYS CHEM C, V115, P1513, DOI 10.1021/jp1082399
   Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574
   YESINOWSKI JP, 1987, J AM CHEM SOC, V109, P6274, DOI 10.1021/ja00255a009
   Zayats M, 2005, NANO LETT, V5, P21, DOI 10.1021/nl048547p
   Zemljic LF, 2009, BIOMACROMOLECULES, V10, P1181, DOI 10.1021/bm801483s
   Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487
NR 60
TC 25
Z9 26
U1 2
U2 91
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 13
PY 2012
VL 28
IS 45
BP 15937
EP 15946
DI 10.1021/la3033435
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 038RH
UT WOS:000311191300022
PM 23088184
DA 2018-10-19
ER

PT J
AU Doi, K
   Oue, H
   Morita, K
   Kajihara, S
   Kubo, T
   Koretake, K
   Perrotti, V
   Iezzi, G
   Piattelli, A
   Akagawa, Y
AF Doi, Kazuya
   Oue, Hiroshi
   Morita, Koji
   Kajihara, Shiho
   Kubo, Takayasu
   Koretake, Katsunori
   Perrotti, Vittoria
   Iezzi, Giovanna
   Piattelli, Adriano
   Akagawa, Yasumasa
TI Development of Implant/Interconnected Porous Hydroxyapatite Complex as
   New Concept Graft Material
SO PLOS ONE
LA English
DT Article
ID RESONANCE FREQUENCY-ANALYSIS; INITIAL BONE REGENERATION; CALCIUM
   HYDROXYAPATITE; INORGANIC POLYPHOSPHATE; BLOCK HYDROXYAPATITE; IMPLANT
   STABILITY; AUTOGENOUS BONE; ARTIFICIAL BONE; DENTAL IMPLANTS;
   OSSEOINTEGRATION
AB Background: Dental implant has been successfully used to replace missing teeth. However, in some clinical situations, implant placement may be difficult because of a large bone defect. We designed novel complex biomaterial to simultaneously restore bone and place implant. This complex was incorporated implant into interconnected porous calcium hydroxyapatite (IP-CHA). We then tested this Implant/IP-CHA complex and evaluated its effect on subsequent bone regeneration and implant stability in vivo.
   Methodology/Principal Findings: A cylinder-type IP-CHA was used in this study. After forming inside of the cylinder, an implant was placed inside to fabricate the Implant/IP-CHA complex. This complex was then placed into the prepared bone socket in the femur of four beagle-Labrador hybrid dogs. As a control, implants were placed directly into the femur without any bone substrate. Bone sockets were allowed to heal for 2, 3 and 6 months and implant stability quotients (ISQ) were measured. Finally, tissue blocks containing the Implant/IP-CHA complexes were harvested. Specimens were processed for histology and stained with toluidine blue and bone implant contact (BIC) was measured. The ISQs of complex groups was 77.8 +/- 2.9 in the 6-month, 72.0 +/- 5.7 in the 3-month and 47.4 +/- 11.0 in the 2-month. There was no significant difference between the 3- or 6-month complex groups and implant control groups. In the 2-month group, connective tissue, including capillary angiogenesis, was predominant around the implants, although newly formed bone could also be observed. While, in the 3 and 6-month groups, newly formed bone could be seen in contact to most of the implant surface. The BICs of complex groups was 2.18 +/- 3.77 in the 2-month, 44.03 +/- 29.58 in the 3- month, and 51.23 +/- 8.25 in the 6-month. Significant difference was detected between the 2 and 6-month.
   Conclusions/Significance: Within the results of this study, the IP-CHA/implant complex might be able to achieve both bone reconstruction and implant stability. Citation: Doi K, Oue H, Morita K, Kajihara S, Kubo T, et al. (2012) Development of Implant/Interconnected Porous Hydroxyapatite Complex as New Concept Graft Material. PLoS ONE 7(11): e49051. doi:10.1371/journal.pone.0049051
C1 [Doi, Kazuya; Oue, Hiroshi; Morita, Koji; Kajihara, Shiho; Kubo, Takayasu; Koretake, Katsunori; Akagawa, Yasumasa] Hiroshima Univ, Grad Sch Biomed Sci, Dept Adv Prosthodont, Hiroshima, Japan.
   [Perrotti, Vittoria; Iezzi, Giovanna; Piattelli, Adriano] Chieti Pescara Univ, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
RP Doi, K (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Adv Prosthodont, Hiroshima, Japan.
EM kazuya17@hiroshima-u.ac.jp
RI Doi, Kazuya/J-6554-2016
OI Doi, Kazuya/0000-0001-9452-4750; Morita, Koji/0000-0002-5724-5573
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [24390435]; Brain circulation program to develop new leaders for
   international dental education course through international
   collaborative dental research
FX This study was supported in part by a Grant-in Aid for Scientific
   Research (No24390435) from the Ministry of Education, Culture, Sports,
   Science and Technology, Japan and Brain circulation program to develop
   new leaders for international dental education course through
   international collaborative dental research. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abrahamsson I, 2009, CLIN ORAL IMPLAN RES, V20, P313, DOI 10.1111/j.1600-0501.2008.01646.x
   ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266
   Ayers RA, 1999, J BIOMED MATER RES, V47, P54, DOI 10.1002/(SICI)1097-4636(199910)47:1<54::AID-JBM7>3.3.CO;2-G
   Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   Becker W, 1990, Int J Periodontics Restorative Dent, V10, P376
   Blanco J, 2011, CLIN ORAL IMPLAN RES, V22, P92, DOI 10.1111/j.1600-0501.2010.02009.x
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Branemark PI, 1985, TISSUE INTEGRATED PR, p[11, 253]
   Chiapasco M, 1999, CLIN ORAL IMPLAN RES, V10, P278, DOI 10.1034/j.1600-0501.1999.100404.x
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   De Santis E, 2011, CLIN ORAL IMPLAN RES, V22, P430, DOI 10.1111/j.1600-0501.2010.02122.x
   Deie M, 2008, KNEE SURG SPORT TR A, V16, P753, DOI 10.1007/s00167-008-0558-2
   Doi K, 2007, DENT MATER J, V26, P162, DOI 10.4012/dmj.26.162
   Friberg B, 1999, INT J ORAL MAX SURG, V28, P266, DOI 10.1034/j.1399-0020.1999.284280405.x
   Glauser R, 2004, CLIN ORAL IMPLAN RES, V15, P428, DOI 10.1111/j.1600-0501.2004.01036.x
   Hayashi K, 2007, DENT MATER J, V26, P170, DOI 10.4012/dmj.26.170
   Hermann JS, 1996, CURR OPIN PERIODONT, V3, P168
   Huang HM, 2000, ORAL SURG ORAL MED O, V90, P285, DOI 10.1067/moe.2000.108918
   Hui E, 2001, Clin Implant Dent Relat Res, V3, P79, DOI 10.1111/j.1708-8208.2001.tb00235.x
   Isoda K, 2011, CLIN ORAL IMPLAN RES, V23, P832
   Kalk WWI, 1996, J ORAL MAXIL SURG, V54, P1424, DOI 10.1016/S0278-2391(96)90257-8
   Kubo T, 2011, J PROSTHODONT RES, V55, P104, DOI 10.1016/j.jpor.2010.10.001
   Kuriyama K, 2009, MOD RHEUMATOL, V19, P180, DOI 10.1007/s10165-008-0147-8
   Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x
   Miyamoto I, 2005, BONE, V37, P776, DOI 10.1016/j.bone.2005.06.019
   Morita K, 2010, ACTA BIOMATER, V6, P2808, DOI 10.1016/j.actbio.2009.12.055
   Shigeishi H, 2012, DENT MATER J, V31, P54, DOI 10.4012/dmj.2011-089
   STEINKAMP JA, 1976, J HISTOCHEM CYTOCHEM, V24, P292, DOI 10.1177/24.1.1254924
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Tamai N, 2010, J ORTHOP SCI, V15, P560, DOI 10.1007/s00776-010-1479-8
   Tawse-Smith A, 2001, Clin Implant Dent Relat Res, V3, P185, DOI 10.1111/j.1708-8208.2001.tb00140.x
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yoshikawa H, 2009, J R SOC INTERFACE, V6, P341
   Yuan Q, 2009, ACTA BIOMATER, V5, P1716, DOI 10.1016/j.actbio.2009.01.034
   ZARB GA, 1991, BRIT DENT J, V170, P439, DOI 10.1038/sj.bdj.4807583
NR 36
TC 12
Z9 12
U1 1
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 9
PY 2012
VL 7
IS 11
AR e49051
DI 10.1371/journal.pone.0049051
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 053LI
UT WOS:000312272600040
PM 23152848
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Hota, MK
   Bera, MK
   Kundu, B
   Kundu, SC
   Maiti, CK
AF Hota, Mrinal K.
   Bera, Milan K.
   Kundu, Banani
   Kundu, Subhas C.
   Maiti, Chinmay K.
TI A Natural Silk Fibroin Protein-Based Transparent Bio-Memristor
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE silk fibroin; scanning tunneling microscopy; bio-memristors
ID BOMBYX-MORI; CHAIN; BIOMATERIALS; NANODEVICES; TRANSISTORS; SILKWORMS
AB The recent discovery of nanoelectronics memristor devices has opened up a new wave of enthusiasm and optimism in revolutionizing electronic circuit design, marking the beginning of new era for the advancement of neuromorphic, high-density logic and memory applications. Here a highly non-linear dynamic response of a bio-memristor is demonstrated using natural silk cocoon fibroin protein of silkworm, Bombyx mori. A film that is transparent across most of the visible spectrum is obtained with the electronic-grade silk fibroin aqueous solution of ca. 2% (wt/v). Bipolar memristive switching is demonstrated; the switching mechanism is confirmed to be the filamentary switching as observed by probing local conduction behavior at nanoscale using scanning tunneling microscopy. The memristive transition is elucidated by a physical model based on the carrier trapping or detrapping in silk fibroin films and this appears to be due to oxidation and reduction procedures, as evidenced from cyclic voltammetry measurements. Hence, silk fibroin protein could be used as a biomaterial for bio-memristor devices for applications in advanced bio-inspired very large scale integration circuit design as well as in biologically inspired synapse links for energy-efficient neuromorphic computing.
C1 [Hota, Mrinal K.; Bera, Milan K.; Maiti, Chinmay K.] Indian Inst Technol, Dept Elect & Elect Commun Engn, Kharagpur 721302, W Bengal, India.
   [Kundu, Banani; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Hota, MK (reprint author), Indian Inst Technol, Dept Elect & Elect Commun Engn, Kharagpur 721302, W Bengal, India.
EM m.k.bera.iitkgp@gmail.com; kundu@hijli.iitkgp.ernet.in
RI Kundu, Banani/O-9320-2016
OI Kundu, Banani/0000-0003-1251-700X; Bera, Milan
   Kumar/0000-0002-2996-890X; Kundu, Subhas C./0000-0002-7170-2291
FU Department of Science and Technology; Department of Chemistry (Indian
   Institute of Technology, Kharagpur); Department of Biotechnology and its
   Bioinformatics facility; Council of Scientific and Industrial Research,
   Government of India, New Delhi
FX This work was financially supported by Department of Science and
   Technology (funding for MGS project), Department of Chemistry (Indian
   Institute of Technology, Kharagpur), Department of Biotechnology and its
   Bioinformatics facility (SCK), Council of Scientific and Industrial
   Research (fellowship to BK), Government of India, New Delhi.
CR Acharya C, 2008, BIOMATERIALS, V29, P4665, DOI 10.1016/j.biomaterials.2008.08.033
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Capelli R, 2011, ORG ELECTRON, V12, P1146, DOI 10.1016/j.orgel.2011.04.005
   Chua L, 2011, APPL PHYS A-MATER, V102, P765, DOI 10.1007/s00339-011-6264-9
   CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337
   Erokhin V., 2010, NANO COMMUN NETW, V1, P108, DOI DOI 10.1016/J.NANCOM.2010.05.002
   Ha SW, 2005, BIOMACROMOLECULES, V6, P2563, DOI 10.1021/bm050294m
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Kim DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238552
   Krejchi MT, 1997, MACROMOLECULES, V30, P5012, DOI 10.1021/ma9614050
   Kugeler C, 2011, APPL PHYS A-MATER, V102, P791, DOI 10.1007/s00339-011-6287-2
   Kundu B, 2010, PROG POLYM SCI, V35, P1116, DOI 10.1016/j.progpolymsci.2010.04.004
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kwon DH, 2010, NAT NANOTECHNOL, V5, P148, DOI [10.1038/NNANO.2009.456, 10.1038/nnano.2009.456]
   Lai PY, 2009, ORG ELECTRON, V10, P1590, DOI 10.1016/j.orgel.2009.09.006
   Lai PY, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3002281
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Liu G, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3276556
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Mathur AB, 2010, NANOMEDICINE-UK, V5, P807, DOI 10.2217/NNM.10.51
   Meng FB, 2011, SMALL, V7, P3016, DOI 10.1002/smll.201101494
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Ong YC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2780084
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Schlaf R, 2000, SURF SCI, V450, P142, DOI 10.1016/S0039-6028(00)00232-6
   Singh M, 2010, ADV MATER, V22, P673, DOI 10.1002/adma.200901141
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932
   Szot K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254001
   Talukdar S., 2011, BIOMATERIALS, V8, P027
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tao H, 2010, ADV MATER, V22, P3527, DOI 10.1002/adma.201000412
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Wang ZS, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3529455
   Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023
   Yang JJ, 2008, NAT NANOTECHNOL, V3, P429, DOI 10.1038/nnano.2008.160
   Yang JJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524521
NR 39
TC 87
Z9 90
U1 15
U2 143
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD NOV 7
PY 2012
VL 22
IS 21
BP 4493
EP 4499
DI 10.1002/adfm.201200073
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 030XF
UT WOS:000310602700011
DA 2018-10-19
ER

PT J
AU O'Donovan, L
   De Bank, PA
AF O'Donovan, Liz
   De Bank, Paul A.
TI A photocleavable linker for the chemoselective functionalization of
   biomaterials
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; DIP-PEN NANOLITHOGRAPHY; TISSUE ARCHITECTURE;
   CELL-ADHESION; MOLECULES; SURFACES; PROTEIN; 3RD-DIMENSION; ADSORPTION;
   HYDROGELS
AB The functionalization of matrices with "caged" functional groups and their subsequent selective uncaging is a promising approach for generating patterns of bioactive molecules to guide cell growth or recreate in vivo microarchitectures. To date, this has been limited to caged carboxylic acids, amines and thiols, functional groups found within biological systems. We present a bifunctional caged carbonyl linker as an alternative approach for the chemoselective functionalization of biomaterials. This linker was readily coupled to collagen, employed as a model biomaterial, and underwent rapid uncaging in aqueous media upon irradiation with ultraviolet light to yield free carbonyl groups. Modified surfaces proved to be non-adhesive to cells until the chemoselective reintroduction of adhesion following incubation of uncaged carbonyls with gelatin hydrazide, with native gelatin failing to elicit a cellular response.
C1 [O'Donovan, Liz; De Bank, Paul A.] Univ Bath, Ctr Regenerat Med, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.
RP De Bank, PA (reprint author), Univ Bath, Ctr Regenerat Med, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.
EM p.debank@bath.ac.uk
RI De Bank, Paul/G-3828-2014
OI De Bank, Paul/0000-0002-5717-7486
FU Engineering and Physical Sciences Research Council [EP/G049572/1]
CR Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De Bank PA, 2005, J MATER CHEM, V15, P2047, DOI 10.1039/b415893h
   De Bank PA, 2007, BIOTECHNOL BIOENG, V97, P1617, DOI 10.1002/bit.21343
   Dupont-Gillain CC, 1999, POLYM INT, V48, P271, DOI 10.1002/(SICI)1097-0126(199904)48:4<271::AID-PI119>3.0.CO;2-J
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Goessl A, 2001, J BIOMED MATER RES, V57, P15, DOI 10.1002/1097-4636(200110)57:1<15::AID-JBM1136>3.0.CO;2-N
   Goncalves IC, 2011, J MATER SCI-MATER M, V22, P2053, DOI 10.1007/s10856-011-4381-9
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   HINMAN RL, 1960, J ORG CHEM, V25, P1775, DOI 10.1021/jo01080a027
   Kaneko S, 2011, PHYS CHEM CHEM PHYS, V13, P4051, DOI 10.1039/c0cp02013c
   Karp JM, 2006, BIOMATERIALS, V27, P4755, DOI 10.1016/j.biomaterials.2006.04.028
   Lamour G, 2010, J CHEM EDUC, V87, P1403, DOI 10.1021/ed100468u
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lee KJ, 2004, LANGMUIR, V20, P1812, DOI 10.1021/la0358163
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   MUIR TW, 1995, STRUCTURE, V3, P649, DOI 10.1016/S0969-2126(01)00200-3
   Nakanishi J, 2004, J AM CHEM SOC, V126, P16314, DOI 10.1021/ja044684c
   Nguyen R, 2003, CHEM COMMUN, P942, DOI 10.1039/b211645f
   Numata M, 2005, ORG BIOMOL CHEM, V3, P2255, DOI 10.1039/b500156k
   Oliva AA, 2003, NEUROCHEM RES, V28, P1639
   Patel N, 1998, FASEB J, V12, P1447
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Ryan D, 2004, LANGMUIR, V20, P9080, DOI 10.1021/la048443u
   Scott WL, 1996, BIOORG MED CHEM LETT, V6, P1491, DOI 10.1016/S0960-894X(96)00265-X
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Stahl A, 2004, BIOCHEM BIOPH RES CO, V322, P684, DOI 10.1016/j.bbrc.2004.07.175
   Tien J, 2002, P NATL ACAD SCI USA, V99, P1758, DOI 10.1073/pnas.042493399
   Wang PF, 2008, J ORG CHEM, V73, P6152, DOI 10.1021/jo8008275
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Wylie RG, 2008, J MATER CHEM, V18, P2716, DOI 10.1039/b718431j
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yarema KJ, 1998, J BIOL CHEM, V273, P31168, DOI 10.1074/jbc.273.47.31168
   Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
NR 36
TC 8
Z9 8
U1 2
U2 51
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD NOV 7
PY 2012
VL 22
IS 41
BP 21878
EP 21884
DI 10.1039/c2jm35173k
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 023PP
UT WOS:000310047200015
DA 2018-10-19
ER

PT J
AU Saska, S
   Teixeira, LN
   de Oliveira, PT
   Gaspar, AMM
   Ribeiro, SJL
   Messaddeq, Y
   Marchetto, R
AF Saska, Sybele
   Teixeira, Lucas Novaes
   de Oliveira, Paulo Tambasco
   Minarelli Gaspar, Ana Maria
   Lima Ribeiro, Sidney Jose
   Messaddeq, Younes
   Marchetto, Reinaldo
TI Bacterial cellulose-collagen nanocomposite for bone tissue engineering
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID RAT CALVARIAL OSTEOBLASTS; POLY-EPSILON-CAPROLACTONE; CROSS-LINKING;
   BIOMEDICAL APPLICATIONS; IN-VITRO; SCAFFOLDS; COMPOSITE; HYDROXYAPATITE;
   REGENERATION; MEMBRANES
AB A nanocomposite based on bacterial cellulose (BC) and type I collagen (COL) was evaluated for in vitro bone regeneration. BC membranes were modified by glycine esterification followed by cross-linking of type I collagen employing 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide. Collagen incorporation was studied by spectroscopy analysis. X-Ray diffraction showed changes in the BC crystallinity after collagen incorporation. The elastic modulus and tensile strength for BC-COL decreased, while the strain at failure showed a slight increase, even after sterilization, as compared to pristine BC. Swelling tests and contact angle measurements were also performed. Cell culture experiments performed with osteogenic cells were obtained by enzymatic digestion of newborn rat calvarium revealed similar features of cell morphology for cultures grown on both membranes. Cell viability/proliferation was not different between BC and BC-COL membranes at day 10 and 14. The high total protein content and ALP activity at day 17 in cells cultured on BC-COL indicate that this composite allowed the development of the osteoblastic phenotype in vitro. Thus, BC-COL should be considered as alternative biomaterial for bone tissue engineering.
C1 [Saska, Sybele; Lima Ribeiro, Sidney Jose; Messaddeq, Younes; Marchetto, Reinaldo] Univ Estadual Paulista UNESP, Inst Chem, Sao Paulo, Brazil.
   [Teixeira, Lucas Novaes; de Oliveira, Paulo Tambasco] Univ Sao Paulo, Fac Dent Ribeirao Preto, Cell Culture Lab, BR-14040904 Sao Paulo, Brazil.
   [Minarelli Gaspar, Ana Maria] Univ Estadual Paulista UNESP, Sch Dent, Dept Morphol, BR-14801903 Sao Paulo, Brazil.
RP Saska, S (reprint author), Univ Estadual Paulista UNESP, Inst Chem, Postal Code 355, Sao Paulo, Brazil.
EM sybele_saska@yahoo.com.br; novaesrp@yahoo.com.br; tambasco@usp.br;
   anamaria@foar.unesp.br; sidney@iq.unesp.br;
   younes.messaddeq@copl.ulaval.ca; marcheto@iq.unesp.br
RI Ribeiro, Sidney/E-9864-2012; FotonicaUFPE, Inct/J-8388-2013; Teixeira,
   Lucas/F-2583-2016; Marchetto, Reinaldo/A-9190-2008; Saska,
   Sybele/B-6745-2011; Tambasco de Oliveira, Paulo/F-9749-2010
OI Ribeiro, Sidney/0000-0002-8162-6747; Marchetto,
   Reinaldo/0000-0002-8757-321X; Saska, Sybele/0000-0002-0229-946X;
   Tambasco de Oliveira, Paulo/0000-0002-6662-0486; Minarelli Gaspar, Ana
   Maria/0000-0002-7168-9971; Teixeira, Lucas/0000-0003-3633-9631; Ribeiro,
   Sidney/0000-0003-3286-9440
FU FAPESP [08-58776-6, 09/09960-1]; CNPq
FX This work was supported by grants from the Brazilian agencies FAPESP
   (grant numbers: 08-58776-6 and 09/09960-1) and CNPq. The authors wish to
   thank Prof. Dr Luiz Geraldo Vaz of Department of Dental Materials and
   Prosthodontics, Dental School at Araraquara - UNESP for support in the
   mechanical tests and Mr Roger Rodrigues Fernandes for technical support.
CR Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   Barud HS, 2007, J THERM ANAL CALORIM, V87, P815, DOI 10.1007/s10973-006-8170-5
   Barud HS, 2008, THERMOCHIM ACTA, V471, P61, DOI 10.1016/j.tca.2008.02.009
   Becker D, 2002, J BIOMED MATER RES, V59, P516, DOI 10.1002/jbm.1265
   Bonucci E., 2007, BIOL CALCIFICATION N, P491
   Caporali Evelyn Hasegawa Gonçalves, 2006, Acta Cir. Bras., V21, P366, DOI 10.1590/S0102-86502006000600003
   Cardoso GBC, 2010, J MATER SCI, V45, P4990, DOI 10.1007/s10853-010-4363-1
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen YM, 2009, J BIOACT COMPAT POL, V24, P137, DOI 10.1177/0883911509102710
   Coic M, 2010, REV STOMATOL CHIR, V111, P286, DOI 10.1016/j.stomax.2010.10.006
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   de Oliva MA, 2009, J HISTOCHEM CYTOCHEM, V57, P265, DOI 10.1369/jhc.2008.952713
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   Forti F. L., 2011, J MATER SCI-MATER M, V22, P1
   Gao C, 2010, CELLULOSE, V17, P365, DOI 10.1007/s10570-009-9371-4
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004
   Honda Y, 2007, J BIOMED MATER RES B, V80B, P281, DOI 10.1002/jbm.b.30595
   Hutchens SA, 2009, CELLULOSE, V16, P887, DOI 10.1007/s10570-009-9300-6
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Irie K, 1998, ANAT RECORD, V252, P554
   Juodzbalys G, 2007, J ORAL REHABIL, V34, P781, DOI 10.1111/j.1365-2842.2006.01679.x
   Karsenty Gerard, 1998, Frontiers in Bioscience, V3, pD834
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lee JJ, 2009, J MATER SCI-MATER M, V20, P1927, DOI 10.1007/s10856-009-3743-z
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Luo HL, 2008, MATER CHEM PHYS, V110, P193, DOI 10.1016/j.matchemphys.2008.01.040
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Rodrigues FT, 2010, POLIMEROS, V20, P92, DOI 10.1590/S0104-14282010005000013
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Saska S, 2011, INT J BIOMATER, DOI 10.1155/2011/175362
   Saska S., 2010, [No title captured], Patent No. [BR Pat., 018100019682, 018100019682]
   Saska S., 2011, WO Pat, Patent No. [2011150482-A 1, 2011150482A1]
   Saska S, 2012, J MATER SCI-MATER M, V23, P2253, DOI 10.1007/s10856-012-4676-5
   Schenzel K, 2005, CELLULOSE, V12, P223, DOI 10.1007/s10570-004-3885-6
   Socrates G., 2001, INFRARED RAMAN CHARA
   Song JH, 2007, J BIOMED MATER RES B, V83B, P248, DOI 10.1002/jbm.b.30790
   Valentine Rowan, 2009, Otolaryngol Clin North Am, V42, P813, DOI 10.1016/j.otc.2009.07.009
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wiegand C, 2006, CELLULOSE, V13, P689, DOI 10.1007/s10570-006-9073-0
   WILEY JH, 1987, CARBOHYD RES, V160, P113, DOI 10.1016/0008-6215(87)80306-3
   Winter LC, 2002, ANN BIOMED ENG, V30, P1242, DOI 10.1114/1.1529195
   Wolff LF, 2000, INT DENT J, V50, P235, DOI 10.1111/j.1875-595X.2000.tb00559.x
   Yu HY, 2008, J BIOMED MATER RES B, V86B, P541, DOI 10.1002/jbm.b.31054
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009
   Zhijiang C., 2011, J APPL POLYM SCI, V120, P2938, DOI DOI 10.1002/APP.33661
NR 56
TC 44
Z9 45
U1 1
U2 97
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PD NOV 7
PY 2012
VL 22
IS 41
BP 22102
EP 22112
DI 10.1039/c2jm33762b
PG 11
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 023PP
UT WOS:000310047200045
DA 2018-10-19
ER

PT J
AU Hansson, A
   Hashom, N
   Falson, F
   Rousselle, P
   Jordan, O
   Borchard, G
AF Hansson, Annasara
   Hashom, Nour
   Falson, Francoise
   Rousselle, Patricia
   Jordan, Olivier
   Borchard, Gerrit
TI In vitro evaluation of an RGD-functionalized chitosan derivative for
   enhanced cell adhesion
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Wound healing; Human dermal fibroblast; Chitosan; RGD peptide; Cell
   adhesion
ID EXTRACELLULAR-MATRIX; SKIN; MODULATION; INTEGRINS; CHITINS
AB Tissue repair is a spontaneous process that is initiated on wounding. However, if this complex mechanism is impaired or not sufficient the use of biomaterials might increase the chance of successful healing. In this view, an RGD-functionalized polymer was developed to promote dermal healing. A water-soluble chitosan derivative, carboxymethyl-trimethylchitosan (CM-TM-chitosan) was synthesized and GRGDS-moieties were grafted to the backbone at a concentration 01 59 nmol/mg polymer to increase cell-biomaterial interaction. Tested in vitro with cultured human dermal fibroblasts, the developed polymer showed good biocompatibility and the initial adhesion was increased by 3-5 times due to the GRGDS-moieties. Moreover, cell spreading was specific to the interaction with GRGDS, giving a 12-fold increase of cells showing a fully spread morphology within 30 min. Overall. CM-TM-chitosan conjugated with GRGDS-peptides may prove useful as a biomaterial in wound healing. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Hansson, Annasara; Hashom, Nour; Jordan, Olivier; Borchard, Gerrit] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva, Switzerland.
   [Hansson, Annasara; Rousselle, Patricia] Univ Lyon 1, CNRS, SFR BioSci Gerland Lyon Sud, Inst Biol & Chim Proteines,FRE 3310, F-69367 Lyon, France.
   [Hansson, Annasara; Falson, Francoise] Univ Lyon 1, Fac Pharm, F-69373 Lyon, France.
RP Borchard, G (reprint author), Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.
EM gerrit.borchard@unige.ch
RI Borchard, Gerrit/A-2316-2010; Jordan, Olivier/B-5590-2009
OI Jordan, Olivier/0000-0003-3752-2198; Rousselle,
   Patricia/0000-0003-0275-4562
FU Ministere de l'Education (France); Region Rhone-Alpes Explo'ra Doc grant
   (France)
FX A. Hansson was a recipient of a 3 years Ph.D. studentship from the
   Ministere de l'Education (France) and of a Region Rhone-Alpes Explo'ra
   Doc grant (France). The authors would like to thank Dr. Lee Ann
   Laurent-Applegate (CHUV, Lausanne, Switzerland) for the kind donation of
   human dermal fibroblasts. We thank Jean-Pierre Andrieu, from the
   IBS-platform of the Partnership for Structural Biology and the Institut
   de Biologie Structurale in Grenoble (PSB/IBS), for the assistance and
   access to Amino Acids determination facility. We are grateful to Dr.
   Elisabeth Rivara-Minten (University of Geneva, Switzerland) for helpful
   discussions and her technical support with the NMR.
CR Affolter Pretsch E. .B., 2000, STRUCTURE DETERMINAT
   Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   Amidi M, 2010, ADV DRUG DELIVER REV, V62, P59, DOI 10.1016/j.addr.2009.11.009
   An NT, 2009, CARBOHYD POLYM, V75, P489, DOI 10.1016/j.carbpol.2008.08.017
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1
   Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   He P, 1998, INT J PHARMACEUT, V166, P75, DOI 10.1016/S0378-5173(98)00027-1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Heuking S, 2009, INT J PHARMACEUT, V381, P97, DOI 10.1016/j.ijpharm.2009.03.039
   Hjerde RJN, 1997, CARBOHYD POLYM, V34, P131, DOI 10.1016/S0144-8617(97)00113-6
   Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Jintapattanakit A, 2008, EUR J PHARM BIOPHARM, V70, P563, DOI 10.1016/j.ejpb.2008.06.002
   Jolles P., 1999, CHITIN CHITINASES
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Li W, 2004, HISTOL HISTOPATHOL, V19, P1311, DOI 10.14670/HH-19.1311
   Lord MS, 2011, BIOMATERIALS, V32, P6655, DOI 10.1016/j.biomaterials.2011.05.062
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Muzzarelli RAA, 2005, ADV POLYM SCI, V186, P151, DOI 10.1007/b136820
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V89, P723, DOI 10.1016/j.carbpol.2012.04.057
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Scherer SS, 2009, ANN SURG, V250, P322, DOI 10.1097/SLA.0b013e3181ae9d45
   Takei T, 2012, ACTA BIOMATER, V8, P686, DOI 10.1016/j.actbio.2011.10.005
NR 32
TC 35
Z9 37
U1 1
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD NOV 6
PY 2012
VL 90
IS 4
BP 1494
EP 1500
DI 10.1016/j.carbpol.2012.07.020
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 013UI
UT WOS:000309331000013
PM 22944407
DA 2018-10-19
ER

PT J
AU Dastidar, TG
   Netravali, AN
AF Dastidar, Trina Ghosh
   Netravali, Anil N.
TI 'Green' crosslinking of native starches with malonic acid and their
   properties
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Starch resins; Green crosslinking; Esterification; Moisture sensitivity;
   Mechanical properties
ID CORN STARCH; BLEND FILMS; POTATO; SUBSTITUTION; DERIVATIVES; ACETATES;
   FIBERS; SHEETS
AB Starch is a highly hydrophilic biomaterial with weak mechanical properties rendering it useless for commercial applications. A fully 'green' water based process is presented to crosslink corn (cereal) and potato (tuber) starch to enhance mechanical properties as well as lower hydrophilicity. In addition, malonic acid, a green, plant based water soluble and relatively inexpensive polycarboxylic acid, was used as the crosslinker. The reactivity of potato starch toward esterification and crosslinking was found to be higher than that of corn starch owing to the inherent differences in the granule morphology and internal structure of the two starches. It was observed that potato starch granules had a higher degree of substitution (DS) of 0.19 than corn starch granules (DS = 0.1) under similar reaction conditions. Chemical, thermal and mechanical test results confirmed the crosslinking as well as reduced moisture sensitivity. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Netravali, Anil N.] Cornell Univ, Dept Fiber Sci & Apparel Design, Ithaca, NY 14853 USA.
   [Dastidar, Trina Ghosh] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.
RP Netravali, AN (reprint author), Cornell Univ, Dept Fiber Sci & Apparel Design, Ithaca, NY 14853 USA.
EM ann2@cornell.edu
FU Wallace Foundation
FX This work was partly supported by the Wallace Foundation. The authors
   also thank the Cornell Center for Materials Research (CCMR) for the use
   of their facilities.
CR ARVANITOYANNIS I, 1994, CARBOHYD POLYM, V24, P1, DOI 10.1016/0144-8617(94)90111-2
   Ayoub AS, 2009, J PLAST FILM SHEET, V25, P25, DOI 10.1177/8756087909336493
   Bhosale R, 2006, CARBOHYD POLYM, V66, P521, DOI 10.1016/j.carbpol.2006.04.007
   Chabba S, 2005, J MATER SCI, V40, P6263, DOI 10.1007/s10853-005-3142-x
   Chen YX, 2006, J APPL POLYM SCI, V102, P1539, DOI 10.1002/app.23323
   Coma V, 2003, CARBOHYD POLYM, V51, P265, DOI 10.1016/S0144-8617(02)00191-1
   Du XF, 2007, STARCH-STARKE, V59, P609, DOI 10.1002/star.200700604
   Fang JM, 2002, CARBOHYD POLYM, V47, P245, DOI 10.1016/S0144-8617(01)00187-4
   Garg S, 2011, CARBOHYD POLYM, V83, P1623, DOI 10.1016/j.carbpol.2010.10.015
   IMBERTY A, 1988, BIOPOLYMERS, V27, P1205, DOI 10.1002/bip.360270803
   Jyothi AN, 2006, STARCH-STARKE, V58, P292, DOI 10.1002/star.200500468
   Lan C, 2010, MACROMOL MATER ENG, V295, P1025, DOI 10.1002/mame.201000186
   Mao GJ, 2006, J APPL POLYM SCI, V102, P5854, DOI 10.1002/app.24947
   Mathew S, 2008, FOOD HYDROCOLLOID, V22, P826, DOI 10.1016/j.foodhyd.2007.03.012
   Mathew S, 2007, FOOD CHEM, V105, P579, DOI 10.1016/j.foodchem.2007.04.032
   Mishra S, 2006, FOOD HYDROCOLLOID, V20, P557, DOI 10.1016/j.foodhyd.2005.01.001
   Pang SC, 2011, CARBOHYD POLYM, V84, P424, DOI 10.1016/j.carbpol.2010.12.002
   Pashkuleva I, 2005, J MATER SCI-MATER M, V16, P81, DOI 10.1007/s10856-005-6450-4
   Pashkuleva I, 2008, MACROMOL BIOSCI, V8, P210, DOI 10.1002/mabi.200700076
   Passauer L, 2009, STARCH-STARKE, V61, P621, DOI 10.1002/star.200900168
   Reddy N, 2010, FOOD CHEM, V118, P702, DOI 10.1016/j.foodchem.2009.05.050
   Reddy N, 2009, BIOTECHNOL BIOENG, V103, P1016, DOI 10.1002/bit.22331
   Santos MI, 2009, J MATER CHEM, V19, P4091, DOI 10.1039/b819089e
   Sauperl O, 2010, TEXT RES J, V80, P383, DOI 10.1177/0040517509343818
   Seidel C, 2001, STARCH-STARKE, V53, P305, DOI 10.1002/1521-379X(200107)53:7<305::AID-STAR305>3.0.CO;2-Z
   Singh N, 2004, FOOD CHEM, V86, P601, DOI 10.1016/j.foodchem.2003.10.008
   vanSoest JJG, 1997, J MACROMOL SCI PURE, VA34, P1665, DOI 10.1080/10601329708010034
   Xu YX, 2004, CEREAL CHEM, V81, P735, DOI 10.1094/CCHEM.2004.81.6.735
   Yang CQ, 2002, TEXT RES J, V72, P817, DOI 10.1177/004051750207200911
   Yun YH, 2008, J POLYM ENVIRON, V16, P12, DOI 10.1007/s10924-008-0084-9
   Zhang SD, 2010, J POLYM RES, V17, P43, DOI 10.1007/s10965-009-9288-5
   Zhou J, 2008, CARBOHYD POLYM, V74, P405, DOI 10.1016/j.carbpol.2008.03.006
   Zhu JF, 2007, POLYM-PLAST TECHNOL, V46, P1135, DOI 10.1080/03602550701558116
   ZOBEL HF, 1988, STARCH-STARKE, V40, P1, DOI 10.1002/star.19880400102
NR 34
TC 30
Z9 30
U1 5
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD NOV 6
PY 2012
VL 90
IS 4
BP 1620
EP 1628
DI 10.1016/j.carbpol.2012.07.041
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 013UI
UT WOS:000309331000031
PM 22944425
DA 2018-10-19
ER

PT J
AU Unnithan, AR
   Barakat, NAM
   Pichiah, PBT
   Gnanasekaran, G
   Nirmala, R
   Cha, YS
   Jung, CH
   El-Newehy, M
   Kim, HY
AF Unnithan, Afeesh R.
   Barakat, Nasser A. M.
   Pichiah, P. B. Tirupathi
   Gnanasekaran, Gopalsamy
   Nirmala, R.
   Cha, Youn-Soo
   Jung, Che-Hun
   El-Newehy, Mohamed
   Kim, Hak Yong
TI Wound-dressing materials with antibacterial activity from electrospun
   polyurethane-dextran nanofiber mats containing ciprofloxacin HCl
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Electrospinning; Ciprofloxacin HCl; Dextran; Polyurethane; Wound
   dressing
ID NANOPARTICLES; HYDROGELS; DESIGN; SILVER; MODEL
AB Dextran is a versatile biomacromolecule for preparing electrospun nanofibrous membranes by blending with either water-soluble bioactive agents or hydrophobic biodegradable polymers for biomedical applications. In this study, an antibacterial electrospun scaffold was prepared by electrospinning of a solution composed of dextran, polyurethane (PU) and ciprofloxacin HCl (CipHCl) drug. The obtained nanofiber mats have good morphology. The mats were characterized by various analytical techniques. The interaction parameters between fibroblasts and the PU-dextran and PU-dextran-drug scaffolds such as viability, proliferation, and attachment were investigated. The results indicated that the cells interacted favorably with the scaffolds especially the drug-containing one. Moreover, the composite mat showed good bactericidal activity against both of Gram-positive and Gram-negative bacteria. Overall, our results conclude that the introduced scaffold might be an ideal biomaterial for wound dressing applications. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Barakat, Nasser A. M.; Nirmala, R.; Kim, Hak Yong] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
   [Unnithan, Afeesh R.] Chonbuk Natl Univ, Bionano Syst Engn Dept, Jeonju 561756, South Korea.
   [Barakat, Nasser A. M.] Menia Univ, Fac Engn, Dept Chem Engn, El Minia, Egypt.
   [Pichiah, P. B. Tirupathi; Cha, Youn-Soo] Chonbuk Natl Univ, Dept Food Sci & Human Nutr, Jeonju 561756, South Korea.
   [Gnanasekaran, Gopalsamy; Jung, Che-Hun] Chonnam Natl Univ, Clin Vaccine R&D Ctr, Dept Mol Med, Hwasun, South Korea.
   [El-Newehy, Mohamed] King Saud Univ, Coll Sci, Dept Chem, Petrochem Res Chair, Riyadh 11451, Saudi Arabia.
   [El-Newehy, Mohamed] Tanta Univ, Fac Sci, Dept Chem, Tanta 31527, Egypt.
RP Barakat, NAM (reprint author), Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea.
EM nasser@jbnu.ac.kr; khy@jbnu.ac.kr
RI Kim, Hak Yong/G-3826-2013; Gnanasekaran, Gopalsamy/G-1012-2016; Barakat,
   Nasser/N-3507-2015; El-Newehy, Mohamed/E-3670-2014; Rajan Unnithan,
   Afeesh/I-2338-2013
OI Kim, Hak Yong/0000-0002-4133-124X; Gnanasekaran,
   Gopalsamy/0000-0001-5849-6588; Barakat, Nasser/0000-0003-0085-5431;
   El-Newehy, Mohamed/0000-0002-4265-0701; Rajan Unnithan,
   Afeesh/0000-0002-0795-1613
FU Regional Research and Development Cluster Project [B0009719]; Ministry
   of Knowledge Economy (MKE) of Korea; NPST program, King Saud University
   [11-ENE1721-02]
FX This work was financially supported by Regional Research and Development
   Cluster Project (B0009719) Funded by the Ministry of Knowledge Economy
   (MKE) of Korea and NPST program, King Saud University project number
   11-ENE1721-02. We thank Mr. T.S. Bae and J.C. Lim, KBSI, Jeonju branch,
   and Mr. Jong-Gyun Kang, Centre for University Research Facility, for
   taking high-quality images.
CR Barakat NAM, 2009, POLYMER, V50, P4389, DOI 10.1016/j.polymer.2009.07.005
   Barakat NAM, 2009, J PHYS CHEM C, V113, P19452, DOI 10.1021/jp905667s
   Bauer R. W., 1966, AM J CLIN PATHOL, V45, P493
   Bolgen N, 2007, J BIOMED MATER RES B, V81B, P530, DOI 10.1002/jbm.b.30694
   Breda SA, 2009, INT J PHARM, V371, P106, DOI 10.1016/j.ijpharm.2008.12.026
   Dillen K, 2004, INT J PHARM, V275, P171, DOI 10.1016/j.ijpharm.2004.01.033
   Gonzalez V, 2000, J APPL POLYM SCI, V78, P850, DOI 10.1002/1097-4628(20001024)78:4<850::AID-APP190>3.0.CO;2-N
   Gu C, 2005, ENVIRON SCI TECHNOL, V39, P9166, DOI 10.1021/es051190f
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hong KH, 2007, POLYM ENG SCI, V47, P43, DOI 10.1002/pen.20660
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jones SA, 2004, WOUND REPAIR REGEN, V12, P288, DOI 10.1111/j.1067-1927.2004.012304.x
   Kerstein M. D., 1994, AM J SURG, V167, P2
   Lakshmi R.L., 2010, J MACROMOLECULAR SCI, V47, P1012
   Leaper David J, 2006, Int Wound J, V3, P282, DOI 10.1111/j.1742-481X.2006.00265.x
   Marziyeh J., 2011, INT J NANOMED, V6, P993
   Prabaharan M, 2012, ADV POLYM SCI, V246, P241, DOI 10.1007/12_2011_125
   Shawki M.M., 2010, ROM J BIOPHYS, V20, P335
   Sikareepaisan P, 2011, CARBOHYD POLYM, V83, P1457, DOI 10.1016/j.carbpol.2010.09.048
   Supaphol P, 2012, ADV POLYM SCI, V246, P213, DOI 10.1007/12_2011_143
   Thompson CJ, 2007, POLYMER, V48, P6913, DOI 10.1016/j.polymer.2007.09.017
   Trivedi P, 2007, ENVIRON SCI TECHNOL, V41, P3153, DOI 10.1021/es061921y
   Tsou TL, 2005, J MATER SCI-MATER M, V16, P95, DOI 10.1007/s10856-005-5954-2
   WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1
   Wright JB, 2002, WOUND REPAIR REGEN, V10, P141, DOI 10.1046/j.1524-475X.2002.10308.x
   Yu HJ, 2006, J APPL POLYM SCI, V101, P2453, DOI 10.1002/app.23344
   Zamani M, 2010, EUR J PHARM BIOPHARM, V75, P179, DOI 10.1016/j.ejpb.2010.02.002
   Zhi J, 2006, SPECTROSC SPECT ANAL, V26, P624
NR 28
TC 168
Z9 174
U1 10
U2 174
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD NOV 6
PY 2012
VL 90
IS 4
BP 1786
EP 1793
DI 10.1016/j.carbpol.2012.07.071
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 013UI
UT WOS:000309331000054
PM 22944448
DA 2018-10-19
ER

PT J
AU Blackledge, TA
   Kuntner, M
   Marhabaie, M
   Leeper, TC
   Agnarsson, I
AF Blackledge, Todd A.
   Kuntner, Matjaz
   Marhabaie, Mohammad
   Leeper, Thomas C.
   Agnarsson, Ingi
TI Biomaterial evolution parallels behavioral innovation in the origin of
   orb-like spider webs
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DRAGLINE SILK; BUILDING SPIDERS; WEAVING SPIDERS; PROTEIN; ARANEAE;
   ELASTICITY; PSECHRIDAE; FIBROIN; HYPOTHESES; PHYLOGENY
AB Correlated evolution of traits can act synergistically to facilitate organism function. But, what happens when constraints exist on the evolvability of some traits, but not others? The orb web was a key innovation in the origin of > 12,000 species of spiders. Orb evolution hinged upon the origin of novel spinning behaviors and innovations in silk material properties. In particular, a new major ampullate spidroin protein (MaSp2) increased silk extensibility and toughness, playing a critical role in how orb webs stop flying insects. Here, we show convergence between pseudo-orb-weaving Fecenia and true orb spiders. As in the origin of true orbs, Fecenia dragline silk improved significantly compared to relatives. But, Fecenia silk lacks the high compliance and extensibility found in true orb spiders, likely due in part to the absence of MaSp2. Our results suggest how constraints limit convergent evolution and provide insight into the evolution of nature's toughest fibers.
C1 [Blackledge, Todd A.; Marhabaie, Mohammad] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Blackledge, Todd A.; Marhabaie, Mohammad; Leeper, Thomas C.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.
   [Kuntner, Matjaz] Slovenian Acad Sci & Arts, Ctr Sci Res, Inst Biol, Ljubljana, Slovenia.
   [Kuntner, Matjaz; Agnarsson, Ingi] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA.
   [Kuntner, Matjaz] Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei, Peoples R China.
   [Leeper, Thomas C.] Univ Akron, Dept Chem, Akron, OH 44325 USA.
   [Agnarsson, Ingi] Univ Vermont, Dept Biol, Burlington, VT USA.
RP Blackledge, TA (reprint author), Univ Akron, Dept Biol, Akron, OH 44325 USA.
EM blackledge@uakron.edu
FU NSF [IOS-0745379, DEB-1050187-1050253]; Slovenian Research Agency [J1 -
   2063]
FX We thank S. Zschokke, M. Herberstein, and an anonymous reviewer for
   insightful comments on earlier drafts of the manuscript. D. Piorkowski
   provided assistance with the collection and mechanical testing of silk.
   S. Bilinovich provided support for the HPLC. M. Gregoric and D. Li
   helped with field collection and/or DNA sequencing. S. Richards and the
   Conservation International RAP program sponsored and organized fieldwork
   in Papua. Work was supported by NSF grants no. IOS-0745379 and
   DEB-1050187-1050253 and by the Slovenian Research Agency grant no. J1 -
   2063. Sequences were deposited in GenBank with accession numbers
   (KC011009-11021).
CR Agnarsson I., 2012, J ZOOLOGICA IN PRESS
   Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   [Anonymous], 2010, MESQUITE MODULAR SYS
   Bayer S, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.153.2110
   Blackledge TA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00782
   Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5
   Blackledge TA, 2011, J ARACHNOL, V39, P205, DOI 10.1636/Chi10-52.1
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Bond JE, 1998, EVOLUTION, V52, P403, DOI 10.1111/j.1558-5646.1998.tb01641.x
   Coddington J., 1986, P319
   Coslovsky M, 2009, J INSECT BEHAV, V22, P29, DOI 10.1007/s10905-008-9151-2
   Craig C. L., 2003, SPIDER WEBS SILK TRA
   Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292
   Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739
   Darwin C. R, 1859, ORIGIN SPECIES MEANS
   Dimitrov D, 2012, P ROY SOC B-BIOL SCI, V279, P1341, DOI 10.1098/rspb.2011.2011
   Eisoldt L, 2011, MATER TODAY, V14, P80, DOI 10.1016/S1369-7021(11)70057-8
   Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c
   Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243
   Gatesy J, 2003, SYST BIOL, V52, P403, DOI 10.1080/10635150350197037
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1
   Griswold CE, 1999, J ARACHNOL, V27, P53
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Herberstein ME, 1999, ANIM BEHAV, V58, P1241, DOI 10.1006/anbe.1999.1255
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Kelly SP, 2011, ZOOLOGY, V114, P233, DOI 10.1016/j.zool.2011.02.001
   Kuntner M, 2010, BIOL J LINN SOC, V99, P849, DOI 10.1111/j.1095-8312.2010.01414.x
   LEVI HW, 1982, PAC INSECTS, V24, P114
   Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115
   Perez-Rigueiro J, 2010, INT J BIOL MACROMOL, V46, P555, DOI 10.1016/j.ijbiomac.2010.03.013
   Platnick N. I., 2012, WORLD SPIDER CATALOG
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x
   ROBINSON MH, 1979, PAC INSECTS, V21, P133
   SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404
   Schluter D., 2000, ECOLOGY ADAPTIVE RAD
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Sensenig AT, 2012, J R SOC INTERFACE, V9, P1880, DOI 10.1098/rsif.2011.0851
   Smith B. J., 2003, METHODS MOL BIOL, V211
   Starrett J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038084
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Swanson BO, 2006, EVOLUTION, V60, P2539
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437
   Venner S, 2005, P ROY SOC B-BIOL SCI, V272, P1587, DOI 10.1098/rspb.2005.3114
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
NR 56
TC 13
Z9 13
U1 1
U2 41
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 2
PY 2012
VL 2
AR 833
DI 10.1038/srep00833
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 037JC
UT WOS:000311098700001
PM 23150784
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Choi, YC
   Choi, JS
   Kim, BS
   Kim, JD
   Yoon, HI
   Cho, YW
AF Choi, Young Chan
   Choi, Ji Suk
   Kim, Beob Soo
   Kim, Jae Dong
   Yoon, Hwa In
   Cho, Yong Woo
TI Decellularized Extracellular Matrix Derived from Porcine Adipose Tissue
   as a Xenogeneic Biomaterial for Tissue Engineering
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID STEM-CELLS; IN-VITRO; SCAFFOLD; DIFFERENTIATION; FUTURE;
   XENOTRANSPLANTATION; REGENERATION; EXPANSION; CARTILAGE; CULTURE
AB Cells in tissues are surrounded by the extracellular matrix (ECM), a gel-like material of proteins and polysaccharides that are synthesized and secreted by cells. Here we propose that the ECM can be isolated from porcine adipose tissue and holds great promise as a xenogeneic biomaterial for tissue engineering and regenerative medicine. Porcine adipose tissue is easily obtained in large quantities from commonly discarded food waste. Decellularization protocols have been developed for extracting an intact ECM while effectively eliminating xenogeneic epitopes and minimally disrupting the ECM composition. Porcine adipose tissue was defatted by homogenization and centrifugation. It was then decellularized via chemical (1.5 M sodium chloride and 0.5% sodium dodecyl sulfate) and enzymatic treatments (DNase and RNase) with temperature control. After decellularization, immunogenic components such as nucleic acids and alpha-Gal were significantly reduced. However, abundant ECM components, such as collagen (332.9 +/- 12.1 mu g/mg ECM dry weight), sulfated glycosaminoglycan (GAG, 85 +/- 0.7 mu g/mg ECM dry weight), and elastin (152.6 +/- 4.5 mu g/mg ECM dry weight), were well preserved in the decellularized material. The biochemical and mechanical features of a decellularized ECM supported the adhesion and growth of human cells in vitro. Moreover, the decellularized ECM exhibited biocompatibility, long-term stability, and bioinductivity in vivo. The overall results suggest that the decellularized ECM derived from porcine adipose tissue could be useful as an alternative biomaterial for xenograft tissue engineering.
C1 [Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
   Hanyang Univ, Dept Bionanotechnol, Ansan 426791, Gyeonggi Do, South Korea.
RP Cho, YW (reprint author), Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
EM ywcho7@hanyang.ac.kr
FU National Research Foundation of Korea (NRF) [2009-0075546, 20110019774];
   Korean government (MEST); Seoul RBD Program [SS110011]
FX This work was supported by the Basic Science Research Program (Grant No.
   2009-0075546) and the Bio & Medical Technology Development Program
   (Grant No. 20110019774) through the National Research Foundation of
   Korea (NRF) funded by the Korean government (MEST). This work was also
   supported by the Seoul R&BD Program (Grant No. SS110011).
CR Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bayrak A, 2010, BIOMATERIALS, V31, P3793, DOI 10.1016/j.biomaterials.2010.01.120
   Brown BN, 2011, TISSUE ENG PART C-ME, V17, P411, DOI [10.1089/ten.tec.2010.0342, 10.1089/ten.TEC.2010.0342]
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Choi JS, 2010, TISSUE ENG PART C-ME, V16, P387, DOI [10.1089/ten.tec.2009.0276, 10.1089/ten.TEC.2009.0276]
   Choi JS, 2012, TISSUE ENG PT A, V18, P80, DOI 10.1089/ten.tea.2011.0103
   Choi JS, 2011, CELL TISSUE RES, V345, P415, DOI 10.1007/s00441-011-1223-5
   Choi JS, 2011, J BIOMED MATER RES A, V97A, P292, DOI 10.1002/jbm.a.33056
   Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034
   Cooper DKC, 2011, INT J SURG, V9, P122, DOI 10.1016/j.ijsu.2010.11.002
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   de la Fuente SG, 2003, J GASTROINTEST SURG, V7, P96, DOI 10.1016/S1091-255X(02)00050-1
   De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
   Deeken CR, 2011, J BIOMED MATER RES B, V96B, P199, DOI 10.1002/jbm.b.31753
   Ekser B, 2010, EXPERT REV CLIN IMMU, V6, P219, DOI 10.1586/ECI.09.81
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Haraida S, 1996, MODERN PATHOL, V9, P137
   Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001
   Hass M.J., 2005, BAILEYS IND OIL FAT, P161
   Hemmrich K, 2005, DIFFERENTIATION, V73, P28, DOI 10.1111/j.1432-0436.2005.07301003.x
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Mauney J, 2009, MATRIX BIOL, V28, P239, DOI 10.1016/j.matbio.2009.04.003
   Mosser G, 2006, MATRIX BIOL, V25, P3, DOI 10.1016/j.matbio.2005.09.002
   Nelson CM, 2006, CURR OPIN BIOTECH, V17, P518, DOI 10.1016/j.copbio.2006.08.011
   Reed B, 2009, ENDOCRINOLOGY, V150, P2934, DOI 10.1210/en.2008-1408
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Schenke-Layland K, 2004, MATRIX BIOL, V23, P113, DOI 10.1016/j.matbio.2004.03.005
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Stone KR, 1998, TRANSPLANTATION, V65, P1577, DOI 10.1097/00007890-199806270-00007
   Taipale J, 1997, FASEB J, V11, P51
   Trujillo ME, 2006, ENDOCR REV, V27, P762, DOI 10.1210/er.2006-0033
   VAN RLR, 1976, J CLIN INVEST, V58, P699, DOI 10.1172/JCI108516
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Xu H, 2009, TISSUE ENG PT A, V15, P1807, DOI 10.1089/ten.tea.2008.0384
   Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]
   Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 42
TC 37
Z9 39
U1 1
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD NOV
PY 2012
VL 18
IS 11
BP 866
EP 876
DI 10.1089/ten.tec.2012.0009
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 030MN
UT WOS:000310574900005
PM 22559904
OA Green Published
DA 2018-10-19
ER

PT J
AU Sobhan, PK
   Seervi, M
   Joseph, J
   Varghese, S
   Pillai, PR
   Sivaraman, DM
   James, J
   George, RE
   Elizabeth, KE
   Santhoshkumar, TR
   Pillai, MR
AF Sobhan, Praveen K.
   Seervi, Mahendra
   Joseph, Jeena
   Varghese, Saneesh
   Pillai, Prakash Rajappan
   Sivaraman, Divya Mundackal
   James, Jackson
   George, Roshin Elizabeth
   Elizabeth, K. E.
   Santhoshkumar, T. R.
   Pillai, M. Radhakrishna
TI Immortalized Functional Endothelial Progenitor Cell Lines from Umbilical
   Cord Blood for Vascular Tissue Engineering
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID MAMMARY EPITHELIAL-CELLS; LARGE T-ANTIGEN; BONE-MARROW;
   PERIPHERAL-BLOOD; IN-VITRO; NEOVASCULARIZATION; ANGIOGENESIS;
   TELOMERASE; TRANSFORMATION; OUTGROWTH
AB Endothelial progenitor cells (EPCs) play a significant role in multiple biological processes such as vascular homeostasis, regeneration, and tumor angiogenesis. This makes them a promising cell of choice for studying a variety of biological processes, toxicity assays, biomaterial-cell interaction studies, as well as in tissue-engineering applications. In this study, we report the generation of two clones of SV40-immortalized EPCs from umbilical cord blood. These cells retained most of the functional features of mature endothelial cells and showed no indication of senescence after repeated culture for more than 240 days. Extensive functional characterization of the immortalized cells by western blot, flow cytometry, and immunofluorescence studies substantiated that these cells retained their ability to synthesize nitric oxide, von Willebrand factor, P-Selectin etc. These cells achieved unlimited proliferation potential subsequent to inactivation of the cyclin-dependent kinase inhibitor p21, but failed to form colonies on soft agar. We also show their enhanced growth and survival on vascular biomaterials compared to parental cultures in late population doubling. These immortalized EPCs can be used as a cellular model system for studying the biology of these cells, gene manipulation experiments, cell-biomaterial interactions, as well as a variety of tissue-engineering applications.
C1 [Sobhan, Praveen K.; Seervi, Mahendra; Joseph, Jeena; Varghese, Saneesh; Pillai, Prakash Rajappan; Santhoshkumar, T. R.; Pillai, M. Radhakrishna] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India.
   [George, Roshin Elizabeth; Elizabeth, K. E.] Sree Avittom Thirunal SAT Hosp Women & Children, Coll Med, Thiruvananthapuram, Kerala, India.
RP Santhoshkumar, TR (reprint author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.
EM trsanthosh@rgcb.res.in
RI Mundackal Sivaraman, Divya/F-1397-2017; Sivaraman, Divya/K-5727-2014
OI Mundackal Sivaraman, Divya/0000-0002-2869-7191; Sivaraman,
   Divya/0000-0002-2869-7191; James, Jackson/0000-0002-7038-2687
FU Department of Biotechnology, Government of India
   [BT/PR7560/MED/14/1031]; Life Science Research Board [DLS/81/4822]
FX This work was supported by a grant from the Department of Biotechnology
   (BT/PR7560/MED/14/1031), Government of India, and Life Science Research
   Board (DLS/81/4822). The authors would like to thank Dr. Bob Weinberg,
   for the expression vector SV40 TL, and Dr. Garry P. Nolan, for the
   Amphophoenix packaging cell line. The authors also thank the flow
   cytometry facility of RGCB for their technical help in FACS experiments.
CR Achneck HE, 2011, BIOMATERIALS, V32, P10, DOI 10.1016/j.biomaterials.2010.08.073
   Ahn JB, 2010, CANCER LETT, V288, P124, DOI 10.1016/j.canlet.2009.06.031
   Andreou I, 2006, ATHEROSCLEROSIS, V189, P247, DOI 10.1016/j.atherosclerosis.2006.06.021
   Arap W, 2004, CANCER CELL, V5, P406, DOI 10.1016/S1535-6108(04)00121-7
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318
   Blann AD, 2006, ATHEROSCLEROSIS, V188, P12, DOI 10.1016/j.atherosclerosis.2005.12.024
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Boos C.J., 2005, NEW ENGL J MED, V353, P2616
   Boos Christopher J, 2005, N Engl J Med, V353, P2613
   Bouchentouf M, 2011, CELL TRANSPLANT, V20, P1431, DOI 10.3727/096368910X557164
   Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513
   Choi JH, 2004, J BIOL CHEM, V279, P49430, DOI 10.1074/jbc.M402088200
   Davies BR, 2003, EXP CELL RES, V288, P390, DOI 10.1016/S0014-4827(03)00218-0
   Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901
   Erusalimsky JD, 2006, HDB EXP PHARM 2, V213- 248, P2006, DOI DOI 10.1007/3-540-36028-X_
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224
   Gehling UM, 2000, BLOOD, V95, P3106
   Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002
   Hahn WC, 1999, NATURE, V400, P464
   Imanishi Toshio, 2010, Ther Adv Cardiovasc Dis, V4, P55, DOI 10.1177/1753944709353173
   Kim KL, 2009, BIOMATERIALS, V30, P3742, DOI 10.1016/j.biomaterials.2009.03.053
   Kumar TRS, 2001, BIOMATERIALS, V22, P2769
   Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071
   Martin-Padura Ines, 2009, Front Biosci (Schol Ed), V1, P304, DOI 10.2741/e28
   Masouleh BK, 2010, J IMMUNOL METHODS, V357, P38, DOI 10.1016/j.jim.2010.03.015
   Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Melero-Martin JM, 2011, STEM CELLS, V29, P163, DOI 10.1002/stem.583
   Mund JA, 2011, CURR STEM CELL RES T, V6, P115
   Qiu HY, 2006, INT J ONCOL, V28, P815
   Rood PML, 2000, EUR J CLIN INVEST, V30, P618
   Sales VL, 2010, TISSUE ENG PT A, V16, P257, DOI [10.1089/ten.tea.2009.0424, 10.1089/ten.TEA.2009.0424]
   Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592
   Singh S, 2011, TISSUE ENG PT A, V17, P1819, DOI [10.1089/ten.tea.2010.0708, 10.1089/ten.TEA.2010.0708]
   SRINIVASAN A, 1989, J VIROL, V63, P5459
   Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340
   Sun B, 2005, STEM CELLS DEV, V14, P292, DOI 10.1089/scd.2005.14.292
   Suriano R, 2008, CANCER RES, V68, P6038, DOI 10.1158/0008-5472.CAN-08-1009
   Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972
   Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x
   Toouli CD, 2002, ONCOGENE, V21, P128, DOI 10.1038/sj.onc.1205014
   Yang DG, 2008, AGEING RES REV, V7, P137, DOI 10.1016/j.arr.2008.02.001
   Yasu T, 2009, CIRC J, V73, P1199, DOI 10.1253/circj.CJ-09-0363
   Zhang ZY, 2011, BIOMATERIALS, V32, P4109, DOI 10.1016/j.biomaterials.2011.02.036
   Zhu CH, 2008, BIOMATERIALS, V29, P2628, DOI 10.1016/j.biomaterials.2008.03.005
   ZHU JY, 1992, J VIROL, V66, P2780
NR 49
TC 1
Z9 2
U1 0
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD NOV
PY 2012
VL 18
IS 11
BP 890
EP 902
DI 10.1089/ten.tec.2011.0482
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 030MN
UT WOS:000310574900007
PM 22889128
OA Green Published
DA 2018-10-19
ER

PT J
AU Sekine, Y
   Moritani, Y
   Ikeda-Fukazawa, T
   Sasaki, Y
   Akiyoshi, K
AF Sekine, Yurina
   Moritani, Yuki
   Ikeda-Fukazawa, Tomoko
   Sasaki, Yoshihiro
   Akiyoshi, Kazunari
TI A Hybrid Hydrogel Biomaterial by Nanogel Engineering: Bottom-Up Design
   with Nanogel and Liposome Building Blocks to Develop a Multidrug
   Delivery System
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID FIBRIN ENCAPSULATED LIPOSOMES; CROSS-LINKING HYDROGEL; HYDROPHOBIZED
   POLYSACCHARIDES; PHARMACEUTICAL CARRIERS; MOLECULAR CHAPERONE;
   SURFACE-PROPERTIES; PROTEIN DELIVERY; COMPLEX FLUIDS; GROWTH-FACTORS;
   RELEASE
AB New hybrid poly(ethylene glycol) (PEG) hydrogels crosslinked with both nanogels and nanogel-coated liposome complexes are obtained by Michael addition of the acryloyl group of a cholesterol-bearing pullulan (CHP) nanogel to the thiol group of pentaerythritol tetra(mercaptoethyl) polyoxyethylene. The nanogel-coated liposome complex is stably retained after gelation and the complexes are well dispersed in the hybrid gel. Microrheological measurements show that the strength and gelation time of the hybrid hydrogel can be controlled by changing the liposome: nanogel ratio. The hydrogel is gradually degraded by hydrolysis under physiological conditions. In this process, the nanogel is released first, followed by the nanogel-coated liposomes. Hybrid hydrogels that can incorporate various molecules into the nanogel and liposomes, and release them in a two-step controllable manner, represent a new functional scaffold capable of delivering multiple drugs, proteins or DNA.
C1 [Sekine, Yurina; Sasaki, Yoshihiro; Akiyoshi, Kazunari] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
   [Sekine, Yurina; Akiyoshi, Kazunari] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan.
   [Moritani, Yuki] NTT Docomo Inc, Res Labs, Kanagawa, Japan.
   [Ikeda-Fukazawa, Tomoko] Meiji Univ, Dept Appl Chem, Kanagawa, Japan.
   [Sasaki, Yoshihiro] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan.
   [Akiyoshi, Kazunari] Kyoto Univ, Dept Polymer Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.
   [Akiyoshi, Kazunari] Japan Sci & Technol Agcy JST, ERATO, Chiyoda Ku, Tokyo 1020076, Japan.
RP Akiyoshi, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
EM akiyoshi@bio.polym.kyoto-u.ac.jp
FU Japan Society for the Promotion of Science (JSPS) [23-5078]
FX This work was supported in part by a Grant-in-Aid from the Japan Society
   for the Promotion of Science (JSPS) Fellows (No. 23-5078).
CR Akiyoshi K, 1999, BIOCONJUGATE CHEM, V10, P321, DOI 10.1021/bc9801272
   Akiyoshi K, 1997, MACROMOLECULES, V30, P857, DOI 10.1021/ma960786e
   AKIYOSHI K, 1993, MACROMOLECULES, V26, P3062, DOI 10.1021/ma00064a011
   Boulmedarat L, 2005, PHARM RES, V22, P962, DOI 10.1007/s11095-005-4591-2
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Chung TW, 2006, INT J PHARM, V311, P122, DOI 10.1016/j.ijpharm.2005.12.038
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dvornic PR, 2002, MACROMOLECULES, V35, P9323, DOI 10.1021/ma020649j
   Hasegawa U, 2009, J CONTROL RELEASE, V140, P312, DOI 10.1016/j.jconrel.2009.06.025
   Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760
   He H., 2003, J CONTROL RELEASE, V95, P391
   Hirakura T., 2009, J CONTROL RELEASE, V142, P483
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284
   Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441
   Kang EC, 1997, J BIOACT COMPAT POL, V12, P14, DOI 10.1177/088391159701200102
   Kimura Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.041005
   Konishi M, 2005, J CONTROL RELEASE, V103, P7, DOI 10.1016/j.conrel.2004.11.014
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lim SM, 2010, J MATER SCI-MATER M, V21, P2593, DOI 10.1007/s10856-010-4118-1
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lu Y, 2007, MACROMOL CHEM PHYSIC, V208, P254, DOI 10.1002/macp.200600534
   Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094
   Meyenburg S, 2000, J CONTROL RELEASE, V69, P159, DOI 10.1016/S0168-3659(00)00295-9
   Morimoto N, 2005, MACROMOL BIOSCI, V5, P710, DOI 10.1002/mabi.200500051
   Morimoto N, 2008, MACROMOL RAPID COMM, V29, P672, DOI 10.1002/marc.200700864
   Mu X., 2006, INT J PHARMACEUT, V2, P55
   Nakajima T, 2010, POLYM CHEM-UK, V1, P693, DOI 10.1039/c0py00031k
   Noichi T, 2010, NAT MATER, V9, P572
   Nomura Y, 2003, FEBS LETT, V553, P271, DOI 10.1016/S0014-5793(03)01028-7
   Raiche AT, 2004, BIOMATERIALS, V25, P677, DOI 10.1016/S0142-9612(03)00564-7
   Reamdonck K., 2009, SOFT MATTER, V5, P707
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   Sasaki Y, 2012, CHEM LETT, V41, P202, DOI 10.1246/cl.2012.202
   Sasaki Y, 2010, CHEM REC, V10, P366, DOI 10.1002/tcr.201000008
   Shimoda A, 2012, MACROMOL RES, V20, P266, DOI 10.1007/s13233-012-0054-x
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Tsuji K, 2008, CANCER IMMUNOL IMMUN, V57, P1429, DOI 10.1007/s00262-008-0478-5
   Ueda T, 1998, CHEM LETT, P417, DOI 10.1246/cl.1998.417
   Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Wei L, 2009, BIOMATERIALS, V30, P2606, DOI 10.1016/j.biomaterials.2009.01.006
   Zhang HB, 2011, EXPERT OPIN DRUG DEL, V8, P171, DOI 10.1517/17425247.2011.547470
   Zhang XZ, 2005, BIOMATERIALS, V26, P3299, DOI 10.1016/j.biomaterials.2004.08.024
NR 46
TC 26
Z9 26
U1 9
U2 128
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD NOV
PY 2012
VL 1
IS 6
BP 722
EP 728
DI 10.1002/adhm.201200175
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092KR
UT WOS:000315120500005
PM 23184823
DA 2018-10-19
ER

PT J
AU Lucas, O
   Hamel, O
   Blanchais, A
   Lesoeur, J
   Abadie, J
   Fellah, BH
   Fusellier, M
   Gauthier, O
   Bord, E
   Grimandi, G
   Vinatier, C
   Guicheux, J
   Clouet, J
AF Lucas, Olivier
   Hamel, Olivier
   Blanchais, Anne
   Lesoeur, Julie
   Abadie, Jerome
   Fellah, Borhane Hakim
   Fusellier, Marion
   Gauthier, Olivier
   Bord, Eric
   Grimandi, Gael
   Vinatier, Claire
   Guicheux, Jerome
   Clouet, Johann
TI Laser-treated Nucleus pulposus as an innovative model of intervertebral
   disc degeneration
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE intervertebral disc degeneration; laser; animal model; tissue
   engineering
ID CELLS; CHONDROCYTES; RABBIT; REGENERATION; REINSERTION; HISTOLOGY;
   THERAPY; REPAIR; MRI
AB This study describes an innovative experimentally induced model of intervertebral disc degeneration. This innovative approach is based on the induction of extracellular matrix disorders in the intervertebral disc (IVD) using a diode laser. For this study, 15 one-year-old and five 30-month-old New Zealand White rabbits were used. Two procedures were tested to trigger IVD degeneration: needle aspiration (reference technique) and a laser approach. The IVD degeneration process was assessed 20, 40, 60, 90 and 120 days after surgery by X-ray radiography (IVD height), magnetic resonance imaging (MRI) (T2 intensity of IVD signal) and histological analysis using modified Boos' scoring. Our data indicate that a marked IVD degeneration was found compared with sham-operated animals regardless of the procedure tested. A significant decrease in disc height on X-ray radiographs was first demonstrated. In addition, MRI disc signals were significantly reduced in both groups. Finally, a statistically significant increase in Boos' scoring was found in both laser and aspiration-induced IVD degeneration. Interestingly, IVD degeneration induced by laser treatment was more progressive compared with aspiration. Moreover, the histological results indicated that laser-induced disc degeneration was quite similar to that obtained during the natural aging process as observed in 30-month-old rabbits. Our study describes the consistency of this innovative experimentally-induced animal model of IVD degeneration. The radiological, MRI and histological data confirm its relevance. The histological examination indicates that IVD degeneration induced by laser treatment is comparable to the degenerative process observed during the onset of spontaneous IVD degeneration. This model could be a useful tool to help us validate biomaterial-assisted, cell-based, regenerative medicine strategies for the prevention and treatment of IVD degeneration.
C1 [Lucas, Olivier; Hamel, Olivier; Blanchais, Anne; Lesoeur, Julie; Fellah, Borhane Hakim; Fusellier, Marion; Gauthier, Olivier; Grimandi, Gael; Vinatier, Claire; Guicheux, Jerome; Clouet, Johann] INSERM, UMRS791, LIOAD, Sch Dent Surg,Grp STEP Skeletal Tissue Engn & Phy, F-44042 Nantes, France.
   [Lucas, Olivier; Hamel, Olivier; Blanchais, Anne; Lesoeur, Julie; Fellah, Borhane Hakim; Fusellier, Marion; Gauthier, Olivier; Bord, Eric; Grimandi, Gael; Vinatier, Claire; Guicheux, Jerome; Clouet, Johann] Univ Nantes, LUNAM, F-44042 Nantes, France.
   [Lucas, Olivier; Hamel, Olivier] Univ Hosp Nantes, Dept Neurotraumatol, F-44093 Nantes, France.
   [Blanchais, Anne] Univ Hosp Nantes, Dept Rheumatol, F-44093 Nantes, France.
   [Abadie, Jerome] Natl Vet Sch ONIRIS, CRIP, Dept Anatomopathol, F-44307 Nantes, France.
   [Fellah, Borhane Hakim; Gauthier, Olivier] Natl Vet Sch ONIRIS, CRIP, Dept Expt Surg, F-44307 Nantes, France.
   [Fusellier, Marion] Natl Vet Sch ONIRIS, CRIP, Dept Imagery, F-44307 Nantes, France.
   [Grimandi, Gael; Clouet, Johann] Univ Hosp Nantes, Dept Pharm, F-44093 Nantes, France.
RP Guicheux, J (reprint author), INSERM, U791, Sch Dent Surg, 1 Pl Alexis Ricordeau, F-44042 Nantes 1, France.
EM jerome.guicheux@inserm.fr
RI guicheux, Jerome/F-7767-2013; Fusellier, Marion/P-1541-2014; FELLAH,
   Borhane/L-6266-2015; Gauthier, Olivier/A-4639-2015; Vinatier,
   Claire/P-1686-2014; Clouet, Johann/P-1358-2014
OI guicheux, Jerome/0000-0003-2754-3024; Vinatier,
   Claire/0000-0002-6063-9901; 
FU Societe Francaise de Rhumatologie; Fondation de l'Avenir pour la
   Recherche Medicale Appliquee [ET8-491, ET9-541]; Societe Francaise de
   Neurochirurgie; Agence Nationale de la Recherche AAP TeCSAN; Agence de
   la Biomedecine; Institut National de la Sante Et de la Recherche
   Medicale (INSERM); Fondation pour la Recherche Medicale-MESCLE
   (FRM-MESCLE); Region des Pays de la Loire; University Hospital of Nantes
FX This study was supported by grants from Societe Francaise de
   Rhumatologie, Fondation de l'Avenir pour la Recherche Medicale Appliquee
   (ET8-491 and ET9-541), Societe Francaise de Neurochirurgie, Agence
   Nationale de la Recherche AAP TeCSAN (Chondrograft project), Agence de
   la Biomedecine, Institut National de la Sante Et de la Recherche
   Medicale (INSERM), Fondation pour la Recherche Medicale-MESCLE
   (FRM-MESCLE), Region des Pays de la Loire (BIOREGOS project) and the
   University Hospital of Nantes. The authors also gratefully acknowledge
   the technical assistance of Pierre Weiss, Pierre Monmousseau, Patrice
   Roy, Stephane Madec, Dominique Rouleau and Christian Raphael, as well as
   Joanna Ashton-Chess and Christopher Bartlett for correcting the
   manuscript. We also thank KaVo Dental GmbH (Biberach, Germany) for
   providing us with a laser KaVo GENTLEray 980 (R) diode.
CR Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y
   Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002
   Clouet J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-147
   Clouet J, 2009, JOINT BONE SPINE, V76, P614, DOI 10.1016/j.jbspin.2009.07.002
   Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262
   Gorensek M, 2004, CELL MOL BIOL LETT, V9, P363
   Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20
   Kalson NS, 2008, REGEN MED, V3, P717, DOI 10.2217/17460751.3.5.717
   Kim KS, 2005, SPINE, V30, P33, DOI 10.1097/01.brs.0000149191.02304.9b
   Lotz JC, 2004, SPINE, V29, P742
   Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016
   Miyamotos T, 2011, ARTHRITIS RES THER, V12, pR206
   Nishimura K, 1998, SPINE, V23, P1531, DOI 10.1097/00007632-199807150-00006
   Nomura T, 2001, CLIN ORTHOP RELAT R, P94
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620
   Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x
   Revell PA, 2007, J MATER SCI-MATER M, V18, P303, DOI 10.1007/s10856-006-0693-6
   Richardson SM, 2007, HISTOL HISTOPATHOL, V22, P1033, DOI 10.14670/HH-22.1033
   Rohanizadeh R, 1999, J DENT RES, V78, P1829, DOI 10.1177/00220345990780121001
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3
   Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5
   Sobajima S, 2005, SPINE, V30, P15, DOI 10.1097/01.brs.0000148048.15348.9b
   Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629
   Vinatier C, 2009, J BIOMED MATER RES A, V89A, P176, DOI 10.1002/jbm.a.31988
NR 26
TC 4
Z9 5
U1 0
U2 21
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 1535-3702
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD NOV
PY 2012
VL 237
IS 11
BP 1359
EP 1367
DI 10.1258/ebm.2012.012049
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 073QC
UT WOS:000313756600014
PM 23239447
DA 2018-10-19
ER

PT J
AU Browne, S
   Fontana, G
   Rodriguez, BJ
   Pandit, A
AF Browne, Shane
   Fontana, Gianluca
   Rodriguez, Brian J.
   Pandit, Abhay
TI A Protective Extracellular Matrix-Based Gene Delivery Reservoir
   Fabricated by Electrostatic Charge Manipulation
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE microspheres; reservoir systems; gene therapy; collagen; drug delivery;
   transfection
ID RECONSTITUTED COLLAGEN; DRUG-DELIVERY; THERAPY; MICROSPHERES;
   BIOMATERIAL; POLYMERS; PROGRESS; BINDING; SYSTEMS; PROTEIN
AB Gene therapy is a field that offers hope and promise for the treatment of diseases and traumas of a genetic nature and otherwise. However, progress toward the clinic has been delayed because of concerns over the safety of viral vectors and the efficacy of safer nonviral systems, which have low transfection efficacy and short transgene expression. This study describes the fabrication and characterization of a safe gene delivery reservoir system that has the potential to overcome issues associated with nonviral systems. Harnessing the electrostatic charges of collagen and polystyrene, microspheres were fabricated using a template-based method and characterized by microscopy techniques such as scanning electron microscopy, transmission electron microscopy, and atomic force microscopy, with the removal of the polystyrene template confirmed by Fourier transform infrared spectroscopy analysis. Loading and release of polyplexes confirmed the ability of the system to prolong polyplex delivery, with minimal cytotoxicity observed from viability studies on 3T3 fibroblasts. Finally, biological activity of released polyplexes was confirmed by reporter gene expression. Taken together, these properties indicate the potential of this system as a reservoir for gene delivery.
C1 [Browne, Shane; Fontana, Gianluca; Pandit, Abhay] Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Rodriguez, Brian J.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Rodriguez, Brian/A-6253-2009; Pandit, Abhay/B-6187-2008
OI Rodriguez, Brian/0000-0001-9419-2717; Pandit, Abhay/0000-0002-6292-4933
FU Science Foundation Ireland [07/SRC/B1163, 07/IN1/B031]; European
   Commission [NMP3-LA-2008-213904]
FX This material is based upon work supported by Science Foundation
   Ireland, Grant 07/SRC/B1163, and the European Commission under the DISC
   REGENERATION project (NMP3-LA-2008-213904). The AFM equipment used for
   this work was funded by Science Foundation Ireland (Grant 07/IN1/B031).
   We thank Mr. Pierce Lalor from the Department of Anatomy, School of
   Medicine, National University of Ireland, for assistance with microscopy
   techniques and Mr. Anthony Sloan for his editorial assistance.
CR Chan OCM, 2008, J CONTROL RELEASE, V129, P135, DOI 10.1016/j.jconrel.2008.04.011
   Daamen WF, 2007, ADV MATER, V19, P673, DOI 10.1002/adma.200601947
   Dahl T, 1998, J STRUCT BIOL, V123, P162, DOI 10.1006/jsbi.1998.4025
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Dash BC, 2011, J CONTROL RELEASE, V152, P382, DOI 10.1016/j.jconrel.2011.03.006
   Dash BC, 2010, BIOMATERIALS, V31, P8188, DOI 10.1016/j.biomaterials.2010.07.067
   Fernandez CA, 2009, MOL PHARMACEUT, V6, P1277, DOI 10.1021/mp900033j
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gao XL, 2011, BIOMATERIALS, V32, P8613, DOI 10.1016/j.biomaterials.2011.07.047
   Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001
   Highberger J. H., 1939, J AM CHEM SOC, V61, P2302
   Holladay C, 2010, NANOSCALE, V2, P2718, DOI 10.1039/c0nr00456a
   Holladay C, 2011, MOL THER, V19, P969, DOI 10.1038/mt.2010.311
   Holladay C, 2009, J CONTROL RELEASE, V136, P220, DOI 10.1016/j.jconrel.2009.02.006
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618
   Kafil V, 2011, BIOIMPACTS, V1, P23, DOI 10.5681/bi.2011.004
   Kulkarni M, 2009, BIOMACROMOLECULES, V10, P1650, DOI 10.1021/bm900248n
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007
   Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x
   Rethore G, 2009, TISSUE ENG PART C-ME, V15, P605, DOI [10.1089/ten.tec.2008.0581, 10.1089/ten.TEC.2008.0581]
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Saralidze K, 2010, BIOMACROMOLECULES, V11, P3556, DOI 10.1021/bm1010273
   Schaffert D, 2008, GENE THER, V15, P1131, DOI 10.1038/gt.2008.105
   Sehgal PK, 2009, EXPERT OPIN DRUG DEL, V6, P687, DOI 10.1517/17425240903025736
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   de Ilarduya CT, 2010, EUR J PHARM SCI, V40, P159, DOI 10.1016/j.ejps.2010.03.019
   WEINSTOCK A, 1967, BIOCHEM J, V102, P983, DOI 10.1042/bj1020983
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
   Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]
NR 32
TC 26
Z9 26
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD NOV
PY 2012
VL 9
IS 11
BP 3099
EP 3106
DI 10.1021/mp300231d
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 073US
UT WOS:000313769200013
PM 23013232
DA 2018-10-19
ER

PT J
AU Singh, A
AF Singh, Anjuvan
TI Hydroxyapatite, a biomaterial: Its chemical synthesis, characterization
   and study of biocompatibility prepared from shell of garden snail, Helix
   aspersa
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE Snail shell; hydroxyapatite; calcination; beta-tricalcium phosphate;
   bioactivity
ID SIMULATED BODY-FLUID; CALCIUM-PHOSPHATE; APATITE FORMATION; BIOCERAMICS;
   GEL; PRECIPITATION; KINETICS; ROUTE
AB The shell of garden snail (Helix aspersa) is basically made of calcium carbonate. An attempt is made to convert calcium carbonate of garden snail shell to hydroxyapatite. The snail shell was found to decompose within 850C to all the carbonate phases. The calcined snail shells were then treated with acids followed by different chemicals in ammoniacal media maintaining proper stoichiometry to produce fine hydroxyapatite (HAP) as filter cake with a CaP molar ratio of 167. The dried HAP powder was extremely pure with a specific surface area of 15 mg. The different characterization techniques were adopted both for calcined snail shell and HAP synthesized by X-ray diffraction (XRD), thermal analysis (DTATGA), Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM). The surface area and particle size of HAP powder prepared by chemical precipitation route, were also determined by BET and Malvern particle size analyser, respectively. The synthesized powder was soaked in stimulated body fluid (SBF) medium for various periods of time in order to evaluate its bioactivity. The changes of pH of SBF medium were measured. High bioactivity of prepared HAP powder due to the formation of apatite on its surface was observed.
C1 Lovely Profess Univ, Dept Biosci & Biotechnol, Phagwara 144411, India.
RP Singh, A (reprint author), Lovely Profess Univ, Dept Biosci & Biotechnol, Phagwara 144411, India.
EM anjuvan@gmail.com
CR Arita IH, 1995, BIOMATERIALS, V16, P404
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   BROWN PW, 1991, J AM CERAM SOC, V74, P934, DOI 10.1111/j.1151-2916.1991.tb04324.x
   CAROLINE E, 2002, TRENDS BIOMATER ARTI, V16, P12
   COWIN SC, 1987, HDB BIOENGINEERING
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Gomez-Morales J, 2001, CRYST RES TECHNOL, V36, P15, DOI 10.1002/1521-4079(200101)36:1<15::AID-CRAT15>3.3.CO;2-5
   HENCH LL, 1993, INTRO BIOCERAMICS
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jarcho M., 1978, US Patent, Patent No. 4097935
   Kangasniemi I, 1994, J NONCRYST SOLIDS, V6, P281
   Kangasniemi I, 1994, J AM CERAM SOC, V12, P1307
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Murugan R, 2005, J CRYST GROWTH, V274, P209, DOI 10.1016/j.jcrysgro.2004.09.069
   Nakanishi K, 1993, BIOMATERIALS, V8, P963
   Neuman W, 1958, EVOLUTION MEDIA EFFE, P34
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Partenfelder UME, 1991, J MAT SCI MAT MED, V4, P292
   Ramanan SR, 2004, MATER LETT, V58, P3320, DOI 10.1016/j.matlet.2004.06.030
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Russell SW, 1996, J AM CERAM SOC, V79, P843
   Sargin Y, 1997, J EUR CERAM SOC, V17, P963, DOI 10.1016/S0955-2219(96)00196-3
   Sinha A, 2001, B MATER SCI, V24, P653, DOI 10.1007/BF02704016
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
   YOUNG RA, 1982, CALCIFIED TISSUE INT, V34, P17
NR 29
TC 35
Z9 35
U1 1
U2 40
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD NOV
PY 2012
VL 35
IS 6
BP 1031
EP 1038
DI 10.1007/s12034-012-0384-5
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 061TU
UT WOS:000312872000015
DA 2018-10-19
ER

PT J
AU Harkin, DG
   Chirila, TV
AF Harkin, Damien G.
   Chirila, Traian V.
TI Silk fibroin in ocular surface reconstruction: what is its potential as
   a biomaterial in ophthalmics?
SO FUTURE MEDICINAL CHEMISTRY
LA English
DT Editorial Material
DE biomaterials; corneal transplantation; eye disease; regenerative
   medicine; silk fibroin; tissue engineering
ID BOMBYX-MORI; MEMBRANES; FILM
C1 [Harkin, Damien G.; Chirila, Traian V.] Queensland Eye Inst, Brisbane, Qld 4101, Australia.
   [Chirila, Traian V.] Univ Queensland, Fac Hlth Sci, Herston, Qld 4006, Australia.
   [Chirila, Traian V.] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.
   [Harkin, Damien G.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4000, Australia.
   [Harkin, Damien G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4000, Australia.
RP Chirila, TV (reprint author), Queensland Eye Inst, 41 Annerley Rd, Brisbane, Qld 4101, Australia.
EM traian.chirila@qei.org.au
OI Harkin, Damien/0000-0002-7358-7987
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bentley E, 2010, CORNEA, V29, P910, DOI 10.1097/ICO.0b013e3181c846aa
   Bray LJ, 2012, BIOMATERIALS, V33, P3529, DOI 10.1016/j.biomaterials.2012.01.045
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Chirila T, 2007, MATER SCI FORUM, V561-565, P1549, DOI 10.4028/www.scientific.net/MSF.561-565.1549
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]
   Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231
   Higa K, 2011, J BIOMAT SCI-POLYM E, V22, P2261, DOI 10.1163/092050610X538218
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sehnal F, 2004, BIOMACROMOLECULES, V5, P666, DOI 10.1021/bm0344046
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
NR 15
TC 7
Z9 8
U1 1
U2 14
PU FUTURE SCI LTD
PI LONDON
PA UNITED HOUSE, 2 ALBERT PL, LONDON, N3 1QB, ENGLAND
SN 1756-8919
J9 FUTURE MED CHEM
JI Future Med. Chem.
PD NOV
PY 2012
VL 4
IS 17
BP 2145
EP 2147
DI 10.4155/FMC.12.155
PG 3
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 059AG
UT WOS:000312676200012
PM 23190102
DA 2018-10-19
ER

PT J
AU Ramanathan, S
   Ponnuswamy, V
   Gowtham, B
   Premnazeer, K
   Murugavel, SC
AF Ramanathan, S.
   Ponnuswamy, V.
   Gowtham, B.
   Premnazeer, K.
   Murugavel, S. C.
TI Effect of ammonium persulfate (aps) concentration on chitosan grafted
   polyaniline
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Conducting polymers; Chitosan; Polyaniline; Grafting
ID COMPOSITES; FILMS
AB Chitosan was grafted with polyaniline (PANI) through oxidative radial copolymerization using ammonium persulfate (APS) initiator to obtain a product called Chitosan-graft-polyaniline (Chit-g-PANI). Chit-g-PANI samples were synthesized by varying the APS concentration. The grafted polymer was characterized by using Fourier Transformation Infrared Spectroscopy (FTIR), X-ray Diffraction (XRD), Scanning Electron Microscopy (SEM), Dielectric Studies and AC Conductivity taking Chitosan as a reference material. The application of conducting biomaterial such as Chit-g-PANI in the electronic devices is especially for the fabrication of sensor devices. FTIR spectra of the Chit-g-PANI revealed that there is a strong interaction between PANI and Chitosan. Morphological studies were carried out to confirm the grafting polymerization and it was further confirmed by XRD pattern. Chit-g-PANI exhibited electrical conductivity, which increase with increase in the APS concentration.
C1 [Ramanathan, S.; Ponnuswamy, V.; Gowtham, B.] Sri Ramakrishna Mission Vidyalaya Coll Arts & Sci, Dept Phys, Coimbatore 641020, Tamil Nadu, India.
   [Premnazeer, K.] Islamiah Coll Arts & Sci, Dept Phys, Vaniyambadi 635752, India.
   [Murugavel, S. C.] PSG Coll Technol, Dept Chem, Coimbatore 641014, Tamil Nadu, India.
RP Ramanathan, S (reprint author), Sri Ramakrishna Mission Vidyalaya Coll Arts & Sci, Dept Phys, Coimbatore 641020, Tamil Nadu, India.
EM sramanathan70@yahoo.co.in
CR Martel-Estrada SA, 2010, CARBOHYD POLYM, V81, P775, DOI 10.1016/j.carbpol.2010.03.032
   AIBA S, 1993, INT J BIOL MACROMOL, V15, P241, DOI 10.1016/0141-8130(93)90044-M
   Duan WG, 2008, CARBOHYD POLYM, V73, P582, DOI 10.1016/j.carbpol.2007.12.025
   Hedvig P., 1977, DIELECTRIC SPECTROSC
   Ismail YA, 2008, SENSOR ACTUAT B-CHEM, V129, P834, DOI 10.1016/j.snb.2007.09.083
   Neagu E, 1997, J PHYS D APPL PHYS, V30, P1551, DOI 10.1088/0022-3727/30/11/003
   Peesan M, 2005, CARBOHYD POLYM, V60, P343, DOI 10.1016/j.carbpol.2005.01.008
   Ramaprasad AT, 2009, SYNTHETIC MET, V159, P1983, DOI 10.1016/j.synthmet.2009.07.006
   Silva SS, 2003, EUR POLYM J, V39, P1515, DOI 10.1016/S0014-3057(03)00013-2
   Thanpitcha T, 2006, CARBOHYD POLYM, V64, P560, DOI 10.1016/j.carbpol.2005.11.026
   Tiwari A, 2007, EXPRESS POLYM LETT, V1, P308, DOI 10.3144/expresspolymlett.2007.44
   Tiwari A, 2009, EXPRESS POLYM LETT, V3, P553, DOI 10.3144/expresspolymlett.2009.69
   Yavuz AG, 2010, CARBOHYD POLYM, V81, P712, DOI 10.1016/j.carbpol.2010.03.045
   Yavuz AG, 2009, CARBOHYD POLYM, V75, P448, DOI 10.1016/j.carbpol.2008.08.005
NR 14
TC 2
Z9 2
U1 0
U2 9
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD NOV-DEC
PY 2012
VL 14
IS 11-12
BP 1011
EP 1015
PG 5
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 058DR
UT WOS:000312614800023
DA 2018-10-19
ER

PT J
AU Dhanalakshmi, CP
   Vijayalakshmi, L
   Narayanan, V
AF Dhanalakshmi, C. P.
   Vijayalakshmi, L.
   Narayanan, V.
TI Synthesis, Characterization, Antimicrobial and Antiinflammatory Effect
   of Chitosan/Hydroxyapatite Nanocomposite
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Hydroxyapatite; Nanocomposite; Chitosan; Antimicrobial activity;
   Antiinflammatory activity
ID HYDROXYAPATITE PARTICLES; CHITOSAN SCAFFOLDS; IN-VITRO; COMPOSITE;
   BIOACTIVITY; DIFFUSION; ACID); VIVO
AB Chitosan/hydroxyapatite nanocomposites of varying composition for biomaterial applications have been synthesized by wet chemical method. The Chitosan/hydroxyapatite nanocomposite materials were characterized by XRD, FTIR, P-31 NMR and FESEM. Hydroxyapatite (HAp) nanorod embedded composite was prepared using chitosan as a matrix with different weight percentages (wt %). The results indicated that the size and crystallinity of hydroxyapatite nano particles decreases with increase in chitosan concentration in the composite. SEM confirms the presence of hydroxyapatite nanorod crystals in chitosan (CHS) matrix, chitosan/hydroxyapatite. The nano composites were screened for antimicrobial activity and also for antiinflammatory activity.
C1 [Dhanalakshmi, C. P.; Narayanan, V.] Univ Madras, Dept Inorgan Chem, Madras 600025, Tamil Nadu, India.
   [Vijayalakshmi, L.] SDNB Vaishnav Coll Women, Dept Chem, Madras 600044, Tamil Nadu, India.
RP Narayanan, V (reprint author), Univ Madras, Dept Inorgan Chem, Guindy Maraimalai Campus, Madras 600025, Tamil Nadu, India.
EM vnnara@yahoo.co.in
OI Narayanan, Vengidusamy/0000-0003-0653-8170
FU University Grants Commission; Council of Scientific and Industrial
   Research, New Delhi, India
FX The authors are grateful for the financial supports from the University
   Grants Commission and Council of Scientific and Industrial Research, New
   Delhi, India.
CR Boissiere M, 2006, J MATER CHEM, V16, P1178, DOI 10.1039/b515797h
   Chen DZ, 2007, COMPOS SCI TECHNOL, V67, P1617, DOI 10.1016/j.compscitech.2006.07.034
   Chen GP, 2001, BIOMATERIALS, V22, P2563, DOI 10.1016/S0142-9612(00)00447-6
   Costescu A, 2010, DIG J NANOMATER BIOS, V5, P989
   Darder M, 2006, CHEM MATER, V18, P1602, DOI 10.1021/cm0523642
   Feng Z., 2002, BIOMATERIALS, V23, P3227
   GANDHIDASAN R, 1991, Fitoterapia, V62, P81
   Gomez-Vega J. M., 2000, BIOMATERIALS, V211, P285
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Ito M., 1991, BIOMATERIALS, V12, P441
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Kawagoe K, 2000, J BIOMED MATER RES, V53, P678, DOI 10.1002/1097-4636(2000)53:6<678::AID-JBM10>3.0.CO;2-E
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Larena A., 2009, OPEN TISSUE ENG RES, V2, P40
   Li JD, 2009, J MATER SCI-MATER M, V20, P1031, DOI 10.1007/s10856-008-3664-2
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Magaldi S, 2004, INT J INFECT DIS, V8, P39, DOI 10.1016/j.ijid.2003.03.002
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Pramanik N, 2006, POLYM COMPOSITE, V27, P633, DOI 10.1002/pc.20246
   Rao KSVK, 2010, IRAN POLYM J, V19, P265
   Sabokbar A, 2001, J MATER SCI-MATER M, V12, P659, DOI 10.1023/A:1011267005465
   Wang MB, 2008, J BIOMED MATER RES A, V85A, P418, DOI 10.1002/jbm.a.31585
   Wiria FE, 2008, J MATER SCI-MATER M, V19, P989, DOI 10.1007/s10856-007-3176-5
   Zhan JH, 2005, ADV FUNCT MATER, V15, P2005, DOI 10.1002/adfm.200500274
   Zhang YJ, 2008, CRYST GROWTH DES, V8, P2101, DOI 10.1021/cg060880e
NR 27
TC 1
Z9 1
U1 0
U2 14
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
J9 ASIAN J CHEM
JI Asian J. Chem.
PD NOV
PY 2012
VL 24
IS 11
BP 5264
EP 5268
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 033CS
UT WOS:000310771100104
DA 2018-10-19
ER

PT J
AU Samundeeswari, A
   Dhas, SP
   Nirmala, J
   John, SP
   Mukherjee, A
   Chandrasekaran, N
AF Samundeeswari, Arputhamani
   Dhas, Sindhu Priya
   Nirmala, Joyce
   John, Shiny Punalur
   Mukherjee, Amitava
   Chandrasekaran, Natarajan
TI Biosynthesis of silver nanoparticles using actinobacterium Streptomyces
   albogriseolus and its antibacterial activity
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Article
DE extracellular synthesis; silver nanoparticles; Streptomyces
   albogriseolus; antibacterial activity; surface plasmon resonance; food
   pathogens
ID FUNGUS-MEDIATED SYNTHESIS; BIOLOGICAL APPROACH; BACILLUS-CEREUS; GREEN
   SYNTHESIS; ANTIBIOTICS; PARTICLES; STRAINS; EXTRACT
AB An eco-friendly approach to the synthesis of silver nanoparticles (AgNPs) by extracellular components of Streptomyces albogriseolus has been reported. The isolated actinobacteria were genotypically identified by 16S rRNA sequencing analysis, and the morphology was observed by high-resolution scanning electron microscopy. The preliminary characterization of synthesized nanoparticles was carried out using ultravioletvisible spectrophotometer. The maximum absorption spectra were found to be 409 nm at the 48th hour of incubation. The yield of AgNPs was found to be 72.64% as quantified by an atomic absorption spectrophotometer. The average size of AgNPs determined by the dynamic light scattering technique was 16.25 +/- 1.6 nm. The results from transmission electron microscopy and X-ray diffraction confirmed the formation of spherical shaped and crystalline AgNPs. The interaction of protein with AgNPs was confirmed by Fourier transform infrared spectroscopy analysis. The biosynthesized AgNPs inhibited the growth of food pathogens (Bacillus cereus, Escherichia coli, and Staphylococcus aureus). Hence, the synthesis of AgNPs by S. albogriseolus could be employed as a probable antimicrobial agent to eliminate pathogenic microorganisms. This approach employed for the synthesis of nanoparticles paves a path for new biomaterial interfaces, which could be applied in different biomedical fields.
C1 [Samundeeswari, Arputhamani; Dhas, Sindhu Priya; Nirmala, Joyce; John, Shiny Punalur; Mukherjee, Amitava; Chandrasekaran, Natarajan] VIT Univ, Ctr Nanobiotechnol, Vellore 632014, Tamil Nadu, India.
RP Chandrasekaran, N (reprint author), VIT Univ, Ctr Nanobiotechnol, Vellore 632014, Tamil Nadu, India.
EM nchandrasekaran@vit.ac.in
OI Mukherjee, Amitava/0000-0001-8682-4278
CR Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   ARAI T, 1976, J ANTIBIOT, V29, P398, DOI 10.7164/antibiotics.29.398
   Beecher DJ, 1997, J BIOL CHEM, V272, P233
   BENEDICT RG, 1954, ANTIBIOT CHEMOTHER, V4, P653
   Canuto MM, 2002, LANCET INFECT DIS, V2, P550, DOI 10.1016/S1473-3099(02)00371-7
   CELEMIN C, 1995, VET MICROBIOL, V45, P121, DOI 10.1016/0378-1135(94)00129-K
   Cui CB, 2007, FITOTERAPIA, V78, P238, DOI 10.1016/j.fitote.2006.11.017
   Duran Nelson, 2005, J Nanobiotechnology, V3, P8, DOI 10.1186/1477-3155-3-8
   Garidel P., 2006, BIOPROCESS TECHNICAL, V33, P48
   Granum P. E., 1994, J APPL BACTERIOL, V76, p61S
   Gurunathan S, 2009, BIOMATERIALS, V30, P6341, DOI 10.1016/j.biomaterials.2009.08.008
   Gusseme B. de, 2010, Applied and Environmental Microbiology, V76, P1082
   Huang JL, 2011, IND ENG CHEM RES, V50, P9095, DOI 10.1021/ie200858y
   Hwang YB, 2007, PROCESS BIOCHEM, V42, P102, DOI 10.1016/j.procbio.2006.06.031
   Kenji K., 1993, BIOSCI BIOTECH BIOCH, V57, P636
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Kramer J. M., 1989, Foodborne bacterial pathogens., P21
   Le Loir Yves, 2003, Genet Mol Res, V2, P63
   Lund T, 1997, MICROBIOL-UK, V143, P3329, DOI 10.1099/00221287-143-10-3329
   Mubarak A. D., 2011, COLLOID SURFACE B, V85, P360, DOI DOI 10.1016/J.COLSURFB.2011.03.009
   Mukherjee P, 2001, NANO LETT, V1, P515, DOI 10.1021/nl0155274
   Nadagouda MN, 2009, CRYST GROWTH DES, V9, P4979, DOI 10.1021/cg9007685
   Otari SV, 2012, MATER LETT, V72, P92, DOI 10.1016/j.matlet.2011.12.109
   Petrus E.M., 2011, INT FOOD RES J, V18, P55
   Prakasham R. S., 2011, J MICROBIOL BIOCH TE, V6, P28
   Pugazhenthiran N, 2009, J NANOPART RES, V11, P1811, DOI 10.1007/s11051-009-9621-2
   Sadhasivam S, 2010, COLLOID SURFACE B, V81, P358, DOI 10.1016/j.colsurfb.2010.07.036
   SASAKI T, 1988, J ANTIBIOT, V41, P835, DOI 10.7164/antibiotics.41.835
   Sastry M, 1997, COLLOID SURFACE A, V127, P221, DOI 10.1016/S0927-7757(97)00087-3
   Sastry M, 2003, CURR SCI INDIA, V85, P162
   Sathishkumar M, 2009, COLLOID SURFACE B, V73, P332, DOI 10.1016/j.colsurfb.2009.06.005
   Sathyanarayana D. N., 2004, VIBRATIONAL SPECTROS
   Senapati S, 2004, INDIAN J PHYS PT-A, V78A, P101
   Sheikpranbabu Sardarpasha, 2009, Journal of Nanobiotechnology, V7, P8, DOI 10.1186/1477-3155-7-8
   Sivalingam P, 2012, COLLOID SURFACE B, V98, P12, DOI 10.1016/j.colsurfb.2012.03.032
   Stapley E. O., 1975, [No title captured], Patent No. [US3914158, 39141458]
   Verma V.C., 2009, NUTR NAT RESOUR, V4, P1
   Vigneshwaran N, 2007, MATER LETT, V61, P1413, DOI 10.1016/j.matlet.2006.07.042
   Wei XT, 2012, BIORESOURCE TECHNOL, V103, P273, DOI 10.1016/j.biortech.2011.09.118
   Zhang HR, 2005, J CHEM TECHNOL BIOT, V80, P285, DOI 10.1002/jctb.1191
NR 41
TC 9
Z9 10
U1 0
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD NOV-DEC
PY 2012
VL 59
IS 6
BP 503
EP 507
DI 10.1002/bab.1054
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 057DP
UT WOS:000312542600015
PM 23586961
DA 2018-10-19
ER

PT J
AU Julca, I
   Alaminos, M
   Gonzalez-Lopez, J
   Manzanera, M
AF Julca, I.
   Alaminos, M.
   Gonzalez-Lopez, J.
   Manzanera, M.
TI Xeroprotectants for the stabilization of biomaterials
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Xeroprotectants; Stabilization for drying; Anhydrobionts; Biomaterials
ID INTRACELLULAR TREHALOSE IMPROVES; EMBRYOGENESIS ABUNDANT PROTEINS;
   SHOCK/ALPHA-CRYSTALLIN PROTEIN; WATER-REPLACEMENT HYPOTHESIS; NEMATODE
   APHELENCHUS-AVENAE; PSEUDOMONAS-PUTIDA KT2440; UNIVERSITY-OF-WISCONSIN;
   HEAT-SHOCK PROTEINS; RED-BLOOD-CELLS; DESICCATION TOLERANCE
AB With the advancement of science and technology, it is crucial to have effective preservation methods for the stable long-term storage of biological material (biomaterials). As an alternative to cryopreservation, various techniques have been developed, which are based on the survival mechanism of anhydrobiotic organisms. In this sense, it has been found that the synthesis of xeroprotectants can effectively stabilize biomaterials in a dry state. The most widely studied xeroprotectant is trehalose, which has excellent properties for the stabilization of certain proteins, bacteria, and biological membranes. There have also been attempts to apply trehalose to the stabilization of eukaryotic cells but without conclusive results. Consequently, a xeroprotectant or method that is useful for the stable drying of a particular biomaterial might not necessarily be suitable for another one. This article provides an overview of recent advances in the use of new techniques to stabilize biomaterials and compare xeroprotectants with other more standard methods. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Julca, I.; Gonzalez-Lopez, J.; Manzanera, M.] Univ Granada, Inst Water Res, Granada, Spain.
   [Julca, I.; Gonzalez-Lopez, J.; Manzanera, M.] Univ Granada, Dept Microbiol, Granada, Spain.
   [Alaminos, M.] Univ Granada, Fac Med, Dept Histol, Granada, Spain.
RP Manzanera, M (reprint author), Univ Granada, Inst Water Res, Granada, Spain.
EM manzanera@ugr.es
RI ALAMINOS, MIGUEL/N-9960-2016; Manzanera, Maximino/L-9098-2014
OI ALAMINOS, MIGUEL/0000-0003-4876-2672; Manzanera,
   Maximino/0000-0001-9555-7490; Julca, Irene/0000-0002-1332-7948
FU Ministry of Science and Innovation in Spain; Andalusian regional
   government (Spain); Technology Transfer Office of the University of
   Granada; BioTic Granada Campus [P07-RNM-02588, CTM2009-09270, PR/11/001,
   20F12/24]; Ministry of Science and Innovation; European Regional
   Development Funds (EU)
FX This research was funded by the Ministry of Science and Innovation in
   Spain, the Andalusian regional government (Spain), the Technology
   Transfer Office of the University of Granada and the BioTic Granada
   Campus within the context of research projects P07-RNM-02588,
   CTM2009-09270, PR/11/001, and 20F12/24, respectively. M. Manzanera
   received a Ramon y Cajal research grant from the Ministry of Science and
   Innovation as well as support from European Regional Development Funds
   (EU).
CR ACKER JP, 2002, CELL PRESERV TECHNOL, V1, P129
   Adams GDJ, 1996, J PHARM SCI, V85, P1301, DOI 10.1021/js960146p
   Allison SD, 1999, ARCH BIOCHEM BIOPHYS, V365, P289, DOI 10.1006/abbi.1999.1175
   Alpert P, 2005, INTEGR COMP BIOL, V45, P685, DOI 10.1093/icb/45.5.685
   Annear DI, 1958, AUSTR J EXPT BIOL, V36, P2111
   Arakawa T, 2007, AMINO ACIDS, V33, P587, DOI 10.1007/s00726-007-0506-3
   ARAKAWA T, 1993, ADV DRUG DELIVER REV, V10, P1, DOI 10.1016/0169-409X(93)90003-M
   Baertschiger RM, 2008, CURR OPIN ORGAN TRAN, V13, P59, DOI 10.1097/MOT.0b013e3282f44a63
   Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159
   BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385
   Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725
   Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357
   BELTON PS, 1994, BIOPOLYMERS, V34, P957, DOI 10.1002/bip.360340713
   Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200
   Benson Erica E., 2008, P15, DOI 10.1007/978-0-387-72276-4_2
   Billi D, 2000, APPL ENVIRON MICROB, V66, P1680, DOI 10.1128/AEM.66.4.1680-1684.2000
   Billi D, 2002, RES MICROBIOL, V153, P7, DOI 10.1016/S0923-2508(01)01279-7
   Bloom FR, 2001, BIOSENS BIOELECTRON, V16, P603, DOI 10.1016/S0956-5663(01)00175-0
   Boggi U, 2004, TRANSPLANTATION, V77, P1186, DOI 10.1097/01.TP.0000120535.89925.CA
   BOND M, 2009, HEALTH TECHNOL ASSES, V13, P1
   BONDOC CC, 1971, ANN SURG, V174, P371, DOI 10.1097/00000658-197109000-00006
   Boschetti C, 2011, J EXP BIOL, V214, P59, DOI 10.1242/jeb.050328
   Boudet J, 2006, PLANT PHYSIOL, V140, P1418, DOI 10.1104/pp.105.074039
   Broadbent JR, 1999, CRYOBIOLOGY, V39, P88, DOI 10.1006/cryo.1999.2190
   Brockbank K. G., 2006, ADV BIOPRESERVATION, P157
   Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a
   Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004
   Buchanan SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012518
   Campbell SA, 1997, NEW PHYTOL, V137, P61, DOI 10.1046/j.1469-8137.1997.00831.x
   Caprioli M, 2004, COMP BIOCHEM PHYS A, V139, P527, DOI 10.1016/j.cbpb.2004.10.019
   CARPENTER JF, 1987, BIOCHIM BIOPHYS ACTA, V923, P109, DOI 10.1016/0304-4165(87)90133-4
   Chakrabortee S, 2012, MOL BIOSYST, V8, P210, DOI 10.1039/c1mb05263b
   Chakraborty N, 2012, CRYOBIOLOGY, V64, P91, DOI 10.1016/j.cryobiol.2011.11.007
   Chaplin M, 2006, NAT REV MOL CELL BIO, V7, P861, DOI 10.1038/nrm2021
   Chaplin MF, 2001, BIOCHEM MOL BIOL EDU, V29, P54, DOI 10.1111/j.1539-3429.2001.tb00070.x
   Chapman T, 2003, NATURE, V421, P661, DOI 10.1038/421661a
   Charniot JC, 2010, J SURG RES, V160, P308, DOI 10.1016/j.jss.2009.03.023
   Chen T, 2001, CRYOBIOLOGY, V43, P168, DOI 10.1006/cryo.2001.2360
   CLEGG JS, 1994, EXP CELL RES, V212, P77, DOI 10.1006/excr.1994.1120
   Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1
   CLEGG JS, 1982, CRYOBIOLOGY, V19, P306, DOI 10.1016/0011-2240(82)90159-6
   Clegg JS, 2005, ARTEMIA INTEGR COMP, V45, P714
   CLOSE TJ, 1989, PLANT MOL BIOL, V13, P95, DOI 10.1007/BF00027338
   Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x
   Close TJ, 1993, CUR TOP PL, V10, P104
   Cobo F, 2006, BANCO CELULAS TEJIDO
   Collins CH, 2004, CELL BIOL INT, V28, P449, DOI 10.1016/j.cellbi.2004.03.014
   COLLINS GM, 1969, LANCET, V2, P1219
   ColmeneroFlores JM, 1997, PLANT MOL BIOL, V35, P393, DOI 10.1023/A:1005802505731
   Conrad PB, 2000, CRYOBIOLOGY, V41, P17, DOI 10.1006/cryo.2000.2260
   Cordone L, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/20/205110
   CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701
   CROWE JH, 1987, BIOCHEM J, V242, P1
   Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353
   Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.physiol.54.1.579
   CROWE JH, 1983, ARCH BIOCHEM BIOPHYS, V220, P477, DOI 10.1016/0003-9861(83)90438-1
   Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7
   CROWE LM, 1992, ADV SPACE RES-SERIES, V12, P239, DOI 10.1016/0273-1177(92)90178-Z
   Cuming AC, 1999, SEED PROTEINS, P753
   Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092
   de Castro AG, 2000, NAT BIOTECHNOL, V18, P473, DOI 10.1038/75237
   de Castro AG, 2000, FEBS LETT, V487, P199
   de Castro AG, 2000, APPL ENVIRON MICROB, V66, P4142, DOI 10.1128/AEM.66.9.4142-4144.2000
   DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962
   Dure L, 1993, CUR TOP PL, V10, P91
   Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643
   Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608
   Fahy GM, 2004, CRYOBIOLOGY, V48, P157, DOI 10.1016/j.cryobiol.2004.02.002
   Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243
   Fuller BJ, 2007, CRYOBIOLOGY, V54, P129, DOI 10.1016/j.cryobiol.2007.01.003
   Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668
   GARCIAPEREZ A, 1991, J MEMBRANE BIOL, V119, P1, DOI 10.1007/BF01868535
   Goldman E., 2009, PRACTICAL HDB MICROB
   Golovina EA, 2009, BIOPHYS J, V97, P490, DOI 10.1016/j.bpj.2009.05.007
   Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931
   Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200
   GRANGER DN, 1989, AM J PHYSIOL, V257, pG683
   Grein TA, 2010, INT J ARTIF ORGANS, V33, P370
   Guan QN, 2012, SURGERY, V151, P364, DOI 10.1016/j.surg.2011.09.032
   Guibert EE, 2011, TRANSFUS MED HEMOTH, V38, P125, DOI 10.1159/000327033
   Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616
   HAFEZ T, 2006, ADV BIOPRESERVATION, V9, P197
   Hajare A, 2009, EUR IND PHARM, V2, P16
   Han Y, 2005, CRYOBIOLOGY, V51, P152, DOI 10.1016/j.cyrobiol.2005.06.002
   Hand SC, 2006, J EXP ZOOL PART A, V305A, P1
   Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203
   Heller MC, 1999, BIOTECHNOL BIOENG, V63, P166, DOI 10.1002/(SICI)1097-0290(19990420)63:2<166::AID-BIT5>3.0.CO;2-H
   Helm RF, 2000, J BACTERIOL, V182, P974, DOI 10.1128/JB.182.4.974-982.2000
   Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P147, DOI 10.1086/658499
   Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x
   Garcia AH, 2011, J BIOSCIENCES, V36, P939, DOI 10.1007/s12038-011-9107-0
   HERSHKOVITZ N, 1991, APPL ENVIRON MICROB, V57, P645
   Hill DR, 1997, J APPL PHYCOL, V9, P237, DOI 10.1023/A:1007965229567
   Hincha DK, 2003, BBA-BIOMEMBRANES, V1612, P172, DOI 10.1016/S0005-2736(03)00116-0
   HODGE JE, 1953, J AGR FOOD CHEM, V1, P928, DOI 10.1021/jf60015a004
   Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0
   Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4
   Illing N, 2005, INTEGR COMP BIOL, V45, P771, DOI 10.1093/icb/45.5.771
   Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377
   ISRAELI E, 1993, CRYOBIOLOGY, V30, P519, DOI 10.1006/cryo.1993.1052
   Iturriaga G, 2000, AUST J BOT, V48, P153, DOI 10.1071/BT98062
   IZUTSU K, 1993, PHARMACEUT RES, V10, P1232, DOI 10.1023/A:1018988823116
   Jackson SA, 1996, DEV GROWTH DIFFER, V38, P153
   Kadam S. S., 2005, Indian Journal of Biotechnology, V4, P106
   KALAYOGLU M, 1988, LANCET, V1, P617
   KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013
   Kelly RF, 2003, ANN THORAC SURG, V75, P1705, DOI 10.1016/S0003-4975(03)00173-5
   Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649
   Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104
   KING RC, 1999, J HEART LUNG TRANSPL, V18, P320
   Klahn S, 2011, ENVIRON MICROBIOL, V13, P551, DOI 10.1111/j.1462-2920.2010.02366.x
   Koster KL, 2003, EUR BIOPHYS J BIOPHY, V32, P96, DOI 10.1007/s00249-003-0277-z
   Kranner I, 2005, INTEGR COMP BIOL, V45, P734, DOI 10.1093/icb/45.5.734
   Kreilgaard L, 1998, J PHARM SCI, V87, P1597
   Krisko A, 2010, J MOL BIOL, V402, P775, DOI 10.1016/j.jmb.2010.08.012
   Kurzawinski TR, 1994, TRANSPL INT, V7, P489
   Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7
   Lee CY, 2009, ORGANOGENESIS, V5, P105, DOI 10.4161/org.5.3.9582
   Lenne T, 2006, PHYSICA B, V385-86, P862, DOI 10.1016/j.physb.2006.05.127
   Liang P, 1997, J BIOL CHEM, V272, P19051, DOI 10.1074/jbc.272.30.19051
   Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x
   Loi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002978
   LOVELOCK JE, 1954, BIOCHEM J, V58, P618, DOI 10.1042/bj0580618
   Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007
   Magan N, 2008, BR MYCOL SY, V28, P63
   Manzanera M, 2004, APPL ENVIRON MICROB, V70, P3143, DOI 10.1128/AEM.70.5.3143-3145.2004
   Manzanera M, 2004, FEMS MICROBIOL LETT, V233, P347, DOI 10.1016/j.femsle.2004.03.005
   Manzanera M, 2002, APPL ENVIRON MICROB, V68, P4328, DOI 10.1128/AEM.68.9.4328-4333.2002
   Mascorro-Gallardo J. O., 2005, Revista Chapingo Serie Horticultura, V11, P193
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   McAnulty JF, 2010, CRYOBIOLOGY, V60, pS13, DOI 10.1016/j.cryobiol.2009.06.004
   Menze Michael A., 2009, Communicative & Integrative Biology, V2, P428
   MERYMAN HT, 1971, CRYOBIOLOGY, V8, P173, DOI 10.1016/0011-2240(71)90024-1
   MERYMAN HT, 1971, CRYOBIOLOGY, V8, P489, DOI 10.1016/0011-2240(71)90040-X
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017
   Mullen Steven F., 2007, V138, P83
   Nakahara Y, 2010, CRYOBIOLOGY, V60, P138, DOI 10.1016/j.cryobiol.2009.10.004
   Narvaez-Reinaldo JJ, 2010, APPL ENVIRON MICROB, V76, P5254, DOI 10.1128/AEM.00855-10
   NURSTEN HE, 1981, FOOD CHEM, V6, P263, DOI 10.1016/0308-8146(81)90014-5
   PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253
   Pegg David E, 2007, Methods Mol Biol, V368, P39
   PORUBCAN RS, 1979, MICROBIAL TECHNOLOGY, V1, P59
   POTTS M, 1994, MICROBIOL REV, V58, P755
   Potts M, 2005, INTEGR COMP BIOL, V45, P800, DOI 10.1093/icb/45.5.800
   Potts M, 2001, TRENDS MICROBIOL, V9, P553, DOI 10.1016/S0966-842X(01)02231-4
   Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363
   Qiu ZJ, 2008, FEBS J, V275, P3556, DOI 10.1111/j.1742-4658.2008.06501.x
   Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472
   Ramanjulu S, 2002, PLANT CELL ENVIRON, V25, P141, DOI 10.1046/j.0016-8025.2001.00764.x
   Raschke TM, 2006, CURR OPIN STRUC BIOL, V16, P152, DOI 10.1016/j.sbi.2006.03.002
   Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6
   Rebecchi Lorena, 2007, ISJ, V4, P65
   Reyes JL, 2005, PLANT CELL ENVIRON, V28, P709, DOI 10.1111/j.1365-3040.2005.01317.x
   Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009
   Rodriguez-Porrata B, 2012, J APPL MICROBIOL, V112, P512, DOI 10.1111/j.1365-2672.2011.05219.x
   Roser B., 1991, Trends in Food Science & Technology, V2, P166, DOI 10.1016/0924-2244(91)90671-5
   RUDOLPH AS, 1986, ARCH BIOCHEM BIOPHYS, V245, P134, DOI 10.1016/0003-9861(86)90197-9
   Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105
   Sandine W. E., 1996, DAIRY STARTER CULTUR, P191
   Sauer T, 1998, BIOTECHNOL BIOENG, V57, P306, DOI 10.1002/(SICI)1097-0290(19980205)57:3<306::AID-BIT7>3.3.CO;2-T
   Scott KL, 2005, TRANSFUS MED REV, V19, P127, DOI 10.1016/j.tmrv.2004.11.004
   Shih MD, 2008, ADV BOT RES, V48, P211, DOI 10.1016/S0065-2296(08)00404-7
   Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f
   Shirakashi R, 2002, J MEMBRANE BIOL, V189, P45, DOI 10.1007/s00232-1003-y
   SIZELAND PCB, 1993, KIDNEY INT, V43, P448, DOI 10.1038/ki.1993.66
   Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10
   Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018
   Solomon A, 2000, PARASITOLOGY, V121, P409, DOI 10.1017/S0031182099006563
   SOUTHARD JH, 1995, ANNU REV MED, V46, P235
   Sun WQ, 1997, COMP BIOCHEM PHYS A, V117, P327, DOI 10.1016/S0300-9629(96)00271-X
   TAKARA T, 1993, TRANSPLANT P, V25, P2999
   Tang XL, 2005, PHARM RES, V22, P1167, DOI 10.1007/s11095-005-6035-4
   Taylor MJ, 2004, LIFE IN THE FROZEN STATE, P603, DOI 10.1201/9780203647073.ch22
   Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008
   Tompa P., 2009, STRUCTURE FUNCTION I
   Tunnacliffe A, 2001, CRYOBIOLOGY, V43, P124, DOI 10.1006/cryo.2001.2356
   Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y
   Tunnacliffe A, 2010, TOP CURR GENET, V21, P91, DOI 10.1007/978-3-642-12422-8_6
   Tyson T, 2007, INT J PARASITOL, V37, P763, DOI 10.1016/j.ijpara.2006.12.015
   Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t
   Vilchez S, 2011, APPL MICROBIOL BIOT, V91, P1297, DOI 10.1007/s00253-011-3461-6
   Vilchez S, 2008, EXTREMOPHILES, V12, P297, DOI 10.1007/s00792-007-0123-9
   Wakayama T, 1998, NAT BIOTECHNOL, V16, P639, DOI 10.1038/nbt0798-639
   Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3
   Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418
   Wei L, 2009, PATHOBIOLOGY, V76, P212, DOI 10.1159/000218338
   Welsh DT, 1999, FEMS MICROBIOL LETT, V174, P57, DOI 10.1016/S0378-1097(99)00122-6
   WESTH P, 1991, J EXP ZOOL, V258, P303, DOI 10.1002/jez.1402580305
   Willsie JK, 2001, J EXP BIOL, V204, P2339
   Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195
   Wolkers WF, 1998, BBA-GEN SUBJECTS, V1379, P83, DOI 10.1016/S0304-4165(97)00085-8
   Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306
   Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688
   XIONG L, 1997, ANN THORAC SURG, V64, P795
   Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730
   Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160
   Zambelli A, 1998, ANTICANCER RES, V18, P4705
NR 200
TC 11
Z9 12
U1 0
U2 45
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
EI 1873-1899
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD NOV-DEC
PY 2012
VL 30
IS 6
BP 1641
EP 1654
DI 10.1016/j.biotechadv.2012.07.002
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 047RQ
UT WOS:000311859100039
PM 22814234
DA 2018-10-19
ER

PT J
AU Joglekar, SB
   Rose, PS
   Lewallen, DG
   Sim, FH
AF Joglekar, Siddharth B.
   Rose, Peter S.
   Lewallen, David G.
   Sim, Franklin H.
TI Tantalum Acetabular Cups Provide Secure Fixation in THA after Pelvic
   Irradiation at Minimum 5-year Followup
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; BONE LOSS; RADIATION-THERAPY; REVISION;
   COMPLICATIONS; COMPONENTS; DISCONTINUITY; BIOMATERIAL; FAILURE; CANCER
AB Background Pelvic radiation has been commonly used to treat gastrointestinal, genitourinary, or hematopoietic malignancies. Conventional THA in these patients reportedly have high rates of fixation failure. Although secure short-term fixation reportedly occurs with trabecular metal implants following pelvic radiation, it is unclear whether the fixation is durable.
   Questions/purposes We determined the survival of trabecular metal acetabular components in patients having THA following pelvic radiation and assessed function and radiographic loosening.
   Methods We retrospectively reviewed 29 patients with prior pelvic radiation who had 34 arthroplasties using trabecular metal acetabular components from 1998 and 2005. The mean pelvic radiation dose was 6300 cGy. We collected the following data: patient demographics, surgery and implant information, clinical and radiographic followup, and tumor and radiotherapy related details. We obtained Harris hip scores (HHS) on all patients. Ten patients died of disease prior to 5 years and two patients were excluded, leaving 17 patients (22 hips) with a minimum of 5 years of clinical (mean, 78 months; median, 71; range, 57-116) and radiographic (mean, 73; median, 65; range, 51-116) followup.
   Results All implants were in place in the surviving patients. The mean HHS improved from 36 preoperatively to 80 at latest followup. There were no reoperations for any reason, and we observed no implant loosening or migration at final followup in surviving or deceased patients.
   Conclusions Tantalum trabecular metal acetabular components restored function and provided durable reconstruction in patients undergoing THA following prior pelvic radiation. We observed no clinical or radiographic failures at a minimum 5-year followup.
   Level of Evidence Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
C1 [Joglekar, Siddharth B.; Rose, Peter S.; Lewallen, David G.; Sim, Franklin H.] Mayo Clin, Dept Orthoped, Rochester, MN 55902 USA.
RP Sim, FH (reprint author), Mayo Clin, Dept Orthoped, 14th Floor,Gonda Bldg,200 1st St SW, Rochester, MN 55902 USA.
EM sim.franklin@mayo.edu
CR Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BRAGG DG, 1970, RADIOLOGY, V97, P103, DOI 10.1148/97.1.103
   Cho MR, 2005, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000167671.10820.29
   DALINKA MK, 1974, SEMIN ROENTGENOL, V9, P29, DOI 10.1016/0037-198X(74)90007-8
   Davies JH, 2011, J ARTHROPLASTY, V26, P1245, DOI 10.1016/j.arth.2011.02.022
   DELEEUW HW, 1988, J BONE JOINT SURG AM, V70A, P293, DOI 10.2106/00004623-198870020-00021
   Fernandez-Fairen M, 2010, J ARTHROPLASTY, V25, P865, DOI 10.1016/j.arth.2009.07.027
   HOWLAND WJ, 1975, RADIOLOGY, V117, P677, DOI 10.1148/117.3.677
   Jacobs JJ, 1995, J BONE JOINT SURG AM, V77A, P1829, DOI 10.2106/00004623-199512000-00006
   Khanuja Harpal S, 2010, J Orthop Surg (Hong Kong), V18, P184
   Kim KI, 2007, J BONE JOINT SURG AM, V89A, P798, DOI 10.2106/JBJS.F.00183
   Kosashvili Y, 2009, J BONE JOINT SURG BR, V91B, P870, DOI 10.1302/0301-620X.91B7.22181
   Kwon JW, 2008, AM J ROENTGENOL, V191, P987, DOI 10.2214/AJR.07.3634
   MASSIN P, 1995, J BONE JOINT SURG BR, V77B, P847
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P741, DOI 10.1016/j.arth.2009.04.025
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P337, DOI 10.1016/j.arth.2009.03.003
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   PHILLIPS TW, 1989, CAN J SURG, V32, P353
   Rose PS, 2006, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000238854.16121.a3
   Sporer SM, 2006, J ARTHROPLASTY, V21, P87, DOI 10.1016/j.arth.2006.05.015
   Springer BD, 2003, J ARTHROPLASTY, V18, P126, DOI 10.1054/S0883-5403(03)00287-0
   YODER SA, 1988, CLIN ORTHOP RELAT R, P79
NR 23
TC 17
Z9 17
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD NOV
PY 2012
VL 470
IS 11
BP 3041
EP 3047
DI 10.1007/s11999-012-2382-8
PG 7
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 054TX
UT WOS:000312368200012
PM 22576931
OA Green Published
DA 2018-10-19
ER

PT J
AU Hermeto, LC
   de Rossi, R
   de Padua, SB
   Pontes, ERJ
   Santana, AE
AF Hermeto, Larissa Correa
   de Rossi, Rafael
   de Padua, Santiago Benites
   Jardim Pontes, Elenir Rose
   Santana, Aureo Evangelista
TI Comparative study between fibrin glue and platelet rich plasma in dogs
   skin grafts
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Surgical Flaps; Fibrin Tissue Adhesive; Platelet-Rich Plasma; Skin; Dogs
ID THICKNESS; SEALANT; GEL; ADHERENCE; SURVIVAL; WOUNDS; FLAPS
AB PURPOSE: Compare fibrin glue (Tissucol (R)) and platelet-rich plasma in full-thickness mesh skin grafts in dogs.
   METHODS: Eighteen dogs were used, divided into two groups: fibrin glue (FG) and platelet-rich plasma (PRP). In all the animals, a full-thickness 3x3 cm mesh skin graft was implanted. In the left limb, the biomaterial was place between the graft and the receptor bed, according to the group, while the right limb served as the control group. All the animals were evaluated clinically every 48 hours until the 14th day, using the variables of exudation, coloration, edema and cosmetic appearance. Three animals were evaluated histologically, on the third, seventh and tenth postoperative days, using the variables of fibroblasts, collagen, granulation tissue, microscopic integration-adherence and acute inflammation.
   RESULTS: Clinical evaluations showed that the group CF showed better scores for all variables compared to PRP group. On the histological evaluations PRP group had a higher presence of fibroblasts in the seventh and fourteenth days.
   CONCLUSION: The fibrin glue group was clinically superior to the platelet-rich group when used on full-thickness skin grafts in dogs.
C1 [Hermeto, Larissa Correa] UNESP, Sch Agr & Vet Sci, Postgrad Program Vet Surg, Jaboticabal, SP, Brazil.
   [de Rossi, Rafael] UFMS, Sch Vet Med & Anim Sci, Anesthesiol & Surg Unit, Dept Vet Med, Mato Grosso, MS, Brazil.
   [Jardim Pontes, Elenir Rose] UFMS, Postgrad Program Hlth & Dev, Ctr W Reg, Mato Grosso, MS, Brazil.
   [Santana, Aureo Evangelista] UNESP, Sch Agr & Vet Sci, Dept Vet Clin Med & Surg, Jaboticabal, SP, Brazil.
RP Hermeto, LC (reprint author), Rua Raposo Tavares 508, BR-79050050 Campo Grande, MS, Brazil.
EM larissa_hermeto@yahoo.com.br
RI De Padua, Santiago/B-5694-2011
OI De Padua, Santiago/0000-0003-1978-7387
CR Altmeppen J, 2004, J SURG RES, V117, P202, DOI 10.1016/j.jss.2003.10.019
   Bhanot Sumeet, 2002, Facial Plast Surg, V18, P27, DOI 10.1055/s-2002-19824
   Branski LK, 2011, BURNS, V37, P1360, DOI 10.1016/j.burns.2009.08.011
   Chen TM, 2010, DERMATOL SURG, V36, P453, DOI 10.1111/j.1524-4725.2010.01480.x
   Crovetti G, 2004, TRANSFUS APHER SCI, V30, P145, DOI 10.1016/j.transci.2004.01.004
   Erba P, 2010, J RECONSTR MICROSURG, V26, P213, DOI 10.1055/s-0030-1247716
   Foster K, 2008, J BURN CARE RES, V29, P293, DOI 10.1097/BCR.0b013e31816673f8
   Fowler D, 2006, VET CLIN N AM-SMALL, V36, P819, DOI 10.1016/j.cvsm.2006.02.004
   Gosain AK, 2002, PLAST RECONSTR SURG, V110, P1581, DOI 10.1097/01.PRS.0000033993.30838.3E
   Henkel G, 2006, ENTODAY, V1
   Jensen AR, 2008, J SURG EDUC, V65, P191, DOI 10.1016/j.jsurg.2008.03.004
   Li WW, 2012, PLAST RECONSTR SURG, V129, P858, DOI 10.1097/PRS.0b013e3182450ac9
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   McCulley SJ, 1999, BURNS, V25, P453, DOI 10.1016/S0305-4179(99)00022-4
   Mittermayr R, 2006, BURNS, V32, P305, DOI 10.1016/j.burns.2005.10.010
   Molnar JA, 2004, PLAST RECONSTR SURG, V113, P1339, DOI 10.1097/01.PRS.0000112746.67050.68
   O'Grady KM, 2000, LARYNGOSCOPE, V110, P1931, DOI 10.1097/00005537-200011000-00031
   SALTZ R, 1991, PLAST RECONSTR SURG, V88, P1005, DOI 10.1097/00006534-199112000-00009
   Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7
   Vendramin FS, 2010, REV BRAS CIR PLAST, V25, P4
NR 20
TC 4
Z9 4
U1 0
U2 18
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD NOV
PY 2012
VL 27
IS 11
BP 789
EP 794
DI 10.1590/S0102-86502012001100008
PG 6
WC Surgery
SC Surgery
GA 029ZB
UT WOS:000310536100008
PM 23117611
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Wolchok, JC
   Tresco, PA
AF Wolchok, Jeffrey C.
   Tresco, Patrick A.
TI Using growth factor conditioning to modify the properties of human cell
   derived extracellular matrix
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE biomaterial; scaffold; extracellular matrix; growth factors
ID VOCAL FOLD FIBROBLASTS; FACTOR-BETA; CONNECTIVE-TISSUE; LUNG
   FIBROBLASTS; GENE-EXPRESSION; TGF-BETA; COLLAGEN; PROLIFERATION;
   STIMULATION; BIOREACTOR
AB We have recently reported on a bench-top approach for isolating extracellular matrix (ECM) from pure populations of cells grown in culture using sacrificial, open-celled foams to concentrate and capture the ECM. To increase both the accumulation and the strength of the ECM harvested, cell-seeded polyurethane (PU) foams were cultured in media supplemented with either transforming growth factor beta-1 (TGF beta 1) or hepatocyte growth factor (HGF). At the end of a 3-week culture period, ECM yield was significantly increased for samples conditioned in supplemented media. Control foams yielded 48 +/- 12 mg of material for every gram of PU foam seeded. Yield values increased to 102 +/- 21 and 243 +/- 25 mg for HGF and TGF beta 1-treated samples, respectively. HGF supplementation increased the modulus by 59%, while TGF beta 1 treatment increased the elastic modulus by 204%. TGF beta 1-stimulated material was organized into a network that was markedly denser than control material, with HGF-stimulated network density intermediate to TGF beta 1 and controls. Our study showed that TGF beta 1-treated samples were collagen enriched while HGF samples had an increased gylcosaminoglycan concentration. The results demonstrate that growth factor supplementation, particularly with TGF beta 1, can significantly alter the biomechanical properties of cell-derived ECM that may be used for therapeutic applications. (C) 2012 American Institute of Chemical Engineers Biotechnol. Prog., 2012
C1 [Wolchok, Jeffrey C.] Univ Arkansas, Coll Engn, Dept Biomed Engn, Fayetteville, AR 72701 USA.
   [Tresco, Patrick A.] Univ Utah, Coll Engn, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA.
RP Wolchok, JC (reprint author), Univ Arkansas, Coll Engn, Dept Biomed Engn, Fayetteville, AR 72701 USA.
EM jwolchok@uark.edu
CR ALLAIRE E, 1994, J VASC SURG, V19, P446, DOI 10.1016/S0741-5214(94)70071-0
   Allaire E, 1997, SURGERY, V122, P73, DOI 10.1016/S0039-6060(97)90267-1
   Amano S, 2004, BRIT J DERMATOL, V151, P961, DOI 10.1111/j.1365-2133.2004.06175.x
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Black LD, 2008, BIOPHYS J, V94, P1916, DOI 10.1529/biophysj.107.107144
   Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874
   BURTONWURSTER N, 1990, ARCH BIOCHEM BIOPHYS, V283, P27, DOI 10.1016/0003-9861(90)90607-Z
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   FINE A, 1987, J BIOL CHEM, V262, P3897
   GRODZINSKY AJ, 1983, CRIT REV BIOMED ENG, V9, P133
   Hahn MS, 2008, ANN OTO RHINOL LARYN, V117, P371, DOI 10.1177/000348940811700508
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311
   Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P1026, DOI 10.1177/000348940311201206
   Hirano S, 2003, LARYNGOSCOPE, V113, P144, DOI 10.1097/00005537-200301000-00027
   Hoben GA, 2008, BIOTECHNOL BIOENG, V100, P587, DOI 10.1002/bit.21768
   Inagaki Y, 2008, GASTROENTEROLOGY, V134, P1180, DOI 10.1053/j.gastro.2008.01.014
   Ke QC, 2011, J TISSUE ENG REGEN M, V5, P138, DOI 10.1002/term.298
   Lasher RA, 2010, BIOTECHNOL PROGR, V26, P857, DOI 10.1002/btpr.380
   Luo Y, 2006, TISSUE ENG, V12, P3365, DOI 10.1089/ten.2006.12.3365
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   Miot S, 2006, J ORTHOP RES, V24, P1078, DOI 10.1002/jor.20098
   Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118
   NARAYANAN AS, 1989, BIOCHEM J, V260, P463, DOI 10.1042/bj2600463
   Ohya W, 2007, BRAIN RES, V1147, P51, DOI 10.1016/j.brainres.2007.02.045
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   Poehling GG, 2005, ARTHROSCOPY, V21, P774, DOI 10.1016/j.arthro.2005.04.112
   Ramos-Nino ME, 2008, AM J RESP CELL MOL, V38, P209, DOI 10.1165/rcmb.2007-0206OC
   Riboh J, 2008, J HAND SURG-AM, V33A, P1388, DOI 10.1016/j.jhsa.2008.04.019
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Throm AM, 2010, J BIOMED MATER RES A, V92A, P533, DOI 10.1002/jbm.a.32369
   VANSTEENSEL CJ, 1987, J BONE JOINT SURG AM, V69A, P860, DOI 10.2106/00004623-198769060-00010
   VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597
   VARGA J, 1986, BIOCHEM BIOPH RES CO, V138, P974, DOI 10.1016/S0006-291X(86)80591-5
   Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026
   Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5
   Wei ZS, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907745
   Wolchok JC, 2010, BIOMATERIALS, V31, P9595, DOI 10.1016/j.biomaterials.2010.08.072
   Wolchok JC, 2009, BIOMATERIALS, V30, P327, DOI 10.1016/j.biomaterials.2008.08.035
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
NR 42
TC 1
Z9 1
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
EI 1520-6033
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD NOV-DEC
PY 2012
VL 28
IS 6
BP 1581
EP 1587
DI 10.1002/btpr.1625
PG 7
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 051VX
UT WOS:000312157100024
PM 22915543
DA 2018-10-19
ER

PT J
AU Timko, BP
   Kohane, DS
AF Timko, Brian P.
   Kohane, Daniel S.
TI Materials to Clinical Devices: Technologies for Remotely Triggered Drug
   Delivery
SO CLINICAL THERAPEUTICS
LA English
DT Editorial Material
DE drug delivery; biomaterial; nanomaterial; on-demand; clinical devices
ID THERMOSENSITIVE LIPOSOMAL DOXORUBICIN; SUPERPARAMAGNETIC IRON-OXIDE;
   NANOWIRE TRANSISTOR ARRAYS; CONTROLLED-RELEASE; THERAPEUTIC
   APPLICATIONS; LOCAL-ANESTHESIA; MAGNETIC-FIELD; HIGH-FREQUENCY;
   LIVER-CANCER; NANOPARTICLES
AB Background: Technologies in which a remote trigger is used to release drug from an implanted or injected device could enable on-demand release profiles that enhance therapeutic effectiveness or reduce systemic toxicity. A number of new materials have been developed that exhibit sensitivity to light, ultrasound, or electrical or magnetic fields. Delivery systems that incorporate these materials might be triggered externally by the patient, parent or physician to provide flexible control of dose magnitude and timing.
   Objectives: To review injectable or implantable systems that are candidates for translation to the clinic, or ones that have already undergone clinical trials. Also considered are applicability in pediatrics and prospects for the future of drug delivery systems.
   Methods: We performed literature searches of the PubMed and Science Citation Index databases for articles in English that reported triggerable drug delivery devices, and for articles reporting related materials and concepts.
   Results: Approaches to remotely-triggered systems that have clinical potential were identified. Ideally, these systems have been engineered to exhibit controlled on-state release kinetics, low baseline leak rates, and reproducible dosing across multiple cycles.
   Conclusions: Advances in remotely-triggered drug delivery have been brought about by the convergence of numerous scientific and engineering disciplines, and this convergence is likely to play an important part in the current trend to develop systems that provide more than one therapeutic modality. Preclinical systems must be carefully assessed for biocompatibility, and engineered to ensure pharmacokinetics within the therapeutic window. Future drug delivery systems may incorporate additional modalities, such as closed-loop sensing or onboard power generation, enabling more sophisticated drug delivery regimens. (Clin Ther. 2012;34:S25-S35) (C) 2012 Elsevier HS Journals, Inc. All rights reserved.
C1 [Timko, Brian P.; Kohane, Daniel S.] Harvard Univ, Sch Med, Div Crit Care Med,Boston Childrens Hosp, Lab Biomat & Drug Delivery,Dept Anesthesiol, Boston, MA 02115 USA.
   [Timko, Brian P.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Kohane, DS (reprint author), Harvard Univ, Sch Med, Div Crit Care Med,Boston Childrens Hosp, Lab Biomat & Drug Delivery,Dept Anesthesiol, Boston, MA 02115 USA.
EM daniel.kohane@childrens.harvard.edu
OI Timko, Brian/0000-0002-7958-8980
FU NIGMS NIH HHS [F32GM096546, F32 GM096546, GM073626, R01 GM073626]
CR [American National Standards Institute National Standards Institute], 1993, AM NAT STAND SAF US
   Ciolino JB, 2011, INVEST OPHTH VIS SCI, V52, P6286, DOI 10.1167/iovs.10-6935
   Dvir T., 2009, NANO LETT, V10, P250
   Dvir T, 2011, NANO LETT, V11, P4411, DOI 10.1021/nl2025882
   Epstein-Barash H, 2012, ACTA BIOMATER, V8, P1703, DOI 10.1016/j.actbio.2012.01.028
   Epstein-Barash H, 2010, BIOMATERIALS, V31, P5208, DOI 10.1016/j.biomaterials.2010.03.008
   Epstein-Barash H, 2009, P NATL ACAD SCI USA, V106, P7125, DOI 10.1073/pnas.0900598106
   Farra R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003276
   Ferrara KW, 2008, ADV DRUG DELIVER REV, V60, P1097, DOI 10.1016/j.addr.2008.03.002
   Frenkel V, 2008, ADV DRUG DELIVER REV, V60, P1193, DOI 10.1016/j.addr.2008.03.007
   Hayashi K, 2010, ACS APPL MATER INTER, V2, P1903, DOI 10.1021/am100237p
   Hoare T, 2011, NANO LETT, V11, P1395, DOI 10.1021/nl200494t
   Hoare T, 2009, NANO LETT, V9, P3651, DOI 10.1021/nl9018935
   Hu SH, 2008, LANGMUIR, V24, P11811, DOI 10.1021/la801138e
   Hu SH, 2008, ADV MATER, V20, P2690, DOI 10.1002/adma.200800193
   Hu SH, 2007, MACROMOLECULES, V40, P6786, DOI 10.1021/ma0707584
   Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789
   Jeong U, 2007, ADV MATER, V19, P33, DOI 10.1002/adma.200600674
   Jesorka A, 2008, ANNU REV ANAL CHEM, V1, P801, DOI 10.1146/annurev.anchem.1.031207.112747
   Katagiri K, 2010, ACS APPL MATER INTER, V2, P768, DOI 10.1021/am900784a
   Kohane DS, 2010, CHEM SCI, V1, P441, DOI 10.1039/c0sc00203h
   Kost J., 1990, PULSED SELF REGULATE
   Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208
   Lin MM, 2008, IEEE T NANOBIOSCI, V7, P298, DOI 10.1109/TNB.2008.2011864
   Liu TY, 2009, ADV FUNCT MATER, V19, P616, DOI 10.1002/adfm.200801304
   Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662
   Muller-Schulte D, 2006, J MAGN MAGN MATER, V302, P267, DOI 10.1016/j.jmmm.2005.05.043
   Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366
   Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640
   Poon RTP, 2011, FUTURE ONCOL, V7, P937, DOI [10.2217/fon.11.73, 10.2217/FON.11.73]
   Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874, 10.1517/14656560802677874 ]
   Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107
   Santini JT, 1999, NATURE, V397, P335
   Satarkar NS, 2008, J CONTROL RELEASE, V130, P246, DOI 10.1016/j.jconrel.2008.06.008
   Schroeder A, 2009, CHEM PHYS LIPIDS, V162, P1, DOI 10.1016/j.chemphyslip.2009.08.003
   Shichor I, 2012, BIOMATERIALS, V33, P3586, DOI 10.1016/j.biomaterials.2012.01.043
   STARK DD, 1988, RADIOLOGY, V168, P297, DOI 10.1148/radiology.168.2.3393649
   Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498
   Tai LA, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/13/135101
   Thomas CR, 2010, J AM CHEM SOC, V132, P10623, DOI 10.1021/ja1022267
   Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/nmat3404, 10.1038/NMAT3404]
   Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033
   Tian B, 2009, CHEM SOC REV, V38, P16, DOI 10.1039/b718703n
   Timko BP, 2011, ANNU REV MATER RES, V41, P1, DOI 10.1146/annurev-matsci-062910-100359
   Timko BP, 2010, ADV MATER, V22, P4925, DOI 10.1002/adma.201002072
   Timko BP, 2010, IEEE T NANOTECHNOL, V9, P269, DOI 10.1109/TNANO.2009.2031807
   Timko BP, 2009, NANO LETT, V9, P914, DOI 10.1021/nl900096z
   Tong R, 2012, WILEY INTERDISC 0809
   Tong R, 2012, J AM CHEM SOC, V134, P8848, DOI 10.1021/ja211888a
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Wang ZL, 2007, MRS BULL, V32, P109, DOI 10.1557/mrs2007.42
   Weldon CB, 2012, J CONTROL RELEASE, V161, P903, DOI 10.1016/j.jconrel.2012.05.021
   Wijaya A, 2009, ACS NANO, V3, P80, DOI 10.1021/nn800702n
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
NR 55
TC 23
Z9 24
U1 0
U2 70
PU ELSEVIER
PI BRIDGEWATER
PA 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA
SN 0149-2918
J9 CLIN THER
JI Clin. Ther.
PD NOV
PY 2012
VL 34
IS 11
BP S25
EP S35
DI 10.1016/j.clinthera.2012.09.012
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 051GS
UT WOS:000312114900009
PM 23149010
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Shimizu, K
   Fukunaga, H
   Tatematsu, S
   Blajan, M
AF Shimizu, Kazuo
   Fukunaga, Hodaka
   Tatematsu, Shigeki
   Blajan, Marius
TI Atmospheric Microplasma Application for Surface Modification of
   Biomaterials
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID DIELECTRIC BARRIER DISCHARGE; POLY(TETRAFLUOROETHYLENE) FILM; PLASMA;
   PRESSURE; AIR; ACID)
AB Atmospheric microplasma has been intensively studied for applications in various fields, since in this technology the generated field is only 1 kV (approx) under atmospheric pressure and a dielectric barrier discharge gap of 10 to 100 mu m. A low discharge voltage atmospheric plasma process is an economical and effective solution for various applications such as indoor air control including sterilization, odor removal, and surface treatment, and would be suitable for medical applications in the field of plasma life sciences. In this paper, we present the application of microplasma for the surface treatment of materials used in medical fields. Moreover, a biomaterial composed of L-lactic acid is used in experiments, which can be biodecomposed in the human body after medical operations. The surface modification process was carried out with active species generated between the microplasma electrodes, which were observed by emission spectrometry. Microplasma treatment of a polymer sheet using Ar as the process gas decreased the contact angle of a water droplet at the surface of the polymer from 78.3 to 45.6 degrees in 10 s, indicating improved surface adhesive characteristics. (C) 2012 The Japan Society of Applied Physics
C1 [Shimizu, Kazuo; Fukunaga, Hodaka; Tatematsu, Shigeki; Blajan, Marius] Shizuoka Univ, Org Innovat & Social Collaborat, Hamamatsu, Shizuoka 4328561, Japan.
RP Shimizu, K (reprint author), Shizuoka Univ, Org Innovat & Social Collaborat, Hamamatsu, Shizuoka 4328561, Japan.
EM shimizu@cjr.shizuoka.ac.jp
CR Babaeva NY, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/18/185206
   Bhoj AN, 2005, IEEE T PLASMA SCI, V33, P250, DOI 10.1109/TPS.2005.845899
   Burgassi S, 2009, J APPL MICROBIOL, V106, P1715, DOI 10.1111/j.1365-2672.2008.04141.x
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   Chen W, 2008, APPL SURF SCI, V254, P2882, DOI 10.1016/j.apsusc.2007.10.029
   Cui NY, 2002, APPL SURF SCI, V189, P31, DOI 10.1016/S0169-4332(01)01035-2
   De Geyter N, 2007, SURF COAT TECH, V201, P7066, DOI 10.1016/j.surfcoat.2007.01.008
   Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154
   Gray JE, 2005, THIN SOLID FILMS, V484, P196, DOI 10.1016/j.tsf.2005.01.090
   Gweon B, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3622631
   Hibert C, 1999, J APPL PHYS, V85, P7070, DOI 10.1063/1.370514
   Hury S, 1998, LETT APPL MICROBIOL, V26, P417
   Iseki S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694928
   Kogelschatz U, 2007, CONTRIB PLASM PHYS, V47, P80, DOI 10.1002/ctpp.200710012
   Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012
   Kuwahata H, 2010, E-J SURF SCI NANOTEC, V8, P381, DOI 10.1380/ejssnt.2010.381
   Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016
   Lerouge S, 2000, J BIOMED MATER RES, V51, P128, DOI 10.1002/(SICI)1097-4636(200007)51:1<128::AID-JBM17>3.3.CO;2-R
   Malik MA, 2001, PLASMA SOURCES SCI T, V10, P82, DOI 10.1088/0963-0252/10/1/311
   Okamura Y, 2009, ADV MATER, V21, P4388, DOI 10.1002/adma.200901035
   Pascual M, 2008, J MATER SCI, V43, P4901, DOI 10.1007/s10853-008-2712-0
   Rossi F, 2006, PLASMA PROCESS POLYM, V3, P431, DOI 10.1002/ppap.200600011
   Shi TN, 2011, APPL SURF SCI, V258, P1474, DOI 10.1016/j.apsusc.2011.09.110
   Shimizu K, 2011, PHARM ANAL ACTA, VS1
   Shimizu K, 2008, IEEE T IND APPL, V44, P462, DOI 10.1109/TIA.2008.916738
   Shimizu K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08KA03
   Shimizu K, 2010, IEEE T IND APPL, V46, P1125, DOI 10.1109/TIA.2010.2044968
   Singh MK, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115027
   Tachibana K, 2006, IEEJ T ELECTR ELECTR, V1, P145, DOI 10.1002/tee.20031
   Tanino M., 2005, 40 IND APPL C IAS, V2, P784
NR 30
TC 3
Z9 3
U1 0
U2 26
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0021-4922
EI 1347-4065
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD NOV
PY 2012
VL 51
IS 11
SI SI
AR 11PJ01
DI 10.1143/JJAP.51.11PJ01
PN 2
PG 4
WC Physics, Applied
SC Physics
GA 049RP
UT WOS:000312001400047
DA 2018-10-19
ER

PT J
AU Ricklin, D
AF Ricklin, Daniel
TI Manipulating the mediator: Modulation of the alternative complement
   pathway C3 convertase in health, disease and therapy
SO IMMUNOBIOLOGY
LA English
DT Review
DE Complement; Complement-targeted therapeutics; Convertase; Immune
   evasion; Innate immunity; Regulators of complement activation
ID PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; HEMOLYTIC-UREMIC SYNDROME;
   FACTOR-H; STAPHYLOCOCCUS-AUREUS; STRUCTURAL BASIS; IMMUNE EVASION;
   PROTEIN FAMILY; COMPONENT C3; NEISSERIA-MENINGITIDIS;
   CONFORMATIONAL-CHANGES
AB The complement network is increasingly recognized as an important triage system that is able to differentiate between healthy host cells, microbial intruders, cellular debris and immune complexes, and tailor its actions accordingly. At the center of this triage mechanism is the alternative pathway C3 convertase (C3bBb), a potent enzymatic protein complex capable of rapidly converting the inert yet abundant component 0 into powerful effector fragments (C3a and C3b), thereby amplifying the initial response on unprotected surfaces and inducing a variety of effector functions. A fascinating molecular mechanism of convertase assembly and intrinsic regulation, as well as the interplay with a panel of cell surface-bound and soluble inhibitors are essential for directing complement attack to intruders and protecting healthy host cells. While efficiently keeping immune surveillance and homeostasis on track, the reliance on an intricate cascade of interaction and conversion steps also renders the C3 convertase vulnerable to derail. On the one hand, tissue damage, accumulation of debris, or polymorphisms in complement genes may unfavorably shift the balance between activation and regulation, thereby contributing to a variety of clinical conditions. On the other hand, pathogens developed powerful evasion strategies to avoid complement attack by targeting the convertase. Finally, we increasingly challenge our bodies with foreign materials such as biomaterial implants or drug delivery vehicles that may induce adverse effects that are at least partially caused by complement activation and amplification via the alternative pathway. The involvement of the C3 convertase in a range of pathological conditions put this complex into the spotlight of complement-targeted drug discovery efforts. Fortunately, the physiological regulation and microbial evasion approaches provide a rich source of inspiration for the development of powerful treatment options. This review provides insight into the current knowledge about the molecular mechanisms that drive C3 convertase activity, reveals common and divergent strategies of convertase inhibition employed by host and pathogens, and how this inhibitory arsenal can be tapped for developing therapeutic options to treat complement-related diseases. (C) 2012 Elsevier GmbH. All rights reserved.
C1 [Ricklin, Daniel] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Ricklin, D (reprint author), 401 Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA.
EM ricklin@upenn.edu
RI Ricklin, Daniel/F-5104-2011
OI Ricklin, Daniel/0000-0001-6140-0233
FU National Institutes of Health [AI030040, AI068730, GM062134, EY020633,
   AI097805]
FX This work was supported by National Institutes of Health grants
   AI030040, AI068730, GM062134, EY020633 and AI097805.
CR Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025
   Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029
   Bray BL, 2003, NAT REV DRUG DISCOV, V2, P587, DOI 10.1038/nrd1133
   Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x
   Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107
   Chi ZL, 2010, ADV EXP MED BIOL, V703, P127, DOI 10.1007/978-1-4419-5635-4_9
   DiLillo DJ, 2006, MOL IMMUNOL, V43, P1010, DOI 10.1016/j.molimm.2005.05.003
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   FEARON DT, 1973, J EXP MED, V138, P1305, DOI 10.1084/jem.138.6.1305
   Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821
   Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646
   Garcia BL, 2012, J BIOL CHEM, V287, P628, DOI 10.1074/jbc.M111.298984
   Garcia BL, 2012, ADV EXP MED BIOL, V946, P113, DOI 10.1007/978-1-4614-0106-3_7
   Garcia BL, 2010, J MOL BIOL, V402, P17, DOI 10.1016/j.jmb.2010.07.029
   Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18
   Ghebremariam YT, 2010, J SURG RES, V159, P747, DOI 10.1016/j.jss.2009.04.049
   Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231
   Gustafsson E, 2009, PROTEIN EXPRES PURIF, V63, P95, DOI 10.1016/j.pep.2008.09.017
   Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200
   Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450
   Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x
   Haspel N, 2008, PROTEIN SCI, V17, P1894, DOI 10.1110/ps.036624.108
   Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250
   Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x
   Ioannou A, 2011, CLIN IMMUNOL, V141, P3, DOI 10.1016/j.clim.2011.07.001
   Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200
   Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172
   Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005
   Jha P, 2003, J BIOSCIENCES, V28, P265, DOI 10.1007/BF02970146
   Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818
   Jongerius I, 2010, J IMMUNOL, V184, P420, DOI 10.4049/jimmunol.0902865
   Jongerius I, 2009, ADV EXP MED BIOL, V666, P32
   Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108
   Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082
   Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200
   Knerr PJ, 2011, ACS CHEM BIOL, V6, P753, DOI 10.1021/cb2000378
   Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051
   Laarman A, 2010, J MOL MED-JMM, V88, P115, DOI 10.1007/s00109-009-0572-y
   Laarman AJ, 2011, J IMMUNOL, V186, P6445, DOI 10.4049/jimmunol.1002948
   Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824
   Lapeyraque AL, 2008, PEDIATR NEPHROL, V23, P1363, DOI 10.1007/s00467-008-0803-4
   Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341
   Lazar H.L., 2007, CIRCULATION, V116, P183
   Le Friec G, 2009, ARCH IMMUNOL THER EX, V57, P393, DOI 10.1007/s00005-009-0047-4
   Li B, 2009, J BIOL CHEM, V284, P35605, DOI 10.1074/jbc.M109.035170
   Li Jennifer S, 2006, Expert Rev Cardiovasc Ther, V4, P649, DOI 10.1586/14779072.4.5.649
   Licht C, 2005, AM J KIDNEY DIS, V45, P415, DOI 10.1053/j.ajkd.2004.10.018
   Lindorfer MA, 2010, BLOOD, V115, P2283, DOI 10.1182/blood-2009-09-244285
   Magotti P, 2009, J MOL RECOGNIT, V22, P495, DOI 10.1002/jmr.972
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x
   Martinez-Barricarte R, 2010, J CLIN INVEST, V120, P3702, DOI 10.1172/JCI43343
   Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018
   MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321
   MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003
   Mullick J, 2003, TRENDS IMMUNOL, V24, P500, DOI 10.1016/S1471-4906(03)00207-2
   Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson P.H., AUTOREGULATION UNPUB
   NILSSON UR, 1992, ARTHRITIS RHEUM, V35, P580, DOI 10.1002/art.1780350516
   Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104
   Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x
   Qu H., 2012, IMMUNOBIOLOGY
   Qu HC, 2011, MOL IMMUNOL, V48, P481, DOI 10.1016/j.molimm.2010.10.004
   Qu H, 2009, MOL IMMUNOL, V47, P185, DOI 10.1016/j.molimm.2009.08.032
   Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x
   Ricklin D., 2012, ADV EXP MED BIOL
   Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20
   Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443
   Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463
   Risitano AM, 2011, MINI-REV MED CHEM, V11, P528
   Risitano AM, 2012, BLOOD, V119, P6307, DOI 10.1182/blood-2011-12-398792
   de Cordoba S, 2011, BBA-MOL BASIS DIS, V1812, P12, DOI 10.1016/j.bbadis.2010.09.002
   Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756
   Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108
   Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225
   Schmidt C.Q., RATIONAL ENG N UNPUB
   Schmidt CQ, 2011, PROTEIN EXPRES PURIF, V76, P254, DOI 10.1016/j.pep.2010.12.002
   Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566
   Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769
   SCHREIBER RD, 1978, P NATL ACAD SCI USA, V75, P3948, DOI 10.1073/pnas.75.8.3948
   Schuster MC, 2008, MOL IMMUNOL, V45, P3142, DOI 10.1016/j.molimm.2008.03.010
   Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366
   Sfyroera G, 2010, MOL IMMUNOL, V47, P2289, DOI 10.1016/j.molimm.2010.05.268
   Sharp JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038407
   Silasi-Mansat R, 2010, BLOOD, V116, P1002, DOI 10.1182/blood-2010-02-269746
   Smith EJ, 2011, INFECT IMMUN, V79, P3801, DOI 10.1128/IAI.05075-11
   Smith RAG, 2002, BIOCHEM SOC T, V30, P1037, DOI 10.1042/bst0301037
   Thurman JM, 2005, MOL IMMUNOL, V42, P87, DOI 10.1016/j.molimm.2004.07.043
   van der Pals J, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-45
   Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003
   Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009
   Ward PA, 2009, J CELL MOL MED, V13, P4154, DOI 10.1111/j.1582-4934.2009.00893.x
   Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449
   Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526
   Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263
   Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Yehoshua Z, 2011, SEMIN OPHTHALMOL, V26, P167, DOI 10.3109/08820538.2011.577132
NR 101
TC 23
Z9 24
U1 0
U2 27
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD NOV
PY 2012
VL 217
IS 11
BP 1057
EP 1066
DI 10.1016/j.imbio.2012.07.016
PG 10
WC Immunology
SC Immunology
GA 038PY
UT WOS:000311187800005
PM 22964231
OA Green Accepted
DA 2018-10-19
ER

PT J
AU DeAngelis, RA
   Reis, ES
   Ricklin, D
   Lambris, JD
AF DeAngelis, Robert A.
   Reis, Edimara S.
   Ricklin, Daniel
   Lambris, John D.
TI Targeted complement inhibition as a promising strategy for preventing
   inflammatory complications in hemodialysis
SO IMMUNOBIOLOGY
LA English
DT Review
DE Complement; Hemodialysis; Inflammation; Therapeutics; Innate immunity
ID NECROSIS-FACTOR-ALPHA; COATED CARDIOPULMONARY BYPASS; MODEL BIOMATERIAL
   SURFACE; HUMAN C4B-BINDING PROTEIN; STREPTOCOCCAL M-PROTEIN; CHRONIC
   KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; FACTOR-H; ALTERNATIVE PATHWAY;
   DIALYSIS PATIENTS
AB Hemodialysis is the most common method used to remove waste and hazardous products of metabolism in patients suffering from renal failure. Hundreds of thousands of people with end-stage renal disease undergo hemodialysis treatment in the United States each year. Strikingly, the 5-year survival rate for all dialysis patients is only 35%. Most of the patients succumb to cardiovascular disease that is exacerbated by the chronic induction of inflammation caused by contact of the blood with the dialysis membrane. The complement system, a strong mediator of pro-inflammatory networks, is a key contributor to such biomaterial-induced inflammation. Though only evaluated in experimental ex vivo settings, specific targeting of complement activation during hemodialysis has uncovered valuable information that points toward the therapeutic use of complement inhibitors as a means to control the unwelcomed inflammatory responses and consequent pathologies in hemodialysis patients. (C) 2012 Elsevier GmbH. All rights reserved.
C1 [DeAngelis, Robert A.; Reis, Edimara S.; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Lambris, JD (reprint author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM lambris@upenn.edu
RI Ricklin, Daniel/F-5104-2011
OI Ricklin, Daniel/0000-0001-6140-0233; Lambris, John/0000-0002-9370-5776
FU NIH [AI068730, AI30040, EY020633, GM097747]
FX This work was funded by NIH (Grant Nos. AI068730, AI30040, and EY020633
   and GM097747).
CR Acosta J, 2000, P NATL ACAD SCI USA, V97, P5450, DOI 10.1073/pnas.97.10.5450
   Agalou S, 2005, J AM SOC NEPHROL, V16, P1471, DOI 10.1681/ASN.2004080635
   AGOSTONI A, 1980, NEW ENGL J MED, V303, P527
   Alcon Research, 2012, EV AL 78898A EX AG R
   Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678
   Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   AUSTIN GE, 1987, CLIN CHEM, V33, P2220
   Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903
   Bologa RM, 1998, AM J KIDNEY DIS, V32, P107, DOI 10.1053/ajkd.1998.v32.pm9669431
   Bray BL, 2003, NAT REV DRUG DISCOV, V2, P587, DOI 10.1038/nrd1133
   Caglar K, 2002, KIDNEY INT, V62, P1408, DOI 10.1111/j.1523-1755.2002.kid556.x
   Caliezi C, 2000, PHARMACOL REV, V52, P91
   CANIVET E, 1994, AM J KIDNEY DIS, V23, P41, DOI 10.1016/S0272-6386(12)80810-9
   Cano NJM, 2007, J AM SOC NEPHROL, V18, P2583, DOI 10.1681/ASN.2007020184
   CAVAILLON JM, 1992, NEPHRON, V60, P307, DOI 10.1159/000186770
   Cavalli A, 2010, MINERVA UROL NEFROL, V62, P1
   Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107
   Cheng Y, 2005, CELL MOL IMMUNOL, V2, P313
   CHENOWETH DE, 1983, KIDNEY INT, V24, P764, DOI 10.1038/ki.1983.225
   CHEUNG AK, 1989, KIDNEY INT, V36, P257, DOI 10.1038/ki.1989.188
   CHEUNG AK, 1990, J AM SOC NEPHROL, V1, P150
   Chi ZL, 2010, ADV EXP MED BIOL, V703, P127, DOI 10.1007/978-1-4419-5635-4_9
   CRADDOCK PR, 1977, NEW ENGL J MED, V296, P769, DOI 10.1056/NEJM197704072961401
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   Cronin RE, 2010, SEMIN DIALYSIS, V23, P510, DOI 10.1111/j.1525-139X.2010.00770.x
   Davenport A, 2010, MINERVA UROL NEFROL, V62, P29
   Davenport A, 2011, NAT REV NEPHROL, V7, P499, DOI 10.1038/nrneph.2011.88
   DAVID S, 1993, NEPHROL DIAL TRANSPL, V8, P1223
   Davies CS, 2005, IMMUNOLOGY, V114, P280, DOI 10.1111/j.1365-2567.2004.02086.x
   De Serres J, 2003, TRANSFUS APHER SCI, V29, P247, DOI 10.1016/j.transci.2003.08.006
   DEPPISCH R, 1990, KIDNEY INT, V37, P696, DOI 10.1038/ki.1990.36
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   ENGELBERTS I, 1994, NEPHRON, V66, P396, DOI 10.1159/000187853
   Fujimori A, 1998, ARTIF ORGANS, V22, P1014, DOI 10.1046/j.1525-1594.1998.06083.x
   Galli F, 2007, NEPHROL DIAL TRANSPL, V22, P20, DOI 10.1093/ndt/gfm294
   Girndt M, 1999, NEPHROL DIAL TRANSPL, V14, P676, DOI 10.1093/ndt/14.3.676
   Grooteman MPC, 1997, J AM SOC NEPHROL, V8, P1745
   HAEFFNERCAVAILLON N, 1993, KIDNEY INT, V43, pS139
   Hair PS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-35
   HAKIM RM, 1993, KIDNEY INT, V44, P484, DOI 10.1038/ki.1993.272
   HAUBITZ M, 1990, NEPHROL DIAL TRANSPL, V5, P500, DOI 10.1093/ndt/5.7.500
   Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250
   HAUSER AC, 1990, CLIN SCI, V79, P471, DOI 10.1042/cs0790471
   HERBELIN A, 1991, KIDNEY INT, V39, P954, DOI 10.1038/ki.1991.120
   HERBELIN A, 1990, KIDNEY INT, V37, P116, DOI 10.1038/ki.1990.16
   Hezmee MNM, 2012, VET J, V192, P264, DOI 10.1016/j.tvjl.2011.12.008
   Himmelifarb J, 2007, J RENAL NUTR, V17, P296, DOI 10.1053/j.jrn.2007.05.011
   Holland M Claire H, 2004, Curr Opin Investig Drugs, V5, P1164
   Hung AM, 2011, J AM SOC NEPHROL, V22, P437, DOI 10.1681/ASN.2010070760
   Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163
   Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200
   Jenkins HT, 2006, J BIOL CHEM, V281, P3690, DOI 10.1074/jbc.M511563200
   Kaizu Y, 1998, AM J KIDNEY DIS, V31, P93, DOI 10.1053/ajkd.1998.v31.pm9428458
   Katragadda M, 2006, J MED CHEM, V49, P4616, DOI 10.1021/jm0603419
   Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x
   Kirschfink M, 2001, Expert Opin Pharmacother, V2, P1073, DOI 10.1517/14656566.2.7.1073
   Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027
   Koehl J, 2006, CURR OPIN MOL THER, V8, P529
   Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051
   Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824
   Lappegard KT, 2008, J BIOMED MATER RES A, V87A, P129, DOI 10.1002/jbm.a.31750
   Lappegard KT, 2004, ANN THORAC SURG, V77, P932, DOI 10.1016/S0003-4975(03)01519-4
   Lauterbach M, 2007, SHOCK, V27, P75, DOI 10.1097/01.shk.0000235093.83915.0b
   Lazar HL, 2007, CIRCULATION, V116, pI83, DOI 10.1161/CIRCULATIONAHA.106.677914
   Lazar HL, 2004, CIRCULATION, V110, pII274, DOI 10.1161/01.CIR.0000138315.99788.eb
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60
   Longhurst HJ, 2007, CLIN EXP IMMUNOL, V147, P11, DOI 10.1111/j.1365-2249.2006.03256.x
   LONNEMANN G, 1987, LYMPHOKINE RES, V6, P63
   Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501
   Magotti P, 2009, J MOL RECOGNIT, V22, P495, DOI 10.1002/jmr.972
   Mares J, 2010, PROTEOM CLIN APPL, V4, P829, DOI 10.1002/prca.201000031
   Mares J, 2009, KIDNEY INT, V76, P404, DOI 10.1038/ki.2009.138
   Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x
   MEGE JL, 1994, NEPHROL DIAL TRANSPL, V9, P1606
   Memoli B, 2000, KIDNEY INT, V58, P417, DOI 10.1046/j.1523-1755.2000.00181.x
   Moen O, 1997, ANN THORAC SURG, V63, P105
   MOLLNES TE, 1995, ARTIF ORGANS, V19, P909, DOI 10.1111/j.1525-1594.1995.tb02450.x
   Nielsen EW, 2007, MOL IMMUNOL, V44, P1819, DOI 10.1016/j.molimm.2006.10.003
   NIEMANN MA, 1991, BIOCHEM J, V274, P473, DOI 10.1042/bj2740473
   Nilsson B, 1998, BLOOD, V92, P1661
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson UR, 2001, MOL IMMUNOL, V38, P151, DOI 10.1016/S0161-5890(01)00039-6
   NKUDIC, 2012, KIDN UR DIS STAT US
   Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x
   PENSKY J, 1961, J BIOL CHEM, V236, P1674
   Pereira B J, 1997, Semin Dial, V10, P61, DOI 10.1111/j.1525-139X.1997.tb00466.x
   Pereira B.J., 1997, KIDNEY INT, V1996, P566
   PEREIRA BJG, 1994, KIDNEY INT, V45, P890, DOI 10.1038/ki.1994.117
   Persson J, 2006, PLOS PATHOG, V2, P442, DOI 10.1371/journal.ppat.0020047
   Pupim LB, 2004, KIDNEY INT, V65, P2371, DOI 10.1111/j.1523-1755.2004.00656.x
   Qu H., 2012, IMMUNOBIOLOGY
   Qu HC, 2011, MOL IMMUNOL, V48, P481, DOI 10.1016/j.molimm.2010.10.004
   Qu H, 2009, MOL IMMUNOL, V47, P185, DOI 10.1016/j.molimm.2009.08.032
   Rao M, 2005, AM J KIDNEY DIS, V45, P324, DOI 10.1053/j.ajkd.2004.09.018
   Ricklin D., 2012, ADV EXP MED IN PRESS
   Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20
   Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Risitano AM, 2011, MINI-REV MED CHEM, V11, P528
   Sahu A, 2003, MOL IMMUNOL, V39, P557, DOI 10.1016/S0161-5890(02)00212-2
   Schindler R, 2000, CLIN NEPHROL, V53, P452
   Schmidt S, 2003, J BIOMED MATER RES A, V66A, P491, DOI 10.1002/jbm.a.10031
   Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566
   Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769
   Schouten WEM, 2000, NEPHROL DIAL TRANSPL, V15, P379, DOI 10.1093/ndt/15.3.379
   Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182
   Silasi-Mansat R, 2010, BLOOD, V116, P1002, DOI 10.1182/blood-2010-02-269746
   Silverstein DM, 2009, PEDIATR NEPHROL, V24, P1445, DOI 10.1007/s00467-008-1046-0
   Soulika AM, 2000, CLIN IMMUNOL, V96, P212, DOI 10.1006/clim.2000.4903
   Stenvinkel P, 2002, SEMIN DIALYSIS, V15, P329, DOI 10.1046/j.1525-139X.2002.00083.x
   Stenvinkel P, 2006, CLIN J AM SOC NEPHRO, V1, P281, DOI 10.2215/CJN.01281005
   Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466
   THERN A, 1995, J IMMUNOL, V154, P375
   Thiara AS, 2011, PERFUSION-UK, V26, P107, DOI 10.1177/0267659110392438
   Thornalley PJ, 2011, FREE RADICAL RES, V45, P89, DOI 10.3109/10715762.2010.534162
   Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763
   Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109
   THORNALLEY PJ, 2006, REDOX PROTEOMICS, P681
   Uda S, 2011, CONTRIB NEPHROL, V173, P23, DOI 10.1159/000328941
   Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009
   Wagenaar-Bos IGA, 2006, IMMUNOL ALLERGY CLIN, V26, P615, DOI 10.1016/j.iac.2006.08.004
   Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545
   Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Yao Q, 2004, ASAIO J, V50, pLII, DOI 10.1097/01.MAT.0000147958.87989.EB
   Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9
   Zhang QB, 2011, J PROTEOME RES, V10, P3076, DOI 10.1021/pr200040j
   Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x
   Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620
NR 136
TC 25
Z9 26
U1 1
U2 18
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD NOV
PY 2012
VL 217
IS 11
BP 1097
EP 1105
DI 10.1016/j.imbio.2012.07.012
PG 9
WC Immunology
SC Immunology
GA 038PY
UT WOS:000311187800009
PM 22964235
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Nilsson, B
   Ekdahl, KN
AF Nilsson, Bo
   Ekdahl, Kristina Nilsson
TI The tick-over theory revisited: Is C3 a contact-activated protein?
SO IMMUNOBIOLOGY
LA English
DT Review
DE Blood interfaces; C3; C3(H2O); Contact activation; Surface interaction;
   Thioester; Tick-over
ID ALTERNATIVE COMPLEMENT PATHWAY; PRIMARY BILIARY-CIRRHOSIS; SODIUM
   DODECYL-SULFATE; CARDIOPULMONARY BYPASS; CONFORMATIONAL-CHANGES;
   MONOCLONAL-ANTIBODIES; PUTATIVE THIOESTER; POLYMER SURFACE; 3RD
   COMPONENT; BINDING
AB The tick-over theory was first introduced in the 1970s to explain the presence of the initial C3b molecules, which are able to trigger complement activation by the alternative pathway in human plasma under physiological conditions. After the identification of the thioester, the predominant hypothesis has been that this bond is hydrolyzed at a slow but constant rate by nucleophilic attack by H2O, leading to the generation of C3(H2O).
   Here we put forward the hypothesis that the rate of hydrolysis of C3 to C3(H2O) may be greatly accelerated by the interaction between C3 and a number of biological and artificial interfaces, including gas bubbles, biomaterial surfaces and different lipid surfaces and complexes. We therefore propose that C3 should preferentially be regarded as a contact activated protein rather than a target for passive, random hydrolysis in the fluid phase. (C) 2012 Elsevier GmbH. All rights reserved.
C1 [Nilsson, Bo; Ekdahl, Kristina Nilsson] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab C5 3, SE-75185 Uppsala, Sweden.
   [Ekdahl, Kristina Nilsson] Linnaeus Univ, Sch Nat Sci, SE-39182 Kalmar, Sweden.
RP Nilsson, B (reprint author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab C5 3, SE-75185 Uppsala, Sweden.
EM Bo.Nilsson@igp.uu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
FU Swedish Research Council (VR) [2009-4675, 2009-4462]; Linnaeus
   University
FX We thank Prof Ulf R. Nilsson for valuable contributions and discussions
   over the years concerning the presented concept and Dr. Deborah
   McClellan for excellent editorial assistance. This work was supported by
   grants from the Swedish Research Council (VR) 2009-4675, 2009-4462, and
   by faculty grants from the Linnaeus University.
CR Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   ATKINSON JP, 1987, IMMUNOL TODAY, V8, P212, DOI 10.1016/0167-5699(87)90167-8
   Barak V, 2009, J AUTOIMMUN, V33, P178, DOI 10.1016/j.jaut.2009.09.010
   Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003
   del Conde I, 2005, J EXP MED, V201, P871, DOI 10.1084/jem.20041497
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   FEARON DT, 1973, J EXP MED, V138, P1305, DOI 10.1084/jem.138.6.1305
   FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856
   FEARON DT, 1977, P NATL ACAD SCI USA, V74, P1683, DOI 10.1073/pnas.74.4.1683
   FEY GH, 1984, PHILOS T ROY SOC B, V306, P333, DOI 10.1098/rstb.1984.0094
   Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231
   Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810
   Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x
   JANATOVA J, 1980, BIOCHEMISTRY-US, V19, P4471
   Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172
   Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005
   Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2
   LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701
   LAW SKA, 1981, BIOCHEMISTRY-US, V20, P7457, DOI 10.1021/bi00529a020
   NICHOLSONWELLER A, 1982, J IMMUNOL, V129, P184
   NICOL PAE, 1973, IMMUNOLOGY, V24, P259
   NILSSON B, 1986, INT ARCH ALLER A IMM, V80, P312, DOI 10.1159/000234071
   NILSSON B, 1990, BIOCHEM J, V268, P55, DOI 10.1042/bj2680055
   NILSSON B, 1986, IMMUNOL LETT, V13, P11, DOI 10.1016/0165-2478(86)90118-5
   NILSSON B, 1987, MOL IMMUNOL, V24, P487, DOI 10.1016/0161-5890(87)90023-X
   NILSSON B, 1985, SCAND J IMMUNOL, V22, P703, DOI 10.1111/j.1365-3083.1985.tb01933.x
   NILSSON B, 1992, BIOCHEM J, V282, P715, DOI 10.1042/bj2820715
   NILSSON B, 1987, J CLIN IMMUNOL, V7, P420, DOI 10.1007/BF00917020
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   NILSSON UR, 1982, J IMMUNOL, V129, P2594
   NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L
   PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102
   PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257
   PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856
   Peerschke EIB, 2006, J THROMB HAEMOST, V4, P2035, DOI 10.1111/j.1538-7836.2006.02065.x
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   PEKNA M, 1994, ANN THORAC SURG, V58, P421, DOI 10.1016/0003-4975(94)92219-5
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600
   TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764
   WHALEY K, 1978, IMMUNOLOGY, V35, P1045
NR 42
TC 53
Z9 54
U1 0
U2 14
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD NOV
PY 2012
VL 217
IS 11
BP 1106
EP 1110
DI 10.1016/j.imbio.2012.07.008
PG 5
WC Immunology
SC Immunology
GA 038PY
UT WOS:000311187800010
PM 22964236
DA 2018-10-19
ER

PT J
AU Ludviksen, JKA
   Hovland, A
   Lappegard, KT
   Mollnes, TE
AF Ludviksen, Judith Krey A.
   Hovland, Anders
   Lappegard, Knut T.
   Mollnes, Tom E.
TI Evidence of classical complement activation during blood-biomaterial
   interaction in LDL apheresis
SO IMMUNOBIOLOGY
LA English
DT Meeting Abstract
C1 [Ludviksen, Judith Krey A.] Nordland Hosp, Res Lab, Bodo, Norway.
   [Hovland, Anders; Lappegard, Knut T.] Nordland Hosp, Div Internal Med, Bodo, Norway.
   [Hovland, Anders; Lappegard, Knut T.] Univ Tromso, Inst Clin Med, N-9001 Tromso, Norway.
   [Mollnes, Tom E.] Univ Tromso, Inst Med Biol, N-9001 Tromso, Norway.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD NOV
PY 2012
VL 217
IS 11
MA 112
BP 1168
EP 1168
DI 10.1016/j.imbio.2012.08.114
PG 1
WC Immunology
SC Immunology
GA 038PY
UT WOS:000311187800126
DA 2018-10-19
ER

PT J
AU Kourtzelis, I
   Rafail, S
   DeAngelis, RA
   Foukas, PG
   Ricklin, D
   Lambris, JD
AF Kourtzelis, Ioannis
   Rafail, Stavros
   DeAngelis, Robert A.
   Foukas, Periklis G.
   Ricklin, Daniel
   Lambris, John D.
TI Inhibition of biomaterial-induced complement activation attenuates the
   inflammatory host response to implantation
SO IMMUNOBIOLOGY
LA English
DT Meeting Abstract
C1 [Kourtzelis, Ioannis; Rafail, Stavros; DeAngelis, Robert A.; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Kourtzelis, Ioannis] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece.
   [Foukas, Periklis G.] Univ Athens, Sch Med, Attikon Univ Hosp, GR-11527 Athens, Greece.
RI Ricklin, Daniel/F-5104-2011
OI Ricklin, Daniel/0000-0001-6140-0233
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD NOV
PY 2012
VL 217
IS 11
MA 142
BP 1179
EP 1179
DI 10.1016/j.imbio.2012.08.144
PG 1
WC Immunology
SC Immunology
GA 038PY
UT WOS:000311187800156
OA Green Published
DA 2018-10-19
ER

PT J
AU Purcell, EK
   Naim, Y
   Yang, A
   Leach, MK
   Velkey, JM
   Duncan, RK
   Corey, JM
AF Purcell, Erin K.
   Naim, Youssef
   Yang, Amy
   Leach, Michelle K.
   Velkey, J. Matthew
   Duncan, R. Keith
   Corey, Joseph M.
TI Combining Topographical and Genetic Cues to Promote Neuronal Fate
   Specification in Stem Cells
SO BIOMACROMOLECULES
LA English
DT Review
ID NEURAL PROGENITOR CELLS; DORSAL-ROOT GANGLIA; EXTRACELLULAR-MATRIX; DNA
   DELIVERY; ELECTROSPUN NANOFIBERS; NERVE REGENERATION; NEURITE EXTENSION;
   IN-VITRO; DIFFERENTIATION; SCAFFOLDS
AB There is little remedy for the devastating,effects resulting from neuronal loss caused by neural injury or neurodegenerative disease. Reconstruction of damaged, neural circuitry with stem cell-derived neurons is a promising approach to repair these defects, but controlling differentiation and guiding synaptic integration with :existing neurons remain significant unmet Challenges. Biomaterial surfaces can present nanoscale topographical Cues that influence neuronal differentiation and process outgrowth: By combining these scaffolds with additional molecular biology strategies, synergistic control over,cell fate can be achieved: Here, we review recent progress in promoting, neuronal fate using techniques at the interface of biomaterial:science and genetic engineering. New data demonstrates that combining nanofiber topography With an induced genetic program. enhances neuritogenesis in a synergistic. fashion: We propose combining patterned biomaterial surface cues with prescribed genetic programs to achieve neuronal cell fates: with the desired sublineage specification, neurochemical profile, targeted integration, and electrophysiological properties.
C1 [Purcell, Erin K.; Naim, Youssef; Yang, Amy; Leach, Michelle K.; Velkey, J. Matthew; Duncan, R. Keith; Corey, Joseph M.] Univ Michigan, Ann Arbor, MI 48109 USA.
RP Purcell, EK (reprint author), Michigan State Univ, Neural Syst Engn Lab, 2153 Engn Bldg,428 S Shaw Lane, E Lansing, MI 48824 USA.
OI Duncan, Robert/0000-0002-8949-8727
FU Hearing Health Foundation; National Institutes of Health [NIDCD T32
   DC00011]
FX This work was supported by a research grant from the Hearing Health
   Foundation and a National Institutes of Health training grant (NIDCD T32
   DC00011).
CR Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007
   Adler AF, 2011, BIOMATERIALS, V32, P3611, DOI 10.1016/j.biomaterials.2011.01.040
   Ali F, 2011, DEVELOPMENT, V138, P4267, DOI 10.1242/dev.067900
   Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029
   Andersen MO, 2010, BIOMATERIALS, V31, P5671, DOI 10.1016/j.biomaterials.2010.03.069
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Assender H, 2002, SCIENCE, V297, P973, DOI 10.1126/science.1074955
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Balasubramaniyan V, 2004, NEUROSCI RES, V49, P261, DOI 10.1016/j.neures.2004.02.010
   Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837
   Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874
   Bolin MH, 2009, SENSOR ACTUAT B-CHEM, V142, P451, DOI 10.1016/j.snb.2009.04.062
   Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256
   Carlberg B, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045004
   Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832
   Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799
   Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061
   Cheng H, 2012, BIOMATERIALS, V33, P5004, DOI 10.1016/j.biomaterials.2012.03.065
   Chew SY, 2011, J BIOMED MATER RES A, V97A, P355, DOI 10.1002/jbm.a.33064
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Coles EG, 2006, DEV BIOL, V289, P218, DOI 10.1016/j.ydbio.2005.10.031
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Cullum R, 2011, RESPIROLOGY, V16, P210, DOI 10.1111/j.1440-1843.2010.01899.x
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108
   Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Gertz CC, 2010, DEV NEUROBIOL, V70, P589, DOI 10.1002/dneu.20792
   Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393
   Gordan OD, 2008, LANGMUIR, V24, P6636, DOI 10.1021/la800728x
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379
   Hill G. W., 2012, STEM CELLS IN PRESS
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Houchin-Ray T, 2007, MOL THER, V15, P705, DOI 10.1038/mt.sj.6300106
   Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Inagaki M, 2012, ADV MATER, V24, P2547, DOI 10.1002/adma.201104940
   Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100
   Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5
   Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   Kabiri M, 2012, BIOTECHNOL LETT, V34, P1357, DOI 10.1007/s10529-012-0889-4
   Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208
   Kaur G, 2010, BIOMATERIALS, V31, P5813, DOI 10.1016/j.biomaterials.2010.04.017
   Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746
   Khadka D.B., 2012, NANOMEDICIN IN PRESS
   Kim HN, 2012, ANN BIOMED ENG, V40, P1339, DOI 10.1007/s10439-012-0510-y
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g
   Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011
   Leach M. K., 2011, J VIS EXP, V48, pe2389
   Leach MK, 2011, J NEUROSCI METH, V199, P192, DOI 10.1016/j.jneumeth.2011.04.033
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee JY, 2010, J BIOMED MATER RES A, V92A, P1398, DOI 10.1002/jbm.a.32471
   Lee J, 2009, SMALL, V5, P1008, DOI 10.1002/smll.200801242
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li YC, 2012, ACTA BIOMATER, V8, P3035, DOI 10.1016/j.actbio.2012.04.036
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960
   Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064
   Loubet D, 2012, FASEB J, V26, P678, DOI 10.1096/fj.11-185579
   Lunn JS, 2011, ANN NEUROL, V70, P353, DOI 10.1002/ana.22487
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5
   Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Markert LD, 2009, STEM CELLS DEV, V18, P1331, DOI 10.1089/scd.2009.0114
   Marshall E, 2000, SCIENCE, V288, P951, DOI 10.1126/science.288.5468.951
   Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616
   Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908
   Meaburn E, 2012, SEMIN CELL DEV BIOL, V23, P192, DOI 10.1016/j.semcdb.2011.10.010
   Mehrotra S, 2009, ACTA BIOMATER, V5, P1474, DOI 10.1016/j.actbio.2009.01.004
   Migliorini E, 2011, BIOTECHNOL BIOENG, V108, P2736, DOI 10.1002/bit.23232
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Nicole M.K., 2008, DRUG DISCOV TODAY, V5, pe107, DOI DOI 10.1016/J.DDTEC.2008.10.002
   Nielson R, 2009, SMALL, V5, P120, DOI 10.1002/smll.200801084
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750
   Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630
   Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Piez KA, 1997, MATRIX BIOL, V16, P85, DOI 10.1016/S0945-053X(97)90037-8
   Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889
   Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012
   Prabhakaran MP, 2012, BIOPOLYMERS, V97, P529, DOI 10.1002/bip.22035
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Spivey EC, 2012, BIOMATERIALS, V33, P4264, DOI 10.1016/j.biomaterials.2012.02.043
   Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3
   Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tatulian SA, 2001, BIOPHYS J, V80, P789, DOI 10.1016/S0006-3495(01)76058-4
   Teichert RW, 2012, P NATL ACAD SCI USA, V109, P1388, DOI 10.1073/pnas.1118833109
   Teo BKK, 2011, BIOMATERIALS, V32, P9866, DOI 10.1016/j.biomaterials.2011.08.088
   Thomas V, 2006, J BIOMAT SCI-POLYM E, V17, P969, DOI 10.1163/156856206778366022
   Tong MJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1335, DOI 10.1152/ajpcell.00207.2010
   Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Velkey J. M., 2005, LINEAGE DIFFERENTIAT, V1
   Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wickstrom SA, 2011, TRENDS CELL BIOL, V21, P266, DOI 10.1016/j.tcb.2011.02.003
   Wickstrom SA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005116
   Xia Y.N., 1998, ANGEW CHEM INT EDIT, V37, P551, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yamada M, 2007, STEM CELLS, V25, P562, DOI 10.1634/stemcells.2006-0011
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang F, 2010, BIOMACROMOLECULES, V11, P1909, DOI 10.1021/bm100357t
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n
   Zhang F, 2012, BIOMACROMOLECULES, V13, P798, DOI 10.1021/bm201719s
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   Zoldan J, 2011, BIOMATERIALS, V32, P7793, DOI 10.1016/j.biomaterials.2011.06.057
   zur Lage PI, 2004, DEV CELL, V7, P687, DOI 10.1016/j.devcel.2004.09.015
NR 143
TC 15
Z9 15
U1 3
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2012
VL 13
IS 11
BP 3427
EP 3438
DI 10.1021/bm301220k
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 035GR
UT WOS:000310931900001
PM 23098293
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Renner, JN
   Cherry, KM
   Su, RSC
   Liu, JC
AF Renner, Julie N.
   Cherry, Kevin M.
   Su, Renay S-C.
   Liu, Julie C.
TI Characterization of Resilin-Based Materials for Tissue Engineering
   Applications
SO BIOMACROMOLECULES
LA English
DT Article
ID ELASTIN-LIKE POLYPEPTIDE; RUBBER-LIKE PROTEIN; VISCOELASTIC SHEAR
   PROPERTIES; CELL ATTACHMENT ACTIVITY; MECHANICAL-PROPERTIES;
   ARTICULAR-CARTILAGE; STEM-CELLS; RGD; FIBRONECTIN; BEHAVIOR
AB Modular proteins have emerged :as powerful tools in tissue engineering because both the mechanical and biochemical properties :an: precisely controlled through amino acid:sequence.:Resilin is an attractive candidate for use in modular proteins because it is well known for having low stiffness, high fatigue lifetime, and high, resilience. However, no studies have been conducted to assess resilin's compressive properties, cytocompatibility with clinically relevant cells, or effect On cell spreading. We. designed a modular protein containing repeating sequences of a motif derived from Anopheles gambiae and cell-binding domains derived from fibronectin. Rapid cross linking with tris(hydroxymethyl)phosphine was observed The hydrogels had a complex modulus of 22 +/- 1 kPa and yield strain of 63% The elastic modulus in compression, Or unconfined compressive modulus, was 2.4 +/- 0.2 MPa, which is on the same order as human cartilage. A LIVE/DEAD assay demonstrated that human mesenchymal stem cells cultured on the resilin-based protein had a Viability of 95% after three days. A cell spreading assay revealed that the cells interacted with the fibronectin-derived domain in a sequence specific manner and resulted in a mean cell area similar to 1.4-fold larger than when cells were seeded on a sequence scrambled negative control protein. These results demonstrate that our resilin-based biomaterial is a promising biomaterial for cartilage tissue engineering.
C1 [Renner, Julie N.; Cherry, Kevin M.; Su, Renay S-C.; Liu, Julie C.] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA.
   [Liu, Julie C.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
RP Liu, JC (reprint author), Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA.
EM julieliu@purdue.edu
RI Liu, Julie/H-7496-2013
OI Liu, Julie/0000-0003-0784-2529; Renner, Julie/0000-0002-6140-4346
FU Purdue School of Chemical Engineering; College of Engineering; National
   Science Foundation [0927100-EEC]; Purdue Summer Undergraduate Research
   Fellowship Program; 3M Nontenured Faculty Award
FX This work was supported by the Purdue School of Chemical Engineering and
   the College of Engineering, the National Science Foundation (Award No.
   0927100-EEC and a Graduate Fellowship to J.N.R.), the Purdue Summer
   Undergraduate Research Fellowship Program, and the 3M Nontenured Faculty
   Award. We appreciate the kind gifts of E. coli expression host
   BL21-CodonPlus(DE3)-RIPL from Dr. Jo Davisson (Purdue University) and
   plasmid pET28aRW from Dr. David Tirrell (California Institute of
   Technology). We thank Richard Galas for assistance in the visualization
   of F-actin networks, Meggan Stanton for analyzing cell-spreading images,
   and Dr. Dorota Inerowicz (Purdue Proteomics Facility) for conducting the
   amino acid analysis. We thank Dr. Elizabeth Topp for access to UV-vis
   and CD spectroscopic instruments and Dr. Sherry Harbin (Purdue
   University) for access to the rheometer.
CR Abramoff MD, 2004, J BIOPHOTONICS INT, V11, P36
   ANDERSON DR, 1991, J ORTHOP RES, V9, P550, DOI 10.1002/jor.1100090411
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Carrico IS, 2007, J AM CHEM SOC, V129, P4874, DOI 10.1021/ja070200b
   Charati MB, 2009, SOFT MATTER, V5, P3412, DOI 10.1039/b910980c
   Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484
   Dutta NK, 2011, ANGEW CHEM INT EDIT, V50, P4428, DOI 10.1002/anie.201007920
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Gabrion A, 2005, SURG RADIOL ANAT, V27, P507, DOI 10.1007/s00276-005-0031-6
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Iatridis JC, 1999, J ORTHOPAED RES, V17, P732, DOI 10.1002/jor.1100170517
   Kim M, 2007, PROTEIN EXPRES PURIF, V52, P230, DOI 10.1016/j.pep.2006.11.003
   Li LQ, 2011, BIOMACROMOLECULES, V12, P2302, DOI 10.1021/bm200373p
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Liu JC, 2008, BIOMACROMOLECULES, V9, P2984, DOI 10.1021/bm800469j
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Lyons RE, 2007, PROTEIN ENG DES SEL, V20, P25, DOI 10.1093/protein/gzl050
   Lyons RE, 2009, BIOMACROMOLECULES, V10, P3009, DOI 10.1021/bm900601h
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n
   Nairn KM, 2008, BIOPHYS J, V95, P3358, DOI 10.1529/biophysj.107.119107
   Nettles DL, 2010, TISSUE ENG PT A, V16, P11, DOI 10.1089/ten.tea.2009.0134
   Parsons J. R., 1998, HDB BIOMATERIAL PROP
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Renner JN, 2012, PROTEIN EXPRES PURIF, V82, P90, DOI 10.1016/j.pep.2011.11.019
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   SETTON LA, 1995, J ORTHOPAED RES, V13, P473, DOI 10.1002/jor.1100130402
   Srokowski EM, 2008, J BIOMAT SCI-POLYM E, V19, P785, DOI 10.1163/156856208784522038
   Tamburro AM, 2010, CHEMBIOCHEM, V11, P83, DOI 10.1002/cbic.200900460
   Truong MY, 2011, BIOMATERIALS, V32, P8462, DOI 10.1016/j.biomaterials.2011.07.064
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   WEISFOGH T, 1961, J MOL BIOL, V3, P520, DOI 10.1016/S0022-2836(61)80018-1
   WEISFOGH T, 1961, J MOL BIOL, V3, P648, DOI 10.1016/S0022-2836(61)80028-4
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   ZHU WB, 1993, J ORTHOPAED RES, V11, P771, DOI 10.1002/jor.1100110602
NR 42
TC 39
Z9 39
U1 2
U2 67
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2012
VL 13
IS 11
BP 3678
EP 3685
DI 10.1021/bm301129b
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 035GR
UT WOS:000310931900028
PM 23057410
DA 2018-10-19
ER

PT J
AU Yao, DY
   Dong, S
   Lu, Q
   Hu, X
   Kaplan, DL
   Zhang, BB
   Zhu, HS
AF Yao, Danyu
   Dong, Sen
   Lu, Qiang
   Hu, Xiao
   Kaplan, David L.
   Zhang, Bingbo
   Zhu, Hesun
TI Salt-Leached Silk Scaffolds with Tunable Mechanical Properties
SO BIOMACROMOLECULES
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; FIBROIN SCAFFOLDS; MATRIX; FILMS; BIOMATERIAL;
   CARTILAGE; GROWTH; ARCHITECTURE; STIFFNESS; BONE
AB Substrate mechanical properties have remarkable influences, on cell: behavior and tissue regeneration. Although salt leached silk scaffolds have been used in tissue engineering, applications in softer tissue regeneration can be with excessive stiffness. In the present study, silk bound water interactions were regulated by controlling processing to allow the preparation of salt-leached,porous scaffolds with tunable mechanical properties. Increasing silk bound water interactions resulted in reduced silk II (beta-sheet crystal) formation during salt leaching, which : resulted in,a modulus decrease in the scaffolds. The microstructures as well as degradation behavior were also changed, implying that this Water control and salt-leaching approach can be used to achieve tunable mechanical properties. Considering. the utility of silk in various fields of biomedicine, the results point to a new approach to generate silk scaffolds with controllable properties to better mimic soft tissues by combining scaffold preparation methods and silk self assembly in aqueous solutions..
C1 [Yao, Danyu; Lu, Qiang] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Dong, Sen] Huludao City Cent Hosp, Huludao 125000, Peoples R China.
   [Hu, Xiao; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Hu, Xiao] Rowan Univ, Dept Phys & Astron, Glassboro, NJ 08028 USA.
   [Zhang, Bingbo] Tongji Univ, Inst Adv Mat & Nano Biomed, Sch Med, Shanghai 200092, Peoples R China.
   [Zhu, Hesun] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, Q (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM lvqiang78@suda.edu.cn
RI Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820; Zhang, Bingbo/0000-0002-0981-7071
FU Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD); National Natural Science Foundation of China
   [21174097]; National Institues of Health (NIH) P41 Resource Center on
   Tissue Engineering, Ph.D. Programs Foundation of Ministry of Education
   of China [201032011200009]; Key Natural Science Foundation of the
   Jiangsu Higher Education Institutions of China [11KGA430002]; Opening
   Project of National Engineering Laboratory for Modern Silk, Soochow
   University
FX We thank the Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD) and National Natural Science Foundation of
   China (21174097) for support of this work. We also thank the National
   Institues of Health (NIH) P41 Resource Center on Tissue Engineering,
   Ph.D. Programs Foundation of Ministry of Education of China
   (201032011200009), the Key Natural Science Foundation of the Jiangsu
   Higher Education Institutions of China (11KGA430002) as well as the
   Opening Project of National Engineering Laboratory for Modern Silk,
   Soochow University for support of this work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang S, 2010, J CONTROL RELEASE, V142, P149, DOI 10.1016/j.jconrel.2009.10.018
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Leisk G. G., 2010, ADV MATER, V22, P710
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104
   Simmons H., 1996, SCIENCE, V271, P84
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2012, J MATER SCI-MATER M, V23, P315, DOI 10.1007/s10856-011-4476-3
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
NR 33
TC 52
Z9 52
U1 9
U2 93
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2012
VL 13
IS 11
BP 3723
EP 3729
DI 10.1021/bm301197h
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 035GR
UT WOS:000310931900033
PM 23016499
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wan, AJ
   Wang, K
   Zhang, HC
   Li, HL
   Wang, DN
AF Wan A-Jun
   Wang Kun
   Zhang Hong-Cai
   Li Hui-Li
   Wang De-Nong
TI Modern Carbohydrate Microarray Biochip Technologies
SO CHINESE JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Review
DE Microarray; Biochips; Carbohydrate microarray; Self-assembly; Review
ID GLYCAN ARRAYS; OLIGOSACCHARIDE MICROARRAYS; PROTEIN INTERACTIONS;
   MASS-SPECTROMETRY; IMMUNE-SYSTEM; ONE-STEP; SURFACE; CONSTRUCTION;
   TOOLS; GLYCOBIOLOGY
AB Carbohydrate microarray (glycochip) is one of modern biotechnologies for monitoring the molecular interactions between carbohydrate ligands and other biomacromolecules. It is characterized by microscale, rapid response, high sensitivity and high-throughput. It is widely applicable in many research and development fields, including, but not limited to, biology, medicine, clinical diagnostics, drug development, biomaterial and biological reagent industry. This article intends to summarize the methods that are currently used for the construction of glycochips. We focus on the immobilization of either chemically modified or non-modified carbohydrates to solid surfaces and self-assembly procedures for the production of three-dimensional glycochips. Current challenges and future trends in the research and development of glycochips are also discussed.
C1 [Wan A-Jun; Wang Kun; Zhang Hong-Cai] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China.
   [Zhang Hong-Cai] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200240, Peoples R China.
   [Li Hui-Li] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China.
   [Wang De-Nong] SRI Int, Biosci Div, Ctr Canc Res, Tumor Glyc Lab, Menlo Pk, CA 94025 USA.
RP Wan, AJ (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China.
EM wanajun@sjtu.edu.cn; denong.wang@sri.com
FU National Natural Science Foundation of China [51173104]; Nanometer
   Technology Program of Science and Technology Committee of Shanghai,
   China [11nm0503500]; NIH Fund Project of China [CA128416]
FX This work was supported by the National Natural Science Foundation of
   China (No. 51173104), the Nanometer Technology Program of Science and
   Technology Committee of Shanghai, China (No. 11nm0503500),and NIH Fund
   Project of China (No. CA128416).
CR Arora H, 2010, SCIENCE, V330, P214, DOI 10.1126/science.1193369
   Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021
   Chang CL, 2011, GENOME RES, V21, P21, DOI 10.1101/gr.110593.110
   Deng LQ, 2011, ORG BIOMOL CHEM, V9, P3188, DOI 10.1039/c1ob05040k
   Dhayal M, 2009, LANGMUIR, V25, P2181, DOI 10.1021/la8031122
   Dyukova VI, 2006, BBA-GEN SUBJECTS, V1760, P603, DOI 10.1016/j.bbagen.2005.12.005
   Ebran J P, 2012, METHOD MOL BIOL, V808, P1377
   Feizi T, 2006, FEBS J, V273, P27
   Feizi T, 2004, INT J EXP PATHOL, V85, pA51, DOI 10.1111/j.0959-9673.2004.0390f.x
   Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P637, DOI 10.1016/j.sbi.2003.09.002
   Fuster M M, 2005, NAT REV CANCER, V5, P1526
   Galan MC, 2010, BIOCHEM SOC T, V38, P1368, DOI 10.1042/BST0381368
   Gao JQ, 2010, TALANTA, V81, P1816, DOI 10.1016/j.talanta.2010.03.052
   Godula K, 2010, J AM CHEM SOC, V132, P9963, DOI 10.1021/ja103009d
   Gregory T C, 2006, LANGMUIR, V22, P2899
   Han E, 2011, BIOSENS BIOELECTRON, V26, P2500, DOI 10.1016/j.bios.2010.10.044
   Hoffmann-Roder A, 2011, CHEM COMMUN, V47, P382, DOI 10.1039/c0cc02250k
   Horlacher T, 2010, CHEMBIOCHEM, V11, P1563, DOI 10.1002/cbic.201000020
   Hsiao HY, 2011, CHEM COMMUN, V47, P1187, DOI 10.1039/c0cc03816d
   Huang CH, 2011, THIN SOLID FILMS, V519, P2763, DOI 10.1016/j.tsf.2010.11.064
   Huang KT, 2011, CHEMBIOCHEM, V12, P56, DOI 10.1002/cbic.201000567
   Katrlik J, 2010, MED RES REV, V30, P394, DOI 10.1002/med.20195
   Ke BB, 2010, LANGMUIR, V26, P8946, DOI 10.1021/la904729b
   Kiessling LL, 2002, NAT BIOTECHNOL, V20, P234, DOI 10.1038/nbt0302-234
   Kosik O, 2010, GLYCOCONJUGATE J, V27, P79, DOI 10.1007/s10719-009-9271-8
   Lee M R, 2012, METHOD MOL BIOL, V808, P1103
   Li BZ, 2010, J IND MICROBIOL BIOT, V37, P43, DOI 10.1007/s10295-009-0646-4
   Li YS, 2010, J MASS SPECTROM, V45, P504, DOI 10.1002/jms.1734
   Liu Y, 2010, BIOCHEM SOC T, V38, P1361, DOI 10.1042/BST0381361
   Liu Y, 2009, BIOL CHEM, V390, P647, DOI 10.1515/BC.2009.071
   Lonardi E, 2010, EXPERT REV PROTEOMIC, V7, P761, DOI 10.1586/EPR.10.41
   Mamidyala SK, 2006, J FLUORINE CHEM, V127, P571, DOI 10.1016/j.fluchem.2006.01.001
   Nelson J, 2001, SCIENCE, V293, P1059, DOI 10.1126/science.1062989
   Norberg O, 2011, ANAL CHEM, V83, P1000, DOI 10.1021/ac102781u
   Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P1406
   Park S, 2004, J AM CHEM SOC, V126, P4812, DOI 10.1021/ja0391661
   Park S, 2008, CHEM COMMUN, P4389, DOI 10.1039/b806699j
   Park S, 2007, NAT PROTOC, V2, P2747, DOI 10.1038/nprot.2007.373
   Park S, 2010, BIOCONJUGATE CHEM, V21, P1246, DOI 10.1021/bc100042j
   Park S, 2009, BIOCONJUGATE CHEM, V20, P155, DOI 10.1021/bc800442z
   Patwa T, 2010, MASS SPECTROM REV, V29, P830, DOI 10.1002/mas.20269
   Pera NP, 2010, CHEMBIOCHEM, V11, P1896, DOI 10.1002/cbic.201000340
   Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14
   Pond MA, 2012, TALANTA, V91, P134, DOI 10.1016/j.talanta.2012.01.036
   Pulsipher A, 2011, CHEM COMMUN, V47, P523, DOI 10.1039/c0cc01509a
   Ratner DM, 2007, CURR PHARM DESIGN, V13, P173, DOI 10.2174/138161207779313650
   Scurr DJ, 2010, LANGMUIR, V26, P17143, DOI 10.1021/la1029933
   Seeberger PH, 2007, NATURE, V446, P1046, DOI 10.1038/nature05819
   Seo J H, 2010, J NANOTECHNOL, V21
   Sharma P, 2010, J COLLOID INTERF SCI, V342, P202, DOI 10.1016/j.jcis.2009.10.038
   Shin I, 2005, CHEM-EUR J, V11, P2894, DOI 10.1002/chem.20041030
   Smith A E, 2004, SCIENCE, V304, P1237
   Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530
   Suvorov A, 2010, ENVIRON HEALTH PERSP, V118, P97, DOI 10.1289/ehp.0901031
   Szczepanek J, 2011, ARCH IMMUNOL THER EX, V59, P61, DOI 10.1007/s00005-010-0110-1
   Szunerits S, 2010, ANAL CHEM, V82, P8203, DOI 10.1021/ac1016387
   Tamborrini M, 2010, BIOORGAN MED CHEM, V18, P3747, DOI 10.1016/j.bmc.2010.04.059
   Tantakitti F, 2012, LANGMUIR, V28, P6950, DOI 10.1021/la300444h
   Tetala KKR, 2011, J MED CHEM, V54, P3500, DOI 10.1021/jm101594s
   Tokunaga Y, 2011, TETRAHEDRON LETT, V52, P240, DOI 10.1016/j.tetlet.2010.11.043
   Tong Q, 2012, ANAL CHEM, V84, P3049, DOI 10.1021/ac203455b
   Tyagi A, 2010, BIOSENS BIOELECTRON, V26, P344, DOI 10.1016/j.bios.2010.08.009
   Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657
   Wang CC, 2008, P NATL ACAD SCI USA, V105, P11661, DOI 10.1073/pnas.0804923105
   Wang D, 2012, METHOD MOL BIOL, V808, p1241~124
   Wang DN, 2007, PROTEOMICS, V7, P180, DOI 10.1002/pmic.200600478
   Wang DN, 2003, PROTEOMICS, V3, P2167, DOI 10.1002/pmic.200300601
   Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275
   Wang X, 2011, CHEM COMMUN, V47, P4261, DOI 10.1039/c0cc05299j
   Wendeln C, 2012, LANGMUIR, V28, P5527, DOI 10.1021/la204721x
   Willats WGT, 2002, PROTEOMICS, V2, P1666, DOI 10.1002/1615-9861(200212)2:12<1666::AID-PROT1666>3.0.CO;2-E
   Yan DY, 2004, SCIENCE, V303, P65, DOI 10.1126/science.1090763
   Zeng Z, 2010, J CHROMATOGR A, V1217, P3307, DOI 10.1016/j.chroma.2009.09.029
   Zhang J, 2009, CHEM COMMUN, P6795, DOI 10.1039/b915132j
   Zhang XJ, 2009, ANAL CHIM ACTA, V649, P1, DOI 10.1016/j.aca.2009.07.027
   Zhang YL, 2010, MOL BIOSYST, V6, P1583, DOI 10.1039/c002259d
   Zhou XC, 2009, J PROTEOME RES, V8, P5031, DOI 10.1021/pr900452s
   Zhu XY, 2009, J AM CHEM SOC, V131, P13646, DOI 10.1021/ja902783n
   Zou L, 2008, ANALYST, V133, P1195, DOI 10.1039/b805346d
NR 79
TC 2
Z9 3
U1 0
U2 69
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0253-3820
J9 CHINESE J ANAL CHEM
JI Chin. J. Anal. Chem.
PD NOV
PY 2012
VL 40
IS 11
BP 1780
EP U46
DI 10.1016/S1872-2040(11)60584-7
PG 10
WC Chemistry, Analytical
SC Chemistry
GA 042QJ
UT WOS:000311485700007
DA 2018-10-19
ER

PT J
AU Roguska, A
   Belcarz, A
   Piersiak, T
   Pisarek, M
   Ginalska, G
   Lewandowska, M
AF Roguska, Agata
   Belcarz, Anna
   Piersiak, Tomasz
   Pisarek, Marcin
   Ginalska, Grazyna
   Lewandowska, Malgorzata
TI Evaluation of the Antibacterial Activity of Ag-Loaded TiO2 Nanotubes
SO EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
LA English
DT Article
DE Titanium; Silver; Nanoparticles; Antibacterial properties; Orthopedic
   implants
ID MEDIATED SILVER RESISTANCE; ESCHERICHIA-COLI;
   STAPHYLOCOCCUS-EPIDERMIDIS; TITANIUM-DIOXIDE; BIOMEDICAL APPLICATIONS;
   BACTERIAL ADHESION; BIOFILM FORMATION; NANOPARTICLES; SURFACE;
   PSEUDOMONAS
AB To date, studies of modified Ti surfaces for biomedical purposes have focused on observations of their morphology and on the identification of the physicochemical properties that influence their biological response. However, for implant materials, antibacterial properties are also of high importance. The use of metal and metal oxide nanoparticles as antimicrobial components of coatings is receiving particular attention. The aim of this work is to create nanoporous oxide layers on Ti with the addition of Ag nanoparticles in order to obtain coatings having both biocompatibility and antibacterial properties for biomedical applications. TiO2 nanotubes (NTs) were grown on a Ti substrate by electrochemical oxidation at constant voltage in a mixture of glycerol, deionized water, and NH4F. Silver particles of size 250 nm were deposited on the surface by the sputter deposition technique. The antimicrobial activities of titanium, TiO2-NT, and Ag/TiO2-NT surfaces were evaluated against four different bacterial strains prevalent in orthopedic infections: S. epidermidis, S. aureus, E. coli, and P. aeruginosa. Our results have shown that Ag nanoparticles can be incorporated into the biomaterial surface in a simple and economic manner suitable for the fabrication of new types of bactericidal materials. The presence of the TiO2-NT layer significantly reduced the adhesion and biofilm formation of S. epidermidis cells on modified surfaces; the deposition of Ag nanoparticles enhanced the antiadhesive properties of the TiO2-NT layer. Thus, these Ag/TiO2-NT composite layers may be promising for combating post-operative infection for applications in hard tissue replacement procedures.
C1 [Roguska, Agata; Pisarek, Marcin] Polish Acad Sci, Inst Phys Chem, PL-01224 Warsaw, Poland.
   [Roguska, Agata; Lewandowska, Malgorzata] Warsaw Univ Technol, Fac Mat Sci & Engn, PL-02507 Warsaw, Poland.
   [Belcarz, Anna; Piersiak, Tomasz; Ginalska, Grazyna] Med Univ Lublin, Dept Biochem & Biotechnol, PL-20093 Lublin, Poland.
RP Roguska, A (reprint author), Polish Acad Sci, Inst Phys Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland.
EM aroguska@ichf.edu.pl
RI Pisarek, Marcin/J-8207-2018
OI Pisarek, Marcin/0000-0002-7424-5954; Belcarz, Anna/0000-0001-9899-5314;
   Lewandowska, Malgorzata/0000-0002-5399-4008; Ginalska,
   Grazyna/0000-0002-9961-4226
FU National Science Center [DEC-2011/01/B/ST5/06257,
   PRO-2011/03/N/ST5/04388]
FX This work was financially supported by the National Science Center
   (decision no. DEC-2011/01/B/ST5/06257 and grant no.
   PRO-2011/03/N/ST5/04388) and was developed by using the equipment
   purchased within the Operational Program Development of Eastern Poland
   2007-2013, Priority Axis I, Modern Economy, Operations 1.3. Innovations
   Promotion (agreement no. POPW.01.03.00-06-010/09-00).
CR Akhavan O, 2009, CURR APPL PHYS, V9, P1381, DOI 10.1016/j.cap.2009.03.003
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   BECKER RO, 1978, J BONE JOINT SURG AM, V60, P871, DOI 10.2106/00004623-197860070-00001
   Belcarz A, 2010, THIN SOLID FILMS, V519, P797, DOI 10.1016/j.tsf.2010.08.117
   Braydich-Stolle LK, 2009, J NANOPART RES, V11, P1361, DOI 10.1007/s11051-008-9523-8
   BRIDGES K, 1979, BRIT MED J, V1, P446, DOI 10.1136/bmj.1.6161.446
   Cabiscol Elisa, 2000, International Microbiology, V3, P3
   Chang S, 2010, ACS APPL MATER INTER, V2, P3333, DOI 10.1021/am100758k
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   DESHPANDE LM, 1994, BIOMETALS, V7, P49
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Fortunati E, 2012, CARBOHYD POLYM, V87, P1596, DOI 10.1016/j.carbpol.2011.09.066
   Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7
   FOX CL, 1974, ANTIMICROB AGENTS CH, V5, P582, DOI 10.1128/AAC.5.6.582
   Goel S.C., 2006, INDIAN J ORTHOP, V40, P133
   Golovlev E. L., 2002, Mikrobiologiya, V71, P293
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545
   Gupta A, 1998, APPL ENVIRON MICROB, V64, P5042
   Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   Jamuna-Thevi K, 2011, VACUUM, V86, P235, DOI 10.1016/j.vacuum.2011.06.011
   Jansen B, 1994, J Biomater Appl, V9, P55, DOI 10.1177/088532829400900103
   Japanese Standard Association, 2000, Z28012000 JIS JAP ST
   Jeyachandran YL, 2007, MAT SCI ENG C-BIO S, V27, P35, DOI 10.1016/j.msec.2006.01.004
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Khosravi A. D., 2009, Research Journal of Microbiology, V4, P158, DOI 10.3923/jm.2009.158.163
   Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4
   Lee SL, 2009, J NANOPART RES, V11, P209, DOI 10.1007/s11051-008-9469-x
   Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x
   LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Martinez-Gutierrez F, 2010, NANOMED-NANOTECHNOL, V6, P681, DOI 10.1016/j.nano.2010.02.001
   MCKEVITT AI, 1990, INFECT IMMUN, V58, P1473
   Mondal B, 2010, CHEM PHYS LETT, V497, P89, DOI 10.1016/j.cplett.2010.07.096
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x
   Roguska A, 2012, J BIOMED MATER RES A, V100A, P1954, DOI 10.1002/jbm.a.34044
   Sheehan E, 2004, J ORTHOPAED RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9
   Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7
   SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125
   VIK H, 1985, LANCET, V1, P872
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wang JC, 2011, MICROPOR MESOPOR MAT, V146, P216, DOI 10.1016/j.micromeso.2011.04.005
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
NR 51
TC 23
Z9 23
U1 1
U2 102
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1434-1948
J9 EUR J INORG CHEM
JI Eur. J. Inorg. Chem.
PD NOV
PY 2012
IS 32
SI SI
BP 5199
EP 5206
DI 10.1002/ejic.201200508
PG 8
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 032BQ
UT WOS:000310687300011
DA 2018-10-19
ER

PT J
AU Fricke, K
   Duske, K
   Quade, A
   Nebe, B
   Schroder, K
   Weltmann, KD
   von Woedtke, T
AF Fricke, Katja
   Duske, Kathrin
   Quade, Antje
   Nebe, Barbara
   Schroeder, Karsten
   Weltmann, Klaus-Dieter
   von Woedtke, Thomas
TI Comparison of Nonthermal Plasma Processes on the Surface Properties of
   Polystyrene and Their Impact on Cell Growth
SO IEEE TRANSACTIONS ON PLASMA SCIENCE
LA English
DT Article
DE Atmospheric-pressure plasma; low-pressure plasma; osteoblastic cells;
   surface modification
ID ATMOSPHERIC-PRESSURE PLASMA; OSTEOBLAST-LIKE CELLS; TITANIUM SURFACES;
   ADHESION; PARAMETERS; CHEMISTRY; POLYMERS
AB The initial adhesion and spreading of cells are crucial factors for the successful performance of a synthetic biomaterial used for cell culture disposables or human medical devices (e.g., implants). Surface properties which allow the control of the attachment of cells are decisive for the acceptance of the provided material. Hence, different surface preparation techniques are used to equip surfaces with functional groups to improve initial surface interactions. In this paper, polystyrene (PS) surfaces were modified by using different nonthermal plasma processes. In particular, low-pressure plasma and atmospheric-pressure plasma were applied to modify surfaces or to deposit thin films on surfaces. Furthermore, the behaviors of human osteoblastic cells with respect to cell viability and cell growth on differently plasma treated PS surfaces are investigated. A comparison is made between plasma-grafted PS and commercially available PS-such as tissue-culture PS and Primaria. The cell studies were accompanied by surface analysis comprising atomic force microscopy, determination of surface energies, and X-ray photoelectron spectroscopy measurements. This work demonstrates that the functionalization of PS substrates by applying low-pressure and atmospheric-pressure plasma processes are equally effective in the improvement of cell attachment and proliferation. Furthermore, it is shown that the enhanced metabolic activity and spreading behavior of osteoblastic cells correlate well with an increase in surface wettability and the introduction of polar oxygen-and/or nitrogen-containing functional groups after plasma treatment.
C1 [Fricke, Katja; Quade, Antje; Schroeder, Karsten; Weltmann, Klaus-Dieter; von Woedtke, Thomas] Leibniz Inst Plasma Sci & Technol INP Greifswald, D-17489 Greifswald, Germany.
   [Duske, Kathrin; Nebe, Barbara] Univ Rostock, Dept Cell Biol, Biomed Res Ctr, D-18057 Rostock, Germany.
RP Fricke, K (reprint author), Leibniz Inst Plasma Sci & Technol INP Greifswald, D-17489 Greifswald, Germany.
EM k.fricke@inp-greifswald.de; kathrin.duske@med.uni-rostock.de;
   quade@inp-greifswald.de; barbara.nebe@med.uni-rostock.de;
   weltmann@inp-greifswald.de; woedtke@inp-greifswald.de
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905; Fricke, Katja/0000-0001-6050-7725
FU Federal Ministry of Education and Research of Germany [13N9779,
   13N11188]
FX This work was supported by the Federal Ministry of Education and
   Research of Germany within the joint research project "Campus PlasmaMed"
   under Grant 13N9779 and Grant 13N11188.
CR Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Barker Susan L., 1994, Journal of Tissue Culture Methods, V16, P151, DOI 10.1007/BF01540642
   Bergemann C, 2012, PLASMA PROCESS POLYM, V9, P261, DOI 10.1002/ppap.201100059
   Bornholdt S, 2010, EUR PHYS J D, V60, P653, DOI 10.1140/epjd/e2010-00245-x
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Da Ponte G, 2011, EUR PHYS J-APPL PHYS, V56, DOI 10.1051/epjap/2011110192
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   Daw R., 1999, PLASMAS POLYM, V4, P113
   De Geyter N, 2008, SURF INTERFACE ANAL, V40, P608, DOI 10.1002/sia.2611
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Ehlbeck J., 2010, POLYM SURFACE MODIFI, P381
   Finke B, 2011, SURF COAT TECH, V205, pS520, DOI 10.1016/j.surfcoat.2010.12.044
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Fricke K, 2012, PLASMA CHEM PLASMA P, V32, P801, DOI 10.1007/s11090-012-9378-8
   Fricke K, 2011, PLASMA PROCESS POLYM, V8, P51, DOI 10.1002/ppap.201000093
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   Gomathi N, 2008, CURR SCI INDIA, V94, P1478
   Hempel F, 2011, BIOMEDICAL ENGINEERING - FRONTIERS AND CHALLENGES, P297
   Kingshott P, 2011, CURR OPIN CHEM BIOL, V15, P667, DOI 10.1016/j.cbpa.2011.07.012
   Legeay G, 2010, J ADHES SCI TECHNOL, V24, P2301, DOI 10.1163/016942410X508037
   Massia S. P., 1999, TISSUE ENG VASCULAR
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Quade A, 2011, PLASMA PROCESS POLYM, V8, P1165, DOI 10.1002/ppap.201100019
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P1191, DOI 10.1163/016942409X12619870771501
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P905, DOI 10.1163/016942409X12598231567989
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Takebe J, 2012, MAT SCI ENG C-MATER, V32, P55, DOI 10.1016/j.msec.2011.09.011
   Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 32
TC 7
Z9 7
U1 0
U2 42
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0093-3813
EI 1939-9375
J9 IEEE T PLASMA SCI
JI IEEE Trans. Plasma Sci.
PD NOV
PY 2012
VL 40
IS 11
SI SI
BP 2970
EP 2979
DI 10.1109/TPS.2012.2204904
PN 2
PG 10
WC Physics, Fluids & Plasmas
SC Physics
GA 040WD
UT WOS:000311355100003
DA 2018-10-19
ER

PT J
AU Edwards, HGM
   Ali, EMA
   O'Connor, S
AF Edwards, Howell G. M.
   Ali, Esam M. A.
   O'Connor, Sonia
TI The Heslington brain: a challenge for analytical Raman spectroscopy
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE Raman spectroscopy; prehistoric skeletal remains; archaeological brain;
   cyanobacteria; scytonemin
ID MUMMIFIED SKIN; SPECIMENS; RELEVANCE; REMAINS; MUMMIES; ICEMAN
AB The survival of brain tissue in archaeological depositional environments is a very unusual occurrence that has generated much discussion and conjecture forensically. Here, we report the Raman spectroscopic analysis of biomaterial found in the cranial cavity of a decapitated skull dating from the Iron Age, some 2500?years ago, from which the presence of degraded protein consistent with it being naturally preserved brain is concluded. The novel observation of characteristic Raman spectroscopic signatures of biochemicals produced by cyanobacteria, namely carotenoids and scytonemin, both in the brain tissue and surrounding deposits from the cranium is consistent with the waterlogged depositional environment in which the human skeletal remains were found. The Raman spectral data are in support of biochemical, morphological and radiographic analyses of this biomaterial, which therefore can be described as brain that has been significantly reduced in volume inside the cranial cavity. Copyright (C) 2012 John Wiley & Sons, Ltd.
C1 [Edwards, Howell G. M.; Ali, Esam M. A.; O'Connor, Sonia] Univ Bradford, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England.
   Univ Sohag, Dept Forens Sci, Sohag, Egypt.
RP Edwards, HGM (reprint author), Univ Bradford, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England.
EM h.g.m.edwards@bradford.ac.uk
FU University of York; English Heritage
FX Our thanks go to the University of York and English Heritage who funded
   the study of the brain remains, to all the members of the Heslington
   Brain Project Team and the York Archaeological Trust, and to Dr Rick Cox
   of DeltaNu Inc., Laramie, WY, USA, for the loan of the 1064 Advantage
   portable spectrometer.
CR Ali EMA, 2010, J RAMAN SPECTROSC, V41, P938, DOI 10.1002/jrs.2518
   CARTER EA, 2000, PRACTICAL SPECTROSCO, V24, P421
   Edwards H. G. M., 2007, ANAL BIOANAL CHEM, V383, P683
   Edwards HGM, 2005, ANAL BIOANAL CHEM, V383, P713, DOI 10.1007/s00216-005-0011-z
   Edwards HGM, 2005, ANALYST, V130, P917, DOI 10.1039/b503533c
   Edwards HGM, 2004, ANALYST, V129, P956, DOI 10.1039/b409224b
   Edwards HGM, 2004, ANALYST, V129, P870, DOI 10.1039/b407167k
   EDWARDS HGM, 1995, J CHEM SOC FARADAY T, V91, P3883, DOI 10.1039/ft9959103883
   Edwards HGM, 2002, VIB SPECTROSC, V28, P3, DOI 10.1016/S0924-2031(01)00141-2
   Edwards HGM, 2001, J RAMAN SPECTROSC, V32, P17, DOI 10.1002/1097-4555(200101)32:1<17::AID-JRS658>3.3.CO;2-T
   Edwards HGM, 1999, SPECTROCHIM ACTA A, V55, P2691, DOI 10.1016/S1386-1425(99)00099-2
   Edwards HGM, 2000, SPECTROCHIM ACTA A, V56, P193, DOI 10.1016/S1386-1425(99)00218-8
   Edwards HGM, 2007, ANAL BIOANAL CHEM, V387, P821, DOI 10.1007/s00216-006-0791-9
   Edwards HGM, 2007, J RAMAN SPECTROSC, V38, P1352, DOI 10.1002/jrs.1775
   Edwards HGM, 2010, PHILOS T R SOC A, V368, P3059, DOI 10.1098/rsta.2010.0100
   Edwards Howell G M, 2005, RAMAN SPECTROSCOPY A
   Gniadecka M, 1999, J RAMAN SPECTROSC, V30, P147, DOI 10.1002/(SICI)1097-4555(199902)30:2<147::AID-JRS370>3.0.CO;2-E
   O'Connor S., 2002, BONES MAN
   O'Connor S, 2011, J ARCHAEOL SCI, V38, P1641, DOI 10.1016/j.jas.2011.02.030
   Oliveira V. E., 2010, J RAMAN SPECTROSC, V41, P642
   Petersen S, 2003, J RAMAN SPECTROSC, V34, P375, DOI 10.1002/jrs.1006
   Vandenabeele P, 2007, CHEM REV, V107, P675, DOI 10.1021/cr068036i
   WILLIAMS AC, 1995, BBA-PROTEIN STRUCT M, V1246, P98, DOI 10.1016/0167-4838(94)00189-N
   Wilson A.S., 1999, J RAMAN SPECTROSC, V30, P378
NR 24
TC 7
Z9 7
U1 0
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD NOV
PY 2012
VL 43
IS 11
SI SI
BP 1658
EP 1662
DI 10.1002/jrs.4049
PG 5
WC Spectroscopy
SC Spectroscopy
GA 041QT
UT WOS:000311417000020
DA 2018-10-19
ER

PT J
AU Mareci, D
   Cimpoesu, N
   Popa, MI
AF Mareci, D.
   Cimpoesu, N.
   Popa, M. I.
TI Electrochemical and SEM characterization of NiTi alloy coated with
   chitosan by PLD technique
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
DE chitosan; EIS; NiTi alloy; PLD; SEM
ID PULSED-LASER EVAPORATION; IN-VITRO CORROSION; SURFACE-ANALYSIS;
   SHAPE-MEMORY; DENTAL APPLICATIONS; TITANIUM-ALLOYS; BEHAVIOR;
   RESISTANCE; BIOCOMPATIBILITY; BIOALLOY
AB The production of a wide variety of biocompatible thin films by laser ablation deposed on the biomaterial substrates does not induce inflammatory response and repulsion by the immunization human body. Anodic potentiodynamic polarization and electrochemical impedance spectroscopy (EIS) techniques were used for the study of the electrochemical behavior of coated NiTi with chitosan through pulsed laser deposition (PLD) technique. Experiments were carried out using two different electrolytes: physiological 0.9?wt% NaCl solution (PS) and PS?+?hydrochloric acid (APS) at 37?+/-?1?degrees C. In addition, scanning electron microscopy was employed to observe the surface morphology after maintaining in both electrolytes. The corrosion resistance was evaluated by means of the corrosion and passive corrosion currents. The electrochemical properties of the coated NiTi sample at the open circuit potential at different immersion time in PS and APS were studied by EIS. Equivalent circuits were used to model EIS data, in order to characterize samples' surface.
C1 [Mareci, D.; Popa, M. I.] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
   [Cimpoesu, N.] Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, Iasi 700050, Romania.
RP Mareci, D (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, 73 Prof Dr Docent Dimitrie Mangeron Rd, Iasi 700050, Romania.
EM danmareci@yahoo.com
RI Cimpoesu, Nicanor/P-5443-2014; Ionel Marcel, Popa/I-8942-2016
OI Mareci, Daniel/0000-0002-5859-1996
FU Romanian CNCS Program [PN-II-ID-PCE-2011-3-0218];  [266]
FX This paper was supported by the project no.266, financed by the Romanian
   CNCS Program PN-II-ID-PCE-2011-3-0218.
CR Assad M, 2003, J BIOMED MATER RES B, V64B, P121, DOI 10.1002/jbm.b.10531
   Attarchi M, 2009, MATER CORROS, V60, P871, DOI 10.1002/maco.200905212
   Baltat-Bazia A, 1992, MATER SCI FORUM, V111-112, P359
   Bauerle D., 2000, LASER PROCESSING CHE
   Brantley WA, 2001, ORTHODONTIC MAT SCI
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Cimpoesu RH, 2010, OPTOELECTRON ADV MAT, V4, P2148
   HANSEN SG, 1988, APPL PHYS LETT, V52, P81, DOI 10.1063/1.99332
   HANSEN SG, 1988, J APPL PHYS, V64, P2122, DOI 10.1063/1.341722
   Ionita D, 2011, MATER CORROS, V62, P1111, DOI 10.1002/maco.201005661
   MANSFELD F, 1973, J ELECTROCHEM SOC, V120, P515, DOI 10.1149/1.2403489
   Mareci D, 2011, MATER CORROS, V62, P1117, DOI 10.1002/maco.201106185
   Mareci D, 2010, MATER CORROS, V61, P829, DOI 10.1002/maco.201005761
   Mareci D, 2010, MATER CORROS, V61, P768, DOI 10.1002/maco.200905527
   Mareci D, 2010, ENVIRON ENG MANAG J, V9, P81
   Miller J., 1998, LASER ABLATION DESOR
   Mohsen Q, 2011, MATER CORROS, V62, P310, DOI 10.1002/maco.200905534
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Pirvu C, 2011, MATER CORROS, V62, P948, DOI 10.1002/maco.201006041
   Popa MV, 2009, MATER CORROS, V60, P949, DOI 10.1002/maco.200905382
   Prymak O, 2005, BIOMATERIALS, V26, P5801, DOI 10.1016/j.biomaterials.2005.02.029
   Rocher P, 2004, SCRIPTA MATER, V50, P255, DOI 10.1016/j.scriptamat.2003.09.028
   Rondelli G, 2006, J BIOMED MATER RES B, V79B, P320, DOI 10.1002/jbm.b.30545
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P3662, DOI 10.1016/j.biomaterials.2009.03.034
   Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Vasilescu E, 2010, MATER CORROS, V61, P947, DOI 10.1002/maco.201005740
   Wang BL, 2009, MATER CORROS, V60, P788, DOI 10.1002/maco.200805173
   Wang BL, 2009, MATER CORROS, V60, P330, DOI 10.1002/maco.200805120
   Wong MH, 2008, J ALLOY COMPD, V466, pL5, DOI 10.1016/j.jallcom.2007.11.077
   Zhang BB, 2011, MATER CORROS, V62, P766, DOI 10.1002/maco.200905561
NR 34
TC 19
Z9 19
U1 0
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-5117
J9 MATER CORROS
JI Mater. Corros.
PD NOV
PY 2012
VL 63
IS 11
BP 985
EP 991
DI 10.1002/maco.201206501
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 037ND
UT WOS:000311112000005
DA 2018-10-19
ER

PT J
AU Florencio, O
   Chaves, JAM
   da Silva, PS
   Grandini, CR
   Libardi, W
   Schneider, SG
AF Florencio, Odila
   Munoz Chaves, Javier Andres
   da Silva Junior, Paulo Sergio
   Grandini, Carlos Roberto
   Libardi, Walter
   Schneider, Sandra Giacomin
TI Dynamical Elastic Moduli of the Ti-13Nb-13Zr Biomaterial Alloy by
   Mechanical Spectroscopy
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE Ti-13Nb-13Zr; aging treatment; elastic modulus; anelastic relaxation
ID BIOMEDICAL APPLICATIONS; INTERNAL-FRICTION; TITANIUM-ALLOYS
AB Dynamical Elastic Moduli of the Ti-13Nb-13Zr biomaterial alloy were obtained using the mechanical spectroscopy technique. The sample with heat treatment at 1170K for 30 minutes and water quenched with subsequent aging treatment at 670 K for 3 hours (TNZ + WQ + 670 K/3 h), was characterized through decay of free oscillations of the sample in the flexural vibration mode. The spectra of anelastic relaxation (internal friction and frequency) in the temperature range from 300 K to 625 K not revealed the presence of relaxation process. As shown in the literature, the hcp structure usually does not exhibit any relaxation due to the symmetry of the sites in the crystalline lattice, but if there is some relaxation, this only occurs in special cases such as low concentration of zirconium or saturation of the stoichiometric ratio of oxygen for zirconium. Dynamical elastic modulus obtained for TNZ + WQ + 670 K/3 h alloy was 87 GPa at room temperature, which is higher than the value for Ti-13Nb-13Zr alloy (64 GPa) of the literature. This increment may be related to the change of the proportion of alpha and beta phases. Besides that, the presence of precipitates in the alloy after aging treatment hardens the material and reduces its ductility.
C1 [Florencio, Odila; Munoz Chaves, Javier Andres; da Silva Junior, Paulo Sergio] Univ Fed Sao Carlos UFSCar, Dept Fis, CP 676, BR-13565905 Sao Carlos, SP, Brazil.
   [Grandini, Carlos Roberto] Univ Estadual Paulista UNESP, Dept Fis, BR-17033360 Bauru, SP, Brazil.
   [Libardi, Walter] Univ Fed Sao Carlos UFSCar, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
   [Schneider, Sandra Giacomin] Univ Sao Paulo, Dept Mat Engn, EEL, BR-12602810 Lorena, SP, Brazil.
RP Florencio, O (reprint author), Univ Fed Sao Carlos UFSCar, Dept Fis, CP 676, BR-13565905 Sao Carlos, SP, Brazil.
EM libardi@ufscar.br
RI Grandini, Carlos Roberto/A-3790-2008; Silva Jr, Paulo/C-9395-2012;
   Schneider, Sandra/E-6087-2015; Florencio, Odila/D-3002-2012; Munoz
   Chaves, Javier Andres/G-1518-2013
OI Grandini, Carlos Roberto/0000-0002-3336-309X; Silva Jr,
   Paulo/0000-0001-9663-7142; Florencio, Odila/0000-0003-3655-4470; Munoz
   Chaves, Javier Andres/0000-0002-9614-2112
FU FAPESP; CNPq; CAPES
FX The authors would like to thank to FAPESP, CNPq and CAPES for financial
   support.
CR AHMAD MS, 1970, J PHYS CHEM SOLIDS, V31, P1799, DOI 10.1016/0022-3697(70)90170-8
   [Anonymous], AE 102 AC EL
   Asundi M. K., 1984, Bulletin of Materials Science, V6, P959, DOI 10.1007/BF02821422
   Blanter MS, 2007, SPRINGER SER MATER S, V90, pVII, DOI 10.1007/978-3-540-68758-0
   BOTTA WJ, 1990, ACTA METALL MATER, V38, P391, DOI 10.1016/0956-7151(90)90143-5
   BUNN PM, 1962, J APPL PHYS, V33, P3009, DOI 10.1063/1.1728554
   Caceres D, 2008, ACTA BIOMATER, V4, P1545, DOI 10.1016/j.actbio.2008.04.009
   Florencio O, 2006, KEY ENG MAT, V319, P121, DOI 10.4028/www.scientific.net/KEM.319.121
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   GUPTA D, 1962, ACTA METALL MATER, V10, P292, DOI 10.1016/0001-6160(62)90005-6
   Kobayashi E, 1998, J MATER SCI-MATER M, V9, P625, DOI 10.1023/A:1008927407556
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Nowick A. S., 1972, ANELASTIC RELAXATION
   POVOLO F, 1966, ACTA METALL MATER, V14, P711, DOI 10.1016/0001-6160(66)90118-0
   Schaller R, 2001, P SUMM SCH Q 1 2001, V366-368
   Schneider Sergio, 2005, Mat. Res., V8, P435, DOI 10.1590/S1516-14392005000400013
   Schneider SG, 2001, THESIS
   Snoek JL, 1939, PHYSICA, V6, P591, DOI 10.1016/S0031-8914(39)90061-3
   SZKOPIAK ZC, 1975, J PHYS D APPL PHYS, V8, P1273, DOI 10.1088/0022-3727/8/11/006
   Wong J.Y., 2007, BIOMATERIALS
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 23
TC 2
Z9 2
U1 1
U2 15
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD NOV-DEC
PY 2012
VL 15
IS 6
BP 911
EP 914
DI 10.1590/S1516-14392012005000109
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 043OR
UT WOS:000311554400012
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Della Rocca, DG
   Willenberg, BJ
   Ferreira, LF
   Wate, PS
   Petersen, JW
   Handberg, EM
   Zheng, T
   Steindler, DA
   Terada, N
   Batich, CD
   Byrne, BJ
   Pepine, CJ
AF Della Rocca, Domenico G.
   Willenberg, Bradley J.
   Ferreira, Leonardo F.
   Wate, Prateek S.
   Petersen, John W.
   Handberg, Eileen M.
   Zheng, Tong
   Steindler, Dennis A.
   Terada, Naohiro
   Batich, Christopher D.
   Byrne, Barry J.
   Pepine, Carl J.
TI A degradable, bioactive, gelatinized alginate hydrogel to improve stem
   cell/growth factor delivery and facilitate healing after myocardial
   infarction
SO MEDICAL HYPOTHESES
LA English
DT Article
ID EXTRACELLULAR-MATRIX; CARDIAC-FUNCTION; POSTMYOCARDIAL INFARCTION;
   INTRACORONARY INJECTION; PROGENITOR CELLS; HEART-FAILURE; TISSUE-REPAIR;
   THERAPY; DIFFERENTIATION; CARDIOMYOPATHY
AB Despite remarkable effectiveness of reperfusion and drug therapies to reduce morbidity and mortality following myocardial infarction (MI), many patients have debilitating symptoms and impaired left ventricular (LV) function highlighting the need for improved post-MI therapies. A promising concept currently under investigation is intramyocardial injection of high-water content, polymeric biomaterial gels (e.g., hydrogels) to modulate myocardial scar formation and LV adverse remodeling. We propose a degradable, bioactive hydrogel that forms a unique microstructure of continuous, parallel capillary-like channels (Capgel). We hypothesize that the innovative architecture and composition of Capgel can serve as a platform for endogenous cell recruitment and drug/cell delivery, therefore facilitating myocardial repair after MI. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Della Rocca, Domenico G.; Willenberg, Bradley J.; Petersen, John W.; Handberg, Eileen M.; Pepine, Carl J.] Univ Florida, Div Cardiovasc Med, Gainesville, FL 32610 USA.
   [Della Rocca, Domenico G.] Univ Roma Tor Vergata, Div Cardiol, Rome, Italy.
   [Willenberg, Bradley J.; Wate, Prateek S.; Batich, Christopher D.] Univ Florida, Coll Engn, Dept Mat Sci & Engn, Gainesville, FL 32610 USA.
   [Ferreira, Leonardo F.] Univ Florida, Coll Hlth & Human Performance, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA.
   [Zheng, Tong; Steindler, Dennis A.] Univ Florida, Evelyn F & William L McKnight Brain Inst, Coll Med, Dept Neurosurg, Gainesville, FL 32610 USA.
   [Terada, Naohiro] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.
   [Byrne, Barry J.] Univ Florida, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32610 USA.
RP Pepine, CJ (reprint author), Univ Florida, Div Cardiovasc Med, 1600 SW Archer Rd,POB 100277, Gainesville, FL 32610 USA.
EM carl.pepine@medicine.ufl.edu
RI Batich, Chris/H-3966-2017
OI Handberg, Eileen/0000-0002-7805-9577
FU NIH/NINDS [NS055165]; Maren fund; McKinney fund; Thompson Regenerative
   Medicine fund; NHLBI [2UM1 HL087366-06]; NIH; NCRR Clinical and
   Translational Science Award [UL1 TR000064]
FX Dr. Steindler receives grant support from NIH/NINDS NS055165 and the
   Maren, McKinney and Thompson Regenerative Medicine funds to DAS.; Dr.
   Carl Pepine is principal investigator for the University of Florida
   Regional Clinical Center of the NHLBI-sponsored Cardiovascular Cell
   Therapy Research Network (2UM1 HL087366-06). Dr. Pepine also receives
   support from an NIH and NCRR Clinical and Translational Science Award to
   the University of Florida (UL1 TR000064).
CR AOYAGI T, 1993, CIRCULATION, V88, P2415, DOI 10.1161/01.CIR.88.5.2415
   Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Doyle B, 2007, J NUCL MED, V48, P1708, DOI 10.2967/jnumed.107.042838
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573
   Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703
   Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078
   Ikaria Holdings Inc, 2012, IK 5001 PREV REM VEN
   Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064
   Kipshidze N, 2000, TEX HEART I J, V27, P196
   Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004
   LoneStar Heart Inc, 2011, SAF FEAS ALG LVR MET
   LoneStar Heart Inc, 2011, RAND CONTR STUD EV A
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Thumbs J, 1996, CHEM PHYS, V208, P9, DOI 10.1016/0301-0104(96)00031-6
   WAAGSTEIN F, 1975, BRIT HEART J, V37, P1022
   Wang XY, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002814
   Willenberg BJ, 2006, J BIOMED MATER RES A, V79A, P440, DOI 10.1002/jbm.a.30942
   Willenberg BJ, 2011, J BIOMAT SCI-POLYM E, V22, P1621, DOI 10.1163/092050610X519453
   Zhang Y, 2008, CIRC-CARDIOVASC IMAG, V1, P197, DOI 10.1161/CIRCIMAGING.108.781120
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
NR 39
TC 5
Z9 5
U1 1
U2 34
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD NOV
PY 2012
VL 79
IS 5
BP 673
EP 677
DI 10.1016/j.mehy.2012.08.006
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 033AS
UT WOS:000310765300027
PM 22939314
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, ZP
   Mei, L
   Feng, SS
AF Zhang, Zhiping
   Mei, Lin
   Feng, Si-Shen
TI Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-based
   nanomedicine
SO NANOMEDICINE
LA English
DT Editorial Material
DE biodegradable polymers; cancer nanotechnology; drug delivery; drug
   formulation; molecular biomaterial; oral chemotherapy
ID TPGS-EMULSIFIED NANOPARTICLES; IN-VITRO; BIODEGRADABLE POLYMERS;
   CHEMOTHERAPY; VIVO; DOCETAXEL; FORMULATION; COPOLYMER; DELIVERY; EFFLUX
C1 [Zhang, Zhiping] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Peoples R China.
   [Zhang, Zhiping] Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430030, Peoples R China.
   [Mei, Lin] Tsinghua Univ, Grad Sch Shenzhen, Div Life & Hlth Sci, Shenzhen Key Lab Gene & Antibody Therapy, Shenzhen 518055, Peoples R China.
   [Feng, Si-Shen] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
   [Feng, Si-Shen] Natl Univ Singapore, Dept Bioengn, Singapore 117576, Singapore.
RP Feng, SS (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Block B5,02-11,4 Engn Dr 4, Singapore 117576, Singapore.
EM chefss@nus.edu.sg
RI zhang, zhiping/H-1786-2011
CR Anbharasi V, 2010, J BIOMED MATER RES A, V94A, P730, DOI 10.1002/jbm.a.32734
   Cao N, 2008, BIOMATERIALS, V29, P3856, DOI 10.1016/j.biomaterials.2008.05.016
   Chandrasekharan P, 2011, BIOMATERIALS, V32, P5663, DOI 10.1016/j.biomaterials.2011.04.037
   Cheow WS, 2011, COLLOID SURFACE B, V85, P214, DOI 10.1016/j.colsurfb.2011.02.033
   Collnot EM, 2006, J CONTROL RELEASE, V111, P35, DOI 10.1016/j.jconrel.2005.11.005
   Collnot EM, 2007, MOL PHARM, V4, P465, DOI 10.1021/mp060121r
   Feng SS, 2007, CHEM ENG SCI, V62, P6641, DOI 10.1016/j.ces.2007.08.006
   Feng SS, 2006, NANOMEDICINE-UK, V1, P297, DOI 10.2217/17435889.1.3.297
   Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045
   Gan CW, 2010, CURR PHARM DESIGN, V16, P2308
   Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1
   Mi Y, 2011, BIOMATERIALS, V32, P4058, DOI 10.1016/j.biomaterials.2011.02.022
   Muthu MS, 2011, INT J PHARMACEUT, V421, P332, DOI 10.1016/j.ijpharm.2011.09.045
   Tan YF, 2011, BIOMATERIALS, V32, P2969, DOI 10.1016/j.biomaterials.2010.12.055
   Varma MVS, 2005, EUR J PHARM SCI, V25, P445, DOI 10.1016/j.ejps.2005.04.003
   Wu SH, 1999, PHARM TECHNOL, V23, P52
   Zhang ZP, 2008, PHARM RES-DORDR, V25, P1925, DOI 10.1007/s11095-008-9611-6
   Zhang ZP, 2011, NANOMEDICINE-UK, V6, P583, DOI [10.2217/nnm.11.66, 10.2217/NNM.11.66]
   Zhang ZP, 2006, BIOMATERIALS, V27, P262, DOI 10.1016/j.biomaterials.2005.05.104
   Zhao LY, 2010, J PHARM SCI-US, V99, P3552, DOI 10.1002/jps.22113
NR 20
TC 41
Z9 43
U1 0
U2 48
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD NOV
PY 2012
VL 7
IS 11
BP 1645
EP 1647
DI 10.2217/NNM.12.117
PG 3
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 040NN
UT WOS:000311329700002
PM 23210711
DA 2018-10-19
ER

PT J
AU Ferreira, AM
   Gentile, P
   Sartori, S
   Pagliano, C
   Cabrele, C
   Chiono, V
   Ciardelli, G
AF Ferreira, Ana Marina
   Gentile, Piergiorgio
   Sartori, Susanna
   Pagliano, Cristina
   Cabrele, Chiara
   Chiono, Valeria
   Ciardelli, Gianluca
TI Biomimetic soluble collagen purified from bones
SO BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE Biomaterials; Biomimetic; Bone; Collagen type I isolation; Proteoglycans
ID THERMAL STABILIZATION; MECHANICAL-PROPERTIES; PROTEOGLYCANS;
   HYDROXYAPATITE; GELATIN; DECORIN; TISSUES; FIBERS; EDTA;
   GLYCOSAMINOGLYCANS
AB Type I collagen has been extensively exploited as a biomaterial for biomedical applications and drug delivery; however, small molecular alterations occurring during the isolation procedure and its interaction with residual bone extracellular matrix molecules or proteins might affect the overall material biocompatibility and performance. The aim of the current work is to study the potential alterations in collagen properties and organization associated with the absence of proteoglycans, which mimic pathological conditions associated with age-related diseases. A new approach for evaluating the effect of proteoglycans on the properties of isolated type I collagen from the bone matrix is described. Additional treatment with guanidine hydrochloride was introduced to remove residual proteoglycans from the collagen matrix. The properties of the isolated collagen with/without guanidine hydrochloride treatment were investigated and compared with a commercial rabbit collagen as control. We demonstrate that the absence of proteoglycans in the isolated type I collagen affects its thermal properties, the extraction into its native structure, and its ability to hydrate and self-assemble into fibers. The fine control and tuning of all these features, linked to the absence of non-collagenous proteins as proteoglycans, offer the possibility of designing new strategies and biomaterials with advanced biomimetic properties aimed at regenerating bone tissue in the case of fragility and/or defects.
C1 [Ferreira, Ana Marina; Gentile, Piergiorgio; Sartori, Susanna; Chiono, Valeria; Ciardelli, Gianluca] Politecn Torino, Dept Mech & Aerosp Engn, I-10129 Turin, Italy.
   [Pagliano, Cristina] Politecn Torino, Dept Appl Sci & Technol, I-10129 Turin, Italy.
   [Cabrele, Chiara] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.
   [Ciardelli, Gianluca] CNR IPCF UOS Pisa, Pisa, Italy.
RP Ciardelli, G (reprint author), Politecn Torino, Dept Mech & Aerosp Engn, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
EM gianluca.ciardelli@polito.it
RI Cabrele, Chiara/B-8790-2015; Chiono, Valeria/G-3631-2014; Gentile,
   Piergiorgio/C-8664-2014
OI Cabrele, Chiara/0000-0002-7550-6896; Gentile,
   Piergiorgio/0000-0002-3036-6594; Ciardelli,
   Gianluca/0000-0003-0199-1427; Ferreira-Duarte, Ana/0000-0002-7728-1619
FU Progetto Lagrange Fondazione CRT
FX The authors thank Dr. Silvia Burchielli (CNR, Institute of Clinical
   Physiology, Pisa, Italy) for providing the rabbit bones. Ana Ferreira
   acknowledges Progetto Lagrange Fondazione CRT for the PhD Grant.
CR Bailey AJ, 2002, INT J BIOCHEM CELL B, V34, P176, DOI 10.1016/S1357-2725(01)00107-8
   BELANGER LF, 1965, ANAT REC, V153, P41, DOI 10.1002/ar.1091530106
   Bihari-Varga M, 1969, J THERM ANAL, V1, P241
   Boskey AL, 1997, CALCIFIED TISSUE INT, V61, P298, DOI 10.1007/s002239900339
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   BRODSKY B, 1982, METHOD ENZYMOL, V82, P127
   CHANDRASEKHAR S, 1987, ANAL BIOCHEM, V161, P103, DOI 10.1016/0003-2697(87)90658-0
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Christopher A. M., 2011, PHYS BIOL, V8
   Ciardelli G, 2010, J BIOMED MATER RES A, V92A, P137, DOI 10.1002/jbm.a.32344
   Cisneros DA, 2006, J STRUCT BIOL, V154, P232, DOI 10.1016/j.jsb.2006.02.006
   Cleland TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031443
   COLLINS MJ, 1995, J ARCHAEOL SCI, V22, P175, DOI 10.1006/jasc.1995.0019
   CONYERS RAJ, 1967, BIOCHIM BIOPHYS ACTA, V139, P363, DOI 10.1016/0005-2744(67)90040-X
   EDWARDS SF, 1969, J PHYS PT A GEN, V2, P145, DOI 10.1088/0305-4470/2/2/001
   Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768
   FINCH A, 1972, BIOCHIM BIOPHYS ACTA, V278, P433, DOI 10.1016/0005-2795(72)90003-7
   FLORY PJ, 1958, J AM CHEM SOC, V80, P4836, DOI 10.1021/ja01551a020
   Fonseca MJ, 1996, BBA-BIOMEMBRANES, V1279, P259
   Francesko A., 2011, BIOTECHNOL J, V6, P1208
   FRANZEN A, 1984, BIOCHEM J, V224, P59, DOI 10.1042/bj2240059
   Fratzl P, 2003, CURR OPIN COLLOID IN, V8, P32, DOI 10.1016/S1359-0294(03)00011-6
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gentile P, 2011, BIOTECHNOL J, V6, P1187, DOI 10.1002/biot.201100294
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001
   KIVIRANTA I, 1980, HISTOCHEMISTRY, V68, P119, DOI 10.1007/BF00489507
   Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2
   Kubisz L, 2005, J NON-CRYST SOLIDS, V351, P2935, DOI 10.1016/j.jnoncrysol.2005.05.041
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lamoureux F, 2007, BIOESSAYS, V29, P758, DOI 10.1002/bies.20612
   LIM JJ, 1974, BIOPOLYMERS, V13, P1791, DOI 10.1002/bip.1974.360130912
   Lozano LF, 2003, J MATER SCI, V38, P4777, DOI 10.1023/A:1027483220584
   Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X
   Noris-Suarez K, 2007, BIOMACROMOLECULES, V8, P941, DOI 10.1021/bm060828z
   Pati F, 2010, BIORESOURCE TECHNOL, V101, P3737, DOI 10.1016/j.biortech.2009.12.133
   Patino Maria G, 2002, Implant Dent, V11, P280, DOI 10.1097/00008505-200207000-00014
   Pietrucha K, 2005, BIOPHYS CHEM, V118, P51, DOI 10.1016/j.bpc.2005.07.006
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   PRINCE CW, 1983, BIOCHEM J, V216, P589, DOI 10.1042/bj2160589
   Rees SG, 2001, BBA-GEN SUBJECTS, V1568, P118, DOI 10.1016/S0304-4165(01)00209-4
   ROBEY PG, 2002, PRINCIPLES BONE BIOL, P225
   SCOTT JE, 1990, J ANAT, V169, P23
   SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313
   Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979
   SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712
   TERMINE JD, 1981, J BIOL CHEM, V256, P403
   Trebacz H, 2005, INT J BIOL MACROMOL, V37, P257, DOI 10.1016/j.ijbiomac.2005.04.007
   Usha R, 2005, COLLOID SURFACE B, V41, P21, DOI 10.1016/j.colsurfb.2004.11.001
   VANDERREST M, 1982, EUR J BIOCHEM, V125, P491, DOI 10.1111/j.1432-1033.1982.tb06709.x
   Wynnyckyj C, 2011, BBA-GEN SUBJECTS, V1810, P192, DOI 10.1016/j.bbagen.2010.10.003
   Yanagishita M, 2009, GLYCOCONJUGATE J, V26, P953, DOI 10.1007/s10719-008-9138-4
   Zhang ZK, 2006, J SOC LEATH TECH CH, V90, P23
NR 54
TC 5
Z9 5
U1 0
U2 22
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1860-6768
EI 1860-7314
J9 BIOTECHNOL J
JI Biotechnol. J.
PD NOV
PY 2012
VL 7
IS 11
DI 10.1002/biot.201200184
PG 10
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 031YG
UT WOS:000310678000016
PM 22829550
DA 2018-10-19
ER

PT J
AU An, B
AF An, Bo
TI Promoting human mesenchymal stem cell growth on silk-based biomaterial
   with bound recombinant collagen proteins
SO GLYCOBIOLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the Society-for-Glycobiology and
   American-Society-for-Matrix-Biology
CY NOV 11-14, 2012
CL San Diego, CA
SP Soc Glycobiol, Amer Soc Matrix Biol
C1 [An, Bo] Tufts Univ, Medford, MA 02155 USA.
RI An, Bo/N-3466-2014
OI An, Bo/0000-0002-1031-3380
NR 0
TC 0
Z9 0
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0959-6658
J9 GLYCOBIOLOGY
JI Glycobiology
PD NOV
PY 2012
VL 22
IS 11
BP 1578
EP 1579
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 027QS
UT WOS:000310368700182
DA 2018-10-19
ER

PT J
AU Park, NY
   Rico, CW
   Lee, SC
   Kang, MY
AF Park, Na Young
   Rico, Catherine W.
   Lee, Sang Chul
   Kang, Mi Young
TI Comparative effects of doenjang prepared from soybean and brown rice on
   the body weight and lipid metabolism in high fat-fed mice
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE brown rice; soybean; doenjang; hypolipidemic effect; obesity
ID GENETICALLY-OBESE MICE; ADIPOSE-TISSUE; CARNITINE PALMITOYLTRANSFERASE;
   SPECTROPHOTOMETRIC ASSAY; GENE-EXPRESSION; ACID SYNTHASE; RATS; PROTEIN;
   BRAN; GINSENG
AB he comparative effects of doenjang prepared from fermented soybean or brown rice on the body weight and lipid metabolism in C57BL/6N mice fed with high fat diet were investigated. The animals were randomly divided and given experimental diets for eight weeks: normal control diet, high fat diet, and high fat diet supplemented with soybean doenjang, brown rice doenjang, brown rice-rice bran doenjang, or brown rice-red ginseng marc doenjang. At the end of the experimental period, the HF group exhibited a marked increase in body weight, body fat, plasma triglyceride concentration, and atherogenic index relative to the normal control diet group. However, diet supplementation of doenjang counteracted this high fat-induced hyperlipidemia through modulation of lipogenesis and adipokine production. In general, compared with soybean doenjang, the brown rice-rice bran doenjang and brown rice-red ginseng marc doenjang were similarly effective in improving the lipid metabolism under high fat diet condition. These findings demonstrate that brown rice, in combination with rice bran or red ginseng marc, may be useful as a functional biomaterial for the preparation of doenjang with strong anti-obesity effect and hypolipidemic action.
C1 [Park, Na Young; Rico, Catherine W.; Kang, Mi Young] Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu 702701, South Korea.
   [Lee, Sang Chul] Kyungpook Natl Univ, Div Plant Biosci, Taegu 702701, South Korea.
RP Kang, MY (reprint author), Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu 702701, South Korea.
EM mykang@knu.ac.kr
FU Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center),
   Rural Development Administration, Republic of Korea [PJ008176]
FX This work was supported by a grant from the Next-Generation BioGreen 21
   Program (Plant Molecular Breeding Center No. PJ008176), Rural
   Development Administration, Republic of Korea.
CR [Anonymous], 1977, J Nutr, V107, P1340
   Aoyama T, 2000, NUTRITION, V16, P349, DOI 10.1016/S0899-9007(00)00230-6
   Aoyama T, 2000, BIOSCI BIOTECH BIOCH, V64, P2594, DOI 10.1271/bbb.64.2594
   Baek SH, 2005, J FOOD SCI, V70, pS527
   Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x
   BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bray GA, 2004, PHYSIOL BEHAV, V83, P549, DOI 10.1016/j.physbeh.2004.08.039
   Chai C, 2012, J CHROMATOGR B, V880, P42, DOI 10.1016/j.jchromb.2011.11.013
   GIBSON DM, 1960, BIOCHEM BIOPH RES CO, V3, P531, DOI 10.1016/0006-291X(60)90169-8
   HALMINSKI MA, 1991, J NUTR, V121, P1554
   HULCHER FH, 1973, J LIPID RES, V14, P625
   Jo YJ, 2011, J FOOD SCI, V76, pC368, DOI 10.1111/j.1750-3841.2011.02068.x
   Jung H.W., 2010, J KOREAN SOC FOOD SC, V39, P1391
   Jung OK, 2006, NUTRITION, V22, P539
   Katyama M, 2002, ONCOL REP, V9, P817
   Kim HK, 2004, J NUTR BIOCHEM, V15, P485, DOI 10.1016/j.jnutbio.2004.02.010
   Kim HJ, 2010, J GINSENG RES, V34, P104, DOI 10.5142/jgr.2010.34.2.104
   Kuno T, 2004, INT J ONCOL, V25, P1809
   Kwak CS, 2012, J MED FOOD, V15, P1, DOI 10.1089/jmf.2010.1224
   Kwon DY, 2010, NUTR RES, V30, P1, DOI 10.1016/j.nutres.2009.11.004
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   Lee GI, 2012, FOOD CONTROL, V24, P1, DOI 10.1016/j.foodcont.2011.09.014
   Lee IK, 2002, J KOREAN PUBLIC HLTH, V28, P282
   Lee SD, 2009, J AM OIL CHEM SOC, V86, P1065, DOI 10.1007/s11746-009-1460-x
   Lim SI, 2011, J KOREAN SOC APPL BI, V54, P237, DOI 10.3839/jksabc.2011.038
   Lim TS, 2004, J MED FOOD, V7, P1, DOI 10.1089/109662004322984626
   OCHOA S, 1955, METHOD ENZYMOL, V1, P735, DOI 10.1016/0076-6879(55)01128-2
   Park KunYoung, 2002, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V31, P343
   Park KY, 2003, MUTAT RES-FUND MOL M, V523, P43, DOI 10.1016/S0027-5107(02)00320-2
   Park KY, 2005, ASIAN FUNCTIONAL FOO, P555
   Pitkanen E, 1997, EUR J CLIN CHEM CLIN, V35, P761
   Putthaphadoong S, 2010, ONCOL REP, V23, P53
   Silha JV, 2006, OBESITY, V14, P1320, DOI 10.1038/oby.2006.150
   Song YB, 2012, J SCI FOOD AGR, V92, P388, DOI 10.1002/jsfa.4589
   Stefanovic-Racic M, 2008, AM J PHYSIOL-ENDOC M, V294, pE969, DOI 10.1152/ajpendo.00497.2007
   Tomita H, 2008, ONCOL REP, V19, P11
   Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI 10.1042/BST0331078
   Velasquez Manuel T, 2007, Int J Med Sci, V4, P72
   Wang Y, 2006, DRUG DEVELOP RES, V67, P677, DOI 10.1002/ddr.20141
   Zhao SM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-6
NR 41
TC 11
Z9 11
U1 0
U2 5
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD NOV 1
PY 2012
VL 51
IS 3
BP 235
EP 240
DI 10.3164/jcbn.12-24
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 037TK
UT WOS:000311129200012
PM 23170053
OA Green Published
DA 2018-10-19
ER

PT J
AU Jose, RR
   Elia, R
   Firpo, MA
   Kaplan, DL
   Peattie, RA
AF Jose, Rod R.
   Elia, Roberto
   Firpo, Matthew A.
   Kaplan, David L.
   Peattie, Robert A.
TI Seamless, axially aligned, fiber tubes, meshes, microbundles and
   gradient biomaterial constructs
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TISSUE ENGINEERING SCAFFOLDS; BONE INSERTION SITE; ELECTROSPUN
   NANOFIBERS; COMPOSITE NANOFIBERS; POLY(ETHYLENE OXIDE); BENDING
   INSTABILITY; POLYMER-SOLUTIONS; VASCULAR GRAFTS; IN-VITRO; SILK
AB A new electrospinning apparatus was developed to generate nanofibrous materials with improved organizational control. The system functions by oscillating the deposition signal (ODS) of multiple collectors, allowing significantly improved nanofiber control by manipulating the electric field which drives the electrospinning process. Other electrospinning techniques designed to impart deposited fiber organizational control, such as rotating mandrels or parallel collector systems, do not generate seamless constructs with high quality alignment in sizes large enough for medical devices. In contrast, the ODS collection system produces deposited fiber networks with highly pure alignment in a variety of forms and sizes, including flat (8 x 8 cm(2)), tubular (1.3 cm diameter), or rope-like microbundle (45 mu m diameter) samples. Additionally, the mechanism of our technique allows for scale-up beyond these dimensions. The ODS collection system produced 81.6 % of fibers aligned within 5 degrees of the axial direction, nearly a four-fold improvement over the rotating mandrel technique. The meshes produced from the 9 % (w/v) fibroin/PEO blend demonstrated significant mechanical anisotropy due to the fiber alignment. In 37 degrees C PBS, aligned samples produced an ultimate tensile strength of 16.47 +/- 1.18 MPa, a Young's modulus of 37.33 MPa, and a yield strength of 7.79 +/- 1.13 MPa. The material was 300 % stiffer when extended in the direction of fiber alignment and required 20 times the amount of force to be deformed, compared to aligned meshes extended perpendicular to the fiber direction. The ODS technique could be applied to any electrospinnable polymer to overcome the more limited uniformity and induced mechanical strain of rotating mandrel techniques, and greatly surpasses the limited length of standard parallel collector techniques.
C1 [Jose, Rod R.; Elia, Roberto; Kaplan, David L.; Peattie, Robert A.] Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, Medford, MA 02155 USA.
   [Firpo, Matthew A.] Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT 84132 USA.
RP Jose, RR (reprint author), Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM rodrigo.jose@tufts.edu
FU National Science Foundation [CBET-0932456]; NIH [EY020856, EB002520];
   AFOSR [FA9550-10-1-0172]
FX Supported by National Science Foundation award CBET-0932456, and
   partially by NIH awards EY020856 and EB002520, and AFOSR award
   FA9550-10-1-0172. We thank Dr. Robert White for contributing microscale
   profilometry measurements, and Dr. Ethan Golden for his assistance in
   design and fabrication.
CR Ahmad Z, 2009, J DRUG TARGET, V17, P724, DOI 10.3109/10611860903085386
   Ahmad Z, 2009, APPL PHYS A-MATER, V97, P31, DOI 10.1007/s00339-009-5359-z
   Angammana CJ, 2011, IEEE T IND APPL, V47, P1028, DOI 10.1109/TIA.2010.2103392
   Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19
   Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   Beachley V, 2009, MAT SCI ENG C-BIO S, V29, P663, DOI 10.1016/j.msec.2008.10.037
   Cai ZX, 2010, INT J MOL SCI, V11, P3529, DOI 10.3390/ijms11093529
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   Drilling S, 2009, J BIOMED MATER RES A, V88A, P923, DOI 10.1002/jbm.a.31926
   Gaumer J, 2009, ACTA BIOMATER, V5, P1552, DOI 10.1016/j.actbio.2009.01.021
   Griffin J, 2011, J BIOMED MATER RES A, V97A, P230, DOI 10.1002/jbm.a.33049
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023
   Kumar A, 2010, MACROMOL MATER ENG, V295, P701, DOI 10.1002/mame.200900425
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Ladd MR, 2011, BIOMATERIALS, V32, P1549, DOI 10.1016/j.biomaterials.2010.10.038
   Lee H, 2011, J BIOMED MATER RES B, V97B, P263, DOI 10.1002/jbm.b.31809
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Liu XA, 2010, J BIOMED MATER RES A, V94A, P1004, DOI 10.1002/jbm.a.32675
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Ma Z, 2011, J COLLOID INTERF SCI, V359, P371, DOI 10.1016/j.jcis.2011.04.023
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nandakumar A, 2010, MACROMOL BIOSCI, V10, P1365, DOI 10.1002/mabi.201000145
   Rajkhowa R, 2011, J BIOMED MATER RES A, V97A, P37, DOI 10.1002/jbm.a.33021
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Saraf A, 2009, TISSUE ENG PART C-ME, V15, P333, DOI 10.1089/ten.tec.2008.0422
   Schreuder-Gibson H. L., 2005, INT NONWOVENS J, V13, P39
   Sell SA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/045001
   Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011
   Stachewicz U, 2011, ACS APPL MATER INTER, V3, P1991, DOI 10.1021/am2002444
   Thakur RA, 2008, INT J PHARMACEUT, V364, P87, DOI 10.1016/j.ijpharm.2008.07.033
   Timnak A, 2011, J MATER SCI-MATER M, V22, P1555, DOI 10.1007/s10856-011-4316-5
   Tong HW, 2011, J BIOMAT SCI-POLYM E, V23, P779
   Vaquette C, 2011, ACTA BIOMATER, V7, P2544, DOI 10.1016/j.actbio.2011.02.036
   Wang H, 2005, J MATER SCI, V40, P5359, DOI 10.1007/s10853-005-4332-2
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Weber N, 2010, ACTA BIOMATER, V6, P3550, DOI 10.1016/j.actbio.2010.03.035
   Wei K, 2011, J BIOMED MATER RES A, V97A, P272, DOI 10.1002/jbm.a.33054
   Wolfe PS, 2010, J BIOMED MATER RES A, V92A, P1321, DOI 10.1002/jbm.a.32458
   Wu HJ, 2010, J MATER SCI-MATER M, V21, P3207, DOI 10.1007/s10856-010-4164-8
   Xie JW, 2010, ACS NANO, V4, P5027, DOI 10.1021/nn101554u
   Xie JW, 2010, NANOSCALE, V2, P923, DOI 10.1039/c0nr00192a
   Xie JW, 2008, MACROMOL RAPID COMM, V29, P1775, DOI 10.1002/marc.200800381
   Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Yoshimatsu K, 2008, BIOSENS BIOELECTRON, V23, P1208, DOI 10.1016/j.bios.2007.12.002
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhang XH, 2009, BIOMATERIALS, V30, P3213, DOI 10.1016/j.biomaterials.2009.02.002
NR 53
TC 20
Z9 21
U1 3
U2 78
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2012
VL 23
IS 11
BP 2679
EP 2695
DI 10.1007/s10856-012-4739-7
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 034KS
UT WOS:000310872400009
PM 22890517
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Dai, XY
   Nie, W
   Wang, YC
   Shen, Y
   Li, Y
   Gan, SJ
AF Dai, Xin-Yi
   Nie, Wei
   Wang, Yong-Chun
   Shen, Yi
   Li, Yan
   Gan, Shu-Jie
TI Electrospun emodin polyvinylpyrrolidone blended nanofibrous membrane: a
   novel medicated biomaterial for drug delivery and accelerated wound
   healing
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLYGONUM-CUSPIDATUM; EXTRACTION; DRESSINGS; SYSTEMS; MICE
AB In this work, blended nanofibrous membranes were prepared by an electrospinning technique with polyvinylpyrrolidone (PVP) K90 as the filament-forming polymer, and emodin, an extract of polygonum cuspidate known as a medicinal plant, as the treatment drug. Detailed analysis of the blended nanofibrous membrane by scanning electron microscopy, Differential scanning calorimetry and X-ray diffraction revealed that emodin was well distributed in the ultrafine fibers in the form of amorphous nanosolid dispersions. Results from attenuated total reflectance Fourier transform infrared spectra suggested that the main interactions between PVP and emodin might be mediated through hydrogen bonding. In vitro dissolution tests proved that the blended nanofibrous membrane produced more desired release kinetics of the entrapped drug (emodin) as compared to the pure drug. Furthermore, wound healing test and histological evaluation revealed that the emodin loaded nanofibrous membrane to be more effective as a healing accelerator thereby proving potential strategies to develop composite drug delivery system as well as promising materials for future therapeutic biomedical applications.
C1 [Dai, Xin-Yi; Wang, Yong-Chun] Shanghai Jiao Tong Univ, Affiliate People Hosp 1, Div Plast Surg, Shanghai 200080, Peoples R China.
   [Nie, Wei] Fudan Univ, Key Lab Targeting Agents, Shanghai 200433, Peoples R China.
   [Shen, Yi] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 201800, Peoples R China.
   [Li, Yan] Shanghai Jiao Tong Univ, Affiliate People Hosp 1, Div Intens Care Unit, Shanghai 200080, Peoples R China.
   [Gan, Shu-Jie] Shanghai Jiao Tong Univ, Affiliate People Hosp 1, Div Vasc Surg, Shanghai 200080, Peoples R China.
RP Dai, XY (reprint author), Shanghai Jiao Tong Univ, Affiliate People Hosp 1, Div Plast Surg, Shanghai 200080, Peoples R China.
EM daixy1979@gmail.com
RI Shen, Yi/C-6332-2013
CR ANANTA M, 2011, TISSUE ENG, V18, P353
   Babaeijandaghi F, 2010, TISSUE ENG PT A, V16, P3527, DOI [10.1089/ten.tea.2009.0829, 10.1089/ten.TEA.2009.0829]
   Buhler V, 2005, POLYVINYLPYRROLIDONE
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Erba P, 2011, J TRAUMA, V71, pS187, DOI 10.1097/TA.0b013e318225583c
   Fischer F, 2009, CHEM UNSERER ZEIT, V43, P376, DOI 10.1002/ciuz.200900492
   Franco RA, 2011, J MATER SCI-MATER M, V22, P1
   Franz MG, 2007, CURR PROB SURG, V44, P691, DOI 10.1067/j.cpsurg.2007.07.001
   Janis JE, 2010, PLAST RECONSTR SURG, V125, p230E, DOI 10.1097/PRS.0b013e3181d9a0d1
   Jannesari Marziyeh, 2011, Int J Nanomedicine, V6, P993, DOI 10.2147/IJN.S17595
   Kang YO, 2010, J BIOMED MATER RES B, V92B, P568, DOI 10.1002/jbm.b.31554
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Liu X, 2010, J BIOMED MATER RES A, V94A, P499, DOI 10.1002/jbm.a.32718
   Lu HM, 2006, J SEP SCI, V29, P2136, DOI 10.1002/jssc.200600012
   Ma K, 2011, TISSUE ENG PT A, V17, P1413, DOI [10.1089/ten.tea.2010.0373, 10.1089/ten.TEA.2010.0373]
   Nie W, 2011, MATER RES INNOV, V16, P14
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Scherer SS, 2009, ANN SURG, V250, P322, DOI 10.1097/SLA.0b013e3181ae9d45
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Slaoui M, 2011, METHODS MOL BIOL, V691, P69, DOI 10.1007/978-1-60761-849-2_4
   Suganya S, 2011, J APPL POLYM SCI, V121, P2893, DOI 10.1002/app.33915
   Tang T, 2007, EUR J PHARMACOL, V567, P177, DOI 10.1016/j.ejphar.2007.02.033
   TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245
   Wang H, 2008, BIOTECHNOL LETT, V30, P2079, DOI 10.1007/s10529-008-9815-1
   Xue L, 2000, Zhongguo Zhong Yao Za Zhi, V25, P651
   Yu D, 2009, ACTA POLYM SIN, V11, P88
   Yu DG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055104
   Zhang X, 2010, BIOMATERIALS, V31, P4376, DOI 10.1016/j.biomaterials.2010.02.017
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
NR 30
TC 29
Z9 30
U1 4
U2 58
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2012
VL 23
IS 11
BP 2709
EP 2716
DI 10.1007/s10856-012-4728-x
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 034KS
UT WOS:000310872400011
PM 22875606
DA 2018-10-19
ER

PT J
AU Battiston, KG
   Labow, RS
   Santerre, JP
AF Battiston, Kyle G.
   Labow, Rosalind S.
   Santerre, J. Paul
TI Protein binding mediation of biomaterial-dependent monocyte activation
   on a degradable polar hydrophobic ionic polyurethane
SO BIOMATERIALS
LA English
DT Article
DE Monocyte; Protein adsorption; Wound healing; Surface characterization;
   alpha(2)-Macroglobulin
ID ENGINEERED VASCULAR GRAFTS; RECEPTOR-ASSOCIATED PROTEIN; DENDRITIC CELL
   MATURATION; SELF-ASSEMBLED MONOLAYERS; KAPPA-B ACTIVATION; IN-VITRO;
   SURFACE-CHEMISTRY; ALPHA(2) MACROGLOBULIN; PROTEOMIC ANALYSIS; ADSORBED
   PROTEINS
AB Protein adsorption is an important phenomenon influencing the cellular response to biomaterials. Previous studies comparing monocyte activation on a degradable polar hydrophobic ionic polyurethane (D-PHI) indicated a reduced pro-inflammatory monocyte response relative to tissue culture polystyrene (TCPS) and poly(lactide-co-glycolide) (PLGA) substrates. The present study investigated the influence of protein binding in order to gain further insight into the observed differential monocyte activation. Several proteins, identified in different relative amounts within the bound protein layers on D-PHI vs. PLGA and TCPS, were evaluated for their effect on monocyte activation. It was found that, in general, both non-coated and protein pre-adsorbed D-PHI supported a reduced pro-inflammatory response relative to PLGA, as indicated by lower levels of tumor necrosis factor-alpha (TNF-alpha) release. An initial increase in TNF-alpha release occurred when alpha(2)-macroglobulin (A2M) was pre-adsorbed to D-PHI, which was shown to involve the alpha(2)-macroglobulin receptor and was active on D-PHI but not on the two other biomaterials. This response was not observed during competitive protein binding in the presence of fetal bovine serum (FBS), suggesting that a more complex arrangement of the bound proteins and their interactions with one another, as well as with the surface chemistry of the individual biomaterials, resulted in the low-activating character of D-PHI when interacting with human monocytes. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Santerre, J. Paul] Univ Toronto, Fac Dent, Dept Biomat, Inst Biomat & Biomed Engn, Toronto, ON M5G 1G6, Canada.
   [Labow, Rosalind S.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Labow, Rosalind S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biomat, Inst Biomat & Biomed Engn, 124 Edward St,Room 464D, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@dentistry.utoronto.ca
FU NSERC/CIHR [337246/83459]; CIHR [230762, STP-53877]; Ontario Graduate
   Scholarship (OGS)
FX Special thanks to Dr. Eric Yang from Sunnybrook Hospital's proteomics
   facility for discussions and help with the 2-DE, in gel digestion,
   LC-MS/MS, and protein identification. This study was funded by an
   NSERC/CIHR collaborative grant #337246/83459 (J.P. Santerre, R.S. Labow)
   and CIHR operating grant #230762 (J.P Santerre, R.S. Labow). K.G.
   Battiston was funded by a CIHR Strategic Training Fellowship (STP-53877)
   and by an Ontario Graduate Scholarship (OGS).
CR Abraham S, 2011, BIOMACROMOLECULES, V12, P3567, DOI 10.1021/bm200778u
   Ali OA, 2008, J CONTROL RELEASE, V132, P273, DOI 10.1016/j.jconrel.2008.07.005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Battiston KG, 2012, ACTA BIOMATER, V8, P89, DOI 10.1016/j.actbio.2011.09.015
   BIRKENMEIER G, 1993, J IMMUNOL METHODS, V162, P59, DOI 10.1016/0022-1759(93)90407-X
   Bonacci GR, 2007, ARCH BIOCHEM BIOPHYS, V460, P100, DOI 10.1016/j.abb.2007.01.004
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   Brennan MP, 2008, ANN SURG, V248, P370, DOI 10.1097/SLA.0b013e318184dcbd
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1
   Caceres LC, 2010, J CELL BIOCHEM, V111, P607, DOI 10.1002/jcb.22737
   Campillo-Fernandez AJ, 2009, TISSUE ENG PT A, V15, P1331, DOI 10.1089/ten.tea.2008.0146
   Candiano G, 2009, ELECTROPHORESIS, V30, P2405, DOI 10.1002/elps.200800762
   Chin-Quee SL, 2010, BIOMATERIALS, V31, P648, DOI 10.1016/j.biomaterials.2009.09.079
   Cho SW, 2009, TISSUE ENG PT A, V15, P901, DOI 10.1089/ten.tea.2008.0172
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Ding TT, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035005
   Gagner JE, 2011, BIOMATERIALS, V32, P7241, DOI 10.1016/j.biomaterials.2011.05.091
   Galvani M, 2001, ELECTROPHORESIS, V22, P2058, DOI 10.1002/1522-2683(200106)22:10<2058::AID-ELPS2058>3.0.CO;2-Z
   Gao RP, 2003, HEPATOL RES, V27, P214, DOI 10.1016/S1386-6346(03)00241-9
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gessner A, 2003, J BIOMED MATER RES A, V65A, P319, DOI 10.1002/jbm.a.10371
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Greulich C, 2011, ACTA BIOMATER, V7, P3505, DOI 10.1016/j.actbio.2011.05.030
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Houchin ML, 2008, J PHARM SCI-US, V97, P2395, DOI 10.1002/jps.21176
   Hsu SH, 2010, BIOMATERIALS, V31, P6796, DOI 10.1016/j.biomaterials.2010.05.015
   Huang H, 2011, CHEMPHYSCHEM, V12, P3642, DOI 10.1002/cphc.201100398
   Iba K, 2009, WOUND REPAIR REGEN, V17, P108, DOI 10.1111/j.1524-475X.2008.00447.x
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jozefowicz M, 1997, BIOMATERIALS, V18, P1633, DOI 10.1016/S0142-9612(97)00145-2
   Kim JK, 2005, J BIOMED MATER RES A, V75A, P199, DOI 10.1002/jbm.a.30424
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Magnani A, 2004, ELECTROPHORESIS, V25, P2413, DOI 10.1002/elps.200305826
   Mansell A, 2001, FEBS LETT, V508, P313, DOI 10.1016/S0014-5793(01)03077-0
   Matheson LA, 2007, BIOTECHNIQUES, V42, P744, DOI 10.2144/000112460
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Mirensky TL, 2010, J PEDIATR SURG, V45, P1299, DOI 10.1016/j.jpedsurg.2010.02.102
   NIELSEN H, 1993, SCAND J IMMUNOL, V37, P39, DOI 10.1111/j.1365-3083.1993.tb01662.x
   Nita IM, 2007, INT J BIOCHEM CELL B, V39, P1165, DOI 10.1016/j.biocel.2007.02.017
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   REPOUX M, 1992, SURF INTERFACE ANAL, V18, P567, DOI 10.1002/sia.740180719
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Song Y, 2011, J BIOMED MATER RES A, V98A, P517, DOI 10.1002/jbm.a.33135
   Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029
   Sudhakaran PR, 2007, GLYCOCONJUGATE J, V24, P49, DOI 10.1007/s10719-006-9011-2
   Udelsman B, 2011, TISSUE ENG PART C-ME, V17, P731, DOI [10.1089/ten.tec.2010.0581, 10.1089/ten.TEC.2010.0581]
   Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536
   White TC, 2008, J THROMB HAEMOST, V6, P995, DOI 10.1111/j.1538-7836.2008.02979.x
   WILLIAMS SE, 1994, ANN NY ACAD SCI, V737, P1, DOI 10.1111/j.1749-6632.1994.tb44297.x
   Willnow TE, 1998, BIOL CHEM, V379, P1025
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WOODHOUSE KA, 1992, J COLLOID INTERF SCI, V152, P60, DOI 10.1016/0021-9797(92)90008-A
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zhu YJ, 2010, BIOCHEM J, V428, P47, DOI 10.1042/BJ20100016
   Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510
NR 67
TC 16
Z9 16
U1 4
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 33
BP 8316
EP 8328
DI 10.1016/j.biomaterials.2012.08.014
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 028CS
UT WOS:000310401000013
PM 22940217
DA 2018-10-19
ER

PT J
AU Masand, SN
   Chen, J
   Perron, IJ
   Hammerling, BC
   Loers, G
   Schachner, M
   Shreiber, DI
AF Masand, Shirley N.
   Chen, Jian
   Perron, Isaac J.
   Hammerling, Babette C.
   Loers, Gabriele
   Schachner, Melitta
   Shreiber, David I.
TI The effect of glycomimetic functionalized collagen on peripheral nerve
   repair
SO BIOMATERIALS
LA English
DT Article
DE Peripheral nerve regeneration; PSA; HNK; Glycomimetics; Collagen
ID RAT SCIATIC-NERVE; L2/HNK-1 CARBOHYDRATE EPITOPE; CELL-ADHESION
   MOLECULE; SILICONE TUBES; FEMORAL NERVE; MOTOR NERVES; HNK-1
   CARBOHYDRATE; MYELINATED FIBERS; POLYSIALIC ACID; NEURITE GROWTH
AB Increasing evidence suggests that the improper synaptic reconnection of regenerating axons is a significant cause of incomplete functional recovery following peripheral nerve injury. In this study, we evaluate the use of collagen hydrogels functionalized with two peptide glycomimetics of naturally occurring carbohydrates polysialic acid (PSA) and human natural killer cell epitope epitope (HNK-1) that have been independently shown to encourage nerve regeneration and axonal targeting. Our novel biomaterial was used to bridge a critical gap size (5 mm) in a mouse femoral nerve injury model. Functional recovery was assessed using gait and hind limb extension, and was significantly better in all glycomimetic peptide-coupled collagen conditions versus non-functional scrambled peptide-coupled collagen, native collagen, and saline controls. Analysis of cross-sections of the regenerated nerve demonstrated that hydrogels coupled with the PSA glycomimetic, but not HNK, had significant increases in the number of myelinated axons over controls. Conversely, hydrogels coupled with HNK, but not PSA, showed improvement in myelination. Additionally, significantly more correctly projecting motoneurons were observed in groups containing coupled HNK-1 mimicking peptide, but not PSA mimicking peptide. Given the distinct morphological outcomes between the two glycomimetics, our study indicates that the enhancement of recovery following peripheral nerve injury induced by PSA- and HNK-functionalized collagen hydrogels likely occurs through distinct mechanisms. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Masand, Shirley N.; Perron, Isaac J.; Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Chen, Jian; Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA.
   [Hammerling, Babette C.] Rutgers State Univ, Sch Environm & Biol Sci, Piscataway, NJ 08854 USA.
   [Loers, Gabriele] Univ Hosp Hamburg Eppendorf, Ctr Mol Neurobiol, Hamburg, Germany.
   [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou 515041, Peoples R China.
RP Shreiber, DI (reprint author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
EM schachner@stu.edu.cn; Shreiber@rci.rutgers.edu
OI Shreiber, David/0000-0001-8248-419X
FU National Institutes of Health [NIH 1R21EB009245-01A1]; US Army
   [W81XWH-04-2-0031]; Rutgers-UMDNJ Biotechnology Training Program (NIH)
   [5T32GM008339-20]; National Science Foundation [NSF DGE 0801620]; Aresty
   Research Center for Undergraduates
FX Funding for these studies was provided by the National Institutes of
   Health (NIH 1R21EB009245-01A1) and US Army contract #W81XWH-04-2-0031,
   and fellowships from the Rutgers-UMDNJ Biotechnology Training Program
   (NIH Grant Number 5T32GM008339-20). the National Science Foundation (NSF
   DGE 0801620, IGERT on the Integrated Science and Engineering of Stem
   Cells), and the Aresty Research Center for Undergraduates. MS is a New
   Jersey Professor of Spinal Cord Research. We confirm that all studies
   involving experimental animals were conducted under the ethical approval
   of all relevant bodies.
CR Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Bock P, 2007, J COMP NEUROL, V505, P572, DOI 10.1002/cne.21519
   BRUSHART TME, 1988, J NEUROSCI, V8, P1026
   BRUSHART TME, 1987, EXP NEUROL, V97, P289, DOI 10.1016/0014-4886(87)90090-2
   BRUSHART TME, 1993, J NEUROSCI, V13, P2730
   Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754
   Chou DKH, 2004, J NEUROCHEM, V90, P1389, DOI 10.1111/j.1471-4159.2004.02609.x
   Eberhardt KA, 2006, EXP NEUROL, V198, P500, DOI 10.1016/j.expneurol.2005.12.018
   El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103
   Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852
   Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y
   Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005
   Franz CK, 2008, BRAIN, V131, P1492, DOI 10.1093/brain/awn039
   HALL H, 1993, EUR J NEUROSCI, V5, P34, DOI 10.1111/j.1460-9568.1993.tb00202.x
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Hudson TW, 1999, CLIN PLAST SURG, V26, P617
   Irintchev A, 2005, EUR J NEUROSCI, V22, P802, DOI 10.1111/j.1460-9568.2005.04274.x
   Irintchev A, 2011, J NEUROTRAUM, V28, P1295, DOI 10.1089/neu.2011.1775
   Irintchev A, 2011, ANN ANAT, V193, P276, DOI 10.1016/j.aanat.2011.02.019
   Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200
   Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z
   Luo J, 2010, GLIA
   Madison RD, 1996, J NEUROSCI, V16, P5698
   Magnani John L, 2009, Discov Med, V8, P247
   MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x
   MARTINI R, 1994, J NEUROSCI, V14, P7180
   MARTINI R, 1988, DEV BIOL, V129, P330, DOI 10.1016/0012-1606(88)90380-6
   Masand SN, 2012, BIOMATERIALS, V33, P790, DOI 10.1016/j.biomaterials.2011.10.013
   McCreery DB, 1997, J NEUROSCI METH, V73, P159, DOI 10.1016/S0165-0270(97)02223-1
   Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235
   Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128
   Monte-Raso VV, 2008, J NEUROSCI METH, V170, P255, DOI 10.1016/j.jneumeth.2008.01.022
   Monteiro GA, 2009, TISSUE ENG A
   Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x
   Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com
   ROSEN JM, 1990, ANN PLAS SURG, V25, P375, DOI 10.1097/00000637-199011000-00006
   SATOU T, 1986, ACTA PATHOL JAPON, V36, P199
   SHENAQ JM, 1989, MICROSURG, V10, P214, DOI 10.1002/micr.1920100315
   Shreiber DI, 2003, BIOPHYS J, V84, P4102, DOI 10.1016/S0006-3495(03)75135-2
   Simon-Haldi M, 2002, J NEUROCHEM, V83, P1380, DOI 10.1046/j.1471-4159.2002.01247.x
   Simova O, 2006, ANN NEUROL, V60, P430, DOI 10.1002/ana.20948
   SUMNER AJ, 1990, MUSCLE NERVE, V13, P801, DOI 10.1002/mus.880130905
   Sundararaghavan HG, 2011, J NEUROTRAUM, V28, P2377, DOI 10.1089/neu.2010.1606
   Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074
   Sunderland S, 1978, NERVES NERVE INJURIE
   Torregrossa P, 2004, J BIOL CHEM, V279, P30707, DOI 10.1074/jbc.M403935200
   Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833
   Verdu E, 2002, RESTOR NEUROL NEUROS, V20, P169
   ZHAO Q, 1993, RESTOR NEUROL NEUROS, V5, P197, DOI 10.3233/RNN-1993-5304
NR 49
TC 12
Z9 14
U1 2
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 33
BP 8353
EP 8362
DI 10.1016/j.biomaterials.2012.08.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 028CS
UT WOS:000310401000016
PM 22917737
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Subramanian, B
   Ko, WC
   Yadav, V
   DesRochers, TM
   Perrone, RD
   Zhou, J
   Kaplan, DL
AF Subramanian, Balajikarthick
   Ko, Wei-Che
   Yadav, Vikas
   DesRochers, Teresa M.
   Perrone, Ronald D.
   Zhou, Jing
   Kaplan, David L.
TI The regulation of cystogenesis in a tissue engineered kidney disease
   system by abnormal matrix interactions
SO BIOMATERIALS
LA English
DT Article
DE Silk; Scaffold; Integrins; Extracellular matrix; Epithelium; Polycystic
   kidney disease
ID EXTRACELLULAR-MATRIX; CELL-PROLIFERATION; CYSTIC DISEASES; GENE-PRODUCT;
   MDCK CELLS; POLYCYSTIN-1; PKD1; BETA-1-INTEGRIN; POLARITY; ADHESION
AB Autosomal Dominant Polycystic Kidney Disease (ADPKD) remains a major health care concern affecting several million patients worldwide and for which there is no specific treatment. We have employed a 3D tissue engineered disease-like system to emulate cystic structures in vitro and analyzed the extracellular matrix (ECM) interactions in it. The tissue system was developed by culturing normal or polycystin-1 silenced mouse Inner Medullary Collecting Duct (mIMCD) cells in ECM infused into 3D porous silk protein biomaterial scaffolds. In this system, the silk scaffolds provide slow degradation, biocompatibility. and maintain structure and transport for the 3D system, while the ECM molecules retain biological signaling. Using this 3D tissue system we provide evidence for an autocrine signaling loop involving abnormal matrix deposition (collagen type IV and laminin) and its integrin receptor subunit protein (Integrin-beta 1) in Pkd1 silenced mIMCD cells. In addition, we report that abnormal pericystic ECM interactions between matrix molecules and integrin subunit proteins regulate the rate of cystogenesis in the disease system. Molecular signaling showed abnormalities in cyclin proteins and cell-cycle progression upon Pkd1 knockdown. Importantly, disruption of the abnormal matrix interactions by an additional knockdown (double-silencing) of integrin-beta 1 in Pkd1 silenced cells reversed the abnormalities and reduced the rate of cystogenesis. Together, these findings indicate that abnormal matrix deposition and altered integrin profile distribution as observed in ADPKD and are critical in cystogenesis and should be considered a target for the development of therapeutics. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Subramanian, Balajikarthick; Ko, Wei-Che; Yadav, Vikas; DesRochers, Teresa M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Subramanian, Balajikarthick] Univ Massachusetts Lowell, Biomed Engn & Biotechnol Program, Lowell, MA 01854 USA.
   [Perrone, Ronald D.] Tufts Univ, Sch Med, Div Nephrol, Tufts Med Ctr, Boston, MA 02111 USA.
   [Zhou, Jing] Harvard Univ, Sch Med, Div Renal, Brigham & Womens Hosp, Boston, MA 02115 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU Genzyme GRIP program; National Institute of Health Tissue Engineering
   Resource Center [P41 EB002520]; Hoffmann-La Roche
FX The authors thank Carmen Preda from Biomedical Engineering, Tufts
   University, for laboratory assistance. This research was supported by
   Genzyme GRIP program; Hoffmann-La Roche and the National Institute of
   Health Tissue Engineering Resource Center [P41 EB002520] to David
   Kaplan.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Battini L, 2006, J AM SOC NEPHROL, V17, P3049, DOI 10.1681/ASN.2006030234
   Bell PD, 2011, J AM SOC NEPHROL, V22, P839, DOI 10.1681/ASN.2010050526
   Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072
   Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4
   Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6
   Bonsib SM, 2010, ARCH PATHOL LAB MED, V134, P554, DOI 10.1043/1543-2165-134.4.554
   Bonsib SM, 2009, CLIN J AM SOC NEPHRO, V4, P1998, DOI 10.2215/CJN.02020309
   Chapin HC, 2011, J CELL BIOL, V191, P701
   CUPPAGE FE, 1980, KIDNEY INT, V17, P372, DOI 10.1038/ki.1980.43
   Gray RS, 2010, CURR OPIN CELL BIOL, V22, P640, DOI 10.1016/j.ceb.2010.08.019
   Henry MD, 2001, J CELL SCI, V114, P1137
   Hines DJ, 2011, BIOMACROMOLECULES, V12, P804, DOI 10.1021/bm101421r
   Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42
   Joly D, 2003, AM J PATHOL, V163, P1791, DOI 10.1016/S0002-9440(10)63539-0
   Joly D, 2006, J BIOL CHEM, V281, P29181, DOI 10.1074/jbc.M606151200
   Kim H, 2004, EUR J HUM GENET, V12, P433, DOI 10.1038/sj.ejhg.5201136
   Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326
   Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179
   Luyten A, 2010, J AM SOC NEPHROL, V21, P1521, DOI 10.1681/ASN.2010010127
   Malhas AN, 2002, J AM SOC NEPHROL, V13, P19
   Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Natoli TA, 2008, AM J PHYSIOL-RENAL, V294, pF73, DOI 10.1152/ajprenal.00362.2007
   Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076
   Nishio S, 2005, J CLIN INVEST, V115, P910, DOI 10.1172/JCI200522850
   O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831
   Perez VAD, 2011, J CELL BIOL, V192, P171, DOI 10.1083/jcb.201008060
   Perin L, 2011, ADV DRUG DELIVER REV, V63, P379, DOI 10.1016/j.addr.2010.12.001
   Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675
   Qin SA, 2010, J CLIN INVEST, V120, P3617, DOI 10.1172/JCI41531
   Ramasubbu K, 1998, J AM SOC NEPHROL, V9, P937
   Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296
   Shannon MB, 2006, J AM SOC NEPHROL, V17, P1913, DOI 10.1681/ASN.2005121298
   Streets AJ, 2009, J CELL SCI, V122, P1410, DOI 10.1242/jcs.045021
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Sullivan LP, 1998, PHYSIOL REV, V78, P1165
   Sweet DH, 2006, KIDNEY INT, V69, P837, DOI 10.1038/sj.ki.5000170
   Takakura A, 2009, HUM MOL GENET, V18, P2523, DOI 10.1093/hmg/ddp147
   Talbot JJ, 2011, P NATL ACAD SCI USA, V108, P7985, DOI 10.1073/pnas.1103816108
   Wilson PD, 2008, CURR TOP DEV BIOL, V84, P311, DOI 10.1016/S0070-2153(08)00606-6
   Wilson PD, 1999, EXP NEPHROL, V7, P114
   Wilson PD, 1999, LAB INVEST, V79, P1311
   WILSON PD, 1992, J CELL PHYSIOL, V150, P360, DOI 10.1002/jcp.1041500220
   Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010
   Yang BX, 2008, J AM SOC NEPHROL, V19, P1300, DOI 10.1681/ASN.2007070828
   Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mcb.E04-05-0435
   Zhang X, 2009, DEVELOPMENT, V136, P3357, DOI 10.1242/dev.036269
   Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621
NR 49
TC 17
Z9 17
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 33
BP 8383
EP 8394
DI 10.1016/j.biomaterials.2012.08.020
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 028CS
UT WOS:000310401000019
PM 22940218
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wang, YW
   Tran, KK
   Shen, H
   Grainger, DW
AF Wang, Yuwei
   Tran, Kenny K.
   Shen, Hong
   Grainger, David W.
TI Selective local delivery of RANK siRNA to bone phagocytes using bone
   augmentation biomaterials
SO BIOMATERIALS
LA English
DT Article
DE siRNA; PLGA microparticles; Calcium phosphate bone cement; Bone
   augmentation
ID CALCIUM-PHOSPHATE CEMENT; OSTEOCLASTOGENESIS-INHIBITORY FACTOR; PLASMID
   DNA; IN-VITRO; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR;
   MECHANICAL-PROPERTIES; INTERFERING RNA; POROUS IMPLANTS; GENE DELIVERY
AB Fracture healing and fracture fixation in the context of osteoporosis is extremely difficult. To inhibit osteoclast-induced bone resorption and associated implant loosening in this pathology, we describe a local delivery strategy to delivery RNA interfering technology to bone sites to target and down-regulate osteoclast formation and function. Resorbable polymer, poly(lactic-co-glycolic acid) (PLGA) microparticles were exploited as a passive phagocyte-targeting carrier to deliver RANK siRNA to both osteoclast precursors and osteoclasts - the professional phagocytes in bone. These natural phagocytes internalize micron-sized particles while most other non-targeted cells in bone cannot. PLGA-siRNA microparticles were dispersed within biomedical grade calcium-based injectable bone cement clinically used in osteoporosis as a bone augmentation biomaterial for fragility fracture prevention and fixation. siRNA released from this formulation in vitro retains bioactivity against the cell target. RANK, in cultured osteoclast precursor cells, inhibiting their progression toward the osteoclastic phenotype. These data support the proof-of-concept to utilize a clinically relevant approach to locally deliver siRNA to phagocytes in bone and improve fragility fracture healing in the context of osteoporosis. This local delivery system delivers siRNA therapeutics directly to osteoporosis sites from clinically familiar injected bone augmentation materials but could be extended to other injectable biomaterials for local siRNA delivery. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Wang, Yuwei; Grainger, David W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Tran, Kenny K.; Shen, Hong] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   [Grainger, David W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Grainger, DW (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
EM Yuwei.wang@utah.edu; kynam@u.washington.edu; hs24@u.washington.edu;
   david.grainger@utah.edu
FU NIH [EB00894]; University of Utah
FX The authors appreciate the generous gift of the RANKL plasmid expression
   construct from Professor M. F. Manolson, University of Toronto, Canada
   and donated CPC samples from BioMet. We thank I. Zharov, University of
   Utah, for access to a ceramic oven, and J. Wolchok for his assistance
   with mechanical testing. This work was partially supported by NIH grant
   EB00894 and a SEED grant from the University of Utah.
CR Abbas AO, 2008, J PHARM SCI-US, V97, P2448, DOI 10.1002/jps.21215
   Achenbach TV, 2003, CHEMBIOCHEM, V4, P928, DOI 10.1002/cbic.200300708
   ALONSO MJ, 1993, PHARMACEUT RES, V10, P945, DOI 10.1023/A:1018942118148
   Blom EJ, 2000, J BIOMED MATER RES, V50, P67, DOI 10.1002/(SICI)1097-4636(200004)50:1<67::AID-JBM10>3.0.CO;2-E
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839
   Capan Y, 1999, PHARMACEUT RES, V16, P509, DOI 10.1023/A:1018862827426
   Cejka D, 2006, CLIN SCI, V110, P47, DOI 10.1042/CS20050162
   Choung S, 2006, BIOCHEM BIOPH RES CO, V342, P919, DOI 10.1016/j.bbrc.2006.02.049
   Cook SD, 2002, J ARTHROPLASTY, V17, P402, DOI 10.1054/arth.2002.32169
   Dong L, 2011, PHARM RES-DORDR, V28, P1349, DOI 10.1007/s11095-010-0334-0
   Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Habraken WJEM, 2006, J BIOMAT SCI-POLYM E, V17, P1057, DOI 10.1163/156856206778366004
   Habraken WJEM, 2008, BIOMATERIALS, V29, P2464, DOI 10.1016/j.biomaterials.2008.02.012
   Hirota K, 2007, J CONTROL RELEASE, V119, P69, DOI 10.1016/j.jconrel.2007.01.013
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jiang G, 2008, BIOPOLYMERS, V89, P635, DOI 10.1002/bip.20978
   KADOYA Y, 1994, BONE MINER, V27, P85, DOI 10.1016/S0169-6009(08)80211-5
   Kong YY, 1999, NATURE, V397, P315
   Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Larsson S, 2002, Scand J Surg, V91, P140
   Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Link DP, 2006, BIOMATERIALS, V27, P4941, DOI 10.1016/j.biomaterials.2006.05.022
   Majling J, 1997, J MATER RES, V12, P198, DOI 10.1557/JMR.1997.0026
   Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788
   OTSUKA M, 1995, J PHARM SCI, V84, P733, DOI 10.1002/jps.2600840614
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Patil Y, 2009, INT J PHARM, V367, P195, DOI 10.1016/j.ijpharm.2008.09.039
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Sabokbar A, 1997, ANN RHEUM DIS, V56, P414, DOI 10.1136/ard.56.7.414
   Sebba A, 2008, CURR OPIN ENDOCRINOL, V15, P502, DOI 10.1097/MED.0b013e328317ca83
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121
   SUMNER DR, 1995, J BONE JOINT SURG AM, V77A, P1135, DOI 10.2106/00004623-199508000-00001
   Takechi M, 1998, J BIOMED MATER RES, V39, P308, DOI 10.1002/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.3.CO;2-F
   Tanzer M, 2005, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000194728.62996.2d
   Tanzer M, 1996, J ORTHOPAED RES, V14, P901, DOI 10.1002/jor.1100140609
   von der Linden P, 2006, J ORTHOP RES, V24, P2230, DOI 10.1002/jor.20299
   Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1197, DOI 10.1021/bm025563c
   Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6
   Wang Y, 2012, ADV DRUG DELIV REV
   Wang Y, 2011, MOL PHARMACEUT, V8, P1016, DOI 10.1021/mp100374n
   Wang YW, 2010, PHARM RES-DORDR, V27, P1273, DOI 10.1007/s11095-010-0099-5
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]
   Wu F, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044105
   Yang KY, 2007, YONSEI MED J, V48, P653, DOI 10.3349/ymj.2007.48.4.653
   Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329
   Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597
   Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617
NR 55
TC 21
Z9 22
U1 0
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 33
BP 8540
EP 8547
DI 10.1016/j.biomaterials.2012.07.039
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 028CS
UT WOS:000310401000033
PM 22951320
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Takamura, T
   Ko, PJ
   Ishikawa, R
   Sandhu, A
AF Takamura, T.
   Ko, P. J.
   Ishikawa, R.
   Sandhu, A.
TI Detection of Nanometer Magnetic Labels' Concentration Via the Movement
   of Micrometer Superparamagnetic in Application of Magnetic Field
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article; Proceedings Paper
CT International Magnetics Conference (INTERMAG)
CY MAY 07-11, 2012
CL Vancouver, CANADA
SP IEEE, Magnet Soc
DE Biomedical transducers; magnetic labeling; magnetoresistive devices;
   medical diagnosis; self-assembly
AB Research on medical diagnostics for point of care treatment (POCT) is driven by demand for rapid, high sensitivity, and inexpensive point of care diagnosis of heart disease, infection, allergies and cancer. Demands to improve quantification and affinity necessitate magnetic labels with sizes comparable to target molecules. However, it is extremely challenging to detect small concentrations of sub-200 nm functionalized magnetic labels using magnetoresistive-based sensors. In order to overcome these limitations we have developed a simple procedure for detecting similar to 130 nm sized magnetic labels via magnetically induced capture of micrometer sized superparamagnetic beads by several 130 nm-diameter target beads immobilized on substrates. Here we demonstrate a new method to improve the quantification of our protocol that exploits magnetically induced frictional forces between micro-sized beads and target magnetic labels. By reducing the external magnetic field, the magnetically captured micro-sized beads restart to flow due to electrostatic forces and the strength of the critical external magnetic field for release depends on the number of nano-sized beads immobilized on substrate. Our protocol has the possibility for quantitative biomaterial detection.
C1 [Takamura, T.; Ishikawa, R.; Sandhu, A.] Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1528552, Japan.
   [Ko, P. J.; Sandhu, A.] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi 4418580, Japan.
RP Sandhu, A (reprint author), Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1528552, Japan.
EM sandhu@eiiris.tut.ac.jp
RI Sandhu, Adarsh/A-1818-2011
CR Mihajlovic G, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2802732
   Morimoto Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3556957
   Morimoto Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3352584
   Morimoto Y, 2009, IEEE T MAGN, V45, P2871, DOI 10.1109/TMAG.2009.2018861
   Sandhu A, 2007, NAT NANOTECHNOL, V2, P746, DOI 10.1038/nnano.2007.398
   Sandhu A, 2007, BIOSENS BIOELECTRON, V22, P2115, DOI 10.1016/j.bios.2006.09.021
   Takamura T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.04DL10
   Tamanaha CR, 2008, BIOSENS BIOELECTRON, V24, P1, DOI 10.1016/j.bios.2008.02.009
   Unni HN, 2007, ELECTROPHORESIS, V28, P658, DOI 10.1002/elps.200600576
   Wang SX, 2008, IEEE T MAGN, V44, P1687, DOI 10.1109/TMAG.2008.920962
NR 10
TC 0
Z9 0
U1 1
U2 12
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD NOV
PY 2012
VL 48
IS 11
BP 2835
EP 2837
DI 10.1109/TMAG.2012.2202096
PG 3
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 025MV
UT WOS:000310194400027
DA 2018-10-19
ER

PT J
AU Chan, BK
   Wippich, CC
   Wu, CJ
   Sivasankar, PM
   Schmidt, G
AF Chan, Burke K.
   Wippich, Caitlin C.
   Wu, Chia-Jung
   Sivasankar, Preeti M.
   Schmidt, Gudrun
TI Robust and Semi-Interpenetrating Hydrogels from Poly(ethylene glycol)
   and Collagen for Elastomeric Tissue Scaffolds
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE collagen; fibroblasts; hydrogels; networks; poly(ethylene glycol)
ID NANOCOMPOSITE HYDROGELS; POLYMER SCAFFOLDS; CELL-ADHESION;
   CROSS-LINKING; SMOOTH-MUSCLE; PEG HYDROGEL; NETWORKS; BIOMATERIALS;
   DESIGN; PROTEIN
AB Here we present an injectable PEG/collagen hydrogel system with robust networks for use as elastomeric tissue scaffolds. Covalently crosslinked PEG and physically crosslinked collagen form semi-interpenetrating networks. The mechanical strength of the hydrogels depends predominantely on the PEG concentration but the incorporation of collagen into the PEG network enhances hydrogel viscoelasticity, elongation, and also cell adhesion properties. Experimental data show that this hydrogel system exhibits tunable mechanical properties that can be further developed. The hydrogels allow cell adhesion and proliferation in vitro. The results support the prospect of a robust and semi-interpenetrating biomaterial for elastomeric tissue scaffolds applications.
C1 [Chan, Burke K.; Wippich, Caitlin C.; Wu, Chia-Jung; Schmidt, Gudrun] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
RP Schmidt, G (reprint author), Purdue Univ, Weldon Sch Biomed Engn, 206 S Martin Jischke Dr, W Lafayette, IN 47907 USA.
EM gudrun@purdue.edu
FU Weldon School of Biomedical Engineering
FX This research has been supported by the Weldon School of Biomedical
   Engineering. We would like to acknowledge Debbie Sherman for assistance
   with cryo-SEM imaging.
CR Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Brigham MD, 2009, TISSUE ENG PT A, V15, P1645, DOI 10.1089/ten.tea.2008.0441
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Chang CW, 2010, SOFT MATTER, V6, P5157, DOI 10.1039/c0sm00067a
   Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P4139, DOI 10.1016/j.actbio.2011.07.023
   Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   Gemeinhart RA, 2000, J BIOMAT SCI-POLYM E, V11, P1371, DOI 10.1163/156856200744390
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Guarino V, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P227, DOI 10.1007/978-1-4419-5919-5_12
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]
   Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284
   Jin R, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P203, DOI 10.1007/978-1-4419-5919-5_11
   Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200
   Jonker AM, 2012, CHEM MATER, V24, P759, DOI 10.1021/cm202640w
   Joshi N, 2008, CURR TOP MED CHEM, V8, P1225, DOI 10.2174/156802608785849067
   Kim SH, 2000, J BIOMED MATER RES, V53, P258, DOI 10.1002/(SICI)1097-4636(2000)53:3<258::AID-JBM11>3.3.CO;2-F
   Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009
   Kutty JK, 2007, BIOMATERIALS, V28, P4928, DOI 10.1016/j.biomaterials.2007.08.007
   Lee JW, 1999, J APPL POLYM SCI, V73, P113
   Lee SY, 2007, J CONTROL RELEASE, V119, P313, DOI 10.1016/j.jconrel.2007.03.007
   Lee WF, 2001, J APPL POLYM SCI, V82, P2487, DOI 10.1002/app.2099
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Matzelle TR, 2002, J PHYS CHEM B, V106, P2861, DOI 10.1021/jp0128426
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Murosaki T, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P285, DOI 10.1007/978-1-4419-5919-5_15
   Nagel T, 2012, J R SOC INTERFACE, V9, P777, DOI 10.1098/rsif.2011.0449
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Robinson KG, 2012, J BIOMED MATER RES A, V100A, P1356, DOI 10.1002/jbm.a.34075
   Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005
   Sargeant TD, 2012, ACTA BIOMATER, V8, P124, DOI 10.1016/j.actbio.2011.07.028
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Skardal A, 2010, BIOMATERIALS, V31, P8426, DOI 10.1016/j.biomaterials.2010.07.047
   Taribagil RR, 2010, MACROMOLECULES, V43, P5396, DOI 10.1021/ma100464z
   Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4
   Vermonden T, 2010, MACROMOLECULES, V43, P782, DOI 10.1021/ma902186e
   Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0
   Weiss P, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P247, DOI 10.1007/978-1-4419-5919-5_13
   Wu CJ, 2011, MACROMOLECULES, V44, P8215, DOI 10.1021/ma200562k
   Zhang J, 2002, J BIOMAT SCI-POLYM E, V13, P511, DOI 10.1163/15685620260178373
NR 56
TC 21
Z9 21
U1 3
U2 66
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD NOV
PY 2012
VL 12
IS 11
BP 1490
EP 1501
DI 10.1002/mabi.201200234
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 030WT
UT WOS:000310601500007
PM 23070957
DA 2018-10-19
ER

PT J
AU Kumar, BS
   Aigal, S
   Ramesh, DV
AF Kumar, B. Santhosh
   Aigal, Sahaja
   Ramesh, D. Vijaya
TI Air-dried 3D-collagen-chitosan biocomposite scaffold for tissue
   engineering application
SO POLYMER COMPOSITES
LA English
DT Article
ID COLLAGEN SPONGE; BIOMATERIAL; CHITOSAN; CALCIFICATION; GENTAMICIN;
   PREVENTION; INFECTION; RELEASE; SURGERY; MTT
AB Collagenchitosan scaffolds of different compositions were developed using emulsion air-drying method. The scaffolds prepared adding 1030 wt% of chitosan to collagen improved the mechanical properties of the composite scaffold, and 7:3 ratio (collagen :chitosan) was found to be a better composite having a tensile strength of 13.57 MPa with 9% elongation at break. The water-uptake characteristics were performed at different pH and found to be ameliorated for the composite scaffolds compared to pure collagen and chitosan scaffold, respectively. The pores ranging from 100 to 300 mu m were well interconnected, and their distribution was fairly homogeneous in the scaffold as observed through scanning electron microscopy. Furthermore, the scaffold decreased the bacterial counts and supported fibroblasts attachment and proliferation, thus demonstrating this composite to be a good substrate for biomedical application.POLYM. COMPOS., 33:20292035, 2012. (C) 2012 Society of Plastics Engineers
C1 [Kumar, B. Santhosh; Ramesh, D. Vijaya] Cent Leather Res Inst, Council Sci & Ind Res Adyar, Biomat Div, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Aigal, Sahaja] Univ Madras, Dept Biotechnol, Madras, Tamil Nadu, India.
RP Ramesh, DV (reprint author), Cent Leather Res Inst, Council Sci & Ind Res Adyar, Biomat Div, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM vija1719@yahoo.com
CR Bi X, 2005, OSTEOARTHR CARTILAGE, V13, P1050, DOI 10.1016/j.joca.2005.07.008
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   Chvapil M, 1980, BIOL COLLAGEN, P313
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   Grzybowski J, 1997, J BIOMED MATER RES, V36, P163, DOI 10.1002/(SICI)1097-4636(199708)36:2<163::AID-JBM4>3.0.CO;2-I
   KLOPPER PJ, 1986, EUR SURG RES, V18, P218, DOI 10.1159/000128529
   Koide T, 1997, Dent Mater J, V16, P1
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lee JE, 2002, ARTIF ORGANS, V26, P521, DOI 10.1046/j.1525-1594.2002.06890.x
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   MATSUDA K, 1992, BIOMATERIALS, V13, P119, DOI 10.1016/0142-9612(92)90007-B
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   OCHI M, 1998, CONTROVERSIES ORTHOP, P549
   PETER XM, 2004, MATER TODAY, V7, P30
   PHARRISS BB, 1980, J AM LEATHER CHEM AS, V75, P474
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Ru C. P., 2004, BIOMATERIALS, V25, P5667
   Ru C. P., 2005, BIOMATERIALS, V26, P6579
   Rutten HJT, 1997, EUR J SURG, V163, P31
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SEHGAL PK, 1999, Patent No. 1351
   Senthil M. K., 2008, J SURG RES, V158, P162
   SPEI M, 1989, COLLOID POLYM SCI, V267, P549, DOI 10.1007/BF01416064
   Sripriya R, 2004, J BIOMED MATER RES B, V70B, P389, DOI 10.1002/jbm.b.30051
   Sripriya R, 2003, J APPL POLYM SCI, V87, P2186, DOI 10.1002/app.11651
   Stemberger H., 1997, EUR J SURG, V163, P17
   TAKAYUKI A, 1982, INT J BIOL MACROMOL, V4, P165
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   Wojciechowska A., 1999, J MOL STRUCT, V511, P307
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 34
TC 8
Z9 8
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-8397
J9 POLYM COMPOSITE
JI Polym. Compos.
PD NOV
PY 2012
VL 33
IS 11
BP 2029
EP 2035
DI 10.1002/pc.22345
PG 7
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 023XC
UT WOS:000310069700019
DA 2018-10-19
ER

PT J
AU Wang, HT
   Yuan, TQ
   Meng, LJ
   She, D
   Geng, ZC
   Sun, RC
AF Wang, Hai-Tao
   Yuan, Tong-Qi
   Meng, Ling-Jun
   She, Diao
   Geng, Zeng-Chao
   Sun, Run-Cang
TI Structural and thermal characterization of lauroylated hemicelluloses
   synthesized in an ionic liquid
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Biomaterial; Lauroylated hemicellulose; Ionic liquid; Degradation;
   Thermal stability
ID WHEAT-STRAW HEMICELLULOSES; GROWING POPLAR WOOD; PHYSICOCHEMICAL
   CHARACTERIZATION; SUGARCANE BAGASSE; LIGNOCELLULOSIC MATERIALS;
   HOMOGENEOUS SYSTEM; ORGANIC-SOLVENT; SUBSTITUTION; FILMS; CELLULOSE
AB Chemical modification provides an efficient way to obtain novel biomaterials from abundant biomacromolecules. In this case, lauroylated hemicelluloses (LH) with degree of substitutions (DS) between 0.43 and 1.82 were synthesized in 1-butyl-3-methylimidazolium chloride ([BMIM]Cl) ionic liquid. The influence of reaction parameters including the molar ratio of lauroyl chloride (LC) to anhydroxylose units in hemicelluloses (0.5:1-3:1), reaction temperature (80-90 degrees C), and reaction time (15-90 min) was studied. The results indicated that homogeneous modification was successfully conducted and highly substituted hemicelluloses esters were obtained. In comparison, the hemicellulose and LH were characterized by both degradative methods such as thermal analysis (TGA/DTG), and non-degradative techniques such as Fourier transform infrared (FT-IR), C-13 nuclear magnetic resonance (NMR) spectroscopy, and scanning electron microscopy (SEM). It was found that a significant degradation of the hemicellulose polymers occurred during lauroylation with the increase of the molar ratio, time, and temperature. The thermal stability of LH was lower that of the native hemicelluloses, and the morphological properties of hemicellulose were significantly changed after the chemical modification. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Yuan, Tong-Qi; Sun, Run-Cang] Beijing Forestry Univ, Inst Biomass Chem & Technol, Beijing 100083, Peoples R China.
   [Wang, Hai-Tao; Meng, Ling-Jun; She, Diao; Geng, Zeng-Chao] NW Agr & Forest Univ, Coll Resources & Environm, Yangling 712100, Peoples R China.
   [Sun, Run-Cang] S China Univ Technol, State Key Lab Pulp & Paper Engineer, Guangzhou 510641, Guangdong, Peoples R China.
RP Sun, RC (reprint author), Beijing Forestry Univ, Inst Biomass Chem & Technol, Beijing 100083, Peoples R China.
EM gengzengchao@126.com; rcsun3@bjfu.edu.cn
FU National Natural Science Foundation of China [30930073, 31070526]; Major
   State Basic Research Projects of China [973-2010CB732204]
FX We express our gratitude for the financial support from the National
   Natural Science Foundation of China (30930073 and 31070526), Major State
   Basic Research Projects of China (973-2010CB732204).
CR Aburto J, 1999, STARCH-STARKE, V51, P132, DOI 10.1002/(SICI)1521-379X(199904)51:4<132::AID-STAR132>3.3.CO;2-Q
   EBRINGEROVA A, 1994, CARBOHYD POLYM, V24, P301, DOI 10.1016/0144-8617(94)90075-2
   Edlund U, 2008, J BIOACT COMPAT POL, V23, P171, DOI 10.1177/0883911507088400
   El Seoud OA, 2007, BIOMACROMOLECULES, V8, P2629, DOI 10.1021/bm070062i
   Feng L, 2008, J MOL LIQ, V142, P1, DOI 10.1016/j.molliq.2008.06.007
   FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125
   Fukaya Y, 2006, BIOMACROMOLECULES, V7, P3295, DOI 10.1021/bm060327d
   Hallac BB, 2009, J AGR FOOD CHEM, V57, P1275, DOI 10.1021/jf8030277
   Hammerschlag R, 2006, ENVIRON SCI TECHNOL, V40, P1744, DOI 10.1021/es052024h
   Hansen NML, 2008, BIOMACROMOLECULES, V9, P1493, DOI 10.1021/bm800053Z
   Hartman J, 2006, J APPL POLYM SCI, V100, P2985, DOI 10.1002/app.22958
   Jang BN, 2004, POLYM DEGRAD STABIL, V86, P419, DOI 10.1016/j.polymdegradstab.2004.05.009
   Joly N, 2006, E-POLYMERS
   Kapusniak J, 2007, J FOOD ENG, V78, P323, DOI 10.1016/j.jfoodeng.2005.09.028
   Kubisa P, 2005, J POLYM SCI POL CHEM, V43, P4675, DOI 10.1002/pola.20971
   Lucas M, 2010, ACS APPL MATER INTER, V2, P2198, DOI 10.1021/am100371q
   Michael Z., 2009, BIORESOURCE TECHNOL, V100, P2580
   Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916
   Montaudo G, 2002, POLYM DEGRAD STABIL, V77, P137, DOI 10.1016/S0141-3910(02)00092-7
   Musser BJ, 1998, ENERG FUEL, V12, P109
   Nadji H, 2009, BIORESOURCE TECHNOL, V100, P3585, DOI 10.1016/j.biortech.2009.01.074
   Nguyen TAD, 2010, BIORESOURCE TECHNOL, V101, P7432, DOI 10.1016/j.biortech.2010.04.053
   Nie XN, 2011, J BIOBASED MATER BIO, V5, P265, DOI 10.1166/jbmb.2011.1136
   Peng XW, 2011, CARBOHYD POLYM, V86, P1768, DOI 10.1016/j.carbpol.2011.07.018
   Peng XW, 2011, BIOMACROMOLECULES, V11, P3519
   Petzold K, 2006, CARBOHYD POLYM, V64, P292, DOI 10.1016/j.carbpol.2005.11.037
   Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947
   Ren JL, 2007, CARBOHYD POLYM, V70, P406, DOI 10.1016/j.carbpol.2007.04.022
   Ren JL, 2007, CARBOHYD POLYM, V67, P347, DOI 10.1016/j.carbpol.2006.06.002
   Ren JL, 2006, POLYM DEGRAD STABIL, V91, P2579, DOI 10.1016/j.polymdegradstab.2006.05.008
   Ren JL, 2008, POLYM DEGRAD STABIL, V93, P786, DOI 10.1016/j.polymdegradstab.2008.01.011
   Ren JL, 2008, J AGR FOOD CHEM, V56, P1251, DOI 10.1021/jf072983q
   Ren JL, 2008, J AGR FOOD CHEM, V56, P11209, DOI 10.1021/jf802538f
   Ruiz G, 2007, J APPL PHYCOL, V19, P1, DOI 10.1007/s10811-006-9103-1
   Samuel R, 2011, POLYM DEGRAD STABIL, V96, P2002, DOI 10.1016/j.polymdegradstab.2011.08.015
   Schwikal K, 2006, MACROMOL SYMP, V232, P49, DOI 10.1002/masy.200551406
   Schwikal K, 2007, POLYM BULL, V59, P161, DOI 10.1007/s00289-007-0755-z
   Sun RC, 2001, CARBOHYD POLYM, V44, P29, DOI 10.1016/S0144-8617(00)00196-X
   Sun RC, 2000, POLYM DEGRAD STABIL, V67, P345, DOI 10.1016/S0141-3910(99)00136-6
   Sun RC, 2002, INT J POLYM ANAL CH, V7, P130, DOI 10.1080/10236660214602
   Sun RC, 2002, J APPL POLYM SCI, V83, P757, DOI 10.1002/app.2270
   Sun RC, 1999, POLYM J, V31, P857, DOI 10.1295/polymj.31.857
   Sun XF, 2004, J SCI FOOD AGR, V84, P800, DOI 10.1002/jsfa.1735
   Vilaplana F, 2010, POLYM DEGRAD STABIL, V95, P2147, DOI 10.1016/j.polymdegradstab.2010.07.016
   Xie H, 2007, BIOMACROMOLECULES, V8, P3740, DOI 10.1021/bm700679s
   Xu F, 2006, POLYM DEGRAD STABIL, V91, P1880, DOI 10.1016/j.polymdegradstab.2005.11.002
   Yuan TQ, 2010, BIOTECHNOL ADV, V28, P583, DOI 10.1016/j.biotechadv.2010.05.016
   Zhang H, 2005, MACROMOLECULES, V38, P8272, DOI 10.1021/ma0505676
NR 48
TC 11
Z9 11
U1 0
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD NOV
PY 2012
VL 97
IS 11
BP 2323
EP 2330
DI 10.1016/j.polymdegradstab.2012.07.033
PG 8
WC Polymer Science
SC Polymer Science
GA 031PS
UT WOS:000310655000028
DA 2018-10-19
ER

PT J
AU Yang, TL
   Lin, L
   Hsiao, YC
   Lee, HW
   Young, TH
AF Yang, Tsung-Lin
   Lin, Lin
   Hsiao, Ya-Chuan
   Lee, Hao-Wei
   Young, Tai-Horng
TI Chitosan Biomaterials Induce Branching Morphogenesis in a Model of
   Tissue-Engineered Glandular Organs in Serum-Free Conditions
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MAMMARY EPITHELIAL-CELLS; SALIVARY-GLAND; BIOMEDICAL APPLICATIONS;
   EXTRACELLULAR-MATRIX; IN-VITRO; EMBRYONIC DEVELOPMENT;
   MOLECULAR-MECHANISMS; GROWTH-FACTOR; KEY STAGES; MOUSE
AB Glandular organs feature ramified structures that are important for regulating physiological transport. The aim of this study was to develop a biomaterial-assisted, serum-free culture system to generate branching structures in explants of glandular organs. The fetal mammary gland (MG) was selected as the model organ to study the formation of glandular structure. Among the many biomaterials tested, chitosan demonstrated a superior effect in promoting branch formation in MGs. The morphogenetic effect toward MG branching was chitosan specific and not observed with other analogs with similar chemical compositions or structures. The molecular weight and specific linkages in the chitosan polymer were important parameters in mediating the morphogenetic effect. MG explants from different anatomical locations effectively promoted structure formation. Blocking endogenous fibroblast growth factor 10 (FGF10) inhibited the morphogenetic effect of chitosan, indicating that the chitosan effect was FGF10 dependent. This work demonstrates the feasibility of creating a serum-free system that is competent in facilitating tissue morphogenesis in MG. MG tissue structure can be efficiently generated in a biocompatible system, which was assisted by biomaterials.
C1 [Yang, Tsung-Lin] Natl Taiwan Univ Hosp & Coll Med, Dept Otolaryngol, Taipei, Taiwan.
   [Yang, Tsung-Lin] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan.
   [Lin, Lin; Lee, Hao-Wei; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan.
   [Lin, Lin; Lee, Hao-Wei; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Hsiao, Ya-Chuan] Taipei City Hosp, Dept Ophthalmol, Zhongxing Branch, Taipei, Taiwan.
   [Hsiao, Ya-Chuan] Natl Yang Ming Univ, Dept Ophthalmol, Coll Med, Taipei 112, Taiwan.
RP Yang, TL (reprint author), 1,Sec 1 Jen Ai Rd, Taipei 100, Taiwan.
EM yangtl@ntu.edu.tw; thyoung@ntu.edu.tw
OI YANG, TSUNG-LIN/0000-0001-6521-8631
FU National Science Council of the Republic of China; National Taiwan
   University Hospital; National Health Research Institutes
FX The authors thank the National Science Council of the Republic of China,
   National Taiwan University Hospital, and National Health Research
   Institutes for their financial support of this research. The authors
   also thank the staff of the Eighth Core Lab, Department of Medical
   Research, National Taiwan University Hospital, for technical support
   during the study.
CR Alsarra IA, 2002, BIOMATERIALS, V23, P3637, DOI 10.1016/S0142-9612(02)00096-0
   BALINSKY BI, 1950, J ANAT, V84, P227
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Brisken C, 2006, J MAMMARY GLAND BIOL, V11, P239, DOI 10.1007/s10911-006-9026-0
   Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/i.devcel.2008.03.003
   Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634
   Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013
   Felt O, 1999, INT J PHARM, V180, P185, DOI 10.1016/S0378-5173(99)00003-4
   HAECKEL R, 1993, ANN BIOL CLIN-PARIS, V51, P903
   Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306
   Hens JR, 2007, DEVELOPMENT, V134, P1221, DOI 10.1242/dev.000182
   Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Hsiao YC, 2011, BIOMATERIALS, V32, P4424, DOI 10.1016/j.biomaterials.2011.02.057
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Ishihara Masayuki, 2006, Current Drug Delivery, V3, P351, DOI 10.2174/156720106778559047
   KRATOCHWIL K, 1976, P NATL ACAD SCI USA, V73, P4041, DOI 10.1073/pnas.73.11.4041
   KRATOCHWIL K, 1971, J EMBRYOL EXP MORPH, V25, P141
   KRATOCHWIL K, 1969, DEV BIOL, V20, P46, DOI 10.1016/0012-1606(69)90004-9
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lopes JB, 2010, ANN THORAC SURG, V90, P566, DOI 10.1016/j.athoracsur.2010.03.086
   Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6
   Mailleux AA, 2002, DEVELOPMENT, V129, P53
   Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021
   Mandal A., 2010, BIOL ENG, V2, P63
   MANDAL AB, 1980, J PHYS CHEM-US, V84, P856, DOI 10.1021/j100445a012
   Mao SR, 2004, INT J PHARM, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019
   Masuoka K, 2005, BIOMATERIALS, V26, P3277, DOI 10.1016/j.biomaterials.2004.07.061
   MCATEER JA, 1983, IN VITRO CELL DEV B, V19, P210, DOI 10.1007/BF02618061
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x
   Patrick CW, 2004, ANNU REV BIOMED ENG, V6, P109, DOI 10.1146/annurev.bioeng.6.040803.140032
   Pavlovich AL, 2010, TISSUE ENG PT A, V16, P3719, DOI [10.1089/ten.tea.2009.0836, 10.1089/ten.TEA.2009.0836]
   Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7
   Pozzi A, 2011, CURR OPIN CELL BIOL, V23, P547, DOI 10.1016/j.ceb.2011.04.003
   Puri V, 2009, INT J GYNECOL OBSTET, V104, P70, DOI 10.1016/j.ijgo.2008.08.002
   Rose C, 1996, INT J BIOL MACROMOL, V18, P41, DOI 10.1016/0141-8130(95)01054-8
   SAKAKURA T, 1976, SCIENCE, V194, P1439, DOI 10.1126/science.827022
   Schneider RK, 2010, BIOMATERIALS, V31, P7948, DOI 10.1016/j.biomaterials.2010.07.003
   Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372
   Simian M, 2001, DEVELOPMENT, V128, P3117
   Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690
   Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368
   Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966
   Stevens MM, 2005, BIOMATERIALS, V26, P7636, DOI 10.1016/j.biomaterials.2005.05.001
   Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   TROWELL OA, 1959, EXP CELL RES, V16, P118, DOI 10.1016/0014-4827(59)90201-0
   Varela LM, 1996, ENDOCRINOLOGY, V137, P4915, DOI 10.1210/en.137.11.4915
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wiesen JF, 1999, DEVELOPMENT, V126, P335
   Xie JW, 1997, ENDOCRINOLOGY, V138, P2466, DOI 10.1210/en.138.6.2466
   Yang TL, 2008, BIOMATERIALS, V29, P2501, DOI 10.1016/j.biomaterials.2008.02.014
   Yang TL, 2008, BIOMED ENG-APP BAS C, V20, P287, DOI 10.4015/S1016237208000908
   Yang TL, 2011, INT J MOL SCI, V12, P1936, DOI 10.3390/ijms12031936
   Yang TL, 2010, BIOMATERIALS, V31, P288, DOI 10.1016/j.biomaterials.2009.09.052
   Yang TL, 2009, J CELL MOL MED, V13, P2853, DOI 10.1111/j.1582-4934.2008.00425.x
   Yang TL, 2009, BIOCHEM BIOPH RES CO, V381, P466, DOI 10.1016/j.bbrc.2008.10.116
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
NR 62
TC 6
Z9 7
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV
PY 2012
VL 18
IS 21-22
BP 2220
EP 2230
DI 10.1089/ten.tea.2011.0527
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 032XG
UT WOS:000310752900004
PM 22889068
DA 2018-10-19
ER

PT J
AU Yang, PJ
   Levenston, ME
   Temenoff, JS
AF Yang, Peter J.
   Levenston, Marc E.
   Temenoff, Johnna S.
TI Modulation of Mesenchymal Stem Cell Shape in Enzyme-Sensitive Hydrogels
   Is Decoupled from Upregulation of Fibroblast Markers Under Cyclic
   Tension
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MARROW STROMAL CELLS; TENOGENIC DIFFERENTIATION; GENE-EXPRESSION;
   TENDON; MATRIX; BIOMATERIALS; TENOCYTES; MICROENVIRONMENTS;
   PROLIFERATION; DEGRADATION
AB Our laboratory has developed a tensile culture bioreactor as a system for understanding mesenchymal stem cell (MSC) differentiation toward a tendon/ligament fibroblast phenotype in response to cyclic tensile strain. In this study, we investigated whether increased degradability of the biomaterial carrier would induce changes in MSC morphology and subsequent upregulation of tendon/fibroblast markers under tensile strain. Degradability of a synthetic poly(ethylene glycol) hydrogel was introduced by incorporating either fast-or slow-degrading matrix metalloproteinase (MMP)-sensitive peptide sequences into the polymer backbone. Although a decline in cellularity was observed over culture in all sample groups, at 14 days, MSCs were significantly more spread in fast-cleaving gels (84%+/- 8%) compared with slow-cleaving gels (59%+/- 4%). Cyclic tensile strain upregulated tendon/ligament fibroblast-related genes, such as collagen III (3.8-fold vs. 2.1-fold in fast-degrading gels) and tenascin-C (2.5-fold vs. 1.7-fold in fast-degrading gels). However, few differences were observed in gene expression between different gel types. Immunostaining demonstrated increased collagen III deposition in dynamically strained gels at day 14, as well as increased collagen I and tenascin-C deposition at day 14 in all groups. Results suggest that cell spreading may not be a major factor controlling MSC response to cyclic strain in this system over 14 days. However, these findings provide key parameters for the design of future biomaterial carriers and strain regimens to prime stem cells to a tendon/ligament phenotype prior to release and use in vivo.
C1 [Temenoff, Johnna S.] Georgia Tech Emory Univ, Wallace H Coulter Dept Biomed Engn, Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Levenston, Marc E.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.
RP Temenoff, JS (reprint author), Georgia Tech Emory Univ, Wallace H Coulter Dept Biomed Engn, Inst Bioengn & Biosci, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM johnna.temenoff@bme.gatech.edu
FU NIH [R21 EB8918]; NSF; NCRR of NIH [P40RR017447]
FX The authors thank Taymour Hammoudi (Temenoff Lab) for developing the
   cryopreservation technique used for histology. This work was supported
   by NIH R21 EB8918, and an NSF Graduate Research Fellowship to P.J.Y.
   Some of the materials employed in this work were provided by the Texas
   A&M Health Science Center College of Medicine Institute for Regenerative
   Medicine at Scott & White through a grant from NCRR of the NIH, Grant
   #P40RR017447.
CR Abramoff MD, 2004, J BIOPHOTONICS INT, V11, P36
   Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415
   Connelly JT, 2010, TISSUE ENG PT A, V16, P1913, DOI 10.1089/ten.TEA.2009.0561
   Doroski DM, 2010, TISSUE ENG PT A, V16, P3457, DOI 10.1089/ten.tea.2010.0233
   Durst CA, 2011, ACTA BIOMATER, V7, P2467, DOI 10.1016/j.actbio.2011.02.018
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Hankemeier S, 2005, TISSUE ENG, V11, P41, DOI 10.1089/ten.2005.11.41
   Heo SJ, 2011, ANN BIOMED ENG, V39, P2780, DOI 10.1007/s10439-011-0365-7
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415
   Lavagnino M, 2008, BIOMECH MODEL MECHAN, V7, P405, DOI 10.1007/s10237-007-0104-z
   Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maffulli N, 2000, AM J SPORT MED, V28, P499, DOI 10.1177/03635465000280040901
   Maier S, 2008, BBA-MOL CELL RES, V1783, P1150, DOI 10.1016/j.bbamcr.2008.01.013
   Mannello F, 2006, STEM CELLS, V24, P475, DOI 10.1634/stemcells.2005-0333
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Patel D, 2011, BIOMACROMOLECULES, V12, P432, DOI 10.1021/bm101214f
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Pennisi E, 2002, SCIENCE, V295, P1011, DOI 10.1126/science.295.5557.1011
   Qiu YZ, 2011, ACTA BIOMATER, V7, P959, DOI 10.1016/j.actbio.2010.11.002
   Rees SG, 2009, SCAND J MED SCI SPOR, V19, P470, DOI 10.1111/j.1600-0838.2009.00938.x
   Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045
   Schneider PRA, 2011, J ORTHOP RES, V29, P1351, DOI 10.1002/jor.21400
   Scott A, 2011, J MUSCULOSKEL NEURON, V11, P124
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046
   Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Thomopoulos S, 2011, TISSUE ENG PT A, V17, P1039, DOI [10.1089/ten.tea.2009.0499, 10.1089/ten.TEA.2009.0499]
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
NR 43
TC 11
Z9 12
U1 0
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV
PY 2012
VL 18
IS 21-22
BP 2365
EP 2375
DI 10.1089/ten.tea.2011.0727
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 032XG
UT WOS:000310752900018
PM 22703182
OA Green Published
DA 2018-10-19
ER

PT J
AU Niinomi, M
   Nakai, M
   Hieda, J
AF Niinomi, Mitsuo
   Nakai, Masaaki
   Hieda, Junko
TI Development of new metallic alloys for biomedical applications
SO ACTA BIOMATERIALIA
LA English
DT Review
DE beta-Type titanium alloy; Low modulus; Self-tunable Young's modulus;
   Nickel-free shape memory titanium alloy; Nickel-free stainless steel
ID TI-NB-TA; SHAPE-MEMORY BEHAVIOR; LOW YOUNGS MODULUS; SPINAL FIXATION
   APPLICATIONS; IN-VITRO DEGRADATION; MG-ZN ALLOY; POROUS TANTALUM
   BIOMATERIAL; ISOTHERMAL AGING BEHAVIOR; BINARY TITANIUM-ZIRCONIUM;
   HEAT-TREATMENT BEHAVIOR
AB New low modulus beta-type titanium alloys for biomedical applications are still currently being developed. Strong and enduring p-type titanium alloy with a low Young's modulus are being investigated. A low modulus has been proved to be effective in inhibiting bone atrophy, leading to good bone remodeling in a bone fracture model in the rabbit tibia. Very recently beta-type titanium alloys with a self-tunable modulus have been proposed for the construction of removable implants. Nickel-free low modulus beta-type titanium alloys showing shape memory and super elastic behavior are also currently being developed. Nickel-free stainless steel and cobalt-chromium alloys for biomedical applications are receiving attention as well. Newly developed zirconium-based alloys for biomedical applications are proving very interesting. Magnesium-based or iron-based biodegradable biomaterials are under development. Further, tantalum, and niobium and its alloys are being investigated for biomedical applications. The development of new metallic alloys for biomedical applications is described in this paper. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Niinomi, Mitsuo; Nakai, Masaaki; Hieda, Junko] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Niinomi, M (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM niinomi@imr.tohoku.ac.jp
RI Niinomi, Mitsuo/B-5965-2011; Nakai, Masaaki/C-1919-2009
CR Afonso CRM, 2007, MAT SCI ENG C-BIO S, V27, P908, DOI 10.1016/j.msec.2006.11.001
   Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   Akahori T, 2011, J JPN I MET, V75, P445, DOI 10.2320/jinstmet.75.445
   Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Ashida S, 2012, MATER SCI FORUM, V706-709, P1943, DOI 10.4028/www.scientific.net/MSF.706-709.1943
   Ban S, 1998, BIOMATERIALS, V19, P1245, DOI 10.1016/S0142-9612(98)00032-5
   BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x
   Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOYCE BF, 1992, J CLIN PATHOL, V45, P502, DOI 10.1136/jcp.45.6.502
   Browy K.-H, 1985, TITANIUM SCI TECHNOL, V2, P1381
   Chen B., 1997, CERAM INT, V33, P701
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   COOK SD, 1985, CLIN ORTHOP RELAT R, P236
   Cui WF, 2009, MAT SCI ENG A-STRUCT, V527, P258, DOI 10.1016/j.msea.2009.08.057
   DEPALMA VA, 1972, J BIOMED MATER RES, V6, P37, DOI 10.1002/jbm.820060406
   Domingo JL, 2002, BIOL TRACE ELEM RES, V88, P97, DOI 10.1385/BTER:88:2:097
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Fontaine AB, 1996, J ENDOVASC SURG, V3, P276, DOI 10.1583/1074-6218(1996)003<0276:PSMOTS>2.0.CO;2
   Fukui H, 2006, J JPN I MET, V70, P337, DOI 10.2320/jinstmet.70.337
   Gabriel SB, 2011, J ALLOYS CO IN PRESS
   Gonzalez S, 2012, J MECH BEHAV BIOMED, V6, P53, DOI 10.1016/j.jmbbm.2011.09.014
   Gu XN, 2011, ACTA BIOMATER, V7, P1880, DOI 10.1016/j.actbio.2010.11.034
   Gu XN, 2009, ACTA BIOMATER, V5, P2790, DOI 10.1016/j.actbio.2009.01.048
   Guo Z, 2009, MAT SCI ENG C-BIO S, V29, P963, DOI 10.1016/j.msec.2008.08.019
   Guo Z, 2009, MAT SCI ENG C, V29, P968
   HANAWA T, 1992, J JPN I MET, V56, P1168, DOI 10.2320/jinstmet1952.56.10_1168
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   Hanawa T., 2010, METALS MED
   Hanawa T, 2009, J ARTIF ORGANS, V12, P73, DOI 10.1007/s10047-008-0456-x
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   Hatanaka S, 2010, ADV MATER RES-SWITZ, V89-91, P232, DOI 10.4028/www.scientific.net/AMR.89-91.232
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   Hiromoto S, 2009, ELECTROCHIM ACTA, V54, P7085, DOI 10.1016/j.electacta.2009.07.033
   Ho WF, 2008, J MATER SCI-MATER M, V19, P3179, DOI 10.1007/s10856-008-3454-x
   Horiuchi Y, 2007, MATER TRANS, V48, P407, DOI 10.2320/matertrans.48.407
   Horiuchi Y, 2007, MATER TRANS, V48, P414, DOI 10.2320/matertrans.48.414
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   HOSODA H, 2004, J JPN SOC MECH ENG, V107, P509
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2010, MATER SCI FORUM, V654-656, P2150, DOI 10.4028/www.scientific.net/MSF.654-656.2150
   Hosoda N., 2001, 2001 FALL M JAP I ME, P401
   Ikarashi Y, 2005, MATER TRANS, V46, P2260, DOI 10.2320/matertrans.46.2260
   Ikeda M, 2005, MATER TRANS, V46, P1604, DOI 10.2320/matertrans.46.1604
   Ikeda M, 2004, MATER TRANS, V45, P1106, DOI 10.2320/matertrans.45.1106
   Ikeda M, 2012, MATER SCI FORUM, V706-709, P1893, DOI 10.4028/www.scientific.net/MSF.706-709.1893
   Ikeda M, 2010, MATER SCI FORUM, V654-656, P855, DOI 10.4028/www.scientific.net/MSF.654-656.855
   Ikeda M, 2005, MAT SCI ENG C, V25, P377
   Ikeda M, 2009, MATER TRANS, V50, P2737, DOI 10.2320/matertrans.MA200902
   IMGRAM AG, 1962, J LESS-COMMON MET, V4, P217, DOI 10.1016/0022-5088(62)90068-1
   Inamura T, 2005, MATER TRANS, V46, P1597, DOI 10.2320/matertrans.46.1597
   Japan Aluminium Association, 2002, AL HLTH, P1
   Jie Z, 2010, RARE METAL MAT ENG, V39, P1707
   Kambouroglou GK, 1998, J HAND SURG-AM, V23A, P737, DOI 10.1016/S0363-5023(98)80063-4
   Kannan MB, 2008, SCRIPTA MATER, V59, P175, DOI 10.1016/j.scriptamat.2008.03.001
   Kasan Y, 2010, MATER SCI FORUM, V654-656, P2118
   Kim H, 2005, J JPN I LIGHT METAL, V55, P613
   Kim H. Y., 2007, 2007 SPRING M JAP I, P91
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   Kim Y, 2012, MAT SCI ENG C-MATER, V32, P503, DOI 10.1016/j.msec.2011.12.001
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kobayashi E, 2007, MATER TRANS, V48, P301, DOI 10.2320/matertrans.48.301
   Koch S, 2002, MATERIALWISS WERKST, V33, P705, DOI 10.1002/mawe.200290000
   Kondo R, 2011, ACTA BIOMATER, V7, P4278, DOI 10.1016/j.actbio.2011.07.020
   Kuroda D, 2005, MAT SCI ENG C-BIO S, V25, P312, DOI 10.1016/j.msec.2005.04.004
   Kuroda D, 2003, MATER TRANS, V44, P414, DOI 10.2320/matertrans.44.414
   Kurosu S, 2010, MATER LETT, V64, P49, DOI 10.1016/j.matlet.2009.10.001
   Lenhart M, 2000, RADIOLOGY, V217, P173, DOI 10.1148/radiology.217.1.r00se28173
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Li Q, 2011, METALL MATER TRANS A, V42A, P2843, DOI 10.1007/s11661-011-0713-0
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Maintz D, 2002, AM J ROENTGENOL, V179, P1319, DOI 10.2214/ajr.179.5.1791319
   Majumdar P, 2011, J MECH BEHAV BIOMED, V4, P1132, DOI 10.1016/j.jmbbm.2011.03.023
   Majumdar P, 2010, MATER CHARACT, V61, P1394, DOI 10.1016/j.matchar.2010.10.004
   Malek J, 2012, MATER DESIGN, V35, P731, DOI 10.1016/j.matdes.2011.10.030
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Masumoto K, 2006, MAT SCI ENG A-STRUCT, V438, P835, DOI 10.1016/j.msea.2006.02.060
   Matkovic T, 2010, METALURGIJA, V49, P33
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   Mishra A. K., 1996, ASTM STP, V1272, P96
   Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   Mori M, 2010, MAT SCI ENG A-STRUCT, V528, P614, DOI 10.1016/j.msea.2010.09.002
   Murayama Y., 2009, B NIIGATA I TECH, V14, P1
   Nakai M, 2010, MAT JPN, V49, P437
   Nakai M, 2012, METALL MATER TRANS A, V43A, P294, DOI 10.1007/s11661-011-0860-3
   Nakai M, 2011, MATER LETT, V65, P688, DOI 10.1016/j.matlet.2010.11.006
   Nakai M, 2009, MATER TRANS, V50, P423, DOI 10.2320/matertrans.MRP2008380
   Narita K, 2008, J JPN I MET, V72, P674, DOI 10.2320/jinstmet.72.674
   Niiinomi M., 2003, BIOMATERIALS, V24, P2673
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2012, WOODH PUBL SER BIOM, V39, P462
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2006, ENCY BIOMATERIALS EN, P1
   Niinomi M., 2008, P 11 WORLD C TIT, P1417
   Niinomi M, 2011, CERAM T, V228, P75
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   Niinomi M., 1998, J JPN SOC MECH ENG A, V64, P312
   Niinomi M., 2002, MAT JPN, V41, P221
   Niinomi MA, 2011, INT J BIOMATER
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2008, MAT SCI ENG C-BIO S, V28, P406, DOI 10.1016/j.msec.2007.04.028
   Niinomi M, 2011, BIOMATERIALS SCIENCE AND ENGINEERING, P249
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Nomura N, 2009, MATER TRANS, V50, P2466, DOI 10.2320/matertrans.M2009187
   O'Brien J, 2008, J MECH BEHAV BIOMED, V1, P303
   O'Brien J, 2008, BIOMATERIALS, V29, P4540
   Obbard EG, 2010, ACTA MAT, V58, P6790
   Ohmatsu Y., 2003, 2003 SPRING M JAP I, P144
   OKAZAKI Y, 1995, J JPN I MET, V59, P108, DOI 10.2320/jinstmet1952.59.1_108
   Oshika N., 2003, 2003 FALL M JAP I ME, P149
   Papakyriacou M, 2000, INT J FATIGUE, V22, P873, DOI 10.1016/S0142-1123(00)00057-8
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Ping DH, 2005, SCRIPTA MATER, V52, P1287, DOI 10.1016/j.scriptamat.2005.02.029
   Rubitschek E, 2012, J MECH BEHAV BIOMED, V5, P181
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Saito Y, 1999, ACTA MATER, V47, P579, DOI 10.1016/S1359-6454(98)00365-6
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   SCOTT NA, 1995, AM HEART J, V129, P866, DOI 10.1016/0002-8703(95)90105-1
   Semlitsch M., 1986, TITAN, V2, P721
   Sevilla P, 2007, J ALLOY COMPD, V439, P67, DOI [10.1016/j.jallcom.2006.08.069, 10.1016/j.jallcom.2006.008.069]
   Song X, 2012, MAT SCI ENG C-MATER, V32, P542, DOI 10.1016/j.msec.2011.12.007
   Song X, 2011, MAT SCI ENG A-STRUCT, V528, P5600, DOI 10.1016/j.msea.2011.03.108
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Song Y, 2010, ACTA BIOMATER, V6, P1736, DOI 10.1016/j.actbio.2009.12.020
   Steib JP, 2004, SPINE, V29, P193, DOI 10.1097/01.BRS.0000107233.99835.A4
   STEINEMANN SG, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2689
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y
   Suyalatu, 2011, ACTA BIOMATER, V7, P4259, DOI 10.1016/j.actbio.2011.07.005
   Tahara M, 2009, MATER TRANS, V50, P2726, DOI 10.2320/matertrans.MA200907
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   Takahashi M, 2000, J JPN I MET, V64, P1120, DOI 10.2320/jinstmet1952.64.11_1120
   Tane M, 2008, ACTA MATER, V56, P2856, DOI 10.1016/j.actamat.2008.02.017
   Tane M, 2011, ACTA MATER, V59, P6975, DOI 10.1016/j.actamat.2011.07.050
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   Thibon I, 2009, J ALLOY COMPD, V470, P127, DOI 10.1016/j.jallcom.2008.02.082
   Thomann UI, 2000, WEAR, V239, P48, DOI 10.1016/S0043-1648(99)00372-5
   Tsutsumi Y, 2009, MAT SCI ENG C-BIO S, V29, P1702, DOI 10.1016/j.msec.2009.01.016
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Uggowitzer PJ, 1997, ADV POWDER METALL PA, V3
   Uyama E, 2010, J J DENT MAT, V29, P415
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Walter MJ, 2006, ADV MATER PROCESS, V164, P84
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Wang HJ, 2012, MATER LETT, V68, P435, DOI 10.1016/j.matlet.2011.11.029
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wang KK, 1996, ASTM STP, V1272, P76
   Wang LQ, 2010, MATER CHARACT, V61, P535, DOI 10.1016/j.matchar.2010.02.009
   Wang P, 2010, MAT SCI ENG C, V30, P1183
   Wei QQ, 2011, MATER DESIGN, V32, P2934, DOI 10.1016/j.matdes.2010.11.049
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wu M. H., 2003, P ASM MAT PROC MED D, P343
   Yamamoto A, 2004, MAT SCI ENG C-BIO S, V24, P737, DOI 10.1016/j.msec.2004.08.017
   Yamanaka K, 2011, MAT SCI ENG A-STRUCT, V528, P5961, DOI 10.1016/j.msea.2011.04.027
   Yamanaka K, 2009, METALL MATER TRANS A, V40A, P1980, DOI 10.1007/s11661-009-9879-0
   Yang GJ, 2005, J ALLOY COMPD, V392, P291, DOI 10.1016/j.jallcom.2004.08.099
   Yilmazer H, 2009, P 18 INT C PROC FABR, V2, P1401
   Yilmazer H, MAT SCI ENG C UNPUB
   Zardiackas L., 1996, ASTM STP, P60
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001
   Zhao CL, 2011, J ALLOY COMPD, V509, P8235, DOI 10.1016/j.jallcom.2011.05.090
   Zhao XL, 2011, J MECH BEHAV BIOMED, V4, P2009, DOI 10.1016/j.jmbbm.2011.06.020
   Zhao XL, 2011, MAT SCI ENG C-MATER, V31, P1436, DOI 10.1016/j.msec.2011.05.013
   Zhao XL, 2011, ACTA BIOMATER, V7, P3230, DOI 10.1016/j.actbio.2011.04.019
   Zhao XF, 2012, ACTA BIOMATER, V8, P2392, DOI 10.1016/j.actbio.2012.02.010
   Zhao XF, 2012, ACTA BIOMATER, V8, P1990, DOI 10.1016/j.actbio.2012.02.004
   Zhilyaev AP, 2008, PROG MATER SCI, V53, P893, DOI 10.1016/j.pmatsci.2008.03.002
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2008, MAT SCI ENG A-STRUCT, V483-84, P153, DOI 10.1016/j.msea.2006.09.173
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 190
TC 388
Z9 402
U1 33
U2 523
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2012
VL 8
IS 11
BP 3888
EP 3903
DI 10.1016/j.actbio.2012.06.037
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 028BV
UT WOS:000310398700002
PM 22765961
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Daghighi, S
   Sjollema, J
   Jaspers, V
   de Boer, L
   Zaat, SAJ
   Dijkstra, RJB
   van Dam, GM
   van der Mei, HC
   Busscher, HJ
AF Daghighi, Seyedmojtaba
   Sjollema, Jelmer
   Jaspers, Valery
   de Boer, Leonie
   Zaat, Sebastian A. J.
   Dijkstra, Rene J. B.
   van Dam, Gooitzen M.
   van der Mei, Henny C.
   Busscher, Henk J.
TI Persistence of a bioluminescent Staphylococcus aureus strain on and
   around degradable and non-degradable surgical meshes in a murine model
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biofilm; Bioluminescence; Degradable material; Foreign body reaction;
   Infection
ID ABDOMINAL-WALL RECONSTRUCTION; BIOMATERIAL-ASSOCIATED INFECTION;
   SMALL-INTESTINAL SUBMUCOSA; FOREIGN-BODY INFECTION; TISSUE; MICE;
   EPIDERMIDIS; BACTERIAL; BIOFILMS; REPAIR
AB Biomaterials are increasingly used for the restoration of human function, but can become infected as a result of peri- or early post-operative bacterial contamination, although biomaterial-associated infections (BAIs) can also initiate at any time from hematogenous spreading of bacteria from an infection elsewhere in the body. Infecting bacteria in BAIs not only seek shelter in their own protective biofilm matrix, but also hide in surrounding tissue. This study compares staphylococcal persistence on and around a degradable and non-degradable surgical mesh through the use of longitudinal bioluminescence imaging in a murine model, including histological evaluation of surrounding tissue after sacrifice. Surgical meshes were first contaminated with bioluminescent Staphylococcus aureus Xen29 and subsequently subcutaneously implanted in mice. Bioluminescent staphylococci persisted on and around non-degradable meshes during the 28-day course of the study, whereas bioluminescence returned to control levels and bacteria disappeared from surrounding tissues once a degradable mesh had fully dissolved. Thus the application of degradable biomaterials yields major advantages with respect to the prevention of BAIs, as dissolution of the implant not only is associated with elimination of the protective biofilm mode of growth of the infecting organisms, but also allows the immune system to clear the surrounding tissue from infecting organisms. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Daghighi, Seyedmojtaba; Sjollema, Jelmer; Dijkstra, Rene J. B.; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, Dept Biomed Engn, WJ Kolff Inst, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands.
   [van Dam, Gooitzen M.] Univ Med Ctr Groningen, Div Vasc Surg, Dept Surg, NL-9700 RB Groningen, Netherlands.
   [Jaspers, Valery; de Boer, Leonie; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Ctr Inject & Immun Amsterdam CINIMA, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Dept Biomed Engn, WJ Kolff Inst, Univ Med Ctr Groningen, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@umcg.nl
FU Dutch Ministry of Economic Affairs, Agriculture and Innovation
FX This research forms part of the NANTICO project of the Bio-Medical
   Materials program, co-funded by the Dutch Ministry of Economic Affairs,
   Agriculture and Innovation. We thank Ethicon, Inc. for the donation of
   the surgical meshes used in this study.
CR Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Bellows CF, 2006, EXPERT REV MED DEVIC, V3, P657, DOI 10.1586/17434440.3.5.657
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   BROWN GL, 1985, ANN SURG, V201, P705, DOI 10.1097/00000658-198506000-00006
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Engelsman AF, 2010, ANN SURG, V251, P133, DOI 10.1097/SLA.0b013e3181b61d9a
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Hoeppner J, 2010, WORLD J GASTROENTERO, V16, P4031, DOI 10.3748/wjg.v16.i32.4031
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   Kluin OS, 2009, BIOMATERIALS, V30, P4738, DOI 10.1016/j.biomaterials.2009.05.012
   Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069
   VAUDAUX PE, 1985, INFECT IMMUN, V50, P472
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 25
TC 7
Z9 7
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2012
VL 8
IS 11
BP 3991
EP 3996
DI 10.1016/j.actbio.2012.07.017
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 028BV
UT WOS:000310398700012
PM 22824527
DA 2018-10-19
ER

PT J
AU Vines, JB
   Lim, DJ
   Anderson, JM
   Jun, HW
AF Vines, Jeremy B.
   Lim, Dong-Jin
   Anderson, Joel M.
   Jun, Ho-Wook
TI Hydroxyapatite nanoparticle reinforced peptide amphiphile nanomatrix
   enhances the osteogenic differentiation of mesenchymal stem cells by
   compositional ratios
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanomatrix; Bone tissue engineering; Hydroxyapatite; Bone marrow
   mesenchymal stem cells; Peptide amphiphile
ID OSTEOBLAST-LIKE CELLS; GENE-EXPRESSION; SERUM-PROTEINS; BONE-MARROW;
   IN-VITRO; ADHESION; REGENERATION; BIOMATERIAL; FIBRONECTIN; PHOSPHATE
AB In the field of bone tissue engineering, there is a need for materials that mimic the native bone extracellular matrix (ECM). This need is met through the creation of biphasic composites intended to mimic both the organic and inorganic facets of the native bone ECM. However, few studies have created composites with organic ECM analogous components capable of directing cellular behaviors and many are not fabricated in the nanoscale. Furthermore, few attempts have been made at investigating how variations of organic and inorganic components affect the osteogenic differentiation of human mesenchymal stem cells (hMSCs). To address these issues, biphasic nanomatrix composites consisting of hydroxyapatite nanoparticles (HANPs) embedded within peptide amphiphile (PA) nanofibers tailored with the RGDS cellular adhesion motif (PA-RGDS) were created at various HANP to PA-RGDS ratios. Fabrication of these biphasic nanomatrix composites was confirmed via scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The long-term cellularity and osteogenic differentiation of hMSCs in response to the different compositional ratios were then assessed by quantifying the timed expression of genes indicative of osteogenic differentiation, alkaline phosphatase activity, and DNA content over time. Decreased cellularity and the expression of genes over time correlated with increasing compositional ratios between HANP and PA-RGDS. The highest HANP to PA-RGDS ratio (66% HANP) exhibited the greatest improvement to the osteogenic differentiation of hMSCs. Overall, these results demonstrate that the compositional ratio of biphasic nanomatrix composites plays an important role in influencing the osteogenic differentiation of hMSCs. Based on the observations presented within this study, these biphasic nanomatrix composites show promise for future usage in bone tissue engineering applications. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Vines, Jeremy B.; Lim, Dong-Jin; Anderson, Joel M.; Jun, Ho-Wook] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
RP Jun, HW (reprint author), Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
EM hwjun@uab.edu
FU NSF [CBET-0952974]; Wallace H. Coulter Foundation; UAB BERM center; NIH
   (NIBIB) [EB004312-01]; Ruth L. Kirschstein National Research Service
   Award Individual Fellowship [1F31DE021286-01]
FX We acknowledge the Mass Spectrometry/Proteomics Shared facility at UAB
   for analyzing all the PA samples. Thanks to Dr. Robin Foley for use of
   the SEM facilities. Special thanks are also extended to Dr. Ralph
   Sanderson for use of his RT-PCR lab facilities and further to Dr. Vishnu
   Ramani for his help with all of the RT-PCR experiments and for providing
   the helpful advice necessary for the optimization and improvement of
   cell culture conditions. This work was supported by the NSF Career Award
   (CBET-0952974), Wallace H. Coulter Foundation, and UAB BERM center pilot
   grant awarded to H.-W.J., along with funding from NIH T32 predoctoral
   training grant (NIBIB #EB004312-01) and Ruth L. Kirschstein National
   Research Service Award Individual Fellowship (1F31DE021286-01) for
   J.M.A.
CR Anderson JM, 2011, ACTA BIOMATER, V7, P675, DOI 10.1016/j.actbio.2010.08.016
   Anderson JM, 2009, ACS NANO, V3, P3447, DOI 10.1021/nn900884n
   Anderson JM, 2009, BIOMACROMOLECULES, V10, P2935, DOI 10.1021/bm9007452
   Andukuri A, 2010, NANOMED-NANOTECHNOL, V6, P289, DOI 10.1016/j.nano.2009.09.004
   Ashman R.F., 2005, TUREKS ORTHOPAEDICS
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Bongio M, 2011, Eur Cell Mater, V22, P359
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Brett PM, 2004, BONE, V35, P124, DOI 10.1016/j.bone.2004.03.009
   Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   COUCHMAN JR, 1990, J INVEST DERMATOL, V94, pS7, DOI 10.1111/1523-1747.ep12874973
   Crowley J, 2008, BIO-MED MATER ENG, V18, P149, DOI 10.3233/BME-2008-0518
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200
   Ghali O, 2010, J BONE MINER RES, V25, P1616, DOI 10.1002/jbmr.52
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   He JW, 2010, TISSUE ENG PT A, V16, P127, DOI 10.1089/ten.TEA.2009.0255
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Kang SW, 2008, J MICROBIOL BIOTECHN, V18, P975
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kim JK, 2009, MOL PHARMACEUT, V6, P978, DOI 10.1021/mp900009n
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Kim SS, 2007, J BIOMED MATER RES A, V80A, P206, DOI 10.1002/jbm.a.30836
   Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   Lao LH, 2011, J MATER SCI-MATER M, V22, P1873, DOI 10.1007/s10856-011-4374-8
   Lee JY, 2007, BIOCHEM BIOPH RES CO, V357, P68, DOI 10.1016/j.bbrc.2007.03.106
   Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lim DJ, 2011, MICRO NANO LETT, V6, P619, DOI 10.1049/mnl.2011.0026
   Lim DJ, 2011, TISSUE ENG PT A, V17, P399, DOI [10.1089/ten.tea.2010.0151, 10.1089/ten.TEA.2010.0151]
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Liu YK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025004
   Liu YK, 2009, J BIOMED MATER RES A, V90A, P1083, DOI 10.1002/jbm.a.32192
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Matsumine A, 2004, J BONE JOINT SURG BR, V86B, P719, DOI 10.1302/0301-620X.86B5.14242
   Meskinfam M, 2011, J BIOMED NANOTECHNOL, V7, P455, DOI 10.1166/jbn.2011.1306
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Patlolla A, 2010, ACTA BIOMATER, V6, P90, DOI 10.1016/j.actbio.2009.07.028
   Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Pratap J, 2003, CANCER RES, V63, P5357
   Ravichandran R, 2011, BIOMED MATER, V7
   Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Sibilla P, 2006, J DENT RES, V85, P354, DOI 10.1177/154405910608500414
   Sogo Y, 2007, BIOMED MATER, V2, P116, DOI 10.1088/1748-6041/2/2/009
   Supova M, 2009, J MATER SCI-MATER M, V20, P1201, DOI 10.1007/s10856-009-3696-2
   Thomas V, 2006, J NANOSCI NANOTECHNO, V6, P487, DOI 10.1166/jnn.2006.097
   Venugopal J, 2008, J BIOMED MATER RES A, V85A, P408, DOI 10.1002/jbm.a.31538
   Vuola J, 1998, BIOMATERIALS, V19, P223, DOI 10.1016/S0142-9612(97)00211-1
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   Xie JW, 2004, J BIOMED MATER RES A, V71A, P108, DOI 10.1002/jbm.a.30140
   Zhao XX, 2011, NANOTOXICOLOGY, V5, P182, DOI 10.3109/17435390.2010.503943
NR 66
TC 18
Z9 19
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2012
VL 8
IS 11
BP 4053
EP 4063
DI 10.1016/j.actbio.2012.07.024
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 028BV
UT WOS:000310398700018
PM 22842043
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hempel, U
   Moller, S
   Noack, C
   Hintze, V
   Scharnweber, D
   Schnabelrauch, M
   Dieter, P
AF Hempel, U.
   Moeller, S.
   Noack, C.
   Hintze, V.
   Scharnweber, D.
   Schnabelrauch, M.
   Dieter, P.
TI Sulfated hyaluronan/collagen I matrices enhance the osteogenic
   differentiation of human mesenchymal stromal cells in vitro even in the
   absence of dexamethasone
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Extracellular matrix; Glycosaminoglycans; Mesenchymal stromal cells;
   Osteogenic differentiation; Sulfated hyaluronan
ID STEM-CELLS; HEPARAN-SULFATE; CHONDROITIN SULFATE; HYALURONIC ACIDS;
   GENE-EXPRESSION; BONE-MARROW; OSTEOBLAST DIFFERENTIATION;
   EXTRACELLULAR-MATRIX; BIOCHEMICAL-ANALYSIS; COLLAGEN I
AB Glycosaminoglycans (GAG) are multifunctional components of the extracellular matrix (ECM) involved in different steps of the regulation of cellular differentiation. In this study artificial extracellular matrices (aECM) consisting of collagen (Col) I and different GAG derivatives were used as a substrate for human mesenchymal stromal cells (hMSC) to study osteogenic differentiation in vitro. hMSC were cultured on aECM containing col and hyaluronan sulfates (HyaS) with increasing degrees of sulfation (DSS) and were compared with aECM containing col and the natural GAG hyaluronan or chondroitin 4-sulfate. hMSC were analyzed for osteogenic differentiation markers such as calcium phosphate deposition, tissue non-specific alkaline phosphatase (TNAP) and expression of runt-related transcription factor 2 (runx2), osteocalcin (ocn) and bone sialoprotein II (bspII). Compared with aECM containing Col and natural GAG all Col/HyaS-containing aECM induced an increase in calcium phosphate deposition, TNAP activity and map expression. These effects were also seen in the absence of dexamethasone (an established osteogenic supplement). The expression of runx2 and ocn was not altered and the expression of bspII was diminished on the col/HyaS-containing aECM. The impact of the Col/HyaS-containing aECM on hMSC differentiation was independent of the DSS of the HyaS derivatives, indicating the importance of the primary (C-6) hydroxyl group of N-acetylglucosamine. These results suggest that Col/HyaS-containing aECM are able to stimulate hMSC to undergo osteogenic differentiation even in the absence of dexamethasone, which makes these matrices an interesting tool for hMSC-based tissue engineering applications and biomaterial functionalizations to enhance bone formation. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hempel, U.; Noack, C.; Dieter, P.] Tech Univ Dresden, Inst Physiol Chem, Fac Med, D-01307 Dresden, Germany.
   [Moeller, S.; Schnabelrauch, M.] INNOVENT eV, Biomat Dept, D-07745 Jena, Germany.
   [Hintze, V.; Scharnweber, D.] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
RP Hempel, U (reprint author), Tech Univ Dresden, Inst Physiol Chem, Fac Med, Fetscherstasse 74, D-01307 Dresden, Germany.
EM ute.hempel@tu-dresden.de
FU Deutsche Forschungsgemeinschaft [SFB/TR67-B1, SFB/TR67-A2, SFB/TR67-A3]
FX The authors thank Carolin Preissler, Christine Kupke and Alina Miron for
   their excellent technical assistance. The authors are very grateful to
   Prof. Bornhauser and colleagues in the stem cell laboratory of the
   University Hospital in Dresden for providing the human mesenchymal
   stromal cells. The authors thank Dr. Jurgen Schiller of the Biophysical
   Department Leipzig for discussing the NMR data. This work was supported
   by grants from the Deutsche Forschungsgemeinschaft (SFB/TR67-B1, A2 and
   A3).
CR Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083
   Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x
   Astachov L, 2011, FRONT BIOSCI-LANDMRK, V16, P261, DOI 10.2741/3687
   Augello A, 2010, EUR CELLS MATER, V20, P121
   Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173
   Barbucci R, 1998, BIOMATERIALS, V19, P801, DOI 10.1016/S0142-9612(97)00231-7
   Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z
   Becker D, 2002, J BIOMED MATER RES, V59, P516, DOI 10.1002/jbm.1265
   Bennett KP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-380
   Bernhardt A, 2009, J BIOMED MATER RES A, V90A, P852, DOI 10.1002/jbm.a.32144
   Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007
   Bruedigam C, 2011, CURR PROTOCOLS STE B, V1B, P31
   Buttner M, 2012, J CELL PHYSL
   Byers BA, 2004, TISSUE ENG, V10, P1623, DOI 10.1089/ten.2004.10.1623
   CHANG NS, 1994, J LEUKOCYTE BIOL, V55, P778
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   CHEN JK, 1992, J BONE MINER RES, V7, P987
   Chen XD, 2010, BIRTH DEFECTS RES C, V90, P45, DOI 10.1002/bdrc.20171
   Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157
   Douglas T, 2007, BIOMACROMOLECULES, V8, P1085, DOI 10.1021/bm0609644
   Eijken M, 2006, MOL CELL ENDOCRINOL, V248, P87, DOI 10.1016/j.mce.2005.11.034
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825
   Hempel U, 2012, ACTA BIOMATER, V8, P659, DOI 10.1016/j.actbio.2011.10.026
   Hempel U, 2010, CLIN ORAL IMPLAN RES, V21, P174, DOI 10.1111/j.1600-0501.2009.01797.x
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   Jackson RA, 2007, J CELL PHYSIOL, V210, P38, DOI 10.1002/jcp.20813
   Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437
   Kim HJ, 2010, BMB REP, V43, P524, DOI 10.5483/BMBRep.2010.43.8.524
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Kunze R, 2010, GLYCOCONJUGATE J, V27, P151, DOI 10.1007/s10719-009-9270-9
   Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200
   Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7
   Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1
   Ling L, 2010, J CELL BIOCHEM, V109, P1222, DOI 10.1002/jcb.22506
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Luong-Van E, 2007, J MOL HISTOL, V38, P459, DOI 10.1007/s10735-007-9129-y
   Lutter AH, 2010, J CELL BIOCHEM, V109, P1025, DOI 10.1002/jcb.22485
   Lynch MP, 1998, J CELL BIOCHEM, V68, P31
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   Magnani A, 1998, POLYM INT, V46, P225, DOI 10.1002/(SICI)1097-0126(199807)46:3<225::AID-PI45>3.0.CO;2-I
   Mania VM, 2009, IUBMB LIFE, V61, P447, DOI 10.1002/iub.167
   MELOAN S N, 1985, Journal of Histotechnology, V8, P11
   Mikami Y, 2011, J CELL PHYSIOL, V226, P739, DOI 10.1002/jcp.22392
   Miyazaki T, 2008, J CELL PHYSIOL, V217, P769, DOI 10.1002/jcp.21557
   Miyazaki T, 2010, DENT MATER J, V29, P403, DOI 10.4012/dmj.2009-132
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   MORRISON N, 1993, J BONE MINER RES, V8, P969
   Murali S, 2011, J BIOL CHEM, V286, P17755, DOI 10.1074/jbc.M110.148874
   Nagahata M, 2004, BIOCHEM BIOPH RES CO, V315, P603, DOI 10.1016/j.bbrc.2004.01.098
   Nagira T, 2007, BIOMATERIALS, V28, P844, DOI 10.1016/j.biomaterials.2006.09.041
   Nikitovic D, 2005, ANTICANCER RES, V25, P2851
   Nurcombe V, 2007, CRIT REV EUKAR GENE, V17, P159, DOI 10.1615/CritRevEukarGeneExpr.v17.i2.50
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Parker RB, 2010, ACS CHEM BIOL, V5, P35, DOI 10.1021/cb9002514
   PAUL H, 1983, ARTHRITIS RHEUM, V26, P191, DOI 10.1002/art.1780260211
   Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2
   PRINCE CW, 1983, J NUTR, V113, P1576
   Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2
   Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952
   Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y
   Schofield KP, 1999, BIOCHEM J, V343, P663, DOI 10.1042/0264-6021:3430663
   Stadlinger B, 2012, J BIOMED MATER RES B, V100B, P331, DOI 10.1002/jbm.b.31953
   Stadlinger B, 2009, J CLIN PERIODONTOL, V36, P698, DOI 10.1111/j.1600-051X.2009.01435.x
   van der Harst MR, 2004, OSTEOARTHR CARTILAGE, V12, P752, DOI 10.1016/j.joca.2004.05.004
   van der Smissen A, 2011, BIOMATERIALS, V32, P8938, DOI 10.1016/j.biomaterials.2011.08.025
   Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037
   Viereck V, 2002, J CELL BIOCHEM, V86, P348, DOI 10.1002/jcb.10220
   von Kossa J, 1901, BEITR PATHOL ANAT AL, V29, P163
   Wennberg C, 2000, J BONE MINER RES, V15, P1879, DOI 10.1359/jbmr.2000.15.10.1879
   YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275
   Zhang LJ, 2010, PROG MOL BIOL TRANSL, V93, P1, DOI 10.1016/S1877-1173(10)93001-9
NR 80
TC 21
Z9 22
U1 2
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2012
VL 8
IS 11
BP 4064
EP 4072
DI 10.1016/j.actbio.2012.06.039
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 028BV
UT WOS:000310398700019
PM 22771456
DA 2018-10-19
ER

PT J
AU Padalino, MA
   Castellani, C
   Dedja, A
   Fedrigo, M
   Vida, VL
   Thiene, G
   Stellin, G
   Angelini, A
AF Padalino, Massimo A.
   Castellani, Chiara
   Dedja, Arben
   Fedrigo, Marnie
   Vida, Vladimiro L.
   Thiene, Gaetano
   Stellin, Giovanni
   Angelini, Annalisa
TI Extracellular matrix graft for vascular reconstructive surgery: evidence
   of autologous regeneration of the neoaorta in a murine model
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE Extracellular matrix; Experimental surgery; Cell proliferation;
   Scaffold; Progenitor cells; Vascular grafts
ID BASEMENT-MEMBRANE; TISSUE RECONSTRUCTION; SCAFFOLD; CELLS; INDUCTION
AB The study aimed to evaluate the efficacy of the porcine small intestine submucosa extracellular matrix (SIS-ECM) in a murine model, as a possible vascular patch for clinical use in reconstructive vascular and potentially cardiac surgery.
   Fifteen adult male Sprague Dawley rats and five green fluorescent protein (GFP) rats were enrolled in this study. The SIS-ECM graft (6 mm long, 4 mm wide) was implanted for patch plasty on the abdominal aorta of the animal, after excising part of its anterior wall. Histology and immunohistochemistry were used to evaluate the results at 15, 30, 90 and 180 days post-surgery.
   Graft re-population was demonstrated 15 days after implantation. The luminal surface of the regenerating tissue was partially covered by endothelial cells, and intimal hyperplasia occurred in the central part of the graft. Complete re-endothelialization of the patch with smooth muscle cells colonizing the graft and acting as the neoaortic wall was observed after 30 days. Near complete absorption of the biomaterial was observed after 180 days. No inflammatory cell reaction occurred. All animals survived and no graft aneurysm was observed.
   A SIS-ECM patch allowed the colonization of host endothelial and smooth muscle cells in the graft. This material may be an ideal substitute for reconstructive vascular surgery, and its use could be extended to surgical repair of cardiac defects.
C1 [Padalino, Massimo A.; Dedja, Arben; Vida, Vladimiro L.; Stellin, Giovanni] Univ Padua, Sch Med, Dept Cardiothorac & Vasc Sci, Padua, Italy.
   [Castellani, Chiara; Fedrigo, Marnie; Thiene, Gaetano; Angelini, Annalisa] Univ Padua, Sch Med, Dept Med Diagnost Sci & Special Therapies, Padua, Italy.
RP Padalino, MA (reprint author), Ctr V Gallucci, UOC Cardiochirurg Pediat & Cardiopatie Congenite, Via Giustiniani 2, I-35120 Padua, Italy.
EM massimo.padalino@unipd.it
RI Dedja, Arben/J-2138-2018; Padalino, Massimo/J-8706-2018
OI Dedja, Arben/0000-0003-3535-598X; Padalino, Massimo/0000-0002-7535-9670;
   STELLIN, GIOVANNI/0000-0002-1903-2542
FU University of Padua [60A07-2538/07, CPDR099073]; Un cuore un mondo
   Padova-ONLUS [032009]
FX This work was supported by the University of Padua (60A07-2538/07 and
   CPDR099073 to C. C. and M.F.] and the 'Un cuore un mondo Padova-ONLUS'
   (032009 to Dr. Arben Dedja).
CR Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P595, DOI 10.1097/01.PRS.0000101064.62289.2F
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.3.CO;2-4
   Castellani C, 2010, HUM PATHOL, V41, P1566, DOI 10.1016/j.humpath.2009.12.017
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Fitzpatrick J. C., 2010, INT J BIOMATER, V2010
   Gilbert CL, 2010, WORLD J PED CONG HEA, V1, P132
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gong J, 2008, EXP EYE RES, V86, P957, DOI 10.1016/j.exer.2008.03.014
   Hare JM, 2008, CURR OPIN ORGAN TRAN, V13, P536, DOI 10.1097/MOT.0b013e32830fdfc4
   Hosokawa T, 2008, BIOCHEM BIOPH RES CO, V368, P426, DOI 10.1016/j.bbrc.2008.01.105
   Hosokawa T, 2007, CONNECT TISSUE RES, V48, P9, DOI 10.1080/03008200601017488
   Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   Padalino MA, 2009, SEMIN THORAC CARDIOV, V12, P48
   Padalino MA, 2008, CARDIOL YOUNG, V18, P415, DOI [10.1017/S1047951108002461, 10.1017/S104795110800246]
   Pandis L, 2010, J BIOMED MATER RES A, V93A, P1289, DOI 10.1002/jbm.a.32626
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   Vacanti J, 2010, J PEDIATR SURG, V45, P291, DOI 10.1016/j.jpedsurg.2009.10.063
   Zou Y, 2012, J SURG RES, V175, P359, DOI 10.1016/j.jss.2011.03.070
   Zou Y, 2011, BIOMECH MODEL MECHAN, V10, P613, DOI 10.1007/s10237-010-0260-4
NR 25
TC 21
Z9 22
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD NOV
PY 2012
VL 42
IS 5
BP E128
EP E135
DI 10.1093/ejcts/ezs462
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 024ZU
UT WOS:000310152600008
PM 22912435
OA Bronze
DA 2018-10-19
ER

PT J
AU Park, SH
   Song, T
   Bae, TS
   Khang, G
   Choi, BH
   Park, SR
   Min, BH
AF Park, Sang-Hyug
   Song, Tongjin
   Bae, Tae Soo
   Khang, Gon
   Choi, Byung Hyune
   Park, So Ra
   Min, Byoung-Hyun
TI Synergistic effects of alginate coating method on cartilage tissue
   engineering using fibrin/ha composite gel
SO INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING
LA English
DT Article
DE Fibrin/HA composite; Alginate coating; Choncrogenesis; Fibrinolysis;
   Degradation
ID MESENCHYMAL STEM-CELLS; HYALURONIC-ACID; IN-VITRO; ARTICULAR
   CHONDROCYTES; OXYGEN-CONSUMPTION; ENCAPSULATION; CHITOSAN; SCAFFOLD;
   HYPOXIA; CHONDROGENESIS
AB The importance of scaffold biomaterials has greatly been emphasized in in vitro culture of tissue-engineered cartilage and threedimensional (3D) environment. The development of new materials which are able to enhance cellular differentiation is critically important for the future use of biomaterial scaffolds in tissue engineering and regenerative medicine. Here, we demonstrated the feasibility of alginate coating method of fibrin/HA composite gel as a novel trial for cartilage formation. Rabbit chondrocytes were isolated and cultured in DMEM with 10% FBS. Once passaged, the cells were encapsulated with fibrin/HA gel. The experimental groups were divided into 4 groups: fibrin/HA gel culture (F/H), with 1 layer alginate coating (F/H+1AC), with 2 layer alginate coating (F/H+2AC), and with 4 layer alginate coating (F/H+4AC). All groups were cultured in serum free defined media (CDM) for in vitro culture for 4 weeks or were implanted in subcutaneous of nude mice in vivo study. Histological examination with safranin-O and alcian blue showed that the chondrogenic area in all the groups became clear at 1 week and widened homogenously until 4 weeks. However, the chondrogenic differentiation was observed in alginate coated fibrin/HA composite gel without size reduction during the culturing. The results of biochemical and molecular biological evaluation were compatible with those of histological examination. Media analysis and mechanical strength were also carried out. The results showed that the coating method provided proper environment for cartilage formation on fibrin/HA composite gel in CDM with no growth factors. This effect could potentially be useful in the study of in vitro cartilage tissue engineering as well as clinical implications for cartilage regeneration.
C1 [Min, Byoung-Hyun] Ajou Univ, Dept Orthopead Surg, Sch Med, Suwon 443749, Gyeonggi, South Korea.
   [Min, Byoung-Hyun] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, Gyeonggi, South Korea.
   [Park, Sang-Hyug; Song, Tongjin; Bae, Tae Soo] Jungwon Univ, Dept Biomed Engn, Goesan Gun 367805, Chungbuk, South Korea.
   [Khang, Gon] Kyung Hee Univ, Dept Biomed Engn, Yongin 446701, Gyeonggi, South Korea.
   [Choi, Byung Hyune] Inha Univ, Div Biomed & Bioengn Sci, Coll Med, Inchon 400712, South Korea.
   [Park, So Ra] Inha Univ, Dept Physiol, Coll Med, Inchon 402751, South Korea.
RP Min, BH (reprint author), Ajou Univ, Dept Orthopead Surg, Sch Med, Suwon 443749, Gyeonggi, South Korea.
EM bhmin@ajou.ac.kr
FU Ministry for Health, Welfare and Family Affairs, Republic of Korea
   [A091120]; Fundamental Technology Development Project [2011-0019730];
   National Research Foundation of Korea (NRF) [2010-0020447]; Ministry of
   Education, Science and Technology
FX This work was supported by a grant of the Korea Healthcare Technology
   R&D Project, Ministry for Health, Welfare and Family Affairs, Republic
   of Korea (A091120) and by Fundamental Technology Development Project
   (2011-0019730) and the Public Welfare & Safety Research Program
   (2010-0020447) through the National Research Foundation of Korea (NRF)
   funded by the Ministry of Education, Science and Technology.
CR Blandino A, 2003, APPL BIOCHEM BIOTECH, V110, P53, DOI 10.1385/ABAB:110:1:53
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carrier RL, 2002, BIOTECHNOL BIOENG, V78, P617, DOI 10.1002/bit.10245
   Chang CH, 2006, BIOMATERIALS, V27, P1876, DOI 10.1016/j.biomaterials.2005.10.014
   Choi NS, 2000, ANAL BIOCHEM, V281, P236, DOI 10.1006/abio.2000.4572
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Fehrenbacher A, 2006, BIORHEOLOGY, V43, P709
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Gavenis K., 2006, J BIOMED MATER RES B, V82, P275
   Heywood HK, 2006, J CELL PHYSIOL, V206, P402, DOI 10.1002/jcp.20491
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Kelly Michael A, 2004, Am J Orthop (Belle Mead NJ), V33, P23
   Kim SH, 1998, ANAL BIOCHEM, V263, P115, DOI 10.1006/abio.1998.2816
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Mais A, 2006, J CELL BIOCHEM, V98, P798, DOI 10.1002/jcb.20786
   Malda J, 2003, CRIT REV BIOTECHNOL, V23, P175, DOI 10.1080/714037688
   MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749
   Outokesh M, 2006, J MICROENCAPSUL, V23, P291, DOI 10.1080/02652040500435188
   Park SH, 2007, KEY ENG MATER, V342-343, P153, DOI 10.4028/www.scientific.net/KEM.342-343.153
   Park SH, 2011, TISSUE ENG PT A, V17, P1277, DOI [10.1089/ten.tea.2010.0337, 10.1089/ten.TEA.2010.0337]
   Park SH, 2009, ARTIF ORGANS, V33, P439, DOI 10.1111/j.1525-1594.2009.00744.x
   Park SH, 2005, ARTIF ORGANS, V29, P838, DOI 10.1111/j.1525-1594.2005.00137.x
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Schipani E, 2005, SEMIN CELL DEV BIOL, V16, P539, DOI 10.1016/j.semcdb.2005.03.003
   Schipani E, 2001, GENE DEV, V15, P2865
   Shu XZ, 2002, EUR J PHARM BIOPHARM, V53, P193, DOI 10.1016/S0939-6411(01)00247-8
   Srivastava R, 2005, MACROMOL BIOSCI, V5, P717, DOI 10.1002/mabi.200500061
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   Studer RK, 2004, OSTEOARTHR CARTILAGE, V12, P863, DOI 10.1016/j.joca.2004.07.005
   von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013
   WHITLEY CB, 1989, CLIN CHEM, V35, P374
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
   Yoo WJ, 2005, ACTA ORTHOP, V76, P628, DOI 10.1080/17453670510041691
   Zhao X, 2006, J BIOMAT SCI-POLYM E, V17, P419, DOI 10.1163/156856206776374115
NR 39
TC 3
Z9 3
U1 1
U2 26
PU KOREAN SOC PRECISION ENG
PI SEOUL
PA RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010,
   SOUTH KOREA
SN 2234-7593
J9 INT J PRECIS ENG MAN
JI Int. J. Precis. Eng. Manuf.
PD NOV
PY 2012
VL 13
IS 11
BP 2067
EP 2074
DI 10.1007/s12541-012-0272-3
PG 8
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 028YV
UT WOS:000310462800019
DA 2018-10-19
ER

PT J
AU Turner, WS
   Wang, XL
   Johnson, S
   Medberry, C
   Mendez, J
   Badylak, SF
   McCord, MG
   McCloskey, KE
AF Turner, William S.
   Wang, Xiaoling
   Johnson, Scott
   Medberry, Christopher
   Mendez, Jose
   Badylak, Stephen F.
   McCord, Marian G.
   McCloskey, Kara E.
TI Cardiac tissue development for delivery of embryonic stem cell-derived
   endothelial and cardiac cells in natural matrices
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell delivery; decellularized tissues; urinary bladder matrix; cardiac
   tissue; hyaluronan hydrogel; cell sheet engineering; embryonic stem
   cells
ID SKELETAL MYOBLAST TRANSPLANTATION; BONE-MARROW; EXTRACELLULAR-MATRIX;
   FUNCTIONAL MYOCARDIUM; INFARCTED MYOCARDIUM; MECHANICAL FUNCTION; RAT
   HEARTS; REPAIR; HYALURONAN; MUSCLE
AB The packaging and delivery of cells for cardiac regeneration has been explored using a variety biomaterials and delivery methods, but these studies often ignore one or more important design factors critical for rebuilding cardiac tissue. These include the biomaterial architecture, strength and stiffness, cell alignment, and/or incorporation of multiple cell types. In this article, we explore the combinatorial use of decellularized tissues, moldable hydrogels, patterned cell-seeding, and cell-sheet engineering and find that a combination of these methods is optimal in the recreation of transplantable cardiac-like tissue in vivo. We show that decellularized urinary bladder matrix (UBM), that is compliant and suturable, supports the survival of cell cultures but does not allow maintenance of cell-to-cell contacts of transferred cell-sheets (presumably, due to its rough surface). Moreover, the UBM material must be filled with hyaluronan (HA) hydrogels for smoothing rough surfaces and allowing the delivery of greater cell numbers. We additionally incorporated our previously developed wrinkled microchip for inducing alignment of cardiac cells with a laser-etched mask for co-seeding patterned channels of cells. This article also introduces a novel method of plasma coating for cell-sheet engineering that compares well with electron bean irradiation methods and may be combined with our wrinkled surfaces to facilitate the alignment of cardiac cells into sheets. Our data shows that an optimal design for generating cardiac tissue would include (1) decellularized matrix seeded with endothelial cells in a HA layered with (2) prealigned cardiac cell-sheets fabricated using our wrinkled microchips and thermo-responsive polymer [poly(N-isopropylacrylamide)] cell sheet transfer system. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Turner, William S.; Mendez, Jose; McCloskey, Kara E.] Univ Calif, Sch Engn, Merced, CA USA.
   [Wang, Xiaoling; McCord, Marian G.] N Carolina State Univ, Dept Text, Raleigh, NC 27695 USA.
   [Johnson, Scott; Medberry, Christopher; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
RP McCloskey, KE (reprint author), Univ Calif, Sch Engn, Merced, CA USA.
EM kmccloskey@ucmerced.edu
RI McCord, Marian/A-7790-2015
OI Badylak, Stephen/0000-0003-3555-0689
FU California Institute of Regenerative Medicine [RN2-00921-1]; NIH
   [F32-HL104924]; NSF [EEC-0832819]
FX Contract grant sponsor: New Faculty Award II from the California
   Institute of Regenerative Medicine; contract grant number: RN2-00921-1;
   Contract grant sponsor: NIH-funded National Research Service Award;
   contract grant number: F32-HL104924; Contract grant sponsor: NSF-funded
   Nanoscale Science and Engineering Center: Center of Integrated
   Nanomechanical Systems; contract grant number: EEC-0832819
CR Akins RE, 2002, CIRC RES, V90, P120, DOI 10.1161/res.90.2.120
   Badie N, 2009, BIOPHYS J, V96, P3873, DOI 10.1016/j.bpj.2009.02.019
   Badylak SF, 2006, CELL TRANSPLANT, V15, pS29, DOI 10.3727/000000006783982368
   Black LD, 2009, TISSUE ENG PT A, V15, P3099, DOI [10.1089/ten.tea.2008.0502, 10.1089/ten.TEA.2008.0502]
   Blancas AA, 2011, STEM CELLS DEV, V20, P2153, DOI 10.1089/scd.2010.0432
   Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB
   Bursac N, 2007, BIOCHEM BIOPH RES CO, V361, P847, DOI 10.1016/j.bbrc.2007.07.138
   Carletti E, 2011, METHODS MOL BIOL, V695, P17, DOI 10.1007/978-1-60761-984-0_2
   Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979
   Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Fu CC, 2009, ADV MATER, V21, P4472, DOI 10.1002/adma.200902294
   George JC, 2010, TRANSL RES, V155, P10, DOI 10.1016/j.trsl.2009.06.009
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goodell MA, 2001, ANN NY ACAD SCI, V938, P208
   GOODELL MA, 2001, ANN NY ACAD SCI, V938, P218
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Kelly DJ, 2009, TISSUE ENG PT A, V15, P2189, DOI 10.1089/ten.tea.2008.0430
   Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kofidis T, 2006, EUR J CARDIO-THORAC, V29, P50, DOI 10.1016/j.ejcts.2005.10.015
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   LAURENT TC, 1992, FASEB J, V6, P2397
   Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Liu YC, 2005, BIOMATERIALS, V26, P4737, DOI 10.1016/j.biomaterials.2005.01.003
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261
   Luna JI, 2011, TISSUE ENG PART C-ME, V17, P579, DOI [10.1089/ten.TEC.2010.0410, 10.1089/ten.tec.2010.0410]
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Methe H, 2008, SEMIN IMMUNOL, V20, P117, DOI 10.1016/j.smim.2007.12.005
   Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218
   Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070
   Orlic D, 2001, ANN NY ACAD SCI, V938, P221
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   ORLIC D, 2001, ANN NY ACAD SCI, V938, P229
   Ota T, 2008, J THORAC CARDIOV SUR, V136, P1309, DOI 10.1016/j.jtcvs.2008.07.008
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Pok S, 2011, J CARDIOVASC TRANSL, V4, P646, DOI 10.1007/s12265-011-9289-8
   Potapova IA, 2008, AM J PHYSIOL-HEART C, V295, pH2257, DOI 10.1152/ajpheart.00219.2008
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Reinecke H, 2000, CARDIOVASC PATHOL, V9, P337, DOI 10.1016/S1054-8807(00)00055-7
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Shah VK, 2011, STEM CELLS INT, DOI 10.4061/2011/536758
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Tomita S, 1999, CIRCULATION, V100, P247
   van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505
   van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001
   Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2002, CIRCULATION S1, V106, pI151
   Zimmermann WH, 2009, PEDIATR CARDIOL, V30, P716, DOI 10.1007/s00246-009-9405-6
NR 58
TC 13
Z9 14
U1 1
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2012
VL 100B
IS 8
BP 2060
EP 2072
DI 10.1002/jbm.b.32770
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 019QD
UT WOS:000309753500006
PM 22888031
DA 2018-10-19
ER

PT J
AU Stylianopoulos, T
   Kokonou, M
   Michael, S
   Tryfonos, A
   Rebholz, C
   Odysseos, AD
   Doumanidis, C
AF Stylianopoulos, Triantafyllos
   Kokonou, Maria
   Michael, Stefanos
   Tryfonos, Antonia
   Rebholz, Claus
   Odysseos, Andreani D.
   Doumanidis, Charalambos
TI Tensile mechanical properties and hydraulic permeabilities of
   electrospun cellulose acetate fiber meshes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterial scaffolds; multiscale simulation; stress; strain
   relationship; tissue engineering; separation processes
ID BIOMEDICAL APPLICATIONS; AFFINITY MEMBRANE; COLLAGEN GELS; NANOFIBER;
   MULTISCALE; SCAFFOLDS; DIAMETER; MATS; BIOMECHANICS; ORIENTATION
AB The mechanical properties and hydraulic permeabilities of biomaterial scaffolds play a crucial role in their efficacy as tissue engineering platforms, separation processors, and drug delivery vehicles. In this study, electrospun cellulose acetate fiber meshes of random orientations were created using four different concentrations, 10.0, 12.5, 15.0, and 17.5 wt % in acetone or ethyl acetate. The tensile mechanical properties and the hydraulic permeabilities of these meshes were measured, and a multiscale model was employed to predict their mechanical behavior. Experimentally, the elastic modulus ranged from 3.5 to 12.4 MPa depending on the polymer concentration and the solvent. Model predictions agreed well with the experimental measurements when a fitted single-fiber modulus of 123.3 MPa was used. The model also predicted that changes in fiber alignment may result in a 3.6-fold increase in the elastic modulus for moderately aligned meshes and a 8.5-fold increase for highly align meshes. Hydraulic permeabilities ranged from 1.4 x 10-12 to 8.9 x 10-12 m2 depending on polymer concentration but not the choice of solvent. In conclusion, polymer concentration, fiber alignment, and solvent have significant impact on the mechanical and fluid transport properties of electrospun cellulose acetate fiber meshes. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Stylianopoulos, Triantafyllos; Kokonou, Maria; Michael, Stefanos; Tryfonos, Antonia; Rebholz, Claus; Doumanidis, Charalambos] Univ Cyprus, Dept Mech & Mfg Engn, CY-1678 Nicosia, Cyprus.
   [Odysseos, Andreani D.] EPOS Iasis R&D, Div Biomed Res, CY-2028 Nicosia, Cyprus.
RP Stylianopoulos, T (reprint author), Univ Cyprus, Dept Mech & Mfg Engn, CY-1678 Nicosia, Cyprus.
EM tstylian@ucy.ac.cy; cdoumani@ucy.ac.cy
OI Stylianopoulos, Triantafyllos/0000-0002-3093-1696
FU Research Promotion Foundation of Cyprus [TEXNOLOGIA/YLIKA/0308(BIE)/05]
FX Contract grant sponsor: Research Promotion Foundation of Cyprus;
   contract grant number: TEXNOLOGIA/YLIKA/0308(BIE)/05 (NanoTissue)
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Christoforou T, 2010, J NANOSCI NANOTECHNO, V10, P6226, DOI 10.1166/jnn.2010.2577
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Han D, 2005, MATER RES SOC SYMP P, V845, P363
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   JACKSON GW, 1986, CAN J CHEM ENG, V64, P364, DOI 10.1002/cjce.5450640302
   Ma ZW, 2006, J MEMBRANE SCI, V272, P179, DOI 10.1016/j.memsci.2005.07.038
   Ma ZW, 2005, J MEMBRANE SCI, V265, P115, DOI 10.1016/j.memsci.2005.04.044
   Matsuda T, 2005, J BIOMED MATER RES A, V73A, P125, DOI 10.1002/jbm.a.30260
   Mattern KJ, 2008, BIOPHYS J, V95, P648, DOI 10.1529/biophysj.107.127316
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Sander EA, 2009, J BIOMED MATER RES A, V88A, P322, DOI 10.1002/jbm.a.31847
   Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106
   Sander EA, 2009, IEEE ENG MED BIOL, V28, P10, DOI 10.1109/MEMB.2009.932486
   Sona WK, 2006, CARBOHYD POLYM, V65, P430
   Stylianopoulos T, 2008, J MECH BEHAV BIOMED, V1, P326, DOI 10.1016/j.jmbbm.2008.01.003
   Stylianopoulos T, 2007, J BIOMECH ENG-T ASME, V129, P611, DOI 10.1115/1.2746387
   Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019
   Stylianopoulos T, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3021477
   Suwantong O, 2007, POLYMER, V48, P7546, DOI 10.1016/j.polymer.2007.11.019
   Taepaiboon P, 2007, EUR J PHARM BIOPHARM, V67, P387, DOI 10.1016/j.ejpb.2007.03.018
   Tang CY, 2008, POLYM ENG SCI, V48, P1296, DOI 10.1002/pen.21090
   Tungprapa S, 2007, CELLULOSE, V14, P563, DOI 10.1007/s10570-007-9113-4
   Tungprapa S, 2007, POLYMER, V48, P5030, DOI 10.1016/j.polymer.2007.06.061
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 32
TC 5
Z9 5
U1 0
U2 45
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2012
VL 100B
IS 8
BP 2222
EP 2230
DI 10.1002/jbm.b.32791
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 019QD
UT WOS:000309753500023
PM 22887702
DA 2018-10-19
ER

PT J
AU Marsolo, K
   Corsmo, J
   Barnes, MG
   Rollick, C
   Chalfin, J
   Nix, J
   Smith, C
   Ganta, R
AF Marsolo, Keith
   Corsmo, Jeremy
   Barnes, Michael G.
   Rollick, Carrie
   Chalfin, Jamie
   Nix, Jeremy
   Smith, Christopher
   Ganta, Rajesh
TI Challenges in creating an opt-in biobank with a registrar-based consent
   process and a commercial EHR
SO JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
LA English
DT Article
AB Residual clinical samples represent a very appealing source of biomaterial for translational and clinical research. We describe the implementation of an opt-in biobank, with consent being obtained at the time of registration and the decision stored in our electronic health record, Epic. Information on that decision, along with laboratory data, is transferred to an application that signals to biobank staff whether a given sample can be kept for research. Investigators can search for samples using our i2b2 data warehouse. Patient participation has been overwhelmingly positive and much higher than anticipated. Over 86% of patients provided consent and almost 83% requested to be notified of any incidental research findings. In 6 months, we obtained decisions from over 18 000 patients and processed 8000 blood samples for storage in our research biobank. However, commercial electronic health records like Epic lack key functionality required by a registrar-based consent process, although workarounds exist.
C1 [Marsolo, Keith; Rollick, Carrie; Nix, Jeremy; Ganta, Rajesh] Cincinnati Childrens Hosp, Div Biomed Informat, Med Ctr, Cincinnati, OH 45229 USA.
   [Marsolo, Keith] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.
   [Corsmo, Jeremy] Cincinnati Childrens Hosp, Off Res Compliance & Regulatory Affairs, Med Ctr, Cincinnati, OH 45229 USA.
   [Barnes, Michael G.; Chalfin, Jamie] Cincinnati Childrens Hosp, Div Rheumatol, Med Ctr, Cincinnati, OH 45229 USA.
   [Barnes, Michael G.] Cincinnati Childrens Hosp, Div Pathol & Lab Med, Med Ctr, Cincinnati, OH 45229 USA.
   [Smith, Christopher] Cincinnati Childrens Hosp, Dept Informat Serv, Med Ctr, Cincinnati, OH 45229 USA.
RP Marsolo, K (reprint author), Cincinnati Childrens Hosp, Div Biomed Informat, Med Ctr, 3333 Burnet Ave,MLC 7024, Cincinnati, OH 45229 USA.
EM keith.marsolo@cchmc.org
FU National Institutes of Health [UL1RR026314]
FX This work was funded in part by UL1RR026314 from the Clinical and
   Translational Science Award Program, National Institutes of Health.
CR [Anonymous], 2011, HHS ANN PROP IMPR RU
   Brothers KB, 2011, AM J MED GENET A, V155A, P2982, DOI 10.1002/ajmg.a.34304
   Daedalus Software, 2012, SEC DAED SOFTW DAED
   Epic, 2012, SEC EP
   Gainer Vivian, 2007, AMIA Annu Symp Proc, P959
   Murphy Shawn N, 2006, AMIA Annu Symp Proc, P1040
   Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893
   Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x
   Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89
   Rothstein MA, 2005, J LAW MED ETHICS, V33, P89, DOI 10.1111/j.1748-720X.2005.tb00213.x
NR 10
TC 13
Z9 13
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1067-5027
EI 1527-974X
J9 J AM MED INFORM ASSN
JI J. Am. Med. Inf. Assoc.
PD NOV
PY 2012
VL 19
IS 6
BP 1115
EP 1118
DI 10.1136/amiajnl-2012-000960
PG 4
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Health Care Sciences & Services;
   Information Science & Library Science; Medical Informatics
SC Computer Science; Health Care Sciences & Services; Information Science &
   Library Science; Medical Informatics
GA 028FP
UT WOS:000310408500029
PM 22878682
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Thebaud, NB
   Siadous, R
   Bareille, R
   Remy, M
   Daculsi, R
   Amedee, J
   Bordenave, L
AF Thebaud, N. B.
   Siadous, R.
   Bareille, R.
   Remy, M.
   Daculsi, R.
   Amedee, J.
   Bordenave, L.
TI Whatever their differentiation status, human progenitor derived - or
   mature - endothelial cells induce osteoblastic differentiation of bone
   marrow stromal cells
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE human endothelial cells; endothelial progenitor cells; co-cultures;
   human bone marrow stromal cells; osteoblastic differentiation; human
   osteoprogenitors
ID UMBILICAL-CORD BLOOD; IN-VITRO; HUMAN OSTEOPROGENITORS; TISSUE;
   VASCULARIZATION; ANGIOGENESIS; BIOMATERIALS; COCULTURE; COMMUNICATION;
   CROSSTALK
AB Association of the bone-forming osteoblasts (OBs) and vascular endothelial cells (ECs) into a biomaterial composite provides a live bone graft substitute that can repair the bone defect when implanted. An intimate functional relationship exists between these cell types. This communication is crucial to the coordinated cell behaviour necessary for bone development and remodelling. Previous studies have shown that direct co-culture of primary human osteoprogenitors (HOPs) with primary human umbilical vein endothelial cells (HUVECs) stimulates HOPs differentiation and induces tubular-like networks. The present work aims to test the use of human bone marrow stromal cells (HBMSCs) co-cultured with human endothelial progenitor cells in order to assess whether progenitor-derived ECs (PDECs) could support osteoblastic differentiation as mature ECs do. Indeed, data generated from the literature by different laboratories considering these co-culture systems appear difficult to compare. Monocultures of HUVECs, HOPs, HBMSCs (in a non-orientated lineage), PDECs (from cord blood) were used as controls and four combinations of co-cultures were undertaken: HBMSCsPDECs, HBMSCsHUVECs, HOPsPDECs, HOPsHUVECs with ECs (mature or progenitor) for 6?h to 7?days. At the end of the chosen co-culture time, intracellular alkaline phosphatase (ALP) activity was detected in HOPs and HBMSCs and quantified in cell extracts. Quantitative real-time polymerase chain reaction (qPCR) of ALP was performed over time and vascular endothelial growth factor (VEGF) was measured. After 21?days, calcium deposition was observed, comparing mono- and co-cultures. We confirm that ECs induce osteoblastic differentiation of mesenchymal stem cells in vitro. Moreover, HUVECs can be replaced by PDECs, the latter being of great interest in tissue engineering. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Thebaud, N. B.; Siadous, R.; Bareille, R.; Remy, M.; Daculsi, R.; Amedee, J.; Bordenave, L.] Univ Bordeaux, U1026, F-33000 Bordeaux, France.
   [Thebaud, N. B.; Siadous, R.; Bareille, R.; Remy, M.; Daculsi, R.; Amedee, J.; Bordenave, L.] INSERM, U1026, F-33000 Bordeaux, France.
   [Bordenave, L.] CHU Bordeaux, CIC IT Biomat, F-33000 Bordeaux, France.
RP Bordenave, L (reprint author), Univ Bordeaux, U1026, F-33000 Bordeaux, France.
EM Laurence.Bordenave@u-bordeaux2.fr
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013
CR Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Berard X, 2009, ACTA BIOMATER, V5, P1147, DOI 10.1016/j.actbio.2008.10.002
   BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   Cai L, 2011, BIOMATERIALS, V32, P8497, DOI 10.1016/j.biomaterials.2011.07.087
   Capobianco S, 2010, WORLD J CARDIOL, V2, P411, DOI 10.4330/wjc.v2.i12.411
   Clarkin CE, 2008, J CELL PHYSIOL, V214, P537, DOI 10.1002/jcp.21234
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Das A, 2011, TISSUE ENG PART B-RE, V17, P403, DOI [10.1089/ten.teb.2011.0190, 10.1089/ten.TEB.2011.0190]
   Fedorovich NE, 2010, TISSUE ENG PT A, V16, P2355, DOI [10.1089/ten.tea.2009.0603, 10.1089/ten.TEA.2009.0603]
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Ghanaati S, 2011, J TISSUE ENG REGEN M, V5, pE136, DOI 10.1002/term.373
   Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001
   Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018
   Guven S, 2011, BIOMATERIALS, V32, P5801, DOI 10.1016/j.biomaterials.2011.04.064
   Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Hildebrandt C, 2009, ANN ANAT, V191, P23, DOI 10.1016/j.aanat.2008.09.009
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Kirkpatrick CJ, 2011, ADV DRUG DELIVER REV, V63, P291, DOI 10.1016/j.addr.2011.01.009
   Kolbe M, 2011, TISSUE ENG PT A, V17, P2199, DOI [10.1089/ten.tea.2010.0474, 10.1089/ten.TEA.2010.0474]
   Krenning G, 2009, TRENDS MOL MED, V15, P180, DOI 10.1016/j.molmed.2009.02.001
   Ladhoff J, 2010, CARDIOVASC RES, V88, P121, DOI 10.1093/cvr/cvq109
   Lavergne M, 2011, CELL PROLIFERAT, V44, P44, DOI 10.1111/j.1365-2184.2010.00722.x
   Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016767
   Li Y, 2001, BIOTECHNOL PROGR, V17, P935, DOI 10.1021/bp0100878
   Ma JL, 2011, TISSUE ENG PART C-ME, V17, P349, DOI 10.1089/ten.TEC.2010.0215
   MAJESKA RJ, 1982, J BIOL CHEM, V257, P3362
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   Rouwkema J, 2009, TISSUE ENG PT A, V15, P2015, DOI 10.1089/ten.tea.2008.0318
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI [10.1089/ten.tea.2009.0715, 10.1089/ten.TEA.2009.0715]
   Thebaud NB, 2010, J TISSUE ENG REGEN M, V4, P473, DOI 10.1002/term.261
   Towler Dwight A, 2008, Curr Osteoporos Rep, V6, P67, DOI 10.1007/s11914-008-0012-x
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2011, METHODS MOL BIOL, V695, P229, DOI 10.1007/978-1-60761-984-0_15
   Verseijden F, 2010, TISSUE ENG PT A, V16, P101, DOI [10.1089/ten.tea.2009.0106, 10.1089/ten.TEA.2009.0106]
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   Wang J, 2011, BIOCHEM BIOPH RES CO, V412, P143, DOI 10.1016/j.bbrc.2011.07.062
NR 48
TC 22
Z9 23
U1 3
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD NOV
PY 2012
VL 6
IS 10
BP e51
EP e60
DI 10.1002/term.1539
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 027IB
UT WOS:000310344600006
PM 22740324
DA 2018-10-19
ER

PT J
AU Callanan, A
   Davis, NF
   Walsh, MT
   McGloughlin, TM
AF Callanan, Anthony
   Davis, Niall F.
   Walsh, Michael T.
   McGloughlin, Timothy M.
TI Mechanical characterisation of unidirectional and cross-directional
   multilayered urinary bladder matrix (UBM) scaffolds
SO MEDICAL ENGINEERING & PHYSICS
LA English
DT Article
DE Tissue engineering; Regenerative medicine; Extracellular matrix; Urinary
   bladder matrix; Mechanical properties
ID SMALL-INTESTINAL SUBMUCOSA; XENOGENEIC EXTRACELLULAR-MATRIX;
   DEGRADATION; REPAIR
AB Multilayered biological scaffolds derived from mammalian extracellular matrix (ECM) have shown promising long-term clinical results when reconstructing damaged tissues and organs. Despite their established clinical applicability, experimental studies that describe the effects of alternate manufacturing protocols on an ECM's mechanical properties are lacking. In the present study the mechanical properties of multilayered 'unidirectional' porcine urinary bladder matrix (UBM) scaffolds were determined in favour of its longitudinal and circumferential axes. The scaffold's unidirectional mechanical properties were then compared with 'cross-directional' UBM scaffolds. The results showed significant variations when alternate manufacturing protocols for multilayered UBM were applied. Unidirectional longitudinal UBM remained the strongest biomaterial on a consistent basis. Its failure strength occurred at 4.79 +/- 0.85 MPa compared to 3.36 +/- 0.53 MPa for unidirectional circumferential and 2.91 +/- 1.05 MPa for cross-directional UBM respectively (p < 0.0001). Distensibility was greatest in unidirectional circumferential UBM with failure extension occurring at 14.77 +/- 1.66 mm. In comparison, failure extension occurred at 12.88 +/- 0.94 mm and 13.04 +/- 4.35 mm for unidirectional longitudinal and cross-directional UBM respectively (p = 0.0024). The present study demonstrates that predefined manufacturing protocols for UBM should be considered when reconstructing anatomical structures with specific mechanical requirements. (C) 2012 IPEM. Published by Elsevier Ltd. All rights reserved.
C1 [McGloughlin, Timothy M.] Univ Limerick, Ctr Appl Biomed Engn Res, Dept Mech Aeronaut & Biomed Engn, Limerick, Ireland.
   Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
RP McGloughlin, TM (reprint author), Univ Limerick, Ctr Appl Biomed Engn Res, Dept Mech Aeronaut & Biomed Engn, Limerick, Ireland.
EM tim.mcgloughlin@ul.ie
RI Callanan, Anthony/D-8670-2013; McGloughlin, Tim/D-3639-2009; Walsh,
   Michael/C-1405-2010; McGloughlin, Tim/G-9526-2015
OI McGloughlin, Tim/0000-0002-6632-2075; McGloughlin,
   Tim/0000-0002-6632-2075; Walsh, Michael T/0000-0002-1672-8106;
   McGloughlin, Tim/0000-0003-3519-8988
FU Enterprise Ireland International Collaboration Fund [IC/2005/27];
   Technology Development Fund CFTD [2007/131]
FX The authors would like to acknowledge the funding support of Enterprise
   Ireland International Collaboration Fund IC/2005/27 (Callanan) and
   Technology Development Fund CFTD 2007/131.
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P594
   Boruch AV, 2000, J SURG RES, V161, P217
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Cloonan AJ, 2011, ACTA BIOMATER, V8, P262
   Davis NF, 2011, J MECH BEHAV BIOMED, V4, P375, DOI 10.1016/j.jmbbm.2010.11.005
   Davis NF, 2010, J UROLOGY, V184, P2246, DOI 10.1016/j.juro.2010.07.038
   Davis NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020323
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Freytes DO, 2008, J BIOMED MATER RES A, V87A, P862, DOI 10.1002/jbm.a.31821
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Medberry CJ, 2010, J SURG RES, V173, P38
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Svensson RB, 2010, J MECH BEHAV BIOMED, V3, P112, DOI 10.1016/j.jmbbm.2009.01.005
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Wang XG, 2011, J MECH BEHAV BIOMED, V4, P922, DOI 10.1016/j.jmbbm.2011.04.009
NR 23
TC 10
Z9 10
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1350-4533
J9 MED ENG PHYS
JI Med. Eng. Phys.
PD NOV
PY 2012
VL 34
IS 9
BP 1368
EP 1374
DI 10.1016/j.medengphy.2012.06.022
PG 7
WC Engineering, Biomedical
SC Engineering
GA 028LH
UT WOS:000310423300019
PM 22885225
DA 2018-10-19
ER

PT J
AU Sangami, G
   Dharmaraj, N
AF Sangami, G.
   Dharmaraj, N.
TI UV-visible spectroscopic estimation of photodegradation of rhodamine-B
   dye using tin(IV) oxide nanoparticles
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Biomaterial; SnO2 nanoparticles; UV-visible spectroscopy; Powder X-ray
   diffraction; Thermal analysis; Heterogeneous photocatalysis
ID RAY PHOTOELECTRON-SPECTROSCOPY; SNO2 THIN-FILMS; TIN-OXIDE; EGGSHELL
   MEMBRANE; WASTE-WATER; DEGRADATION; TEMPERATURE; SENSORS;
   PHOTOCATALYSIS; NANOCRYSTALS
AB Nanocrystalline, tin(IV) oxide (SnO2) particles has been prepared by thermal decomposition of tin oxalate precursor obtained from the reactions of tin(IV) chloride and sodium oxalate using eggshell membrane (ESM). The as-prepared SnO2 nanoparticles were characterized by thermal studies, transmission electron microscopy (TEM), powder X-ray diffraction (XRD), Raman, FT-IR and UV-visible studies and used as a photocatalyst for the degradation of rhodamine-B (Rh-B) dye. The size of the prepared nanoparticles was in the range of 5-12 nm as identified from the TEM images. Powder XRD data revealed the presence of a tetragonal, rutile crystalline phase of the tin(IV) oxide nanoparticles. Thermal analysis showed that the decomposition of tin oxalate precursor to yield the titled tin(IV) oxide nanoparticles was completed below 500 degrees C. The extent of degradation of Rh-B in the presence of SnO2 monitored by absorption spectral measurements demonstrated that 94.48% of the selected dye was degraded upon irradiation with UV light for 60 min. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Sangami, G.; Dharmaraj, N.] Bharathiar Univ, Dept Chem, Coimbatore 641046, Tamil Nadu, India.
RP Dharmaraj, N (reprint author), Bharathiar Univ, Dept Chem, Coimbatore 641046, Tamil Nadu, India.
EM dharmaraj@buc.edu.in
RI Nataraj, Devaraj/T-1700-2017
OI Nataraj, Devaraj/0000-0002-4711-8263
FU Extramural Research & Intellectual Property Rights (ER&IPR), Defence
   Research and Development Organization (DRDO), Ministry of Defence,
   Government of India, New Delhi under ER IPR project
   [ERIP/ER/0803730/M/01/1166]
FX The authors thank Extramural Research & Intellectual Property Rights
   (ER&IPR), Defence Research and Development Organization (DRDO), Ministry
   of Defence, Government of India, New Delhi, for the award of Senior
   Research Fellowship (SRF) to one of the authors (G.S) under ER & IPR
   project. (Sanction no. ERIP/ER/0803730/M/01/1166 dated 30.07.2009).
CR Amanullah FM, 1998, MAT SCI ENG B-SOLID, V52, P93, DOI 10.1016/S0921-5107(98)00113-5
   Aoki A., 1970, JPN J APPL PHYS, P9582
   Arslan I, 2000, J ENVIRON ENG-ASCE, V126, P903, DOI 10.1061/(ASCE)0733-9372(2000)126:10(903)
   Bharathi S, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/1/015501
   Chaudhuri SK, 2000, J ENVIRON ENG-ASCE, V126, P583, DOI 10.1061/(ASCE)0733-9372(2000)126:7(583)
   De G, 1999, SENSOR ACTUAT B-CHEM, V55, P134, DOI 10.1016/S0925-4005(99)00043-X
   Devi GS, 1999, SENSOR ACTUAT B-CHEM, V56, P98, DOI 10.1016/S0925-4005(99)00164-1
   Dharmaraj N, 2006, SPECTROCHIM ACTA A, V64, P136, DOI 10.1016/j.saa.2005.07.007
   Dong Q, 2007, J SOLID STATE CHEM, V180, P949, DOI 10.1016/j.jssc.2006.12.027
   Dong Q, 2006, SCRIPTA MATER, V55, P799, DOI 10.1016/j.scriptamat.2006.07.012
   Gu F, 2003, CHEM PHYS LETT, V372, P451, DOI 10.1016/S0009-2614(03)00440-8
   HARRISON PG, 1988, NATURE, V332, P337, DOI 10.1038/332337a0
   He Y., 1999, MATER LETT, V40, P3
   HE YS, 1993, J MATER RES, V8, P3131, DOI 10.1557/JMR.1993.3131
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Ji ZG, 2003, J CRYST GROWTH, V259, P282, DOI 10.1016/.j.jcrysgro.2003.07.003
   Knez M, 2003, NANO LETT, V3, P1079, DOI 10.1021/nl0342545
   Lee SC, 2003, SOL ENERG MAT SOL C, V75, P481, DOI 10.1016/S0927-0248(02)00201-5
   Liu H, 2009, SENSOR ACTUAT B-CHEM, V140, P190, DOI 10.1016/j.snb.2009.04.027
   Lodha S, 2011, ARAB J CHEM, V4, P383, DOI 10.1016/j.arabjc.2010.07.008
   Manorama SV, 2001, APPL SURF SCI, V174, P93, DOI 10.1016/S0169-4332(00)00914-4
   Meng ZD, 2012, ULTRASON SONOCHEM, V19, P143, DOI 10.1016/j.ultsonch.2011.05.006
   Merouani S, 2010, CHEM ENG J, V158, P550, DOI 10.1016/j.cej.2010.01.048
   MINAMI T, 1988, JPN J APPL PHYS 2, V27, pL287, DOI 10.1143/JJAP.27.L287
   Neelakandeswari N, 2011, SPECTROCHIM ACTA A, V78, P1592, DOI 10.1016/j.saa.2011.02.008
   Pattabi M, 2000, SOL ENERG MAT SOL C, V63, P309, DOI 10.1016/S0927-0248(00)00050-7
   PORTO SPS, 1967, PHYS REV, V154, P522, DOI 10.1103/PhysRev.154.522
   Pouretedal HR, 2009, J HAZARD MATER, V162, P674, DOI 10.1016/j.jhazmat.2008.05.128
   Rao A.N., 2009, J MOL CATAL A-CHEM, V30, P77
   Rauf MA, 2009, J HAZARD MATER, V166, P6, DOI 10.1016/j.jhazmat.2008.11.043
   Sathish M, 2006, INT J HYDROGEN ENERG, V31, P891, DOI 10.1016/j.ijhydene.2005.08.002
   Schlosser V., 1998, P 8 EC PHOT SOL EN C, P998
   Seddigi Z.S., 2010, CONTAM TOXICOL, V84, P564
   Seshadri R, 2000, ADV MATER, V12, P1149, DOI 10.1002/1521-4095(200008)12:15<1149::AID-ADMA1149>3.3.CO;2-Y
   Sharma N, 2005, J POWER SOURCES, V139, P250, DOI 10.1016/j.jpowsour.2004.06.057
   STAMPFL SR, 1987, J CATAL, V105, P445, DOI 10.1016/0021-9517(87)90072-8
   Stock N, 2000, CHEM COMMUN, P2277, DOI 10.1039/b006511k
   Stock NL, 2000, ENVIRON SCI TECHNOL, V34, P1747, DOI 10.1021/es991231c
   Su H., 2008, SMART MATER STRUCT, V17, P015
   Su HL, 2006, J MEMBRANE SCI, V283, P7, DOI 10.1016/j.memsci.2006.07.010
   Su HL, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/02/025601
   Sun B., 2005, J APPL CATAL B, V57, P39
   TAREY RD, 1985, THIN SOLID FILMS, V128, P181
   Xu CK, 2002, SCRIPTA MATER, V46, P789, DOI 10.1016/S1359-6462(02)00077-5
   Zhang W, 2009, MAT SCI ENG C-BIO S, V29, P92, DOI 10.1016/j.msec.2008.05.013
   Zhang WF, 2000, APPL PHYS B-LASERS O, V70, P261, DOI 10.1007/s003400050043
   Zhang ZH, 2007, ENVIRON SCI TECHNOL, V41, P6259, DOI 10.1021/es070212x
   Zheng BZ, 2010, TALANTA, V82, P177, DOI 10.1016/j.talanta.2010.04.014
   Zheng DS, 2003, APPL SURF SCI, V211, P24, DOI 10.1016/S0169-4332(02)01333-8
NR 49
TC 26
Z9 29
U1 0
U2 49
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD NOV
PY 2012
VL 97
BP 847
EP 852
DI 10.1016/j.saa.2012.07.068
PG 6
WC Spectroscopy
SC Spectroscopy
GA 028AS
UT WOS:000310395800113
PM 22902583
DA 2018-10-19
ER

PT J
AU Davis, NF
   Smyth, LG
   Giri, SK
   Flood, HD
AF Davis, N. F.
   Smyth, L. G.
   Giri, S. K.
   Flood, H. D.
TI Evaluation of Endoscopic Laser Excision of Polypropylene Mesh/Sutures
   Following Anti-Incontinence Procedures
SO JOURNAL OF UROLOGY
LA English
DT Article
DE urinary incontinence; intraoperative complications; endoscopy; lasers,
   solid-state
ID FREE VAGINAL TAPE; STRESS URINARY-INCONTINENCE; HOLMIUM LASER;
   TRANSURETHRAL RESECTION; URETHRAL EROSION; COMPLICATIONS; METAANALYSIS;
   MANAGEMENT; ABLATION; SURGERY
AB Purpose: We reviewed our experience with and outcome of the largest series to our knowledge of patients who underwent endoscopic laser excision of eroded polypropylene mesh or sutures as a complication of previous anti-incontinence procedures.
   Materials and Methods: A total of 12 female patients underwent endoscopic laser excision of suture/mesh erosions at 1 center during a 10-year period. Primary outcome variables were the requirement of additional endoscopic or open surgery to remove mesh/sutures. Secondary outcome variables were persistence of urinary symptoms, postoperative complications, continence status and requirement of additional anti-incontinence procedures.
   Results: The mean interval from previous surgery to erosion was 59 months (range 7 to 144) and the duration of presenting symptoms ranged from 3 to 84 months (mean 19). Ten patients underwent endoscopic excision of the mesh/suture with the holmium: YAG laser and 2 underwent excision with the thulium laser. Mean operative duration was 19 minutes (range 10 to 25) and followup was 65.5 months (range 6 to 134). Postoperatively 6 patients remain asymptomatic and 2 required a rectus fascial sling for recurrent stress urinary incontinence. Four patients underwent a second endoscopic excision due to minor persistence of erosion. Only 1 patient ultimately required open cystotomy to remove the eroded biomaterial. No intraoperative complications were recorded and all patients are currently asymptomatic.
   Conclusions: Endoscopic laser excision is an acceptable first line approach for the management of eroded biomaterials due to its high long-term success rate and minimally invasive nature.
C1 [Davis, N. F.; Smyth, L. G.; Giri, S. K.; Flood, H. D.] Mid Western Reg Hosp, Dept Urol, Limerick, Ireland.
RP Flood, HD (reprint author), Mid Western Reg Hosp, Dept Urol, Dooradoyle, Co Limerick, Ireland.
EM stiflood555@hotmail.com
CR Bach T, 2007, WORLD J UROL, V25, P263, DOI 10.1007/s00345-007-0169-4
   Doumouchtsis SK, 2011, BJU INT, V108, P1472, DOI 10.1111/j.1464-410X.2010.10012.x
   Frenkl TL, 2008, NEUROUROL URODYNAM, V27, P491, DOI 10.1002/nau.20558
   Fried NM, 2005, J ENDOUROL, V19, P25, DOI 10.1089/end.2005.19.25
   Giri SK, 2005, J UROLOGY, V174, P1306, DOI 10.1097/01.ju.0000173926.04596.55
   Hodroff M, 2004, J UROLOGY, V172, P1361, DOI 10.1097/01.ju.0000139659.67173.e2
   Huwyler M, 2008, BJU INT, V102, P582, DOI 10.1111/j.1464-410X.2008.07734.x
   Jo DJ, 2011, KOREAN J UROL, V52, P829, DOI 10.4111/kju.2011.52.12.829
   Lane BR, 2005, UROLOGY, V65, P991, DOI 10.1016/j.urology.2005.01.050
   Latthe PM, 2007, BJOG-INT J OBSTET GY, V114, P522, DOI 10.1111/j.1471-0528.2007.01268.x
   McLennan MT, 2004, INT UROGYNECOL J, V15, P360, DOI 10.1007/s00192-004-1169-1
   MUSCHTER R, 1994, UROLOGY, V44, P856, DOI 10.1016/S0090-4295(94)80170-3
   Novara G, 2008, EUR UROL, V53, P288, DOI 10.1016/j.eururo.2007.10.073
   Sakalis VI, 2012, INT UROGYNECOL J, V23, P769, DOI 10.1007/s00192-011-1574-1
   SCHOMACKER KT, 1991, LASER SURG MED, V11, P141, DOI 10.1002/lsm.1900110208
   Sweat SD, 2002, J UROLOGY, V168, P144, DOI 10.1016/S0022-5347(05)64848-3
   Tsivian A, 2004, J UROLOGY, V171, P762, DOI 10.1097/01.ju.0000106083.51860.ca
   Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378
   Velemir L, 2008, INT UROGYNECOL J, V19, P999, DOI 10.1007/s00192-007-0558-7
   Volkmer BG, 2003, J UROLOGY, V169, P570, DOI 10.1097/01.ju.0000046542.45062.37
   Wohlrab KJ, 2009, INT UROGYNECOL J, V20, P417, DOI 10.1007/s00192-008-0787-4
NR 21
TC 13
Z9 14
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD NOV
PY 2012
VL 188
IS 5
BP 1828
EP 1832
DI 10.1016/j.juro.2012.07.040
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 028QY
UT WOS:000310438600052
PM 22999703
DA 2018-10-19
ER

PT J
AU Akin, S
   Sonmezoglu, S
AF Akin, S.
   Sonmezoglu, S.
TI Nanostructured TiO2 thin films: synthesis and characterisations
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Nanostructured TiO2 thin films; Williamson-Hall plot; Swanepoel's
   method; Refractive index; Dielectric constant
ID FERRITE COMPOSITE NANOPARTICLES; OPTICAL-CONSTANTS; NICKEL FERRITE;
   BIOMATERIAL SYSTEM; PHOTOCATALYTIC ACTIVITY; ANTIMICROBIAL ACTIVITY;
   AMORPHOUS-SILICON; MAGNETIC CORE; ANATASE; SEMICONDUCTORS
AB In the present study, TiO2 thin film was fabricated by sol-gel dip coating technique, and the structural, optical and dielectric characteristics of the film have been investigated to identify the basic characteristics. By the help of the X-ray diffraction spectrum, the structural parameters of the nanostructured TiO2 thin film, such as lattice constants, texture coefficient and crystallite size, were analysed. The value of crystallite size has been evaluated by the Debye-Scherrer and Williamson-Hall methods and also estimated from the field emission SEM images. There was a consistency for the values of crystallite size obtained from all the methods. Swanepoel's method and transmittance measurements were used to analyse the optical parameters of the TiO2 thin film. Film thickness, refractive index n, extinction coefficient k, band gap energy E-g and Urbach energy E-u have been determined as 264.03 nm, 2.67, 0.067, 3.22 eV and 0.127 eV respectively. It is seen that the real and imaginary parts of the static dielectric constants follow the same pattern and have the values of the real part (7.436 at 655 nm) higher than the imaginary parts (0.038 at 655 nm). Moreover, the Spitzer-Fan model was used for investigation of the values of high frequency dielectric constant epsilon(infinity) and free optical carrier concentration N-opt. Furthermore, the dissipation factor and optical conductivity of the TiO2 thin film were examined. These results show that understanding the fundamental characteristics of this structure may be of great help in improving the quality of TiO2 for the future of the optoelectronic device technology.
C1 [Akin, S.] Karamanoglu Mehmetbey Univ, Dept Phys, Fac Kamil Ozdag Sci, TR-70100 Karaman, Turkey.
   [Sonmezoglu, S.] Karamanoglu Mehmetbey Univ, Fac Engn, Dept Mat Sci & Engn, TR-70100 Karaman, Turkey.
RP Akin, S (reprint author), Karamanoglu Mehmetbey Univ, Dept Phys, Fac Kamil Ozdag Sci, TR-70100 Karaman, Turkey.
EM seckinakin@kmu.edu.tr
RI SONMEZOGLU, Savas/K-9362-2016
OI SONMEZOGLU, Savas/0000-0002-6011-3504
CR Assim EM, 2008, J ALLOY COMPD, V465, P1, DOI 10.1016/j.jallcom.2007.10.059
   Barret C., 1980, STRUCTURE METALS
   Bass M., 2009, HDB OPTICS OPTICAL P
   Brunik A., 1991, THIN SOLID FILMS, V45, P199
   Choi YJ, 2012, MATER TECHNOL, V27, P21, DOI 10.1179/175355511X13240279339563
   Crisan D, 2008, J PHYS CHEM SOLIDS, V69, P2548, DOI 10.1016/j.jpcs.2008.05.014
   Cullity B. D., 2001, ELEMENTS XRAY DIFFRA
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Guinebretiere R., 2010, XRAY DIFFRACTION POL
   GURUMURUGAN K, 1994, SEMICOND SCI TECH, V9, P1827, DOI 10.1088/0268-1242/9/10/013
   Gyorgy E, 2005, APPL SURF SCI, V247, P429, DOI 10.1016/j.apsusc.2005.01.074
   Heavens O.S., 1955, OPTICAL PROPERTIES T
   Heo CH, 2005, THIN SOLID FILMS, V475, P183, DOI 10.1016/j.tsf.2004.08.033
   King H., 1994, XRAY DIFFRACTION PRO
   Lee GW, 2009, MATER CHARACT, V60, P1476, DOI 10.1016/j.matchar.2009.08.001
   Liu QJ, 2012, MATER TECHNOL, V27, P34, DOI 10.1179/175355511X13240279340769
   Mott N. F., 1979, ELECT PROCESSES NONC
   Nagels P, 1979, ELECT TRANSPORT AMOR
   Nair P. J., 1998, SEMICOND SCI TECH, V13, P340
   Pankove J. I., 1975, OPTICAL PROCESSES SE
   Pankove JI, 1971, OPTICAL PROCESSES SE
   PARTLOW DP, 1990, APPL OPTICS, V29, P1526, DOI 10.1364/AO.29.001526
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Saloum S., 2008, VACUUM, V82, P50
   Scherrer P., 1918, GOTTINGER NACHRICHTE, V2, P98
   Sharma K, 2012, MATER RES BULL, V47, P1400, DOI 10.1016/j.materresbull.2012.03.008
   Singh P, 2008, PHYSICA B, V403, P3769, DOI 10.1016/j.physb.2008.07.021
   Sonawane RS, 2004, MATER CHEM PHYS, V85, P52, DOI 10.1016/j.matchemphys.2003.12.007
   Sonmezoglu S, 2011, MAT SCI ENG C-MATER, V31, P1619, DOI 10.1016/j.msec.2011.08.003
   SPITZER WG, 1957, PHYS REV, V106, P882, DOI 10.1103/PhysRev.106.882
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   SWANEPOEL R, 1983, J PHYS E SCI INSTRUM, V16, P1214, DOI 10.1088/0022-3735/16/12/023
   SWANEPOEL R, 1984, J PHYS E SCI INSTRUM, V17, P896, DOI 10.1088/0022-3735/17/10/023
   TAUC J, 1970, MATER RES BULL, V5, P721, DOI 10.1016/0025-5408(70)90112-1
   Toyoda T, 2003, REV SCI INSTRUM, V74, P782, DOI 10.1063/1.1512984
   TOYODA T, 1985, J PHYS D APPL PHYS, V18, pL129, DOI 10.1088/0022-3727/18/8/008
   Turan E, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/24/245408
   Valtierra JM, 2006, J MEX CHEM SOC, V50, P8
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
   Yakuphanoglu F., 2005, OPT MATER, V27, P1366
   YANG L, 1994, ANAL CHEM, V66, P1254, DOI 10.1021/ac00080a010
   Zhang WZ, 2007, CHINESE J CHEM PHYS, V20, P95, DOI 10.1360/cjcp2007.20(1).95.4
NR 46
TC 13
Z9 13
U1 1
U2 36
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD NOV
PY 2012
VL 27
IS 5
BP 342
EP 349
DI 10.1179/1753555712Y.0000000017
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 022PE
UT WOS:000309970700002
DA 2018-10-19
ER

PT J
AU Cai, XY
   Liu, YJ
   Zeng, H
   Cai, Y
   Li, H
   Zhang, F
   Wang, YD
AF Cai, X. Y.
   Liu, Y. J.
   Zeng, H.
   Cai, Y.
   Li, H.
   Zhang, F.
   Wang, Y. D.
TI Synthesis and characterisation of alkali metal (Mn, Fe) oxide-ZnO
   nanorod composites and their photocatalytic decolourization of rhodamine
   B under visible light
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Nanorod composites; ZnO; Photocatalysis; Rhodaming B
ID DOPED ZNO; BIOMATERIAL SYSTEM; MAGNETIC CORE; ANTIMICROBIAL ACTIVITY;
   THIN-FILMS; NANOPARTICLES; SEMICONDUCTOR; DEGRADATION; SHELL;
   SUSPENSIONS
AB Semiconductor photocatalyst has attracted a great deal of attention in environmental wastewater treatment. As versatile semiconductor materials, ZnO nanocomposites composed of two or more oxide particles with different energy levels exhibit better photocatalytic activity due to more efficient charge separation. The alkali metal (Mn, Fe) oxide-ZnO nanocomposites have reported little work on the photodegradation of organic contaminants under visible light irradiation. In this paper, the main research is focused on the preparation process and the removal properties of organic pollutants rhodamine B (RB) from the wastewater using the alkali metal (Mn, Fe) oxide-ZnO nanorod composites. The proposed research investigates the alkali metal (Mn, Fe) oxide-ZnO nanorod composites with varied Mn or Fe content that are important in understanding structure, morphology and photocatalytic performances. The well crystalline phase alkali metal (Mn, Fe) oxide-ZnO nanorod composites have been directly synthesised at low temperature (90 degrees C) by a simple water bath method. The thorough structural characterization included X-ray diffraction, scanning electron microscopy and ultraviolet-visible spectroscopy were used to examine the morphology and microstructure of the final products. The photoactivity of nanostructured composites was tested by the degradation of RB under visible light. The results show that the removal of RB follows a Langmuir-Hinshelwood first order kinetic law over the initial stage of the reaction time by using the composites as photocatalyst. The composites are found to be efficient and generating less toxic secondary pollutants, which can easily be eliminated from the system by subjecting further to traditional physical, chemical and biologic treatments. The well crystalline phase and the excellent removal capacity for organic pollutants RB from wastewater make them promising candidates for wastewater treatment.
C1 [Cai, X. Y.; Zeng, H.; Cai, Y.; Li, H.; Zhang, F.; Wang, Y. D.] Yunnan Univ, Dept Mat Sci & Engn, Kunming 650091, Peoples R China.
   [Liu, Y. J.] Yunnan Univ, Adv Anal & Measurement Ctr, Kunming 650091, Peoples R China.
RP Wang, YD (reprint author), Yunnan Univ, Dept Mat Sci & Engn, Kunming 650091, Peoples R China.
EM ydwang@ynu.edu.cn
RI Wang, Yude/G-6188-2012
FU Department of Science and Technology of Yunnan Province via the Key
   Project for the Science and Technology [2011FA001]; Key Project of
   Chinese Ministry of Education [210206]; National Natural Science
   Foundation of China [50662006]
FX This work was supported by the Department of Science and Technology of
   Yunnan Province via the Key Project for the Science and Technology
   (grant no. 2011FA001), the Key Project of Chinese Ministry of Education
   (grant no. 210206) and the National Natural Science Foundation of China
   (grant no. 50662006).
CR Barick KC, 2010, MICROPOR MESOPOR MAT, V134, P195, DOI 10.1016/j.micromeso.2010.05.026
   Chen LC, 2008, J PHOTOCH PHOTOBIO A, V199, P170, DOI 10.1016/j.jphotochem.2008.05.022
   Chen SF, 2009, CHEM ENG J, V148, P263, DOI 10.1016/j.cej.2008.08.039
   Dhananjay S.D., 2001, J CHEM TECHNOL BIOT, V77, P102, DOI DOI 10.1002/JCTB.532
   Dindar S., 2001, J PHOTOCH PHOTOBIO A, V140, P263
   Ekambaram S, 2007, J ALLOY COMPD, V433, P237, DOI 10.1016/j.jallcom.2006.06.045
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   Gan Y, 2010, J NANOMATER, DOI 10.1155/2010/289173
   Georgekutty R, 2008, J PHYS CHEM C, V112, P13563, DOI 10.1021/jp802729a
   Hameed A, 2009, PHOTOCH PHOTOBIO SCI, V8, P677, DOI 10.1039/b817396f
   He C, 2008, APPL SURF SCI, V254, P2196, DOI 10.1016/j.apsusc.2007.09.007
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Kanade G., 2007, MATER CHEM PHYS, V102, P98
   Kaneko M., 2002, PHOTOCATALYSIS SCI T
   Karunakaran C, 2010, MATER CHEM PHYS, V123, P585, DOI 10.1016/j.matchemphys.2010.05.019
   Khodja AA, 2001, J PHOTOCH PHOTOBIO A, V141, P231, DOI 10.1016/S1010-6030(01)00423-3
   Kong JZ, 2010, J SOLID STATE CHEM, V183, P1359, DOI 10.1016/j.jssc.2010.04.005
   Konstantinou IK, 2001, ENVIRON SCI TECHNOL, V35, P398, DOI 10.1021/es001271c
   Li CR, 2011, MATER LETT, V65, P1327, DOI 10.1016/j.matlet.2011.01.075
   Lin HF, 2005, J PHOTOCH PHOTOBIO A, V174, P82, DOI 10.1016/j.jphotochem.2005.02.015
   Liu E, 2008, CURR APPL PHYS, V8, P408, DOI 10.1016/j.cap.2007.10.025
   Mohan R, 2012, SOLID STATE COMMUN, V152, P375, DOI 10.1016/j.ssc.2011.12.008
   Nagaraja R., 2011, POWDER TECHNOL, V215, P91
   Norberg NS, 2004, J AM CHEM SOC, V126, P9387, DOI 10.1021/ja048427j
   Patil AB, 2010, J HAZARD MATER, V183, P315, DOI 10.1016/j.jhazmat.2010.07.026
   Pradhan G.K., 2010, J ENG SCI TECHNOL, V2, P53
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Ullah R, 2008, J HAZARD MATER, V156, P194, DOI 10.1016/j.jhazmat.2007.12.033
   Xiao Q., 2010, MATER CHEM PHYS, V130, P5
   Xiao Q, 2009, J ALLOY COMPD, V479, pL4, DOI 10.1016/j.jallcom.2008.12.085
   Xu C, 2010, J ALLOY COMPD, V497, P373, DOI 10.1016/j.jallcom.2010.03.076
   Yousefi M, 2011, J ELECTROANAL CHEM, V661, P106, DOI 10.1016/j.jelechem.2011.07.022
   Zeng HB, 2008, J PHYS CHEM C, V112, P19620, DOI 10.1021/jp807309s
   Zhang JZ, 1997, ACCOUNTS CHEM RES, V30, P423, DOI 10.1021/ar960178j
   Zhang ZY, 2010, ACS APPL MATER INTER, V2, P2915, DOI 10.1021/am100618h
   Zhao J, 2011, MATER RES BULL, V46, P1207, DOI 10.1016/j.materresbull.2011.04.008
NR 42
TC 4
Z9 4
U1 2
U2 69
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD NOV
PY 2012
VL 27
IS 5
BP 380
EP 387
DI 10.1179/1753555712Y.0000000023
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 022PE
UT WOS:000309970700008
DA 2018-10-19
ER

PT J
AU Giri, TK
   Thakur, D
   Alexander, A
   Ajazuddin
   Badwaik, H
   Tripathi, DK
AF Giri, Tapan Kumar
   Thakur, Deepa
   Alexander, Amit
   Ajazuddin
   Badwaik, Hemant
   Tripathi, Dulal Krishna
TI Alginate based Hydrogel as a Potential Biopolymeric Carrier for Drug
   Delivery and Cell Delivery Systems: Present Status and Applications
SO CURRENT DRUG DELIVERY
LA English
DT Review
DE Alginate; hydrogels; drug delivery; cell delivery; bovine serum albumin;
   diclofenac sodium
ID ALGINATE/GALACTOSYLATED CHITOSAN SCAFFOLD; POLY(ALDEHYDE GULURONATE)
   HYDROGELS; POLYMER NETWORK MICROSPHERES; NEURAL STEM-CELLS;
   CONTROLLED-RELEASE; CALCIUM ALGINATE; IN-VITRO; OXIDIZED ALGINATE; GEL
   BEADS; SODIUM ALGINATE
AB Alginate is a non-toxic, biocompatible and biodegradable natural polymer with a number of peculiar physicochemical properties for which it has wide applications in drug delivery and cell delivery systems. Hydrogel formation can be obtained by interactions of anionic alginates with multivalent inorganic cations by simple ionotropic gelation method. Hydrophilic polymeric network of three dimensional cross linked structures of hydrogels absorb substantial amount of water or biological fluids. Among the numerous biomaterials used for hydrogel formation alginate has been and will continue to be one of the most important biomaterial. Therefore, in view of the vast literature support, we focus in this review on alginate - based hydrogel as drug delivery and cell delivery carriers for biomedical applications. Various properties of alginates, their hydrogels and also various techniques used for preparing alginate hydrogels have been reviewed.
C1 [Giri, Tapan Kumar; Thakur, Deepa; Alexander, Amit; Ajazuddin; Badwaik, Hemant; Tripathi, Dulal Krishna] Rungta Coll Pharmaceut Sci & Res, Kurud 491024, Bhilai, India.
RP Giri, TK (reprint author), Rungta Coll Pharmaceut Sci & Res, Kohka Rd, Kurud 491024, Bhilai, India.
EM tapan_ju01@rediffmail.com
OI Alexander, Amit/0000-0003-0391-7650
CR Aguzzi C, 2007, APPL CLAY SCI, V36, P22, DOI 10.1016/j.clay.2006.06.015
   Almeida PF, 2004, J CONTROL RELEASE, V97, P431, DOI 10.1016/j.conrel.2004.03.015
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038
   Aslani P, 1996, J CONTROL RELEASE, V42, P75, DOI 10.1016/0168-3659(96)01369-7
   Athawale VD, 1999, J MACROMOL SCI R M C, VC39, P445
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Balakrishnan B, 2006, BIOMATERIALS, V27, P1355, DOI 10.1016/j.biomaterials.2005.08.021
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Balasubramaniam J., 2007, Current Drug Delivery, V4, P249
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Becker TA, 2001, J BIOMED MATER RES, V54, P76, DOI 10.1002/1097-4636(200101)54:1<76::AID-JBM9>3.0.CO;2-V
   Betigeri SS, 2002, BIOMATERIALS, V23, P3627, DOI 10.1016/S0142-9612(02)00095-9
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   Bidarra SJ, 2011, BIOMATERIALS, V32, P7897, DOI 10.1016/j.biomaterials.2011.07.013
   Bokharaei M, 2011, CURR DRUG DELIV, V8, P164, DOI 10.2174/156720111794479862
   Bouhadir KH, 2000, J PHARM SCI-US, V89, P910, DOI 10.1002/1520-6017(200007)89:7<910::AID-JPS8>3.0.CO;2-#
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Bouhadir KH, 2001, BIOMATERIALS, V22, P2625, DOI 10.1016/S0142-9612(01)00003-5
   Bunaprasert T., 2006, J MED ASS THAI, V89, P108
   BURNS MA, 1985, BIOTECHNOL BIOENG, V27, P137, DOI 10.1002/bit.260270206
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Choonara YE, 2011, COLLOID SURFACE B, V87, P243, DOI 10.1016/j.colsurfb.2011.05.025
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Cohen S, 1997, J CONTROL RELEASE, V44, P201, DOI 10.1016/S0168-3659(96)01523-4
   Coilent I., 2009, EUR J PHARM BIOPHARM, V73, P345
   Correa R.M., 2004, CURR DRUG DELIV, V1, P265
   DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7
   Drufy H., 2004, BIOMATERIALS, V25, P3187
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Edelman ER, 2000, BIOMATERIALS, V21, P2279, DOI 10.1016/S0142-9612(00)00154-X
   EI-Sherbiny I.M., 2010, INT J PHARMACEUT, V395, P132
   EI-Sherbiny I.M., 2011, DRUG DEV IND PHARM, V37, P121
   EI-Sherbiny I. M, 2011, CARBOHYD POLYM, V83, P1345
   El-Sherbiny IM, 2010, CARBOHYD POLYM, V80, P1125, DOI 10.1016/j.carbpol.2010.01.034
   Espevik T., 1996, CARBOHYDR EUR, V14, P19
   Farhana S.A., 2009, CURR DRUG DELIV, V7, P98
   Foldvari Marianna, 2006, Current Drug Delivery, V3, P1, DOI 10.2174/156720106775197457
   Gangopadhyay R, 2002, SYNTHETIC MET, V132, P21, DOI 10.1016/S0379-6779(02)00212-6
   Gao CM, 2012, J BIOMAT SCI-POLYM E, V23, P1039, DOI 10.1163/092050611X570653
   George M, 2007, INT J PHARM, V335, P123, DOI 10.1016/j.ijpharm.2006.11.009
   Giovagnoli S, 2010, AAPS PHARMSCITECH, V11, P212, DOI 10.1208/s12249-009-9361-8
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Gonazalez-Rodriguez M.L., 2002, INT J PHARMACEUT, V232, P225
   Gong RM, 2011, CARBOHYD POLYM, V85, P869, DOI 10.1016/j.carbpol.2011.04.011
   Haug A., 1964, THESIS TRONDHEIM
   HUGUET ML, 1994, J APPL POLYM SCI, V51, P1427, DOI 10.1002/app.1994.070510810
   Inukai M, 1999, CHEM PHARM BULL, V47, P1059
   Jamstorp Erik, 2010, Current Drug Delivery, V7, P297, DOI 10.2174/156720110793360630
   Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014
   Jeong SI, 2011, TISSUE ENG PT A, V17, P59, DOI [10.1089/ten.tea.2010.0086, 10.1089/ten.TEA.2010.0086]
   Jork A, 2000, APPL MICROBIOL BIOT, V53, P224, DOI 10.1007/s002530050012
   Josef E, 2010, ACTA BIOMATER, V6, P4642, DOI 10.1016/j.actbio.2010.06.032
   Jun Y., 2001, BIOTECHNOL LETT, V23, P1385
   Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852
   Kennedy KL, 2011, CURR DRUG DELIV, V8, P534
   Kim S., 1997, IPNS WORLD SCI ENG
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   Kulkarni R.V., 2009, J APPL POLYM SCI, V115, P1180
   Kulkarni RV, 2010, INT J BIOL MACROMOL, V47, P520, DOI 10.1016/j.ijbiomac.2010.07.009
   Kulkarni RV, 2009, J BIOMAT SCI-POLYM E, V20, P235, DOI 10.1163/156856209X404514
   Kulkarni Raghavendra. V., 2008, Current Drug Delivery, V5, P256, DOI 10.2174/156720108785915014
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   La Gatta A, 2009, J BIOMED MATER RES A, V90A, P292, DOI 10.1002/jbm.a.32094
   Laroui H, 2010, GASTROENTEROLOGY, V138, P843, DOI 10.1053/j.gastro.2009.11.003
   Lawson MA, 2004, TISSUE ENG, V10, P1480, DOI 10.1089/ten.2004.10.1480
   Lee Beom-Jin, 1999, Pharmacy and Pharmacology Communications, V5, P85
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Lee SB, 2004, MACROMOL RES, V12, P269, DOI 10.1007/BF03218399
   Lemberti F.V., 1983, BIOCHIM BIOPHYS ACTA, V759, P81
   Levy MC, 1996, J MICROENCAPSUL, V13, P169, DOI 10.3109/02652049609052905
   Li XQ, 2006, BIOTECHNOL PROGR, V22, P1683, DOI 10.1021/bp060185z
   Lin HR, 2004, BIOMACROMOLECULES, V5, P2358, DOI 10.1021/bm0496965
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Lin YH, 2005, BIOMATERIALS, V26, P2105, DOI 10.1016/j.biomaterials.2004.06.011
   Liu HX, 2008, INT J PHARMACEUT, V351, P104, DOI 10.1016/j.ijpharm.2007.09.019
   Liu HJ, 2010, DRUG DEV IND PHARM, V36, P1286, DOI 10.3109/03639041003758689
   Liu LS, 1997, J CONTROL RELEASE, V43, P65, DOI 10.1016/S0168-3659(96)01471-X
   Liu WG, 2008, J MATER SCI-MATER M, V19, P3365, DOI 10.1007/s10856-008-3486-2
   Lu HH, 2008, J BIOMED MATER RES A, V86A, P1128, DOI 10.1002/jbm.a.31740
   Malik Dhirendra Kumar, 2007, Current Drug Delivery, V4, P141
   Mandal S, 2010, CARBOHYD POLYM, V82, P867, DOI 10.1016/j.carbpol.2010.06.009
   Manju S, 2011, J BIOMED MATER RES B, V98B, P139, DOI 10.1002/jbm.b.31843
   Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307
   MARTINSEN A, 1991, CARBOHYD POLYM, V15, P171, DOI 10.1016/0144-8617(91)90031-7
   Matricardi P, 2006, INT J PHARM, V316, P21, DOI 10.1016/j.ijpharm.2006.02.024
   Matricardi P, 2008, BIOMACROMOLECULES, V9, P2014, DOI 10.1021/bm800252c
   McHugh D. J, 2003, GUIDE SEAWEED IND
   Mekhloufi G, 2005, LANGMUIR, V21, P386, DOI 10.1021/la0486786
   Mi FL, 2005, J BIOMAT SCI-POLYM E, V16, P1333, DOI 10.1163/156856205774472317
   Nanno K, 2009, CLIN ORTHOP RELAT R, V467, P3149, DOI 10.1007/s11999-009-0899-2
   Navratil M, 2002, ARTIF CELL BLOOD SUB, V30, P199, DOI 10.1081/BIO-120004340
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   OSTBERG T, 1994, INT J PHARM, V112, P241, DOI 10.1016/0378-5173(94)90360-3
   OSTBERG T, 1993, INT J PHARM, V97, P183, DOI 10.1016/0378-5173(93)90138-6
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   Park H, 2011, CARBOHYD POLYM, V86, P1107, DOI 10.1016/j.carbpol.2011.05.032
   Perione M., 1998, J BIOMED MATER RES, V42, P587
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   POLK A, 1994, J PHARM SCI, V83, P178, DOI 10.1002/jps.2600830213
   Pourjavadi A, 2005, MACROMOL RES, V13, P45, DOI 10.1007/BF03219014
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Quong D, 1999, APPL BIOCHEM BIOTECH, V81, P67, DOI 10.1385/ABAB:81:1:67
   RAJAONARIVONY M, 1993, J PHARM SCI, V82, P912, DOI 10.1002/jps.2600820909
   Raof NA, 2011, BIOMATERIALS, V32, P4498, DOI 10.1016/j.biomaterials.2011.03.011
   Rayatpisheh S, 2011, J BIOMED MATER RES A, V98A, P235, DOI 10.1002/jbm.a.33085
   Reyes N, 2006, BIOCHEM ENG J, V32, P43, DOI 10.1016/j.bej.2006.09.001
   Rigo MVR, 2006, INT J PHARM, V322, P36, DOI 10.1016/j.ijpharm.2006.05.025
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Rokhade AP, 2007, CARBOHYD POLYM, V67, P605, DOI 10.1016/j.carbpol.2006.07.001
   Rokhade AP, 2006, CARBOHYD POLYM, V65, P243, DOI 10.1016/j.carbpol.2006.01.013
   Safely S., 2008, J DIABETES SCI TECHN, V2, P760
   Schoyo O., 2000, INT J PHARMACEUT, V207, P109
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SEGI N, 1989, CHEM PHARM BULL, V37, P3092
   Seo SJ, 2006, BIOMATERIALS, V27, P1487, DOI 10.1016/j.biomaterials.2005.09.018
   Shah S.B., 2003, CHEMIE, V214, P75
   Shastri D. H., 2010, Current Drug Delivery, V7, P238
   Shen F, 2005, J BIOMED MATER RES B, V75B, P425, DOI 10.1002/jbm.b.30323
   Shi J, 2006, MACROMOL BIOSCI, V6, P358, DOI 10.1002/mabi.200600013
   SIEGEL RA, 1993, ADV POLYM SCI, V109, P233
   Silva CM, 2006, EUR J PHARM SCI, V29, P148, DOI 10.1016/j.ejps.2006.06.008
   Singh B, 2010, CHEM ENG RES DES, V88, P997, DOI 10.1016/j.cherd.2010.01.017
   SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239
   SMIDSR OD, 1996, CARBOHYDR EUR, V14, P6
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Spitzer RS, 2002, J BIOMED MATER RES, V59, P690, DOI 10.1002/jbm.1277
   Sugiura S, 2005, BIOMATERIALS, V26, P3327, DOI 10.1016/j.biomaterials.2004.08.029
   Suzuki K, 1999, NEUROREPORT, V10, P2891, DOI 10.1097/00001756-199909290-00003
   Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8
   Tavakol M, 2009, CARBOHYD POLYM, V77, P326, DOI 10.1016/j.carbpol.2009.01.005
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   TOMIDA H, 1993, CHEM PHARM BULL, V41, P1475
   Tripathy T, 1999, EUR POLYM J, V35, P2057, DOI 10.1016/S0014-3057(98)00284-5
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Wang FQ, 2011, PHARM DEV TECHNOL, V16, P228, DOI 10.3109/10837451003592217
   Wang Q., 2008, CARBOHYD POLYM, V78, P731
   Wang XW, 1998, POLYMER, V39, P2759, DOI 10.1016/S0032-3861(97)00597-1
   Wei L, 2011, EUR J PHARM BIOPHARM, V78, P346, DOI 10.1016/j.ejpb.2011.01.015
   Weng YL, 2006, TISSUE ENG, V12, P1503, DOI 10.1089/ten.2006.12.1503
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Xin JY, 2010, INT J PHARMACEUT, V386, P221, DOI 10.1016/j.ijpharm.2009.11.024
   Xu YM, 2007, INT J PHARM, V336, P329, DOI 10.1016/j.ijpharm.2006.12.019
   Yang J, 2002, BIOMATERIALS, V23, P471, DOI 10.1016/S0142-9612(01)00129-6
   Yao KD, 1994, J POLYM SCI A, V32, P1213
   YOTSUYANAGI T, 1987, CHEM PHARM BULL, V35, P1555
   Zhang H, 2007, MACROMOL RAPID COMM, V28, P527, DOI 10.1002/marc.200600776
   Zhao LB, 2009, LAB CHIP, V9, P2981, DOI 10.1039/b907478c
   Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
   Zohuriaan-Mehr MJ, 2005, IRAN POLYM J, V14, P235
   Zohuriaan-Mehr MJ, 2003, POLYM ADVAN TECHNOL, V14, P508, DOI 10.1002/pat.362
NR 154
TC 46
Z9 47
U1 7
U2 212
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1567-2018
J9 CURR DRUG DELIV
JI Curr. Drug Deliv.
PD NOV
PY 2012
VL 9
IS 6
BP 539
EP 555
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 022OP
UT WOS:000309969000001
PM 22998675
DA 2018-10-19
ER

PT J
AU Mehrkens, A
   Muller, AM
   Valderrabano, V
   Scharen, S
   Vavken, P
AF Mehrkens, A.
   Mueller, A. M.
   Valderrabano, V.
   Schaeren, S.
   Vavken, P.
TI Tissue engineering approaches to degenerative disc disease - A
   meta-analysis of controlled animal trials
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE Evidence-based medicine; Tissue engineering; Regenerative medicine; Disc
   disease; Disc degeneration
ID MESENCHYMAL STEM-CELLS; LOW-BACK-PAIN; OSTEOGENIC PROTEIN-1 INJECTION;
   LUMBAR INTERVERTEBRAL DISC; NUCLEUS PULPOSUS CELLS;
   EXTRACELLULAR-MATRIX; END-PLATE; MODEL; TRANSPLANTATION; REGENERATION
AB Objective: The objective of this systematic review was to assess cell/biomaterial treatments of degenerative disc disease in controlled animal trails. The primary endpoints were restoration of disc height and T2 signal intensity.
   Method: PubMed, CINAHL, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), and Cochrane Database of Systematic Reviews (CDSR) were searched for studies reporting on the use of tissue engineering treatments (cells/biomaterials/cells and biomaterials) for degenerative disc disease treatments in a controlled trial. Publication bias was assessed graphically using funnel plots and Egger's regression. Data were grouped by follow-up duration - early (< 4 weeks), intermediate (4-12 weeks) and late (> 12 weeks), and weighted mean differences (WMD) were calculated using DerSimonian-Laird Random Effect models.
   Results: Thirteen papers, published between 2004 and 2011, were included in this study. In comparison with the injured disc, all three treatments showed a positive effect in disc height, but none of the treatments restored disc height compared to the healthy disc. Overall, there seemed to be a better effect on disc height restoration for the treatment with cells and biomaterials. None of the treatments could achieve the same T2 signal intensity as the healthy disc, and compared to the injured disc, only the treatment with cells and biomaterials showed consistently better results.
   Conclusion: Treatment of an injured/degenerating disc with cells, cells plus biomaterial or biomaterial alone has a potential for at least a partial regeneration of the disc. However, so far, none of the treatments is able to effectively restore the properties of a healthy disc. (C) 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 [Vavken, P.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Orthoped Surg, Boston, MA 02115 USA.
   [Mehrkens, A.] Univ Toronto, Toronto Western Hosp, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada.
   [Mehrkens, A.; Mueller, A. M.; Valderrabano, V.; Schaeren, S.; Vavken, P.] Univ Basel, Univ Basel Hosp, Dept Orthopaed, CH-4003 Basel, Switzerland.
   [Mueller, A. M.] Beth Israel Deaconess Med Ctr, Ctr Adv Orthoped Studies, Boston, MA 02215 USA.
   [Vavken, P.] Harvard Univ, Sch Publ Hlth, Ctr Populat & Dev Studies, Boston, MA 02115 USA.
RP Vavken, P (reprint author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Orthoped Surg, Boston, MA 02115 USA.
EM patrick.vavken@childrens.harvard.edu
CR Abbushi A, 2008, SPINE, V33, P1527, DOI 10.1097/BRS.0b013e3181788760
   Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y
   An HS, 2005, SPINE, V30, P25, DOI 10.1097/01.brs.0000148002.68656.4d
   Antoniou J, 1996, SPINE, V21, P1153, DOI 10.1097/00007632-199605150-00006
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Bhandari M, 2001, J BONE JOINT SURG AM, V83A, P15, DOI 10.2106/00004623-200101000-00003
   Botelho RV, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1032
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   Buttermann Glenn R, 2004, Spine J, V4, P495, DOI 10.1016/j.spinee.2004.03.024
   Cherkin DC, 1998, SPINE, V23, P607, DOI 10.1097/00007632-199803010-00015
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Erwin WM, 2006, ARTHRITIS RHEUM, V54, P3859, DOI 10.1002/art.22258
   Erwin WM, 2006, SPINE, V31, P1094, DOI 10.1097/01.brs.0000216593.97157.dd
   Feng GJ, 2011, J NEUROSURG-SPINE, V14, P322, DOI 10.3171/2010.11.SPINE10285
   Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1
   Halloran DO, 2008, BIOMATERIALS, V29, P438, DOI 10.1016/j.biomaterials.2007.10.009
   Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584
   Imai Y, 2007, SPINE, V32, P1197, DOI 10.1097/BRS.0b013e3180574d26
   Iwashina T, 2006, SPINE, V31, P1177, DOI 10.1097/01.brs.0000217687.36874.c4
   Jeong JH, 2010, ACTA NEUROCHIR, V152, P1771, DOI 10.1007/s00701-010-0698-2
   Jeong JH, 2009, CYTOTECHNOLOGY, V59, P55, DOI 10.1007/s10616-009-9192-1
   Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273
   Kovacs FM, 2005, SPINE, V30, P1786, DOI 10.1097/01.brs.0000172159.47152.dc
   Kumar MN, 2001, EUR SPINE J, V10, P309, DOI 10.1007/s005860000207
   Mariconda M, 2010, EUR SPINE J, V19, P136, DOI 10.1007/s00586-009-1201-8
   Masuda K, 2006, SPINE, V31, P742, DOI 10.1097/01.brs.0000206358.66412.7b
   Miyamoto T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3182
   Mwale F, 2004, Eur Cell Mater, V8, P58
   Nishimura K, 1998, SPINE, V23, P1531, DOI 10.1097/00007632-199807150-00006
   Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620
   Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011
   Purmessur D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3344
   Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64
   Risbud MV, 2010, DEV DYNAM, V239, P2141, DOI 10.1002/dvdy.22350
   Ruan DK, 2010, TISSUE ENG PT A, V16, P2381, DOI 10.1089/ten.TEA.2009.0770
   Rubin DI, 2007, NEUROL CLIN, V25, P353, DOI 10.1016/j.ncl.2007.01.004
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705
   Sato M, 2003, MED BIOL ENG COMPUT, V41, P365, DOI 10.1007/BF02348444
   Sawamura K, 2009, TISSUE ENG PT A, V15, P3719, DOI 10.1089/ten.TEA.2008.0697
   Serigano K, 2010, J ORTHOP RES, V28, P1267, DOI 10.1002/jor.21147
   Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52
   van Tulder MW, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000335
   Yang HL, 2010, SPINE J, V10, P802, DOI 10.1016/j.spinee.2010.06.019
NR 47
TC 11
Z9 11
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD NOV
PY 2012
VL 20
IS 11
BP 1316
EP 1325
DI 10.1016/j.joca.2012.06.001
PG 10
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 020YV
UT WOS:000309853400014
PM 22789805
OA Bronze
DA 2018-10-19
ER

PT J
AU Soccio, M
   Lotti, N
   Gazzano, M
   Govoni, M
   Giordano, E
   Munari, A
AF Soccio, Michelina
   Lotti, Nadia
   Gazzano, Massimo
   Govoni, Marco
   Giordano, Emanuele
   Munari, Andrea
TI Molecular architecture and solid-state properties of novel biocompatible
   PBS-based copolyesters containing sulphur atoms
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE Poly(butylene succinate); Thiodiethylene glycol; Reactive blending;
   Block copolymers; Biocompatibility
ID CONTAINING POLYMERS; THERMAL-PROPERTIES; POLY(BUTYLENE SUCCINATE);
   CARDIAC MYOBLASTS; MELTING BEHAVIOR; MODEL; BIOMATERIAL; APOPTOSIS;
   ISCHEMIA; GLYCOL
AB Poly(butylene/thiodiethylene succinate) block copolymers (PBSPTDGS), prepared by reactive blending of the parent homopolymers (PBS and PTDGS) in the presence of Ti(OBu)(4), underwent molecular and solid-state characterization, in order to investigate the effects of the transesterification reactions. C-13 NMR analysis demonstrated the formation of copolymers whose degree of randomness increased with the mixing time. Thermal measurements showed that all the samples were semicrystalline, with a soft amorphous phase and a rigid crystal phase. WAXD measurements indicated that the copolymers are characterized by the presence of a pure PBS crystal phase, with the exception of physical mixture. The mechanical properties were related to degree of crystallinity. The random copolymer, characterized by the lowest crystallinity degree, exhibits the lowest elastic modulus and the highest deformation at break. When evaluated for indirect cytotoxicity, all the polymers under investigation appeared entirely biocompatible. In addition, positive results from cellular adhesion and proliferation assays carried out with H9c2 cells seeded and grown up to 14 days in culture over films of PBSPTDGS30 and PBSPTDGS240 demonstrated that these new materials might be of interest for tissue engineering applications. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Lotti, Nadia; Munari, Andrea] Univ Bologna, Dipartimento Ingn Civile Ambientale & Mat, I-40131 Bologna, Italy.
   [Soccio, Michelina] CSIC, Inst Estruct Mat, Dept Fis Macromol, E-28006 Madrid, Spain.
   [Gazzano, Massimo] CNR, Ist Sintesi Organ & Fotoreatt, I-40126 Bologna, Italy.
   [Govoni, Marco; Giordano, Emanuele] Univ Bologna, HST ICIR, Lab Cellular & Mol Engn S Cavalcanti, I-47521 Cesena, FC, Italy.
RP Lotti, N (reprint author), Univ Bologna, Dipartimento Ingn Civile Ambientale & Mat, Via Terracini 28, I-40131 Bologna, Italy.
EM m.soccio@iem.cfmac.csic.es; nadia.lotti@unibo.it;
   massimo.gazzano@unibo.it; marco.govoni6@unibo.it; giordano@unibo.it;
   andrea.munari@unibo.it
RI Gazzano, Massimo/D-9880-2012
OI Gazzano, Massimo/0000-0003-1352-9547; SOCCIO,
   MICHELINA/0000-0003-3646-9612; Govoni, Marco/0000-0002-1876-8101; LOTTI,
   NADIA/0000-0002-7976-2934
CR Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003
   Berti C, 2002, EUR POLYM J, V38, P1281, DOI 10.1016/S0014-3057(02)00012-5
   Berti C, 2005, EUR POLYM J, V41, P1812, DOI 10.1016/j.europolymj.2005.02.024
   Bonavita F, 2003, FEBS LETT, V536, P85, DOI 10.1016/S0014-5793(03)00029-2
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   CHEN MS, 1990, J APPL POLYM SCI, V40, P1053, DOI 10.1002/app.1990.070400537
   CHU CC, 1985, POLYMER, V26, P591, DOI 10.1016/0032-3861(85)90160-0
   Deshmukh S., 2011, POP PLAST PACK, V56, P48
   Eglin D, 2010, J BIOMAT SCI-POLYM E, V21, P477, DOI 10.1163/156856209X424404
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Focarete ML, 2010, J BIOMAT SCI-POLYM E, V21, P1283, DOI 10.1163/092050609X12517190417597
   Govoni M, 2010, AMINO ACIDS, V38, P541, DOI 10.1007/s00726-009-0415-8
   Gualandi C, 2012, J BIOACT COMPAT POL, V27, P244, DOI 10.1177/0883911512440536
   Ichikawa Y, 2001, POLYMER, V42, P847, DOI 10.1016/S0032-3861(00)00390-6
   Kumar D, 2011, POP PLAST PACK, V56, P24
   LEGRAS R, 1986, POLYMER, V27, P109, DOI 10.1016/0032-3861(86)90364-2
   Lotti N, 2006, EUR POLYM J, V42, P3374, DOI 10.1016/j.eurpolymj.2006.08.022
   Lutke-Eversloh T, 2002, NAT MATER, V1, P236, DOI 10.1038/nmat773
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Singh S, 2007, J NANOSCI NANOTECHNO, V7, P2596, DOI 10.1166/jnn.2007.909
   Soccio M, 2008, EUR POLYM J, V44, P1722, DOI 10.1016/j.eurpolymj.2008.03.022
   Soccio M, 2009, EUR POLYM J, V45, P171, DOI 10.1016/j.eurpolymj.2008.10.018
   Soccio M, 2007, J POLYM SCI POL PHYS, V45, P1694, DOI 10.1002/polb.21225
   Tantini B, 2006, J MOL CELL CARDIOL, V40, P775, DOI 10.1016/j.yjmcc.2006.03.002
   Yang YY, 2011, MACROMOL RAPID COMM, V32, P887, DOI 10.1002/marc.201100095
   Yasuniwa M, 2002, J POLYM SCI POL PHYS, V40, P2411, DOI 10.1002/polb.10298
   Yoo ES, 1999, J POLYM SCI POL PHYS, V37, P1357, DOI 10.1002/(SICI)1099-0488(19990701)37:13<1357::AID-POLB2>3.0.CO;2-Q
   ZIMMERMANN H, 1984, DEGRADATION STABILIZ, pCH3
NR 28
TC 20
Z9 21
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD NOV
PY 2012
VL 72
IS 11
BP 856
EP 867
DI 10.1016/j.reactfunctpolym.2012.08.002
PG 12
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 017WO
UT WOS:000309622100010
DA 2018-10-19
ER

PT J
AU Hamada, Y
   Fujitani, W
   Kawaguchi, N
   Daito, K
   Niido, T
   Uchinaka, A
   Mori, S
   Kojima, Y
   Manabe, M
   Nishida, K
   Arita, K
   Nakano, T
   Matsuura, N
AF Hamada, Yoshinosuke
   Fujitani, Wataru
   Kawaguchi, Naomasa
   Daito, Kiyoshi
   Niido, Tsutsu
   Uchinaka, Ayako
   Mori, Seiji
   Kojima, Yoshihisa
   Manabe, Masashi
   Nishida, Kiheiji
   Arita, Kenji
   Nakano, Takayoshi
   Matsuura, Nariaki
TI The preparation of PLLA/calcium phosphate hybrid composite and its
   evaluation of biocompatibility
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE PLLA/OCP composite; Biocompatibility; Tissue engineering; Bone
   regeneration
ID FT-IR; BONE; BIOMATERIALS; TITANIUM; GROWTH; TISSUE; IMPLANTS; KINETICS;
   TEXTURE; CRYSTAL
AB In tissue engineering, biodegradable polymer materials with both high biocompatibility and high strength are very important as scaffolds for long term use. Therefore, in this research, we tried to prepare the three types of poly(L-lactic acid) (PLLA)/calcium phosphate (CP) hybrid composite for a scaffold biomaterial. The effects of addition of different CP on both biocompatibility and mechanical properties were evaluated. CP powders and voids were three-dimensionally and uniformly distributed in the solid samples and porous composite samples. These compositions of CP and PLLA greatly improved the cellular adhesiveness, which increased as the volume fraction of CP in the composite increased. For the porous samples, cells migrated into the pores. This study demonstrated that a composite of PLLA and CP is an effective new scaffold material that results in better osteoconductivity, bone regeneration, and mineralization and has moderately high strength.
C1 [Hamada, Yoshinosuke; Kawaguchi, Naomasa; Niido, Tsutsu; Uchinaka, Ayako; Mori, Seiji; Kojima, Yoshihisa; Matsuura, Nariaki] Osaka Univ, Grad Sch Med & Hlth Sci, Dept Mol Pathol, Osaka 5650871, Japan.
   [Hamada, Yoshinosuke; Daito, Kiyoshi; Arita, Kenji] Osaka Dent Univ, Dept Pediat Dent, Osaka 5731121, Japan.
   [Fujitani, Wataru; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Osaka 5650871, Japan.
   [Kawaguchi, Naomasa] Osaka Univ, Grad Sch Med & Hlth Sci, Dept Cardiovasc Pathol, Osaka 5650871, Japan.
   [Hamada, Yoshinosuke; Manabe, Masashi; Nishida, Kiheiji] Osaka Univ, Grad Sch Med, Dept Med Econ & Management, Osaka 5650871, Japan.
RP Hamada, Y (reprint author), Osaka Univ, Grad Sch Med & Hlth Sci, Dept Mol Pathol, Osaka 5650871, Japan.
EM y-hamada@sahs.med.osaka-u.ac.jp
CR Alberts B, 2001, MOL BIOL CELL, P1065
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   Elliott JC, 1994, STRUCTURE CHEM APATI, V18, P1
   Fujitani W., 2010, NANO BIOMED, V2, P37
   Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Mao CB, 1999, J CRYST GROWTH, V206, P308, DOI 10.1016/S0022-0248(99)00315-2
   Matsumoto T, 2006, DENT MATER J, V25, P360, DOI 10.4012/dmj.25.360
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   Nakano T, 2002, INT CONGR SER, V1243, P95
   Nakano T, 2001, SCRIPTA MATER, V44, P811, DOI 10.1016/S1359-6462(00)00656-4
   Nakano T, 2001, 4 PAC RIM INT C ADV, P225
   Nakano T, 2006, MATER TRANS, V47, P2233, DOI 10.2320/matertrans.47.2233
   Nakano T, 2011, ISIJ INT, V51, P262, DOI 10.2355/isijinternational.51.262
   OKAZAKI M, 1986, CARIES RES, V20, P324, DOI 10.1159/000260952
   Okazaki M, 2001, DENT JPN, V37, P95
   Okazaki M, 2010, DENT MATER J, V29, P1, DOI 10.4012/dmj.2009-R01
   OWEN M, 1963, J CELL BIOL, V19, P19, DOI 10.1083/jcb.19.1.19
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P375, DOI 10.1002/jbm.820060506
   Schneider U, 1996, PHYS MED BIOL, V41, P111, DOI 10.1088/0031-9155/41/1/009
   Umakoshi Y, 2001, P 5 AS S BIOM MAT AS, P1
   Yokota R, 2006, DENT MATER J, V25, P597, DOI 10.4012/dmj.25.597
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 29
TC 8
Z9 9
U1 1
U2 11
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD NOV
PY 2012
VL 31
IS 6
BP 1087
EP 1096
DI 10.4012/dmj.2012-117
PG 10
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 224ON
UT WOS:000324898000029
PM 23207220
OA Bronze
DA 2018-10-19
ER

PT J
AU Avashia, YJ
   Sastry, A
   Fan, KL
   Mir, HS
   Thaller, SR
AF Avashia, Yash J.
   Sastry, Ananth
   Fan, Kenneth L.
   Mir, Haaris S.
   Thaller, Seth R.
TI Materials Used for Reconstruction After Orbital Floor Fracture
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Orbital floor reconstruction; biomaterials; implants; orbital floor
   fractures
AB Advances in biotechnology continue to introduce new materials for reconstruction of orbital floor fractures. Which material is best fit for orbital floor reconstruction has been a controversial topic. Individual surgeon preferences have been supported by inconsistent inconclusive data. The purpose of this study was to assess and analyze published evidence supporting various materials used for orbital floor reconstruction and to develop a decision-making algorithm for clinical application. A systematic literature review was performed from which 48 studies were selected after primary and secondary screening based on set inclusion and exclusion criteria. This cumulatively included 3475 separate orbital floor reconstructions. Results revealed risk and benefit profiles for all materials. Autologous calvarial bone grafts, porous polyethylene, and polydioxanone (PDS) were most widely used for orbital floor reconstruction. Increased infection rates were reported with polyglactin 910/PDS composites and silastic rubber. Ocular motility was reduced most with lyophilized dura and PDS. Preoperative and postoperative rates for diplopia and enophthalmos varied among the materials. In conclusion, our results revealed continued inadequate evidence to exclusively support the use of any one biomaterial/implant for orbital floor reconstruction. Results have served to create a decision-making algorithm for clinical application. Our authors propose certain parameters for future studies seeking to demonstrate a comparison between 2 or more materials for orbital floor reconstruction.
C1 [Avashia, Yash J.; Sastry, Ananth; Fan, Kenneth L.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Mir, Haaris S.; Thaller, Seth R.] Univ Miami, Miller Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Miami, FL 33136 USA.
RP Thaller, SR (reprint author), Univ Miami Hlth Syst, DeWitt Daughtry Family Dept Surg, Div Plast & Reconstruct Surg, Clin Res Bldg,1120 NW 14th St,4th Floor, Miami, FL 33136 USA.
EM SThaller@med.miami.edu
CR Aho AJ, 1998, ACTA ORTHOP SCAND, V69, P559, DOI 10.3109/17453679808999255
   Aitasalo K, 2001, J ORAL MAXIL SURG, V59, P1390, DOI 10.1053/joms.2001.27524
   Al-Sukhun J, 2006, J ORAL MAXIL SURG, V64, P1038, DOI 10.1016/j.joms.2006.03.010
   Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x
   Baino F, 2011, ACTA BIOMATER, V7, P3248, DOI 10.1016/j.actbio.2011.05.016
   Ballin M, 1921, SURG GYNECOL OBSTET, V33, P79
   Bayat M, 2010, BRIT J ORAL MAX SURG, V48, P617, DOI 10.1016/j.bjoms.2009.10.019
   Buchel P, 2005, J ORAL MAXIL SURG, V63, P646, DOI 10.1016/j.joms.2004.11.013
   BURRES SA, 1981, LARYNGOSCOPE, V91, P1881
   Campbell DG, 1999, AUST NZ J SURG, V69, P517, DOI 10.1046/j.1440-1622.1999.01615.x
   Chowdhury K, 1998, ARCH OTOLARYNGOL, V124, P1398, DOI 10.1001/archotol.124.12.1398
   Ellis E, 2003, J ORAL MAXIL SURG, V61, P442, DOI 10.1053/joms.2003.50085
   FRANCEL TJ, 1992, PLAST RECONSTR SURG, V90, P568, DOI 10.1097/00006534-199210000-00004
   GLASSMAN RD, 1990, PLAST RECONSTR SURG, V86, P1103, DOI 10.1097/00006534-199012000-00009
   Guerra MFM, 2000, J ORAL MAXIL SURG, V58, P1361, DOI 10.1053/joms.2000.18266
   Han DH, 2011, J CRANIOFAC SURG, V22, P1422, DOI 10.1097/SCS.0b013e31821cc2b5
   HEIKKILA JT, 1995, ACTA ORTHOP SCAND, V66, P463, DOI 10.3109/17453679508995588
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hollier LH, 2001, J CRANIOFAC SURG, V12, P242, DOI 10.1097/00001665-200105000-00009
   Hwang K, 2010, J CRANIOFAC SURG, V21, P847, DOI 10.1097/SCS.0b013e3181d7f2ff
   IIZUKA T, 1991, INT J ORAL MAX SURG, V20, P83
   ILANKOVAN V, 1992, BRIT J ORAL MAX SURG, V30, P92, DOI 10.1016/0266-4356(92)90077-V
   Jank S, 2003, ORAL SURG ORAL MED O, V95, P16, DOI 10.1067/moe.2003.11
   KAPPIS A, 1915, ZENTRALBL CHIR, V42, P897
   Kinnunen I, 2000, J CRANIO MAXILL SURG, V28, P229, DOI 10.1054/jcms.2000.0140
   KLINE RM, 1995, PLAST RECONSTR SURG, V95, P5, DOI 10.1097/00006534-199501000-00002
   Kontakis GM, 2007, ACTA ORTHOP BELG, V73, P159
   Kontio R, 2001, INT J ORAL MAX SURG, V30, P278, DOI 10.1054/ijom.2001.0067
   Kozakiewicz M, 2009, J CRANIO MAXILL SURG, V37, P229, DOI 10.1016/j.jcms.2008.11.009
   Kraus M, 2001, J ORAL MAXIL SURG, V59, P1397, DOI 10.1053/joms.2001.28265
   Kruschewsky LD, 2011, J CRANIOFAC SURG, V22, P1256, DOI 10.1097/SCS.0b013e31821c6a77
   Lai A, 1998, LARYNGOSCOPE, V108, P645, DOI 10.1097/00005537-199805000-00004
   LASKIN DM, 1953, SURG GYNECOL OBSTET, V96, P493
   Laxenaire A., 1997, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V98, P96
   Lee HBH, 2009, OPHTHAL PLAST RECONS, V25, P33, DOI 10.1097/IOP.0b013e3181929b6e
   Lieger O, 2010, ARCH FACIAL PLAST S, V12, P186, DOI 10.1001/archfacial.2010.26
   LIPSHUTZ H, 1963, J Trauma, V3, P563, DOI 10.1097/00005373-196311000-00006
   Lupi E, 2004, INVEST OPHTH VIS SCI, V45, pE4700
   MARCHAC D, 1978, PLAST RECONSTR SURG, V61, P823, DOI 10.1097/00006534-197861060-00001
   MARX RE, 1991, J ORAL MAXIL SURG, V49, P272, DOI 10.1016/0278-2391(91)90218-B
   Mauclaire H, 1908, B MEM SOC CHIR PARIS, V34, P232
   MAURIELLO JA, 1984, OPHTHALMOLOGY, V91, P102
   Miyasaka Muneo, 2008, Tokai J Exp Clin Med, V33, P35
   Morax S, 1993, Ann Chir Plast Esthet, V38, P445
   MORRISON AD, 1995, J ORAL MAXIL SURG, V53, P412, DOI 10.1016/0278-2391(95)90714-9
   NOLASCO FP, 1995, OTOLARYNG HEAD NECK, V112, P549, DOI 10.1016/S0194-5998(95)70210-5
   Nunery WR, 2008, OPHTHAL PLAST RECONS, V24, P271, DOI 10.1097/IOP.0b013e3181788de8
   Park DJJ, 2008, OPHTHAL PLAST RECONS, V24, P266, DOI 10.1097/IOP.0b013e31817e0fe0
   PARKIN JL, 1987, LARYNGOSCOPE, V97, P1
   Peltola M, 2008, J ORAL MAXIL SURG, V66, P639, DOI 10.1016/j.joms.2007.11.019
   PENSLER J, 1985, PLAST RECONSTR SURG, V75, P648, DOI 10.1097/00006534-198505000-00005
   Pietrzak WS, 2009, J CRANIOFAC SURG, V20, P1533, DOI 10.1097/SCS.0b013e3181b09bd8
   Pietrzak WS, 2000, TISSUE ENG, V6, P425, DOI 10.1089/107632700418128
   POLLEY JW, 1987, PLAST RECONSTR SURG, V79, P39
   Prowse SJB, 2010, J PLAST RECONSTR AES, V63, P1105, DOI 10.1016/j.bjps.2009.05.057
   Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721
   Romano J J, 1993, J Craniofac Surg, V4, P142, DOI 10.1097/00001665-199307000-00007
   Sallam MM, 2010, J APPL SCI RES, V6, P653
   SARGENT LA, 1991, PLAST RECONSTR SURG, V88, P31, DOI 10.1097/00006534-199107000-00006
   Schlickewei W, 2007, MACROMOL SYMP, V253, P10, DOI 10.1002/masy.200750702
   Schwartz Z, 1996, J PERIODONTOL, V67, P918, DOI 10.1902/jop.1996.67.9.918
   STOSS H, 1977, FORTSCHR MED, V95, P1018
   Talesh KT, 2009, BRIT J ORAL MAX SURG, V47, P10, DOI 10.1016/j.bjoms.2008.04.017
   TESSIER P, 1982, CLIN PLAST SURG, V9, P531
   Tuncer S, 2007, J CRANIOFAC SURG, V18, P598, DOI 10.1097/01.scs.0000246735.92095.ef
   WEBSTER K, 1988, ORAL SURG ORAL MED O, V65, P161, DOI 10.1016/0030-4220(88)90158-2
   YOUNG VL, 1990, PLAST RECONSTR SURG, V86, P763, DOI 10.1097/00006534-199010000-00029
   ZINS JE, 1983, PLAST RECONSTR SURG, V72, P778, DOI 10.1097/00006534-198312000-00005
NR 68
TC 36
Z9 37
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD NOV
PY 2012
VL 23
SU 1
BP 1991
EP 1997
DI 10.1097/SCS.0b013e31825aada1
PG 7
WC Surgery
SC Surgery
GA V40MA
UT WOS:000209481500017
PM 23154365
DA 2018-10-19
ER

PT J
AU Patel, JD
   Colton, E
   Ebert, M
   Anderson, JM
AF Patel, Jasmine D.
   Colton, Erica
   Ebert, Michael
   Anderson, James M.
TI Gene expression during S. epidermidis biofilm formation on biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Staphylococcus epidermidis; biofilm; genetics; biomaterials
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   CATHETER-ASSOCIATED INFECTION; LEUKOCYTE ADHESION; BACTERIAL ADHESION;
   SURFACE-CHEMISTRY; RAT MODEL; PROTEIN; ACCUMULATION; PATHOGENESIS
AB Biomaterial-centered infections are initiated by adhesion of bacteria to an implant, followed by colonization and mature biofilm formation. Staphylococcus epidermidis is commonly identified as the cause of these device-centered infections. This study used an in vitro model to evaluate temporal changes in the expression of genesicaADBC, agrBDCA, aap, and atlethat have been identified to play a role in the pathogenesis of S. epidermidis infections. Real-time reverse transcriptionpolymerase chain reaction was used to determine changes in gene expression from S epidermidis biofilm grown on polyurethanes (Elasthane 80A, hydrophobic) modified with polyethylene oxide (Elasthane 80A6PEO, hydrophilic) and fluorocarbon (Elasthane 80A6F, hydrophobic). In vitro expression of the ica locus, which is involved in initial adhesion and intracellular aggregation, increased up to 100-fold from 2 to 48 h, whereas gene expression for autolysin AtlE decreased slightly from 2 to 12 h, followed by a 10-fold increase by 48 h. Upregulation of the aap gene associated with bacterial accumulation and the agr quorum-sensing system was observed during biofilm formation over 48 h. In addition, no correlation was observed between S. epidermidis gene expression and biomaterial surface chemistry. This study used an in vitro model to demonstrate that enhanced expression of the atle, aap, agr, and ica genes plays an important role in initial foreign body colonization and potentially in the establishment of a device-associated infection. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A:28632869, 2012.
C1 [Patel, Jasmine D.; Colton, Erica; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Ebert, Michael] Medtronic Inc, Minneapolis, MN USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM jma6@case.edu
CR Beamish JA, 2009, BIOMATERIALS, V30, P4127, DOI 10.1016/j.biomaterials.2009.04.038
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   GRAY ED, 1984, LANCET, V1, P365
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Higashi JM, 1999, HDB BIOMATERIALS EVA, P493
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   MACK D, 1992, INFECT IMMUN, V60, P2048
   McCrea KW, 2000, MICROBIOL-UK, V146, P1535, DOI 10.1099/00221287-146-7-1535
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   MULLER E, 1993, J INFECT DIS, V168, P1211, DOI 10.1093/infdis/168.5.1211
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   Otto M, 1998, FEBS LETT, V424, P89, DOI 10.1016/S0014-5793(98)00145-8
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Patel JD, 2005, J BIOMED MATER RES A, V73A, P359, DOI 10.1002/jbm.a.30302
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   PULVERER G, 1987, ZBL BAKT-INT J MED M, V264, P1
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   Saenz HL, 2000, ARCH MICROBIOL, V174, P452, DOI 10.1007/s002030000223
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Veenstra GJC, 1996, J BACTERIOL, V178, P537, DOI 10.1128/jb.178.2.537-541.1996
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000
   Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606
   Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945
   Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004
NR 47
TC 16
Z9 18
U1 4
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2012
VL 100A
IS 11
BP 2863
EP 2869
DI 10.1002/jbm.a.34221
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 009ZF
UT WOS:000309063400001
PM 22623350
DA 2018-10-19
ER

PT J
AU Tovar, N
   Murthy, NS
   Kohn, J
   Gatt, C
   Dunn, M
AF Tovar, Nick
   Murthy, N. Sanjeeva
   Kohn, Joachim
   Gatt, Charles
   Dunn, Michael
TI ACL reconstruction using a novel hybrid scaffold composed of polyarylate
   fibers and collagen fibers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tissue regeneration; ligament graft; cell-biomaterial interaction;
   polymer scaffold
ID ANTERIOR CRUCIATE LIGAMENT; STRUCTURE-PROPERTY RELATIONSHIPS; ERODABLE
   POLYMERIC BIOMATERIALS; TYROSINE-DERIVED POLYCARBONATES; POLY
   DESAMINOTYROSYL ARYLATES; PATELLAR TENDON AUTOGRAFT; FOLLOW-UP
   EVALUATION; MECHANICAL-PROPERTIES; BIOLOGICAL RESPONSE;
   GAMMA-IRRADIATION
AB The objective was to perform an initial in vivo evaluation of a novel braided hybrid polyarylate and collagen fiber scaffold for the reconstruction of the anterior cruciate ligament (ACL). The braided hybrid scaffold is composed of 75% poly(desaminotyrosyl-tyrosine dodecyl dodecanedioate)(12,10), [p(DTD DD)] fibers and 25% type I bovine collagen fibers. The scaffold is designed to temporarily bear mechanical loads and gradually degrade as neoligament tissue is deposited. Scaffolds were electron beam sterilized and used to reconstruct the ACL in five Finnish Dorset crossed-bred sheep in this feasibility study. At 4 (n = 1) and 12 (n = 4) weeks post-op, scaffolds were retrieved and analyzed for cellular ingrowth and strength retention. There was extensive cell infiltration and vascularity, which increased with time. Tissue ingrowth occurred throughout the cross section in the midsubstance of the scaffolds. After 12 weeks all scaffolds were intact. Femurscaffoldtibia complex (FSTC) explanted at 12 weeks had a yield load of 42 +/- 22 N and a stiffness of 9 +/- 3 N mm-1. All scaffolds were well tolerated in the intraarticular space and induced tissue ingrowth, including new blood vessels, fibroblasts, inflammatory cells, and newly deposited collagen, throughout the cross section of the scaffold. Tissue ingrowth is critical to the success of a degradable scaffold for ACL reconstruction. Long-term studies in a large animal model are required to determine the efficacy of these novel hybrid scaffolds for ACL reconstruction.(C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A:29132920, 2012.
C1 [Tovar, Nick; Gatt, Charles; Dunn, Michael] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Orthoped Res Lab, New Brunswick, NJ USA.
   [Tovar, Nick] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA.
   [Murthy, N. Sanjeeva; Kohn, Joachim] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA.
RP Tovar, N (reprint author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Orthoped Res Lab, New Brunswick, NJ USA.
EM nicktovar@gmail.com
FU NIH [R01 AR42230, RO1 EB00286]; Colonel William Van Allen Fellowship; La
   Unidad Latina Fellowship; New Jersey Center for Biomaterials (NJCBM)
FX Contract grant sponsor: NIH; contract grant numbers: R01 AR42230, RO1
   EB00286; Contract grant sponsor: Colonel William Van Allen Fellowship;
   Contract grant sponsor: La Unidad Latina Fellowship; Contract grant
   sponsor: New Jersey Center for Biomaterials (NJCBM)
CR Atala A, 1997, SYNTHETIC BIODEGRADA, V12
   Bach BR, 1998, AM J SPORT MED, V26, P30, DOI 10.1177/03635465980260012201
   Bach BR, 1998, AM J SPORT MED, V26, P20, DOI 10.1177/03635465980260012101
   Benjamin M, 2000, INT REV CYTOL, V196, P85
   Beynnon BD, 2005, AM J SPORT MED, V33, P1579, DOI 10.1177/0363546505279913
   Blassingame TM, 2005, DEV SYNTHETIC COLLAG
   Bourke SL, 2004, TISSUE ENG, V10, P43, DOI 10.1089/107632704322791682
   Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   Caruso AB, 2005, J BIOMED MATER RES A, V73A, P388, DOI 10.1002/jbm.a.30233
   Caruso AB, 2004, J BIOMED MATER RES A, V69A, P164, DOI 10.1002/jbm.a.20136
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   Collins G, 2007, POLYMER, V48, P975, DOI 10.1016/j.polymer.2006.11.049
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104
   Crawford C, 2005, CLIN INFECT DIS, V41, P195, DOI 10.1086/430911
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   DUNN MG, 1995, J BIOMED MATER RES, V29, P1363, DOI 10.1002/jbm.820291107
   Dunn MG, 1997, J APPL POLYM SCI, V63, P1423, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1423::AID-APP4>3.0.CO;2-O
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   Durselen L, 2006, J BIOMED MATER RES B, V76B, P265, DOI 10.1002/jbm.b.30381
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   Fox DB, 2006, TISSUE ENG, V12, P1526
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Hunt P, 2006, KNEE SURG SPORT TR A, V14, P1245, DOI 10.1007/s00167-006-0082-1
   Jaffe M, 2002, POLYM ADVAN TECHNOL, V13, P926, DOI 10.1002/pat.278
   Jaffe M, 2003, POLYMER, V44, P6033, DOI 10.1016/S0032-3861(03)00559-7
   Kaeding CC, 2011, SPORTS HEALTH, V3, P73, DOI 10.1177/1941738110386185
   Ko F, 1989, 3 DIMENSIONAL FABRIC
   Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443
   LIU BC, 1989, J BIOMED MATER RES, V23, P833, DOI 10.1002/jbm.820230803
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   MATSUSUE Y, 1995, CLIN ORTHOP RELAT R, P246
   Murray MM, 2000, J BONE JOINT SURG AM, V82A, P1387, DOI 10.2106/00004623-200010000-00004
   Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017
   ROGERS GJ, 1990, BIOMATERIALS, V11, P89, DOI 10.1016/0142-9612(90)90122-7
   Singhatat W, 2002, AM J SPORT MED, V30, P506, DOI 10.1177/03635465020300041001
   SUGANUMA J, 1993, J APPL BIOMATER, V4, P13, DOI 10.1002/jab.770040103
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Tovar N, 2010, J BIOMED MATER RES A, V93A, P738, DOI 10.1002/jbm.a.32567
   Tria Jr AJ, 1995, LIGAMENTS KNEE
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   VANSLIEDREGT A, 1994, BIOMATERIALS, V15, P251, DOI 10.1016/0142-9612(94)90047-7
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   WOO SLY, 1991, AM J SPORT MED, V19, P217, DOI 10.1177/036354659101900303
NR 46
TC 12
Z9 13
U1 5
U2 39
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2012
VL 100A
IS 11
BP 2913
EP 2920
DI 10.1002/jbm.a.34229
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 009ZF
UT WOS:000309063400007
PM 22696232
DA 2018-10-19
ER

PT J
AU Dumas, V
   Rattner, A
   Vico, L
   Audouard, E
   Dumas, JC
   Naisson, P
   Bertrand, P
AF Dumas, Virginie
   Rattner, Aline
   Vico, Laurence
   Audouard, Eric
   Dumas, Jean Claude
   Naisson, Pierre
   Bertrand, Philippe
TI Multiscale grooved titanium processed with femtosecond laser influences
   mesenchymal stem cell morphology, adhesion, and matrix organization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE femtosecond laser; multiscale texturing; biomaterial; osseointegration;
   mesenchymal stem cells
ID OSTEOBLAST ADHESION; SURFACE TREATMENTS; CONTACT GUIDANCE; IN-VITRO;
   DIFFERENTIATION; ALIGNMENT; IMPLANTS; OSSEOINTEGRATION; MINERALIZATION;
   TRANSMISSION
AB The femtosecond laser processing enabled the structuring of six types of surfaces on titanium-6aluminium-4vanadium (Ti-6Al-4V) plates. The obtained hierarchical features consisted of a combination of microgrooves and oriented nanostructures. By adjusting beam properties such as laser polarization, the width of the microgrooves (20 or 60 mu m) and the orientation of the nanostructures (parallel or perpendicular to the microgrooves) can be precisely controlled. Mesenchymal stem cells (MSCs) grown on these structured surfaces produced cytoplasmic extensions with focal contacts, while on the smooth titanium, the cells were found to be well spread and without any focal contact 12 h postseeding. The 600-nm wide nanostructures on their own were sufficient to orient the MSCs. For the multiscale structured areas, when the orientation of the nanostructures was orthogonal in relation to the microgrooves, there was an important decrease in or even a loss of cell alignment signifying that cells were sensitive to the directional nanostructures in the microgrooves. At 7 days, cell proliferation was not affected but the direction of nanostructures controlled the matrix organization. The ultrafast laser, as a new method for producing micro-nanohybrid surfaces, is a promising approach to promote desired tissue organization for tissue engineering. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A:31083116, 2012.
C1 [Dumas, Virginie; Naisson, Pierre] Univ Lyon, ENISE, LTDS, CNRS,UMR 5513, F-42023 St Etienne, France.
   [Rattner, Aline; Vico, Laurence] Univ Lyon, INSERM, Lab Biol Tissu Osseux, U1059, F-42023 St Etienne, France.
   [Audouard, Eric] Univ Lyon, Lab Hubert Curien, CNRS, UMR 5516, F-42000 St Etienne, France.
   [Dumas, Jean Claude; Bertrand, Philippe] Univ Lyon, ENISE, Lab Diagnost & Ingn Proc Ind, F-42023 St Etienne, France.
RP Dumas, V (reprint author), Univ Lyon, ENISE, LTDS, CNRS,UMR 5513, F-42023 St Etienne, France.
EM virginie.dumas@enise.fr
RI Vico, Laurence/O-1927-2018
OI Vico, Laurence/0000-0002-2110-287X; BERTRAND,
   Philippe/0000-0001-6619-4176
FU Saint Etienne Metropole
FX Contract grant sponsor: Saint Etienne Metropole
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Ascenzi MG, 2006, J STRUCT BIOL, V153, P14, DOI 10.1016/j.jsb.2005.08.007
   Ascenzi MG, 2003, J STRUCT BIOL, V141, P22, DOI 10.1016/S1047-8477(02)00578-6
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Biggs M, 2007, COMP BIOCHEM PHYS A, V146, pS64, DOI 10.1016/j.cbpa.2007.01.063
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Chalut KJ, 2010, SOFT MATTER, V6, P1675, DOI 10.1039/b921206j
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Davidson PM, 2009, ADV MATER, V21, P3586, DOI 10.1002/adma.200900582
   Dusser B, 2010, OPT EXPRESS, V18, P2913, DOI 10.1364/OE.18.002913
   Freeman JW, 2005, CONNECT TISSUE RES, V46, P107, DOI 10.1080/03008200590954140
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Ishizaki T, 2010, LANGMUIR, V26, P8147, DOI 10.1021/la904447c
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Koutnikova H, 2001, ANN MED, V33, P556, DOI 10.3109/07853890108995966
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Le Harzic R, 2002, APPL PHYS LETT, V80, P3886, DOI 10.1063/1.1481195
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Nayak B, 2007, NANOTECHNOLOGY, V18, P195
   Nayak BK, 2008, APPL PHYS A-MATER, V90, P399, DOI 10.1007/s00339-007-4349-2
   Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069
   Raspanti M, 1995, ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY, VOL 100 - SUPPLEMENT N.1 - 1995, P103
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Tuennermann A., 2010, LASER TECH J, V7, P34, DOI DOI 10.1002/LATJ.201090006
   Vorobyev AY, 2007, APPL SURF SCI, V253, P7272, DOI 10.1016/j.apsusc.2007.03.006
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Yang GL, 2008, ORAL SURG ORAL MED O, V106, P516, DOI 10.1016/j.tripleo.2008.03.017
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
NR 38
TC 33
Z9 35
U1 6
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2012
VL 100A
IS 11
BP 3108
EP 3116
DI 10.1002/jbm.a.34239
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 009ZF
UT WOS:000309063400027
PM 22791663
DA 2018-10-19
ER

PT J
AU Liao, WH
   Lin, CR
   Wei, DH
   Shen, YR
   Li, YC
   Lee, JA
   Liang, CY
AF Liao, Wen-Hsiang
   Lin, Chii-Ruey
   Wei, Da-Hua
   Shen, You-Ruey
   Li, Yi-Chieh
   Lee, Jen-Ai
   Liang, Chia-Yao
TI Concurrent improvement in biocompatibility and bioinertness of
   diamond-like carbon films with nitrogen doping
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE implantable biomaterials; n-doped diamond-like carbon; biocompatibility;
   bioinertness; adhesion; cell proliferation
ID NANOCOMPOSITE FILMS; AMORPHOUS-CARBON; THIN-FILMS;
   MECHANICAL-PROPERTIES; NITRIDE FILMS; COATINGS; MICROSTRUCTURE;
   DEPOSITION; ADHESION; BEHAVIOR
AB The surfaces of implantable biomaterials improving biocompatibility and bioinertness are critical for new application of bioimplantable devices. Diamond-like carbon (DLC) film is a promising biomaterial with use for coating bioimplantable devices because of its good biocompatibility, bioinertness, and mechanical properties. In this study, concurrent improvement in biocompatibility and bioinertness of DLC films has been achieved using N-incorporation technique. The N doping degree was found to play an important role in affecting the biocompatibility and bioinertness of N-doped DLC films. The results indicated that the N-doped DLC films deposited at N2 concentration of 5% could help to create suitable condition of surface/structure/adhesion combination of DLC films in the both affinity of the L929 mouse fibroblasts and electrochemical inertness in the Hank's balanced salt solutions (simulating human body fluids). N doping supports the attachment and proliferation of cells and prevents the permeation of electrolyte solutions, thereby simultaneity improved the biocompatibility and bioinertness of DLC films. This finding is useful for the fabrication and encapsulation of in vivo devices without induced immune response in the human body. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A:31513156, 2012.
C1 [Liao, Wen-Hsiang; Lin, Chii-Ruey; Wei, Da-Hua; Shen, You-Ruey; Liang, Chia-Yao] Natl Taipei Univ Technol, Inst Mfg Technol, Dept Mech Engn, Taipei 106, Taiwan.
   [Liao, Wen-Hsiang; Lin, Chii-Ruey; Wei, Da-Hua; Liang, Chia-Yao] Natl Taipei Univ Technol, Grad Inst Mech & Elect Engn, Taipei 106, Taiwan.
   [Lin, Chii-Ruey; Wei, Da-Hua; Shen, You-Ruey] Natl Taipei Univ Technol, Inst Mechatron Engn, Taipei 106, Taiwan.
   [Li, Yi-Chieh; Lee, Jen-Ai] Taipei Med Univ, Sch Pharm, Taipei 11031, Taiwan.
RP Lin, CR (reprint author), Natl Taipei Univ Technol, Inst Mfg Technol, Dept Mech Engn, Taipei 106, Taiwan.
EM crlin@ntut.edu.tw; dhwei@ntut.edu.tw
FU National Science Council of R.O.C. [NSC 100-2221-E-027-015, NSC
   100-2221-E-027-047]; National Taipei University of Technology-Taipei
   Medical University Joint Research Program [NTUT-TMU-101-07]
FX Contract grant sponsor: National Science Council of R.O.C.; contract
   grant numbers: NSC 100-2221-E-027-015, NSC 100-2221-E-027-047; Contract
   grant sponsor: National Taipei University of Technology-Taipei Medical
   University Joint Research Program; contract grant number:
   NTUT-TMU-101-07
CR Ban M, 2003, DIAM RELAT MATER, V12, P47, DOI 10.1016/S0925-9635(02)00265-0
   Bertran E, 2003, DIAM RELAT MATER, V12, P1008, DOI 10.1016/S0925-9635(02)00303-5
   Chiu MC, 2005, THIN SOLID FILMS, V476, P258, DOI 10.1016/j.tsf.2004.09.029
   Chowdhury AKMS, 1999, SURF COAT TECH, V112, P133, DOI 10.1016/S0257-8972(98)00761-0
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Dai W, 2011, J ALLOY COMPD, V509, P4626, DOI 10.1016/j.jallcom.2011.01.132
   de Haro C, 2002, BIOMATERIALS, V23, P4515, DOI 10.1016/S0142-9612(02)00195-3
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Hovsepian PE, 2004, THIN SOLID FILMS, V447, P7, DOI 10.1016/j.tsf.2003.09.009
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ji L, 2008, DIAM RELAT MATER, V17, P1949, DOI 10.1016/j.diamond.2008.04.018
   Khun NW, 2010, SURF COAT TECH, V204, P3125, DOI 10.1016/j.surfcoat.2010.02.057
   Khun NW, 2009, CORROS SCI, V51, P2158, DOI 10.1016/j.corsci.2009.05.050
   LAWN BR, 1980, J AM CERAM SOC, V63, P574, DOI 10.1111/j.1151-2916.1980.tb10768.x
   Lin CR, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.035802
   Ma WJ, 2007, BIOMATERIALS, V28, P1620, DOI 10.1016/j.biomaterials.2006.12.010
   MCKENZIE DR, 1991, PHYS REV LETT, V67, P773, DOI 10.1103/PhysRevLett.67.773
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Sen A, 2009, BIOMATERIALS, V30, P1604, DOI 10.1016/j.biomaterials.2008.11.039
   Singh V, 2005, THIN SOLID FILMS, V489, P150, DOI 10.1016/j.tsf.2005.04.104
   Titantah JT, 2007, DIAM RELAT MATER, V16, P581, DOI 10.1016/j.diamond.2006.11.048
   Voevodin AA, 1999, SURF COAT TECH, V116, P36, DOI 10.1016/S0257-8972(99)00228-5
   Wang AY, 2006, CARBON, V44, P1826, DOI 10.1016/j.carbon.2005.12.045
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yang WJ, 2005, THIN SOLID FILMS, V473, P252, DOI 10.1016/j.tsf.2004.07.077
   Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779
   Zhang S, 2005, SURF COAT TECH, V198, P74, DOI 10.1016/j.surfcoat.2004.10.021
NR 30
TC 14
Z9 14
U1 6
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2012
VL 100A
IS 11
BP 3151
EP 3156
DI 10.1002/jbm.a.34235
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 009ZF
UT WOS:000309063400032
PM 22829476
DA 2018-10-19
ER

PT J
AU Zhou, Y
   Xu, FM
   Jiang, GH
   Wang, XH
   Hu, RB
   Wang, RJ
   Xi, XG
   Wang, S
   Wang, T
   Chen, WX
AF Zhou, Yang
   Xu, Fengming
   Jiang, Guohua
   Wang, Xiaohong
   Hu, Ruanbing
   Wang, Rijing
   Xi, Xiaoguang
   Wang, Sheng
   Wang, Tao
   Chen, Wenxing
TI Superhydrophobic and high adhesive performance of functionalized
   graphene films
SO POWDER TECHNOLOGY
LA English
DT Article
DE Superhydrophobic; Adhesive performance; Graphene; Film
ID GRAPHITE OXIDE; SURFACES; SHEETS; WATER; FABRICATION
AB Graphene films with high hydrophobic and adhesive performance were fabricated via chemical modification of graphite oxide and heat reduction processes. Irregularly stacked multilayer graphene nanosheets comprised the microstructure, whereas folding and agglomeration of graphene nanoflakes with few layers comprised the nanostructure. The resulting films showed remarkable superhydrophobic property with a static contact angle of 160.5 degrees. Unlike many superhydrophobic materials, the obtained film is highly adhesive, allowing water drops as large as 50 mu L to be inverted. Meanwhile, the film can be absolutely wet by silicone oil. This highly hydrophobic. oleophilic and adhesive performance of the graphene films could be useful in the device and biomaterial application. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Zhou, Yang; Xu, Fengming; Jiang, Guohua; Wang, Xiaohong; Hu, Ruanbing; Wang, Rijing; Xi, Xiaoguang; Wang, Sheng; Wang, Tao; Chen, Wenxing] Zhejiang Sci Tech Univ, Coll Mat & Text, Dept Mat Engn, Hangzhou 310018, Zhejiang, Peoples R China.
   [Jiang, Guohua; Wang, Xiaohong; Hu, Ruanbing; Wang, Rijing; Xi, Xiaoguang; Wang, Sheng; Wang, Tao; Chen, Wenxing] Zhejiang Sci Tech Univ, Minist Educ, Key Lab Adv Text Mat & Mfg Technol ATMT, Hangzhou 310018, Zhejiang, Peoples R China.
RP Jiang, GH (reprint author), Zhejiang Sci Tech Univ, Coll Mat & Text, Dept Mat Engn, Hangzhou 310018, Zhejiang, Peoples R China.
EM polymer_jiang@hotmail.com
FU Qianjiang Talents Project of Zhejiang Province [2010R10023]; Scientific
   Research Foundation for the Returned Overseas Chinese Scholars, the
   State Education Ministry [1001603-C]; Natural Science Foundation of
   Zhejiang Province [Y4100045, R210154]; Training Foundation for the
   Excellent Young Talents by the Key Laboratory of Advanced Textile
   Materials and Manufacturing Technology (ATMT), Ministry of Education
   [2011QN04]; National Natural Science Foundation of China [51133006]
FX This work was financially supported by the Qianjiang Talents Project of
   Zhejiang Province (2010R10023), the Scientific Research Foundation for
   the Returned Overseas Chinese Scholars, the State Education Ministry
   (1001603-C), the Natural Science Foundation of Zhejiang Province
   (Y4100045, R210154), Training Foundation for the Excellent Young Talents
   by the Key Laboratory of Advanced Textile Materials and Manufacturing
   Technology (ATMT), Ministry of Education (2011QN04) and the National
   Natural Science Foundation of China (51133006).
CR Arbatan T, 2011, CHEM ENG J, V166, P787, DOI 10.1016/j.cej.2010.11.015
   Bourlinos AB, 2003, LANGMUIR, V19, P6050, DOI 10.1021/la026525h
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379
   Gordillo MC, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075432
   Ju HM, 2010, J KOREAN PHYS SOC, V57, P1649, DOI 10.3938/jkps.57.1649
   Kimmel GA, 2009, J AM CHEM SOC, V131, P12838, DOI 10.1021/ja904708f
   Leenaerts O, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235440
   Lian PC, 2010, ELECTROCHIM ACTA, V55, P3909, DOI 10.1016/j.electacta.2010.02.025
   Lin ZY, 2010, LANGMUIR, V26, P16110, DOI 10.1021/la102619n
   Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t
   Mukhopadhyay P, 2011, PLAST ENG, V67, P32, DOI 10.1002/j.1941-9635.2011.tb00669.x
   Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o
   Pandey D, 2008, SURF SCI, V602, P1607, DOI 10.1016/j.susc.2008.02.025
   Pham TA, 2010, SYNTHETIC MET, V160, P2028, DOI 10.1016/j.synthmet.2010.07.034
   Rafiee J, 2010, ADV MATER, V22, P2151, DOI 10.1002/adma.200903696
   Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f
   Shin YJ, 2010, LANGMUIR, V26, P3798, DOI 10.1021/la100231u
   Szabo T, 2006, CHEM MATER, V18, P2740, DOI 10.1021/cm060258
   Tu CW, 2007, MACROMOL RAPID COMM, V28, P2262, DOI 10.1002/marc.200700447
   Wang GX, 2009, CARBON, V47, P68, DOI 10.1016/j.carbon.2008.09.002
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   XUE G, 1986, ANGEW MAKROMOL CHEM, V140, P127, DOI 10.1002/apmc.1986.051400110
   Zhang XQ, 2011, J MATER CHEM, V21, P12251, DOI 10.1039/c1jm12087e
   Zhu Q, 2011, J PHYS CHEM C, V115, P17464, DOI 10.1021/jp2043027
NR 25
TC 11
Z9 13
U1 9
U2 120
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD NOV
PY 2012
VL 230
BP 247
EP 251
DI 10.1016/j.powtec.2012.07.032
PG 5
WC Engineering, Chemical
SC Engineering
GA 013IX
UT WOS:000309300200032
DA 2018-10-19
ER

PT J
AU Mccoy, CP
   Craig, RA
   McGlinchey, SM
   Carson, L
   Jones, DS
   Gorman, SP
AF McCoy, Colin P.
   Craig, Rebecca A.
   McGlinchey, Seana M.
   Carson, Louise
   Jones, David S.
   Gorman, Sean P.
TI Surface localisation of photosensitisers on intraocular lens
   biomaterials for prevention of infectious endophthalmitis and retinal
   protection
SO BIOMATERIALS
LA English
DT Article
DE Bacterial adhesion; Copolymer; Endophthalmitis; Hydrogel; Intraocular
   lens; Photosensiter
ID INTERPENETRATING POLYMER NETWORKS; STAPHYLOCOCCUS-AUREUS;
   CATARACT-SURGERY; IN-VITRO; PHYSICOCHEMICAL CHARACTERIZATION; URETERAL
   BIOMATERIALS; RESISTANCE; INACTIVATION; LIGHT; THERAPY
AB Cataract surgery is one of the most commonly-practiced surgical procedures in Western medicine, and, while complications are rare, the most serious is infectious postoperative endophthalmitis. Bacteria may adhere to the implanted intraocular lens (IOL) and subsequent biofilm formation can lead to a chronic, difficult to treat infection. To date, no method to reduce the incidence of infectious endophthalmitis through bacterial elimination, while retaining optical transparency, has been reported. In this study we report a method to optimise the localisation of a cationic porphyrin at the surface of suitable acrylate copolymers, which is the first point of contact with potential pathogens. The porphyrin catalytically generates short-lived singlet oxygen, in the presence of visible light, which kills adherent bacteria indiscriminately. By restricting the photosensitiser to the surface of the biomaterial, reduction in optical transparency is minimised without affecting efficacy of singlet oxygen production. Hydrogel IOL biomaterials incorporating either methacrylic acid (MAA) or methyl methacrylate (MMA) co-monomers allow tuning of the hydrophobic and anionic properties to optimise the localisation of porphyrin. Physiochemical and antimicrobial properties of the materials have been characterised, giving candidate materials with self-generating, persistent anti-infective character against Gram-positive and Gram-negative organisms. Importantly, incorporation of porphyrin can also serve to protect the retina by filtering damaging shortwave visible light, due to the Soret absorption (lambda(max) 430 nm). (C) 2012 Elsevier Ltd. All rights reserved.
C1 [McCoy, Colin P.; Craig, Rebecca A.; McGlinchey, Seana M.; Carson, Louise; Jones, David S.; Gorman, Sean P.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland.
RP Mccoy, CP (reprint author), Queens Univ Belfast, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM c.mccoy@qub.ac.uk
OI McCoy, Colin/0000-0002-6468-2018
FU Department for Employment and Learning (Northern Ireland)
FX We acknowledge funding for this work from the Department for Employment
   and Learning (Northern Ireland). The authors thank Stef McGrath for
   technical assistance.
CR Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032
   Brady C, 2007, J PHYS CHEM B, V111, P527, DOI 10.1021/jp066217i
   Brockmann C, 2008, J CATARACT REFR SURG, V34, P1161, DOI 10.1016/j.jcrs.2008.03.039
   Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246
   Demidova TN, 2005, ANTIMICROB AGENTS CH, V49, P2329, DOI 10.1128/AAC.49.6.2329-2335.2005
   ELDER MJ, 1995, EYE, V9, P102, DOI 10.1038/eye.1995.16
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Griffiths MA, 1997, J ANTIMICROB CHEMOTH, V40, P873, DOI 10.1093/jac/40.6.873
   Grimm C, 2001, INVEST OPHTH VIS SCI, V42, P497
   Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a
   Henderson BA, 2010, SURV OPHTHALMOL, V55, P284, DOI 10.1016/j.survophthal.2009.07.007
   Jackson TL, 2003, SURV OPHTHALMOL, V48, P403, DOI 10.1016/S0039-6257(03)00054-7
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Jones DS, 1997, J MATER SCI-MATER M, V8, P713, DOI 10.1023/A:1018596109061
   Jones DS, 2005, BIOMATERIALS, V26, P1761, DOI 10.1016/j.biomaterials.2004.06.002
   Jones DS, 2002, PHARMACEUT RES, V19, P818, DOI 10.1023/A:1016104516034
   Jori G, 2004, PHOTOCH PHOTOBIO SCI, V3, P403, DOI 10.1039/b311904c
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kim SY, 2001, BIOCHIMIE, V83, P437, DOI 10.1016/S0300-9084(01)01258-5
   Kresloff MS, 1998, SURV OPHTHALMOL, V43, P193, DOI 10.1016/S0039-6257(98)00036-8
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   MCELDOWNEY S, 1986, APPL ENVIRON MICROB, V52, P460
   Orenstein A, 1997, FEMS IMMUNOL MED MIC, V19, P307, DOI 10.1016/S0928-8244(97)00097-7
   Parsons C, 2005, EXPERT REV MED DEVIC, V2, P161, DOI 10.1586/17434440.2.2.161
   Parsons C, 2009, BIOMATERIALS, V30, P597, DOI 10.1016/j.biomaterials.2008.10.015
   Cormick MP, 2009, EUR J MED CHEM, V44, P1592, DOI 10.1016/j.ejmech.2008.07.026
   Schagen FHE, 1999, GENE THER, V6, P873, DOI 10.1038/sj.gt.3300897
   Sharma M, 2008, ANTIMICROB AGENTS CH, V52, P299, DOI 10.1128/AAC.00988-07
   Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007
   Taban M, 2005, ARCH OPHTHALMOL-CHIC, V123, P613, DOI 10.1001/archopht.123.5.613
   Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13
   Wainwright M, 1998, FEMS MICROBIOL LETT, V160, P177, DOI 10.1016/S0378-1097(97)00545-4
   West ES, 2005, OPHTHALMOLOGY, V112, P1388, DOI 10.1016/j.ophtha.2005.02.028
NR 35
TC 28
Z9 30
U1 0
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 32
BP 7952
EP 7958
DI 10.1016/j.biomaterials.2012.07.052
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013LL
UT WOS:000309306800004
PM 22889489
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Angius, D
   Wang, H
   Spinner, RJ
   Gutierrez-Cotto, Y
   Yaszemski, MJ
   Windebank, AJ
AF Angius, Diana
   Wang, Huan
   Spinner, Robert J.
   Gutierrez-Cotto, Yearim
   Yaszemski, Michael J.
   Windebank, Anthony J.
TI A systematic review of animal models used to study nerve regeneration in
   tissue-engineered scaffolds
SO BIOMATERIALS
LA English
DT Review
DE Peripheral nerve injury; Peripheral nerve repair; Nerve tube; Nerve
   scaffold; Biodegradable
ID RAT SCIATIC-NERVE; PERIPHERAL-NERVE; SYNTHETIC CONDUITS; REPAIR; INJURY;
   TUBES; STRATEGIES; UPDATE; DOGS
AB Research on biomaterial nerve scaffolds has been carried out for 50 years. Only three materials (collagen, polycaprolactone and polyglycollic acid) have progressed to clinical use. Pre-clinical animal models are critical for testing nerve scaffolds prior to implementation in clinical practice. We have conducted a systematic review of 416 reports in which animal models were used for evaluation of nerve regeneration into synthetic conduits. A valid animal model of nerve regeneration requires it to reproduce the specific processes that take place in regeneration after human peripheral nerve injury. No distinct animal species meets all the requirements for an ideal animal model. Certain models are well suited for understanding regenerative neurobiology while others are better for pre-clinical evaluation of efficacy. The review identified that more than 70 synthetic materials were tested in eight species using 17 different nerves. Nerve gaps ranged from 1 to 90 mm. More than 20 types of assessment methodology were used with no standardization of methods between any of the publications. The review emphasizes the urgent need for standardization or rationalization of animal models and evaluation methods for studying nerve repair. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Windebank, Anthony J.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.
   [Angius, Diana; Wang, Huan; Spinner, Robert J.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.
   [Gutierrez-Cotto, Yearim] Univ Puerto Rico, Escuela Med, San Juan, PR 00936 USA.
   [Yaszemski, Michael J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
RP Windebank, AJ (reprint author), Mayo Clin, Coll Med, Dept Neurol, Guggenheim Bldg,15th Floor,200 1st St SW, Rochester, MN 55905 USA.
EM windebank.anthony@mayo.edu
FU National Center for Advancing Translational Sciences (NCATS) [UL1
   TR000135]
FX This publication was supported by Grant Number UL1 TR000135 from the
   National Center for Advancing Translational Sciences (NCATS). Its
   contents are solely the responsibility of the authors and do not
   necessarily represent the official views of the NIH.
CR Allen MJ, 2009, VET SURG, V38, P555, DOI 10.1111/j.1532-950X.2009.00528.x
   Altevogt BM, 2011, CHIMPANZEES IN BIOMEDICAL AND BEHAVIORAL RESEARCH: ASSESSING THE NECESSITY, P1
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Braden TD, 1999, AM J VET RES, V60, P1337
   BUCHTHAL F, 1979, J NEUROL NEUROSUR PS, V42, P436, DOI 10.1136/jnnp.42.5.436
   Chalfoun CT, 2006, J CELL MOL MED, V10, P309, DOI 10.1111/j.1582-4934.2006.tb00401.x
   Chiono V, 2009, INT REV NEUROBIOL, V87, P173, DOI 10.1016/S0074-7742(09)87009-8
   de Ruiter GC, 2008, J BIOMED MATER RES A, V84A, P643, DOI 10.1002/jbm.a.31298
   de Ruiter GCW, 2009, NEUROSURG CLIN N AM, V20, P91, DOI 10.1016/j.nec.2008.08.001
   DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5
   DOLENC V, 1976, ACTA NEUROCHIR, V34, P223, DOI 10.1007/BF01405877
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   FU SY, 1995, J NEUROSCI, V15, P3876
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   HAZZARD DG, 1992, J GERONTOL, V47, pB63, DOI 10.1093/geronj/47.3.B63
   Hesbach AL, 2007, CLIN TECH SMALL AN P, V22, P146, DOI 10.1053/j.ctsap.2007.09.002
   Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0
   Ijpma FFA, 2008, J HAND SURG-EUR VOL, V33E, P581, DOI 10.1177/1753193408091349
   IJpma Frank F A, 2009, Tech Hand Up Extrem Surg, V13, P116, DOI 10.1097/BTH.0b013e31818f8dfd
   Jiang X, 2009, EXP NEUROL
   Johnson EO, 2008, INJURY, V39, pS30, DOI 10.1016/j.injury.2008.05.018
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005
   Nordgren A, 2004, BIOMATERIALS, V25, P1723, DOI 10.1016/S0142-9612(03)00506-4
   Pan YA, 2003, J NEUROSCI, V23, P11479
   Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x
   Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5
   SCHIMANDLE JH, 1994, SPINE, V19, P1998, DOI 10.1097/00007632-199409000-00023
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   SORENSON EJ, 1993, J NEUROPATH EXP NEUR, V52, P216, DOI 10.1097/00005072-199305000-00005
   Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3
   Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9212(03)00497-6
   Vincent P, 2006, EMBO REP, V7, P1154, DOI 10.1038/sj.embor.7400801
   Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168
   Wadman M, 2011, NATURE, V480, P424, DOI 10.1038/480424a
   Zhang M, 2005, ADV BIOCHEM ENG BIOT, V94, P67, DOI 10.1007/b100000
NR 39
TC 72
Z9 75
U1 2
U2 90
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 32
BP 8034
EP 8039
DI 10.1016/j.biomaterials.2012.07.056
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013LL
UT WOS:000309306800012
PM 22889485
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Guo, QY
   Wang, XB
   Tibbitt, MW
   Anseth, KS
   Montell, DJ
   Elisseeff, JH
AF Guo, Qiongyu
   Wang, Xiaobo
   Tibbitt, Mark W.
   Anseth, Kristi S.
   Montell, Denise J.
   Elisseeff, Jennifer H.
TI Light activated cell migration in synthetic extracellular matrices
SO BIOMATERIALS
LA English
DT Article
DE Mesenchymal stem cells; Optical activation; Cell migration; Biomaterial
   scaffolds
ID IN-VIVO; LIVING CELLS; MORPHOGENESIS; HYDROGELS; MOTILITY; ADHESION;
   RAC; 3D; REGENERATION; STIFFNESS
AB Synthetic extracellular matrices provide a framework in which cells can be exposed to defined physical and biological cues. However no method exists to manipulate single cells within these matrices. It is desirable to develop such methods in order to understand fundamental principles of cell migration and define conditions that support or inhibit cell movement within these matrices. Here, we present a strategy for manipulating individual mammalian stem cells in defined synthetic hydrogels through selective optical activation of Rac, which is an intracellular signaling protein that plays a key role in cell migration. Photoactivated cell migration in synthetic hydrogels depended on mechanical and biological cues in the biomaterial. Real-time hydrogel photodegradation was employed to create geometrically defined channels and spaces in which cells could be photoactivated to migrate. Cell migration speed was significantly higher in the photo-etched channels and cells could easily change direction of movement compared to the bulk hydrogels. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Guo, Qiongyu; Elisseeff, Jennifer H.] Johns Hopkins Sch Med, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
   [Guo, Qiongyu; Elisseeff, Jennifer H.] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD 21231 USA.
   [Wang, Xiaobo; Montell, Denise J.] Johns Hopkins Sch Med, Dept Biol Chem, Ctr Cell Dynam, Baltimore, MD 21205 USA.
   [Tibbitt, Mark W.; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Sch Med, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
EM dmontell@jhmi.edu; jhe@jhu.edu
RI Guo, Qiongyu/J-3118-2014
OI Guo, Qiongyu/0000-0002-1916-9100; Tibbitt, Mark/0000-0002-4917-7187
FU Arthritis Foundation
FX The authors gratefully acknowledge the generous support from the
   Arthritis Foundation Postdoctoral Fellowship (QG), the Jules Stein
   Professorship (JE), and NIH GM46425 (DM).
CR Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062
   Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331
   Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002
   Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Pethig R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/182581
   Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Tanase M, 2007, METHOD CELL BIOL, V83, P473, DOI 10.1016/S0091-679X(07)83020-2
   Tayalia P, 2011, BIOMATERIALS, V32, P2634, DOI 10.1016/j.biomaterials.2010.12.019
   Tibbitt MW, 2010, SOFT MATTER, V6, P5100, DOI 10.1039/c0sm00174k
   Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061
   Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 26
TC 18
Z9 19
U1 2
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 32
BP 8040
EP 8046
DI 10.1016/j.biomaterials.2012.07.013
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013LL
UT WOS:000309306800013
PM 22889487
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lewicka, M
   Hermanson, O
   Rising, AU
AF Lewicka, Michalina
   Hermanson, Ola
   Rising, Anna U.
TI Recombinant spider silk matrices for neural stem cell cultures
SO BIOMATERIALS
LA English
DT Article
DE Neural stem cell; Biomaterial; Spider silk; Recombinant; Matrice;
   Scaffold
ID IN-VIVO; DIFFERENTIATION; BIOMATERIALS; FIBERS; VITRO; INTEGRINS;
   HYDROGELS; PROTEINS; POLYMERS; CNS
AB Neural stem cells (NSCs) have the capacity to differentiate into neurons, astrocytes, and oligodendrocytes. Accordingly, NSCs hold great promise in drug screening and treatment of several common diseases. However, a major obstacle in applied stem cell research is the limitation of synthetic matrices for culturing stem cells. The objective of this study was to evaluate the suitability of recombinant spider silk (4RepCT) matrices for growth of NSCs. NSCs isolated from the cerebral cortices of mid-gestation rat embryos were cultured on either 4RepCT matrices or conventional poly-L-ornithine and fibronectin (P + F) coated polystyrene plates. From 48 h of culture, no significant differences in cell proliferation or viability were detected in NSC cultures on 4RepCT compared to control matrices (polystyrene plates coated with P + F). The NSCs retained an undifferentiated state, displaying low or no staining for markers of differentiated cells. Upon stimulation NSCs grown on 4RepCT differentiated efficiently into neuronal and astrocytic cells to virtually the same degree as control cultures, but a slightly less efficient oligodendrocyte differentiation was noted. We suggest that recombinant spider silk matrices provide a functional microenvironment and represent a useful tool for the development of new strategies in neural stem cell research. (c) 2012 Published by Elsevier Ltd.
C1 [Rising, Anna U.] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, SE-14186 Stockholm, Sweden.
   [Lewicka, Michalina; Hermanson, Ola] Karolinska Inst, Linnaeus Ctr Dev Biol Regenerat Med DBRM, Dept Neurosci, SE-17177 Stockholm, Sweden.
   [Rising, Anna U.] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, SE-75123 Stockholm, Sweden.
   [Rising, Anna U.] Spiber Technol AB, SE-75651 Uppsala, Sweden.
RP Rising, AU (reprint author), Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Novum 5th Floor, SE-14186 Stockholm, Sweden.
EM Ola.Hermanson@ki.se; Anna.Rising@ki.se
OI Rising, Anna/0000-0002-1872-1207; Hermanson, Ola/0000-0001-9320-7921
FU VR-MH (OBOE); SSF (OBOE); Vinnova (OBOE); Swedish Cancer Society (CF);
   Swedish Childhood Cancer Foundation (BCF); Karolinska Institutets
   Forskningsstiftelser [2011FoBiO23]
FX The authors would like to thank Drs. My Hedhammar and Jan Johansson for
   valuable discussions and comments on the manuscript. We thank Spiber
   Technologies AB for providing the 4RepCT matrices. This work was funded
   by grants from VR-MH, SSF and Vinnova (OBOE), The Swedish Cancer Society
   (CF), the Swedish Childhood Cancer Foundation (BCF) (to O.H.), and
   Karolinska Institutets Forskningsstiftelser (2011FoBiO23) (to A.R.).
CR Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Andersson T, 2011, MOL CELL NEUROSCI, V47, P10, DOI 10.1016/j.mcn.2011.01.006
   Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200
   Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Lathia JD, 2007, J COMP NEUROL, V505, P630, DOI 10.1002/ene.21520
   Leao RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013833
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Nakaji-Hirabayashi T, 2012, BIOCONJUGATE CHEM, V23, P212, DOI 10.1021/bc200481v
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Skottman H, 2007, REGEN MED, V2, P265, DOI 10.2217/17460751.2.3.265
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Teixeira AI, 2010, MRS BULL, V35, P591, DOI 10.1557/mrs2010.527
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   Vollrath F, 2002, IN VIVO, V16, P229
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Wojcik-Stanaszek L, 2011, ACTA NEUROBIOL EXP, V71, P103
NR 34
TC 23
Z9 27
U1 4
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 31
BP 7712
EP 7717
DI 10.1016/j.biomaterials.2012.07.021
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 003NQ
UT WOS:000308619000004
PM 22863380
DA 2018-10-19
ER

PT J
AU Samavedi, S
   Guelcher, SA
   Goldstein, AS
   Whittington, AR
AF Samavedi, Satyavrata
   Guelcher, Scott A.
   Goldstein, Aaron S.
   Whittington, Abby R.
TI Response of bone marrow stromal cells to graded co-electrospun scaffolds
   and its implications for engineering the ligament-bone interface
SO BIOMATERIALS
LA English
DT Article
DE Ligament-bone interface; Graded scaffold; Electrospinning;
   Hydroxyapatite; Bone marrow stromal cells; Osteoblastic differentiation
ID MESENCHYMAL STEM-CELLS; BETA-TRICALCIUM PHOSPHATE; OSTEOGENIC
   DIFFERENTIATION; CALCIUM-PHOSPHATE; GENE-EXPRESSION; IN-VITRO;
   PROLIFERATION; HYDROXYAPATITE; POLYCAPROLACTONE; NANOPARTICLES
AB Biomaterial scaffolds with gradients in architecture, mechanical and chemical properties have the potential to improve the osseointegration of ligament grafts by recapitulating phenotypic gradients that exist at the natural ligament-bone (L-B) interface. Towards the larger goal of regenerating the L-B interface, this in vitro study was performed to investigate the potential of two scaffolds with mineral gradients in promoting a spatial gradient of osteoblastic differentiation. Specifically, the first graded scaffold was fabricated by co-electrospinning two polymer solutions (one doped with nano-hydroxyapatite particles) from offset spinnerets, while the second was created by immersing the first scaffold in a 5 x simulated body fluid. Rat bone marrow stromal cells, cultured in the presence of osteogenic supplements, were found to be metabolically active on all regions of both scaffolds after 1 and 7 days of culture. Gene expression of bone morphogenic protein-2 and osteopontin was elevated on mineral-containing regions as compared to regions without mineral, while the expression of alkaline phosphatase mRNA revealed the opposite trend. Finally, the presence of osteopontin and bone sialoprotein confirmed osteoblastic phenotypic maturation by day 28. This study indicates that co-electrospun scaffolds with gradients in mineral content can guide the formation of phenotypic gradients and may thus promote the regeneration of the L-B interface. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Samavedi, Satyavrata; Goldstein, Aaron S.; Whittington, Abby R.] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
   [Guelcher, Scott A.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN USA.
   [Goldstein, Aaron S.; Whittington, Abby R.] Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
   [Whittington, Abby R.] Virginia Polytech Inst & State Univ, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA.
RP Goldstein, AS (reprint author), Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
EM goldst@vt.edu
RI Whittington, Abby/D-9266-2014; Whittington, Abby/C-7910-2013
OI Whittington, Abby/0000-0001-7401-7209; Whittington,
   Abby/0000-0002-9667-0089
FU Institute for Critical Technologies and Applied Sciences at Virginia
   Tech
FX The authors thank the Institute for Critical Technologies and Applied
   Sciences at Virginia Tech for funding, Dr. Garth Wilkes (Department of
   Chemical Engineering, Virginia Tech) for the use of the electrospinning
   apparatus, Riley Chan and Michael Vaught (Department of Chemical
   Engineering, Virginia Tech) for help with designing the electrospinning
   mandrel, Stephen McCartney (Nano-characterization and Fabrication
   Laboratory, Virginia Tech) for help with SEM imaging and Dr. Robyn
   Cardwell (Genomic Health Incorporation, CA) for help with primer design.
CR Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Barrere F, 2006, INT J NANOMED, V1, P317
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Bernhardt A, 2009, J TISSUE ENG REGEN M, V3, P54, DOI 10.1002/term.134
   Du FY, 2012, BIOMATERIALS, V33, P762, DOI 10.1016/j.biomaterials.2011.10.037
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Fang B, 2009, TISSUE ENG PT A, V15, P1091, DOI 10.1089/ten.tea.2008.0110
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Haimi S, 2009, TISSUE ENG PT A, V15, P1473, DOI 10.1089/ten.tea.2008.0241
   Hu QH, 2007, J MATER CHEM, V17, P4690, DOI 10.1039/b710936a
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jung GY, 2010, J MATER SCI-MATER M, V21, P1649, DOI 10.1007/s10856-010-4011-y
   Kavlock KD, 2007, ACTA BIOMATER, V3, P475, DOI 10.1016/j.actbio.2007.02.001
   Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Lee JH, 2010, MACROMOL BIOSCI, V10, P173, DOI 10.1002/mabi.200900169
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Liu Y, 2009, J BIOMED MATER RES A, V90A, P972, DOI 10.1002/jbm.a.32156
   Liu Y, 2007, BIOMATERIALS, V28, P1393, DOI 10.1016/j.biomaterials.2006.11.019
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu HH, 2006, ADV BIOCHEM ENG BIOT, V102, P91, DOI 10.1007/b138509
   Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105
   Moffat KL, 2009, CLIN SPORT MED, V28, P157, DOI 10.1016/j.csm.2008.08.006
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Ogata K, 2005, J BIOMED MATER RES A, V72A, P127, DOI 10.1002/jbm.a.30146
   Okada S, 2010, ACTA BIOMATER, V6, P591, DOI 10.1016/j.actbio.2009.07.037
   Popp JR, 2011, J TISSUE ENG REGEN M, V5, P780, DOI 10.1002/term.376
   Samavedi S, 2011, ACTA BIOMATER, V7, P4131, DOI 10.1016/j.actbio.2011.07.008
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Whited BM, 2006, J BIOMED MATER RES A, V76A, P596, DOI 10.1002/jbm.a.30573
   Wutticharoenmongkol P, 2006, MACROMOL BIOSCI, V6, P70, DOI 10.1002/mabi.200500150
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Zhou GS, 2007, BIO-MED MATER ENG, V17, P387
NR 39
TC 43
Z9 44
U1 5
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 31
BP 7727
EP 7735
DI 10.1016/j.biomaterials.2012.07.008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 003NQ
UT WOS:000308619000006
PM 22835644
DA 2018-10-19
ER

PT J
AU Vaijayanthimala, V
   Cheng, PY
   Yeh, SH
   Liu, KK
   Hsiao, CH
   Chao, JI
   Chang, HC
AF Vaijayanthimala, V.
   Cheng, Po-Yun
   Yeh, Shih-Hua
   Liu, Kuang-Kai
   Hsiao, Cheng-Hsiang
   Chao, Jui-I
   Chang, Huan-Cheng
TI The long-term stability and biocompatibility of fluorescent nanodiamond
   as an in vivo contrast agent
SO BIOMATERIALS
LA English
DT Article
DE Animal model; Biocompatibility; Diamond; Fluorescence; Nanoparticle;
   Sentinel lymph node
ID INTRAPERITONEAL INJECTION; SILICA NANOPARTICLES; DIAMOND; CANCER;
   NANOMEDICINE; BIODISTRIBUTION; CYTOTOXICITY; BIOPSY; CELLS; DOTS
AB Nanocarbon is a promising type of biomaterial for diagnostic and therapeutic applications. Fluorescent nanodiamond (FND) containing nitrogen-vacancy centers as built-in fluorophores is a new addition to the nanocarbon family. Here, we study the long-term stability and biocompatibility of 100-nm FNDs in rats through intraperitoneal injection over 5 months and develop the potential application of this biomaterial for sentinel lymph node mapping in a mouse model. From both in vivo and ex vivo fluorescence imaging as well as transmission electron microscopy, we found that the intradermally administered FND particles can be drained from the injection sites by macrophages and selectively accumulated in the axillary lymph nodes of the treated mice. Our measurements of water consumption, fodder consumption, body weight, and organ index showed no significant difference between control and FND-treated groups of the rats. Histopathological analysis of various tissues and organs indicated that FNDs are non-toxic even when a large quantity, up to 75 mg/kg body weight, of the particles was administered intraperitoneally to the living animals. With the properties of wide-ranging biocompatibility and perfect chemical and photophysical stability, FND is well suited for use as a contrast agent for long-term in vivo imaging. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Vaijayanthimala, V.; Chang, Huan-Cheng] Acad Sinica, Inst Atom & Mol Sci, Taipei 10672, Taiwan.
   [Cheng, Po-Yun; Liu, Kuang-Kai; Chao, Jui-I] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30068, Taiwan.
   [Yeh, Shih-Hua; Chang, Huan-Cheng] Natl Taiwan Univ, Dept Chem, Taipei 10672, Taiwan.
   [Hsiao, Cheng-Hsiang] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10002, Taiwan.
   [Hsiao, Cheng-Hsiang] Natl Taipei Univ Nursing & Hlth Sci, Gen Educ Ctr, Taipei 11219, Taiwan.
RP Chang, HC (reprint author), Acad Sinica, Inst Atom & Mol Sci, Taipei 10672, Taiwan.
EM chhsiao7@ntu.edu.tw; jichao@faculty.nctu.edu.tw;
   hchang@gate.sinica.edu.tw
RI Chang, Huan-Cheng/A-9358-2012
OI Liu, Kuang Kai/0000-0002-2746-1945
FU Academia Sinica; National Science Council (NSC) of Taiwan [NSC
   100-2119M-001-028, NSC 99-2311-B-009-003-MY3]; National Research Program
   for Genomic Medicine (NRPGM) at NSC
FX This work is supported by Academia Sinica and the National Science
   Council (NSC) of Taiwan with Grant Nos. NSC 100-2119M-001-028 and NSC
   99-2311-B-009-003-MY3. We thank the Taiwan Mouse Clinic, funded by the
   National Research Program for Genomic Medicine (NRPGM) at NSC for
   technical support in tissue sectioning. We also thank Wan-Yu Hsieh at
   the National Taiwan University and Tzu-Han Hsu at the Core Facility of
   the Institute of Cellular and Organismic Biology, Academia Sinica, for
   assistance in fluorescence and TEM imaging.
CR Bonnema J, 2002, ANN ONCOL, V13, P1531, DOI 10.1093/annonc/mdf319
   Chang CW, 2007, METHOD CELL BIOL, V81, P495, DOI 10.1016/S0091-679X(06)81024-1
   Chang YR, 2008, NAT NANOTECHNOL, V3, P284, DOI 10.1038/nnano.2008.99
   Chow EK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001713
   COLLINS AT, 1983, J PHYS C SOLID STATE, V16, P2177, DOI 10.1088/0022-3719/16/11/020
   DAVIES G, 1974, J PHYS C SOLID STATE, V7, P3797, DOI 10.1088/0022-3719/7/20/019
   Faklaris O, 2008, SMALL, V4, P2236, DOI 10.1002/smll.200800655
   Fang CY, 2011, SMALL, V7, P3363, DOI 10.1002/smll.201101233
   Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104
   Guan B, 2010, SMALL, V6, P1514, DOI 10.1002/smll.200902305
   Ho D., 2009, NANODIAMONDS APPL BI
   Huang H, 2007, NANO LETT, V7, P3305, DOI 10.1021/nl071521o
   Hui YY, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/37/374021
   Intra J, 2008, J CONTROL RELEASE, V130, P129, DOI 10.1016/j.jconrel.2008.04.014
   Jakub JW, 2003, ONCOLOGIST, V8, P59, DOI 10.1634/theoncologist.8-1-59
   Jeon YH, 2010, MOL IMAGING BIOL, V12, P155, DOI 10.1007/s11307-009-0262-8
   Juzenas P, 2002, PHOTOCH PHOTOBIO SCI, V1, P745, DOI 10.1039/b203459j
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Li XX, 2011, J MATER CHEM, V21, P7966, DOI 10.1039/c1jm10653h
   Liu KK, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/31/315106
   Liu KK, 2009, BIOMATERIALS, V30, P4249, DOI 10.1016/j.biomaterials.2009.04.056
   Liu KK, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/20/205102
   Liu TL, 2012, BIOMATERIALS, V33, P2399, DOI 10.1016/j.biomaterials.2011.12.008
   Marcon L, 2010, J MATER CHEM, V20, P8064, DOI 10.1039/c0jm01570a
   McGuinness LP, 2011, NAT NANOTECHNOL, V6, P358, DOI [10.1038/NNANO.2011.64, 10.1038/nnano.2011.64]
   Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/NNANO.2011.209, 10.1038/nnano.2011.209]
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Mohan N, 2011, MRS P, V1362
   Mohan N, 2010, NANO LETT, V10, P3692, DOI 10.1021/nl1021909
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Pons T, 2010, ACS NANO, V4, P2531, DOI 10.1021/nn901421v
   Puzyr AP, 2007, DIAM RELAT MATER, V16, P2124, DOI 10.1016/j.diamond.2007.07.025
   Robe A., 2008, BMC CANC, V8
   Rojas S, 2011, ACS NANO, V5, P5552, DOI 10.1021/nn200986z
   Sanhai WR, 2008, NAT NANOTECHNOL, V3, P242, DOI 10.1038/nnano.2008.114
   Schrand Amanda M., 2009, P159, DOI 10.1007/978-0-387-78608-7_8
   Service RF, 2005, SCIENCE, V310, P1132, DOI 10.1126/science.310.5751.1132
   Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688
   Tzeng YK, 2011, ANGEW CHEM INT EDIT, V50, P2262, DOI 10.1002/anie.201007215
   Urayama PK, 2003, HDB BIOMEDICAL FLUOR, P211
   Vaijayanthimala V, 2009, NANOMEDICINE-UK, V4, P47, DOI 10.2217/17435889.4.1.47
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   Xing Y, 2011, ACS NANO, V5, P2376, DOI 10.1021/nn200279k
   Xing Y, 2009, NANOMEDICINE-UK, V4, P207, DOI 10.2217/17435889.4.2.207
   Yang ST, 2009, J AM CHEM SOC, V131, P11308, DOI 10.1021/ja904843x
   Yu SJ, 2005, J AM CHEM SOC, V127, P17604, DOI 10.1021/ja0567081
   Yuan Y, 2010, DIAM RELAT MATER, V19, P291, DOI 10.1016/j.diamond.2009.11.022
   Yuan Y, 2009, DIAM RELAT MATER, V18, P95, DOI 10.1016/j.diamond.2008.10.031
   Zaitsev A. M., 2010, OPTICAL PROPERTIES D
NR 50
TC 114
Z9 117
U1 4
U2 129
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2012
VL 33
IS 31
BP 7794
EP 7802
DI 10.1016/j.biomaterials.2012.06.084
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 003NQ
UT WOS:000308619000013
PM 22863379
DA 2018-10-19
ER

PT J
AU Blackledge, TA
   Perez-Rigueiro, J
   Plaza, GR
   Perea, B
   Navarro, A
   Guinea, GV
   Elices, M
AF Blackledge, Todd A.
   Perez-Rigueiro, Jose
   Plaza, Gustavo R.
   Perea, Belen
   Navarro, Andres
   Guinea, Gustavo V.
   Elices, Manuel
TI Sequential origin in the high performance properties of orb spider
   dragline silk
SO SCIENTIFIC REPORTS
LA English
DT Article
ID WEB-SPINNING SPIDERS; MECHANICAL-PROPERTIES; SUPERCONTRACTION;
   EVOLUTION; BEHAVIOR; FIBERS; BIOMATERIAL; PROLINE; THREADS; FORCE
AB Major ampullate (MA) dragline silk supports spider orb webs, combining strength and extensibility in the toughest biomaterial. MA silk evolved similar to 376 MYA and identifying how evolutionary changes in proteins influenced silk mechanics is crucial for biomimetics, but is hindered by high spinning plasticity. We use supercontraction to remove that variation and characterize MA silk across the spider phylogeny. We show that mechanical performance is conserved within, but divergent among, major lineages, evolving in correlation with discrete changes in proteins. Early MA silk tensile strength improved rapidly with the origin of GGX amino acid motifs and increased repetitiveness. Tensile strength then maximized in basal entelegyne spiders, similar to 230 MYA. Toughness subsequently improved through increased extensibility within orb spiders, coupled with the origin of a novel protein (MaSp2). Key changes in MA silk proteins therefore correlate with the sequential evolution high performance orb spider silk and could aid design of biomimetic fibers.
C1 [Blackledge, Todd A.] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Blackledge, Todd A.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.
   [Perez-Rigueiro, Jose; Plaza, Gustavo R.; Guinea, Gustavo V.; Elices, Manuel] Univ Politecn Madrid, Ctr Tecnol Biomed, Pozuelo De Alarcon 28223, Madrid, Spain.
   [Perez-Rigueiro, Jose; Plaza, Gustavo R.; Perea, Belen; Navarro, Andres; Guinea, Gustavo V.; Elices, Manuel] Univ Politecn Madrid, ETSI Caminos Canales & Puertos, Dept Ciencia Mat, E-28040 Madrid, Spain.
RP Blackledge, TA (reprint author), Univ Akron, Dept Biol, Akron, OH 44325 USA.
EM blackledge@uakron.edu
RI GUINEA TORTUERO, GUSTAVO VICTOR/N-1241-2014; Elices, Manuel/F-7703-2016;
   Plaza, Gustavo R./E-4455-2012
OI GUINEA TORTUERO, GUSTAVO VICTOR/0000-0002-4326-3746; Elices,
   Manuel/0000-0002-8204-1580; Plaza, Gustavo R./0000-0002-5555-5498
FU National Science Foundation [IOS 0745379]; Ministerio de Educacion y
   Ciencia, Spain [MAT 2009-10258]; Fundacion Marcelino Botin, Spain
FX This investigation was funded by National Science Foundation award IOS
   0745379 to TAB, by Ministerio de Educacion y Ciencia, Spain (Grant MAT
   2009-10258) and by Fundacion Marcelino Botin, Spain.
CR Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   [Anonymous], 2010, MESQ MOD SYST EV AN
   Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Bittencourt D, 2010, COMP BIOCHEM PHYS B, V155, P419, DOI 10.1016/j.cbpb.2010.01.005
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Boutry C, 2010, J EXP BIOL, V213, P3505, DOI 10.1242/jeb.046110
   Cheng RC, 2010, J EXP BIOL, V213, P759, DOI 10.1242/jeb.037291
   Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739
   Dimitrov D., 2011, P ROYAL SOC B, V279, P1341
   Eles PT, 2004, MACROMOLECULES, V37, P1342, DOI 10.1021/ma035567p
   Elices M., 2011, MACROMOLECULES, V44
   Elices M, 2011, J MECH BEHAV BIOMED, V4, P658, DOI 10.1016/j.jmbbm.2010.09.008
   Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c
   Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Griswold Charles E., 2005, Proceedings of the California Academy of Sciences, V56, P1
   Guan J, 2011, BIOMACROMOLECULES, V12, P4030, DOI 10.1021/bm201032v
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   Liu Y, 2005, CHEM COMMUN, P2489, DOI 10.1039/b500319a
   Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Ortlepp CS, 2004, BIOMACROMOLECULES, V5, P727, DOI 10.1021/bm034269x
   Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3
   Perez-Rigueiro J, 2010, INT J BIOL MACROMOL, V46, P555, DOI 10.1016/j.ijbiomac.2010.03.013
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1
   Selden PA, 2008, P NATL ACAD SCI USA, V105, P20781, DOI 10.1073/pnas.0809174106
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Sensenig AT, 2012, J R SOC INTERFACE, V9, P1880, DOI 10.1098/rsif.2011.0851
   Starrett J., 2012, PLOS ONE, P7
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Swanson BO, 2006, EVOLUTION, V60, P2539
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221
   WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang ZT, 2000, J AM CHEM SOC, V122, P9019, DOI 10.1021/ja0017099
NR 41
TC 28
Z9 28
U1 1
U2 49
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 29
PY 2012
VL 2
AR 782
DI 10.1038/srep00782
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 028VC
UT WOS:000310451100003
PM 23110251
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Rizzello, L
   Galeone, A
   Vecchio, G
   Brunetti, V
   Sabella, S
   Pompa, PP
AF Rizzello, Loris
   Galeone, Antonio
   Vecchio, Giuseppe
   Brunetti, Virgilio
   Sabella, Stefania
   Pompa, Pier Paolo
TI Molecular response of Escherichia coli adhering onto nanoscale
   topography
SO NANOSCALE RESEARCH LETTERS
LA English
DT Article
DE Bacteria; Nanotopography; Adhesion; Molecular response
ID BACTERIAL DEPOSITION; BIOFILM FORMATION; SURFACES; ROUGHNESS; ADHESION;
   ENVIRONMENT
AB Bacterial adhesion onto abiotic surfaces is an important issue in biology and medicine since understanding the bases of such interaction represents a crucial aspect in the design of safe implant devices with intrinsic antibacterial characteristics. In this framework, we investigated the effects of nanostructured metal substrates on Escherichia coli adhesion and adaptation in order to understand the bio-molecular dynamics ruling the interactions at the interface. In particular, we show how highly controlled nanostructured gold substrates impact the bacterial behavior in terms of morphological changes and lead to modifications in the expression profile of several genes, which are crucially involved in the stress response and fimbrial synthesis. These results mainly demonstrate that E. coli cells are able to sense even slight changes in surface nanotopography and to actively respond by activating stress-related pathways. At the same time, our findings highlight the possibility of designing nanoengineered substrates able to trigger specific bio-molecular effects, thus opening the perspective of smartly tuning bacterial behavior by biomaterial design.
C1 [Rizzello, Loris; Galeone, Antonio; Vecchio, Giuseppe; Brunetti, Virgilio; Sabella, Stefania; Pompa, Pier Paolo] Inst Italiano Tecnol UniLe, Ctr Biomol Nanotechnol, I-73010 Lecce, Italy.
RP Pompa, PP (reprint author), Inst Italiano Tecnol UniLe, Ctr Biomol Nanotechnol, Via Barsanti, I-73010 Lecce, Italy.
EM pierpaolo.pompa@iit.it
RI Vecchio, Giuseppe/C-4823-2011
OI Vecchio, Giuseppe/0000-0002-3002-8501
CR Adiciptaningrum AM, 2009, EMBO REP, V10, P527, DOI 10.1038/embor.2009.25
   Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0
   Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Charman KM, 2009, LETT APPL MICROBIOL, V48, P472, DOI 10.1111/j.1472-765X.2008.02551.x
   Connell I., 1996, P NATL ACAD SCI USA, V93, P9827, DOI DOI 10.1073/PNAS.93.18.9827
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Diaz C, 2007, LANGMUIR, V23, P11206, DOI 10.1021/la700650q
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Klemm P, 2010, APPL MICROBIOL BIOT, V88, P451, DOI 10.1007/s00253-010-2805-y
   Liang HP, 2004, ANGEW CHEM INT EDIT, V43, P1540, DOI 10.1002/anie.200352956
   Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044
   Mitik-Dineva N, 2009, BIOFOULING, V25, P621, DOI 10.1080/08927010903012773
   Okinaka Y, 1998, GOLD BULL, V31, P3, DOI 10.1007/BF03215469
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9
   Rizzello L, 2009, LANGMUIR, V25, P6019, DOI 10.1021/la900893m
   Rizzello L, 2011, ACS NANO, V5, P1865, DOI 10.1021/nn102692m
   Satriano C, 2006, MAT SCI ENG C-BIO S, V26, P942, DOI 10.1016/j.msec.2005.09.096
   Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219
   Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x
   Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x
   Shankar SS, 2009, ACS NANO, V3, P893, DOI 10.1021/nn900077s
   Shellenberger K, 2002, ENVIRON SCI TECHNOL, V36, P184, DOI 10.1021/es015515k
   Sheng XX, 2008, J COLLOID INTERF SCI, V321, P256, DOI 10.1016/j.jcis.2008.02.038
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
NR 27
TC 13
Z9 13
U1 0
U2 42
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1931-7573
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD OCT 18
PY 2012
VL 7
AR 575
DI 10.1186/1556-276X-7-575
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 078AW
UT WOS:000314071500001
PM 23078758
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Macocinschi, D
   Filip, D
   Vlad, S
   Oprea, AM
   Gafitanu, CA
AF Macocinschi, Doina
   Filip, Daniela
   Vlad, Stelian
   Oprea, Ana Maria
   Gafitanu, Carmen Anatolia
TI Characterization of a poly(ether urethane)-based controlled release
   membrane system for delivery of ketoprofen
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Polyurethane biomaterial; Ketoprofen; Membrane; Moisture sorption;
   Controlled release drug delivery; Surface tension
ID CONTACT-ANGLE MEASUREMENTS; SURFACE-TENSION; CELLULOSE DERIVATIVES;
   SUSTAINED-RELEASE; DRUG-DELIVERY; DIFFUSION; POLYMERS; POLYURETHANES;
   PARAMETERS; ADHESION
AB A poly(ether urethane) based on polytetrahydrofuran containing hydroxypropyl cellulose for biomedical applications was tested for its biocompatibility. Ketoprofen was incorporated (3% and 6%) in the polyurethane matrix as an anti-inflammatory drug. Kinetic and drug release mechanisms were studied. The pore size and pore size distribution of the polyurethane membranes were investigated by scanning electron microscopy. Surface tension characteristics as well as moisture sorption properties such as diffusion coefficients and equilibrium moisture contents of the membrane material were studied. It was found that kinetics and release mechanisms are in function of medium pH, composition of polymer-drug system, pore morphology and pore size distribution. Prolonged nature of release of ketoprofen is assured by low amount of drug in polyurethane membrane and physiological pH. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Macocinschi, Doina; Filip, Daniela; Vlad, Stelian; Oprea, Ana Maria] Petru Poni Inst Macromol Chem, Dept Phys Chem Polymers, Iasi 700487, Romania.
   [Gafitanu, Carmen Anatolia] Gr T Popa Univ Med & Pharm, Fac Pharm, Iasi 700115, Romania.
RP Macocinschi, D (reprint author), Petru Poni Inst Macromol Chem, Dept Phys Chem Polymers, Aleea Gr Ghica Voda 41 A, Iasi 700487, Romania.
EM eradro2002@yahoo.com
RI Filip, Daniela/F-6636-2013; Vlad, Stelian/C-3430-2011; Macocinschi,
   Doina/C-2565-2012
OI Vlad, Stelian/0000-0002-5895-438X
FU European Union's Seventh Framework Programme [264115-STREAM]
FX The research leading to these results has received funding from the
   European Union's Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no. 264115-STREAM.
CR Crank J, 1975, MATH DIFFUSION
   Dahlberg C, 2010, EUR J PHARM SCI, V39, P125, DOI 10.1016/j.ejps.2009.11.005
   Dong ZH, 2009, APPL SURF SCI, V255, P6087, DOI 10.1016/j.apsusc.2009.01.083
   Erbil HY, 1997, HANDBOOK OF SURFACE AND COLLOID CHEMISTRY, P265
   Faibish RS, 2002, J COLLOID INTERF SCI, V256, P341, DOI 10.1006/jcis.2002.8612
   Filip D, 2012, EUR POLYM J, V48, P464, DOI 10.1016/j.eurpolymj.2011.12.013
   Gisselfalt K, 2002, BIOMACROMOLECULES, V3, P951, DOI 10.1021/bm025535u
   Homocianu M, 2011, J MACROMOL SCI B, V50, P720, DOI 10.1080/00222341003785045
   Iskakov R, 2000, J APPL POLYM SCI, V75, P35, DOI 10.1002/(SICI)1097-4628(20000103)75:1<35::AID-APP5>3.0.CO;2-2
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kalble D. H., 1969, J ADHESION, V1, P102
   Kidane AG, 2009, ACTA BIOMATER, V5, P2409, DOI 10.1016/j.actbio.2009.02.025
   Korsmeyer R. W., 1983, J CONTROL RELEASE, V1, P89
   KORSMEYER RW, 1986, J POLYM SCI POL PHYS, V24, P395, DOI 10.1002/polb.1986.090240214
   Lucas TC, 2009, APPL SURF SCI, V256, P1419, DOI 10.1016/j.apsusc.2009.08.102
   Macocinschi D, 2009, J MATER SCI-MATER M, V20, P1659, DOI 10.1007/s10856-009-3731-3
   Macocinschi D, 2009, J MATER SCI-MATER M, V20, P775, DOI 10.1007/s10856-008-3626-8
   Mandru M, 2011, DIG J NANOMATER BIOS, V6, P1227
   NEUMANN AW, 1979, J POLY SCI        PS, V66, P391
   Oh JM, 2004, J APPL POLYM SCI, V94, P327, DOI 10.1002/app.20911
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Rabel W., 1977, Physikalische Blaetter, V33, P151
   Rankl M, 2003, COLLOID SURFACE B, V30, P177, DOI 10.1016/S0927-7765(03)00085-7
   Rivera-Armenta JL, 2004, EUR POLYM J, V40, P2803, DOI 10.1016/j.eurpolymj.2004.07.015
   Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034
   Rosenheck S, 2000, EUROPACE, V2, P60, DOI 10.1053/eupc.1999.0062
   Serra L, 2006, BIOMATERIALS, V27, P5440, DOI 10.1016/j.biomaterials.2006.06.011
   STONADGE PR, 1993, Z PHYS CHEM, V181, P125, DOI 10.1524/zpch.1993.181.Part_1_2.125
   STROM G, 1987, J COLLOID INTERF SCI, V119, P352, DOI 10.1016/0021-9797(87)90280-3
   Tarimci N, 1997, INT J PHARM, V147, P71, DOI 10.1016/S0378-5173(96)04790-4
   Uner Melike, 2005, Farmaco (Lausanne), V60, P27, DOI 10.1016/j.farmac.2004.08.008
   Van Oss C. J., 1994, INTERFACIAL FORCES A
   VANOSS CJ, 1989, J COLLOID INTERF SCI, V128, P313, DOI 10.1016/0021-9797(89)90345-7
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Vueba ML, 2004, EUR J PHARM BIOPHARM, V58, P51, DOI 10.1016/j.ejpb.2004.03.006
   Wong EH, 2003, MICROELECTRON RELIAB, V43, P2087, DOI 10.1016/S0026-2714(03)00378-0
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yang MJ, 1997, ARTIF ORGANS, V21, P121
   Zhang CH, 2008, BIOMATERIALS, V29, P3781, DOI 10.1016/j.biomaterials.2008.06.009
   Zhou LJ, 2011, MACROMOLECULES, V44, P857, DOI 10.1021/ma102346a
NR 41
TC 9
Z9 9
U1 0
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD OCT 15
PY 2012
VL 259
BP 416
EP 423
DI 10.1016/j.apsusc.2012.07.060
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 028QJ
UT WOS:000310436900066
DA 2018-10-19
ER

PT J
AU Liu, CZ
   Cui, NY
   Osbeck, S
   Liang, H
AF Liu, Chaozong
   Cui, Nai-Yi
   Osbeck, Susan
   Liang, He
TI Air plasma processing of poly(methyl methacrylate) micro-beads: Surface
   characterisations
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Air plasma processing; Poly(methyl methacrylate) beads; Wettability;
   Surface texture
ID DIELECTRIC BARRIER DISCHARGE; POLYSTYRENE MICROSPHERES;
   ENDOTHELIAL-CELLS; IN-VITRO; BIOMATERIAL; PARAMETERS; ADHESION;
   BEHAVIOR; SCAFFOLD; RELEASE
AB This paper reports the surface processing of poly(methyl methacrylate) (PMMA) micro-beads by using a rotary air plasma reactor, and its effects on surface properties. The surface properties, including surface wettability, surface chemistry and textures of the PMMA beads, were characterised. It was observed that the air plasma processing can improve the surface wettability of the PMMA microbeads significantly. A 15 min plasma processing can reduce the surface water contact angle of PMMA beads to about 50 degrees from its original value of 80.3 degrees. This was accompanied by about 8% increase in surface oxygen concentration as confirmed by XPS analysis. The optical profilometry examination revealed the air plasma processing resulted in a rougher surface that has a "delicate" surface texture. It is concluded that the surface chemistry and texture, induced by air plasma processing, co-contributed to the surface wettability improvement of PMMA micro-beads. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Liu, Chaozong] Newcastle Univ, Sch Mech & Syst Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Liu, Chaozong; Osbeck, Susan; Liang, He] Robert Gordon Univ, Sch Engn, Adv Mat & Biomat Res Ctr, Aberdeen AB10 1FR, Scotland.
   [Cui, Nai-Yi] N China Univ Technol, Dept Phys & Chem Sci, Beijing 100144, Peoples R China.
RP Liu, CZ (reprint author), Newcastle Univ, Sch Mech & Syst Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM Chaozong.Liu@ncl.ac.uk
FU EPSRC; Northern Research Partnership Program (NRP)
FX This work was financially supported by EPSRC and the Northern Research
   Partnership Program (NRP). NRP is a partnership of the Robert Gordon
   University, University of Dundee, and University of Aberdeen.
CR Bacon A, 2002, DRUG DISCOV TODAY, V7, P1202, DOI 10.1016/S1359-6446(02)02531-X
   Badey JP, 1996, POLYMER, V37, P1377, DOI 10.1016/0032-3861(96)81135-9
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Christoforou C, 1998, J BIOMED MATER RES, V42, P376, DOI 10.1002/(SICI)1097-4636(19981205)42:3<376::AID-JBM5>3.0.CO;2-G
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   DAVIES PF, 1981, EXP CELL RES, V134, P367, DOI 10.1016/0014-4827(81)90436-5
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Huang W, 2010, BIOMATERIALS, V31, P4278, DOI 10.1016/j.biomaterials.2010.01.059
   Karches M, 2001, SURF COAT TECH, V142, P28, DOI 10.1016/S0257-8972(01)01145-8
   Kempen DHR, 2006, J BIOMED MATER RES A, V77A, P103, DOI 10.1002/jbm.a.30336
   Lee HR, 2001, SURF COAT TECH, V142, P468, DOI 10.1016/S0257-8972(01)01137-9
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Liu C, 2004, SURF COAT TECH, V185, P311
   Liu CZ, 2008, J BIONIC ENG, V5, P204, DOI 10.1016/S1672-6529(08)60026-8
   Liu CZ, 2006, SURF COAT TECH, V201, P2341, DOI 10.1016/j.surfcoat.2006.04.001
   Liu CZ, 2011, J BIONIC ENG, V8, P223, DOI 10.1016/S1672-6529(11)60029-2
   Liu CZ, 2005, SURF SCI, V575, P273, DOI 10.1016/j.susc.2004.11.026
   Lubarsky GV, 2004, APPL SURF SCI, V227, P268, DOI 10.1016/j.apsusc.2003.12.001
   Merck & Co Inc, 1984, PRETR MICR CELL CULT
   Meyer-Plath AA, 2003, VACUUM, V71, P391, DOI 10.1016/S0042-207X(02)00766-2
   Morent R, 2009, PLASMA CHEM PLASMA P, V29, P103, DOI 10.1007/s11090-009-9167-1
   Nakamatsu J, 1999, J ADHES SCI TECHNOL, V13, P753, DOI 10.1163/156856199X00983
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   Richey T, 2000, BIOMATERIALS, V21, P1057, DOI 10.1016/S0142-9612(99)00281-1
   Upadhyay DJ, 2005, POLYM DEGRAD STABIL, V87, P33, DOI 10.1016/j.polymdegradstab.2004.07.006
   Vicario P. P., 2008, J BIOMEDICAL MAT R B, V89B, P114
   Wang YJ, 2009, MAT SCI ENG C-MATER, V29, P2502, DOI 10.1016/j.msec.2009.07.018
   Xu QG, 2008, J CONTROL RELEASE, V127, P146, DOI 10.1016/j.jconrel.2009.01.017
   Yosomiya R., 1990, ADHESION BONDING COM
   Zauner W, 2001, J CONTROL RELEASE, V71, P39, DOI 10.1016/S0168-3659(00)00358-8
   Zhang X, 2008, J MATER CHEM, V18, P621, DOI 10.1039/b711226b
NR 31
TC 2
Z9 2
U1 1
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD OCT 15
PY 2012
VL 259
BP 840
EP 846
DI 10.1016/j.apsusc.2012.07.140
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 028QJ
UT WOS:000310436900126
DA 2018-10-19
ER

PT J
AU Luxenhofer, R
   Han, YC
   Schulz, A
   Tong, J
   He, ZJ
   Kabanov, AV
   Jordan, R
AF Luxenhofer, Robert
   Han, Yingchao
   Schulz, Anita
   Tong, Jing
   He, Zhijian
   Kabanov, Alexander V.
   Jordan, Rainer
TI Poly(2-oxazoline)s as Polymer Therapeutics
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Review
DE biomaterial; cancer; drug delivery; gene delivery; nanomedicine;
   polymer-conjugates; polymer therapeutic; polyoxazoline; protein
ID RING-OPENING POLYMERIZATION; CYCLIC IMINO ETHERS; CRITICAL SOLUTION
   TEMPERATURE; AIR-WATER-INTERFACE; TELECHELIC ANTIMICROBIAL FUNCTIONS;
   UTILIZING LIVING POLYMERIZATION; PLURONIC((R)) BLOCK-COPOLYMERS;
   ENHANCED CELLULAR DELIVERY; MIMICKING LIPID MIXTURES; DRUG-DELIVERY
AB Poly(2-oxazoline)s (POx) are currently discussed as an upcoming polymer platform for biomaterials design and especially for polymer therapeutics. POx meet specific requirements needed for the development of next-generation polymer therapeutics such as biocompatibility, high modulation of solubility, variation of size, architecture as well as chemical functionality. Although in the early 1990s first and promising POx-based systems were presented, the field lay dormant for almost two decades. Only very recently, POx-based polymer therapeutics came back into the focus of very intensive research. In this review, we give an overview on the chemistry and physicochemical properties of POx and summarize the research of POxprotein conjugates, POxdrug conjugates, POx-based polyplexes and POx micelles for drug delivery.
C1 [Luxenhofer, Robert; Schulz, Anita; Jordan, Rainer] Tech Univ Dresden, Dept Chem, D-01069 Dresden, Germany.
   [Han, Yingchao; Tong, Jing; He, Zhijian; Kabanov, Alexander V.] Univ Nebraska Med Ctr, Coll Pharm, Ctr Drug Delivery & Nanomed, Omaha, NE 68198 USA.
   [Han, Yingchao; Tong, Jing; He, Zhijian; Kabanov, Alexander V.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA.
   [Jordan, Rainer] CRTD, D-01307 Dresden, Germany.
   [Han, Yingchao] Wuhan Univ Technol, Biomed Mat & Engn Ctr, Wuhan 430070, Peoples R China.
RP Luxenhofer, R (reprint author), Tech Univ Dresden, Dept Chem, Zellescher Weg 19, D-01069 Dresden, Germany.
EM Robert.Luxenhofer@chemie.tu-dresden.de; Rainer.Jordan@tu-dresden.de
RI Luxenhofer, Robert/C-2825-2008; Jordan, Rainer/B-6542-2008; Tong,
   Jing/G-4612-2014
OI Luxenhofer, Robert/0000-0001-5567-7404; Jordan,
   Rainer/0000-0002-9414-1597; 
FU NIH through the Alliance Nanotechnology in cancer of the National Cancer
   Institute (NCI) [UO1 CA116591]; DFG through the center of excellence for
   regenerative therapies Dresden (CRTD); Fonds der Chemischen Industrie
   (FCI); China Scholarship Council (CSC); PCSIRT
FX The authors gratefully acknowledge financial support by the NIH through
   the Alliance Nanotechnology in cancer (UO1 CA116591) of the National
   Cancer Institute (NCI). R.J. additionally acknowledges support by the
   DFG through the center of excellence for regenerative therapies Dresden
   (CRTD). R. L. is thankful for additional financial support by the Fonds
   der Chemischen Industrie (FCI). Y.H. is grateful to the China
   Scholarship Council (CSC) for a postdoctoral fellowship and the support
   by PCSIRT.
CR Adams N, 2007, ADV DRUG DELIVER REV, V59, P1504, DOI 10.1016/j.addr.2007.08.018
   Ali AE, 2011, J APPL POLYM SCI, V120, P3071, DOI 10.1002/app.33480
   AOI K, 1992, MACROMOLECULES, V25, P7073, DOI 10.1021/ma00051a056
   Aoi K, 1996, PROG POLYM SCI, V21, P151, DOI 10.1016/0079-6700(95)00020-8
   Baekmark TR, 1999, LANGMUIR, V15, P3616, DOI 10.1021/la981360r
   Bailon P, 2009, EXPERT OPIN DRUG DEL, V6, P1, DOI [10.1517/17425240802650568, 10.1517/17425240802650568 ]
   Barz M, 2011, POLYM CHEM-UK, V2, P1900, DOI 10.1039/c0py00406e
   Barz M, 2009, BIOMATERIALS, V30, P5682, DOI 10.1016/j.biomaterials.2009.06.058
   Ben-Haim N, 2008, NANO LETT, V8, P1368, DOI 10.1021/nl080105g
   Bender J. C. M. E., 2011, PCT Int. Appl. WO 2011/002285, Patent No. 2011002285
   Bonne TB, 2004, COLLOID POLYM SCI, V282, P833, DOI 10.1007/s00396-004-1131-2
   Bonne TB, 2007, MACROMOL CHEM PHYSIC, V208, P1402, DOI 10.1002/macp.200700140
   Bortenschlager M, 2007, CHEM-EUR J, V13, P520, DOI 10.1002/chem.200600718
   Brown Larry R, 2005, Expert Opin Drug Deliv, V2, P29, DOI 10.1517/17425247.2.1.29
   Broz P, 2005, J CONTROL RELEASE, V102, P475, DOI 10.1016/j.jconrel.2004.10.014
   Broz P, 2008, J CARDIOVASC PHARM, V51, P246, DOI 10.1097/FJC.0b013e3181624aed
   Cesana S, 2006, MACROMOL CHEM PHYSIC, V207, P183, DOI 10.1002/macp.200500495
   Cesana S, 2007, MACROMOL RAPID COMM, V28, P608, DOI 10.1002/marc.200600737
   Chang JY, 2000, MACROMOLECULES, V33, P321, DOI 10.1021/ma991471c
   Chen B, 2009, J CONTROL RELEASE, V140, P203, DOI 10.1016/j.jconrel.2009.05.021
   CHEN FP, 1990, MACROMOLECULES, V23, P4688, DOI 10.1021/ma00223a029
   Choi HJ, 2006, NANOTECHNOLOGY, V17, P2198, DOI 10.1088/0957-4484/17/9/020
   Choi HJ, 2005, NANO LETT, V5, P2538, DOI 10.1021/nl051896e
   Choi HJ, 2005, NANOTECHNOLOGY, V16, pS143, DOI 10.1088/0957-4484/16/5/002
   Christova D, 2003, POLYMER, V44, P2255, DOI 10.1016/S0032-3861(03)00139-3
   CHUJO Y, 1990, MACROMOLECULES, V23, P2636, DOI 10.1021/ma00212a007
   CHUJO Y, 1993, MACROMOLECULES, V26, P883, DOI 10.1021/ma00057a001
   CHUJO Y, 1989, MACROMOLECULES, V22, P1074, DOI 10.1021/ma00193a013
   CHUJO Y, 1993, MACROMOLECULES, V26, P5611, DOI 10.1021/ma00073a012
   CHUJO Y, 1990, MACROMOLECULES, V23, P1234, DOI 10.1021/ma00207a002
   Deverall MA, 2008, SOFT MATTER, V4, P1899, DOI 10.1039/b800801a
   Diab C, 2004, MACROMOLECULES, V37, P2556, DOI 10.1021/ma0358733
   Diehl C, 2009, CHEM-EUR J, V15, P11469, DOI 10.1002/chem.200901420
   Diehl C, 2009, MACROMOL BIOSCI, V9, P157, DOI 10.1002/mabi.200800213
   Donev R, 2011, WORLD J BIOL PSYCHIA, V12, P44, DOI 10.3109/15622975.2011.599209
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Egli S, 2011, J AM CHEM SOC, V133, P4476, DOI 10.1021/ja110275f
   Einzmann M, 2001, J POLYM SCI POL CHEM, V39, P2821, DOI 10.1002/pola.1262
   Farkas P, 2010, EUR J MED CHEM, V45, P795, DOI 10.1016/j.ejmech.2009.11.002
   Fijten MWM, 2008, MACROMOL CHEM PHYSIC, V209, P1887, DOI 10.1002/macp.200800226
   Foreman MB, 2003, LANGMUIR, V19, P326, DOI 10.1921/la0261390
   Fortig A, 2004, MACROMOL SYMP, V210, P329, DOI 10.1002/masy.200450637
   Fustin CA, 2007, MACROMOL CHEM PHYSIC, V208, P2026, DOI 10.1002/macp.200700231
   Fustin CA, 2007, SOFT MATTER, V3, P79, DOI 10.1039/b611962j
   Gaertner FC, 2007, J CONTROL RELEASE, V119, P291, DOI 10.1016/j.jconrel.2007.02.015
   Garg S, 2007, BIOPHYS J, V92, P1263, DOI 10.1529/biophysj.106.091082
   Gillies ER, 2005, MOL PHARMACEUT, V2, P129, DOI 10.1021/mp049886u
   GODDARD P, 1989, Journal of Controlled Release, V10, P5, DOI 10.1016/0168-3659(89)90013-8
   Graff A, 2002, P NATL ACAD SCI USA, V99, P5064, DOI 10.1073/pnas.062654499
   Gress A, 2007, MACROMOLECULES, V40, P7928, DOI 10.1021/ma071357r
   Gross A, 1996, MACROMOL CHEM PHYSIC, V197, P2811, DOI 10.1002/macp.1996.021970919
   Guillerm B, 2012, CHEM COMMUN, V48, P2879, DOI 10.1039/c2cc30191a
   Hamaguchi T, 2007, BRIT J CANCER, V97, P170, DOI 10.1038/sj.bjc.6603855
   Han YC, 2012, MOL PHARMACEUT, V9, P2302, DOI 10.1021/mp300159u
   Harris J. M., 2010, 8 INT S POL THER LAB, P19
   Hoogenboom R, 2006, MACROMOLECULES, V39, P4719, DOI 10.1021/ma060952a
   Hoogenboom R, 2008, CHEM COMMUN, P5758, DOI 10.1039/b813140f
   Hoogenboom R, 2007, MACROMOLECULES, V40, P2837, DOI 10.1021/ma062725e
   Hoogenboom R, 2006, COLLOID POLYM SCI, V284, P1313, DOI 10.1007/s00396-006-1496-5
   Hoogenboom R, 2009, ANGEW CHEM INT EDIT, V48, P7978, DOI 10.1002/anie.200901607
   Hruby M., 2010, MACROMOL BIOSCI
   Hsiue GH, 2006, BIOCONJUGATE CHEM, V17, P781, DOI 10.1021/bi050317u
   Hsiue GH, 2006, INT J PHARM, V317, P69, DOI 10.1016/j.ijpharm.2006.03.002
   Huang HY, 2006, J AM CHEM SOC, V128, P3784, DOI 10.1021/ja057762k
   Huber S, 2008, COLLOID POLYM SCI, V286, P1653, DOI 10.1007/s00396-008-1942-7
   Huber S, 2008, COLLOID POLYM SCI, V286, P395, DOI 10.1007/s00396-007-1781-y
   Hutter NA, 2011, SOFT MATTER, V7, P4861, DOI 10.1039/c1sm05082f
   Huynh L, 2008, PHARM RES, V25, P147, DOI 10.1007/s11095-007-9412-3
   Ivanova R, 2008, MACROMOL CHEM PHYS, V209, P2248, DOI 10.1002/macp.200800232
   Jeong JH, 2001, J CONTROL RELEASE, V73, P391, DOI 10.1016/S0168-3659(01)00310-8
   Jin RH, 2004, J MATER CHEM, V14, P320, DOI 10.1039/b307439k
   Jordan R, 1998, J AM CHEM SOC, V120, P243, DOI 10.1021/ja973392r
   Jordan R, 2001, MACROMOLECULES, V34, P8858, DOI 10.1021/ma011573e
   Jordan R, 2001, MACROMOLECULES, V34, P1606, DOI 10.1021/ma001615j
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P759, DOI 10.1016/S0169-409X(02)00047-9
   Kabanov AV, 2002, CRIT REV THER DRUG, V19, P1, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.10
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P223, DOI 10.1016/S0169-409X(02)00018-2
   Kan P, 1999, J CONTROL RELEASE, V58, P271, DOI 10.1016/S0168-3659(98)00164-3
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kelly AM, 2011, MACROMOL RAPID COMM, V32, P1815, DOI 10.1002/marc.201100409
   Kempe K, 2011, MACROMOLECULES, V44, P6424, DOI 10.1021/ma201385k
   Kempe K, 2010, MACROMOL RAPID COMM, V31, P1869, DOI 10.1002/marc.201000283
   Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   KOBAYASHI S, 1992, MACROMOLECULES, V25, P3232, DOI 10.1021/ma00038a031
   KOBAYASHI S, 1990, MACROMOLECULES, V23, P54, DOI 10.1021/ma00203a011
   KOBAYASHI S, 1985, POLYM BULL, V13, P447, DOI 10.1007/BF01033343
   KOBAYASHI S, 1989, MACROMOLECULES, V22, P2878, DOI 10.1021/ma00197a002
   KOBAYASHI S, 1986, MACROMOLECULES, V19, P535, DOI 10.1021/ma00157a006
   KOBAYASHI S, 1987, MACROMOLECULES, V20, P1729, DOI 10.1021/ma00174a001
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Kowalczuk A, 2011, POLYM INT, V60, P1001, DOI 10.1002/pi.3103
   Kronek J, 2010, J MATER SCI-MATER M, V21, P879, DOI 10.1007/s10856-009-3949-0
   Krumm C, 2012, MACROMOL RAPID COMM, V33, P1677, DOI 10.1002/marc.201200192
   Kumar M, 2007, P NATL ACAD SCI USA, V104, P20719, DOI 10.1073/pnas.0708762104
   Lambermont-Thijs HML, 2009, J POLYM SCI POL CHEM, V47, P515, DOI 10.1002/pola.23168
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   Lee SC, 2003, J CONTROL RELEASE, V89, P437, DOI 10.1016/S0168-3659(03)00162-7
   Lee SC, 1999, MACROMOLECULES, V32, P1847, DOI 10.1021/ma981664k
   Lehmann T, 1999, MACROMOL SYMP, V142, P1, DOI 10.1002/masy.19991420103
   LITT M, 1975, J MACROMOL SCI CHEM, VA  9, P703, DOI 10.1080/00222337508065890
   Lo CL, 2006, ADV FUNCT MATER, V16, P2309, DOI 10.1002/adfm.200500627
   Ludtke K, 2005, MACROMOL BIOSCI, V5, P384, DOI 10.1002/mabi.200500004
   Ludtke K, 2008, LANGMUIR, V24, P5580, DOI 10.1021/la8001493
   Luxenhofer R, 2006, MACROMOLECULES, V39, P3509, DOI 10.1021/ma052515m
   Luxenhofer R., 2006, PMSE PREPR, V95, P283
   Luxenhofer R., 2007, THESIS TU MUNCHEN GA
   Luxenhofer R, 2008, MACROMOL RAPID COMM, V29, P1509, DOI 10.1002/marc.200800293
   Luxenhofer R, 2011, J CONTROL RELEASE, V153, P73, DOI 10.1016/j.jconrel.2011.04.010
   Luxenhofer R, 2010, BIOMATERIALS, V31, P4972, DOI 10.1016/j.biomaterials.2010.02.057
   Manzenrieder F, 2011, ANGEW CHEM INT EDIT, V50, P2601, DOI 10.1002/anie.201006134
   Meier W, 2000, ANGEW CHEM INT EDIT, V39, P4599, DOI 10.1002/1521-3773(20001215)39:24<4599::AID-ANIE4599>3.0.CO;2-Y
   Mero A, 2008, J CONTROL RELEASE, V125, P87, DOI 10.1016/j.jconrel.2007.10.010
   Mero A, 2012, J CONTROL RELEASE, V159, P353, DOI 10.1016/j.jconrel.2012.02.025
   Meyer M, 2007, SOFT MATTER, V3, P430, DOI 10.1039/b616678d
   Milonaki Y, 2012, J POLYM SCI POL CHEM, V50, P1226, DOI 10.1002/pola.25888
   Mitra A, 2004, PHARM RES, V21, P1153, DOI 10.1023/B:PHAM.0000033001.49737.b7
   MIYAMOTO M, 1990, MACROMOLECULES, V23, P3201, DOI 10.1021/ma00215a001
   Naka K, 1997, MACROMOL CHEM PHYSIC, V198, P101, DOI 10.1002/macp.1997.021980109
   Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u
   Nuyken O, 1997, MACROMOL RAPID COMM, V18, P125, DOI 10.1002/marc.1997.030180209
   Nuyken O, 1996, MACROMOL CHEM PHYSIC, V197, P83, DOI 10.1002/macp.1996.021970106
   Obeid R, 2011, BIOMACROMOLECULES, V12, P3797, DOI 10.1021/bm201048x
   Obeid R, 2009, MACROMOLECULES, V42, P2204, DOI 10.1021/ma802592f
   Onaca O, 2009, MACROMOL BIOSCI, V9, P129, DOI 10.1002/mabi.200800248
   Papadakis CM, 2007, J APPL CRYSTALLOGR, V40, pS361, DOI 10.1107/S0021889806056184
   PARK IH, 1991, ANGEW MAKROMOL CHEM, V190, P165, DOI 10.1002/apmc.1991.051900111
   Park JS, 2007, MACROMOLECULES, V40, P3599, DOI 10.1021/ma0701181
   Park JS, 2006, MACROMOLECULES, V39, P6622, DOI 10.1021/ma0605548
   Park JS, 2004, MACROMOLECULES, V37, P6786, DOI 10.1021/ma049677n
   Pasut G, 2006, ADV POLYM SCI, V192, P95, DOI 10.1007/12_022
   Persigehl P, 2000, MACROMOLECULES, V33, P6977, DOI 10.1021/ma0007381
   Pidhatika B, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0001-y
   Pidhatika B, 2010, BIOMATERIALS, V31, P9462, DOI 10.1016/j.biomaterials.2010.08.033
   Price TO, 2010, J PHARMACOL EXP THER, V333, P253, DOI 10.1124/jpet.109.158147
   Purrucker O, 2005, J AM CHEM SOC, V127, P1258, DOI 10.1021/ja045713m
   Purrucker O, 2004, CHEMPHYSCHEM, V5, P327, DOI 10.1002/cphc.200300863
   Purrucker O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.078102
   Purrucker O, 2007, SOFT MATTER, V3, P333, DOI 10.1039/b612069e
   Qiu LY, 2006, PHARM RES, V23, P1, DOI 10.1007/s11095-005-9046-2
   Ranquin A, 2005, NANO LETT, V5, P2220, DOI 10.1021/nl051523d
   Rehfeldt F, 2002, LANGMUIR, V18, P4908, DOI 10.1021/la0112559
   Reif M, 2011, MACROMOL CHEM PHYS, V212, P1815, DOI 10.1002/macp.201100276
   Rio E. D., 2011, J POLYM SCI A, V49, P3069
   Salzinger S, 2012, COLLOID POLYM SCI, V290, P385, DOI 10.1007/s00396-011-2564-z
   Schlaad H, 2010, MACROMOL RAPID COMM, V31, P511, DOI 10.1002/marc.200900683
   SCHULZ A, 2012, POLYM PREPR, V53, P354
   Schulz A., 2012, POLYM PREPR, V53, P305
   Schwekendiek K, 2006, SYNTHESIS-STUTTGART, P2996, DOI 10.1055/s-2006-950198
   SEELIGER W, 1966, ANGEW CHEM INT EDIT, V5, P875, DOI 10.1002/anie.196608751
   Seitz PC, 2011, J PHYS CHEM B, V115, P2256, DOI 10.1021/jp1106718
   Seitz PC, 2009, CHEMPHYSCHEM, V10, P2876, DOI 10.1002/cphc.200900553
   Shieh MJ, 2010, MOL PHARMACEUT, V7, P1244, DOI 10.1021/mp100060v
   SHIMANO Y, 1995, J POLYM SCI POL CHEM, V33, P2715, DOI 10.1002/pola.1995.080331605
   SHODA S, 1992, J POLYM SCI POL CHEM, V30, P1489, DOI 10.1002/pola.1992.080300728
   Siegel AP, 2011, BIOPHYS J, V101, P1642, DOI 10.1016/j.bpj.2011.08.040
   Siegel AP, 2010, SOFT MATTER, V6, P2723, DOI 10.1039/c001394c
   Singer JW, 2003, ADV EXP MED BIOL, V519, P81
   Steenackers M, 2009, ADV MATER, V21, P2921, DOI 10.1002/adma.200900500
   Stoenescu R, 2004, MACROMOL BIOSCI, V4, P930, DOI 10.1002/mabi.200400065
   Stoenescu R, 2002, CHEM COMMUN, P3016, DOI 10.1039/b209352a
   Taubert A, 2004, CURR OPIN CHEM BIOL, V8, P598, DOI 10.1016/j.cbpa.2004.09.008
   Taubmann C, 2005, MACROMOL BIOSCI, V5, P603, DOI 10.1002/mabi.200500059
   Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102
   Tiller JC, 2011, ADV POLYM SCI, V240, P193, DOI 10.1007/12_2010_101
   TOMALIA DA, 1985, ENCY POLYM SCI ENG, P680
   Tong J, 2011, BIOMATERIALS, V32, P3654, DOI 10.1016/j.biomaterials.2011.01.068
   Tong J, 2010, MOL PHARMACEUT, V7, P984, DOI 10.1021/mp100102p
   Torchilin VP, 2004, CELL MOL LIFE SCI, V61, P2549, DOI 10.1007/s00018-004-4153-5
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   Tsutsumiuchi K, 1997, MACROMOLECULES, V30, P4013, DOI 10.1021/ma970086p
   UYAMA H, 1993, J POLYM SCI POL CHEM, V31, P123, DOI 10.1002/pola.1993.080310114
   VELANDER WH, 1992, BIOTECHNOL BIOENG, V39, P1024, DOI 10.1002/bit.260391006
   Vicent MJ, 2009, ADV DRUG DELIVER REV, V61, P1117, DOI 10.1016/j.addr.2009.08.001
   Viegas TX, 2011, BIOCONJUGATE CHEM, V22, P976, DOI 10.1021/bc200049d
   Volet G, 2005, MACROMOLECULES, V38, P5190, DOI 10.1021/ma050407u
   Volet G, 2011, MACROMOL CHEM PHYS, V212, P118, DOI 10.1002/macp.201000556
   von Erlach T, 2011, BIOMATERIALS, V32, P5291, DOI 10.1016/j.biomaterials.2011.03.080
   Wang CH, 2005, J CONTROL RELEASE, V108, P140, DOI 10.1016/j.jconrel.2005.07.017
   Wang CH, 2003, BIOMACROMOLECULES, V4, P1487, DOI 10.1021/bm034190s
   Wang CH, 2012, BIOMACROMOLECULES, V13, P40, DOI 10.1021/bm2009558
   Wang CH, 2009, BIOMATERIALS, V30, P3352, DOI 10.1016/j.biomaterials.2009.02.041
   Wang H, 2011, ACS APPL MATER INTER, V3, P3463, DOI 10.1021/am200690s
   Wang X, 2011, ACTA BIOMATER, V7, P4149, DOI 10.1016/j.actbio.2011.07.011
   Waschinski CJ, 2008, BIOMACROMOLECULES, V9, P1764, DOI 10.1021/bm7013944
   Waschinski CJ, 2008, ADV MATER, V20, P104, DOI 10.1002/adma.200701095
   Waschinski CJ, 2005, BIOMACROMOLECULES, V6, P235, DOI 10.1021/bm049553i
   Waschinski CJ, 2004, MACROMOL BIOSCI, V5, P149, DOI 10.1002/mabi.200400169
   Weber C., 2011, PROG POLYM SCI
   Weber C, 2011, MACROMOL SYMP, V308, P17, DOI 10.1002/masy.201151004
   Weber C, 2010, MACROMOLECULES, V43, P160, DOI 10.1021/ma902014q
   Weberskirch R, 1999, MACROMOL CHEM PHYSIC, V200, P863, DOI 10.1002/(SICI)1521-3935(19990401)200:4<863::AID-MACP863>3.0.CO;2-N
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   Yi X, 2008, BIOCONJUGATE CHEM, V19, P1071, DOI 10.1021/bc700443k
   Yi XA, 2010, FREE RADICAL BIO MED, V49, P548, DOI 10.1016/j.freeradbiomed.2010.04.039
   Yokoyama M, 1999, J DRUG TARGET, V7, P171, DOI 10.3109/10611869909085500
   Zalipsky S, 1996, J PHARM SCI, V85, P133, DOI 10.1021/js9504043
   Zarka MT, 2003, CHEM-EUR J, V9, P3228, DOI 10.1002/chem.200304729
   Zhang N, 2012, MACROMOL BIOSCI, V12, P926, DOI 10.1002/mabi.201200026
   Zhang N, 2012, MACROMOL CHEM PHYS, V213, P973, DOI 10.1002/macp.201200015
   Zhang N, 2009, MACROMOLECULES, V42, P2215, DOI 10.1021/ma802627y
NR 201
TC 184
Z9 187
U1 14
U2 230
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD OCT 15
PY 2012
VL 33
IS 19
SI SI
BP 1613
EP 1631
DI 10.1002/marc.201200354
PG 19
WC Polymer Science
SC Polymer Science
GA 015MS
UT WOS:000309451000004
PM 22865555
OA Green Accepted
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Dargaville, TR
   Forster, R
   Farrugia, BL
   Kempe, K
   Voorhaar, L
   Schubert, US
   Hoogenboom, R
AF Dargaville, Tim R.
   Forster, Rebecca
   Farrugia, Brooke L.
   Kempe, Kristian
   Voorhaar, Lenny
   Schubert, Ulrich S.
   Hoogenboom, Richard
TI Poly(2-oxazoline) Hydrogel Monoliths via Thiol-ene Coupling
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE hydrogels; photo-crosslinking; poly(2-oxazoline); thiol-ene
ID NONIONIC HYDROGEL; DELIVERY-SYSTEMS; DRUG-DELIVERY; TUNABLE LCST;
   POLYOXAZOLINE; 2-METHYL-2-OXAZOLINE; SURFACES; RELEASE;
   COPOLY(2-OXAZOLINE)S; ALTERNATIVES
AB Copoly(2-oxazoline)s, prepared by the cationic ring-opening polymerization of 2-(dec-9-enyl)-2-oxazoline with either 2-methyl-2-oxazoline or 2-ethyl-2-oxazoline, are crosslinked with small dithiol molecules under UV irradiation to form homogeneous networks. In situ monitoring of the crosslinking reaction by photo-rheology reveals the formation of soft gels within minutes. The degree of swelling in water is tunable based on the hydrophilicity of the starting macromers and the proportion of alkene side arms present. Furthermore, degradable hydrogels are prepared based on incorporation of a hydrolytically cleavable dithiol crosslinker. The rapid synthesis of the macromers and mild crosslinking conditions make these materials ideal for future biomaterial applications.
C1 [Dargaville, Tim R.; Forster, Rebecca; Farrugia, Brooke L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Repair & Regenerat Program, Kelvin Grove, Qld 4059, Australia.
   [Kempe, Kristian; Schubert, Ulrich S.] Univ Jena, Lab Organ & Macromol Chem IOMC, D-07743 Jena, Germany.
   [Kempe, Kristian; Schubert, Ulrich S.] Univ Jena, Jena Ctr Soft Matter JCSM, D-07743 Jena, Germany.
   [Voorhaar, Lenny; Hoogenboom, Richard] Univ Ghent, Dept Organ Chem, Supramol Chem Grp, B-9000 Ghent, Belgium.
RP Dargaville, TR (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Repair & Regenerat Program, Kelvin Grove, Qld 4059, Australia.
EM t.dargaville@qut.edu.au; richard.hoogenboom@ugent.be
RI Schubert, Ulrich/B-5777-2009; Farrugia, Brooke/J-1292-2012; Hoogenboom,
   Richard/B-8977-2008
OI Schubert, Ulrich/0000-0003-4978-4670; Farrugia,
   Brooke/0000-0003-1303-4165; Hoogenboom, Richard/0000-0001-7398-2058;
   Dargaville, Tim/0000-0003-4665-9508; Voorhaar,
   Lenny/0000-0002-4741-9381; Kempe, Kristian/0000-0002-0136-9403
FU Ghent University; BOF-GOA; Thuringian Ministry for Education, Science,
   and Culture [B514-09051]; Carl-Zeiss-Stiftung (Strukturantrag JCSM)
FX Ghent University is acknowledged for a BOF fellowship for LV and a
   BOF-GOA research grant for RH. USS and KK would like to thank the
   Thuringian Ministry for Education, Science, and Culture (grant #
   B514-09051, NanoConSens) and the Carl-Zeiss-Stiftung (Strukturantrag
   JCSM) for funding. Thanks also to Dr Paul Dalton for helpful
   discussions.
CR Adams N, 2007, ADV DRUG DELIVER REV, V59, P1504, DOI 10.1016/j.addr.2007.08.018
   Barz M, 2011, POLYM CHEM-UK, V2, P1900, DOI 10.1039/c0py00406e
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534
   Cao Y, 2011, J BIOMED MATER RES A, V96A, P663, DOI 10.1002/jbm.a.33027
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Chen C., 1994, THESIS VIRGINIA TECH
   CHUJO Y, 1990, MACROMOLECULES, V23, P2636, DOI 10.1021/ma00212a007
   CHUJO Y, 1993, MACROMOLECULES, V26, P883, DOI 10.1021/ma00057a001
   CHUJO Y, 1989, MACROMOLECULES, V22, P1074, DOI 10.1021/ma00193a013
   CHUJO Y, 1990, MACROMOLECULES, V23, P2693, DOI 10.1021/ma00212a017
   Cortez MA, 2010, MACROMOLECULES, V43, P4081, DOI 10.1021/ma9028294
   Diehl C, 2009, CHEM-EUR J, V15, P11469, DOI 10.1002/chem.200901420
   Diehl C, 2009, MACROMOL BIOSCI, V9, P157, DOI 10.1002/mabi.200800213
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Fijten MWM, 2007, MACROMOLECULES, V40, P5879, DOI 10.1021/ma070720r
   Gress A, 2007, MACROMOLECULES, V40, P7928, DOI 10.1021/ma071357r
   Hoogenboom R, 2009, ANGEW CHEM INT EDIT, V48, P7978, DOI 10.1002/anie.200901607
   Hruby M, 2010, MACROMOL BIOSCI, V10, P916, DOI 10.1002/mabi.201000034
   Kelly AM, 2011, MACROMOL RAPID COMM, V32, P1815, DOI 10.1002/marc.201100409
   Kempe K, 2011, MACROMOLECULES, V44, P6424, DOI 10.1021/ma201385k
   Kempe K, 2011, MACROMOL RAPID COMM, V32, P1484, DOI 10.1002/marc.201100271
   Kempe K, 2011, POLYM CHEM-UK, V2, P1737, DOI 10.1039/c1py00099c
   Kempe K, 2011, BIOMACROMOLECULES, V12, P2591, DOI 10.1021/bm2003847
   Kempe K, 2010, MACROMOL RAPID COMM, V31, P1869, DOI 10.1002/marc.201000283
   Klein TJ, 2010, SOFT MATTER, V6, P5175, DOI 10.1039/c0sm00229a
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lutolf MP, 2009, NAT MATER, V8, P451, DOI 10.1038/nmat2458
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Luxenhofer R, 2011, J CONTROL RELEASE, V153, P73, DOI 10.1016/j.jconrel.2011.04.010
   Luxenhofer R, 2010, BIOMATERIALS, V31, P4972, DOI 10.1016/j.biomaterials.2010.02.057
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Mero A, 2008, J CONTROL RELEASE, V125, P87, DOI 10.1016/j.jconrel.2007.10.010
   MIYAMOTO M, 1990, MACROMOLECULES, V23, P3201, DOI 10.1021/ma00215a001
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Pidhatika B, 2010, BIOMATERIALS, V31, P9462, DOI 10.1016/j.biomaterials.2010.08.033
   Rydholm AE, 2007, POLYMER, V48, P4589, DOI 10.1016/j.polymer.2007.05.063
   Schenk V, 2012, MACROMOL RAPID COMM, V33, P396, DOI 10.1002/marc.201100717
   Tong J, 2010, MOL PHARMACEUT, V7, P984, DOI 10.1021/mp100102p
   VELANDER WH, 1992, BIOTECHNOL BIOENG, V39, P1024, DOI 10.1002/bit.260391006
   Viegas TX, 2011, BIOCONJUGATE CHEM, V22, P976, DOI 10.1021/bc200049d
   Wang H, 2011, ACS APPL MATER INTER, V3, P3463, DOI 10.1021/am200690s
   Wiesbrock F, 2005, MACROMOLECULES, V38, P5025, DOI 10.1021/ma0474170
   Yigit S, 2011, CHEM-ASIAN J, V6, P2648, DOI 10.1002/asia.201100440
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 49
TC 46
Z9 46
U1 3
U2 123
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD OCT 15
PY 2012
VL 33
IS 19
SI SI
BP 1695
EP 1700
DI 10.1002/marc.201200249
PG 6
WC Polymer Science
SC Polymer Science
GA 015MS
UT WOS:000309451000011
PM 22887564
DA 2018-10-19
ER

PT J
AU Paulino, AT
   Pereira, AGB
   Fajardo, AR
   Erickson, K
   Kipper, MJ
   Muniz, EC
   Belfiore, LA
   Tambourgi, EB
AF Paulino, Alexandre T.
   Pereira, Antonio G. B.
   Fajardo, Andre R.
   Erickson, Kristin
   Kipper, Matt J.
   Muniz, Edvani C.
   Belfiore, Laurence A.
   Tambourgi, Elias B.
TI Natural polymer-based magnetic hydrogels: Potential vectors for
   remote-controlled drug release
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Polysaccharide; Magnetic hydrogel; Swelling; Controlled release;
   Curcumin; Magnetite
ID DIFFERENTIAL SCANNING CALORIMETRY; GLYCIDYL METHACRYLATE; CHITOSAN;
   DELIVERY; STARCH; WATER; BIOMATERIAL; ADSORPTION; NETWORKS; DEXTRAN
AB The preparation and characterization of natural polymer-based hydrogels that contain 50-nm diameter magnetite (i.e., FeO:Fe2O3) nanoparticles are described herein. Fourier-transform infrared spectroscopy (FTIR) analysis confirmed the efficiency of the polysaccharide-modifying process. Thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), and compressive moduli demostrate that the presence of magnetite improves thermal and mechanical resistance. Transient diffusion of water in magnetic hydrogels was analyzed via boundary layer mass transfer across an expaning interface, and the degree of swelling of these polysaccharide hydrogels decreases in the presence of magnetite, with no variation in the binary diffusion mechanism. The absence of hysteresis loops and coercivity observed via magnetometry suggests that magnetic hydrogels are useful for remote-controlled drug release, as demonstrated by magnetic-field-induced release of curcumin. Experiments reveal that magnetic hydrogels with greater magnetic susceptibility have the potential to release larger concentrations of drugs from the hydrogel network. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Paulino, Alexandre T.; Tambourgi, Elias B.] Univ Estadual Campinas, Separat Proc Lab, Dept Chem Syst Engn, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
   [Paulino, Alexandre T.; Erickson, Kristin; Kipper, Matt J.; Belfiore, Laurence A.] Colorado State Univ, Dept Chem & Biol Engn, Polymer Phys & Engn Lab, Ft Collins, CO 80523 USA.
   [Paulino, Alexandre T.] Santa Catarina State Univ, Higher Educ Ctr W, Dept Food Engn, BR-89870000 Chapeco Pinhalzinho, SC, Brazil.
   [Pereira, Antonio G. B.; Fajardo, Andre R.; Muniz, Edvani C.] GMPC UEM, Polymer Mat & Composite Lab, Dept Chem, BR-87050900 Maringa, Parana, Brazil.
RP Paulino, AT (reprint author), Univ Estadual Campinas, Separat Proc Lab, Dept Chem Syst Engn, Sch Chem Engn, Av Albert Einstein 500,Bloco A, BR-13083852 Campinas, SP, Brazil.
EM atpaulino10@gmail.com
RI Paulino, Alexandre/B-8075-2013; Inomat, Inct/H-9989-2013; Fajardo,
   Andre/H-1783-2012; Tambourgi, Elias/E-1863-2012; Basso Pereira, Antonio
   Guilherme/B-1041-2012; Kipper, Matt/B-6941-2013
OI Paulino, Alexandre/0000-0001-7076-2797; Fajardo,
   Andre/0000-0001-5362-6478; Tambourgi, Elias/0000-0002-4734-9723; Kipper,
   Matt/0000-0002-8818-745X; Muniz, Edvani/0000-0001-6685-1519
FU State of Sao Paulo Research Foundation (FAPESP, Brazil) [2008/00285-7];
   Coordination of Improvement of Higher Education Personnel (CAPES,
   Brazil) [5267/09-9]
FX AT Paulino and EB Tambourgi thank the State of Sao Paulo Research
   Foundation (FAPESP, Brazil) for the post-doctorate fellowship (Process
   No. 2008/00285-7). AT Paulino is grateful to the Coordination of
   Improvement of Higher Education Personnel (CAPES, Brazil) for the
   fellowship (Process No. 5267/09-9) to support his post-doctoral research
   experience with LA Belfiore and MJ Kipper at Colorado State University
   in Fort Collins, CO, USA.
CR Almodovar J, 2011, BIOMACROMOLECULES, V12, P2755, DOI 10.1021/bm200519y
   Arizaga A, 2010, J COLLOID INTERF SCI, V348, P668, DOI 10.1016/j.jcis.2010.05.051
   Bajpai AK, 2008, PROG POLYM SCI, V33, P1088, DOI 10.1016/j.progpolymsci.2008.07.005
   Baolin G., 2011, J POLYM SCI POL CHEM, V49, P2097
   Belfiore L.A., 2003, TRANSPORT PHENOMENA, P327
   Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   Chaterji S, 2007, PROG POLYM SCI, V32, P1083, DOI 10.1016/j.progpolymsci.2007.05.018
   Chatterjee J, 2003, COLLOID POLYM SCI, V281, P892, DOI 10.1007/s00396-003-0916-z
   Deligkaris K, 2010, SENSOR ACTUAT B-CHEM, V147, P765, DOI 10.1016/j.snb.2010.03.083
   Deng YH, 2003, ADV MATER, V15, P1729, DOI 10.1002/adma.200305459
   Friedrich T, 2010, MACROMOL SY, V298, P57, DOI 10.1002/masy.201000021
   GUTOWSKA A, 1994, MACROMOLECULES, V27, P4167, DOI 10.1021/ma00093a018
   Kirwan LJ, 2003, LANGMUIR, V19, P5802, DOI 10.1021/la027012d
   Kittur FS, 2002, CARBOHYD POLYM, V49, P185, DOI 10.1016/S0144-8617(01)00320-4
   Lau KT, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/7/070201
   Lawrie G, 2007, BIOMACROMOLECULES, V8, P2533, DOI 10.1021/bm070014y
   Lewandowska K, 2009, THERMOCHIM ACTA, V493, P42, DOI 10.1016/j.tca.2009.04.003
   Liu YJ, 2009, MOL PHARMACEUT, V6, P1891, DOI 10.1021/mp900215p
   Mahkam M, 2010, J BIOACT COMPAT POL, V25, P406, DOI 10.1177/0883911510369038
   Neto CGT, 2005, CARBOHYD POLYM, V62, P97, DOI 10.1016/j.carbpol.2005.02.022
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   Ostrowska-Czubenko J, 2009, CARBOHYD POLYM, V77, P590, DOI 10.1016/j.carbpol.2009.01.036
   Paulino AT, 2011, DESALINATION, V275, P187, DOI 10.1016/j.desal.2011.02.056
   Paulino AT, 2011, POLYM INT, V60, P1324, DOI 10.1002/pi.3084
   Paulino AT, 2010, MACROMOL CHEM PHYS, V211, P1196, DOI 10.1002/macp.200900657
   Paulino AT, 2009, J MAGN MAGN MATER, V321, P2636, DOI 10.1016/j.jmmm.2009.03.078
   Paulino AT, 2011, CHEM ENG J, V168, P68, DOI 10.1016/j.cej.2010.12.037
   Rueda DR, 1999, CARBOHYD POLYM, V40, P49, DOI 10.1016/S0144-8617(99)00033-8
   Shalviri A, 2010, CARBOHYD POLYM, V79, P898, DOI 10.1016/j.carbpol.2009.10.016
   Simionato JI, 2006, POLYM INT, V55, P1243, DOI 10.1002/pi.2070
   Snyder RL, 2010, ACTA MATER, V58, P5620, DOI 10.1016/j.actamat.2010.06.035
   Snyder RL, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/5/055017
   Song F, 2010, COLLOID SURFACE B, V79, P142, DOI 10.1016/j.colsurfb.2010.03.045
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P3411, DOI 10.1021/ma961764v
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Wang WB, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/2/025006
   Zhang YX, 2005, POLYMER, V46, P7695, DOI 10.1016/j.polymer.2005.05.121
NR 37
TC 30
Z9 30
U1 1
U2 97
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD OCT 15
PY 2012
VL 90
IS 3
BP 1216
EP 1225
DI 10.1016/j.carbpol.2012.06.051
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 010JY
UT WOS:000309091900004
PM 22939334
DA 2018-10-19
ER

PT J
AU Keller, J
   Brink, S
   Busse, B
   Schilling, AF
   Schinke, T
   Amling, M
   Lange, T
AF Keller, Johannes
   Brink, Silja
   Busse, Bjoern
   Schilling, Arndt F.
   Schinke, Thorsten
   Amling, Michael
   Lange, Tobias
TI Divergent Resorbability and Effects on Osteoclast Formation of Commonly
   Used Bone Substitutes in a Human In Vitro-Assay
SO PLOS ONE
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; SINUS FLOOR AUGMENTATION; RESORPTION PITS;
   BIOMATERIALS; DEFECTS; SURGERY; REGENERATION; DISEASE; GRAFTS
AB Bioactive bone substitute materials are a valuable alternative to autologous bone transplantations in the repair of skeletal defects. However, clinical studies have reported varying success rates for many commonly used biomaterials. While osteoblasts have traditionally been regarded as key players mediating osseointegration, increasing evidence suggests that bone-resorbing osteoclasts are of crucial importance for the longevity of applied biomaterials. As no standardized data on the resorbability of biomaterials exists, we applied an in vitro-assay to compare ten commonly used bone substitutes. Human peripheral blood mononuclear cells (PBMCs) were differentiated into osteoclasts in the co-presence of dentin chips and biomaterials or dentin alone (control) for a period of 28 days. Osteoclast maturation was monitored on day 0 and 14 by light microscopy, and material-dependent changes in extracellular pH were assessed twice weekly. Mature osteoclasts were quantified using TRAP stainings on day 28 and their resorptive activity was determined on dentin (toluidin blue staining) and biomaterials (scanning electron microscopy, SEM). The analyzed biomaterials caused specific changes in the pH, which were correlated with osteoclast multinuclearity (r = 0.942; p = 0.034) and activity on biomaterials (r = 0.594; p = 0.041). Perossal led to a significant reduction of pH, nuclei per osteoclast and dentin resorption, whereas Tutogen bovine and Tutobone human strikingly increased all three parameters. Furthermore, natural biomaterials were resorbed more rapidly than synthetic biomaterials leading to differential relative resorption coefficients, which indicate whether bone substitutes lead to a balanced resorption or preferential resorption of either the biomaterial or the surrounding bone. Taken together, this study for the first time compares the effects of widely used biomaterials on osteoclast formation and resorbability in an unbiased approach that may now aid in improving the preclinical evaluation of bone substitute materials.
C1 [Keller, Johannes; Brink, Silja; Busse, Bjoern; Schilling, Arndt F.; Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany.
   [Lange, Tobias] Univ Med Ctr Hamburg Eppendorf, Dept Anat & Expt Morphol, Hamburg, Germany.
RP Keller, J (reprint author), Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany.
EM j.keller@uke.de
RI Busse, Bjorn/O-8462-2016; Lange, Tobias/K-8689-2015
OI Busse, Bjorn/0000-0002-3099-8073; 
CR Bauer TW, 2007, SKELETAL RADIOL, V36, P1105, DOI 10.1007/s00256-007-0377-4
   David JP, 2010, CURR DIR AUTOIMMUN, V11, P135, DOI 10.1159/000289202
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Edwards RC, 2001, J ORAL MAXIL SURG, V59, P19, DOI 10.1053/joms.2001.19267
   Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056
   Gallo J, 2008, PHYSIOL RES, V57, P339
   Heini P.F., 2001, EUR SPINE J, V10, P205
   Hillmeier J, 2003, OPERAT ORTHOP TRAUMA, V15, P343
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Horvai AE, 2011, SEMIN DIAGN PATHOL, V28, P13, DOI 10.1053/j.semdp.2011.02.004
   Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026
   Knop C, 2006, ARCH ORTHOP TRAUM SU, V126, P204, DOI 10.1007/s00402-006-0107-8
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   Lange T, 2011, BIOMATERIALS, V32, P4067, DOI 10.1016/j.biomaterials.2011.02.039
   Lange T, 2009, BIOMATERIALS, V30, P5312, DOI 10.1016/j.biomaterials.2009.06.023
   Linhart W, 2003, UNFALLCHIRURG, V106, P618, DOI 10.1007/s00113-003-0628-3
   Meyer S, 2008, ARCH ORTHOP TRAUM SU, V128, P539, DOI 10.1007/s00402-007-0402-z
   Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6
   Parikka V, 2001, ENDOCRINOLOGY, V142, P5371, DOI 10.1210/en.142.12.5371
   PIPER K, 1992, ANAT EMBRYOL, V186, P291
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Rueger JM, 1998, ORTHOPADE, V27, P72
   Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Schnettler R, 2009, J BIOMED MATER RES B, V90B, P75, DOI 10.1002/jbm.b.31255
   Sen MK, 2007, INJURY, V1, P75
   SHIBUTANI T, 1993, J BONE MINER RES, V8, P331
   Shin Hong-In, 2005, Implant Dent, V14, P328
   Soysa Niroshani Surangika, 2009, Journal of Medical and Dental Sciences, V56, P107
   Spies CKG, 2009, ARCH ORTHOP TRAUM SU, V129, P979, DOI 10.1007/s00402-008-0705-8
   TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017
   Tudor C, 2008, ORAL SURG ORAL MED O, V105, P430, DOI 10.1016/j.tripleo.2007.07.037
   von Stechow D, 2009, EUR SURG RES, V43, P298, DOI 10.1159/000233525
   Winkler T, 2010, INT J ARTIF ORGANS, V33, P198
   Yamada Y, 2007, MAT SCI ENG C-BIO S, V27, P762, DOI 10.1016/j.msec.2006.08.006
   Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432
NR 36
TC 15
Z9 15
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 10
PY 2012
VL 7
IS 10
AR e46757
DI 10.1371/journal.pone.0046757
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 054ZU
UT WOS:000312385200042
PM 23071629
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Blamires, SJ
   Wu, CL
   Blackledge, TA
   Tso, IM
AF Blamires, Sean J.
   Wu, Chung-Lin
   Blackledge, Todd A.
   Tso, I-Min
TI Post-secretion processing influences spider silk performance
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE biomaterial plasticity; MaSp expression model; mechanical properties;
   orb web; spider silk; supercontraction
ID DRAGLINE SILK; PHENOTYPIC PLASTICITY; MECHANICAL-PROPERTIES; ORB WEBS;
   EVOLUTION; SUPERCONTRACTION; BEHAVIOR; PROLINE; ARANEAE; ENVIRONMENTS
AB Phenotypic variation facilitates adaptations to novel environments. Silk is an example of a highly variable biomaterial. The two-spidroin (MaSp) model suggests that spider major ampullate (MA) silk is composed of two proteins-MaSp1 predominately contains alanine and glycine and forms strength enhancing beta-sheet crystals, while MaSp2 contains proline and forms elastic spirals. Nonetheless, mechanical properties can vary in spider silks without congruent amino acid compositional changes. We predicted that post-secretion processing causes variation in the mechanical performance of wild MA silk independent of protein composition or spinning speed across 10 species of spider. We used supercontraction to remove post-secretion effects and compared the mechanics of silk in this 'ground state' with wild native silks. Native silk mechanics varied less among species compared with 'ground state' silks. Variability in the mechanics of 'ground state' silks was associated with proline composition. However, variability in native silks did not. We attribute interspecific similarities in the mechanical properties of native silks, regardless of amino acid compositions, to glandular processes altering molecular alignment of the proteins prior to extrusion. Such post-secretion processing may enable MA silk to maintain functionality across environments, facilitating its function as a component of an insect-catching web.
C1 [Blamires, Sean J.; Tso, I-Min] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.
   [Tso, I-Min] Tunghai Univ, Ctr Trop Ecol & Biodivers, Taichung 40704, Taiwan.
   [Wu, Chung-Lin] Ind Technol Res Inst, Ctr Measurement Stand, Hsinchu 30011, Taiwan.
   [Blackledge, Todd A.] Univ Akron, Dept Biol, Integrated Biosci Program, Akron, OH 44325 USA.
RP Tso, IM (reprint author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.
EM spider@thu.edu.tw
FU NSC [NSC-98-2811-B-029-002, NSC-99-2621-13-002-MY3]
FX The study was assisted financially by a NSC postdoctoral fellowship
   (NSC-98-2811-B-029-002) to S.J.B. and a NSC grant
   (NSC-99-2621-13-002-MY3) to I.M.T. We thank Chen-Pan Liao, Ren-Chun
   Cheng, Albert Yue and Madeleine Blamires for assistance collecting
   spiders and silks. Yi-Hsuan Tseng, Chao-Chia Wu (Taiwan) and Cecelia
   Boutry (USA) assisted with the mechanical tests. We thank two anonymous
   referees for their valued feedback.
CR Agnarsson I, 2009, ZOOLOGY, V112, P325, DOI 10.1016/j.zool.2008.11.003
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Behera N, 2004, J THEOR BIOL, V226, P177, DOI 10.1016/j.jtbi.2003.08.011
   Bittencourt D, 2007, COMP BIOCHEM PHYS B, V147, P597, DOI 10.1016/j.cbpb.2007.03.013
   Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Blamires SJ, 2010, J EXP BIOL, V213, P3906, DOI 10.1242/jeb.046730
   Blamires S. J., 2012, SILKS PROPERTIES PRO, P139
   Blamires S. J., BIOL J LINN SOC, DOI [10.1111/j.1095-8312.2012.01884.x, DOI 10.1111/J.1095-8312.2012.01884.X)]
   Blamires SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031626
   Boutry C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022467
   Boutry C, 2010, J EXP BIOL, V213, P3505, DOI 10.1242/jeb.046110
   Brooks AE, 2008, NANOTECHNOL SCI APPL, V1, P9, DOI 10.2147/NSA.S3961
   BULL JJ, 1987, EVOLUTION, V41, P303, DOI 10.1111/j.1558-5646.1987.tb05799.x
   Casem ML, 2002, TISSUE CELL, V34, P427, DOI [10.1016/S0040816602000836, 10.1016/S0040-8166(02)00083-6]
   Creager MS, 2010, BIOMACROMOLECULES, V11, P2039, DOI 10.1021/bm100399x
   Dicko C, 2004, BIOCHEMISTRY-US, V43, P14080, DOI 10.1021/bi0483413
   Elices M, 2011, MACROMOLECULES, V44, P1166, DOI 10.1021/ma102291m
   Elices M, 2011, J MECH BEHAV BIOMED, V4, P658, DOI 10.1016/j.jmbbm.2010.09.008
   Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c
   FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325
   Fu CJ, 2009, MACROMOLECULES, V42, P7877, DOI 10.1021/ma901321k
   Fudge DS, 2009, INTEGR COMP BIOL, V49, P32, DOI 10.1093/icb/icp007
   Garrido MA, 2002, POLYMER, V43, P1537, DOI 10.1016/S0032-3861(01)00713-3
   Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v
   Guinea GV, 2010, BIOMACROMOLECULES, V11, P1174, DOI 10.1021/bm901285c
   HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841
   Herberstein ME, 2000, J ARACHNOL, V28, P180, DOI 10.1636/0161-8202(2000)028[0180:EOFTET]2.0.CO;2
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Lefevre T, 2011, J MOL BIOL, V405, P238, DOI 10.1016/j.jmb.2010.10.052
   Liao CP, 2009, BEHAV ECOL, V20, P1194, DOI 10.1093/beheco/arp119
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x
   Peng XN, 2005, BIOMACROMOLECULES, V6, P302, DOI 10.1021/bm049598j
   Rice S. H, 2004, EVOLUTIONARY THEORY
   Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217
   Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225
   Scoville AG, 2010, P NATL ACAD SCI USA, V107, P4260, DOI 10.1073/pnas.0912748107
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Sensenig AT, 2011, J ZOOL, V285, P28, DOI 10.1111/j.1469-7998.2011.00809.x
   Swanson BO, 2006, EVOLUTION, V60, P2539
   Tso IM, 2000, ZOOL STUD, V39, P236
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2011, SOFT MATTER, V7, P9595, DOI 10.1039/c1sm05812f
   Waite JH, 2012, J EXP BIOL, V215, P873, DOI 10.1242/jeb.058925
   WORK RW, 1985, J EXP BIOL, V118, P379
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
NR 52
TC 16
Z9 16
U1 1
U2 40
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD OCT 7
PY 2012
VL 9
IS 75
BP 2479
EP 2487
DI 10.1098/rsif.2012.0277
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 998LK
UT WOS:000308240400010
PM 22628213
OA Green Published
DA 2018-10-19
ER

PT J
AU Ungaro, F
   De Stefano, D
   Giovino, C
   Masuccio, A
   Miro, A
   Sorrentino, R
   Carnuccio, R
   Quaglia, F
AF Ungaro, Francesca
   De Stefano, Daniela
   Giovino, Concetta
   Masuccio, Alessia
   Miro, Agnese
   Sorrentino, Raffaella
   Carnuccio, Rosa
   Quaglia, Fabiana
TI PEI-Engineered Respirable Particles Delivering a Decoy Oligonucleotide
   to NF-kappa B: Inhibiting MUC2 Expression in LPS-Stimulated Airway
   Epithelial Cells
SO PLOS ONE
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; CONTROLLED-RELEASE;
   GENE-EXPRESSION; LUNG-DISEASE; DRUG-RELEASE; IN-VIVO; POLYETHYLENIMINE;
   MICROSPHERES; ACTIVATION
AB A specific and promising approach to limit inflammation and mucin iperproduction in chronic lung diseases relies on specific inhibition of nuclear Factor-kappa B (NF-kappa B) by a decoy oligonucleotide (dec-ODN). To fulfill the requirements dictated by translation of dec-ODN therapy in humans, inhalable dry powders were designed on a rational basis to provide drug protection, sustained release and to optimize pharmacological response. To this end, large porous particles (LPP) for dec-ODN delivery made of a sustained release biomaterial (poly(lactic-co-glycolic) acid, PLGA) and an "adjuvant'' hydrophilic polymer (polyethylenimine, PEI) were developed and their effects on LPS-stimulated human airway epithelial cells evaluated. The composite PLGA/PEI particles containing dec-ODN (i.e., LPPPEI) were successfully engineered for widespread deposition in the lung and prolonged release of intact dec-ODN in vitro. LPPPEI caused a prolonged inhibition of IL-8 and MUC2 expression in CF human bronchial epithelial cells and human epithelial pulmonary NCI-H292 cells, respectively, as compared to naked dec-ODN. Nonetheless, as compared to previously developed LPP, the presence of PEI was essential to construct a dec-ODN delivery system able to act in mucoepidermoid lung epithelial cells. In perspective, engineering LPP with PEI may become a key factor for tuning carrier properties, controlling lung inflammation and mucin production which, in turn, can foster in vivo translation of dec-ODN therapy.
C1 [Ungaro, Francesca; Giovino, Concetta; Miro, Agnese; Quaglia, Fabiana] Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, Naples, Italy.
   [De Stefano, Daniela; Masuccio, Alessia; Sorrentino, Raffaella; Carnuccio, Rosa] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy.
RP Ungaro, F (reprint author), Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, Naples, Italy.
EM ungaro@unina.it
RI Quaglia, Fabiana/I-9415-2012
OI Quaglia, Fabiana/0000-0001-6223-0782; SORRENTINO,
   RAFFAELLA/0000-0002-0284-5424; Ungaro, Francesca/0000-0003-0850-9533;
   Miro, Agnese/0000-0002-2255-8094
FU Fondazione per la Ricerca sulla Fibrosi Cistica-Onlus/Delegazione FFC
   del Lago di Garda [23/2011]
FX The work has been supported by Fondazione per la Ricerca sulla Fibrosi
   Cistica-Onlus/Delegazione FFC del Lago di Garda (Project FFC#23/2011).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; The financial
   support of Fondazione per la Ricerca sulla Fibrosi
   Cistica-Onlus/Delegazione FFC del Lago di Garda (FFC#23/2011) is
   gratefully acknowledged.
CR Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008
   Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117
   Berger JT, 1999, AM J RESP CELL MOL, V20, P500, DOI 10.1165/ajrcmb.20.3.3383
   Beyerle A, 2010, MOL PHARMACEUT, V7, P727, DOI 10.1021/mp900278x
   Beyerle A, 2009, TOXICOL IN VITRO, V23, P500, DOI 10.1016/j.tiv.2009.01.001
   Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107
   Bragonzi A., 2002, Current Gene Therapy, V2, P295, DOI 10.2174/1566523023347832
   Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939
   De Rosa G, 2003, BIOMACROMOLECULES, V4, P529, DOI 10.1021/bm025684c
   De Rosa G., 2008, HDB PARTICULATE DRUG, P61
   De Stefano D, 2011, J GENE MED, V13, P200, DOI 10.1002/jgm.1546
   DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865
   Edwards DA, 1998, J APPL PHYSIOL, V85, P379
   Egashira K, 2008, J GENE MED, V10, P805, DOI 10.1002/jgm.1192
   Ferrari N, 2011, FUTURE MED CHEM, V3, P1647, DOI [10.4155/FMC.11.108, 10.4155/fmc.11.108]
   Gambari R, 2010, BIOCHEM PHARMACOL, V80, P1887, DOI 10.1016/j.bcp.2010.06.047
   Gunther M, 2011, EUR J PHARM BIOPHARM, V77, P438, DOI 10.1016/j.ejpb.2010.11.007
   Hauber Hans-Peter, 2006, Can Respir J, V13, P327
   Heijerman H, 2009, J CYST FIBROS, V8, P295, DOI 10.1016/j.jcf.2009.04.005
   Helander IM, 1997, MICROBIOL-UK, V143, P3193, DOI 10.1099/00221287-143-10-3193
   Ibrahim BM, 2011, EXPERT OPIN DRUG DEL, V8, P451, DOI 10.1517/17425247.2011.561310
   Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010
   Khalil H, 2008, ANTIMICROB AGENTS CH, V52, P1635, DOI 10.1128/AAC.01071-07
   Lam JKW, 2012, ADV DRUG DELIVER REV, V64, P1, DOI 10.1016/j.addr.2011.02.006
   Lemaire V, 2003, INT J PHARM, V258, P95, DOI 10.1016/S0378-5173(03)00165-0
   Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718
   Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967
   Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005
   Patton JS, 2010, J AEROSOL MED PULM D, V23, pS71, DOI 10.1089/jamp.2010.0836
   Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038
   Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005
   Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011
   Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441
   Ungaro F, 2005, J DRUG DELIV SCI TEC, V15, P137, DOI 10.1016/S1773-2247(05)50018-2
   Ungaro F, 2003, J PHARMACEUT BIOMED, V31, P143, DOI 10.1016/S0731-7085(02)00571-X
   Ungaro F, 2012, J PHARM PHA IN PRESS
   Ungaro F, 2010, EUR J PHARM SCI, V41, P60, DOI 10.1016/j.ejps.2010.05.011
   Ungaro F, 2009, J CONTROL RELEASE, V135, P25, DOI 10.1016/j.jconrel.2008.12.011
   Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF
NR 39
TC 6
Z9 7
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 3
PY 2012
VL 7
IS 10
AR e46457
DI 10.1371/journal.pone.0046457
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 015NU
UT WOS:000309454000046
PM 23056313
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wei, Y
   Wang, YX
   Wang, W
   Ho, SV
   Qi, F
   Ma, GH
   Su, ZG
AF Wei, Yi
   Wang, Yu Xia
   Wang, Wei
   Ho, Sa V.
   Qi, Feng
   Ma, Guang Hui
   Su, Zhi Guo
TI Microcosmic Mechanisms for Protein Incomplete Release and Stability of
   Various Amphiphilic mPEG-PLA Microspheres
SO LANGMUIR
LA English
DT Article
ID HUMAN GROWTH-HORMONE; POLY-DL-LACTIDE-POLY(ETHYLENE GLYCOL)
   MICROSPHERES; QUARTZ-CRYSTAL MICROBALANCE; SUSTAINED-RELEASE; MEMBRANE
   EMULSIFICATION; PROCESS PARAMETERS; DELIVERY-SYSTEM; BIOMATERIAL; ACID);
   ENCAPSULATION
AB The microcosmic mechanisms of protein (recombinant human growth hormone, rhGH) incomplete release and stability from amphiphilic poly(monomethoxypolyethylene glycol-co-D,L-lactide) (mPEG-PLA, PELA) microspheres were investigated. PELA with different hydrophilicities (PELA-1, PELA-2, and PELA-3) based on various ratios of mPEG to PLA were employed to prepare microspheres exhibiting a narrow size distribution using a combined double emulsion and premix membrane emulsification method. The morphology, rhGH encapsulation efficiency, in vitro release profile, and rhGH stability of PELA microspheres during the release were characterized and compared in detail. It was found that increasing amounts of PLA enhanced the encapsulation efficiency of PELA microspheres but reduced both the release rate of rhGH and its stability. Contact angle, atomic force microscope (AFM), and quartz crystal microbalance with dissipation (QCM-D) techniques were first combined to elucidate the microcosmic mechanism of incomplete release by measuring the hydrophilicity of the PELA film and its interaction with rhGH. In addition, the pH change within the microsphere microenvironment was monitored by confocal laser scanning microscopy (CLSM) employing a pH-sensitive dye, which clarified the stability of rhGH during the release. These results suggested that PELA hydrophilicity played an important role in rhGH incomplete release and stability. Thus, the selection of suitable hydrophilic polymers with adequate PEG lengths is critical in the preparation of optimum protein drug sustained release systems. This present work is a first report elucidating the microcosmic mechanisms responsible for rhGH stability and its interaction with the microspheres. Importantly, this research demonstrated the application of promising new experimental methods in investigating the interaction between biomaterials and biomacromolecules, thus opening up a range of exciting potential applications in the biomedical field including drug delivery and tissue regeneration.
C1 [Wei, Yi; Wang, Yu Xia; Qi, Feng; Ma, Guang Hui; Su, Zhi Guo] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
   [Wei, Yi; Qi, Feng] Chinese Acad Sci, Grad Sch, Beijing 100190, Peoples R China.
   [Wang, Wei; Ho, Sa V.] Pfizer Inc, BioTherapeut R&D, Chesterfield, MO 63017 USA.
RP Wang, YX (reprint author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
EM yxwang@home.ipe.ac.cn; ghma@home.ipe.ac.cn
RI Qi, Feng/J-4625-2014; Su, Zhiguo/G-2422-2011
OI Qi, Feng/0000-0002-4632-4778; 
FU National Natural Science Foundation of China [20820102036]; 973 project
   [2009CB724700]
FX We thank Pfizer Inc. for kindly providing the material, and we are
   grateful for the financial support of the National Natural Science
   Foundation of China (20820102036) and the 973 project (2009CB724700).
CR Brodbeck KJ, 1999, PHARMACEUT RES, V16, P1825, DOI 10.1023/A:1018943107688
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CHEN ZP, 1995, CHEM MATER, V7, P1779, DOI 10.1021/cm00058a005
   Cleland JL, 1997, J CONTROL RELEASE, V49, P193, DOI 10.1016/S0168-3659(97)00075-8
   Cui F, 2005, J CONTROL RELEASE, V107, P310, DOI 10.1016/j.jconrel.2005.07.001
   Gasparini G, 2008, COLLOID SURFACE B, V61, P199, DOI 10.1016/j.colsurfb.2007.08.011
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Ibrahim MA, 2005, J CONTROL RELEASE, V106, P241, DOI 10.1016/j.jconrel.2005.02.025
   Kakizawa Y., J CONTROLLED RELEASE, V8-13
   KATAKAM M, 1995, J PHARM SCI, V84, P713, DOI 10.1002/jps.2600840609
   Kidchob T, 1998, J CONTROL RELEASE, V51, P241, DOI 10.1016/S0168-3659(97)00176-4
   Kim HK, 1999, BIOTECHNOL BIOENG, V65, P659, DOI 10.1002/(SICI)1097-0290(19991220)65:6<659::AID-BIT6>3.0.CO;2-9
   Kwok AY, 2004, CHEM MATER, V16, P5650, DOI 10.1021/cm040349b
   Lam XM, 2000, J CONTROL RELEASE, V67, P281, DOI 10.1016/S0168-3659(00)00224-8
   Langkamp M, 2008, GROWTH HORM IGF RES, V18, P526, DOI 10.1016/j.ghir.2008.04.007
   Lao J, 2008, CHEM MATER, V20, P4969, DOI 10.1021/cm800993s
   Li XH, 2000, J APPL POLYM SCI, V78, P140, DOI 10.1002/1097-4628(20001003)78:1<140::AID-APP180>3.0.CO;2-P
   Li XH, 1999, INT J PHARM, V178, P245, DOI 10.1016/S0378-5173(98)00379-2
   Li XH, 2000, J CONTROL RELEASE, V68, P41, DOI 10.1016/S0168-3659(00)00235-2
   Li XH, 2001, PHARMACEUT RES, V18, P117, DOI 10.1023/A:1011043230573
   Limson J, 2004, S AFR J SCI, V100, P678
   Liu Y, 2002, J CONTROL RELEASE, V83, P147, DOI 10.1016/S0168-3659(02)00176-1
   Mak WC, 2008, CHEM MATER, V20, P5475, DOI 10.1021/cm702254h
   Muller-Borer BJ, 1998, AM J PHYSIOL-HEART C, V275, pH1937, DOI 10.1152/ajpheart.1998.275.6.H1937
   Nagatomi Y, 2000, GROWTH HORM IGF RES, V10, P207, DOI 10.1054/ghir.2000.0156
   Ogata A, 1998, J NEUROL SCI, V159, P135, DOI 10.1016/S0022-510X(98)00150-6
   Phadtare S, 2003, CHEM MATER, V15, P1944, DOI 10.1021/cm020784a
   Prior S, 2000, INT J PHARM, V196, P115, DOI 10.1016/S0378-5173(99)00448-2
   Ruan G, 2003, BIOMATERIALS, V24, P5037, DOI 10.1016/S0142-9612(03)00419-8
   Ruan G, 2002, J CONTROL RELEASE, V84, P151, DOI 10.1016/S0168-3659(02)00292-4
   Tobio M, 1999, VACCINE, V18, P618, DOI 10.1016/S0264-410X(99)00313-8
   Wei Y, 2011, COLLOID SURFACE B, V87, P399, DOI 10.1016/j.colsurfb.2011.05.051
   WHITAKER JE, 1991, ANAL BIOCHEM, V194, P330, DOI 10.1016/0003-2697(91)90237-N
   Wong HM, 2001, IND ENG CHEM RES, V40, P933, DOI 10.1021/ie0006256
   WU SG, 1993, CHEM MATER, V5, P115, DOI 10.1021/cm00025a022
   Ye ML, 2010, J CONTROL RELEASE, V146, P241, DOI 10.1016/j.jconrel.2010.05.011
   Zhang JY, 2009, CHEM MATER, V21, P3996, DOI 10.1021/cm901371r
   Zhou SB, 2001, J CONTROL RELEASE, V75, P27, DOI 10.1016/S0168-3659(01)00379-0
NR 38
TC 16
Z9 16
U1 4
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 2
PY 2012
VL 28
IS 39
BP 13984
EP 13992
DI 10.1021/la3017112
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 015FF
UT WOS:000309431100029
PM 22937802
DA 2018-10-19
ER

PT J
AU Cholas, R
   Hsu, HP
   Spector, M
AF Cholas, Rahmatullah
   Hsu, Hu-Ping
   Spector, Myron
TI Collagen Scaffolds Incorporating Select Therapeutic Agents to Facilitate
   a Reparative Response in a Standardized Hemiresection Defect in the Rat
   Spinal Cord
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; SOLUBLE NOGO-66 RECEPTOR; ADULT-RAT; FUNCTIONAL
   RECOVERY; AXONAL REGENERATION; NEURAL STEM; NERVOUS-SYSTEM; NEURITE
   EXTENSION; SCAR FORMATION; CROSS-LINKING
AB A multifaceted therapeutic approach involving biomaterial scaffolds, neurotrophic factors, exogenous cells, and antagonists to axon growth inhibitors may ultimately prove necessary for the treatment of defects resulting from spinal cord injury (SCI). The objective of this study was to begin to lay the groundwork for such strategies by implanting type I collagen scaffolds alone and incorporating individually a soluble Nogo receptor, chondroitinase ABC (ChABC), and mesenchymal stem cells (MSCs) into a standardized 3-mm-long hemiresection defect in the rat spinal cord. Statistically significant improvement in hincllimb motor function between the first and fourth weeks post-SCI was recorded for the scaffold-alone group and for the ChABC and MSC groups, but not the control group. Four weeks post-SCI, the scaffolds appeared intact with open pores, which were infiltrated with host cells. Of note is that in some cases, a few growth-associated protein 43 (GAP-43)-positive axons were seen reaching the center of the scaffold in the scaffold-alone and ChABC groups, but not in control animals. Angiogenic cells were prevalent in the scaffolds; however, the number of both macrophages and angiogenic cells in the scaffolds was significantly less than in the control lesion at 4 weeks. The results lay the foundation for future dose response studies and to further investigate a range of therapeutic agents to enhance the regenerative response in SCI.
C1 [Cholas, Rahmatullah; Hsu, Hu-Ping; Spector, Myron] VA Boston Healthcare Syst, Tissue Engn Labs, Boston, MA 02130 USA.
   [Cholas, Rahmatullah] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Hsu, Hu-Ping; Spector, Myron] Harvard Univ, Sch Med, Dept Orthoped Surg, Brigham & Womens Hosp, Boston, MA 02115 USA.
RP Spector, M (reprint author), VA Boston Healthcare Syst, Tissue Engn Labs, Mail Stop 151,Res 150 S Huntington Ave, Boston, MA 02130 USA.
EM mspector@rics.bwh.harvard.edu
OI Spector, Myron/0000-0003-3328-4858
FU U.S. Department of Veterans Affairs; Veterans Health Administration;
   Rehabilitation Research and Development Service; Department of Defense;
   VA Research Career Scientist Award; Gates Millennium Scholars Program
FX The research reported here was supported by the U.S. Department of
   Veterans Affairs, Veterans Health Administration, Rehabilitation
   Research and Development Service, and the Department of Defense. MS was
   supported by a VA Research Career Scientist Award, and RC received a
   fellowship from the Gates Millennium Scholars Program. We thank Dr.
   Daniel Lee and Dr. Paul Weinreb at Biogen Idec for generously providing
   the soluble Nogo receptor. The authors are grateful to Larry Benowitz,
   Ph.D., for supplying the GAP-43 antibody.
CR Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Blesch A, 2003, J COMP NEUROL, V467, P403, DOI 10.1002/cne.10934
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014
   Buss A, 2005, BRAIN, V128, P356, DOI 10.1093/brain/awh355
   Cai J, 2007, J BIOMED MATER RES A, V83A, P512, DOI 10.1002/jbm.a.31296
   Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005
   Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001
   Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827
   Chamberlain L J, 1999, Methods Mol Med, V18, P3, DOI 10.1385/0-89603-516-6:3
   Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje
   Cholas R.H., 2011, THESIS MIT CAMBRIDGE
   Chou AK, 2005, MOL BRAIN RES, V133, P198, DOI 10.1016/j.molbrainres.2004.10.036
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   ECCLESTON PA, 1989, EXP CELL RES, V182, P173, DOI 10.1016/0014-4827(89)90289-9
   Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   FIRKINS SS, 1993, EXP NEUROL, V120, P1, DOI 10.1006/exnr.1993.1036
   Fitch MT, 1999, J NEUROSCI, V19, P8182
   Franzen R, 1999, NEUROREPORT, V10, P1551, DOI 10.1097/00001756-199905140-00029
   Fukunaga S, 2004, J ORTHOP SCI, V9, P605, DOI 10.1007/s00776-004-0833-0
   GELDERD JB, 1990, BRAIN RES, V511, P80, DOI 10.1016/0006-8993(90)90227-3
   Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006
   Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harvey PA, 2009, J NEUROSCI, V29, P6285, DOI 10.1523/JNEUROSCI.5885-08.2009
   Ji BX, 2005, EUR J NEUROSCI, V22, P587, DOI 10.1111/j.1460-9568.2005.04241.x
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335
   Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229
   Kostyk SK, 2008, NEUROSCIENCE, V156, P498, DOI 10.1016/j.neuroscience.2008.08.013
   Kuh SU, 2005, ACTA NEUROCHIR, V147, P985, DOI 10.1007/s00701-005-0538-y
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228
   LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0
   Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004
   Li WW, 2004, J BIOL CHEM, V279, P43780, DOI 10.1074/jbc.M401803200
   Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627
   Lopez-Vales R, 2006, NEUROBIOL DIS, V21, P57, DOI 10.1016/j.nbd.2005.06.011
   Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Ma W, 2008, TISSUE ENG PT A, V14, P1673, DOI 10.1089/ten.tea.2007.0357
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   MARCHAND R, 1990, NEUROSCIENCE, V36, P45, DOI 10.1016/0306-4522(90)90350-D
   Mastrogiacomo M, 2001, OSTEOARTHR CARTILAGE, V9, pS36, DOI 10.1053/joca.2001.0442
   MCGRATH MH, 1982, PLAST RECONSTR SURG, V69, P975, DOI 10.1097/00006534-198206000-00012
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S
   Quarto N, 2006, TISSUE ENG, V12, P1405, DOI 10.1089/ten.2006.12.1405
   Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591
   Rooney GE, 2009, TISSUE ENG PT A, V15, P3049, DOI [10.1089/ten.tea.2009.0045, 10.1089/ten.TEA.2009.0045]
   Ruitenberg MJ, 2005, BRAIN, V128, P839, DOI 10.1093/brain/awh424
   Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272
   Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360
   Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238
   Spilker MH, 2001, RESTOR NEUROL NEUROS, V18, P23
   Spilker MH, 1997, TISSUE ENG, V3, P309, DOI 10.1089/ten.1997.3.309
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Suzuki Y, 2002, NEUROSCI LETT, V318, P121, DOI 10.1016/S0304-3940(01)02359-X
   Takahashi K, 1999, J COMP NEUROL, V404, P159, DOI 10.1002/(SICI)1096-9861(19990208)404:2<159::AID-CNE2>3.0.CO;2-E
   TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   Vacanti MP, 2001, TRANSPLANT P, V33, P592, DOI 10.1016/S0041-1345(00)02158-8
   Watanabe K, 2007, RESTOR NEUROL NEUROS, V25, P109
   Weinreb PH, 2010, BIOTECHNOL APPL BIOC, V57, P31, DOI 10.1042/BA20100061
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7
   Yin YQ, 2003, J NEUROSCI, V23, P2284
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Zukor K, 2011, NATURE, V475, P178, DOI 10.1038/475178a
NR 82
TC 20
Z9 22
U1 0
U2 12
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD OCT
PY 2012
VL 18
IS 19-20
BP 2158
EP 2172
DI 10.1089/ten.tea.2011.0577
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 024OM
UT WOS:000310118500022
PM 22827732
DA 2018-10-19
ER

PT J
AU Wang, XT
   Boire, TC
   Bronikowski, C
   Zachman, AL
   Crowder, SW
   Sung, HJ
AF Wang, Xintong
   Boire, Timothy C.
   Bronikowski, Christine
   Zachman, Angela L.
   Crowder, Spencer W.
   Sung, Hak-Joon
TI Decoupling Polymer Properties to Elucidate Mechanisms Governing Cell
   Behavior
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; POLY(ETHYLENE GLYCOL)
   HYDROGELS; ESTER) NETWORK PROPERTIES; CROSS-LINKING DENSITY;
   EXTRACELLULAR-MATRIX; MOLECULAR-WEIGHT; FOCAL ADHESIONS; GROWTH-FACTOR;
   MESH SIZE
AB Determining how a biomaterial interacts with cells ("structure-function relationship'') reflects its eventual clinical applicability. Therefore, a fundamental understanding of how individual material properties modulate cell-biomaterial interactions is pivotal to improving the efficacy and safety of clinically translatable biomaterial systems. However, due to the coupled nature of material properties, their individual effects on cellular responses are difficult to understand. Structure-function relationships can be more clearly understood by the effective decoupling of each individual parameter. In this article, we discuss three basic decoupling strategies: (1) surface modification, (2) cross-linking, and (3) combinatorial approaches (i.e., copolymerization and polymer blending). Relevant examples of coupled material properties are briefly reviewed in each section to highlight the need for improved decoupling methods. This follows with examples of more effective decoupling techniques, mainly from the perspective of three primary classes of synthetic materials: polyesters, polyethylene glycol, and polyacrylamide. Recent strides in decoupling methodologies, especially surface-patterning and combinatorial techniques, offer much promise in further understanding the structure-function relationships that largely govern the success of future advancements in biomaterials, tissue engineering, and drug delivery.
C1 [Wang, Xintong; Boire, Timothy C.; Bronikowski, Christine; Zachman, Angela L.; Crowder, Spencer W.; Sung, Hak-Joon] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.
RP Sung, HJ (reprint author), Vanderbilt Univ, Dept Biomed Engn, VU Stn B 351631,2301 Vanderbilt Pl, Nashville, TN 37235 USA.
EM hak-joon.sung@vanderbilt.edu
RI Wang, Xintong/I-8169-2013
FU National Science Foundation [NSF CAREER CBET 1056046, NSF DMR 1006558];
   National Institutes of Health [NIH HL091465]
FX The authors acknowledge grant supports from the National Science
   Foundation (NSF CAREER CBET 1056046, NSF DMR 1006558) and the National
   Institutes of Health (NIH HL091465).
CR Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Aplin AE, 1998, PHARMACOL REV, V50, P197
   Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881
   Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4
   BRANDLEY BK, 1987, J BIOL CHEM, V262, P6431
   Brey DM, 2008, J BIOMED MATER RES A, V85A, P731, DOI 10.1002/jbm.a.31494
   Brey DM, 2008, ACTA BIOMATER, V4, P207, DOI 10.1016/j.actbio.2007.10.002
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Browning MB, 2011, J BIOMED MATER RES A, V98A, P268, DOI 10.1002/jbm.a.33109
   Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Buxton AN, 2007, TISSUE ENG, V13, P2549, DOI 10.1089/ten.2007.0075
   Byers BA, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P541, DOI 10.1007/978-3-7091-0385-2_19
   Cai L, 2010, POLYMER, V51, P164, DOI 10.1016/j.polymer.2009.11.042
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cha C, 2011, ACTA BIOMATER, V7, P3719, DOI 10.1016/j.actbio.2011.06.017
   Cha C, 2009, ADV FUNCT MATER, V19, P3056, DOI 10.1002/adfm.200900865
   Chatterjee K, 2011, BIOMATERIALS, V32, P1361, DOI 10.1016/j.biomaterials.2010.10.043
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   Chong MSK, 2009, BIOMATERIALS, V30, P2241, DOI 10.1016/j.biomaterials.2008.12.056
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   Dey T, 2011, BIOCHEM BIOPH RES CO, V413, P541, DOI 10.1016/j.bbrc.2011.08.133
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dolatshahi-Pirouz Alireza, 2011, J Funct Biomater, V2, P88, DOI 10.3390/jfb2030088
   DUNN GA, 1986, J CELL SCI, V83, P313
   Eltoukhy AA, 2012, BIOMATERIALS, V33, P3594, DOI 10.1016/j.biomaterials.2012.01.046
   Engelhardt EM, 2011, BIOMATERIALS, V32, P3969, DOI 10.1016/j.biomaterials.2011.02.012
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fozdar DY, 2008, BIOMED MICRODEVICES, V10, P839, DOI 10.1007/s10544-008-9198-z
   Frisman I, 2011, BIOMATERIALS, V32, P7839, DOI 10.1016/j.biomaterials.2011.06.078
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Gonen-Wadmany M, 2011, BIOMATERIALS, V32, P6025, DOI 10.1016/j.biomaterials.2011.04.055
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Gribova V, 2011, J MATER CHEM, V21, P14354, DOI 10.1039/c1jm11372k
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Gupta MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028935
   Han JJ, 2011, BIOMACROMOLECULES, V12, P399, DOI 10.1021/bm101149r
   Hasirci N, 2010, SURF INTERFACE ANAL, V42, P486, DOI 10.1002/sia.3247
   He W, 2009, J BIOMED MATER RES A, V90A, P205, DOI 10.1002/jbm.a.32081
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Holle AW, 2011, CURR OPIN BIOTECH, V22, P648, DOI 10.1016/j.copbio.2011.04.007
   Hsiong SX, 2008, J BIOMED MATER RES A, V85A, P145, DOI 10.1002/jbm.a.31521
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Jose MV, 2009, POLYMER, V50, P3778, DOI 10.1016/j.polymer.2009.05.035
   Joy A, 2011, LANGMUIR, V27, P1891, DOI 10.1021/la103722m
   Karakecili A, 2007, J MATER SCI-MATER M, V18, P317, DOI 10.1007/s10856-006-0695-4
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Le DM, 2011, ADV MATER, V23, P3278, DOI 10.1002/adma.201100821
   Lee HJ, 2011, ACTA BIOMATER, V7, P1281, DOI 10.1016/j.actbio.2010.11.006
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Liu JJ, 2011, J BIOMED MATER RES A, V96A, P13, DOI 10.1002/jbm.a.32946
   Marquardt L, 2011, J BIOMED MATER RES A, V98A, P1, DOI 10.1002/jbm.a.33044
   MATSUOKA M, 1990, BRAIN RES, V507, P351, DOI 10.1016/0006-8993(90)90297-O
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   Metter RB, 2010, ACTA BIOMATER, V6, P1219, DOI 10.1016/j.actbio.2009.10.027
   Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1
   Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114
   Munoz-Pinto DJ, 2009, J BIOMED MATER RES A, V90A, P303, DOI 10.1002/jbm.a.32492
   Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peters A, 2009, TISSUE ENG PART B-RE, V15, P225, DOI [10.1089/ten.teb.2009.0049, 10.1089/ten.TEB.2009.0049]
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473
   Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Russell SM, 2005, IND ENG CHEM RES, V44, P8213, DOI 10.1021/ie050079m
   Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Scott RA, 2011, ACTA BIOMATER, V7, P3841, DOI 10.1016/j.actbio.2011.06.054
   Serrano MC, 2009, ACTA BIOMATER, V5, P2045, DOI 10.1016/j.actbio.2009.02.034
   Serrano MC, 2005, MACROMOL BIOSCI, V5, P415, DOI 10.1002/mabi.200400214
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Skornia SL, 2007, J APPL BIOMATER BIOM, V5, P176
   Spokoyny AM, 2009, CHEM SOC REV, V38, P1218, DOI 10.1039/b807085g
   Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004
   Sung FJ, 2005, BIOMATERIALS, V26, P4557, DOI 10.1016/j.biomaterials.2004.11.034
   Tae G, 2006, J BIOMAT SCI-POLYM E, V17, P187, DOI 10.1163/156856206774879090
   Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215
   Temenoff J.S., 2008, BIOMATERIALS INTERSE
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Ueda M, 1998, BIOPHYS CHEM, V71, P113, DOI 10.1016/S0301-4622(98)00093-3
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wan Yuqing, 2004, Biomaterials, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
   Webster DC, 2010, ADV POLYM SCI, V225, P1, DOI 10.1007/12_2009_15
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yang IH, 2011, J BIOMED MATER RES A, V97A, P451, DOI 10.1002/jbm.a.33082
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Zajac AL, 2008, CURR OPIN CELL BIOL, V20, P609, DOI 10.1016/j.ceb.2008.09.006
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P984, DOI 10.1002/jbm.a.32504
   Zhu AP, 2006, BIOMATERIALS, V27, P2566, DOI 10.1016/j.biomaterials.2005.11.039
   Zhu YB, 2005, J BIOMED MATER RES B, V75B, P193, DOI 10.1002/jbm.b.30305
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
   Zimerman B, 2004, IEE Proc Nanobiotechnol, V151, P62, DOI 10.1049/ip-nbt:20040474
   Zustiak SP, 2010, ACTA BIOMATER, V6, P3404, DOI 10.1016/j.actbio.2010.03.040
NR 122
TC 9
Z9 9
U1 0
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD OCT
PY 2012
VL 18
IS 5
BP 396
EP 404
DI 10.1089/ten.teb.2012.0011
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 016KI
UT WOS:000309516500005
PM 22536977
OA Green Published
DA 2018-10-19
ER

PT J
AU Mirfazaelian, H
   Nikfar, S
   Derakhshani, S
   Abdollahi, M
AF Mirfazaelian, Hadi
   Nikfar, Shekoufeh
   Derakhshani, Saeed
   Abdollahi, Mohammad
TI Efficacy and Incontinence Rate of Biomaterials (Fibrin Glue and Fibrin
   Plug) in Comparison to Surgical Interventions in the Treatment of
   Perianal Fistula: A Systematic Review and Meta-analysis of Randomized,
   Controlled Trials
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Fistula; biomaterial; fibrin glue; fibrin plug; systematic review;
   meta-analysis
ID ANAL FISTULA; IN-ANO; CROHNS-DISEASE; ADVANCEMENT FLAP; CLINICAL-TRIAL;
   CONVENTIONAL TREATMENT; ANTIBIOTICS; SEALANT; PLACEBO; CLOSURE
AB Anal fistula is an abnormal connection between the anal or rectal lumen and perianal skin that reduce quality of life. There are various surgical options for treatment with variable success rate. A novel treatment is to seal the fistula tract using biomaterials (fibrin glue and fibrin plug). Objective of this study was to evaluate the healing efficacy and incontinence rate of biomaterials (fibrin glue and fibrin plug) in comparison to surgical interventions in the treatment of cryptoglandular perianal fistula using meta-analysis of randomized controlled trials. PubMed, Scopus, Google Scholar and Web of Science were searched for clinical trial studies investigated the effects of biomaterials in the treatment of fistula-in-ano. Studies on patient with anal fistulae underwent fibrin glue, fibrin plug or other biomaterials application and surgical management for healing of fistula were included. Clinical response and incontinence were the key outcomes of interest. Six randomized placebo-controlled clinical trials consisting 315 patients in various arms met our criteria (comparing biomaterial with surgical interventions) and were included in the analysis. Pooling of data showed that effectiveness of biomaterials in comparison to surgical interventions was non-significant with relative risk (RR) of 0.73 (95% CI of 0.31-0.89, p = 0.096). The incontinence rate RR in biomaterials and intervention was also non significant with RR of 0.35 (95% CI = 0.05-2.28, p = 0.27). The included clinical trials had different follow-up durations, causes of fistula and method of intervention in treated patients. This meta-analysis demonstrates that the effectiveness and incontinence rate of biomaterials and conservative treatment is not significantly different.
C1 [Mirfazaelian, Hadi] Univ Tehran Med Sci, Sch Med, Dept Emergency Med, Tehran, Iran.
   [Nikfar, Shekoufeh] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacoecon & Pharmaceut Adm, Tehran, Iran.
   [Nikfar, Shekoufeh] Food & Drug Org, Food & Drug Lab Res Ctr, Tehran, Iran.
   [Derakhshani, Saeed] Parsian Hosp, Dept Colorectal Surg, Tehran, Iran.
   [Abdollahi, Mohammad] Univ Tehran Med Sci, Fac Pharm, Tehran, Iran.
   [Abdollahi, Mohammad] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran, Iran.
RP Abdollahi, M (reprint author), Univ Tehran Med Sci, Fac Pharm, Tehran, Iran.
RI Abdollahi, Mohammad/B-9232-2008; Mirfazaelian, Hadi/J-9317-2017
OI Abdollahi, Mohammad/0000-0003-0123-1209; Mirfazaelian,
   Hadi/0000-0001-9299-8928
CR Altomare DF, 2011, COLORECTAL DIS, V13, P82, DOI 10.1111/j.1463-1318.2009.02056.x
   Ba-bai-ke-re MMTJA, 2010, WORLD J GASTROENTERO, V16, P3279, DOI 10.3748/wjg.v16.i26.3279
   Buchanan GN, 2003, DIS COLON RECTUM, V46, P1167, DOI 10.1097/01.DCR.0000084408.85802.A2
   Chung W, 2009, AM J SURG, V197, P604, DOI 10.1016/j.amjsurg.2008.12.013
   Cirocchi R, 2010, ANN ITAL CHIR, V81, P349
   Cirocchi Roberto, 2009, Ann Surg Innov Res, V3, P12, DOI 10.1186/1750-1164-3-12
   Ellis CN, 2006, DIS COLON RECTUM, V49, P1736, DOI 10.1007/s10350-006-0718-8
   Garcia-Aguilar J, 2000, DIS COLON RECTUM, V43, P1206, DOI 10.1007/BF02237422
   Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487
   Garg P, 2009, COLORECTAL DIS, V11, P588, DOI 10.1111/j.1463-1318.2008.01632.x
   Jadad A, 1998, RANDOMISED CONTROLLE
   Johnson EK, 2006, DIS COLON RECTUM, V49, P371, DOI 10.1007/s10350-005-0288-1
   Lindsey I, 2002, DIS COLON RECTUM, V45, P1608, DOI 10.1097/01.DCR.0000034622.59957.55
   Nikfar S, 2011, INT J PHARMACOL, V7, P325, DOI 10.3923/ijp.2011.325.332
   Nikfar S, 2010, CURR PHARM DESIGN, V16, P3684, DOI 10.2174/138161210794079236
   O'Riordan JM, 2012, DIS COLON RECTUM, V55, P351, DOI 10.1097/DCR.0b013e318239d1e4
   Ortiz H, 2009, BRIT J SURG, V96, P608, DOI 10.1002/bjs.6613
   PARKS AG, 1961, BRIT MED J, V1, P463, DOI 10.1136/bmj.1.5224.463
   Rahimi R, 2007, BIOMED PHARMACOTHER, V61, P75, DOI 10.1016/j.biopha.2006.06.022
   Rahimi R, 2006, CLIN THER, V28, P1983, DOI 10.1016/j.clinthera.2006.12.012
   Rezaie A, 2005, INT J PHARMACEUT, V1, P17
   Rezaie A, 2006, ANN NY ACAD SCI, V1091, P110, DOI 10.1196/annals.1378.060
   Singer M, 2005, DIS COLON RECTUM, V48, P799, DOI 10.1007/s10350-004-0898-z
   van der Hagen SJ, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/186350
   van Koperen PJ, 2008, INT J COLORECTAL DIS, V23, P697, DOI 10.1007/s00384-008-0460-x
   van Koperen PJ, 2011, DIS COLON RECTUM, V54, P387, DOI 10.1007/DCR.0b013e318206043e
   Zmora O, 2003, DIS COLON RECTUM, V46, P584, DOI 10.1097/01.DCR.0000064697.21308.37
NR 27
TC 0
Z9 0
U1 0
U2 3
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PD OCT 1
PY 2012
VL 8
IS 7
BP 621
EP 627
DI 10.3923/ijp.2012.621.627
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 117UB
UT WOS:000316977500003
OA Bronze
DA 2018-10-19
ER

PT J
AU Wang, MM
   Zhang, FJ
   Qian, XQ
   Zhao, X
AF Wang, Mengmeng
   Zhang, Fengju
   Qian, Xiuqing
   Zhao, Xu
TI Regional Biomechanical Properties of Human Sclera After Cross-linking by
   Riboflavin/Ultraviolet A
SO JOURNAL OF REFRACTIVE SURGERY
LA English
DT Article
ID ULTRAVIOLET-A LIGHT; REINFORCEMENT MATERIALS; RIBOFLAVIN; COLLAGEN;
   RABBIT; UVA; KERATOCONUS; CORNEAS; SAFETY; MYOPIA
AB PURPOSE: To evaluate the biomechanical difference of human scleral collagen cross-linking (CXL) by comparing different riboflavin-instilling methods and different crosslinked regions (equatorial and posterior sclera).
   METHODS: Fifteen donor human eyes were randomly divided into five groups. One group, in which CXL was not applied, was designated as the control group. In the remaining four groups, 0.1% riboflavin solution was instilled on the scleral surface for 5, 10, 20, or 30 minutes, respectively, followed by 30 minutes of ultraviolet A irradiation. The equatorial and posterior scleral strips in each eye were dissected. Stress-strain measurements of all scleral strips were performed by a biomaterial tester. Young modulus was calculated at 8% strain. Data of the stress and Young modulus in different regions and groups were compared using one-way analysis of variance.
   RESULTS: Under a 1 mm/minute stretching, the sclera exhibited an exponential stress-strain behavior. The stress and modulus of equatorial and posterior sclera after CXL gradually increased with riboflavin instillation before surgery. No statistical difference was noted in the modulus between 20 and 30 minutes riboflavin infiltration after CXL (P >.05). At the same strain levels, equatorial sclera with and without CXL exhibited higher stress and Young modulus than that of posterior sclera.
   CONCLUSIONS: Equatorial and posterior human sclera may be enhanced by CXL with riboflavin/ultraviolet A irradiation. Equatorial scleral CXL may be a good choice for the treatment of progressive myopia. Because of its safety and efficacy, 20 minutes of riboflavin infiltration before CXL is recommended. [J Refract Surg. 2012;28(10):723-728.] doi:10.3928/1081597X-20120921-08
C1 [Wang, Mengmeng; Zhang, Fengju; Zhao, Xu] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing 100730, Peoples R China.
   [Qian, Xiuqing] Capital Med Univ, Sch Biomed Engn, Beijing 100730, Peoples R China.
RP Zhang, FJ (reprint author), Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, 1 Dongjiaomin Xiang, Beijing 100730, Peoples R China.
EM fjz269@yahoo.com
FU National Natural Science Foundation of China [81070763]
FX This work is supported by a grant from the National Natural Science
   Foundation of China (no. 81070763).
CR Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618
   Curtin B J, 1969, Trans Am Ophthalmol Soc, V67, P417
   Downs JC, 2003, J BIOMECH ENG-T ASME, V125, P124, DOI 10.1115/1.1536930
   Elsheikh A, 2010, EXP EYE RES, V90, P624, DOI 10.1016/j.exer.2010.02.010
   Iseli HP, 2008, J REFRACT SURG, V24, pS752
   Jacob JT, 1996, J BIOMED MATER RES, V32, P181, DOI 10.1002/(SICI)1097-4636(199610)32:2<181::AID-JBM5>3.0.CO;2-P
   Jacob JT, 1997, J BIOMED MATER RES, V37, P525, DOI 10.1002/(SICI)1097-4636(19971215)37:4<525::AID-JBM11>3.0.CO;2-7
   Jung GB, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3662458
   Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092
   McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0
   Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039
   Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410
   Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78
   Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Wollensak G, 2009, ACTA OPHTHALMOL, V87, P193, DOI 10.1111/j.1755-3768.2008.01229.x
   Xu Y, 1996, Zhonghua Yan Ke Za Zhi, V32, P38
NR 19
TC 14
Z9 21
U1 2
U2 13
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 1081-597X
J9 J REFRACT SURG
JI J. Refractive Surg.
PD OCT
PY 2012
VL 28
IS 10
BP 723
EP 728
DI 10.3928/1081597X-20120921-08
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 084DB
UT WOS:000314515700010
PM 23062003
DA 2018-10-19
ER

PT J
AU Mattei, G
   Tirella, A
   Ahluwalia, A
AF Mattei, G.
   Tirella, A.
   Ahluwalia, A.
TI Functionally Graded Materials (FGMs) with Predictable and Controlled
   Gradient Profiles: Computational Modelling and Realisation
SO CMES-COMPUTER MODELING IN ENGINEERING & SCIENCES
LA English
DT Article
DE Functionally graded materials; computational modelling; sedimentation;
   tissue engineering; scaffold
ID HYDROXYAPATITE CERAMICS; ARTICULAR-CARTILAGE; OPTIMAL-DESIGN; GRANULAR
   FLOW; SCAFFOLD; DEPOSITION; POROSITY; BONE; SEDIMENTATION; FLUIDIZATION
AB Biological function is intricately linked with structure. Many biological structures are characterised by functional spatially distributed gradients in which each layer has one or more specific functions to perform. Reproducing such structures is challenging, and usually an experimental trial-and-error approach is used. In this paper We investigate how the gravitational sedimentation of discrete solid particles (secondary phase) within a primary fluid phase with a time-varying dynamic viscosity can be used for the realisation of stable and reproducible continuous functionally graded materials (FGMs). Computational models were used to simulate the distribution of a particle phase in a fluid domain. Firstly a model of particle sedimentation was implemented in order to predict the particle gradient profiles. Then the fluid domain was modelled as phase with time dependent viscosity. Experiments were then used to validate the computational results. The models show that selected composition gradients can be tailored by controlling fluid and particle properties. Using this method the gradient of a custom two-phase system can be designed and tailored in a simple fashion. Moreover this approach can also be employed for the fabrication of porous structures, using a porogen as settling particle. The method is particularly useful in tissue engineering applications, to first predict and then control biomaterial gradients without the use of complicated rapid prototyping or computer aided manufacturing systems.
C1 [Mattei, G.; Tirella, A.; Ahluwalia, A.] Univ Pisa, Dept Chem Engn Ind Chem & Mat Sci, Fac Engn, I-56126 Pisa, Italy.
   [Mattei, G.; Tirella, A.; Ahluwalia, A.] Univ Pisa, Interdept Res Ctr E Piaggio, Fac Engn, I-56126 Pisa, Italy.
RP Mattei, G (reprint author), Univ Pisa, Dept Chem Engn Ind Chem & Mat Sci, Fac Engn, Via Diotisalvi 2, I-56126 Pisa, Italy.
OI Tirella, Annalisa/0000-0002-3743-3593; Ahluwalia,
   Arti/0000-0001-5370-6750; Mattei, Giorgio/0000-0003-0441-9653
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   BATCHELOR GK, 1972, J FLUID MECH, V52, P245, DOI 10.1017/S0022112072001399
   Dalla Valle J., 1948, MICROMERITICS
   DING J, 1990, AICHE J, V36, P523, DOI 10.1002/aic.690360404
   Dullien F. A. L., 1992, POROUS MEDIA FLUID T
   Fels I. G., 1964, J APPL POLYM SCI, V8, P1813
   Ford R., 1999, FUNCTIONALLY GRADED, P7
   GARSIDE J, 1977, IND ENG CHEM PROC DD, V16, P206, DOI 10.1021/i260062a008
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutchmacher D.W., 2007, J CELL MOL MED, V11, P654, DOI DOI 10.1111/J.1582-4934.2007.00078.X
   Kalita SJ, 2003, MAT SCI ENG C-BIO S, V23, P611, DOI 10.1016/S0928-4931(03)00052-3
   Klein TJ, 2007, J BIOMECH, V40, P182, DOI 10.1016/j.jbiomech.2005.11.002
   LUN CKK, 1984, J FLUID MECH, V140, P223, DOI 10.1017/S0022112084000586
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   OGAWA S, 1980, Z ANGEW MATH PHYS, V31, P483, DOI 10.1007/BF01590859
   Richardson J.F., 1954, T I CHEM ENG-LOND, V32, P35
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Smith MH, 2007, INT J MED ROBOT COMP, V3, P207, DOI 10.1002/rcs.143
   Song C, 2008, NATURE, V453, P629, DOI 10.1038/nature06981
   Sun T, 2007, J MATER SCI-MATER M, V18, P321, DOI 10.1007/s10856-006-0696-3
   Syamlal M., 1987, DOEMC213532373 NAT T
   Syamlal M., 1989, AICHE S SER 270, P22
   Syamlal M., 1993, DOEMETC9411004 NAT T
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Tirella A, 2011, TISSUE ENG PART C-ME, V17, P229, DOI [10.1089/ten.tec.2010.0195, 10.1089/ten.TEC.2010.0195]
   Van Cleynenbreugel T, 2002, J MATER SCI-MATER M, V13, P1245, DOI 10.1023/A:1021183230549
   Vozzi G, 2007, J MATER CHEM, V17, P1248, DOI 10.1039/b613511k
   Werner J, 2002, BIOMATERIALS, V23, P4285, DOI 10.1016/S0142-9612(02)00191-6
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Zeschky J, 2005, ACTA MATER, V53, P927, DOI 10.1016/j.actamat.2004.10.039
NR 32
TC 7
Z9 8
U1 1
U2 13
PU TECH SCIENCE PRESS
PI NORCROSS
PA 6825 JIMMY CARTER BLVD, STE 1850, NORCROSS, GA 30071 USA
SN 1526-1492
J9 CMES-COMP MODEL ENG
JI CMES-Comp. Model. Eng. Sci.
PD OCT
PY 2012
VL 87
IS 6
BP 483
EP 503
PG 21
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
SC Engineering; Mathematics
GA 068YV
UT WOS:000313403000002
DA 2018-10-19
ER

PT J
AU Khanna, R
   Katti, DR
   Katti, KS
AF Khanna, R.
   Katti, D. R.
   Katti, K. S.
TI AFM and Nanoindentation Studies of Bone Nodules on
   Chitosan-Polygalacturonic Acid-Hydroxyapatite Nanocomposites
SO CMES-COMPUTER MODELING IN ENGINEERING & SCIENCES
LA English
DT Article
DE nanoindentation; mechanical behavior; cell-substrate indentation; tissue
   engineering
ID FILM MECHANICAL-PROPERTIES; ATOMIC-FORCE MICROSCOPY; VISCOELASTIC
   PROPERTIES; STEM-CELLS; NANOMECHANICAL PROPERTIES; COLLAGEN FIBRILS;
   ELASTIC-MODULUS; YEAST-CELLS; TISSUE; BIOMATERIALS
AB Here we report a new in situ nanoindentation technique developed to evaluate the composite mechanical behavior of cell-biomaterial construct under physiological conditions over the time scale of bone nodule generation. Using this technique, mechanical behavior of osteoblast cell-substrate interfaces on tissue engineered materials (chitosan-polygalacturonic acid-nanohydroxyapatite (CPH) films) is investigated. Mechanical behavior of cells in the elastic regime over the time scale of cell adhesion (1 day), proliferation (4 days), development (8 days) and maturation (22 days) of bone nodules is evaluated. Our results indicate that the elastic properties of flat cells are higher (indicating stiffer response, after 4 days, as compared to the round cells after 1 day and oriented cells after 8 days. Elastic properties of cells (similar to 5-12 MPa), soaked CPH films (similar to 10-20 MPa) and that of cell-CPH composites (similar to 3-9 MPa) fall in the same order of magnitude. A similar range of elastic properties of cell-CPH composites are measured over time, implying that unique interactions between cells and CPH films are maintained that may provide a favorable mechanical environment to growing cells and bone nodules. Atomic Force Microscopy (AFM) imaging studies on individual cells reveal that the cells respond to local changes in substrate topography (as a result of substrate swelling) by modulating their shapes and various focal adhesions. Overall, CPH films provide a favorable microenvironment for cell organization and bone nodule regeneration that regulates the mechanical behavior of cell-substrate interactions.
C1 [Khanna, R.; Katti, D. R.; Katti, K. S.] N Dakota State Univ, Dept Civil Engn, Fargo, ND 58105 USA.
RP Khanna, R (reprint author), Chubu Univ, Coll Life & Hlth Sci JSPS Fellow, Dept Biomed Sci, Kasugai, Aichi 487, Japan.
RI KHANNA, ROHIT/A-6652-2011
FU NSF
FX Authors would like to acknowledge support from ND EPSCoR for tissue
   culture laboratory facilities. Additionally, author RK would like to
   acknowledge assistantship from NDSU graduate school. The nanoindentation
   and atomic force microscopy equipment used was obtained through NSF
   Instrumentation for Materials Research grant.
CR Abrahamsson CK, 2010, TISSUE ENG PT A, V16, P3709, DOI [10.1089/ten.tea.2010.0190, 10.1089/ten.TEA.2010.0190]
   Ahearne M, 2005, J R SOC INTERFACE, V2, P455, DOI 10.1098/rsif.2005.0065
   Allan S. H., 2002, ADV DRUG DELIVERY RE, V54, P3
   Ambre A, 2011, MAT SCI ENG C-MATER, V31, P1017, DOI 10.1016/j.msec.2011.03.001
   Arfsten J, 2008, J MATER RES, V23, P3153, DOI 10.1557/JMR.2008.0383
   Balland M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021911
   Balooch M, 2008, J STRUCT BIOL, V162, P404, DOI 10.1016/j.jsb.2008.02.010
   Banwell EF, 2009, NAT MATER, V8, P596, DOI [10.1038/nmat2479, 10.1038/NMAT2479]
   Basu S, 2007, J MATER RES, V22, P2470, DOI 10.1557/JMR.2007.0305
   CROLET JM, 1993, J BIOMECH, V26, P677, DOI 10.1016/0021-9290(93)90031-9
   Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105
   Ebenstein DM, 2004, J BIOMED MATER RES A, V69A, P222, DOI 10.1002/jbm.a.20096
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   Eberhardsteiner L, 2014, COMPUT METHOD BIOMEC, V17, P48, DOI 10.1080/10255842.2012.670227
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Fritsch A, 2007, J THEOR BIOL, V244, P597, DOI 10.1016/j.jtbi.2006.09.013
   Fritsch A, 2009, J THEOR BIOL, V260, P230, DOI 10.1016/j.jtbi.2009.05.021
   Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hellmich C, 2004, EUR J MECH A-SOLID, V23, P783, DOI 10.1016/j.euromechsol.2004.05.004
   Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333
   Katti DR, 2010, J BIOMECH, V43, P1723, DOI 10.1016/j.jbiomech.2010.02.027
   Katti K.S., 2006, AM J BIOCH BIOTECHNO, V2, P73, DOI DOI 10.3844/AJBBSP.2006.73.79
   Katti KS, 2010, PHILOS T R SOC A, V368, P1963, DOI 10.1098/rsta.2010.0008
   Katti KS, 2006, J MATER RES, V21, P1237, DOI 10.1557/JMR.2006.0147
   Khanna R., 2011, ASME J NANO IN PRESS
   Khanna R, 2010, INT J POLYM SCI, DOI 10.1155/2010/175264
   Khanna R, 2011, ACTA BIOMATER, V7, P1173, DOI 10.1016/j.actbio.2010.10.028
   Khanna R, 2009, J ENG MECH, V135, P468, DOI 10.1061/(ASCE)EM.1943-7889.0000002
   Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9
   Mashmoushy H, 1998, BIOTECHNOL TECH, V12, P925, DOI 10.1023/A:1008825830928
   Mohanty B, 2006, J MATER RES, V21, P2045, DOI 10.1557/JMR.2006.0247
   Ng L, 2007, J BIOMECH, V40, P1011, DOI 10.1016/j.jbiomech.2006.04.004
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Oliver WC, 2010, MRS BULL, V35, P897, DOI 10.1557/mrs2010.717
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Pagliari S, 2011, ADV MATER, V23, P514, DOI 10.1002/adma.201003479
   Park S, 2009, P I MECH ENG H, V223, P339, DOI 10.1243/09544119JEIM516
   PHARR GM, 1992, MRS BULL, V17, P28, DOI 10.1557/S0883769400041634
   Pidaparti RMV, 1996, J BIOMECH, V29, P909, DOI 10.1016/0021-9290(95)00147-6
   Pradhan S., 2012, ASCE J ENG IN PRESS
   Pradhan SM, 2011, J NANOMECHANICS MICR, V1, P104, DOI 10.1061/(ASCE)NM.2153-5477.0000035
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5
   Roy ME, 1999, J BIOMED MATER RES, V44, P191, DOI 10.1002/(SICI)1097-4636(199902)44:2<191::AID-JBM9>3.0.CO;2-G
   Saha R, 2002, ACTA MATER, V50, P23, DOI 10.1016/S1359-6454(01)00328-7
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Subra S., 2007, ACTA BIOMATER, V3, P413
   Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241
   Van Vliet KJ, 2003, ACTA MATER, V51, P5881, DOI 10.1016/j.actamat.2003.09.001
   Verma D, 2006, J BIOMED MATER RES A, V77A, P59, DOI 10.1002/jbm.a.30592
   Verma D, 2008, ANN BIOMED ENG, V36, P1024, DOI 10.1007/s10439-008-9483-2
   Verma D, 2008, MAT SCI ENG C-BIO S, V28, P399, DOI 10.1016/j.msec.2007.04.026
   Verma D, 2006, J BIOMED MATER RES A, V78A, P772, DOI 10.1002/jbm.a.30774
   Verma D, 2010, PHILOS T R SOC A, V368, P2083, DOI 10.1098/rsta.2010.0013
   Verma D, 2009, MAT SCI ENG C-MATER, V29, P2079, DOI 10.1016/j.msec.2009.04.006
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Wheeldon I, 2010, JALA-J ASSOC LAB AUT, V15, P440, DOI 10.1016/j.jala.2010.05.003
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
NR 69
TC 1
Z9 1
U1 0
U2 22
PU TECH SCIENCE PRESS
PI NORCROSS
PA 6825 JIMMY CARTER BLVD, STE 1850, NORCROSS, GA 30071 USA
SN 1526-1492
J9 CMES-COMP MODEL ENG
JI CMES-Comp. Model. Eng. Sci.
PD OCT
PY 2012
VL 87
IS 6
BP 530
EP 555
PG 26
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
SC Engineering; Mathematics
GA 068YV
UT WOS:000313403000004
DA 2018-10-19
ER

PT J
AU Campoccia, D
   Cangini, I
   Selan, L
   Vercellino, M
   Montanaro, L
   Visai, L
   Arciola, CR
AF Campoccia, Davide
   Cangini, Ilaria
   Selan, Laura
   Vercellino, Marco
   Montanaro, Lucio
   Visai, Livia
   Arciola, Carla Renata
TI An overview of the methodological approach to the in vitro study of
   anti-infective biomaterials
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE Implant infections; Anti-infective biomaterials; Bacterial adhesion;
   Biofilm
ID ORTHOPEDIC IMPLANT INFECTIONS; DEPENDENT BACTERIAL ADHESION; BIOFILM
   EXTRACELLULAR-DNA; STAPHYLOCOCCUS-EPIDERMIDIS; PSEUDOMONAS-AERUGINOSA;
   ANTIBIOTIC-RESISTANCE; ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-MUTANS;
   BIOMEDICAL POLYMERS; TISSUE INTEGRATION
AB Biomaterial-associated infections have an enormous impact in terms of morbidity of the patients and costs to national health systems. Perioperative antibiotics and aseptic procedures have not proved sufficient to eradicate the occurrence of this type of infections which often lead to devastating effects. Adjunctive strategies for preventing the establishment of infections are increasingly being centered on the development of new biomaterials with anti-infective properties. The creation of new anti-infective biomaterials can be obtained by alternative approaches oriented to achieve either bacteria-repellent surfaces or bioactive surfaces expressing self-sterilizing properties when not even able to treat preexisting infections in the surrounding tissues. Here, we offer a short overview of the currently available in vitro methods that can be used to investigate and assess the performance of anti-infective biometerials, with special emphasis on those whose mechanism of action is based on bacteria-repellent surfaces.
C1 [Campoccia, Davide; Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Rizzoli Orthopaed Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   [Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   [Selan, Laura] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Vercellino, Marco; Visai, Livia] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.
   [Vercellino, Marco; Visai, Livia] Univ Pavia, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Visai, Livia] IRCCS, Salvatore Maugeri Fdn, Pavia, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
FU "5 per mille" financial contribution for Health Research
FX This work was supported by a "5 per mille" financial contribution for
   Health Research to the Rizzoli Orthopaedic Institute of Bologna, a
   portion of which was assigned by the Scientific Director to the Research
   Unit on Implant Infections.
CR ABBOTT A, 1983, J GEN MICROBIOL, V129, P439
   An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2011, INT J ARTIF ORGANS, V34, P771, DOI 10.5301/ijao.5000046
   Arciola CR, 2011, INT J ARTIF ORGANS, V34, P727, DOI 10.5301/IJAO.2011.8784
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2004, BIOMATERIALS, V25, P4117, DOI 10.1016/j.biomaterials.2003.11.027
   Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   Auschill TM, 2001, ARCH ORAL BIOL, V46, P471, DOI 10.1016/S0003-9969(00)00136-9
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06
   BOCHNER BR, 1977, APPL ENVIRON MICROB, V33, P434
   BUNT CR, 1995, INT J PHARM, V113, P257, DOI 10.1016/0378-5173(94)00205-J
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   Campoccia D, 2007, INT J ARTIF ORGANS, V30, P842
   Campoccia D, 2006, INT J ARTIF ORGANS, V29, P622
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2008, INT J ARTIF ORGANS, V31, P841
   Campoccia D, 2011, INT J ARTIF ORGANS, V34, P832, DOI 10.5301/ijao.5000048
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Campoccia D, 2009, BIOMATERIALS, V30, P6621, DOI 10.1016/j.biomaterials.2009.08.032
   Cirioni O, 2007, ANTIMICROB AGENTS CH, V51, P4518, DOI 10.1128/AAC.00808-07
   Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002
   Costerton J. W., 1989, ASM News (Washington), V55, P650
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   Duarte M, 2009, EXP PARASITOL, V123, P195, DOI 10.1016/j.exppara.2009.07.002
   DUNNE WM, 1991, APPL ENVIRON MICROB, V57, P863
   DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390
   Fitzgerald R H Jr, 1989, Infect Dis Clin North Am, V3, P329
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184
   Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07
   Gallant-Behm CL, 2005, WOUND REPAIR REGEN, V13, P412, DOI 10.1111/j.1067-1927.2005.130409.x
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gristina AG, 1987, PATHOGENICITY CLIN S, P143
   HALL RE, 1987, J ORAL MAXIL SURG, V45, P779, DOI 10.1016/0278-2391(87)90202-3
   HARBER MJ, 1983, J GEN MICROBIOL, V129, P621
   Hoefel D, 2003, J MICROBIOL METH, V52, P379, DOI 10.1016/S0167-7012(02)00207-5
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Hook AL, 2012, JOVE-J VIS EXP, DOI 10.3791/3636
   Ip M, 2006, J MED MICROBIOL, V55, P59, DOI 10.1099/jmm.0.46124-0
   Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   Klapper I, 2002, BIOTECHNOL BIOENG, V80, P289, DOI 10.1002/bit.10376
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Kuehn M, 2001, WATER SCI TECHNOL, V43, P143
   LOCCI R, 1981, ZBL BAKT MIK HYG B, V173, P285
   Ma HL, 2004, J THEOR BIOL, V226, P237, DOI 10.1016/j.jtbi.2003.09.008
   Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MIORNER H, 1980, INFECT IMMUN, V29, P879
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Montanaro L, 2010, J BIOMED MATER RES A, V94A, P825, DOI 10.1002/jbm.a.32764
   Morisaki H, 1999, MICROBIOL-SGM, V145, P2797, DOI 10.1099/00221287-145-10-2797
   Nejadnik MR, 2008, J ANTIMICROB CHEMOTH, V62, P1323, DOI 10.1093/jac/dkn395
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321
   Ravaioli S, 2011, INT J ARTIF ORGANS, V34, P840, DOI 10.5301/ijao.5000057
   Razatos A, 2001, METHOD ENZYMOL, V337, P276, DOI 10.1016/S0076-6879(01)37021-0
   REYNOLDS EC, 1983, INFECT IMMUN, V39, P1285
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P5, DOI DOI 10.1016/0927-7765(94)01146-V
   RODRIGUEZ GG, 1992, APPL ENVIRON MICROB, V58, P1801
   SCHAULE G, 1993, APPL ENVIRON MICROB, V59, P3850
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B
   Strathmann M, 2002, J MICROBIOL METH, V50, P237, DOI 10.1016/S0167-7012(02)00032-5
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x
   THORPE TC, 1990, J CLIN MICROBIOL, V28, P1608
   Ueshima M, 2002, J BIOMED MATER RES, V60, P578, DOI 10.1002/jbm.10113
   van Oss CJ, 2003, J MOL RECOGNIT, V16, P177, DOI 10.1002/jmr.618
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANOSS CJ, 1991, J DISPER SCI TECHNOL, V12, P201, DOI 10.1080/01932699108913120
   VANPETT K, 1990, J ORTHOPAED RES, V8, P321, DOI 10.1002/jor.1100080303
   Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360
   Nguyen VT, 2011, J MICROBIOL METH, V86, P89, DOI 10.1016/j.mimet.2011.04.005
   Wagner C, 2011, INT J ARTIF ORGANS, V34, P811, DOI 10.5301/ijao.5000061
NR 93
TC 6
Z9 6
U1 1
U2 28
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD OCT
PY 2012
VL 35
IS 10
BP 800
EP 816
DI 10.5301/ijao.5000140
PG 17
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 066LX
UT WOS:000313223400012
PM 23065889
DA 2018-10-19
ER

PT J
AU Subbiahdoss, G
   Aleyt, T
   Kuijer, R
   Busscher, HJ
   van der Mei, HC
AF Subbiahdoss, Guruprakash
   Aleyt, Thomas
   Kuijer, Roe
   Busscher, Henk J.
   van der Mei, Henny C.
TI Influence of prophylactic antibiotics on tissue integration versus
   bacterial colonization on poly(methyl methacrylate)
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Biomaterial-associated infection; Race for the surface; S. aureus;
   Biomaterials; Antibiotics; Biofilm
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOMATERIALS; INFECTIONS; IMPLANTS; SURGERY;
   SURFACE; RACE
AB Purpose: Biomaterial-associated infections (BAI) remain a major concern in modern health care. BAI is difficult to treat and often results in implant replacement or removal. Pathogens can be introduced on implant surfaces during surgery and compete with host cells attempting to integrate the implant. Here we studied the influence of prophylactically given cephatholin in the competition between highly virulent Staphylococcus aureus and human osteoblast-like cells (U-2 OS, ATCC HTB-94) for a poly(methyl methacrylate) surface in vitro using a peri-operative contamination model.
   Method: S. aureus was seeded on the acrylic surface in a parallel plate flow chamber prior to adhesion of U-2 OS cells. Next, S. aureus and U-2 OS cells were allowed to grow simultaneously under shear (0.14 1/s) in a modified culture medium containing cephatholin for 8 h, the time period this drug is supposed to be active in situ. Subsequently, the flow was continued with modified culture medium for another 64 h.
   Results: In the absence of cephatholin, highly virulent S. aureus caused U-2 OS cell death within 18 h. In contrast, the presence of cephatholin for 8 h resulted in survival of U-2 OS cell up to 72 h during simultaneous growth of U-2 OS cells and bacteria. Not all adhering bacteria were killed however, but they showed a delayed growth.
   Conclusions: These findings are in line with the recalcitrance of biofilms against antibiotic treatment observed clinically, and represent another support for the use of in vitro co-culture models in mimicking the clinical situation.
C1 [Kuijer, Roe] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   Univ Groningen, NL-9700 AD Groningen, Netherlands.
RP Kuijer, R (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, POB 196, NL-9700 AD Groningen, Netherlands.
EM r.kuijer@umcg.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944; Subbiahdoss,
   Guruprakash/0000-0002-6684-7322
FU University Medical Center Groningen, Groningen, The Netherlands
FX This work was funded by the University Medical Center Groningen,
   Groningen, The Netherlands.
CR Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0
   Evans RP, 2009, J BONE JOINT SURG AM, V91A, P2, DOI 10.2106/JBJS.I.00549
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002
   Lee JH, 2011, TISSUE ENG PART C-ME, V17, P39, DOI [10.1089/ten.tec.2010.0285, 10.1089/ten.TEC.2010.0285]
   Massey RC, 2006, NAT REV MICROBIOL, V4, P953, DOI 10.1038/nrmicro1551
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Trampuz Andrej, 2005, Curr Opin Investig Drugs, V6, P185
   Verkkala K, 1998, EUR J CARDIO-THORAC, V14, P206, DOI 10.1016/S1010-7940(98)00150-X
NR 17
TC 4
Z9 5
U1 1
U2 19
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD OCT
PY 2012
VL 35
IS 10
BP 840
EP 846
DI 10.5301/ijao.5000155
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 066LX
UT WOS:000313223400016
PM 23138708
DA 2018-10-19
ER

PT J
AU Mei, L
   Ren, YJ
   Loontjens, TJA
   van der Mei, HC
   Busscher, HJ
AF Mei, Li
   Ren, Yijin
   Loontjens, Ton J. A.
   van der Mei, Henny C.
   Busscher, Henk J.
TI Contact-killing of adhering streptococci by a quaternary ammonium
   compound incorporated in an acrylic resin
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Acrylates; Quaternary ammonium compounds; Contact-killing; Biomaterial
   implants; Biofilms
ID ANTIBACTERIAL ACTIVITY; BONE CEMENTS; IN-VIVO; ADHESIVE; COATINGS;
   NANOPARTICLES; PROTEINS; SURFACES; BIOFILMS; BACTERIA
AB Purpose: Acrylates for bonding of joint prostheses and stainless-steel brackets in orthopedics and orthodontics are prone to bacterial adhesion and biofilm formation, respectively, leading to serious infectious complications. Here we describe the preparation of a contact-killing acrylic resin by incorporation of [3-(methacryloylamino)propyl] trimethylammonium chloride (MAPTAC).
   Methods: Physicochemical properties of the acrylates with and without MAPTAC incorporated were determined with X-ray photoelectron spectroscopy and water contact angles. The bond-strength of the acrylate with different percentages of MAPTAC was determined in a shear mode. The efficacy in contact-killing of the acrylate with MAPTAC incorporated with and without an adsorbed salivary coating was evaluated for various oral streptococcal strains. Cytotoxicity was tested against human skin fibroblasts.
   Results: Actylates with 16 wt% and 20 wt% incorporated MAPTAC showed strong contact-killing of various oral streptococcal strains up to challenge concentrations of 10(9) mL(-1) within 15 min, with no elution of antimicrobial polymers. Contact-killing reduced after coating with a salivary conditioning film, but still remained significant up to a challenge concentration of 10(5) mL(-1). No cytotoxicity of acrylate with incorporated MAPTAC was observed toward human skin fibroblasts. The bond strengths of stainless-steel brackets fixed to etched enamel through the resin (12 +/- 3 MPa) decreased with increasing amounts MAPTAC to half of the original value when 20 wt% of MAPTAC was incorporated, which remained within a clinically acceptable range.
   Conclusions: These results suggest that MAPTAC can be effectively incorporated in orthodontic resin to provide long-term bactericidal activity against oral bacteria, with potential application in orthopedics.
C1 [Mei, Li; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, NL-9700 AD Groningen, Netherlands.
   [Loontjens, Ton J. A.] Univ Groningen, Zernike Sci Inst, Dept Polymer Chem, NL-9700 AD Groningen, Netherlands.
   [Ren, Yijin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthodont, NL-9700 AD Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, POB 196, NL-9700 AD Groningen, Netherlands.
EM h.c.van.der.mei@umcg.nl
CR Al-Musallam TA, 2006, AM J ORTHOD DENTOFAC, V129, P245, DOI 10.1016/j.ajodo.2005.10.015
   Alexander H, 1996, BIOMATERIAL SCI, P94
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Berg C H, 2001, Eur J Oral Sci, V109, P316
   Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003
   Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107
   Bieser AM, 2011, MACROMOL BIOSCI, V11, P526, DOI 10.1002/mabi.201000398
   Dunbar Michael J, 2009, Orthopedics, V32, DOI 10.3928/01477447-20090728-20
   Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417
   Imazato S, 1999, BIOMATERIALS, V20, P899, DOI 10.1016/S0142-9612(98)00247-6
   Imazato S, 2003, BIOMATERIALS, V24, P3605, DOI 10.1016/S0142-9612(03)00217-5
   Lewis G, 2009, J BIOMED MATER RES B, V89B, P558, DOI 10.1002/jbm.b.31220
   Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x
   Martin TP, 2007, BIOMATERIALS, V28, P909, DOI 10.1016/j.biomaterials.2006.10.009
   Namura Y, 2010, EUR J ORTHODONT, V32, P620, DOI 10.1093/ejo/cjq015
   Ogaard B., 2008, SEMIN ORTHOD, V14, P183, DOI DOI 10.1053/J.SODO.2008.03.003
   Olsson ALJ, 2012, APPL ENVIRON MICROB, V78, P99, DOI 10.1128/AEM.06912-11
   Saito K, 2007, ANGLE ORTHOD, V77, P532, DOI 10.2319/042606-175
   Schaer TP, 2012, BIOMATERIALS, V33, P1245, DOI 10.1016/j.biomaterials.2011.10.038
   Sehgal V, 2007, AM J ORTHOD DENTOFAC, V131, P525, DOI 10.1016/j.ajodo.2005.06.033
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tiller JC, 2011, ADV POLYM SCI, V240, P193, DOI 10.1007/12_2010_101
   Uysal T, 2011, AM J ORTHOD DENTOFAC, V139, P650, DOI 10.1016/j.ajodo.2009.06.038
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 26
TC 10
Z9 11
U1 2
U2 38
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD OCT
PY 2012
VL 35
IS 10
BP 854
EP 863
DI 10.5301/ijao.5000149
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 066LX
UT WOS:000313223400018
PM 23065883
DA 2018-10-19
ER

PT J
AU Della Valle, C
   Visai, L
   Santin, M
   Cigada, A
   Candiani, G
   Pezzoli, D
   Arciola, CR
   Imbriani, M
   Chiesa, R
AF Della Valle, Cinzia
   Visai, Livia
   Santin, Matteo
   Cigada, Alberto
   Candiani, Gabriele
   Pezzoli, Daniele
   Arciola, Carla Renata
   Imbriani, Marcello
   Chiesa, Roberto
TI A novel antibacterial modification treatment of titanium capable to
   improve osseointegration
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Biomimetic; Silver nanoparticles; Antibacterial activity; Silicon;
   Streptococcus mutans; Staphylococcus epidermidis; Escherichia coli
ID SILVER NANOPARTICLES; CALCIUM-PHOSPHATE; DENTAL IMPLANTS; ORAL BACTERIA;
   SURFACE; ADHESION; OXIDATION; CHITOSAN; DEVICES; IONS
AB Background: Among the different causes of orthopedic and dental implant failure, infection remains the most serious and devastating complication associated with biomaterial devices.
   Purpose: The aim of this study was to develop an innovative osteointegrative and antibacterial biomimetic coating on titanium and to perform a chemical-physical and in vitro biological characterization of the coating using the SAOS-2 cell line. We also studied the antibacterial properties of the coating against both Gram-positive and Gram-negative bacteria strains.
   Methods: An electrochemical solution containing silicon, calcium, phosphorous, sodium, and silver nanoparticles was used to obtain the antibacterial by Anodic Spark Deposition (ASD) treatment. Surface morphology was characterized using SEM and laser profilometry. A qualitative analysis of the chemical composition of the coating was assessed by EDS. The adhesion properties of the coating to the titanium bulk were performed with a 3-point bending test. SAOS-2 osteoblastic cell line spreading and morphology and viability were investigated. The bacterial adhesion and the antibacterial properties were investigated after 3 h and 24 h of incubation with Streptococcus mutans, Streptococcus epidermidis, and Escherichia coli bacterial strains.
   Results: The proposed anodization treatment created a chemically and morphologically modified, adherent titanium oxide layer, characterized by a microporous morphology enriched by calcium, silicon, phosphorous, and silver The preliminary biological characterization showed optimal SAOS-2 cell adhesion and proliferation as well as a strong antibacterial effect.
   Conclusions: Based on the results of this study, we believe that this novel biomimetic and antibacterial treatment hold promise for enhancing osteointegration while conferring strong antibacterial properties to titanium.
C1 [Della Valle, Cinzia; Cigada, Alberto; Candiani, Gabriele; Chiesa, Roberto] Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, I-201331 Milan, Italy.
   [Visai, Livia] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.
   [Visai, Livia] Univ Pavia, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Visai, Livia; Imbriani, Marcello] IRCCS, Salvatore Maugeri Fdn, Pavia, Italy.
   [Santin, Matteo] Brighton Univ, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.
   [Candiani, Gabriele; Pezzoli, Daniele] Politecn Milan, Res Unit, INSTM Italian Natl Consortium Mat Sci & Technol, I-20133 Milan, Italy.
   [Arciola, Carla Renata] Rizzoli Orthoped Inst, Res Unit Implant Infect, Bologna, Italy.
   [Arciola, Carla Renata] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   [Imbriani, Marcello] Univ Pavia, Dept Publ Hlth Neurosci Expt Med & Forens, I-27100 Pavia, Italy.
RP Chiesa, R (reprint author), Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, Via Luigi Mancinelli 7, I-201331 Milan, Italy.
EM roberto.chiesa@polimi.it
RI Chiesa, Roberto/N-2605-2013; Pezzoli, Daniele/J-4308-2012; Candiani,
   Gabriele/A-9744-2009
OI Pezzoli, Daniele/0000-0002-6780-6979; Candiani,
   Gabriele/0000-0003-0575-068X; IMBRIANI, MARCELLO/0000-0002-2752-1565;
   Chiesa, Roberto/0000-0002-5317-6849
FU Italian Ministry of Education and Scientific Research (PRIN)
FX This work was supported by grants from the Italian Ministry of Education
   and Scientific Research (PRIN 2006 to L.V.).
CR Aparicio C, 2011, J MECH BEHAV BIOMED, V4, P1672, DOI 10.1016/j.jmbbm.2011.05.005
   Byun IS, 2010, J MATER SCI-MATER M, V21, P1937, DOI 10.1007/s10856-010-4061-1
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Chiesa R, 2003, J Appl Biomater Biomech, V1, P91
   Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021
   Coathup MJ, 2011, J BONE JOINT SURG AM, V93A, P2219, DOI [10.2106/JBJS.J.01623, 10.2106/JBJS.I.01623]
   Damm C, 2008, MATER CHEM PHYS, V108, P61, DOI 10.1016/j.matchemphys.2007.09.002
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   Della Valle C, 2012, J APPL BIOMATER FUNC
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kawahara K, 2000, DENT MATER, V16, P452, DOI 10.1016/S0109-5641(00)00050-6
   KiremitciGumusderelioglu M, 1996, BIOMATERIALS, V17, P443, DOI 10.1016/0142-9612(96)89662-1
   Lansdown ABG, 2010, ADV PHARMACOL SCI, DOI 10.1155/2010/910686
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Oshida Y, 2010, INT J MOL SCI, V11, P1580, DOI 10.3390/ijms11041580
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Porter AE, 2006, MICRON, V37, P681, DOI 10.1016/j.micron.2006.03.006
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Rupp ME, 2005, ANN INTERN MED, V143, P570, DOI 10.7326/0003-4819-143-8-200510180-00007
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Sladkova M, 2009, J MOL STRUCT, V924, P567, DOI 10.1016/j.molstruc.2008.11.006
   Song WH, 2009, J BIOMED MATER RES A, V88A, P246, DOI 10.1002/jbm.a.31877
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Visai L, 2008, J APPL BIOMATER BIOM, V6, P170
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Yu X, 2012, J MAT SCI MAT MED
   Zareidoost A, 2012, J MATER SCI-MATER M, V23, P1479, DOI 10.1007/s10856-012-4611-9
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 37
TC 26
Z9 26
U1 1
U2 68
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD OCT
PY 2012
VL 35
IS 10
BP 864
EP 875
DI 10.5301/ijao.5000161
PG 12
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 066LX
UT WOS:000313223400019
PM 23138702
DA 2018-10-19
ER

PT J
AU Altomare, L
   Visai, L
   Bloise, N
   Arciola, CR
   Ulivi, L
   Candiani, G
   Cigada, A
   Chiesa, R
   De Nardo, L
AF Altomare, Lina
   Visai, Livia
   Bloise, Nora
   Arciola, Carla Renata
   Ulivi, Lorenzo
   Candiani, Gabriele
   Cigada, Alberto
   Chiesa, Roberto
   De Nardo, Luigi
TI Electrochemically deposited gentamicin-loaded calcium phosphate coatings
   for bone tissue integration
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Biomaterial surface modifications; Electrochemical deposition; Calcium
   phosphate coatings; Antibacterial properties; Gentamicin sulfate
ID ELECTROPHORETIC DEPOSITION; IN-VITRO; HYDROXYAPATITE COATINGS; IMPLANT
   INFECTIONS; JOINT INFECTION; CHITOSAN FILMS; TITANIUM; STAPHYLOCOCCUS;
   SURFACE; BRUSHITE
AB Purpose: Despite improvements in operative environment and surgical techniques, post-operative infections remain one of the most devastating complications in total joint replacement prostheses. Several efforts have been made to modify the surface of materials in order to prevent bacterial adhesion and colonization. Here, we show a one-pot electrochemical surface modification process for co-deposition of calcium phosphate and gentamicin, with the aim of triggering specific biological responses and imparting antibacterial properties on titanium alloy prostheses.
   Methods: Gentamicin-loaded calcium phosphate coatings were deposited on 77 specimens via cathodic polarization in an electrochemical bath containing different amounts of the antibiotic salt (1-10 mg mL(-1)). Coatings were evaluated in terms of chemico-physical properties, via SEM/EDX, XRD, and ICP analysis, and antibacterial activity, via agar disc diffusion test on Staphylococcus aureus 8325-4 and Staphylococcus aureus SA113.
   Results: An effective incorporation of gentamicin was achieved without any major effect on the morphology and structure. Morphology resulted in a typical plate-like brushite structure, confirmed by chemical composition and crystallographic structure. Gentamicin-loaded coatings showed an antibacterial efficacy on both staphlococcal strains, with a dose-dependent activity.
   Conclusions: Electrochemical technology can be advantageously exploited in order to obtain coatings for bone-contact prostheses with tailored antibacterial properties.
C1 [Altomare, Lina; Ulivi, Lorenzo; Candiani, Gabriele; Cigada, Alberto; Chiesa, Roberto; De Nardo, Luigi] Politecn Milan, Giulio Natta Dept Chem Mat & Chem Engn, I-20133 Milan, Italy.
   [Visai, Livia; Bloise, Nora] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.
   [Visai, Livia; Bloise, Nora] Univ Pavia, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Visai, Livia] IRCCS, Salvatore Maugeri Fdn, Pavia, Italy.
   [Arciola, Carla Renata] Rizzoli Orthoped Inst Bologna, Res Unit Implant Infect, Bologna, Italy.
   [Arciola, Carla Renata] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   [De Nardo, Luigi] Politecn Milan, Local Unit, Natl Consortium Mat Sci & Technol, INSTM, I-20133 Milan, Italy.
RP De Nardo, L (reprint author), Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Piazza L da Vinci 32, I-20133 Milan, Italy.
EM luigi.denardo@polimi.it
RI De Nardo, Luigi/B-7523-2009; Altomare, Lina/F-7526-2011; Bloise,
   Nora/M-5699-2016; Candiani, Gabriele/A-9744-2009; Chiesa,
   Roberto/N-2605-2013
OI De Nardo, Luigi/0000-0002-7492-6012; Bloise, Nora/0000-0002-6000-5036;
   Candiani, Gabriele/0000-0003-0575-068X; Cigada,
   Alberto/0000-0002-0925-5558; Chiesa, Roberto/0000-0002-5317-6849; Ulivi,
   Lorenzo/0000-0002-3541-0419; ALTOMARE, LINA/0000-0001-9555-1291
FU INSTM; Regione Lombardia; Regione Sardegna; MIUR-FIRB Futuro in ricerca
   (Surface-associated selective transfection - SAST) [RBFR08XH0H]
FX LDN acknowledges INSTM, Regione Lombardia and Regione Sardegna for the
   "ChitoStrip" grant. GC, LA, and LDN acknowledge MIUR-FIRB Futuro in
   ricerca (Surface-associated selective transfection - SAST, RBFR08XH0H)
   for the financial support.
CR Altomare L, 2011, J MATER SCI-MATER M, V22, P1303, DOI 10.1007/s10856-011-4307-6
   Altomare L, 2008, J APPL BIOMATER BIOM, V6, P132
   Altomare L, 2012, MATER LETT, V78, P18, DOI 10.1016/j.matlet.2012.03.035
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2011, INT J ARTIF ORGANS, V34, P727, DOI 10.5301/IJAO.2011.8784
   Arnone A, 2003, TETRAHEDRON, V59, P5033, DOI 10.1016/S0040-4020(03)00738-5
   Bauer TW, 2010, J BONE JOINT SURG AM, V92A, P524
   Boccaccini AR, 2010, J R SOC INTERFACE, V7, pS581, DOI 10.1098/rsif.2010.0156.focus
   Chiesa R, 2003, J Appl Biomater Biomech, V1, P91
   de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917
   De Nardo L, 2012, COATINGS FOR BIOMEDICAL APPLICATIONS, P106
   Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038
   Fernandes R, 2003, LANGMUIR, V19, P4058, DOI 10.1021/la027052h
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Ince A, 2008, J ARTHROPLASTY, V23, P762, DOI 10.1016/j.arth.2007.06.018
   Jiang T, 2010, BIOMACROMOLECULES, V11, P1254, DOI 10.1021/bm100050d
   Kazemzadeh-Narbat M, 2012, J BIOMED MATER RES B, V100B, P1344, DOI 10.1002/jbm.b.32701
   Kingshott P, 2011, CURR OPIN CHEM BIOL, V15, P667, DOI 10.1016/j.cbpa.2011.07.012
   Li Y, 2011, MATER LETT, V65, P1463, DOI 10.1016/j.matlet.2011.02.038
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Pang X, 2005, MATER CHEM PHYS, V94, P245, DOI 10.1016/j.matchemphys.2005.04.040
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Pezzoli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034711
   Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4
   Redepenning J, 2003, J BIOMED MATER RES A, V66A, P411, DOI 10.1002/jbm.a.10571
   Redepenning J, 1996, J BIOMED MATER RES, V30, P287
   REDEPENNING J, 1990, CHEM MATER, V2, P625, DOI 10.1021/cm00012a001
   Sendi P, 2011, INT J ARTIF ORGANS, V34, P947, DOI 10.5301/ijao.5000032
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   SHIRKHANZADEH M, 1993, J MATER SCI LETT, V12, P16
   Shirkhanzadeh M, 1991, J MATER SCI LETT, V10, P1415
   Simchi A, 2009, MATER LETT, V63, P2253, DOI 10.1016/j.matlet.2009.07.046
   Speziale P, 2008, CURR MED CHEM, V15, P3185, DOI 10.2174/092986708786848442
   Tanzi MC, 2011, J APPL BIOMATER BIOM, V9, P87, DOI 10.5301/JABB.2011.8563
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Wang J, 2004, J DENT RES, V83, P296, DOI 10.1177/154405910408300405
   Williams DF, 1981, BIOCOMPATIBILITY CLI
   Wu LQ, 2002, LANGMUIR, V18, P8620, DOI 10.1021/la020381p
   Zhang JM, 1998, J ELECTROANAL CHEM, V452, P235, DOI 10.1016/S0022-0728(98)00107-7
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zhitomirsky I, 2007, J MATER PROCESS TECH, V191, P68, DOI 10.1016/j.jmatprotec.2007.03.043
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 45
TC 3
Z9 3
U1 1
U2 50
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD OCT
PY 2012
VL 35
IS 10
BP 876
EP 883
DI 10.5301/ijao.5000162
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 066LX
UT WOS:000313223400020
PM 23138703
DA 2018-10-19
ER

PT J
AU Saveanu, CI
   Dragos, O
AF Saveanu, Catalina Iulia
   Dragos, Oana
TI IN VITRO STUDY OF DENTIN HYBRID LAYER OF A NEW RESIN COMPOSITE MATERIAL:
   COMPARISON BETWEEN THE USE OF DIAMOND AND ER, CR: YSGG LASER CAVITY
   PREPARATION
SO DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
LA English
DT Article
DE Biomaterial; composite resin; adhesive
ID YAG LASER
AB The aim of this study is the analysis by Scanning Electrono Microscopy (SEM) of hybrid layer thickness cavities prepared with diamond burs and with Er, Cr: YSGG laser, filled with two resin composite materials with low viscosity Smart Dentin Replacement (SDR (TM)) by DENTSPLYDeTrey-Konstanz- Germany and Tetric (R) flow (T (R) f) by Ivoclar-Vivadent-Liechtenstein. The study was realized in vitro on samples of 20 human premolar and molar teeth extracted for orthodontic or periodontal reasons, divided at randomly into four groups (Gr.1 to 4) of 5 teeth. The teeth were prepared and restored according to the manufacturers instructions. The specimens were prepared for SEM observation and analyzed using ANOVA tests (p <= 0.05). The resulting thicknesses has highlighted differences between groups (p <= 0.05): Group1:17.27(+/- 8.12)mu m>Group3:14.08(+/- 7.58)mu m>Group2:8.77(+/- 4.44)mu m>Group4:6.51 (+/- 1)1 mu m. In conclusion, the preparation technique and the material used determine the thickness of the hybrid layer in favor of diamond cavity preparations filled with SDR (TM).
C1 [Saveanu, Catalina Iulia] Univ Med & Pharm Gr T Popa, Fac Med Dent, Dept Prevent Dent, Iasi 700115, Romania.
   [Dragos, Oana] Natl Inst Res Dev Tech Phys IFT Iasi, Iasi, Romania.
RP Saveanu, CI (reprint author), Univ Med & Pharm Gr T Popa, Fac Med Dent, Dept Prevent Dent, Str Univ 16, Iasi 700115, Romania.
EM cisaveanu@prevod.umfiasi.ro
FU CNCSIS [2669/2008]
FX This study was supported by the CNCSIS grant budget, no. 2669/2008 -
   ideas competition-exploratory research projects.
CR Abdalla A I, 1993, Am J Dent, V6, P295
   Barceleiro MO, 2008, OPER DENT, V33, P294, DOI 10.2341/07-84
   Bouillaguet S, 2000, J Adhes Dent, V2, P201
   Giachetti L, 2004, J PROSTHET DENT, V92, P233, DOI 10.1016/j.prosdent.2004.06.021
   Giachetti L, 2004, J CLIN LASER MED SUR, V22, P35
   Gregoire G., 2004, QUINTESSENCE INT, V30, P123
   Gwinnett A J, 1994, Am J Dent, V7, P243
   Hashimoto M, 2000, DENT MATER, V16, P406, DOI 10.1016/S0109-5641(00)00035-X
   Itoh S, 2010, DENT MATER J, V29, P623, DOI 10.4012/dmj.2010-028
   JOSEPH VP, 1994, AM J ORTHOD DENTOFAC, V105, P362, DOI 10.1016/S0889-5406(94)70130-X
   Kersten S., 2000, REV MENS SUISSE DODO, V110, P1185
   Matos A B, 1997, Braz Dent J, V8, P35
   Pashley D H, 1992, Oper Dent, VSuppl 5, P137
   Popovici A, 2009, OPTOELECTRON ADV MAT, V3, P616
   Popovici A, 2009, J OPTOELECTRON ADV M, V11, P490
   Popovici A., 2009, J OPTOELECTRON ADV M, V1, P20
   Soanca A, 2011, DIG J NANOMATER BIOS, V6, P349
   Soraia M., 2002, BRAZ DENT J, V13, P33
   Sugizaki J, 1991, JPN J CONSERV DENT, V34, P228
   Tsanova Snejana Ts, 2010, Folia Med (Plovdiv), V52, P46
NR 20
TC 3
Z9 3
U1 0
U2 7
PU INST MATERIALS PHYSICS
PI BUCHAREST
PA NATL INST R&D MATERIALS PHYSICS, ATOMISTILOR STR, 105 BIS, BUCHAREST,
   077125, ROMANIA
SN 1842-3582
J9 DIG J NANOMATER BIOS
JI Dig. J. Nanomater. Biostruct.
PD OCT-DEC
PY 2012
VL 7
IS 4
BP 1473
EP 1480
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 059MT
UT WOS:000312710300011
DA 2018-10-19
ER

PT J
AU Yu, GY
   Li, XB
AF Yu, Guiying
   Li, Xiaobing
TI Fabrication and bio-tribological properties of medical
   polyurethane/carbon nanotubes composites
SO ENERGY EDUCATION SCIENCE AND TECHNOLOGY PART A-ENERGY SCIENCE AND
   RESEARCH
LA English
DT Article
DE Medical Polyurethane; CNTs; Ultrasonic dispersion; Tibological
   performance; Hydrophobic property
ID FILMS
AB The urine encrustation is one of main problems of medical polymer materials in the clinical use. In the paper, the fabrication, tribological and hydrophobic properties of the PU(polyurethane) and CNTs(carbon nanotubes) composites were investigated. PU composites reinforced with CNTs were fabricated by solution-blending and ultrasonic dispersion method. The effects of CNTs content and dispersion method on the properties of the composites were analyzed. The experimental results indicated that the friction coefficient of the composites decreased due to the self-lubrication property of CNTs. However, the effect of ultrasonic dispersion time on the friction coefficient of the composites was to be minimal. The favorable effects of CNTs on hydrophobic performance were attributed to their random micro/nano double topological structures. CNTs as an supplement of PU can reduce the friction coefficient and enhance the hydrophobic performance of PU/CNTs composites, which can improve the anti-encrustation property of PU biomaterial and has a positive role to reduce the pain of patient.
C1 [Yu, Guiying; Li, Xiaobing] Nanchang Univ, Sch Mechatron Engn, Nanchang 330031, Peoples R China.
RP Li, XB (reprint author), Nanchang Univ, Sch Mechatron Engn, Nanchang 330031, Peoples R China.
EM lixiaobing@ncu.edu.cn
FU Science and Technology Support Program of Jiangxi Province, China
   [2009BGB01300]
FX This work was supported by a grant from the Science and Technology
   Support Program of Jiangxi Province, China (Grant No.2009BGB01300).
CR Behcet R, 2011, ENER EDUC SCI TECH-A, V28, P239
   Bo ML, 2011, ENER EDUC SCI TECH-A, V28, P161
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jia ZY, 2012, ENER EDUC SCI TECH-A, V29, P811
   Karakaya H, 2012, ENER EDUC SCI TECH-A, V28, P577
   Li XB, 2009, CONTACT ANGLE BIONIC
   Liu H, 2006, SOFT MATTER, V2, P811, DOI 10.1039/b606654b
   Mulazimoglu AD, 2012, ENER EDUC SCI TECH-A, V28, P995
   Mulazimoglu IE, 2012, ENER EDUC SCI TECH-A, V28, P957
   Nakajima A, 2001, MONATSH CHEM, V132, P31, DOI 10.1007/s007060170142
   Pan ZW, 1998, NATURE, V394, P631, DOI 10.1038/29206
   Saidur R, 2011, ENER EDUC SCI TECH-A, V26, P87
   Stickler DJ, 2003, LANCET, V361, P1435, DOI 10.1016/S0140-6736(03)13104-2
   Thierry Massart, 2008, INFORM PROCESS LETT, V106, P120
   Zhang Y, 2011, ENER EDUC SCI TECH-A, V28, P95
NR 15
TC 0
Z9 0
U1 2
U2 11
PU SILA SCIENCE
PI TRABZON
PA UNIV MAH,MEKAN SOK NO 24, TRABZON, 00000, TURKEY
SN 1308-772X
J9 ENER EDUC SCI TECH-A
JI Energy Educ. Sci. Technol.-Part A
PD OCT
PY 2012
VL 30
IS 1
BP 475
EP 480
PG 6
WC Energy & Fuels; Engineering, Environmental; Engineering, Chemical
SC Energy & Fuels; Engineering
GA 057QF
UT WOS:000312577400054
DA 2018-10-19
ER

PT J
AU Cantu, DA
   Hematti, P
   Kao, WJ
AF Cantu, David Antonio
   Hematti, Peiman
   Kao, Weiyuan John
TI Cell Encapsulating Biomaterial Regulates Mesenchymal Stromal/Stem Cell
   Differentiation and Macrophage Immunophenotype
SO STEM CELLS TRANSLATIONAL MEDICINE
LA English
DT Article
DE Cell biology; Multipotential differentiation; Monocyte; Mesenchymal stem
   cells
ID HUMAN ADIPOSE-TISSUE; STEM-CELLS; GROWTH-FACTORS; OSTEOGENIC
   DIFFERENTIATION; MYOCARDIAL-INFARCTION; ACTIVATION; HYDROGELS;
   CHONDROGENESIS; MICROSPHERES; CYTOKINES
AB Bone marrow mesenchymal stromal/stem cell (MSC) encapsulation within a biomatrix could improve cellular delivery and extend survival and residence time over conventional intravenous administration. Although MSCs modulate monocyte/macrophage (Mempty set) immunophenotypic properties, little is known about how such interactions are influenced when MSCs are entrapped within a biomaterial. Furthermore, the impact of the cell-encapsulating matrix on MSC multipotency and on Mempty sets, which infiltrate biomaterials, remains poorly understood. Here we elucidate this three-way interaction. The Mempty set immunophenotype and MSC differentiation were examined with regard to established and experimental collagen-based biomaterials for MSC entrapment. Tumor necrosis factor-alpha secretion was acutely inhibited at 4 days. MSCs cocultured with Mempty sets demonstrated attenuated chondrocyte differentiation, whereas osteoblast differentiation was enhanced. Adipocyte differentiation was considerably enhanced for MSCs entrapped within the gelatin/polyethylene glycol-based matrix. A better understanding of the effect of cell encapsulation on differentiation potency and immunomodulation of MSCs is essential for MSC-based, biomaterial-enabled therapies. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:740-749
C1 [Cantu, David Antonio; Kao, Weiyuan John] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53706 USA.
   [Cantu, David Antonio; Kao, Weiyuan John] Univ Wisconsin, Dept Biomed Engn, Coll Engn, Madison, WI USA.
   [Hematti, Peiman] Univ Wisconsin, Div Hematol Oncol Bone Marrow Transplantat, Dept Med, Madison, WI USA.
   [Hematti, Peiman] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.
   [Kao, Weiyuan John] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA.
RP Kao, WJ (reprint author), 777 Highland Ave,7123 Rennebohm Hall, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU University of Wisconsin-Madison School of Pharmacy; NIH [EB6613]
FX We thank J. Hardin, B. Gray, and R. Sullivan for technical assistance
   involving bone marrow MSC-biomaterial histological processing and
   differentiation staining. We also thank Kedi Xu and Yao Fu for
   immunocytochemistry staining and gelatin/polyethylene glycol synthesis
   assistance, respectively. This research was supported in part by the
   University of Wisconsin-Madison School of Pharmacy and NIH Grant EB6613.
   D.A.C. and W.J.K. are currently affiliated with the School of Pharmacy,
   University of Wisconsin Madison, Madison, Wisconsin.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4
   Ashcroft GS, 2012, WOUND REPAIR REGEN, V20, P38, DOI 10.1111/j.1524-475X.2011.00748.x
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024
   Chung SA, 2009, J BIOMED MATER RES A, V89, P841
   Dadsetan M, 2008, BIOMATERIALS, V29, P2193, DOI 10.1016/j.biomaterials.2008.01.006
   Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dudhia J, 2005, CELL MOL LIFE SCI, V62, P2241, DOI 10.1007/s00018-005-5217-x
   Flynn Lauren, 2008, Organogenesis, V4, P228
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031
   Hanson SE, 2011, TISSUE ENG PT A, V17, P2463, DOI [10.1089/ten.tea.2010.0716, 10.1089/ten.TEA.2010.0716]
   Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013
   Heo SC, 2011, J INVEST DERMATOL, V131, P1559, DOI 10.1038/jid.2011.64
   Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252
   Jackson WM, 2012, STEM CELL TRANSL MED, V1, P44, DOI 10.5966/sctm.2011-0024
   Jones E, 2010, ANN RHEUM DIS, V69, P450, DOI 10.1136/ard.2008.106435
   Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kellar KL, 2003, J IMMUNOL METHODS, V279, P277, DOI 10.1016/S0022-1759(03)00248-5
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059
   Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430
   Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Murphy JM, 2002, ARTHRITIS RHEUM, V46, P704, DOI 10.1002/art.10118
   Nishimoto N, 2004, CURR OPIN PHARMACOL, V4, P386, DOI 10.1016/j.coph.2004.03.005
   Park JS, 2011, BIOMATERIALS, V32, P28, DOI 10.1016/j.biomaterials.2010.08.088
   Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704
   Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211
   Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
   Schmidt D, 2011, ACTA BIOMATER, V7, P515, DOI 10.1016/j.actbio.2010.08.022
   Spagnoli A, 2005, ENDOCRIN DEV, V9, P17, DOI 10.1159/000085719
   Takahashi N, 2008, ARTHRITIS RHEUM-US, V58, P3471, DOI 10.1002/art.23956
   TILG H, 1994, BLOOD, V83, P113
   Tomizawa Yasuko, 2005, J Artif Organs, V8, P137, DOI 10.1007/s10047-005-0296-x
   Trengove NJ, 2000, WOUND REPAIR REGEN, V8, P13, DOI 10.1046/j.1524-475x.2000.00013.x
   Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Waldeck H, 2012, BIOMATERIALS, V33, P29, DOI 10.1016/j.biomaterials.2011.09.044
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Wang XT, 2011, J BIOMAT SCI-POLYM E, V22, P1343, DOI 10.1163/092050610X508400
   Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088
   Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352
   Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503
NR 63
TC 25
Z9 25
U1 0
U2 43
PU ALPHAMED PRESS
PI DURHAM
PA 318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA
SN 2157-6564
J9 STEM CELL TRANSL MED
JI Stem Cells Transl. Med.
PD OCT
PY 2012
VL 1
IS 10
BP 740
EP 749
DI 10.5966/sctm.2012-0061
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 057OG
UT WOS:000312572300005
PM 23197666
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Horiuchi, N
   Nakamura, M
   Nagai, A
   Katayama, K
   Yamashita, K
AF Horiuchi, N.
   Nakamura, M.
   Nagai, A.
   Katayama, K.
   Yamashita, K.
TI Proton conduction related electrical dipole and space charge
   polarization in hydroxyapatite
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID CERAMIC HYDROXYAPATITE; MONOCLINIC HYDROXYAPATITE; SINGLE-CRYSTALS;
   DRUG-DELIVERY; SYSTEMS; REORIENTABILITY; RELAXATION
AB Hydroxyapatite (HAp), well known as a biomaterial, is also known as a proton conductor. Its electrical properties are related strongly to its stability and surface properties. In particular, persistent electrical polarization related to proton conductivity of hydroxyapatite has a substantial influence on hydroxyapatite surface properties. The origins of polarizations were investigated in proton-defect-induced HAp ceramics using thermally stimulated depolarization current (TSDC) measurements. Two peaks were observed, indicating that the persistent polarization comprises polarization elements of two kinds. The TSDC response as a function of the applied electric field in polarization treatments indicated that the persistent polarization is dipole polarization and space charge polarization. The former, dipole polarization, increased continuously with increased defect concentration. The activation energies were 0.67-0.86 eV, which are comparable to proton conduction activation energy. Results show that dipole polarization consists of electrical dipoles of the defect pairs, which are formed through proton conduction. The activation energies of 1.01 +/- 0.01 eV for space charge polarization are independent of the defect concentration, suggesting that these originated from protons trapped at the grain boundaries as a result of long-range proton conduction. The polarization of two different types is expected to exert different effects on the HAp surface properties. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.4754298]
C1 [Horiuchi, N.; Nakamura, M.; Nagai, A.; Yamashita, K.] Tokyo Med & Dent Univ, Dept Inorgan Mat, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Katayama, K.] Tokai Univ, Dept Appl Chem, Hiratsuka, Kanagawa 2591292, Japan.
RP Horiuchi, N (reprint author), Tokyo Med & Dent Univ, Dept Inorgan Mat, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM nhori.bcr@tmd.ac.jp
RI Nakamura, Miho/T-3166-2017
CR ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Fujimori H, 2000, CHEM PHYS LETT, V325, P383, DOI 10.1016/S0009-2614(00)00695-3
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HITMI N, 1980, SOLID STATE COMMUN, V33, P1003, DOI 10.1016/0038-1098(80)90301-4
   HITMI N, 1988, J PHYS CHEM SOLIDS, V49, P541, DOI 10.1016/0022-3697(88)90065-0
   HITMI N, 1986, J PHYS CHEM SOLIDS, V47, P533, DOI 10.1016/0022-3697(86)90155-1
   Ikoma T, 1999, J MATER SCI LETT, V18, P1225, DOI 10.1023/A:1006610521173
   Itoh S, 2006, ARTIF ORGANS, V30, P863, DOI 10.1111/j.1525-1594.2006.00313.x
   Kalogeras IM, 2002, J APPL PHYS, V92, P406, DOI 10.1063/1.1481776
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Liu W, 2008, J AM CERAM SOC, V91, P3245, DOI 10.1111/j.1551-2916.2008.02595.x
   Liu W, 2008, J AM CERAM SOC, V91, P3251, DOI 10.1111/j.1551-2916.2008.02613.x
   Ma GB, 2009, CRYST GROWTH DES, V9, P2991, DOI 10.1021/cg900156w
   MAITI GC, 1981, J CHEM SOC DALTON, P949, DOI 10.1039/dt9810000949
   Nakamura M, 2010, J BIOMED MATER RES A, V92A, P783, DOI 10.1002/jbm.a.32404
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   Neagu RM, 2001, MATER RES INNOV, V4, P115, DOI 10.1007/PL00010780
   Sessler G.M., 1999, ELECTRETS, V1
   Tanaka Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3265429
   Ueshima M, 2002, ADV MATER, V14, P591, DOI 10.1002/1521-4095(20020418)14:8<591::AID-ADMA591>3.0.CO;2-7
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   VANDERSCHUEREN J, 1979, THERMALLY STIMULATED, pCH4
   Vassilikou-Dova A, 1999, J APPL PHYS, V85, P352, DOI 10.1063/1.369455
   YAMASHITA K, 1995, J AM CERAM SOC, V78, P1191, DOI 10.1111/j.1151-2916.1995.tb08468.x
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Yashima M, 2011, J PHYS CHEM C, V115, P25077, DOI 10.1021/jp208746y
NR 29
TC 24
Z9 24
U1 2
U2 26
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD OCT 1
PY 2012
VL 112
IS 7
AR 074901
DI 10.1063/1.4754298
PG 6
WC Physics, Applied
SC Physics
GA 029IT
UT WOS:000310489400157
DA 2018-10-19
ER

PT J
AU Mareci, D
   Punguta, C
   Romas, M
   Bistriceanu, IL
   Munteanu, C
   Sutiman, D
AF Mareci, Daniel
   Punguta, Catalin
   Romas, Manuela
   Bistriceanu, Ionut Lucian
   Munteanu, Corneliu
   Sutiman, Daniel
TI CORROSION BEHAVIOR OF CoCrMo ALLOY IN NON-PASTEURIZED AND PASTEURIZED
   APPLE JUICE
SO ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL
LA English
DT Article
DE CoCrMo alloy; cyclic potentiodynamic polarisation curves; EIS;
   pasteurized apple juice; SEM
ID PULSED ELECTRIC-FIELDS; IN-VITRO CORROSION; DENTAL ALLOYS;
   ELECTROCHEMICAL CHARACTERIZATION; ARTIFICIAL SALIVA; TI-6AL-7NB ALLOY;
   RESISTANCE; TITANIUM; SERUM; EIS
AB CoCrMo alloy used currently as metallic biomaterial was investigated in view of dental applications using electrochemical methods. The prevalence of dental corrosion in human mouth has increased in the few decades as a result of an increasing consumption of commercial fruit juices. Two electrochemical techniques were used: cyclic potentiodynamic polarization and electrochemical impedance spectroscopy (EIS) in non-pasteurized and pasteurized apple juice at 25 degrees C. The electrochemical corrosion properties of CoCrMo alloy was measured in terms of zero current potential (ZCP) and corrosion current density (i(corr)). EIS technique was applied to study the nature of the passive film formed on CoCrMo sample at various time immersed in non-pasteurized and pasteurized apple juice: 1 minute, 1 hour and 3 hours. From EIS data, an equivalent circuit (EC) with on time constant was modelled.
C1 [Mareci, Daniel; Romas, Manuela; Sutiman, Daniel] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
   [Punguta, Catalin; Bistriceanu, Ionut Lucian; Munteanu, Corneliu] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Iasi 700050, Romania.
RP Mareci, D (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, 73 Prof Dr Doc D Mangeron Blvd, Iasi 700050, Romania.
EM danmareci@yahoo.com
RI Munteanu, Corneliu/P-5414-2014
OI Mareci, Daniel/0000-0002-5859-1996
CR Airoldi G, 1997, AM J ORTHOD DENTOFAC, V112, P58, DOI 10.1016/S0889-5406(97)70274-9
   Cheng XL, 2005, BIOMATERIALS, V26, P7350, DOI 10.1016/j.biomaterials.2005.05.047
   Contu F, 2002, J BIOMED MATER RES, V62, P412, DOI 10.1002/jbm.10329
   GEISGERSTORFER J, 1994, J DENT, V22, P247, DOI 10.1016/0300-5712(94)90124-4
   Kobayashi E, 1998, J MATER SCI-MATER M, V9, P567, DOI 10.1023/A:1008909408948
   MANSFELD F, 1973, J ELECTROCHEM SOC, V120, P515, DOI 10.1149/1.2403489
   Mareci D, 2010, J OPTOELECTRON ADV M, V12, P1590
   Mareci D, 2007, ENVIRON ENG MANAG J, V6, P313, DOI 10.30638/eemj.2007.034
   Mareci D, 2010, ENVIRON ENG MANAG J, V9, P81
   Mareci D, 2009, ENVIRON ENG MANAG J, V8, P397
   Milosev I, 2008, ELECTROCHIM ACTA, V53, P3547, DOI 10.1016/j.electacta.2007.12.041
   Mirza Rosca J.C., 2007, MICROSC MICROANAL, V13, P478
   Qin BL, 1995, FOOD TECHNOL-CHICAGO, V49, P55
   Qin BL, 1996, CRIT REV FOOD SCI, V36, P603, DOI 10.1080/10408399609527741
   Raistrick I. D., 1987, IMPEDANCE SPECTROSCO
   Sanchez G A, 2003, Int J Paediatr Dent, V13, P251, DOI 10.1046/j.1365-263X.2003.00469.x
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Strugaru SI, 2010, ENVIRON ENG MANAG J, V9, P779
   Tahmassebi JF, 2006, J DENT, V34, P2, DOI 10.1016/j.jdent.2004.11.006
   Vega-Mercado H., 1997, TRENDS FOOD SCI, V62, P399
   Von Fraunhofer J.A., 1994, CORROSION, V1
NR 21
TC 1
Z9 1
U1 1
U2 15
PU GH ASACHI TECHNICAL UNIV IASI
PI IASI
PA 71 MANGERON BLVD, IASI, 700050, ROMANIA
SN 1582-9596
J9 ENVIRON ENG MANAG J
JI Environ. Eng. Manag. J.
PD OCT
PY 2012
VL 11
IS 10
BP 1865
EP 1871
DI 10.30638/eemj.2012.232
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 043QI
UT WOS:000311559500018
OA Bronze
DA 2018-10-19
ER

PT J
AU Aryee, FNA
   Nickerson, MT
AF Aryee, Felix N. A.
   Nickerson, Michael T.
TI Formation of electrostatic complexes involving mixtures of lentil
   protein isolates and gum Arabic polysaccharides
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Lentil protein isolates; Gum Arabic; Complex coacervation; Associative
   phase separation
ID FUNCTIONAL-PROPERTIES; BETA-LACTOGLOBULIN; WHEY PROTEINS; ISOELECTRIC
   PRECIPITATION; KAPPA-CARRAGEENAN; CHITOSAN MIXTURES; PHASE-SEPARATION;
   IONIC-STRENGTH; AQUEOUS-MEDIUM; COACERVATION
AB Formation of electrostatic complexes involving a mixture of lentil protein isolates (LPI) and gum Arabic (GA) as a function of pH (1.50-8.00) and biopolymer mixing ratio (1:4-10:1 LPI:GA) were investigated by turbidimetric analyses during an acid titration. The nature of interactions was also studied in the presence of destabilizing agents (e.g., 100 mM urea and NaCl), at an elevated temperature (60 degrees C), and as a function of lentil processing (e.g., hulled vs. dehulled). Complex formation followed two pH-dependent structure forming events associated with the formation of soluble and insoluble complexes. For the 1:1 LPI:GA ratio, soluble and insoluble complexes formed at pH 5.87 and 3.62, respectively, with maximum formation occurring at pH 3.50. The addition of GA also resulted in a shift from of LPI's isoelectric point (pH 4.70) to a lower pH (3.17) as chains complexed to the surface of the protein, as measured by electrophoretic mobility versus pH. As the biopolymer mixing ratios increased, critical pHs shifted towards higher pH until reaching the 1:1 mixing ratio, afterwards becoming relatively ratio independent. Complex formation was found to be primarily driven by electrostatic attractive forces with secondary stabilization by hydrogen bonding. Hydrophobic interactions were thought to play a role in the stabilization of LPI-LPI aggregates as part of the formed complexes, rather than in its formation. Removal of the hull resulted in an isolate product with higher surface hydrophobicity than that with the hull. Complex formation shifted slightly to higher pH within the mixture containing isolates derived from dehulled lentil than with, thought to be associated with the higher surface hydrophobicity on the surface. Knowledge of mechanisms driving complex formation within LPI:GA mixtures could lead to improved utilization as food and/or biomaterial ingredients. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Aryee, Felix N. A.; Nickerson, Michael T.] Univ Saskatchewan, Dept Food & Bioprod Sci, Saskatoon, SK S7N 5A8, Canada.
RP Nickerson, MT (reprint author), Univ Saskatchewan, Dept Food & Bioprod Sci, 51 Campus Dr, Saskatoon, SK S7N 5A8, Canada.
EM Michael.Nickerson@usask.ca
FU Natural Science and Engineering Research Council of Canada
FX Financial assistance for this study was provided by the Natural Science
   and Engineering Research Council of Canada.
CR [Anonymous], 1995, OFFICIAL METHODS ANA
   Antonov YA, 2000, INT J BIOL MACROMOL, V27, P279, DOI 10.1016/S0141-8130(00)00129-X
   AOAC, 2003, OFFICIAL METHODS ANA
   Boral S, 2010, J PHYS CHEM B, V114, P12027, DOI 10.1021/jp105431t
   Boye JI, 2010, FOOD RES INT, V43, P537, DOI 10.1016/j.foodres.2009.07.021
   Boye J, 2010, FOOD RES INT, V43, P414, DOI 10.1016/j.foodres.2009.09.003
   Chourpa I, 2006, BIOMACROMOLECULES, V7, P2616, DOI 10.1021/bm060131d
   Dickinson E, 1998, FOOD HYDROCOLLOID, V12, P417, DOI 10.1016/S0268-005X(98)00055-1
   Doublier JL, 2000, CURR OPIN COLLOID IN, V5, P202, DOI 10.1016/S1359-0294(00)00054-6
   Dror Y, 2006, J POLYM SCI POL PHYS, V44, P3265, DOI 10.1002/polb.20970
   Ducel V, 2004, COLLOID SURFACE A, V232, P239, DOI 10.1016/j.corlsurfa.2003.11.001
   Elmer C, 2011, FOOD RES INT, V44, P1441, DOI 10.1016/j.foodres.2011.03.011
   Girard M, 2002, FOOD HYDROCOLLOID, V16, P585, DOI 10.1016/S0268-005X(02)00020-6
   Gupta A. N., 2007, J PHYS CHEM B, V111, P1137
   Jaramillo DP, 2011, FOOD RES INT, V44, P911, DOI 10.1016/j.foodres.2011.01.057
   Kaibara K, 2000, BIOMACROMOLECULES, V1, P100, DOI 10.1021/bm990006k
   Karaca AC, 2011, FOOD RES INT, V44, P2742, DOI 10.1016/j.foodres.2011.06.012
   KATO A, 1980, BIOCHIM BIOPHYS ACTA, V624, P13, DOI 10.1016/0005-2795(80)90220-2
   Klassen DR, 2011, FOOD CHEM, V126, P1094, DOI 10.1016/j.foodchem.2010.11.138
   Klemmer KJ, 2012, FOOD CHEM, V130, P710, DOI 10.1016/j.foodchem.2011.07.114
   Landry J, 1993, FOOD CHEM, V49, P95
   Lee HC, 2007, FOOD CHEM, V102, P1199, DOI 10.1016/j.foodchem.2006.07.008
   Lii CY, 2002, EUR POLYM J, V38, P1377, DOI 10.1016/S0014-3057(02)00008-3
   Liu S, 2010, FOOD RES INT, V43, P489, DOI 10.1016/j.foodres.2009.07.022
   Liu SH, 2010, J AGR FOOD CHEM, V58, P552, DOI 10.1021/jf902768v
   Liu SH, 2009, J AGR FOOD CHEM, V57, P1521, DOI 10.1021/jf802643n
   Mounsey JS, 2008, FOOD HYDROCOLLOID, V22, P65, DOI 10.1016/j.foodhyd.2007.04.006
   Papalamprou EM, 2009, FOOD HYDROCOLLOID, V23, P337, DOI 10.1016/j.foodhyd.2008.03.006
   Pearson A. M., 1983, DEV FOOD PROTEINS, P67
   Roy F, 2010, FOOD RES INT, V43, P432, DOI 10.1016/j.foodres.2009.09.002
   Schmitt C, 1999, FOOD HYDROCOLLOID, V13, P483, DOI 10.1016/S0268-005X(99)00032-6
   Schmitt C, 1998, CRIT REV FOOD SCI, V38, P689, DOI 10.1080/10408699891274354
   Schmitt C, 2011, ADV COLLOID INTERFAC, V167, P63, DOI 10.1016/j.cis.2010.10.001
   Singh S., 2007, INT J BIOL MACROMOL, V41, P158
   Stone AK, 2012, FOOD HYDROCOLLOID, V27, P271, DOI 10.1016/j.foodhyd.2011.08.006
   SWANSON BG, 1990, J AM OIL CHEM SOC, V67, P276, DOI 10.1007/BF02539676
   Tolstoguzov VB, 1991, FOOD HYDROCOLLOID, V4, P429
   Turgeon SL, 2003, CURR OPIN COLLOID IN, V8, P401, DOI 10.1016/S1359-0294(03)00093-1
   Uruakpa FO, 2005, FOOD RES INT, V38, P659, DOI 10.1016/j.foodres.2005.01.004
   Uruakpa FO, 2006, INT J BIOL MACROMOL, V38, P115, DOI 10.1016/j.ijbiomac.2006.01.016
   Uruakpa FO, 2006, FOOD CHEM, V95, P255, DOI 10.1016/j.foodchem.2005.01.030
   Veis A, 2011, ADV COLLOID INTERFAC, V167, P2, DOI 10.1016/j.cis.2011.01.007
   Wang N, 2005, CEREAL CHEM, V82, P671, DOI 10.1094/CC-82-0671
   Weinbreck F, 2003, BIOMACROMOLECULES, V4, P293, DOI 10.1021/bm025667n
   Weinbreck F, 2003, LANGMUIR, V19, P9404, DOI 10.1021/la0348214
   Weinbreck F, 2004, J AGR FOOD CHEM, V52, P3550, DOI 10.1021/jf034969t
   Weinbreck F, 2004, J RHEOL, V48, P1215, DOI 10.1122/1.1795191
   WHITE JA, 1986, J AUTOM CHEM, V8, P170, DOI 10.1155/S1463924686000330
   Ye AQ, 2008, INT J FOOD SCI TECH, V43, P406, DOI 10.1111/j.1365-2621.2006.01454.x
NR 49
TC 29
Z9 29
U1 3
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0963-9969
J9 FOOD RES INT
JI Food Res. Int.
PD OCT
PY 2012
VL 48
IS 2
BP 520
EP 527
DI 10.1016/j.foodres.2012.05.012
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA 038OX
UT WOS:000311185100024
DA 2018-10-19
ER

PT J
AU Ning, Y
   Li, JH
   Cai, WS
   Shao, XG
AF Ning, Yu
   Li, Jihui
   Cai, Wensheng
   Shao, Xueguang
TI Simultaneous determination of heavy metal ions in water using
   near-infrared spectroscopy with preconcentration by nano-hydroxyapatite
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Near-infrared spectroscopy; Quantitative determination; Adsorption;
   Multivariate calibration; Heavy metal ion; Water sample
ID DIFFUSE-REFLECTANCE SPECTROSCOPY; AQUEOUS-SOLUTION; SYNTHETIC
   HYDROXYAPATITE; ACTIVATED CARBON; ADSORPTION; SORPTION; REMOVAL;
   CONTAMINATION; CADMIUM; SOILS
AB A method for simultaneous determination of metal ions in river water was developed by using preconcentration and near-infrared diffuse reflectance spectroscopy (NIRDRS). An inorganic biomaterial, nano-hydroxyapatite (HAP) was used as a high-efficient adsorbent for gathering the ions from water samples. After adsorbing the analytes onto the adsorbent. NIRDRS was measured and partial least squares (PLS) models were established for fast and simultaneous quantitative prediction. With the samples prepared by river water, determination of Pb2+, Zn2+, Cu2+, Cd2+ and Cr3+ was investigated. The calibration models of Cu2+, Cr3+ and total content were proven to be efficient enough for precise prediction. The determination coefficients (R-2) of the independent validation were found as high as 0.9924, 0.9869 and 0.9273 for Cu2+, Cr3+ and total content, respectively. Therefore, the feasibility of NIRDRS for microanalysis of heavy metal ions in waste water was demonstrated. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Ning, Yu; Li, Jihui; Cai, Wensheng; Shao, Xueguang] Nankai Univ, Coll Chem, Res Ctr Analyt Sci, Tianjin 300071, Peoples R China.
RP Shao, XG (reprint author), Nankai Univ, Coll Chem, Res Ctr Analyt Sci, Tianjin 300071, Peoples R China.
EM xshao@nankai.edu.cn
OI Shao, Xueguang/0000-0001-5027-4382
FU National Natural Science Foundation of China [20835002]
FX This work is supported by the National Natural Science Foundation of
   China (No. 20835002).
CR Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x
   Chodak M, 2007, BIOL FERT SOILS, V44, P171, DOI 10.1007/s00374-007-0192-z
   Corami A, 2008, MATER SCI ENG B-ADV, V149, P209, DOI 10.1016/j.mseb.2007.11.006
   Corami A, 2008, J COLLOID INTERF SCI, V317, P402, DOI 10.1016/j.jcis.2007.09.075
   Font R, 2004, ANAL CHEM, V76, P3893, DOI 10.1021/ac035377c
   Forouzangohar M, 2009, ENVIRON SCI TECHNOL, V43, P4049, DOI 10.1021/es8029945
   Frost RL, 2011, SPECTROCHIM ACTA A, V78, P996, DOI 10.1016/j.saa.2010.12.014
   Guo XY, 2008, J HAZARD MATER, V151, P134, DOI 10.1016/j.jhazmat.2007.05.065
   HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020
   Huang ZX, 2009, CHEMOMETR INTELL LAB, V98, P195, DOI 10.1016/j.chemolab.2009.07.001
   Islam A, 2010, TALANTA, V81, P1772, DOI 10.1016/j.talanta.2010.03.035
   Kandori K, 2007, LANGMUIR, V23, P2064, DOI 10.1021/la062562n
   Kara D, 2009, J HAZARD MATER, V165, P1165, DOI 10.1016/j.jhazmat.2008.10.111
   Kemper T, 2002, ENVIRON SCI TECHNOL, V36, P2742, DOI 10.1021/es015747j
   Kooistra L, 2001, ANAL CHIM ACTA, V446, P97, DOI 10.1016/S0003-2670(01)01265-X
   Lagadic IL, 2001, ENVIRON SCI TECHNOL, V35, P984, DOI 10.1021/es001526m
   Li JH, 2011, TALANTA, V84, P679, DOI 10.1016/j.talanta.2011.01.072
   Li ZH, 2009, ANAL CHIM ACTA, V632, P272, DOI 10.1016/j.aca.2008.11.001
   Lin KL, 2009, J HAZARD MATER, V161, P231, DOI 10.1016/j.jhazmat.2008.03.076
   Liu JF, 2008, ENVIRON SCI TECHNOL, V42, P6949, DOI 10.1021/es800924c
   Malley DF, 1997, ENVIRON SCI TECHNOL, V31, P3461, DOI 10.1021/es970214p
   Marchat D, 2007, J HAZARD MATER, V139, P453, DOI 10.1016/j.jhazmat.2006.02.040
   Mavropoulos E, 2002, ENVIRON SCI TECHNOL, V36, P1625, DOI 10.1021/es0155938
   Mikula B, 2007, TALANTA, V71, P136, DOI 10.1016/j.talanta.2006.03.041
   Monteil-Rivera F, 2000, J COLLOID INTERF SCI, V221, P291, DOI 10.1006/jcis.1999.6566
   Moros J, 2009, TALANTA, V78, P388, DOI 10.1016/j.talanta.2008.11.041
   Moros J, 2008, ANAL CHIM ACTA, V624, P113, DOI 10.1016/j.aca.2008.06.030
   Moros J, 2010, TRAC-TREND ANAL CHEM, V29, P578, DOI 10.1016/j.trac.2009.12.012
   Moros J, 2009, ENVIRON SCI TECHNOL, V43, P9314, DOI 10.1021/es9005898
   Oliva J, 2011, J HAZARD MATER, V194, P312, DOI 10.1016/j.jhazmat.2011.07.104
   Palmer SJ, 2011, SPECTROCHIM ACTA A, V79, P69, DOI 10.1016/j.saa.2011.02.001
   Pyrzynska K, 2010, TRAC-TREND ANAL CHEM, V29, P718, DOI 10.1016/j.trac.2010.03.013
   Shafei G. ?M., 2001, J COLLOID INTERF SCI, V238, P160, DOI DOI 10.1006/JCIS.2001.7474
   Sheng N, 2009, TALANTA, V79, P339, DOI 10.1016/j.talanta.2009.03.059
   Wakamura M, 1998, COLLOID SURFACE A, V142, P107, DOI 10.1016/S0927-7757(98)00486-5
   WILLIAMS PC, 1975, CEREAL CHEM, V52, P561
   Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1
   Xia XQ, 2007, ENVIRON SCI TECHNOL, V41, P3449, DOI 10.1021/es0624422
   XU YP, 1994, ENVIRON SCI TECHNOL, V28, P1472, DOI 10.1021/es00057a015
   Zhou D, 2004, WATER RES, V38, P2643, DOI 10.1016/j.watres.2004.03.026
NR 40
TC 23
Z9 26
U1 2
U2 46
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD OCT
PY 2012
VL 96
BP 289
EP 294
DI 10.1016/j.saa.2012.05.034
PG 6
WC Spectroscopy
SC Spectroscopy
GA 039LY
UT WOS:000311248500035
PM 22698846
DA 2018-10-19
ER

PT J
AU Silvestre, JS
AF Silvestre, Jean-Sebastien
TI Pro-angiogenic cell-based therapy for the treatment of ischemic
   cardiovascular diseases
SO THROMBOSIS RESEARCH
LA English
DT Article
ID ACUTE MYOCARDIAL-INFARCTION; ENDOTHELIAL PROGENITOR CELLS; PLURIPOTENT
   STEM-CELLS; RANDOMIZED PHASE-1 TRIAL; SEVERE LIMB ISCHEMIA;
   BONE-MARROW-CELLS; POSTNATAL VASCULOGENESIS; NEOVASCULARIZATION;
   TRANSPLANTATION; REGENERATION
AB Pro-angiogenic cell therapy has emerged as a promising option to treat patients with acute myocardial infarction or with critical limb ischemia. Exciting pre-clinical studies have prompted the initiation of numerous clinical trials based on administration of stem/progenitor cells with pro-angiogenic potential. Most of the clinical studies performed so far have used bone marrow-derived or peripheral blood-derived mononuclear cells and showed, overall, a modest but significant benefit on tissue remodeling and function in patients with ischemic diseases. These mixed results pave the way for the development of strategies to overcome the limitation of autologous cell therapy and to propose more efficient approaches. Such strategies include pretreatment of cells with activators to augment cell recruitment and survival in the ischemic target area and/or the improvement of cell functions such as their paracrine ability to release proangiogenic factors and vasoactive molecules. In addition, efforts should be directed towards stimulation of both angiogenesis and vessel maturation, the development of a composite product consisting of stem/progenitor cells encapsulated in a biomaterial and the use of additional sources of regenerative cells. (C) 2012 Elsevier Ltd. All rights reserved.
C1 Univ Paris 05, Paris Cardiovasc Res Ctr, INSERM U970, F-75015 Paris, France.
RP Silvestre, JS (reprint author), Univ Paris 05, Paris Cardiovasc Res Ctr, INSERM U970, 56 Rue Leblanc, F-75015 Paris, France.
EM jean-sebastien.silvestre@inserm.fr
RI Silvestre, Jean-Sebastien/K-7695-2017
OI Silvestre, Jean-Sebastien/0000-0003-3962-2205
CR Aicher A, 2007, CIRC RES, V100, P581, DOI 10.1161/01.RES.0000259562.63718.35
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Broqueres-You D, 2012, DIABETES
   Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318
   Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166
   Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643
   Ebrahimian TG, 2006, AM J PATHOL, V169, P719, DOI 10.2353/ajpath.2006.060042
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Fadini GP, 2010, ATHEROSCLEROSIS, V209, P10, DOI 10.1016/j.atherosclerosis.2009.08.033
   Feihl F, 2008, CARDIOVASC RES, V78, P274, DOI 10.1093/cvr/cvn022
   Foubert P, 2008, CIRC RES, V103, P751, DOI 10.1161/CIRCRESAHA.108.175083
   Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338
   Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Iekushi K, 2012, CIRCULATION, V125, P1765, DOI 10.1161/CIRCULATIONAHA.111.079699
   Kim SW, 2006, STEM CELLS, V24, P1620, DOI 10.1634/stemcells.2005-0365
   Lasala GP, 2012, J THORAC CARDIOV SUR, V144, P377, DOI 10.1016/j.jtcvs.2011.08.053
   Lasala GP, 2010, ANGIOLOGY, V61, P551, DOI 10.1177/0003319710364213
   Lassaletta AD, 2011, BASIC RES CARDIOL, V106, P897, DOI 10.1007/s00395-011-0200-1
   Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154
   Leroyer AS, 2009, CIRCULATION, V119, P2808, DOI 10.1161/CIRCULATIONAHA.108.816710
   Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002
   Loinard C, 2012, CIRCULATION, V125, P1014, DOI 10.1161/CIRCULATIONAHA.111.041830
   Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195
   Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Lyngbaek S, 2007, BASIC RES CARDIOL, V102, P101, DOI 10.1007/s00395-007-0638-3
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220
   Mees B, 2011, AM J PATHOL, V178, P55, DOI 10.1016/j.ajpath.2010.11.043
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562
   Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154
   Oh YZ, 2012, HEART, V98, P443, DOI 10.1136/heartjnl-2011-301317
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Rufaihah AJ, 2011, ARTERIOSCL THROM VAS, V31, pE72, DOI 10.1161/ATVBAHA.111.230938
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905
   Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8
   Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93
   Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670
   Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182
   Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003
   Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433
   You D, 2008, HYPERTENSION, V51, P1537, DOI 10.1161/HYPERTENSIONAHA.107.109066
   You D, 2008, J PHARMACOL EXP THER, V325, P766, DOI 10.1124/jpet.107.131532
   You D, 2006, CIRCULATION, V114, P328, DOI 10.1161/CIRCULATIONAHA.105.589937
   Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463
NR 52
TC 12
Z9 14
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD OCT
PY 2012
VL 130
SU 1
BP S90
EP S94
DI 10.1016/j.thromres.2012.08.287
PG 5
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 027JU
UT WOS:000310349200029
PM 23026676
DA 2018-10-19
ER

PT J
AU Xiao, DM
   Yang, YQ
   Su, XB
   Wang, D
   Luo, ZY
AF Xiao Dong-ming
   Yang Yong-qiang
   Su Xu-bin
   Wang Di
   Luo Zi-yi
TI Topology optimization of microstructure and selective laser melting
   fabrication for metallic biomaterial scaffolds
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE topology optimization; selective laser melting (SLM); microstructure;
   metallic biomaterial scaffolds
ID TISSUE ENGINEERING SCAFFOLDS; DESIGN; TITANIUM; SURFACES; POROSITY;
   ALLOY
AB The precise design and fabrication of biomaterial scaffolds is necessary to provide a systematic study for bone tissue engineering. Biomaterial scaffolds should have sufficient stiffness and large porosity. These two goals generally contradict since larger porosity results in lower mechanical properties. To seek the microstructure of maximum stiffness with the constraint of volume fraction by topology optimization method, algorithms and programs were built to obtain 2D and 3D optimized microstructure and then they were transferred to CAD models of STL format. Ti scaffolds with 30% volume fraction were fabricated using a selective laser melting (SLM) technology. The architecture and pore shape in the metallic biomaterial scaffolds were relatively precise reproduced and the minimum mean pore size was 231 mu m. The accurate fabrication of intricate microstructure has verified that the SLM process is suitable for fabrication of metallic biomaterial scaffolds.
C1 [Su Xu-bin] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
   [Xiao Dong-ming; Yang Yong-qiang; Wang Di] S China Univ Technol, Sch Mech & Automot Engn, Guangzhou 510641, Guangdong, Peoples R China.
   [Xiao Dong-ming] Hunan Univ Sci & Technol, Sch Electromech Engn, Xiangtan 411201, Peoples R China.
   [Luo Zi-yi] Guangzhou Res Inst Nonferrous Met, Guangzhou 510650, Guangdong, Peoples R China.
RP Su, XB (reprint author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
EM scutsxb@yahoo.com.cn
FU National Natural Science Foundation of China [51275179]; Industry,
   University and Research Institute Combination of Ministry of Education,
   Ministry of Science and Technology and Guangdong Province, China
   [2010A090200072]; China Postdoctoral Science Foundation [2012M511797];
   Fundamental Research Funds for the Central Universities of China
   [2012ZB0014]
FX Foundation item: Project (51275179) supported by the National Natural
   Science Foundation of China; Project (2010A090200072) supported by
   Industry, University and Research Institute Combination of Ministry of
   Education, Ministry of Science and Technology and Guangdong Province,
   China; Project (2012M511797) supported by China Postdoctoral Science
   Foundation; Project (2012ZB0014) supported by Fundamental Research Funds
   for the Central Universities of China
CR Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Gu YW, 2009, MAT SCI ENG C-BIO S, V29, P1515, DOI 10.1016/j.msec.2008.11.003
   Hollister SJ, 2007, COMPUT METHOD APPL M, V196, P2991, DOI 10.1016/j.cma.2006.09.023
   Huang X, 2007, FINITE ELEM ANAL DES, V43, P1039, DOI 10.1016/j.finel.2007.06.006
   Kang H, 2010, STRUCT MULTIDISCIP O, V42, P633, DOI 10.1007/s00158-010-0508-8
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Li JP, 2005, J MATER SCI-MATER M, V16, P1159, DOI 10.1007/s10856-005-4723-6
   Lin LL, 2007, J RARE EARTH, V25, P379
   Miyao R., 2000, J JAPAN SOC POWDER M, V47, P1239
   Murr LE, 2009, MATER CHARACT, V60, P96, DOI 10.1016/j.matchar.2008.07.006
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Prymak O, 2005, BIOMATERIALS, V26, P5801, DOI 10.1016/j.biomaterials.2005.02.029
   Sigmund O, 1997, J MECH PHYS SOLIDS, V45, P1037, DOI 10.1016/S0022-5096(96)00114-7
   Singare S, 2004, MED ENG PHYS, V26, P671, DOI 10.1016/j.medengphy.2004.06.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001
   Van Cleynenbreugel T, 2002, J MATER SCI-MATER M, V13, P1245, DOI 10.1023/A:1021183230549
   Wang D., 2011, INT J ADV MANUF TECH, V54, P1
   Yang XY, 1999, AIAA J, V37, P1483, DOI 10.2514/2.626
   Yang Y, 2011, P I MECH ENG B-J ENG, V225, P2249, DOI 10.1177/0954405411407997
   Yoo DJ, 2011, INT J PRECIS ENG MAN, V12, P61, DOI 10.1007/s12541-011-0008-9
NR 23
TC 14
Z9 16
U1 3
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD OCT
PY 2012
VL 22
IS 10
BP 2554
EP 2561
DI 10.1016/S1003-6326(11)61500-8
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 030IU
UT WOS:000310565200034
DA 2018-10-19
ER

PT J
AU Guo, YY
   Cheng, MQ
   Chen, DS
   Xue, XB
   Zhang, XL
AF Guo Yong-yuan
   Cheng Meng-qi
   Chen De-sheng
   Xue Xiao-bing
   Zhang Xian-long
TI In vitro corrosion resistance and cytotoxicity of novel TiNbTaZr alloy
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE beta-type titanium alloy; corrosion behavior; electrochemical
   techniques; cytotoxicity
ID TITANIUM-ALLOY; BEHAVIOR; BIOCOMPATIBILITY; TANTALUM; NIOBIUM;
   OSTEOBLASTS; IMPLANTS; IONS
AB A novel beta type Ti35Nb2Ta3Zr alloy with low modulus (48 GPa) was fabricated using vacuum consumable arc melting. The corrosion resistance and cytotoxicity of Ti35Nb2Ta3Zr were evaluated. The open circuit potential, electrochemical impedance spectroscopy (EIS) and potentiodynamic polarization methods were used to determine the corrosion resistance. In Ringer's solution, Ti35Nb2Ta3Zr alloy exhibits better corrosion resistance, as compared to that of Ti6Al4V and Ti. The cytotoxicity tests indicate that the biocompatibility of Ti35Nb2Ta3Zr is as good as Ti and Ti6Al4V which are widely used in biomedical fields. Based on corrosion resistance and cytotoxicity, the novel beta type Ti35Nb2Ta3Zr alloy can be considered as a potential biomaterial.
C1 [Guo Yong-yuan; Cheng Meng-qi; Chen De-sheng; Zhang Xian-long] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Orthopaed, Shanghai 200233, Peoples R China.
   [Xue Xiao-bing] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
RP Zhang, XL (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Orthopaed, Shanghai 200233, Peoples R China.
EM titanium12@163.com; orthopedics2012@163.com
FU National Natural Science Foundation of China [81171688];
   Interdisciplinary (Engineering-Medical) Research Fund of Shanghai Jiao
   Tong University, China [YG2011MS30]; Shanghai Municipal Health Bureau
   Science Fund for Young Scholars, China [2010QJ036A]
FX Project (81171688) supported by the National Natural Science Foundation
   of China; Project (YG2011MS30) supported by the Interdisciplinary
   (Engineering-Medical) Research Fund of Shanghai Jiao Tong University,
   China; Project (2010QJ036A) supported by the Shanghai Municipal Health
   Bureau Science Fund for Young Scholars, China
CR Bertrand E, 2010, J MECH BEHAV BIOMED, V3, P559, DOI 10.1016/j.jmbbm.2010.06.007
   Cabrini R L, 1993, Implant Dent, V2, P264, DOI 10.1097/00008505-199312000-00008
   Godley R, 2006, J MATER SCI-MATER M, V17, P63, DOI 10.1007/s10856-006-6330-6
   GUO L, 2001, CHINESE J NONFERROUS, V11, P4
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Hamdy AS, 2006, INT J ELECTROCHEM SC, V1, P171
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Jung TK, 2010, MATER SCI FORUM, V631-632, P205, DOI 10.4028/www.scientific.net/MSF.631-632.205
   Kulakov O B, 2005, Morfologiia, V127, P52
   Li YC, 2009, TISSUE ENG PT A, V15, P3151, DOI [10.1089/ten.tea.2009.0150, 10.1089/ten.TEA.2009.0150]
   LUO L J, 2005, CHINESE J RARE METAL, V29, P3
   Mareci D, 2009, ACTA BIOMATER, V5, P3625, DOI 10.1016/j.actbio.2009.05.037
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P3506, DOI 10.1016/j.electacta.2005.10.007
   Oliveira NTC, 2004, ELECTROCHIM ACTA, V49, P4563, DOI 10.1016/j.electacta.2004.04.042
   Park CH, 2011, CLIN ORAL IMPLAN RES, V22, P735, DOI 10.1111/j.1600-0501.2010.02053.x
   Robin A, 2000, INT J REFRACT MET H, V18, P13, DOI 10.1016/S0263-4368(99)00034-7
   Rosalbino F, 2011, J MATER SCI-MATER M, V22, P1293, DOI 10.1007/s10856-011-4301-z
   Ruan JM, 2001, J CENT SOUTH UNIV T, V8, P147, DOI 10.1007/s11771-001-0044-1
   Samuel S, 2010, J BIOMED MATER RES A, V94A, P1251, DOI 10.1002/jbm.a.32782
   Sherepo K.M., 2004, MED TEKH, V2, P22
   Wang LQ, 2008, MAT SCI ENG A-STRUCT, V490, P421, DOI 10.1016/j.msea.2008.03.003
   WANG R, 2007, J CLIN STOMATOLOGY, V23, P4
   Wang XJ, 2010, TISSUE ENG PT A, V16, P309, DOI [10.1089/ten.tea.2009.0074, 10.1089/ten.TEA.2009.0074]
   Yang HP, 2011, T NONFERR METAL SOC, V21, P179, DOI 10.1016/S1003-6326(11)60696-1
   Yu WQ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065012
NR 28
TC 5
Z9 5
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1003-6326
EI 2210-3384
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD OCT
PY 2012
VL 22
SU 1
BP S175
EP S180
DI 10.1016/S1003-6326(12)61705-1
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 030JP
UT WOS:000310567300031
DA 2018-10-19
ER

PT J
AU Steinbach, A
   Tautzenberger, A
   Schaller, A
   Kalytta-Mewes, A
   Trankle, S
   Ignatius, A
   Volkmer, D
AF Steinbach, Annina
   Tautzenberger, Andrea
   Schaller, Andreas
   Kalytta-Mewes, Andreas
   Traenkle, Sebastian
   Ignatius, Anita
   Volkmer, Dirk
TI Plasma-Enhanced Chemical Vapor Deposition of n-Heptane and Methyl
   Methacrylate for Potential Cell Alignment Applications
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE biomaterials; thin films; plasma enhanced chemical vapor deposition
   (PE-CVD); plasma polymers; micropatterning; MC3T3-E1
ID OSTEOBLAST-LIKE CELLS; MC3T3-E1 CELLS; POLY(METHYL METHACRYLATE);
   SURFACE CHARACTERIZATION; POLYMERIZATION; POLYMERS; BONE; BIOMATERIALS;
   ORGANIZATION; ORIENTATION
AB Plasma-enhanced chemical vapor deposited polymers (plasma polymers) are promising candidates for biomaterials applications. In the present study, plasma deposition as a fast and easily scalable method was adapted to deposit coatings from n-heptane and methyl methacrylate monomers onto glass substrates. Linear patterns with line and groove widths between 1.25 and 160 mu m were introduced by degrative UV-lithography for cell alignment. Differential interference contrast optical microscopy, profilometry and atomic force microscopy revealed that the patterned surfaces had a smooth, homogeneous appearance and a pattern height of 8 and 45 nm for plasma deposited n-heptane and methyl methacrylate, respectively. UV-lithography increased the oxygen content on the surface drastically as shown by X-ray photoelectron spectroscopy. After immersion in simulated body fluid for 21 days, the pattern was still intact, and the ester groups were also maintained for the most part as shown by infrared spectroscopy. To test the coatings' potential applicability for biomaterial surfaces in a preliminary experiment, we cultured murine preosteoblastic MC3T3-E1 cells on these coatings. Light and electron microscopically, a normal spindle-shaped and aligned cell morphology was observed. At the mRNA level, cells showed no signs of diminished proliferation or elevated expression of apoptosis markers. In conclusion, plasma-enhanced chemical vapor deposited polymers can be patterned with a fast and feasible method and might be suitable materials to guide cell alignment.
C1 [Steinbach, Annina; Schaller, Andreas; Kalytta-Mewes, Andreas; Traenkle, Sebastian; Volkmer, Dirk] Univ Augsburg, Inst Phys, Chair Solid State Chem, D-86159 Augsburg, Germany.
   [Tautzenberger, Andrea; Ignatius, Anita] Ctr Musculoskeletal Res Ulm, Inst Orthopaed Res & Biomech, D-89081 Ulm, Germany.
RP Volkmer, D (reprint author), Univ Augsburg, Inst Phys, Chair Solid State Chem, Univ Str 1, D-86159 Augsburg, Germany.
EM dirk.volkmer@physik.uni-augsburg.de
RI Ignatius, Anita/M-6012-2013
OI Ignatius, Anita/0000-0002-4782-1979
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   Arias JL, 2004, J MATER CHEM, V14, P2154, DOI 10.1039/b401396d
   Ball V, 2012, BIONANOSCIENCE, V2, P16, DOI 10.1007/s12668-011-0032-3
   Buehler M. J., 2009, P ASME INT MECH ENG, P795
   Casserly TB, 2006, CHEM VAPOR DEPOS, V12, P59, DOI 10.1002/cvde.200506409
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   DiMaio FR, 2002, ORTHOPEDICS, V25, P1399
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Forch R., 2005, PLASMA PROCESS POLYM, V2, P351
   Gengenbach TR, 1998, J POLYM SCI POL CHEM, V36, P985, DOI 10.1002/(SICI)1099-0518(19980430)36:6<985::AID-POLA14>3.0.CO;2-H
   Gijsman P, 1999, POLYM DEGRAD STABIL, V65, P433, DOI 10.1016/S0141-3910(99)00033-6
   Kenar H, 2008, J BIOMED MATER RES A, V85A, P1001, DOI 10.1002/jbm.a.31638
   KIM YS, 1987, CALCIFIED TISSUE INT, V41, P218, DOI 10.1007/BF02555241
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Letsche S. A., 2012, THESIS U ULM
   Lewis HGP, 2000, CHEM MATER, V12, P3488
   Limb SJ, 1998, J APPL POLYM SCI, V67, P1489, DOI 10.1002/(SICI)1097-4628(19980222)67:8<1489::AID-APP14>3.0.CO;2-X
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Meier C, 2011, BIOMACROMOLECULES, V12, P3453, DOI 10.1021/bm2005752
   Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2
   Oonishi Hiroyuki, 2011, Acta Orthop, V82, P553, DOI 10.3109/17453674.2011.625538
   Ploux L, 2009, LANGMUIR, V25, P8161, DOI 10.1021/la900457f
   Robinson DE, 2010, PLASMA PROCESS POLYM, V7, P102, DOI 10.1002/ppap.200900115
   Saito M, 2003, J BONE MINER RES, V18, P1695, DOI 10.1359/jbmr.2003.18.9.1695
   SANTAVIRTA S, 1991, ACTA ORTHOP SCAND, V62, P29, DOI 10.3109/17453679108993087
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Soeriyadi AH, 2012, J POLYM SCI POL CHEM, V50, P1801, DOI 10.1002/pola.25947
   Steinbach A, 2012, J MATER SCI-MATER M, V23, P573, DOI 10.1007/s10856-011-4525-y
   Suffner J, 2007, CHEM VAPOR DEPOS, V13, P459, DOI 10.1002/cvde.200606522
   Thian ES, 2006, J BIOMED MATER RES B, V76B, P326, DOI 10.1002/jbm.b.30368
   Timmons RB, 2004, PLASMA POLYM FILMS, P217
   Topala I, 2009, IEEE T PLASMA SCI, V37, P946, DOI 10.1109/TPS.2009.2016424
   Tsutsumimoto T, 1999, J BONE MINER RES, V14, P1751, DOI 10.1359/jbmr.1999.14.10.1751
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   YASUDA H, 1977, J POLYM SCI POL CHEM, V15, P81, DOI 10.1002/pol.1977.170150109
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   Zahor D, 2007, MAT SCI ENG C-BIO S, V27, P117, DOI 10.1016/j.msec.2006.03.005
   Zhang W, 2011, BIO-MED MATER ENG, V21, P75, DOI 10.3233/BME-2011-0657
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
NR 45
TC 4
Z9 4
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD OCT
PY 2012
VL 4
IS 10
BP 5196
EP 5203
DI 10.1021/am301124b
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 024KV
UT WOS:000310109000021
PM 22992135
DA 2018-10-19
ER

PT J
AU Wang, ZZ
   Wang, Q
   Dang, LP
AF Wang, Zhanzhong
   Wang, Qian
   Dang, Leping
TI Ionic liquids as selectors for controlling the crystallization
   nucleation of hen egg white lysozyme
SO BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
LA English
DT Article
DE lysozyme; nucleation control; ionic liquids; crystallization separation
ID PROTEIN CRYSTAL NUCLEATION; INDUCTION TIME; ADDITIVES; TEMPERATURE;
   SOLUBILITY; KINETICS; GROWTH; SALTS
AB Ionic liquids (ILs) have biomaterial applications and are used for protein crystallization. The effect of two imidazolium-based ILs, 1-butyl-3-methylimidazolium chloride ([C(4)mim]Cl) and 1,3-dimethylimidazolium iodide ([dmim]I), on the nucleation kinetics of lysozyme was investigated by determining the nucleation induction time, and nucleation parameters were evaluated. The values of interfacial tension calculated for solutions with added 30 g/L ILs [C(4)mim]Cl and [dmim]I, and without added ILs were 99.03, 109.7, and 107.3 mJ/m(2), respectively. Compared with solutions without IL addition, the critical free energy change, size, and molecular number of critical nuclei decreased and the nucleation rate increased after the addition of [C(4)mim]Cl. In contrast, the critical free energy change, size, and molecular number of critical nuclei increased and the nucleation rate decreased after the addition of [dmim]I. These new findings provide insights into controlling lysozyme crystallization separation, and present ILs as potentially useful additives for controlling the crystallization of macromolecules.
C1 [Wang, Zhanzhong; Wang, Qian; Dang, Leping] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
RP Wang, ZZ (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
EM dleping@hotmail.com
FU National Natural Science Foundation of China [20806053]; Ministry of
   Education of China [200800561029]; China Postdoctoral Science Foundation
   [200902274]
FX This work was funded by the National Natural Science Foundation of China
   (No. 20806053), Doctoral Fund of Ministry of Education of China (No.
   200800561029) and China Postdoctoral Science Foundation (No. 200902274).
CR Aldabaibeh N, 2009, CRYST GROWTH DES, V9, P3313, DOI 10.1021/cg900113e
   Annunziata O, 2008, J AM CHEM SOC, V130, P13347, DOI 10.1021/ja804304e
   Astier JP, 2008, CRYST GROWTH DES, V8, P4215, DOI 10.1021/cg800665b
   Bernardo A, 2004, CRYST GROWTH DES, V4, P799, DOI 10.1021/cg034170+
   Bhamidi V, 2002, CRYST GROWTH DES, V2, P395, DOI 10.1021/cg025504i
   Carbone MN, 2006, BIOTECHNOL BIOENG, V93, P1221, DOI 10.1002/bit.20813
   Gehle D., 1984, APPL MICROBIOL BIOT, V20, P133
   Hekmat D, 2007, BIOTECHNOL LETT, V29, P1703, DOI 10.1007/s10529-007-9456-9
   Judge RA, 2009, CRYST GROWTH DES, V9, P3463, DOI 10.1021/cg900140b
   Knezic D, 2004, J PHYS CHEM B, V108, P10672, DOI 10.1021/jp049586s
   Liu Y., 2003, J TIANJIN U, V5, P553
   Markman O, 1996, J CRYST GROWTH, V160, P382, DOI 10.1016/0022-0248(95)00745-8
   Nanev CN, 2007, CRYST RES TECHNOL, V42, P4, DOI 10.1002/crat.200610761
   Pusey ML, 2007, CRYST GROWTH DES, V7, P787, DOI 10.1021/cg060696t
   Ruckenstein E, 2006, ADV COLLOID INTERFAC, V123, P97, DOI 10.1016/j.cis.2006.05.018
   Van Driessche AES, 2008, CRYST GROWTH DES, V8, P4316, DOI 10.1021/cg800782r
   Wang ZZ, 2011, J CHEM ENG DATA, V56, P1700, DOI 10.1021/je100880a
   Wang ZZ, 2010, J AGR FOOD CHEM, V58, P5444, DOI 10.1021/jf1000343
NR 18
TC 4
Z9 4
U1 2
U2 37
PU KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING
PI SEOUL
PA KOREAN SCIENCE TECHNOLOGY CENTER, #704 YEOGSAM-DONG, KANGNAM-KU, SEOUL
   135-703, SOUTH KOREA
SN 1226-8372
J9 BIOTECHNOL BIOPROC E
JI Biotechnol. Bioprocess Eng.
PD OCT
PY 2012
VL 17
IS 5
BP 1025
EP 1030
DI 10.1007/s12257-012-0096-0
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 026AI
UT WOS:000310239800016
DA 2018-10-19
ER

PT J
AU Lai, JY
AF Lai, Jui-Yang
TI Solvent Composition is Critical for Carbodiimide Cross-Linking of
   Hyaluronic Acid as an Ophthalmic Biomaterial
SO MATERIALS
LA English
DT Article
DE hyaluronic acid; carbodiimide; cross-linking; solvent composition;
   ophthalmic biomaterial
ID LINKED GELATIN MEMBRANES; PIGMENT EPITHELIAL-CELLS; SHEET
   TRANSPLANTATION; SODIUM HYALURONATE; DELIVERY CARRIERS; DRUG-DELIVERY;
   HYDROGELS; STRATEGY; GELS; FUNCTIONALITY
AB Hyaluronic acid (HA) is one of the most important ophthalmic biomaterials, while also being used for tissue engineering and drug delivery. Although chemical cross-linking is an effective way to improve the material performance, it may as a consequence be detrimental to the living cells/tissues. Given that the cross-linking efficiency is mediated by the solvent composition during the chemical modification, this study aims to explore the stability and biocompatibility of carbodiimide cross-linked HA in relation to material processing conditions by varying the acetone/water volume ratio (from 70:30 to 95:5) at a constant 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC) concentration of 100 mM. Our results indicated that after the EDC treatment in the presence of an acetone/water mixture (85:15, v/v), the HA hydrogel membranes have the lowest equilibrium water content, the highest stress at break and the greatest resistance to hyaluronidase digestion. Live/Dead assays and pro-inflammatory cytokine expression analyses showed that the cross-linked HA hydrogel membranes, irrespective of the solvent composition, are compatible with human RPE cell lines without causing toxicity and inflammation. However, it should be noted that the test samples prepared by the cross-linking in the presence of acetone/water mixtures containing 70, 75, and 95 vol % of acetone slightly inhibit the metabolic activity of viable ARPE-19 cultures, probably due to the alteration in the ionic interaction between the medium nutrients and polysaccharide biomaterials. In summary, the water content, mechanical strength and RPE cell proliferative capacity strongly depends on the solvent composition for carbodiimide cross-linking of HA materials.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC100-2628-E-182-004-MY3]; Chang Gung Memorial Hospital [CMRPD2A0111]
FX This work was supported by grant NSC100-2628-E-182-004-MY3 from the
   National Science Council of Republic of China and grant CMRPD2A0111 from
   Chang Gung Memorial Hospital. The author is grateful to I-Hao Tu
   (Institute of Biochemical and Biomedical Engineering, Chang Gung
   University) for technical assistance.
CR Bae MS, 2011, BIOMATERIALS, V32, P8161, DOI 10.1016/j.biomaterials.2011.07.045
   Bhattacharyya S, 2008, BIOMACROMOLECULES, V9, P505, DOI 10.1021/bm7009976
   Bochot A, 2012, J CONTROL RELEASE, V161, P628, DOI 10.1016/j.jconrel.2012.01.019
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Chang-Lin JE, 2011, INVEST OPHTH VIS SCI, V52, P80, DOI 10.1167/iovs.10-5285
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Collins MN, 2007, J APPL POLYM SCI, V104, P3183, DOI 10.1002/app.25993
   Collins MN, 2008, J MATER SCI-MATER M, V19, P3335, DOI 10.1007/s10856-008-3476-4
   Collins MN, 2011, J APPL POLYM SCI, V120, P1040, DOI 10.1002/app.33241
   Dentini M, 2001, MACROMOLECULES, V34, P1449, DOI 10.1021/ma001185x
   Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3
   Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c
   Hsiue GH, 2002, J BIOMED MATER RES, V61, P19, DOI 10.1002/jbm.2000
   Jeng BH, 2004, J CATARACT REFR SURG, V30, P85, DOI 10.1016/S0886-3350(03)00669-2
   Jin R, 2010, BIOMATERIALS, V31, P3103, DOI 10.1016/j.biomaterials.2010.01.013
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Maharjan AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026078
   McDonald CC, 2002, EYE, V16, P601, DOI 10.1038/sj.eye.6700169
   Nakaji-Hirabayashi T, 2009, BIOMATERIALS, V30, P4581, DOI 10.1016/j.biomaterials.2009.05.009
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Shimmura S, 2005, CORNEA, V24, P178, DOI 10.1097/01.ico.0000138843.83044.7d
   Spitzer MS, 2008, ACTA OPHTHALMOL, V86, P842, DOI 10.1111/j.1755-3768.2007.01149.x
   Suri S, 2006, J BIOMED MATER RES A, V79A, P650, DOI 10.1002/jbm.a.30917
   Tomihata K, 1997, BIOMATERIALS, V18, P189, DOI 10.1016/S0142-9612(96)00116-0
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tomihata K, 1996, Tissue Eng, V2, P307, DOI 10.1089/ten.1996.2.307
   Wells LA, 2011, BIOMACROMOLECULES, V12, P923, DOI 10.1021/bm101233m
   Yeom J, 2010, BIOCONJUGATE CHEM, V21, P240, DOI 10.1021/bc9002647
   Zhao X, 2006, J BIOMAT SCI-POLYM E, V17, P419, DOI 10.1163/156856206776374115
NR 49
TC 16
Z9 16
U1 0
U2 41
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD OCT
PY 2012
VL 5
IS 10
BP 1986
EP 2002
DI 10.3390/ma5101986
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA 029OI
UT WOS:000310504800017
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Gong, PY
   Zheng, WF
   Xiao, D
   Jiang, XY
AF Gong PeiYuan
   Zheng WenFu
   Xiao Dan
   Jiang XingYu
TI Microscale methods to assemble mammalian cells into tissue-like
   structures
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Review
DE microscale; cell assembly; tissue-like structures; tissue engineering
ID LIVING CELLS; SOFT LITHOGRAPHY; EXTRACELLULAR-MATRIX;
   MORPHOLOGICAL-DIFFERENTIATION; BASEMENT-MEMBRANE; OPTICAL TWEEZERS;
   SURFACE-PROTEINS; BIOTIN LIGASE; SIALIC-ACID; MANIPULATION
AB Different cell types make up tissues and organs hierarchically and communicate within a complex, three-dimensional (3D) environment. The in vitro recapitulation of tissue-like structures is meaningful, not only for fundamental cell biology research, but also for tissue engineering (TE). Currently, TE research adopts either the top-down or bottom-up approach. The top-down approach involves defining the macroscopic tissue features using biomaterial scaffolds and seeding cells into these scaffolds. Conversely, the bottom-up approach aims at crafting small tissue building blocks with precision-engineered structural and functional microscale features, using physical and/or chemical approaches. The bottom-up strategy takes advantage of the repeating structural and functional units that facilitate cell-cell interactions and cultures multiple cells together as a functional unit of tissue. In this review, we focus on currently available microscale methods that can control mammalian cells to assemble into 3D tissue-like structures.
C1 [Gong PeiYuan; Xiao Dan] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.
   [Zheng WenFu; Jiang XingYu] Natl Ctr Nanosci & Technol, Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
RP Xiao, D (reprint author), Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.
EM xiaodan@scu.edu.cn; xingyujiang@nanoctr.cn
OI Jiang, Xingyu/0000-0002-5008-4703
FU Ministry of Science and Technology of China [2009CB930001,
   2011CB933201]; Chinese Academy of Sciences [KJCX2-YW-M15]; National
   Natural Science Foundation of China [20890020, 90813032, 21025520,
   51073045]
FX This work was supported by Ministry of Science and Technology of China
   (Grant Nos. 2009CB930001 and 2011CB933201), Chinese Academy of Sciences
   (Grant No. KJCX2-YW-M15), and the National Natural Science Foundation of
   China (Grant Nos. 20890020, 90813032, 21025520 and 51073045).
CR Akiyama H, 2010, BIOMATERIALS, V31, P1251, DOI 10.1016/j.biomaterials.2009.11.017
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653
   Bratt-Leal AM, 2011, INTEGR BIOL-UK, V3, P1224, DOI 10.1039/c1ib00064k
   CATTERALL AW, 1995, ANNU REV BIOCHEM, V64, P493
   Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   Chanana M, 2005, NANO LETT, V5, P2605, DOI 10.1021/nl0521219
   Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735
   Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8
   Chen X, 2006, J AM CHEM SOC, V128, P6292, DOI 10.1021/ja060276s
   Choudhury D, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3593407
   De Bank PA, 2003, BIOTECHNOL BIOENG, V81, P800, DOI 10.1002/bit.10525
   De Bank PA, 2007, BIOTECHNOL BIOENG, V97, P1617, DOI 10.1002/bit.21343
   Dobson J, 2008, NAT NANOTECHNOL, V3, P139, DOI 10.1038/nnano.2008.39
   Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105
   Dube DH, 2003, CURR OPIN CHEM BIOL, V7, P616, DOI 10.1016/j.cbpa.2003.08.006
   Dutta D, 2011, J AM CHEM SOC, V133, P8704, DOI 10.1021/ja2022569
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Gartner ZJ, 2009, P NATL ACAD SCI USA, V106, P4606, DOI 10.1073/pnas.0900717106
   Ho VHB, 2010, BIOMATERIALS, V31, P3095, DOI 10.1016/j.biomaterials.2009.12.047
   Hollister SJ, 2006, NAT MATER, V5, P590, DOI 10.1038/nmat1683
   Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102
   Hultstrom J, 2007, ULTRASOUND MED BIOL, V33, P145, DOI 10.1016/j.ultrasmedbio.2006.07.024
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O
   Inaba R, 2009, BIOMATERIALS, V30, P3573, DOI 10.1016/j.biomaterials.2009.03.045
   Ino K, 2008, LAB CHIP, V8, P134, DOI 10.1039/b712330b
   Isenberg BC, 2006, ANN BIOMED ENG, V34, P971, DOI 10.1007/s10439-006-9101-0
   Iwasaki Y, 2005, BIOCONJUGATE CHEM, V16, P567, DOI 10.1021/bc049707r
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kato-Negishi M, 2010, BIOMATERIALS, V31, P8939, DOI 10.1016/j.biomaterials.2010.08.008
   KAYSER H, 1992, J BIOL CHEM, V267, P16934
   Kellam B, 2003, CHEM SOC REV, V32, P327, DOI 10.1039/b211643j
   Khademhosseini A, 2003, ADV MATER, V15, P1995, DOI 10.1002/adma.200305433
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kickhoefer V. A., 2008, ACS NANO, V3, P27
   Kimura T, 2004, LANGMUIR, V20, P572, DOI 10.1021/la035768m
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kojima N, 2011, BIOMATERIALS, V32, P6059, DOI 10.1016/j.biomaterials.2011.04.081
   Krebs MD, 2009, NANO LETT, V9, P1812, DOI 10.1021/nl803757u
   Krishnamachari Y, 2008, ADV MATER, V20, P989, DOI 10.1002/adma.200701689
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Laurell T, 2007, CHEM SOC REV, V36, P492, DOI 10.1039/b601326k
   Lee JH, 1999, J BIOL CHEM, V274, P21878, DOI 10.1074/jbc.274.31.21878
   Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125
   Manneberg O, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2971030
   Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216
   Molloy JE, 2002, CONTEMP PHYS, V43, P241, DOI 10.1080/00107510110116051
   Nahmias Y, 2005, BIOTECHNOL BIOENG, V92, P129, DOI 10.1002/bit.20585
   Nahmias Y, 2006, NAT PROTOC, V1, P2288, DOI 10.1038/nprot.2006.386
   Nahmias YK, 2004, APPL OPTICS, V43, P3999, DOI 10.1364/AO.43.003999
   Nahmias YK, 2002, IEEE J QUANTUM ELECT, V38, P131, DOI 10.1109/3.980265
   Nauman DA, 2001, BBA-GEN SUBJECTS, V1568, P147, DOI 10.1016/S0304-4165(01)00211-2
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Nilsson J, 2009, ANAL CHIM ACTA, V649, P141, DOI 10.1016/j.aca.2009.07.017
   Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787
   Odde DJ, 1999, TRENDS BIOTECHNOL, V17, P385, DOI 10.1016/S0167-7799(99)01355-4
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.0.CO;2-F
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o
   Piggee C., 2008, ANAL CHEM, V81, P16
   Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791
   Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sampathkumar SG, 2006, NAT CHEM BIOL, V2, P149, DOI 10.1038/nchembio770
   Sarkar D, 2008, BIOCONJUGATE CHEM, V19, P2105, DOI 10.1021/bc800345q
   Schulze S, 2010, ADV ENG MATER, V12, pB558, DOI 10.1002/adem.201080023
   Shi JJ, 2009, LAB CHIP, V9, P2890, DOI 10.1039/b910595f
   Stephan MT, 2011, NANO TODAY, V6, P309, DOI 10.1016/j.nantod.2011.04.001
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180
   Suzuki M, 2008, BIOSENS BIOELECTRON, V24, P1043, DOI 10.1016/j.bios.2008.06.051
   Swiston AJ, 2008, NANO LETT, V8, P4446, DOI 10.1021/nl802404h
   TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.bi.59.070190.001321
   Teramura Y, 2010, BIOCONJUGATE CHEM, V21, P792, DOI 10.1021/bc900494x
   Teramura Y, 2010, BIOMATERIALS, V31, P2229, DOI 10.1016/j.biomaterials.2009.11.098
   Teramura Y, 2009, BIOMATERIALS, V30, P2270, DOI 10.1016/j.biomaterials.2009.01.036
   Vermesh U, 2011, ANGEW CHEM INT EDIT, V50, P7378, DOI 10.1002/anie.201102249
   VERNON RB, 1992, LAB INVEST, V66, P536
   Voldman J, 2006, ANNU REV BIOMED ENG, V8, P425, DOI 10.1146/annurev.bioeng.8.061505.095739
   Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d
   White SH, 2005, CURR OPIN STRUC BIOL, V15, P378, DOI 10.1016/j.sbi.2005.07.004
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Winkleman A, 2004, APPL PHYS LETT, V85, P2411, DOI 10.1063/1.1794372
   Xia Y.N., 1998, ANGEW CHEM INT EDIT, V37, P551, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553
   Yu MR, 2011, ACS NANO, V5, P2447, DOI 10.1021/nn103618d
   Yuan B, 2012, ADV MATER, V24, P890, DOI 10.1002/adma.201104589
NR 93
TC 3
Z9 3
U1 1
U2 48
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD OCT
PY 2012
VL 55
IS 10
BP 862
EP 871
DI 10.1007/s11427-012-4385-9
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 028PB
UT WOS:000310433400003
PM 23108863
OA Bronze
DA 2018-10-19
ER

PT J
AU Hou, CX
   Luo, Q
   Liu, JL
   Miao, L
   Zhang, CQ
   Gao, YZ
   Zhang, XY
   Xu, JY
   Dong, ZY
   Liu, JQ
AF Hou, Chunxi
   Luo, Quan
   Liu, Jinliang
   Miao, Lu
   Zhang, Chunqiu
   Gao, Yuzhou
   Zhang, Xiyu
   Xu, Jiayun
   Dong, Zeyuan
   Liu, Junqiu
TI Construction of GPx Active Centers on Natural Protein Nanodisk/Nanotube:
   A New Way to Develop Artificial Nanoenzyme
SO ACS NANO
LA English
DT Article
DE tobacco mosaic virus; artificial enzyme; self-asselmbly; nanodisk;
   nanotube; glutathione peroxidase
ID TOBACCO-MOSAIC-VIRUS; GLUTATHIONE-PEROXIDASE ACTIVITY; TEMPLATE;
   SELENOCYSTEINE; ANTIOXIDANTS; TRANSFERASE; ELIMINATION; EXPRESSION;
   NANOTUBES; MIMICS
AB Construction of catalytic centers on natural protein aggregates is a challenging topic in biomaterial and biomedicine research. Here we report a novel construction of artificial nanoenzyme with glutathione peroxidase (GPx)-like function. By engineering the surface of tobacco mosaic virus (TMV) coat protein, the main catalytic components of GPx were fabricated on TMV protein monomers. Through direct self-assembly of the functionalized viral coat proteins, the multi-GPx centers were installed on these well-defined nanodisks or nanotubes. With the help of muti-selenoenzyme centers, the resulting organized nanoenzyme exhibited remarkable GPx activity, even approaching the level of natural GPx. The antioxidation study on subcell mitochondrial level demonstrated that virus-based nanoenzyme exerted excellent capacity for protecting cell from oxidative damage. This strategy represents a new way to develop artificial nanoenzymes.
C1 [Hou, Chunxi; Luo, Quan; Miao, Lu; Zhang, Chunqiu; Gao, Yuzhou; Zhang, Xiyu; Xu, Jiayun; Dong, Zeyuan; Liu, Junqiu] Jilin Univ, Coll Chem, State Key Lab Supramol Struct & Mat, Changchun 130012, Peoples R China.
   [Liu, Jinliang] Jilin Univ, Coll Plant Sci, Changchun 130062, Peoples R China.
RP Liu, JQ (reprint author), Jilin Univ, Coll Chem, State Key Lab Supramol Struct & Mat, 2699 Qianjin St, Changchun 130012, Peoples R China.
EM junqiuliu@jlu.edu.cn
RI Dong, Zeyuan/A-7226-2011
OI Dong, Zeyuan/0000-0001-6509-9724
FU Natural Science Foundation of China [21234004, 91027023, 20921003,
   21004028]; 111 project [B06009]
FX We thank M.B. Francis for the expression plasmid containing the gene of
   tobacco mosaic virus coat protein and A. Bock for the cysteine
   auxotrophic expression system. This work was supported by the Natural
   Science Foundation of China (No: 21234004, 91027023, 20921003, 21004028)
   and 111 project (B06009).
CR Bhabak KP, 2010, ACCOUNTS CHEM RES, V43, P1408, DOI 10.1021/ar100059g
   Bruckman MA, 2011, ACS NANO, V5, P1606, DOI 10.1021/nn1025719
   Bruckman MA, 2010, J MATER CHEM, V20, P5715, DOI 10.1039/c0jm00634c
   Carette N, 2007, NAT NANOTECHNOL, V2, P226, DOI 10.1038/nnano.2007.76
   Casi G, 2008, CHEMBIOCHEM, V9, P1623, DOI 10.1002/cbic.200700745
   Dedeo MT, 2010, NANO LETT, V10, P181, DOI 10.1021/nl9032395
   Dong ZY, 2004, J AM CHEM SOC, V126, P16395, DOI 10.1021/ja045964v
   EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x
   Fang ZH, 2011, ELECTROANAL, V23, P2415, DOI 10.1002/elan.201100211
   Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h
   Ge Y, 2009, INT J BIOCHEM CELL B, V41, P900, DOI 10.1016/j.biocel.2008.08.032
   Gorzny ML, 2010, ADV FUNCT MATER, V20, P1295, DOI 10.1002/adfm.200902196
   Haratake M, 2008, BIOCONJUGATE CHEM, V19, P1831, DOI 10.1021/bc800086z
   Jiang ZH, 2004, BIOCHEM BIOPH RES CO, V321, P94, DOI 10.1016/j.bbrc.2004.06.110
   Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651
   Komatsu T, 2011, CHEM-EUR J, V17, P1849, DOI 10.1002/chem.201001937
   Lee YJ, 2009, SCIENCE, V324, P1051, DOI [10.1126/science.1171541, 10.1126/science.1169041]
   Lin Y, 2010, ANGEW CHEM INT EDIT, V49, P868, DOI 10.1002/anie.200904993
   Liu XF, 2008, J STAT COMPUT SIM, V78, P1065, DOI 10.1080/00949650701519635
   Maiorino M, 1996, EUR J BIOCHEM, V238, P838, DOI 10.1111/j.1432-1033.1996.0838w.x
   Makino N, 2004, BBA-GEN SUBJECTS, V1673, P149, DOI 10.1016/j.bbagen.2004.04.011
   Makino N, 2008, BBA-GEN SUBJECTS, V1780, P927, DOI 10.1016/j.bbagen.2008.03.010
   Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740
   Miller RA, 2010, J AM CHEM SOC, V132, P6068, DOI 10.1021/ja909566z
   Mueller H.S., 1994, BIOCHEMISTRY-US, V33, P3404
   Nam YS, 2010, NAT NANOTECHNOL, V5, P340, DOI [10.1038/nnano.2010.57, 10.1038/NNANO.2010.57]
   Ng CF, 2007, FREE RADICAL RES, V41, P1201, DOI 10.1080/10715760701625075
   Rong JH, 2009, J MATER CHEM, V19, P2841, DOI 10.1039/b901130g
   Schlick TL, 2005, J AM CHEM SOC, V127, P3718, DOI 10.1021/ja046239n
   Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6
   Shenton W, 1999, ADV MATER, V11, P253, DOI 10.1002/(SICI)1521-4095(199903)11:3<253::AID-ADMA253>3.0.CO;2-7
   Stephanopoulos N, 2009, ANGEW CHEM INT EDIT, V48, P9498, DOI 10.1002/anie.200902727
   Tang Y, 2010, ANGEW CHEM INT EDIT, V49, P3920, DOI 10.1002/anie.200907036
   Wilner OI, 2009, NANO LETT, V9, P2040, DOI 10.1021/nl900302z
   Wilner OI, 2009, NAT NANOTECHNOL, V4, P249, DOI [10.1038/NNANO.2009.50, 10.1038/nnano.2009.50]
   WILSON SR, 1989, J AM CHEM SOC, V111, P5936, DOI 10.1021/ja00197a065
   Witus LS, 2011, ACCOUNTS CHEM RES, V44, P774, DOI 10.1021/ar2001292
   Wu LY, 2011, J MATER CHEM, V21, P8550, DOI 10.1039/c1jm00078k
   Yu HJ, 2005, J BIOL CHEM, V280, P11930, DOI 10.1074/jbc.M408574200
   Yu HJ, 2007, BIOCHEM BIOPH RES CO, V358, P873, DOI 10.1016/j.bbrc.2007.05.007
   Zahr OK, 2012, NANO LETT, V12, P629, DOI 10.1021/nl203368v
   Zhang Y, 2005, BBA-PROTEINS PROTEOM, V1747, P27, DOI 10.1016/j.bbapap.2004.09.022
   Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200
   ZHU ZQ, 1994, BIOCHEM BIOPH RES CO, V202, P1645, DOI 10.1006/bbrc.1994.2122
NR 44
TC 46
Z9 48
U1 12
U2 146
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD OCT
PY 2012
VL 6
IS 10
BP 8692
EP 8701
DI 10.1021/nn302270b
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 024FW
UT WOS:000310096100027
PM 22992167
DA 2018-10-19
ER

PT J
AU Zhao, K
   Jiao, W
   Ma, J
   Gao, XQ
   Wang, WH
AF Zhao, Kun
   Jiao, Wei
   Ma, Jiang
   Gao, Xuan Qiao
   Wang, Wei Hua
TI Formation and properties of strontium-based bulk metallic glasses with
   ultralow glass transition temperature
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID AMORPHOUS-ALLOYS; STRUCTURAL MODEL; FORMING ABILITY; BEHAVIOR; FLOW;
   CRYSTALLIZATION; DEFORMATION
AB We report a family of novel Strontium (Sr)-based bulk metallic glasses (BMGs) with good glass-forming ability and ultralow glass transition temperature (T-g) by strategic composition design. The Sr-based BMGs can be easily formed with wide composition range by a conventional copper mold cast method. The glassy alloys have many unique and diversified properties such as lowest glass transition temperature, ultralow elastic modulus, small value of Poisson's ratio and fragility, homogeneous flow at room temperature and tunable water degradation behavior. The BMGs with novel physical and chemical properties could have potential applications for biomaterial and micromanufacture, and are model system for studying some fundamental issues such as crystallization, relaxation and deformation in metallic glass.
C1 [Zhao, Kun; Jiao, Wei; Ma, Jiang; Gao, Xuan Qiao; Wang, Wei Hua] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.
   [Zhao, Kun] Hebei Univ Sci & Technol, Shijiazhuang 050018, Peoples R China.
RP Zhao, K (reprint author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.
EM zhk3415@163.com
RI wei, jiao/I-7244-2013
FU NSF of China [50921091, 50731008]; MOST973 of China [2007CB613904,
   2010CB731603]
FX Financial support from NSF of China (50921091 and 50731008) and MOST973
   of China (2007CB613904 and 2010CB731603) is greatly appreciated.
   Experimental aid of H. B. Ke, and T. Wang is acknowledged. The provision
   of Mg-Li master alloy by Prof. M.L. Zhang is acknowledged.
CR ANGELL CA, 1991, J NON-CRYST SOLIDS, V131, P13, DOI 10.1016/0022-3093(91)90266-9
   Bletry M, 2006, ACTA MATER, V54, P1257, DOI 10.1016/j.actamat.2005.10.054
   BOHMER R, 1993, J CHEM PHYS, V99, P4201, DOI 10.1063/1.466117
   Borrego JM, 2002, J APPL PHYS, V92, P2073, DOI 10.1063/1.1494848
   BRUNING R, 1992, PHYS REV B, V46, P11318, DOI 10.1103/PhysRevB.46.11318
   Chu JP, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2431710
   COHEN MH, 1961, NATURE, V189, P131, DOI 10.1038/189131b0
   Dahlman J, 2007, MATER TRANS, V48, P1850, DOI 10.2320/matertrans.MJ200732
   Evenson Z, 2010, J APPL PHYS, V107, DOI 10.1063/1.3452381
   Gao XQ, 2011, J NON-CRYST SOLIDS, V357, P3557, DOI 10.1016/j.jnoncrysol.2011.07.016
   Greer AL, 2009, MATER TODAY, V12, P14, DOI 10.1016/S1369-7021(09)70037-9
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Harmon JS, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2717017
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Johnson WL, 2011, SCIENCE, V332, P828, DOI 10.1126/science.1201362
   Kato H, 1998, APPL PHYS LETT, V73, P3665, DOI 10.1063/1.122856
   Kumar G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834712
   Kumar G, 2009, NATURE, V457, P868, DOI 10.1038/nature07718
   Lewandowski JJ, 2005, PHIL MAG LETT, V85, P77, DOI 10.1080/09500830500080474
   Li JF, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2998262
   Li JF, 2010, SCI CHINA PHYS MECH, V53, P409, DOI 10.1007/s11433-010-0138-6
   Louzguine-Luzgin V, 2008, ADV ENG MATER, V10, P1008, DOI 10.1002/adem.200800134
   Lu J, 2003, ACTA MATER, V51, P3429, DOI 10.1016/S1359-6454(03)00164-2
   Luo Q, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2201863
   Miracle DB, 2006, ACTA MATER, V54, P4317, DOI 10.1016/j.actamat.2006.06.002
   Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219
   Pan CT, 2008, SENSOR ACTUAT A-PHYS, V141, P422, DOI 10.1016/j.sna.2007.10.040
   Park ES, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2759266
   Pauly S, 2010, NAT MATER, V9, P473, DOI [10.1038/nmat2767, 10.1038/NMAT2767]
   Penera D. N., 1999, J PHYS CONDENS MATT, V11, P3807
   Saotome Y, 2001, SCRIPTA MATER, V44, P1541, DOI 10.1016/S1359-6462(01)00837-5
   Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052
   Senkov ON, 2008, METALL MATER TRANS A, V39A, P1888, DOI 10.1007/s11661-007-9334-z
   Senkov ON, 2005, J APPL PHYS, V97, DOI 10.1063/1.1896434
   Shadowspeaker L, 2004, APPL PHYS LETT, V85, P2508, DOI 10.1063/1.1796523
   SPAEPEN F, 1977, ACTA METALL MATER, V25, P407, DOI 10.1016/0001-6160(77)90232-2
   Takeuchi A, 2011, INTERMETALLICS, V19, P1546, DOI 10.1016/j.intermet.2011.05.030
   Wang G, 2009, ADV ENG MATER, V11, P27, DOI 10.1002/adem.200800313
   Wang JQ, 2008, J NON-CRYST SOLIDS, V354, P5440, DOI 10.1016/j.jnoncrysol.2008.08.010
   Wang WH, 2007, PROG MATER SCI, V52, P540, DOI 10.1016/j.pmatsci.2006.07.003
   Wang WH, 2006, J APPL PHYS, V99, DOI 10.1063/1.2193060
   Wang WH, 2012, PROG MATER SCI, V57, P487, DOI 10.1016/j.pmatsci.2011.07.001
   Wang WH, 2005, J NON-CRYST SOLIDS, V351, P1481, DOI 10.1016/j.jnoncrysol.2005.03.024
   Wang YB, 2011, ACTA BIOMATER, V7, P3196, DOI 10.1016/j.actbio.2011.04.027
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang B, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.224208
   Zhang B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.205502
   Zhang W, 2009, SCRIPTA MATER, V61, P744, DOI 10.1016/j.scriptamat.2009.06.020
   Zhang Z, 2004, MAT SCI ENG A-STRUCT, V385, P38, DOI 10.1016/j.msea.2004.04.050
   Zhao K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3575562
   Zhao K, 2009, SCRIPTA MATER, V61, P1091, DOI 10.1016/j.scriptamat.2009.08.042
   Zhao ZF, 2003, APPL PHYS LETT, V82, P4699, DOI 10.1063/1.1588367
NR 52
TC 7
Z9 8
U1 4
U2 26
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0884-2914
EI 2044-5326
J9 J MATER RES
JI J. Mater. Res.
PD OCT
PY 2012
VL 27
IS 20
BP 2593
EP 2600
DI 10.1557/jmr.2012.214
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 019HH
UT WOS:000309728300003
DA 2018-10-19
ER

PT J
AU Crouzier, T
   Beckwitt, CH
   Ribbeck, K
AF Crouzier, Thomas
   Beckwitt, Colin H.
   Ribbeck, Katharina
TI Mucin Multilayers Assembled through Sugar-Lectin Interactions
SO BIOMACROMOLECULES
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; WHEAT-GERM-AGGLUTININ; POLYELECTROLYTE
   MULTILAYERS; CONCANAVALIN-A; BIOMEDICAL APPLICATIONS;
   EXPONENTIAL-GROWTH; PROTEIN LAYERS; DRUG-DELIVERY; THIN-FILMS; STABILITY
AB Multi layer films of biopolymers are attractive tools to exploit the extraordinary properties of certain biomacromolecules and introduce new functionalities to surfaces. Mucins, the gel-forming constituents of mucus, are versatile glycoproteins that have potential as new building blocks for biomaterial surface coatings. Multi layer films have mostly been assembled through the electrostatic pairing of polyelectrolytes, which results in limited pH and salt stability and screens charges otherwise available for useful payload binding. Here, we aim at assembling mucin multilayer films that differ from conventional paired polyelectrolyte assemblies to obtain highly stable and functional surface modifications. Using the lectin wheat germ agglutinin (WGA) to cross-link mucin-bound sugar residues, we show that (Mucin/WGA) films can grow into hydrated films and sustain exceptional resistance to extreme salt conditions and a large range of pH. Furthermore, we show that the addition of soluble N-acetyl-D-glucosamine can induce the controlled release of WGA from (Mucin/WGA) films. Last, we show that (Mucin/WGA) films can repeatedly incorporate and release a positively charged model cargo. The lubricating, hydration, barrier, and antimicrobial properties of mucins open multiple applicative perspectives for these highly stable mucin-based multilayer films.
C1 [Crouzier, Thomas; Beckwitt, Colin H.; Ribbeck, Katharina] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
RP Ribbeck, K (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave,Bldg 56-341C, Cambridge, MA 02139 USA.
EM ribbeck@mit.edu
OI Crouzier, Thomas/0000-0002-1981-3736
FU Johnson & Johnson Corporate Office of Science and Technology; MIT;
   National Science Foundation [DMR - 819762]
FX We thank the Johnson & Johnson Corporate Office of Science and
   Technology for the postdoctoral fellowship provided to T.C, and MIT
   startup funds to K.R. This work made use of the MRSEC Shared Experiment
   Facilities supported by the National Science Foundation under award
   number DMR - 819762. We are also grateful to Ronn Friedlander for his
   assistance with the AFM experiments.
CR Aknin MLR, 2004, CELL TISSUE RES, V318, P545, DOI 10.1007/s00441-004-0957-8
   Anzai J, 2000, LANGMUIR, V16, P2851, DOI 10.1021/la9910024
   BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223
   Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001
   Berg MC, 2006, BIOMACROMOLECULES, V7, P357, DOI 10.1021/bm050174e
   Bies C, 2004, ADV DRUG DELIVER REV, V56, P425, DOI 10.1016/j.addr.2003.10.030
   Blin G, 2010, BIOMATERIALS, V31, P1742, DOI 10.1016/j.biomaterials.2009.11.055
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   BOURDILLON C, 1994, J AM CHEM SOC, V116, P10328, DOI 10.1021/ja00101a074
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Bushnak IA, 2010, BIOFOULING, V26, P387, DOI 10.1080/08927011003646809
   Calarco A, 2010, J CELL BIOCHEM, V110, P903, DOI 10.1002/jcb.22602
   Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h
   Cassier T, 1998, SUPRAMOL SCI, V5, P309, DOI 10.1016/S0968-5677(98)00024-8
   Celli J, 2005, BIOMACROMOLECULES, V6, P1329, DOI 10.1021/bm0493990
   Cho C., 2011, LANGMUIR, P841
   Chuang HF, 2008, BIOMACROMOLECULES, V9, P1660, DOI 10.1021/bm800185h
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2010, CURR OPIN COLLOID IN, V15, P417, DOI 10.1016/j.cocis.2010.05.007
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   Dalla Pellegrina C, 2004, TOXICOL IN VITRO, V18, P821, DOI 10.1016/j.tiv.2004.04.008
   Dedinaite A, 2005, LANGMUIR, V21, P9502, DOI 10.1021/la0511844
   Haberska K, 2008, TALANTA, V76, P1159, DOI 10.1016/j.talanta.2008.05.017
   Halthur TJ, 2010, LANGMUIR, V26, P4901, DOI 10.1021/la902267c
   Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y
   Iijima M, 2008, LANGMUIR, V24, P3987, DOI 10.1021/la7038043
   Kharlampieva E, 2003, LANGMUIR, V19, P1235, DOI 10.1021/la026546b
   Laugel N., 2006, J PHYS CHEM B, V110, P19433
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lehr CM, 2000, J CONTROL RELEASE, V65, P19, DOI 10.1016/S0168-3659(99)00228-X
   Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5
   Lindh L, 2007, J COLLOID INTERF SCI, V310, P74, DOI 10.1016/j.jcis.2007.01.086
   Lundin M, 2009, J COLLOID INTERF SCI, V336, P30, DOI 10.1016/j.jcis.2009.03.061
   McAloney RA, 2001, LANGMUIR, V17, P6655, DOI 10.1021/la010136q
   Murphy MS, 1998, NUTRITION, V14, P771, DOI 10.1016/S0899-9007(98)00081-1
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Ravaine V, 2008, J CONTROL RELEASE, V132, P2, DOI 10.1016/j.jconrel.2008.08.009
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Roland S., 1985, TRENDS BIOCHEM SCI, V10, P357
   Sandberg T., 2008, J MATER SCI-MATER M, V20, P621
   Sandberg T, 2009, J BIOMED MATER RES A, V91A, P773, DOI 10.1002/jbm.a.32315
   Sato K, 2005, LANGMUIR, V21, P797, DOI 10.1021/la048059x
   Sato K, 2004, ANAL SCI, V20, P1247, DOI 10.2116/analsci.20.1247
   Sato K, 2009, J NANOSCI NANOTECHNO, V9, P386, DOI 10.1166/jnn.2009.J037
   Schwarz RE, 1999, BRIT J CANCER, V80, P1754, DOI 10.1038/sj.bjc.6690593
   Schwefel D, 2010, J AM CHEM SOC, V132, P8704, DOI 10.1021/ja101646k
   Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486
   Such GK, 2006, J AM CHEM SOC, V128, P9318, DOI 10.1021/ja063043+
   Svensson O, 2006, J COLLOID INTERF SCI, V299, P608, DOI 10.1016/j.jcis.2006.02.027
   Svensson O, 2010, CURR OPIN COLLOID IN, V15, P395, DOI 10.1016/j.cocis.2010.05.015
   Tanaka S, 1997, AM J PHYSIOL-GASTR L, V272, pG1473
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Vreuls C, 2010, BIOFOULING, V26, P645, DOI 10.1080/08927014.2010.506678
   Weber N, 2005, J BIOMED MATER RES A, V72A, P420, DOI 10.1002/jbm.a.30272
   Wright CS, 1996, PROTEIN SCI, V5, P1466, DOI 10.1002/pro.5560050803
   Zahn R, 2012, BIOMATERIALS, V33, P3421, DOI 10.1016/j.biomaterials.2012.01.019
NR 60
TC 23
Z9 23
U1 8
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT
PY 2012
VL 13
IS 10
BP 3401
EP 3408
DI 10.1021/bm301222f
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 016AC
UT WOS:000309488600041
PM 22920681
DA 2018-10-19
ER

PT J
AU Ferraris, S
   Pan, G
   Cassinelli, C
   Mazzucco, L
   Verne, E
   Spriano, S
AF Ferraris, S.
   Pan, G.
   Cassinelli, C.
   Mazzucco, L.
   Verne, E.
   Spriano, S.
TI Effects of sterilization and storage on the properties of ALP-grafted
   biomaterials for prosthetic and bone tissue engineering applications
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID GAMMA-IRRADIATION; ALKALINE-PHOSPHATASE; TITANIUM; RADIATION; IMPLANTS;
   GLASSES; MATRIX; CELLS; MODEL
AB Grafting of the biomaterial surfaces with biomolecules is nowadays a challenging research field for prosthetic and bone tissue engineering applications. On the other hand, very few research works investigate the effect of the sterilization processes on the properties of functionalized biomaterials. In this study, the effects of different sterilization techniques (e. g. gamma and electron beam irradiation, ethylene oxide) on the enzymatic activity of bioactive glasses and Ti6Al4V grafted with alkaline phosphatase (ALP) have been analyzed. Sterility maintenance and in vitro bioactivity of the sterilized surfaces have also been investigated. Finally the effect of packaging and storage conditions has been considered.
C1 [Ferraris, S.; Pan, G.; Verne, E.; Spriano, S.] Politecn Torino, Dept Appl Sci & Technol, I-10129 Turin, Italy.
   [Cassinelli, C.] NobilBio Ric Srl, I-14037 Portacomaro, AT, Italy.
RP Ferraris, S (reprint author), Politecn Torino, Dept Appl Sci & Technol, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
EM sara.ferraris@polito.it
RI Pan, Guanjun/I-3113-2012
OI Pan, Guanjun/0000-0002-9691-1145; Verne, Enrica/0000-0002-8649-4739;
   Spriano, Silvia/0000-0002-7367-9777
FU Regione Piemonte
FX Regione Piemonte is acknowledged for funding the BIOSURF project (CIPE
   2006, 'Biosurf-Biactive surface for tissue integration'). P Gentile and
   C Tondaturo (Politecnico di Torino, Mechanical Department) are kindly
   acknowledged for freeze-drying operations.
CR Alanay A, 2008, SPINE J, V8, P789, DOI 10.1016/j.spinee.2007.06.009
   Ehlert N, 2010, MICROPOR MESOPOR MAT, V131, P51, DOI 10.1016/j.micromeso.2009.11.040
   ElBatal FH, 2008, MATER CHEM PHYS, V110, P352, DOI 10.1016/j.matchemphys.2008.02.011
   Ferraris S, 2011, J MATER SCI-MATER M, V22, P1835, DOI 10.1007/s10856-011-4365-9
   Ferraris S, 2011, J MATER SCI-MATER M, V22, P533, DOI 10.1007/s10856-011-4246-2
   Ferraris S, 2010, THESIS POLITECNICO T
   Furuta M, 2002, RADIAT PHYS CHEM, V63, P323, DOI 10.1016/S0969-806X(01)00520-5
   HALLFELDT KKJ, 1995, J SURG RES, V59, P614, DOI 10.1006/jsre.1995.1213
   IAEA-International Atomic Energy Agency, 1997, EFF ION RAD BLOOD BL
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014
   Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3
   Moyne P, 2002, RADIAT PHYS CHEM, V63, P703, DOI 10.1016/S0969-806X(01)00563-1
   Narayan P, 2008, RADIAT MEAS, V43, P1237, DOI 10.1016/j.radmeas.2008.02.021
   Pegueroles M, 2008, SURF COAT TECH, V202, P3470, DOI 10.1016/j.surfcoat.2007.12.021
   Rodrigues AD, 2002, RADIAT PHYS CHEM, V63, P765, DOI 10.1016/S0969-806X(01)00637-5
   Serro AP, 2003, BIOMATERIALS, V24, P4749, DOI 10.1016/S0142-9612(03)00372-7
   Seto A, 2009, CLIN ORTHOP RELAT R, V467, P2994, DOI 10.1007/s11999-009-0934-3
   Spriano S., European Patent, Patent No. 2214732
   Spriano S, 2009, J MATER SCI, V3, P203
   Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616
   Verne E, 2008, KEY ENG MATER, V361-363, P593, DOI 10.4028/www.scientific.net/KEM.361-363.593
   Verne E, 2010, ACTA BIOMATER, V6, P229, DOI 10.1016/j.actbio.2009.06.025
   Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1
   von Woedtke T, 2002, BIOSENS BIOELECTRON, V17, P373, DOI 10.1016/S0956-5663(01)00310-4
   WAGNER R, 1957, BLOOD, V12, P733
   Wolkers W F, 2007, CRYOBIOLOGY, V55, P324
NR 27
TC 10
Z9 10
U1 0
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD OCT
PY 2012
VL 7
IS 5
AR 054102
DI 10.1088/1748-6041/7/5/054102
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 016VN
UT WOS:000309547900003
PM 22971978
DA 2018-10-19
ER

PT J
AU Grefte, S
   Vullinghs, S
   Kuijpers-Jagtman, AM
   Torensma, R
   Von den Hoff, JW
AF Grefte, S.
   Vullinghs, S.
   Kuijpers-Jagtman, A. M.
   Torensma, R.
   Von den Hoff, J. W.
TI Matrigel, but not collagen I, maintains the differentiation capacity of
   muscle derived cells in vitro
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID MOUSE SKELETAL-MUSCLE; SATELLITE CELLS; SELF-RENEWAL; STEM-CELLS;
   GROWTH-FACTORS; EXTRACELLULAR-MATRIX; TEMPORAL EXPRESSION; MYOTUBE
   FORMATION; REGENERATION; TISSUE
AB Satellite cells are key cells for post-natal muscle growth and regeneration and they play a central role in the search for therapies to treat muscle injuries. In this study the proliferation and differentiation capacity of muscle progenitor cells was studied in 2D and 3D cultures with collagen type I and Matrigel, which contain the niche factors laminin and collagen type IV. Muscle progenitor cells were cultured to induce proliferation and differentiation in collagenor Matrigel-coated surfaces (2D) or in gels (3D). In the 2D cultures, muscle progenitor cells proliferated faster in Matrigel than in collagen. The numbers of Pax7(+) and MyoD(+) cells were also significantly higher in Matrigel than in collagen. During differentiation, muscle progenitor cells formed more and larger MyoD(+) and myogenin(+) myotubes in Matrigel. In the 3D cultures, muscle progenitor cells in Matrigel expressed higher mRNA levels of MyoD and myogenin, and formed elongated myotubes expressing myogenin and myosin. In collagen gels, the myotubes were short and rounded. In conclusion, muscle progenitor cells, both in 2D and 3D, lose their differentiation capacity in collagen but not in Matrigel. Although Matrigel contains growth factors, our results indicate that the kind of biomaterial steers the maintenance of the myogenic potential and their proper differentiation to achieve optimal skeletal muscle restoration.
C1 [Grefte, S.; Vullinghs, S.; Kuijpers-Jagtman, A. M.; Von den Hoff, J. W.] Radboud Univ Nijmegen, Dept Orthodont & Craniofacial Biol, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
   [Torensma, R.] Radboud Univ Nijmegen, Dept Tumor Immunol, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
RP Von den Hoff, JW (reprint author), Radboud Univ Nijmegen, Dept Orthodont & Craniofacial Biol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM H.vondenHoff@dent.umcn.nl
RI Kuijpers-Jagtman, Anne Marie/A-9413-2008; Torensma, Ruurd/H-3830-2015;
   Von den Hoff, Johannes/L-8762-2015
OI Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090; Torensma,
   Ruurd/0000-0002-0555-7903; 
FU NICHD; Radboud University Nijmegen Medical Centre, The Netherlands
FX The Pax7 antibody developed by Atsushi Kawakami and the myogenin (F5D)
   antibody developed by Woodring E Wright were obtained from the
   Developmental Studies Hybridoma Bank developed under the auspices of the
   NICHD and maintained by Department of Biological Sciences, The
   University of Iowa, Iowa City, IA 52242. Confocal laser scanning
   microscopy was performed at the microscopic imaging centre (MIC) of the
   Nijmegen Centre for Molecular Life Sciences (NCMLS). This study was
   supported by a grant from the Radboud University Nijmegen Medical
   Centre, The Netherlands. The authors have no other relevant affiliations
   or financial involvement with any organization or entity with a
   financial interest in or financial conflict with the subject matter or
   materials discussed in the manuscript apart from those disclosed. No
   writing assistance was utilized in the production of this manuscript.
CR Barbero A, 2001, J CELL PHYSIOL, V186, P183, DOI 10.1002/1097-4652(200102)186:2<183::AID-JCP1020>3.3.CO;2-H
   Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221
   Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113
   Beier JP, 2006, PLAST RECONSTR SURG, V118, P1113, DOI 10.1097/01.prs.0000221007.97115.1d
   Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009
   Boonen KJM, 2010, J BIOMECH, V43, P1514, DOI 10.1016/j.jbiomech.2010.01.039
   Boonen KJM, 2008, TISSUE ENG PART B-RE, V14, P419, DOI 10.1089/ten.teb.2008.0045
   Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017
   Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010
   Cooper RN, 1999, J CELL SCI, V112, P2895
   Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721
   Deasy BM, 2005, MOL BIOL CELL, V16, P3323, DOI 10.1091/mbc.E05-02-0169
   Eberli D, 2009, METHODS, V47, P98, DOI 10.1016/j.ymeth.2008.10.016
   FOSTER RF, 1987, DEV BIOL, V122, P11, DOI 10.1016/0012-1606(87)90327-7
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x
   Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058
   Grefte S, 2010, REGEN MED, V5, P737, DOI 10.2217/RME.10.69
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P2414
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Kaariainen M, 2000, SCAND J MED SCI SPOR, V10, P332, DOI 10.1034/j.1600-0838.2000.010006332.x
   Kasemkijwattana C, 1998, CELL TRANSPLANT, V7, P585, DOI 10.1016/S0963-6897(98)00037-2
   Kasemkijwattana C, 2000, CLIN ORTHOP RELAT R, P272
   Kin S, 2007, ASAIO J, V53, P506, DOI 10.1097/MAT.0b013e3180d09d81
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044
   Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705
   Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x
   Machida S, 2004, CELL PROLIFERAT, V37, P267, DOI 10.1111/j.1365-2184.2004.00311.x
   MALEY MAL, 1995, EXP CELL RES, V219, P169, DOI 10.1006/excr.1995.1217
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954
   Minotti S, 1998, CELL GROWTH DIFFER, V9, P155
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   MUIR AR, 1965, J ANAT, V99, P435
   Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436
   Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037
   Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021
   SMITH CK, 1994, J CELL PHYSIOL, V159, P379, DOI 10.1002/jcp.1041590222
   Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127
   Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223
   van Wachem PB, 1999, BIOMATERIALS, V20, P419, DOI 10.1016/S0142-9612(98)00185-9
   WILSCHUT KJ, 2009, EXP CELL RES, V316, P341
   YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226
   Yao CC, 1996, J CELL SCI, V109, P3139
   Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007
NR 52
TC 36
Z9 36
U1 1
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD OCT
PY 2012
VL 7
IS 5
AR 055004
DI 10.1088/1748-6041/7/5/055004
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 016VN
UT WOS:000309547900013
PM 22791687
OA Bronze
DA 2018-10-19
ER

PT J
AU Lu, HB
   Zhou, L
   Wan, L
   Li, SB
   Rong, MD
   Guo, ZH
AF Lu, Haibin
   Zhou, Lei
   Wan, Lei
   Li, Shaobing
   Rong, Mingdeng
   Guo, Zehong
TI Effects of storage methods on time-related changes of titanium surface
   properties and cellular response
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID PROTEIN ADSORPTION; IMPLANT SURFACES; BONE; STERILIZATION; BIOMATERIAL;
   ADHESION; INTEGRATION; MECHANISM; ROUGHNESS; TIO2
AB Titanium implants are sold in the market as storable medical devices. All the implants have a certain shelf life during which they maintain their sterility, but variations of the surface properties through this duration have not been subject to a comprehensive assessment. The aim of this study was to investigate the effects of storage methods on time-related changes of titanium surface properties. Acid-etched titanium discs (Sa = 0.82 mu m) were placed in a sealed container (tradition method) or submerged in the ddH(2)O/NaCl solution (0.15 mol L-1)/CaCl2 solution (0.15 mol L-1), and new titanium discs were used as a control group. SEM and optical profiler showed that surface morphology and roughness did not change within different groups, but the XPS analysis confirmed that the surface chemistry altered by different storage protocols as the storage duration increased, and the contact angle also varied with storage methods. The storage method also affected the protein adsorption capacity and cellular response on the titanium surface. All titanium discs stored in the solution maintained their excellent bioactivity even after four weeks storage time, but titanium discs stored in a traditional manner decreased substantially in an age-dependent manner. Much effort is needed to improve the storage methods in order to maintain the bioactivity of a titanium dental implant.
C1 [Lu, Haibin; Zhou, Lei; Wan, Lei; Li, Shaobing; Rong, Mingdeng; Guo, Zehong] So Med Univ, Guangdong Prov Stomatol Hosp, Guangzhou, Guangdong, Peoples R China.
RP Zhou, L (reprint author), So Med Univ, Guangdong Prov Stomatol Hosp, Guangzhou, Guangdong, Peoples R China.
EM zho668@263.net
OI Wan, Lei/0000-0002-9525-3232
FU National Natural Science Foundation of China [81170998]
FX This work was supported by National Natural Science Foundation of China
   (no 81170998).
CR An YH, 2005, INT J ARTIF ORGANS, V28, P1126
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Atta W, 2009, BIOMATERIALS, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Faghihi S, 2007, BIOMATERIALS, V28, P3887, DOI 10.1016/j.biomaterials.2007.05.010
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hori N, 2009, J DENT RES, V88, P663, DOI 10.1177/0022034509339567
   Hori N, 2010, ACTA BIOMATER, V6, P4175, DOI 10.1016/j.actbio.2010.05.006
   Iwanaga S, 2005, BIOMATERIALS, V26, P5395, DOI 10.1016/j.biomaterials.2005.01.021
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kilpadi DV, 2000, INT J ORAL MAX IMPL, V15, P219
   Klauber C, 1990, Int J Oral Maxillofac Implants, V5, P264
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Liu SC, 2000, J CELL SCI, V113, P3563
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Mata A, 2003, IEEE T NANOBIOSCI, V2, P287, DOI 10.1109/TNB.2003.820268
   MEYER A E, 1988, Journal of Oral Implantology, V14, P363
   Park JH, 2012, ACTA BIOMATER, V8, P1966, DOI 10.1016/j.actbio.2011.11.026
   Rong MD, 2009, J MATER SCI-MATER M, V20, P1721, DOI 10.1007/s10856-009-3730-4
   Stumm W., 1992, CHEM SOLID WATER INT, P428
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Takeuchi M, 2005, J PHYS CHEM B, V109, P7387, DOI 10.1021/jp040630d
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   Zhao LZ, 2010, BIOMATERIALS, V31, P2055, DOI 10.1016/j.biomaterials.2009.11.103
NR 30
TC 8
Z9 8
U1 1
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD OCT
PY 2012
VL 7
IS 5
AR 055002
DI 10.1088/1748-6041/7/5/055002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 016VN
UT WOS:000309547900011
PM 22781962
DA 2018-10-19
ER

PT J
AU Hum, J
   Boccaccini, AR
AF Hum, Jasmin
   Boccaccini, Aldo R.
TI Bioactive glasses as carriers for bioactive molecules and therapeutic
   drugs: a review
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Review
ID TISSUE ENGINEERING APPLICATIONS; TRICALCIUM-PHOSPHATE COMPOSITE; BONE
   MORPHOGENETIC PROTEINS; IN-VITRO; DELIVERY-SYSTEM; CONTROLLED-RELEASE;
   POLYMETHYLMETHACRYLATE BEADS; OSTEOGENIC DIFFERENTIATION; BIOMEDICAL
   APPLICATIONS; ANTIBACTERIAL ACTIVITY
AB Bioactive glasses (BG) show great promise for bone tissue engineering based on their key properties, e.g., biocompatibility, biodegradability, osteoconductivity as well as osteogenic and angiogenic potential, which make them excellent candidates for bone tissue scaffolds and bone substitute materials. Recent work has shown that dissolution products of bioactive glasses have the potential to induce angiogenesis in addition to their known effect of influencing gene expression and promoting osteoblastic differentiation. One of the most interesting features of BG is their ability to bond both to soft and hard tissues, depending on their composition. To intensify the positive impact of BG for medical applications, there are considerable research efforts on using bioactive glass based platforms as carriers for the encapsulation, delivery and controlled release of bioactive molecules and therapeutic drugs. Different types of bioactive glasses have been considered in combination with different therapeutic drugs, hormones, growth factors and peptides. Using bioactive glasses as drug delivery system combines thus the effectiveness of therapeutic drugs (or bioactive/signaling molecules) with the intrinsic advantages of this inorganic biomaterial. Considering research carried out in the last 15 years, this review presents the different chemical compositions and morphologies of bioactive glasses used as carrier for bioactive molecules and therapeutic drugs and discusses the expanding potential of BG with drug delivery capability focusing in the field of bone tissue engineering.
C1 [Hum, Jasmin; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, D-91058 Erlangen, Germany.
RP Boccaccini, AR (reprint author), Univ Erlangen Nurnberg, Inst Biomat, Cauerstr 6, D-91058 Erlangen, Germany.
EM aldo.boccaccini@ww.uni-erlangen.de
RI Boccaccini, Aldo/C-7905-2013
CR AGRAWAL CM, 1995, BIOMATERIALS, V16, P1255, DOI 10.1016/0142-9612(95)98133-Y
   Allan I, 2001, BIOMATERIALS, V22, P1683, DOI 10.1016/S0142-9612(00)00330-6
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Andrade AL, 2009, J NON-CRYST SOLIDS, V355, P811, DOI 10.1016/j.jnoncrysol.2009.01.015
   Arcos D, 2001, BIOMATERIALS, V22, P701, DOI 10.1016/S0142-9612(00)00233-7
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Arun RA, 2008, SCI PHARM, V76, P567, DOI DOI 10.3797/scipharm.0808-05
   ATHANASIOU KA, 1995, CLIN ORTHOP RELAT R, P272
   Balamurugan A, 2006, MATER LETT, V60, P3752, DOI 10.1016/j.matlet.2006.03.102
   Balas F, 2006, J AM CHEM SOC, V128, P8116, DOI 10.1021/ja062286z
   Barrias CC, 2005, J BIOMED MATER RES A, V72A, P57, DOI 10.1002/jbm.a.30217
   BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9
   Bergeron E, 2007, J MATER SCI-MATER M, V18, P255, DOI 10.1007/s10856-006-0687-4
   Bertoldi C, 2008, BIOMATERIALS, V29, P1817, DOI 10.1016/j.biomaterials.2007.12.034
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   BOYLE VJ, 1973, ANTIMICROB AGENTS CH, V3, P418, DOI 10.1128/AAC.3.3.418
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Cevc G, 2004, BBA-BIOMEMBRANES, V1663, P61, DOI 10.1016/j.bbamem.2004.01.006
   Cevher E, 2006, INT J PHARM, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen QZ, 2008, J BIOMED MATER RES A, V86A, P987, DOI 10.1002/jbm.a.31718
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Ciampolini J, 2000, POSTGRAD MED J, V76, P479, DOI 10.1136/pmj.76.898.479
   Colilla M, 2008, EXPERT OPIN THER PAT, V18, P639, DOI 10.1517/13543770802106746
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Day DE, 2003, GLASS TECHNOL, V44, P75
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   Domingues RZ, 2001, J BIOMED MATER RES, V55, P468, DOI 10.1002/1097-4636(20010615)55:4<468::AID-JBM1038>3.0.CO;2-T
   Domingues ZR, 2004, BIOMATERIALS, V25, P327, DOI 10.1016/S0142-9612(03)00524-6
   Fu HL, 2009, MAT SCI ENG C-MATER, V29, P2275, DOI 10.1016/j.msec.2009.05.013
   GOODSON JM, 1991, J PERIODONTAL RES, V26, P371, DOI 10.1111/j.1600-0765.1991.tb02076.x
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Halder A, 2005, J MICROENCAPSUL, V22, P67, DOI 10.1080/02652040500045003
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1971, J BIOMED MATER RES, V5, P117
   Hench LL, 2010, J R SOC INTERFACE, V7, P379, DOI DOI 10.1098/RSIF.2010.0151.FOCUS
   Heule M, 2003, ADV MATER, V15, P1191, DOI 10.1002/adma.200304670
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hong YL, 2010, ADV FUNCT MATER, V20, P1503, DOI 10.1002/adfm.200901627
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Horcajada P, 2004, SOLID STATE SCI, V6, P1295, DOI 10.1016/j.solidstatesciences.2004.07.026
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Irie T, 1997, J PHARM SCI-US, V86, P147, DOI 10.1021/js960213f
   Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011
   Kang SW, 2008, J BIOMED MATER RES A, V85A, P747, DOI 10.1002/jbm.a.31572
   Katanec D, 2004, COLLEGIUM ANTROPOL, V28, P331
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Laczka M, 2000, J BIOMED MATER RES, V52, P601, DOI 10.1002/1097-4636(20001215)52:4<601::AID-JBM4>3.3.CO;2-9
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Leu A, 2009, TISSUE ENG PT A, V15, P877, DOI 10.1089/ten.tea.2008.0018
   Li HY, 2005, J CONTROL RELEASE, V107, P463, DOI 10.1016/j.jconrel.2005.05.019
   Li N, 2005, CERAM INT, V31, P641, DOI 10.1016/j.ceramint.2004.05.011
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Li X, 2008, J BIOMED MATER RES A, V84A, P84, DOI 10.1002/jbm.a.31371
   Liang W, 2008, J NON-CRYST SOLIDS, V354, P1690, DOI 10.1016/j.jnoncrysol.2007.10.003
   Liu YL, 2001, J BIOMED MATER RES, V57, P327, DOI 10.1002/1097-4636(20011205)57:3<327::AID-JBM1175>3.0.CO;2-J
   Lopez-Noriega A, 2006, CHEM MATER, V18, P3137, DOI 10.1021/cm060488o
   McCann SJ, 2002, J ANTIMICROB CHEMOTH, V50, P107, DOI 10.1093/jac/dkf067
   Miguel BS, 2010, J BIOMED MATER RES A, V94A, P1023, DOI 10.1002/jbm.a.32773
   Miyai T, 2008, BIOMATERIALS, V29, P350, DOI 10.1016/j.biomaterials.2007.09.040
   MONSIGNY M, 1994, ADV DRUG DELIVER REV, V14, P1, DOI 10.1016/0169-409X(94)90003-5
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q
   Nielsen FH, 2000, NUTRITION, V16, P512, DOI 10.1016/S0899-9007(00)00324-5
   O'Keefe RJ, 2011, TISSUE ENG PART B-RE, V17, P389, DOI [10.1089/ten.teb.2011.0475, 10.1089/ten.TEB.2011.0475]
   OH S, 2006, AM J BIOCH BIOTECHNO, V2, P49, DOI DOI 10.3844/AJBBSP.2006.49.56
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Pekkarinen T, 2003, Scand J Surg, V92, P227
   Phaechamud T, 2008, AAPS PHARMSCITECH, V9, P829, DOI 10.1208/s12249-008-9117-x
   Prabaharan M, 2008, J BIOMATER APPL, V23, P5, DOI 10.1177/0885328208091562
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   SAMPATH SS, 1990, J PHARM SCI, V79, P428, DOI 10.1002/jps.2600790514
   Santos EM, 1999, BIOMATERIALS, V20, P1695, DOI 10.1016/S0142-9612(99)00066-6
   Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339
   Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015
   SELIGSON D, 1993, J BONE JOINT SURG AM, V75A, P714, DOI 10.2106/00004623-199305000-00011
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Soundrapandian C, 2011, DRUG DEV IND PHARM, V37, P538, DOI 10.3109/03639045.2010.528427
   Sun J, 2008, J NON-CRYST SOLIDS, V354, P3799, DOI 10.1016/j.jnoncrysol.2008.05.001
   Takita H, 2004, J BIOMED MATER RES A, V71A, P181, DOI 10.1002/jbm.a.30152
   Tolli H, 2010, J MATER SCI-MATER M, V21, P1677, DOI 10.1007/s10856-010-4017-5
   UEKAMA K, 1987, CRIT REV THER DRUG, V3, P1
   Valimaki VV, 2005, J BIOMED MATER RES A, V75A, P501, DOI 10.1002/jbm.a.30236
   Vallet-Regi M, 2000, J BIOMED MATER RES, V51, P23, DOI 10.1002/(SICI)1097-4636(200007)51:1<23::AID-JBM4>3.0.CO;2-B
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vandekerckhove BNA, 1997, J PERIODONTOL, V68, P353, DOI 10.1902/jop.1997.68.4.353
   Varanasi VG, 2009, ACTA BIOMATER, V5, P3536, DOI 10.1016/j.actbio.2009.05.035
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
   WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270
   Wang M, 2006, AM J BIOCH BIOTECHNO, V2, P80
   Wei J, 2009, BIOMATERIALS, V30, P1080, DOI 10.1016/j.biomaterials.2008.10.046
   WILLIAMS RA, 1994, BIOSENS BIOELECTRON, V9, P159, DOI 10.1016/0956-5663(94)80108-8
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2011, ACTA BIOMATER, V7, P2229, DOI 10.1016/j.actbio.2010.12.019
   Wu CT, 2011, ACTA BIOMATER, V7, P1797, DOI 10.1016/j.actbio.2010.12.018
   Wu CT, 2010, J BIOMED MATER RES A, V95A, P476, DOI 10.1002/jbm.a.32873
   Wu CT, 2010, J BIOMED MATER RES B, V94B, P32, DOI 10.1002/jbm.b.31621
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu C, 2009, BIOMATERIALS, V30, P2199, DOI 10.1016/j.biomaterials.2009.01.029
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xia W, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/13/135601
   Xiao YT, 2007, BIOCHEM BIOPH RES CO, V362, P550, DOI 10.1016/j.bbrc.2007.08.045
   Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012
   Xue JM, 2004, J CONTROL RELEASE, V98, P209, DOI 10.1016/j.jconrel.2004.04.023
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Yao AH, 2007, J AM CERAM SOC, V90, P303, DOI 10.1111/j.1551-2916.2006.01358.x
   Yu XZ, 2008, MAT SCI ENG C-BIO S, V28, P1138, DOI 10.1016/j.msec.2007.08.001
   Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564
   Zhang PB, 2009, BIOMATERIALS, V30, P58, DOI 10.1016/j.biomaterials.2008.08.041
   ZHANG XC, 1994, J CONTROL RELEASE, V31, P129
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao YF, 2008, J BIOMED MATER RES A, V85A, P1032, DOI 10.1002/jbm.a.31545
   Zhu M, 2011, J MATER CHEM, V21, P1064, DOI 10.1039/c0jm02179b
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
NR 129
TC 55
Z9 56
U1 3
U2 97
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2012
VL 23
IS 10
BP 2317
EP 2333
DI 10.1007/s10856-012-4580-z
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 017BF
UT WOS:000309563000002
PM 22361998
DA 2018-10-19
ER

PT J
AU Gustavsson, J
   Ginebra, MP
   Planell, J
   Engel, E
AF Gustavsson, J.
   Ginebra, M. P.
   Planell, J.
   Engel, E.
TI Osteoblast-like cellular response to dynamic changes in the ionic
   extracellular environment produced by calcium-deficient hydroxyapatite
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ALKALINE-PHOSPHATASE ACTIVITY; SAOS-2 CELLS; IN-VITRO; BONE
   MINERALIZATION; BIOLOGICAL BASIS; DIFFERENTIATION; CULTURE; MATRIX;
   PROLIFERATION; TOPOGRAPHY
AB Solution-mediated reactions due to ionic substitutions are increasingly explored as a strategy to improve the biological performance of calcium phosphate-based materials. Yet, cellular response to well-defined dynamic changes of the ionic extracellular environment has so far not been carefully studied in a biomaterials context. In this work, we present kinetic data on how osteoblast-like SAOS-2 cellular activity and calcium-deficient hydroxyapatite (CDHA) influenced extracellular pH as well as extracellular concentrations of calcium and phosphate in standard in vitro conditions. Since cells were grown on membranes permeable to ions and proteins, they could share the same aqueous environment with CDHA, but still be physically separated from the material. In such culture conditions, it was observed that gradual material-induced adsorption of calcium and phosphate from the medium had only minor influence on cellular proliferation and alkaline phosphatase activity, but that competition for calcium and phosphate between cells and the biomaterial delayed and reduced significantly the cellular capacity to deposit calcium in the extracellular matrix. The presented work thus gives insights into how and to what extent solution-mediated reactions can influence cellular response, and this will be necessary to take into account when interpreting CDHA performance both in vitro and in vivo.
C1 [Gustavsson, J.; Planell, J.; Engel, E.] Inst Bioengn Catalonia IBEC, Barcelona 08028, Spain.
   [Gustavsson, J.; Ginebra, M. P.; Planell, J.; Engel, E.] Tech Univ Catalonia UPC, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn Grp, Barcelona 08028, Spain.
   [Gustavsson, J.; Ginebra, M. P.; Planell, J.; Engel, E.] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza 50018, Spain.
RP Engel, E (reprint author), Inst Bioengn Catalonia IBEC, Baldiri Reixac 15-21, Barcelona 08028, Spain.
EM elisabeth.engel@upc.edu
RI Ginebra, Maria-Pau/J-8149-2017; Engel, Elisabeth/D-4365-2014
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Engel,
   Elisabeth/0000-0003-4855-8874
FU European Commission [NMP3-CT-2005-013912, NMP-LA-2008-214402];
   Generalitat de Catalunya; prize "ICREA Academia" for excellence in
   research
FX Funding was obtained from the European Commission for projects
   NMP3-CT-2005-013912 and NMP-LA-2008-214402. J. G. acknowledges FI grant
   from the Generalitat de Catalunya. Support for the research by M. P. G.
   was received through the prize "ICREA Academia" for excellence in
   research, funded by the Generalitat de Catalunya.
CR Aguirre A, 2010, BIOCHEM BIOPH RES CO, V393, P156, DOI 10.1016/j.bbrc.2010.01.109
   Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011
   Allori AC, 2008, TISSUE ENG PART B-RE, V14, P259, DOI 10.1089/ten.teb.2008.0082
   Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083
   Arnett TR, 1998, METHODS BONE BIOL, P15
   Balint E, 2001, BONE, V28, P21, DOI 10.1016/S8756-3282(00)00426-9
   Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033
   CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Eklou-Kalonji E, 1998, CELL TISSUE RES, V292, P163, DOI 10.1007/s004410051046
   El-Ghannam A, 2006, J BIOMED MATER RES A, V76A, P386, DOI 10.1002/jbm.a.30517
   Engel E, 2008, TISSUE ENG PT A, V14, P1341, DOI 10.1089/ten.tea.2007.0287
   Espanol M, 2009, ACTA BIOMATER, V5, P2752, DOI 10.1016/j.actbio.2009.03.011
   FARLEY JR, 1994, J BONE MINER RES, V9, P497
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fujita T, 2001, BIOCHEM BIOPH RES CO, V280, P348, DOI 10.1006/bbrc.2000.4108
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Gustavsson J, J TISSUE ENG REGEN M, DOI [10.1002/term550, DOI 10.1002/TERM550]
   Habel B, 1998, EUR BIOPHYS J BIOPHY, V27, P411, DOI 10.1007/s002490050149
   Hausser HJ, 2005, BIOCHEM BIOPH RES CO, V333, P216, DOI 10.1016/j.bbrc.2005.05.097
   Hempel U, 2004, J BIOMED MATER RES B, V71B, P130, DOI 10.1002/jbm.b.30082
   KHOUJA HI, 1990, BONE, V11, P385, DOI 10.1016/8756-3282(90)90131-H
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Liu Y.K., 2009, BIOMED MATER, V4, P1
   MATSUMOTO A, 1991, TOXICOL IN VITRO, V5, P51, DOI 10.1016/0887-2333(91)90047-H
   Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205
   Orimo H, 2008, MOL CELL BIOCHEM, V315, P51, DOI 10.1007/s11010-008-9788-3
   Radin S, 2005, J BIOMED MATER RES A, V73A, P21, DOI 10.1002/jbm.a.30241
   RODAN SB, 1987, CANCER RES, V47, P4961
   Schroder HC, 2005, J BIOMED MATER RES B, V75B, P387, DOI 10.1002/jbm.b.30322
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420
   Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yoshimura Y, 1996, ARCH ORAL BIOL, V41, P41, DOI 10.1016/0003-9969(95)00104-2
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 39
TC 16
Z9 17
U1 0
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2012
VL 23
IS 10
BP 2509
EP 2520
DI 10.1007/s10856-012-4705-4
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 017BF
UT WOS:000309563000019
PM 22729593
DA 2018-10-19
ER

PT J
AU Peirovi, H
   Rezvani, N
   Hajinasrollah, M
   Mohammadi, SS
   Niknejad, H
AF Peirovi, Habibollah
   Rezvani, Navid
   Hajinasrollah, Mostafa
   Mohammadi, Seied Sajjad
   Niknejad, Hassan
TI Implantation of amniotic membrane as a vascular substitute in the
   external jugular vein of juvenile sheep
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID HUMAN FETAL MEMBRANES; EPITHELIAL-CELLS; ENDOTHELIAL-CELLS; EXPRESSION;
   RUPTURE; MATRIX; IDENTIFICATION; SUPPRESSION; GRAFTS
AB Objective: Amniotic membrane, as a natural biomaterial, has many advantages, such as low immunogenicity, anti-inflammation, antifibrosis, and rich extracellular matrix components, which make it a promising source for vascular tissue engineering. This study assessed the feasibility of constructing a vein conduit from the amniotic membrane and implanting it in the external jugular vein of juvenile sheep.
   Methods: Human amniotic membrane was prepared using fresh human placenta. For construction of a tube such as a vein, the membrane was rolled around a tube and amniotic membrane-constructed conduits were interposed to the external jugular vein by end-to-end anastomosis. Grafts were assessed for patency at weeks 5 and 48 and explanted for evaluation with histologic and microscopic techniques.
   Results: At 5 weeks after implantation, the grafts were completely patent and displayed no signs of dilation. The internal surface was smooth and shiny, without any evidence of thrombus formation. After 48 weeks, grafts were still completely patent and displayed no signs of intimal thickening, dilation, or stenosis. No inflammation or fibrosis was evident. Histologic evaluation of the explanted grafts demonstrated a monolayer of endothelial cells. Scanning electron microscopy revealed a confluent layer of cells with normal endothelial cell morphology. A monolayer of cells positive for von Willebrand factor was detected in histology sections.
   Conclusions: The findings of this study confirm that the amniotic membrane can be a proper substitute for vascular tissue engineering. (J Vasc Surg 2012; 56: 1098-104.)
C1 [Peirovi, Habibollah; Rezvani, Navid; Mohammadi, Seied Sajjad; Niknejad, Hassan] Shahid Beheshti Univ Med Sci, Nanomed & Tissue Engn Res Ctr, Tehran, Iran.
   [Hajinasrollah, Mostafa] Shahid Beheshti Univ Med Sci, Loghman Hosp, Lab Anim Res, Tehran, Iran.
RP Niknejad, H (reprint author), Shahid Beheshti Univ Med Sci, Nanomed & Tissue Engn Res Ctr, POB 1985711151, Tehran, Iran.
EM niknejad@sbmu.ac.ir
FU Nanomedicine and Tissue Engineering Research Center
FX This study was supported by Nanomedicine and Tissue Engineering Research
   Center.
CR Buhimschi IA, 2004, AM J OBSTET GYNECOL, V191, P1678, DOI 10.1016/j.ajog.2004.03.081
   Carnagey J, 2003, J BIOMED MATER RES B, V65B, P171, DOI 10.1002/jbm.b.10558
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   King AE, 2007, PLACENTA, V28, P161, DOI 10.1016/j.placenta.2006.01.006
   King AE, 2003, J CLIN ENDOCR METAB, V88, P4426, DOI 10.1210/jc.2003-030239
   Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539
   Lee SB, 2000, CURR EYE RES, V20, P325, DOI 10.1076/0271-3683(200004)20:4;1-5;FT325
   Lefebvre S, 2000, HUM IMMUNOL, V61, P1095, DOI 10.1016/S0198-8859(00)00192-0
   MALAK TM, 1994, BRIT J OBSTET GYNAEC, V101, P375, DOI 10.1111/j.1471-0528.1994.tb11908.x
   McLaren J, 2000, AM J OBSTET GYNECOL, V182, P409, DOI 10.1016/S0002-9378(00)70232-8
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Miki T, 2007, J REPROD IMMUNOL, V75, P91, DOI 10.1016/j.jri.2007.03.017
   Moore RM, 2006, PLACENTA, V27, P1037, DOI 10.1016/j.placenta.2006.01.002
   Niknejad H, 2011, NEUROSCI LETT, V506, P22
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Niknejad H, 2011, CRYOBIOLOGY, V63, P145, DOI 10.1016/j.cryobiol.2011.08.003
   Niknejad H, 2010, EUR CELLS MATER, V19, P22, DOI 10.22203/eCM.v019a03
   Rose ML, 1998, CELL MOL LIFE SCI, V54, P965, DOI 10.1007/s000180050226
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   Suma H, 1999, Ann Thorac Cardiovasc Surg, V5, P141
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Szurman P, 2006, CORNEA, V25, P460, DOI 10.1097/01.ico.0000183493.00884.8f
   Tatewaki H, 2007, J VASC SURG, V45, P1236, DOI 10.1016/j.jvs.2007.01.066
   Yang DP, 2009, ANN PLAS SURG, V62, P297, DOI 10.1097/SAP.0b013e318197eb19
NR 29
TC 17
Z9 17
U1 0
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD OCT
PY 2012
VL 56
IS 4
BP 1098
EP 1104
DI 10.1016/j.jvs.2012.02.036
PG 7
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 016IV
UT WOS:000309512300030
PM 22560305
OA Bronze
DA 2018-10-19
ER

PT J
AU Cohen-Karni, T
   Jeong, KJ
   Tsui, JH
   Reznor, G
   Mustata, M
   Wanunu, M
   Graham, A
   Marks, C
   Bell, DC
   Langer, R
   Kohane, DS
AF Cohen-Karni, Tzahi
   Jeong, Kyung Jae
   Tsui, Jonathan H.
   Reznor, Gally
   Mustata, Mirela
   Wanunu, Meni
   Graham, Adam
   Marks, Carolyn
   Bell, David C.
   Langer, Robert
   Kohane, Daniel S.
TI Nanocomposite Gold-Silk Nanofibers
SO NANO LETTERS
LA English
DT Article
DE Silk; nanofibers; gold nanoparticles; cellular adhesion; tissue
   engineering; mesenchymal stem cells
ID CELL FATE; ADHESION; RGD; NANOPARTICLES; INTERFACES; NANOSCALE;
   SURFACES; LIGANDS; FIBERS; SIZE
AB Cell-biomaterial interactions can be controlled by modifying the surface chemistry or nanotopography of the material, to induce cell proliferation and differentiation if desired. Here we combine both approaches in forming silk nanofibers (SNFs) containing gold nanoparticles (AuNPs) and subsequently chemically modifying the fibers. Silk fibroin mixed with gold seed nanoparticles was electrospun to form SNFs doped with gold seed nanoparticles (SNFseed). Following gold reduction, there was a 2-fold increase in particle diameter confirmed by the appearance of a strong absorption peak at 525 nm. AuNPs were dispersed throughout the AuNP-doped silk nanofibers (SNFs(Au)). The Young's modulus of the SNFs(Au) was almost 70% higher than that of SNFs. SNFs(Au) were modified with the arginine-glycine-aspartic acid (RGD) peptide. Human mesenchymal stem cells that were cultured on RGD-modified SNFAu had a more than 2-fold larger cell area compared to the cells cultured on bare SNFs; SNFAu also increased cell size. This approach may be used to alter the cell-material interface in tissue engineering and other applications.
C1 [Cohen-Karni, Tzahi; Jeong, Kyung Jae; Tsui, Jonathan H.; Reznor, Gally; Kohane, Daniel S.] Harvard Univ, Sch Med, Boston Childrens Hosp,Div Crit Care Med, Lab Biomat & Drug Delivery,Dept Anesthesiol, Boston, MA 02115 USA.
   [Cohen-Karni, Tzahi; Jeong, Kyung Jae; Tsui, Jonathan H.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Mustata, Mirela; Wanunu, Meni] Northeastern Univ, Dept Phys, Dana Res Ctr, Boston, MA 02115 USA.
   [Bell, David C.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Graham, Adam; Marks, Carolyn; Bell, David C.] Harvard Univ, Ctr Nanoscale Syst, Cambridge, MA 02138 USA.
RP Kohane, DS (reprint author), Harvard Univ, Sch Med, Boston Childrens Hosp,Div Crit Care Med, Lab Biomat & Drug Delivery,Dept Anesthesiol, 300 Longwood Ave, Boston, MA 02115 USA.
EM Daniel.Kohane@childrens.harvard.edu
RI Wanunu, Meni/A-3627-2011
OI Wanunu, Meni/0000-0002-9837-0004
FU NIH [R37-EB000244, R01-EB006365, GM073626]
FX T.C.-K. would like to thank the Juvenile Diabetes Research Foundation
   (JDRF), R.L. would like to acknowledge the Max Planck Award and funding
   from NIH grants R37-EB000244 and R01-EB006365, and D.S.K. would like to
   acknowledge funding from NIH grant GM073626.
CR Adamcik J, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3589369
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   DUFF DG, 1993, LANGMUIR, V9, P2301, DOI 10.1021/la00033a010
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Feinberg AW, 2010, NANO LETT, V10, P2184, DOI 10.1021/nl100998p
   Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hu X, 2012, MATER TODAY, V15, P208, DOI 10.1016/S1369-7021(12)70091-3
   Kharlampieva E, 2010, ADV FUNCT MATER, V20, P840, DOI 10.1002/adfm.200901774
   Levy R, 2004, J AM CHEM SOC, V126, P10076, DOI 10.1021/ja0487269
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Link S, 1999, J PHYS CHEM B, V103, P4212, DOI 10.1021/jp984796o
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schon P, 2011, EUR POLYM J, V47, P692, DOI 10.1016/j.eurpolymj.2010.09.029
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
NR 28
TC 40
Z9 40
U1 3
U2 130
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD OCT
PY 2012
VL 12
IS 10
BP 5403
EP 5406
DI 10.1021/nl302810c
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 017TX
UT WOS:000309615000054
PM 22928701
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Schulz, S
   Tomakidi, P
   Mauth, C
   Kohal, R
   Steinberg, T
AF Schulz, Simon
   Tomakidi, Pascal
   Mauth, Corinna
   Kohal, Ralf
   Steinberg, Thorsten
TI Interactive Fibroblast-Keratinocyte Co-cultures: An In Vivo-Like Test
   Platform for Dental Implant-Based Soft Tissue Integration
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID HUMAN GINGIVAL FIBROBLASTS; HUMAN PERIODONTAL-LIGAMENT;
   PERI-IMPLANTITIS; SURFACE-TOPOGRAPHY; TITANIUM IMPLANTS; CELL-ADHESION;
   BIOLOGIC SEAL; EXPRESSION; ATTACHMENT; COLLAGEN
AB For clinicians, soft connective tissue integration (STI), one of the critical issues for dental implant success, is usually tested using the fibroblasts monolayer regime. Therefore, we aimed at an extension of this regime by employing interactive gingival fibroblast-keratinocyte cocultures (CCs) as an in vivo-like test platform. In the extended regime, 13 STI-relevant genes were analyzed in response to five different titanium implant biomaterial surfaces. The genes quantitated by real-time polymerase chain reaction were categorized as pro supportive or contra supportive, that is, nonsupportive for cell growth on an engineered surface. Monocultures had higher levels of contra supportive gene expression, but the fibroblast-keratinocyte CC had two out of five of the titanium surfaces with more pro supportive gene expression than contra supportive gene expression. We defined this change from contra supportive gene expression to pro supportive gene expression by developing the "relative supportive difference'' index. Hence, interactive CCs exhibit valuable supportive effects on the expression of STI-relevant genes, possibly via physiological cell-to-cell-interactions. Our results render interactive gingival CCs suitable as a test platform for dental implant-related STI under more in vivo-like conditions.
C1 [Schulz, Simon; Tomakidi, Pascal; Steinberg, Thorsten] Univ Hosp Freiburg, Sch Dent, Dept Oral Biotechnol, D-79106 Freiburg, Germany.
   [Mauth, Corinna] Inst Straumann AG, Basel, Switzerland.
   [Kohal, Ralf] Univ Hosp Freiburg, Sch Dent, Dept Prosthodont, D-79106 Freiburg, Germany.
RP Steinberg, T (reprint author), Univ Hosp Freiburg, Sch Dent, Dept Oral Biotechnol, D-79106 Freiburg, Germany.
EM thorsten.steinberg@uniklinik-freiburg.de
RI Schulz, Simon/A-2428-2013
OI Schulz, Simon/0000-0002-3747-3093; Kohal, Ralf/0000-0001-7095-4190
FU Institut Straumannn AG, Basel, Switzerland [ZVK 201-00-111]; University
   of Freiburg; Institut Straumann AG
FX This work was supported by a grant from Institut Straumannn AG, Basel,
   Switzerland, to the Department of Oral Biotechnology (Thorsten Steinberg
   and Pascal Tomakidi; Soft Tissue Screening Model: ZVK 201-00-111),
   University of Freiburg. Titanium biomaterial implant surfaces were
   kindly provided by Institut Straumann AG. The authors are grateful to
   Dr. Simon Berner for measurement of surface textures and contact angles
   as well as XPS analyses.
CR Abrahamsson I, 1998, J CLIN PERIODONTOL, V25, P721, DOI 10.1111/j.1600-051X.1998.tb02513.x
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   BARTOLD PM, 1991, J PERIODONTAL RES, V26, P339, DOI 10.1111/j.1600-0765.1991.tb02072.x
   Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7
   Borsani E, 2005, ACTA HISTOCHEM, V107, P231, DOI 10.1016/j.acthis.2005.06.002
   Chanut-Delalande H, 2004, MOL CELL BIOL, V24, P6049, DOI 10.1128/MCB.24.13.6049-6057.2004
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   Comut AA, 2001, CLIN ORAL IMPLAN RES, V12, P433, DOI 10.1034/j.1600-0501.2001.120502.x
   Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   GUY SC, 1993, J PERIODONTOL, V64, P542, DOI 10.1902/jop.1993.64.6.542
   HAKKINEN L, 1988, J BIOMED MATER RES, V22, P1043, DOI 10.1002/jbm.820221108
   HUANG MC, 1991, EUR J BIOCHEM, V195, P593, DOI 10.1111/j.1432-1033.1991.tb15742.x
   JANSEN JA, 1985, J DENT RES, V64, P891, DOI 10.1177/00220345850640060601
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   JUHASZ I, 1993, AM J PATHOL, V143, P1458
   Kasten F H, 1990, Int J Periodontics Restorative Dent, V10, P68
   Kawahara H, 1998, INT J ORAL MAX IMPL, V13, P457
   Kawahara H, 1998, INT J ORAL MAX IMPL, V13, P465
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Kokoti M, 2001, J ORAL REHABIL, V28, P880, DOI 10.1046/j.1365-2842.2001.00764.x
   Koldsland OC, 2010, J PERIODONTOL, V81, P231, DOI 10.1902/jop.2009.090269
   Konittinen YT, 2006, INT J PERIODONT REST, V26, P135
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Konttinen YT, 2011, REGENERATIVE MEDICINE: FROM PROTOCOL TO PATIENT, P21, DOI 10.1007/978-90-481-9075-1_2
   KURASHINA K, 1984, BIOMATERIALS, V5, P215, DOI 10.1016/0142-9612(84)90018-8
   Kuula H, 2008, ARCH ORAL BIOL, V53, P175, DOI 10.1016/j.archoralbio.2007.09.010
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LUKINMAA PL, 1992, J DENT RES, V71, P36, DOI 10.1177/00220345920710010601
   MCKINNEY RV, 1985, J PERIODONTOL, V56, P579, DOI 10.1902/jop.1985.56.10.579
   Mombelli A, 1998, PERIODONTOL 2000, V17, P63, DOI 10.1111/j.1600-0757.1998.tb00124.x
   Nakamura M, 2005, J HISTOCHEM CYTOCHEM, V53, P1553, DOI 10.1369/jhc.5A6669.2005
   Ong J L, 1997, Implant Dent, V6, P19, DOI 10.1097/00008505-199700610-00004
   Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Raisanen L, 2000, J BIOMED MATER RES, V49, P79
   Rinke S, 2011, CLIN ORAL IMPLAN RES, V22, P826, DOI 10.1111/j.1600-0501.2010.02061.x
   Roesch-Ely M, 2006, DIFFERENTIATION, V74, P622, DOI 10.1111/j.1432-0436.2006.00099.x
   Rompen E, 2006, CLIN ORAL IMPLAN RES, V17, P55, DOI 10.1111/j.1600-0501.2006.01367.x
   Sauberlich S, 1999, CLIN ORAL IMPLAN RES, V10, P379, DOI 10.1034/j.1600-0501.1999.100505.x
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Tomakidi P, 2000, BIOMATERIALS, V21, P1549, DOI 10.1016/S0142-9612(00)00037-5
   Tomakidi P, 1998, CELL TISSUE RES, V292, P355, DOI 10.1007/s004410051066
   Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6
   van der Pauw MTM, 2002, J PERIODONTAL RES, V37, P317, DOI 10.1034/j.1600-0765.2002.00349.x
   Winter S, 2005, CELL TISSUE RES, V319, P467, DOI 10.1007/s00441-004-1026-z
   Yamano S, 2011, CLIN ORAL IMPLAN RES, V22, P815, DOI 10.1111/j.1600-0501.2010.02059.x
   Yeong WY, 2007, J BIOMED MATER RES B, V82B, P260, DOI 10.1002/jbm.b.30729
   Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x
NR 51
TC 6
Z9 6
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD OCT
PY 2012
VL 18
IS 10
BP 785
EP 796
DI 10.1089/ten.tec.2012.0027
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 016ZO
UT WOS:000309558600006
PM 22571675
DA 2018-10-19
ER

PT J
AU Wong, VW
   Wan, DC
   Gurtner, GC
   Longaker, MT
AF Wong, Victor W.
   Wan, Derrick C.
   Gurtner, Geoffrey C.
   Longaker, Michael T.
TI Regenerative Surgery: Tissue Engineering in General Surgical Practice
SO WORLD JOURNAL OF SURGERY
LA English
DT Article
ID INTERNAL ANAL-SPHINCTER; EX-VIVO TRANSDUCTION; SMOOTH-MUSCLE-CELLS;
   STEM-CELLS; IN-VIVO; EXTRACELLULAR-MATRIX; BIOARTIFICIAL LIVER; COLLAGEN
   SPONGE; HERNIA REPAIR; TRANSPLANTATION
AB Tissue engineering is a broad interdisciplinary field that aims to develop complex tissue and organ constructs through a combination of cell-, biomaterial-, and molecular-based approaches. This approach has the potential to transform the surgical treatment for diseases including trauma, cancer, and congenital malformations. A fundamental knowledge of key concepts in regenerative medicine is imperative for surgeons to maintain a leading role in developing and implementing these technologies. Researchers have started to elucidate the biologic mechanisms that maintain organ homeostasis throughout life, indicating that humans may have the latent capacity to regenerate complex tissues. By exploiting this intrinsic potential of the body, we can move even closer to developing functional, autologous replacement parts for a wide range of surgical diseases.
C1 [Wong, Victor W.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97239 USA.
   [Wong, Victor W.; Wan, Derrick C.; Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA.
RP Wong, VW (reprint author), Oregon Hlth & Sci Univ, Dept Surg, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
EM vicw.wong@gmail.com
CR Altman AM, 2010, PLAST RECONSTR SURG, V126, P845, DOI 10.1097/PRS.0b013e3181e6044f
   Araki M, 2009, ARTIF ORGANS, V33, P818, DOI 10.1111/j.1525-1594.2009.00808.x
   Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Baillie DR, 2007, OSTOMY WOUND MANAG, V53, P30
   Bellows CF, 2006, EXPERT REV MED DEVIC, V3, P657, DOI 10.1586/17434440.3.5.657
   Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bitar KN, 2012, NEUROGASTROENT MOTIL, V24, P7, DOI 10.1111/j.1365-2982.2011.01843.x
   Boyce ST, 1999, J BURN CARE REHABIL, V20, P453, DOI 10.1097/00004630-199920060-00006
   Bruns H, 2005, TISSUE ENG, V11, P1718, DOI 10.1089/ten.2005.11.1718
   Chang EI, 2009, FASEB J, V23, P906, DOI 10.1096/fj.08-114868
   Chen MK, 2004, BIOMATERIALS, V25, P1675, DOI 10.1016/S0142-9612(03)00517-9
   Dabbas Natalie, 2011, JRSM Short Rep, V2, P5, DOI 10.1258/shorts.2010.010071
   El-Khatib FH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000619
   Fann SA, 2006, J INVEST SURG, V19, P193, DOI 10.1080/08941930600674736
   Fiegel HC, 2010, J CELL MOL MED, V14, P267, DOI 10.1111/j.1582-4934.2008.00369.x
   Fiegel HC, 2009, PEDIATR SURG INT, V25, P667, DOI 10.1007/s00383-009-2389-8
   Flum DR, 2003, ANN SURG, V237, P129, DOI 10.1097/00000658-200301000-00018
   Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185
   Glotzbach JP, 2011, CURR PROB SURG, V48, P148, DOI 10.1067/j.cpsurg.2010.11.002
   Gobin AS, 2006, TISSUE ENG, V12, P3383, DOI 10.1089/ten.2006.12.3383
   Grikscheit TC, 2003, ANN SURG, V238, P35, DOI 10.1097/01.SLA.0000074964.77367.4a
   Grikscheit TC, 2002, SURGERY, V132, P200, DOI 10.1067/msy.2002.125310
   Gupta A, 2006, BIOMACROMOLECULES, V7, P2701, DOI 10.1021/bm060383e
   Hamid M, 2001, CELL BIOL INT, V25, P553, DOI 10.1006/cbir.2000.0663
   Hashish M, 2010, J PEDIATR SURG, V45, P52, DOI 10.1016/j.jpedsurg.2009.10.010
   Hayashi K, 2004, ASAIO J, V50, P261, DOI 10.1097/01.MAT.0000123688.45717.A4
   Hori Y, 2001, ASAIO J, V47, P206, DOI 10.1097/00002480-200105000-00008
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Javaid-Ur-Rehman, 2008, SURG TODAY, V38, P484, DOI 10.1007/s00595-007-3671-9
   Kazemnejad S, 2009, J GASTROEN HEPATOL, V24, P278, DOI 10.1111/j.1440-1746.2008.05530.x
   Kim JH, 2010, ASAIO J, V56, P349, DOI 10.1097/MAT.0b013e3181e4848a
   Kodama S, 2009, TISSUE ENG PT A, V15, P3321, DOI [10.1089/ten.tea.2008.0459, 10.1089/ten.TEA.2008.0459]
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li J, 2010, STEM CELLS DEV, V19, P1427, DOI 10.1089/scd.2009.0415
   Linden PK, 2009, CRIT CARE CLIN, V25, P165, DOI 10.1016/j.ccc.2008.12.001
   Logan MS, 2010, ANN PLAS SURG, V64, P794, DOI 10.1097/SAP.0b013e3181b025cb
   Maemura T, 2004, TRANSPLANT P, V36, P1595, DOI 10.1016/j.transproceed.2004.05.020
   Maemura T, 2008, ARTIF ORGANS, V32, P234, DOI 10.1111/j.1525-1594.2007.00528.x
   Marston WA, 2004, EXPERT REV MED DEVIC, V1, P21, DOI 10.1586/17434440.1.1.21
   Michaels J, 2004, ANN PLAS SURG, V52, P581, DOI 10.1097/01.sap.0000122652.81844.37
   Michaels J, 2006, PLAST RECONSTR SURG, V118, P54, DOI 10.1097/01.prs.0000220466.27521.22
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Nakase Y, 2008, J THORAC CARDIOV SUR, V136, P850, DOI 10.1016/j.jtcvs.2008.05.027
   Ohashi K, 2005, CELL TRANSPLANT, V14, P621, DOI 10.3727/000000005783982620
   Ohashi K, 2005, HEPATOLOGY, V41, P132, DOI 10.1002/hep.20484
   Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Pless G, 2010, METHODS MOL BIOL, V640, P511, DOI 10.1007/978-1-60761-688-7_28
   Raghavan S, 2010, AM J PHYSIOL-GASTR L, V299, pG430, DOI 10.1152/ajpgi.00269.2009
   Raikwar SP, 2011, TRANSPLANTATION, V91, P11, DOI 10.1097/TP.0b013e3181fdd98b
   Saito T, 2011, TRANSPLANTATION, V92, P1231, DOI 10.1097/TP.0b013e3182375835
   Sala FG, 2011, TISSUE ENG PT A, V17, P1841, DOI [10.1089/ten.tea.2010.0564, 10.1089/ten.TEA.2010.0564]
   Saxena AK, 2009, J GASTROINTEST SURG, V13, P1037, DOI 10.1007/s11605-009-0836-4
   Schaffellner S, 2005, TRANSPL P, V37, P248, DOI 10.1016/j.transproceed.2005.01.042
   Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x
   Shankaran V, 2011, ANN SURG, V253, P16, DOI 10.1097/SLA.0b013e3181f9b6e6
   Simons BD, 2011, EXP CELL RES, V317, P2719, DOI 10.1016/j.yexcr.2011.07.010
   Somara S, 2009, GASTROENTEROLOGY, V137, P53, DOI 10.1053/j.gastro.2009.03.036
   Speer AL, 2011, J SURG RES, V171, P6, DOI 10.1016/j.jss.2011.03.062
   Stanwix MG, 2011, ANN PLAS SURG, V66, P403, DOI 10.1097/SAP.0b013e3181e051ed
   Still J, 2003, BURNS, V29, P837, DOI 10.1016/S0305-4179(03)00164-5
   Sugimoto S, 2005, TISSUE ENG, V11, P626, DOI 10.1089/ten.2005.11.626
   Suh S, 2004, ASAIO J, V50, P464, DOI 10.1097/01.MAT.0000138016.83837.8A
   Sumi S, 2004, PANCREAS, V29, pE85, DOI 10.1097/00006676-200410000-00017
   Tepper OM, 2004, FASEB J, V18, P1231, DOI 10.1096/fj.03-0847fje
   Tsang WG, 2007, TRANSPLANTATION, V83, P685, DOI 10.1097/01.tp.0000256178.57359.4f
   Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Watanabe FD, 1997, ANN SURG, V225, P484, DOI 10.1097/00000658-199705000-00005
   WATANABE FD, 1997, ANN SURG, V225, P491
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212
   Yang J, 2010, PLAST RECONSTR SURG, V125, P901, DOI 10.1097/PRS.0b013e3181cc9665
   Zaulyanov L, 2007, CLIN INTERV AGING, V2, P93, DOI 10.2147/ciia.2007.2.1.93
   Zhang F, 2011, TISSUE ENG PART B-RE, V17, P115, DOI [10.1089/ten.teb.2010.0549, 10.1089/ten.TEB.2010.0549]
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
   Zhao R, 2010, STEM CELL REV REP, V6, P345, DOI 10.1007/s12015-010-9128-3
NR 82
TC 0
Z9 2
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-2313
J9 WORLD J SURG
JI World J.Surg.
PD OCT
PY 2012
VL 36
IS 10
BP 2288
EP 2299
DI 10.1007/s00268-012-1710-1
PG 12
WC Surgery
SC Surgery
GA 017AA
UT WOS:000309559800003
PM 22777416
DA 2018-10-19
ER

PT J
AU Park, J
   Babensee, JE
AF Park, Jaehyung
   Babensee, Julia E.
TI Differential functional effects of biomaterials on dendritic cell
   maturation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biocompatibility; Immunomodulation; Dendritic cells; Biomaterials;
   Combination products
ID ARTICULAR-CARTILAGE REPAIR; NECROSIS-FACTOR-ALPHA; KAPPA-B ACTIVATION;
   BONE-MARROW; POLY(LACTIC-CO-GLYCOLIC ACID); IMMUNE-RESPONSE; CYTOKINE
   PRODUCTION; PROTEIN ADSORPTION; SURFACE-CHEMISTRY; ADSORBED PROTEINS
AB The immunological outcome of dendritic cell (DC) treatment with different biomaterials was assessed to demonstrate the range of DC phenotypes induced by biomaterials commonly used in combination products. Immature DCs (iDCs) were derived from human peripheral blood monocytes, and treated with different biomaterial films of alginate, agarose, chitosan, hyaluronic acid (HA), or 75:25 poly(lactic-co-glycolic acid) (PLGA) and a comprehensive battery of phenotypic functional outcomes was assessed. Different levels of functional changes in DC phenotype were observed depending on the type of biomaterial films used to treat the DCs. Treatment of DCs with PLGA or chitosan films supported DC maturation, with higher levels of DC allostimulatory capacity, pro-inflammatory cytokine release, and expression of CD80, CD86, CD83, HLA-DQ and CD44 compared with iDCs, and lower endocytic ability compared with iDCs. Alginate film induced pro-inflammatory cytokine release from DCs at levels higher than from iDCs. Dendritic cells treated with HA film expressed lower levels of CD40, CD80, CD86 and HLA-DR compared with iDCs. They also exhibited lower endocytic ability and CD44 expression than iDCs, possibly due to an insolubilized (cross-linked) form of high molecular weight HA. Interestingly, treatment of DCs with agarose film maintained the DC functional phenotype at levels similar to iDCs except for CD44 expression, which was lower than that of iDCs. Taken together, these results can provide selection criteria for biomaterials to be used in immunomodulating applications and can inform potential outcomes of biomaterials within combination products on associated immune responses as desired by the application. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU National Institutes of Health [1RO1EB004633-01A1]; National Science
   Foundation under a CAREER Grant [BES-0239152]; Arthritis Foundation
   through an Arthritis Investigator Grant
FX The authors thank Dr. Brani Vidakovic and Dr. Jongphil Kim (Georgia
   Institute of Technology) for their valuable advice on statistical
   analysis. This work was supported by the National Institutes of Health
   through Grant No. 1RO1EB004633-01A1, the National Science Foundation
   under a CAREER Grant No. BES-0239152 and by the Arthritis Foundation
   through an Arthritis Investigator Grant.
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228
   Ajdary S, 2007, VACCINE, V25, P4595, DOI 10.1016/j.vaccine.2007.03.039
   Ardeshna KM, 2000, BLOOD, V96, P1039
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   BRASH JL, 1983, ABSTR PAP AM CHEM S, V185, P190
   Bu WF, 2002, J COLLOID INTERF SCI, V251, P120, DOI 10.1006/jcis.2002.8380
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D
   Do Y, 2004, J IMMUNOTHER, V27, P1, DOI 10.1097/00002371-200401000-00001
   Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   Foti M, 2006, J LEUKOCYTE BIOL, V79, P913, DOI 10.1189/jlb.1005547
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   Fukumoto T, 2003, OSTEOARTHR CARTILAGE, V11, P55, DOI 10.1053/joca.2002.0869
   Gamvrellis A, 2004, IMMUNOL CELL BIOL, V82, P506, DOI 10.1111/j.1440-1711.2004.01271.x
   Godek ML, 2009, J BIOMED MATER RES A, V88A, P503, DOI 10.1002/jbm.a.31886
   Hitchen PG, 1998, BIOCHEM J, V333, P601, DOI 10.1042/bj3330601
   Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007
   Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   JIANG SX, 1994, BLOOD, V84, P4151
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Jones KS, 2006, TRANSPLANTATION, V82, P415, DOI 10.1097/01.tp.0000228917.57323.ec
   Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5
   Kishida A, 2001, BIOMATERIALS, V22, P541, DOI 10.1016/S0142-9612(00)00210-6
   Kustritz MVR, 2000, J AM VET MED ASSOC, V216, P181, DOI 10.2460/javma.2000.216.181
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Li WJ, 2005, MACROMOL SYMP, V227, P65, DOI 10.1002/masy.200550906
   Liman M, 2007, VACCINE, V25, P7914, DOI 10.1016/j.vaccine.2007.09.001
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Lokshin AE, 2002, INT IMMUNOL, V14, P1027, DOI 10.1093/intimm/dxf073
   Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mizuno K, 2004, J INVEST DERMATOL, V122, P300, DOI 10.1046/j.0022-202X.2004.22206.x
   Moldenhauer A, 2003, VOX SANG, V84, P228, DOI 10.1046/j.1423-0410.2003.00283.x
   Mukherjee S, 1997, PHYSIOL REV, V77, P759
   Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019
   NEWTONNASH DK, 1990, J LEUKOCYTE BIOL, V48, P297
   Norde W, 1986, ABSTR PAP AM CHEM SO, V192, P27
   Norton LW, 2010, J CONTROL RELEASE, V146, P341, DOI 10.1016/j.jconrel.2010.05.032
   Orive G, 2005, BIOMACROMOLECULES, V6, P927, DOI 10.1021/bm049380x
   Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P231, DOI 10.1002/(SICI)1097-0290(1999)66:4<231::AID-BIT4>3.3.CO;2-L
   Park Y, 2002, J IMMUNOL, V168, P5, DOI 10.4049/jimmunol.168.1.5
   Piemonti L, 1999, INT IMMUNOL, V11, P1519, DOI 10.1093/intimm/11.9.1519
   Pope RM, 2002, NAT REV IMMUNOL, V2, P527, DOI 10.1038/nri846
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Rogers TH, 2011, BIOMATERIALS, V32, P1270, DOI 10.1016/j.biomaterials.2010.10.014
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   Schnurr M, 2001, CANCER RES, V61, P6445
   Seferian PG, 2000, VACCINE, V19, P661, DOI 10.1016/S0264-410X(00)00248-6
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Tam SK, 2005, BIOMATERIALS, V26, P6950, DOI 10.1016/j.biomaterials.2005.05.007
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Tashiro H, 1998, TRANSPLANT P, V30, P490, DOI 10.1016/S0041-1345(97)01369-9
   Termeer C, 2001, J LEUKOCYTE BIOL, V70, P715
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tun T, 1996, CELL TRANSPLANT, V5, pS59, DOI 10.1016/0963-6897(96)00042-5
   van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182
   WARR GA, 1980, BIOCHEM BIOPH RES CO, V93, P737, DOI 10.1016/0006-291X(80)91139-0
   Weiss JM, 1997, J CELL BIOL, V137, P1137, DOI 10.1083/jcb.137.5.1137
   Xaus J, 2000, BLOOD, V95, P3823
   Yang TB, 2002, CANCER RES, V62, P2583
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Yoshida M, 2006, J BIOMAT SCI-POLYM E, V17, P893, DOI 10.1163/156856206777996844
   You RI, 2008, BLOOD, V111, P1480, DOI 10.1182/blood-2007-09-114850
   YOUNG BR, 1988, J COLLOID INTERF SCI, V124, P28, DOI 10.1016/0021-9797(88)90321-9
   Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200
   Zou GM, 2002, EUR CYTOKINE NETW, V13, P186
NR 87
TC 45
Z9 48
U1 0
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2012
VL 8
IS 10
BP 3606
EP 3617
DI 10.1016/j.actbio.2012.06.006
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013JJ
UT WOS:000309301400007
PM 22705044
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Maciel, J
   Oliveira, MI
   Goncalves, RM
   Barbosa, MA
AF Maciel, J.
   Oliveira, M. I.
   Goncalves, R. M.
   Barbosa, M. A.
TI The effect of adsorbed fibronectin and osteopontin on macrophage
   adhesion and morphology on hydrophilic and hydrophobic model surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Fibronectin; Osteopontin; Macrophages; Self-assembled monolayers;
   Biomaterials
ID SELF-ASSEMBLED MONOLAYERS; GIANT-CELL FORMATION; INDUCED
   CONFORMATIONAL-CHANGES; PROTEIN ADSORPTION; SERUM-PROTEINS;
   MONOCYTE/MACROPHAGE ADHESION; INTEGRIN BINDING; CHEMISTRY; BEHAVIOR;
   BIOMATERIALS
AB Macrophages play a crucial role in the host response to biomaterials. Here we investigated the effect of adsorbed fibronectin (FN) and osteopontin (OPN), two important proteins for tissue repair, on macrophage adhesion and morphology. Since cell-biomaterial interactions are modulated via proteins adsorbed onto biomaterial surfaces, FN and OPN were adsorbed on model self-assembled monolayers (SAMs) of alkanethiols on gold with different functional terminal groups (CH3, OH and tetra(ethylene-glycol)). The initial interaction of inflammatory cells with a biomaterial is crucial for the ensuing phases of an inflammatory reaction. For this reason short-term cultures of primary human macrophages were performed. To account for the competitive adsorption of other proteins serum was added to the culture medium and the effect compared with serum-free medium cultures. In the presence of serum hydrophilic surfaces increased macrophage adhesion. In particular, FN induced a higher cell density, while OPN tended to decrease it. In serum-free medium cell adhesion was greater on hydrophobic surfaces, except for OPN-coated SAMs. Importantly, FN no longer enhanced macrophage adhesion, while OPN maintained its inhibitory effect. Cell polarization studies indicated that macrophage morphology variations induced by surface chemistry are overcome by pre-adsorbed OPN. Taken together our results show that in the presence of serum macrophage adhesion is promoted by FN hydrophilic surfaces, but impaired on OPN-coated surfaces. The effects of inhibited macrophage adhesion on macrophage fusion, and its relevance to the initial stages of the inflammatory response to biomaterials are discussed. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Maciel, J.; Oliveira, M. I.; Goncalves, R. M.; Barbosa, M. A.] Univ Porto, INEB Inst Biomed Engn, P-4150180 Oporto, Portugal.
   [Maciel, J.] Univ Porto, Fac Engn, P-4150180 Oporto, Portugal.
   [Barbosa, M. A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4150180 Oporto, Portugal.
RP Barbosa, MA (reprint author), Univ Porto, INEB Inst Biomed Engn, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM mbarbosa@ineb.up.pt
RI Oliveira, Marta/M-9386-2013; Barbosa, Mario/F-5964-2011; Maciel,
   Joana/J-3956-2014; Goncalves, Raquel/C-5940-2012
OI Oliveira, Marta/0000-0002-0578-9202; Barbosa, Mario/0000-0003-3568-7482;
   Maciel, Joana/0000-0003-3546-3817; Goncalves, Raquel/0000-0003-2841-0485
FU FEDER funds through the Programa Operacional Factores de Competitividade
   - COMPETE; Portuguese funds through the Fundacao para a Ciencia e a
   Tecnologia (FCT) [PEst-C/SAU/LA0002/2011, PTDC/SAU-BEB/099954/2008]; FCT
   [SFRH/BD/37582/2007, SFRH/BPD/37090/2007]; EC, FP7 [CP-IP 213904]
FX The authors are grateful to the Instituto Portugues do Sangue for
   donating the buffy coats. This work was financed by FEDER funds through
   the Programa Operacional Factores de Competitividade - COMPETE and by
   Portuguese funds through the Fundacao para a Ciencia e a Tecnologia
   (FCT) within the framework of the projects PEst-C/SAU/LA0002/2011 and
   PTDC/SAU-BEB/099954/2008. J.M. and M.I.O. are grateful to the FCT for
   awarding them a doctoral (SFRH/BD/37582/2007) and a post-doctoral
   (SFRH/BPD/37090/2007) fellowships, respectively. R.M.G. is grateful to
   DISC Regeneration Project, funded by EC, FP7, Grant agreement no.: CP-IP
   213904. The authors are also thankful to Fatima Pina and Sandra Alves
   (INEB) for helpful discussions on the statistical analysis.
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Amersham, 1993, IOD 125 GUID RAD TEC
   Anderson James M., 1994, P113
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barrias CC, 2005, BIOMATERIALS, V26, P2695, DOI 10.1016/j.biomaterials.2004.07.033
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   Collier TO, 2002, J BIOMED MATER RES, V59, P136, DOI 10.1002/jbm.1225
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   Dee K C, 2003, PROTEIN SURFACE INTE, P37
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DENHARDT DT, 1993, FASEB J, V7, P1475
   Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723
   Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980
   Gehanno V, 1999, IEEE T MAGN, V35, P4361, DOI 10.1109/20.799086
   Giachelli CM, 1998, AM J PATHOL, V152, P353
   Giamblanco N., 2010, LANGMUIR, V27, P312
   Goncalves IC, 2009, J BIOMED MATER RES A, V89A, P642, DOI 10.1002/jbm.a.32011
   Goncalves R, 2010, J BIOMED MATER RES A, V94A, P576, DOI 10.1002/jbm.a.32723
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HORBETT TA, 1987, ACS SYM SER, V343, P1
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Jensen T, 2011, J BIOMED MATER RES A, V99A, P94, DOI 10.1002/jbm.a.33166
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Latour R. A., 2008, ENCY BIOMATERIALS BI, P270
   Liu LY, 2005, J BIOMED MATER RES A, V74A, P23, DOI 10.1002/jbm.a.30221
   Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0
   Maciel J, 2010, J BIOMED MATER RES A, V94A, P833, DOI 10.1002/jbm.a.32746
   Malmstrom J, 2010, J BIOMED MATER RES A, V95A, P518, DOI 10.1002/jbm.a.32879
   Martins MCL, 2009, J BIOMED MATER RES A, V88A, P162, DOI 10.1002/jbm.a.31849
   Martins MC, 2012, NANOTECHNOLOGY REGEN, P141
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   Martins MCL, 2003, BIOMATERIALS, V24, P3697, DOI 10.1016/S0142-9612(03)00244-8
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pedraza CE, 2008, BONE, V43, P708, DOI 10.1016/j.bone.2008.06.010
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   Stein MJ, 2009, J PHYS CHEM B, V113, P11550, DOI 10.1021/jp9015867
   Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
NR 58
TC 10
Z9 12
U1 2
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2012
VL 8
IS 10
BP 3669
EP 3677
DI 10.1016/j.actbio.2012.06.010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013JJ
UT WOS:000309301400013
PM 22705043
DA 2018-10-19
ER

PT J
AU Kew, SJ
   Gwynne, JH
   Enea, D
   Brookes, R
   Rushton, N
   Best, SM
   Cameron, RE
AF Kew, S. J.
   Gwynne, J. H.
   Enea, D.
   Brookes, R.
   Rushton, N.
   Best, S. M.
   Cameron, R. E.
TI Synthetic collagen fascicles for the regeneration of tendon tissue
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tendon; Regeneration; Collagen; Fibre; Tissue
ID ANTERIOR CRUCIATE LIGAMENT; ROTATOR CUFF REPAIRS; MECHANICAL-PROPERTIES;
   CROSS-LINKING; ENGINEERING APPLICATIONS; ACHILLES-TENDON;
   EXTRACELLULAR-MATRIX; FIBERS; SCAFFOLDS; BIOMATERIALS
AB The structure of an ideal scaffold for tendon regeneration must be designed to provide a mechanical, structural and chemotactic microenvironment for native cellular activity to synthesize functional (i.e. load bearing) tissue. Collagen fibre scaffolds for this application have shown some promise to date, although the microstructural control required to mimic the native tendon environment has yet to be achieved allowing for minimal control of critical in vivo properties such as degradation rate and mass transport. In this report we describe the fabrication of a novel multi-fibre collagen fascicle structure, based on type-I collagen with failure stress of 25-49 MPa, approximating the strength and structure of native tendon tissue. We demonstrate a microscopic fabrication process based on the automated assembly of type-I collagen fibres with the ability to produce a controllable fascicle-like, structural motif allowing variable numbers of fibres per fascicle. We have confirmed that the resulting post-fabrication type-I collagen structure retains the essential phase behaviour, alignment and spectral characteristics of aligned native type-I collagen. We have also shown that both ovine tendon fibroblasts and human white blood cells in whole blood readily infiltrate the matrix on a macroscopic scale and that these cells adhere to the fibre surface after seven days in culture. The study has indicated that the synthetic collagen fascicle system may be a suitable biomaterial scaffold to provide a rationally designed implantable matrix material to mediate tendon repair and regeneration. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kew, S. J.] Tigenix Ltd, Cambridge CB4 0WZ, England.
   [Gwynne, J. H.; Best, S. M.; Cameron, R. E.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   [Enea, D.; Brookes, R.; Rushton, N.] Univ Cambridge, Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
RP Kew, SJ (reprint author), Tigenix Ltd, Byron House,Cambridge Business Pk,Milton Rd, Cambridge CB4 0WZ, England.
EM sjkew@hotmail.com
OI Cameron, Ruth/0000-0003-1573-4923
FU Technology Strategy Board [TP/8/BIO/6/1/Q0052K]; Tigenix Ltd, Cambridge,
   UK
FX S.J.K., J.H.G., D.E., R.B., N.R., S.M.B. and R.E.C. would like to thank
   the Technology Strategy Board for support under Grant No.
   TP/8/BIO/6/1/Q0052K. We would also like to thank Timothy Mead and Oliver
   Ferguson for assistance in construction of the extrusion equipment.;
   This work was supported in part by Tigenix Ltd, Cambridge, UK.
CR Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   Caves JM, 2010, J BIOMED MATER RES B, V93B, P24, DOI 10.1002/jbm.b.31555
   Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   Enea D, 2011, J MATER SCI-MATER M, V22, P1569, DOI 10.1007/s10856-011-4336-1
   Feeney MS, 2003, J SHOULDER ELB SURG, V12, P20, DOI 10.1067/mse.2003.128565
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   Gentleman E, 2006, ANN BIOMED ENG, V34, P726, DOI 10.1007/s10439-005-9058-4
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   ITOI E, 1995, J ORTHOPAED RES, V13, P578, DOI 10.1002/jor.1100130413
   KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Longo UG, 2012, MED SPORT SCI, V57, P1, DOI 10.1159/000328868
   Maffulli N, 1999, J BONE JOINT SURG AM, V81A, P1019, DOI 10.2106/00004623-199907000-00017
   Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001
   MODY BS, 1993, J BONE JOINT SURG BR, V75, P818
   NOYES FR, 1976, J BONE JOINT SURG AM, V58, P1074, DOI 10.2106/00004623-197658080-00006
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Rotini Roberto, 2008, Chir Organi Mov, V91, P87, DOI 10.1007/s12306-007-0015-2
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   SUNG NH, 1972, THESIS MIT
   Walton JR, 2007, J BONE JOINT SURG AM, V89A, P786, DOI 10.2106/JBJS.F.00315
   WANG MC, 1994, BIOMATERIALS, V15, P507
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   Wren TAL, 2001, CLIN BIOMECH, V16, P245, DOI 10.1016/S0268-0033(00)00089-9
   Zeugolis DI, 2008, J BIOMED MATER RES B, V85B, P343, DOI 10.1002/jbm.b.30952
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 35
TC 26
Z9 26
U1 3
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2012
VL 8
IS 10
BP 3723
EP 3731
DI 10.1016/j.actbio.2012.06.018
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013JJ
UT WOS:000309301400019
PM 22728568
DA 2018-10-19
ER

PT J
AU Rebl, H
   Finke, B
   Lange, R
   Weltmann, KD
   Nebe, JB
AF Rebl, Henrike
   Finke, Birgit
   Lange, Regina
   Weltmann, Klaus-Dieter
   Nebe, J. Barbara
TI Impact of plasma chemistry versus titanium surface topography on
   osteoblast orientation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Actin cytoskeleton; Osteoblast; Plasma polymerization; Surface
   topography; Allylamine
ID CELL-ADHESION; BIOMEDICAL APPLICATIONS; IMPLANT SURFACES; MODEL
   SURFACES; IN-VITRO; BONE; ROUGHNESS; SUBSTRATUM; ALLYLAMINE; POLYSTYRENE
AB Topographical and chemical modifications of biomaterial surfaces both influence tissue physiology, but unfortunately little knowledge exists as to their combined effect. There are many indications that rough surfaces positively influence osteoblast behavior. Having determined previously that a positively charged, smooth titanium surface boosts osteoblast adhesion, we wanted to investigate the combined effects of topography and chemistry and elucidate which of these properties is dominant. Polished, machined and corundum-blasted titanium of increasing microroughness was additionally coated with plasma-polymerized allylamine (PPAAm). Collagen I was then immobilized using polyethylene glycol diacid and glutar dialdehyde. On all PPAAm-modified surfaces (i) adhesion of human MG-63 osteoblastic cells increased significantly in combination with roughness, (ii) cells resemble the underlying structure and melt with the surface, and (iii) cells overcome the restrictions of a grooved surface and spread out over a large area as indicated by actin staining. Interestingly, the cellular effects of the plasma-chemical surface modification are predominant over surface topography, especially in the initial phase. Collagen I, although it is the gold standard, does not improve surface adhesion features comparably. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Rebl, Henrike; Nebe, J. Barbara] Univ Rostock, Biomed Res Ctr, Dept Cell Biol, D-18057 Rostock, Germany.
   [Finke, Birgit; Weltmann, Klaus-Dieter] Leibniz Inst Plasma Sci & Technol INP, D-17489 Greifswald, Germany.
   [Lange, Regina] Univ Rostock, Dept Elect Engn & Informat Technol, D-18119 Rostock, Germany.
RP Nebe, JB (reprint author), Univ Rostock, Biomed Res Ctr, Dept Cell Biol, D-18057 Rostock, Germany.
EM barbara.nebe@med.uni-rostock.de
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905; Finke, Birgit/0000-0002-5941-0376
FU German Ministry of Education and Research (BMBF) [13N9779, 13N11188]
FX The authors thank E. Pauthe (University of Cergy-Pontoise, France) and
   T. Vorhaben (INP) for fruitful discussions. The excellent technical
   assistance of A. Schella, U. Kellner U. Lindemann, R. Ihrke, M. Bruser
   and G. Friedrichs (INP) is kindly acknowledged. We kindly thank Dr. A.
   Weidmann (formerly University of Rostock) for excellent support. This
   work was realized within the framework of the multidisciplinary research
   cooperation "Campus PlasmaMed", particularly within the project
   "Plasmalmp". The financial support of the German Ministry of Education
   and Research (BMBF, Grant Nos. 13N9779, 13N11188) for H.R. and B.F. is
   gratefully acknowledged. We appreciate the technical assistance of the
   EMZ at University of Rostock.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670
   Balazic Matej, 2007, International Journal of Nano and Biomaterials, V1, P3, DOI 10.1504/IJNBM.2007.016517
   Barbour ME, 2007, J MATER SCI-MATER M, V18, P1439, DOI 10.1007/s10856-007-0141-2
   Beamson G, 1992, SCI ESCA 300 DATABAS, P202
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Donahue HJ, 2004, BONE TISSUE ENG, P44
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Garcia AJ, 2000, BIOMIMETIC MAT DESIG, P29
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Keller JC, 1997, DENT MATER, V13, P62, DOI 10.1016/S0109-5641(97)80010-3
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   Kiberstis P, 2000, SCIENCE, V289, P1497, DOI 10.1126/science.289.5484.1497
   Kubies D, 2011, PHYSIOL RES, V60, P95
   Lange R, 2010, SURF INTERFACE ANAL, V42, P497, DOI 10.1002/sia.3320
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Mendonca DBS, 2011, BONE, V49, P463, DOI 10.1016/j.bone.2011.04.019
   Morra M, 2007, EXPERT REV MED DEVIC, V4, P361, DOI 10.1586/17434440.4.3.361
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Nebe JB, 2010, MATER SCI FORUM, V638-642, P652, DOI 10.4028/www.scientific.net/MSF.638-642.652
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park KH, 2007, J ORAL REHABIL, V34, P517, DOI 10.1111/j.1365-2842.2006.01688.x
   Rabel W., 1971, FARBE LACK, V77, P997
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Rebl H, 2010, INT J ARTIF ORGANS, V33, P738
   Rebl H, 2010, ADV ENG MATER, V12, pB356, DOI 10.1002/adem.200980070
   Ren TB, 2008, J BIOMED MATER RES A, V86A, P209, DOI 10.1002/jbm.a.31508
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P1191, DOI 10.1163/016942409X12619870771501
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P905, DOI 10.1163/016942409X12598231567989
   Schuler M, 2006, NANOMEDICINE-UK, V1, P449, DOI 10.2217/17435889.1.4.449
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V68B, P149, DOI 10.1002/jbm.b.20003
   Tsukimura N, 2008, J BIOMED MATER RES A, V84A, P108, DOI 10.1002/jbm.a.31422
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   VOGLER EA, 1987, J BIOMED MATER RES, V21, P1197, DOI 10.1002/jbm.820211004
   Wende K, 2006, PLASMA PROCESS POLYM, V3, P524, DOI 10.1002/ppap.200600019
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 53
TC 18
Z9 18
U1 2
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2012
VL 8
IS 10
BP 3840
EP 3851
DI 10.1016/j.actbio.2012.06.015
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 013JJ
UT WOS:000309301400031
PM 22705633
DA 2018-10-19
ER

PT J
AU Sotoudeh, A
   Jahanshahi, G
   Jahanshahi, A
   Takhtfooladi, MA
   Shabani, I
   Soleimani, M
AF Sotoudeh, Amir
   Jahanshahi, Gholamreza
   Jahanshahi, Amirali
   Takhtfooladi, Mohammad Ashrafzadeh
   Shabani, Iman
   Soleimani, Masoud
TI Combination of poly L-lactic acid nanofiber scaffold with omentum graft
   for bone healing in experimental defect in tibia of rabbits
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Lactic Acid; Omentum; Bone Regeneration; Rabbits
ID FIBROBLAST-GROWTH-FACTOR; PEPTIDE-AMPHIPHILE NANOFIBERS; MESENCHYMAL
   STEM-CELLS; FRACTURE REPAIR; FACTOR-BETA; SUBSTITUTES; HYDROXYAPATITE;
   ANGIOGENESIS; STIMULATION; COLLAGEN
AB PURPOSE: To investigate the osteoconductive properties and biological performance of Poly L-lactic acid (PLLA) with omentum in bone defects.
   METHODS: PLLA nanofiber scaffolds were prepared via electrospinning technique. Forty four New Zealand white female rabbits randomly divided into three groups of 18 rabbits each. Created defects in right tibias were filled in group I with omentum, in group II with PLLA nanofiber scaffold and in group III with combination of the omentum and PLLA. The same defects were created in left tibia of all groups but did not receive any treatment (control group). Histological and histomorphometric evaluations were performed at two, four and six weeks after the implantation.
   RESULTS: Histological changes on all groups along with the time course were scored and statistical analysis showed that the average scores in group III were significantly higher than the other groups.
   CONCLUSION: Histomorphometric analysis of bone healing was shown to be significantly improved by the combined PLLA with omentum compared with the other groups, suggesting this biomaterial promote the healing of cortical bone, presumably by acting as an osteoconductive scaffold.
C1 [Sotoudeh, Amir] Islamic Azad Univ, Kahnooj Branch, Fac Vet, Dept Expt Surg, Kahnooj, Iran.
RP Sotoudeh, A (reprint author), Islamic Azad Univ, Kahnooj Branch, Fac Vet, Dept Expt Surg, Kahnooj, Iran.
EM dramirsotoudeh@kahnoojiau.ac.ir
RI Shabani, Iman/M-8551-2017
OI Shabani, Iman/0000-0003-2614-3088; jahanshahi,
   gholamreza/0000-0003-2481-3383
CR Abedi G, 2011, J BIOMAT SCI-POLYM E, V22, P2445, DOI 10.1163/092050610X540503
   Andreshak JL, 1997, ANAT RECORD, V248, P198, DOI 10.1002/(SICI)1097-0185(199706)248:2<198::AID-AR6>3.0.CO;2-P
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   BIKFALVI A, 1990, J CELL PHYSIOL, V144, P151, DOI 10.1002/jcp.1041440120
   Bilkay U, 2004, J CRANIOFAC SURG, V15, P585, DOI 10.1097/00001665-200407000-00011
   Bland YS, 1995, ACTA ORTHOP SCAND, V66, P543, DOI 10.3109/17453679509002313
   Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS124
   Brand JC, 2005, ARTHROSCOPY, V21, P911, DOI 10.1016/j.arthro.2005.05.009
   Brown GD, 1998, J PERIODONTOL, V69, P146, DOI 10.1902/jop.1998.69.2.146
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   BUCHOLZ RW, 2002, CLIN ORTHOP FEBRUARY, V395, P44
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   Cowan CM, 2005, CURR TOP DEV BIOL, V66, P239, DOI 10.1016/S0070-2153(05)66008-5
   Cruz Fernando, 2012, BIOPOLYMERS, V11, P227
   Daculsi G., 2004, EUR CELLS MATER, V13, P1
   Dupraz A, 1998, J BIOMED MATER RES, V42, P368, DOI 10.1002/(SICI)1097-4636(19981205)42:3<368::AID-JBM4>3.3.CO;2-V
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   FISHER JP, 2003, TOPICS TISSUE ENG, pCH5
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5089, DOI 10.1016/j.biomaterials.2006.05.050
   Inui Atsuyuki, 2011, Sports Med Arthrosc Rehabil Ther Technol, V3, P29, DOI 10.1186/1758-2555-3-29
   JOYCE ME, 1990, ORTHOP CLIN N AM, V21, P199
   KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   KOBAYASHI S, 1987, NEUROSURGERY, V21, P751, DOI 10.1227/00006123-198711000-00032
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Kos J., 2006, Veterinarski Arhiv, V76, P367
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Kurtz LT, 1989, SPINE, V14, P1324
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Liang H, 1999, ENDOCRINOLOGY, V140, P5788
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Nakamura K, 1998, INT ORTHOP, V22, P49, DOI 10.1007/s002640050207
   Narhi TO, 2003, BIOMATERIALS, V24, P1697, DOI 10.1016/S0142-9612(02)00546-X
   NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Palissery V, 2004, J MATER SCI-MATER M, V15, P61, DOI 10.1023/B:JMSM.0000010098.65572.3b
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Rainer A, 2011, ANN BIOMED ENG, V39, P1882, DOI 10.1007/s10439-011-0289-2
   REDDI AH, 1994, J CELL BIOCHEM, V56, P192, DOI 10.1002/jcb.240560213
   Ripamonti U, 1996, MRS BULL, V21, P36
   Rosier RN, 1998, CLIN ORTHOP S, V355, pS294
   Sammarco V James, 2002, Foot Ankle Clin, V7, P19, DOI 10.1016/S1083-7515(01)00003-1
   Sepulveda P, 2000, J AM CERAM SOC, V83, P3021, DOI 10.1111/j.1151-2916.2000.tb01677.x
   Shabani I, 2011, TISSUE ENG PT A, V17, P1209, DOI [10.1089/ten.tea.2010.0356, 10.1089/ten.TEA.2010.0356]
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014
   Vadasz Z, 2004, EXP MOL PATHOL, V77, P145, DOI 10.1016/j.yexmp.2004.06.002
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 59
TC 2
Z9 2
U1 0
U2 11
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD OCT
PY 2012
VL 27
IS 10
BP 694
EP 701
DI 10.1590/S0102-86502012001000005
PG 8
WC Surgery
SC Surgery
GA 015DI
UT WOS:000309425300005
PM 23033130
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Rath, SN
   Strobel, LA
   Arkudas, A
   Beier, JP
   Maier, AK
   Greil, P
   Horch, RE
   Kneser, U
AF Rath, Subha N.
   Strobel, Leonie A.
   Arkudas, Andreas
   Beier, Justus P.
   Maier, Anne-Kathrin
   Greil, Peter
   Horch, Raymund E.
   Kneser, Ulrich
TI Osteoinduction and survival of osteoblasts and bone-marrow stromal cells
   in 3D biphasic calcium phosphate scaffolds under static and dynamic
   culture conditions
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE osteoblasts; bone-marrow stromal cells; bioreactor; biphasic calcium
   phosphate (BCP); 3D printing method
ID MESENCHYMAL STEM-CELLS; IN-VITRO; OSTEOGENIC DIFFERENTIATION; INDUCED
   APOPTOSIS; GENE-EXPRESSION; TISSUE; MATRIX; INHIBITION; GENERATION;
   SYSTEM
AB In many tissue engineering approaches, the basic difference between in vitro and in vivo conditions for cells within three-dimensional (3D) constructs is the nutrition flow dynamics. To achieve comparable results in vitro, bioreactors are advised for improved cell survival, as they are able to provide a controlled flow through the scaffold. We hypothesize that a bioreactor would enhance long-term differentiation conditions of osteogenic cells in 3D scaffolds. To achieve this either primary rat osteoblasts or bone marrow stromal cells (BMSC) were implanted on uniform-sized biphasic calcium phosphate (BCP) scaffolds produced by a 3D printing method. Three types of culture conditions were applied: static culture without osteoinduction (Group A); static culture with osteoinduction (Group B); dynamic culture with osteoinduction (Group C). After 3 and 6 weeks, the scaffolds were analysed by alkaline phosphatase (ALP), dsDNA amount, SEM, fluorescent labelled live-dead assay, and real-time RT-PCR in addition to weekly alamarBlue assays. With osteoinduction, increased ALP values and calcium deposition are observed; however, under static conditions, a significant decrease in the cell number on the biomaterial is observed. Interestingly, the bioreactor system not only reversed the decreased cell numbers but also increased their differentiation potential. We conclude from this study that a continuous flow bioreactor not only preserves the number of osteogenic cells but also keeps their differentiation ability in balance providing a suitable cell-seeded scaffold product for applications in regenerative medicine.
C1 [Rath, Subha N.; Strobel, Leonie A.; Arkudas, Andreas; Beier, Justus P.; Horch, Raymund E.; Kneser, Ulrich] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, D-91054 Erlangen, Germany.
   [Maier, Anne-Kathrin; Greil, Peter] Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91054 Erlangen, Germany.
RP Horch, RE (reprint author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, Krankenhausstr 12, D-91054 Erlangen, Germany.
EM raymund.horch@uk-erlangen.de
RI Bittrich, Leonie Anna/A-6407-2016; Beier, Justus/L-9094-2016
OI Bittrich, Leonie Anna/0000-0002-4640-8517; Beier,
   Justus/0000-0002-0179-1962; Horch, Raymund E./0000-0002-6561-2353
FU Deutsche Forschungsgemeinschaft (DFG) [KN 578/2-1]
FX This work was supported by a grant from the Deutsche
   Forschungsgemeinschaft (DFG) (grant number KN 578/2-1). The authors
   thank Stefan Fleischer and Ilse Arnold for their technical support. This
   work contains parts of Leonie Strobel's doctoral thesis.
CR Alves H, 2010, J CELL MOL MED, V14, P2729, DOI 10.1111/j.1582-4934.2009.00931.x
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Barrena E, 2011, J CELL MOL MED, V15, P1266
   Bear J., 1972, DYNAMICS FLUIDS PORO
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   Boland T, 2007, MAT SCI ENG C-BIO S, V27, P372, DOI 10.1016/j.msec.2006.05.047
   Bonab MM, 2006, BMC CELL BIOL, V7, P7
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Depprich R, 2008, BRIT J ORAL MAX SURG, V46, P349, DOI 10.1016/j.bjoms.2008.01.012
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339
   Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191
   Gothard D, 2009, TISSUE ENG PART C-ME, V16, P583
   Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904
   Jager M, 2005, ANN BIOMED ENG, V33, P1319, DOI 10.1007/s10439-005-5889-2
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KLOTH S, 1995, FASEB J, V9, P963
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Leven RM, 2004, J BIOMED MATER RES A, V70A, P391, DOI 10.1002/jbm.a.30082
   Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x
   Minuth WW, 2010, BIOMATERIALS, V31, P2945, DOI 10.1016/j.biomaterials.2009.12.048
   Pereira RMR, 2001, BONE, V28, P484, DOI 10.1016/S8756-3282(01)00422-7
   Pneumaticos SG, 2010, J CELL MOL MED, V14, P2561, DOI 10.1111/j.1582-4934.2010.01062.x
   Rath SN, 2011, J MATER SCI-MATER M, V22, P1279, DOI 10.1007/s10856-011-4300-0
   Roessger A, 2009, BIOMATERIALS, V30, P3723, DOI 10.1016/j.biomaterials.2009.03.041
   Schrepfer S, 2007, STEM CELLS DEV, V16, P105, DOI 10.1089/scd.2006.0041
   Song IH, 2009, J ORTHOP RES, V27, P216, DOI 10.1002/jor.20726
   Stangenberg L, 2005, TISSUE ENG, V11, P855, DOI 10.1089/ten.2005.11.855
   Strehl R, 2005, BIOMATERIALS, V26, P4540, DOI 10.1016/j.biomaterials.2004.11.037
   Thibault RA, 2010, TISSUE ENG PT A, V16, P431, DOI [10.1089/ten.tea.2009.0583, 10.1089/ten.TEA.2009.0583]
   Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038
   Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231
   Weinand C, 2009, J BIOMED MATER RES B, V91B, P80, DOI 10.1002/jbm.b.31376
   Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yun SI, 2009, J BONE MINER METAB, V27, P140, DOI 10.1007/s00774-008-0019-5
NR 40
TC 50
Z9 51
U1 0
U2 79
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD OCT
PY 2012
VL 16
IS 10
BP 2350
EP 2361
DI 10.1111/j.1582-4934.2012.01545.x
PG 12
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 012LK
UT WOS:000309237500011
PM 22304383
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Ionita, D
   Dilea, M
   Titorencu, I
   Demetrescu, I
AF Ionita, D.
   Dilea, M.
   Titorencu, I.
   Demetrescu, I.
TI Merit and demerit effects of silver nanoparticles in the bioperformance
   of an electrodeposited hydroxyapatite: nanosilver composite coating
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Ti alloy; Antimicrobial activity; Biocompatibility; RT-PCR
ID ANTIBACTERIAL; TOXICITY; CELLS; BIOCOMPATIBILITY; CYTOTOXICITY;
   BIOMATERIAL; DEPOSITION; PARTICLES; INTERFACE; SURFACE
AB For this research, TiAlZr specimens were covered with a hydroxyapatite-silver nanoparticles composite coatings (nAg-HA) prepared by pulse electrodeposition. The morphological texture of the nAg-HA nanoparticles on TiAlZr surface was investigated with scanning electron microscopy and energy dispersive X-ray spectroscopy. Electrochemical parameters from dynamic polarization tests performed in Ringer's solution indicate better anti-corrosive properties for the TiAlZr alloy after nAg-HA electrodeposition. Bacteriological experiments performed in vitro demonstrate the efficacy of TiAlZr implants coated with nAg-HA against the growth of Escherichia coli bacteria quantified in a 98% inhibition of Escherichia coli growth. The biocompatibility tests regarding cell adherence, proliferation, and viability of coating (also by means of Reverse Transcription Polymerase Chain Reaction-RT-PCR) completed the characterization of the coating, enabling us to discuss the merit and demerit effects of Ag nanoparticles (nAg) effects on bioperformance. Based on experimental and literature data, the coating could be considered a passive-active structure.
C1 [Ionita, D.; Dilea, M.; Demetrescu, I.] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Polizu 1-7, Bucharest 011061, Romania.
   [Titorencu, I.] Inst Cellular Biol & Pathol, Bucharest 050568, Romania.
RP Demetrescu, I (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Polizu 1-7, Bucharest 011061, Romania.
EM md_ionita@yahoo.com; mirela_dilea@yahoo.com; irina.titorencu@icbp.ro;
   i_demetrescu@chim.upb.ro
FU CNCSIS-UEFISCSU [PNII-IDEI PCCE 248/2010]; Romanian Ministry of Labour,
   Family, and Social Protection [POSDRU/88/1.5/S/60203]
FX This work was supported by CNCSIS-UEFISCSU, project number PNII-IDEI
   PCCE 248/2010. The author M. Dilea wishes to thank the Sectorial
   Operational Programme Human Resources Development 2007-2013 of the
   Romanian Ministry of Labour, Family, and Social Protection through the
   Financial Agreement POSDRU/88/1.5/S/60203.
CR Aillon KL, 2009, ADV DRUG DELIVER REV, V61, P457, DOI 10.1016/j.addr.2009.03.010
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Balagna C, 2011, J BIOMATER APPL, V25, P595, DOI 10.1177/0885328209356603
   Ballarre J, 2010, ACTA BIOMATER, V6, P1601, DOI 10.1016/j.actbio.2009.10.015
   Cao XL, 2010, J MATER SCI-MATER M, V21, P2861, DOI 10.1007/s10856-010-4133-2
   Chen YK, 2008, J MATER SCI-MATER M, V19, P3603, DOI 10.1007/s10856-008-3529-8
   Chen YK, 2009, SURF COAT TECH, V204, P685, DOI 10.1016/j.surfcoat.2009.09.010
   de Oliveira PT, 2003, J HISTOCHEM CYTOCHEM, V51, P633, DOI 10.1177/002215540305100509
   Demetrescu I, 2010, BIOELECTROCHEMISTRY, V79, P122, DOI 10.1016/j.bioelechem.2010.02.001
   Demetrescu I., 2008, MOL CRYST LIQ CRYST, V486, P110
   Hoonacker AV, 2006, CURR NANOSCI, V2, P359
   Hsu SH, 2010, BIOMATERIALS, V31, P6796, DOI 10.1016/j.biomaterials.2010.05.015
   Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034
   Iafisco M, 2012, ADV ENG MATER, V14, pB13, DOI 10.1002/adem.201180062
   Ionita D, 2011, J BIOSCI BIOENG, V112, P630, DOI 10.1016/j.jbiosc.2011.07.022
   Ionita D, 2011, APPL SURF SCI, V257, P9164, DOI 10.1016/j.apsusc.2011.05.125
   KUNIN CM, 1987, DETECTION PREVENTION
   Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P8617, DOI 10.1021/es8026314
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Maury F, 2009, KEY ENG MAT, V415, P1
   Mo AC, 2008, APPL SURF SCI, V255, P435, DOI 10.1016/j.apsusc.2008.06.083
   Morgan MLD, 1998, MOL BIOL POLYAMINE 4, P179
   Narayan RJ, 2009, JOM-US, V61, P12, DOI 10.1007/s11837-009-0081-z
   Narayanan R, 2008, CORROS SCI, V50, P1521, DOI 10.1016/j.corsci.2008.02.023
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Papp T, 2008, NANOTOXICOLOGY, V2, P9, DOI 10.1080/17435390701847935
   Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001
   Popa MV, 2007, BIOELECTROCHEMISTRY, V71, P126, DOI 10.1016/j.bioelechem.2007.02.007
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Roco MC, 2004, AICHE J, V50, P890, DOI 10.1002/aic.10087
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s
   Stickler DJ, 2000, CURR OPIN INFECT DIS, V13, P389, DOI 10.1097/00001432-200008000-00011
   Stratton TR, 2010, BIOMACROMOLECULES, V11, P1286, DOI 10.1021/bm1000839
   Subramanian V, 2010, J NANOPART RES, V12, P1, DOI 10.1007/s11051-009-9729-4
   Titorencu I, 2007, CYTOTHERAPY, V9, P682, DOI 10.1080/14653240701561329
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   Watari F, 2010, NANOBIOMEDICINE, V1, P2
   Watari F, 2009, J R SOC INTERFACE, V6, pS371, DOI 10.1098/rsif.2008.0488.focus
   Yaser G, 2012, J ORTHOP RES, V30, P356
NR 41
TC 9
Z9 9
U1 2
U2 39
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD OCT
PY 2012
VL 14
IS 10
AR UNSP 1152
DI 10.1007/s11051-012-1152-6
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 013YD
UT WOS:000309341200016
DA 2018-10-19
ER

PT J
AU Zielak, JC
   Mathias, AL
   Da Silva, R
   Ton, BS
   Sobreiro, AGC
   Giovanini, AF
   Deliberador, TM
   Baratto, F
   Ulbrich, LM
AF Zielak, Joao Cesar
   Mathias, Alvaro Luiz
   Da Silva, Rosiellen
   Ton, Bruno Skronski
   Cidral Sobreiro, Aline Graziela
   Giovanini, Allan Fernando
   Deliberador, Tatiana Miranda
   Baratto Filho, Flares
   Ulbrich, Lucienne Miranda
TI Oral tissue response to ovine grafting biomaterial: Morphological and
   morphometric study using scanning electron and light microscopy tissue
   response to ovine grafting biomaterial
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE bone grafting; biomaterials; microscopy; materials testing
ID CRITICAL-SIZE DEFECTS; OSTEOBLAST-LIKE CELLS; BONE REGENERATION;
   TRICALCIUM PHOSPHATE; IMPLANT PLACEMENT; BOVINE BONE; IN-VITRO; RIDGE
   PRESERVATION; AUTOGENOUS BONE; CANCELLOUS BONE
AB OBJECTIVE: To evaluate the oral tissue response to an experimental particle ovine biomaterial by scanning electron microscopy (SEM) and light microscopy (LM). MATERIAL AND METHODS: Forty-eight rats had surgical periodontal defects treated with either blood clotting (control), bovine biomaterial (TM) (B), or an experimental ovine biomaterial (O). Data from SEM analysis (defect exposure, root surface exposure, diameter of matrix fibers and bundles, and globuli areas; n = 5) were applied to ShapiroWilk, KruskalWallis, and Dunn's test, whereas LM analysis (tissue cicatrization characteristics and diameter defect; n = 3) had data applied to two-way analysis of variance. Animals were monitored for 1 and 3 weeks. RESULTS: By SEM, the O samples showed significant differences from B and C in the area of defect exposure (H2,15 = 8.66; P < 0.05). In both periods, O and B samples showed similar results for matrix fiber diameters, differently than C samples (H2,15 = 14.0; P < 0.05). All other SEM variables were considered equivalent among the groups (P > 0.05). Under LM, an acute and chronic granulomatous inflammation was seen in the presence of both biomaterials (B and O, 1 week); both the control and the ovine grafting samples showed mature bone in the repair site (3 weeks); the defect diameter showed similar values among groups, at both monitoring periods (F2,12 = 1.0401; P > 0.05). CONCLUSION: The ovine particles of this study showed a favorable response to oral tissue repair, demonstrating to be a potential source for the development of bone grafting biomaterials. Microsc. Res. Tech. 2012. (c) 2012 Wiley Periodicals, Inc.
C1 [Zielak, Joao Cesar; Ton, Bruno Skronski; Cidral Sobreiro, Aline Graziela; Giovanini, Allan Fernando; Deliberador, Tatiana Miranda; Baratto Filho, Flares; Ulbrich, Lucienne Miranda] Univ Posit, Masters Program Clin Dent, BR-81280330 Curitiba, PR, Brazil.
   [Zielak, Joao Cesar; Da Silva, Rosiellen] Univ Posit, Masters Program Ind Biotechnol, BR-81280330 Curitiba, PR, Brazil.
   [Mathias, Alvaro Luiz] Univ Fed Parana, Technol Sect, Dept Chem Engn, BR-81531990 Curitiba, PR, Brazil.
RP Zielak, JC (reprint author), Univ Posit, Masters Program Clin Dent, R Prof Pedro Viriato Parigot de Souza 5300, BR-81280330 Curitiba, PR, Brazil.
EM jzielak2@gmail.com
RI Baratto Filho, Flares/O-2007-2015; Deliberador, Tatiana/C-3022-2016;
   Giovanini, Allan/K-5215-2012
OI Deliberador, Tatiana/0000-0003-4076-4905; Giovanini,
   Allan/0000-0002-1637-2955; Baratto Filho, Flares/0000-0002-5649-7234
CR Allegrini Sergio Jr., 2008, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V54, P70
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P1034, DOI 10.1111/j.1600-0501.2008.01573.x
   Chang SH, 2009, J MATER SCI-MATER M, V20, P23, DOI 10.1007/s10856-008-3507-1
   Chang-Jung C, 2008, SPINE, V33, P2524, DOI 10.1097/BRS.0b013e318185289c
   Cheng MH, 2005, TISSUE ENG, V11, P214, DOI 10.1089/ten.2005.11.214
   Collignon H, 1997, ARCH PHYSIOL BIOCHEM, V105, P158, DOI 10.1076/apab.105.2.158.12924
   Cordioli G, 1999, INT J PERIODONT REST, V19, P45
   de Oliveira RC, 2008, CLIN ORAL IMPLAN RES, V19, P749, DOI 10.1111/j.1600-0501.2008.01521.x
   FRANCEY T, 1992, J LEUKOCYTE BIOL, V51, P525
   Giavaresi G, 2008, INT J ORAL MAX IMPL, V23, P659
   Grimm B, 2001, J MATER SCI-MATER M, V12, P929, DOI 10.1023/A:1012840527774
   Hashizume H, 1998, J Orthop Sci, V3, P42, DOI 10.1007/s007760050020
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Iyomasa MM, 2012, MICROSC RES TECHNIQ, V75, P117, DOI 10.1002/jemt.21033
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P427, DOI 10.1023/A:1008987908917
   Karimbux N Y, 1995, J Oral Implantol, V21, P107
   Karimbux NY, 1995, J ORAL IMPLANTOL, V21, P114
   Katz J, 2009, J BIOMATER APPL, V24, P159, DOI 10.1177/0885328208095174
   Kim SS, 2008, DENT MATER J, V27, P368, DOI 10.4012/dmj.27.368
   Kim YK, 2009, ORAL SURG ORAL MED O, V107, pE21, DOI 10.1016/j.tripleo.2008.09.033
   Kwitek-Black AE, 2000, LAB ANIMAL, V29, P44
   Longo UG, 2009, J BONE JOINT SURG AM, V91A, P945, DOI 10.2106/JBJS.H.00224
   Leite FRM, 2008, J APPL ORAL SCI, V16, P122, DOI 10.1590/S1678-77572008000200008
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Misch C E, 1993, Implant Dent, V2, P158, DOI 10.1097/00008505-199309000-00003
   Nakadate M, 2008, MICROSC RES TECHNIQ, V71, P93, DOI 10.1002/jemt.20532
   Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55
   Okamoto H, 2003, ACTA DERM-VENEREOL, V83, P171, DOI 10.1080/00015550310007148
   Okuda T, 2008, BIOMATERIALS, V29, P2719, DOI 10.1016/j.biomaterials.2008.03.028
   ORR RD, 1992, CELL MATER, V2, P241
   Paknejad M, 2008, IMPLANT DENT, V17, P471, DOI 10.1097/ID.0b013e3181815596
   Pereira NT, 2012, MICROSC RES TECHNIQ, V75, P36, DOI 10.1002/jemt.21019
   Pieri F, 2008, J PERIODONTOL, V79, P2093, DOI [10.1902/jop.2008.080061, 10.1902/jop.2008.080061 ]
   Pratt JNJ, 2002, BIOMATERIALS, V23, P3309, DOI 10.1016/S0142-9612(02)00018-2
   Rabelo GD, 2010, MICROSC RES TECHNIQ, V73, P1015, DOI 10.1002/jemt.20826
   Rhodes NP, 2004, J MATER SCI-MATER M, V15, P397, DOI 10.1023/B:JMSM.0000021109.21807.f0
   Rosito R, 2008, CLINICS, V63, P509, DOI 10.1590/S1807-59322008000400016
   Santoni BG, 2008, CLIN ORTHOP RELAT R, V466, P1921, DOI 10.1007/s11999-008-0297-1
   Schmitt SC, 2008, J MATER SCI-MATER M, V19, P1441, DOI 10.1007/s10856-007-3238-8
   Schultheiss M, 2005, EUR SPINE J, V14, P192, DOI 10.1007/s00586-004-0764-7
   Simunek A, 2008, INT J ORAL MAX IMPL, V23, P935
   Swennen GRJ, 2005, INT J ORAL MAX SURG, V34, P64, DOI 10.1016/j.ijom.2004.03.019
   Trelles MA, 1999, INT J DERMATOL, V38, P58, DOI 10.1046/j.1365-4362.1999.00626.x
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Vlaminck L, 2008, IMPLANT DENT, V17, P439, DOI 10.1097/ID.0b013e31818c5c18
   Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x
   Wu XH, 2010, MICROSC RES TECHNIQ, V73, P540, DOI 10.1002/jemt.20792
   Zielak JC, 2007, SCAND J LAB ANIM SCI, V34, P201
   Zielak JC, 2007, REV SUL BRAS ODONTOL, V4, P22
   Zunino J. H., 2004, Cell and Tissue Banking, V5, P141
NR 51
TC 0
Z9 0
U1 2
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD OCT
PY 2012
VL 75
IS 10
BP 1395
EP 1401
DI 10.1002/jemt.22079
PG 7
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 010CH
UT WOS:000309071600013
PM 22648931
DA 2018-10-19
ER

PT J
AU Sencadas, V
   Ribeiro, C
   Heredia, A
   Bdikin, IK
   Kholkin, AL
   Lanceros-Mendez, S
AF Sencadas, V.
   Ribeiro, C.
   Heredia, A.
   Bdikin, I. K.
   Kholkin, A. L.
   Lanceros-Mendez, S.
TI Local piezoelectric activity of single poly(L-lactic acid) (PLLA)
   microfibers
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; NANOFIBROUS SCAFFOLD; POLY(LACTIC ACID); FORCE
   MICROSCOPY; NANOMETER-SCALE; BONE; POLYMER
AB Local piezoelectric properties of the poly(L-lactic acid) individual electrospun fibers have been studied by Piezoresponse Force Microscopy. Piezoelectric response, polarization switching, and nanoscale patterning of the fibers have been demonstrated in this important biomaterial, thus opening interesting possibilities for tissue engineering and sensing/actuating applications.
C1 [Sencadas, V.; Ribeiro, C.; Lanceros-Mendez, S.] Univ Minho, Ctr Dept Fis, P-4710058 Braga, Portugal.
   [Heredia, A.; Bdikin, I. K.; Kholkin, A. L.] Univ Aveiro, CICECO, Dept Engn Ceram & Vidro, P-3810193 Aveiro, Portugal.
   [Bdikin, I. K.] Univ Aveiro, TEMA, Dept Mech Engn, P-3810193 Aveiro, Portugal.
   [Lanceros-Mendez, S.] INL Int Iberian Nanotechnol Lab, P-4715330 Braga, Portugal.
RP Lanceros-Mendez, S (reprint author), Univ Minho, Ctr Dept Fis, Campus Gualtar, P-4710058 Braga, Portugal.
EM lanceros@fisica.uminho.pt
RI lanceros-mendez, senentxu/A-1730-2011; Bdikin, Igor/J-4898-2013;
   Sencadas, Vitor/A-3932-2008; Research Unit, TEMA/H-9264-2012; Kholkin,
   Andrei/G-5834-2010; Division, Nanotechnology/O-2342-2013
OI lanceros-mendez, senentxu/0000-0001-6791-7620; Bdikin,
   Igor/0000-0001-6318-1425; Sencadas, Vitor/0000-0003-1986-1348; Kholkin,
   Andrei/0000-0003-3432-7610; Ribeiro, Clarisse/0000-0002-9120-4847;
   Heredia Barbero, Alejandro/0000-0002-3887-610X
FU FEDER funds through the "Programa Operacional Factores de
   Competitividade-COMPETE"; FCT-Fundacao para a Ciencia e a Tecnologia
   [NANO/NMed-SD/0156/2007, PTDC/CTM/73030/2006, PTDC/CTM/69316/2006]; COST
   Action [MP1003]; European Scientific Network for Artificial Muscles; FCT
   [SFRH/BPD/63148/2009]
FX This work is funded by FEDER funds through the "Programa Operacional
   Factores de Competitividade-COMPETE" and by national funds arranged by
   FCT-Fundacao para a Ciencia e a Tecnologia, project references
   NANO/NMed-SD/0156/2007, PTDC/CTM/73030/2006 and PTDC/CTM/69316/2006. The
   authors also thank the support from the COST Action MP1003, 2010
   "European Scientific Network for Artificial Muscles." V. S. thanks the
   FCT for the SFRH/BPD/63148/2009 grant. C. R. thanks the IINL for a
   financial support via a Ph.D. grant. I. B. is thankful to FCT for the
   financial support via the Ciencia 2008 fellowship.
CR Ahn AC, 2009, MED ENG PHYS, V31, P733, DOI 10.1016/j.medengphy.2009.02.006
   Christman JA, 1998, APPL PHYS LETT, V73, P3851, DOI 10.1063/1.122914
   Clarisse R., 2011, SCI TECHNOL ADV MAT, V12
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Fukada E, 2000, IEEE T ULTRASON FERR, V47, P1277, DOI 10.1109/58.883516
   Fukada E., 1957, J PHYS SOC JPN, V12, P5
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gomes J, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/6/065010
   Gruverman A, 2001, APPL PHYS LETT, V78, P2751, DOI 10.1063/1.1366644
   Halperin C, 2004, NANO LETT, V4, P1253, DOI 10.1021/nl0494561
   Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137
   Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731
   Ikada Y, 1996, J BIOMED MATER RES, V30, P553
   Isakov DV, 2010, J APPL PHYS, V108, DOI 10.1063/1.3474966
   Kalinin SV, 2009, MRS BULL, V34, P634, DOI 10.1557/mrs2009.174
   Kholkin A. L., 2006, SCANNING PROBE MICRO, V1, P173
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004
   MAEDA H, 1982, BIOPOLYMERS, V21, P2055, DOI 10.1002/bip.360211010
   NIJENHUIS AJ, 1992, MACROMOLECULES, V25, P6419, DOI 10.1021/ma00050a006
   Ochiai T, 1998, JPN J APPL PHYS 1, V37, P3374, DOI 10.1143/JJAP.37.3374
   Prashanthi K, 2012, PHYS STATUS SOLIDI-R, V6, P77, DOI 10.1002/pssr.201105538
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Shin J, 2005, J VAC SCI TECHNOL B, V23, P2102, DOI 10.1116/1.2052714
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Sugita A, 2004, J POLYM SCI POL PHYS, V42, P4433, DOI 10.1002/polb.20016
   Tsuji H, 2003, BIOMACROMOLECULES, V4, P835, DOI 10.1021/bm034060j
   Valasek J, 1921, PHYS REV, V17, P475, DOI 10.1103/PhysRev.17.475
   Wang T, 2007, DENT MATER, V23, P450, DOI 10.1016/j.dental.2006.02.016
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
NR 33
TC 16
Z9 16
U1 6
U2 74
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD OCT
PY 2012
VL 109
IS 1
BP 51
EP 55
DI 10.1007/s00339-012-7095-z
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 012GQ
UT WOS:000309224600008
DA 2018-10-19
ER

PT J
AU Piero, B
   Mario, V
   Niccolo, N
   Marco, F
AF Piero, Balleri
   Mario, Veltri
   Niccolo, Nuti
   Marco, Ferrari
TI Implant Placement in Combination with Sinus Membrane Elevation without
   Biomaterials: A 1-Year Study on 15 Patients
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE bone reformation; minimal intervention; sinus membrane
ID MAXILLARY SINUS; DENTAL IMPLANTS; SIMULTANEOUS INSERTION; POSTERIOR
   MAXILLA; BONE-FORMATION; AUGMENTATION; FLOOR; CAVITY
AB Background: Membrane elevation in combination with implant placement without biomaterials is a rather new technique proposed for sinus lifting. Purpose: This study assessed the clinical outcome of such technique during the first year of loading. Material and Methods: Fifteen patients with a mean residual bone height of 6.2 mm were consecutively recruited for sinus lifting. After opening a replaceable bone window, the membrane was dissected from the sinus walls. A total of 28 implants were placed in the residual crest and they kept the membrane lifted upwards. After window repositioning, the flap was sutured. A 6-month healing period was allowed. Patients were re-examined after 12 months of loading. Results: All the implants survived at the end of the follow-up. The 5.5 mm mean bone reformation was significantly lower than the 8.2 mm mean membrane lift achieved after implant placement. Regeneration at the distal surface of the most posterior implants was significantly less than at other aspects. The height of membrane lift was not correlated with the amount of regenerated bone. Conclusions: All of the 28 implants placed in combination with sinus membrane elevation were stable during the first year of loading. No extra costs for biomaterial or morbidity for bone harvesting were necessary.
C1 [Piero, Balleri; Mario, Veltri; Niccolo, Nuti] Univ Siena, Dept Oral Surg, I-53100 Siena, Italy.
   [Marco, Ferrari] Univ Siena, Dept Dent Mat & Fixed Prosthodont, I-53100 Siena, Italy.
RP Piero, B (reprint author), Univ Siena, Dipartimento Sci Odontostomatol, Policlin Le Scotte, Vle Bracci, I-53100 Siena, Italy.
EM balleri2@unisi.it
RI ferrari, marco/R-4094-2018
OI ferrari, marco/0000-0001-5375-076X
CR Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Esposito M., 2008, COCHRANE DB SYST REV, V16
   Fermergard R, 2007, CLIN IMPL DENT RELAT, V10, P62
   Friberg B, 2008, PERIODONTOL 2000, V47, P67, DOI 10.1111/j.1600-0757.2007.00238.x
   Haas R, 2002, CLIN ORAL IMPLAN RES, V13, P396, DOI 10.1034/j.1600-0501.2002.130408.x
   Hatano N, 2007, CLIN IMPLANT DENT R, V9, P150, DOI 10.1111/j.1708-8208.2007.00043.x
   Jung JH, 2006, ORAL SURG ORAL MED O, V102, P602, DOI 10.1016/j.tripleo.2005.10.061
   Lundgren S, 2008, PERIODONTOL 2000, V47, P193, DOI 10.1111/j.1600-0757.2008.00264.x
   Lundgren Stefan, 2003, Clin Implant Dent Relat Res, V5, P78, DOI 10.1111/j.1708-8208.2003.tb00187.x
   Lundgren Stefan, 2004, Clin Implant Dent Relat Res, V6, P165, DOI 10.1111/j.1708-8208.2004.tb00217.x
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   Palma VC, 2006, CLIN IMPLANT DENT R, V8, P11, DOI 10.2310/6480.2005.00026
   Sani E, 2008, INT J ORAL MAX SURG, V37, P966, DOI 10.1016/j.ijom.2008.07.006
   Srouji S, 2009, CALCIFIED TISSUE INT, V84, P138, DOI 10.1007/s00223-008-9202-x
   Sul SH, 2008, ORAL SURG ORAL MED O, V105, P684, DOI 10.1016/j.tripleo.2007.09.024
   Sul SH, 2008, ORAL SURG ORAL MED O, V105, pE1, DOI 10.1016/j.tripleo.2007.11.019
   Thor A., 2008, APPL OSSEOINTEGRATIO, V7, P17
   Thor A, 2007, J ORAL MAXIL SURG, V65, P64, DOI 10.1016/j.joms.2006.10.047
   Wennstrom JL, 2005, J CLIN PERIODONTOL, V32, P567, DOI 10.1111/j.1600-051X.2005.00715.x
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P493, DOI 10.1016/j.bjoms.2005.02.001
NR 21
TC 25
Z9 28
U1 1
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD OCT
PY 2012
VL 14
IS 5
BP 682
EP 689
DI 10.1111/j.1708-8208.2010.00318.x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 014TU
UT WOS:000309399400006
PM 21176096
DA 2018-10-19
ER

PT J
AU Galindo-Moreno, P
   Padial-Molina, M
   Avila, G
   Rios, HF
   Hernandez-Cortes, P
   Wang, HL
AF Galindo-Moreno, Pablo
   Padial-Molina, Miguel
   Avila, Gustavo
   Rios, Hector F.
   Hernandez-Cortes, Pedro
   Wang, Hom-Lay
TI Complications associated with implant migration into the maxillary sinus
   cavity
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE alveolar ridge augmentation; bone grafting; complications; dental
   implants; maxillary sinus; migration
ID FLOOR ELEVATION; DENTAL IMPLANT; SCHNEIDERIAN MEMBRANE; ENDOSCOPIC
   REMOVAL; ALVEOLAR BONE; PART I; AUGMENTATION; SURVIVAL; REHABILITATION;
   CLASSIFICATION
AB Background Migration of dental implants into the maxillary sinus is an uncommon, but increasingly reported complication. Implant migration may result from initial lack of primary stability, intrasinusal and nasal pressure changes, autoimmune reaction to the implant or incorrect distribution of occlusal forces. This retrospective study aims at analyzing the factors that may influence implant migration into the maxillary sinus cavity. Material and methods Fourteen patients presenting a total 15 implants that migrated into the maxillary sinus were recruited. Diagnosis of this complication was based on imaging techniques, such as cone beam computerized tomography scan and panoramic radiography. Clinical data were recorded in all cases and processed for statistical analysis. Results ABH was below 6 similar to mm in the majority of cases. However, almost 50% of the patients did not receive any site preparation treatment prior to implant insertion. Five patients (33.3%) were treated by osteotome techniques, but only one of them had bone grafting. Therefore, 73.3% of sites did not receive any biomaterial to increase available bone height. The most common complication-associated factors found on this study were related to implant design (cylindrical), implant dimension (diameter), implant restoration/rehabilitation method (partial removable denture), site-specific anatomy (initial residual bone height between 5 and 6.9 similar to mm), demographics (age), and biomaterials. Conclusion Patient selection and proper treatment planning, as well as the application of the appropriate sinus augmentation technique, are critical aspects that should be controlled to minimize the risk of implant migration into the maxillary sinus cavity. [Correction added after online publication August 17 2011: The Conclusion was revised to provide better clarity to the reader.]
C1 [Galindo-Moreno, Pablo] Univ Granada, Sch Dent, Oral Surg & Implant Dent Dept, Granada, Spain.
   [Padial-Molina, Miguel; Rios, Hector F.; Wang, Hom-Lay] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.
   [Avila, Gustavo] Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA.
   [Hernandez-Cortes, Pedro] San Cecilio Clin Hosp, Orthoped Surg Unit, Granada, Spain.
RP Galindo-Moreno, P (reprint author), C Recogidas,39 5 Izq, Granada 18005, Spain.
EM pgalindo@ugr.es
RI Padial-Molina, Miguel/L-9882-2013; Galindo-Moreno, Pablo/F-5567-2015;
   Avila-Ortiz, Gustavo/R-7784-2018
OI Padial-Molina, Miguel/0000-0001-6222-1341; Galindo-Moreno,
   Pablo/0000-0002-6614-6470; Avila-Ortiz, Gustavo/0000-0002-5763-0201
FU Junta de Andalucia Funding Program for research groups in Spain
   [CTS-138, CTS-583]; Regional Ministry for Innovation, Science and
   Enterprise - Junta de Andalucia (Spain)
FX The authors would like to thank Miguel Velasco-Torres, DDS, Dental
   Radiologist at Centro de Diagnostico Granada, for his collaboration in
   the development of this study, Andres Catena for his statistical
   advices, and Francisco O'Valle for the histopathological support. This
   study was partially supported by Junta de Andalucia Funding Program for
   research groups in Spain (Projects #CTS-138 and #CTS-583). MPM was also
   supported by the Talentia Scholarship Program from the Regional Ministry
   for Innovation, Science and Enterprise - Junta de Andalucia (Spain).
   Authors do not have any financial interests, either directly or
   indirectly, in the products listed in the study.
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P233
   AKAGAWA Y, 1986, J PROSTHET DENT, V55, P96, DOI 10.1016/0022-3913(86)90083-1
   Balshi TJ, 1999, INT J ORAL MAX IMPL, V14, P398
   Berengo M, 2004, INT J ORAL MAX SURG, V33, P189, DOI 10.1054/ijom.2002.0459
   Borgonovo A, 2010, Minerva Stomatol, V59, P45
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   BOYNE PJ, 1993, J LONG-TERM EFF MED, V3, P143
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Chiapasco M, 2009, INT J ORAL MAX SURG, V38, P1273, DOI 10.1016/j.ijom.2009.09.001
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x
   Cho S C, 2001, Pract Proced Aesthet Dent, V13, P160
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   Engelke W, 1997, CLIN ORAL IMPLAN RES, V8, P527, DOI 10.1034/j.1600-0501.1997.080612.x
   Engelke W, 2003, INT J ORAL MAX IMPL, V18, P135
   Ferrigno N, 2006, CLIN ORAL IMPLAN RES, V17, P194, DOI 10.1111/j.1600-0501.2005.01192.x
   Flanagan D, 2009, J ORAL IMPLANTOL, V35, P70, DOI 10.1563/1548-1336(2008)34[7:MOTFLO]2.0.CO;2
   Galindo P, 2005, INT J ORAL MAX IMPL, V20, P291
   Galindo-Moreno P, 2008, CLIN ORAL IMPLAN RES, V19, P755, DOI 10.1111/j.1600-0501.2008.01536.x
   Galindo-Moreno P, 2007, CLIN ORAL IMPLAN RES, V18, P376, DOI 10.1111/j.1600-0501.2007.01337.x
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P122, DOI 10.1111/j.1600-0501.2009.01814.x
   Guler N, 2007, QUINTESSENCE INT, V38, pE238
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   Hernandez-Alfaro F, 2008, CLIN ORAL IMPLAN RES, V19, P91, DOI 10.1111/j.1600-0501.2007.01372.x
   Iida S, 2000, INT J ORAL MAX SURG, V29, P358, DOI 10.1034/j.1399-0020.2000.290509.x
   Katranji A, 2008, IMPLANT DENT, V17, P339, DOI 10.1097/ID.0b013e3181815660
   Kim JW, 2007, BRIT J ORAL MAX SURG, V45, P408, DOI 10.1016/j.bjoms.2005.12.003
   Kitamura A, 2007, BRIT J ORAL MAX SURG, V45, P410, DOI 10.1016/j.bjoms.2005.12.007
   Kitamura A, 2010, IMPLANT DENT, V19, P16, DOI 10.1097/ID.0b013e3181c419a8
   Kluppel LE, 2010, ORAL MAXILLOFAC SURG, V14, P63, DOI 10.1007/s10006-009-0184-2
   Lubbe DE, 2008, BRIT DENT J, V204, P435, DOI 10.1038/sj.bdj.2008.293
   Lundgren Stefan, 2004, Clin Implant Dent Relat Res, V6, P165, DOI 10.1111/j.1708-8208.2004.tb00217.x
   Malevez C, 2004, CLIN ORAL IMPLAN RES, V15, P18, DOI 10.1046/j.1600-0501.2003.00985.x
   Misch C, 1990, Dent Today, V9, P28
   Misch C E, 1990, Int J Oral Implantol, V7, P9
   Nakamura N, 2004, INT J ORAL MAX SURG, V33, P195, DOI 10.1054/ijom.2003.0470
   Nedir R, 2006, CLIN ORAL IMPLAN RES, V17, P679, DOI 10.1111/j.1600-0501.2006.01264.x
   Nkenke E, 2002, INT J ORAL MAX IMPL, V17, P557
   Ogunsalu C, 2009, IMPLANT DENT, V18, P249, DOI 10.1097/ID.0b013e3181991096
   Olson J W, 2000, Ann Periodontol, V5, P152, DOI 10.1902/annals.2000.5.1.152
   Peleg M, 1999, INT J ORAL MAX IMPL, V14, P549
   Penarrocha M, 2009, INT J ORAL MAX IMPL, V24, P720
   Pikos M A, 1999, Implant Dent, V8, P29, DOI 10.1097/00008505-199901000-00003
   Pikos MA, 2009, IMPLANT DENT, V18, P193, DOI 10.1097/ID.0b013e31819fe727
   PILLIAR RM, 1991, BONE-BIOMATERIAL INTERFACE, P380
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Pjetursson BE, 2009, CLIN ORAL IMPLAN RES, V20, P667, DOI 10.1111/j.1600-0501.2009.01704.x
   Pommer B, 2009, INT J ORAL MAX IMPL, V24, P817
   Pommer B, 2009, CLIN ORAL IMPLAN RES, V20, P633, DOI 10.1111/j.1600-0501.2008.01686.x
   Raghoebar GM, 2003, INT J ORAL MAX IMPL, V18, P745
   Ramotar H, 2010, J LARYNGOL OTOL, V124, P433, DOI 10.1017/S0022215109990958
   Regev E, 1995, Int J Oral Maxillofac Implants, V10, P451
   Ridaura-Ruiz Lourdes, 2009, Clin Implant Dent Relat Res, V11 Suppl 1, pe38, DOI 10.1111/j.1708-8208.2009.00175.x
   Rios HF, 2009, IMPLANT DENT, V18, P402, DOI 10.1097/ID.0b013e3181b4af93
   Scarano A, 2011, ORAL MAXILLOFAC SURG, V15, P239, DOI 10.1007/s10006-010-0243-8
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Small SA, 1996, J AM DENT ASSOC, V127, P51
   Srouji S, 2010, INT J ORAL MAX SURG, V39, P793, DOI 10.1016/j.ijom.2010.03.009
   Srouji S, 2009, CALCIFIED TISSUE INT, V84, P138, DOI 10.1007/s00223-008-9202-x
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Tan WC, 2008, J CLIN PERIODONTOL, V35, P241, DOI 10.1111/j.1600-051X.2008.01273.x
   Testori T, 2008, CLIN ORAL IMPLAN RES, V19, P227, DOI [10.1111/j.1600-0501.2007.01472.x, 10.1111/j.1600-0501.2007.01472x]
   Thor A, 2007, J ORAL MAXIL SURG, V65, P64, DOI 10.1016/j.joms.2006.10.047
   Toffler M, 2004, INT J ORAL MAX IMPL, V19, P266
   Trisi P, 1999, CLIN ORAL IMPLAN RES, V10, P1
   Tsodoulos S, 2012, J ORAL IMPLANTOL, V38, P189, DOI 10.1563/AAID-JOI-D-10-00053
   Ulm C, 1999, CLIN ORAL IMPLAN RES, V10, P459, DOI 10.1034/j.1600-0501.1999.100604.x
   Varol A, 2006, INT J ORAL MAX IMPL, V21, P801
   Vitkov L, 2005, CLIN ORAL IMPLAN RES, V16, P615, DOI 10.1111/j.1600-0501.2005.01161.x
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wang HL, 2008, INT J PERIODONT REST, V28, P383
   Wheeler Stephen, 2009, J Calif Dent Assoc, V37, P647
   Whitehouse J., 2008, DENT TODAY, V27, P122
   Whitehouse J., 2008, DENT TODAY, V27, P124
   Whitehouse Joseph, 2008, Dent Today, V27, P124
NR 74
TC 24
Z9 26
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2012
VL 23
IS 10
BP 1152
EP 1160
DI 10.1111/j.1600-0501.2011.02278.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 008DW
UT WOS:000308938600005
PM 22092923
DA 2018-10-19
ER

PT J
AU Cuellar-Cruz, M
   Vega-Gonzalez, A
   Mendoza-Novelo, B
   Lopez-Romero, E
   Ruiz-Baca, E
   Quintanar-Escorza, MA
   Villagomez-Castro, JC
AF Cuellar-Cruz, M.
   Vega-Gonzalez, A.
   Mendoza-Novelo, B.
   Lopez-Romero, E.
   Ruiz-Baca, E.
   Quintanar-Escorza, M. A.
   Villagomez-Castro, J. C.
TI The effect of biomaterials and antifungals on biofilm formation by
   Candida species: a review
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Review
ID DIFFERENTIAL GENE-EXPRESSION; HUMAN-IMMUNODEFICIENCY-VIRUS;
   MULTIDRUG-RESISTANCE GENE; CDNA MICROARRAY ANALYSIS; FUNGAL
   DRUG-RESISTANCE; GENOME-WIDE EXPRESSION; AZOLE RESISTANCE; FLUCONAZOLE
   RESISTANCE; ALBICANS BIOFILMS; IN-VITRO
AB Candida albicans, C. glabrata, C. parapsilosis, and C. tropicalis are able to form biofilms on virtually any biomaterial implanted in a human host. Biofilms are a primary cause of mortality in immunocompromised and hospitalized patients, as they cause recurrent and invasive candidiasis, which is difficult to eradicate. This is due to the fact that the biofilm cells show high resistance to antifungal treatments and the host defense mechanisms, and exhibit an excellent ability to adhere to biomaterials. Elucidation of the mechanisms of antifungal resistance in Candida biofilms is of unquestionable importance; therefore, this review analyzes both the chemical composition of biomaterials used to fabricate the medical devices, as well as the Candida genes and proteins that confer drug resistance.
C1 [Cuellar-Cruz, M.] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Unidad Biotecnol Med & Farmaceut, Guadalajara 44270, Jalisco, Mexico.
   [Vega-Gonzalez, A.; Mendoza-Novelo, B.] Univ Guanajuato, Dept Ingn Quim & Elect Biomed, Div Ciencias & Ingn, Guanajuato, Mexico.
   [Lopez-Romero, E.; Villagomez-Castro, J. C.] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato, Mexico.
   [Ruiz-Baca, E.] Univ Juarez Estado Durango, Dept Biol Celular & Mol, Fac Ciencias Quim, Durango, Mexico.
   [Quintanar-Escorza, M. A.] Univ Juarez Estado Durango, Fac Med & Nutr, Victoria De Durango, Durango, Mexico.
RP Cuellar-Cruz, M (reprint author), Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Unidad Biotecnol Med & Farmaceut, Av Normalistas 800, Guadalajara 44270, Jalisco, Mexico.
EM cuellarmay@yahoo.com.mx
RI Vega-Gonzalez, Arturo/B-6379-2008; Cuellar-Cruz, Mayra/A-3148-2014;
   VILLAGOMEZ-CASTRO, JULIO CESAR/T-5379-2018; Mendoza-Novelo,
   Birzabith/M-8588-2016
OI Vega-Gonzalez, Arturo/0000-0002-2193-3331; VILLAGOMEZ-CASTRO, JULIO
   CESAR/0000-0002-3834-1631; Mendoza-Novelo,
   Birzabith/0000-0001-6604-395X; QUINTANAR-ESCORZA, MARTHA
   ANGELICA/0000-0003-4256-7526
FU University of Guanajuato, Mexico [UGTO-000165/11, UGTO-00023/11]
FX The authors are thankful for the financial support provided by grant
   nos. UGTO-000165/11 and UGTO-00023/11 from the University of Guanajuato,
   Mexico (E.L.-R. and J.C.V.-C., respectively). The authors thank John Dye
   for his invaluable review of this edition of the manuscript.
CR Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344
   Adams ML, 2003, BIOMACROMOLECULES, V4, P750, DOI 10.1021/bm0257614
   Al-Fattani MA, 2004, ANTIMICROB AGENTS CH, V48, P3291, DOI 10.1128/AAC.48.9.3291-3297.2004
   Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0
   Albertson GD, 1996, ANTIMICROB AGENTS CH, V40, P2835, DOI 10.1128/AAC.40.12.2835
   Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x
   Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021239
   Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI [10.1038/nrmicro1179, 10.1038/nrmicrol179]
   Ardizzoni A, 2011, J MATER SCI-MATER M, V22, P2329, DOI 10.1007/s10856-011-4408-2
   Baillie GS, 2000, J ANTIMICROB CHEMOTH, V46, P397, DOI 10.1093/jac/46.3.397
   Bassetti M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-21
   Basso LR, 2010, EUKARYOT CELL, V9, P960, DOI 10.1128/EC.00355-09
   Ben-Abraham R, 2004, J INFECTION, V49, P317, DOI 10.1016/j.jinf.2004.02.015
   BENYAACOV R, 1994, ANTIMICROB AGENTS CH, V38, P648, DOI 10.1128/AAC.38.4.648
   Berila N, 2010, EPIDEMIOL MIKROBI IM, V59, P67
   Bigerelle M, 2002, BIOMOL ENG, V19, P79, DOI 10.1016/S1389-0344(02)00048-5
   Bizerra FC, 2008, FEMS YEAST RES, V8, P442, DOI 10.1111/j.1567-1364.2007.00347.x
   Borah S, 2011, J BIOL CHEM, V286, P34311, DOI 10.1074/jbc.M111.264671
   Borecka-Melkusova S, 2009, MYCOSES, V52, P118, DOI 10.1111/j.1439-0507.2008.01550.x
   Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743
   Cannon R D, 1998, Nihon Ishinkin Gakkai Zasshi, V39, P73
   Caudle KE, 2011, EUKARYOT CELL, V10, P373, DOI 10.1128/EC.00073-10
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Chau AS, 2004, ANTIMICROB AGENTS CH, V48, P2124, DOI 10.1128/AAC.48.6.2124-2131.2004
   Colombo AL, 2007, INFECT CONT HOSP EP, V28, P570, DOI 10.1086/513615
   Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07
   Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08
   Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Darwish RM, 2011, J MATER SCI-MATER M, V22, P1885, DOI 10.1007/s10856-009-3893-z
   Depprich RA, 2008, J PROSTHET DENT, V99, P400, DOI 10.1016/S0022-3913(08)60089-X
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Douglas L. Julia, 2002, Revista Iberoamericana de Micologia, V19, P139
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06
   Dufrene YF, 2000, BIOPHYS J, V78, P3286, DOI 10.1016/S0006-3495(00)76864-0
   Duran MT, 2003, ENFERM INFEC MICR CL, V21, P488, DOI 10.1157/13052332
   Eggimann P, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-37
   Estivill D, 2011, J MICROBIOL METH, V86, P238, DOI 10.1016/j.mimet.2011.05.019
   Ferrari S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017589
   Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268
   FLING ME, 1991, MOL GEN GENET, V227, P318
   Frade JP, 2011, MYCOSES, V54, pE154, DOI 10.1111/j.1439-0507.2010.01862.x
   Franca EJG, 2011, MICRON, V42, P726, DOI 10.1016/j.micron.2011.03.008
   Garcia-San Miguel L, 2006, INFECT CONT HOSP EP, V27, P576, DOI 10.1086/505094
   Gupta V, 1998, CURR GENET, V34, P192, DOI 10.1007/s002940050385
   Haroun AA, 2011, J MATER SCI-MATER M, V22, P2545, DOI 10.1007/s10856-011-4437-x
   Harrison JJ, 2007, APPL ENVIRON MICROB, V73, P4940, DOI 10.1128/AEM.02711-06
   HAZAN R, 1993, BIOMATERIALS, V14, P570, DOI 10.1016/0142-9612(93)90172-X
   Hazen KC, 2003, J CLIN MICROBIOL, V41, P5623, DOI 10.1128/JCM.41.12.5623-5632.2003
   Henry KW, 2000, ANTIMICROB AGENTS CH, V44, P2693, DOI 10.1128/AAC.44.10.2693-2700.2000
   Hirota K, 2005, FEMS MICROBIOL LETT, V248, P37, DOI 10.1016/j.femsle.2005.05.019
   HITCHCOCK CA, 1993, ANTIMICROB AGENTS CH, V37, P1962, DOI 10.1128/AAC.37.9.1962
   Holmes AR, 2008, ANTIMICROB AGENTS CH, V52, P3851, DOI 10.1128/AAC.00463-08
   Holmes AR, 2012, ANTIMICROB AGENTS CH, V56, P1508, DOI 10.1128/AAC.05706-11
   Honraet K, 2005, J MICROBIOL METH, V63, P287, DOI 10.1016/j.mimet.2005.03.014
   Iltis GC, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009410
   Iraqui I, 2005, MOL MICROBIOL, V55, P1259, DOI 10.1111/j.1365-2958.2004.04475.x
   Karaagaclioglu L, 2008, J MATER SCI-MATER M, V19, P959, DOI 10.1007/s10856-007-3177-4
   Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004
   Karlsson AJ, 2010, BIOMACROMOLECULES, V11, P2321, DOI 10.1021/bm100424s
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   Khot PD, 2006, ANTIMICROB AGENTS CH, V50, P3708, DOI 10.1128/AAC.00997-06
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Kokare CR, 2009, INDIAN J BIOTECHNOL, V8, P159
   Kong H, 2008, BIOMACROMOLECULES, V9, P2677, DOI 10.1021/bm800574x
   Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0
   Krishnamurthy S, 1998, FEMS MICROBIOL LETT, V160, P191, DOI 10.1111/j.1574-6968.1998.tb12910.x
   Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002
   Kumamoto CA, 2002, CURR OPIN MICROBIOL, V5, P608, DOI 10.1016/S1369-5274(02)00371-5
   LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069
   Lee HB, 1989, FRONTIERS MACROMOLEC, P579
   Li L, 2010, MOL ORAL MICROBIOL, V25, P384, DOI 10.1111/j.2041-1014.2010.00586.x
   Lopez-Ribot JL, 1998, ANTIMICROB AGENTS CH, V42, P2932, DOI 10.1128/AAC.42.11.2932
   Mann PA, 2009, ANTIMICROB AGENTS CH, V53, P5026, DOI 10.1128/AAC.01031-09
   Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637
   Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701
   Marichal P, 1997, ANTIMICROB AGENTS CH, V41, P2229, DOI 10.1128/AAC.41.10.2229
   Marie C, 2009, CURR FUNGAL INFECT R, V3, P163, DOI 10.1007/s12281-009-0021-y
   Martel CM, 2010, ANTIMICROB AGENTS CH, V54, P4527, DOI 10.1128/AAC.00348-10
   Martin D, 2005, EUR J CLIN MICROBIOL, V24, P329, DOI 10.1007/s10096-005-1321-y
   Martinez LR, 2010, J INFECT DIS, V201, P1436, DOI 10.1086/651558
   Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1
   Mogavero S, 2011, ANTIMICROB AGENTS CH, V55, P2061, DOI 10.1128/AAC.01467-10
   Monteiro DR, 2011, BIOFOULING, V27, P711, DOI 10.1080/08927014.2011.599101
   Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164
   Morschhauser J, 2002, BBA-MOL BASIS DIS, V1587, P240, DOI 10.1016/S0925-4439(02)00087-X
   Mukherjee PK, 2003, INFECT IMMUN, V71, P4333, DOI 10.1128/IAI.71.84333-4340.2003
   Mukherjee PK, 2009, MYCOSES, V52, P440, DOI 10.1111/j.1439-0507.2008.01632.x
   Nakamura Tatsuya, 2006, Journal of Infection and Chemotherapy, V12, P132, DOI 10.1007/s10156-006-0438-y
   Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06
   Nett J, 2006, CURR OPIN MICROBIOL, V9, P340, DOI 10.1016/j.mib.2006.06.007
   Nikawa H, 1999, MYCOSES, V42, P37, DOI 10.1046/j.1439-0507.1999.00270.x
   Paulitsch AH, 2009, MED MYCOL, V47, P690, DOI 10.3109/13693780802635237
   Paulo CSO, 2010, BIOMACROMOLECULES, V11, P2810, DOI 10.1021/bm100893r
   Percival SL, 2011, INT WOUND J, V8, P237, DOI 10.1111/j.1742-481X.2011.00774.x
   Perumal P, 2007, ANTIMICROB AGENTS CH, V51, P2454, DOI 10.1128/AAC.01237-06
   Pfaller MA, 2007, J CLIN MICROBIOL, V45, P1735, DOI 10.1128/JCM.00409-07
   Pfaller MA, 2011, J CLIN MICROBIOL, V49, P845, DOI 10.1128/JCM.02441-10
   Pfaller MA, 2010, DRUG RESIST UPDATE, V13, P180, DOI 10.1016/j.drup.2010.09.002
   Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3185, DOI 10.1128/JCM.00946-09
   Pfaller MA, 2004, J CLIN MICROBIOL, V42, P3607, DOI [10.1128/JCM.42.8.3607-3612.2004, 10.1128/jcm.42.8.3607-3612.2004]
   Pfaller MA, 2004, DIAGN MICR INFEC DIS, V48, P201, DOI 10.1016/j.diagmicrobio.2003.09.008
   Pfaller MA, 2004, CLIN MICROBIOL INFEC, V10, P11, DOI 10.1111/j.1470-9465.2004.t01-1-00844.x
   Pfaller MA, 2007, J INVASIVE FUNGAL IN, V1, P74
   Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016
   Pfaller MA, 2011, J CLIN MICROBIOL, V49, P396, DOI 10.1128/JCM.01398-10
   Pfaller MA, 2009, DIAGN MICR INFEC DIS, V65, P27, DOI 10.1016/j.diagmicrobio.2009.05.007
   Prasad R, 1995, ACTA BIOCHIM POL, V42, P497
   PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101
   Prasad R, 2011, J AMINO ACIDS, V2011
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI [10.1093/jac/dkf049, 10.1093/jac.dkf049]
   Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163
   Ramage G, 2008, REV IBEROAM MICOL, V25, P37, DOI 10.1016/S1130-1406(08)70009-3
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436
   Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257
   Robbins N, 2010, FUNGAL GENET BIOL, V47, P81, DOI 10.1016/j.fgb.2009.07.004
   Rogers PD, 2003, ANTIMICROB AGENTS CH, V47, P1220, DOI 10.1128/AAC.47.4.1220-1227.2003
   Rogers PD, 2002, ANTIMICROB AGENTS CH, V46, P3412, DOI 10.1128/AAC.46.11.3312-3417.2002
   dos Santos JFR, 2010, ACTA BIOMATER, V6, P3919, DOI 10.1016/j.actbio.2010.04.013
   Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753
   Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0
   Sanglard D, 1997, MICROBIOL-UK, V143, P405, DOI 10.1099/00221287-143-2-405
   Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001
   Sanguinetti M, 2005, ANTIMICROB AGENTS CH, V49, P668, DOI 10.1128/AAC.49.2.668-679.2005
   Schinabeck MK, 2004, ANTIMICROB AGENTS CH, V48, P1727, DOI 10.1128/AAC.48.5.1727-1732.2004
   Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10
   Shin JH, 2002, J CLIN MICROBIOL, V40, P1244, DOI 10.1128/JCM.40.4.1244-1248.2002
   Shreaz S, 2012, EUR J MED CHEM, V48, P363, DOI 10.1016/j.ejmech.2011.12.007
   Silva S, 2011, TRENDS MICROBIOL, V19, P241, DOI 10.1016/j.tim.2011.02.003
   Silva S, 2010, J MED MICROBIOL, V59, P747, DOI 10.1099/jmm.0.017517-0
   Silva S, 2009, MED MYCOL, V47, P681, DOI 10.3109/13693780802549594
   Singh R, 2011, MICROBIOL-SGM, V157, P2611, DOI 10.1099/mic.0.048504-0
   Song JW, 2009, MED MYCOL, V47, P545, DOI 10.1080/13693780802210726
   Sorgo AG, 2011, EUKARYOT CELL, V10, P1071, DOI 10.1128/EC.05011-11
   Sun LM, 2010, J APPL MICROBIOL, V108, P341, DOI 10.1111/j.1365-2672.2009.04429.x
   Swinne D, 2004, EPIDEMIOL INFECT, V132, P1175, DOI 10.1017/S095026880400295X
   Takeshita F, 1997, J BIOMED MATER RES, V37, P235, DOI 10.1002/(SICI)1097-4636(199711)37:2<235::AID-JBM13>3.0.CO;2-D
   Taylor RL, 2003, J MATER SCI-MATER M, V14, P497, DOI 10.1023/A:1023451812658
   Teodor E, 2009, J MATER SCI-MATER M, V20, P1307, DOI 10.1007/s10856-008-3684-y
   Tournu H, 2012, INT J MICROBIOL, V2012, DOI DOI 10.1155/2012/845352
   Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08
   Tsai HF, 2010, ANTIMICROB AGENTS CH, V54, P3308, DOI 10.1128/AAC.00535-10
   Tsao S, 2009, ANTIMICROB AGENTS CH, V53, P1344, DOI 10.1128/AAC.00926-08
   Tumbarello M, 2007, J CLIN MICROBIOL, V45, P1843, DOI 10.1128/JCM.00131-07
   Tyllianakis M, 2010, J MATER SCI-MATER M, V21, P2201, DOI 10.1007/s10856-010-4086-5
   Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828
   Uppuluri P, 2009, MYCOPATHOLOGIA, V168, P101, DOI 10.1007/s11046-009-9205-9
   Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687
   Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x
   Wang HP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-167
   Webb JS, 1999, APPL ENVIRON MICROB, V65, P3575
   White TC, 1997, ANTIMICROB AGENTS CH, V41, P1488, DOI 10.1128/AAC.41.7.1488
   White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002
   White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482
   Wiegand C, 2011, J MATER SCI-MATER M, V22, P2583, DOI 10.1007/s10856-011-4423-3
   Wiley JM, 2005, PEDIATR INFECT DIS J, V24, P167, DOI 10.1097/01.inf.0000153183.51258.b8
   Wong JY, 2006, BIOMEDICAL ENG FUNDA, pV1
   Xu Z, 2006, INT J MED MICROBIOL, V296, P421, DOI 10.1016/j.ijmm.2006.03.004
   Zhou L, 2010, ARCH ORAL BIOL, V55, P401, DOI 10.1016/j.archoralbio.2010.03.013
   Zumbuehl A, 2008, EUR CELLS MATER, V16, P62
   Zumbuehl A, 2007, P NATL ACAD SCI USA, V104, P12994, DOI 10.1073/pnas.0705250104
NR 164
TC 39
Z9 42
U1 0
U2 50
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD OCT
PY 2012
VL 31
IS 10
BP 2513
EP 2527
DI 10.1007/s10096-012-1634-6
PG 15
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 012CZ
UT WOS:000309214300004
PM 22581304
DA 2018-10-19
ER

PT J
AU Cosentino, M
   Gaya, JM
   Breda, A
   Palou, J
   Villavicencio, H
AF Cosentino, Marco
   Gaya, Josep M.
   Breda, Alberto
   Palou, Joan
   Villavicencio, Humberto
TI Alloplastic bladder substitution: are we making progress?
SO INTERNATIONAL UROLOGY AND NEPHROLOGY
LA English
DT Review
DE Urinary tract; Transplantation; Silicone; Scaffold; Bladder tissue
   engineering; Bladder
ID QUALITY-OF-LIFE; RADICAL CYSTECTOMY; PROSTHETIC BLADDER; ARTIFICIAL
   BLADDER; URINARY-BLADDER; CANCER; REPLACEMENT; COMPLICATIONS; SURVIVAL;
   UROLOGY
AB Radical cystectomy with lymphadenectomy and urinary diversion is the gold standard treatment for bladder cancer in organ-confined muscle-invasive disease and selected patients who have high-grade non-muscle-invasive disease or are non-responders to BCG. The main and most morbid complications of this challenging surgery are related to the use of bowel for urinary tract reconstruction. For this reason, many past projects were devoted to finding an alternative to the use of bowel. The aim of this review is to provide a summary of the evolution of alloplastic bladder substitution. A comprehensive review of the literature was performed using the Medline National Library of Medicine database and Google Scholar. Keywords used were cystectomy and intestine/bowel, replacement, bladder substitution, organ replacement, artificial bladder, alloplastic material, biomaterial, and tissue engineering. Various prostheses have been proposed for replacement of the urinary bladder, silicone being the most frequently used material. The first published model of an alloplastic bladder was described by Bogash et al. in late 1959, while the last, in 1996, was suggested by Rohrmann. Interprofessional collaboration, recent advances in technology, and tissue engineering may help in developing suitable bladder prostheses. Urologists as well as engineers and the industry need to give this matter serious attention.
C1 [Cosentino, Marco; Gaya, Josep M.; Breda, Alberto; Palou, Joan; Villavicencio, Humberto] Univ Autonoma Barcelona, Dept Urol, Fundacio Puigvert, Barcelona 08025, Spain.
RP Cosentino, M (reprint author), Univ Autonoma Barcelona, Dept Urol, Fundacio Puigvert, C Cartagena 340, Barcelona 08025, Spain.
EM doccosentino@gmail.com
OI Breda, Alberto/0000-0002-7842-9048
CR ABBOU C, 1977, T AM SOC ART INT ORG, V23, P371
   Alberti C, 2004, INT J ARTIF ORGANS, V27, P737
   Apoil A, 1981, GENITOURINARY RECONS, P75
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003
   AUVERT J, 1976, UROL RES, V4, P143, DOI 10.1007/BF00262345
   BARRETT DM, 1992, MAYO CLIN PROC, V67, P215, DOI 10.1016/S0025-6196(12)60095-0
   Belden L, 1990, 85 ANN M AM UR ASS N
   BITSCHAI J, 1952, AM J SURG, V83, P215, DOI 10.1016/0002-9610(52)90214-6
   BOGASH M, 1960, Surg Forum, V10, P900
   Davis NF, 2011, J MECH BEHAV BIOMED, V4, P375, DOI 10.1016/j.jmbbm.2010.11.005
   Desgrandchamps F, 1999, EUR UROL, V35, P257
   Dominguez L, 2006, J NUTR HEALTH AGING, V10, P143
   Ferlay J, 2004, IARC CANC BASE
   FRIEDMAN BERNARD, 1964, INVEST UROL, V1, P323
   Gleeson M J, 1990, ASAIO Trans, V36, pM429
   Gurpinar T, 1996, WORLD J UROL, V14, P47, DOI 10.1007/BF01836344
   Hardt J, 2000, QUAL LIFE RES, V9, P1, DOI 10.1023/A:1008927809013
   Hollenbeck BK, 2004, UROLOGY, V64, P292, DOI 10.1016/j.urology.2004.03.034
   Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062
   KLINE J, 1978, T AM SOC ART INT ORG, V24, P254
   Konety BR, 2006, UROLOGY, V68, P58, DOI 10.1016/j.urology.2006.01.051
   Korossis S, 2006, TISSUE ENG, V12, P4
   Kuaksizoglu H, 2002, EUR UROL, V42, P350
   Lutzeyer W, 1984, 95 ANN M AM ASS GEN
   Mansson A, 2002, BJU INT, V90, P386, DOI 10.1046/j.1464-4096.2002.02899.x
   McAteer H, 2007, J TISSUE ENG REGEN M, V1, P343, DOI 10.1002/term.36
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Miller DC, 2003, J UROLOGY, V169, P105, DOI 10.1097/01.ju.0000039705.36504.12
   Novotny V, 2007, EUR UROL, V51, P401
   Novotny V, 2007, EUR UROL, V51, P397, DOI 10.1016/j.eururo.2006.06.014
   Orlando G, 2011, TRANSPL INT, V24, P223, DOI [10.1111/j.1432-2277.2010.01182.x, DOI 10.1111/J.1432-2277.2010.01182.X]
   OSULLIVAN DC, 1994, J UROLOGY, V151, P776, DOI 10.1016/S0022-5347(17)35086-3
   Palapattu GS, 2004, J UROLOGY, V172, P1814, DOI 10.1097/01.ju.0000141245.08456.1a
   Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3
   Rigotti E, 1976, Minerva Urol, V28, P1
   Rohrmann D, 1996, J UROLOGY, V156, P2094, DOI 10.1016/S0022-5347(01)65442-9
   Stanasel I, 2010, UROL CLIN N AM, V37, P593, DOI 10.1016/j.ucl.2010.06.008
   STERN A, 1976, EUR SURG RES, V8, P179
   Studer UE, 2006, J UROLOGY, V176, P161, DOI 10.1016/S0022-5347(06)00573-8
   Tanaka ST, 2010, TISSUE ENG PT A, V16, P2121, DOI 10.1089/ten.TEA.2009.0557
   VACANT J, 1976, EUR SURG RES, V8, P180
   Wood D, 2008, CURR OPIN UROL, V18, P564, DOI 10.1097/MOU.0b013e32830f9402
   Yu RN, 2010, UROLOGY, V75, P664, DOI 10.1016/j.urology.2009.03.058
NR 44
TC 0
Z9 0
U1 1
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-1623
J9 INT UROL NEPHROL
JI Int. Urol. Nephrol.
PD OCT
PY 2012
VL 44
IS 5
BP 1295
EP 1303
DI 10.1007/s11255-012-0249-2
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA 008LB
UT WOS:000308957400001
PM 22821051
DA 2018-10-19
ER

PT J
AU Vega, SL
   Liu, E
   Patel, PJ
   Kulesa, AB
   Carlson, AL
   Ma, YR
   Becker, ML
   Moghe, PV
AF Vega, Sebastian L.
   Liu, Er
   Patel, Parth J.
   Kulesa, Anthony B.
   Carlson, Aaron L.
   Ma, Yanrui
   Becker, Matthew L.
   Moghe, Prabhas V.
TI High-Content Imaging-Based Screening of Microenvironment-Induced Changes
   to Stem Cells
SO JOURNAL OF BIOMOLECULAR SCREENING
LA English
DT Article
DE cell-based assays; high content screening; image analysis; stem cells
ID GENE-EXPRESSION; DIFFERENTIATION; MICROARRAY; BIOMATERIALS;
   CYTOSKELETAL; SURFACES
AB Effective screening methodologies for cells are challenged by the divergent and heterogeneous nature of phenotypes inherent to stem cell cultures, particularly on engineered biomaterial surfaces. In this study, we showcase a high-content, confocal imaging-based methodology to parse single-cell phenotypes by quantifying organizational signatures of specific subcellular reporter proteins and applied this profiling approach to three human stem cell types (embryonic-human embryonic stem cell [hESC], induced pluripotent-induced pluripotent stem cell [iPSC], and mesenchymal-human mesenchymal stem cell [hMSC]). We demonstrate that this method could distinguish self-renewing subpopulations of hESCs and iPSCs from heterogeneous populations. This technique can also provide insights into how incremental changes in biomaterial properties, both physiochemical and mechanical, influence stem cell fates by parsing the organization of stem cell proteins. For example, hMSCs cultured on polymeric films with varying degrees of poly(ethylene glycol) to modulate osteogenic differentiation were parsed using high-content organization of the cytoskeletal protein F-actin. In addition, hMSCs cultured on a self-assembled monolayer platform featuring compositional gradients were screened and descriptors obtained to correlate substrate variations with adipogenic lineage commitment. Taken together, high-content imaging of structurally sensitive proteins can be used as a tool to identify stem cell phenotypes at the single-cell level across a diverse range of culture conditions and microenvironments.
C1 [Vega, Sebastian L.; Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
   [Liu, Er; Patel, Parth J.; Kulesa, Anthony B.; Carlson, Aaron L.; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Liu, Er] La Jolla Bioengn Inst, La Jolla, CA USA.
   [Ma, Yanrui; Becker, Matthew L.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
   [Becker, Matthew L.] Austen Bioinnovat Inst Akron, Ctr Biomat Med, Akron, OH USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
EM Moghe@rutgers.edu
RI Liu, Er/H-8441-2012
OI Liu, Er/0000-0001-7858-1333
FU National Institute Of Biomedical Imaging And Bioengineering (NIBIB)
   [P41EB001046]
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: The project
   described was supported by Award Number P41EB001046 from the National
   Institute Of Biomedical Imaging And Bioengineering (NIBIB). The content
   is solely the responsibility of the authors and does not necessarily
   represent the official views of the NIBIB or the National Institutes of
   Health.
CR Bowtell DDL, 1999, NAT GENET, V21, P25, DOI 10.1038/4455
   Briggs T, 2009, J BIOMED MATER RES A, V91A, P975, DOI 10.1002/jbm.a.32310
   Dahl KN, 2011, J CELL SCI, V124, P675, DOI 10.1242/jcs.069096
   Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622
   Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gallant ND, 2007, ADV MATER, V19, P965, DOI 10.1002/adma.200602221
   GOLDSCHNEIDER I, 1980, J EXP MED, V152, P419, DOI 10.1084/jem.152.2.419
   Jin HJ, 2009, BIOCHEM BIOPH RES CO, V381, P676, DOI 10.1016/j.bbrc.2009.02.118
   KUMAR A, 1994, SCIENCE, V263, P60, DOI 10.1126/science.263.5143.60
   Kunisada Y, 2012, J BIOMOL SCREEN, V17, P140, DOI 10.1177/1087057111422101
   Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8
   Liu E, 2010, CELL CYCLE, V9, P2108, DOI 10.4161/cc.9.11.11864
   Liu E, 2009, COMB CHEM HIGH T SCR, V12, P646, DOI 10.2174/138620709788923737
   Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675
   Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177
   Maffia AM, 1999, J BIOMOL SCREEN, V4, P137, DOI 10.1177/108705719900400307
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Moore NM, 2010, BIOMATERIALS, V31, P1604, DOI [10.1016/j.biomatetials.2009.11.011, 10.1016/j.biomaterials.2009.11.011]
   Peters A, 2009, TISSUE ENG PART B-RE, V15, P225, DOI [10.1089/ten.teb.2009.0049, 10.1089/ten.TEB.2009.0049]
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4
   Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003
   Treiser MD, 2007, BIOTECHNIQUES, V43, P361, DOI 10.2144/000112533
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
NR 31
TC 10
Z9 10
U1 1
U2 31
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1087-0571
J9 J BIOMOL SCREEN
JI J. Biomol. Screen
PD OCT
PY 2012
VL 17
IS 9
SI SI
BP 1151
EP 1162
DI 10.1177/1087057112453853
PG 12
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry
GA 014CG
UT WOS:000309352100005
PM 22811477
OA Bronze, Green Accepted
DA 2018-10-19
ER

PT J
AU Sasikumar, Y
   Rajendran, N
AF Sasikumar, Y.
   Rajendran, N.
TI Surface Modification and In Vitro Characterization of Cp-Ti and
   Ti-5Al-2Nb-1Ta Alloy in Simulated Body Fluid
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE AFM; apatite; biomaterial; polarization; simulated body fluid; Ti alloy
ID CHEMICALLY TREATED TITANIUM; CORROSION BEHAVIOR; BIOMEDICAL
   APPLICATIONS; APATITE FORMATION; TI-6AL-4V; BIOACTIVITY; HYDROXYAPATITE;
   WEAR; SPECTROSCOPY; TI-13NB-13ZR
AB Ti and its alloys are widely used in manufacturing orthopedic implants as prostheses for joint replacement because of their high corrosion resistance and excellent biocompatibility. However, they lack in bone-bonding ability and leads to higher rate of osteolysis and subsequent loosening of implants. In order to enhance the bone-bonding ability of these alloys, various surface-modification techniques are generally employed. The present investigation is mainly concerned with the surface modification of Cp-Ti and Ti-5Al-2Nb-1Ta alloy using a mixture of alkali and hydrogen peroxide followed by subsequent heat treatment to produce a porous gel layer with anatase structure, which enhances osseointegration. The morphological behavior was examined by x-ray diffractometer (XRD), atomic force microscopy (AFM), and scanning electron microscopy (SEM) coupled with energy dispersive x-ray analysis (EDX). The in vitro characterization of all the specimens was evaluated by immersing the specimens in simulated body fluid solution to assess the apatite formation over the metal surface. The apatite formation was confirmed by XRD, SEM-EDX, and Fourier transform infrared spectroscopy (FT-IR). Further, the electrochemical corrosion behaviors of both the untreated and treated specimens were evaluated using potentiodynamic polarization and electrochemical impedance spectroscopy. The results revealed that the surface-modified and heat-treated specimens exhibited higher corrosion resistance and excellent biocompatibility when compared to the chemical and untreated specimens.
C1 [Sasikumar, Y.; Rajendran, N.] Anna Univ, Dept Chem, Madras 600025, Tamil Nadu, India.
RP Sasikumar, Y (reprint author), Anna Univ, Dept Chem, Madras 600025, Tamil Nadu, India.
EM nrajendran@annauniv.edu
RI Yesudass, Sasikumar/M-1949-2015
OI Yesudass, Sasikumar/0000-0002-8262-2705
FU Council of Scientific and Industrial Research (CSIR), New Delhi
FX One of the authors, Y. Sasikumar, acknowledges the financial support
   received from the Council of Scientific and Industrial Research (CSIR),
   New Delhi.
CR Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Chosa N, 2004, J DENT RES, V83, P465, DOI 10.1177/154405910408300606
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Hench LL, 1999, MRS BULL, V24, P13
   Hodgson AWE, 2002, ELECTROCHIM ACTA, V47, P1913, DOI 10.1016/S0013-4686(02)00029-4
   Ji HB, 2000, WEAR, V246, P40, DOI 10.1016/S0043-1648(00)00444-0
   Karthega M, 2010, ELECTROCHIM ACTA, V55, P2201, DOI 10.1016/j.electacta.2009.11.057
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Liang FH, 2003, J MATER SCI LETT, V22, P1665, DOI 10.1023/B:JMSL.0000004643.03120.ca
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   Lin FH, 2004, MATER CHEM PHYS, V87, P24, DOI 10.1016/j.matchemphys.2004.03.030
   Lindgren T, 2003, J PHYS CHEM B, V107, P5709, DOI 10.1021/jp027345j
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   RIE KT, 1985, MATER SCI ENG, V69, P473, DOI 10.1016/0025-5416(85)90349-0
   Sasikumar Y, 2011, J MATER ENG PERFORM, V20, P1271, DOI 10.1007/s11665-010-9772-4
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   Shi P, 2006, MATER LETT, V60, P1996, DOI 10.1016/j.matlet.2005.12.066
   Shukla AK, 2006, CORROS SCI, V48, P1696, DOI 10.1016/j.corsci.2005.06.003
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   Tamilselvi S, 2007, MATER CORROS, V58, P285, DOI 10.1002/maco.200604001
   Tamilselvi S, 2011, CORROS ENG SCI TECHN, V46, P585, DOI 10.1179/147842209X12590591256936
   Tamilselvi S, 2010, J APPL ELECTROCHEM, V40, P285, DOI 10.1007/s10800-009-9972-5
   VARDIMAN RG, 1982, J APPL PHYS, V53, P690, DOI 10.1063/1.329977
   Wang CX, 2002, LANGMUIR, V18, P7641, DOI 10.1021/la011877u
   Wang K., 1996, MAT SCI ENG A-STRUCT, V213, P134
   Wen HB, 1997, BIOMATERIALS, V18, P1471, DOI 10.1016/S0142-9612(97)82297-1
   Yi JH, 2006, SURF SCI, V600, P4613, DOI 10.1016/j.susc.2006.07.053
   Zhou Y., 2009, BIOMED MATER, V4
NR 38
TC 11
Z9 11
U1 1
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD OCT
PY 2012
VL 21
IS 10
BP 2177
EP 2187
DI 10.1007/s11665-012-0143-1
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 010OG
UT WOS:000309103200022
DA 2018-10-19
ER

PT J
AU Boni, L
   Chalajour, F
   Sasaki, T
   Snyder, RL
   Boyd, WD
   Riemer, RK
   Reddy, VM
AF Boni, Lorenzo
   Chalajour, Fariba
   Sasaki, Takashi
   Snyder, Radhika Lal
   Boyd, Walter D.
   Riemer, R. Kirk
   Reddy, V. Mohan
TI Reconstruction of pulmonary artery with porcine small intestinal
   submucosa in a lamb surgical model: Viability and growth potential
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID BIOLOGIC SCAFFOLD MATERIALS; EXTRACELLULAR-MATRIX; REPAIR; CELLS;
   AUGMENTATION; BIOMATERIALS; DEGRADATION; GRAFT; DOG
AB Objectives: This study investigated the time-dependent remodeling and growth potential of porcine small intestine submucosa as a biomaterial for the reconstruction of pulmonary arteries in a lamb model.
   Methods: Left pulmonary arteries were partially replaced with small intestine submucosal biomaterial in 6 lambs. Two animals each were humanely killed at 1, 3, and 6 months. Computed tomographic angiography, macroscopic examination of the implanted patch, and microscopic analysis of tissue explants were performed.
   Results: All animals survived without complications. Patency and arborization of the pulmonary arteries were detected 6 months after implantation. There was no macroscopic narrowing or aneurysm formation in the patch area. The luminal appearance of the patch was similar to the intimal layer of the adjacent native pulmonary artery. Scanning electron microscopy showed that the luminal surface of the patch was covered by confluent cells. Immunohistochemical examination confirmed endothelialization of the luminal side of the patch in all of the explanted patches. The presence of smooth muscle cells in the medial layer was confirmed at all time points; however, expression of elastin, growth of the muscular layer, and complete degradation of patch material were detectable only after 6 months. The presence of c-Kit-positive cells suggests migration of multipotent cells into the patch, which may play a role in remodeling the small intestine submucosal biomaterial.
   Conclusions: Our data confirmed that remodeling and growth potential of the small intestine submucosal biomaterial are time dependent. Additional experiments are required to investigate the stability of the patch material over a longer period. (J Thorac Cardiovasc Surg 2012; 144: 963-9)
C1 [Boni, Lorenzo; Chalajour, Fariba; Sasaki, Takashi; Snyder, Radhika Lal; Riemer, R. Kirk; Reddy, V. Mohan] Stanford Univ, Div Pediat Cardiac Surg, Dept Cardiothorac Surg, Stanford, CA 94305 USA.
   [Boyd, Walter D.] Univ Calif Davis, Med Ctr, Dept Cardiothorac Surg, Sacramento, CA USA.
RP Chalajour, F (reprint author), Falk Cardiovasc Res Ctr, 300 Pasteur Dr, Stanford, CA 94305 USA.
EM fchalajour@gmail.com
OI Riemer, Robert/0000-0002-3054-9809; Boni, Lorenzo/0000-0002-7831-4670
FU Oak Foundation
FX This work was partially supported by the Oak Foundation.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Deeken CR, 2012, ANN SURG, V255, P595, DOI 10.1097/SLA.0b013e3182445341
   Du XF, 2012, INT J PEDIATR OTORHI, V76, P345, DOI 10.1016/j.ijporl.2011.12.005
   Fallon A, 2012, J SURG RES, V175, pE25, DOI 10.1016/j.jss.2011.11.001
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   MATSUMOTO T, 1966, ANN SURG, V164, P845
   McCready RA, 2005, J VASC SURG, V41, P782, DOI 10.1016/j.jvs.2005.02.035
   NARAYANAN AS, 1976, J CELL BIOL, V68, P411, DOI 10.1083/jcb.68.3.411
   Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375
   Quarti A, 2011, INTERACT CARDIOV TH, V6, P569
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   REDDY VM, 1995, J THORAC CARDIOV SUR, V109, P832, DOI 10.1016/S0022-5223(95)70305-5
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   Ruiz CE, 2005, J THORAC CARDIOV SUR, V130, P477, DOI 10.1016/j.jtcvs.2005.04.008
   Tang GHL, 2005, ANN THORAC SURG, V79, P1831, DOI 10.1016//j.athoracsur.2004.08.039
   Tottey S, 2011, BIOMATERIALS, V32, P128, DOI 10.1016/j.biomaterials.2010.09.006
   Ueno T, 2004, J GASTROINTEST SURG, V8, P109, DOI 10.1016/j.gassur.2003.09.025
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 26
TC 11
Z9 12
U1 0
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD OCT
PY 2012
VL 144
IS 4
BP 963
EP +
DI 10.1016/j.jtcvs.2012.07.024
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 010RK
UT WOS:000309111600034
PM 22917684
OA Bronze
DA 2018-10-19
ER

PT J
AU Yoshida, R
   Vavken, P
   Murray, MM
AF Yoshida, Ryu
   Vavken, Patrick
   Murray, Martha M.
TI Decellularization of bovine anterior cruciate ligament tissues minimizes
   immunogenic reactions to alpha-gal epitopes by human peripheral blood
   mononuclear cells
SO KNEE
LA English
DT Article
DE Tissue engineering; Anterior cruciate ligament; Graft rejection;
   Inflammation; Wound healing
ID PLATELET-RICH PLASMA; COLLAGEN; XENOTRANSPLANTATION; SCAFFOLD; PORCINE;
   MODEL; RECONSTRUCTION; ANTIBODY; ACTIVATION; GRAFTS
AB Rupture of ACL is a common injury. While the current surgical treatments are effective, many patients still suffer from precocious osteoarthritis, and there is an increasing interest in bioengineering approaches to improve ACL repair. Bovine collagen is a material currently in use for tissue engineering of ligaments. The alpha-gal epitopes found on bovine cells are a source of immunogenic stimulus for human cells. In this study, we wished to determine if those epitopes could be removed sufficiently to mitigate an immunogenic response using either a decellularization protocol or decellularization followed by alpha-galactosidase treatment. Bovine ACLs were treated with Triton-X, sodium deoxycholate, ribonuclease, and deoxyribonuclease to remove cells. A subset of the decellularized tissues was further treated with alpha-galactosidase. Human peripheral blood mononuclear cells (PBMCs) were exposed to untreated, decellularized, and alpha-galactosidase-treated tissues, and PBMC migration and IL-6 release were measured. PBMCs were significantly more attracted to untreated ACL compared to decellularized or alpha-galactosidase-treated tissue, but no difference was seen between the two treatment groups. PBMCs also released significantly more IL-6 when exposed to untreated tissue compared to decellularized ACL or alpha-galactosidase-treated ACL, but no difference was seen between the two treatment groups. Immunohistochemistry using anti-alpha-gal antibody detected the epitopes throughout the untreated ACL, but similar areas of reaction were not seen on decellularized or alpha-galactosidase-treated ACL These results suggest that our decellularization protocol minimizes the immunogenic reactions of human PBMCs to bovine ACL tissue. Therefore, decellularized bovine ACL tissue may be a safe, effective biomaterial for ACL injury treatments. (C) 2011 Elsevier By. All rights reserved.
C1 [Yoshida, Ryu; Vavken, Patrick; Murray, Martha M.] Harvard Univ, Dept Orthopaed Surg, Sch Med, Childrens Hosp Boston, Boston, MA 02115 USA.
RP Murray, MM (reprint author), Harvard Univ, Dept Orthopaed Surg, Sch Med, Childrens Hosp Boston, 300 Longwood Ave, Boston, MA 02115 USA.
EM Martha.murray@childrens.harvard.edu
FU NIH-NIAMS [052772]
FX This study was supported by the NIH-NIAMS grant 052772 (MMM).
CR Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Das REG, 2004, J IMMUNOL METHODS, V288, P165, DOI 10.1016/j.jim.2004.03.002
   Dumont CE, 1997, TRANSPLANTATION, V63, P1210, DOI 10.1097/00007890-199705150-00004
   Farhat WA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025015
   Fleming BC, 2009, AM J SPORT MED, V37, P1554, DOI 10.1177/0363546509332257
   Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921
   Friedman T, 1999, J IMMUNOL, V162, P5256
   Fufa D, 2008, J ORAL MAXIL SURG, V66, P684, DOI 10.1016/j.joms.2007.06.635
   Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x
   GALILI U, 1993, IMMUNOL TODAY, V14, P480, DOI 10.1016/0167-5699(93)90261-I
   Galili U, 2006, TRANSFUS APHER SCI, V35, P45, DOI 10.1016/j.transci.2006.05.007
   Kibler WB, 2009, ORTHOPAEDIC KNOWLEDG, P135
   Liden M, 2008, ARTHROSCOPY, V24, P899, DOI 10.1016/j.arthro.2008.04.066
   Miller SL, 2002, ORTHOP CLIN N AM, V33, P675, DOI 10.1016/S0030-5898(02)00027-5
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073
   Neuman P, 2008, AM J SPORT MED, V36, P1717, DOI 10.1177/0363546508316770
   Pietramaggiori G, 2010, J SURG RES, V160, P169, DOI 10.1016/j.jss.2008.09.010
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Robayo LM, 2011, WOUND REPAIR REGEN, V19, P38, DOI 10.1111/j.1524-475X.2010.00640.x
   Sandmann GH, 2009, J BIOMED MATER RES A, V91A, P567, DOI 10.1002/jbm.a.32269
   Spindler KP, 2009, J ORTHOP RES, V27, P631, DOI 10.1002/jor.20785
   Stone KR, 2007, TRANSPLANTATION, V83, P211, DOI 10.1097/01.tp.0000250598.29377.13
   Vavken P, 2009, J ORTHOP RES, V27, P1612, DOI 10.1002/jor.20932
NR 27
TC 11
Z9 11
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0968-0160
J9 KNEE
JI Knee
PD OCT
PY 2012
VL 19
IS 5
BP 672
EP 675
DI 10.1016/j.knee.2011.08.002
PG 4
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 013OA
UT WOS:000309313500031
PM 21925883
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Alijotas-Reig, J
   Garcia-Gimenez, V
   Llurba, E
   Vilardell-Tarres, M
AF Alijotas-Reig, J.
   Garcia-Gimenez, V.
   Llurba, E.
   Vilardell-Tarres, M.
TI Autoimmune/inflammatory syndrome (ASIA) induced by biomaterials
   injection other than silicone medical grade
SO LUPUS
LA English
DT Article
DE Acrylamides; adjuvant; autoimmune diseases; bioimplants; granuloma;
   hyaluronic acid; methacrylate
ID TOLL-LIKE RECEPTORS; ADVERSE-REACTIONS; AUTOIMMUNITY; FILLERS;
   ACTIVATION; INFECTION; ADJUVANTS
AB Background: Systemic autoimmune/granulomatous adverse reactions related to biomaterials other than silicone have rarely been reported. Aim: The aim of this paper is to communicate the cases of autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in a study of Spanish patients suffering from inflammatory disorders related to biomaterial injections other than silicone, principally hyaluronic acid, acrylamides or methacrylate compounds. Methods: The authors performed a retrospective analysis of the clinical, laboratory, histopathology and follow-up of a cohort of 250 cases of patients suffering from inflammatory/autoimmune disorders related to bioimplant injections. Results: Of these 250 cases, patients with adverse reactions related to silicone injections (n = 65) were excluded. Of the remaining 185, 15 cases (8%) had systemic or distant and multiple complaints that could be categorized as ASIA. In all but four patients, inflammatory features at the implantation site preceded distant or systemic manifestations. Abnormal blood tests were common. Eleven cases (73.3%) with inflammatory localized nodules and panniculitis evolved into a variety of disorders, namely, primary biliary cirrhosis, Sjogren's syndrome, sarcoidosis, human adjuvant disease and inflammatory polyradiculopathy. Four cases presented primarily with systemic autoimmune disorders. Conclusions: Infrequently, biomaterials other than silicone can provoke local inflammatory adverse reactions that may evolve into systemic autoimmune and/or granulomatous disorders. Whether or not these biomaterials act as an adjuvant, they could be included in the ASIA category. Lupus (2012) 21, 1326-1334.
C1 [Alijotas-Reig, J.; Vilardell-Tarres, M.] Vall dHebron Univ Hosp, Dept Internal Med 1, Ageing Res & System Autoimmune Dis Unit, Barcelona, Spain.
   [Alijotas-Reig, J.; Llurba, E.] Vall dHebron Univ Hosp, CIBBIM Nanomed, Biochem & Mol Biol Res Ctr Nanomed, Barcelona, Spain.
   [Alijotas-Reig, J.; Vilardell-Tarres, M.] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.
   [Llurba, E.] Vall dHebron Univ Hosp, Obstetr Dept, High Risk Obstet Unit, Barcelona, Spain.
   [Llurba, E.] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBERER, Barcelona, Spain.
RP Alijotas-Reig, J (reprint author), Josep Ma de Sagarra 2-F, Barcelona 08195, Spain.
EM jalijota@vhebron.net
RI Alijotas-Reig, Jaume/H-9262-2016
OI Alijotas-Reig, Jaume/0000-0002-9212-3619; Llurba Olive,
   Elisa/0000-0003-4048-6407
CR Agmon-Levin N, 2008, AUTOIMMUN REV, V8, P52
   Alijotas-Reig J, 2008, J EUR ACAD DERMATOL, V22, P50
   Alijotas-Reig J, 2008, ARCH DERMATOL, V144, P637, DOI 10.1001/archderm.144.5.637
   Alijotas-Reig J, 2010, J BIOMED MATER RES A, V95A, P180, DOI 10.1002/jbm.a.32794
   Alijotas-Reig J, 2010, DERMATOL SURG, V36, P272, DOI 10.1111/j.1524-4725.2009.01416.x
   American Society of Plastic Surgery, 2010, STAT 2010
   Andre P, 2005, J Cosmet Laser Ther, V7, P171, DOI 10.1080/14764170500344393
   Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933
   Bergeret-Galley Catherine, 2004, Aesthet Surg J, V24, P33, DOI 10.1016/j.asj.2004.01.006
   BRODY GS, 1992, PLAST RECONSTR SURG, V90, P1102, DOI 10.1097/00006534-199212000-00029
   Caruso C, 2000, HUM IMMUNOL, V61, P942, DOI 10.1016/S0198-8859(00)00168-3
   Cervera R, 2011, LUPUS, V20, P665, DOI 10.1177/0961203311402247
   Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016
   Christen U, 2005, J IMMUNOL, V174, P7481, DOI 10.4049/jimmunol.174.12.7481
   Christensen L, 2005, AESTHET PLAST SURG, V29, P34, DOI 10.1007/s00266-004-0113-6
   De Boulle Koenraad, 2004, J Cosmet Dermatol, V3, P2, DOI 10.1111/j.1473-2130.2004.00058.x
   Duffy DM, 2005, DERMATOL SURG, V31, P1626, DOI 10.2310/6350.2005.31251
   Ellis D A, 2001, Facial Plast Surg Clin North Am, V9, P405
   Engelman Dendy E, 2005, J Cosmet Laser Ther, V7, P29, DOI 10.1080/147641700510037716
   Frank PJ, 2005, COSMETIC S RESTYLANE
   Hirsch Ranella J, 2008, J Drugs Dermatol, V7, P841
   Israeli E, 2009, LUPUS, V18, P1217, DOI 10.1177/0961203309345724
   James DG, 1985, MAJOR PROBLEMS INTER, P1
   Miro-Mur F, 2009, J BIOMED MATER RES B, V90B, P510, DOI 10.1002/jbm.b.31312
   Miyoshi K, 1964, IJISHIMPO, V2122, P9
   Miyoshi K, 1973, CLIN IMMUNOL, V5, P785
   Mosca M, 2004, CLIN EXP RHEUMATOL, V22, pS14
   Mosca M, 1999, CLIN EXP RHEUMATOL, V17, P585
   MOYA C, 1994, LANCET, V344, P498, DOI 10.1016/S0140-6736(94)91896-1
   Pons-Guiraud A, 2003, NOUV DERMATOL, V22, P205
   Raschi E, 2008, LUPUS, V17, P937, DOI 10.1177/0961203308095140
   Requena C, 2001, AM J DERMATOPATH, V23, P197, DOI 10.1097/00000372-200106000-00006
   Roitt I, 1986, INMUNOLOGIA
   Rose NR, 2010, LUPUS, V19, P354, DOI 10.1177/0961203309360670
   Sanchez O, 2012, IMMUNOBIOLOGY, V217, P44, DOI 10.1016/j.imbio.2011.08.003
   Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003
   TABUENCA JM, 1981, LANCET, V2, P567
   Vera-Lastra O, 2012, LUPUS, V21, P128, DOI 10.1177/0961203311429317
NR 38
TC 13
Z9 13
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0961-2033
J9 LUPUS
JI Lupus
PD OCT
PY 2012
VL 21
IS 12
BP 1326
EP 1334
DI 10.1177/0961203312458838
PG 9
WC Rheumatology
SC Rheumatology
GA 013CK
UT WOS:000309283100009
PM 22952322
DA 2018-10-19
ER

PT J
AU D'Alessandro, D
   Danti, S
   De Vito, A
   Forli, F
   Bruschini, L
   Berrettini, S
AF D'Alessandro, Delfo
   Danti, Serena
   De Vito, Andrea
   Forli, Francesca
   Bruschini, Luca
   Berrettini, Stefano
TI Histologic Characterization of Human Ear Ossicles for the Development of
   Tissue-Engineered Replacements
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE Ear histology; Mesenchymal stem cells; Ossicular chain; Partial
   ossicular replacement prosthesis; Scaffold; Tissue engineering
ID EXTRACELLULAR-MATRIX; AUDITORY OSSICLES; STROMAL CELLS; BONE;
   OSSICULOPLASTY; PROSTHESES; TYMPANOPLASTY; EXPRESSION; TORPS; PORPS
AB Hypothesis: Precise knowledge of the expression and distribution of extracellular matrix (ECM) molecules and osteochondrogenic markers helps target the proper in vitro regeneration of novel ossicular chain (OC) replacements via tissue engineering (TE).
   Background: We performed an extensive histologic analysis of human ear ossicles in healthy adults. A variety of OC prostheses are currently available, but extrusion of synthetic devices still represents an important clinical phenomenon. TE is a novel discipline combining stem cells, bioresorbable biomaterials, and stimulatory factors for the development of new living tissues in vitro, which might offer forefront opportunities to otologic surgery. However, to drive stem cell differentiation correctly, the final tissue target must be accurately known.
   Methods: Malleus, incus, and stapes were collected from cadaveric temporal bones. TE PORPs were obtained via osteodifferentiation of human mesenchymal stromal cells on polymeric scaffolds. Histochemical and immunohistochemical analyses were performed to detect ECM molecules and osteochondrogenic markers.
   Results: Malleus and incus showed the same histologic tissue type, with similar levels of expression and distributions for both ECM molecules and osteochondrogenic markers, whereas the stapes showed self-standing histologic patterns. In TE PORPs, mesenchymal ECM synthesis and early stage development of ossification sites could be observed, highlighting good cellular integration with the scaffold biomaterial.
   Conclusion: Detailed morphologic study of the ossicles provides data related to tissue dynamics involved in their development, defining features of tissue differentiation and maturation. Such findings underpin the future development of biomimetic ossicular replacement, data that can guide tissue-engineered ossiculoplasty.
C1 [D'Alessandro, Delfo; Danti, Serena; De Vito, Andrea; Berrettini, Stefano] Univ Pisa, Dept Neurosci, Pisa, Italy.
   [De Vito, Andrea; Forli, Francesca; Bruschini, Luca; Berrettini, Stefano] Azienda Osped Univ Pisana, Operat Unit Otorhinolaryngol Audiol & Phoniatr, I-56124 Pisa, Italy.
RP Berrettini, S (reprint author), Azienda Osped Univ Pisana, Cisanello Hosp, Otorhinolaryngol Audiol & Phoniatr Unit, Via Paradisa 2, I-56124 Pisa, Italy.
EM s.berrettini@med.unipi.it
RI Danti, Serena/N-2375-2015
OI Danti, Serena/0000-0002-8155-8537; Bruschini, Luca/0000-0002-6900-1306
FU Regione Toscana; Tuscany Region
FX This study was funded by Regione Toscana (grant "Toscana Salute 2009").;
   The authors thank the Tuscany Region for funding this research (grant
   "Toscana Salute 2009").
CR Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899
   Berrettini S, 2011, ANN OTO RHINOL LARYN, V120, P9, DOI 10.1177/000348941112000102
   BOJRAB DI, 1994, OTOLARYNG CLIN N AM, V27, P759
   Danti S, 2010, J BIOMED MATER RES A, V92A, P1343, DOI 10.1002/jbm.a.32447
   Danti S, 2009, BIOMED MICRODEVICES, V11, P783, DOI 10.1007/s10544-009-9293-9
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Dormer KJ, 2001, OTOLARYNG CLIN N AM, V34, P289, DOI 10.1016/S0030-6665(05)70332-7
   Dornelles Cristina, 2007, Braz J Otorhinolaryngol, V73, P738, DOI 10.1016/S1808-8694(15)31169-1
   Ferrero V, 2000, Acta Otorhinolaryngol Ital, V20, P159
   GILLANDERS DA, 1980, J OTOLARYNGOL, V9, P169
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265
   Javia LR, 2006, OTOLARYNG CLIN N AM, V39, P1177, DOI 10.1016/j.otc.2006.08.010
   Lian J B, 1995, Iowa Orthop J, V15, P118
   LIM DJ, 1987, AM J OTOLARYNG, V8, P282, DOI 10.1016/S0196-0709(87)80047-9
   Nguyen D Q, 2004, Rev Laryngol Otol Rhinol (Bord), V125, P157
   Niedermeyer HP, 2007, ADV OTO-RHINO-LARYNG, V65, P45, DOI 10.1159/000098668
   Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Pyle GM, 2003, OP TECH OTOLARYNGOL, V14, P237, DOI DOI 10.1053/S1043-1810(03)00058-7
   Quaranta N, 2001, EUR ARCH OTO-RHINO-L, V258, P20, DOI 10.1007/s004050000300
   SARRAT R, 1992, ACTA ANAT, V144, P189
   SELLARIFRANCESCHINI S, 1987, AM J OTOL, V8, P551
   Slater PW, 1997, LARYNGOSCOPE, V107, P1193, DOI 10.1097/00005537-199709000-00007
   Unur E, 2002, ERCIYES MED J, V24, P57
   Whyte J, 2008, HISTOL HISTOPATHOL, V23, P1049, DOI 10.14670/HH-23.1049
   Yetiser S, 2008, AM J OTOLARYNG, V29, P31, DOI 10.1016/j.amjoto.2007.01.001
   Yokoyama T, 1999, LARYNGOSCOPE, V109, P927, DOI 10.1097/00005537-199906000-00016
NR 28
TC 3
Z9 4
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1531-7129
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD OCT
PY 2012
VL 33
IS 8
BP 1458
EP 1468
DI 10.1097/MAO.0b013e31826a527d
PG 11
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 010SH
UT WOS:000309113900033
PM 22975908
DA 2018-10-19
ER

PT J
AU Matsugaki, A
   Aramoto, G
   Nakano, T
AF Matsugaki, Aira
   Aramoto, Gento
   Nakano, Takayoshi
TI The alignment of MC3T3-E1 osteoblasts on steps of slip traces introduced
   by dislocation motion
SO BIOMATERIALS
LA English
DT Article
DE Osteoblast; Titanium; Crystallography; Cell adhesion; Cell morphology
ID CONTACT GUIDANCE; SINGLE-CRYSTALS; MICROGROOVED SURFACES; BIOMATERIAL
   SURFACES; PLASTIC-DEFORMATION; TITANIUM SUBSTRATA; CELL-SHAPE; IN-VITRO;
   FIBROBLASTS; MATRIX
AB Bone tissue shows a highly anisotropic microstructure comprising biological apatite and collagen fibrils produced by the mutual activities of bone cells, which dominates its mechanical function. Accordingly, directional control of osteoblasts is crucial for forming anisotropic bone tissue. A new approach was proposed for controlling cell directionality by using crystallographic slip traces caused by dislocation glide. Dislocations were introduced into alpha-titanium single crystals by plastic deformation of (01 (1) over bar0)[2 (1) over bar(1) over bar0] slip system, inducing a step-like structure with acute angles between the surface normal and the slip plane. Topographical properties of step patterning, including step interval and step height, could be controlled by varying the compressive plastic strain. The step geometry introduced by plastic deformation strongly influenced osteoblast elongation, and it aligned preferentially along slip traces. Ti substrates under 10% plastic strain with step height of approximately 300 nm and step interval of 10 mu m induced osteoblast alignment most successfully. Actin stress fibers elongated parallel to slip traces, with polarized vinculin accumulation between steps. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Matsugaki, Aira; Aramoto, Gento; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Suita, Osaka 5650871, Japan.
RP Nakano, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.
EM nakano@mat.eng.osaka-u.ac.jp
CR Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Brunette DM, 1986, EXP CELL RES, V40, P425
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   DUNN GA, 1986, J CELL SCI, V83, P313
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   Fisher NI, 1993, STAT ANAL CIRCULAR D
   Fratzl-Zelman N, 1998, BONE, V23, P511, DOI 10.1016/S8756-3282(98)00139-2
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Guillemette M. D., 2009, INTEGR BIOL, V1, P133
   Harrison RG, 1912, ANAT REC, V6, P181, DOI 10.1002/ar.1090060404
   KAWAHARA H, 1980, J BIOMED MATER RES, V14, P597, DOI 10.1002/jbm.820140506
   Kim SJ, 2008, J MATER SCI-MATER M, V19, P2953, DOI 10.1007/s10856-008-3413-6
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   MEYLE J, 1994, J MATER SCI-MATER M, V5, P463, DOI 10.1007/BF00058984
   NAKA S, 1982, MATER SCI ENG, V56, P19, DOI 10.1016/0025-5416(82)90178-1
   Nakano T, 1998, ACTA MATER, V46, P4311, DOI 10.1016/S1359-6454(98)00088-3
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   OAKLEY C, 1993, J CELL SCI, V106, P343
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015
   Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003
   Tane M, 2008, ACTA MATER, V56, P2856, DOI 10.1016/j.actamat.2008.02.017
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhao XL, 2011, MAT SCI ENG C-MATER, V31, P1436, DOI 10.1016/j.msec.2011.05.013
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
NR 40
TC 27
Z9 27
U1 1
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2012
VL 33
IS 30
BP 7327
EP 7335
DI 10.1016/j.biomaterials.2012.06.022
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 002HZ
UT WOS:000308524000002
PM 22818653
DA 2018-10-19
ER

PT J
AU Liu, Z
   Zhou, Q
   Zhu, JX
   Xiao, JH
   Wan, PX
   Zhou, CJ
   Huang, ZQ
   Qiang, N
   Zhang, W
   Wu, Z
   Quan, DP
   Wang, ZC
AF Liu, Zhao
   Zhou, Qiang
   Zhu, Jixiang
   Xiao, Jianhui
   Wan, Pengxia
   Zhou, Chenjing
   Huang, Zheqian
   Qiang, Na
   Zhang, Wei
   Wu, Zheng
   Quan, Daping
   Wang, Zhichong
TI Using genipin-crosslinked acellular porcine corneal stroma for cosmetic
   corneal lens implants
SO BIOMATERIALS
LA English
DT Article
DE Corneal tissue engineering; Scaffold; Decellularization; Crosslinking;
   Genipin
ID IN-VITRO; LINKING; SCAFFOLD; HYDROGELS; CHITOSAN; REPAIR
AB Acellular porcine corneal stroma (APCS) has been proven to maintain the matrix microenvironment and is therefore an ideal biomaterial for the repair and reconstruction of corneal stroma. This study aims to develop a method to prepare cosmetic corneal lens implants for leukoma using genipin-crosslinked APCS (Gc-APCS). The Gc-APCS was prepared from APCS immersed in 1.0% genipin aqueous solution (pH 5.5) for 4 h at 37 degrees C, followed by lyophilization at -10 degrees C. The color of the Gc-APCS gradually deepened to dark-blue. The degree of crosslinking was 45.7 +/- 4.6%, measured by the decrease of basic and hydroxy amino acids. The porous structure and ultrastructure of collagenous lamellae were maintained, and the porosity and BET SSA were 72.7 +/- 4.6% and 23.01 +/- 3.45 m(2)/g, respectively. The Gc-APCS rehydrated to the physiological water content within 5 min and was highly resistant to collagenase digestion. There were no significant differences in the areal modulus and curvature variation between Gc-APCS and nature porcine cornea. The dark-blue pigments were stable to pH, light and implantation in vivo. Gc-APCS extracts had no inhibitory effects on the proliferation of keratocytes. Corneal neovascularization, graft degradation and corneal rejection were not observed within 6 months. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Liu, Zhao; Zhou, Qiang; Xiao, Jianhui; Wan, Pengxia; Zhou, Chenjing; Huang, Zheqian; Zhang, Wei; Wu, Zheng; Wang, Zhichong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.
   [Zhu, Jixiang; Qiang, Na; Quan, Daping] Sun Yat Sen Univ, Sch Chem & Chem Engn, Inst Polymer Sci, DSAPM Lab,PCFM Lab, Guangzhou 510275, Guangdong, Peoples R China.
RP Wang, ZC (reprint author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.
EM cesqdp@mail.sysu.edu.cn; wzc001@hotmail.com
FU National High Technology Research and Development Program (863 program)
   of China [2012AA020507]; Guangdong Province - Ministry of Education
   Industry - University - Research Institute Collaboration Project of
   China [2011B090400353]; Sun Yat-Sen University 985 Project of China
   [90035-3283310]; Fundamental Research Funds of State Key Laboratory of
   Ophthalmology of China
FX This study was supported by Grant No. 2012AA020507 from the National
   High Technology Research and Development Program (863 program) of China,
   Grant No. 2011B090400353 from Guangdong Province - Ministry of Education
   Industry - University - Research Institute Collaboration Project of
   China, Grant No. 90035-3283310 from Sun Yat-Sen University 985 Project
   of China and the Fundamental Research Funds of State Key Laboratory of
   Ophthalmology of China.
CR Alio JL, 2010, BRIT J OPHTHALMOL, V94, P245, DOI 10.1136/bjo.2008.149435
   Avila MY, 2010, J CATARACT REFR SURG, V36, P659, DOI 10.1016/j.jcrs.2009.11.003
   Barraquer J I, 1972, Trans Ophthalmol Soc U K, V92, P499
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Chang CJ, 2009, TISSUE ENG PT A, V15, P547, DOI 10.1089/ten.tea.2007.0342
   Chang Ki Cheol, 2010, Korean J Ophthalmol, V24, P148, DOI 10.3341/kjo.2010.24.3.148
   Chang WH, 2003, J BIOMAT SCI-POLYM E, V14, P481, DOI 10.1163/156856203766652084
   Chen MC, 2009, BIOMATERIALS, V30, P5560, DOI 10.1016/j.biomaterials.2009.06.039
   EHLERS N, 1966, ACTA OPHTHALMOL, V44, P461
   FATT I, 1965, J COLL SCI IMP U TOK, V20, P962, DOI 10.1016/0095-8522(65)90068-1
   Huang MH, 2011, BIOMATERIALS, V32, P7812, DOI 10.1016/j.biomaterials.2011.07.012
   KAUFMAN HE, 1982, AM J OPHTHALMOL, V93, P342, DOI 10.1016/0002-9394(82)90537-2
   Ke QC, 2011, J TISSUE ENG REGEN M, V5, P138, DOI 10.1002/term.298
   Kim C, 2011, CORNEA, V30, P1135, DOI 10.1097/ICO.0b013e3181f2391a
   Liu BS, 2008, MACROMOL BIOSCI, V8, P932, DOI 10.1002/mabi.200800053
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Paik YS, 2001, J AGR FOOD CHEM, V49, P430, DOI 10.1021/jf000978f
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Sekundo W, 1999, BRIT J OPHTHALMOL, V83, P219, DOI 10.1136/bjo.83.2.219
   Sirerol B, 2011, CORNEA, V30, P344, DOI 10.1097/ICO.0b013e3181eae251
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Thakur G, 2011, J MATER SCI-MATER M, V22, P115, DOI 10.1007/s10856-010-4185-3
   VANDERVELDENSAMDERUBUN EM, 1994, CORNEA, V13, P349, DOI 10.1097/00003226-199407000-00011
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Wu Z, 2009, BIOMATERIALS, V30, P3513, DOI 10.1016/j.biomaterials.2009.03.003
   Xiao JH, 2011, BIOMATERIALS, V32, P6962, DOI 10.1016/j.biomaterials.2011.05.084
   Yang YM, 2011, EUR J PHARM BIOPHARM, V79, P519, DOI 10.1016/j.ejpb.2011.06.008
   Zoldan J, 2011, BIOMATERIALS, V32, P9612, DOI 10.1016/j.biomaterials.2011.09.012
NR 30
TC 16
Z9 20
U1 2
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2012
VL 33
IS 30
BP 7336
EP 7346
DI 10.1016/j.biomaterials.2012.06.080
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 002HZ
UT WOS:000308524000003
PM 22795849
DA 2018-10-19
ER

PT J
AU Kundu, B
   Kundu, SC
AF Kundu, Banani
   Kundu, Subhas C.
TI Silk sericin/polyacrylamide in situ forming hydrogels for dermal
   reconstruction
SO BIOMATERIALS
LA English
DT Article
DE Silk sericin; Hydrogel; Biomaterial; Dermal reconstruction;
   Semi-interpenetrating network
ID SWELLING BEHAVIOR; PROTEIN SERICIN; SCAFFOLDS; POLYMERIZATION;
   FABRICATION; HYALURONAN; HYDRATION; DELIVERY; CHITOSAN
AB In situ forming tissue sealants are advantageous due to ease in application, complete coverage of defect site and assured comfort levels to patients. The interconnected three-dimensional hydrophilic networks perfectly manage typical dermal wounds by suitably scaffolding skin fibroblast, diffusing the nutrients, therapeutics and exudates while still maintaining an adequately moist environment. We evaluate the cell homing ability of semi-interpenetrating non-mulberry tropical tasar silk sericin/polyacrylamide hydrophilic network with a keen understanding of its network characteristics and correlation of protein concentration with the performance as cell scaffold. Interconnectivity of porous networks observed through scanning electron micrograph revealed pore sizes ranging from 23 to 52 mu m. The enhanced beta-sheet content with the increasing sericin concentration in far red spectroscopy study supported their corresponding improved compressive strength. These semi-interpenetrating networks were found to possess a maximum fluid uptake of 112% of its weight, hence preventing the accumulation of exudates at the wound area. The present systems appear to possess characteristics like rapid gelation (similar to 5min) at 37 degrees C, 98% porosity enabling the migration of fibroblasts during healing (observed through confocal and scanning electron micrographs), cell adhesion together with the absence of any cyto-toxic effect suggesting its potential as in situ tissue sealants. The compressive strength up to 61 kPa ensured ease in handling even when wet. The results prove the suitability to use non-mulberry tasar cocoon silk sericin/polyacrylamide semi-interpenetrating network as a reconstructive dermal sealant. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Kundu, Banani; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Banani/O-9320-2016
OI Kundu, Banani/0000-0003-1251-700X; Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology and its Bioinformatics facility; Department
   of Science and Technology; Council of Scientific and Industrial
   Research, Government of India, New Delhi
FX We very much appreciate the assistance renders by Dr. Joydip Kundu
   during the course of initial experimentation of hydrogel fabrication and
   also for helpful discussion. This work is financially supported by
   Department of Biotechnology and its Bioinformatics facility, Department
   of Science and Technology, and BK is thankful for her individual
   fellowship to Council of Scientific and Industrial Research, Government
   of India, New Delhi.
CR Almutawah A, 2007, BIOMACROMOLECULES, V8, P1601, DOI 10.1021/bm061206g
   Aramwit P, 2010, INT J BIOL MACROMOL, V47, P668, DOI 10.1016/j.ijbiomac.2010.08.015
   Barnett S. E., 1991, HIGH PERFORMANCE BIO, P583
   Bastide J., 1996, PHYS PROPERTIES POLY, P143
   Cheng CJ, 2008, COLLOID POLYM SCI, V286, P571, DOI 10.1007/s00396-007-1817-3
   Chitkara D, 2006, MACROMOL BIOSCI, V6, P977, DOI 10.1002/mabi.200600129
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Gao XY, 2010, CARBOHYD POLYM, V79, P507, DOI 10.1016/j.carbpol.2009.08.033
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hu XB, 2011, POLYM BULL, V66, P447, DOI 10.1007/s00289-010-0285-y
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kasgoz H, 2008, POLYM ADVAN TECHNOL, V19, P213, DOI 10.1002/pat.999
   Kim S, 2010, INT J POLYM ANAL CH, V15, P307, DOI 10.1080/1023666X.2010.493271
   Kundu B., 2010, PROG POLYM SCI, V35, P116
   Li X, 2012, SOFT MATTER, V8, P3781, DOI 10.1039/c2sm06994f
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Mequanint K, 2006, BIOMACROMOLECULES, V7, P883, DOI 10.1021/bm0507047
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   Monti P, 2007, J MOL STRUCT, V834, P202, DOI 10.1016/j.molstruc.2006.11.009
   Murali MY, 2007, REACT FUNCT POLYM, V67, P144
   Nagura Masanobu, 2001, Journal of Insect Biotechnology and Sericology, V70, P149
   Nayak BR, 2001, J APPL POLYM SCI, V81, P1776, DOI 10.1002/app.1610.abs
   Nilasaroya A, 2008, BIOMATERIALS, V29, P4658, DOI 10.1016/j.biomaterials.2008.08.011
   Park H, 2006, J BIOMED MATER RES A, V76A, P144, DOI 10.1002/jbm.a.30533
   Peng HT, 2009, J MATER SCI-MATER M, V20, P1753, DOI 10.1007/s10856-009-3721-5
   Rajvaidya S, 2005, B MATER SCI, V28, P529, DOI 10.1007/BF02706338
   Schneider M, 2001, POLYM BULL, V47, P269, DOI 10.1007/s289-001-8181-2
   Schulz JT, 2000, ANNU REV MED, V51, P231, DOI 10.1146/annurev.med.51.1.231
   Shamsudeen RK, 2006, INDIAN J ENG MATER S, V13, P62
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331
   Tamada Y, 2004, J BIOMAT SCI-POLYM E, V15, P971, DOI 10.1163/1568562041526469
   Tan QG, 2011, INT J MOL SCI, V12, P890, DOI 10.3390/ijms12020890
   Tang QW, 2008, CARBOHYD POLYM, V74, P215, DOI 10.1016/j.carbpol.2008.02.008
   Tarasevich YI, 2002, COLLOID J+, V64, P482, DOI 10.1023/A:1016828322434
   Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667
   Thakur G, 2011, J MATER SCI-MATER M, V22, P115, DOI 10.1007/s10856-010-4185-3
   Vazquez B, 1997, MACROMOLECULES, V30, P8440, DOI 10.1021/ma970863l
   Wang LM, 2010, TISSUE ENG PT A, V16, P1937, DOI [10.1089/ten.tea.2009.0706, 10.1089/ten.TEA.2009.0706]
   Weng L, 2008, BIOMATERIALS, V29, P3905, DOI 10.1016/j.biomaterials.2008.06.025
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Zhang YW, 2007, POLYMER, V48, P5639, DOI 10.1016/j.polymer.2007.07.046
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 46
TC 77
Z9 80
U1 4
U2 92
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2012
VL 33
IS 30
BP 7456
EP 7467
DI 10.1016/j.biomaterials.2012.06.091
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 002HZ
UT WOS:000308524000015
PM 22819495
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Li, LQ
   Zhu, J
   Kuang, H
   Dong, SW
   Wang, HW
   Zhang, X
   Zhou, Y
AF Zhang, Yuan
   Li, Liqi
   Zhu, Jie
   Kuang, Hong
   Dong, Shiwu
   Wang, Hongwei
   Zhang, Xia
   Zhou, Yue
TI In vitro observations of self-assembled ECM-mimetic bioceramic
   nanoreservoir delivering rFN/CDH to modulate osteogenesis
SO BIOMATERIALS
LA English
DT Article
DE Extracellular matrix; Self-assembly; Fibronectin; Cadherin; Osteogenesis
ID MESENCHYMAL STEM-CELLS; BONE-FORMATION; FIBRONECTIN; DIFFERENTIATION;
   ADHESION; SURFACES; IMPLANTS; PROTEIN; OSSEOINTEGRATION; BIOMATERIALS
AB The cell-extracellular matrix (ECM) interaction has been employed to direct tissue-specific cellular responses and tailor biomaterial development. Given the important roles of integrin-fibronectin interactions and homophilic cadherin responses, we postulated that the recreation of the biological function of ECM in a recombinant fibronectin/cadherin chimera (rFN/CDH) at the nanoscale may properly address the integration impediment at the interface. This study aimed to investigate the feasibility and validity of an rFN/CDH bio-inspired ceramic surface generated via layer-by-layer (LbL) self-assembly to induce osteogenesis. The successful fabrication of a multilayered structure of BCP/LbL/[Chi-rFN/CDH] and excellent physico-chemical properties were confirmed by X-ray photoelectron spectroscopy, Fourier-transform infrared spectroscopy, contact angle, and scanning electron microscopy. Sustained release was observed during degradation, and the multilayered construct also displayed a significantly enhanced ability to guide bMSC adhesion, proliferation, and osteogenic differentiation. A mechanistic exploration revealed that the interaction of rFN/CDH with integrin alpha 5 beta 1/alpha nu beta 3 may be a regulatory pivot. These results demonstrate the hybrid potential of bioceramics coated with biofunctional rFN/CDH multilayers in osteoconductive and osteoinducive potency. This study therefore presents a basis for fabricating potential bio-functionalised ceramic-based substitutions for preclinical and clinical application to bone defects and reconstruction. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Zhang, Yuan; Li, Liqi; Wang, Hongwei; Zhang, Xia; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing 400037, Peoples R China.
   [Zhu, Jie] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China.
   [Kuang, Hong] 452nd Hosp Chinese PLA, Cent Lab, Sichuan 600021, Peoples R China.
   [Dong, Shiwu] Third Mil Med Univ, Dept Anat, Chongqing 400038, Peoples R China.
RP Zhang, X (reprint author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing 400037, Peoples R China.
EM dpapofman@gmail.com
RI zhu, jie/S-8849-2016
OI zhu, jie/0000-0003-1008-2014
FU National Natural Science Foundation of China [30901512]
FX The authors thank professor Liangming Liu of the Research Institute of
   Surgery and Dr. Zhong Luo of Chongqing University for help with this
   study. This work is supported by the National Natural Science Foundation
   of China (no. 30901512).
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Altrock E, 2012, BIOMATERIALS, V33, P3107, DOI 10.1016/j.biomaterials.2012.01.002
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Born AK, 2012, J CELL BIOCHEM, V113, P313, DOI 10.1002/jcb.23357
   Coyer SR, 2011, ADV MATER, V23, P1550, DOI 10.1002/adma.201003744
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Eisenberg JL, 2009, LANGMUIR, V25, P13942, DOI 10.1021/la901528c
   Fong E, 2010, ADV MATER, V22, P5271, DOI 10.1002/adma.201002448
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Guan M, 2012, NAT MED, V18, P456, DOI 10.1038/nm.2665
   Hu Y, 2012, BIOMATERIALS, V33, P3515, DOI 10.1016/j.biomaterials.2012.01.040
   Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim DH, 2010, ADV MATER, V22, P4551, DOI 10.1002/adma.201000468
   Kodama T, 2008, INT J ORAL MAX IMPL, V23, P1013
   Koper MTM, 2011, NANOSCALE, V3, P2054, DOI 10.1039/c0nr00857e
   Kopesky PW, 2011, TISSUE ENG PT A, V17, P83, DOI [10.1089/ten.tea.2010.0198, 10.1089/ten.TEA.2010.0198]
   Labat-Robert J, 2012, PATHOL BIOL, V60, P15, DOI 10.1016/j.patbio.2011.10.003
   Lee JS, 2011, BIOMATERIALS, V32, P760, DOI 10.1016/j.biomaterials.2010.09.042
   Li LQ, 2012, PROTEIN PEPTIDE LETT, V19, P375, DOI 10.2174/092986612799789369
   Li LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031057
   Li YP, 2012, ANGEW CHEM INT EDIT, V51, P2864, DOI 10.1002/anie.201107144
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957
   Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Petrie TA, 2009, J CELL MOL MED, V13, P2602, DOI 10.1111/j.1582-4934.2008.00476.x
   Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X
   Sanchez-Cortes J, 2011, ACS CHEM BIOL, V6, P1078, DOI 10.1021/cb200186j
   Sanchez-Cortes J, 2010, J AM CHEM SOC, V132, P9733, DOI 10.1021/ja1016188
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Sporer SM, 2005, ORTHOP CLIN N AM, V36, P105, DOI 10.1016/j.ocl.2004.06.007
   Vo TN, 2012, ADV DRUG DELIV REV
   Willner I, 2010, NANO LETT, V10, P3805, DOI 10.1021/nl102083j
   Yagi T, 2000, GENE DEV, V14, P1169
   Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025
   Zhang Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1999, DOI 10.1271/bbb.90187
NR 40
TC 13
Z9 15
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2012
VL 33
IS 30
BP 7468
EP 7477
DI 10.1016/j.biomaterials.2012.06.095
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 002HZ
UT WOS:000308524000016
PM 22805316
DA 2018-10-19
ER

PT J
AU Ruediger, T
   Berg, A
   Guellmar, A
   Rode, C
   Schnabelrauch, M
   Urbanek, A
   Wagner, K
   Wyrwa, R
   Kinne, RW
   Sigusch, BW
AF Ruediger, Tina
   Berg, Albrecht
   Guellmar, Andre
   Rode, Claudia
   Schnabelrauch, Matthias
   Urbanek, Annett
   Wagner, Kerstin
   Wyrwa, Ralf
   Kinne, Raimund W.
   Sigusch, Bernd W.
TI Cytocompatibility of polymer-based periodontal bone substitutes in
   gingival fibroblast and MC3T3 osteoblast cell cultures
SO DENTAL MATERIALS
LA English
DT Article
DE Dental material; Bone substitute; Periodontitis; Polymer;
   Biocompatibility; Human gingival fibroblasts (HGFs); Osteoblast
ID POLYLACTIDE-GRAFTED DEXTRAN; CONTROLLED DRUG-DELIVERY; COMPARATIVE
   IN-VITRO; TISSUE; SCAFFOLDS; SURFACE; ADHESION; GROWTH;
   BIOCOMPATIBILITY; PROLIFERATION
AB Objectives. Inflammatory periodontal diseases are accompanied by destruction of periodontal tissue and alveolar bone. Infrabony lesions can be regenerated with adequate bone substitutes, which require high biocompatibility of the material.
   Methods. To rate the biocompatibility of nine polymeric periodontal bone substitutes (Bio 1-Bio 9), cell viability and cytotoxicity assays were performed. For viability, human gingival fibroblasts (HGFs) and MC3T3 osteoblasts were cultured on the bone substitutes. For cytotoxicity, biomaterial extracts were prepared by incubation with culture medium for maximally 28 days, and cells were exposed to the extracts for 1 day. Polymers Bio 1 to Bio 5 were prepared by solvent casting, Bio 6 to Bio 9 by photopolymerization of the monomers at wavelengths of 400-500 nm in the presence of a suitable photoinitiation system.
   Results. Bio 1, Bio 3, Bio 4, Bio 5, and Bio 7 showed moderate to excellent cytocompatibility for both HGFs and osteoblasts in viability tests. Together with the results of the cytotoxicity assays, four of the nine tested polymers were considered cytocompatible: Bio 1 (poly(vinyl butyral-co-vinyl alcohol-co-vinyl acetate; PVB)), Bio 4 and Bio 5 (functionalized oligolactones), and, to a limited degree, Bio 7 (urethane methacrylate). Except for Bio 7, the cytocompatible polymers showed intermediate water contact angles (74-85.) and therefore moderate to low hydrophilicity.
   Significance. The non-cross-linked polymers Bio 1, Bio 4, or Bio 5, and the photopolymerized polymeric network Bio 7 display good/excellent cytocompatibility and are therefore potential candidates for tissue engineering in alveolar bone substitution. (C) 2012 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Ruediger, Tina; Guellmar, Andre; Kinne, Raimund W.] Waldkrankenhaus Rudolph Elle, Univ Hosp Jena, Dept Orthoped, Expt Rheumatol Unit, D-07607 Eisenberg, Germany.
   [Ruediger, Tina; Guellmar, Andre; Urbanek, Annett; Sigusch, Bernd W.] Univ Hosp Jena, Dept Conservat Dent, Jena, Germany.
   [Berg, Albrecht; Rode, Claudia; Schnabelrauch, Matthias; Wagner, Kerstin; Wyrwa, Ralf] INNOVENT eV, Biomat Dept, Jena, Germany.
RP Kinne, RW (reprint author), Waldkrankenhaus Rudolph Elle, Univ Hosp Jena, Dept Orthoped, Expt Rheumatol Unit, Klosterlausnitzer Str 81, D-07607 Eisenberg, Germany.
EM raimund.w.kinne@med.uni-jena.de
FU Thuringian Ministry of Economics, Technology and Labour [2007 VF 0012]
FX The authors gratefully acknowledge support of this work by the
   Thuringian Ministry of Economics, Technology and Labour (grant no. 2007
   VF 0012).
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Arpornmaeklong P, 2007, INT J ORAL MAX SURG, V36, P328, DOI 10.1016/j.ijom.2006.09.023
   Baker PJ, 2000, MICROBES INFECT, V2, P1181, DOI 10.1016/S1286-4579(00)01272-7
   Bartold PM, 2006, PERIODONTOL 2000, V41, P123, DOI 10.1111/j.1600-0757.2006.00156.x
   Bennett S, 1996, BONE, V19, pS101, DOI 10.1016/S8756-3282(96)00130-5
   Berg A, 2011, ADV ENG MATER, V13, pB274, DOI 10.1002/adem.201080092
   Berridge M.V., 1996, BIOCHEMICA, V4, P14
   Betz RR, 2002, ORTHOPEDICS, V25, pS561
   Bhat RR, 2005, ADV MATER, V17, P2802, DOI 10.1002/adma.200500858
   Brown RF, 2008, ACTA BIOMATER, V4, P387, DOI 10.1016/j.actbio.2007.07.006
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cai KY, 2009, COLLOID SURFACE B, V72, P230, DOI 10.1016/j.colsurfb.2009.04.008
   Chang MC, 2009, DENT MATER, V25, P261, DOI 10.1016/j.dental.2008.07.005
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Drosse I, 2008, INJURY, V39, pS9, DOI 10.1016/S0020-1383(08)70011-1
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Ghoshal S, 2010, J POLYM ENVIRON, V18, P216, DOI 10.1007/s10924-010-0182-3
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Gross U, 1987, BIOMATERIALS CLIN AP, P547
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Hanes Philip J, 2007, Oral Maxillofac Surg Clin North Am, V19, P499, DOI 10.1016/j.coms.2007.06.001
   Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057
   Holland TA, 2006, ADV BIOCHEM ENG BIOT, V102, P161, DOI 10.1007/b137205
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Itthichaisri C, 2007, J BIOMED MATER RES A, V82A, P777, DOI 10.1002/jbm.a.31191
   Jandt KD, 2009, DENT MATER, V25, P1001, DOI 10.1016/j.dental.2009.02.009
   Joy A, 2011, LANGMUIR, V27, P1891, DOI 10.1021/la103722m
   Kao Solon T, 2007, Oral Maxillofac Surg Clin North Am, V19, P513, DOI 10.1016/j.coms.2007.06.002
   Ki CS, 2008, BIOTECHNOL LETT, V30, P405, DOI 10.1007/s10529-007-9581-5
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kluger PJ, 2010, J MATER SCI-MATER M, V21, P2665, DOI 10.1007/s10856-010-4128-z
   Kroth J, 2009, THESIS J GUTENBERG U
   Liu DM, 1996, BIOMATERIALS, V17, P1955, DOI 10.1016/0142-9612(95)00301-0
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lyu SP, 2009, INT J MOL SCI, V10, P4033, DOI 10.3390/ijms10094033
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Moldovan L, 2004, HISTOCHEM CELL BIOL, V122, P395, DOI 10.1007/s00418-004-0676-y
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   NAGAHARA K, 1992, International Journal of Oral and Maxillofacial Implants, V7, P72
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Nouvel C, 2004, J POLYM SCI POL CHEM, V42, P2577, DOI 10.1002/pola.20100
   Ouchi T, 2003, J POLYM SCI POL CHEM, V41, P2462, DOI 10.1002/pola.10783
   Parikh S N, 2002, J Postgrad Med, V48, P142
   Patel NP, 2005, J MEMBRANE SCI, V251, P51, DOI 10.1016/j.memsci.2004.11.003
   Preeti DRR, 2003, S PACIFIC J NATURAL, V21, P47
   Reynolds Mark A, 2010, Dent Clin North Am, V54, P55, DOI 10.1016/j.cden.2009.09.003
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   ROSS DD, 1989, CANCER RES, V49, P3776
   Schepers E J, 1993, Implant Dent, V2, P151, DOI 10.1097/00008505-199309000-00002
   Schmitt SC, 2008, J MATER SCI-MATER M, V19, P1441, DOI 10.1007/s10856-007-3238-8
   Schwach G, 2002, BIOMATERIALS, V23, P993, DOI 10.1016/S0142-9612(01)00209-5
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Sigusch B, 2001, J PERIODONTOL, V72, P275, DOI 10.1902/jop.2001.72.3.275
   Sigusch BW, 2007, DENT MATER, V23, P1342, DOI 10.1016/j.dental.2006.11.013
   Sigusch BW, 2009, DENT MATER, V25, P1446, DOI 10.1016/j.dental.2009.06.016
   Sigusch BW, 2005, J PERIODONTOL, V76, P1100, DOI 10.1902/jop.2005.76.7.1100
   Smith IO, 2006, INT J NANOMED, V1, P189, DOI 10.2147/nano.2006.1.2.189
   SOUCACOS PN, 2008, INJURY S2, V39, pS1
   Strunz V, 1988, Z ZAHNARZTLICHE IMPL, V4, P270
   Sugawara A, 2008, DENT MATER J, V27, P787, DOI 10.4012/dmj.27.787
   Suphasiriroj W, 2009, J MATER SCI-MATER M, V20, P309, DOI 10.1007/s10856-008-3575-2
   Vasudeva Gaurav, 2009, J Calif Dent Assoc, V37, P389
   Vogt S., 2002, European Cells & Materials, V4, P30
   Vogt S, 2005, BIO-MED MATER ENG, V15, P73
   Weiss T, 2011, ADV ENG MATER, V13, pB264, DOI 10.1002/adem.201080090
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang XF, 2009, DENT MATER, V25, P473, DOI 10.1016/j.dental.2008.09.007
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
NR 73
TC 5
Z9 5
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD OCT
PY 2012
VL 28
IS 10
BP E239
EP E249
DI 10.1016/j.dental.2012.05.008
PG 11
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 001OF
UT WOS:000308469300006
PM 22727357
DA 2018-10-19
ER

PT J
AU Oliveira, R
   El Hage, M
   Carrel, JP
   Lombardi, T
   Bernard, JP
AF Oliveira, Rita
   El Hage, Marc
   Carrel, Jean-Pierre
   Lombardi, Tommaso
   Bernard, Jean-Pierre
TI Rehabilitation of the Edentulous Posterior Maxilla After Sinus Floor
   Elevation Using Deproteinized Bovine Bone: A 9-Year Clinical Study
SO IMPLANT DENTISTRY
LA English
DT Article
DE dental implant; sinus elevation; biomaterial
ID BIO-OSS; DENTAL IMPLANTS; AUTOGENOUS BONE; FOLLOW-UP; AUGMENTATION;
   HYDROXYAPATITE; SURFACE; PLACEMENT; CULTURE; 5-YEAR
AB Objectives: To evaluate the long-term survival rate of rough-surfaced implants placed in maxillary sinuses augmented with deproteinized bovine bone (Bio-Oss; Geistlich Pharma AG, Wolhusen, Switzerland).
   Materials and Methods: Thirteen maxillary sinuses were augmented in 10 patients with Bio-Oss. After an average healing period of 13.8 months, 24 implants were placed. In 4 cases, biopsies were performed and submitted to histological analysis. Clinical and radiographic evaluation was performed 9 years after implant placement and minimum 8 years after functional loading.
   Results: At the 9-year control, all the 24 implants were still functional. Thus, the implant survival rate was 100%.
   Conclusions: Bio-Oss is an acceptable substitute to the autogenous bone, and it can be used as a unique material for sinus floor elevation. Rough-surfaced implants placed in 100% Bio-Oss grafts showed a high survival rate (100%) on the long term. Larger clinical trials are necessary to confirm our results. (Implant Dent 2012;21:422-426)
C1 [Lombardi, Tommaso] Univ Geneva, Dept Oral Surg Oral Med Oral & Maxillofacial Radi, Sch Dent Med, Lab Oral & Maxillofacial Pathol, Geneva, Switzerland.
RP Oliveira, R (reprint author), Chemin Ruisselet 15, CH-1009 Pully, Switzerland.
EM oliveiragrbavac@gmail.com
CR Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x
   Asai S, 2002, CLIN ORAL IMPLAN RES, V13, P405, DOI 10.1034/j.1600-0501.2002.130409.x
   Astrand P, 2008, CLIN IMPLANT DENT R, V10, P207, DOI 10.1111/j.1708-8208.2007.00081.x
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x
   Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P3
   Fugazzotto PA, 2007, IMPLANT DENT, V16, P369, DOI 10.1097/ID.0b013e318157086c
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P107, DOI 10.1034/j.1600-0501.1998.090206.x
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P117, DOI 10.1034/j.1600-0501.1998.090207.x
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hising P, 2001, INT J ORAL MAX IMPL, V16, P90
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   Javed F, 2011, IMPLANT DENT, V20, P40, DOI 10.1097/ID.0b013e31820867da
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Kaptein MLA, 1998, CLIN ORAL IMPLAN RES, V9, P321, DOI 10.1034/j.1600-0501.1998.090505.x
   Merkx MAW, 2003, INT J ORAL MAX SURG, V32, P1, DOI 10.1054/ijom.2002.0346
   Misch C E, 1993, Implant Dent, V2, P158, DOI 10.1097/00008505-199309000-00003
   PEETZ M, 1997, OSSEOUS RECONSTRUCTI, P87
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Solar P, 1999, CLIN ORAL IMPLAN RES, V10, P34, DOI 10.1034/j.1600-0501.1999.100105.x
   Steigenga Jennifer T, 2003, Implant Dent, V12, P306, DOI 10.1097/01.ID.0000091140.76130.A1
   Tarnow DP, 2000, INT J PERIODONT REST, V20, P117
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Viornery C, 2002, J BIOMED MATER RES, V62, P149, DOI 10.1002/jbm.10205
   Wallace SS, 2005, INT J PERIODONT REST, V25, P551
   Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x
NR 34
TC 17
Z9 17
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD OCT
PY 2012
VL 21
IS 5
BP 422
EP 426
DI 10.1097/ID.0b013e3182691873
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 007CG
UT WOS:000308865800014
PM 22968571
DA 2018-10-19
ER

PT J
AU Brackett, MG
   Lewis, JB
   Kious, AR
   Messer, RLW
   Lockwood, PE
   Brackett, WW
   Wataha, JC
AF Brackett, Martha Goel
   Lewis, Jill B.
   Kious, Andrew R.
   Messer, Regina L. W.
   Lockwood, Petra E.
   Brackett, William W.
   Wataha, John C.
TI Cytotoxicity of endodontic sealers after one year of aging in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE osteoblast; monocyte; MTT; cell-culture; cytokines; biomaterial;
   inflammation; root canal
ID ROOT-CANAL SEALERS; END FILLING MATERIALS; DENTAL MATERIALS;
   DEHYDROGENASE-ACTIVITY; CLINICAL-PERFORMANCE; METHACRYLATE RESIN;
   INVITRO ASSESSMENT; WATER SORPTION; CELL-LINES; BIOCOMPATIBILITY
AB The in vitro cytotoxic response to endodontic sealers was assessed for one year. AH-Plus (AHP), Epiphany (EPH), EndoRez (ER), Guttaflow (GF), InnoEndo (IN), and Pulp Canal Sealer (PCS) were exposed to mouse osteoblasts and human monocytes after curing, 52 weeks of aging, and after resurfacing post-aging; cellular response was estimated by succinate dehydrogenase (SDH) activity. The effect of materials on TNFa secretion from activated (LPS) and inactivated monocytes also was measured. Cell responses were compared with ANOVA and Tukey post hoc analysis (a = 0.05). Initially, all materials except GF suppressed osteoblastic SDH activity compared with Teflon (Tf) controls. SDH activity in cells exposed to some aged sealers improved significantly; but IN and ER remained cytotoxic. When aged materials were resurfaced then tested, AHP, ER, GF, and IN did not change. EPH and PCS were more toxic. Monocytes responded similarly to the osteoblasts. No endodontic sealer activated monocytic TNFa secretion (p > 0.05 vs. -LPS Tf-controls). LPS-activated monocytes exposed to unresurfaced AHP and IN significantly suppressed TNFa secretion. When activated monocytes were exposed to the resurfaced sealers, differential suppression of TNFa secretion was observed for three of the four sealers tested (EPH, IN, and PCS). The results suggest that long-term aging may be a useful adjunct to in vitro assessment of these materials. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Brackett, Martha Goel; Kious, Andrew R.; Brackett, William W.] Georgia Hlth Sci Univ Coll Dent Med, Dept Oral Rehabil, Augusta, GA USA.
   [Lewis, Jill B.; Messer, Regina L. W.; Lockwood, Petra E.] Georgia Hlth Sci Univ Coll Dent Med, Dept Oral Biol, Augusta, GA USA.
   [Wataha, John C.] Univ Washington Sch Dent, Dept Restorat Dent, Seattle, WA USA.
RP Brackett, MG (reprint author), Georgia Hlth Sci Univ Coll Dent Med, Dept Oral Rehabil, Augusta, GA USA.
EM mbrackett@georgiahealth.edu
OI Brackett, William/0000-0003-3256-9827; Brackett,
   Martha/0000-0003-3740-7886
FU Georgia Health Science University, College of Dental Medicine
FX Contract grant sponsor: Georgia Health Science University, College of
   Dental Medicine
CR Al-Sa'eed OR, 2008, J ENDODONT, V34, P1410, DOI 10.1016/j.joen.2008.08.001
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Bouillaguet S, 2004, EUR J ORAL SCI, V112, P182, DOI 10.1111/j.1600-0722.2004.00115.x
   Bouillaguet S, 2006, J ENDODONT, V32, P989, DOI 10.1016/j.joen.2006.05.006
   Brackett MG, 2008, INT ENDOD J, V41, P1072, DOI 10.1111/j.1365-2591.2008.01471.x
   Brackett MG, 2008, DENT MATER, V24, P450, DOI 10.1016/j.dental.2007.06.013
   Brackett MG, 2010, J BIOMED MATER RES B, V95B, P380, DOI 10.1002/jbm.b.31727
   Brackett MG, 2009, J BIOMED MATER RES B, V91B, P839, DOI 10.1002/jbm.b.31465
   BROWNE RM, 1988, INT ENDOD J, V21, P50
   CAICEDO R, 1988, J ENDODONT, V14, P527, DOI 10.1016/S0099-2399(88)80084-0
   Camps J, 2003, J ENDODONT, V29, P583, DOI 10.1097/00004770-200309000-00010
   Da Silva D, 2002, INT ENDOD J, V35, P1005, DOI 10.1046/j.1365-2591.2002.00610.x
   Donnelly A, 2007, J ENDODONT, V33, P990, DOI 10.1016/j.joen.2006.03.021
   Eldeniz AU, 2007, INT ENDOD J, V40, P329, DOI 10.1111/j.1365-2591.2007.01211.x
   Finer Y, 2004, J BIOMED MATER RES A, V69A, P233, DOI 10.1002/jbm.a.30000
   Geurtsen W, 1997, Clin Oral Investig, V1, P5, DOI 10.1007/s007840050002
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Huang TH, 2002, BIOMATERIALS, V23, P77, DOI 10.1016/S0142-9612(01)00081-3
   Kim YK, 2010, J ENDODONT, V36, P383, DOI 10.1016/j.joen.2009.10.023
   Leung VWH, 1997, J DENT, V25, P475, DOI 10.1016/S0300-5712(96)00068-1
   Lin CP, 2004, J BIOMED MATER RES B, V71B, P429, DOI 10.1002/jbm.b.30107
   Lodiene G, 2008, INT ENDOD J, V41, P72, DOI 10.1111/j.1365-2591.2007.01321.x
   Miletic I, 2005, J ENDODONT, V31, P307, DOI 10.1097/01.don.0000140570.95688.ee
   Mortier E, 2004, OPER DENT, V29, P669
   Nielsen BA, 2006, J ENDODONT, V32, P130, DOI 10.1016/j.joen.2005.10.024
   ORSTAVIK D, 1987, ENDOD DENT TRAUMATOL, V3, P178
   PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x
   Pinna L, 2008, J ENDODONT, V34, P1085, DOI 10.1016/j.joen.2008.06.020
   Pommel L, 2001, J ENDODONT, V27, P449, DOI 10.1097/00004770-200107000-00003
   Santerre JP, 2001, CRIT REV ORAL BIOL M, V12, P136, DOI 10.1177/10454411010120020401
   Schafer E, 2003, INT ENDOD J, V36, P660, DOI 10.1046/j.1365-2591.2003.00705.x
   Schwarze T, 2002, J ENDODONT, V28, P749, DOI 10.1097/00004770-200211000-00001
   SJOGREN U, 1990, J ENDODONT, V16, P498
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   Versiani MA, 2006, INT ENDOD J, V39, P464, DOI 10.1111/j.1365-2591.2006.01105.x
   Waltimo TMT, 2001, ORAL SURG ORAL MED O, V92, P89, DOI 10.1067/moe.2001.116154
   WATAHA JC, 1992, DENT MATER, V8, P65, DOI 10.1016/0109-5641(92)90056-I
   WENNBERG A, 1988, INT ENDOD J, V21, P67
NR 38
TC 5
Z9 5
U1 1
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2012
VL 100B
IS 7
BP 1729
EP 1735
DI 10.1002/jbm.b.32739
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 000QU
UT WOS:000308403200002
PM 22807227
DA 2018-10-19
ER

PT J
AU Brochu, ABW
   Chyan, WJ
   Reichert, WM
AF Brochu, Alice B. W.
   Chyan, William J.
   Reichert, William M.
TI Microencapsulation of 2-octylcyanoacrylate tissue adhesive for
   self-healing acrylic bone cement
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE self-healing; microencapsulation; bone cement; cyanoacrylate;
   biomaterial
ID SOLUBLE PESTICIDE MONOCROTOPHOS; POLYURETHANE MICROCAPSULES; INTERFACIAL
   POLYCONDENSATION; MECHANICAL-PROPERTIES; BIOLOGICAL-MATERIALS;
   GAS-PERMEABILITY; BIOMATERIALS; MINIEMULSION; NANOCAPSULES; COMPOSITES
AB Here, we report the first phase of developing self-healing acrylic bone cement: the preparation and characterization of polyurethane (PUR) microcapsules containing a medical cyanoacrylate tissue adhesive. Capsules were prepared by interfacial polymerization of a toluene-2,4-diisocyanate-based polyurethane prepolymer with 1,4-butanediol to encapsulate 2-octylcyanoacrylate (OCA). Various capsule characteristics, including: resultant morphology, average size and size distribution, shell thickness, content and reactivity of encapsulated agent, and shelf life are investigated and their reliance on solvent type and amount, surfactant type and amount, temperature, pH, agitation rate, reaction time, and mode of addition of the oil phase to the aqueous phase are presented. Capsules had average diameters ranging from 74 to 222 mu m and average shell thicknesses ranging from 1.5 to 6 mu m. The capsule content was determined via thermogravimetric analysis and subsequent analysis of the capsules following up to 8 weeks storage revealed minimal loss of core contents. Mechanical testing of OCA-containing capsules showed individual capsules withstood compressive forces up to a few tenths of Newtons, and the contents released from crushed capsules generated tensile adhesive forces of a few Newtons. Capsules were successfully mixed into the poly(methyl methacrylate) bone cement, surviving the mixing process, exposure to methyl methacrylate monomer, and the resulting exothermic matrix curing. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Brochu, Alice B. W.; Chyan, William J.; Reichert, William M.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Brochu, Alice B. W.; Reichert, William M.] Duke Univ, Ctr Biomol & Tissue Engn, Durham, NC 27708 USA.
RP Reichert, WM (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
EM reichert@duke.edu
FU NIH [T32-GM8555, R21 EB 013874-01]
FX Contract grant sponsor: NIH; contract grant numbers: T32-GM8555 (ABWB),
   R21 EB 013874-01 (WMR)
CR Andersson HM, 2007, SPRINGER SER MATER S, V100, P19, DOI 10.1007/978-1-4020-6250-6_2
   Corcuera MA, 2011, J APPL POLYM SCI, V122, P3677, DOI 10.1002/app.34781
   Bergman SD, 2007, SPRINGER SER MATER S, V100, P45, DOI 10.1007/978-1-4020-6250-6_3
   Bhatt H, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/042001
   Blaiszik BJ, 2008, COMPOS SCI TECHNOL, V68, P978, DOI 10.1016/j.compscitech.2007.07.021
   Blaiszik BJ, 2009, POLYMER, V50, P990, DOI 10.1016/j.polymer.2008.12.040
   Brochu ABW, 2011, J BIOMED MATER RES A, V96A, P492, DOI 10.1002/jbm.a.32987
   Brown EN, 2003, J MICROENCAPSUL, V20, P719, DOI 10.1080/0265204031000154160
   Caruso MM, 2010, ACS APPL MATER INTER, V2, P1195, DOI 10.1021/am100084k
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   Cho JS, 2002, COLLOID POLYM SCI, V280, P260, DOI 10.1007/s00396-001-0603-x
   Coulthard P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004287.pub3
   Dunne NJ, 2002, J MATER SCI-MATER M, V13, P17, DOI 10.1023/A:1013670132001
   Edidin AA, 2000, J ARTHROPLASTY, V15, P321, DOI 10.1016/S0883-5403(00)90647-8
   Frere W, 1998, EUR POLYM J, V34, P193
   Gaudin F, 2008, COLLOID SURFACE A, V331, P133, DOI 10.1016/j.colsurfa.2008.07.028
   Giddings VL, 2001, BIOMATERIALS, V22, P1875, DOI 10.1016/S0142-9612(00)00372-0
   Hong K, 2000, POLYM TEST, V19, P975, DOI 10.1016/S0142-9418(99)00070-7
   Hong K, 1999, REACT FUNCT POLYM, V42, P193, DOI 10.1016/S1381-5148(98)00068-6
   HSIEH KH, 1990, J MEMBRANE SCI, V49, P341, DOI 10.1016/S0376-7388(00)80647-X
   HSIEH KH, 1991, J MEMBRANE SCI, V56, P279, DOI 10.1016/S0376-7388(00)83038-0
   Johnsen H, 2007, J MICROENCAPSUL, V24, P731, DOI 10.1080/02652040701585179
   Keller MW, 2006, EXP MECH, V46, P725, DOI 10.1007/s11340-006-9659-3
   Kessler MR, 2007, P I MECH ENG G-J AER, V221, P479, DOI 10.1243/09544100JAERO172
   Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6
   Kessler MR, 2001, COMPOS PART A-APPL S, V32, P683, DOI 10.1016/S1359-835X(00)00149-4
   Kim MD, 2006, POLYM SCI SER A+, V48, P1257, DOI 10.1134/S0965545X06120054
   Kurtz S. M., 2004, UHMWPE HDB ULTRAHIGH
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Mizuno K, 2005, J CHEM ENG JPN, V38, P45, DOI 10.1252/jcej.38.45
   Moore NC, 2009, SELF HEALING CONCRET
   Ovcharenko A, 2009, J TRIBOL-T ASME, V131, DOI 10.1115/1.3002330
   Ratner BD, 2007, POLYM INT, V56, P1183, DOI 10.1002/pi.2319
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Shukla PG, 1999, J MICROENCAPSUL, V16, P517
   Shukla PG, 2002, J MICROENCAPSUL, V19, P293, DOI 10.1080/02652040110081343
   Su JF, 2006, J APPL POLYM SCI, V102, P4996, DOI 10.1002/app.25001
   Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934
   Torini L, 2005, MACROMOLECULES, V38, P3225, DOI 10.1021/ma047808e
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   Yang JL, 2008, MACROMOLECULES, V41, P9650, DOI 10.1021/ma801718v
   Yuan YC, 2008, EXPRESS POLYM LETT, V2, P238, DOI 10.3144/expresspolymlett.2008.29
NR 45
TC 18
Z9 21
U1 4
U2 73
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2012
VL 100B
IS 7
BP 1764
EP 1772
DI 10.1002/jbm.b.32743
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 000QU
UT WOS:000308403200006
PM 22807313
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kasoju, N
   Bora, U
AF Kasoju, Naresh
   Bora, Utpal
TI Fabrication and characterization of curcumin-releasing silk fibroin
   scaffold
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE freeze-thaw; silk fibroin; curcumin; scaffold; controlled release
ID TISSUE ENGINEERING APPLICATIONS; NONWOVEN SCAFFOLD; DELIVERY SYSTEMS;
   DRUG-RELEASE; CANCER-CELLS; GROWTH; BIOMATERIAL; NANOCARRIER; MATRICES;
   ASSAY
AB Here, we report the fabrication of a curcumin-releasing porous silk fibroin scaffold by simple mixing of fibroin solution (aqueous) with curcumin solution (organic) followed by freezethaw of the mixture. The scaffold has a uniform pore distribution with an average pore size of similar to 115 mu m and a degree of swelling of 2.42% and water uptake capacity of 70.81%. Fibroin showed thermal stability up to similar to 280 degrees C, whereas encapsulated curcumin disintegrated at similar to 180 degrees C. Fourier transform infrared, powder X-ray diffraction, and nuclear magnetic resonance studies together with UVvisible and fluorescence spectroscopy investigations revealed the solvent (which was used to dissolve curcumin) induced conformational transition of fibroin from silk-I to silk-II that led to the formation of water-stable structure. Fluorescence spectroscopy data also suggested the presence of hydrophobic domains in fibroin and encapsulation of curcumin in such domains through hydrophobic interactions. Release kinetics and mathematical modeling studies indicated a slow and sustained release profile with diffusion as the predominant mode of release. Further, in vitro anticancer, antioxidant, and antimicrobial assays suggested that the biological activity of encapsulated curcumin remains unaltered. The fabrication process is simple, reproducible, and does not require any sophisticated instruments or toxic crosslinking agents. It is anticipated that the curcumin-loaded fibroin scaffold could be used in soft tissue replacements including localized postsurgical chemotherapy against tumors, dressing material for quick healing of wounds and burns, and other related applications. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Kasoju, Naresh; Bora, Utpal] Indian Inst Technol Guwahati, Biomat & Tissue Engn Lab, Dept Biotechnol, Gauhati 781039, Assam, India.
   [Bora, Utpal] Indian Inst Technol Guwahati, Ctr Environm, Gauhati 781039, Assam, India.
RP Bora, U (reprint author), Indian Inst Technol Guwahati, Biomat & Tissue Engn Lab, Dept Biotechnol, Gauhati 781039, Assam, India.
EM ubora@iitg.ernet.in
RI Kasoju, Naresh/A-5295-2009
OI Kasoju, Naresh/0000-0002-8700-0729
FU Central Silk Board and Department of Biotechnology (Government of
   India); IITG (MHRD)
FX The authors thank the Central Silk Board and Department of Biotechnology
   (Government of India) for funding this work. N.K. thanks IITG (MHRD) for
   senior research fellowship and Dr. Abhishek Sahu (former Ph.D. student)
   for his suggestions in carrying the fluorescence studies.
CR Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1
   Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002
   Ali SS, 2008, FOOD RES INT, V41, P1, DOI 10.1016/j.foodres.2007.10.001
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   Balasubramanyam M, 2003, J BIOSCIENCES, V28, P715, DOI 10.1007/BF02708432
   Basniwal R.K., 2011, J AGR FOOD CHEM, V59, P2056
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Bisht Savita, 2009, Curr Drug Discov Technol, V6, P192
   Chaturvedi T P, 2009, Indian J Dent Res, V20, P107
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   Das RK, 2010, NANOMED-NANOTECHNOL, V6, P153, DOI 10.1016/j.nano.2009.05.009
   Dash AK, 1998, J PHARMACOL TOXICOL, V40, P1, DOI 10.1016/S1056-8719(98)00027-6
   Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   Hess S, 2002, ANAL BIOCHEM, V311, P19, DOI 10.1016/S0003-2697(02)00402-5
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kasoju N, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045004
   Kasoju N, 2010, ADV ENG MATER, V12, pB139, DOI 10.1002/adem.200980055
   Kasoju N, 2009, MATER LETT, V63, P2466, DOI 10.1016/j.matlet.2009.08.037
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   Kesarvani RC, 1999, INDIAN J SURG, V61, P22
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kohli K, 2005, ANN INDIAN J PHARM, V37, P141
   Korsmeyer R. W., 1983, INT J PHARMACEUT, V15, P23, DOI DOI 10.1016/0378-5173(83)90064-9
   Kulkarni SK, 2010, INDIAN J PHARM SCI, V72, P149, DOI 10.4103/0250-474X.65012
   Kumar Virender, 2002, Indian Journal of Physiology and Pharmacology, V46, P209
   Liang L, 2008, BIOMACROMOLECULES, V9, P50, DOI 10.1021/bm700728k
   Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007
   Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mukherjee Pulok K, 2010, J Ayurveda Integr Med, V1, P100, DOI 10.4103/0975-9476.65077
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Pan CJ, 2006, J CONTROL RELEASE, V116, P42, DOI 10.1016/j.jcornel.2006.08.023
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Sahu A, 2008, BIOMACROMOLECULES, V9, P2905, DOI 10.1021/bm800683f
   Sahu A, 2011, J BIOMATER APPL, V25, P619, DOI 10.1177/0885328209357110
   Sahu A, 2008, ACTA BIOMATER, V4, P1752, DOI 10.1016/j.actbio.2008.04.021
   Shaffrathul J. H., 2007, Indian Journal of Dermatology, V52, P116
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Soudamini K. R., 1988, INDIAN J PHARM, V20, P95
   Suwantong O, 2007, POLYMER, V48, P7546, DOI 10.1016/j.polymer.2007.11.019
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zhu N, 1997, ANAL BIOCHEM, V246, P155, DOI 10.1006/abio.1997.2018
NR 52
TC 28
Z9 32
U1 4
U2 60
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2012
VL 100B
IS 7
BP 1854
EP 1866
DI 10.1002/jbm.b.32753
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 000QU
UT WOS:000308403200016
PM 22807040
DA 2018-10-19
ER

PT J
AU Sivaraman, B
   Bashur, CA
   Ramamurthi, A
AF Sivaraman, Balakrishnan
   Bashur, Chris A.
   Ramamurthi, Anand
TI Advances in biomimetic regeneration of elastic matrix structures
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Review
DE Elastin; Elastic fibers; Induced elastogenesis; Extracellular matrix;
   Matrix assembly; Regenerative tissue repair
AB Elastin is a vital component of the extracellular matrix, providing soft connective tissues with the property of elastic recoil following deformation and regulating the cellular response via biomechanical transduction to maintain tissue homeostasis. The limited ability of most adult cells to synthesize elastin precursors and assemble them into mature crosslinked structures has hindered the development of functional tissue-engineered constructs that exhibit the structure and biomechanics of normal native elastic tissues in the body. In diseased tissues, the chronic overexpression of proteolytic enzymes can cause significant matrix degradation, to further limit the accumulation and quality (e.g., fiber formation) of newly deposited elastic matrix. This review provides an overview of the role and importance of elastin and elastic matrix in soft tissues, the challenges to elastic matrix generation in vitro and to regenerative elastic matrix repair in vivo, current biomolecular strategies to enhance elastin deposition and matrix assembly, and the need to concurrently inhibit proteolytic matrix disruption for improving the quantity and quality of elastogenesis. The review further presents biomaterial-based options using scaffolds and nanocarriers for spatio-temporal control over the presentation and release of these biomolecules, to enable biomimetic assembly of clinically relevant native elastic matrix-like superstructures. Finally, this review provides an overview of recent advances and prospects for the application of these strategies to regenerating tissue-type specific elastic matrix structures and superstructures.
C1 [Sivaraman, Balakrishnan; Bashur, Chris A.; Ramamurthi, Anand] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA.
RP Ramamurthi, A (reprint author), Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave,ND 20, Cleveland, OH 44195 USA.
EM ramamua@ccf.org
OI Sivaraman, Balakrishnan/0000-0002-4538-8665; Bashur,
   Chris/0000-0002-2637-9149
FU National Institutes of Health [HL092051]
FX Representative data from the Ramamurthi laboratory, included as
   illustrative examples in this manuscript, were generated with grant
   support from the National Institutes of Health [HL092051] awarded to
   Anand Ramamurthi.
CR ABRAMS WR, 1995, GENOMICS, V26, P47, DOI 10.1016/0888-7543(95)80081-V
   Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Ahmann KA, 2010, TISSUE ENG PT A, V16, P3261, DOI 10.1089/ten.TEA.2009.0708
   Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972
   Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969
   Aitken KJ, 2009, NAT REV UROL, V6, P596, DOI 10.1038/nrurol.2009.201
   Aitken KJ, 2009, NAT REV UROL, V6, P612, DOI 10.1038/nrurol.2009.202
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amadeu TP, 2004, WOUND REPAIR REGEN, V12, P169, DOI 10.1111/j.1067-1927.2004.012209.x
   Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Andrade CF, 2007, AM J PHYSIOL-LUNG C, V292, pL510, DOI 10.1152/ajplung.00175.2006
   ARMENTANO RL, 1991, AM J PHYSIOL, V260, pH1870
   Arvizo RR, 2010, NANO LETT, V10, P2543, DOI 10.1021/nl101140t
   Azarmi S, 2008, ADV DRUG DELIVER REV, V60, P863, DOI 10.1016/j.addr.2007.11.006
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bailey MM, 2009, MED RES REV, V29, P196, DOI 10.1002/med.20140
   Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584
   Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0
   Banerjee J, 2009, BIOCONJUGATE CHEM, V20, P1332, DOI 10.1021/bc9000646
   BARONE LM, 1985, BIOCHIM BIOPHYS ACTA, V840, P245, DOI 10.1016/0304-4165(85)90125-4
   Bashur CA, 2012, J TISSUE ENG REGEN M, V6, P673, DOI 10.1002/term.470
   Bashur CA, 2012, TISSUE ENG PART B-RE, V18, P203, DOI [10.1089/ten.teb.2011.0521, 10.1089/ten.TEB.2011.0521]
   Bax DV, 2007, J CELL SCI, V120, P1383, DOI 10.1242/jcs.003954
   Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200
   Baxter BT, 2002, J VASC SURG, V36, P1, DOI 10.1067/mva.2002.125018
   Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]
   Bendeck MP, 2002, AM J PATHOL, V160, P1089, DOI 10.1016/S0002-9440(10)64929-2
   BERGETHON PR, 1989, BIOCHEM J, V258, P279, DOI 10.1042/bj2580279
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/ten.2004.10.1526
   Berk JL, 2005, AM J PHYSIOL-LUNG C, V289, pL931, DOI 10.1152/ajplung.00037.2005
   Bilensoy E, 2009, INT J PHARMACEUT, V371, P170, DOI 10.1016/j.ijpharm.2008.12.015
   Bosquillon C, 2001, J CONTROL RELEASE, V70, P329, DOI 10.1016/S0168-3659(00)00362-X
   BRESSAN GM, 1986, J ULTRA MOL STRUCT R, V94, P209, DOI 10.1016/0889-1605(86)90068-6
   BRETTELL LM, 1994, AM J RESP CELL MOL, V10, P306, DOI 10.1165/ajrcmb.10.3.8117449
   Brown RA, 2002, EXP CELL RES, V274, P310, DOI 10.1006/excr.2002.5471
   BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   Buijtenhuijs P, 2004, BIOTECHNOL APPL BIOC, V39, P141, DOI 10.1042/BA20030105
   Bump RC, 1998, OBSTET GYN CLIN N AM, V25, P723, DOI 10.1016/S0889-8545(05)70039-5
   Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Carreras I, 2002, J CELL BIOCHEM, V85, P592, DOI 10.1002/jcb.10163
   Casasco M, 2004, J MOL HISTOL, V35, P421
   Castro GA, 2009, INT J PHARMACEUT, V381, P77, DOI 10.1016/j.ijpharm.2009.07.025
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200
   Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000
   Chau Y, 2004, BIOCONJUGATE CHEM, V15, P931, DOI 10.1021/bc0499174
   Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167
   Chen G, 2009, BRIT J DERMATOL, V161, P48, DOI 10.1111/j.1365-2133.2009.09094.x
   Chen HB, 2006, J CONTROL RELEASE, V110, P296, DOI 10.1016/jjconrel.2005.09.052
   Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen YC, 2010, MOL THER, V18, P1650, DOI 10.1038/mt.2010.136
   Chetty A, 2008, AM J PHYSIOL-LUNG C, V295, pL584, DOI 10.1152/ajplung.00441.2007
   Chhetri DK, 2004, OTOLARYNG HEAD NECK, V131, P864, DOI 10.1016/j.otohns.2004.07.010
   Clark R. A. F., 2000, PRINCIPLES TISSUE EN, P855
   Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d
   Clutterbuck AL, 2009, CURR DRUG TARGETS, V10, P1245, DOI 10.2174/138945009789753264
   Cortiella J, 2006, TISSUE ENG, V12, P1213, DOI 10.1089/ten.2006.12.1213
   CORTIVO R, 1981, BRIT J UROL, V53, P134, DOI 10.1111/j.1464-410X.1981.tb03151.x
   Cortizo MC, 2004, BIOL TRACE ELEM RES, V102, P129, DOI 10.1385/BTER:102:1-3:129
   Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100
   CROUCH E, 1990, AM J PHYSIOL, V259, pL159
   Cu Y, 2009, NAT MATER, V8, P11, DOI 10.1038/nmat2347
   Cu Y, 2009, MOL PHARMACEUT, V6, P173, DOI 10.1021/mp8001254
   Curci JA, 2000, J VASC SURG, V31, P325, DOI 10.1016/S0741-5214(00)90163-0
   Curci JA, 1998, J VASC SURG, V28, P1082, DOI 10.1016/S0741-5214(98)70035-7
   D'Armiento J, 2003, J CLIN INVEST, V112, P1308, DOI 10.1172/JCI200320226
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Daamen WF, 2008, TISSUE ENG PT A, V14, P349, DOI 10.1089/tea.2007.0076
   Dai JP, 2005, CIRCULATION, V112, P1008, DOI 10.1161/CIRCULATIONAHA.104.523357
   Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.000011013.72016.ea
   Davidson JM, 2002, AM J RESP CELL MOL, V26, P164, DOI 10.1165/ajrcmb.26.2.f228
   Davidson JM, 1997, J BIOL CHEM, V272, P345
   Davies SR, 1996, J BIOL CHEM, V271, P25966, DOI 10.1074/jbc.271.42.25966
   Davis EC, 1998, MATRIX BIOL, V17, P245, DOI 10.1016/S0945-053X(98)90078-6
   DAVIS EC, 1993, LAB INVEST, V68, P89
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   De Jong WH, 2008, INT J NANOMED, V3, P133
   de Vries H J, 1994, Wound Repair Regen, V2, P37, DOI 10.1046/j.1524-475X.1994.20107.x
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   DEVRIES HJC, 1995, BRIT J DERMATOL, V132, P690
   DeWitt A, 2002, DEV BIOL, V250, P305, DOI 10.1006/dbio.2002.0807
   Ding H, 2001, J SPEECH LANG HEAR R, V44, P317, DOI 10.1044/1092-4388(2001/026)
   Ding R, 2005, VASCULAR, V13, P290
   Drewes PG, 2007, AM J PATHOL, V170, P578, DOI 10.2353/ajpath.2007.060662
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   DUNN DM, 1982, BIOCHEMISTRY-US, V21, P4195, DOI 10.1021/bi00261a001
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Elegbede AI, 2008, J AM CHEM SOC, V130, P10633, DOI 10.1021/ja801548g
   Eley JG, 2007, J MICROENCAPSUL, V24, P225, DOI 10.1080/02652040601162335
   Ely L, 2007, EUR J PHARM BIOPHARM, V65, P346, DOI 10.1016/j.ejpb.2006.10.021
   Erdogar N, 2012, J MICROENCAPSUL, V29, P576, DOI 10.3109/02652048.2012.668957
   Fahmy TM, 2008, NANOMEDICINE-UK, V3, P343, DOI 10.2217/17435889.3.3.343
   FARIS B, 1984, BIOCHIM BIOPHYS ACTA, V797, P71, DOI 10.1016/0304-4165(84)90383-0
   FAURY G, 1995, J VASC RES, V32, P112, DOI 10.1159/000159084
   Faury G, 1998, CIRC RES, V82, P328, DOI 10.1161/01.RES.82.3.328
   Fenner DE, 2010, PELVIC FLOOR DISORDERS: IMAGING AND MULTIDISCIPLINARY APPROACH TO MANAGEMENT, P25, DOI 10.1007/978-88-470-1542-5_3
   Fernandes H, 2009, J MATER CHEM, V19, P5474, DOI 10.1039/b822177d
   Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Foster KA, 2001, J PHARM PHARMACOL, V53, P57, DOI 10.1211/0022357011775190
   Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   FRISCH SM, 1985, MOL CELL BIOL, V5, P253, DOI 10.1128/MCB.5.1.253
   Fulop T, 2012, PATHOL BIOL, V60, P28, DOI 10.1016/j.patbio.2011.10.006
   Gacchina C, 2011, TISSUE ENG PT A, V17, P1945, DOI [10.1089/ten.TEA.2010.0475, 10.1089/ten.tea.2010.0475]
   Gacchina CE, 2011, TISSUE ENG PT A, V17, P1699, DOI 10.1089/ten.tea.2010.0526
   Gacchina CE, 2011, J TISSUE ENG REGEN M, V5, P85, DOI 10.1002/term.286
   GERTLER A, 1971, EUR J BIOCHEM, V20, P541, DOI 10.1111/j.1432-1033.1971.tb01425.x
   Ghosh J, 2005, CARDIOVASC PATHOL, V14, P28, DOI 10.1016/j.carpath.2004.11.005
   Gibson MA., 2000, MICROFIBRIL ASS GLYC
   GIRO MG, 1985, J CLIN INVEST, V75, P672, DOI 10.1172/JCI111746
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Gomez-Gaete C, 2008, J CONTROL RELEASE, V128, P41, DOI 10.1016/j.jconrel.2008.02.008
   Gomez-Graete C, 2007, INT J PHARM, V331, P153, DOI 10.1016/j.ijpharm.2006.11.028
   Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115
   Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006
   Greenwood Heather L., 2006, International Journal of Biotechnology, V8, P60
   Grieshaber SE, 2009, MACROMOLECULES, V42, P2532, DOI 10.1021/ma802791z
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guzman LA, 1996, CIRCULATION, V94, P1441, DOI 10.1161/01.CIR.94.6.1441
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Haslik W, 2007, BURNS, V33, P364, DOI 10.1016/j.burns.2006.07.021
   Hatakeyama H, 2007, GENE THER, V14, P68, DOI 10.1038/sj.gt.3302843
   Hatakeyama H, 2007, INT J PHARM, V342, P194, DOI 10.1016/j.ijpharm.2007.04.037
   HAYASHI A, 1995, J BIOCHEM-TOKYO, V117, P132, DOI 10.1093/oxfordjournals.jbchem.a124699
   Hedberg EL, 2004, J CONTROL RELEASE, V100, P257, DOI 10.1016/j.jconrel.2004.08.020
   Hegeman MA, 2011, BRIT J PHARMACOL, V163, P1048, DOI 10.1111/j.1476-5381.2011.01314.x
   Heise RL, 2009, TISSUE ENG PT A, V15, P3951, DOI [10.1089/ten.tea.2009.0044, 10.1089/ten.TEA.2009.0044]
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Hickey T, 2002, J BIOMED MATER RES, V61, P180, DOI 10.1002/jbm.10016
   Hinek A, 2000, AM J HUM GENET, V66, P859, DOI 10.1086/302829
   Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9
   HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538
   HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563
   Hinek A, 2005, J DERMATOL SCI, V39, P155, DOI 10.1016/j.jdermsci.2005.04.002
   Hirano E, 2002, J DERMATOL SCI, V28, P60, DOI 10.1016/S0923-1811(01)00148-7
   Hirano M., 1981, ASHA REP, V11, P11
   Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P1026, DOI 10.1177/000348940311201206
   Hirano S, 2004, LARYNGOSCOPE, V114, P548, DOI 10.1097/00005537-200403000-00030
   Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P617, DOI 10.1177/000348940311200708
   Hirano S, 2003, LARYNGOSCOPE, V113, P144, DOI 10.1097/00005537-200301000-00027
   Hirano S, 2002, ANN OTO RHINOL LARYN, V111, P661, DOI 10.1177/000348940211100801
   Hirano Shigeru, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P143, DOI 10.1097/01.moo.0000162261.49739.b7
   HORRIGAN SK, 1992, J BIOL CHEM, V267, P10087
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ibrahim S, 2011, ACTA BIOMATER, V7, P653, DOI 10.1016/j.actbio.2010.08.006
   Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   Ito S, 1997, Cardiovasc Surg, V5, P176, DOI 10.1016/S0967-2109(97)00004-5
   Jelovsek JE, 2005, AM J OBSTET GYNECOL, V193, P2105, DOI 10.1016/j.ajog.2005.07.016
   Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6
   Joddar B, 2007, BIOMATERIALS, V28, P3918, DOI 10.1016/j.biomaterials.2007.05.019
   Joddar B, 2006, BIOMATERIALS, V27, P2994, DOI 10.1016/j.biomaterials.2006.01.020
   Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   JONES PA, 1979, P NATL ACAD SCI USA, V76, P353, DOI 10.1073/pnas.76.1.353
   JORDAN RE, 1974, BIOCHEMISTRY-US, V13, P3497, DOI 10.1021/bi00714a013
   Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002
   Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331
   Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413
   KAGAN HM, 1972, BIOCHEMISTRY-US, V11, P3412, DOI 10.1021/bi00768a014
   KAGAN HM, 1981, CONNECT TISSUE RES, V8, P213, DOI 10.3109/03008208109152378
   KAGAN HM, 1981, J BIOL CHEM, V256, P5417
   KAGAN HM, 1979, BIOCHEM J, V177, P203, DOI 10.1042/bj1770203
   Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Keire PA, 2010, TISSUE ENG PT A, V16, P501, DOI [10.1089/ten.tea.2009.0129, 10.1089/ten.TEA.2009.0129]
   Kielty CM, 2007, PHILOS T R SOC B, V362, P1293, DOI 10.1098/rstb.2007.2134
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kolachala VL, 2010, LARYNGOSCOPE, V120, P988, DOI 10.1002/lary.20856
   Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C
   Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g
   Korossis S, 2006, TISSUE ENG, V12, P635, DOI 10.1089/ten.2006.12.635
   Kothapalli CR, 2008, J TISSUE ENG REGEN M, V2, P106, DOI 10.1002/term.70
   Kothapalli CR, 2009, TISSUE ENG PT A, V15, P3247, DOI [10.1089/ten.tea.2008.0593, 10.1089/ten.TEA.2008.0593]
   Kothapalli CR, 2009, J TISSUE ENG REGEN M, V3, P655, DOI 10.1002/term.214
   Kothapalli CR, 2009, ACTA BIOMATER, V5, P541, DOI 10.1016/j.actbio.2008.09.004
   Kothapalli CR, 2009, TISSUE ENG PT A, V15, P501, DOI 10.1089/ten.tea.2008.0040
   Kothapalli CR, 2009, TISSUE ENG PT A, V15, P103, DOI 10.1089/ten.tea.2007.0390
   Kuhn C, 1997, AM J RESP CELL MOL, V17, P287, DOI 10.1165/ajrcmb.17.3.f139
   Kuntsche J, 2008, INT J PHARM, V354, P180, DOI 10.1016/j.ijpharm.2007.08.028
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   Labhasetwar V, 1998, J PHARM SCI, V87, P1229, DOI 10.1021/js980021f
   Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104
   Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   Lamme EN, 1998, J INVEST DERMATOL, V111, P989, DOI 10.1046/j.1523-1747.1998.00459.x
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lanone S, 2002, J CLIN INVEST, V110, P463, DOI 10.1172/JCI200214136
   Lateef SS, 2002, BIOMATERIALS, V23, P3159, DOI 10.1016/S0142-9612(02)00062-5
   Lau AC, 2008, ARTHRITIS RHEUM, V58, P854, DOI 10.1002/art.23225
   Lausen M, 1999, J BIOL CHEM, V274, P32234, DOI 10.1074/jbc.274.45.32234
   Leach JB, 2005, ACTA BIOMATER, V1, P155, DOI 10.1016/j.actbio.2004.12.001
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee KY, 2000, NATURE, V408, P998
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lemack GE, 1999, NEUROUROL URODYNAM, V18, P55, DOI 10.1002/(SICI)1520-6777(1999)18:1<55::AID-NAU8>3.0.CO;2-C
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liu J, 2007, INT J PHARM, V328, P191, DOI 10.1016/j.ijpharm.2006.08.007
   Liu WG, 1997, HUM GENET, V99, P578, DOI 10.1007/s004390050409
   Liu XQ, 2006, AM J PATHOL, V168, P519, DOI 10.2353/ajpath.2006.050399
   Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297
   Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400
   Long JL, 2010, OTOLARYNG HEAD NECK, V142, P438, DOI 10.1016/j.otohns.2009.11.020
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Losy F, 2003, J VASC SURG, V37, P1301, DOI 10.1016/S0741-5214(02)75336-6
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Lu LC, 2001, J BONE JOINT SURG AM, V83A, pS82
   Lu Z, 2004, CLIN CANCER RES, V10, P7677, DOI 10.1158/1078-0432.CCR-04-1443
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Luo Y, 2006, TISSUE ENG, V12, P3365, DOI 10.1089/ten.2006.12.3365
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Maegdefessel L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003441
   Maegdefessel L, 2012, J CLIN INVEST, V122, P497, DOI 10.1172/JCI61598
   Maia CS, 2002, J DRUG TARGET, V10, P489, DOI 10.1080/1061186021000038364
   Mallipeddi R, 2010, EXPERT OPIN DRUG DEL, V7, P37, DOI 10.1517/17425240903338055
   Mandawgade SD, 2008, INT J PHARMACEUT, V363, P132, DOI 10.1016/j.ijpharm.2008.06.028
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mariani TJ, 1997, EXP LUNG RES, V23, P131, DOI 10.3109/01902149709074026
   Martin ND, 2005, J SURG RES, V129, P17, DOI 10.1016/j.jss.2005.06.037
   Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168
   Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1
   Massaro GD, 1997, NAT MED, V3, P675, DOI 10.1038/nm0697-675
   Massaro GD, 1996, AM J PHYSIOL-LUNG C, V270, pL305
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   Mastrandrea LD, 2006, ADV DRUG DELIVER REV, V58, P1061, DOI 10.1016/j.addr.2006.07.019
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MECHAM RP, 1981, J CELL BIOL, V90, P332, DOI 10.1083/jcb.90.2.332
   MECHAM RP, 1985, J BIOL CHEM, V260, P3255
   MEHTA K, 1994, LEUKEMIA RES, V18, P587, DOI 10.1016/0145-2126(94)90040-X
   Meinel L, 2003, BONE, V33, P660, DOI 10.1016/S8756-3282(03)00207-2
   Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p
   Mitts TF, 2010, J INVEST DERMATOL, V130, P2396, DOI 10.1038/jid.2010.155
   Miyamoto K, 2009, INT J BIOL MACROMOL, V45, P33, DOI 10.1016/j.ijbiomac.2009.03.014
   Moller W, 2002, TOXICOL APPL PHARM, V182, P197, DOI 10.1006/taap.2002.9430
   Mondalek FG, 2008, BIOMATERIALS, V29, P1159, DOI 10.1016/j.biomaterials.2007.11.020
   Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717
   Moore J, 2011, J VOICE, DOI [10.1016/j.jvoice.2011.05.003:7., DOI 10.1016/J.JVOICE.2011.05.003:7]
   Mortensen M, 2006, LARYNGOSCOPE, V116, P1735, DOI 10.1097/01.mlg.0000231455.19183.8c
   Mundargi RC, 2007, J CONTROL RELEASE, V119, P59, DOI 10.1016/j.jconrel.2007.01.008
   Mura S, 2011, INT J NANOMED, V6, P2591, DOI 10.2147/IJN.S24552
   MURAKUMO M, 1995, J UROLOGY, V154, P251, DOI 10.1016/S0022-5347(01)67289-6
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Murthy N, 2003, BIOCONJUGATE CHEM, V14, P412, DOI 10.1021/bc020056d
   Nagatomi J, 2005, BIOCHEM BIOPH RES CO, V334, P1159, DOI 10.1016/j.bbrc.2005.07.011
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nguyen KT, 2009, J BIOMED MATER RES A, V88A, P1022, DOI 10.1002/jbm.a.31734
   Nichols JE, 2009, ORGANOGENESIS, V5, P57, DOI 10.4161/org.5.2.8564
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nivison-Smith L, 2012, J BIOMED MATER RES A, V100A, P155, DOI 10.1002/jbm.a.33255
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Nuttelman CR, 2006, J BIOMED MATER RES A, V76A, P183, DOI 10.1002/jbm.a.30537
   Ohta K, 1996, DRUG METAB DISPOS, V24, P1291
   Oitate M, 2007, DRUG METAB DISPOS, V35, P1846, DOI 10.1124/dmd.107.016121
   Oitate M, 2007, J PHARMACOL EXP THER, V320, P1195, DOI 10.1124/jpet.106.114447
   Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200
   Orens Jonathan B, 2009, Proc Am Thorac Soc, V6, P13, DOI 10.1513/pats.200807-072GO
   Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477
   Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Parekh A, 2009, J UROLOGY, V182, P1216, DOI 10.1016/j.juro.2009.05.004
   Parekh A, 2009, J UROLOGY, V182, P1210, DOI 10.1016/j.juro.2009.05.002
   Park H, 2010, TISSUE ENG PT A, V16, P535, DOI [10.1089/ten.tea.2009.0029, 10.1089/ten.TEA.2009.0029]
   Parthasarathy R, 1998, CANCER LETT, V134, P121, DOI 10.1016/S0304-3835(98)00226-2
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Patel P, 2008, J APPL POLYM SCI, V108, P4038, DOI 10.1002/app.28040
   Patel RS, 2012, J MICROENCAPSUL, V29, P344, DOI 10.3109/02652048.2011.651499
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Pierce RA, 1995, CIBA F SYMP, V192, P199
   Piette M, 2007, J INCL PHENOM MACRO, V57, P101, DOI 10.1007/s10847-006-9214-y
   Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5
   Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757
   Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]
   Prow TW, 2011, ADV DRUG DELIVER REV, V63, P470, DOI 10.1016/j.addr.2011.01.012
   Quattrin T, 2004, EXPERT OPIN PHARMACO, V5, P2597, DOI 10.1517/14656566.5.12.2597
   Raghunath M, 1996, J INVEST DERMATOL, V106, P1090, DOI 10.1111/1523-1747.ep12339373
   Rahn DD, 2008, AM J PHYSIOL-REG I, V295, pR1351, DOI 10.1152/ajpregu.90447.2008
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489
   RICH CB, 1993, BIOCHEM BIOPH RES CO, V196, P1316, DOI 10.1006/bbrc.1993.2396
   Rippon Helen J, 2008, Proc Am Thorac Soc, V5, P717, DOI 10.1513/pats.200801-008AW
   Rnjak J, 2011, TISSUE ENG PART B-RE, V17, P81, DOI [10.1089/ten.teb.2010.0452, 10.1089/ten.TEB.2010.0452]
   Robb BW, 1999, MOL BIOL CELL, V10, P3595, DOI 10.1091/mbc.10.11.3595
   Robert L, 1995, CIBA F SYMP, V192, P286
   Ross R. N, 2000, PRINCIPLES TISSUE EN, P879
   Roten SV, 1996, J CUTAN PATHOL, V23, P37, DOI 10.1111/j.1600-0560.1996.tb00775.x
   Roth CC, 2011, BJU INT, V108, P148, DOI 10.1111/j.1464-410X.2010.09757.x
   Roth CC, 2010, PEDIATR RES, V67, P509, DOI 10.1203/PDR.0b013e3181d35034
   Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007
   Rucker RB, 1998, AM J CLIN NUTR, V67, p996S, DOI 10.1093/ajcn/67.5.996S
   Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008
   Safran SA, 2005, PHYSICA A, V352, P171, DOI 10.1016/j.physa.2004.12.035
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Sales VL, 2006, CIRCULATION, V114, pI193, DOI 10.1161/CIRCULATIONAHA.105.001628
   Sangare L, 2001, J ANTIMICROB CHEMOTH, V47, P323, DOI 10.1093/jac/47.3.323
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   SATO K, 1995, ANN OTO RHINOL LARYN, V104, P138, DOI 10.1177/000348949510400210
   SATO K, 1995, ANN OTO RHINOL LARYN, V104, P839, DOI 10.1177/000348949510401102
   Sayes CM, 2007, TOXICOL SCI, V97, P163, DOI 10.1093/toxsci/kfm018
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926
   SEPHEL GC, 1986, J INVEST DERMATOL, V86, P279, DOI 10.1111/1523-1747.ep12285424
   Shah KA, 2007, INT J PHARM, V345, P163, DOI 10.1016/j.ijpharm.2007.05.061
   Sharma A, 2004, J ANTIMICROB CHEMOTH, V54, P761, DOI 10.1093/jac/dkh411
   Sherratt MJ, 2009, AGE, V31, P305, DOI 10.1007/s11357-009-9103-6
   Sherratt MJ, 2004, BIOPHYS J, V86, P3211, DOI 10.1016/S0006-3495(04)74369-6
   Sherratt MJ, 2005, BIOMATERIALS, V26, P7192, DOI 10.1016/j.biomaterials.2005.05.010
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Silva EA, 2004, CURR TOP DEV BIOL, V64, P181, DOI 10.1016/S0070-2153(04)64008-7
   Simionescu A, 2005, BIOCHEM BIOPH RES CO, V334, P524, DOI 10.1016/j.bbrc.2005.06.119
   Sokolis DP, 2007, ACTA PHYSIOL, V190, P277, DOI 10.1111/j.1748-1716.2006.01661.x
   Solorio LD, 2010, J BIOMED MATER RES A, V92A, P1139, DOI 10.1002/jbm.a.32440
   Song CX, 1997, J CONTROL RELEASE, V43, P197, DOI 10.1016/S0168-3659(96)01484-8
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Starcher BC, 2000, CHEST, V117, p229S, DOI 10.1378/chest.117.5_suppl_1.229S-a
   Stephan S, 2006, J ANAT, V209, P495, DOI 10.1111/j.1469-7580.2006.00633.x
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sutherland RS, 1997, PEDIATR RES, V41, P430, DOI 10.1203/00006450-199703000-00021
   SUYAMA K, 1990, BIOCHEM BIOPH RES CO, V170, P713, DOI 10.1016/0006-291X(90)92149-T
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899
   Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760
   Tajima S, 1997, J DERMATOL SCI, V15, P166, DOI 10.1016/S0923-1811(97)00598-7
   Tanaka H, 2005, J BIOMED MATER RES A, V73A, P255, DOI 10.1002/jbm.a.30187
   TeKoppele J M, 1998, Adv Dent Res, V12, P63
   Terada T, 2006, J CONTROL RELEASE, V111, P333, DOI 10.1016/j.jconrel.2005.12.023
   Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4
   Toyoshima T, 1999, J HISTOCHEM CYTOCHEM, V47, P1049, DOI 10.1177/002215549904700809
   Tsapis N, 2002, P NATL ACAD SCI USA, V99, P12001, DOI 10.1073/pnas.182233999
   TSUJI T, 1987, J CUTAN PATHOL, V14, P106, DOI 10.1111/j.1600-0560.1987.tb00481.x
   van Zuijlen PPM, 2000, PLAST RECONSTR SURG, V106, P615, DOI 10.1097/00006534-200009030-00014
   Vandenbroucke RE, 2011, EUR RESPIR J, V38, P1200, DOI 10.1183/09031936.00027411
   Venkataraman L, 2011, TISSUE ENG PT A, V17, P2879, DOI [10.1089/ten.tea.2010.0749, 10.1089/ten.TEA.2010.0749]
   Wang AZ, 2008, EXPERT OPIN BIOL TH, V8, P1063, DOI [10.1517/14712590802181330, 10.1517/14712598.8.8.1063 ]
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   Wang DC, 2010, MOL THER, V18, P625, DOI 10.1038/mt.2009.317
   Wang XY, 2012, MATER SCI ENG B-ADV, V177, P367, DOI 10.1016/j.mseb.2011.12.030
   Weber AM, 2005, OBSTET GYNECOL, V106, P615, DOI 10.1097/01.AOG.0000175832.13266.bb
   Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Wognum S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000182
   WOLFE BL, 1993, J BIOL CHEM, V268, P12418
   WOOD JR, 1984, THORAX, V39, P780, DOI 10.1136/thx.39.10.780
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a
   Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009
   Yang GC, 2002, J AM CHEM SOC, V124, P10648, DOI 10.1021/ja027302g
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zeitels SM, 2002, ANN OTO RHINOL LARYN, V111, P21
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang P, 2012, ARTERIOSCL THROM VAS, V32, P756, DOI 10.1161/ATVBAHA.111.238113
   Zhang Z, 2004, BIOMATERIALS, V25, P177, DOI 10.1016/S0142-9612(03)00478-2
   ZIMMERMANN DR, 1994, J CELL BIOL, V124, P817, DOI 10.1083/jcb.124.5.817
NR 398
TC 9
Z9 9
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD OCT
PY 2012
VL 2
IS 5
BP 323
EP 350
DI 10.1007/s13346-012-0070-6
PG 28
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA V39PY
UT WOS:000209424100005
PM 23355960
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Vonwil, D
   Trussel, A
   Haupt, O
   Gobaa, S
   Barbero, A
   Shastri, VP
   Martin, I
AF Vonwil, Daniel
   Truessel, Andreas
   Haupt, Olivia
   Gobaa, Samy
   Barbero, Andrea
   Shastri, V. Prasad
   Martin, Ivan
TI Substrate elasticity modulates TGF beta stimulated re-differentiation of
   expanded human articular chondrocytes
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Article
DE Biomaterial interface; Regenerative medicine; Cartilage repair;
   Cartilage differentiation
AB Substrate elasticity has emerged as important biomaterial design parameter. In particular, it has been reported that on soft substrates (similar to 4 kPa) freshly isolated porcine chondrocytes better maintain their phenotype than on stiffer ones (> 20 kPa). Thus, we investigated whether this also applies to re-differentiating, expanded/de-differentiated (EDD) human articular chondrocytes (HAC). EDD HAC were seeded onto Type I collagen functionalized poly acrylamide (PA) films with a Young's modulus of 0.26 +/- 0.08 kPa (soft), 21.32 +/- 0.79 kPa (intermediately stiff) and 74.88 +/- 5.13 kPa (stiff), or type I collagen-coated plastic dishes (TCPS w/CI). Cells were cultured for 7 to 14 days in chondrogenic medium supplemented with transforming growth factor beta-1 (TGF-beta 1) and assessed for attachment, initial adhesion strength, proliferation, morphology as well as for expression of type I and II collagen at mRNA and type II collagen on protein level. Attachment and adhesion strength was similar on the different PA substrates and proliferation remained marginal (< 1 doubling/week). On intermediately stiff to infinitely stiff substrates EDD HAC assumed a spindle shaped, fibroblastic morphology, whereas on the soft substrate they remained more spherical, as assessed by shape factor analysis, and had a reduced spreading area (up to 3.2-fold). F-actin organization on the soft substrate was restricted cortically, while on the stiffer substrates F-actin assembled into stress fibers. While type II collagen mRNA expression on the soft substrate was (similar to that in aggregate culture and) 18-fold higher than on TCPS w/CI, it was not detectable on protein level. On all substrates, in the absence of TGF-beta 1 type II collagen mRNA remained at levels expressed by EDD HAC. In summary, substrate elasticity modulated the TGF-beta 1 stimulated re-differentiation of EDD HAC. Mechanical compliance is thus an important parameter to be coupled with the delivery of appropriate morphogens in designing biomaterials for cartilage engineering and repair.
C1 [Vonwil, Daniel; Haupt, Olivia; Barbero, Andrea; Martin, Ivan] Univ Basel Hosp, Dept Surg & Biomed, CH-4031 Basel, Switzerland.
   [Truessel, Andreas] ETH, Inst Biomech, CH-8093 Zurich, Switzerland.
   [Gobaa, Samy] Lab Stem Cell Bioengn, CH-1015 Lausanne, Switzerland.
   [Shastri, V. Prasad] Univ Freiburg, BIOSS, D-79100 Freiburg, Germany.
   [Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, D-79100 Freiburg, Germany.
RP Martin, I (reprint author), Univ Basel Hosp, Dept Surg & Biomed, Hebelstr 20, CH-4031 Basel, Switzerland.
EM vonwilda@gmail.com; atruessel@ethz.ch; olivia.haupt@spirig.ch;
   samy.gobaa@epfl.ch; abarbero@uhbs.ch; prasad.shastri@gmail.com;
   IMartin@uhbs.ch
OI Gobaa, Samy/0000-0002-0125-8674; Barbero, Andrea/0000-0001-5252-789X;
   Vonwil, Daniel/0000-0003-3314-445X
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Abramoff D., 2004, BIOPHOTONICS INT, V11, P36
   Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Aspenstrom P, 1999, EXP CELL RES, V246, P20, DOI 10.1006/excr.1998.4300
   AULTHOUSE AL, 1989, IN VITRO CELL DEV B, V25, P659
   Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010
   Barbero A, 2003, ARTHRITIS RHEUM, V48, P1315, DOI 10.1002/art.10950
   Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1
   Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X
   Bi WM, 1999, NAT GENET, V22, P85
   Calvet D, 2004, MACROMOLECULES, V37, P7762, DOI 10.1021/ma049072r
   Channavajjala LS, 1997, J CELL SCI, V110, P249
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   DESSAU W, 1980, J EMBRYOL EXP MORPH, V57, P51
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632
   Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336
   LOTY S, 1995, BIOL CELL, V83, P149, DOI 10.1016/0248-4900(96)81303-7
   Maheshwari G, 1999, BIOPHYS J, V76, P2814, DOI 10.1016/S0006-3495(99)77435-7
   Marlovits S, 2004, J BONE JOINT SURG BR, V86B, P286, DOI 10.1302/0301-620X.86B2.14918
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Richter W, 2009, J INTERN MED, V266, P390, DOI 10.1111/j.1365-2796.2009.02153.x
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Schuh E, 2010, TISSUE ENG PT A, V16, P1281, DOI 10.1089/ten.TEA.2009.0614
   Schuh E, 2012, J BIOMED MATER RES A, V100A, P38, DOI 10.1002/jbm.a.33226
   Schuler M, 2009, J BIOMED MATER RES A, V88A, P12, DOI 10.1002/jbm.a.31720
   Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   STOCKDALE FE, 1963, DEV BIOL, V7, P293, DOI 10.1016/0012-1606(63)90125-8
   Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010
   Takigawa T, 1996, POLYM GELS NETW, V4, P1, DOI 10.1016/0966-7822(95)00013-5
   Tan SCW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-40
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Vonwil D, 2010, EUR CELLS MATER, V20, P316
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wells RG, 2008, SCIENCE, V1, P11
   Wolf F, 2008, EUR CELLS MATER, V16, P92, DOI 10.22203/eCM.v016a10
   YASUI N, 1982, EXP CELL BIOL, V50, P92
   Zajac AL, 2008, CURR OPIN CELL BIOL, V20, P609, DOI 10.1016/j.ceb.2008.09.006
   ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115
NR 59
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD OCT
PY 2012
VL 2
IS 5
BP 351
EP 362
DI 10.1007/s13346-012-0080-4
PG 12
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA V39PY
UT WOS:000209424100006
PM 25787174
DA 2018-10-19
ER

PT J
AU Irvine, SA
   Yun, X
   Venkatraman, S
AF Irvine, Scott Alexander
   Yun, Xia
   Venkatraman, Subbu
TI Anti-platelet and tissue engineering approaches to biomaterial blood
   compatibilization: how well have these been translated into the clinic?
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Review
DE Anti-platelet; Blood compatible; Heparin; Endothelialization; Surface
   modification; Ex vivo seeding
AB In this article, we provide an update on the various approaches to "blood compatibilization", and include both passive and active approaches to compatibilizing biomaterials in contact with blood. Broadly speaking, the surface modification approaches involved either repel platelets or attract endothelial cells. For platelet-repelling surfaces, heparin immobilization seems to be the most successful approach. At least two such surfaces have been approved by the health authorities in various countries for applications involving short-term contact with blood. For active endothelialization, ex vivo seeding with autologous cells has been translated into the clinic, while selective endothelial cell capture is a promising approach. In spite of over 30 years of research in this area, a truly intrinsically non-clotting surface has not been developed yet; certain promising avenues have been indicated by the research, which we will critically assess here.
C1 [Irvine, Scott Alexander; Yun, Xia; Venkatraman, Subbu] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
RP Venkatraman, S (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM assubbu@ntu.edu.sg
RI Venkatraman, Subramanian/A-2228-2011
OI Venkatraman, Subramanian/0000-0002-8693-1070; Irvine,
   Scott/0000-0002-8926-1543
FU National Research Foundation, Singapore
FX Some of the work reported here has been funded by the National Research
   Foundation, Singapore. We gratefully acknowledge their contribution.
CR Allen JB, 2010, STEM CELLS, V28, P318, DOI 10.1002/stem.275
   Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Billinger Michael, 2006, J Invasive Cardiol, V18, P423
   Bowlin GL, 2001, J BIOMATER APPL, V16, P157, DOI 10.1106/NCQT-JFV9-2EQ1-EBGU
   Chang Y, 2011, LANGMUIR, V27, P5445, DOI 10.1021/la1048369
   Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Crouzier D, 2010, TOXICOLOGY, V272, P39, DOI 10.1016/j.tox.2010.04.001
   Damman P, 2012, CATHETER CARDIO INTE, V79, P243, DOI 10.1002/ccd.23156
   Deible CR, 1999, BIOMATERIALS, V20, P101, DOI 10.1016/S0142-9612(98)00001-5
   den Dekker WK, 2011, ATHEROSCLEROSIS, V219, P245, DOI 10.1016/j.atherosclerosis.2011.06.032
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GREISLER HP, 1987, J VASC SURG, V5, P393, DOI 10.1067/mva.1987.avs0050393
   Gupta Vishal, 2004, J Invasive Cardiol, V16, P304
   Hoffmann J, 2004, J BIOMED MATER RES A, V84, P614
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Jun HW, 2005, J BIOMED MATER RES B, V72B, P131, DOI 10.1002/jbm.b.30135
   Koh LB, 2010, PHYS CHEM CHEM PHYS, V12, P10301, DOI 10.1039/c001747g
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Koh LB, 2009, ACTA BIOMATER, V5, P3411, DOI 10.1016/j.actbio.2009.06.003
   Krawiec JT, 2012, BIOMATERIALS, V33, P3388, DOI 10.1016/j.biomaterials.2012.01.014
   Kutryk M, 2010, US Patent, Patent No. [7,803,183 B2, 7803183]
   Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233
   LANE DA, 1978, THROMB RES, V12, P257, DOI 10.1016/0049-3848(78)90297-9
   LARSSON R, 1987, ANN NY ACAD SCI, V516, P102, DOI 10.1111/j.1749-6632.1987.tb33034.x
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015
   Olsson P, 2000, J BIOMAT SCI-POLYM E, V11, P1261, DOI 10.1163/156856200744192
   Palanzo DA, 2001, PERFUSION-UK, V16, P279, DOI 10.1177/026765910101600403
   Park K, 2000, J BIOMAT SCI-POLYM E, V11, P1121, DOI 10.1163/156856200744228
   Pawlowski KJ, 2004, FRONT BIOSCI-LANDMRK, V9, P1412, DOI 10.2741/1302
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Rossi ML, 2010, INT J CARDIOL, V141, pE20, DOI 10.1016/j.ijcard.2008.11.134
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403
   Sharkawi T, 2011, J BIOMED MATER RES A, V98A, P80, DOI 10.1002/jbm.a.33099
   Shimizu K, 2001, NAT MED, V7, P738, DOI 10.1038/89121
   Shin HS, 2009, J BIOACT COMPAT POL, V24, P316, DOI 10.1177/0883911509104273
   Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8
   Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095
   Thierry B, 2008, LANGMUIR, V24, P11834, DOI 10.1021/la801359w
   TURNER JS, 1994, J BIOMAT SCI-POLYM E, V5, P353, DOI 10.1163/156856294X00077
   van Beusekom HMM, 2012, CATHETER CARDIO INTE, V79, P231, DOI 10.1002/ccd.22928
   Venkatraman S, 2007, J CONTROL RELEASE, V120, P149, DOI 10.1016/j.jconrel.2007.04.022
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
   Wendel HP, 2010, INT J CARDIOL, V145, P115, DOI 10.1016/j.ijcard.2009.06.020
   Wu W, 2011, TISSUE ENG PT A, V17, P1979, DOI [10.1089/ten.tea.2010.0550, 10.1089/ten.TEA.2010.0550]
   Xia Y, 2012, J TISSUE EN IN PRESS
   Xia Y, 2010, BIOINTERPHASES, V5, pFA32, DOI 10.1116/1.3467508
   Zhang L, 2008, BIOTECHNOL BIOENG, V99, P1007, DOI 10.1002/bit.21629
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
NR 59
TC 3
Z9 3
U1 1
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD OCT
PY 2012
VL 2
IS 5
BP 384
EP 397
DI 10.1007/s13346-012-0077-z
PG 14
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA V39PY
UT WOS:000209424100009
PM 25787176
DA 2018-10-19
ER

PT J
AU Foster, LJR
   Karsten, E
AF Foster, L. John R.
   Karsten, Elizabeth
TI A Chitosan Based, Laser Activated Thin Film Surgical Adhesive,
   'SurgiLux': Preparation and Demonstration
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 68; Chitosan; Infra-red Laser; Indocyanine Green;
   Biomaterial; SurgiLux; Surgical Adhesive
AB Sutures are a 4,000 year old technology that remain the 'gold-standard' for wound closure by virtue of their repair strength (similar to 100 KPa). However, sutures can act as a nidus for infection and in many procedures are unable to effect wound repair or interfere with functional tissue regeneration.(1) Surgical glues and adhesives, such as those based on fibrin and cyanoacrylates, have been developed as alternatives to sutures for the repair of such wounds. However, current commercial adhesives also have significant disadvantages, ranging from viral and prion transfer and a lack of repair strength as with the fibrin glues, to tissue toxicity and a lack of biocompatibility for the cyanoacrylate based adhesives. Furthermore, currently available surgical adhesives tend to be gel-based and can have extended curing times which limit their application.(2) Similarly, the use of UV lasers to facilitate cross-linking mechanisms in protein-based or albumin 'solders' can lead to DNA damage while laser tissue welding (LTW) predisposes thermal damage to tissues.(3) Despite their disadvantages, adhesives and LTW have captured approximately 30% of the wound closure market reported to be in excess of US $5 billion per annum, a significant testament to the need for sutureless technology.(4)
   In the pursuit of sutureless technology we have utilized chitosan as a biomaterial for the development of a flexible, thin film, laser-activated surgical adhesive termed 'SurgiLux'. This novel bioadhesive uses a unique combination of biomaterials and photonics that are FDA approved and successfully used in a variety of biomedical applications and products. SurgiLux overcomes all the disadvantages associated with sutures and current surgical adhesives (see Table 1).
   In this presentation we report the relatively simple protocol for the fabrication of SurgiLux and demonstrate its laser activation and tissue weld strength. SurgiLux films adhere to collagenous tissue without chemical modification such as cross-linking and through irradiation using a comparatively low-powered (120 mW) infrared laser instead of UV light. Chitosan films have a natural but weak adhesive attraction to collagen (similar to 3 KPa), laser activation of the chitosan based SurgiLux films emphasizes the strength of this adhesion through polymer chain interactions as a consequence of transient thermal expansion.(5) Without this 'activation' process, SurgiLux films are readily removed.(6-9) SurgiLux has been tested both in vitro and in vivo on a variety of tissues including nerve, intestine, dura mater and cornea. In all cases it demonstrated good biocompatibility and negligible thermal damage as a consequence of irradiation.(6-10)
C1 [Foster, L. John R.; Karsten, Elizabeth] Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW, Australia.
EM J.Foster@unsw.edu.au
FU National Health and Medical Research Council of Australia (NHMRC)
   [1000674]
FX The authors acknowledge a grant from the National Health and Medical
   Research Council of Australia (NHMRC #1000674) to L.J.R. Foster.
CR Foster LJR, 2010, BIOMACROMOLECULES, V11, P3563, DOI 10.1021/bm101028g
   Fung LC, 1999, LASER SURG MED, V25, P285, DOI 10.1002/(SICI)1096-9101(1999)25:4<285::AID-LSM3>3.0.CO;2-S
   Kjaergard H.K., 2001, AM J SURG, V182, P15
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 2005, LASER SURG MED, V36, P193, DOI 10.1002/lsm.20145
   Lauto A, 2008, PHOTOMED LASER SURG, V26, P227, DOI 10.1089/pho.2007.2131
   Lauto A, 2008, J CHEM TECHNOL BIOT, V83, P464, DOI 10.1002/jctb.1771
   Marcal H., 2008, LASER MED SCI, V23, P96
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Piribo, 2005, GLUES SEAL IND BACKG
   Shahbazi J., 2011, LASERS SURG MED
NR 11
TC 1
Z9 1
U1 1
U2 13
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD OCT
PY 2012
IS 68
AR UNSP e3527
DI 10.3791/3527
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36QJ
UT WOS:000209225700005
PM 23117533
OA Green Published
DA 2018-10-19
ER

PT J
AU Ferreira, MSV
   Jahnen-Dechent, W
   Labude, N
   Bovi, M
   Hieronymus, T
   Zenke, M
   Schneider, RK
   Neurs, S
AF Ferreira, Monica S. Ventura
   Jahnen-Dechent, Willi
   Labude, Norina
   Bovi, Manfred
   Hieronymus, Thomas
   Zenke, Martin
   Schneider, Rebekka K.
   Neurs, Sabine
TI Cord blood-hematopoietic stem cell expansion in 3D fibrin scaffolds with
   stromal support
SO BIOMATERIALS
LA English
DT Article
DE Bone marrow; Fibrin; Transplantation; Scaffold; Stem cell
ID EX-VIVO EXPANSION; HUMAN UMBILICAL-CORD; HUMAN BONE-MARROW; OF-THE-ART;
   PROGENITOR CELLS; STEM/PROGENITOR CELLS; 3-DIMENSIONAL SCAFFOLDS;
   COLLAGEN SCAFFOLDS; MONONUCLEAR-CELLS; CULTURE
AB Expansion of multipotent, undifferentiated and proliferating cord blood (CB)-hematopoietic stem cells (HSC) in vitro is limited and insufficient. Bone marrow (BM) engineering in vitro allows mimicking the main components of the hematopoietic niche compared to conventional expansion strategies. In this study, four different 3D biomaterial scaffolds (PCL, PLGA, fibrin and collagen) were tested for freshly isolated cord blood (CB)-CD34(+) cell expansion in presence of (i) efficient exogenous cytokine supplementation and (ii) umbilical cord (UC)-mesenchymal stem cells (MSC). Cell morphology, growth and proliferation were analyzed in vitro as well as multi-organ engraftment and multilineage differentiation in a murine transplantation model. All scaffolds, except 3D PLGA meshes, supported CB-CD34(+) cell expansion, which was additionally stimulated by UC-MSC support. CB-CD34(+) cells cultured on human-derived 3D fibrin scaffolds with UC-MSC support i) reached the highest overall growth (5 x 10(8)-fold expansion of total nuclear cells after fourteen days and 3 x 10(7)-fold expansion of CD34(+) cells after seven days, p < 0.001), ii) maintained a more primitive immunophenotype for more cell divisions, iii) exhibited superior morphological, migratory and adhesive properties, and iv) showed the significantly highest numbers of engraftment and multilineage differentiation (CD45, CD34, CD13, CD3 and CD19) in BM, spleen and peripheral blood in long-term transplanted NSG mice compared to the other 3D biomaterial scaffolds. Thus, the 3D fibrin scaffold based BM-mimicry strategy reveals optimal requirements for translation into clinical protocols for CB expansion and transplantation. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Ferreira, Monica S. Ventura; Labude, Norina; Schneider, Rebekka K.; Neurs, Sabine] Rhein Westfal TH Aachen, Inst Pathol, D-52074 Aachen, Germany.
   [Jahnen-Dechent, Willi; Neurs, Sabine] Rhein Westfal TH Aachen, Biointerface Grp, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
   [Bovi, Manfred] Univ Hosp Aachen, Electron Microscop Facil, Aachen, Germany.
   [Hieronymus, Thomas; Zenke, Martin] Rhein Westfal TH Aachen, Dept Cell Biol, Inst Biomed Engn, D-52074 Aachen, Germany.
RP Neurs, S (reprint author), Rhein Westfal TH Aachen, Inst Pathol, Pauwelsstr 30, D-52074 Aachen, Germany.
EM sabine.neuss@post.rwth-aachen.de
RI Ventura Ferreira, Monica/P-5910-2017; Jahnen-Dechent, Willi/A-7608-2011
OI Ventura Ferreira, Monica/0000-0002-1437-1342; Jahnen-Dechent,
   Willi/0000-0003-1315-4407
FU Federal Ministry of Education and Research (BMBF), Germany [01GN0931]
FX This work was financially supported by the Federal Ministry of Education
   and Research (BMBF), Germany (Grant-Number: 01GN0931). We thank the
   Department for Gynecology and Obstetrics from the University Hospital
   Aachen (RWTH Aachen University, Germany) for providing cord blood and
   umbilical cords. We further thank the Institute for Textile Technology
   (RWTH Aachen University, Germany) for kindly providing the 3D PLGA
   meshes. We thank M.Sc. Carina Adamzyk for the assistance with scaffold
   preparation.
CR Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331
   Alakel N, 2009, EXP HEMATOL, V37, P504, DOI 10.1016/j.exphem.2008.12.005
   Bagley J, 1999, EXP HEMATOL, V27, P496, DOI 10.1016/S0301-472X(98)00053-8
   Bakhshi T, 2008, TRANSFUSION, V48, P2638, DOI 10.1111/j.1537-2995.2008.01926.x
   Banu N, 2001, CYTOKINE, V13, P349, DOI 10.1006/cyto.2001.0836
   Battiwalla M, 2009, CYTOTHERAPY, V11, P503, DOI 10.1080/14653240903193806
   Bladergroen BA, 2009, TISSUE ENG PT A, V15, P1591, DOI 10.1089/ten.tea.2008.0348
   Blanco TM, 2010, BIOMATERIALS, V31, P2243, DOI 10.1016/j.biomaterials.2009.11.094
   Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328
   Chua KN, 2007, EXP HEMATOL, V35, P771, DOI 10.1016/j.exphem.2007.02.002
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   da Silva CL, 2010, J TISSUE ENG REGEN M, V4, P149, DOI 10.1002/term.226
   Douay L, 2001, J HEMATOTH STEM CELL, V10, P341, DOI 10.1089/152581601750288948
   Ehring B, 2003, CYTOTHERAPY, V5, P490, DOI 10.1080/14653240310003585
   Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829
   Ferreira MV, 2012, J MATER SCI-MATER M, V23, P109, DOI 10.1007/s10856-011-4483-4
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511
   Gluckman E, 2009, HAEMATOL-HEMATOL J, V94, P451, DOI 10.3324/haematol.2009.005694
   Goncalves R, 2006, EXP HEMATOL, V34, P1353, DOI 10.1016/j.exphem.2006.05.024
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Ivanovic Z, 2006, TRANSFUSION, V46, P126, DOI 10.1111/j.1537-2995.2006.00675.x
   Jiang XS, 2006, BIOMATERIALS, V27, P2723, DOI 10.1016/j.biomaterials.2005.12.001
   Kim DH, 2006, J KOREAN MED SCI, V21, P1000, DOI 10.3346/jkms.2006.21.6.1000
   Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034
   Li Y, 2001, J HEMATOTH STEM CELL, V10, P355, DOI 10.1089/152581601750288966
   Mantalaris A, 1998, BIOTECHNOL PROGR, V14, P126, DOI 10.1021/bp970136+
   McNiece I, 2004, CYTOTHERAPY, V6, P311, DOI 10.1080/14653240410004871
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Mortera-Blanco T, 2011, BIOMATERIALS, V32, P9263, DOI 10.1016/j.biomaterials.2011.08.051
   Neuss S, 2010, CELLS TISSUES ORGANS, V191, P36, DOI 10.1159/000215579
   Nichols JE, 2009, BIOMATERIALS, V30, P1071, DOI 10.1016/j.biomaterials.2008.10.041
   Pierres A, 2008, BIOPHYS J, V94, P4114, DOI 10.1529/biophysj.107.125278
   Robinson SN, 2006, BONE MARROW TRANSPL, V37, P359, DOI 10.1038/sj.bmt.1705258
   Simon SP, 1994, ORTHOPAEDIC BASIC SC, P127
   Tan J, 2010, CYTOTECHNOLOGY, V62, P439, DOI 10.1007/s10616-010-9297-6
   Ventura Ferreira MS, 2012, TISSUE EN C IN PRESS
   Ventura Ferreira MS, 2012, J TISSUE ENG REGEN M
   Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280
   Walenda T, 2011, EXP HEMATOL, V39, P617, DOI 10.1016/j.exphem.2011.02.011
   Walenda T, 2010, J CELL MOL MED, V14, P337, DOI 10.1111/j.1582-4934.2009.00776.x
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Wang JCY, 1997, BLOOD, V89, P3919
   Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119
NR 51
TC 64
Z9 64
U1 1
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2012
VL 33
IS 29
BP 6987
EP 6997
DI 10.1016/j.biomaterials.2012.06.029
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 998VX
UT WOS:000308269600009
PM 22800538
DA 2018-10-19
ER

PT J
AU Zhang, XX
   Guo, SY
   Fan, R
   Yu, MR
   Li, FF
   Zhu, CL
   Gan, Y
AF Zhang, Xinxin
   Guo, Shiyan
   Fan, Rong
   Yu, Miaorong
   Li, Feifei
   Zhu, Chunliu
   Gan, Yong
TI Dual-functional liposome for tumor targeting and overcoming multidrug
   resistance in hepatocellular carcinoma cells
SO BIOMATERIALS
LA English
DT Article
DE Dual-functional liposome; Galactosyl conjugated pluronic P123; Tumor
   targeting; Multidrug resistance; Mitoxantrone; Hepatocellular carcinoma
ID DRUG-RESISTANCE; ANTICANCER-DRUG; POLYMERIC MICELLES; BLOCK-COPOLYMERS;
   CANCER-CELLS; DELIVERY; PACLITAXEL; THERAPY; LIVER; PHARMACOKINETICS
AB The purpose of this study was to design and evaluate the dual-functional liposome (LPG) with synthetic polymeric nano-biomaterial (Gal-P123) that targets cancer cells and reverses multidrug resistance (MDR) in hepatocellular carcinoma (HCC) cells. The mitoxantrone (MX) loaded LPG (MX-LPG) was about 100 nm in diameter, spherically shaped, and had an encapsulation efficiency of 97.3%. The cytotoxicity and cellular uptake of MX-LPG were evaluated in HCC Huh-7 cells. BCRP-overexpressing MDCKII/BCRP cells were used to certify the inhibitory effect of LPG on drug efflux transporter. Compared with MX, MX-LPG had 2.3-fold higher cytotoxicity in Huh-7 cells and a 14.9-fold increase in cellular MX accumulation in MDCKII/BCRP cells. The pharmacokinetic study in rats showed that LPG significantly prolonged the circulation time and enhanced the bioavailability of MX. Moreover, MX-LPG increased antitumor activity and improved selectivity in BALB/c mice bearing orthotopic xenograft HCC tumors. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Zhang, Xinxin; Guo, Shiyan; Fan, Rong; Yu, Miaorong; Li, Feifei; Zhu, Chunliu; Gan, Yong] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China.
RP Gan, Y (reprint author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China.
EM simm2122@vip.sina.com
FU National Natural Science Foundation of China [30901865]; Natural Science
   Foundation of Hebei Province of China [C2011319010]; National Key
   Technology Research and Development Program of China
   [2012ZX09301001-001]
FX This work was supported by the National Natural Science Foundation of
   China (grant number 30901865), Natural Science Foundation of Hebei
   Province of China (grant number C2011319010) and National Key Technology
   Research and Development Program of China during the "12th Five-Year
   Plan" (grant number 2012ZX09301001-001). We thank Dr. Schinkel for
   generously providing BCRP-transfected MDCKII cells and wild type MDCKII
   cells.
CR Alakhova DY, 2010, J CONTROL RELEASE, V142, P89, DOI 10.1016/j.jconrel.2009.09.026
   Alvarez-Lorenzo C, 2011, CURR DRUG TARGETS, V12, P1112, DOI 10.2174/138945011795906615
   Batrakova EV, 2004, PHARM RES, V21, P2226, DOI 10.1007/s11095-004-7675-5
   Batrakova EV, 2004, J CONTROL RELEASE, V100, P389, DOI 10.1016/j.jconrel.2004.09.002
   Cheng J, 2011, INT J NANOMED, V6, P2123, DOI 10.2147/IJN.S24309
   Christian DA, 2010, MACROMOL RAPID COMM, V31, P135, DOI 10.1002/marc.200900589
   DRORI S, 1995, EUR J BIOCHEM, V228, P1020, DOI 10.1111/j.1432-1033.1995.tb20352.x
   FALLON R J, 1989, Advanced Drug Delivery Reviews, V4, P49, DOI 10.1016/0169-409X(89)90037-9
   Han LM, 2006, ACTA PHARMACOL SIN, V27, P747, DOI 10.1111/j.1745-7254.2006.00340.x
   Han M, 2011, INT J PHARMACEUT, V420, P404, DOI 10.1016/j.ijpharm.2011.09.009
   Holan V, 2011, J CONTROL RELEASE, V156, P406, DOI 10.1016/j.jconrel.2011.07.022
   Houghton P, 2007, METHODS, V42, P377, DOI 10.1016/j.ymeth.2007.01.003
   Hu CMJ, 2012, BIOCHEM PHARMACOL, V83, P1104, DOI 10.1016/j.bcp.2012.01.008
   Huang SJ, 2009, EUR J PHARM SCI, V38, P64, DOI 10.1016/j.ejps.2009.06.002
   Jabr-Milane LS, 2008, CANCER TREAT REV, V34, P592, DOI 10.1016/j.ctrv.2008.04.003
   Juszynski MD, 1971, CARBOHYD RES, V18, P219
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Li B, 2012, INT J NANOMED, V7, P187, DOI 10.2147/IJN.S27864
   Li GP, 2007, J HUAZHONG U SCI-MED, V27, P173, DOI 10.1007/s11596-007-0217-8
   Li XR, 2010, PHARM RES-DORDR, V27, P1498, DOI 10.1007/s11095-010-0147-1
   Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359
   Mamot C, 2003, DRUG RESIST UPDATE, V6, P271, DOI 10.1016/S1368-7646(03)00082-7
   Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003
   Michaelis M, 2005, ONCOL REP, V13, P157
   Michal TK, 2009, METHOD ENZYMOL, P351
   Morgan NY, 2005, ACAD RADIOL, V12, P313, DOI 10.1016/j.acra.2004.04.023
   Patil Y, 2009, J CONTROL RELEASE, V136, P21, DOI 10.1016/j.jconrel.2009.01.021
   PEC EA, 1992, J PHARM SCI-US, V81, P626, DOI 10.1002/jps.2600810707
   PENNOCK GD, 1991, J NATL CANCER I, V83, P105, DOI 10.1093/jnci/83.2.105
   Pick A, 2010, CHEMMEDCHEM, V5, P1498, DOI 10.1002/cmdc.201000216
   Renugalakshmi A, 2011, CURR DRUG DELIV, V8, P586, DOI 10.2174/156720111796642336
   Rudra A, 2010, INT J NANOMED, V5, P811, DOI 10.2147/IJN.S13031
   Song CK, 2011, J MICROENCAPSUL, V28, P575, DOI 10.3109/02652048.2011.599436
   Song XR, 2010, J PHARM SCI-US, V99, P4874, DOI 10.1002/jps.22200
   Sonoke S, 2011, BIOL PHARM BULL, V34, P1338, DOI 10.1248/bpb.34.1338
   Sun ZG, 2010, TUMORI, V96, P90
   Tiourina O, 2003, J LIPOSOME RES, V13, P213, DOI 10.1081/LPR-120026388
   Ueda K, 2008, BIOL PHARM BULL, V31, P2283, DOI 10.1248/bpb.31.2283
   Wang FH, 2011, BIOMATERIALS, V32, P9444, DOI 10.1016/j.biomaterials.2011.08.041
   Wang YJ, 2011, DRUG DEV IND PHARM, V29, P1
   Wang YZ, 2008, ARCH PHARM RES, V31, P530, DOI 10.1007/s12272-001-1189-2
   Wei W, 2010, NANOMEDICINE-UK, V5, P589, DOI [10.2217/nnm.10.27, 10.2217/NNM.10.27]
   Wei Z, 2010, EUR J PHARM BIOPHARM, V75, P341, DOI 10.1016/j.ejpb.2010.04.017
   Wu DQ, 2009, BIOMATERIALS, V30, P1363, DOI 10.1016/j.biomaterials.2008.11.027
   Wu J, 2007, J PHARM PHARM SCI, V10, P350
   Yamagata T, 2009, INT J PHARMACEUT, V370, P216, DOI 10.1016/j.ijpharm.2008.12.005
   Yang R, 2011, BIOMACROMOLECULES, V12, P3047, DOI 10.1021/bm2006856
   Yik JHN, 2002, J BIOL CHEM, V277, P23076, DOI 10.1074/jbc.M202748200
   Zen Y, 2007, AM J PATHOL, V170, P1750, DOI 10.2353/ajpath.2007.060798
NR 49
TC 45
Z9 51
U1 6
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2012
VL 33
IS 29
BP 7103
EP 7114
DI 10.1016/j.biomaterials.2012.06.048
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 998VX
UT WOS:000308269600021
PM 22796159
DA 2018-10-19
ER

PT J
AU Zhang, L
   Yuan, T
   Guo, LK
   Zhang, XD
AF Zhang, Li
   Yuan, Tun
   Guo, Likun
   Zhang, Xingdong
TI An in vitro study of collagen hydrogel to induce the chondrogenic
   differentiation of mesenchymal stem cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE contraction; chondrogenesis; mesenchymal stem cells; collagen hydrogel;
   cell aggregates
ID MARROW STROMAL CELLS; EXTRACELLULAR-MATRIX; CARTILAGE DEFECTS;
   PROGENITOR CELLS; REPAIR; VIVO; BIOMATERIALS; SCAFFOLDS; MODEL; GELS
AB It is controversial whether a biomaterial itself, rather than addition of any exogenous growth factor, could induce mesenchymal stem cells (MSCs) to differentiate into chondrogenic lineage, further to regenerate cartilage. Previous studies have shown that collagen-based hydrogel could induce MSCs to differentiate into chondrocytes in vivo but the in vitro studies only have a few reports. The evidence that biomaterials could induce chondrogenesis is not adequate. In this study, we tried to address whether type I collagen hydrogel has chondro-inductive capability in vitro and how this scaffold induces MSCs to generate cartilage tissue without exogenous growth factors in the culture medium. We encapsulated neonatal rabbit bone marrow mesenchymal stem cells (BMSCs) in type I collagen hydrogel homogeneously or implanted cell aggregates in hydrogel, and cultured them in nonchondrogenic inductive media. After at least 28 days culture, cells in the homogeneous group were tending to chondrogenic differentiation while cell density was high, and cells in the aggregate group have almost gone through chondrogenesis and formed neo-cartilage tissue with abundant specific extracellular matrix (ECM) deposition. These results indicate collagen hydrogel has inherent inductivity for the chondrogenic differentiation of BMSCs, and the optimum specification and tissue formation were accompanied with local high cell density. This research suggests a feasible strategy to induce the chondro differentiation of BMSCs independent of exogenous growth factors, which may greatly contribute to clinical cartilage regeneration. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A 100A: 2717-2725, 2012.
C1 [Zhang, Li; Yuan, Tun; Guo, Likun; Zhang, Xingdong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Sichuan, Peoples R China.
RP Zhang, XD (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Sichuan, Peoples R China.
EM zhangxd@scu.edu.cn
FU National Basic Research Program of China; National Natural Science
   Foundation of China [2011CB606201, 31100684]
FX Contract grant sponsor: National Basic Research Program of China and
   National Natural Science Foundation of China; contract grant numbers:
   2011CB606201, 31100684
CR Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070
   EdwallArvidsson C, 1996, ANAT EMBRYOL, V193, P453
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng Z, 2003, ARTIF ORGANS, V27, P84, DOI 10.1046/j.1525-1594.2003.07187.x
   Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Leach JK, 2006, REGEN MED, V1, P447, DOI 10.2217/17460751.1.4.447
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Lewus KE, 2005, TISSUE ENG, V11, P1015, DOI 10.1089/ten.2005.11.1015
   Liu XD, 1998, AM J PHYSIOL-LUNG C, V274, pL58, DOI 10.1152/ajplung.1998.274.1.L58
   Lu J, 2005, KEY ENG MAT, V288-289, P377, DOI 10.4028/www.scientific.net/KEM.288-289.377
   Mandelbaum BR, 1998, AM J SPORT MED, V26, P853, DOI 10.1177/03635465980260062201
   Massimo Sabatini PP, 2004, CARTILAGE OSTEOARTHR, P1
   Mauney J, 2010, MATRIX BIOL, V29, P657, DOI 10.1016/j.matbio.2010.08.008
   Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Nishihara A, 2003, BIOCHEM BIOPH RES CO, V301, P617, DOI 10.1016/S0006-291X(02)03068-1
   NOBLE BS, 1995, BONE, V17, P375, DOI 10.1016/S8756-3282(95)00247-2
   Noth U, 2007, J BIOMED MATER RES A, V83A, P626, DOI 10.1002/jbm.a.31254
   Pei M, 2008, OSTEOARTHR CARTILAGE, V16, P1110, DOI 10.1016/j.joca.2007.12.011
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Revell CM, 2009, TISSUE ENG PART B-RE, V15, P1, DOI 10.1089/ten.teb.2008.0189
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   YAMAGUCHI A, 1995, SEMIN CELL BIOL, V6, P165, DOI 10.1006/scel.1995.0023
   Yan H, 2007, ARTHROSCOPY, V23, P178, DOI 10.1016/j.arthro.2006.09.005
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x
   Zheng L, 2010, J BIOMED MATER RES A, V93A, P783, DOI 10.1002/jbm.a.32588
   Zheng L, 2009, TISSUE ENG PT A, V15, P2145, DOI 10.1089/ten.tea.2008.0268
NR 40
TC 44
Z9 48
U1 2
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2012
VL 100A
IS 10
BP 2717
EP 2725
DI 10.1002/jbm.a.34194
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 993VP
UT WOS:000307888200020
PM 22623365
DA 2018-10-19
ER

PT J
AU Miranda, SCCC
   Silva, GAB
   Mendes, RM
   Abreu, FAM
   Caliari, MV
   Alves, JB
   Goes, AM
AF Miranda, Suzana C. C. C.
   Silva, Gerluza A. B.
   Mendes, Renato M.
   Abreu, Fernando Antonio M.
   Caliari, Marcelo V.
   Alves, Jose B.
   Goes, Alfredo M.
TI Mesenchymal stem cells associated with porous chitosan-gelatin scaffold:
   A potential strategy for alveolar bone regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan-gelatin scaffold; mesenchymal stem cells; tissue engineering;
   bone healing; tooth socket
ID TISSUE-ENGINEERED BONE; IN-VITRO; OSTEOGENIC DIFFERENTIATION; COMPOSITE
   SCAFFOLDS; FLUORESCENT PROTEIN; STROMAL CELLS; REPAIR; RATS;
   BIOCOMPATIBILITY; INJECTION
AB Tissue engineering has emerged as a novel treatment for replacement of lost bone tissue. This study evaluated the effects of a chitosangelatin scaffold seeded with bone marrow mesenchymal stem cells (BMMSCs) in the healing process of tooth sockets in rats. BMMSCs isolated from transgenic rats expressing enhanced green fluorescent protein (eGFP) were expanded and seeded on a chitosangelatin scaffold. These constructs were cultured for three days and characterized by scanning electronic microscopy (SEM) and energy dispersion spectroscopy (EDS). Receptor rats received the implant in the left sockets, after upper first-molar extraction. Right alveoli served as control. Animals were sacrificed at days 5, 21, and 35 post-graft for examination. Morphometry demonstrated increased bone mineralization after 21 and 35 days in transplanted sockets. Migration, differentiation, and fate of eGFP-labeled BMMSCs were monitored by immunohistochemistry. Tartrate-resistant acid phosphatase staining (TRAP) was carried out at 21 days, to identify the involvement of osteoclastic cells in the scaffold resorption. The biomaterial was resorbed by TRAP-negative giant cells in a typical foreign body reaction. Immunohistochemical findings showed that BMMSCs contributed to bone, epithelial, and vascular repair. Together, results indicate that BMMSCs loaded in the chitosangelatin scaffold is a strategy for tissue development in bone engineering. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A 100A:2775-2786, 2012.
C1 [Miranda, Suzana C. C. C.; Silva, Gerluza A. B.; Mendes, Renato M.; Abreu, Fernando Antonio M.; Alves, Jose B.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Caliari, Marcelo V.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Pathol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Alves, Jose B.] Univ Uberaba, Lab Biopathol & Mol Biol, BR-38055500 Uberaba, MG, Brazil.
   [Goes, Alfredo M.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, BR-31270901 Belo Horizonte, MG, Brazil.
RP Silva, GAB (reprint author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Presidente Antonio Carlos Ave 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM gerluza@terra.com.br
RI Caliari, Marcelo/N-1171-2016
OI Caliari, Marcelo/0000-0001-8354-8407; MAUAD DE ABREU, FERNANDO
   ANTONIO/0000-0001-7399-7153
FU FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais/Brazil); CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil)
FX Contract grant sponsors: FAPEMIG (Fundacao de Amparo a Pesquisa de Minas
   Gerais/Brazil); CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/Brazil)
CR Ashammakhi N, 2005, J CRANIOFAC SURG, V16, P195, DOI 10.1097/00001665-200503000-00002
   Brandão Alexandre C., 2002, Braz. Dent. J., V13, P147, DOI 10.1590/S0103-64402002000300001
   Breyner NM, 2010, CELLS TISSUES ORGANS, V191, P119, DOI 10.1159/000231472
   BURDICK JA, 2009, TISSUE ENG PT A, V15, P205, DOI DOI 10.1089/ten.tea.2008.0131
   Castanheira P, 2009, CELL TRANSPLANT, V18, P423, DOI 10.3727/096368909788809811
   Chlopek J, 2006, CARBON, V44, P1106, DOI 10.1016/j.carbon.2005.11.022
   Davies JE, 2002, METHODS TISSUE ENG, P333
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Kanyama M, 2003, ARCH ORAL BIOL, V48, P723, DOI 10.1016/S0003-9969(03)00153-5
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Komori M, 2005, J GASTROENTEROL, V40, P591, DOI 10.1007/s00535-005-1593-0
   Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884
   Le Trong I, 2003, ACTA CRYSTALLOGR D, V59, P828, DOI 10.1107/S0907444903004153
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Machado CB, 2007, BIOMED MATER, V2, P124, DOI 10.1088/1748-6041/2/2/010
   Mendes RM, 2008, ARCH ORAL BIOL, V53, P1155, DOI 10.1016/j.archoralbio.2008.07.001
   Miranda SCCC, 2011, ARCH ORAL BIOL, V56, P1, DOI 10.1016/j.archoralbio.2010.08.018
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Nakagawa K, 2004, TISSUE ENG, V10, P93, DOI 10.1089/107632704322791736
   Piscioneri A, 2011, ACTA BIOMATER, V7, P171, DOI 10.1016/j.actbio.2010.07.039
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Hell RCR, 2009, NEUROBIOL DIS, V33, P290, DOI 10.1016/j.nbd.2008.10.017
   Schleicher U, 2000, J IMMUNOL METHODS, V246, P165, DOI 10.1016/S0022-1759(00)00298-2
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624
   Sun L. P., 2009, BIOMED MATER, V4, P1
   Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Valerio P, 2005, J MATER SCI-MATER M, V16, P851, DOI 10.1007/s10856-005-3582-5
   Weng YL, 2006, TISSUE ENG, V12, P1503, DOI 10.1089/ten.2006.12.1503
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Yang ZY, 2010, SCI CHINA LIFE SCI, V53, P215, DOI 10.1007/s11427-010-0036-1
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Zheng L, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035003
   Zhu L, 2006, TISSUE ENG, V12, P423, DOI 10.1089/ten.2006.12.423
NR 39
TC 29
Z9 30
U1 0
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2012
VL 100A
IS 10
BP 2775
EP 2786
DI 10.1002/jbm.a.34214
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 993VP
UT WOS:000307888200027
PM 22623117
DA 2018-10-19
ER

PT J
AU Gomez-Barrena, E
   Esteban, J
   Medel, F
   Molina-Manso, D
   Ortiz-Perez, A
   Cordero-Ampuero, J
   Puertolas, JA
AF Gomez-Barrena, Enrique
   Esteban, Jaime
   Medel, Francisco
   Molina-Manso, Diana
   Ortiz-Perez, Alberto
   Cordero-Ampuero, Jose
   Puertolas, Jose A.
TI Bacterial adherence to separated modular components in joint prosthesis:
   A clinical study
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE prosthesis; infection
ID INFECTION; IMPLANTS; DIAGNOSIS; SONICATION; SURFACE
AB Bacterial adherence on total joint replacement implants may lead to biofilm formation and implant-related osteoarticular infection. It is unclear if different biomaterials in the prosthetic components are more prone to facilitate this bacterial adherence, although ultrahigh molecular weight polyethylene (UHMWPE) component exchange in modular systems has been clinically utilized in the early management of these infections. To clarify if the amount of clinically adhered microorganisms was related to the material or the component, we investigated retrieved implants from infected joint replacements. Thirty-two patients were revised after confirmed implant-related infection through positive cultures. Eighty-seven total joint components (hip and knee) were obtained and separately sonicated following a previously published protocol. Cultures were quantified, and detected colony forming units (CFU) were adjusted according to the component surface and compared based on the component material and location. Variable adherence of bacteria to chrome cobalt alloys, UHMWPE, hydroxyapatite coated components, and titanium alloys. The commonest isolated organisms were Staphylococcus epidermidis (23 of 87 components) and Staphylococcus aureus (10 of 87). Twelve components did not show any microorganism adhered despite location in an infected joint, with positive cultures in other components. A mixed linear model adjusted for random effects (the random effect being the infected patient) obtained convergence for the CFU/mm2 variable, but could not confirm a significantly higher adherence to a particular component or to a particular biomaterial. Therefore, the bacterial adherence primarily depends on the infective microorganism and the response of each individual patient, rather than materials or components. (c) 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 30:16341639, 2012
C1 [Gomez-Barrena, Enrique] Univ Autonoma Madrid, Dept Orthopaed Surg, IdiPaz Hosp La Paz, Madrid, Spain.
   [Esteban, Jaime; Molina-Manso, Diana; Ortiz-Perez, Alberto] IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Madrid, Spain.
   [Medel, Francisco; Puertolas, Jose A.] Univ Zaragoza, Dept Mat Sci & Technol, CPS I3A, E-50009 Zaragoza, Spain.
   [Cordero-Ampuero, Jose] Univ Autonoma Madrid, Dept Orthopaed Surg, Hosp La Princesa, Madrid, Spain.
   [Puertolas, Jose A.] Univ Zaragoza, CSIC, Inst Ciencia Mat Aragon, ICMA, E-50009 Zaragoza, Spain.
RP Gomez-Barrena, E (reprint author), Univ Autonoma Madrid, Dept Orthopaed Surg, IdiPaz Hosp La Paz, Madrid, Spain.
EM enrique.gomezbarrena@uam.es
RI Esteban, Jaime/S-6554-2018; GOMEZ-BARRENA, ENRIQUE/A-2799-2008
OI Esteban, Jaime/0000-0002-8971-3167; GOMEZ-BARRENA,
   ENRIQUE/0000-0003-1065-6137; Puertolas Rafales, Jose
   Antonio/0000-0002-3125-5802; Medel Rezusta, Francisco
   Javier/0000-0001-9972-0902; Cordero-Ampuero, Jose/0000-0001-7843-3971
FU Fundacion Conchita Rabago de Jimenez Diaz; Spanish Ministry of Science
   [FUNCOAT-CSD2008-00023]
FX Dr. Rosario Madero and Elia Perez, statisticians at the Hospital La Paz,
   directed and performed the statistical analysis on the mixed linear
   models. DMM was funded by a grant from the Fundacion Conchita Rabago de
   Jimenez Diaz. This study was partly funded by a grant from the Spanish
   Ministry of Science (FUNCOAT-CSD2008-00023).
CR Achermann Y, 2010, J CLIN MICROBIOL, V48, P1208, DOI 10.1128/JCM.00006-10
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   Cordero J, 1996, INJURY, V27, P34
   Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029
   Esteban J, 2008, J CLIN MICROBIOL, V46, P488, DOI 10.1128/JCM.01762-07
   Esteban J, 2011, EXPERT OPIN PHARMACO, V12, P899, DOI 10.1517/14656566.2011.543676
   Esteban J, 2010, ACTA ORTHOP, V81, P674, DOI 10.3109/17453674.2010.537810
   Gomez E., 2011, Clinical Microbiology Newsletter, V33, P63, DOI 10.1016/j.clinmicnews.2011.04.001
   Gomez E., 2011, Clinical Microbiology Newsletter, V33, P55, DOI 10.1016/j.clinmicnews.2011.03.004
   Gomez-Barrena E, 2011, J MATER SCI-MATER M, V22, P1701, DOI 10.1007/s10856-011-4340-5
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kinnari TJ, 2010, CLIN MICROBIOL INFEC, V16, P1036, DOI 10.1111/j.1469-0691.2009.02995.x
   Kinnari TJ, 2009, J BIOMED MATER RES A, V89A, P215, DOI 10.1002/jbm.a.31943
   Kurtz SM, 2011, INT ORTHOP, V35, P1783, DOI 10.1007/s00264-011-1235-5
   Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6
   Kurtz SM, 2009, J ARTHROPLASTY, V24, P195, DOI 10.1016/j.arth.2007.11.015
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
NR 21
TC 30
Z9 31
U1 0
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD OCT
PY 2012
VL 30
IS 10
BP 1634
EP 1639
DI 10.1002/jor.22114
PG 6
WC Orthopedics
SC Orthopedics
GA 994VP
UT WOS:000307962500017
PM 22467526
DA 2018-10-19
ER

PT J
AU Ribeiro, AA
   Vaz, LG
   Guastaldi, AC
   Campos, JSC
AF Ribeiro, A. A.
   Vaz, L. G.
   Guastaldi, A. C.
   Campos, J. S. C.
TI Adhesion strength characterization of PVDF/HA coating on cp Ti surface
   modified by laser beam irradiation
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Polyvinylidene fluoride; Hydroxyapatite; Titanium; Laser beam
   irradiation; Coating; Adhesion strength; Biomaterial
ID HYDROXYAPATITE COATINGS; IN-VITRO; DEPOSITION; TITANIUM; ALLOYS
AB Up to the moment, there is no standardized test for measuring the adhesion strength of polymeric coatings on titanium substrate modified by laser beam irradiation. The present work aimed to assess the adhesion strength of polyvinylidene fluoride (alpha-PVDF)/hydroxyapatite (HA) composite coating on commercially pure titanium (alpha-cp Ti) substrate surface modified by laser beam irradiation, using the three-point bending test. The preparation of coating was carried out by mixing alpha-PVDF pellets dissolved in dimethylacetamide (DMA) with HA/DMA emulsion. The mixture was poured onto the alpha-cp Ti sample and left to dry in an oven. Commercially pure titanium plates were coated with alpha-PVDF/HA composite film, in proportions of 100/00 (PVDF) and 60/40 (PVDF/HA) in weight. The Ti-PVDF/HA samples were subjected to the three-point bending test and analyzed by scanning electron microscopy. According to the results, PVDF and PVDF/HA coatings showed a good adhesion strength on alpha-cp Ti surface, since no detachment was observed. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Ribeiro, A. A.; Campos, J. S. C.] Univ Estadual Campinas, Sch Chem Engn, Dept Polymer Technol, UNICAMP, BR-13083970 Campinas, SP, Brazil.
   [Vaz, L. G.] UNESP, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, BR-14801903 Araraquara, SP, Brazil.
   [Guastaldi, A. C.] UNESP, Inst Chem, Dept Phys Chem, BR-14801970 Araraquara, SP, Brazil.
RP Ribeiro, AA (reprint author), Univ Estadual Campinas, Sch Chem Engn, Dept Polymer Technol, UNICAMP, POB 6066, BR-13083970 Campinas, SP, Brazil.
EM aantunesr@yahoo.com.br
RI Biofabris, Inct/I-2418-2013; Guastaldi, Antonio/O-7379-2014
OI Guastaldi, Antonio/0000-0002-6433-3555; Vaz, Luis
   Geraldo/0000-0003-0916-1962
FU Coordination for the Improvement of Higher Education Personnel
   (CAPES/Brazil)
FX The authors thank to the Coordination for the Improvement of Higher
   Education Personnel (CAPES/Brazil) for granting a fellowship. The
   authors also thank Giovani Costa de Oliveira for his assistance with the
   English language.
CR Braga FJC, 2007, APPL SURF SCI, V253, P9203, DOI 10.1016/j.apsusc.2007.05.048
   Braga Francisco José Correa, 2007, Mat. Res., V10, P247, DOI 10.1590/S1516-14392007000300005
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   Callegari Bianca, 2004, Acta ortop. bras., V12, P160, DOI 10.1590/S1413-78522004000300005
   Campos JSD, 2007, MAT SCI ENG B-SOLID, V136, P123, DOI 10.1016/j.mseb.2006.09.017
   DASGUPTA DK, 1988, THIN SOLID FILMS, V158, P93, DOI 10.1016/0040-6090(88)90306-9
   Fatehi K, 2008, B MATER SCI, V31, P101, DOI 10.1007/s12034-008-0018-0
   INDERHERBERGH J, 1991, FERROELECTRICS, V115, P295, DOI 10.1080/00150199108222386
   Lacefield W R, 1993, ADV SERIES CERAMICS, V1, P223
   Leon Betty, 2009, THIN CALCIUM PHOSPHA
   Liu YL, 2010, J R SOC INTERFACE, V7, pS631, DOI 10.1098/rsif.2010.0115.focus
   Man HC, 2009, THIN SOLID FILMS, V517, P5496, DOI 10.1016/j.tsf.2009.03.208
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   Nicholson J. W, 2002, CHEM MED DENT MAT
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Park DS, 2010, J BIOMED MATER RES B, V94B, P353, DOI 10.1002/jbm.b.31658
   Ribeiro AA, 2009, J MATER SCI, V44, P4056, DOI 10.1007/s10853-009-3585-6
   Tajima K, 2008, DENT MATER J, V27, P258, DOI 10.4012/dmj.27.258
   Yang S, 2009, SURF COAT TECH, V203, P3116, DOI 10.1016/j.surfcoat.2009.03.034
NR 19
TC 9
Z9 11
U1 1
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD OCT 1
PY 2012
VL 258
IS 24
BP 10110
EP 10114
DI 10.1016/j.apsusc.2012.06.084
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 991VB
UT WOS:000307729600096
OA Bronze
DA 2018-10-19
ER

PT J
AU Hatakeyama, H
   Kato, N
   Nanbo, T
   Hatakeyama, T
AF Hatakeyama, Hyoe
   Kato, Naomi
   Nanbo, Takashi
   Hatakeyama, Tatsuko
TI Water absorbent polyurethane composites derived from molasses and lignin
   filled with microcrystalline cellulose
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID THERMAL-PROPERTIES; FOAMS
AB Water absorbent polyurethane (PU) rigid composite foam was prepared using polyols derived from molasses and lignin filled with microcrystalline cellulose (MCC) powder with various particle sizes. By combining biomaterial components, preparation conditions were examined in order to obtain PU foams showing reliable water-adsorbing properties. Water absorbing capabilities, such as, water absorbing time, water retention in air as a function of time, and also mechanical properties in dry and wet state, were investigated. Rigid PU composite foams having equilibrium water retention ca. 1.0 g cm(-3), maintain ca. 0.7 g cm(-3) retention water in air after 24 h. Compression strength in the wet state was ca. 50 kPa and compression modulus ca. 1 MPa. MCC acts as a quick water absorbent in the initial stage of water immersion and PU matrix restrains a large amount of water for a long period.
C1 [Hatakeyama, Hyoe; Kato, Naomi; Nanbo, Takashi] Fukui Univ Technol, Fukui 9108505, Japan.
RP Hatakeyama, T (reprint author), Lignocel Res Co, 73-8 Yatsumata, Fukui 9103558, Japan.
EM lignocel@mx3.fctv.ne.jp
CR Chen SJ, 2011, J MATER SCI, V46, P6581, DOI 10.1007/s10853-011-5606-5
   Gandini A, 2002, CHEMICAL MODIFICATION, PROPERTIES, AND USAGE OF LIGNIN, P57
   Hatakeyama H, 2008, J THERM ANAL CALORIM, V92, P419, DOI 10.1007/s10973-007-8963-1
   Hatakeyama H, 1998, THERMOCHIM ACTA, V308, P3, DOI 10.1016/S0040-6031(97)00325-0
   Hatakeyama H, 2005, MACROMOL SYMP, V224, P219, DOI 10.1002/masy.200550619
   Hatakeyama H, 2005, COMPOS PART A-APPL S, V36, P698, DOI 10.1016/j.compositesa.2004.03.022
   Hatakeyama H, 2003, BIODEGRADABLE POLYMERS AND PLASTICS, P103
   Hatakeyama H, 2002, CHEMICAL MODIFICATION, PROPERTIES, AND USAGE OF LIGNIN, P41
   Hatakeyama H., 1997, JP, Patent No. 2663390
   Hatakeyama H, 1997, Preparation method of biodegradable polyurethane composites, Patent No. [JP-2613834, 2613834]
   Hatakeyama H, 2004, Patent title: translated from Japanese, Patent No. [JP-3567286, 3567286]
   Hatakeyama H, 2002, Patent title: translated from Japanese, Patent No. [JP-3341116, 3341116]
   Hatakeyama H., 1991, USP, Patent No. 4987213
   Hatakeyama H., 2008, CHARACTERIZATION LIN, P275
   Hatakeyama H, 2000, Biodegradable polyurethane composites and their preparation methods, Patent No. [JP-3095144, 3095144]
   Hatakeyama H, 2011, J MATER SCI, V46, P7475, DOI 10.1007/s10853-011-5717-z
   Hatakeyama H, 2010, ADV POLYM SCI, V232, P1, DOI 10.1007/12_2009_12
   Hatakeyama T, 1998, MACROMOL SYMP, V130, P139, DOI 10.1002/masy.19981300113
   Hatakeyama T, 2004, THERMOCHIM ACTA, V416, P29, DOI 10.1016/j.tca.2002.12.002
   Hatakeyama T, 2010, ACTA BIOMATER, V6, P2077, DOI 10.1016/j.actbio.2009.12.018
   Hatakeyama T, 2004, THERMAL PROPERTIES G
   Hatakeyama T, 1999, THERMAL ANAL FUNDAME
   Hirose S., 2002, JP, Patent No. 3341115
   Hirose S., 2000, JPat., Patent No. 3101701
   Hirose S, 1994, Patent title: translated from Japanese, Patent No. [JP-1813561, 1813561]
   Hirose S., 2009, ZL, Patent No. [02816051.7, 028160517]
   Hirose S., 2007, JP, Patent No. 4019346
   Hirose S., 1997, JP, Patent No. 2675997
   Homshaw LG, 1981, COLLOID INTERFACE SC, V84, P127
   Homshaw LG, 1981, COLLOID INTERFACE SC, V84, P141
   ISHIKIRIYAMA K, 1995, J COLLOID INTERF SCI, V171, P92, DOI 10.1006/jcis.1995.1154
   Ishikiriyama K, 1991, NETSU SOKUTEI, V18, P229
   Ishikiriyama K, 1987, NETSU SOKUTEI, V14, P125
   Kuriyagawa M, 2011, J MATER SCI, V46, P1264, DOI 10.1007/s10853-010-4910-9
   Maji PK, 2009, J MATER SCI, V44, P5861, DOI 10.1007/s10853-009-3827-7
   Morohoshi N, 1995, J TEX SCI TECHNOL JA, V51, P143
   Nakamura K, 1993, JP, Patent No. 1791797
   Oprea S, 2011, J MATER SCI, V46, P2251, DOI 10.1007/s10853-010-5064-5
   Saunders JH, 1962, POLYURETHANE CHEM 1, P73
   Song B, 2009, J MATER SCI, V44, P351, DOI 10.1007/s10853-008-3105-0
NR 40
TC 16
Z9 17
U1 3
U2 50
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD OCT
PY 2012
VL 47
IS 20
BP 7254
EP 7261
DI 10.1007/s10853-012-6674-x
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 986LB
UT WOS:000307342000026
DA 2018-10-19
ER

PT J
AU Erdal, E
   Kavaz, D
   Sam, M
   Demirbilek, M
   Demirbilek, ME
   Saglam, N
   Denkbas, EB
AF Erdal, Ebru
   Kavaz, Doga
   Sam, Mesut
   Demirbilek, Murat
   Demirbilek, Melike Erol
   Saglam, Necdet
   Denkbas, Emir Baki
TI Preparation and Characterization of Magnetically Responsive Bacterial
   Polyester Based Nanospheres for Cancer Therapy
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Polyhydroxybutyrate; Magnetically Responsive Nanospheres; Cancer
   Therapy; Etaposide; Concanavalin-A
ID DRUG-DELIVERY SYSTEM; EMULSIFICATION-DIFFUSION; ORAL DELIVERY; IN-VIVO;
   NANOPARTICLES; POLYHYDROXYALKANOATES; ETOPOSIDE; POLYMERS;
   GLYCONANOPARTICLES; NANOTECHNOLOGY
AB Polyhydroxyalkanoates (PHA) are natural, thermoplastic polyesters and due to their biocompatible and biodegradable properties they are good alternatives for the production of scaffolds for engineered tissues or nanoparticles for drug delivery. As a member of polyhydroxyalkanoate family, polyhydroxybutyrates (PHB) have been widely used as a biomaterial for in vitro and in vivo studies since their mechanical properties are very similar to conventional plastics. By using multi-emulsion technique, iron oxide particles were coated with polyhydroxybutyrate (PHB) polymer synthesized from Alcaligenes eutrophus bacteria and the magnetic carrier system was prepared accordingly. The bare nanoparticles and magnetic nanoparticles were morphologically, structurally and magnetically characterized by using Scanning electron microscope (SEM) and Atomic force microscope (AFM); Fourier Transform Infrared Spectrometry (FTIR), and Electron Spin Resonance (ESR) and Vibrating Sample Magnetometer (VSM) techniques, respectively. Particle size of PHB nanoparticles was determined by Zeta Sizer. It was found that the smallest particles were in the range of 239,43+/-5,25 nm in diameter. Concanavalin-A (Con-A) was used for targeting the Cancer cells while etoposide was used as drug. Con-A and etoposide were loaded onto the particles. Release studies of etoposide were evaluated and the system was optimized for the further in vivo applications. Finally different formulation magnetic PHB nanoparticles cytotoxicity were evaluated in cell culture studies and used He La cell line (cervical cancer cells) as a cancer cells and L929 cells (mouse fibroblast cells) as a non-cancer cell line.
C1 [Erdal, Ebru; Demirbilek, Murat; Saglam, Necdet; Denkbas, Emir Baki] Hacettepe Univ, Nanotechnol & Nanomed Div, TR-06800 Ankara, Turkey.
   [Kavaz, Doga; Denkbas, Emir Baki] Hacettepe Univ, Dept Chem, Div Biochem, TR-06800 Ankara, Turkey.
   [Sam, Mesut] Aksaray Univ, Dept Biol, TR-06800 Ankara, Turkey.
   [Demirbilek, Melike Erol] Aksaray Univ, Sch Hlth, TR-06800 Ankara, Turkey.
   [Saglam, Necdet] Aksaray Univ, Dept Secondary Sci & Math Educ, TR-06800 Ankara, Turkey.
RP Denkbas, EB (reprint author), Hacettepe Univ, Nanotechnol & Nanomed Div, TR-06800 Ankara, Turkey.
RI Science and Arts Faculty, Aksaray University/Q-7606-2016; University,
   Aksaray/A-1857-2018
OI SAM, Mesut/0000-0002-6429-7144
FU Hacettepe University Scientific Researches Unit
FX This project was supported by Hacettepe University Scientific Researches
   Unit and the authors would like to thank Bilkent University, Institute
   of Materials Science and Nanotechnology (UNAM).
CR Alison M. R., 2003, CANC HDB
   Babak VG, 2007, COLLOID SURFACE B, V59, P194, DOI 10.1016/j.colsurfb.2007.05.010
   Bachur N. R., 2002, ENCY CANC, V1, P57
   Bayram C, 2008, J BIOACT COMPAT POL, V23, P334, DOI 10.1177/0883911508092790
   Bentzen SM, 2005, LANCET ONCOL, V6, P112, DOI 10.1016/S1470-2045(05)01737-7
   Budhian A, 2007, INT J PHARM, V336, P367, DOI 10.1016/j.ijpharm.2006.11.061
   Catane R, 2006, HDB ADV CANC CARE
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Denkbas EB, 2008, NANO, V3, P263, DOI 10.1142/S1793292008001313
   FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0
   Gabriel J., 2007, BIOL CANC
   Galindo-Rodriguez S, 2004, PHARM RES, V21, P1428, DOI 10.1023/B:PHAM.0000036917.75634.be
   Gaucher G., 2007, J PHARM SCI, V96, P7
   Gilles C, 1996, INT J CANCER, V65, P209
   Han HD, 2008, INT J PHARM, V350, P27, DOI 10.1016/j.ijpharm.2007.08.014
   Jung T, 2000, EUR J PHARM BIOPHARM, V50, P147, DOI 10.1016/S0939-6411(00)00084-9
   Kavaz D, 2010, J BIOACT COMPAT POL, V25, P305, DOI 10.1177/0883911509360735
   Kekkonen V, 2009, J MAGN MAGN MATER, V321, P1393, DOI 10.1016/j.jmmm.2009.02.045
   Lamprecht A, 2006, J CONTROL RELEASE, V112, P208, DOI 10.1016/j.jconrel.2006.02.014
   Law KH, 2003, BIOCHEM ENG J, V16, P203, DOI 10.1016/S1369-703X(03)00039-1
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001
   Moros M, 2010, NANOSCALE, V2, P1746, DOI 10.1039/c0nr00104j
   Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064
   Poletto FS, 2008, COLLOID SURFACE A, V324, P105, DOI 10.1016/j.colsurfa.2008.04.003
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Reis CP, 2006, NANOMED-NANOTECHNOL, V2, P8, DOI 10.1016/j.nano.2005.12.003
   Rello-Varona S, 2006, INT J BIOCHEM CELL B, V38, P2183, DOI 10.1016/j.biocel.2006.06.013
   Rodriguez L.L., 2010, INT J PHARMACEUT, V402, P165
   Senear D. F., 1981, BIOCHEMISTRY-US, V26, P3083
   Silva GA, 2004, SURG NEUROL, V61, P216, DOI 10.1016/j.surneu.2003.09.036
   SMITH FE, 1951, SCIENCE, V113, P751, DOI 10.1126/science.113.2948.751-a
   Tang BC, 2010, BIOMATERIALS, V31, P339, DOI 10.1016/j.biomaterials.2009.09.033
   TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836
   van Kasteren SI, 2009, P NATL ACAD SCI USA, V106, P18, DOI 10.1073/pnas.0806787106
   Weyermann J, 2005, INT J PHARM, V288, P369, DOI 10.1016/j.ijpharm.2004.09.018
   Yamaura M, 2004, J MAGN MAGN MATER, V279, P210, DOI 10.1016/j.jmmm.2004.01.094
   Zhang TC, 2011, EUR J PHARM SCI, V43, P174, DOI 10.1016/j.ejps.2011.04.005
NR 38
TC 35
Z9 37
U1 1
U2 85
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD OCT
PY 2012
VL 8
IS 5
BP 800
EP 808
DI 10.1166/jbn.2012.1431
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 981BV
UT WOS:000306941400011
PM 22888751
DA 2018-10-19
ER

PT J
AU Trovatti, E
   Freire, CSR
   Pinto, PC
   Almeida, IF
   Costa, P
   Silvestre, AJD
   Neto, CP
   Rosado, C
AF Trovatti, Eliane
   Freire, Carmen S. R.
   Pinto, Pedro C.
   Almeida, Isabel F.
   Costa, Paulo
   Silvestre, Armando J. D.
   Pascoal Neto, Carlos
   Rosado, Catarina
TI Bacterial cellulose membranes applied in topical and transdermal
   delivery of lidocaine hydrochloride and ibuprofen: In vitro diffusion
   studies
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Bacterial cellulose; Topical and transdermal drug delivery
ID PERCUTANEOUS PENETRATION; ABSORPTION; FILM
AB Bacterial cellulose (BC) is a biomaterial with unique physical and mechanical properties that triggered considerable interest, but there are few studies addressing the use of such membranes for drug loading and controlled release. This study aimed to investigate the applicability of BC membranes in topical or transdermal drug delivery systems. To assess its therapeutic feasibility, the permeation through human epidermis of two model drugs (lidocaine hydrochloride and ibuprofen) in BC and other formulation systems was compared in vitro.
   A uniform distribution of both drugs in the BC membranes was achieved. Diffusion studies with Franz cells showed that the incorporation of lidocaine hydrochloride in BC membranes provided lower permeation rates than those obtained with the conventional formulations. However, the results obtained with the lipophilic drug were quite different, since permeation of ibuprofen in BC was almost three times higher than that of the drug in the gel or in a PEG400 solution.
   These results indicate that this technology can be successfully applied to modulate the bioavailability of drugs for percutaneous administration, which could be particularly advantageous in the design of delivery systems that have, simultaneously, the ability to absorb exudates and to adhere to irregular skin surfaces. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Pinto, Pedro C.; Rosado, Catarina] Lusofona Univ, Fac Hlth Sci & Technol, CBIOS Expt Dermatol Unit, P-1749024 Lisbon, Portugal.
   [Trovatti, Eliane; Freire, Carmen S. R.; Silvestre, Armando J. D.; Pascoal Neto, Carlos] Univ Aveiro, CICECO, P-3810193 Aveiro, Portugal.
   [Trovatti, Eliane; Freire, Carmen S. R.; Silvestre, Armando J. D.; Pascoal Neto, Carlos] Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal.
   [Almeida, Isabel F.; Costa, Paulo] Univ Porto, Lab Pharmaceut Technol, Ctr Res Pharmaceut Sci LTF CICF, Dept Drug Sci,Fac Pharm, Oporto, Portugal.
RP Rosado, C (reprint author), Lusofona Univ, Fac Hlth Sci & Technol, CBIOS Expt Dermatol Unit, Campo Grande 376, P-1749024 Lisbon, Portugal.
EM catarina.rosado@ulusofona.pt
RI Contreiras Pinto, Pedro/E-6315-2014; Rosado, Catarina/M-4679-2013;
   Freire, Carmen/E-4549-2013; iMed.ULisboa, iMed.ULisboa/C-6292-2014;
   iMed.ULisboa, PharmRegSci/B-5723-2014; Silvestre, Armando/E-6201-2010;
   NETO, CARLOS/C-8625-2011; Almeida, Isabel/N-9141-2017; Costa,
   Paulo/G-2820-2011; Trovatti, Eliane/B-9177-2012
OI Contreiras Pinto, Pedro/0000-0002-5723-0750; Rosado,
   Catarina/0000-0002-6429-6213; Freire, Carmen/0000-0002-6320-4663;
   iMed.ULisboa, PharmRegSci/0000-0003-0910-7245; Silvestre,
   Armando/0000-0001-5403-8416; NETO, CARLOS/0000-0002-8562-9275; Almeida,
   Isabel/0000-0002-1498-048X; Costa, Paulo/0000-0002-1152-3398; Trovatti,
   Eliane/0000-0002-0495-8115
CR A-sasutjarit R, 2005, PHARM RES, V22, P2134, DOI 10.1007/s11095-005-8244-2
   AKHTER SA, 1985, J PHARM PHARMACOL, V37, P27, DOI 10.1111/j.2042-7158.1985.tb04926.x
   [Anonymous], 2010, SCCS ITS 7 PLEN M 22
   Bach M, 1998, EUR J PHARM BIOPHARM, V46, P1, DOI 10.1016/S0939-6411(97)00149-5
   Barry BW, 2001, EUR J PHARM SCI, V14, P101, DOI 10.1016/S0928-0987(01)00167-1
   Bodhibukkana C, 2006, J CONTROL RELEASE, V113, P43, DOI 10.1016/j.jconrel.2006.03.007
   Brain KR, 2002, DRUGS PHARM SCI, V119, P197
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Dias M, 1999, INT J PHARM, V182, P41, DOI 10.1016/S0378-5173(99)00067-8
   Diez-Sales O, 2005, J PHARM SCI-US, V94, P1039, DOI 10.1002/jps.20317
   DIEZSALES O, 1991, INT J PHARM, V77, P1, DOI 10.1016/0378-5173(91)90295-Y
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Hu Y, 2011, ACTA BIOMATER, V7, P2835, DOI 10.1016/j.actbio.2011.03.028
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2009, MACROMOL SYMP, V280, P60, DOI 10.1002/masy.200950608
   Kligman A.M., 1963, ARCH DERMATOL, V88, P70
   Lorenzo C.A., 1999, INT J PHARMACEUT, V180, P91
   Padula C, 2003, J CONTROL RELEASE, V88, P277, DOI 10.1016/S0168-3659(03)00015-4
   PELTONEN L, 1984, CURR THER RES CLIN E, V35, P78
   RAWLINGS AV, 2002, SKIN MOISTURIZATION, P245
   Roongnapa S., 2008, J CONTROL RELEASE, V129, P170
   Sanchavanakit N, 2006, BIOTECHNOL PROGR, V22, P1194, DOI 10.1021/bp060035o
   Trovatti E, 2011, CARBOHYD POLYM, V86, P1417, DOI 10.1016/j.carbpol.2011.06.046
   Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025
   Yuan JS, 2008, INT J PHARM, V349, P130, DOI 10.1016/j.ijpharm.2007.07.047
NR 25
TC 52
Z9 55
U1 3
U2 78
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD OCT 1
PY 2012
VL 435
IS 1
BP 83
EP 87
DI 10.1016/j.ijpharm.2012.01.002
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 976UV
UT WOS:000306612300012
PM 22266531
DA 2018-10-19
ER

PT J
AU Demangel, C
   Auzene, D
   Vayssade, M
   Duval, JL
   Vigneron, P
   Nagel, MD
   Puippe, JC
AF Demangel, Clemence
   Auzene, Delphine
   Vayssade, Muriel
   Duval, Jean-Luc
   Vigneron, Pascale
   Nagel, Marie-Daniele
   Puippe, Jean-Claude
TI Cytocompatibility of titanium metal injection molding with various
   anodic oxidation post-treatments
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Metal injection molding; Anodic oxidation; Biocompatibility; Titanium;
   Implant
ID IN-VITRO; MECHANICAL-PROPERTIES; OSTEOBLAST BEHAVIOR; SURFACE-ROUGHNESS;
   ORGAN-CULTURE; OXIDE-FILMS; CELL; MICROSTRUCTURE; FIBRONECTIN;
   BIOMATERIAL
AB Metal injection molding (MIM) is a near net shape manufacturing method that allows for the production of components of small to moderate size and complex shape. MIM is a cost-effective and flexible manufacturing technique that provides a large innovative potential over existing methods for the industry of implantable devices. Commercially pure titanium (CP-Ti) samples were machined to the same shape as a composite feedstock with titanium and polyoxymethylene, and these metals were injected, debinded and sintered to assess comparative biological properties. Moreover, we treated MIM-Ti parts with BIOCOAT (R), BIODIZE (R) and BIOCER (R), three different anodic oxidation techniques that treat titanium using acid, alkaline and anion enriched electrolytes, respectively. Cytocompatibility as well as morphological and chemical features of surfaces was comparatively assessed on each sample, and the results revealed that MIM-Ti compared to CP-Ti demonstrated a specific surface topography with a higher roughness. MIM-Ti and BIOCER samples significantly enhanced cell proliferation, cell adhesion and cell differentiation compared to CP-Ti. Interestingly, in the anodization post-treatment established in this study, we demonstrated the ability to improve osseointegration through anionic modification treatment. The excellent biological response we observed with MIM parts using the injection molding process represents a promising manufacturing method for the future implantable devices in direct contact with bones. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Vayssade, Muriel; Duval, Jean-Luc; Vigneron, Pascale; Nagel, Marie-Daniele] Univ Technol Compiegne, UMR Biomecan Bioingn 7338, F-60205 Compiegne, France.
   [Demangel, Clemence; Auzene, Delphine] CRITT MDTS, ZHT Moulin Leblanc, F-08000 Charleville Mezieres, France.
   [Puippe, Jean-Claude] Steiger Galvanotech, CH-1618 Chatel St Denis, Switzerland.
RP Duval, JL (reprint author), Univ Technol Compiegne, UMR Biomecan Bioingn 7338, BP 20529, F-60205 Compiegne, France.
EM jean-luc.duval@utc.fr
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Brunette D.M., 2001, TITANIUM MED, V8, P233
   Bussy C, 2008, J BIOMED MATER RES A, V86A, P597, DOI 10.1002/jbm.a.31729
   Capek D, 2008, SURF COAT TECH, V202, P1379, DOI 10.1016/j.surfcoat.2007.06.027
   Delvat E, 2008, J MECH BEHAV BIOMED, V1, P345, DOI 10.1016/j.jmbbm.2008.01.006
   DUVAL JL, 1988, BIOMATERIALS, V9, P155, DOI 10.1016/0142-9612(88)90115-9
   DUVAL JL, 1992, CELL MATER, V2, P179
   Ebel T., 2008, PIM INT, V2, P21
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   Ferri OM, 2010, MAT SCI ENG A-STRUCT, V527, P1800, DOI 10.1016/j.msea.2009.11.007
   German R M, 2009, POWDER INJECTION MOU, V3, P21
   Ibrahim R., 2010, Advances in Science and Technology, V76, P247, DOI 10.4028/www.scientific.net/AST.76.247
   Itoh Yoshinori, 2009, Metal Powder Report, V64, P17, DOI 10.1016/S0026-0657(09)70155-9
   Itoh Y, 2009, J SOLID MECH MAT ENG, V3, P1297
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim MJ, 2006, BIOMATERIALS, V27, P5502, DOI 10.1016/j.biomaterials.2006.06.023
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leclerc E, 2009, MAT SCI ENG C-BIO S, V29, P861, DOI 10.1016/j.msec.2008.07.019
   Limberg W., 2005, Metal Powder Report, V60, P22, DOI 10.1016/S0026-0657(05)00368-1
   Muhonen V, 2009, J BIOMED MATER RES A, V88A, P787, DOI 10.1002/jbm.a.31953
   Nyberg E, 2005, MAT SCI ENG C-BIO S, V25, P336, DOI 10.1016/j.msec.2005.04.006
   Nyberg E., 2005, Metal Powder Report, V60, P8, DOI 10.1016/S0026-0657(05)70496-3
   Puippe J.-C., 2004, Galvanotechnik, V95, P2908
   Shibo G., 2006, J MATER PROCESS TECH, V173, P310
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Weil KS, 2006, J MATER PROCESS TECH, V176, P205, DOI [10.1016/j.jmatprotec.2006.03.154, 10.1016/j.jmatprotec.2006.03-154]
   Wennerberg A, 1998, INT J MACH TOOL MANU, V38, P657, DOI 10.1016/S0890-6955(97)00114-4
   Whiteside P, 2010, J BIOMED MATER RES A, V94A, P38, DOI 10.1002/jbm.a.32664
   Zhang YM, 2004, J BIOMED MATER RES A, V68A, P383, DOI 10.1002/jbm.a.20063
   Zhu SH, 2005, J CENT SOUTH UNIV T, V12, P9, DOI 10.1007/s11771-005-0362-9
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 35
TC 9
Z9 11
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2012
VL 32
IS 7
BP 1919
EP 1925
DI 10.1016/j.msec.2012.05.037
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 981AM
UT WOS:000306937700026
DA 2018-10-19
ER

PT J
AU Li, F
   Ba, QJ
   Niu, SM
   Guo, Y
   Duan, YK
   Zhao, P
   Lin, C
   Sun, J
AF Li, Fang
   Ba, Qiujie
   Niu, Sumei
   Guo, Yi
   Duan, Yankang
   Zhao, Peng
   Lin, Chao
   Sun, Jing
TI In-situ forming biodegradable glycol chitosan-based hydrogels:
   Synthesis, characterization, and chondrocyte culture
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydrogel; Glycol chitosan; In-situ forming; Poly(ethylene glycol);
   Michael addition
ID BIOREDUCIBLE POLY(AMIDO AMINE)S; MICHAEL ADDITION; BIOMEDICAL
   APPLICATIONS; GENE DELIVERY; CROSS-LINKING; DEGRADATION; BIOMATERIAL;
   DESIGN; CHITIN; VITRO
AB In-situ forming hydrogels from thiolated glycol chitosan (GCH-SH) and vinyl sulfone-modified PEG (PL-VS) were designed, prepared and successfully applied as biodegradable, non-toxic bio-scaffolds for chondrocyte culture. The hydrogels could be formed in situ under physiological conditions via Michael-type addition between the GCH-SH and PL-VS at a low polymer concentration of 1-3% (w/v). Gelation times varied from 0.75 to 50 min, depending on the polymer concentration and the arm number of PEG-VS. Moreover, a high arm number and a high polymer concentration may lead to efficient network formation of GCH-SH/PEG-VS hydrogels. These hydrogels were found biodegradable in the presence of lysozyme, a cationic protein in the body, for a long period of time. Rheological studies indicated that these hydrogels generally displayed highly elastic property and had higher mechanical strength than those from thiolated hyaluronic acid/PEG-VS reported previously. SEM observation revealed that these hydrogels possessed well-interconnected microporous morphology. Besides these, the chondrocytes could be incorporated and homogeneously distributed in the hydrogel based on GCH-SH and 4-arm PL-VS. Importantly, after cell culture of 14 days, the chondrocytes in the hydrogel remained viable, as determined by a live-dead assay, and the cells kept their round chondrocytic phenotype. These results suggest that Michael-type addition is an effective method in the preparation of in-situ forming, biodegradable GCH-based hydrogels serving as bio-scaffolds for chondrocyte culture. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Li, Fang; Ba, Qiujie; Niu, Sumei; Guo, Yi; Duan, Yankang; Sun, Jing] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Shanghai 200040, Peoples R China.
   [Li, Fang; Zhao, Peng; Lin, Chao] Tongji Univ, Sch Med, Inst Adv Mat & NanoBiomed, Shanghai 200092, Peoples R China.
RP Li, F (reprint author), Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Shanghai 200040, Peoples R China.
EM 09lifang@tongji.edu.cn; chaolin@tongji.edu.cn; sunjing61867@yahoo.com.cn
FU Science and Technology Committee of Shanghai [1052nm01200]; Health
   Bureau of Shanghai [20114150]; Ministry of Science and Technology of
   China [2012CB966300]; Innovation Program of Shanghai Municipal Education
   Commission [10ZZ26]; National Natural Science Foundation of China
   [20904041]
FX This work was supported by grants from the Science and Technology
   Committee of Shanghai (1052nm01200, F.L) and Health Bureau of Shanghai
   (20114150, F.L), the Ministry of Science and Technology of China
   (2012CB966300, P.Z.), the Innovation Program of Shanghai Municipal
   Education Commission (no. 10ZZ26, C.L.), and the National Natural
   Science Foundation of China (no. 20904041, C.L).
CR Amsden BG, 2007, BIOMACROMOLECULES, V8, P3758, DOI 10.1021/bm700691e
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Ding CX, 2010, BIOMACROMOLECULES, V11, P1043, DOI 10.1021/bm1000179
   ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6
   Frohlich M, 2007, CELL BIOL INT, V31, P620, DOI 10.1016/j.cellbi.2006.12.003
   Greenwald R.A., 1972, J CLIN INVEST, V51, P2261
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hiemstra C, 2007, BIOMACROMOLECULES, V8, P1548, DOI 10.1021/bm061191m
   Hiemstra C, 2007, MACROMOLECULES, V40, P1165, DOI 10.1021/ma062468d
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hong Y, 2006, J BIOMED MATER RES A, V79A, P913, DOI 10.1002/jbm.a.30837
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024
   Jin R, 2009, BIOMATERIALS, V30, P2544, DOI 10.1016/j.biomaterials.2009.01.020
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Jin R, 2010, TISSUE ENG PT A, V16, P2429, DOI [10.1089/ten.tea.2009.0764, 10.1089/ten.TEA.2009.0764]
   Jukes JM, 2010, TISSUE ENG PT A, V16, P565, DOI [10.1089/ten.tea.2009.0173, 10.1089/ten.TEA.2009.0173]
   Lin C, 2007, BIOCONJUGATE CHEM, V18, P138, DOI 10.1021/bc060200l
   Lin C, 2011, MAT SCI ENG C-MATER, V31, P1330, DOI 10.1016/j.msec.2011.04.017
   Lin C, 2010, MAT SCI ENG C-MATER, V30, P1236, DOI 10.1016/j.msec.2010.07.004
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001
   Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Xia W, 2012, J CONTROL RELEASE, V157, P427, DOI 10.1016/j.jconrel.2011.10.011
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhao LL, 2011, INT J PHARMACEUT, V410, P83, DOI 10.1016/j.ijpharm.2011.03.034
NR 34
TC 16
Z9 16
U1 5
U2 82
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2012
VL 32
IS 7
BP 2017
EP 2025
DI 10.1016/j.msec.2012.05.021
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 981AM
UT WOS:000306937700040
DA 2018-10-19
ER

PT J
AU Shen, JF
   Li, T
   Shi, M
   Li, N
   Ye, MX
AF Shen, Jianfeng
   Li, Tie
   Shi, Min
   Li, Na
   Ye, Mingxin
TI Polyelectrolyte-assisted one-step hydrothermal synthesis of Ag-reduced
   graphene oxide composite and its antibacterial properties
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Polyelectrolyte; Graphene; Silver; Hydrothermal; Antibacterial
ID NANOPARTICLES; DISPERSIONS; GRAPHITE
AB We demonstrate an effective one-pot hydrothermal route for the synthesis of Poly (diallyldimethylammonium chloride) (PDDA)-protected reduced graphene oxide (RGO) sheets-silver (Ag) nanocomposite in the absence of any seeds and surfactants. In this method, PDDA, an ordinary and water-soluble polyelectrolyte, acts as both a reducing and a stabilizing agent. More importantly, the incorporation of PDDA as a "glue" molecule successfully turns RGO into general platforms for in situ growth of Ag. Small Ag nanoparticles with average height of 4 nm are distributed on the surface of RGO sheets. It is also found that the antibacterial activity of Ag nanoparticles is retained in the composite, suggesting that it can be used as RGO-based biomaterial. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Shen, Jianfeng; Li, Tie; Shi, Min; Li, Na; Ye, Mingxin] Fudan Univ, Ctr Special Mat & Technol, Shanghai 200433, Peoples R China.
RP Ye, MX (reprint author), Fudan Univ, Ctr Special Mat & Technol, Shanghai 200433, Peoples R China.
EM mxye@fudan.edu.cn
FU Fundamental Research Funds for the Central Universities [10FX011];
   National Basic Research Program of China [2011CB605704]
FX We gratefully acknowledge the financial sponsor by the Fundamental
   Research Funds for the Central Universities (No. 10FX011) and National
   Basic Research Program of China (2011CB605704).
CR Akhavan O, 2009, J PHYS CHEM C, V113, P20214, DOI 10.1021/jp906325q
   Chen H, 2007, INORG CHEM, V46, P10587, DOI 10.1021/ic7009572
   Chen Y, 2011, CARBON, V49, P573, DOI 10.1016/j.carbon.2010.09.060
   Compton OC, 2010, SMALL, V6, P711, DOI 10.1002/smll.200901934
   Dato A, 2008, NANO LETT, V8, P2012, DOI 10.1021/nl8011566
   Domingues SH, 2011, CHEM COMMUN, V47, P2592, DOI 10.1039/c0cc04304d
   Forbeaux I, 1998, PHYS REV B, V58, P16396, DOI 10.1103/PhysRevB.58.16396
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Goncalves G, 2009, CHEM MATER, V21, P4796, DOI 10.1021/cm901052s
   Han PX, 2011, CARBON, V49, P693, DOI 10.1016/j.carbon.2010.10.022
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Ishigami M, 2007, NANO LETT, V7, P1643, DOI 10.1021/nl070613a
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Li J., 2010, EUR J INORG CHEM, V8, P1244
   Liu L, 2008, NANO LETT, V8, P1965, DOI 10.1021/nl0808684
   Liu M, 2011, CHEM COMMUN, V47, P4084, DOI 10.1039/c1cc00107h
   Ma JZ, 2011, J MATER CHEM, V21, P3350, DOI 10.1039/c0jm02806a
   Niyogi S, 2006, J AM CHEM SOC, V128, P7720, DOI 10.1021/ja060680r
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/NNANO.2009.58, 10.1038/nnano.2009.58]
   Pasricha R, 2009, SMALL, V5, P2253, DOI 10.1002/smll.200900726
   Rao CNR, 2009, J MATER CHEM, V19, P2457, DOI 10.1039/b815239j
   Shen JF, 2011, J MATER CHEM, V21, P7795, DOI 10.1039/c1jm10671f
   Shen JF, 2010, NANO RES, V3, P339, DOI 10.1007/s12274-010-1037-x
   Shen JF, 2010, J PHYS CHEM C, V114, P1498, DOI 10.1021/jp909756r
   Shen JF, 2009, CHEM MATER, V21, P3514, DOI 10.1021/cm901247t
   Si YC, 2008, CHEM MATER, V20, P6792, DOI 10.1021/cm801356a
   Sun ST, 2011, J MATER CHEM, V21, P4095, DOI 10.1039/c1jm10276a
   Tang XZ, 2011, CHEM COMMUN, V47, P3084, DOI 10.1039/c0cc05613h
   Tien HW, 2011, CARBON, V49, P1550, DOI 10.1016/j.carbon.2010.12.022
   Wan Y, 2011, ANAL CHEM, V83, P648, DOI 10.1021/ac103047c
   Wang J, 2009, ADV MATER, V21, P2430, DOI 10.1002/adma.200803616
   Wen YQ, 2010, CHEM COMMUN, V46, P2596, DOI 10.1039/b924832c
   Xu WP, 2011, J MATER CHEM, V21, P4593, DOI 10.1039/c0jm03376f
   Zhang S, 2011, ACS NANO, V5, P1785, DOI 10.1021/nn102467s
   Zhang S, 2009, J MATER CHEM, V19, P7995, DOI 10.1039/b912104h
   Zhou XZ, 2009, J PHYS CHEM C, V113, P10842, DOI 10.1021/jp903821n
NR 36
TC 34
Z9 35
U1 1
U2 85
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2012
VL 32
IS 7
BP 2042
EP 2047
DI 10.1016/j.msec.2012.05.017
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 981AM
UT WOS:000306937700043
DA 2018-10-19
ER

PT J
AU Volden, S
   Ese, MHG
   Zhu, KZ
   Yasuda, M
   Nystrom, B
   Glomm, WR
AF Volden, Sondre
   Ese, Marit-Helen G.
   Zhu, Kaizheng
   Yasuda, Masahiro
   Nystrom, Bo
   Glomm, Wilhelm R.
TI Interactions between bovine serum albumin and Langmuir films composed of
   charged and uncharged poly(N-isopropylacrylamide) block copolymers
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Monolayers; Thermoresponsive polymers; Protein interaction at
   interfaces; Brewster angle microscopy
ID AIR-WATER-INTERFACE; AIR/WATER INTERFACE; DIBLOCK COPOLYMER;
   AQUEOUS-SOLUTIONS; NANOPARTICLES; ADSORPTION; TEMPERATURE; PROTEINS;
   POLYMERS; DELIVERY
AB The thermoresponsive poly(N-isopropylacrylamide) (PNIPAAM) and NIPAAM block copolymer derivatives are attractive for drug delivery applications as they contract reversibly at lower critical solution temperatures (LCST) close to physiological conditions. In order to investigate biomaterial-protein compatibility, we have studied the interaction between PNIPAAM copolymer films spread at the air-water surface and bovine serum albumin (BSA) injected below the precompressed polymer films, using the Langmuir technique coupled with Brewster angle microscopy (BAM). A PNIPAAM homopolymer was applied together with a number of PNIPAAM-based di- and triblock copolymers, to assess effects of e.g., charge and hydrophobicity on protein-polymer interactions. The nature and strength of protein-polymer interaction was found to be tunable, ranging from complex formation (PNIPAAM homopolymer) to mixed monolayers and electrostatic cross-linking, according to the nature of the co-monomer. Results show that intercalation versus adsorption can be controlled through polymer composition. (C) 2012 Elsevier By. All rights reserved.
C1 [Volden, Sondre; Glomm, Wilhelm R.] Norwegian Univ Sci & Technol NTNU, Dept Chem Engn, Ugelstad Lab, N-7491 Trondheim, Norway.
   [Ese, Marit-Helen G.] SINTEF Energy Res, N-7465 Trondheim, Norway.
   [Zhu, Kaizheng; Nystrom, Bo] Univ Oslo, Dept Chem, N-0315 Oslo, Norway.
   [Yasuda, Masahiro] Osaka Prefecture Univ, Dept Chem Engn, Sakai, Osaka 5998531, Japan.
RP Glomm, WR (reprint author), Norwegian Univ Sci & Technol NTNU, Dept Chem Engn, Ugelstad Lab, N-7491 Trondheim, Norway.
EM glomm@nt.ntnu.no
RI Yasuda, Masahiro/B-2271-2010
FU Research Council of Norway (NFR) within the FRINAT [177556/V30]
FX The authors gratefully acknowledge the Research Council of Norway (NFR)
   for financial support within the FRINAT program, project No. 177556/V30.
CR Bawa P., 2009, BIOMED MATER, V4, P15
   Burkert S., 2009, LANGMUIR, V26, P1786
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   da Silva AMPSG, 2008, J COLLOID INTERF SCI, V327, P129, DOI 10.1016/j.jcis.2008.08.011
   Doorty KB, 2003, CARDIOVASC PATHOL, V12, P105, DOI 10.1016/S1054-8807(02)00165-5
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Glomm WR, 2011, J DISPER SCI TECHNOL, V32, P150, DOI 10.1080/01932690903543287
   Glomm WR, 2009, ANAL CHEM, V81, P3042, DOI 10.1021/ac8027257
   Gulati N, 2010, COLLOID SURFACE B, V79, P164, DOI 10.1016/j.colsurfb.2010.03.049
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Kavanagh CA, 2005, J BIOMED MATER RES A, V72A, P25, DOI 10.1002/jbm.a.30192
   Kjoniksen AL, 2008, J PHYS CHEM B, V112, P3294, DOI 10.1021/jp800404a
   Lindman S, 2007, NANO LETT, V7, P914, DOI 10.1021/nI062743+
   Liu GM, 2007, J PHYS CHEM B, V111, P3633, DOI 10.1021/jp066702d
   Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021
   Lystvet SM, 2011, NANOSCALE, V3, P1788, DOI 10.1039/c0nr00948b
   Pamies R, 2009, POLYM BULL, V62, P487, DOI 10.1007/s00289-008-0029-4
   Rezwan K, 2004, LANGMUIR, V20, P10055, DOI 10.1021/la048459k
   SAITO W, 1995, MACROMOLECULES, V28, P7945, DOI 10.1021/ma00127a049
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmaljohann D, 2003, BIOMACROMOLECULES, V4, P1733, DOI 10.1021/bm034160p
   Volden S, 2010, ACS NANO, V4, P1187, DOI 10.1021/nn901517u
   Wei H, 2009, PROG POLYM SCI, V34, P893, DOI 10.1016/j.progpolymsci.2009.05.002
   Yu Q, 2010, LANGMUIR, V26, P8582, DOI 10.1021/la904663m
   Zhang J, 1996, LANGMUIR, V12, P2611, DOI 10.1021/la950548x
   Zhu K, 2007, J PHYS CHEM B, V111, P10862, DOI 10.1021/jp074163m
NR 29
TC 10
Z9 10
U1 0
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2012
VL 98
BP 50
EP 57
DI 10.1016/j.colsurfb.2012.04.038
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 976WT
UT WOS:000306618800008
PM 22652359
DA 2018-10-19
ER

PT J
AU Ravichandran, R
   Venugopal, JR
   Sundarrajan, S
   Mukherjee, S
   Sridhar, R
   Ramakrishna, S
AF Ravichandran, Rajeswari
   Venugopal, Jayarama Reddy
   Sundarrajan, Subramanian
   Mukherjee, Shayanti
   Sridhar, Radhakrishnan
   Ramakrishna, Seeram
TI Minimally invasive injectable short nanofibers of poly(glycerol
   sebacate) for cardiac tissue engineering
SO NANOTECHNOLOGY
LA English
DT Article
ID STEM-CELL TRANSPLANTATION; HEART-FAILURE; MYOCARDIAL-INFARCTION;
   IN-VITRO; BIODEGRADABLE ELASTOMERS; REPAIR; BIOMATERIALS; REGENERATION;
   SCAFFOLDS; STIFFNESS
AB Myocardial tissue lacks the ability to appreciably regenerate itself following myocardial infarction (MI) which ultimately results in heart failure. Current therapies can only retard the progression of disease and hence tissue engineering strategies are required to facilitate the engineering of a suitable biomaterial to repair MI. The aim of this study was to investigate the in vitro properties of an injectable biomaterial for the regeneration of infarcted myocardium. Fabrication of core/shell fibers was by co-axial electrospinning, with poly(glycerol sebacate) (PGS) as core material and poly-L-lactic acid (PLLA) as shell material. The PLLA was removed by treatment of the PGS/PLLA core/shell fibers with DCM: hexane (2: 1) to obtain PGS short fibers. These PGS short fibers offer the advantage of providing a minimally invasive injectable technique for the regeneration of infarcted myocardium. The scaffolds were characterized by SEM, FTIR and contact angle and cell-scaffold interactions using cardiomyocytes. The results showed that the cardiac marker proteins actinin, troponin, myosin heavy chain and connexin 43 were expressed more on short PGS fibers compared to PLLA nanofibers. We hypothesized that the injection of cells along with short PGS fibers would increase cell transplant retention and survival within the infarct, compared to the standard cell injection system.
C1 [Ravichandran, Rajeswari; Venugopal, Jayarama Reddy; Sundarrajan, Subramanian; Mukherjee, Shayanti; Sridhar, Radhakrishnan; Ramakrishna, Seeram] Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Fac Engn, Healthcare & Energy Mat Lab, Singapore 117576, Singapore.
   [Ravichandran, Rajeswari; Sundarrajan, Subramanian; Sridhar, Radhakrishnan; Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Venugopal, JR (reprint author), Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Fac Engn, Healthcare & Energy Mat Lab, Block E3,05-12 2 Engn Dr 3, Singapore 117576, Singapore.
EM nnijrv@nus.edu.sg
RI Subramanian, Sundarrajan/E-8022-2011; Radhakrishnan, Sridhar/B-7439-2013
OI Radhakrishnan, Sridhar/0000-0002-5068-3175; Jayarama Reddy,
   Venugopal/0000-0001-5867-8007
FU NRF-Technion [R-398-001-065-592]; Ministry of Education
   [R-265-000-318-112]; NUSNNI, National University of Singapore, Singapore
FX This study was supported by the NRF-Technion (R-398-001-065-592),
   Ministry of Education (R-265-000-318-112) and NUSNNI, National
   University of Singapore, Singapore.
CR Amsden B, 2004, BIOMACROMOLECULES, V5, P1399, DOI 10.1021/bm034538j
   [Anonymous], IM J IM PROC AN JAV
   Bel A, 2003, NY TIMES        1026, V108, pII247
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Buckberg GD, 2002, J THORAC CARDIOV SUR, V124, P863, DOI 10.1067/mtc.2002.122439
   Burdick JA, 2001, BIOMATERIALS, V22, P1779, DOI 10.1016/S0142-9612(00)00347-1
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Cassell OCS, 2001, ANN NY ACAD SCI, V944, P429
   Chachques JC, 2004, ANN THORAC SURG, V77, P1121, DOI 10.1016/j.athoracsur.2003.09.081
   Chachques JC, 2007, CELL TRANSPLANT, V16, P927, DOI 10.3727/096368907783338217
   Chang AC, 2006, HEART FAILURE CHILDR, P828
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Dib N, 2010, JACC-CARDIOVASC INTE, V3, P265, DOI 10.1016/j.jcin.2009.12.013
   Drexler Helmut, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS65, DOI 10.1038/ncpcardio0407
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Escott EJ, 2003, RADIOGRAPHICS, V23, P1341, DOI 10.1148/rg.235035047
   Fiebiger W, 2011, CLIN TRANSL ONCOL, V13, P43, DOI 10.1007/s12094-011-0615-z
   Frigerio M, 2005, AM J CARDIOL, V96, p10L, DOI 10.1016/j.amjcard.2005.09.060
   Gao J, 2007, J BIOMED MATER RES A, V83A, P1070, DOI 10.1002/jbm.a.31434
   Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004
   Heidenreich PA, 2001, AM J MED, V110, P165, DOI 10.1016/S0002-9343(00)00712-9
   Hickman MA, 2010, P NATL ACAD SCI USA, V107, P19384, DOI 10.1073/pnas.1006436107
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   Kim DH, 2006, LANGMUIR, V22, P5419, DOI 10.1021/la060283u
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Koninckx R, 2011, CELL MOL LIFE SCI, V68, P2141, DOI 10.1007/s00018-010-0560-y
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2000, CIRCULATION, V102, P56
   Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Minatoguchi S, 2004, CIRCULATION, V109, P2572, DOI 10.1161/01.CIR.0000129770.93985.3E
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   NAKANO K, 1990, CIRCULATION, V82, P1352, DOI 10.1161/01.CIR.82.4.1352
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Ohtsuka M, 2004, FASEB J, V18, P851, DOI 10.1096/fj.03-0637fje
   Ota T, 2008, CIRCULATION, V118, pS115, DOI 10.1161/CIRCULATIONAHA.107.756049
   Ozawa T, 2002, J THORAC CARDIOV SUR, V124, P1157, DOI 10.1067/mtc.2002.127449
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Parmacek MS, 2005, CELL, V120, P295, DOI 10.1016/j.cell.2005.01.025
   Patel AN, 2005, J THORAC CARDIOV SUR, V130, P1631, DOI 10.1016/j.jtcvs.2005.07.056
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Ravichandran R, 2012, INT J CARDI IN PRESS
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Reinecke H, 2002, J MOL CELL CARDIOL, V34, P251, DOI 10.1006/jmcc.2001.1494
   Reinecke H, 2000, CARDIOVASC PATHOL, V9, P337, DOI 10.1016/S1054-8807(00)00055-7
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   von Harsdorf R, 2004, LANCET, V363, P1306, DOI 10.1016/S0140-6736(04)16006-6
   Vunjak-Novakovic G, 2006, J CHEM TECHNOL BIOT, V81, P485, DOI 10.1002/jctb.1467
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Watanabe S, 2006, EUR HEART J, V27, P832, DOI 10.1093/eurheartj/ehi772
   Xing Yu, 2003, Fa Yi Xue Za Zhi, V19, P242
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2009, P NATL ACAD SCI USA, V106, P10086, DOI 10.1073/pnas.0900004106
   Yeo Y, 2007, J BIOMED MATER RES B, V81B, P312, DOI 10.1002/jbm.b.30667
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
   Yildirim Y, 2007, CIRCULATION, V116, pI16, DOI 10.1161/CIRCULATIONAHA.106.679688
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 77
TC 43
Z9 43
U1 1
U2 75
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD SEP 28
PY 2012
VL 23
IS 38
AR 385102
DI 10.1088/0957-4484/23/38/385102
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 006IQ
UT WOS:000308813100002
PM 22947662
DA 2018-10-19
ER

PT J
AU Moyal, T
   Bavikar, SN
   Karthikeyan, SV
   Hemantha, HP
   Brik, A
AF Moyal, Tal
   Bavikar, Sudhir N.
   Karthikeyan, Subramanian Vedhanarayanan
   Hemantha, Hosahalli P.
   Brik, Ashraf
TI Polymerization Behavior of a Bifunctional Ubiquitin Monomer as a
   Function of the Nucleophile Site and Folding Conditions
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID NATIVE CHEMICAL LIGATION; LYS48-LINKED DI-UBIQUITIN; POLYUBIQUITIN
   CHAINS; CRYSTAL-STRUCTURE; BINDING DOMAINS; PROTEIN; UBIQUITYLATION;
   TETRAUBIQUITIN; CONFORMATION; DIUBIQUITIN
AB Biopolymers with repeating modules composed of either folded peptides or tertiary protein domains are considered some of the basic biomaterials that nature has evolved to optimize for energy efficient synthesis and unique functions. Such biomaterials continue to inspire scientists to mimic their exceptional properties and the ways that nature adopts to prepare them. Ubiquitin chains represent another example of nature's approach to use a protein-repeating module to prepare functionally important biopolymers. In the current work, we utilize a novel synthetic strategy to prepare bifunctional ubiquitin monomers having a C-terminal thioester and a nucleophilic 1,2-aminothiol at a desired position to examine their polymerization products under different conditions. Our study reveals that such analogues, when subjected to polymerization conditions under different folding states, afford distinct patterns of polymerization products where both the dynamic and the tertiary structures of the chains play important roles in such processes. Moreover, we also show that the presence of a specific ubiquitin-binding domain, which binds specifically to some of these chains, could interfere selectively with the polymerization outcome. Our study represents the first example of examining the polymerization of designed and synthetic repeating modules based on tertiary protein domains and affords early lessons in the design and synthesis of biomaterial. In regards to the ubiquitin system, our study may have implications on the ease of synthesis of ubiquitin chains with varying lengths and types for structural and functional analyses. Importantly, such an approach could also assist in understanding the enzymatic machinery and the factors controlling the assembly of these chains with a desired length.
C1 [Moyal, Tal; Bavikar, Sudhir N.; Karthikeyan, Subramanian Vedhanarayanan; Hemantha, Hosahalli P.; Brik, Ashraf] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel.
RP Brik, A (reprint author), Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel.
EM abrik@bgu.ac.il
RI Brik, Ashraf/F-1583-2012
FU Israel Science Foundation
FX This work was supported by the Israel Science Foundation. We wish to
   thank Liat Spasser, Prof N. Gabriel Lemcoff, Dr. David Lukatsky, and
   Prof. Taleb Mokari for useful discussions as well as Dr. Alexandra
   Massarwa for proofreading this manuscript.
CR Bavikar SN, 2012, ANGEW CHEM INT EDIT, V51, P758, DOI 10.1002/anie.201106430
   Beligere GS, 1999, J AM CHEM SOC, V121, P6332, DOI 10.1021/ja9907919
   Birk A., 2007, CHEM-EUR J, V13, P5670
   Castaneda C, 2011, J AM CHEM SOC, V133, P17855, DOI 10.1021/ja207220g
   Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]
   Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]
   Coltart DM, 2000, TETRAHEDRON, V56, P3449, DOI 10.1016/S0040-4020(00)00147-2
   Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090
   DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629
   Dickinson BC, 2007, PROTEIN SCI, V16, P369, DOI 10.1110/062508007
   Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767
   Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010
   Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065
   Eger S, 2010, J AM CHEM SOC, V132, P16337, DOI 10.1021/ja1072838
   El Oualid F, 2010, ANGEW CHEM INT EDIT, V49, P10149, DOI 10.1002/anie.201005995
   Erlich LA, 2010, ORG BIOMOL CHEM, V8, P2392, DOI 10.1039/c000332h
   Fekner T, 2011, CHEMBIOCHEM, V12, P21, DOI 10.1002/cbic.201000625
   Hackenberger CPR, 2008, ANGEW CHEM INT EDIT, V47, P10030, DOI 10.1002/anie.200801313
   Haj-Yahya M, 2010, BIOPOLYMERS, V94, P504, DOI 10.1002/bip.21384
   Hejjaoui M, 2011, ANGEW CHEM INT EDIT, V50, P405, DOI 10.1002/anie.201005546
   Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138
   Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93
   Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i
   KEMP DS, 1981, BIOPOLYMERS, V20, P1793, DOI 10.1002/bip.1981.360200904
   Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j
   Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937
   Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55
   Kumar KSA, 2011, ANGEW CHEM INT EDIT, V50, P6137, DOI 10.1002/anie.201101920
   Kumar KSA, 2010, ANGEW CHEM INT EDIT, V49, P9126, DOI 10.1002/anie.201003763
   Kumar KSA, 2009, ANGEW CHEM INT EDIT, V48, P8090, DOI 10.1002/anie.200902936
   Kushner AM, 2011, ANGEW CHEM INT EDIT, V50, P9026, DOI 10.1002/anie.201006496
   Lutsky MY, 2008, CHEM COMMUN, P1229, DOI 10.1039/b718945a
   McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906
   Meier F, 2012, J AM CHEM SOC, V134, P5468, DOI 10.1021/ja300094r
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009
   Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503
   Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712
   Rohaim A, 2012, ACTA CRYSTALLOGR D, V68, P102, DOI 10.1107/S0907444911051195
   Ryabov Y, 2007, J AM CHEM SOC, V129, P7894, DOI 10.1021/ja071185d
   Ryadnov MG, 2007, J AM CHEM SOC, V129, P14074, DOI 10.1021/ja072960s
   Satoh T, 2010, BIOCHEM BIOPH RES CO, V400, P329, DOI 10.1016/j.bbrc.2010.08.057
   Shanmugham A, 2010, J AM CHEM SOC, V132, P8834, DOI 10.1021/ja101803s
   Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/NMETH.1888, 10.1038/nmeth.1888]
   Sommer S, 2011, ANGEW CHEM INT EDIT, V50, P9888, DOI 10.1002/anie.201102531
   Spasser L, 2012, ANGEW CHEM INT EDIT, V51, P6840, DOI 10.1002/anie.201200020
   Strieter ER, 2012, ACS CHEM BIOL, V7, P52, DOI 10.1021/cb2004059
   Tingting Y., 2000, J BIOL CHEM, V275, P36862
   Valkevich EM, 2012, J AM CHEM SOC, V134, P6916, DOI 10.1021/ja300500a
   van Dijk ADJ, 2005, PROTEINS, V60, P367, DOI 10.1002/prot.20476
   Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200
   Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013
   VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6
   Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]
   Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013
   Weissman M, 2001, NAT REV MOL CELL BIO, V2, P169
   Yang RL, 2009, J AM CHEM SOC, V131, P13592, DOI 10.1021/ja905491p
   Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780
NR 58
TC 18
Z9 18
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD SEP 26
PY 2012
VL 134
IS 38
BP 16085
EP 16092
DI 10.1021/ja3078736
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 010MY
UT WOS:000309099700070
PM 22963682
DA 2018-10-19
ER

PT J
AU Busscher, HJ
   van der Mei, HC
   Subbiahdoss, G
   Jutte, PC
   van den Dungen, JJAM
   Zaat, SAJ
   Schultz, MJ
   Grainger, DW
AF Busscher, Henk J.
   van der Mei, Henny C.
   Subbiahdoss, Guruprakash
   Jutte, Paul C.
   van den Dungen, Jan J. A. M.
   Zaat, Sebastian A. J.
   Schultz, Marcus J.
   Grainger, David W.
TI Biomaterial-Associated Infection: Locating the Finish Line in the Race
   for the Surface
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Review
ID GLYCOL)-BASED POLYMER-COATINGS; CENTRAL VENOUS CATHETERS; BLOOD-STREAM
   INFECTIONS; PERI-IMPLANT TISSUE; BACTERIAL-COLONIZATION; IN-VITRO;
   STAPHYLOCOCCUS-EPIDERMIDIS; MICROBIAL ADHESION; HIP-ARTHROPLASTY;
   OPERATING-ROOM
AB Biomaterial-associated infections occur on both permanent implants and temporary devices for restoration or support of human functions. Despite increasing use of biomaterials in an aging society, comparatively few biomaterials have been designed that effectively reduce the incidence of biomaterial-associated infections. This review provides design guidelines for infection-reducing strategies based on the concept that the fate of biomaterial implants or devices is a competition between host tissue cell integration and bacterial colonization at their surfaces.
C1 [Busscher, Henk J.; van der Mei, Henny C.; Subbiahdoss, Guruprakash] Univ Med Ctr Groningen, Dept BioMed Engn, NL-9713 AV Groningen, Netherlands.
   [Busscher, Henk J.; van der Mei, Henny C.; Subbiahdoss, Guruprakash] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Jutte, Paul C.] Univ Med Ctr Groningen, Dept Orthopaed Surg, NL-9713 GZ Groningen, Netherlands.
   [Jutte, Paul C.; van den Dungen, Jan J. A. M.] Univ Groningen, NL-9713 GZ Groningen, Netherlands.
   [van den Dungen, Jan J. A. M.] Univ Med Ctr Groningen, Dept Surg, NL-9713 GZ Groningen, Netherlands.
   [Zaat, Sebastian A. J.] Univ Amsterdam, NL-1105 AZ Amsterdam, Netherlands.
   [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   [Grainger, David W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Grainger, David W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept BioMed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@umcg.nl
RI Schultz, Marcus/K-6147-2012
OI Subbiahdoss, Guruprakash/0000-0002-6684-7322
CR Bach A, 1999, CRIT CARE MED, V27, P515, DOI 10.1097/00003246-199903000-00028
   Baldoni D, 2009, ANTIMICROB AGENTS CH, V53, P1142, DOI 10.1128/AAC.00775-08
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Bhende Shubhangi, 2007, Surg Infect (Larchmt), V8, P405, DOI 10.1089/sur.2005.061
   Bistolfi A, 2011, ISRN ORTHOP
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bosse MJ, 2005, J BONE JOINT SURG AM, V87A, P1343, DOI 10.2106/JBJS.D.02649
   Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937
   Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09
   Broekhuizen CAN, 2008, CRIT CARE MED, V36, P2395, DOI 10.1097/CCM.0b013e3181818268
   Brun-Buisson C, 2004, INTENS CARE MED, V30, P837, DOI 10.1007/s00134-004-2221-9
   Burns CA, 2006, SCAND J INFECT DIS, V38, P133, DOI 10.1080/00365540500277292
   Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006
   Chang WK, 2012, ANN SURG, V255, P854, DOI 10.1097/SLA.0b013e31824e7005
   Choy MH, 2008, J MED MICROBIOL, V57, P1539, DOI 10.1099/jmm.0.2008/003723-0
   Corbin A, 2011, ANTIMICROB AGENTS CH, V55, P3338, DOI 10.1128/AAC.00206-11
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Dave RN, 2011, ANTIMICROB AGENTS CH, V55, P845, DOI 10.1128/AAC.00477-10
   Deacon JM, 1996, J BONE JOINT SURG AM, V78A, P1755, DOI 10.2106/00004623-199611000-00020
   Deliaert AE, 2009, J PLAST RECONSTR AES, V62, P771, DOI 10.1016/j.bjps.2007.10.075
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dobbins BM, 2002, J CLIN PATHOL, V55, P824, DOI 10.1136/jcp.55.11.824
   Eerenstein SEJ, 1999, CLIN OTOLARYNGOL, V24, P398, DOI 10.1046/j.1365-2273.1999.00245.x
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Fernandez ICS, 2007, BIOMATERIALS, V28, P4105, DOI 10.1016/j.biomaterials.2007.05.023
   Fernandez ICS, 2011, BIOMATERIALS, V32, P979, DOI 10.1016/j.biomaterials.2010.10.011
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Ford Henri R, 2005, Surg Infect (Larchmt), V6, P313, DOI 10.1089/sur.2005.6.313
   Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hansen LK, 2009, PACE, V32, P898, DOI 10.1111/j.1540-8159.2009.02406.x
   He J, 2012, J BIOMED MATER RES A, V100A, P1706, DOI 10.1002/jbm.a.34121
   HEATON JM, 1994, ACTA OTO-LARYNGOL, V114, P675, DOI 10.3109/00016489409126125
   Hendriks JGE, 2005, J BONE JOINT SURG BR, V87B, P272, DOI 10.1302/0301-620X.87B2.14781
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Hughes SPF, 1999, J BONE JOINT SURG BR, V81B, P754, DOI 10.1302/0301-620X.81B5.10370
   Jen MC, 2012, ADV FUNCT MATER, V22, P239, DOI 10.1002/adfm.201101707
   Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126
   John AK, 2009, ANTIMICROB AGENTS CH, V53, P2719, DOI 10.1128/AAC.00047-09
   Johnson JR, 2006, ANN INTERN MED, V144, P116, DOI 10.7326/0003-4819-144-2-200601170-00009
   Junge K, 2005, BIOMATERIALS, V26, P787, DOI 10.1016/j.biomaterials.2004.02.070
   Karrholm J, 2010, ACTA ORTHOP, V81, P3, DOI 10.3109/17453671003635918
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Knobben BAS, 2006, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000229339.11351.ea
   Kuijer R, 2007, BIOMATERIALS, V28, P5148, DOI 10.1016/j.biomaterials.2007.06.003
   LaPorte R J, 1997, HYDROPHILIC POLYM CO
   Lavernia C, 2006, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000214424.67453.9a
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Lee JH, 2011, TISSUE ENG PART C-ME, V17, P39, DOI [10.1089/ten.tec.2010.0285, 10.1089/ten.TEC.2010.0285]
   Lee JH, 2010, ACTA BIOMATER, V6, P4422, DOI 10.1016/j.actbio.2010.05.021
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Loftus RW, 2008, ANESTHESIOLOGY, V109, P399, DOI 10.1097/ALN.0b013e318182c855
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Mathews SM, 2006, CORNEA, V25, P806, DOI 10.1097/01.ico.0000224636.57062.90
   Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000
   Morgan PB, 2005, BRIT J OPHTHALMOL, V89, P430, DOI 10.1136/bjo.2004.052688
   MURPHY GH, 1951, CAN MED ASSOC J, V65, P68
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Nejadnik MR, 2008, J ANTIMICROB CHEMOTH, V62, P1323, DOI 10.1093/jac/dkn395
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Neut D, 2011, J ORTHOP RES, V29, P1654, DOI 10.1002/jor.21433
   PEARD MC, 1970, BMJ-BRIT MED J, V4, P410, DOI 10.1136/bmj.4.5732.410
   Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002
   Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184
   Rossi S, 2008, CLIN ORAL IMPLAN RES, V19, P348, DOI 10.1111/j.1600-0501.2007.01478.x
   Saballs M, 2006, J ANTIMICROB CHEMOTH, V58, P697, DOI 10.1093/jac/dkl274
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h
   Smith RS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004120
   Spaulding C, 2011, JACC-CARDIOVASC INTE, V4, P14, DOI 10.1016/j.jcin.2010.10.007
   Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827
   Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Tambyah PA, 1999, MAYO CLIN PROC, V74, P131, DOI 10.4065/74.2.131
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Verkkala K, 1998, EUR J CARDIO-THORAC, V14, P206, DOI 10.1016/S1010-7940(98)00150-X
   Wang Y., BIOFILMS BI IN PRESS
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Wilson SK, 2012, J SEX MED, V9, P44, DOI 10.1111/j.1743-6109.2011.02428.x
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Yamada M, 2011, BIOMATERIALS, V32, P8474, DOI 10.1016/j.biomaterials.2011.07.074
   Yan Y, 2010, CARDIOVASC DRUG THER, V24, P189, DOI 10.1007/s10557-010-6238-8
   Young S, 2011, ACTA ORTHOP, V82, P737, DOI 10.3109/17453674.2011.636680
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
   Zhang F, 2010, AM J CARDIOL, V105, P64, DOI 10.1016/j.amjcard.2009.08.652
   Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047
   Zilberman Meital, 2010, Handb Exp Pharmacol, P299, DOI 10.1007/978-3-642-00477-3_11
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 98
TC 203
Z9 205
U1 22
U2 147
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD SEP 26
PY 2012
VL 4
IS 153
DI 10.1126/scitranslmed.3004528
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 016NL
UT WOS:000309525600001
OA Green Published
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Fornell, J
   Gonzalez, S
   Pellicer, E
   Van Steenberge, N
   Perez, P
   Surinach, S
   Baro, MD
   Sort, J
AF Fornell, J.
   Gonzalez, S.
   Pellicer, E.
   Van Steenberge, N.
   Perez, P.
   Surinach, S.
   Baro, M. D.
   Sort, J.
TI Deformation and fracture behavior of corrosion-resistant, potentially
   biocompatible, Ti40Zr10Cu38Pd12 bulk metallic glass
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Metallic glass; Mechanical properties; Elastic properties; Corrosion
ID INTRINSIC PLASTICITY; MOHR-COULOMB; STRENGTH; ALLOYS; INDENTATION;
   HARDNESS; NI
AB Metallic glass rods (2.5 mm in diameter) with composition Ti40Zr10Cu38Pd12 exhibit considerably high compressive yield stress (1.9 GPa), hardness above 7 GPa, total engineering strain around 2.7% and Young's modulus of 100 GPa. The fracture angle in this alloy is around 42 degrees (i.e., lower than 45 degrees), which evidences that yielding is influenced by normal stresses acting on the shear plane. Finite-element simulations of nanoindentation curves confirm that the Mohr-Coulomb yield criterion, rather than the conventional Tresca criterion, governs the deformation behavior of this material. The compressive yield stress and plasticity of the investigated alloy correlate with its glass transition temperature and the ratio between the shear and bulk elastic moduli, respectively. The Young's modulus of Ti40Zr10Cu38Pd12 is also relatively low. In addition, Ti40Zr10Cu38Pd12 exhibits good corrosion resistance in simulated body fluid ( Hank's solution). From all these interesting properties this alloy may be a good candidate to be used as biomaterial. (c) 2011 Elsevier B.V. All rights reserved.
C1 [Fornell, J.; Gonzalez, S.; Pellicer, E.; Surinach, S.; Baro, M. D.; Sort, J.] Univ Autonoma Barcelona, Dept Fis, Bellaterra 08193, Spain.
   [Van Steenberge, N.] OCAS NV, BE-9060 Zelzate, Belgium.
   [Perez, P.] CSIC, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
   [Sort, J.] Univ Autonoma Barcelona, Inst Catalana Recerca & Estudis Avancats, Bellaterra 08193, Spain.
RP Gonzalez, S (reprint author), Univ Autonoma Barcelona, Dept Fis, Bellaterra 08193, Spain.
EM Sergio.Gonzalez@uab.es; Eva.Pellicer.icn@uab.cat; Jordi.Sort@uab.es
RI Pellicer, Eva/G-2917-2014; Surinach, Santiago/A-1749-2009; Sort,
   Jordi/F-6582-2014; BAI, JIE/D-7448-2016; Baro, Maria Dolors/A-2096-2009
OI Pellicer, Eva/0000-0002-8901-0998; Surinach,
   Santiago/0000-0001-8125-0594; Sort, Jordi/0000-0003-1213-3639; Baro,
   Maria Dolors/0000-0002-8636-1063; Perez Zubiaur,
   Pablo/0000-0002-4218-2573; Gonzalez Sanchez, Sergio/0000-0002-0211-7822
FU Juan de la Cierva contract from the Spanish Ministry of Science and
   Innovation; ICREA Academia award;  [2009-SGR-1292]; 
   [MAT2011-27380-C02-01];  [FP7-PEOPLE-2010-ITN-264635]; ICREA
FX This work has been partially financed by the 2009-SGR-1292 and
   MAT2011-27380-C02-01 research projects and the
   FP7-PEOPLE-2010-ITN-264635 research training network. J.F. and S.G.
   acknowledge the PhD Fellowship and Juan de la Cierva contract from the
   Spanish Ministry of Science and Innovation, respectively. M. D. B. was
   partially supported by an ICREA Academia award.
CR Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051
   Cortizo MC, 2004, BIOL TRACE ELEM RES, V102, P129, DOI 10.1385/BTER:102:1-3:129
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Fischer-Cripps AC, 2004, J MATER SCI, V39, P5849, DOI 10.1023/B:JMSC.0000040100.68809.24
   Fornell J, 2009, INT J PLASTICITY, V25, P1540, DOI 10.1016/j.ijplas.2008.11.002
   Guo F, 2005, APPL PHYS LETT, V86, DOI DOI 10.1063/1.1872214
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   Kim YC, 2004, MAT SCI ENG A-STRUCT, V375, P127, DOI 10.1016/j.msea.2003.10.115
   Kumari T. V., 2002, TRENDS BIOMATER ARTI, V15, P37
   Kusy M, 2006, INTERMETALLICS, V14, P982, DOI 10.1016/j.intermet.2006.01.017
   Lewandowski JJ, 2005, PHIL MAG LETT, V85, P77, DOI 10.1080/09500830500080474
   Lund AC, 2004, INTERMETALLICS, V12, P1159, DOI 10.1016/j.intermet.2004.07.001
   Manaranche C., 2005, EUR CELL MAT S1, V9, P35
   Ogata S, 2006, INTERMETALLICS, V14, P1033, DOI 10.1016/j.intermet.2006.01.022
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Peker A., 1994, US Patent, Patent No. [5,288,344, 5288344]
   Qin FX, 2007, MATER TRANS, V48, P515, DOI 10.2320/matertrans.48.515
   Souza MEP, 2009, J MATER SCI-MATER M, V20, P549, DOI 10.1007/s10856-008-3623-y
   Vaidyanathan R, 2001, ACTA MATER, V49, P3781, DOI 10.1016/S1359-6454(01)00263-4
   Yang B, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206099
   Zhang HW, 2006, PHIL MAG LETT, V86, P333, DOI 10.1080/09500830600788935
   Zhang ZF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.045505
   Zhao J, 2000, INT J ROCK MECH MIN, V37, P1115, DOI 10.1016/S1365-1609(00)00049-6
   Zhu SL, 2007, MAT SCI ENG A-STRUCT, V459, P233, DOI 10.1016/j.msea.2007.01.044
NR 24
TC 5
Z9 6
U1 0
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD SEP 25
PY 2012
VL 536
SU 1
BP S74
EP S77
DI 10.1016/j.jallcom.2011.10.057
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 033YO
UT WOS:000310837500017
DA 2018-10-19
ER

PT J
AU Ahmed, MH
   Byrne, JA
   McLaughlin, J
AF Ahmed, Mukhtar H.
   Byrne, John A.
   McLaughlin, James
TI Evaluation of glycine adsorption on diamond like carbon (DLC) and
   fluorinated DLC deposited by plasma-enhanced chemical vapour deposition
   (PECVD)
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Fluorinated Diamond Like Carbon (F-DLC); Glycine adsorption; XPS; Raman
   spectroscopy; Atomic force microscopy; Spectroscopic ellipsometry
ID AMORPHOUS-CARBON; THIN-FILMS; PHASE-TRANSITION; ION-IMPLANTATION;
   RAMAN-SPECTRA; IN-VITRO; PART I; HEMOCOMPATIBILITY; PRESSURE; COATINGS
AB To gain a better understanding of protein adsorption onto biomaterial surfaces is required for the control of biocompatibility and bioactivity. Various samples of (DLC) and fluorine-doped DLC thin films (F-DLC) were deposited onto silicon substrates using plasma-enhanced chemical vapour deposition (PECVD) with source gases of Argon, acetylene (C2H2) and carbon tetra-fluoride (CF4). The adsorption of the simplest amino acid glycine on the surfaces of the thin films was investigated in order to elucidate the mechanism of protein adsorption on biomaterials. The properties of prepared films were examined using X-ray photoelectron spectroscopy (XPS), Raman spectroscopy, spectroscopic ellipsometry (SE) and atomic force microscopy (AFM). The results highlighted an increase in both the I-d/I-g ratio and surface roughness with increasing the fluorine dopant levels. Following exposure to glycine solutions, the presence of bands at 1738 cm(-1), 1438 cm(-1) and 1199 cm(-1) indicates that the adsorption of glycine onto the surfaces has taken place via both deprotonated carboxyl and protonated amino groups. AFM analysis showed that the surface roughness value well significantly increased following exposure to glycine. The results indicate that at low fluorine doping the adsorption of the amino acid was enhanced whilst increased doping levels led to a reduced adsorption compared to undoped DLC. Therefore, doping of DLC may provide an approach to control the protein adsorption. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Ahmed, Mukhtar H.; Byrne, John A.; McLaughlin, James] Univ Ulster, Nanotechnol Integrated Bioengn Ctr, Belfast BT37 0QB, Antrim, North Ireland.
RP Ahmed, MH (reprint author), Univ Ulster, Nanotechnol Integrated Bioengn Ctr, Belfast BT37 0QB, Antrim, North Ireland.
EM ahmed-m@email.ulster.ac.uk
RI Byrne, John/F-8568-2011
OI Byrne, John/0000-0001-9527-7659; McLaughlin, James/0000-0001-6026-8971
FU University of Ulster
FX The authors would like to thank all the staff of Nanotechnology
   Integrated Bio-Engineering Centre (NIBEC) for their help and assistance;
   and the University of Ulster for financial support.
CR Ahmed M, 2012, J MATER SCI, V47, P1729, DOI 10.1007/s10853-011-5952-3
   Ahmed MH, 2012, APPL SURF SCI, V258, P5166, DOI 10.1016/j.apsusc.2012.01.162
   Ahmed S.F., 2007, J PHYS CONDENS MATT, V19, P1
   Arwin H, 2000, THIN SOLID FILMS, V377, P48, DOI 10.1016/S0040-6090(00)01385-7
   Baran J, 2007, VIB SPECTROSC, V43, P125, DOI 10.1016/j.vibspec.2006.07.002
   Bendavid A, 2010, DIAM RELAT MATER, V19, P1466, DOI 10.1016/j.diamond.2010.10.001
   Bruinink A, 2005, BIOMATERIALS, V26, P3487, DOI 10.1016/j.biomaterials.2004.09.030
   Chang JP, 1999, MATER RES SOC SYMP P, V565, P117, DOI 10.1557/PROC-565-117
   Choi J, 2008, SURF INTERFACE ANAL, V40, P806, DOI 10.1002/sia.2707
   Choudhury RR, 2008, SOLID STATE COMMUN, V145, P407, DOI 10.1016/j.ssc.2007.11.010
   Easwarakhanthan T, 2006, J VAC SCI TECHNOL A, V24, P1036, DOI 10.1116/1.2209654
   Fedosenko G, 2002, THIN SOLID FILMS, V406, P275, DOI 10.1016/S0040-6090(01)01768-0
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Foong YM, 2011, J MATER RES, V26, P2761, DOI 10.1557/jmr.2011.318
   Golden J.H., 2001, DESIGNING POROUS LOW, P79
   Goryainov SV, 2005, PHYSICA B, V357, P340, DOI 10.1016/j.physb.2004.11.089
   Grill A, 1999, IBM J RES DEV, V43, P147, DOI 10.1147/rd.431.0147
   Gupta P, 2004, TRIBOL INT, V37, P1019, DOI 10.1016/j.triboint.2004.07.020
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Hasebe T, 2007, THIN SOLID FILMS, V516, P299, DOI 10.1016/j.tsf.2007.06.033
   Ishihara M, 2005, DIAM RELAT MATER, V14, P989, DOI 10.1016/j.diamond.2004.12.019
   Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016
   Jelinek M, 2010, APPL PHYS A-MATER, V101, P579, DOI 10.1007/s00339-010-5912-9
   Jiang MF, 2006, SURF COAT TECH, V200, P3682, DOI 10.1016/j.surfcoat.2005.03.023
   Jiang MF, 2005, J NON-CRYST SOLIDS, V351, P2462, DOI 10.1016/j.jnoncrysol.2005.06.042
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Lai SH, 2004, APPL PHYS LETT, V85, P6248, DOI 10.1063/1.1828595
   Lamperti A, 2003, APPL SURF SCI, V205, P113, DOI 10.1016/S0169-4332(02)01041-3
   Li Q, 2011, ARTIF CELL BLOOD SUB, V39, P137, DOI 10.3109/10731199.2010.502880
   Logothetidis S, 2005, THIN SOLID FILMS, V482, P126, DOI 10.1016/j.tsf.2004.11.131
   Lousinian S, 2007, BIOMOL ENG, V24, P107, DOI 10.1016/j.bioeng.2006.05.014
   Mahajan SS, 1997, THIN SOLID FILMS, V302, P250, DOI 10.1016/S0040-6090(96)09519-3
   Mohanty B, 2008, MECH RES COMMUN, V35, P17, DOI 10.1016/j.mechrescom.2007.09.006
   Pandiarajan S, 2005, SPECTROCHIM ACTA A, V62, P630, DOI 10.1016/j.saa.2005.02.008
   Sajan D, 2004, SPECTROCHIM ACTA A, V60, P173, DOI 10.1016/S1386-1425(03)00193-8
   Sallustio BC, 1997, DRUG METAB DISPOS, V25, P55
   Stewart S, 1999, SPECTROCHIM ACTA A, V55, P1641, DOI 10.1016/S1386-1425(98)00294-7
   Teixeira M.C., 2007, J COLLOID INTERF SCI, V31, P128
   Trippe SC, 2004, THIN SOLID FILMS, V446, P85, DOI 10.1016/j.tsf.2003.08.069
   Vijayakumar T, 2008, J MOL STRUCT, V877, P20, DOI 10.1016/j.molstruc.2007.07.021
   Xu T, 1999, J MATER SCI-MATER M, V10, P83, DOI 10.1023/A:1008916903171
   Yao ZQ, 2004, APPL SURF SCI, V230, P172, DOI 10.1016/j.apsusc.2004.02.044
   Yokota T, 2006, NUCL INSTRUM METH B, V242, P48, DOI 10.1016/j.nimb.2005.08.107
   Yu GQ, 2005, SURF COAT TECH, V191, P236, DOI 10.1016/j.surfcoat.2004.04.060
   Yu GQ, 2003, APPL SURF SCI, V219, P228, DOI 10.1016/S0169-4332(03)00644-5
NR 45
TC 19
Z9 20
U1 2
U2 55
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP 25
PY 2012
VL 209
BP 8
EP 14
DI 10.1016/j.surfcoat.2012.07.011
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 031QE
UT WOS:000310656200002
DA 2018-10-19
ER

PT J
AU Zanetti-Domingues, LC
   Martin-Fernandez, ML
   Needham, SR
   Rolfe, DJ
   Clarke, DT
AF Zanetti-Domingues, Laura C.
   Martin-Fernandez, Marisa L.
   Needham, Sarah R.
   Rolfe, Daniel J.
   Clarke, David T.
TI A Systematic Investigation of Differential Effects of Cell Culture
   Substrates on the Extent of Artifacts in Single-Molecule Tracking
SO PLOS ONE
LA English
DT Article
ID BIOMATERIAL SURFACE-CHEMISTRY; BINDING AFFIBODY MOLECULE; LIPID RAFTS;
   FLUORESCENCE MICROSCOPY; PARTICLE TRACKING; EGF RECEPTOR; PROTEIN;
   MEMBRANE; ADHESION; DOMAIN
AB Single-molecule techniques are being increasingly applied to biomedical investigation, notwithstanding the numerous challenges they pose in terms of signal-to-noise ratio issues. Non-specific binding of probes to glass substrates, in particular, can produce experimental artifacts due to spurious molecules on glass, which can be particularly deleterious in live-cell tracking experiments. In order to resolve the issue of non-specific probe binding to substrates, we performed systematic testing of a range of available surface coatings, using three different proteins, and then extended our assessment to the ability of these coatings to foster cell growth and retain non-adhesive properties. Linear PEG, a passivating agent commonly used both in immobilized-molecule single-molecule techniques and in tissue engineering, is able to both successfully repel non-specific adhesion of fluorescent probes and to foster cell growth when functionalized with appropriate adhesive peptides. Linear PEG treatment results in a significant reduction of tracking artifacts in EGFR tracking with Affibody ligands on a cell line expressing EGFR-eGFP. The findings reported herein could be beneficial to a large number of experimental situations where single-molecule or single-particle precision is required.
C1 [Zanetti-Domingues, Laura C.; Martin-Fernandez, Marisa L.; Needham, Sarah R.; Rolfe, Daniel J.; Clarke, David T.] Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England.
RP Clarke, DT (reprint author), Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Res Complex Harwell, Didcot OX11 0QX, Oxon, England.
EM dave.clarke@stfc.ac.uk
OI Rolfe, Daniel/0000-0002-8394-8395; martin-fernandez,
   marisa/0000-0001-5496-6300; Zanetti-Domingues, Laura
   Carolina/0000-0003-0514-3185; Clarke, David/0000-0002-8776-1341;
   Needham, Sarah/0000-0002-3311-1036
FU Biotechnology and Biological Sciences Research Council [BB/G006911/1];
   UK Biotechnology and Biological Sciences Research Council
   [BB/G006911/1]; Biotechnology and Biological Sciences Research Council
   [BB/G007160/1]
FX This work was supported by Biotechnology and Biological Sciences
   Research Council (http://www.bbsrc.ac.uk/), Grant number BB/G006911/1.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; The authors
   acknowledge and thank Dr. Sarah Cartmell (Manchester X-Ray Imaging
   Facility) and Dr. Paul Roach (Institute for Science and Technology in
   Medicine, Keele University) for useful advice about biomaterials, Dr.
   Donna Arndt-Jovin (Max Planck Institute for Biophysical Chemistry) for
   the kind gift of CHO-EGFR-eGFP cells and Dr. Christopher J Tynan for
   critical reading of the manuscript and helpful suggestions. The authors
   gratefully acknowledge funding from the UK Biotechnology and Biological
   Sciences Research Council (BB/G006911/1).
CR ATTO-TEC GmbH, 2011, PROD INF ATTO 647N
   Balbis A, 2010, J CELL BIOCHEM, V109, P1103, DOI 10.1002/jcb.22505
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827
   Clarke DT, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3635536
   DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349
   Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9
   Fordyce PM, 2008, SINGLE MOL TECHNIQUE, P431
   Friedman M, 2007, PROTEIN ENG DES SEL, V20, P189, DOI 10.1093/protein/gzm011
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Harris JM, 1997, ACS S SERIES, V680
   Heyes CD, 2004, J PHYS CHEM B, V108, P13387, DOI 10.1021/jp049057o
   Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753
   Holtzer L, 2009, SINGLE PARTICLE TRAC, P25
   Hovius R, 2006, SINGLE MOL DETECTION
   IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1349, DOI 10.1093/oxfordjournals.jbchem.a133103
   Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0
   Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106
   Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929
   Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Nakao A, 1987, J Biomater Appl, V2, P219, DOI 10.1177/088532828700200203
   Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218
   Nordberg E, 2007, NUCL MED BIOL, V34, P609, DOI 10.1016/j.nucmedbio.2007.05.010
   Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521
   Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192
   Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910
   Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005
   Qin M, 2007, COLLOID SURFACE B, V60, P243, DOI 10.1016/j.colsurfb.2007.06.018
   Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101
   Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7
   Roy R, 2008, NAT METHODS, V5, P507, DOI [10.1038/nmeth.1208, 10.1038/NMETH.1208]
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Selvin PR, 2007, SINGLE MOL TECHNIQUE
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Tessler LA, 2011, J R SOC INTERFACE, V8, P1400, DOI 10.1098/rsif.2010.0669
   Tessler LA, 2009, ANAL CHEM, V81, P7141, DOI 10.1021/ac901068x
   Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096
   Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350
   Wikman M, 2004, PROTEIN ENG DES SEL, V17, P455, DOI 10.1093/protein/gzh053
   Xiao ZY, 2008, BIOCHEM BIOPH RES CO, V369, P730, DOI 10.1016/j.bbrc.2008.02.084
   Yao JZ, 2012, J AM CHEM SOC, V134, P3720, DOI 10.1021/ja208090p
   Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s
   Zhong H, 2010, COLD SPRING HARBBOR, V2010
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 59
TC 6
Z9 6
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 25
PY 2012
VL 7
IS 9
AR e45655
DI 10.1371/journal.pone.0045655
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 016YP
UT WOS:000309556100064
PM 23049831
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Kang, CK
   Lee, YS
AF Kang, Chan-Koo
   Lee, Yoon-Sik
TI Carbohydrate polymer grafting on stainless steel surface and its
   biocompatibility study
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE Surface modification; Stainless steel; Chitosan; Dextran;
   Biocompatibility
ID PROTEIN ADSORPTION; CHITOSAN; BIOMATERIALS; MEMBRANE; SCIENCE; STENTS
AB Surface science plays a critical role in biomaterials development as most biological reactions occur at their surfaces. The suitable choice of coating material, the surface structure and its biocompatibility are essential for fabricating a biomaterial. Herein, we have developed a biocompatible surface modification technology composed of surface electropolishing and carbohydrate polymer grafting, which can be applied to stainless steel, the most widely used stent. The surface of the stainless steel was sequentially modified by acid-treatment, silanization, and covalent attachment of chitosan and dextran. The extensive surface analysis confirmed that the surface was changed from hydrophobic to hydrophilic and from rough to smooth. The biological experiments revealed that the surface-modified stainless steel not only inhibited non-specific fibrinogen adsorption but also repelled most of proteins from human blood, when compared to bare stainless steel. It was demonstrated that our simple approach for surface modification could efficiently improve the biocompatibility of a stainless steel-based medical device. (C) 2012 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [Kang, Chan-Koo; Lee, Yoon-Sik] Seoul Natl Univ, Sch Chem & Biol Engn, Organ Synth Lab, Seoul 151747, South Korea.
   [Kang, Chan-Koo; Lee, Yoon-Sik] Seoul Natl Univ, Interdisciplinary Program Bioengn, Seoul 151747, South Korea.
   [Kang, Chan-Koo] Samsung Econ Res Inst, Ind & Strategy Dept, Seoul 137955, South Korea.
RP Lee, YS (reprint author), Seoul Natl Univ, Sch Chem & Biol Engn, Organ Synth Lab, Seoul 151747, South Korea.
EM yslee@snu.ac.kr
FU Korea Healthcare Technology R&D Project, Ministry for Health, Welfare
   and Family Affairs, Korea [A092099]
FX This study was supported by a grant of the Korea Healthcare Technology
   R&D Project, Ministry for Health, Welfare and Family Affairs, Korea
   (A092099).
CR Caro A, 2009, J PHYS CHEM B, V113, P2101, DOI 10.1021/jp805284s
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Charles PT, 2009, SENSORS-BASEL, V9, P645, DOI 10.3390/s90100645
   Chaudhari S, 2007, PROG ORG COAT, V58, P54, DOI 10.1016/j.porgcoat.2006.12.001
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Eidelman Rachel S, 2003, Eur Heart J, V24, P499, DOI 10.1016/S0195-668X(02)00810-2
   Eriksson M, 2007, J COLLOID INTERF SCI, V310, P312, DOI 10.1016/j.jcis.2007.01.089
   Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Ha CS, 2005, CHEM REV, V105, P4205, DOI 10.1021/cr040419y
   Helsen J.A., 1998, METALS BIOMATERIALS
   Hoven VP, 2007, CARBOHYD POLYM, V68, P44, DOI 10.1016/j.carbpol.2006.07.008
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kang CK, 2007, J MATER SCI-MATER M, V18, P1389, DOI 10.1007/s10856-006-0079-9
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934
   Martz EO, 1997, J BIOMED MATER RES, V38, P267, DOI 10.1002/(SICI)1097-4636(199723)38:3<267::AID-JBM12>3.0.CO;2-8
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   Shaulov Y, 2009, ACS APPL MATER INTER, V1, P2519, DOI 10.1021/am900465t
   Tang CJ, 2011, J VASC SURG, V53, P461, DOI 10.1016/j.jvs.2010.08.020
   Tao YY, 2008, J CHROMATOGR A, V1211, P70, DOI 10.1016/j.chroma.2008.09.096
   Thierry B, 2002, BIOMATERIALS, V23, P2997, DOI 10.1016/S0142-9612(02)00030-3
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   Wang AJ, 2007, J CHROMATOGR A, V1147, P120, DOI 10.1016/j.chroma.2007.02.030
   Ye P, 2007, COLLOID SURFACE B, V60, P62, DOI 10.1016/j.colsurfb.2007.05.022
   Yu DG, 2007, COLLOID SURFACE B, V54, P222, DOI 10.1016/j.colsurfb.2006.10.026
NR 28
TC 9
Z9 10
U1 5
U2 47
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD SEP 25
PY 2012
VL 18
IS 5
BP 1670
EP 1675
DI 10.1016/j.jiec.2012.03.007
PG 6
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 004KJ
UT WOS:000308680300022
DA 2018-10-19
ER

PT J
AU Yao, BJ
   Zhu, QZ
   Liu, H
   Qiao, L
   Hao, JC
   Qi, F
AF Yao, Bingjian
   Zhu, Qingzeng
   Liu, Hui
   Qiao, Liang
   Hao, Jingcheng
   Qi, Feng
TI Conformation and aggregation behavior of poly(ethylene
   glycol)-b-poly(lactic acid) amphiphilic copolymer chains in
   dilute/semidilute THF solutions
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; diblock copolymer; transmission electron microscopy;
   dynamic light scattering; gel permeation chromatography
ID OXIDE) BLOCK-COPOLYMERS; DIBLOCK COPOLYMERS; AQUEOUS-SOLUTION; MULTIPLE
   MORPHOLOGIES; ASSOCIATION BEHAVIOR; TRIBLOCK COPOLYMERS;
   LIGHT-SCATTERING; PHASE-BEHAVIOR; MICELLES; VESICLES
AB The behavior of amphiphilic copolymer chains in a solvent is not the same as that of homopolymers. As an important synthetic biomaterial, poly(ethylene glycol)-b-poly(lactic acid) copolymers are often dissolved in tetrahydrofuran (THF) for study. Few studies have focused on the potential aggregation behavior and compact conformation of the amphiphilic macromolecules in a THF solution. In this study, a series of poly(ethylene glycol)-b-poly(lactic acid) diblock copolymers were synthesized and characterized using fourier-transform infrared spectroscopy, nuclear magnetic resonance, thermogravimetric analysis, and gel permeation chromatography methods. The aggregation behavior of amphiphilic molecular chains in a THF solution was studied using dynamic light scattering and transmission electron microscopy. The results showed that the aggregation size in solutions at a concentration of 2.0 mg/mL is within the range of 50-250 nm. It was further demonstrated that molecular chains exhibit a compact conformation in a dilute THF solution, which leads to a comparatively larger deviation in the characterization of molecular weights using GPC method. Here, a model is proposed to elucidate the dynamic evolution between compact amphiphilic single chains and aggregates. (C) 2012 Wiley Periodicals, Inc. J Appl Polym Sci, 2012
C1 [Yao, Bingjian; Zhu, Qingzeng; Liu, Hui; Qiao, Liang; Hao, Jingcheng] Shandong Univ, Sch Chem & Chem Engn, Minist Educ, Key Lab Special Funct Aggregated Mat, Jinan 250100, Peoples R China.
   [Hao, Jingcheng] Shandong Univ, Sch Chem & Chem Engn, Minist Educ, Key Lab Colloid & Interface Chem, Jinan 250100, Peoples R China.
   [Qi, Feng] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China.
RP Zhu, QZ (reprint author), Shandong Univ, Sch Chem & Chem Engn, Minist Educ, Key Lab Special Funct Aggregated Mat, Jinan 250100, Peoples R China.
EM qzzhu@sdu.edu.cn
RI Mo, Xiulei/A-1616-2017; Qiao, Liang/H-7048-2016
OI Qiao, Liang/0000-0002-6345-3504
FU Natural Science Foundation of China [20404006]; Shandong Province
   Natural Science Foundation [ZR2009BM038]; China Postdoctoral Science
   Foundation [20090461212]; Science and Technology Development Planning of
   Shandong province [2009GG20003016]; Independent Innovation Foundation of
   Shandong University IIFSDU [2011JC012]; National Basic Research Program
   of China [2009CB930103]
FX Contract grant sponsor: Natural Science Foundation of China; contract
   grant number: 20404006.; Contract grant sponsor: Shandong Province
   Natural Science Foundation; contract grant number: ZR2009BM038.;
   Contract grant sponsor: China Postdoctoral Science Foundation; contract
   grant number: 20090461212.; Contract grant sponsor: Science and
   Technology Development Planning of Shandong province; contract grant
   number: 2009GG20003016.; Contract grant sponsor: Independent Innovation
   Foundation of Shandong University IIFSDU; contract grant number:
   2011JC012.; Contract grant sponsor: National Basic Research Program of
   China; contract grant number: 2009CB930103.
CR ALMGREN M, 1995, COLLOID POLYM SCI, V273, P2, DOI 10.1007/BF00655668
   ASTAFIEVA I, 1993, MACROMOLECULES, V26, P7339, DOI 10.1021/ma00078a034
   Blanazs A, 2011, J AM CHEM SOC, V133, P16581, DOI 10.1021/ja206301a
   Bronich TK, 2001, NANO LETT, V1, P535, DOI 10.1021/nl0100365
   Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/nmat2512, 10.1038/NMAT2512]
   Chu B., 1996, SURF SCI SERIES, V60, P67
   Clapper JD, 2007, POLYMER, V48, P6554, DOI 10.1016/j.polymer.2007.08.023
   Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768
   Ding HY, 2011, J CONTROL RELEASE, V151, P271, DOI 10.1016/j.jconrel.2011.01.004
   Ding JF, 1997, POLYMER, V38, P5497, DOI 10.1016/S0032-3861(97)00200-0
   Du ZX, 2007, MACROMOLECULES, V40, P7633, DOI 10.1021/ma070977p
   Edelmann K, 2001, MACROMOL CHEM PHYS, V202, P1638, DOI 10.1002/1521-3935(20010601)202:9<1638::AID-MACP1638>3.0.CO;2-4
   Giacomelli G., 2010, LANGMUIR, V26, P15734
   Gohy JF, 2005, ADV POLYM SCI, V190, P65, DOI 10.1007/12_048
   Govender T, 2000, INT J PHARMACEUT, V199, P95, DOI 10.1016/S0378-5173(00)00375-6
   Hanley KJ, 2000, MACROMOLECULES, V33, P5918, DOI 10.1021/ma000318b
   Hanley KJ, 1998, J POLYM SCI POL PHYS, V36, P3101, DOI 10.1002/(SICI)1099-0488(199812)36:17<3101::AID-POLB10>3.0.CO;2-X
   Hussain H, 2009, LANGMUIR, V25, P5557, DOI 10.1021/la8042389
   Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193
   Jiang Y, 2005, J PHYS CHEM B, V109, P21549, DOI 10.1021/jp052420m
   Ke FY, 2009, MACROMOLECULES, V42, P5339, DOI 10.1021/ma900740b
   Kukula H, 2002, J AM CHEM SOC, V124, P1658, DOI 10.1021/ja012091l
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350
   Liggins RT, 2002, ADV DRUG DELIVER REV, V54, P191, DOI 10.1016/S0169-409X(02)00016-9
   Liu T, 2000, AMPHIPHILIC BLOCK CO
   Liu Y., 2010, INT J PHARMACEUT, V394, P43
   Liu Y., 2007, J COLLOID INTERF SCI, V314, P470
   Luo LB, 2001, LANGMUIR, V17, P6804, DOI 10.1021/la0104370
   Molina I, 2001, BIOMATERIALS, V22, P363, DOI 10.1016/S0142-9612(00)00192-7
   Motokawa R, 2005, MACROMOLECULES, V38, P5748, DOI 10.1021/ma047393x
   Nuopponen M, 2004, POLYMER, V45, P3643, DOI 10.1016/j.polymer.2004.03.083
   Pu Z. C., 1999, POLYM DATE HDB, P542
   Raez J, 2002, J AM CHEM SOC, V124, P10381, DOI 10.1021/ja020349h
   Riegel IC, 2003, POLYMER, V44, P2117, DOI 10.1016/S0032-3861(03)00013-2
   Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7
   Schmidt RR, 2010, J PHYS CHEM B, V114, P8887, DOI 10.1021/jp102442q
   Ruan G, 2003, BIOMATERIALS, V24, P5037, DOI 10.1016/S0142-9612(03)00419-8
   Schuch H, 2000, MACROMOLECULES, V33, P1734, DOI 10.1021/ma991491e
   Siao W. Y., 2009, J APPL POLYM SCI, V114, P509
   Tang XZ, 2007, POLYMER, V48, P6354, DOI 10.1016/j.polymer.2007.08.030
   Tominaga Y, 2002, MACROMOLECULES, V35, P1381, DOI 10.1021/ma011348x
   Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382
   Wei Q, 2010, BIOMATERIALS, V31, P7332, DOI 10.1016/j.biomaterials.2010.06.014
   Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960
   Won YY, 2002, J PHYS CHEM B, V106, P3354, DOI 10.1021/jp013639d
   Xie DH, 2007, J PHYS CHEM B, V111, P778, DOI 10.1021/jp066438o
   Xiong JA, 2011, J MATER CHEM, V21, P5786, DOI 10.1039/c0jm04410e
   XU RL, 1991, MACROMOLECULES, V24, P87, DOI 10.1021/ma00001a014
   Yan G., 2006, POLYMER, V47, P2519
   Yan JJ, 2008, MACROMOLECULES, V41, P4908, DOI 10.1021/ma7026726
   Yang H, 2010, MACROMOLECULES, V43, P10442, DOI 10.1021/ma100921s
   Yang YW, 1995, LANGMUIR, V11, P4703, DOI 10.1021/la00012a021
   Yao J, 2004, LANGMUIR, V20, P2157, DOI 10.1021/la0355343
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728
   Zhang WQ, 2004, MACROMOLECULES, V37, P2551, DOI 10.1021/ma035801b
   Zhou JH, 2011, SOFT MATTER, V7, P9956, DOI 10.1039/c1sm05963g
   Zupancich JA, 2006, MACROMOLECULES, V39, P4286, DOI 10.1021/ma060642s
NR 59
TC 2
Z9 2
U1 1
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 25
PY 2012
VL 125
SU 2
SI SI
BP E223
EP E230
DI 10.1002/app.36613
PG 8
WC Polymer Science
SC Polymer Science
GA 953JJ
UT WOS:000304862900026
DA 2018-10-19
ER

PT J
AU Sahal, G
   Bilkay, IS
AF Sahal, Gulcan
   Bilkay, Isil Seyis
TI Determination of biofilm formation in clinical strains of Proteus
   mirabilis
SO NEW BIOTECHNOLOGY
LA English
DT Meeting Abstract
DE Biofilm Formation; Biomaterial-associated infections; Proteus mirabilis
C1 [Sahal, Gulcan; Bilkay, Isil Seyis] Hacettepe Univ, Fac Sci, Biol, Biotechnol, Ankara, Turkey.
NR 0
TC 1
Z9 1
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
EI 1876-4347
J9 NEW BIOTECHNOL
JI New Biotech.
PD SEP 23
PY 2012
VL 29
SU S
MA 5.0.34
BP S170
EP S171
DI 10.1016/j.nbt.2012.08.474
PG 2
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA V45GR
UT WOS:000209805600467
DA 2018-10-19
ER

PT J
AU Zheng, JN
   Xie, HG
   Yu, WT
   Tan, MQ
   Gong, FQ
   Liu, XD
   Wang, F
   Lv, GJ
   Liu, WF
   Zheng, GS
   Yang, Y
   Xie, WY
   Ma, XJ
AF Zheng, Jiani
   Xie, Hongguo
   Yu, Weiting
   Tan, Mingqian
   Gong, Faquan
   Liu, Xiudong
   Wang, Feng
   Lv, Guojun
   Liu, Wanfa
   Zheng, Guoshuang
   Yang, Yan
   Xie, Weiyang
   Ma, Xiaojun
TI Enhancement of Surface Graft Density of MPEG on Alginate/Chitosan
   Hydrogel Microcapsules for Protein Repellency
SO LANGMUIR
LA English
DT Article
ID RAY PHOTOELECTRON-SPECTROSCOPY; POLY(ETHYLENE GLYCOL); FIBRINOGEN
   ADSORPTION; CELL ENCAPSULATION; POLYMER BRUSHES; OXIDE SURFACES;
   CHITOSAN; RESISTANCE; BIOCOMPATIBILITY; NANOPARTICLES
AB Alginate/chitosan/alginate (ACA) hydrogel microcapsules were modified with methoxy poly(ethylene glycol) (MPEG) to improve protein repellency and biocompatibility. Increased MPEG surface graft density (n(S)) on hydrogel microcapsules was achieved by controlling the grafting parameters including the buffer layer substrate, membrane thickness, and grafting method. X-ray photoelectron spectroscopy (XPS) model was employed to quantitatively analyze n(S) on this three-dimensional (3D) hydrogel network structure. Our results indicated that neutralizing with alginate, increasing membrane thickness, and in situ covalent grafting could increase n(S) effectively. ACAC(PEG) was more promising than ACC(PEG) in protein repellency because alginate supplied more -COO- negative binding sites and prevented MPEG from diffusing. The n(S) increased with membrane thickness, showing better protein repellency. Moreover, the in situ covalent grafting provided an effective way to enhance n(S), and 1.00 +/- 0.03 chains/nm(2) was achieved, exhibiting almost complete immunity to protein adsorption. This antifouling hydrogel biomaterial is expected to be useful in transplantation in vivo.
C1 [Zheng, Jiani; Xie, Hongguo; Yu, Weiting; Tan, Mingqian; Lv, Guojun; Zheng, Guoshuang; Yang, Yan; Xie, Weiyang; Ma, Xiaojun] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Peoples R China.
   [Gong, Faquan; Liu, Wanfa] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Coil Efficiency & Opt Resonator, Dalian 116023, Peoples R China.
   [Wang, Feng] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Opt Fabricat & Coating, Dalian 116023, Peoples R China.
   [Liu, Xiudong] Dalian Univ, Coll Environm & Chem Engn, Dalian 116622, Peoples R China.
   [Zheng, Jiani; Zheng, Guoshuang; Yang, Yan] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China.
RP Xie, HG (reprint author), Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Peoples R China.
EM xiehg@dicp.ac.cn; liuxd@dicp.ac.cn
RI Tan, Mingqian/B-4697-2012
OI Tan, Mingqian/0000-0002-7535-0035
FU National Basic Research Program of China [2012CB720801]; National
   Natural Science Foundation of China [10979050, 51103157]; Chinese
   Academy of Sciences, Stem Cell and Regenerative Medicine Research
   [XDA01030303]; National Key Sci-Tech Special Project of China
   [2012ZX10002011-013]
FX This project was supported by the National Basic Research Program of
   China (grant 2012CB720801), the National Natural Science Foundation of
   China (grant 10979050, 51103157), "Strategic Priority Research Program"
   of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine
   Research (grant XDA01030303), and the National Key Sci-Tech Special
   Project of China (grant 2012ZX10002011-013).
CR ALEXANDER S, 1977, J PHYS-PARIS, V38, P977, DOI 10.1051/jphys:01977003808097700
   Babensee JE, 1997, J BIOMAT SCI-POLYM E, V8, P655, DOI 10.1163/156856297X00470
   Bajpai AK, 2008, J MATER SCI-MATER M, V19, P343, DOI 10.1007/s10856-006-0024-y
   Bastian F, 2008, BIOMATERIALS, V29, P1824, DOI 10.1016/j.biomaterials.2008.01.005
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bentley MD, 1998, J PHARM SCI, V87, P1446, DOI 10.1021/js980064w
   Blanka R, 2000, ADV DRUG DELIVERY, V42, P65
   CANN JR, 1949, J BIOL CHEM, V181, P161
   Chandy T, 1999, ARTIF ORGANS, V23, P894, DOI 10.1046/j.1525-1594.1999.06244.x
   Chang TMS, 2004, ARTIF ORGANS, V28, P265, DOI 10.1111/j.1525-1594.2004.47343.x
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   Cvitas J. T., 2009, BIMACROMOLECULES, V10, P2885
   Damodaran VB, 2010, LANGMUIR, V26, P7299, DOI 10.1021/la9041502
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   Elisseeff J, 2008, NAT MATER, V7, P271, DOI 10.1038/nmat2147
   Fan XW, 2006, BIOMACROMOLECULES, V7, P2443, DOI 10.1021/bm060276k
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Geoffrey O., 2008, LANGMUIR, V24, P5341
   Gon S, 2011, MACROMOLECULES, V44, P8161, DOI 10.1021/ma201484h
   Gon S, 2011, LANGMUIR, V27, P1487, DOI 10.1021/la104592f
   Gon S, 2010, LANGMUIR, V26, P12147, DOI 10.1021/la1016752
   Gorochovceva N, 2005, EUR POLYM J, V41, P2653, DOI 10.1016/j.eurpolymj.2005.05.021
   Gregory L., 2000, J PHYS CHEM B, VB104, P3298
   Groll J, 2005, BIOMACROMOLECULES, V6, P956, DOI 10.1021/bm049350u
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Huang NP, 2011, BIOMACROMOLECULES, V12, P4213, DOI 10.1021/bm2009872
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   LIMOR B, 2006, BIOPOLYMERS, V82, P570
   LYONS JS, 1981, AUST J CHEM, V34, P1167, DOI 10.1071/CH9811167
   Moudler J. F., 1992, HDB XRAY PHOTOELECTR
   Ohno K, 2012, BIOMACROMOLECULES, V13, P927, DOI 10.1021/bm201855m
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Orive G, 2003, TRENDS PHARMACOL SCI, V24, P207, DOI 10.1016/S0165-6147(03)0073-7
   Polizzotti BD, 2008, BIOMACROMOLECULES, V9, P1084, DOI 10.1021/bm7012636
   Pop-Georgievski O, 2011, BIOMACROMOLECULES, V12, P3232, DOI 10.1021/bm2007086
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ruiz-Taylor LA, 2001, LANGMUIR, V17, P7313, DOI 10.1021/la010620t
   Rundqvist J, 2005, LANGMUIR, V21, P2981, DOI 10.1021/la0471792
   Stephanie P., 2003, LANGMUIR, V19, P9216
   Strand BL, 2003, BIOTECHNOL BIOENG, V82, P386, DOI 10.1002/bit.10577
   Susan J., 1998, MACROMOLECULES, V31, P5059
   Tama S. K., 2005, BIOMATERIALS, V26, P6950
   Tao SL, 2008, LANGMUIR, V24, P2631, DOI 10.1021/la703066z
   Tasima H., 2005, BIOTECHNOL LETT, V27, P317
   TERBOJEVICH M, 1993, CARBOHYD RES, V250, P301, DOI 10.1016/0008-6215(93)84008-T
   Tria MCR, 2010, BIOMACROMOLECULES, V11, P3422, DOI 10.1021/bm1009365
   Wattendorf U, 2008, BIOMACROMOLECULES, V9, P100, DOI 10.1021/bm700857s
   Werner C, 1998, J COLLOID INTERF SCI, V208, P329, DOI 10.1006/jcis.1998.5787
   Xie HG, 2010, LANGMUIR, V26, P5587, DOI 10.1021/la903874g
   Xie HG, 2010, J BIOMED MATER RES A, V92A, P1357, DOI 10.1002/jbm.a.32437
   Yu WT, 2011, J MEMBRANE SCI, V377, P214, DOI 10.1016/j.memsci.2011.04.053
   Yu WT, 2010, J MEMBRANE SCI, V346, P296, DOI 10.1016/j.memsci.2009.09.049
   Zahr AS, 2006, LANGMUIR, V22, P8178, DOI 10.1021/la060951b
   Zahr AS, 2005, LANGMUIR, V21, P403, DOI 10.1021/la0478595
   Zhang WJ, 2008, CYTOTHERAPY, V10, P90, DOI 10.1080/14653240701762372
   Zhao YJ, 2009, J APPL POLYM SCI, V111, P1638, DOI 10.1002/app.29140
   Zheng JN, 2010, LANGMUIR, V26, P17156, DOI 10.1021/la1030203
   Zhou Y, 2007, J COLLOID INTERF SCI, V305, P62, DOI 10.1016/j.jcis.2006.09.058
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 61
TC 37
Z9 41
U1 5
U2 150
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 18
PY 2012
VL 28
IS 37
BP 13261
EP 13273
DI 10.1021/la302615t
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 005ZC
UT WOS:000308787700017
PM 22921144
DA 2018-10-19
ER

PT J
AU Hryniewicz, T
   Rokosz, K
   Valicek, J
   Rokicki, R
AF Hryniewicz, Tadeusz
   Rokosz, Krzysztof
   Valicek, Jan
   Rokicki, Ryszard
TI Effect of magnetoelectropolishing on nanohardness and Young's modulus of
   titanium biomaterial
SO MATERIALS LETTERS
LA English
DT Article
DE Nanoindentation; Titanium biomaterial; Magnetoelectropolishing; Surface
   layer; Nanohardness
ID SURFACE; NANOINDENTATION; INDENTATION
AB Nanoindentation studies were performed on CP-titanium biomaterial after its treatment under a standard electropolishing (EP) and magnetoelectropolishing (MEP) conditions, with abrasive finishing (MP) carried out on the samples for reference. The Young's modulus of elasticity and nanohardness were investigated. The mechanical properties of titanium biomaterial demonstrated an evident dependence on the surface treatment conditions. After magnetoelectropolishing (MEP) treatment a considerable deviation in mechanical properties of the same Ti biomaterial is observed in comparison with the mechanical properties obtained from the samples after abrasive finishing (MP) and a standard electropolishing (EP). (C) 2012 Elsevier B.V. All rights reserved.
C1 [Hryniewicz, Tadeusz; Rokosz, Krzysztof] Politechn Koszalinska, Div Surface Electrochem, PL-75620 Koszalin, Poland.
   [Valicek, Jan] Dept Phys VSB TU Ostrava, Ostrava, Czech Republic.
   [Rokicki, Ryszard] Electrobright, Macungie, PA USA.
RP Hryniewicz, T (reprint author), Politechn Koszalinska, Div Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl
FU project GA CR [101/09/0650]; project RMTVC [CZ.1.05/2.1.00/01.0040];
   IT4Innovations Centre of Excellence project [CZ.1.05/1.1.00/02.0070];
   SGS [SP2011/78]; MSMT [MSM6198910016, MEB051021]
FX The contribution was partly supported by the projects GA CR No.
   101/09/0650, RMTVC No. CZ.1.05/2.1.00/01.0040, IT4Innovations Centre of
   Excellence project, reg. no. CZ.1.05/1.1.00/02.0070, SGS No. SP2011/78,
   MSMT No. MSM6198910016, and MEB051021.
CR Burstein GT, 2000, NATURE, V407, P885, DOI 10.1038/35038040
   Chuang LC, 2011, APPL SURF SCI, V258, P297, DOI 10.1016/j.apsusc.2011.08.055
   Chuang LC, 2011, ADV MATER RES-SWITZ, V214, P388, DOI 10.4028/www.scientific.net/AMR.214.388
   Grauman JS, 1997, ENCY CHEM PROCESSING, V58, P123
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz Tadeusz, 2009, Pomiary Automatyka Kontrola, V55, P247
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Hryniewicz T, 2009, MRS P, P21
   Hryniewicz T., 2011, BIOMATERIALS, P227
   Kuhn A., 2004, MET FINISH, V102, P80
   Lu G, 2000, SURF SCI, V458, P80, DOI 10.1016/S0039-6028(00)00420-9
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI [10.2174/1877610801002010040, DOI 10.2174/1877610801002010040]
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Pluta Z., 2011, J QUANTUM INFORM SCI, V1, P127, DOI DOI 10.4236/JQIS.2011.13018
   Rokicki R., 2008, MED DEVICE DIAGN IND, V30, P102
   Rokicki R., 2009, US Patent, Patent No. 7632390
   Rokicki R, 2012, J MATER SCI-MATER M, V23, P2127, DOI 10.1007/s10856-012-4696-1
   Shuman D, 2005, NANOINDENTATION, P21
   StatSoft Inc, 2004, STATISTICA DAT AN SO
   Yang Y, 2011, JOM-US, V63, P66, DOI 10.1007/s11837-011-0161-8
   Zambaldi C, 2012, J MATER RES, V27, P356, DOI 10.1557/jmr.2011.334
NR 22
TC 27
Z9 27
U1 3
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD SEP 15
PY 2012
VL 83
BP 69
EP 72
DI 10.1016/j.matlet.2012.06.010
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 996TU
UT WOS:000308118500021
DA 2018-10-19
ER

PT J
AU Wu, NJ
   Ding, MC
   Zhang, JM
   Lin, RX
AF Wu, Ningjing
   Ding, Meichun
   Zhang, Jianming
   Lin, Runxiong
TI Mechanical properties and crystallization of Poly(L-lactide) films with
   several percents of ACR nanoparticles
SO MATERIALS LETTERS
LA English
DT Article
DE biomaterial; PLLA; mechanical properties; crystallization; ACR
ID BLENDS; POLY(3-HYDROXYBUTYRATE); COPOLYMERS; BEHAVIOR; ACID)
AB The mechanical properties measurement of Poly(L-lactide) (PLLA) films modified by adding just several percents of acrylic rubber (ACR) nanoparticles showed that the elongation at break and tensile strength increased obviously by comparing with neat PLLA film. The crystallization behavior of modified PLEA blend films was characterized by Differential Scanning Calorimetry (DSC) and Wide-angle X-ray diffraction (WAXD); it was found that the crystallization degree of PLEA was improved with small amount of ACR nanoparticles. The results indicate that ACR nanoparticles not only take the role of the toughening agents for PLLA films, but also increase the crystallization degree of PLEA as nucleation agents, which contribute to the enhancement of the tensile strength and modulus of PLLA films. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Wu, Ningjing; Ding, Meichun; Zhang, Jianming; Lin, Runxiong] Qingdao Univ Sci & Technol, Shandong Prov Key Lab Rubber Plast, Minist Educ, Key Lab Rubber Plast, Qingdao 266042, Peoples R China.
RP Wu, NJ (reprint author), Qingdao Univ Sci & Technol, Shandong Prov Key Lab Rubber Plast, Minist Educ, Key Lab Rubber Plast, Qingdao 266042, Peoples R China.
EM ningjing_wu@yahoo.com.cn; zjmin20002000@yahoo.com
FU Natural Science Foundation of China [21104038, 21074063]; Doctoral
   Foundation of Shandong Province [2010BSE08010]
FX It is grateful for the financial supports from Natural Science
   Foundation of China (21104038, 21074063), Doctoral Foundation of
   Shandong Province (2010BSE08010).
CR Focarete ML, 2002, MACROMOLECULES, V35, P8472, DOI 10.1021/ma020940z
   Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803
   Hideko T. O., 2009, POLYMER, V50, P747
   Hu Y, 2008, POLYMER, V49, P4204, DOI 10.1016/j.polymer.2008.07.031
   Kazuhiro H., 2012, POLYMER, V51, P3934
   Kelly S., 2008, POLYM REV, V48, P85
   Kulinski Z, 2005, POLYMER, V46, P10290, DOI 10.1016/j.polymer.2005.07.101
   Li YJ, 2008, MACROMOLECULES, V41, P3120, DOI 10.1021/ma7027402
   Liu HZ, 2011, J POLYM SCI POL PHYS, V49, P1051, DOI 10.1002/polb.22283
   Miyata T, 1998, POLYMER, V39, P5515, DOI 10.1016/S0032-3861(97)10203-8
   Na YH, 2002, BIOMACROMOLECULES, V3, P1179, DOI 10.1021/bm020050r
   Nijenhuis AJ, 1996, POLYMER, V37, P5849, DOI 10.1016/S0032-3861(96)00455-7
   Wu P. X., 2004, POLYM BLENDS MODIFIC, P37
   Zhang JM, 2004, MACROMOLECULES, V37, P6433, DOI 10.1021/ma049288t
NR 14
TC 7
Z9 8
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP 15
PY 2012
VL 83
BP 148
EP 150
DI 10.1016/j.matlet.2012.06.001
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 996TU
UT WOS:000308118500044
DA 2018-10-19
ER

PT J
AU Pichavant, L
   Amador, G
   Jacqueline, C
   Brouillaud, B
   Heroguez, V
   Durrieu, MC
AF Pichavant, Loic
   Amador, Gilles
   Jacqueline, Cedric
   Brouillaud, Brigitte
   Heroguez, Valerie
   Durrieu, Marie-Christine
TI pH-controlled delivery of gentamicin sulfate from orthopedic devices
   preventing nosocomial infections
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Antibiotic delivery system; pH-controlled release; Titanium surface
   grafting; Functionalized nanoparticles; Antibacterial activity
ID ANTIBIOTIC DELIVERY; CONTROLLED-RELEASE; SYSTEM; BONE; OSTEOMYELITIS;
   INFLAMMATION; ADHESION; AGENTS; ARTHROPLASTY; CARBONATE)
AB Since the beginning of the 1970s, controlled release technology has witnessed great advancement, and motivated numerous researchers in materials science. These systems overcome the drawbacks of traditional drug dosage form, and offer more effective and favorable methods to optimize drug delivery in optimum dose to specific sites or to prolong delivery duration. This paper deals with the synthesis of pH-controlled drug delivery systems for bone implant, allowing the local release of gentamicin sulfate (GS), an antibiotic commonly used to prevent infections during orthopedic surgeries. We present a biomaterial synthesis allowing the controlled release of GS at the site of surgical implantation (over an adjustable period of time). In our design, spherical nanoparticles (NPs) functionalized by the chosen antibiotic (Gentamicin sulfate, GS), are chemically anchored to the biomaterial surface. A cleavage reaction of the chemical bond between NPs and GS, effected by the contact of material with a solution presenting an acidic pH (in the case of infection, there is a decrease of the physiological medium pH), induces controlled release of the bioactive molecule in its native form.
   In this paper, we discuss the synthesis of a bioactive titanium based biomaterial in general, and the grafting of the NPs onto the titanium surfaces in particular. We have paid particular attention to the characterization of the drug surface density and the release kinetic of the active molecule as a function of the pH. In vitro bacterial growth inhibition tests after GS delivery at acidic pH (with Staphylococcus aureus) have also been carried out in order to prove the efficiency of such biomaterials. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Pichavant, Loic; Durrieu, Marie-Christine] Univ Bordeaux 1, UMR CBMN CNRS5248, IECB, F-33607 Pessac, France.
   [Pichavant, Loic; Heroguez, Valerie] Univ Bordeaux, LCPO, UMR 5629, F-33600 Pessac, France.
   [Pichavant, Loic; Heroguez, Valerie] CNRS, LCPO, UMR 5629, F-33600 Pessac, France.
   [Amador, Gilles; Jacqueline, Cedric] Univ Nantes, Fac Med, EA3826, F-44035 Nantes, France.
   [Brouillaud, Brigitte] Univ Bordeaux Segalen, U1026, F-33000 Bordeaux, France.
RP Pichavant, L (reprint author), Univ Bordeaux 1, UMR CBMN CNRS5248, IECB, 2 Rue Robert Escarpit, F-33607 Pessac, France.
EM lpichavant@enscbp.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; Jacqueline,
   Cedric/0000-0001-9606-5930
FU French "Agence Nationale de la Recherche" (ANR); GIS "Advanced Materials
   in Aquitaine" (AMA)
FX The authors would like to thank the French "Agence Nationale de la
   Recherche" (ANR) for providing financial support to this project and the
   GIS "Advanced Materials in Aquitaine" (AMA;
   http://www.ama-materials.com) for financial support. The authors
   acknowledge Dr. Rajat Kumar Das for his help for the redaction of this
   article.
CR Al-Abd AM, 2010, J CONTROL RELEASE, V142, P101, DOI 10.1016/j.jconrel.2009.10.003
   Allison DC, 2010, CLIN ORTHOP RELAT R, V468, P2107, DOI 10.1007/s11999-010-1271-2
   Anal AK, 2007, RECENT PATENTS ENDOC, V1, P83, DOI 10.2174/187221407779814598
   Arenberg D.A., 1999, ANGIOGENESIS INFLAMM
   Azengonca A., 2004, BIOTECHNOLOGICAL DEV, P249
   Bernard L, 2004, J ANTIMICROB CHEMOTH, V53, P127, DOI 10.1093/jac/dkh033
   Bertin PA, 2006, J AM CHEM SOC, V128, P4168, DOI 10.1021/ja056378k
   Bistrian B, 2007, NUTR REV, V65, pS170, DOI 10.1301/nr.2007.dec.S170-S172
   Blower S, 1999, NAT MED, V5, P358, DOI 10.1038/7328
   BUNETEL L, 1989, CLIN PHARMACOKINET, V17, P291, DOI 10.2165/00003088-198917040-00006
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chang HI, 2006, J CONTROL RELEASE, V110, P414, DOI 10.1016/j.jconrel.2005.10.028
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Cote Dennis, 2010, Can J Hosp Pharm, V63, P304
   Dashti A, 2010, J BIOMED MATER RES B, V93B, P394, DOI 10.1002/jbm.b.31594
   Durrieu M.C., 2006, [No title captured], Patent No. [WO2006008386, 2006008386]
   El-Ghannam A, 2010, J BIOMED MATER RES A, V94A, P308, DOI 10.1002/jbm.a.32705
   Florey ME, 1943, LANCET, V1, P387
   Gaudin A, 2011, LETT APPL MICROBIOL, V52, P253, DOI 10.1111/j.1472-765X.2010.02992.x
   Gautam M, 2010, NEUROSCIENCE, V170, P893, DOI 10.1016/j.neuroscience.2010.08.003
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   Gudmundsson A., 1991, IMPACT PH CATIONIC S, V35
   Guillemot F., 2007, IRBM, V28, P86
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   ISSEKUTZ AC, 1982, INFECT IMMUN, V36, P558
   Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794
   Kluin OS, 2009, BIOMATERIALS, V30, P4738, DOI 10.1016/j.biomaterials.2009.05.012
   Kuhn K.D., 2000, BONE CEMENTS, P253
   Kundu B, 2011, J MATER SCI-MATER M, V22, P705, DOI 10.1007/s10856-010-4221-3
   Lazzarini Luca, 2002, Curr Infect Dis Rep, V4, P439, DOI 10.1007/s11908-002-0012-4
   Ma L., 2009, INT J PHARMACEUT, V385, P86
   Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.04
   Nguyen MN, 2012, BIOMACROMOLECULES, V13, P896, DOI 10.1021/bm201812u
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Neut D, 2009, ACTA ORTHOP, V80, P514, DOI 10.3109/17453670903350040
   Ong KL, 2009, J ARTHROPLASTY, V24, P1137, DOI 10.1016/j.arth.2008.08.005
   Ouchi T, 1997, ACS SYM SER, V680, P284
   Pavlukhina S, 2010, BIOMACROMOLECULES, V11, P3448, DOI 10.1021/bm100975w
   Pedersen AB, 2010, ACTA ORTHOP, V81, P542, DOI 10.3109/17453674.2010.519908
   Peng KT, 2010, BIOMATERIALS, V31, P5227, DOI 10.1016/j.biomaterials.2010.03.027
   Pichavant L, 2011, MACROMOLECULES, V44, P7879, DOI 10.1021/ma2015479
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   Rissing J., 1990, INFECT DIS CLIN N AM, V4, P439
   SANDERSON PJ, 1991, J HOSP INFECT, V18, P1
   SCHOIFET SD, 1990, J BONE JOINT SURG AM, V72A, P1383, DOI 10.2106/00004623-199072090-00018
   SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144
   Shi M, 2010, BIOMATERIALS, V31, P4146, DOI 10.1016/j.biomaterials.2010.01.112
   SIMMEN HP, 1993, AM J SURG, V166, P24, DOI 10.1016/S0002-9610(05)80576-8
   Sirivisoot S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/8/085101
   Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Szelenyi ER, 2012, MUSCLE NERVE, V45, P552, DOI 10.1002/mus.22323
   Tanihara M, 1999, J PHARM SCI, V88, P510, DOI 10.1021/js980418j
   Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004
   Wang GH, 2004, INT J PHARM, V273, P203, DOI 10.1016/j.ijpharm.2004.01.010
   WATSON R A A, 1976, Clinica Chimica Acta, V73, P51
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Zeller V, 2006, REV RHUM, V73, P183
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
NR 62
TC 37
Z9 38
U1 4
U2 71
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP 10
PY 2012
VL 162
IS 2
BP 373
EP 381
DI 10.1016/j.jconrel.2012.06.033
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 029OY
UT WOS:000310506400014
PM 22771533
DA 2018-10-19
ER

PT J
AU Abarrategi, A
   Fernandez-Valle, ME
   Desmet, T
   Castejon, D
   Civantos, A
   Moreno-Vicente, C
   Ramos, V
   Sanz-Casado, JV
   Martinez-Vazquez, FJ
   Dubruel, P
   Miranda, P
   Lopez-Lacomba, JL
AF Abarrategi, A.
   Fernandez-Valle, M. E.
   Desmet, T.
   Castejon, D.
   Civantos, A.
   Moreno-Vicente, C.
   Ramos, V.
   Sanz-Casado, J. V.
   Martinez-Vazquez, F. J.
   Dubruel, P.
   Miranda, P.
   Lopez-Lacomba, J. L.
TI Label-free magnetic resonance imaging to locate live cells in
   three-dimensional porous scaffolds
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE magnetic resonance imaging; scaffolds; cell culture; in vitro
ID CALCIUM-PHOSPHATE SCAFFOLDS; MESENCHYMAL STEM-CELLS;
   MECHANICAL-PROPERTIES; POLYMERIC SCAFFOLDS; PCL SCAFFOLDS; STROMAL
   CELLS; CELLULAR MRI; IN-VITRO; BONE; MICROSCOPY
AB Porous scaffolds are widely tested materials used for various purposes in tissue engineering. A critical feature of a porous scaffold is its ability to allow cell migration and growth on its inner surface. Up to now, there has not been a method to locate live cells deep inside a material, or in an entire structure, using real-time imaging and a non-destructive technique. Herein, we seek to demonstrate the feasibility of the magnetic resonance imaging (MRI) technique as a method to detect and locate in vitro non-labelled live cells in an entire porous material. Our results show that the use of optimized MRI parameters (4.7 T; repetition time = 3000 ms; echo time = 20 ms; resolution 39 x 39 mu m) makes it possible to obtain images of the scaffold structure and to locate live non-labelled cells in the entire material, with a signal intensity higher than that obtained in the culture medium. In the current study, cells are visualized and located in different kinds of porous scaffolds. Moreover, further development of this MRI method might be useful in several three-dimensional biomaterial tests such as cell distribution studies, routine qualitative testing methods and in situ monitoring of cells inside scaffolds.
C1 [Abarrategi, A.; Civantos, A.; Moreno-Vicente, C.; Ramos, V.; Sanz-Casado, J. V.; Lopez-Lacomba, J. L.] Univ Complutense, Inst Biofunct Studies, E-28040 Madrid, Spain.
   [Fernandez-Valle, M. E.; Castejon, D.] Univ Complutense, Res Assistance Ctr, E-28040 Madrid, Spain.
   [Abarrategi, A.] Inst Salud Carlos III, Area Biol Celular & Desarrollo, Majadahonda 28220, Spain.
   [Desmet, T.; Dubruel, P.] Univ Ghent, Dept Organ Chem, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
   [Martinez-Vazquez, F. J.; Miranda, P.] Univ Extremadura, Dept Ingn Mecan Energet & Mat, E-06071 Badajoz, Spain.
RP Lopez-Lacomba, JL (reprint author), Univ Complutense, Inst Biofunct Studies, Paseo Juan XXIII 1, E-28040 Madrid, Spain.
EM lacomba@farm.ucm.es
RI Abarrategi, Ander/A-1785-2009; Miranda, Pedro/C-4465-2008; Castejon,
   David/M-4039-2017; Fernandez-Valle, Encarnacion/M-2316-2014
OI Abarrategi, Ander/0000-0002-6510-2337; Miranda,
   Pedro/0000-0003-4348-110X; Civantos Fernandez, Ana/0000-0002-5349-7183
FU MEC; Ministerio de Ciencia e Innovacion [PET2008-0168, CSD2009-00088];
   Fondo Social Europeo [PTQ05-02-02498]; Fundacion PCM [MAT 2006-08720];
   Ministerio de Educacion y Ciencia
FX We thank Alba Cuenca-Moya for her technical support. C.M.-V. and
   F.J.M.-V. thank the MEC for their PhD fellowships. This work was
   supported by the Ministerio de Ciencia e Innovacion (PET2008-0168,
   CSD2009-00088), and the Ministerio de Educacion y Ciencia y Fondo Social
   Europeo (PTQ05-02-02498 and Fundacion PCM, MAT 2006-08720).
CR Arbab AS, 2008, REGEN MED, V3, P199, DOI 10.2217/17460751.3.2.199
   Berman SMC, 2011, WIRES NANOMED NANOBI, V3, P343, DOI 10.1002/wnan.140
   Bernsen MR, 2010, EUR RADIOL, V20, P255, DOI 10.1007/s00330-009-1540-1
   Bhirde A, 2011, NANOSCALE, V3, P142, DOI 10.1039/c0nr00493f
   Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107
   Burg KJL, 2002, J BIOMED MATER RES, V61, P380, DOI 10.1002/jbm.10146
   Cheng HLM, 2010, TISSUE ENG PART C-ME, V16, P643, DOI [10.1089/ten.tec.2009.0099, 10.1089/ten.TEC.2009.0099]
   Chesnick IE, 2008, BIOPHYS J, V95, P2017, DOI 10.1529/biophysj.107.120923
   Chesnick IE, 2007, BONE, V40, P904, DOI 10.1016/j.bone.2006.10.020
   Chim H, 2006, INT J ORAL MAX SURG, V35, P928, DOI 10.1016/j.ijom.2006.03.024
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Constantinidis I., 2007, ADV EXP MED BIOL, V585, P261, DOI [10.1007/978-0-387-34133-0_18, DOI 10.1007/978-0-387-34133-0_18]
   Constantinidis I, 2007, BIOMATERIALS, V28, P2438, DOI 10.1016/j.biomaterials.2007.01.012
   Desmet T, 2010, MACROMOL BIOSCI, V10, P1484, DOI 10.1002/mabi.201000147
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Greco JB, 2005, BIOREACTORS FOR TISSUE ENGINEERING: PRINCIPLES, DESIGN AND OPERATION, P135, DOI 10.1007/1-4020-3741-4_6
   Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hoque ME, 2009, TISSUE ENG PT A, V15, P3013, DOI 10.1089/ten.TEA.2008.0355
   Hsu SH, 2007, J BIOMED MATER RES B, V80B, P519, DOI 10.1002/jbm.b.30626
   Hutmacher DW, 2007, J CELL MOL MED, V11, P654, DOI 10.1111/j.1582-4934.2007.00078.x
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Kim HJ, 2010, J BIOMED MATER RES A, V92A, P659, DOI 10.1002/jbm.a.32414
   Kim T, 2011, J AM CHEM SOC, V133, P2955, DOI 10.1021/ja1084095
   Kraitchman DL, 2008, J MAGN RESON IMAGING, V27, P299, DOI 10.1002/jmri.21263
   Kraitchman DL, 2009, JACC-CARDIOVASC IMAG, V2, P1123, DOI 10.1016/j.jcmg.2009.05.010
   Lalande C, 2011, EUR CELLS MATER, V21, P341, DOI 10.22203/eCM.v021a25
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   LeGeros Racquel Z., 2008, P153, DOI 10.1007/978-1-59745-239-7_8
   Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Miranda P, 2006, ACTA BIOMATER, V2, P457, DOI 10.1016/j.actbio.2006.02.004
   Miranda P, 2008, J BIOMED MATER RES A, V85A, P218, DOI 10.1002/jbm.a.31587
   Neves AA, 2006, TISSUE ENG, V12, P53, DOI 10.1089/ten.2006.12.53
   Nitzsche H, 2009, TISSUE ENG PART C-ME, V15, P513, DOI [10.1089/ten.tec.2008.0488, 10.1089/ten.TEC.2008.0488]
   Novotny JE, 2006, TISSUE ENG, V12, P2755, DOI 10.1089/ten.2006.12.2755
   Olah L, 2006, POLYM ADVAN TECHNOL, V17, P889, DOI 10.1002/pat.768
   Peptan IA, 2006, TISSUE ENG, V12, P843, DOI 10.1089/ten.2006.12.843
   Perez-Rodriguez J, 2009, RADIOLOGY, V250, P371, DOI 10.1148/radiol.2502080498
   Pham DT, 2000, RAPID MANUFACTURING, P19
   Poirier-Quinot M, 2010, TISSUE ENG PART C-ME, V16, P185, DOI [10.1089/ten.tec.2009.0015, 10.1089/ten.TEC.2009.0015]
   Ramaswamy S, 2008, TISSUE ENG PART C-ME, V14, P243, DOI 10.1089/ten.tec.2007.0423
   Riegler J, 2010, BIOMATERIALS, V31, P5366, DOI 10.1016/j.biomaterials.2010.03.032
   Roth Y, 2008, MAGN RESON IMAGING, V26, P88, DOI 10.1016/j.mri.2007.04.013
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sanchez-Salcedo S, 2006, TISSUE ENG, V12, P279, DOI 10.1089/ten.2006.12.279
   Schafer R, 2010, TRANSFUS MED HEMOTH, V37, P85, DOI 10.1159/000287271
   Tay BY, 2003, INT MATER REV, V48, P341, DOI 10.1179/095066003225010263
   Terrovitis JV, 2006, TISSUE ENG, V12, P2765, DOI 10.1089/ten.2006.12.2765
   Walter GA, 2008, FUND BIOMED TECHNOL, V3, P91
   Washburn NR, 2004, J BIOMED MATER RES A, V69A, P738, DOI 10.1002/jbm.a.30054
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xu HH, 2006, PHYS MED BIOL, V51, P719, DOI 10.1088/0031-9155/51/3/016
   Xu HH, 2008, J BIOSCI BIOENG, V106, P515, DOI 10.1263/jbb.106.515
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yilgor P, 2008, MACROMOL SYMP, V269, P92, DOI 10.1002/masy.200850911
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
NR 60
TC 6
Z9 6
U1 1
U2 21
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD SEP 7
PY 2012
VL 9
IS 74
BP 2321
EP 2331
DI 10.1098/rsif.2012.0068
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 978NR
UT WOS:000306750500027
PM 22442095
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Alrifaiy, A
   Lindahl, OA
   Ramser, K
AF Alrifaiy, Ahmed
   Lindahl, Olof A.
   Ramser, Kerstin
TI Polymer-Based Microfluidic Devices for Pharmacy, Biology and Tissue
   Engineering
SO POLYMERS
LA English
DT Review
DE microfluidics; tissue engineering; biomedical engineering; polymers;
   biocompatibility; cell sorting; cell analysis; cell biology
ID ON-A-CHIP; TOTAL ANALYSIS SYSTEMS; SINGLE-CELL ANALYSIS; MINIATURIZED
   TOTAL ANALYSIS; CHEMICAL-ANALYSIS SYSTEMS; BREAST-CANCER CELLS;
   ENDOTHELIAL-CELLS; OPTICAL TWEEZERS; MAMMALIAN-CELLS;
   CAPILLARY-ELECTROPHORESIS
AB This paper reviews microfluidic technologies with emphasis on applications in the fields of pharmacy, biology, and tissue engineering. Design and fabrication of microfluidic systems are discussed with respect to specific biological concerns, such as biocompatibility and cell viability. Recent applications and developments on genetic analysis, cell culture, cell manipulation, biosensors, pathogen detection systems, diagnostic devices, high-throughput screening and biomaterial synthesis for tissue engineering are presented. The pros and cons of materials like polydimethylsiloxane (PDMS), polymethylmethacrylate (PMMA), polystyrene (PS), polycarbonate (PC), cyclic olefin copolymer (COC), glass, and silicon are discussed in terms of biocompatibility and fabrication aspects. Microfluidic devices are widely used in life sciences. Here, commercialization and research trends of microfluidics as new, easy to use, and cost-effective measurement tools at the cell/tissue level are critically reviewed.
C1 [Alrifaiy, Ahmed; Lindahl, Olof A.; Ramser, Kerstin] Lulea Univ Technol, Dept Comp Sci Elect & Space Engn, SE-97187 Lulea, Sweden.
   [Alrifaiy, Ahmed; Lindahl, Olof A.; Ramser, Kerstin] Lulea Univ Technol, Ctr Biomed Engn & Phys, CMTF, SE-97187 Lulea, Sweden.
   [Lindahl, Olof A.] Umea Univ, Dept Radiat Sci, SE-90187 Umea, Sweden.
RP Ramser, K (reprint author), Lulea Univ Technol, Dept Comp Sci Elect & Space Engn, SE-97187 Lulea, Sweden.
EM ahmed.alrifaiy@ltu.se; olof.lindahl@ltu.se; kerstin.ramser@ltu.se
OI Family Name Deactivated, Given Names Deactivated/0000-0003-3268-1691
CR Allain M, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/3/035006
   Allen PB, 2008, ANAL CHEM, V80, P7153, DOI 10.1021/ac801059h
   Alrifaiy A, 2011, BIOMED OPT EXPRESS, V2, P2299, DOI 10.1364/BOE.2.002299
   AMSTEIN CF, 1975, J CLIN MICROBIOL, V2, P46
   Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   Andersson H, 2000, SENSOR ACTUAT B-CHEM, V67, P203, DOI 10.1016/S0925-4005(00)00413-5
   Antia M, 2008, CELL MICROBIOL, V10, P1968, DOI 10.1111/j.1462-5822.2008.01216.x
   Arai F, 2005, LAB CHIP, V5, P1399, DOI 10.1039/b502546j
   Arai F, 2001, ELECTROPHORESIS, V22, P283, DOI 10.1002/1522-2683(200101)22:2<283::AID-ELPS283>3.0.CO;2-C
   Arai Y, 1999, NATURE, V399, P446
   ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0
   Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163
   Attia UM, 2009, MICROFLUID NANOFLUID, V7, P1, DOI 10.1007/s10404-009-0421-x
   Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t
   Avila K, 2011, SCIENCE, V333, P192, DOI 10.1126/science.1203223
   Avni R.D., 2003, BIOTECHNIQUES, V34, P530
   Bakajin O., 1998, P MICR TOT AN SYST 1, P193
   Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173
   Battye FL, 2000, J IMMUNOL METHODS, V243, P25, DOI 10.1016/S0022-1759(00)00225-8
   Bazou D, 2008, TOXICOL IN VITRO, V22, P1321, DOI 10.1016/j.tiv.2008.03.014
   Bazou D, 2005, ULTRASOUND MED BIOL, V31, P423, DOI 10.1016/j.ultrasmedbio.2004.12.007
   Bazou D, 2008, MOL MEMBR BIOL, V25, P102, DOI 10.1080/09687680701618365
   BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860
   Becker H, 1998, P SOC PHOTO-OPT INS, V3515, P177, DOI 10.1117/12.322081
   Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   Becker H, 2000, SENSOR ACTUAT A-PHYS, V83, P130, DOI 10.1016/S0924-4247(00)00296-X
   Becker H., 1999, P 3 INT C MICR TECHN
   Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097
   Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Berger M, 2001, ELECTROPHORESIS, V22, P3883, DOI 10.1002/1522-2683(200110)22:18<3883::AID-ELPS3883>3.0.CO;2-4
   Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a
   Bings NH, 1999, ANAL CHEM, V71, P3292, DOI 10.1021/ac981419z
   Birkbeck AL, 2003, BIOMED MICRODEVICES, V5, P47, DOI 10.1023/A:1024463316562
   Blankenstein G, 1998, BIOSENS BIOELECTRON, V13, P427, DOI 10.1016/S0956-5663(97)00109-7
   Blau AW, 2001, J BIOCHEM BIOPH METH, V50, P15, DOI 10.1016/S0165-022X(01)00163-4
   Bomberger C, 1998, BLOOD, V91, P2588
   Borenstein JT, 2002, BIOMED MICRODEVICES, V4, P167, DOI 10.1023/A:1016040212127
   Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106
   Brunnschweiler A, 2000, MICROFLUIDIC TECHNOL
   Bruzewicz DA, 2008, LAB CHIP, V8, P663, DOI 10.1039/b719806j
   Bu MQ, 2004, SENSOR ACTUAT A-PHYS, V115, P476, DOI 10.1016/j.sna.2003.12.013
   Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484
   Cao H, 2002, APPL PHYS LETT, V81, P3058, DOI 10.1063/1.1515115
   Carlson RH, 1997, PHYS REV LETT, V79, P2149, DOI 10.1103/PhysRevLett.79.2149
   Carrion B, 2010, BIOTECHNOL BIOENG, V107, P1020, DOI 10.1002/bit.22891
   Chang WC, 2005, LAB CHIP, V5, P64, DOI 10.1039/b400455h
   Charati SG, 1998, MACROMOLECULES, V31, P5529, DOI 10.1021/ma980387e
   Chen AA, 2010, INTEGR BIOL-UK, V2, P517, DOI 10.1039/c0ib00054j
   Chen DL, 2006, CURR OPIN CHEM BIOL, V10, P226, DOI 10.1016/j.cbpa.2006.04.004
   Chen JM, 2008, MICROFLUID NANOFLUID, V4, P427, DOI 10.1007/s10404-007-0196-x
   Chen TH, 2003, BIOMACROMOLECULES, V4, P1558, DOI 10.1021/bm034145k
   Chen WY, 2009, LAB CHIP, V9, P2947, DOI 10.1039/b906254h
   Chen YH, 2000, ELECTROPHORESIS, V21, P165, DOI 10.1002/(SICI)1522-2683(20000101)21:1<165::AID-ELPS165>3.0.CO;2-I
   Cheng J, 1998, NAT BIOTECHNOL, V16, P541, DOI 10.1038/nbt0698-541
   Cheng Y, 2004, OPT LETT, V29, P2007, DOI 10.1364/OL.29.002007
   Cheung YK, 2007, LAB CHIP, V7, P574, DOI 10.1039/b700869d
   Chien RD, 2006, SENSOR ACTUAT A-PHYS, V128, P238, DOI 10.1016/j.sna.2006.02.029
   Cho H, 2007, J COLLOID INTERF SCI, V306, P379, DOI 10.1016/j.jcis.2006.10.077
   Choi CH, 2007, BIOMED MICRODEVICES, V9, P855, DOI 10.1007/s10544-007-9098-7
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Chou C.F., 2002, MICROTOTAL ANAL SYST, V1, P25
   Chou CF, 2002, BIOPHYS J, V83, P2170, DOI 10.1016/S0006-3495(02)73977-5
   Chovan T, 2002, TRENDS BIOTECHNOL, V20, P116, DOI 10.1016/S0167-7799(02)01905-4
   Chronis N, 2005, J MICROELECTROMECH S, V14, P857, DOI 10.1109/JMEMS.2005.845445
   Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a
   Cinamon G, 2003, J IMMUNOL METHODS, V273, P53, DOI 10.1016/S0022-1759(02)00418-0
   Clarson S. J., 1993, SILOXANE POLYM
   Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004
   Clemmens J, 2004, LAB CHIP, V4, P83, DOI 10.1039/b317059d
   Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652
   Coulter W.H, 1956, P NATIONAL ELECTRONI, V12, P1034
   Cox JD, 2002, BIOMATERIALS, V23, P929, DOI 10.1016/S0142-9612(01)00205-8
   Cran DG, 1996, HUM REPROD UPDATE, V2, P355, DOI 10.1093/humupd/2.4.355
   CROSLANDTAYLOR PJ, 1953, NATURE, V171, P37, DOI 10.1038/171037b0
   Cui L, 2001, ELECTROPHORESIS, V22, P3893, DOI 10.1002/1522-2683(200110)22:18<3893::AID-ELPS3893>3.0.CO;2-2
   Currie I. G., 2002, FUNDAMENTAL MECH FLU
   Daniel K., 2009, CHRONOPHARMACEUTICS, P187
   Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1
   Davidsson R, 2004, ANAL CHEM, V76, P4715, DOI 10.1021/ac095249o
   de Boer MJ, 2000, J MICROELECTROMECH S, V9, P94, DOI 10.1109/84.825783
   DeBusschere BD, 2001, BIOSENS BIOELECTRON, V16, P543, DOI 10.1016/S0956-5663(01)00168-3
   Deere D, 1998, YEAST, V14, P147, DOI 10.1002/(SICI)1097-0061(19980130)14:2<147::AID-YEA207>3.3.CO;2-C
   Dennison C., 2003, GUIDE PROTEIN ISOLAT, P115
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985
   Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5
   Dolezel J, 2011, METHODS MOL BIOL, V701, P221, DOI 10.1007/978-1-61737-957-4_12
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Durr M, 2003, ELECTROPHORESIS, V24, P722, DOI 10.1002/elps.200390087
   Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652
   Edwards GO, 2007, CELL COMMUN ADHES, V14, P9, DOI 10.1080/15419060701224849
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   El-Naggar Adel K, 2004, Methods Mol Biol, V263, P371
   Enger J, 2004, LAB CHIP, V4, P196, DOI 10.1039/b307960k
   Erickson D, 2003, ANAL BIOCHEM, V317, P186, DOI 10.1016/S0003-2697(03)00090-3
   Evander M, 2007, ANAL CHEM, V79, P2984, DOI 10.1021/ac061576v
   Farinas J, 2001, ANAL BIOCHEM, V295, P138, DOI 10.1006/abio.2001.5202
   Ferguson-Smith MA, 2005, CYTOGENET GENOME RES, V108, P112, DOI 10.1159/000080809
   Fiedler S, 1998, ANAL CHEM, V70, P1909, DOI 10.1021/ac971063b
   Flynn RA, 2002, SENSOR ACTUAT B-CHEM, V87, P239, DOI 10.1016/S0925-4005(02)00242-3
   Frame MD, 2000, MICROCIRCULATION, V7, P419
   Frame MDS, 1998, BIORHEOLOGY, V35, P245, DOI 10.1016/S0006-355X(99)80009-2
   Fu AY, 1999, NAT BIOTECHNOL, V17, P1109
   Fu AY, 2002, ANAL CHEM, V74, P2451, DOI 10.1021/ac0255330
   FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910
   Furdui VI, 2004, LAB CHIP, V4, P614, DOI 10.1039/b409366f
   Futai N, 2006, LAB CHIP, V6, P149, DOI 10.1039/b510901a
   Gast FU, 2003, LAB CHIP, V3, p6N, DOI 10.1039/b212706g
   Gawad S., 2002, MICROTOTAL ANAL SYST, P253
   Gherardini L, 2005, ULTRASOUND MED BIOL, V31, P261, DOI 10.1016/j.ultrasmedbio.2004.10.010
   Gift EA, 1996, NAT BIOTECHNOL, V14, P884, DOI 10.1038/nbt0796-884
   Giordano BC, 2001, ANAL BIOCHEM, V291, P124, DOI 10.1006/abio.2000.4974
   Glasgow I., 2000, P MOCR TOT AN SYST 2
   Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w
   Gong Z., 2009, P SOL STAT SENS ACT, P1043
   Gong ZC, 2011, BIOMED MICRODEVICES, V13, P215, DOI 10.1007/s10544-010-9486-2
   Gossett DR, 2010, ANAL BIOANAL CHEM, V397, P3249, DOI 10.1007/s00216-010-3721-9
   Gradl G, 2000, MESA MG, P443
   Gravesen P., 1993, Journal of Micromechanics and Microengineering, V3, P168, DOI 10.1088/0960-1317/3/4/002
   Gray BL, 2002, BIOMED MICRODEVICES, V4, P9, DOI 10.1023/A:1014211627166
   Grodzinski P, 2003, BIOMED MICRODEVICES, V5, P303, DOI 10.1023/A:1027357713526
   Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784
   Grover WH, 2003, SENSOR ACTUAT B-CHEM, V89, P315, DOI 10.1016/S0925-4005(02)00468-9
   Grund T., 2008, P MULT MICR CARD UK
   GUASCH RM, 1993, EXP CELL RES, V207, P136, DOI 10.1006/excr.1993.1172
   Gui L, 2004, J MICROMECH MICROENG, V14, P242, DOI 10.1088/0960-1317/14/2/011
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   Han A., 2002, P MOCR TOT AN SYST 2
   Han KH, 2006, LAB CHIP, V6, P265, DOI 10.1039/b514539b
   Han KH, 2004, J APPL PHYS, V96, P5797, DOI 10.1063/1.1803628
   Hardt D.E., 2009, DEV LOW COST RAPID C
   HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895
   Haussinger D, 1996, BIOCHEM J, V313, P697
   Hayenga J., 2002, P MOCR TOT AN SYST 2
   Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102
   Heckele M, 2004, J MICROMECH MICROENG, V14, pR1, DOI 10.1088/0960-1317/14/3/R01
   Hediger S, 2000, SENSOR ACTUAT B-CHEM, V63, P63, DOI 10.1016/S0925-4005(00)00292-6
   Hediger S, 2001, BIOSENS BIOELECTRON, V16, P689, DOI 10.1016/S0956-5663(01)00232-9
   Heuschkel MO, 1998, SENSOR ACTUAT B-CHEM, V48, P356, DOI 10.1016/S0925-4005(98)00071-9
   Ho CM, 1998, ANNU REV FLUID MECH, V30, P579, DOI 10.1146/annurev.fluid.30.1.579
   Holloway JW, 2004, CHEM IMMUNOL, V84, P1, DOI 10.1146/annurev.immunol.22.012703.104727
   Hosokawa K, 2000, J MICROMECH MICROENG, V10, P415, DOI 10.1088/0960-1317/10/3/317
   Hua SZ, 2009, LAB CHIP, V9, P251, DOI 10.1039/b806003g
   Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a
   Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567
   Huang Y, 2002, ANAL BIOANAL CHEM, V372, P49, DOI 10.1007/s00216-001-1191-9
   Huang Y, 2001, ANAL CHEM, V73, P1549, DOI 10.1021/ac001109s
   Huang Y, 2002, ANAL CHEM, V74, P3362, DOI 10.1021/ac011273v
   Huebner A, 2009, LAB CHIP, V9, P692, DOI 10.1039/b813709a
   Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Hultstrom J, 2007, ULTRASOUND MED BIOL, V33, P145, DOI 10.1016/j.ultrasmedbio.2006.07.024
   Hung PJ, 2005, LAB CHIP, V5, P44, DOI 10.1039/b410743h
   Hupert ML, 2007, MICROFLUID NANOFLUID, V3, P1, DOI 10.1007/s10404-006-0091-x
   Hwang DK, 2009, J AM CHEM SOC, V131, P4499, DOI 10.1021/ja809256d
   Ichiki T, 2002, ELECTROPHORESIS, V23, P2029, DOI 10.1002/1522-2683(200207)23:13<2029::AID-ELPS2029>3.0.CO;2-R
   Inglis DW, 2004, APPL PHYS LETT, V85, P5093, DOI 10.1063/1.1823015
   Irimia D, 2006, LAB CHIP, V6, P345, DOI 10.1039/b515983k
   Jacobson SC, 1999, ANAL CHEM, V71, P3273, DOI 10.1021/ac990059s
   Jacobson SC, 1996, ANAL CHEM, V68, P720, DOI 10.1021/ac951230c
   Jakeway SC, 2000, FRESEN J ANAL CHEM, V366, P525, DOI 10.1007/s002160051548
   Ji HM, 2008, BIOMED MICRODEVICES, V10, P251, DOI 10.1007/s10544-007-9131-x
   Jia ZJ, 2004, ANAL CHEM, V76, P5597, DOI 10.1021/ac0494477
   Jochem FJ, 2005, CYTOM PART A, V65A, P77, DOI 10.1002/cyto.a.20137
   Juncker D, 2002, ANAL CHEM, V74, P6139, DOI 10.1021/ac0261449
   Kaigala GV, 2008, LAB CHIP, V8, P1071, DOI 10.1039/b802853b
   KAMENTSKY LA, 1965, SCIENCE, V150, P630, DOI 10.1126/science.150.3696.630
   KAMENTSKY LA, 1967, SCIENCE, V156, P1364, DOI 10.1126/science.156.3780.1364
   Kaneta T, 2012, J SEP SCI, V35, P431, DOI 10.1002/jssc.201100909
   Kang LF, 2008, DRUG DISCOV TODAY, V13, P1, DOI 10.1016/j.drudis.2007.10.003
   Khademhosseini A, 2004, LAB CHIP, V4, P425, DOI 10.1039/b404842c
   Kim C, 2008, LAB CHIP, V8, P473, DOI 10.1039/b714536e
   Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b
   Kim P, 2006, LAB CHIP, V6, P1432, DOI 10.1039/b610503c
   Kirby BJ, 2003, LAB CHIP, V3, P5, DOI 10.1039/b21062ln
   Kojima K, 2003, LAB CHIP, V3, P292, DOI 10.1039/b304652d
   Komen J, 2008, BIOMED MICRODEVICES, V10, P727, DOI 10.1007/s10544-008-9184-5
   Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046
   Kovac JR, 2007, ANAL CHEM, V79, P9321, DOI 10.1021/ac071366y
   Kovarik ML, 2011, ELECTROPHORESIS, V32, P3180, DOI 10.1002/elps.201100234
   Kozlowski F, 1996, SENSOR ACTUAT A-PHYS, V54, P659, DOI 10.1016/S0924-4247(97)80033-7
   KRICKA LJ, 1993, CLIN CHEM, V39, P1944
   Kruger J., 2002, P MOCR TOT AN SYST 2
   Ku CJ, 2008, ANAL CHEM, V80, P7543, DOI 10.1021/ac801114j
   Kumachev A, 2011, BIOMATERIALS, V32, P1477, DOI 10.1016/j.biomaterials.2010.10.033
   Lahann J, 2003, ANAL CHEM, V75, P2117, DOI 10.1021/ac020557s
   Laser DJ, 2004, J MICROMECH MICROENG, V14, pR35, DOI 10.1088/0960-1317/14/6/R01
   Leclerc E, 2004, BIOCHEM ENG J, V20, P143, DOI 10.1016/j.bej.2003.09.010
   Leclerc E, 2004, BIOMATERIALS, V25, P4683, DOI 10.1016/j.biomaterials.2003.10.060
   Lee B.K., 2010, J MICROMECH MICROENG, V20
   Lee DE, 2008, MICROSYST TECHNOL, V14, P1751, DOI 10.1007/s00542-008-0594-3
   Lee H, 2004, APPL PHYS LETT, V85, P1063, DOI 10.1063/1.1776339
   Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711
   Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+
   Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z
   Lee PJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1938253
   Lehnert T, 2002, APPL PHYS LETT, V81, P5063, DOI 10.1063/1.1528292
   Li CW, 2003, ANALYST, V128, P1137, DOI 10.1039/b304354a
   Li H, 2007, BIOMATERIALS, V28, P4098, DOI 10.1016/j.biomaterials.2007.06.005
   Li HB, 2002, SENSOR ACTUAT B-CHEM, V86, P215, DOI 10.1016/S0925-4005(02)00172-7
   Li Nianzhen, 2003, Crit Rev Biomed Eng, V31, P423, DOI 10.1615/CritRevBiomedEng.v31.i56.20
   Li PCH, 1997, ANAL CHEM, V69, P1564, DOI 10.1021/ac9606564
   Li YL, 2004, ANAL CHIM ACTA, V507, P151, DOI 10.1016/j.aca.2003.08.071
   Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030
   Lii J, 2008, ANAL CHEM, V80, P3640, DOI 10.1021/ac8000034
   Lindmo T., 1990, FLOW CYTOMETRY SORTI, P145
   Liu CW, 2007, J MICROMECH MICROENG, V17, P1985, DOI 10.1088/0960-1317/17/10/009
   Liu J, 2007, J CELL BIOCHEM, V102, P1180, DOI 10.1002/jcb.21345
   Liu JJ, 2009, LAB CHIP, V9, P1301, DOI 10.1039/b819219g
   Liu K, 2008, LANGMUIR, V24, P5955, DOI 10.1021/la8003917
   Liu RH, 2004, SENSOR ACTUAT B-CHEM, V98, P328, DOI 10.1016/j.snb.2003.09.037
   Liu SJ, 2012, POLYM ENG SCI, V52, P1395, DOI 10.1002/pen.23068
   Lu H., 2002, MICROTOTAL ANAL SYST, P784
   Lucas JA, 2011, J AGR SCI, V149, P91, DOI 10.1017/S0021859610000997
   Luo XC, 2005, J MATER PROCESS TECH, V167, P515, DOI 10.1016/j.jmatprotec.2005.05.050
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144
   Maerkl SJ, 2009, INTEGR BIOL, V1, P19, DOI 10.1039/b819762h
   Maharbiz MM, 2003, J MICROELECTROMECH S, V12, P590, DOI 10.1109/JMEMS.2003.815828
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Maillefer D, 2001, PROC IEEE MICR ELECT, P413, DOI 10.1109/MEMSYS.2001.906566
   Makamba H, 2003, ELECTROPHORESIS, V24, P3607, DOI 10.1002/elps.200305627
   MANZ A, 1994, J MICROMECH MICROENG, V4, P257, DOI 10.1088/0960-1317/4/4/010
   MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I
   Mappes T, 2007, MICROELECTRON ENG, V84, P1235, DOI 10.1016/j.mee.2007.01.154
   MARKX GH, 1994, MICROBIOL-SGM, V140, P585, DOI 10.1099/00221287-140-3-585
   Martin K, 2003, LAB CHIP, V3, P202, DOI 10.1039/b301258c
   McClain MA, 2001, ANAL CHEM, V73, P5334, DOI 10.1021/ac010504v
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Mecomber JS, 2006, ANAL CHEM, V78, P936, DOI 10.1021/ac051523y
   Melamed M., 1979, FLOW CYTOMETRY SORTI, P1
   Miao JC, 2007, INT J ADV MANUF TECH, V31, P897, DOI 10.1007/s00170-005-0276-6
   MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203
   Mohamed H, 2004, IEEE T NANOBIOSCI, V3, P251, DOI 10.1109/TNB.2004.837903
   Moldavan A, 1934, Science, V80, P188, DOI 10.1126/science.80.2069.188
   Monaghan P., 2000, P MOCR TOT AN SYST 2
   Moorthy J, 2003, LAB CHIP, V3, P62, DOI 10.1039/b300450c
   Moreno J.M., 2010, J MICROMECH MICROENG, V20
   Moriguchi H, 2002, LAB CHIP, V2, P125, DOI 10.1039/b202569h
   Muller T, 1999, BIOSENS BIOELECTRON, V14, P247, DOI 10.1016/S0956-5663(99)00006-8
   Muller T., 2002, BIOWORLD, V2, P12
   Murayama A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195308
   Murthy SK, 2004, LANGMUIR, V20, P11649, DOI 10.1021/la048047b
   Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8
   Nieuwenhuis J., 2002, MICROTOTAL ANAL SYST, P67
   Ocvirk G, 2000, ELECTROPHORESIS, V21, P107, DOI 10.1002/(SICI)1522-2683(20000101)21:1<107::AID-ELPS107>3.0.CO;2-Y
   Okazaki K., 2000, P ASPE ANN M SCOTTSD, P197
   Omasu F, 2005, ELECTROPHORESIS, V26, P1163, DOI 10.1002/elps.200410182
   Ormerod M.G., 2008, FLOW CYTOMETRY A BAS
   Ozkan M, 2003, BIOMED MICRODEVICES, V5, P61, DOI 10.1023/A:1024467417471
   Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k
   Paguirigan AL, 2009, INTEGR BIOL, V1, P182, DOI 10.1039/b814565b
   Pamme N, 2006, LAB CHIP, V6, P24, DOI 10.1039/b513005k
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Park DSW, 2008, BIOMED MICRODEVICES, V10, P21, DOI 10.1007/s10544-007-9106-y
   Park DSW, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/5/055003
   Park T., 2009, P ASME IMECE LAK BUE, P295
   Paulus A., 1998, P SOC PHOTO-OPT INS
   Pautot S, 2008, NAT METHODS, V5, P735, DOI 10.1038/nmeth.1236
   Pearce TM, 2005, LAB CHIP, V5, P97, DOI 10.1039/b407871c
   Pemble CM, 1999, SENSOR ACTUAT A-PHYS, V77, P145, DOI 10.1016/S0924-4247(99)00157-0
   PETERSEN KE, 1979, IEEE T ELECTRON DEV, V26, P1918, DOI 10.1109/T-ED.1979.19796
   Pethig R, 1998, J MICROMECH MICROENG, V8, P57, DOI 10.1088/0960-1317/8/2/004
   Pilarski PM, 2005, J IMMUNOL METHODS, V305, P48, DOI 10.1016/j.jim.2005.07.009
   Piruska A, 2005, LAB CHIP, V5, P1348, DOI 10.1039/b508288a
   Pol F., 1990, MICROLIQUID HANDLING
   Pregibon DC, 2007, SCIENCE, V315, P1393, DOI 10.1126/science.1134929
   Prieto A, 2010, J CHROMATOGR A, V1217, P2642, DOI 10.1016/j.chroma.2009.12.051
   Prokop A, 2004, BIOMED MICRODEVICES, V6, P325, DOI 10.1023/B:BMMD.0000048564.37800.d6
   Pruitt Steven C, 2004, Methods Mol Biol, V263, P239
   Qi H, 2010, ADV MATER, V22, P5276, DOI 10.1002/adma.201002873
   Qi SZ, 2002, LAB CHIP, V2, P88, DOI [10.1039/b200370h, 10.1039/b20037h]
   Qu BY, 2008, ANAL BIOANAL CHEM, V392, P1317, DOI 10.1007/s00216-008-2382-4
   Rabinovitch P., 2000, FLOW CYTOMETRY PRACT, P203
   Raley NF, 1995, P SOC PHOTO-OPT INS, V2639, P40, DOI 10.1117/12.221298
   Ramser K, 2008, SPECTROSC-INT J, V22, P287, DOI 10.3233/SPE-2008-0353
   Ramser K, 2010, J BIOPHOTONICS, V3, P187, DOI 10.1002/jbio.200910050
   RAMSEY JM, 1995, NAT MED, V1, P1093, DOI 10.1038/nm1095-1093
   Raty S, 2004, LAB CHIP, V4, P186, DOI 10.1039/b316437c
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Revzin A, 2005, LAB CHIP, V5, P30, DOI 10.1039/b405557h
   Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435
   Rhee SW, 2005, LAB CHIP, V5, P102, DOI 10.1039/b403091e
   Riegger L., 2010, J MICROMECH MICROENG, V20
   Roberts MA, 1997, ANAL CHEM, V69, P2035, DOI 10.1021/ac961038q
   Rodrigo PJ, 2002, OPT EXPRESS, V10, P1550
   Rossier J, 2002, ELECTROPHORESIS, V23, P858, DOI 10.1002/1522-2683(200203)23:6<858::AID-ELPS858>3.0.CO;2-3
   Rotting O, 2002, MICROSYST TECHNOL, V8, P32, DOI 10.1007/s00542-002-0106-9
   Ruano JM, 2000, ANAL CHEM, V72, P1093, DOI 10.1021/ac9906983
   Ruedas-Rama MJ, 2007, ANAL CHEM, V79, P7853, DOI 10.1021/ac0711211
   Rusu C, 2001, J MICROELECTROMECH S, V10, P238, DOI 10.1109/84.925758
   Sakai Y., 2004, LAB CHIPS CELLOMICS, P299
   Schaff UY, 2007, LAB CHIP, V7, P448, DOI 10.1039/b617915k
   Schasfoort RBM, 1999, SCIENCE, V286, P942, DOI 10.1126/science.286.5441.942
   Schift H, 2002, MICROELECTRON ENG, V61-2, P423, DOI 10.1016/S0167-9317(02)00513-0
   Schmidt C, 2000, ANGEW CHEM, V112, P3267
   Schonfeld F, 2004, LAB CHIP, V4, P65, DOI 10.1039/b310802c
   Schwarz A., 1998, P MUTAS 98 WORKSH OC, P241
   Seger U, 2004, LAB CHIP, V4, P148, DOI 10.1039/b311210a
   Sekar R, 2004, APPL ENVIRON MICROB, V70, P6210, DOI 10.1128/AEM.70.10.6210-6219.2004
   Shah RK, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70053-1
   Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h
   Shao PE, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2181631
   SHAPIRO H, 2003, PRACTICAL FLOW CYTOM
   Shelby JP, 2003, P NATL ACAD SCI USA, V100, P14618, DOI 10.1073/pnas.2433968100
   Shoffner MA, 1996, NUCLEIC ACIDS RES, V24, P375, DOI 10.1093/nar/24.2.375
   Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795
   Sniadecki NJ, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2906228
   Song H, 2006, ANGEW CHEM INT EDIT, V45, P7336, DOI 10.1002/anie.200601554
   Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o
   STEINER P, 1995, THIN SOLID FILMS, V255, P52, DOI 10.1016/0040-6090(95)91137-B
   Stjernstrom M, 1998, J MICROMECH MICROENG, V8, P33, DOI 10.1088/0960-1317/8/1/006
   Studer V, 2004, J APPL PHYS, V95, P393, DOI 10.1063/1.1629781
   Su YC, 2004, J MICROMECH MICROENG, V14, P415, DOI 10.1088/0960-1317/14/3/015
   Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820
   Sundararajan N, 2005, LAB CHIP, V5, P350, DOI 10.1039/b500792p
   Suzuki A, 2004, HEPATO-GASTROENTEROL, V51, P423
   Szaniszlo P, 2004, CYTOM PART A, V59A, P191, DOI 10.1002/cyto.a.20055
   Takayama S, 2001, ADV MATER, V13, P570, DOI 10.1002/1521-4095(200104)13:8<570::AID-ADMA570>3.0.CO;2-B
   Tallarek U, 2000, ANAL CHEM, V72, P2292, DOI 10.1021/ac991303i
   Tamaki E, 2002, ANAL CHEM, V74, P1560, DOI 10.1021/ac011092t
   Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021
   Tan YC, 2006, J AM CHEM SOC, V128, P5656, DOI 10.1021/ja056641h
   Tanaka Y, 2007, ANAL SCI, V23, P261, DOI 10.2116/analsci.23.261
   Tani H, 2004, ANAL CHEM, V76, P6693, DOI 10.1021/ac049401d
   Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v
   Telleman P, 2000, MESA MG, P39
   TERRY SC, 1979, IEEE T ELECTRON DEV, V26, P1880, DOI 10.1109/T-ED.1979.19791
   Thiebaud P, 2002, BIOSENS BIOELECTRON, V17, P87, DOI 10.1016/S0956-5663(01)00279-2
   Thiel A, 1998, IMMUNOTECHNOLOGY, V4, P89, DOI 10.1016/S1380-2933(98)00010-4
   Thompson DM, 2004, ANAL CHEM, V76, P4098, DOI 10.1021/ac0354241
   Thompson PA, 1997, NATURE, V389, P360, DOI 10.1038/38686
   Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c
   Toh YC, 2007, LAB CHIP, V7, P302, DOI 10.1039/b614872g
   Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108
   Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h
   Tracey M., 1998, P MOCR TOT AN SYST 1
   Trivedi V, 2009, IEEE ENG MED BIO, P7037, DOI 10.1109/IEMBS.2009.5333308
   Tudos AJ, 2001, LAB CHIP, V1, P83, DOI 10.1039/b106958f
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Umehara S, 2003, BIOCHEM BIOPH RES CO, V305, P534, DOI 10.1016/S0006-291X(03)00794-0
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   van der Wijngaart W, 2007, J MICROELECTROMECH S, V16, P765, DOI 10.1109/JMEMS.2007.893514
   Van Midwoud P.M., 2010, THESIS U GRONINGEN G
   van Midwoud PM, 2010, BIOTECHNOL BIOENG, V105, P184, DOI 10.1002/bit.22516
   Verpoorte E, 2002, ELECTROPHORESIS, V23, P677, DOI 10.1002/1522-2683(200203)23:5<677::AID-ELPS677>3.0.CO;2-8
   Vo-Dinh T, 2000, FRESEN J ANAL CHEM, V366, P540, DOI 10.1007/s002160051549
   Voldman J, 2002, ANAL CHEM, V74, P3984, DOI 10.1021/ac0256235
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Vulto P, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/7/077001
   Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d
   Walker GM, 2002, BIOMED MICRODEVICES, V4, P161, DOI 10.1023/A:1016088128057
   Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e
   Wallner G, 1997, APPL ENVIRON MICROB, V63, P4223
   Wang MM, 2005, NAT BIOTECHNOL, V23, P83, DOI 10.1038/nbt1050
   Wang XB, 2000, ANAL CHEM, V72, P832, DOI 10.1021/ac990922o
   Warrick J, 2007, LAB CHIP, V7, P316, DOI 10.1039/b613350a
   Waters LC, 1998, ANAL CHEM, V70, P158, DOI 10.1021/ac970642d
   Weibel DB, 2005, ANAL CHEM, V77, P4726, DOI 10.1021/ac048303p
   Weibel DB, 2007, LAB CHIP, V7, P1832, DOI 10.1039/b714664g
   Weigl BH, 1999, SCIENCE, V283, P346, DOI 10.1126/science.283.5400.346
   Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758
   Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591
   Wilding P, 1998, ANAL BIOCHEM, V257, P95, DOI 10.1006/abio.1997.2530
   WILLIAMS C, 1993, HUM MOL GENET, V2, P445, DOI 10.1093/hmg/2.4.445
   Wolbers F, 2006, ELECTROPHORESIS, V27, P5073, DOI 10.1002/elps.200600203
   Worgull M, 2005, MICROSYST TECHNOL, V12, P110, DOI 10.1007/s00542-005-0012-z
   Xu J, 2001, DRUG DISCOV TODAY, V6, P1278, DOI 10.1016/S1359-6446(01)02095-5
   Xu J., 2001, MICROTOTAL ANAL SY C, P313
   Yamaguchi Y, 2009, SENSOR ACTUAT B-CHEM, V136, P555, DOI 10.1016/j.snb.2008.11.052
   Yang BZ, 2007, SENSOR ACTUAT A-PHYS, V134, P194, DOI 10.1016/j.sna.2006.07.017
   Yang J, 2004, LAB CHIP, V4, P53, DOI 10.1039/b309940g
   Yang MS, 2002, ANAL CHEM, V74, P3991, DOI 10.1021/ac025536c
   Yang R, 2005, SENSOR ACTUAT A-PHYS, V118, P259, DOI 10.1016/j.sna.2004.09.001
   Yao DG, 2002, POLYM ENG SCI, V42, P2471, DOI 10.1002/pen.11133
   Yoo JC, 2007, SENSOR ACTUAT A-PHYS, V139, P216, DOI 10.1016/j.sna.2007.04.056
   Young EWK, 2007, LAB CHIP, V7, P1759, DOI 10.1039/b712486d
   Yu CH, 2005, ADV MATER, V17, P1477, DOI 10.1002/adma.200401586
   Yu HM, 2005, LAB CHIP, V5, P1089, DOI 10.1039/b504403k
   Yu Q, 2001, APPL PHYS LETT, V78, P2589, DOI 10.1063/1.1367010
   Yuen PK, 2001, GENOME RES, V11, P405, DOI 10.1101/gr.155301
   Zborowski M, 2003, BIOPHYS J, V84, P2638, DOI 10.1016/S0006-3495(03)75069-3
   Zborowski M, 1999, J MAGN MAGN MATER, V194, P224, DOI 10.1016/S0304-8853(98)00581-2
   ZBOROWSKI M, 1995, ANAL CHEM, V67, P3702, DOI 10.1021/ac00116a014
   Zeng SJ, 2011, TOP CURR CHEM, V304, P69, DOI 10.1007/128_2011_149
   Zhang XL, 2006, MRS BULL, V31, P95, DOI 10.1557/mrs2006.22
   Zheng B, 2004, ADV MATER, V16, P1365, DOI 10.1002/adma.200400590
   Zheng W, 2004, ASSAY DRUG DEV TECHN, V2, P543, DOI 10.1089/adt.2004.2.543
   Zhu L, 2004, LAB CHIP, V4, P337, DOI 10.1039/b401834f
   Zhu XY, 2004, ANALYST, V129, P1026, DOI 10.1039/b407623k
NR 393
TC 53
Z9 53
U1 4
U2 261
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD SEP
PY 2012
VL 4
IS 3
BP 1349
EP 1398
DI 10.3390/polym4031349
PG 50
WC Polymer Science
SC Polymer Science
GA 068HO
UT WOS:000313357300002
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Watanabe, H
   Saito, K
   Kokubun, K
   Sasaki, H
   Yoshinari, M
AF Watanabe, Hiroaki
   Saito, Kensuke
   Kokubun, Katsutoshi
   Sasaki, Hodaka
   Yoshinari, Masao
TI Change in surface properties of zirconia and initial attachment of
   osteoblast-like cells with hydrophilic treatment
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Tetragonal zirconia polycrystals (TZP); Surface wettability;
   Oxygen-plasma treatment; UV treatment; Initial attachment of osteoblasts
ID IMPLANT SURFACES; TITANIUM; ADHESION; BIOMATERIAL; ADSORPTION;
   MECHANISM; RESPONSES; WATER
AB The objectives of this study were to characterize change in surface properties of tetragonal zirconia polycrystals (TZP) after hydrophilic treatment, and to determine the effect of such changes on initial attachment of osteoblast-like cells. Roughened surfaces were produced by alumina-blasting and acid-etching. Hydrophilic treatment comprised application of immediately after blasting and acid-etching (Blast/Etch), oxygen plasma (O2-Plasma), ultraviolet light (UV). Specimens stored in air were used as a control. The water contact angle was determined and surface analysis was performed using an X-ray photoelectron spectroscopy. Blast/Etch, O2-Plasma and UV specimens showed superhydrophilicity, and these hydrophilic treatments to TZP elicited a marked decrease in carbon content and an increase in hydroxyl groups. Hydrophilic treatments enhanced initial attachment of osteoblast-like cells and a change in cell morphologies. These results indicate that Blast/Etch, O2-Plasma, or UV treatment has potential in the creation and maintenance of superhydrophilic surfaces and enhancing initial attachment of osteoblast-like cells.
C1 [Watanabe, Hiroaki; Saito, Kensuke; Kokubun, Katsutoshi; Sasaki, Hodaka; Yoshinari, Masao] Tokyo Dent Coll, Oral Hlth Sci Ctr, Div Oral Implants Res, Mihama Ku, Chiba 2618501, Japan.
   [Watanabe, Hiroaki; Saito, Kensuke] Tokyo Dent Coll, Dept Endodont & Clin Cariol, Mihama Ku, Chiba 2618502, Japan.
   [Kokubun, Katsutoshi] Tokyo Dent Coll, Dept Clin Pathophysiol, Mihama Ku, Chiba 2618502, Japan.
   [Sasaki, Hodaka] Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Mihama Ku, Chiba 2618502, Japan.
RP Yoshinari, M (reprint author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Div Oral Implants Res, Mihama Ku, 1-2-2 Masago, Chiba 2618501, Japan.
EM yosinari@tdc.ac.jp
FU Foundation of the Japan Medical Association; Oral Health Science Center
   from Tokyo Dental College [hrc7]; "High-Tech Research Center" Project
   for Private Universities: matching fund subsidy from MEXT (Ministry of
   Education, Culture, Sports, Science and Technology) of Japan
FX This research was supported by the Foundation of the Japan Medical
   Association, by Oral Health Science Center Grant hrc7 from Tokyo Dental
   College, and by a "High-Tech Research Center" Project for Private
   Universities: matching fund subsidy from MEXT (Ministry of Education,
   Culture, Sports, Science and Technology) of Japan, 2006-2011. The
   authors would like to thank Associate Professor Jeremy Williams for his
   assistance with the English of this article.
CR Aita H, 2009, ACTA BIOMATER, V5, P3247, DOI 10.1016/j.actbio.2009.04.022
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Att W, 2009, BIOMATERIALS, V30, P1273, DOI 10.1016/j.biomaterials.2008.11.024
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Drelich J, 2010, LANGMUIR, V26, P18621, DOI 10.1021/la1039893
   Egusa H, 2008, J PROSTHET DENT, V100, P344, DOI 10.1016/S0022-3913(08)60233-4
   Feng J, 2003, BIOMATERIALS, V24, P4663
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Hayakawa T, 2004, BIOMATERIALS, V25, P119, DOI 10.1016/S0142-9612(03)00484-8
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Kilpadi DV, 2000, INT J ORAL MAX IMPL, V15, P219
   Kim WJ, 2009, LANGMUIR, V25, P11692, DOI 10.1021/la901615e
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Liu Z, 2005, J PHYS CHEM B, V109, P1251, DOI 10.1021/jp046368q
   Osathanon Thanaphum, 2011, J Oral Sci, V53, P23
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pivodova V, 2011, BIOMED PAP, V155, P109, DOI 10.5507/bp.2011.021
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Takeuchi M, 2005, J PHYS CHEM B, V109, P15422, DOI 10.1021/jp058075i
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233
   Wang XC, 2006, ENVIRON SCI TECHNOL, V40, P2369, DOI 10.1021/es052000a
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
   YANAGISAWA I, 1989, Journal of Oral Implantology, V15, P168
   Yoshinari M, 2011, PROCESSING FABRICATI, P1440
   Yoshinari M, 2004, J ORAL TISSUE ENG, V1, P69
   Yoshinari M, 2011, JPN DENT SCI REV, V47, P89, DOI 10.1016/j.jdsr.2011.03.001
   Zubkov T, 2005, J PHYS CHEM B, V109, P15454, DOI 10.1021/jp058101c
NR 33
TC 29
Z9 29
U1 0
U2 6
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD SEP
PY 2012
VL 31
IS 5
BP 806
EP 814
DI 10.4012/dmj.2012-069
PG 9
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 055PQ
UT WOS:000312429300014
PM 23037844
OA Bronze
DA 2018-10-19
ER

PT J
AU Costa, LMM
   de Olyveira, GM
   Basmaji, P
   Xavier, L
AF Manzine Costa, Ligia Maria
   de Olyveira, Gabriel Molina
   Basmaji, Pierre
   Xavier Filho, Lauro
TI Bacterial Cellulose Towards Functional Medical Materials
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Bacterial Cellulose; Bionanocomposites; Animal Medicine; Human Medicine;
   Medical Applications
ID GUIDED BONE REGENERATION; IN-VIVO EVALUATION; ACETOBACTER-XYLINUM;
   MICROBIAL CELLULOSE; CELL-ADHESION; BIOMEDICAL APPLICATIONS; TISSUE;
   MEMBRANE; SURFACE; GROWTH
AB Bacterial cellulose (BC) has established to be a remarkably versatile biomaterial and can be used in wide variety of applied scientific endeavors, especially for medical devices. In fact, biomedical devices recently have gained a significant amount of attention because of increased interesting tissue-engineered products for both wound care and the regeneration of damaged or diseased organs. The architecture of BC materials can be engineered over length scales ranging from nano to macro by controlling the biofabrication process. It has unique properties that make it an exciting candidate as a medical material: strength, good integration into host tissue, and flexibility of production in various shapes and sizes. This review describes the fundamentals, purification and morphological investigation of bacterial cellulose. Furthermore, provides deep knowledge of current and applications of bacterial cellulose and their green nanocomposites to obtain a biomaterial with less rejection and better cellular contact and blood contact cells interation in human and animal medicine. Besides, futures insights and researches in bacterial cellulose are discussed.
C1 [Manzine Costa, Ligia Maria; de Olyveira, Gabriel Molina] Univ Fed Abc, Dept Nanosci & Adv Mat, BR-09291210 Santo Andre, SP, Brazil.
   [Basmaji, Pierre; Xavier Filho, Lauro] Innovatecs Biotechnol Res & Dev, BR-13566610 Sao Carlos, SP, Brazil.
RP de Olyveira, GM (reprint author), Univ Fed Abc, Dept Nanosci & Adv Mat, Rua Santa Adelia 166, BR-09291210 Santo Andre, SP, Brazil.
RI Manzine Costa, Ligia Maria/N-1780-2015
OI Manzine Costa, Ligia Maria/0000-0001-6483-7633
CR Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Aslan M., 2004, J CONT DENT PRACT, V5, P114
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Barbanti Samuel H., 2005, Polímeros, V15, P13, DOI 10.1590/S0104-14282005000100006
   Basmaji P., 2011, J NANOTECH ENG MED, V2
   Basmaji P., 2011, P NAN BIOS INSTR MED
   Bielecki S., 2005, Polysaccharides and polyamides in the food industry: properties, production, and patents, P31
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Borges JP, 2001, MECH COMPOS MATER, V37, P257, DOI 10.1023/A:1010650803273
   Carvalho RS, 2003, AM J ORTHOD DENTOFAC, V123, P455, DOI 10.1067/mod.2003.59
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chang DK, 2009, J BIOL CHEM, V284, P12905, DOI 10.1074/jbc.M900280200
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Cienchanska D., 2004, FIBRES TEXT EAST EUR, V12, P69
   CLARK P, 1994, BIOSENS BIOELECTRON, V9, P657, DOI 10.1016/0956-5663(94)80062-6
   Coelho Maria Cristina de Oliveira Cardoso, 2002, Acta Cir. Bras., V17, P11, DOI 10.1590/S0102-86502002000700003
   Costa L. M. M., 2012, J BIOMATER NANOBIOTE, V3, P92, DOI [10.4236/jbnb.2012.31012, DOI 10.4236/JBNB.2012.31012]
   Costa L. M. M., 2010, 7 INT S NAT POL COMP
   Cremonini DN, 2010, ARQ BRAS MED VET ZOO, V62, P791, DOI 10.1590/S0102-09352010000400004
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   Esguerra M., 2009, J BIOMEDICAL MAT R A, V39, P140
   Falcao SC, 2008, ACTA CIR BRAS, V23, P78, DOI 10.1590/S0102-86502008000100013
   FOSANG AJ, 1996, EXTRACELLULAR MATRIX, V2, P200
   Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   Grande J. C., 2009, MAT SCI ENG C, V29, P1098
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Han G, 2007, NANOMEDICINE-UK, V2, P113, DOI 10.2217/17435889.2.1.113
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   Hong M, 2009, CHEM-EUR J, V15, P5935, DOI 10.1002/chem.200802632
   Iamaguti LS, 2008, PESQUISA VET BRASIL, V28, P195, DOI 10.1590/S0100-736X2008000400001
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Johansson S., 1996, EXTRACELLULAR MATRIX, P68
   Kalita S, 2011, INT J POLYM SCI, V1, P1
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Kumari T. V., 2002, TRENDS BIOMATER ARTI, V15, P37
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Macedo N., 2004, BRAZ J ORAL SCI, V3, P395
   MacNeil R. L., 1995, OSTEOPONTIN ROLE CEL
   Marques Silvio Romero de Barros, 2007, J. vasc. bras., V6, P309, DOI 10.1590/S1677-54492007000400003
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   MASAOKA S, 1993, J FERMENT BIOENG, V75, P18, DOI 10.1016/0922-338X(93)90171-4
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   Mello L. R., 1996, ARQ BRAS NEUROCIRURG, V15, P14
   Mello L. R., 2001, ARQ NEURO-PSIQUIAT, V59, p2B
   Mendes PN, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-12
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   NARAYANAN AS, 1983, COLLAGEN REL RES, V3, P33
   Nogi M, 2008, ADV MATER, V20, P1849, DOI 10.1002/adma.200702559
   Novaes A B Jr, 1993, Clin Oral Implants Res, V4, P106, DOI 10.1034/j.1600-0501.1993.040207.x
   Okahisa Y, 2009, COMPOS SCI TECHNOL, V69, P1958, DOI 10.1016/j.compscitech.2009.04.017
   Olyveira G. M., 2011, J BIOMATER NANOBIOTE, V02, P239
   Onizawa K., 2009, PULM PHARMACOL THER, V22, P340
   Orts WJ, 2005, J POLYM ENVIRON, V13, P301, DOI 10.1007/s10924-005-5514-3
   PITARU S, 1993, J PERIODONTAL RES, V28, P560, DOI 10.1111/j.1600-0765.1993.tb02124.x
   Queiroz V. F., 1989, ACTA CIR BRAS, V4, P144
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   Ramana KV, 2000, WORLD J MICROB BIOT, V16, P245, DOI 10.1023/A:1008958014270
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   Ren D. H., 2009, INT J ANTIMICROB AG, V33, P587
   Reshan B., 2008, ADV DRUG DELIVERY RE, V60, P1289
   Riesenfeld J, 1995, Med Device Technol, V6, P24
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Salata LA, 2001, CLIN ORAL IMPLAN RES, V12, P62, DOI 10.1034/j.1600-0501.2001.012001062.x
   SALATA LA, 1995, J DENT RES, V74, P825
   Sanderberg D., 1993, J ORAL MAXILLOFAC SU, V51, P1106
   Sandhiya S, 2009, FUND CLIN PHARMACOL, V23, P263, DOI 10.1111/j.1472-8206.2009.00692.x
   Sani A, 2010, J CHEM TECHNOL BIOT, V85, P151, DOI 10.1002/jctb.2300
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Schrecker ST, 2005, BIOTECHNOL LETT, V27, P1435, DOI 10.1007/s10529-005-1465-y
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Seifert M, 2004, J POLYM SCI POL CHEM, V42, P463, DOI 10.1002/pola.10862
   Shi C., 2008, UROL ONCOL-SEMIN ORI, V26, P26
   Silva E. C., 2009, THESIS VICOSA FEDERA
   Souza F. C., 2010, J VOICE, V25, P765
   STOCKMANN A, 1993, J BIOL CHEM, V268, P22874
   Szymanska-Chargot M, 2011, SENSORS-BASEL, V11, P5543, DOI 10.3390/s110605543
   Tang WH, 2010, WORLD J MICROB BIOT, V26, P125, DOI 10.1007/s11274-009-0151-y
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Valido D. P., 2012, J BIOMATER TISS ENG, V2, P48
   VANDERREST M, 1990, BIOCHIMIE, V72, P473, DOI 10.1016/0300-9084(90)90071-N
   Waters N E, 1980, Symp Soc Exp Biol, V34, P99
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   You CC, 2007, NAT NANOTECHNOL, V2, P318, DOI 10.1038/nnano.2007.99
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
NR 97
TC 15
Z9 15
U1 2
U2 50
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD SEP
PY 2012
VL 2
IS 3
BP 185
EP 196
DI 10.1166/jbt.2012.1044
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 057NS
UT WOS:000312570900001
DA 2018-10-19
ER

PT J
AU Singh, H
   James, E
   Kan, HM
   Nair, LS
AF Singh, Hardeep
   James, Eric
   Kan, Ho-Man
   Nair, Lakshmi S.
TI Fabrication and Evaluation of Resveratrol Loaded Polymeric Nanofibers
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Resveratrol; MC3T3-E1; Electrospinning; Sustained Release; Nanofibers
ID GROWTH-FACTOR-II; DIFFERENTIATION; CELLS; BIOAVAILABILITY;
   PROLIFERATION; MICROSPHERES; BONE; WINE
AB Resveratrol is a phytoestrogen, known to serve as an agonist for the estrogen receptor, promoting estrogen-like effects such as neuroprotection and bone growth. Estrogen has been shown to decrease the turnover of bone, prevent bone loss, and increase bone mass. Estrogen replacement therapy is used to decrease bone loss in postmenopausal women which presumably acts by increasing osteoblast activity and decreasing the number and activity of osteoclasts. The present study evaluated the effects of resveratrol on late stage osteogenesis of MC3T3-E1 cells and the feasibility to develop resveratrol loaded poly(caprolactone) nanofibers as scaffolds for bone regeneration. The extent of mineral deposition after exposing cells to different concentrations of resveratrol for 2 and 3 weeks was followed by alizarin red staining. The results demonstrated that resveratrol treated groups irrespective of the concentrations studied showed a significant increase in mineralized matrix deposition compared to the control group at both time points. qRT-PCR studies showed a significant up-regulation of IGF2, RunX2, and osteopontin by resveratrol treated cells. Poly(caprolactone) nanofibers with different resveratrol loadings were prepared by the process of electrospinning. The nanofibers showed a sustained release of resveratrol without a burst effect. The bioactivity of the resveratrol loaded nanofibers was confirmed by the increase in mineralized matrix deposition by cells cultured on resveratrol loaded nanofibers compared to control fibers. In conclusion, the results demonstrate that the resveratrol loaded PCL nanofiber matrix is bioactive and has the potential to serve as an osteogenic biomaterial.
C1 [Nair, Lakshmi S.] Univ Connecticut, Inst Mat Sci, Dept Chem Mat & Biomol Engn, Storrs, CT 06269 USA.
   [Singh, Hardeep] Univ Connecticut, Ctr Hlth, Sch Med, Farmington, CT 06032 USA.
   [Kan, Ho-Man; Nair, Lakshmi S.] Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Dept Orthopaed Surg, Farmington, CT 06032 USA.
RP Nair, LS (reprint author), Univ Connecticut, Inst Mat Sci, Dept Chem Mat & Biomol Engn, Storrs, CT 06269 USA.
CR Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Boissy P, 2005, CANCER RES, V65, P9943, DOI 10.1158/0008-5472.CAN-05-0651
   Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133
   Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437
   Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003
   Denhardt D T, 1998, J Cell Biochem Suppl, V30-31, P92
   Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5
   Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138
   Gangji V, 1998, ENDOCRINOLOGY, V139, P2287, DOI 10.1210/en.139.5.2287
   Gu XL, 2000, J CHROMATOGR A, V881, P471, DOI 10.1016/S0021-9673(00)00211-9
   Huang ZM, 2006, J BIOMED MATER RES A, V77A, P169, DOI 10.1002/jbm.a.30564
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218
   Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lu XW, 2009, INT J PHARMACEUT, V375, P89, DOI 10.1016/j.ijpharm.2009.03.021
   Martinez J, 2000, BIOCHEM PHARMACOL, V59, P865, DOI 10.1016/S0006-2952(99)00380-9
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Mizutani K, 1998, BIOCHEM BIOPH RES CO, V253, P859, DOI 10.1006/bbrc.1998.9870
   Nam JB, 2005, POLYMER, V46, P8956, DOI 10.1016/j.polymer.2005.07.016
   Peng HL, 2010, FOOD CHEM, V121, P23, DOI 10.1016/j.foodchem.2009.11.085
   Santos AC, 2011, EXPERT OPIN DRUG DEL, V8, P973, DOI 10.1517/17425247.2011.581655
   SIEMANN EH, 1992, AM J ENOL VITICULT, V43, P49
   Vyas S, 2005, ENDOCRINOLOGY, V146, P4224, DOI 10.1210/en.2004-1344
NR 24
TC 13
Z9 13
U1 1
U2 31
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD SEP
PY 2012
VL 2
IS 3
BP 228
EP 235
DI 10.1166/jbt.2012.1049
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 057NS
UT WOS:000312570900006
DA 2018-10-19
ER

PT J
AU De Nardo, L
   Raffaini, G
   Ebramzadeh, E
   Ganazzoli, F
AF De Nardo, Luigi
   Raffaini, Giuseppina
   Ebramzadeh, Edward
   Ganazzoli, Fabio
TI Titanium oxide modeling and design for innovative biomedical surfaces: a
   concise review
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE Biomaterial surface modifications; Theoretical modeling; Metal oxide
   hydration; Surface adsorption; Implantable prostheses
ID CALCIUM-PHOSPHATE FORMATION; GEL-DERIVED TITANIA; ELECTROPHORETIC
   DEPOSITION; MOLECULAR-DYNAMICS; TIO2 SURFACES; AB-INITIO; IN-VITRO;
   DENTAL IMPLANTS; GALVANOSTATIC ANODIZATION; OSTEOBLAST ADHESION
AB The natural oxide layer on implantable alloys insulates the reactive underlying metal from the physiological environment, preventing substrate corrosion and device failure. This type of oxide film has had a major role in the minimization of functional failure and toxic response after implantation in the first generation biomaterials. Recent advances in theoretical, computational, and experimental surface engineering tools provide the foundation for the design of novel devices with improved performances in this regard based on conventional implantable metal alloys. An increasing number of technologies provide the possibility of tailoring chemico-physical and morphological parameters of the surface oxide layers. For some applications, such as dental implants, surface modifications result in substantial innovation and economic success. However, the selection of novel surfaces is in general based on experimental studies and has a limited theoretical and computational foundation. In this review, we offer a perspective analysis of the correlation between theoretical studies and chemical surface modification technologies, with a special emphasis on titanium oxide on 77 alloys. Theoretical approaches for the surface behavior at an atomistic level of description are presented, together with some adsorption studies on a rutile surface. The role of chemical and electrochemical surface modification technologies in modifying the TiO2 structure, morphology, and chemistry to tailor in vivo biological response is then briefly reviewed. Finally, we discuss the role of surface modeling as a powerful design tool for a new generation of implantable devices in which metal oxide surface can be tuned to yield specific biological response.
C1 [De Nardo, Luigi; Raffaini, Giuseppina; Ganazzoli, Fabio] Politecn Milan, Dept Chem Mat & Chem Engn G Natta, I-20133 Milan, Italy.
   [Ebramzadeh, Edward] UCLA Orthopaed, Hosp Dept Orthopaed Surg, David Geffen Sch Med, JVL Orthopaed Res Ctr, Los Angeles, CA USA.
RP De Nardo, L (reprint author), Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Piazza L da Vinci 32, I-20133 Milan, Italy.
EM luigi.denardo@polimi.it
RI Raffaini, Giuseppina/N-1578-2014; Ganazzoli, Fabio/F-9543-2013; De
   Nardo, Luigi/B-7523-2009
OI Raffaini, Giuseppina/0000-0003-3462-6514; Ganazzoli,
   Fabio/0000-0002-9762-4535; De Nardo, Luigi/0000-0002-7492-6012
FU MIUR - FIRB Futuro in Ricerca (Surface-Associated Selective Transfection
   - SAST) [RBFR08XH0H]; Politecnico di Milano; Italian Institute of
   Technology (IIT)
FX L. De Nardo and G. Raffaini are grateful for funding from MIUR - FIRB
   Futuro in Ricerca (Surface-Associated Selective Transfection - SAST,
   RBFR08XH0H). L. De Nardo also thanks the Politecnico di Milano (Grant: 5
   per Mille Junior) and the Italian Institute of Technology (IIT) for
   financial support.
CR Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   ALADJEM A, 1973, J MATER SCI, V8, P688, DOI 10.1007/BF00561225
   Alfieri I, 2010, J APPL BIOMATER BIOM, V8, P14
   Altomare L, 2011, J MATER SCI-MATER M, V22, P1303, DOI 10.1007/s10856-011-4307-6
   Altomare L, 2010, ACTA BIOMATER, V6, P1948, DOI 10.1016/j.actbio.2009.12.040
   Altomare L, 2008, J APPL BIOMATER BIOM, V6, P132
   Arcos D, 2009, J MATER SCI-MATER M, V20, P447, DOI 10.1007/s10856-008-3616-x
   Areva S, 2002, CHEM MATER, V14, P1614, DOI 10.1021/cm0107272
   ASK M, 1989, APPL SURF SCI, V35, P283, DOI 10.1016/0169-4332(89)90013-5
   Balamurugan A, 2008, MATER CORROS, V59, P855, DOI 10.1002/maco.200804173
   Barnard AS, 2005, J CHEM THEORY COMPUT, V1, P107, DOI 10.1021/ct0499635
   Besra L, 2007, PROG MATER SCI, V52, P1, DOI 10.1016/j.pmatsci.2006.07.001
   Billi F, 2010, J APPL BIOMATER BIOM, V8, P1
   Blackwood DJ, 2003, CORROS REV, V21, P97
   Boemio G, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/4/045008
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Brunski JB, 1996, BIOMATERIALS SCI INT, P37
   Cabailh G, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.241403
   Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001
   Carravetta V, 2006, J PHYS CHEM B, V110, P6160, DOI 10.1021/jp056760j
   Catauro M, 2007, J APPL BIOMATER BIOM, V5, P41
   Charlton G, 1997, PHYS REV LETT, V78, P495, DOI 10.1103/PhysRevLett.78.495
   Cheng J, 2010, J CHEM THEORY COMPUT, V6, P880, DOI 10.1021/ct100013q
   Chiesa R, 2003, J Appl Biomater Biomech, V1, P91
   Chiesa R, 2007, ORAL SURG ORAL MED O, V103, P745, DOI 10.1016/j.tripleo.2006.09.025
   Cigada A, 2008, J APPL BIOMATER BIOM, V6, P127
   CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   Corni I, 2008, J EUR CERAM SOC, V28, P1353, DOI 10.1016/j.jeurceramsoc.2007.12.011
   De Nardo L, 2011, SURFACE MODIFICATION, P102
   De Nardo L, 2010, J MATER SCI-MATER M, V21, P2067, DOI 10.1007/s10856-010-4082-9
   Del Curto B, 2009, J APPL BIOMATER BIOM, V7, P153
   DELPLANCKE JL, 1982, SURF TECHNOL, V16, P153, DOI 10.1016/0376-4583(82)90033-4
   DELPLANCKE JL, 1988, ELECTROCHIM ACTA, V33, P1551, DOI 10.1016/0013-4686(88)80224-X
   DELPLANCKE JL, 1988, ELECTROCHIM ACTA, V33, P1539, DOI 10.1016/0013-4686(88)80223-8
   Deskins NA, 2007, J PHYS CHEM C, V111, P9290, DOI 10.1021/jp0713211
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   Esposito M, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/
   Fortunelli A, 2008, LANGMUIR, V24, P10145, DOI 10.1021/la801787s
   Freese HL, 2001, ENG MAT SER, P25
   Ganazzoli F, 2005, PHYS CHEM CHEM PHYS, V7, P3651, DOI 10.1039/b506813d
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gottlander M, 1997, BIOMATERIALS, V18, P551, DOI 10.1016/S0142-9612(96)00168-8
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   Harrison NM, 1999, FARADAY DISCUSS, V114, P305, DOI 10.1039/a906386b
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6
   HURLEN T, 1994, ELECTROCHIM ACTA, V39, P2169, DOI 10.1016/S0013-4686(94)85069-0
   Kang BS, 2009, ACTA BIOMATER, V5, P2222, DOI 10.1016/j.actbio.2009.01.049
   Labat F, 2008, J CHEM THEORY COMPUT, V4, P341, DOI 10.1021/ct700221w
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LAUSMAA J, 2001, ENG MAT SER, P231
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   Lindan PJD, 1996, SURF SCI, V364, P431, DOI 10.1016/0039-6028(96)00646-2
   Lindsay R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246102
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Machesky ML, 2008, LANGMUIR, V24, P12331, DOI 10.1021/la801356m
   Monti S, 2008, LANGMUIR, V24, P3205, DOI 10.1021/la702956t
   Moskalewicz T, 2007, SURF COAT TECH, V201, P7467, DOI 10.1016/j.surfcoat.2007.02.016
   Muscat J, 2000, SURF SCI, V446, P119, DOI 10.1016/S0039-6028(99)01125-5
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   Nishimura I, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/24/245101
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Raffaini G, 2007, MACROMOL BIOSCI, V7, P552, DOI 10.1002/mabi.200600278
   Raffaini G, 2010, J APPL BIOMATER BIOM, V8, P135, DOI 10.5301/JABB.2010.6093
   Sader MS, 2005, CLIN ORAL IMPLAN RES, V16, P667, DOI 10.1111/j.1600-0501.2005.01135.x
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Sittig C, 1999, J MATER SCI-MATER M, V10, P191, DOI 10.1023/A:1008997726370
   Song DP, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/7/075002
   Song DP, 2009, APPL SURF SCI, V255, P5702, DOI 10.1016/j.apsusc.2008.12.062
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Sousa SR, 2007, LANGMUIR, V23, P7046, DOI 10.1021/la062956e
   Sousa SR, 2004, LANGMUIR, V20, P9745, DOI 10.1021/la049158d
   STREICHER RM, 1991, BIOMATERIALS, V12, P125, DOI 10.1016/0142-9612(91)90190-L
   Swamy V, 2002, SURF SCI, V504, P115, DOI 10.1016/S0039-6028(01)01925-2
   Textor M, 2001, ENG MAT SER, P171
   Thompson TL, 2006, CHEM REV, V106, P4428, DOI 10.1021/cr050172k
   Van der Biest OO, 1999, ANNU REV MATER SCI, V29, P327, DOI 10.1146/annurev.matsci.29.1.327
   Variola F, 2009, SMALL, V5, P996, DOI 10.1002/smll.200801186
   Visai L, 2008, J APPL BIOMATER BIOM, V6, P170
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Voros J, 2001, ENG MAT SER, P87
   Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wu CY, 2010, J PHYS CHEM B, V114, P4692, DOI 10.1021/jp9109223
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Yin XL, 1997, APPL SURF SCI, V119, P199, DOI 10.1016/S0169-4332(97)00207-9
   Zhang Z, 2004, LANGMUIR, V20, P4954, DOI 10.1021/la0353834
   Zhitomirsky I, 2002, ADV COLLOID INTERFAC, V97, P279, DOI 10.1016/S0001-8686(01)00068-9
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 97
TC 13
Z9 13
U1 1
U2 82
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2012
VL 35
IS 9
BP 629
EP 641
DI 10.5301/ijao.5000040
PG 13
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 049JH
UT WOS:000311978700002
PM 23065887
DA 2018-10-19
ER

PT J
AU Affatato, S
   Modena, E
   Toni, A
   Taddei, P
AF Affatato, S.
   Modena, E.
   Toni, A.
   Taddei, P.
TI Retrieval analysis of three generations of Biolox (R) femoral heads:
   Spectroscopic and SEM characterisation
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Biolox (R); Biolox (R) forte; Biolox (R) delta; SEM; Raman spectroscopy;
   Fluorescence
ID PHOTOLUMINESCENCE INVESTIGATIONS; RESIDUAL-STRESSES; RAMAN-SPECTRA;
   ZIRCONIA; CERAMICS; ALUMINA; WEAR; TRANSFORMATION; BIOMATERIAL;
   COMPOSITES
AB Wear and osteolysis continue to be the major reasons for revision surgery in Total Hip Arthroplasty. The introduction of the ceramic-on-ceramic bearings eliminates the problem of polyethylene wear debris. During the last 40 years, three generations of Biolox (R) ceramics were developed (Biolox (R), Biolox (R) forte, and Biolox (R) delta), each better than the previous from the density, grain size and purity point of view.
   We conducted a retrieval study on 15 Biolox (R) femoral heads (Biolox (R), Biolox (R) forte, and Biolox (R) delta) articulating against liners of the same type. Surface properties and residual stress were assessed using SEM, fluorescence and Raman spectroscopy.
   At SEM examination, the Biolox (R) delta retrievals showed a lower wear than the previous generations. The fluorescence measurements suggested different wear mechanisms in the three sets of retrievals. Micro-cracking was predominant in Biolox (R), while in Biolox (R) forte and Biolox (R) delta a wider range of residual stress values was observed upon wear. Surface polishing was observed only in Biolox (R) and Biolox (R) forte. Raman spectroscopy of Biolox (R) delta femoral heads showed a progressive improvement in material composition. Wear induced a tetragonal to monoclinic transformation. The Raman results on the retrievals, here reported for the first time, allowed to validate the in vitro ageing protocols proposed in the literature to simulate the effects of the in vivo wear. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Affatato, S.; Toni, A.] Ist Ortoped Rizzoli, Lab Tecnol Med, I-40136 Bologna, Italy.
   [Modena, E.; Taddei, P.] Univ Bologna, Sez Chim & Propedeut Biochim, Dipartimento Biochim G Moruzzi, Bologna, Italy.
RP Affatato, S (reprint author), Ist Ortoped Rizzoli, Lab Tecnol Med, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM affatato@tecno.ior.it
OI TADDEI, PAOLA/0000-0001-8478-4508
CR BOEHLER M, 1994, J BONE JOINT SURG BR, V76B, P53
   Burger W., 2001, KEY ENG MATER, p[192, 545], DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.545
   Callaghan JJ, 2008, J AM ACAD ORTHOP SUR, V16, pS33, DOI 10.5435/00124635-200800001-00008
   Ceramtec, 2011, BIOLOX DELT NAN ARTH
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J., J MECH BEHAV BIOMEDI, V4, P303
   Chevalier J, 2009, BIOMATERIALS, V30, P5279, DOI 10.1016/j.biomaterials.2009.06.022
   Christian J.W., 1965, THEORY TRANSFORMATIO, P525
   CLARKE DR, 1982, J AM CERAM SOC, V65, P284, DOI 10.1111/j.1151-2916.1982.tb10445.x
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   DERBYSHIRE B, 1994, MED ENG PHYS, V16, P229, DOI 10.1016/1350-4533(94)90042-6
   Deville S., J AM CERAMIC SOC, V88, P1273
   Garcia MA, 2002, MAT SCI ENG A-STRUCT, V325, P302, DOI 10.1016/S0921-5093(01)01461-7
   GRABNER L, 1978, J APPL PHYS, V49, P580, DOI 10.1063/1.324682
   Hue J, 1995, J AM CERAM SOC, V78, P1347
   Insley G. M., 2004, KEY ENG MATER, V192-195, P781
   ISHIGAME M, 1977, J AM CERAM SOC, V60, P367, DOI 10.1111/j.1151-2916.1977.tb15561.x
   Johnson WA, 1939, T AM I MIN MET ENG, V135, P416
   Katagiri G., 1988, SCI TECHNOLOGY ZIRCO, P537
   Krishnan R, 2003, SCRIPTA MATER, V48, P1099, DOI 10.1016/S1359-6462(02)00631-0
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   Macchi F, 2001, ALLUMINA BIOLOX FORT, V15, P99
   MUKHOPADHYAY AK, 1993, WEAR, V162, P258, DOI 10.1016/0043-1648(93)90508-J
   Tabares JAM, 2010, J AM CERAM SOC, V93, P1790, DOI 10.1111/j.1551-2916.2010.03635.x
   ORTIZ M, 1993, J APPL MECH-T ASME, V60, P77, DOI 10.1115/1.2900782
   Pattyn C., 2008, ORTHOPEDICS
   Pezzotti G, 2008, J AM CERAM SOC, V91, P1199, DOI 10.1111/j.1551-2916.2007.01507.x
   PHILLIPPI CM, 1971, J AM CERAM SOC, V54, P254, DOI 10.1111/j.1151-2916.1971.tb12283.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   PORTO SPS, 1967, J CHEM PHYS, V47, P1009, DOI 10.1063/1.1711980
   Rhoads D. P., 2008, J ARTHROPLASTY, V23, P25
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Sergo V, 1998, ACTA MATER, V46, P1701, DOI 10.1016/S1359-6454(97)00348-0
   Taddei P, 2006, J MATER SCI, V41, P5310, DOI 10.1007/s10853-006-0356-5
   Taddei P, 2006, J MATER SCI, V41, P399, DOI 10.1007/s10853-005-2515-5
   WILLMANN G, 2000, HIP INT, V10, P193
NR 38
TC 30
Z9 31
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD SEP
PY 2012
VL 13
BP 118
EP 128
DI 10.1016/j.jmbbm.2012.04.003
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 042KE
UT WOS:000311469300012
PM 22842282
DA 2018-10-19
ER

PT J
AU Pan, YS
   Xu, CY
   Ding, GX
AF Pan, Yusong
   Xu, Chuyang
   Ding, Guoxin
TI Stress Relaxation Behaviour and Model of Multi-Layered
   Nano-Hydroxyapatite Reinforced PVA Gel Biocomposites
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 5th Korea-China International Conference on Multi-Functional Materials
   and Application
CY NOV 05, 2011
CL Hefei Univ, Hefei, PEOPLES R CHINA
HO Hefei Univ
DE Multi-layered graded nano-hydroxyapatite/PVA gel composites; Stress
   relaxation; Relaxation model; Normalized equilibrium modulus
AB Stress relaxation characteristics of multi-layered graded nano-hydroxyapatite/PVA gel biomaterial under different effect factors were studied. The results showed that the stress relaxation behaviour of the biocomposites is similar to that of natural articular cartilage and it can be described by logarithmic model. The stress relaxation rate declined with the rise of relaxation time, but it increases with the rise of compressive strain level and freeze-thaw cycle times under the whole relaxation time. Moreover, the normalized equilibrium relaxation modulus of the composites decreases with the rise of strain and freeze-thaw cycle times.
C1 [Pan, Yusong; Xu, Chuyang; Ding, Guoxin] Anhui Univ Sci & Technol, Dept Mat Sci & Engn, Huainan 232001, Peoples R China.
RP Pan, YS (reprint author), Anhui Univ Sci & Technol, Dept Mat Sci & Engn, Huainan 232001, Peoples R China.
EM yusongpan@163.com
CR [孟广伟 Meng Guangwei], 2003, [医用生物力学, Journal of medical biomechanics], V18, P239
   Pan YS, 2009, J MATER SCI-MATER M, V20, P1291, DOI 10.1007/s10856-008-3679-8
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Poursamar S A, 2010, International Journal of Nanomanufacturing, V5, P330
   Weng X.S., 1999, ACTA ACAD MED SINICA, V21, P53
NR 5
TC 0
Z9 1
U1 0
U2 3
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
J9 ASIAN J CHEM
JI Asian J. Chem.
PD SEP
PY 2012
VL 24
IS 9
BP 4106
EP 4108
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 033CQ
UT WOS:000310770900091
DA 2018-10-19
ER

PT J
AU Daculsi, G
   Durand, M
   Fabre, T
   Vogt, F
   Uzel, AP
   Rouvillain, JL
AF Daculsi, G.
   Durand, M.
   Fabre, T.
   Vogt, F.
   Uzel, A. -P.
   Rouvillain, J. -L.
TI Development and clinical cases of injectable bone void filler used in
   orthopaedic
SO IRBM
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; SUBSTITUTE; COMPOSITE; SURGERY; DEFECTS
AB This study reports several clinical cases for orthopaedic bone regeneration using an injectable hone substitute (MBCP Gel (R)) to demonstrate its safe use and efficiency in clinical applications. The biomaterial is a composite of microporous bioceramic hydroxyapatite granules that are associated with beta tricalcium phosphate (MBCP) and a synthetic hydrosoluble polysaccharide hydrogel (CE mark 123 and FDA dental domain registered). The present exploratory study demonstrated the generative osseous performance of this injectable bioceramic for filling various orthopaedic bone defects. The clinical cases showed hone ingrowth into the cavities created by drilling when removing the aseptic osteonecrosis of the femoral head during biopsy taking. Furthermore, bone reconstruction was seen after filling large cystic defects, at the time of the revision surgery of the hip prosthesis. Resorption and bone ingrowth with trabecular hone architecture were observed in defects created in long bones (femur and tibia). Patients were followed during 5 months to 1 year. The overall results demonstrated the safe use and the clinical performance of this injectable bioceramic in orthopaedics. (C) 2012 Elsevier Masson SAS. All rights reserved.
C1 [Daculsi, G.; Durand, M.] Univ Bordeaux, PTIB Hop Xavier Arnozan, CHU Bordeaux, CIC Inserm, F-33600 Pessac, France.
   [Daculsi, G.; Uzel, A. -P.] Univ Nantes, INSERM, LIOAD, ERT 2004,U791, F-44000 Nantes, France.
   [Fabre, T.] CHU Bordeaux, Hop Pellegrin, F-33000 Bordeaux, France.
   [Vogt, F.] CHU Cannes, F-06400 Cannes, France.
   [Uzel, A. -P.] CHU Pointe A Pitre Abymes, F-97110 Pointe a Pitre, Guadeloupe, Guadeloupe.
   [Rouvillain, J. -L.] CHU Ft de France, F-97200 Fort De France, Martinique, France.
RP Durand, M (reprint author), Univ Bordeaux, PTIB Hop Xavier Arnozan, CHU Bordeaux, CIC Inserm, F-33600 Pessac, France.
EM marlene.durand@chu-bordeaux.fr
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446; ROUVILLAIN, JEAN
   LOUIS/0000-0002-9076-9096
CR Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Daculsi Guy, 2006, Advances in Science and Technology, V49, P9, DOI 10.4028/www.scientific.net/AST.49.9
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Daculsi G, 2010, J MATER SCI-MATER M, V21, P855, DOI 10.1007/s10856-009-3914-y
   Daculsi G, 1999, BONE, V25, p59S, DOI 10.1016/S8756-3282(99)00135-0
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Daculsi G, 1995, CNRS patent, Patent No. [9521634, WO 95/21634]
   DAUBIGNE RM, 1990, REV CHIR ORTHOP, V76, P371
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P100
   GOUIN F, 1995, REV CHIR ORTHOP, V81, P59
   Jarcho M, 1981, CLIN ORTHOP RELAT R, V27, P157
   Le Nihouannen D, 2008, J MATER SCI-MATER M, V19, P667, DOI 10.1007/s10856-007-3206-3
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LeGeros RZ, 1990, HDB BIOACTIVE CERAMI, V2, P1728
   Malard O, 2005, BONE, V36, P323, DOI 10.1016/j.bone.2004.07.018
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Niwa S, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P385
   Ransford AO, 1998, J BONE JOINT SURG BR, V80B, P13, DOI 10.1302/0301-620X.80B1.7276
   Soares EJC, 1998, BIOCERAMICS, P633
   Weiss P, 1997, J MATER SCI-MATER M, V8, P621, DOI 10.1023/A:1018519419539
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
   WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405
   WYKROTA LL, 1998, BIOCERAMICS, V11, P641
NR 28
TC 4
Z9 4
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1959-0318
EI 1876-0988
J9 IRBM
JI IRBM
PD SEP
PY 2012
VL 33
IS 4
BP 253
EP 261
DI 10.1016/j.irbm.2012.06.001
PG 9
WC Engineering, Biomedical
SC Engineering
GA 033UL
UT WOS:000310826500003
DA 2018-10-19
ER

PT J
AU Rivas, DF
   Verhaagen, B
   Seddon, JRT
   Zijlstra, AG
   Jiang, LM
   van der Sluis, LWM
   Versluis, M
   Lohse, D
   Gardeniers, HJGE
AF Rivas, David Fernandez
   Verhaagen, Bram
   Seddon, James R. T.
   Zijlstra, Aaldert G.
   Jiang, Lei-Meng
   van der Sluis, Luc W. M.
   Versluis, Michel
   Lohse, Detlef
   Gardeniers, Han J. G. E.
TI Localized removal of layers of metal, polymer, or biomaterial by
   ultrasound cavitation bubbles
SO BIOMICROFLUIDICS
LA English
DT Article
ID ENTEROCOCCUS-FAECALIS; BACTERIAL BIOFILMS; ADHESION; SURFACES;
   SONOLUMINESCENCE; DETACHMENT; DYNAMICS; FORCE; CELLS; GLASS
AB We present an ultrasonic device with the ability to locally remove deposited layers from a glass slide in a controlled and rapid manner. The cleaning takes place as the result of cavitating bubbles near the deposited layers and not due to acoustic streaming. The bubbles are ejected from air-filled cavities micromachined in a silicon surface, which, when vibrated ultrasonically at a frequency of 200 kHz, generate a stream of bubbles that travel to the layer deposited on an opposing glass slide. Depending on the pressure amplitude, the bubble clouds ejected from the micropits attain different shapes as a result of complex bubble interaction forces, leading to distinct shapes of the cleaned areas. We have determined the removal rates for several inorganic and organic materials and obtained an improved efficiency in cleaning when compared to conventional cleaning equipment. We also provide values of the force the bubbles are able to exert on an atomic force microscope tip. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.4747166]
C1 [Rivas, David Fernandez; Gardeniers, Han J. G. E.] Univ Twente, Mesoscale Chem Syst Grp, MESA Res Inst, NL-7500 AE Enschede, Netherlands.
   [Verhaagen, Bram; Seddon, James R. T.; Zijlstra, Aaldert G.; Versluis, Michel; Lohse, Detlef] Univ Twente, Phys Fluids Grp, MIRA, NL-7500 AE Enschede, Netherlands.
   [Verhaagen, Bram; Seddon, James R. T.; Zijlstra, Aaldert G.] Univ Twente, MESA Res Inst, Fac Sci & Technol, NL-7500 AE Enschede, Netherlands.
   [Jiang, Lei-Meng; van der Sluis, Luc W. M.] Acad Ctr Dent Amsterdam, Dept Cario Endo & Periodontol, Amsterdam, Netherlands.
RP Rivas, DF (reprint author), Univ Twente, Mesoscale Chem Syst Grp, MESA Res Inst, ME147,POB 217, NL-7500 AE Enschede, Netherlands.
EM d.fernandezrivas@utwente.nl
RI Gardeniers, Johannes/B-6309-2013; Seddon, James/J-6214-2014; Lohse,
   Detlef/B-4915-2013; Versluis, Michel/F-3541-2011; Fernandez Rivas,
   David/B-6687-2008
OI Gardeniers, Johannes/0000-0003-0581-2668; Lohse,
   Detlef/0000-0003-4138-2255; Versluis, Michel/0000-0002-2296-1860;
   Fernandez Rivas, David/0000-0003-4329-3248
FU Technology Foundation STW; Applied Science Division of NWO; Technology
   Program of the Ministry of Economic Affairs, The Netherlands
FX This research was supported by the Technology Foundation STW, Applied
   Science Division of NWO and the Technology Program of the Ministry of
   Economic Affairs, The Netherlands.
CR An YH, 2000, HDB BACTERIAL ADHESI
   Arora M, 2007, J ACOUST SOC AM, V121, P3432, DOI 10.1121/1.2722045
   Ashokkumar M., 2000, KIRK OTHMER ENCY CHE
   Bang JH, 2010, ADV MATER, V22, P1039, DOI 10.1002/adma.200904093
   BARNETT SB, 1994, ULTRASOUND MED BIOL, V20, P205, DOI 10.1016/0301-5629(94)90060-4
   Bayoudh S, 2009, COLLOID SURFACE B, V73, P1, DOI 10.1016/j.colsurfb.2009.04.030
   BENJAMIN P, 1960, PROC R SOC LON SER-A, V254, P177, DOI 10.1098/rspa.1960.0013
   Borkent BM, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3249602
   Bremond N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.224501
   Brenner MP, 2002, REV MOD PHYS, V74, P425, DOI 10.1103/RevModPhys.74.425
   Brujan EA, 2009, MED ENG PHYS, V31, P742, DOI 10.1016/j.medengphy.2009.03.007
   Cobley A, 2011, CIRCUIT WORLD, V37, P15, DOI 10.1108/03056121111101241
   Cravotto G, 2012, CHEM SCI, V3, P295, DOI 10.1039/c1sc00740h
   Didenko YT, 2002, NATURE, V418, P394, DOI 10.1038/nature00895
   Dijkink R, 2008, PHYS MED BIOL, V53, P375, DOI 10.1088/0031-9155/53/2/006
   Dini J. W., 1993, ELECTRODEPOSITION MA
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07
   Flemming HC, 2011, SPRINGER SER BIOFILM, V5, P81, DOI 10.1007/978-3-642-19940-0_5
   Freitas AM, 1999, LANGMUIR, V15, P2466, DOI 10.1021/la9807107
   Gogate PR, 2004, ULTRASON SONOCHEM, V11, P105, DOI 10.1016/j.ultsonch.2004.01.005
   ISRAELACHVILI JN, 1984, J COLLOID INTERF SCI, V98, P500
   Jatariu AN, 2011, J BIOMED MATER RES A, V98A, P342, DOI 10.1002/jbm.a.33122
   Karshafian R, 2009, ULTRASOUND MED BIOL, V35, P847, DOI 10.1016/j.ultrasmedbio.2008.10.013
   Kuznetsova LA, 2007, BIOSENS BIOELECTRON, V22, P1567, DOI 10.1016/j.bios.2006.08.023
   Lau PCY, 2009, BIOPHYS J, V96, P2935, DOI 10.1016/j.bpj.2008.12.3943
   Lee H, 2010, J ARTIF ORGANS, V13, P17, DOI 10.1007/s10047-010-0490-3
   Lohse D, 2005, NATURE, V434, P33, DOI 10.1038/434033a
   Lohse D, 2003, PHYS TODAY, V56, P36, DOI 10.1063/1.1564347
   Marmottant P, 2003, NATURE, V423, P153, DOI 10.1038/nature01613
   Mason TJ, 2011, ULTRASON SONOCHEM, V18, P226, DOI 10.1016/j.ultsonch.2010.05.008
   Mayer C, 1999, INT J BIOL MACROMOL, V26, P3, DOI 10.1016/S0141-8130(99)00057-4
   Meinhart CD, 2000, MEAS SCI TECHNOL, V11, P809, DOI 10.1088/0957-0233/11/6/326
   Minford J., 1991, ADHESIVE BONDING, V1991, P239
   Mittal K., 1976, ADHESION MEASUREMENT, P5
   Ohl CD, 1999, PHILOS T R SOC A, V357, P269, DOI 10.1098/rsta.1999.0327
   Ohl CD, 2003, BBA-GEN SUBJECTS, V1624, P131, DOI 10.1016/j.bbagen.2003.10.005
   Ohl CD, 2006, BIOPHYS J, V91, P4285, DOI [10.1529/biophysj.105.075366, 10.1529/biophysj.106.075366]
   Ohl SW, 2009, PHYS MED BIOL, V54, P6313, DOI 10.1088/0031-9155/54/20/019
   OKADA T, 1995, WEAR, V184, P231, DOI 10.1016/0043-1648(94)06581-0
   Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205
   Portenier I, 2005, J ENDODONT, V31, P380, DOI 10.1097/01.don.0000145421.84121.c8
   Prosperetti A, 2004, PHYS FLUIDS, V16, P1852, DOI 10.1063/1.1695308
   RIEMER DE, 1985, IEEE T COMPON HYBR, V8, P474, DOI 10.1109/TCHMT.1985.1136525
   RIESZ P, 1992, FREE RADICAL BIO MED, V13, P247, DOI 10.1016/0891-5849(92)90021-8
   Rivas D. Fernandez, ULTRASON SO IN PRESS
   Rivas D. Fernandez, 2012, THESIS U TWENTE
   Rivas DF, 2012, ULTRASON SONOCHEM, V19, P1252, DOI 10.1016/j.ultsonch.2012.04.008
   Rivas DF, 2010, ANGEW CHEM INT EDIT, V49, P9699, DOI 10.1002/anie.201005533
   Sagvolden G, 1998, LANGMUIR, V14, P5984, DOI 10.1021/la980271b
   SELTZER S, 1967, ORAL SURG ORAL MED O, V23, P500, DOI 10.1016/0030-4220(67)90546-4
   Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B
   Stoodley P., 2001, SURF BIOM 2001 S P M, P189
   van der Waal SV, 2011, INT ENDOD J, V44, P1110, DOI 10.1111/j.1365-2591.2011.01929.x
   Vos R, 2001, J ELECTROCHEM SOC, V148, pG683, DOI 10.1149/1.1413483
   Vossen J., 1976, ADHESIVE MEASUREMENT, P122
   Weast R., 1971, CRC HDB CHEM PHYS
   Yeo LY, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3056040
   Yoon RH, 1997, J COLLOID INTERF SCI, V185, P363, DOI 10.1006/jcis.1996.4583
   Zijlstra A., 2011, THESIS U TWENTE
NR 60
TC 26
Z9 26
U1 1
U2 39
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1932-1058
J9 BIOMICROFLUIDICS
JI Biomicrofluidics
PD SEP
PY 2012
VL 6
IS 3
AR 034114
DI 10.1063/1.4747166
PG 20
WC Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology;
   Physics, Fluids & Plasmas
SC Biochemistry & Molecular Biology; Biophysics; Science & Technology -
   Other Topics; Physics
GA 014PB
UT WOS:000309386900015
PM 23964308
OA Green Published
DA 2018-10-19
ER

PT J
AU Kashanian, S
   Rafipour, R
   Tarighat, FA
   Ravan, H
AF Kashanian, S.
   Rafipour, R.
   Tarighat, F. A.
   Ravan, H.
TI Immobilisation of cobaltferritin onto gold electrode based on
   self-assembled monolayers
SO IET NANOBIOTECHNOLOGY
LA English
DT Article
ID INDIUM OXIDE ELECTRODES; HORSE SPLEEN FERRITIN; PROTEIN CAGE; REDOX
   PROTEINS; NANOPARTICLES; IRON; APOFERRITIN; ELECTROCHEMISTRY;
   ENVIRONMENT; FABRICATION
AB The iron storage protein, ferritin, has a cavity of similar to 7 nm in diameter in which iron is oxidised and stored as a hydrated oxide core. Electron transfer is known to be an important step in the sequestering of iron by cellular ferritin. The cavity was used as a nanocontainer to grow cobalt nanoparticles. The immobilisation of ferritin on the electrode surface is essential for various bioelectronic applications. A cobaltferritin-immobilised electrode based on self-assembled monolayer (SAM)-modified gold electrode was developed. The cobaltferritin-immobilised SAM-modified electrode was characterised by electrochemical and atomic force microscopy (AFM) techniques. The results indicated that cobaltferritin was selectively immobilised onto succinimidyl alkanedisulfide-modified Au electrode by the covalent interaction between cobaltferritin and the terminal functional groups of the SAMs. The cobaltferritin immobilised modified electrode showed a direct electron transfer reaction between cobaltferritin and the electrode. The electrochemically regulated uptake and release of cobalts for cobaltferritin immobilised on the SAMs were demonstrated. The results obtained in this study indicate that cobaltferritin has potential for a biomaterial in nanoscale synthesis for potential magnetic, catalytic and biomedical-sensing applications.
C1 [Kashanian, S.] Razi Univ, Fac Chem, SBRC, Kermanshah, Iran.
   [Kashanian, S.] Razi Univ, NNRC, Kermanshah, Iran.
   [Tarighat, F. A.] Razi Univ, Fac Sci, Dept Biol, Kermanshah, Iran.
   [Ravan, H.] Shahid Bahonar Univ, Fac Sci, Dept Biol, Kerman, Iran.
RP Kashanian, S (reprint author), Razi Univ, Fac Chem, SBRC, POB 67149, Kermanshah, Iran.
EM kashanian_s@yahoo.com
RI Ravan, Hadi/H-1919-2017
OI Ravan, Hadi/0000-0001-8560-4900
CR Bard A. J, 2001, ELECTROCHEMICAL METH
   Biswas P, 2005, J AIR WASTE MANAGE, V55, P708, DOI 10.1080/10473289.2005.10464656
   Bowden E.F., 2000, THESIS
   Cherry RJ, 1998, LANGMUIR, V14, P1971, DOI 10.1021/la970685p
   Crespilho FN, 2006, INT J ELECTROCHEM SC, V1, P194
   Douglas T, 2000, INORG CHEM, V39, P1828, DOI 10.1021/ic991269q
   Fragoso A, 2008, ANAL CHEM, V80, P2556, DOI 10.1021/ac702195v
   Gooding JJ, 2003, ELECTROANAL, V15, P81, DOI 10.1002/elan.200390017
   Guifang C., 2008, BIOCHEMISTRY-US, V72, P77
   Hong J, 2006, ELECTROCHEM COMMUN, V8, P1572, DOI 10.1016/j.elecom.2006.07.011
   Iwahori K, 2007, J PHYS CONF SER, V61, P492, DOI 10.1088/1742-6596/61/1/100
   Kim J.W., 2007, J ELECTROANAL CHEM, V601, P8
   Klem MT, 2008, INORG CHEM, V47, P2237, DOI 10.1021/ic701740q
   Klem MT, 2007, J AM CHEM SOC, V129, P197, DOI 10.1021/ja0667561
   Mahdavian L., 2009, INT J GREEN NANOTECH, V1, pM61
   Marken F, 2002, NEW J CHEM, V26, P259, DOI 10.1039/b108500j
   Martin TD, 1997, J ELECTROANAL CHEM, V420, P279, DOI 10.1016/S0022-0728(96)04790-0
   MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B
   Nigovic B, 2002, POLYHEDRON, V21, P1661, DOI 10.1016/S0277-5387(02)01024-0
   Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006
   Okuda M, 2003, BIOTECHNOL BIOENG, V84, P187, DOI 10.1002/bit.10748
   Omidfar K, 2010, APPL BIOCHEM BIOTECH, V160, P843, DOI 10.1007/s12010-009-8535-x
   Park CW, 2009, ULTRAMICROSCOPY, V109, P1001, DOI 10.1016/j.ultramic.2009.03.002
   Polanams J, 2005, INORG CHEM, V44, P3203, DOI 10.1021/ic048819r
   Pyon MS, 1999, LANGMUIR, V15, P7040, DOI 10.1021/la990403g
   Quan L.T., 2004, THESIS NCS U
   Reshetilov A.N., 2008, APPL BIOCHEM MICRO+, V4, P3
   Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b
   Tominaga M, 2004, J ELECTROANAL CHEM, V566, P323, DOI 10.1016/j.jelechem.2003.11.056
   Tominaga M, 2008, J ELECTROANAL CHEM, V617, P78, DOI 10.1016/j.jelechem.2008.01.022
   Tsukamoto R, 2005, B CHEM SOC JPN, V78, P2075, DOI 10.1246/bcsj.78.2075
   Weinstein RD, 2007, LANGMUIR, V23, P2887, DOI 10.1021/la062905h
   Won K, 2008, ULTRAMICROSCOPY, V108, P1342, DOI 10.1016/j.ultramic.2008.04.088
   Wu CG, 2002, LANGMUIR, V18, P7473, DOI 10.1021/la011792t
   Wu YH, 2007, MICROCHIM ACTA, V159, P1, DOI 10.1007/s00604-007-0749-4
   Yoshimura H, 2006, COLLOID SURFACE A, V282, P464, DOI 10.1016/j.colsurfa.2006.01.037
   Yunhua W., 2004, ANAL CHIM ACTA, V527, P37
   Zapien DC, 2000, J ELECTROANAL CHEM, V494, P114, DOI 10.1016/S0022-0728(00)00364-8
   Zhang B, 2005, INORG CHEM, V44, P3738, DOI 10.1021/ic0490851
NR 39
TC 6
Z9 6
U1 0
U2 18
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1751-8741
J9 IET NANOBIOTECHNOL
JI IET Nanobiotechnol.
PD SEP
PY 2012
VL 6
IS 3
BP 102
EP 109
DI 10.1049/iet-nbt.2011.0042
PG 8
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA 029SZ
UT WOS:000310517500003
PM 22894534
DA 2018-10-19
ER

PT J
AU Lindgren, C
   Mordenfeld, A
   Johansson, CB
   Hallman, M
AF Lindgren, Christer
   Mordenfeld, Arne
   Johansson, Carina B.
   Hallman, Mats
TI A 3-Year Clinical Follow-up of Implants Placed in Two Different
   Biomaterials Used for Sinus Augmentation
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE biphasic calcium phosphate; deproteinized bovine bone; histology;
   implants; sinus floor augmentation
ID BIPHASIC CALCIUM-PHOSPHATE; RESONANCE FREQUENCY-ANALYSIS; BOVINE
   SPONGIFORM ENCEPHALOPATHY; FLOOR AUGMENTATION; AUTOGENOUS BONE;
   DEPROTEINIZED BOVINE; DENTAL IMPLANTS; TITANIUM SURFACE; ELEVATION;
   DEFECTS
AB Purpose: The aims of the present study were to compare a novel biphasic calcium phosphate (BCP) with deproteinized bovine bone (DBB) for maxillary sinus floor augmentation in a split-mouth design and to perform a clinical follow-up of dental implants placed in the augmented sinuses. Materials and Methods: Partially or completely edentulous patients requiring bilateral sinus augmentation were included in the study. The patients were randomized for augmentation with BCP (test) and DBB (control) in the contralateral side. Eight months after grafting, dental implants were placed. After 3 years of graft healing, core biopsy specimens were obtained from the grafted areas for histologic and histomorphometric analyses. After 3 years of functional implant loading, implant survival/success rates and clinical indices were assessed and radiographic examination and resonance frequency analysis were performed. Results: Nine completely edentulous patients and two partially edentulous patients (mean age, 67 years) who required bilateral sinus augmentation were included in the study, and 62 implants were placed. The mean values for the area of newly formed bone in the retrieved specimens were 29% +/- 14.3% and 32% +/- 18.0% for BCP and DBB, respectively; the percentage of graft particles in contact with bone was 38% +/- 10.9% in the BCP group and 44% +/- 12.1% in the DBB group (no statistical significant differences between groups). The mean values for the area of BCP particles and DBB particles were 20% +/- 7.5% and 24% +/- 13.5%, respectively (difference not significant). One dental implant was lost from each group, resulting in an overall implant survival rate of 96.8% after 3 years of loading. Conclusion: After 3 years, a similar amount of newly formed bone was present regardless of the biomaterial used. The choice of biomaterial did not seem to influence implant survival rates. INT J ORAL MAXILLOFAC IMPLANTS 2012;27:1151-1162
C1 [Lindgren, Christer; Mordenfeld, Arne; Hallman, Mats] Gavle Cty Hosp, Dept Oral & Maxillofacial Surg, Gavle, Sweden.
   [Lindgren, Christer] Linkoping Univ Hosp, Linkoping, Sweden.
   [Mordenfeld, Arne] Gothenburg Univ, Dept Biomat, Inst Clin Sci, S-41124 Gothenburg, Sweden.
   [Johansson, Carina B.] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden.
   [Hallman, Mats] Umea Univ, Dept Oral & Maxillofacial Surg, Umea, Sweden.
   [Hallman, Mats] Uppsala Univ, Ctr Res & Dev, Gavleborg Cty Council, Uppsala, Sweden.
RP Lindgren, C (reprint author), Cty Hosp, Dept Oral & Maxillofacial Surg, S-80187 Gavle, Sweden.
EM christer.lindgren@lio.se
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   BEIRNE OR, 1986, INT J ORAL MAX SURG, V15, P269
   Bischof M, 2004, CLIN ORAL IMPLAN RES, V15, P529, DOI 10.1111/j.1600-0501.2004.01042.x
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Degidi M, 2009, INT J PERIODONT REST, V29, P607
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Esposito M, 2008, COCHRANE DB SYST REV
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Ferguson SJ, 2006, J BIOMED MATER RES A, V78A, P291, DOI 10.1002/jbm.a.30678
   Friedmann A, 2009, CLIN ORAL IMPLAN RES, V20, P708, DOI 10.1111/j.1600-0501.2009.01708.x
   Hallman M, 2005, INT J ORAL MAX SURG, V34, P273, DOI 10.1016/j.ijom.2004.09.009
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hallman M, 2008, PERIODONTOL 2000, V47, P172, DOI 10.1111/j.1600-0757.2008.00251.x
   Honig JF, 1999, PLAST RECONSTR SURG, V103, P1324
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Jensen SS, 2009, J BIOMED MATER RES B, V90B, P171, DOI 10.1002/jbm.b.31271
   Johansson B, 2001, DENTOMAXILLOFAC RAD, V30, P157, DOI 10.1038/sj.dmfr.4600601
   KORLOF B, 1973, PLAST RECONSTR SURG, V52, P378, DOI 10.1097/00006534-197352040-00009
   Lindgren C, 2012, CLIN IMPLANT DENT R, V14, P41, DOI 10.1111/j.1708-8208.2010.00224.x
   Lindgren C, 2010, CLIN ORAL IMPLAN RES, V21, P924, DOI 10.1111/j.1600-0501.2010.01933.x
   Lindgren C, 2009, INT J ORAL MAX IMPL, V24, P1093
   Lundgren S, 2008, PERIODONTOL 2000, V47, P193, DOI 10.1111/j.1600-0757.2008.00264.x
   Mamalis AA, 2011, CLIN ORAL IMPLAN RES, V22, DOI 10.1111/j.1600-0501.2010.02027.x
   Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Morton D, 2010, CLIN IMPLANT DENT R, V12, P9, DOI 10.1111/j.1708-8208.2009.00204.x
   Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Perrotti V, 2009, J BIOMED MATER RES A, V90A, P238, DOI 10.1002/jbm.a.32079
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   Sjostrom M, 2005, INT J ORAL MAX SURG, V34, P45, DOI 10.1016/j.ijom.2004.03.007
   Summers R B, 1998, J Esthet Dent, V10, P164, DOI 10.1111/j.1708-8240.1998.tb00352.x
   Thor A, 2007, J ORAL MAXIL SURG, V65, P64, DOI 10.1016/j.joms.2006.10.047
   Timmenga NM, 1997, J ORAL MAXIL SURG, V55, P936, DOI 10.1016/S0278-2391(97)90063-X
   Trombelli L, 2010, J PERIODONTOL, V81, P158, DOI 10.1902/jop.2009.090275
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Walsh NC, 2010, IMMUNOL REV, V233, P301, DOI 10.1111/j.0105-2896.2009.00857.x
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
   Wiltfang J, 2005, INT J ORAL MAX SURG, V34, P885, DOI 10.1016/j.ijom.2005.04.026
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 48
TC 22
Z9 24
U1 1
U2 4
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2012
VL 27
IS 5
BP 1151
EP 1162
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 028AT
UT WOS:000310395900021
PM 23057029
DA 2018-10-19
ER

PT J
AU Tirella, A
   Ahluwalia, A
AF Tirella, Annalisa
   Ahluwalia, Arti
TI The impact of fabrication parameters and substrate stiffness in direct
   writing of living constructs
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE biofabrication; living systems; scaffold; biomaterials; cell culture
ID CELL BEHAVIOR; STEM-CELLS; TISSUE; DROP; CHEMOTAXIS; SCAFFOLDS;
   VIABILITY; SURFACES; SYSTEM; BONE
AB Biomolecules and living cells can be printed in high-resolution patterns to fabricate living constructs for tissue engineering. To evaluate the impact of processing cells with rapid prototyping (RP) methods, we modeled the printing phase of two RP systems that use biomaterial inks containing living cells: a high-resolution inkjet system (BioJet) and a lower-resolution nozzle-based contact printing system (PAM2). In the first fabrication method, we reasoned that cell damage occurs principally during drop collision on the printing surface, in the second we hypothesize that shear stresses act on cells during extrusion (within the printing nozzle). The two cases were modeled changing the printing conditions: biomaterial substrate stiffness and volumetric flow rate, respectively, in BioJet and PAM2. Results show that during inkjet printing impact energies of about 10-8 J are transmitted to cells, whereas extrusion energies of the order of 10-11 J are exerted in direct printing. Viability tests of printed cells can be related to those numerical simulations, suggesting a threshold energy of 10-9 J to avoid permanent cell damage. To obtain well-defined living constructs, a combination of these methods is proposed for the fabrication of scaffolds with controlled 3D architecture and spatial distribution of biomolecules and cells. (c) 2012 American Institute of Chemical Engineers Biotechnol. Prog., 2012
C1 [Tirella, Annalisa; Ahluwalia, Arti] Univ Pisa, Fac Engn, Interdept Res Ctr E Piaggio, I-56126 Pisa, Italy.
RP Tirella, A (reprint author), Univ Pisa, Fac Engn, Interdept Res Ctr E Piaggio, I-56126 Pisa, Italy.
EM a.tirella@centropiaggio.unipi.it
OI Tirella, Annalisa/0000-0002-3743-3593; Ahluwalia,
   Arti/0000-0001-5370-6750
CR Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Boland T, 2007, MAT SCI ENG C-BIO S, V27, P372, DOI 10.1016/j.msec.2006.05.047
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Chahal D, 2012, BIOTECHNOL BIOENG, V109, P2932, DOI 10.1002/bit.24562
   Chung S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045001
   Doddi SK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046318
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Garcia GL, 2008, J MICROSC-OXFORD, V231, P529, DOI 10.1111/j.1365-2818.2008.02066.x
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Glaser T, 2007, STEM CELLS, V25, P3016, DOI 10.1634/stemcells.2007-0218
   Jordanova A, 2009, CELL BIOCHEM BIOPHYS, V54, P47, DOI 10.1007/s12013-009-9050-y
   Ker EDP, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025
   Kim SE, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044106
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee BK, 2012, INT J PHARMACEUT, V427, P305, DOI 10.1016/j.ijpharm.2012.02.011
   Li J, 2011, TRENDS CELL BIOL, V21, P489, DOI 10.1016/j.tcb.2011.05.002
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Saunders RE, 2008, BIOMATERIALS, V29, P193, DOI 10.1016/j.biomatei-ials.2007.09.032
   Tilles AW, 2001, BIOTECHNOL BIOENG, V73, P379, DOI 10.1002/bit.1071
   Tirella A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/4/045002
   Tirella A, 2012, RAPID PROTOTYPING J, V18, P299, DOI 10.1108/13552541211231725
   Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002
   Vozzi G, 2002, TISSUE ENG, V8, P1089, DOI 10.1089/107632702320934182
   Wang W, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896118
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Zhou C, 2008, INT J MULTIPHAS FLOW, V34, P102, DOI 10.1016/j.ijmultiphaseflow.2007.09.002
NR 31
TC 10
Z9 10
U1 0
U2 48
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD SEP-OCT
PY 2012
VL 28
IS 5
BP 1315
EP 1320
DI 10.1002/btpr.1586
PG 6
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 019DV
UT WOS:000309718200024
PM 22736619
DA 2018-10-19
ER

PT J
AU Luvizuto, ER
   Queiroz, TP
   Margonar, R
   Panzarini, SR
   Hochuli-Vieira, E
   Okamoto, T
   Okamoto, R
AF Luvizuto, Eloa R.
   Queiroz, Thallita P.
   Margonar, Rogerio
   Panzarini, Sonia R.
   Hochuli-Vieira, Eduardo
   Okamoto, Tetuo
   Okamoto, Roberta
TI Osteoconductive Properties of beta-Tricalcium Phosphate Matrix,
   Polylactic and Polyglycolic Acid Gel, and Calcium Phosphate Cement in
   Bone Defects
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Osteoconductive properties; beta-tricalcium phosphate; polylactic and
   polyglycolic acid; calcium phosphate cement; rats; calvarial; bone;
   biomaterials
ID MAXILLARY SINUS FLOOR; AUTOGENOUS BONE; ENDOSSEOUS IMPLANTS; GRAFTS;
   AUGMENTATION; MODEL; AUTOGRAFT; MARROW; TCP
AB Extensive bone defects in maxillofacial region can be corrected with autogenous grafts; otherwise, the disadvantages of the therapeutics modality take the research for new bone substitutes. The aim of the study was to evaluate and compare the osteoconductive properties of 3 commercial available biomaterials. A total of 30 calvarial defects (5-mm diameter) were randomly divided into 5 treatment groups, with a total of 6 defects per treatment group (n = 6). The treatment groups were as follows: 500 to 1000 Km beta-tricalcium phosphate (beta-TCP), polylactic and polyglycolic acid (PL/PG) gel, calcium phosphate cement, untreated control, and autograft control. The evaluations were based on histomorphometric analysis at 60 postoperative days. The results have shown that beta-TCP and autograft control supported bone formation at 60 postoperative days. beta-Tricalcium phosphate showed the highest amount of mineralized area per total area and statistically significant compared with PL/PG, calcium phosphate cement, and untreated control groups. The PL/PG gel does not have osteoconductive properties and performed similar to empty control. Calcium phosphate cement showed higher number of multinucleated giant cells around the sites of the biomaterial and showed newly formed bone only at the edges of the biomaterial, without bone formation within the biomaterial. The findings presented herein indicate that bone formation reached a maximum level when rat calvarial defects were filled with beta-TCP at 60 postoperative days. Further studies should be conducted with beta-TCP to understand the potential of this biomaterial in bone regeneration.
C1 [Luvizuto, Eloa R.; Panzarini, Sonia R.] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Surg, BR-16015050 Sao Paulo, Brazil.
   [Luvizuto, Eloa R.; Panzarini, Sonia R.] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Integrated Clin, BR-16015050 Sao Paulo, Brazil.
   [Queiroz, Thallita P.; Margonar, Rogerio] UNIARA, Univ Ctr Araraquara, Sch Dent, Dept Hlth Sci,Implantol Post Grad Course, Sao Paulo, Brazil.
   [Hochuli-Vieira, Eduardo] Univ Estadual Paulista, Araraquara Dent Sch, Dept Diagnost & Surg, Div Oral & Maxillofacial Surg, Sao Paulo, Brazil.
RP Luvizuto, ER (reprint author), UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Surg, Rua Jose Bonifacio 1193, BR-16015050 Sao Paulo, Brazil.
EM eloa@foa.unesp.br
RI Queiroz, Thallita/C-5085-2012
OI Queiroz, Thallita/0000-0002-2464-8181
CR BOYNE PJ, 1980, J ORAL SURG, V38, P613
   BRANEMARK PI, 1975, SCAND J PLAST RECONS, V9, P116, DOI 10.3109/02844317509022776
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Dai LY, 2008, SPINE, V33, P1299, DOI 10.1097/BRS.0b013e3181732a8e
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Handschel J, 2002, BIOMATERIALS, V23, P1689, DOI 10.1016/S0142-9612(01)00296-4
   Hirsch JM, 1991, CLIN ORAL IMPLAN RES, V2, P91, DOI 10.1034/j.1600-0501.1991.020207.x
   Issa JPM, 2008, ANAT HISTOL EMBRYOL, V37, P181, DOI 10.1111/j.1439-0264.2007.00824.x
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Lundgren S, 1996, Int J Oral Maxillofac Implants, V11, P760
   Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Proussaefs P, 2005, INT J PERIODONT REST, V25, P351
   RAGHOEBAR GM, 1993, J ORAL MAXIL SURG, V51, P1198, DOI 10.1016/S0278-2391(10)80288-5
   Schlegel KA, 2009, ORAL SURG ORAL MED O, V108, pE37, DOI 10.1016/j.tripleo.2009.05.037
   Szabo G, 2005, INT J ORAL MAX IMPL, V20, P371
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tessier P, 2005, PLAST RECONSTR SURG, V116, p6S, DOI 10.1097/01.prs.0000173862.20563.12
   Triplett RG, 1996, J ORAL MAXIL SURG, V54, P486, DOI 10.1016/S0278-2391(96)90126-3
   Ueno T, 2008, ACTA HISTOCHEM, V110, P217, DOI 10.1016/j.acthis.2007.10.008
   Wada K, 2001, J PERIODONTICS RESTO, V21, P252
   Weijs WLJ, 2010, INT J ORAL MAX SURG, V39, P424, DOI 10.1016/j.ijom.2010.02.004
   Wood R M, 1988, Int J Oral Maxillofac Implants, V3, P209
NR 24
TC 14
Z9 15
U1 0
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD SEP
PY 2012
VL 23
IS 5
BP E430
EP E433
DI 10.1097/SCS.0b013e31825e4abf
PG 5
WC Surgery
SC Surgery
GA 016VG
UT WOS:000309547200023
PM 22976694
DA 2018-10-19
ER

PT J
AU Lee, AJ
   Chung, WH
   Kim, DH
   Lee, KP
   Suh, HJ
   Do, SH
   Eom, KD
   Kim, HY
AF Lee, A-Jin
   Chung, Wook-Hun
   Kim, Dae-Hyun
   Lee, Kyung-Pil
   Suh, Hyun Jung
   Do, Sun Hee
   Eom, Ki-dong
   Kim, Hwi-Yool
TI Use of canine small intestinal submucosa allograft for treating perineal
   hernias in two dogs
SO JOURNAL OF VETERINARY SCIENCE
LA English
DT Article
DE biomaterial scaffold; canine small intestinal submucosa (canine SIS);
   perineal hernia
ID INTERNAL OBTURATOR MUSCLE; REPAIR; TRANSPOSITION; HERNIORRHAPHY;
   COMPLICATIONS
AB Here, we describe two dogs in which canine small intestinal submucosa (SIS) was implanted as a biomaterial scaffold during perineal herniorrhaphy. Both dogs had developed severe muscle weakness, unilaterally herniated rectal protrusions, and heart problems with potential anesthetic risks. Areas affected by the perineal hernia (PH) located between the internal obturator and external anal sphincter muscles were reconstructed with naive canine SIS sheets. In 12 months, post-operative complications such as wound infections, sciatic paralysis, rectal prolapse, or recurrence of the hernia were not observed. Symptoms of defecatory tenesmus also improved. Neither case showed any signs of rejection or specific immune responses as determined by complete and differential cell counts. Our findings demonstrate that canine SIS can be used as a biomaterial scaffold for PH repair in dogs.
C1 [Lee, A-Jin; Chung, Wook-Hun; Kim, Dae-Hyun; Lee, Kyung-Pil; Suh, Hyun Jung; Kim, Hwi-Yool] Konkuk Univ, Coll Vet Med, Dept Vet Surg, Seoul 143701, South Korea.
   [Do, Sun Hee] Konkuk Univ, Dept Vet Clin Pathol, Coll Vet Med, Seoul 143701, South Korea.
   [Eom, Ki-dong] Konkuk Univ, Dept Vet Radiol, Coll Vet Med, Seoul 143701, South Korea.
RP Kim, HY (reprint author), Konkuk Univ, Coll Vet Med, Dept Vet Surg, Seoul 143701, South Korea.
EM hykim@konkuk.ac.kr
CR Anderson MA, 1998, CURRENT TECHNIQUES S, P555
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BELLENGER CR, 1980, AUST VET J, V56, P434, DOI 10.1111/j.1751-0813.1980.tb02637.x
   Bellenger CR, 2003, TXB SMALL ANIMAL SUR, V1, P487
   BURROWS CF, 1973, J SMALL ANIM PRACT, V14, P315, DOI 10.1111/j.1748-5827.1973.tb06466.x
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   DORN AS, 1982, J AM ANIM HOSP ASSOC, V18, P624
   FRANKLAND AL, 1986, VET REC, V119, P13, DOI 10.1136/vr.119.1.13
   HARDIE EM, 1983, VET SURG, V12, P69, DOI 10.1111/j.1532-950X.1983.tb00709.x
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   MATTHIESEN DT, 1989, COMP CONT EDUC PRACT, V11, P797
   Niebauer GW, 2005, ANN NY ACAD SCI, V1041, P415, DOI 10.1196/annals.1282.062
   Novitsky YW, 2007, J SURG RES, V140, P6, DOI 10.1016/j.jss.2006.09.015
   RAFFAN PJ, 1993, J SMALL ANIM PRACT, V34, P13, DOI 10.1111/j.1748-5827.1993.tb02568.x
   Schumpelick V, 2003, BRIT J SURG, V90, P1457, DOI 10.1002/bjs.4385
   Shahar R, 1996, CAN VET J, V37, P614
   SJOLLEMA BE, 1989, VET QUART, V11, P18, DOI 10.1080/01652176.1989.9694191
   Stoll MR, 2002, VET SURG, V31, P379, DOI 10.1053/jvet.2002.33596
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 20
TC 5
Z9 6
U1 1
U2 18
PU KOREAN SOC VETERINARY SCIENCE
PI SEOUL
PA SEOUL NATL UNIV,  COLLEGE VETERINARY MEDICINE,, SEOUL, 151-742, SOUTH
   KOREA
SN 1229-845X
J9 J VET SCI
JI J. Vet. Sci.
PD SEP
PY 2012
VL 13
IS 3
BP 327
EP 330
DI 10.4142/jvs.2012.13.3.327
PG 4
WC Veterinary Sciences
SC Veterinary Sciences
GA 013PG
UT WOS:000309316700016
PM 23000591
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Paganias, CG
   Tsakotos, GA
   Koutsostathis, SD
   Macheras, GA
AF Paganias, Christos G.
   Tsakotos, George A.
   Koutsostathis, Stephanos D.
   Macheras, George A.
TI Osseous integration in porous tantalum implants
SO INDIAN JOURNAL OF ORTHOPAEDICS
LA English
DT Review
DE Bone ingrowth; osseous integration; osteoblast; osteoconductive; porous
   tantalum; scaffold
ID MONOBLOCK ACETABULAR COMPONENT; OSTEOBLAST-LIKE CELLS; SIMULATED
   BODY-FLUID; MECHANICAL-PROPERTIES; SURFACE-ROUGHNESS; APATITE FORMATION;
   TITANIUM-ALLOY; METAL IMPLANTS; BONE INGROWTH; TRICALCIUM PHOSPHATE
AB Porous tantalum is a biomaterial that was recently introduced in orthopedics in order to overcome problems related to implant loosening. It is found to have osteoconductive, and possibly, osteoinductive properties hence useful in difficult cases with severe bone defects. So, it is of great interest to shed light on the mechanisms through which this material leads to new bone formation, after being implanted. Porous tantalum is biologically relatively inert, with restricted bonding capacity to the bone is restricted. In order to overcome this obstacle, it undergoes thermal processing in an alkaline environment. This process leads to extensive hydroxyapatite formation on its surface, and thus, to better integration of porous tantalum implants. Apart from this, new bone tissue formation occurs inside the pores of the porous tantalum after its implantation and this new bone retains the characteristics of the normal bone, that is, bone remodeling and Haversian systems formation. This finding is enhanced by the observation that porous tantalum is an appropriate substrate for osteoblast adherence, proliferation, and differentiation. Furthermore, the finding that osteoblasts derived from old women (> 60 years old) and cultivated on porous tantalum may grow faster than osteoblasts taken from younger women (< 45 years old) and cultivated on other substrates, can partially explain porous tantalum's good performance in cases of patients with severe bone defects. In conclusion, porous tantalum's chemical and mechanical properties are those that probably define the already noticed good performance of this material. However, further research is needed to totally clarify the mechanisms.
C1 [Paganias, Christos G.; Tsakotos, George A.; Koutsostathis, Stephanos D.; Macheras, George A.] KAT Hosp, Dept Orthoped 4, Athens, Greece.
RP Paganias, CG (reprint author), 2 Nikis Str, Athens 14561, Greece.
EM chrpag@gmail.com
CR Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   D'Angelo F, 2008, INDIAN J ORTHOP, V42, P275, DOI 10.4103/0019-5413.39553
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Frenkel SR, 2004, J BIOMED MATER RES B, V71B, P387, DOI 10.1002/jbm.b.30104
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   GOLDBERG VM, 1995, CLIN ORTHOP RELAT R, P122
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Hacking SA, 1999, CLIN ORTHOP RELAT R, P240
   JASTY M, 1993, J BIOMED MATER RES, V27, P639, DOI 10.1002/jbm.820270511
   Justesen J, 2009, J BIOMED MATER RES A, V89A, P885, DOI 10.1002/jbm.a.32032
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Keller J C, 1998, Implant Dent, V7, P331, DOI 10.1097/00008505-199807040-00012
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kitsugi T, 1996, J BIOMED MATER RES, V30, P261, DOI 10.1002/(SICI)1097-4636(199602)30:2<261::AID-JBM17>3.0.CO;2-P
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2004, Med J Malaysia, V59 Suppl B, P91
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kosmulski M, 1997, LANGMUIR, V13, P6315, DOI 10.1021/la970469g
   Kostakos AT, 2010, J ARTHROPLASTY, V25, P35, DOI 10.1016/j.arth.2008.09.027
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   Koutsostathis S.D., 2009, J ORTHOPAEDICS, V6, pe3
   Levine B, 2008, ADV ENG MATER, V10, P788, DOI 10.1002/adem.200800215
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Macheras GA, 2010, J BONE JOINT SURG BR, V92B, P624, DOI 10.1302/0301-620X.92B5.23256
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   Malizos KN, 2008, CLIN ORTHOP RELAT R, V466, P159, DOI 10.1007/s11999-007-0008-3
   Miyazaki T, 2000, J BIOMED MATER RES, V50, P35, DOI 10.1002/(SICI)1097-4636(200004)50:1<35::AID-JBM6>3.0.CO;2-8
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Nelson CL, 2003, J ARTHROPLASTY, V18, P37, DOI 10.1054/S0883-5403(03)00290-0
   Nishiquchi S, 2011, J BIOMED MATER RES, V54, P198
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002
   PIDHORZ LE, 1993, J ARTHROPLASTY, V8, P213
   Ramappa M, 2009, HIP INT, V19, P239
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Rose PS, 2006, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000238854.16121.a3
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   Schwartz Z, 2001, BIOMATERIALS, V22, P731, DOI 10.1016/S0142-9612(00)00241-6
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   Stein GS, 1996, PHYSIOL REV, V76, P593
   Takadama H, 2000, J CERAM SOC JPN, V108, P118, DOI 10.2109/jcersj.108.1254_118
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Yuan H., 2001, THESIS LEIDEN U NETH
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
   Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x
NR 68
TC 11
Z9 13
U1 1
U2 35
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0019-5413
EI 1998-3727
J9 INDIAN J ORTHOP
JI Indian J. Orthop.
PD SEP-OCT
PY 2012
VL 46
IS 5
BP 505
EP 513
DI 10.4103/0019-5413.101032
PG 9
WC Orthopedics
SC Orthopedics
GA 017OF
UT WOS:000309599000002
PM 23162141
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Peng, WX
   Wang, LS
   Xu, Q
   Wu, QD
   Xiang, SL
AF Peng, Wanxi
   Wang, Lansheng
   Xu, Qiu
   Wu, Qingding
   Xiang, Shilong
TI TD-GC-MS Analysis on Thermal Release Behavior of Poplar Composite
   Biomaterial Under High Temperature
SO JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Physical and Numerical Simulation of
   Materials Processing (ICPNS 2010)
CY NOV 16-19, 2010
CL Guilin Univ Elect Technol, Guilin, PEOPLES R CHINA
SP Wollongong Univ, Chinese Mech Engn Soc, Minerals, Metals & Mat Soc, Dynam Syst Inc, Harbin Inst Technol, Huaqiao Univ, Henan Polytechn Univ, Graz Univ Technol, Univ Sao Paulo, McGill Univ, Beijing Aviat Mfg Engn Inst, Univ Rijeka, Univ W Bohemia, Univ Oulu, GKSS Res Ctr, Hong Kong Polytechn Univ, Univ Delhi, Univ Osaka, JWRI, Univ Electro Commun, Chungnam Natl Univ, Korea Inst Machinery & Mat, Pusan Natl Univ, Riga Tech Univ, Delft Univ Technol, Moscow State Univ, RAS, Inst Phys & Mat Sci, Moscow State Inst Elect & Math, Moscow State Inst Steel & Alloys, Nanyang Technol Univ, Natl Taiwan Univ, Ege Univ, Univ Cambridge, Dept Mat & Matallurgy, EO Paton Elect Weld Inst, BATTELLE
HO Guilin Univ Elect Technol
DE TD-GC-MS; Thermal Release Behavior; Poplar; Composite Biomaterials; High
   Temperature
AB With the development of plantation forestry, poplar tree has become one of the most useful plantion species for the composite biomaterials in China. Therefore, the thermal release behavior of poplar composite biomaterial under high temperature was studied by TD-GC/MS in order to reveal environmental protective performance. The results were: (1) The main constituents of thermal release volatiles at 90 degrees C were acetic acid (81.45%), furfural (2.66%), cedrol (1.7%), formic acid (1.67%), benzenemethanamine, N-hydroxy-N-(p henylmethyl)-(1.42%), 2-propanone, 1-hydroxy-(0.88%), 1,2-benzenedicarboxylic acid, mono(2-ethylhexyl) ester (0.66%), etc. (2) The main constituents of thermal release volatiles at 150 degrees C were acetic acid (68.55%), furfural (7.26%), formic acid (7.22%), 2-propanone, 1-hydroxy-(2.22%), thiourea (1.96%), 2-furancarboxaldehyde, 5-methyl-(1.82%), propane, 2-ethoxy-(1.37%), 2-furanmethanol (1.32%), 2-pentanone (0.72%), 1H-pyrrole-2-carboxaldehyde (0.72%), etc. The result revealed that the poplar composite biomaterial is safe under high temperature, but its fire risk rised up.
C1 [Peng, Wanxi] Cent S Univ Forestry & Technol, Sch Mat Sci & Engn, Changsha 410004, Hunan, Peoples R China.
   Cent S Univ Forestry & Technol, Hunan Prov Lab Forestry Biotechnol, Changsha 410004, Hunan, Peoples R China.
RP Peng, WX (reprint author), Cent S Univ Forestry & Technol, Sch Mat Sci & Engn, Changsha 410004, Hunan, Peoples R China.
CR 1iurong Z., 2008, CHINA FORESTRY IND A, P24
   Fengzhen F., 2010, J NW FORESTRY U, V25, P221
   Wenguo L., 2010, WORLD FORESTRY RES, V23, P50
   Xiaohua S., 2010, FOREST RES, V23, P31
   ZHIYONG H, 2005, FOOD SCI TECHNOLOG A, V9, P98
NR 5
TC 18
Z9 25
U1 1
U2 13
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1546-1955
J9 J COMPUT THEOR NANOS
JI J. Comput. Theor. Nanosci.
PD SEP
PY 2012
VL 9
IS 9
SI SI
BP 1431
EP 1433
DI 10.1166/jctn.2012.2217
PG 3
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 016CW
UT WOS:000309495900062
DA 2018-10-19
ER

PT J
AU Tsuchiya, H
   Shirai, T
   Nishida, H
   Murakami, H
   Kabata, T
   Yamamoto, N
   Watanabe, K
   Nakase, J
AF Tsuchiya, Hiroyuki
   Shirai, Toshiharu
   Nishida, Hideji
   Murakami, Hideki
   Kabata, Tamon
   Yamamoto, Norio
   Watanabe, Koji
   Nakase, Junsuke
TI Innovative antimicrobial coating of titanium implants with iodine
SO JOURNAL OF ORTHOPAEDIC SCIENCE
LA English
DT Article
ID ANTIBACTERIAL ACTIVITY; EXTERNAL FIXATION; SURGICAL SITE; IN-VITRO;
   INFECTION; PREVENTION; EFFICACY; ARTHROPLASTY; CATHETERS; SURFACES
AB Postoperative infection associated with implants remains a serious complication in orthopedic surgery. Several biomaterial surface treatments have been proposed as a means of reducing the incidence of implant-associated infections. In this study, a clinical trial was performed using an iodine-supported titanium that suppresses the microbial activities.
   A total of 222 patients with postoperative infection or compromised status were treated using iodine-supported titanium implants. The mean age of the patients was 49.4 years (range 5-85 years). One hundred twenty-seven patients were male and 95 were female. In 158 patients, iodine-supported implants were used to prevent infection, such as compromised hosts and conditions, and in 64 patients to treat active infection. White blood cell (WBCs) and C-reactive protein (CRP) levels were measured pre- and postoperatively in all patients. To confirm whether iodine from the implant affected physiological functions, thyroid hormone levels in the blood were examined. Both examinations were conducted sequentially for a year. Radiological evaluations were performed regularly after the operation. The chronological changes of the iodine amount were evaluated using half pins removed after completion of external fixation.
   The mean follow-up period was 18.4 months (range 3-44 months). Acute infection developed in three tumor cases among the 158 patients on preventive therapy. All three recovered without removal of the implants. Infection was cured in all 64 patients with infection. Median WBC levels were in the normal range, and median CRP levels returned to < 0.5 within 4 weeks after surgery. Abnormalities of thyroid gland function were not detected. None of the patients experienced loosening of the implants. There were two patients with mechanical implant failure, which was treated by re-implantation. Excellent bone ingrowth and ongrowth were found around all hip and tumor prostheses. One year later, the amount of iodine on external fixation pins remained about 20-30 %.
   Iodine-supported titanium implants can be very effective for preventing and treating infections after orthopedic surgery. Cytotoxicity and adverse effects were not detected.
C1 [Tsuchiya, Hiroyuki; Shirai, Toshiharu; Nishida, Hideji; Murakami, Hideki; Kabata, Tamon; Yamamoto, Norio; Watanabe, Koji; Nakase, Junsuke] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan.
RP Tsuchiya, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.
EM tsuchi@med.kanazawa-u.ac.jp
CR Albrektsson T., 2001, EUR SPINE J, V10, P96
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   CAUDLE RJ, 1987, J BONE JOINT SURG AM, V69A, P801, DOI 10.2106/00004623-198769060-00002
   Cen L, 2004, J BIOMED MATER RES A, V71A, P70, DOI 10.1002/jbm.a.30125
   Chai H, 2011, J MAT SCI MAT MED, P26
   Crabtree JH, 2003, PERITON DIALYSIS INT, V23, P368
   Darouiche RO, 1998, J BONE JOINT SURG AM, V80A, P1336, DOI 10.2106/00004623-199809000-00013
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008
   Harris LG, 2006, J BIOMED MATER RES A, V78A, P50, DOI 10.1002/jbm.a.30611
   Hashimoto K, 1999, INORG MATER, V6, P457
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Kinnari TJ, 2005, OTOL NEUROTOL, V26, P380, DOI 10.1097/01.mao.0000169767.85549.87
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   Lin J, 2001, J CHEMOTHERAPY, V13, P54, DOI 10.1179/joc.2001.13.Supplement-2.54
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   MALAWER MM, 1995, J BONE JOINT SURG AM, V77A, P1154, DOI 10.2106/00004623-199508000-00003
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   NOHR RS, 1994, J BIOMAT SCI-POLYM E, V5, P607, DOI 10.1163/156856294X00239
   Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515
   Quan GM, 2011, EUR SPINE J, P26
   Ridgeway S, 2005, J BONE JOINT SURG BR, V87B, P844, DOI 10.1302/0301-620X.87B6.15121
   RILEY DM, 1995, AM J MED, V98, P349, DOI 10.1016/S0002-9343(99)80313-1
   Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036
   Shirai T, 2009, J BIOMED MATER RES B, V91B, P373, DOI 10.1002/jbm.b.31412
   Swanson TE, 2011, J BIOMED MATER RES A, V97A, P167, DOI 10.1002/jbm.a.33043
   Walder B, 2002, INFECT CONT HOSP EP, V23, P748, DOI 10.1086/502005
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
NR 30
TC 52
Z9 52
U1 1
U2 17
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0949-2658
J9 J ORTHOP SCI
JI J. Orthop. Sci.
PD SEP
PY 2012
VL 17
IS 5
BP 595
EP 604
DI 10.1007/s00776-012-0247-3
PG 10
WC Orthopedics
SC Orthopedics
GA 015XZ
UT WOS:000309481000015
PM 22806173
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Kroehle, J
   Volovsek, B
   Singer, D
   Sarazan, RD
AF Kroehle, John
   Volovsek, Becky
   Singer, Dan
   Sarazan, R. Dustan
TI A novel biomaterial catheter for improved cardiac contractility
   measurement in freely moving animals
SO JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
LA English
DT Meeting Abstract
C1 [Kroehle, John; Volovsek, Becky; Singer, Dan; Sarazan, R. Dustan] DSI, St Paul, MN USA.
CR [Anonymous], 2011, INT J TOXICOLOG 0428
NR 1
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8719
J9 J PHARMACOL TOX MET
JI J. Pharmacol. Toxicol. Methods
PD SEP-OCT
PY 2012
VL 66
IS 2
BP 190
EP 190
DI 10.1016/j.vascn.2012.08.112
PG 1
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 006IM
UT WOS:000308812700125
DA 2018-10-19
ER

PT J
AU Kuo, CT
   Chiang, CL
   Huang, RYJ
   Lee, H
   Wo, AM
AF Kuo, Ching-Te
   Chiang, Chi-Ling
   Huang, Ruby Yun-Ju
   Lee, Hsinyu
   Wo, Andrew M.
TI Configurable 2D and 3D spheroid tissue cultures on bioengineered
   surfaces with acquisition of epithelial-mesenchymal transition
   characteristics
SO NPG ASIA MATERIALS
LA English
DT Article
DE cell pattern; EMT; epithelial-mesenchymal transition; microfluidics;
   microsystem; spheroid
ID CELL-CULTURE; NANOPARTICLES; PROTEIN
AB Both two-dimensional (2D) and three-dimensional (3D) biomaterial-based culture platforms that are capable of mimicking the in vivo microenvironment to recapitulate the physiological conditions are vital tools in a wide range of cellular and clinical research. Here we report tissue cultures in a microfluidic chip that allows deterministic patterning of cells in 2D/3D. The chip contains a cell-supporting membrane bioengineered to attain either 2D or 3D cell patterns by selectable deposition of extracellular matrix molecules. Results show a cell-trapping rate as high as 97% in our microchip. Tuning of the surface enables not only highly controlled geometry of the monolayer (2D) cell mass but also 3D culture of uniformly sized multicellular spheroids. The 3D spheroid culture of human epithelial ovarian cancer cells in the microfluidic chip resulted in acquisition of mesenchymal traits-increased expressions of N-cadherin, vimentin and fibronectin-and lowered expression of epithelial marker (CD326/epithelial cell adhesion molecule) compared with that in traditional 2D cultures, which is indicative of epithelial-mesenchymal transition in the spheres. In conclusion, these results offer new opportunities to achieve active control of 2D cellular patterns and 3D multicellular spheroids on demand, and may be amenable toward the study of the metastatic processes by in vitro modeling. NPG Asia Materials (2012) 4, e27; doi:10.1038/am.2012.50; published online 21 September 2012
C1 [Kuo, Ching-Te; Wo, Andrew M.] Natl Taiwan Univ, Inst Appl Mech, Taipei 10617, Taiwan.
   [Chiang, Chi-Ling; Lee, Hsinyu] Natl Taiwan Univ, Dept Life Sci, Taipei 10617, Taiwan.
   [Huang, Ruby Yun-Ju] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 117548, Singapore.
   [Huang, Ruby Yun-Ju] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.
RP Wo, AM (reprint author), Natl Taiwan Univ, Inst Appl Mech, Room 317,1,Sect 4,Roosevelt Rd, Taipei 10617, Taiwan.
EM hsinyu@ntu.edu.tw; andrew@iam.ntu.edu.tw
RI Chiang, Chi-Ling/O-3038-2016
OI Chiang, Chi-Ling/0000-0002-0275-9673; Lee, Hsinyu/0000-0002-1477-0183
FU National Science Council, Taiwan [NSC 100-2120-M-002-001]
FX We are grateful to Professor Jiahn-Chun Wu for providing SKOV3 cancer
   cells and Mr Chen-Tse Wu for assistance with real time RT-PCR analyses.
   Financial support from the National Science Council, Taiwan, under grant
   NSC 100-2120-M-002-001 is gratefully acknowledged.
CR Aokage K, 2011, INT J CANCER, V128, P1585, DOI 10.1002/ijc.25500
   BENBROOK DM, 2006, DRUG DISCOV TODAY DI, V3, P143
   Berthier E, 2011, LAB CHIP, V11, P2060, DOI 10.1039/c0lc00539h
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179
   Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939
   Chen CL, 2011, LAB CHIP, V11, P474, DOI 10.1039/c0lc00332h
   Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339
   Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031864
   Cheng Q, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462326
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Corey JM, 2010, J BIOMED MATER RES A, V93A, P673, DOI 10.1002/jbm.a.32485
   Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106
   Effenhauser CS, 2002, BIOMED MICRODEVICES, V4, P27, DOI 10.1023/A:1014215728074
   Fan CY, 2008, ADV MATER, V20, P1418, DOI 10.1002/adma.200702191
   Farokhzad OC, 2005, ANAL CHEM, V77, P5453, DOI 10.1021/ac050312q
   Guttilla I. K., 2011, BREAST CANC RES TREA, V132, P75
   Hardelauf H, 2011, LAB CHIP, V11, P419, DOI 10.1039/c0lc00089b
   Ho CT, 2006, LAB CHIP, V6, P724, DOI 10.1039/b60203d
   Hsiung LC, 2011, LAB CHIP, V11, P2333, DOI 10.1039/c1lc20147f
   Jamil E. A., 2006, NATURE, V442, P403
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Kuo C. -T., 2011, 15 INT C MIN SYST CH, P145
   Lindstrom S, 2008, ELECTROPHORESIS, V29, P1219, DOI 10.1002/elps.200700536
   Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027
   Mikolajczyk SD, 2011, J ONCOL, DOI 10.1155/2011/252361
   Nikitin MP, 2010, P NATL ACAD SCI USA, V107, P5827, DOI 10.1073/pnas.1001142107
   Pecot CV, 2011, CANCER DISCOV, V1, P580, DOI 10.1158/2159-8290.CD-11-0215
   Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Torisawa YS, 2007, LAB CHIP, V7, P770, DOI 10.1039/b618439a
   Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b
   VanDersarl JJ, 2011, LAB CHIP, V11, P3057, DOI 10.1039/c1lc20311h
   Wan LQ, 2011, P NATL ACAD SCI USA, V108, P12295, DOI 10.1073/pnas.1103834108
   Yuan B, 2012, ADV MATER, V24, P890, DOI 10.1002/adma.201104589
NR 37
TC 24
Z9 24
U1 1
U2 47
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1884-4049
EI 1884-4057
J9 NPG ASIA MATER
JI NPG Asia Mater.
PD SEP
PY 2012
VL 4
AR e27
DI 10.1038/am.2012.50
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 016NW
UT WOS:000309526900004
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Gruskin, E
   Doll, BA
   Futrell, FW
   Schmitz, JP
   Hollinger, JO
AF Gruskin, Elliott
   Doll, Bruce A.
   Futrell, F. William
   Schmitz, John P.
   Hollinger, Jeffrey O.
TI Demineralized bone matrix in bone repair: History and use
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Demineralized bone matrix; DBM; Bone graft; Growth factors; Bone
   regeneration; Osteoinductive
ID ATTACHMENT APPARATUS FORMATION; GROWTH-FACTOR-BETA; MORPHOGENETIC
   PROTEIN; SPINE FUSION; HISTOLOGIC EVALUATION; EXTRACELLULAR-MATRIX;
   BISPHOSPHONATE USE; OSSEOUS DEFECTS; CANCELLOUS BONE; CRANIAL DEFECTS
AB Demineralized bone matrix (DBM) is an osteoconductive and osteoinductive commercial biomaterial and approved medical device used in bone defects with a long track record of clinical use in diverse forms. True to its name and as an acid-extracted organic matrix from human bone sources, DBM retains much of the proteinaceous components native to bone, with small amounts of calcium-based solids, inorganic phosphates and some trace cell debris. Many of DBM's proteinaceous components (e.g., growth factors) are known to be potent osteogenic agents. Commercially sourced as putty, paste, sheets and flexible pieces. DBM provides a degradable matrix facilitating endogenous release of these compounds to the bone wound sites where it is surgically placed to fill bone defects, inducing new bone formation and accelerating healing. Given DBM's long clinical track record and commercial accessibility in standard forms and sources, opportunities to further develop and validate DBM as a versatile bone biomaterial in orthopedic repair and regenerative medicine contexts are attractive. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Gruskin, Elliott] Synthes USA, W Chester, PA 19380 USA.
   [Hollinger, Jeffrey O.] Carnegie Mellon Univ, Dept Biol Sci, Bone Tissue Engn Ctr, Pittsburgh, PA 15213 USA.
RP Gruskin, E (reprint author), Synthes USA, 1230 Wilson Dr, W Chester, PA 19380 USA.
EM gruskin.elliott@synthes.com
CR Aaboe M, 1998, CLIN ORAL IMPLAN RES, V9, P313, DOI 10.1034/j.1600-0501.1998.090504.x
   Acarturk O., J PLASTIC R IN PRESS
   Acarturk O., 2006, J PLAST RECONSTR, V118, P862
   Adkisson H.A., 2005, J ORTHOP RES, V18, P503
   AN HS, 1995, SPINE, V20, P2211, DOI 10.1097/00007632-199510001-00006
   ASPENBERG P, 1991, J ORTHOPAED RES, V9, P20, DOI 10.1002/jor.1100090104
   Aspenberg P, 1998, ACTA ORTHOP SCAND, V69, P173, DOI 10.3109/17453679809117622
   Axhausen G., 1912, ARCH KLIN CHIR, V99, P1
   Bae HW, 2006, SPINE, V31, P1299, DOI 10.1097/01.brs.0000218581.92992.b7
   Barth F., 1893, ARCH KLIN CHIR, V46, P409
   Blum B, 2004, ORTHOPEDICS, V27, pS161
   Bomback DA, 2004, SPINE, V29, P1612, DOI 10.1097/01.BRS.0000132512.53305.A1
   Bostrom MPG, 2001, SPINE, V26, P1425, DOI 10.1097/00007632-200107010-00007
   BOWERS GM, 1989, J PERIODONTOL, V60, P675, DOI 10.1902/jop.1989.60.12.675
   BOWERS GM, 1989, J PERIODONTOL, V60, P683, DOI 10.1902/jop.1989.60.12.683
   BURWELL RG, 1964, J BONE JOINT SURG BR, V46, P110
   Cammisa FP, 2004, SPINE, V29, P660, DOI 10.1097/01.BRS.0000116588.17129.B9
   Carnes D.J., 1999, J PERIODONTAL, V70
   Carpenter JF, 1997, PHARMACEUT RES, V14, P969, DOI 10.1023/A:1012180707283
   Chesmel KD, 1998, J ORAL MAXIL SURG, V56, P857, DOI 10.1016/S0278-2391(98)90015-5
   Curtis B.F., 1890, AM J MED SCI, V106, P30
   Deaver J.B., 1889, MED NEWS, V55, P714
   DOHERTY MJ, 1993, BIOMATERIALS, V14, P994
   DUPOIRIEUX L, 1994, INT J ORAL MAX SURG, V23, P395, DOI 10.1016/S0901-5027(05)80028-1
   Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x
   Ferreira SD, 2001, CLIN ORTHOP RELAT R, P233
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   GLOWACKI J, 1981, CALCIFIED TISSUE INT, V33, P71, DOI 10.1007/BF02409414
   GLOWACKI J, 1985, CLIN PLAST SURG, V12, P233
   Glowacki Julie, 2005, Cell and Tissue Banking, V6, P3, DOI 10.1007/s10561-005-4252-z
   GROESSNERSCHREIBER B, 1992, MECH AGEING DEV, V62, P143, DOI 10.1016/0047-6374(92)90051-E
   Groves EWH, 1917, BRIT J SURG, V5, P185, DOI 10.1002/bjs.1800051803
   Habal M B, 1992, J Craniofac Surg, V3, P113, DOI 10.1097/00001665-199209000-00012
   Han B, 2005, J ORTHOP RES, V23, P855, DOI 10.1016/j.orthres.2004.11.007
   HARAKAS NK, 1984, CLIN ORTHOP RELAT R, P239
   HOLLINGER JO, 1991, CLIN ORTHOP RELAT R, P255
   Honsawek Sittisak, 2005, J Med Assoc Thai, V88 Suppl 4, pS260
   Honsawek Sittisak, 2005, Cell and Tissue Banking, V6, P13, DOI 10.1007/s10561-005-1445-4
   Huggins CB, 1930, P SOC EXP BIOL MED, V27, P349
   Huggins CB, 1931, ARCH SURG-CHICAGO, V22, P377, DOI 10.1001/archsurg.1931.01160030026002
   Hunter SA, 2011, J PERIODONTOL, V82, P281, DOI 10.1902/jop.2010.100236
   IJIRI S, 1994, J ORTHOP RES, V12, P628, DOI 10.1002/jor.1100120505
   Kado K E, 1996, J Foot Ankle Surg, V35, P59
   Killian JT, 1998, J PEDIATR ORTHOPED, V18, P621, DOI 10.1097/00004694-199809000-00013
   LACROIX P, 1947, J BONE JOINT SURG, V29, P292
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Lavender G, 1938, SURG GYNECOL OBSTET, V67, P705
   Lee Kenneth J H, 2005, Spine J, V5, p217S, DOI 10.1016/j.spinee.2005.02.006
   Lekishvili M. V., 2004, Cell and Tissue Banking, V5, P231, DOI 10.1007/s10561-004-1443-y
   LEVANDER G, 1934, ACTA CHIR SCAND, V74, P425
   LINDHOLM TS, 1982, CLIN ORTHOP RELAT R, P251
   LINDHOLM TS, 1980, CLIN ORTHOP RELAT R, P288
   Lohmann CH, 2001, ARCH ORTHOP TRAUM SU, V121, P583, DOI 10.1007/s004020100291
   Lomas RJ, 2001, BIOMATERIALS, V22, P913, DOI 10.1016/S0142-9612(00)00255-6
   M.R. Group, 2005, US MARK ORTH BIOIM
   M.R. Group, 2004, MECH AGEING DEV
   Macewen W, 1881, P R SOC LOND, V32, P232
   Mackie W., 1890, MED NEWS, V57, P202
   Meek'ren J.J.V., 1632, OBSERVATIONS MED CHI, P6
   Michelson JD, 1996, CLIN ORTHOP RELAT R, P203
   Moore TM, 2004, J ORTHOP RES, V22, P1358, DOI 10.1016/j.orthres.2004.05.002
   MULLIKEN JB, 1981, ANN SURG, V194, P366, DOI 10.1097/00000658-198109000-00015
   MUNTING E, 1988, ACTA ORTHOP SCAND, V59, P34, DOI 10.3109/17453678809149340
   MUTHUKUMARAN N, 1988, COLLAGEN REL RES, V8, P433
   NEUHOF H, 1917, SURG GYNECOL OBSTET, V24, P383
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   Nevins ML, 2000, INT J PERIODONT REST, V20, P459
   Oakes DA, 2003, CLIN ORTHOP RELAT R, P281, DOI 10.1097/01.blo.0000073347.50837.16
   OUSTERHOUT DK, 1985, ANN PLAS SURG, V15, P367, DOI 10.1097/00000637-198511000-00001
   OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x
   PEARSON GE, 1981, J PERIODONTOL, V52, P55, DOI 10.1902/jop.1981.52.2.55
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   Pfeilschifter J, 1998, J BONE MINER RES, V13, P716, DOI 10.1359/jbmr.1998.13.4.716
   Phemister DB, 1914, SURG GYNECOL OBSTET, V18, P333
   Pietrzak WS, 2006, J CRANIOFAC SURG, V17, P84, DOI 10.1097/01.scs.0000179745.91165.73
   PIKE RL, 1973, J ORAL SURG, V31, P905
   Pruss A, 2002, BIOLOGICALS, V30, P125, DOI 10.1006/biol.2002.0326
   PUOLAKKAINEN PA, 1993, TRANSFUSION, V33, P679, DOI 10.1046/j.1537-2995.1993.33893342752.x
   RAY RD, 1957, J BONE JOINT SURG AM, V39, P1119, DOI 10.2106/00004623-195739050-00012
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   REDDI AH, 1975, P SOC EXP BIOL MED, V150, P324
   Reddi AH, 2000, BIOCHEM SOC T, V28, P345, DOI 10.1042/0300-5127:0280345
   REDDI AH, 1973, P SOC EXP BIOL MED, V143, P634
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REDDI AH, 1975, P NATL ACAD SCI USA, V72, P2212, DOI 10.1073/pnas.72.6.2212
   Russell JL, 1999, ORTHOPEDICS, V22, P524
   Safdar N., 2001, SPINE, V26, P1425
   Salyer K E, 1992, J Craniofac Surg, V3, P55, DOI 10.1097/00001665-199209000-00002
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   Sassard WR, 2000, ORTHOPEDICS, V23, P1059
   Scarborough N L, 1995, Contemp Orthop, V31, P257
   Schouten CC, 2005, J MATER SCI-MATER M, V16, P149, DOI 10.1007/s10856-005-6034-3
   Schwartz Z, 1996, J PERIODONTOL, V67, P918, DOI 10.1902/jop.1996.67.9.918
   Schwartz Z, 1998, J PERIODONTOL, V69, P470, DOI 10.1902/jop.1998.69.4.470
   Schwartz Z, 2011, J BONE JOINT SURG AM, V93A, P2278, DOI [10.2106/JBJS.J.01469, 10.2106/JBJSJ.01469]
   Senn N, 1889, AM J MED SCI, V98, P219
   SOLHEIM E, 1995, J CRANIOFAC SURG, V6, P195, DOI 10.1097/00001665-199505000-00004
   Sonis S T, 1983, J Oral Med, V38, P117
   Takikawa S, 2003, J BIOMED MATER RES A, V65A, P37, DOI 10.1002/jbm.a.10345
   Tiedeman JJ, 1995, ORTHOPEDICS, V18, P1153
   Traianedes K, 2004, J BIOMED MATER RES B, V70B, P21, DOI 10.1002/jbm.b.30015
   UPTON J, 1992, J HAND SURG-AM, V17A, P704, DOI 10.1016/0363-5023(92)90321-F
   Urist M R, 1970, Symp Soc Dev Biol, V29, P125
   Urist M. R., 1980, FUNDAMENTAL CLIN BON
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Urist MR, 1998, PLAST RECONSTR SURG, V101, P408, DOI 10.1097/00006534-199802000-00023
   URIST MR, 1974, ARCH SURG-CHICAGO, V109, P486
   URIST MR, 1968, CLIN ORTHOP RELAT R, P59
   Wang J.C., 2000, PROSPECTIVE COMP COM, P35
   Weinraub Glenn M, 2003, J Foot Ankle Surg, V42, P86, DOI 10.1016/S1067-2516(03)70006-4
   WHITEMAN D, 1993, J HAND SURG-BRIT EUR, V18B, P487, DOI 10.1016/0266-7681(93)90154-8
   WIENTROUB S, 1988, CALCIFIED TISSUE INT, V42, P255, DOI 10.1007/BF02553752
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
   Zhang M, 1997, J PERIODONTOL, V68, P1076, DOI 10.1902/jop.1997.68.11.1076
NR 117
TC 111
Z9 113
U1 4
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP
PY 2012
VL 64
IS 12
BP 1063
EP 1077
DI 10.1016/j.addr.2012.06.008
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 003QQ
UT WOS:000308626800002
PM 22728914
DA 2018-10-19
ER

PT J
AU Lienemann, PS
   Lutolf, MP
   Ehrbar, M
AF Lienemann, Philipp S.
   Lutolf, Matthias P.
   Ehrbar, Martin
TI Biomimetic hydrogels for controlled biomolecule delivery to augment bone
   regeneration
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Biomimetic hydrogels; Bone; Controlled delivery; ECM-mimicking; Growth
   factors
ID ENDOTHELIAL GROWTH-FACTOR; SPINAL-CORD-INJURY; COVALENTLY IMMOBILIZED
   GRADIENTS; POLY(ETHYLENE GLYCOL) HYDROGELS; HEPARINIZED COLLAGEN
   MATRICES; HEPARAN-SULFATE PROTEOGLYCANS; CELL-INGROWTH MATRICES;
   ADHESION MOLECULE L1; IG-LIKE DOMAIN; EXTRACELLULAR-MATRIX
AB The regeneration of large bone defects caused by trauma or disease remains a significant clinical problem. Although osteoinductive growth factors such as bone morphogenetic proteins have entered clinics, transplantation of autologous bone remains the gold standard to treat bone defects. The effective treatment of bone defects by protein therapeutics in humans requires quantities that exceed the physiological doses by several orders of magnitude. This not only results in very high treatment costs but also bears considerable risks for adverse side effects. These issues have motivated the development of biomaterials technologies allowing to better control biomolecule delivery from the solid phase. Here we review recent approaches to immobilize biomolecules by affinity binding or by covalent grafting to biomaterial matrices. We focus on biomaterials concepts that are inspired by extracellular matrix (ECM) biology and in particular the dynamic interaction of growth factors with the ECM. We highlight the value of synthetic, ECM-mimicking matrices for future technologies to study bone biology and develop the next generation of 'smart' implants. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Lienemann, Philipp S.; Ehrbar, Martin] Univ Zurich Hosp, Dept Obstet, CH-8091 Zurich, Switzerland.
   [Lienemann, Philipp S.; Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.
   [Ehrbar, Martin] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.
RP Ehrbar, M (reprint author), Univ Zurich Hosp, Dept Obstet, Schmelzbergstr 12,PATH G48, CH-8091 Zurich, Switzerland.
EM Martin.Ehrbar@usz.ch
RI Ehrbar, Martin/F-4578-2012; Lutolf, Matthias/E-5914-2010
OI Ehrbar, Martin/0000-0003-2707-4870; Lienemann,
   Philipp/0000-0002-0272-3988
FU Swiss National Foundation [CR3213-125426/1, 310000-116240]; European
   Community's Angioscaff Program contract [214402]; EURYI grant
FX This work has been supported by grants from the Swiss National
   Foundation (CR3213-125426/1 and 310000-116240), the European Community's
   Angioscaff Program contract 214402 and a EURYI grant.
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083
   Arrighi I, 2009, BIOMATERIALS, V30, P1763, DOI 10.1016/j.biomaterials.2008.12.023
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g
   Barnes GL, 2008, J BONE JOINT SURG AM, V90A, P120, DOI 10.2106/JBJS.G.01443
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8
   Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   Bladergroen BA, 2009, TISSUE ENG PT A, V15, P1591, DOI 10.1089/ten.tea.2008.0348
   BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Castillo RC, 2005, J ORTHOP TRAUMA, V19, P151, DOI 10.1097/00005131-200503000-00001
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002
   Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f
   Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027
   Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x
   ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6
   Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179
   EVERTS V, 1992, J CELL PHYSIOL, V150, P221, DOI 10.1002/jcp.1041500202
   Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695
   FARLEY JR, 1987, METABOLISM, V36, P314, DOI 10.1016/0026-0495(87)90200-9
   Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203
   Fischer J, 2011, J CRANIO MAXILL SURG, V39, P54, DOI 10.1016/j.jcms.2010.03.016
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Gandhi Ankur, 2006, Foot Ankle Clin, V11, P805, DOI 10.1016/j.fcl.2006.06.009
   Gandhi NS, 2009, GLYCOBIOLOGY, V19, P1103, DOI 10.1093/glycob/cwp101
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334
   Giannoudis PV, 2010, J ORTHOP TRAUMA, V24, pS9, DOI 10.1097/BOT.0b013e3181cde5be
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390
   Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Grieb G, 2010, CELLS TISSUES ORGANS, V191, P96, DOI 10.1159/000231473
   Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008
   Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000
   Guldberg RE, 2009, J BONE MINER RES, V24, P1507, DOI [10.1359/JBMR.090801, 10.1359/jbmr.090801]
   Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681
   Hall H, 2004, MICROVASC RES, V68, P169, DOI 10.1016/j.mvr.2004.07.001
   Hall Heike, 2004, Angiogenesis, V7, P213, DOI 10.1007/s10456-004-1328-5
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Iyer AKV, 2007, J CELL PHYSIOL, V211, P748, DOI 10.1002/jcp.20986
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kobel S, 2011, CURR OPIN BIOTECH, V22, P690, DOI 10.1016/j.copbio.2011.07.001
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee RJ, 2000, CIRCULATION, V102, P898
   Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Little DG, 2007, J BONE JOINT SURG BR, V89B, P425, DOI 10.1302/0301-620X.89B4.18301
   Liu YC, 2007, WOUND REPAIR REGEN, V15, P245, DOI 10.1111/j.1524-475X.2007.00211.x
   Lorentz KM, 2012, BIOMATERIALS, V33, P494, DOI 10.1016/j.biomaterials.2011.09.088
   Lorentz KM, 2011, BIOMATERIALS, V32, P430, DOI 10.1016/j.biomaterials.2010.08.109
   Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667
   Luhmann T, 2009, BIOMATERIALS, V30, P4503, DOI 10.1016/j.biomaterials.2009.05.041
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lynch JR, 2008, J AM ACAD ORTHOP SUR, V16, P88, DOI 10.5435/00124635-200802000-00006
   MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Markowicz M, 2005, INT J ARTIF ORGANS, V28, P1251
   Martinez-Sanz E, 2011, J CONTROL RELEASE, V152, P232, DOI 10.1016/j.jconrel.2011.02.003
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Martino MM, 2011, SCI TRANSL MED, V3
   MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226
   Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002
   Molin D, 2007, CURR OPIN PHARMACOL, V7, P158, DOI 10.1016/j.coph.2006.10.006
   Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Ramirez F, 2007, CELL MOL LIFE SCI, V64, P2437, DOI 10.1007/s00018-007-7166-z
   Ramirez F, 2009, J BIOL CHEM, V284, P14677, DOI 10.1074/jbc.R900004200
   Riley CM, 2006, BIOMATERIALS, V27, P5935, DOI 10.1016/j.biomaterials.2006.08.029
   Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002
   Saik JE, 2011, BIOMACROMOLECULES, V12, P2715, DOI 10.1021/bm200492h
   Saik JE, 2011, ACTA BIOMATER, V7, P133, DOI 10.1016/j.actbio.2010.08.018
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Sakiyama-Elbert SE, 2008, J HAND SURG-AM, V33A, P1548, DOI 10.1016/j.jhsa.2008.05.030
   Sala A, 2011, INTEGR BIOL-UK, V3, P1102, DOI 10.1039/c1ib00045d
   Sasso RC, 1998, J BONE JOINT SURG AM, V80A, P631, DOI 10.2106/00004623-199805000-00003
   Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200
   Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226
   Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882
   Stalmans I, 2002, J CLIN INVEST, V109, P327
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948
   Sun WJ, 2007, GROWTH FACTORS, V25, P309, DOI 10.1080/08977190701803885
   Tae G, 2006, J BIOMAT SCI-POLYM E, V17, P187, DOI 10.1163/156856206774879090
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Thomopoulos S, 2007, J ORTHOP RES, V25, P1358, DOI 10.1002/jor.20444
   Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Uebersax L, 2009, TISSUE ENG PART B-RE, V15, P263, DOI 10.1089/ten.TEB.2008.0668
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van Wachem PB, 2001, J BIOMED MATER RES, V55, P368, DOI 10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
   Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9
   Weber CC, 2005, J BIOL CHEM, V280, P22445, DOI 10.1074/jbc.M410367200
   Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wissink MJB, 2000, J CONTROL RELEASE, V67, P141, DOI 10.1016/S0168-3659(00)00202-9
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   Wukich DK, 2008, J BONE JOINT SURG AM, V90A, P1570, DOI 10.2106/JBJS.G.01673
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
   Yang YF, 2009, TISSUE ENG PT A, V15, P3589, DOI [10.1089/ten.tea.2008.0648, 10.1089/ten.TEA.2008.0648]
   Yu YY, 2010, BONE, V46, P841, DOI 10.1016/j.bone.2009.11.005
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
   Zhang L, 2006, J CONTROL RELEASE, V114, P130, DOI 10.1016/j.jconrel.2006.06.005
   Zhao J, 2008, MACROMOL BIOSCI, V8, P836, DOI 10.1002/mabi.200700334
   Zhao WX, 2008, J MOL MED, V86, P1127, DOI 10.1007/s00109-008-0372-9
   Zhao WX, 2009, TISSUE ENG PT A, V15, P991, DOI 10.1089/ten.tea.2008.0240
   Zisch AH, 2004, BIOMATERIALS, V25, P3245, DOI 10.1016/j.biomaterials.2003.10.015
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 170
TC 60
Z9 61
U1 3
U2 69
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP
PY 2012
VL 64
IS 12
BP 1078
EP 1089
DI 10.1016/j.addr.2012.03.010
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 003QQ
UT WOS:000308626800003
PM 22465487
DA 2018-10-19
ER

PT J
AU Ginebra, MP
   Canal, C
   Espanol, M
   Pastorino, D
   Montufar, EB
AF Ginebra, Maria-Pau
   Canal, Cristina
   Espanol, Montserrat
   Pastorino, David
   Montufar, Edgar B.
TI Calcium phosphate cements as drug delivery materials
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Biomaterial; Calcium phosphate cement; Ceramic matrix; Bioceramic;
   Hydroxyapatite; Bone regeneration; Protein; Growth factor; Ions;
   Antibiotic
ID ALPHA-TRICALCIUM PHOSPHATE; IN-VIVO BEHAVIOR; OSTEOCLASTIC
   BONE-RESORPTION; SETTING CARBONATED-APATITE; TIBIAL PLATEAU FRACTURES;
   LOCAL ANTIBIOTIC-THERAPY; MESENCHYMAL STEM-CELLS; MIXING SOLUTION
   VOLUME; HYDROXYAPATITE CEMENT; CONTROLLED-RELEASE
AB Calcium phosphate cements are used as synthetic bone grafts, with several advantages, such as their osteoconductivity and injectability. Moreover, their low-temperature setting reaction and intrinsic porosity allow for the incorporation of drugs and active principles in the material. It is the aim of the present work to: a) provide an overview of the different approaches taken in the application of calcium phosphate cements for drug delivery in the skeletal system, and b) identify the most significant achievements. The drugs or active principles associated to calcium phosphate cements are classified in three groups, i) low molecular weight drugs; ii) high molecular weight biomolecules; and iii) ions. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Ginebra, Maria-Pau; Canal, Cristina; Espanol, Montserrat; Pastorino, David; Montufar, Edgar B.] Tech Univ Catalonia UPC, Dept Mat Sci & Met Engn, Biomat Biomech & Tissue Engn Grp, Barcelona 08028, Spain.
   [Ginebra, Maria-Pau; Canal, Cristina; Espanol, Montserrat; Pastorino, David; Montufar, Edgar B.] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza 50118, Spain.
   [Montufar, Edgar B.] Inst Bioengn Catalonia, Barcelona 08028, Spain.
RP Ginebra, MP (reprint author), Tech Univ Catalonia UPC, Dept Mat Sci & Met Engn, Biomat Biomech & Tissue Engn Grp, Av Diagonal 647, Barcelona 08028, Spain.
EM maria.pau.ginebra@upc.edu
RI Espanol, Montserrat/J-8293-2017; Ginebra, Maria-Pau/J-8149-2017;
   Montufar, Edgar/F-8040-2016
OI Espanol, Montserrat/0000-0001-7510-0602; Ginebra,
   Maria-Pau/0000-0002-4700-5621; Montufar, Edgar/0000-0002-8122-4000
FU Spanish Ministry of Science and Innovation in the MAT project; Juan de
   la Cierva fellowship; prize "ICREA Academia" for excellence in research;
   Generalitat de Catalunya
FX Authors acknowledge the financial support of the Spanish Ministry of
   Science and Innovation in the MAT 2009-13547 project and for the Juan de
   la Cierva fellowship of CC. Support for the research of MPG was received
   through the prize "ICREA Academia" for excellence in research, funded by
   the Generalitat de Catalunya.
CR Akashi A, 2001, BIOMATERIALS, V22, P2713, DOI 10.1016/S0142-9612(00)00438-5
   Alkhraisat MH, 2008, BIOMATERIALS, V29, P4691, DOI 10.1016/j.biomaterials.2008.08.026
   Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Aral A, 2008, CLIN ORAL IMPLAN RES, V19, P612, DOI 10.1111/j.1600-0501.2007.01518.x
   Bai B, 1999, SPINE, V24, P1521, DOI 10.1097/00007632-199908010-00004
   Bajpai P., 1987, DEV TRICALCIUM PHOSP, P377
   BAKER R, 1987, CONTROLLED RELEASE B
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Bigi A, 2004, BIOMATERIALS, V25, P2893, DOI 10.1016/j.biomaterials.2003.09.059
   Blom EJ, 2001, MATERIALWISS WERKST, V32, P962, DOI 10.1002/1521-4052(200112)32:12<962::AID-MAWE962>3.3.CO;2-T
   Blom EJ, 2002, J BIOMED MATER RES, V59, P265, DOI 10.1002/jbm.1241
   Blom EJ, 2001, CLIN ORAL IMPLAN RES, V12, P609, DOI 10.1034/j.1600-0501.2001.120609.x
   Blom EJ, 2000, J BIOMED MATER RES, V50, P67, DOI 10.1002/(SICI)1097-4636(200004)50:1<67::AID-JBM10>3.0.CO;2-E
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bodde EWH, 2008, J BIOMED MATER RES A, V87A, P780, DOI 10.1002/jbm.a.31830
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bohner M, 2000, J PHARM SCI, V89, P1262, DOI 10.1002/1520-6017(200010)89:10<1262::AID-JPS4>3.3.CO;2-Z
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Boron WF, 2004, MED PHYSL CELLULAR M
   Boskey A.L, 2001, BONE MINERALIZATION
   BRIEN WW, 1993, CLIN ORTHOP RELAT R, P242
   Brown W.E., 1991, J AM CERAM SOC, V74, P934
   Brown W.E., 1985, US Patent, Patent No. [RE33,221, 33221]
   BROWN WE, 1983, J DENT RES, V62, P672
   BUCHHOLZ HW, 1984, CLIN ORTHOP RELAT R, P96
   CALHOUN JH, 1989, AM J SURG, V157, P443, DOI 10.1016/0002-9610(89)90597-7
   CALHOUN JH, 1993, CLIN ORTHOP RELAT R, P23
   Camire CL, 2006, J BIOMED MATER RES B, V76B, P424, DOI 10.1002/jbm.b.30385
   Canal C, 2011, J MECH BEHAV BIOMED, V4, P1658, DOI 10.1016/j.jmbbm.2011.06.023
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Cazalbou S, 2004, J MATER CHEM, V14, P2148, DOI 10.1039/b401318b
   Cerovic A, 2007, BIOL TRACE ELEM RES, V116, P61, DOI 10.1007/s12011-007-9016-0
   Chen CHD, 2011, MAT SCI ENG C-MATER, V31, P334, DOI 10.1016/j.msec.2010.10.002
   Chen WC, 2003, J BIOMED MATER RES A, V64A, P664, DOI 10.1002/jbm.a.10250
   Clement J L, 1994, Met Based Drugs, V1, P467, DOI 10.1155/MBD.1994.467
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   Crank J., 1979, MATH DIFFUSION
   Dagang G., 2008, J BIOMED MATER RES A, V86, P947
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   del Valle S, 2007, J MATER SCI-MATER M, V18, P353, DOI 10.1007/s10856-006-0700-y
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010
   Espanol M, 2009, ACTA BIOMATER, V5, P2752, DOI 10.1016/j.actbio.2009.03.011
   Ethell MT, 2000, VET SURG, V29, P375, DOI 10.1053/jvet.2000.7535
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Fadeev IV, 2003, INORG MATER+, V39, P947, DOI 10.1023/A:1025509305805
   Fei ZQ, 2008, J MATER SCI-MATER M, V19, P1109, DOI 10.1007/s10856-007-3050-5
   Fernandez E, 1999, J BIOMED MATER RES, V47, P466, DOI 10.1002/(SICI)1097-4636(19991215)47:4<466::AID-JBM2>3.0.CO;2-R
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Fullana SG, 2010, ACTA BIOMATER, V6, P2294, DOI 10.1016/j.actbio.2009.11.019
   Gbureck U, 2005, BIOMATERIALS, V26, P6880, DOI 10.1016/j.biomaterials.2005.05.035
   Gbureck U, 2008, ACTA BIOMATER, V4, P1480, DOI 10.1016/j.actbio.2008.02.027
   Ginebra MP, 2009, WOODHEAD PUBL MATER, P271, DOI 10.1533/9781845696610.2.271
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Ginebra MP, 1999, J AM CERAM SOC, V82, P2808
   Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049
   Ginebra MP, 2001, J BIOMED MATER RES, V57, P113, DOI 10.1002/1097-4636(200110)57:1<113::AID-JBM1149>3.0.CO;2-5
   Giocondi JL, 2010, PHILOS T R SOC A, V368, P1937, DOI 10.1098/rsta.2010.0006
   Grover LM, 2003, BIOMATERIALS, V24, P4133, DOI 10.1016/S0142-9612(03)00293-X
   GRYNPAS MD, 1990, BONE, V11, P313, DOI 10.1016/8756-3282(90)90086-E
   Gu Y, 2011, J BIOMED MATER RES A, V97A, P177, DOI 10.1002/jbm.a.33018
   Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032
   Gustavsson J, 2012, ACTA BIOMATER, V8, P386, DOI 10.1016/j.actbio.2011.10.002
   Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027
   Habraken WJEM, 2009, J BIOMED MATER RES A, V91A, P614, DOI 10.1002/jbm.a.32263
   Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R
   Alkhraisat MH, 2010, ACTA BIOMATER, V6, P1522, DOI 10.1016/j.actbio.2009.10.043
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HENRY SL, 1993, CLIN ORTHOP RELAT R, P54
   Hesaraki S, 2009, MED ENG PHYS, V31, P1205, DOI 10.1016/j.medengphy.2009.07.019
   Hesaraki S, 2009, ADV APPL CERAM, V108, P231, DOI 10.1179/174367608X353656
   Hesaraki S, 2008, J BIOMED MATER RES B, V86B, P208, DOI 10.1002/jbm.b.31008
   Hesaraki S, 2009, J BIOMED MATER RES B, V89B, P342, DOI 10.1002/jbm.b.31222
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hofmann MP, 2009, ACTA BIOMATER, V5, P43, DOI 10.1016/j.actbio.2008.08.005
   Horstmann WG, 2003, INJURY, V34, P141, DOI 10.1016/S0020-1383(02)00105-5
   [黄相杰 HUANG Xiangjie], 2008, [中国修复重建外科杂志, Chinese Journal of Reparative and Reconstructive Surgery], V22, P307
   Huot L, 2008, OSTEOPOROSIS INT, V19, P1047, DOI 10.1007/s00198-008-0587-1
   Huse RO, 2004, CLIN ORAL IMPLAN RES, V15, P741, DOI 10.1111/j.1600-0501.2004.01068.x
   Ishikawa K, 1997, J BIOMED MATER RES, V36, P393, DOI 10.1002/(SICI)1097-4636(19970905)36:3<393::AID-JBM14>3.0.CO;2-F
   Ishikawa K, 2008, KEY ENG MATER, V361-363, P319, DOI 10.4028/www.scientific.net/KEM.361-363.319
   Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697
   Jiang HJ, 2009, CHIN J TRAUMATOL, V12, P285, DOI 10.3760/cma.j.issn.1008-1275.2009.05.006
   Jiang Hongjiang, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P1113
   Jiang PJ, 2010, J BIOMED MATER RES B, V93B, P51, DOI 10.1002/jbm.b.31557
   Jindong Z., 2010, ORTHOPEDICS, V33, P561
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   KAMERER DB, 1994, AM J OTOL, V15, P47
   Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6
   Kasten P, 2008, J BIOMATER APPL, V23, P169, DOI 10.1177/0885328207088269
   Kasten P, 2006, CELLS TISSUES ORGANS, V183, P68, DOI 10.1159/000095511
   Kempen DHR, 2010, TISSUE ENG PART B-RE, V16, P551, DOI 10.1089/ten.teb.2010.0176
   Kendall RW, 1996, CLIN ORTHOP RELAT R, P273
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   Khairoun I, 1997, J BIOMED MATER RES, V38, P356, DOI 10.1002/(SICI)1097-4636(199724)38:4<356::AID-JBM8>3.0.CO;2-N
   Kisanuki O, 2007, J ORTHOP SCI, V12, P281, DOI 10.1007/s00776-007-1124-3
   Kroese-Deutman HC, 2005, BIOMATERIALS, V26, P1131, DOI 10.1016/j.biomaterials.2004.04.021
   Le Nihouannen D, 2008, BIOMATERIALS, V29, P3253, DOI 10.1016/j.biomaterials.2008.03.035
   Le Nihouannen D, 2008, EUR J PHARM BIOPHARM, V70, P813, DOI 10.1016/j.ejpb.2008.07.018
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lemaitre J, 1987, SIL IND CERAM SCI TE, V52, P141
   Leroux L, 2001, J MATER RES, V16, P171, DOI 10.1557/JMR.2001.0028
   Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398
   Li DX, 2007, J MATER SCI-MATER M, V18, P2225, DOI 10.1007/s10856-007-3084-8
   Li D, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025007
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Li X, 2009, MAT SCI ENG C-BIO S, V29, P969, DOI 10.1016/j.msec.2008.08.021
   Libicher M, 2006, OSTEOPOROSIS INT, V17, P1208, DOI 10.1007/s00198-006-0128-8
   Link DP, 2008, BIOMATERIALS, V29, P675, DOI 10.1016/j.biomaterials.2007.10.029
   Liu WN, 2009, MAT SCI ENG C-MATER, V29, P2486, DOI 10.1016/j.msec.2009.07.015
   Liu YK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025004
   Liverneaux PA, 2004, EUR J ORTHOP SURG TR, V15, P1
   Lode A, 2008, J BIOMED MATER RES A, V86A, P749, DOI 10.1002/jbm.a.31581
   Lode A, 2007, J BIOMED MATER RES A, V81A, P474, DOI 10.1002/jbm.a.31024
   Lopez-Heredia MA, 2011, BIOMATERIALS, V32, P5411, DOI 10.1016/j.biomaterials.2011.04.010
   Lowe NM, 2002, P NUTR SOC, V61, P181, DOI 10.1079/PNS2002154
   Lu JX, 2011, J MATER SCI-MATER M, V22, P607, DOI 10.1007/s10856-011-4228-4
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Maao J., 2008, J HAUZHONG U SCI MED, V28, P483
   Maestretti G, 2007, EUR SPINE J, V16, P601, DOI 10.1007/s00586-006-0258-x
   MANN S, 1989, BIOMINERALIZATION CH
   Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082
   MARIE PJ, 1985, MINER ELECTROL METAB, V11, P5
   Maus U, 2008, J BIOMED MATER RES B, V85B, P87, DOI 10.1002/jbm.b.30920
   MCNALLY MA, 1993, J BONE JOINT SURG BR, V75, P375
   Mermelstein LE, 1996, J ORTHOP TRAUMA, V10, P15, DOI 10.1097/00005131-199601000-00003
   Mestres G, 2012, ACTA BIOMATER, V8, P1169, DOI 10.1016/j.actbio.2011.11.021
   MICLAU T, 1993, J ORTHOPAED RES, V11, P627, DOI 10.1002/jor.1100110503
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   Montufar EB, 2010, ACTA BIOMATER, V6, P876, DOI 10.1016/j.actbio.2009.10.018
   Montufar EB, 2010, J MATER SCI-MATER M, V21, P863, DOI 10.1007/s10856-009-3918-7
   Moojen DJF, 2007, J BONE JOINT SURG AM, V89A, P1298, DOI 10.2106/JBJS.F.00822
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   Morgan EF, 1997, J MATER SCI-MATER M, V8, P559, DOI 10.1023/A:1018550831834
   NEUMAN WF, 1958, CHEM DYNAMICS BONE M
   Niedhart C, 2004, J BIOMED MATER RES A, V69A, P680, DOI 10.1002/jbm.a.30037
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   Ooms EM, 2003, J BIOMED MATER RES B, V66B, P447, DOI 10.1002/jbm.b.10039
   OSTERMANN PAW, 1995, J BONE JOINT SURG BR, V77B, P93
   OSTERMANN PAW, 1993, CLIN ORTHOP RELAT R, P102
   Otsuka M, 1998, J CONTROL RELEASE, V52, P281, DOI 10.1016/S0168-3659(97)00264-2
   OTSUKA M, 1994, J PHARM SCI, V83, P611, DOI 10.1002/jps.2600830502
   Otsuka M, 1997, J CONTROL RELEASE, V43, P115, DOI 10.1016/S0168-3659(96)01493-9
   Otsuka M, 2000, ADV DRUG DELIVER REV, V42, P249, DOI 10.1016/S0169-409X(00)00065-X
   OTSUKA M, 1994, J PHARM SCI, V83, P1569, DOI 10.1002/jps.2600831110
   OTSUKA M, 1994, J PHARM SCI, V83, P1565, DOI 10.1002/jps.2600831109
   OTSUKA M, 1995, J PHARM SCI, V84, P733, DOI 10.1002/jps.2600840614
   OTSUKA M, 1994, J PHARM SCI, V83, P259, DOI 10.1002/jps.2600830230
   Otsuka M, 1997, PHARMACEUT RES, V14, P444, DOI 10.1023/A:1012039214184
   Otsuka M, 1997, J PHARM PHARMACOL, V49, P1182, DOI 10.1111/j.2042-7158.1997.tb06067.x
   Otsuka M, 2011, COLLOID SURFACE B, V85, P338, DOI 10.1016/j.colsurfb.2011.03.006
   Otsuka M, 2010, J PHARM SCI-US, V99, P286, DOI 10.1002/jps.21835
   Pan WM, 2011, J ORTHOP RES, V29, P1015, DOI 10.1002/jor.21351
   Panzavolta S, 2008, J BIOMED MATER RES A, V84A, P965, DOI 10.1002/jbm.a.31412
   Panzavolta S, 2010, J INORG BIOCHEM, V104, P1099, DOI 10.1016/j.jinorgbio.2010.06.008
   Panzavolta S, 2009, J INORG BIOCHEM, V103, P101, DOI 10.1016/j.jinorgbio.2008.09.012
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Pina S, 2010, EUR CELLS MATER, V20, P162
   Pina S, 2010, ACTA BIOMATER, V6, P928, DOI 10.1016/j.actbio.2009.09.001
   Pina S, 2010, J MATER SCI-MATER M, V21, P431, DOI 10.1007/s10856-009-3890-2
   Plachokova AS, 2008, J PERIODONTAL RES, V43, P55, DOI 10.1111/j.1600-0765.2007.00994.x
   PRASAD AS, 1995, NUTRITION, V11, P93
   Qi GC, 2008, APPL SURF SCI, V255, P304, DOI 10.1016/j.apsusc.2008.06.106
   Ratier A, 2004, INT J PHARM, V274, P261, DOI 10.1016/j.ijpharm.2004.01.021
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   Ruhe P., 2005, J CONTROL RELEASE, V106, P161
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Saint-Jean SJ, 2005, J MATER SCI-MATER M, V16, P993, DOI 10.1007/s10856-005-4754-z
   Sasaki S, 1999, J Orthop Sci, V4, P361, DOI 10.1007/s007760050117
   Sasaki T, 2005, J ARTHROPLASTY, V20, P1055, DOI 10.1016/j.arth.2005.03.035
   SAUNDERS WP, 1994, ENDOD DENT TRAUMATOL, V10, P105
   Schildhauer TA, 1999, J ORTHOPAED RES, V17, P67, DOI 10.1002/jor.1100170111
   Schnieders J, 2006, BIOMATERIALS, V27, P4239, DOI 10.1016/j.biomaterials.2006.03.032
   Schnitzler V, 2011, ACTA BIOMATER, V7, P759, DOI 10.1016/j.actbio.2010.09.017
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015
   Siepmann F, 2008, J CONTROL RELEASE, V128, P233, DOI 10.1016/j.jconrel.2008.03.009
   Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051
   Sogo Y, 2004, MAT SCI ENG C-BIO S, V24, P709, DOI 10.1016/j.msec.2004.08.016
   Sorensen RG, 2004, J CLIN PERIODONTOL, V31, P796, DOI 10.1111/j.1600-051X.2004.00544.x
   Stallmann HP, 2008, J ORTHOP RES, V26, P531, DOI 10.1002/jor.20511
   Stallmann HP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-18
   Stallmann HP, 2004, J ANTIMICROB CHEMOTH, V54, P472, DOI 10.1093/jac/dkh346
   Stallmann HP, 2003, J ANTIMICROB CHEMOTH, V52, P853, DOI 10.1093/jac/dkg443
   Strauss EJ, 2007, INJURY, V38, P2, DOI 10.1016/j.injury.2007.08.005
   Su K, 2011, EXPERT OPIN DRUG DEL, V8, P113, DOI 10.1517/17425247.2011.541438
   Suzuki T, 2002, CHEM PHARM BULL, V50, P741, DOI 10.1248/cpb.50.741
   Tahara Y, 2001, J Orthop Sci, V6, P556, DOI 10.1007/s007760100012
   TAKANO I, 1997, J ORTHOP SCI, V2, P98
   Takechi M, 2002, J MATER SCI-MATER M, V13, P973, DOI 10.1023/A:1019816830793
   Takechi M, 1998, J BIOMED MATER RES, V39, P308, DOI 10.1002/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.3.CO;2-F
   Takemasa R., 2007, SPINE J, V7, p148S
   Tamimi F., 2007, J BIOMED MATER RES A, V81, P93
   Tamimi F, 2008, J BIOMED MATER RES A, V85A, P707, DOI 10.1002/jbm.a.31610
   Tani T, 2006, IN VIVO, V20, P55
   Tanzawa Y, 2011, J ORTHOP SCI, V16, P77, DOI 10.1007/s00776-011-0045-3
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Thomes B, 2002, J Bone Joint Surg Br, V84, P758
   Tomita Seiji, 2003, J Orthop Sci, V8, P192, DOI 10.1007/s007760300032
   Trostle SS, 1996, J AM VET MED ASSOC, V208, P404
   TUNG IC, 1995, ARTIF CELL BLOOD SUB, V23, P81, DOI 10.3109/10731199509117669
   Urabe K, 2009, J ORTHOP SCI, V14, P784, DOI 10.1007/s00776-009-1397-9
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x
   Vergnaud J.-M., 1993, CONTROLLED DRUG RELE
   VERMEER C, 1995, ANNU REV NUTR, V15, P1, DOI 10.1146/annurev.nutr.15.1.1
   Wang C.J., 2001, FUDAN U J MED SCI, V28, P473
   Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574
   Wang Wei, 1999, International Journal of Pharmaceutics (Amsterdam), V185, P129, DOI 10.1016/S0378-5173(99)00152-0
   Weir MD, 2010, ACTA BIOMATER, V6, P4118, DOI 10.1016/j.actbio.2010.04.029
   Welch RD, 2003, J BONE JOINT SURG AM, V85A, P222, DOI 10.2106/00004623-200302000-00007
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   Yamaguchi M, 1998, J TRACE ELEM EXP MED, V11, P119
   Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0
   Young AM, 2008, ACTA BIOMATER, V4, P1081, DOI 10.1016/j.actbio.2007.12.009
   Yu XH, 2011, J BIOMED MATER RES B, V97B, P345, DOI 10.1002/jbm.b.31820
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 232
TC 210
Z9 218
U1 25
U2 288
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP
PY 2012
VL 64
IS 12
BP 1090
EP 1110
DI 10.1016/j.addr.2012.01.008
PG 21
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 003QQ
UT WOS:000308626800004
PM 22310160
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Hickok, NJ
   Shapiro, IM
AF Hickok, Noreen J.
   Shapiro, Irving M.
TI Immobilized antibiotics to prevent orthopaedic implant infections
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Antibiotics; Bacteria; Staphylococcal aureus; Vancomycin; Titanium;
   Implants; Orthopaedic
ID SELF-ASSEMBLED MONOLAYERS; TOTAL HIP-ARTHROPLASTY;
   BIOMATERIAL-ASSOCIATED INFECTION; OSTEOBLAST-LIKE CELLS; INTRACELLULAR
   STAPHYLOCOCCUS-AUREUS; INSTRUMENTED SPINAL-FUSION; IMPACTED BONE
   ALLOGRAFTS; MICROBIAL BIOFILM GROWTH; GROUP-A STREPTOCOCCI; IN-VITRO
AB Many surgical procedures require the placement of an inert or tissue-derived implant deep within the body cavity. While the majority of these implants do not become colonized by bacteria, a small percentage develops a biofilm layer that harbors invasive microorganisms. In orthopaedic surgery, unresolved periprosthetic infections can lead to implant loosening, arthrodeses, amputations and sometimes death. The focus of this review is to describe development of an implant in which an antibiotic tethered to the metal surface is used to prevent bacterial colonization and biofilm formation. Building on well-established chemical syntheses, studies show that antibiotics can be linked to titanium through a self-assembled monolayer of siloxy amines. The stable metal antibiotic construct resists bacterial colonization and biofilm formation while remaining amenable to osteoblastic cell adhesion and maturation. In an animal model, the antibiotic modified implant resists challenges by bacteria that are commonly present in periprosthetic infections. While the long-term efficacy and stability is still to be established, ongoing studies support the view that this novel type of bioactive surface has a real potential to mitigate or prevent the devastating consequences of orthopaedic infection. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Hickok, Noreen J.; Shapiro, Irving M.] Thomas Jefferson Univ, Dept Orthopaed Surg, Jefferson Med Coll, Philadelphia, PA 19107 USA.
RP Hickok, NJ (reprint author), Thomas Jefferson Univ, Dept Orthopaed Surg, Jefferson Med Coll, 1015 Walnut St,Suite 501, Philadelphia, PA 19107 USA.
EM Noreen.Hickok@jefferson.edu
FU MTF; NIH [DE-13319, DE-10875, AR-051303, DE-019901, HD-061053];
   Department of Defense [DAMD17-03-1-0713]
FX The authors thank Christopher S. Adams, Valentin Antoci, Jr., Theresa A.
   Freeman, Constantinos Ketonis, and Javad Parvizi, along with countless
   other colleagues who have been instrumental in furthering this work. The
   authors thank the MTF, NIH (grants DE-13319, DE-10875, AR-051303,
   DE-019901, and HD-061053) and the Department of Defense (grant
   DAMD17-03-1-0713) for research support. Results presented are not the
   statement or policy of the funding agencies.
CR Adams CS, 2009, J ORTHOP RES, V27, P701, DOI 10.1002/jor.20815
   Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001
   Alexander EH, 2001, APPL MICROBIOL BIOT, V56, P361, DOI 10.1007/s002530100703
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85
   Anderson JA, 2009, J ARTHROPLASTY, V24, P631, DOI 10.1016/j.arth.2008.04.003
   Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50
   Antoci V, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e318073c2b2
   Antoci V, 2007, CLIN ORTHOP RELAT R, P200, DOI 10.1097/BLO.0b013e31811ff866
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043
   Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   Aslam S., 2008, AM J INFECT CONTROL, V36
   Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30
   Baltch AL, 2005, J ANTIMICROB CHEMOTH, V56, P104, DOI 10.1093/jac/dki186
   Betsch BY, 2008, CLIN INFECT DIS, V46, P1221, DOI 10.1086/529436
   Billon A, 2005, J MICROENCAPSUL, V22, P841, DOI 10.1080/02652040500162790
   BLOCK M S, 1989, International Journal of Oral and Maxillofacial Implants, V4, P219
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Boks NP, 2009, J COLLOID INTERF SCI, V331, P60, DOI 10.1016/j.jcis.2008.11.025
   Bonazzi M, 2006, FEBS LETT, V580, P2962, DOI 10.1016/j.febslet.2006.04.010
   Bost KL, 1999, J INFECT DIS, V180, P1912, DOI 10.1086/315138
   Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09
   Broekhuizen CAN, 2008, CRIT CARE MED, V36, P2395, DOI 10.1097/CCM.0b013e3181818268
   Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Buttaro MA, 2005, J BONE JOINT SURG BR, V87B, P1684, DOI 10.1302/0301-620X.87B12.16781
   Buttaro MA, 2005, J BONE JOINT SURG BR, V87B, P314, DOI 10.1302/0301-620X.87B3.14788
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   Cavalcanti-Adam EA, 2002, J BONE MINER RES, V17, P2130, DOI 10.1359/jbmr.2002.17.12.2130
   CDC Center for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P207
   Chen CP, 2010, BIOCONJUGATE CHEM, V21, P1978, DOI 10.1021/bc100136e
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Cierny G, 2002, CLIN ORTHOP RELAT R, P23, DOI 10.1097/01.blo.0000030334.53928.23
   Collins I, 2008, EUR SPINE J, V17, P445, DOI 10.1007/s00586-007-0559-8
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9
   Coughlan A, 2008, J MATER SCI-MATER M, V19, P3555, DOI 10.1007/s10856-008-3519-x
   Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464
   Danahy MP, 2004, LANGMUIR, V20, P5333, DOI 10.1021/la036084h
   Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842
   DE GROOD M P, 1951, Arch Chir Neerl, V3, P128
   DEBASTIANI G, 1986, INT ORTHOP, V10, P95, DOI 10.1007/BF00267748
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   Derda R, 2007, LANGMUIR, V23, P11164, DOI 10.1021/la701386v
   Duarte PM, 2009, J PERIODONTOL, V80, P1824, DOI 10.1902/jop.2009.090273
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P531
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Duggan JM, 2001, INFECT MED, V18, P534
   Duncan CP, 1995, AAOS INSTR COURS LEC, V44, P305
   Edin ML, 1996, CLIN ORTHOP RELAT R, P245
   Edupuganti OP, 2007, BIOORG MED CHEM LETT, V17, P2692, DOI 10.1016/j.bmcl.2007.03.005
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V68A, P615, DOI 10.1002/jbm.a.20051
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Ellington JK, 2006, J ORTHOP RES, V24, P87, DOI 10.1002/jor.20003
   Ellington JK, 1999, MICROB PATHOGENESIS, V26, P317, DOI 10.1006/mpat.1999.0272
   Ellington JK, 2003, J BONE JOINT SURG BR, V85B, P918, DOI 10.1302/0301-620X.85B6.13509
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Fink B, 2009, CLIN ORTHOP RELAT R, V467, P1848, DOI 10.1007/s11999-008-0611-y
   Fiorilli S, 2008, J COLLOID INTERF SCI, V321, P235, DOI 10.1016/j.jcis.2007.12.041
   FISH DN, 1992, AM J HOSP PHARM, V49, P2469
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Fu JH, 2006, J BIOMED MATER RES A, V79A, P665, DOI 10.1002/jbm.a.30819
   Furkert FH, 2011, CURR MICROBIOL, V62, P1743, DOI 10.1007/s00284-011-9923-3
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   GALANTE JO, 1992, CLIN ORTHOP RELAT R, P41
   Garvin K L, 1994, Semin Arthroplasty, V5, P142
   Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005
   Gitelis Steven, 2002, J Orthop Surg (Hong Kong), V10, P53
   Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9
   GRAY JC, 1981, J BONE JOINT SURG BR, V63, P441
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hanssen AD, 2002, J ARTHROPLASTY, V17, P98, DOI 10.1054/arth.2002.32458
   Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Hauck CR, 2006, CURR OPIN MICROBIOL, V9, P5, DOI 10.1016/j.mib.2005.12.002
   Hauck CR, 2002, MED MICROBIOL IMMUN, V191, P55, DOI 10.1007/s00430-002-0119-0
   Heijink A, 2008, CLIN ORTHOP RELAT R, V466, P977, DOI 10.1007/s11999-008-0117-7
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075
   Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025
   Humphrey JS, 1998, CLIN ORTHOP RELAT R, P218
   Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2
   Isefuku S, 2001, J ORTHOP RES, V19, P950, DOI 10.1016/S0736-0266(01)00022-5
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Jain A, 2007, CRIT REV THER DRUG, V24, P393, DOI 10.1615/CritRevTherDrugCarrierSyst.v24.i5.10
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Kalicke T, 2006, J ORTHOP RES, V24, P1622, DOI 10.1002/jor.20193
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Kaplan EL, 2006, CLIN INFECT DIS, V43, P1398, DOI 10.1086/508773
   Kassler Jackie, 2008, Urol Nurs, V28, P97
   Ketonis C, 2010, TISSUE ENG PT A, V16, P2041, DOI [10.1089/ten.tea.2009.0610, 10.1089/ten.TEA.2009.0610]
   Ketonis C, 2011, ANTIMICROB AGENTS CH, V55, P487, DOI 10.1128/AAC.00741-10
   Ketonis C, 2009, CLIN ORTHOP RELAT R, V467, P1678, DOI 10.1007/s11999-009-0828-4
   Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Kim JI, 2010, J SPINAL DISORD TECH, V23, P258, DOI 10.1097/BSD.0b013e3181a9452c
   Kouidhi B, 2010, MICROB PATHOGENESIS, V49, P14, DOI 10.1016/j.micpath.2010.03.007
   Krut O, 2004, J ANTIMICROB CHEMOTH, V53, P167, DOI 10.1093/jac/dkh076
   Kuijpers AJ, 1998, J CONTROL RELEASE, V53, P235, DOI 10.1016/S0168-3659(97)00257-5
   Lawson MC, 2007, CLIN ORTHOP RELAT R, P96, DOI 10.1097/BLO.0b013e3180986706
   Lawson MC, 2010, CLIN ORTHOP RELAT R, V468, P2081, DOI 10.1007/s11999-010-1266-z
   Lawson MC, 2009, BIOMACROMOLECULES, V10, P2221, DOI 10.1021/bm900410a
   Lazennec JY, 2011, ORTHOP TRAUMATOL-SUR, V97, P373, DOI 10.1016/j.otsr.2011.02.006
   Lee MH, 2005, BIOMATERIALS, V26, P1721, DOI 10.1016/j.biomaterials.2004.05.026
   Lewis K, 2008, CURR TOP MICROBIOL, V322, P107
   Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452
   Liao JA, 2010, INT J NANOMED, V5, P261
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Loll PJ, 2000, ANNU REV BIOPH BIOM, V29, P265, DOI 10.1146/annurev.biophys.29.1.265
   LORD CF, 1988, J BONE JOINT SURG AM, V70A, P369, DOI 10.2106/00004623-198870030-00008
   MANKIN HJ, 1983, CLIN ORTHOP RELAT R, P69
   Mankin HJ, 2005, CLIN ORTHOP RELAT R, P210, DOI 10.1097/01.blo.0000150371.77314.52
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   McPherson EJ, 2002, CLIN ORTHOP RELAT R, P8, DOI 10.1097/01.blo.0000030172.56585.c6
   Meadows Steve E., 1993, Bulletin Hospital for Joint Diseases, V52, P11
   MELCHER GA, 1994, J BONE JOINT SURG BR, V76B, P955
   Mikulec LJ, 1996, J BIOMED MATER RES, V32, P203, DOI 10.1002/(SICI)1097-4636(199610)32:2<203::AID-JBM8>3.0.CO;2-X
   Mody RM, 2009, J TRAUMA, V67, P758, DOI 10.1097/TA.0b013e3181af6aa6
   Moriarty TF, 2010, J MATER SCI-MATER M, V21, P1031, DOI 10.1007/s10856-009-3907-x
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Nair SP, 2000, RHEUMATOLOGY, V39, P821, DOI 10.1093/rheumatology/39.8.821
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   OGA M, 1993, ACTA ORTHOP SCAND, V64, P273, DOI 10.3109/17453679308993623
   Okamoto K, 1998, J DENT RES, V77, P481, DOI 10.1177/00220345980770030701
   Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4
   Parvizi J, 2004, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000150116.65231.45
   Peersman G, 2001, CLIN ORTHOP RELAT R, P15
   Piroth L, 2008, INFECT IMMUN, V76, P3824, DOI 10.1128/IAI.00405-08
   Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Puleo DA, 1997, J BIOMED MATER RES, V37, P222, DOI 10.1002/(SICI)1097-4636(199711)37:2<222::AID-JBM11>3.0.CO;2-G
   Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4
   Raulio M, 2008, J IND MICROBIOL BIOT, V35, P751, DOI 10.1007/s10295-008-0343-8
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Riedewald Frank, 2006, PDA J Pharm Sci Technol, V60, P164
   Rushton N, 1997, EUR J SURG, V163, P27
   SANDERSON PJ, 1991, J HOSP INFECT, V18, P367, DOI 10.1016/0195-6701(91)90043-8
   Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200
   SCHRODER HA, 1986, ARCH ORTHOP TRAUM SU, V105, P28, DOI 10.1007/BF00625656
   Secchi AG, 2007, J BIOMED MATER RES A, V83A, P577, DOI 10.1002/jbm.a.31007
   Shirtliff ME, 2002, CLIN ORTHOP RELAT R, P239
   Sierra-Hoffman M, 2010, SOUTH MED J, V103, P25, DOI 10.1097/SMJ.0b013e3181c4e00b
   Sinha B, 2005, THROMB HAEMOSTASIS, V94, P266, DOI 10.1160/TH05-04-0235
   Smith K, 2009, INT J ANTIMICROB AG, V33, P374, DOI 10.1016/j.ijantimicag.2008.08.029
   Spivak JM, 2010, EUR SPINE J, V19, P677, DOI 10.1007/s00586-009-1226-z
   STEINBRINK K, 1990, CLIN ORTHOP RELAT R, P19
   Stewart PS, 2009, ANTIMICROB AGENTS CH, V53, P3505, DOI 10.1128/AAC.01728-08
   Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0
   Subbiahdoss G, 2010, J BIOMED MATER RES A, V94A, P533, DOI 10.1002/jbm.a.32731
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Suh H, 1994, ASAIO J, V40, pM406, DOI 10.1097/00002480-199407000-00031
   Sukeik M, 2009, INT J MED SCI, V6, P253
   Sykes R, 2010, J ANTIMICROB CHEMOTH, V65, P1842, DOI 10.1093/jac/dkq217
   THAKUR AJ, 1991, J BONE JOINT SURG BR, V73, P448
   TOMFORD WW, 1990, J BONE JOINT SURG AM, V72A, P1137, DOI 10.2106/00004623-199072080-00003
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   Valappil SP, 2008, APPL ENVIRON MICROB, V74, P5228, DOI 10.1128/AEM.00086-08
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   Weinstein MA, 2000, J SPINAL DISORD, V13, P422, DOI 10.1097/00002517-200010000-00009
   Wimpenny J, 2009, ADV MICROB PHYSIOL, V56, P29, DOI 10.1016/S0065-2911(09)05602-1
   Witso E, 2005, ACTA ORTHOP, V76, P481, DOI 10.1080/17453670510041457
   Witso E, 2002, ACTA ORTHOP SCAND, V73, P199, DOI 10.1080/000164702753671812
   Wojcik S M, 1997, Biomed Sci Instrum, V33, P166
   WYATT JE, 1990, J APPL BACTERIOL, V69, P834
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 182
TC 115
Z9 115
U1 5
U2 93
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP
PY 2012
VL 64
IS 12
BP 1165
EP 1176
DI 10.1016/j.addr.2012.03.015
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 003QQ
UT WOS:000308626800010
PM 22512927
OA Green Accepted
DA 2018-10-19
ER

PT J
AU King, WJ
   Krebsbach, PH
AF King, William J.
   Krebsbach, Paul H.
TI Growth factor delivery: How surface interactions modulate release in
   vitro and in vivo
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Tissue engineering; Drug delivery; Biomaterials; Ceramic/polymer
   composites; Hydrogels
ID BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; RAT ECTOPIC MODEL;
   CALCIUM-PHOSPHATE; NONHUMAN PRIMATE; BINDING PEPTIDE;
   BIODEGRADABLE-HYDROGEL; CONFORMATIONAL-CHANGE; DRUG-DELIVERY;
   THERMOREVERSIBLE POLYMERS
AB Biomaterial scaffolds have been extensively used to deliver growth factors to induce new bone formation. The pharmacokinetics of growth factor delivery has been a critical regulator of their clinical success. This review will focus on the surface interactions that control the non-covalent incorporation of growth factors into scaffolds and the mechanisms that control growth factor release from clinically relevant biomaterials. We will focus on the delivery of recombinant human bone morphogenetic protein-2 from materials currently used in the clinical practice. but also suggest how general mechanisms that control growth factor incorporation and release delineated with this growth factor could extend to other systems. A better understanding of the changing mechanisms that control growth factor release during the different stages of preclinical development could instruct the development of future scaffolds for currently untreatable injuries and diseases. Published by Elsevier B.V.
C1 [King, William J.; Krebsbach, Paul H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   [Krebsbach, Paul H.] Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Krebsbach, PH (reprint author), 1011 N Univ, Ann Arbor, MI 48109 USA.
EM paulk@umich.edu
FU NIH [R01 DE018890]; NIDCR
FX This research was supported by NIH grant R01 DE018890 and the NIDCR T32
   Tissue Engineering and Regeneration Training Program fellowship for WJK.
CR Ackerman SJ, 2002, SPINE, V27, pS94, DOI 10.1097/01.BRS.0000020741.77873.D3
   Akamaru T, 2003, SPINE, V28, P429, DOI 10.1097/00007632-200303010-00004
   Alanay A, 2008, SPINE, V33, P1709, DOI 10.1097/BRS.0b013e31817e9dfd
   Alaoui-Ismaili MH, 2009, CYTOKINE GROWTH F R, V20, P501, DOI 10.1016/j.cytogfr.2009.10.001
   Allen RT, 2007, SPINE, V32, P2996, DOI 10.1097/BRS.0b013e31815cde3e
   Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003
   Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342
   BASSETT CAL, 1993, J CELL BIOCHEM, V51, P387, DOI 10.1002/jcb.2400510402
   Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916
   Behnam K, 2005, J ORTHOP RES, V23, P175, DOI 10.1016/j.orthres.2004.05.001
   Blumenfeld I, 2002, EXP GERONTOL, V37, P553, DOI 10.1016/S0531-5565(01)00215-7
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Boix T, 2005, J INORG BIOCHEM, V99, P1043, DOI 10.1016/j.jinorgbio.2005.01.011
   Bouxsein ML, 2001, J BONE JOINT SURG AM, V83A, P1219, DOI 10.2106/00004623-200108000-00012
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Burkus JK, 2011, SPINE, V36, P2158, DOI 10.1097/BRS.0b013e3182059a8c
   Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Chatzinikolaidou M, 2002, MATERIALWISS WERKST, V33, P720, DOI 10.1002/mawe.200290002
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chen FM, 2005, ACTA PHARMACOL SIN, V26, P1093, DOI 10.1111/j.1745-7254.2005.00180.x
   Chen XQ, 2002, J ORTHOPAED RES, V20, P142, DOI 10.1016/S0736-0266(01)00060-2
   Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   D Schwartz, 2005, THESIS
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Dickerman RD, 2007, SPINE J, V7, P508, DOI 10.1016/j.spinee.2007.03.003
   Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81
   Dmitriev AE, 2011, SPINE J, V11, P500, DOI 10.1016/j.spinee.2011.05.002
   Docherty-Skogh AC, 2010, PLAST RECONSTR SURG, V125, P1383, DOI 10.1097/PRS.0b013e3181d629dc
   Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168
   Duggirala S S, 1996, Pharm Dev Technol, V1, P11, DOI 10.3109/10837459609031413
   DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167
   Ehlert N, 2011, ACTA BIOMATER, V7, P1772, DOI 10.1016/j.actbio.2010.12.028
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   Ekrol I, 2008, INJURY, V39, pS73, DOI 10.1016/S0020-1383(08)70018-4
   Elkasabi YM, 2011, BIOMATERIALS, V32, P1809, DOI 10.1016/j.biomaterials.2010.10.046
   ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203
   Fang F, 2005, BIOPHYS J, V89, P1516, DOI 10.1529/biophysj.104.055079
   FDA, 2010, FOOD DRUG ADM EX SUM
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   Gao T, 2001, MATERIALWISS WERKST, V32, P953
   Gao TJ, 2002, TISSUE ENG, V8, P429, DOI 10.1089/107632702760184691
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Gessner A, 2002, EUR J PHARM BIOPHARM, V54, P165, DOI 10.1016/S0939-6411(02)00081-4
   Gessner A, 2003, J BIOMED MATER RES A, V65A, P319, DOI 10.1002/jbm.a.10371
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Han ZJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295712
   He XZ, 2010, INT J PHARMACEUT, V390, P107, DOI 10.1016/j.ijpharm.2009.12.063
   Henle P, 2005, BONE, V37, P791, DOI 10.1016/j.bone.2005.06.015
   Hiemstra C, 2007, J CONTROL RELEASE, V122, P71, DOI 10.1016/j.jconrel.2007.06.011
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Hollister SJ, 2011, TISSUE ENG PART B-RE, V17, P459, DOI [10.1089/ten.teb.2011.0251, 10.1089/ten.TEB.2011.0251]
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   Hsu HP, 2006, J ORTHOP RES, V24, P1660, DOI 10.1002/jor.20204
   Hu JL, 2011, INT J PHARMACEUT, V413, P140, DOI 10.1016/j.ijpharm.2011.04.043
   Hu JL, 2010, BIOCONJUGATE CHEM, V21, P1762, DOI 10.1021/bc9005706
   Hu WW, 2010, J DENT RES, V89, P77, DOI 10.1177/0022034509352151
   Hu WW, 2009, BIOMATERIALS, V30, P5785, DOI 10.1016/j.biomaterials.2009.06.041
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   Hunt DR, 2001, J PERIODONTOL, V72, P651, DOI 10.1902/jop.2001.72.5.651
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jha AK, 2009, BIOMATERIALS, V30, P6964, DOI 10.1016/j.biomaterials.2009.09.009
   JOHNSON EE, 1988, CLIN ORTHOP RELAT R, P249
   JOHNSON EE, 1988, CLIN ORTHOP RELAT R, P257
   JOHNSON EE, 1992, CLIN ORTHOP RELAT R, P229
   Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381
   Jongpaiboonkit L, 2008, BIOMATERIALS, V29, P3346, DOI 10.1016/j.biomaterials.2008.04.040
   Jongpaiboonkit L, 2009, TISSUE ENG PT A, V15, P343, DOI 10.1089/ten.tea.2008.0096
   Jongpoiboonkit L, 2009, ADV MATER, V21, P1960, DOI 10.1002/adma.200801808
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kempen DHR, 2010, TISSUE ENG PT A, V16, P3769, DOI 10.1089/ten.TEA.2010.0173
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kim J, 2009, TISSUE ENG PT A, V15, P2299, DOI 10.1089/ten.tea.2008.0326
   King WJ, 2011, POLYM CHEM-UK, V2, P476, DOI 10.1039/c0py00244e
   King WJ, 2011, CHEM COMMUN, V47, P526, DOI 10.1039/c0cc02716b
   King WJ, 2011, ACTA BIOMATER, V7, P975, DOI 10.1016/j.actbio.2010.10.026
   King WJ, 2010, MACROMOL BIOSCI, V10, P580, DOI 10.1002/mabi.200900382
   King WJ, 2010, J BIOMED MATER RES A, V93A, P1110, DOI 10.1002/jbm.a.32601
   King WJ, 2009, SOFT MATTER, V5, P2399, DOI 10.1039/b819060g
   Kinsella CR, 2011, PLAST RECONSTR SURG, V127, P1865, DOI 10.1097/PRS.0b013e31820cf2c9
   Kinstler O, 2002, ADV DRUG DELIVER REV, V54, P477, DOI 10.1016/S0169-409X(02)00023-6
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Klimo P, 2009, SPINE J, V9, P959, DOI 10.1016/j.spinee.2009.05.008
   Koepsel JT, 2009, LANGMUIR, V25, P12825, DOI 10.1021/la901938e
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Krebsbach PH, 2003, J GENE MED, V5, P11, DOI 10.1002/jgm.292
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Lan J, 2006, J PERIODONTOL, V77, P357, DOI 10.1902/jop.2006.050016
   Laub M, 2001, MATERIALWISS WERKST, V32, P926, DOI 10.1002/1521-4052(200112)32:12<926::AID-MAWE926>3.3.CO;2-T
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970
   Lee JS, 2010, J MATER CHEM, V20, P8894, DOI 10.1039/c0jm01389g
   Lee J, 2011, ACTA BIOMATER, V7, P244, DOI 10.1016/j.actbio.2010.08.017
   Lee KB, 2011, SPINE J, V11, P568, DOI 10.1016/j.spinee.2011.02.001
   Lee KY, 2000, NATURE, V408, P998
   Li CF, 1997, BIOCHEMISTRY-US, V36, P15404, DOI 10.1021/bi971817g
   Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011
   Liu HW, 2007, TISSUE ENG, V13, P1113, DOI 10.1089/ten.2006.0209
   Lorenz C, 2011, MACROMOL BIOSCI, V11, P234, DOI 10.1002/mabi.201000342
   Louis-Ugbo J, 2002, J ORTHOPAED RES, V20, P1050, DOI 10.1016/S0736-0266(02)00011-6
   Lu Y, 2009, ARTHROSCOPY, V25, P1427, DOI 10.1016/j.arthro.2009.06.008
   Luca L, 2010, INT J PHARMACEUT, V391, P48, DOI 10.1016/j.ijpharm.2010.02.015
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Martin GJ, 1999, J SPINAL DISORD, V12, P179, DOI 10.1097/00002517-199906000-00001
   Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   Mckay William F., 2008, P7, DOI 10.1007/978-3-7643-8552-1_2
   Medtronic Sofamor Danek, 2002, PREM APPR APPL INFUS
   Mitsak AG, 2011, TISSUE ENG PT A, V17, P1831, DOI [10.1089/ten.TEA.2010.0560, 10.1089/ten.tea.2010.0560]
   Mohammed JS, 2009, ADV MATER, V21, P2361, DOI 10.1002/adma.200803785
   Molina I, 2001, BIOMATERIALS, V22, P363, DOI 10.1016/S0142-9612(00)00192-7
   Morgan AW, 2010, MAT SCI ENG C-MATER, V30, P686, DOI 10.1016/j.msec.2010.02.025
   Murota K, 2007, CHEM LETT, V36, P1320, DOI 10.1246/cl.2007.1320
   Murphy WL, 2007, ANGEW CHEM INT EDIT, V46, P3066, DOI 10.1002/anie.200604808
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   Nakahara H, 2010, CELL TRANSPLANT, V19, P791, DOI 10.3727/096368910X508906
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   NEWMAN RJ, 1987, CLIN ORTHOP RELAT R, P253
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   Nussenbaum B, 2006, ADV DRUG DELIVER REV, V58, P577, DOI 10.1016/j.addr.2006.03.009
   Park MS, 2006, J BIOMED MATER RES B, V79B, P353, DOI 10.1002/jbm.b.30549
   Pasche S, 2005, J PHYS CHEM B, V109, P17545, DOI 10.1021/jp050431+
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Reves BT, 2009, J BIOMED MATER RES B, V90B, P1, DOI 10.1002/jbm.b.31390
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ripamonti U, 2009, J CRANIOFAC SURG, V20, P1544, DOI 10.1097/SCS.0b013e3181b09ca6
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Schrier J A, 2001, AAPS PharmSciTech, V2, pE17
   Schuckert KH, 2009, TISSUE ENG PT A, V15, P493, DOI 10.1089/ten.tea.2008.0033
   Seeherman H, 2006, J BONE JOINT SURG AM, V88A, P144, DOI 10.2106/JBJS.D.02453
   Seeherman H., 1998, T 44 ANN M ORTH RES
   Seeherman HJ, 2008, J BONE JOINT SURG AM, V90A, P2206, DOI [10.2106/JBJS.G.00742, 10.2106/0S.G.00742]
   Seeherman HJ, 2010, J BONE JOINT SURG AM, V92A, P411, DOI 10.2106/JBJS.H.01732
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096
   Shiozawa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010853
   Southwood LL, 2004, J ORTHOPAED RES, V22, P66, DOI 10.1016/S0736-0266(03)00129-3
   Springer ING, 2008, J CRANIO MAXILL SURG, V36, P210, DOI 10.1016/j.jcms.2007.09.001
   Steinmuller-Nethl D, 2006, BIOMATERIALS, V27, P4547, DOI 10.1016/j.biomaterials.2006.04.036
   Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095
   Suarez-Gonzalez D, 2010, J BIOMED MATER RES A, V95A, P222, DOI 10.1002/jbm.a.32833
   Sui ZJ, 2008, ADV FUNCT MATER, V18, P1824, DOI 10.1002/adfm.200701288
   Sui ZJ, 2007, ADV MATER, V19, P3377, DOI 10.1002/adma.200700092
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Taghavi CE, 2010, SPINE, V35, P2049, DOI 10.1097/BRS.0b013e3181cc0220
   Takahashi Y, 2007, TISSUE ENG, V13, P293, DOI 10.1089/ten.2006.0088
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   Tazaki J, 2009, BIO-MED MATER ENG, V19, P141, DOI 10.3233/BME-2009-0573
   Tolli H, 2011, INT ORTHOP, V35, P615, DOI 10.1007/s00264-010-1034-4
   Toth JM, 2009, SPINE, V34, P539, DOI 10.1097/BRS.0b013e3181952695
   Tsujigiwa H, 2006, J BIOMED MATER RES A, V77A, P507, DOI 10.1002/jbm.a.30661
   Tsujigiwa H, 2005, J BIOMED MATER RES A, V75A, P210, DOI 10.1002/jbm.a.30416
   Turhani D, 2007, J ORAL MAXIL SURG, V65, P485, DOI 10.1016/j.joms.2005.12.065
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vallejo LF, 2004, BIOTECHNOL BIOENG, V85, P601, DOI 10.1002/bit.10906
   Vihola H, 2005, BIOMATERIALS, V26, P3055, DOI 10.1016/j.biomaterials.2004.09.008
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Ward BB, 2010, ORAL DIS, V16, P709, DOI 10.1111/j.1601-0825.2010.01682.x
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Xu X, 2011, ACTA BIOMATER, V7, P3050, DOI 10.1016/j.actbio.2011.04.018
   Yamamoto M, 2005, KEY ENG MATER, V288-289, P253, DOI 10.4028/www.scientific.net/KEM.288-289.253
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yamamoto M, 1998, J BIOMAT SCI-POLYM E, V9, P439, DOI 10.1163/156856298X00550
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yeung DKW, 2004, J MAGN RESON IMAGING, V19, P222, DOI 10.1002/jmri.10453
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
   Zhang HN, 2010, TISSUE ENG PT A, V16, P3441, DOI [10.1089/ten.tea.2010.0132, 10.1089/ten.TEA.2010.0132]
   Zhang L, 2006, J CONTROL RELEASE, V114, P130, DOI 10.1016/j.jconrel.2006.06.005
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
   Zhou H, 2007, BIOCHEM BIOPH RES CO, V361, P91, DOI 10.1016/j.bbrc.2007.06.169
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 207
TC 74
Z9 75
U1 5
U2 84
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP
PY 2012
VL 64
IS 12
BP 1239
EP 1256
DI 10.1016/j.addr.2012.03.004
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 003QQ
UT WOS:000308626800015
PM 22433783
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mehta, M
   Schmidt-Bleek, K
   Duda, GN
   Mooney, DJ
AF Mehta, Manav
   Schmidt-Bleek, Katharina
   Duda, Georg N.
   Mooney, David J.
TI Biomaterial delivery of morphogens to mimic the natural healing cascade
   in bone
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Growth factor delivery; Bone regeneration; Biomaterials; Tissue
   engineering; Spatial regulation; Temporal regulation; Bio-inspired
ID GROWTH-FACTOR DELIVERY; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS;
   NONVIRAL GENE DELIVERY; SEQUENTIAL BMP-2/BMP-7 DELIVERY; CONTROLLED
   SCAFFOLD DEGRADATION; SYNTHETIC EXTRACELLULAR-MATRIX;
   CERVICAL-SPINAL-PROCEDURES; ACUTE-AIRWAY-OBSTRUCTION; HYPOXIA-INDUCIBLE
   FACTOR
AB Complications in treatment of large bone defects using bone grafting still remain. Our understanding of the endogenous bone regeneration cascade has inspired the exploration of a wide variety of growth factors (GFs) in an effort to mimic the natural signaling that controls bone healing. Biomaterial-based delivery of single exogenous GFs has shown therapeutic efficacy, and this likely relates to its ability to recruit and promote replication of cells involved in tissue development and the healing process. However, as the natural bone healing cascade involves the action of multiple factors, each acting in a specific spatiotemporal pattern, strategies aiming to mimic the critical aspects of this process will likely benefit from the usage of multiple therapeutic agents. This article reviews the current status of approaches to deliver single GFs, as well as ongoing efforts to develop sophisticated delivery platforms to deliver multiple lineage-directing morphogens (multiple GFs) during bone healing. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Core Fac, Cambridge, MA 02138 USA.
   [Mehta, Manav; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02139 USA.
   [Mehta, Manav; Schmidt-Bleek, Katharina; Duda, Georg N.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Schmidt-Bleek, Katharina; Duda, Georg N.] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.
RP Mooney, DJ (reprint author), Harvard Univ, Wyss Inst Biol Inspired Engn, Core Fac, 29 Oxford St, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
RI Duda, Georg/H-2085-2016
OI Duda, Georg/0000-0001-7605-3908
FU Einstein Foundation Berlin through the Charite - Universitatsmedizin
   Berlin, Berlin-Brandenburg School for Regenerative Therapies [GSC 203];
   Nachwuchsakademie Medizintechnik [DFG-ME 4083/1-1]; NIH [R37 DE013033]
FX The authors gratefully acknowledge the award of an Einstein Visiting
   Fellowship by the Einstein Foundation Berlin through the Charite -
   Universitatsmedizin Berlin, Berlin-Brandenburg School for Regenerative
   Therapies GSC 203 (DM), and financial support from the Nachwuchsakademie
   Medizintechnik (DFG-ME 4083/1-1), and NIH (R37 DE013033).
CR Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   AMENDE MT, 1995, REACT POLYM, V25, P127, DOI 10.1016/0923-1137(94)00040-C
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712
   Aslan H, 2006, TISSUE ENG, V12, P877, DOI 10.1089/ten.2006.12.877
   Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Bauer S, 2011, INTEGR BIOL-UK, V3, P927, DOI 10.1039/c0ib00155d
   Beck LS, 1998, J PHARM SCI, V87, P1379, DOI 10.1021/js9800883
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Bonadio J, 2000, ADV DRUG DELIVER REV, V44, P185, DOI 10.1016/S0169-409X(00)00094-6
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613
   Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018
   Buchowski JM, 2011, LARYNGOSCOPE, V121, P2501, DOI 10.1002/lary.21784
   Bundesamt S., 2003, BEVOLKERUNG DEUTSCHL
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Calori GM, 2008, INJURY, V39, P1391, DOI 10.1016/j.injury.2008.08.011
   Caplan AI, 2009, TISSUE ENG PART B-RE, V15, P195, DOI [10.1089/ten.teb.2008.0515, 10.1089/ten.TEB.2008.0515]
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Carter DR, 1998, CLIN ORTHOP RELAT R, pS41
   Ceylan H, 2012, SOFT MATTER, V8, P3929, DOI 10.1039/c2sm25127b
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com
   Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513
   Claes L, 2000, CHIRURG, V71, P989, DOI 10.1007/s001040051172
   Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5
   Claes L, 2009, J ORTHOP RES, V27, P22, DOI 10.1002/jor.20712
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   CRITCHLOW MA, 1995, BONE, V16, P521, DOI 10.1016/8756-3282(95)00085-R
   Cuevas P, 1997, SURG NEUROL, V47, P242, DOI 10.1016/S0090-3019(96)00438-7
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dupoirieux L, 2009, J CRANIO MAXILL SURG, V37, P30, DOI 10.1016/j.jcms.2008.08.004
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Endo M, 2006, TISSUE ENG, V12, P489, DOI 10.1089/ten.2006.12.489
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   Epari DR, 2010, P I MECH ENG H, V224, P1543, DOI 10.1243/09544119JEIM808
   Epari DR, 2007, J BONE JOINT SURG AM, V89A, P1575, DOI 10.2106/JBJS.F.00247
   Epari DR, 2006, BONE, V38, P864, DOI 10.1016/j.bone.2005.10.023
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd
   Epstein Nancy E, 2011, Surg Neurol Int, V2, P10, DOI 10.4103/2152-7806.76147
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Forslund C, 2002, J ORTHOPAED RES, V20, P1170, DOI 10.1016/S0736-0266(02)00078-5
   FROST HM, 1983, CLIN ORTHOP RELAT R, P286
   Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584
   Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893
   Goldstein SA, 2000, CLIN ORTHOP RELAT R, pS113
   Gong JS, 2008, CYTOTECHNOLOGY, V58, P141, DOI 10.1007/s10616-008-9179-3
   Griffin XL, 2009, INJURY, V40, P158, DOI 10.1016/j.injury.2008.06.025
   Groothuis A, 2010, BONE, V47, P438, DOI 10.1016/j.bone.2010.05.026
   Guldberg RE, 2003, IEEE ENG MED BIOL, V22, P77, DOI 10.1109/MEMB.2003.1256276
   Guldberg RE, 2009, J BONE MINER RES, V24, P1507, DOI [10.1359/JBMR.090801, 10.1359/jbmr.090801]
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Han DQ, 2008, MED HYPOTHESES, V71, P374, DOI 10.1016/j.mehy.2008.01.035
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Harry LE, 2009, PLAST RECONSTR SURG, V124, P1211, DOI 10.1097/PRS.0b013e3181b5a308
   Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490
   Hong L, 2000, TISSUE ENG, V6, P331, DOI 10.1089/107632700418056
   Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423
   Huang Z, 2010, CYTOKINE, V51, P305, DOI 10.1016/j.cyto.2010.06.002
   Hubbell J.A, 2003, NAT BIOTECHNOL, V21, P513
   Ishibe T, 2009, ORAL SURG ORAL MED O, V108, P867, DOI 10.1016/j.tripleo.2009.06.039
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   JOHNSON EE, 1988, CLIN ORTHOP RELAT R, P249
   Feito MJ, 2011, J MATER SCI-MATER M, V22, P405, DOI 10.1007/s10856-010-4193-3
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kandziora F, 2002, J NEUROSURG, V97, P40, DOI 10.3171/spi.2002.97.1.0040
   Kanjickal DG, 2004, CRIT REV THER DRUG, V21, P345
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49
   Kawai M, 2009, BIOCHEM BIOPH RES CO, V390, P1012, DOI 10.1016/j.bbrc.2009.10.099
   Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014
   Kempen DHR, 2010, TISSUE ENG PART B-RE, V16, P551, DOI 10.1089/ten.teb.2010.0176
   Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Keramaris NC, 2008, INJURY, V39, pS45, DOI 10.1016/S0020-1383(08)70015-9
   Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794
   Kim J, 2011, NANO LETT, V11, P694, DOI 10.1021/nl103812a
   Kimelman N, 2006, REGEN MED, V1, P549, DOI 10.2217/17460751.1.4.549
   Kimoto T, 1998, J DENT RES, V77, P1965, DOI 10.1177/00220345980770120301
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   Kofron MD, 2006, ADV DRUG DELIVER REV, V58, P555, DOI 10.1016/j.addr.2006.03.008
   Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   Kostenuik PJ, 2001, CURR PHARM DESIGN, V7, P613, DOI 10.2174/1381612013397807
   Kozloff KM, 2010, J BONE MINER RES, V25, P1748, DOI 10.1002/jbmr.66
   Kratzel C, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-135
   Kumar S, 2010, MOL THER, V18, P1026, DOI 10.1038/mt.2009.315
   Lane JM, 1999, CLIN ORTHOP RELAT R, pS107
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee KY, 2000, NATURE, V408, P998
   Lee YM, 2000, J PERIODONTOL, V71, P418, DOI 10.1902/jop.2000.71.3.418
   Li G, 2002, J ORTHOP RES, V20, P779, DOI 10.1016/S0736-0266(01)00166-8
   Li R, 2009, J ORTHOP RES, V27, P8, DOI 10.1002/jor.20658
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lienau J, 2010, TISSUE ENG PT A, V16, P191, DOI [10.1089/ten.tea.2009.0187, 10.1089/ten.TEA.2009.0187]
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Liu RJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-288
   Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434
   Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054
   Lu LC, 2001, J BONE JOINT SURG AM, V83A, pS82
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031
   Marsh D, 1998, CLIN ORTHOP RELAT R, pS22
   McKinney L, 1996, J CRANIOFAC SURG, V7, P36, DOI 10.1097/00001665-199601000-00010
   Mehta M, 2011, ARCH ORTHOP TRAUM SU, V131, P121, DOI 10.1007/s00402-010-1155-7
   Meinel L, 2003, BONE, V33, P660, DOI 10.1016/S8756-3282(03)00207-2
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.TEB.2011.0182, 10.1089/ten.teb.2011.0182]
   Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x
   Muscolo DL, 2006, ORTHOP CLIN N AM, V37, P65, DOI 10.1016/j.ocl.2005.08.003
   NASH TJ, 1994, BONE, V15, P203, DOI 10.1016/8756-3282(94)90709-9
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Okuda T, 2010, J CONTROL RELEASE, V143, P258, DOI 10.1016/j.jconrel.2009.12.029
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Paliwal Sumit, 2006, Expert Opin Drug Deliv, V3, P713, DOI 10.1517/17425247.3.6.713
   Parikh S N, 2002, J Postgrad Med, V48, P142
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Pelissier P, 2003, PLAST RECONSTR SURG, V111, P1932, DOI 10.1097/01.PRS.0000055044.14093.EA
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Perka C, 2005, CLIN ORTHOP RELAT R, P153
   Pernagallo S, 2011, METHODS MOL BIOL, V706, P171, DOI 10.1007/978-1-61737-970-3_14
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Peters A, 2009, TISSUE ENG PT A, V15, P2947, DOI [10.1089/ten.tea.2009.0058, 10.1089/ten.TEA.2009.0058]
   Peters A, 2010, HISTOL HISTOPATHOL, V25, P1149, DOI 10.14670/HH-25.1149
   Phillips JE, 2007, BIOMATERIALS, V28, P211, DOI 10.1016/j.biomaterials.2006.07.032
   Pillay V, 2005, DRUG DEV IND PHARM, V31, P191, DOI 10.1081/DDC-200047806
   Pneumaticos SG, 2010, J CELL MOL MED, V14, P2561, DOI 10.1111/j.1582-4934.2010.01062.x
   Pohl TLM, 2012, ACTA BIOMATER, V8, P772, DOI 10.1016/j.actbio.2011.10.019
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Radomsky ML, 1999, J ORTHOPAED RES, V17, P607, DOI 10.1002/jor.1100170422
   Raheja LF, 2011, CELL BIOL INT, V35, P981, DOI 10.1042/CBI20100733
   Raiche AT, 2004, BIOMATERIALS, V25, P677, DOI 10.1016/S0142-9612(03)00564-7
   Raschke M, 2002, BONE, V30, P144, DOI 10.1016/S8756-3282(01)00640-8
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   Ripamonti U, 1996, GROWTH FACTORS, V13, P273, DOI 10.3109/08977199609003228
   Ripamonti U, 1997, J BONE MINER RES, V12, P1584, DOI 10.1359/jbmr.1997.12.10.1584
   Rodriguez-Merchan EC, 2004, CLIN ORTHOP RELAT R, P4, DOI 10.1097/00003086-200402000-00003
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Santo VE, 2009, BIOMACROMOLECULES, V10, P1392, DOI 10.1021/bm8014973
   Santos JL, 2011, CURR GENE THER, V11, P46
   Sarkar MR, 2006, BIOMATERIALS, V27, P1817, DOI 10.1016/j.biomaterials.2005.10.039
   Schell H, 2008, J BIOMECH, V41, P3066, DOI 10.1016/j.jbiomech.2008.06.038
   Schmidmaier G, 2002, BONE, V30, P816, DOI 10.1016/S8756-3282(02)00740-8
   Schmidmaier G, 2004, J ORTHOPAED RES, V22, P514, DOI 10.1016/j.orthres.2003.09.009
   Schmidmaier G, 2003, ACTA ORTHOP SCAND, V74, P604, DOI 10.1080/00016470310018036
   Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7
   Schugar RC, 2008, GENE THER, V15, P126, DOI 10.1038/sj.gt.3303062
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Sheyn D, 2008, GENE THER, V15, P257, DOI 10.1038/sj.gt.3303070
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Si XH, 1998, INT J ORAL MAX SURG, V27, P310, DOI 10.1016/S0901-5027(05)80622-8
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Snoeks TJA, 2011, BONE, V48, P106, DOI 10.1016/j.bone.2010.07.027
   Stangenberg L, 2005, TISSUE ENG, V11, P855, DOI 10.1089/ten.2005.11.855
   Stefani C M, 2000, Implant Dent, V9, P126, DOI 10.1097/00008505-200009020-00004
   Steffen T, 2001, EUR SPINE J, V10, pS132, DOI 10.1007/s005860100325
   STEVENSON S, 1994, J BONE JOINT SURG AM, V76A, P1676, DOI 10.2106/00004623-199411000-00011
   Strayhorn CL, 1999, J PERIODONTOL, V70, P1345, DOI 10.1902/jop.1999.70.11.1345
   Street J, 2000, CLIN ORTHOP RELAT R, P224
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Strobel C, 2011, J CONTROL RELEASE, V156, P37, DOI 10.1016/j.jconrel.2011.07.006
   Stubbe BG, 2004, PHARM RES, V21, P1732, DOI 10.1023/B:PHAM.0000045223.45400.01
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Tanihara M., 2005, J BIOMED MATER RES A, V72A, P77
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   THALLER SR, 1993, ANN PLAS SURG, V31, P429, DOI 10.1097/00000637-199311000-00007
   Theos C, 2008, ARCH ORTHOP TRAUM SU, V128, P179, DOI 10.1007/s00402-007-0301-3
   Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185
   Toung JS, 1999, ARCH OTOLARYNGOL, V125, P451, DOI 10.1001/archotol.125.4.451
   Trepczik B, 2007, BONE, V40, P597, DOI 10.1016/j.bone.2006.10.011
   Tseng S.S., 2010, BONE, P92
   Tzafriri AR, 2005, CLIN CANCER RES, V11, P826
   Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   van de Wetering P, 2005, J CONTROL RELEASE, V102, P619, DOI 10.1016/j.jconrel.2004.10.029
   van Midwoud PM, 2011, JALA-J LAB AUTOM, V16, P468, DOI 10.1016/j.jala.2011.07.003
   Vonau RL, 2001, CLIN ORTHOP RELAT R, P243
   Wan C., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P323
   Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JC131581
   Webster A, 2010, ANAL METHODS-UK, V2, P1005, DOI 10.1039/c0ay00293c
   Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159
   Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917
   Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483
   WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263
   Wells DJ, 2004, GENE THER, V11, P1363, DOI 10.1038/sj.gt.3302337
   WILLENEGGER H, 1971, CHIRURG, V42, P241
   Willie B, 2009, J ORTHOP RES, V27, P687, DOI 10.1002/jor.20792
   Willie BM, 2010, SOFT MATTER, V6, P4976, DOI 10.1039/c0sm00262c
   Wilson CJ, 2009, MICROVASC RES, V78, P358, DOI 10.1016/j.mvr.2009.08.002
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Wulsten D, 2011, EUR CELLS MATER, V21, P177, DOI 10.22203/eCM.v021a14
   Yaremchuk KL, 2010, LARYNGOSCOPE, V120, P1954, DOI 10.1002/lary.21096
   Yilgor P, 2010, J BIOMED MATER RES A, V93A, P528, DOI 10.1002/jbm.a.32520
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Yonamine Y, 2010, ORAL SURG ORAL MED O, V109, P225, DOI 10.1016/j.tripleo.2009.09.010
   Yoneda A, 2000, NAT BIOTECHNOL, V18, P641, DOI 10.1038/76487
   Yoshimoto T, 2006, J PERIODONTAL RES, V41, P140, DOI 10.1111/j.1600-0765.2005.00847.x
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
   Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107
   Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005
   Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
NR 255
TC 107
Z9 107
U1 2
U2 77
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP
PY 2012
VL 64
IS 12
BP 1257
EP 1276
DI 10.1016/j.addr.2012.05.006
PG 20
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 003QQ
UT WOS:000308626800016
PM 22626978
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Vo, TN
   Kasper, FK
   Mikos, AG
AF Vo, Tiffany N.
   Kasper, F. Kurtis
   Mikos, Antonios G.
TI Strategies for controlled delivery of growth factors and cells for bone
   regeneration
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Bone tissue engineering; Controlled delivery; Growth factors; Cells;
   Scaffolds
ID MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE CEMENT; MARROW STROMAL CELLS;
   IN-VIVO EVALUATION; TISSUE-ENGINEERING APPLICATIONS; PLATELET-RICH
   PLASMA; INFLUENCES OSTEOBLAST DIFFERENTIATION; INJECTABLE HYDROGEL
   COMPOSITES; GENERATED EXTRACELLULAR-MATRIX; FLOW PERFUSION BIOREACTOR
AB The controlled delivery of growth factors and cells within biomaterial carriers can enhance and accelerate functional bone formation. The carrier system can be designed with pre-programmed release kinetics to deliver bioactive molecules in a localized, spatiotemporal manner most similar to the natural wound healing process. The carrier can also act as an extracellular matrix-mimicking substrate for promoting osteoprogenitor cellular infiltration and proliferation for integrative tissue repair. This review discusses the role of various regenerative factors involved in bone healing and their appropriate combinations with different delivery systems for augmenting bone regeneration. The general requirements of protein, cell and gene therapy are described, with elaboration on how the selection of materials, configurations and processing affects growth factor and cell delivery and regenerative efficacy in both in vitro and in vivo applications for bone tissue engineering. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Vo, Tiffany N.; Kasper, F. Kurtis; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   [Mikos, Antonios G.] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77251 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, POB 1892,MS 142, Houston, TX 77251 USA.
EM mikos@rice.edu
FU National Institutes of Health (NIH) [R01 DE17441, R01 AR57083, R01
   AR48756]; National Institutes of Health
FX This work was funded by the National Institutes of Health (NIH; R01
   DE17441, R01 AR57083 and R01 AR48756). T.N.V. is also supported by the
   T32 grant from the National Institutes of Health Baylor's Scientific
   Training Program for Dental Academic Researchers.
CR Almeida JD, 2007, INT J ORAL MAX SURG, V36, P435, DOI 10.1016/j.ijom.2006.12.006
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Arrighi I, 2009, BIOMATERIALS, V30, P1763, DOI 10.1016/j.biomaterials.2008.12.023
   Aslan H, 2006, TISSUE ENG, V12, P877, DOI 10.1089/ten.2006.12.877
   AUFDEMORTE TB, 1992, J BONE JOINT SURG AM, V74A, P1153, DOI 10.2106/00004623-199274080-00004
   Balasundaram G, 2011, J BIOMED MATER RES A, V98A, P192, DOI 10.1002/jbm.a.33105
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Barnes G.L., 1999, J BONE MINER RES, V14
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Belthur MV, 2008, CLIN ORTHOP RELAT R, V466, P2973, DOI 10.1007/s11999-008-0538-3
   Bencherif SA, 2009, J BIOMED MATER RES A, V90A, P142, DOI 10.1002/jbm.a.32069
   Bessa PC, 2010, J CONTROL RELEASE, V142, P312, DOI 10.1016/j.jconrel.2009.11.003
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Beutner R, 2009, BIOMATERIALS, V30, P2774, DOI 10.1016/j.biomaterials.2009.01.047
   Bi L, 2010, BIOMATERIALS, V31, P3201, DOI 10.1016/j.biomaterials.2010.01.038
   Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017
   Bodde EWH, 2008, J BIOMED MATER RES A, V87A, P780, DOI 10.1002/jbm.a.31830
   Bosch C, 1996, J CRANIOFAC SURG, V7, P300, DOI 10.1097/00001665-199607000-00011
   Bosetti M, 2007, BIOMOL ENG, V24, P613, DOI 10.1016/j.bioeng.2007.08.019
   Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Caplan AI, 2009, TISSUE ENG PART B-RE, V15, P195, DOI [10.1089/ten.teb.2008.0515, 10.1089/ten.TEB.2008.0515]
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   Chan BP, 2010, TISSUE ENG PART C-ME, V16, P225, DOI 10.1089/ten.tec.2008.0709
   Chan OCM, 2008, J CONTROL RELEASE, V129, P135, DOI 10.1016/j.jconrel.2008.04.011
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Chen FM, 2006, INT J PHARMACEUT, V307, P23, DOI 10.1016/j.ijpharm.2005.09.024
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Chen L, 2011, J NANOSCI NANOTECHNO, V11, P3107, DOI 10.1166/jnn.2011.3820
   Chen Y, 2003, GENE THER, V10, P1345, DOI 10.1038/sj.gt.3301999
   Cho E, 2009, J BIOMED MATER RES A, V90A, P1073, DOI 10.1002/jbm.a.32172
   Choi DH, 2010, J CONTROL RELEASE, V147, P193, DOI 10.1016/j.jconrel.2010.07.103
   Choi J, 2009, BIOMATERIALS, V30, P5201, DOI 10.1016/j.biomaterials.2009.06.003
   Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   Chun C, 2009, BIOMATERIALS, V30, P6295, DOI 10.1016/j.biomaterials.2009.08.011
   Chung EH, 2006, J BIOMED MATER RES A, V79A, P815, DOI 10.1002/jbm.a.30809
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   Conway JD, 2010, ORTHOP CLIN N AM, V41, P75, DOI 10.1016/j.ocl.2009.07.006
   D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061
   Dai CY, 2005, COLLOID SURFACE B, V42, P253, DOI 10.1016/j.colsurfb.2004.12.020
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   De la Riva B, 2009, EUR J PHARM BIOPHARM, V73, P50, DOI 10.1016/j.ejpb.2009.04.014
   de Mulder ELW, 2009, MATERIALS, V2, P1674, DOI 10.3390/ma2041674
   Deutsch ER, 2010, J MATER CHEM, V20, P8942, DOI 10.1039/c0jm01070g
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Edlund U, 2008, BIOMACROMOLECULES, V9, P901, DOI 10.1021/bm701267u
   Ehlert N, 2011, ACTA BIOMATER, V7, P1772, DOI 10.1016/j.actbio.2010.12.028
   Facca S, 2010, P NATL ACAD SCI USA, V107, P3406, DOI 10.1073/pnas.0908531107
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Fei ZQ, 2008, J MATER SCI-MATER M, V19, P1109, DOI 10.1007/s10856-007-3050-5
   Fischer J, 2011, J CRANIO MAXILL SURG, V39, P54, DOI 10.1016/j.jcms.2010.03.016
   Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Gafni Y, 2004, MOL THER, V9, P587, DOI 10.1016/j.ymthe.2003.12.009
   Gallego L, 2010, TISSUE ENG PT A, V16, P1179, DOI [10.1089/ten.tea.2009.0517, 10.1089/ten.TEA.2009.0517]
   Garbern JC, 2010, BIOMACROMOLECULES, V11, P1833, DOI 10.1021/bm100318z
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Gersbach CA, 2006, GENE THER, V13, P873
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Greenwald A.S., 2001, BONE GRAFT SUBSTITUT
   Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   Guo X, 2010, ACTA BIOMATER, V6, P2920, DOI 10.1016/j.actbio.2010.02.046
   Guo X, 2009, BIOMATERIALS, V30, P2741, DOI 10.1016/j.biomaterials.2009.01.048
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Haidar ZS, 2010, GROWTH FACTORS, V28, P44, DOI 10.3109/08977190903367788
   Harkness L, 2011, BONE, V48, P231, DOI 10.1016/j.bone.2010.09.023
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   He QF, 2011, ACTA BIOMATER, V7, P1084, DOI 10.1016/j.actbio.2010.10.022
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   Ho YC, 2009, INT J PHARMACEUT, V376, P69, DOI 10.1016/j.ijpharm.2009.04.048
   Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024
   Hokugo A, 2007, ORAL SURG ORAL MED O, V104, P44, DOI 10.1016/j.tripleo.2006.11.032
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Ichinohe N, 2008, TISSUE ENG PT A, V14, P1663, DOI 10.1089/ten.tea.2006.0350
   Ishibe T, 2009, ORAL SURG ORAL MED O, V108, P867, DOI 10.1016/j.tripleo.2009.06.039
   Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105
   Jager M, 2010, ORTHOP REV, V2, P79, DOI 10.4081/or.2010.e20
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Jang JH, 2011, MOL THER, V19, P1407, DOI 10.1038/mt.2011.111
   Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Jo YS, 2010, J BIOMED MATER RES A, V93A, P870, DOI 10.1002/jbm.a.32580
   Johnson MR, 2009, ACTA BIOMATER, V5, P23, DOI 10.1016/j.actbio.2008.09.001
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI [10.1016/j.biomaterials.2007.12.031, 10.1016/j.biomaterials.2007.12-031]
   Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059
   Kang SM, 2010, COLLOID SURFACE B, V75, P385, DOI 10.1016/j.colsurfb.2009.08.039
   Kang YQ, 2011, BIOMATERIALS, V32, P6119, DOI 10.1016/j.biomaterials.2011.05.015
   Kanzaki S, 2008, J CELL PHYSIOL, V216, P844, DOI 10.1002/jcp.21468
   Karner E, 2007, STEM CELLS DEV, V16, P39, DOI 10.1089/scd.2006.0010
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014
   Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019
   Kawai M, 2009, BIOCHEM BIOPH RES CO, V390, P1012, DOI 10.1016/j.bbrc.2009.10.099
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kempen DHR, 2010, TISSUE ENG PT A, V16, P3769, DOI 10.1089/ten.TEA.2010.0173
   Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kim DH, 2009, SPINE J, V9, P886, DOI 10.1016/j.spinee.2009.05.006
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim HK, 2009, TISSUE ENG PT A, V15, P923, DOI 10.1089/ten.tea.2007.0407
   Kim HS, 2010, J CONTROL RELEASE, V145, P264, DOI 10.1016/j.jconrel.2010.03.006
   Kim J, 2009, TISSUE ENG PART C-ME, V15, P583, DOI [10.1089/ten.tec.2008.0642, 10.1089/ten.TEC.2008.0642]
   Kim J, 2009, TISSUE ENG PT A, V15, P2299, DOI 10.1089/ten.tea.2008.0326
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kim J, 2010, J BIOMED MATER RES A, V95A, P673, DOI 10.1002/jbm.a.32884
   Kim K, 2007, J DRUG TARGET, V15, P241, DOI 10.1080/10611860701289818
   Kim MS, 2006, TISSUE ENG, V12, P2863, DOI 10.1089/ten.2006.12.2863
   Kim SJ, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-20
   Kimelman N, 2007, TISSUE ENG, V13, P1135, DOI 10.1089/ten.2007.0096
   Kimura Y, 2010, TISSUE ENG PT A, V16, P1263, DOI 10.1089/ten.TEA.2009.0322
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kleinheinz J, 2005, J ORAL MAXIL SURG, V63, P1310, DOI 10.1016/j.joms.2005.05.303
   Klouda L, 2011, ACTA BIOMATER, V7, P1460, DOI 10.1016/j.actbio.2010.12.027
   Koh JT, 2006, MOL THER, V14, P684, DOI 10.1016/j.ymthe.2006.05.021
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Kolk A, 2011, BIOMATERIALS, V32, P6850, DOI 10.1016/j.biomaterials.2011.05.071
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI 10.1089/ten.TEA.2010.0338
   Kretlow JD, 2010, TISSUE ENG PT A, V16, P3555, DOI 10.1089/ten.TEA.2010.0471
   Kroese-Deutman HC, 2005, BIOMATERIALS, V26, P1131, DOI 10.1016/j.biomaterials.2004.04.021
   Kumar S, 2010, MOL THER, V18, P1026, DOI 10.1038/mt.2009.315
   Laffargue P, 1999, BONE, V25, p55S, DOI 10.1016/S8756-3282(99)00134-9
   Lanao RPF, 2011, ACTA BIOMATER, V7, P3459, DOI 10.1016/j.actbio.2011.05.036
   Lang I, 2008, DIFFERENTIATION, V76, P1031, DOI 10.1111/j.1432-0436.2008.00302.x
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033
   Lee GS, 2011, ACTA BIOMATER, V7, P3178, DOI 10.1016/j.actbio.2011.04.008
   Lee JS, 2011, BIOMATERIALS, V32, P760, DOI 10.1016/j.biomaterials.2010.09.042
   Lee JY, 2006, J BIOMED MATER RES A, V76A, P530, DOI 10.1002/jbm.a.30434
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee K, 2009, J BIOMED MATER RES B, V89B, P252, DOI 10.1002/jbm.b.31199
   Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Leeuwenburgh SCG, 2010, BIOMACROMOLECULES, V11, P2653, DOI 10.1021/bm1006344
   Li F, 2010, J CELL BIOCHEM, V109, P643, DOI 10.1002/jcb.22440
   Li R, 2009, J ORTHOP RES, V27, P8, DOI 10.1002/jor.20658
   Liao JH, 2010, ACTA BIOMATER, V6, P2386, DOI 10.1016/j.actbio.2010.01.011
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Link DP, 2008, BIOMATERIALS, V29, P675, DOI 10.1016/j.biomaterials.2007.10.029
   Liu HN, 2010, J BIOMED MATER RES A, V93A, P1180, DOI 10.1002/jbm.a.32614
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Lochmann A, 2010, J CONTROL RELEASE, V147, P92, DOI 10.1016/j.jconrel.2010.06.021
   Lu HH, 2008, J BIOMED MATER RES A, V86A, P1128, DOI 10.1002/jbm.a.31740
   Luca L, 2010, J CONTROL RELEASE, V147, P38, DOI 10.1016/j.jconrel.2010.06.011
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malafaya PB, 2002, CURR OPIN SOLID ST M, V6, P297, DOI 10.1016/S1359-0286(02)00077-3
   Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355
   McKinney L, 1996, J CRANIOFAC SURG, V7, P36, DOI 10.1097/00001665-199601000-00010
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Mercado AE, 2010, MICROSC RES TECHNIQ, V73, P824, DOI 10.1002/jemt.20846
   Miyazaki M, 2008, SPINE, V33, P1410, DOI 10.1097/BRS.0b013e3181761003
   Miyazaki M, 2008, SPINE, V33, P863, DOI 10.1097/BRS.0b013e31816b45c3
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022
   Morin R, 2006, BIOMACROMOLECULES, V7, P131, DOI 10.1021/bm050461i
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Mountziaris P.M., 2011, TISSUE ENG PART B-RE, V00, P1
   Mountziaris PM, 2008, TISSUE ENG PT B-REV, V14, P179, DOI 10.1089/ten.teb.2008.0038
   Mourtas S, 2007, COLLOID SURFACE B, V55, P212, DOI 10.1016/j.colsurfb.2006.12.005
   Na K, 2007, BIOMATERIALS, V28, P2631, DOI 10.1016/j.biomaterials.2007.02.008
   Nandagiri VK, 2011, J MECH BEHAV BIOMED, V4, P1318, DOI 10.1016/j.jmbbm.2011.04.019
   Nauth A, 2011, INJURY, V42, P574, DOI 10.1016/j.injury.2011.03.034
   Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904
   Nikolidakis D, 2009, BIOMATERIALS, V30, P94, DOI 10.1016/j.biomaterials.2008.09.022
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   Park SH, 2011, J BIOMED MATER RES B, V97B, P235, DOI 10.1002/jbm.b.31805
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Patois E, 2009, J BIOMED MATER RES A, V91A, P324, DOI 10.1002/jbm.a.32211
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Pelled G, 2010, TISSUE ENG PART B-RE, V16, P13, DOI 10.1089/ten.teb.2009.0156
   Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708
   Peng HR, 2004, MOL THER, V9, P885, DOI 10.1016/j.ymthe.2004.02.023
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Pham QP, 2009, J BIOMED MATER RES A, V88A, P295, DOI 10.1002/jbm.a.31875
   Phillips Frank M, 2006, Spine J, V6, P500, DOI 10.1016/j.spinee.2006.01.014
   Phillips JE, 2007, BIOMATERIALS, V28, P211, DOI 10.1016/j.biomaterials.2006.07.032
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Ramoshebi Lentsha N, 2002, Expert Rev Mol Med, V4, P1
   Rauh J, 2011, TISSUE ENG PART B-RE, V17, P263, DOI [10.1089/ten.teb.2010.0612, 10.1089/ten.TEB.2010.0612]
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ripamonti U, 2006, BIOMATERIALS, V27, P807, DOI 10.1016/j.biomaterials.2005.09.021
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Rundle CH, 2008, J GENE MED, V10, P229, DOI 10.1002/jgm.1148
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Schliephake H, 2008, BIOMATERIALS, V29, P103, DOI 10.1016/j.biomaterials.2007.09.019
   Schliephake H, 2010, ORAL MAXILLOFAC SURG, V14, P17, DOI 10.1007/s10006-009-0185-1
   Schuessele A, 2009, J BIOMED MATER RES A, V90A, P959, DOI 10.1002/jbm.a.31745
   Schwartz CE, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-49
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036
   Sheller MR, 2004, J ORTHOPAED RES, V22, P1094, DOI 10.1016/j.orthres.2004.03.009
   Shen H, 2010, ACTA BIOMATER, V6, P455, DOI 10.1016/j.actbio.2009.07.016
   Sheyn D, 2008, GENE THER, V15, P257, DOI 10.1038/sj.gt.3303070
   Shi J, 2008, POLYM ADVAN TECHNOL, V19, P1467, DOI 10.1002/pat.1149
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Shimizu T, 2009, ARTERIOSCL THROM VAS, V29, P1104, DOI 10.1161/ATVBAHA.109.187856
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Srouji S, 2011, TISSUE ENG PT A, V17, P269, DOI [10.1089/ten.tea.2010.0250, 10.1089/ten.TEA.2010.0250]
   Stadlinger B, 2008, INT J ORAL MAX SURG, V37, P54, DOI 10.1016/j.ijom.2007.05.024
   Stevens B, 2008, J BIOMED MATER RES B, V85B, P573, DOI 10.1002/jbm.b.30962
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Strohbach CA, 2008, CALCIFIED TISSUE INT, V83, P202, DOI 10.1007/s002-13-008-9163-0
   Sun HC, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-41
   Sun HL, 2010, BIOMATERIALS, V31, P1133, DOI 10.1016/j.biomaterials.2009.10.030
   Tabata Y, 2006, J DRUG TARGET, V14, P483, DOI 10.1080/10611860600844879
   Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104
   Tao J, 2009, CELLS TISSUES ORGANS, V190, P185, DOI 10.1159/000218139
   Tarkka T, 2003, J GENE MED, V5, P560, DOI 10.1002/jgm.392
   Terella A, 2010, ARCH FACIAL PLAST S, V12, P166, DOI 10.1001/archfacial.2010.37
   Thibault RA, 2010, TISSUE ENG PT A, V16, P431, DOI [10.1089/ten.tea.2009.0583, 10.1089/ten.TEA.2009.0583]
   Tour G, 2011, TISSUE ENG PT A, V17, P127, DOI [10.1089/ten.tea.2010.0175, 10.1089/ten.TEA.2010.0175]
   Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006
   Tsurushima H, 2010, ACTA BIOMATER, V6, P2751, DOI 10.1016/j.actbio.2009.12.045
   Ueda H, 2002, BIOMATERIALS, V23, P1003, DOI 10.1016/S0142-9612(01)00211-3
   Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Wang HJ, 2010, BIOMATERIALS, V31, P8741, DOI 10.1016/j.biomaterials.2010.07.082
   Wang LM, 2009, J TISSUE ENG REGEN M, V3, P398, DOI 10.1002/term.176
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   WEISS RE, 1981, J CLIN INVEST, V68, P815, DOI 10.1172/JCI110319
   Wernike E, 2010, J BIOMED MATER RES A, V92A, P463, DOI 10.1002/jbm.a.32411
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   Wolf-Brandstetter C, 2006, J BIOMED MATER RES A, V79A, P882, DOI 10.1002/jbm.a.30826
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   Wozney JM, 2004, CURR OPIN BIOTECH, V15, P392, DOI 10.1016/j.copbio.2004.08.001
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   Wu CT, 2010, ACTA BIOMATER, V6, P820, DOI 10.1016/j.actbio.2009.09.025
   Xu HHK, 2008, DENT MATER, V24, P1212, DOI 10.1016/j.dental.2008.02.001
   Xue Y, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-34
   Yamamoto M, 2006, TISSUE ENG, V12, P1305, DOI 10.1089/ten.2006.12.1305
   Yang CM, 2009, J TISSUE ENG REGEN M, V3, P601, DOI 10.1002/term.201
   Yang H., 2011, TISSUE ENG, V17, P1
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Yang WD, 2005, TISSUE ENG, V11, P76, DOI 10.1089/ten.2005.11.76
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138
   Yilgor P, 2010, J BIOMED MATER RES A, V93A, P528, DOI 10.1002/jbm.a.32520
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
   Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
   Zhang Y, 2010, INT J PHARMACEUT, V386, P15, DOI 10.1016/j.ijpharm.2009.10.045
   Zhang YF, 2011, TISSUE ENG PART C-ME, V17, P789, DOI 10.1089/ten.tec.2010.0453
   Zhao JY, 2009, J BIOSCI BIOENG, V107, P318, DOI 10.1016/j.jbiosc.2008.10.007
   Zhao YN, 2010, J CONTROL RELEASE, V141, P30, DOI 10.1016/j.jconrel.2009.06.032
   Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043
   Ziegler J, 2008, J BIOMED MATER RES A, V86A, P89, DOI 10.1002/jbm.a.31625
   Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]
NR 289
TC 242
Z9 254
U1 28
U2 299
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP
PY 2012
VL 64
IS 12
BP 1292
EP 1309
DI 10.1016/j.addr.2012.01.016
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 003QQ
UT WOS:000308626800018
PM 22342771
OA Green Accepted
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Muszanska, AK
   Nejadnik, MR
   Chen, Y
   van den Heuvel, ER
   Busscher, HJ
   van der Mei, HC
   Norde, W
AF Muszanska, Agnieszka K.
   Nejadnik, M. Reza
   Chen, Yun
   van den Heuvel, Edwin R.
   Busscher, Henk J.
   van der Mei, Henny C.
   Norde, Willem
TI Bacterial Adhesion Forces with Substratum Surfaces and the
   Susceptibility of Biofilms to Antibiotics
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; RESISTANCE
AB Biofilms causing biomaterial-associated infection resist antibiotic treatment and usually necessitate the replacement of infected implants. Here we relate bacterial adhesion forces and the antibiotic susceptibility of biofilms on uncoated and polymer brush-coated silicone rubber. Nine strains of Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa adhered more weakly to brush-coated silicone rubber (-0.05 +/- 0.03 to -0.51 +/- 0.62 nN) than to uncoated silicone rubber (-1.05 +/- 0.46 to -5.1 +/- 1.3 nN). Biofilms of weakly adhering organisms on polymer brush coatings remained in a planktonic state, susceptible to gentamicin, unlike biofilms formed on uncoated silicone rubber.
C1 [Muszanska, Agnieszka K.; Nejadnik, M. Reza; Chen, Yun; Busscher, Henk J.; van der Mei, Henny C.; Norde, Willem] Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Muszanska, Agnieszka K.; Nejadnik, M. Reza; Chen, Yun; Busscher, Henk J.; van der Mei, Henny C.; Norde, Willem] Univ Groningen, Groningen, Netherlands.
   [van den Heuvel, Edwin R.] Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@umcg.nl
RI Van den Heuvel, Edwin/C-5166-2013; Chen, Yun/J-3051-2012
OI Van den Heuvel, Edwin/0000-0001-9157-7224; Chen, Yun/0000-0002-8917-7923
FU University Medical Center, Groningen, The Netherlands
FX This work was supported by the University Medical Center, Groningen, The
   Netherlands.
CR Andrews JM, 2009, J ANTIMICROB CHEMOTH, V64, P454, DOI 10.1093/jac/dkp244
   Bolshakova AV, 2001, ULTRAMICROSCOPY, V86, P121, DOI 10.1016/S0304-3991(00)00075-9
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DAVIES DG, 1995, APPL ENVIRON MICROB, V61, P860
   del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.2007.6100247
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Schachter B, 2003, NAT BIOTECHNOL, V21, P361, DOI 10.1038/nbt0403-361
   Verkkala K, 1998, EUR J CARDIO-THORAC, V14, P206, DOI 10.1016/S1010-7940(98)00150-X
   Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627
NR 15
TC 19
Z9 20
U1 2
U2 33
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2012
VL 56
IS 9
BP 4961
EP 4964
DI 10.1128/AAC.00431-12
PG 4
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 994CN
UT WOS:000307908600056
PM 22733073
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Baier, RE
   Kurusz, M
AF Baier, Robert E.
   Kurusz, Mark
TI Understanding Blood/Material Interactions: Contributions From the
   Columbia University Biomaterials Seminar
SO ASAIO JOURNAL
LA English
DT Article
AB Meetings of the Columbia University Biomaterial Seminars held in the 1970s and 80s are recounted from the personal perspectives of a participant and attendee. Important lessons regarding blood/foreign surface interactions that emanated from the seminars are reproduced along with a list of contemporary contributing members. These lessons continue to have broad relevance in furthering our understanding of the behavior of blood whenever it is used in artificial organ technology. ASAIO Journal 2012;58:450-454.
C1 [Kurusz, Mark] Univ Texas Med Branch, Dept Surg, Galveston, TX USA.
   [Baier, Robert E.] SUNY Buffalo, Ind Univ Ctr Biosurfaces, Buffalo, NY 14260 USA.
RP Kurusz, M (reprint author), Univ Texas Med Branch, Dept Surg, Galveston, TX USA.
EM mkurusz@utmb.edu
CR Leonard E. F., 1987, BLOOD CONTACT NATURA, V516
   Vroman L, 1977, BEHAV BLOOD ITS COMP, V283
NR 2
TC 1
Z9 1
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD SEP-OCT
PY 2012
VL 58
IS 5
BP 450
EP 454
DI 10.1097/MAT.0b013e3182631e3e
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 003KS
UT WOS:000308611000003
PM 22850408
OA Bronze
DA 2018-10-19
ER

PT J
AU Lai, JY
AF Lai, Jui-Yang
TI Biocompatibility of Genipin and Glutaraldehyde Cross-Linked Chitosan
   Materials in the Anterior Chamber of the Eye
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE biocompatibility; chemical cross-linking; chitosan; ocular anterior
   chamber
ID TISSUE ENGINEERING APPLICATIONS; HYALURONIC-ACID HYDROGELS; PIGMENT
   EPITHELIAL-CELLS; DELIVERY CARRIERS; GELATIN MEMBRANES; LINKING;
   TRANSPLANTATION; FUNCTIONALITY; BIOMATERIALS; DERIVATIVES
AB Chitosan is a naturally occurring cationic polysaccharide and has attracted much attention in the past decade as an important ophthalmic biomaterial. We recently demonstrated that the genipin (GP) cross-linked chitosan is compatible with human retinal pigment epithelial cells. The present work aims to further investigate the in vivo biocompatibility of GP-treated chitosan (GP-chi group) by adopting the anterior chamber of a rabbit eye model. The glutaraldehyde (GTA) cross-linked samples (GTA-chi group) were used for comparison. The 7-mm-diameter membrane implants made from either non-cross-linked chitosan or chemically modified materials with a cross-linking degree of around 80% were inserted in the ocular anterior chamber for 24 weeks and characterized by slit-lamp and specular microscopic examinations, intraocular pressure measurements, and corneal thickness measurements. The interleukin-6 expressions at mRNA level were also detected by quantitative real-time reverse transcription polymerase chain reaction. Results of clinical observations showed that the overall ocular scores in the GTA-chi groups were relatively high. In contrast, the rabbits bearing GP-chi implants in the anterior chamber of the eye exhibited no signs of ocular inflammation. As compared to the non-cross-linked counterparts, the GP-chi samples improved the preservation of corneal endothelial cell density and possessed better anti-inflammatory activities, indicating the benefit action of the GP cross-linker. In summary, the intracameral tissue response to the chemically modified chitosan materials strongly depends on the selection of cross-linking agents.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC100-2628-E-182-004-MY3]; Chang Gung Memorial Hospital [CMRPD190431]
FX This work was supported by grant NSC100-2628-E-182-004-MY3 from the
   National Science Council of Republic of China and grant CMRPD190431 from
   Chang Gung Memorial Hospital. The author is grateful to Ya-Ting Li and
   Tsu-Pin Wang (Institute of Biochemical and Biomedical Engineering, Chang
   Gung University) for technical assistance.
CR Avila MY, 2010, J CATARACT REFR SURG, V36, P659, DOI 10.1016/j.jcrs.2009.11.003
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009
   Grolik M, 2012, J MATER SCI-MATER M, V23, P1991, DOI 10.1007/s10856-012-4666-7
   Hu M, 2010, J AGR FOOD CHEM, V58, P1283, DOI 10.1021/jf903270y
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   Jeon WK, 2011, ARCH BIOCHEM BIOPHYS, V512, P119, DOI 10.1016/j.abb.2011.05.016
   Karnchanajindanun J, 2011, CARBOHYD POLYM, V85, P674, DOI 10.1016/j.carbpol.2011.03.035
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kitano A, 2006, OPHTHAL RES, V38, P355, DOI 10.1159/000096231
   Kitano A, 2006, J CATARACT REFR SURG, V32, P1727, DOI 10.1016/j.jcrs.2006.05.015
   Koo HJ, 2004, EUR J PHARMACOL, V495, P201, DOI 10.1016/j.ejphar.2004.05.031
   Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39
   Lu GY, 2007, EUR POLYM J, V43, P3807, DOI 10.1016/j.eurpolymj.2007.06.016
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004
   Mi FL, 2001, J BIOMAT SCI-POLYM E, V12, P835, DOI 10.1163/156856201753113051
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Nam KN, 2010, INT IMMUNOPHARMACOL, V10, P493, DOI 10.1016/j.intimp.2010.01.011
   Park BK, 2010, INT J MOL SCI, V11, P5153, DOI 10.3390/ijms11125152
   WILLIAMS D. F., 1987, P BIOCH, P49
   Yang TL, 2011, INT J MOL SCI, V12, P1936, DOI 10.3390/ijms12031936
NR 39
TC 42
Z9 42
U1 0
U2 43
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1661-6596
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2012
VL 13
IS 9
BP 10970
EP 10985
DI 10.3390/ijms130910970
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 012YN
UT WOS:000309272700018
PM 23109832
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Olmedilla, MPR
   Lebourg, M
   Ivirico, JLE
   Nebot, I
   Giralt, NG
   Ferrer, GG
   Soria, JM
   Ribelles, JLG
AF Perez Olmedilla, Marcos
   Lebourg, M.
   Escobar Ivirico, J. L.
   Nebot, I.
   Garcia Giralt, N.
   Gallego Ferrer, G.
   Soria, J. M.
   Gomez Ribelles, J. L.
TI In vitro 3D culture of human chondrocytes using modified
   epsilon-caprolactone scaffolds with varying hydrophilicity and porosity
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Scaffold; tissue engineering; biodegradable; poly(epsilon-caprolactone);
   chondrocyte; cartilage; proliferation
ID HUMAN ARTICULAR CHONDROCYTES; CARTILAGE REPAIR; METHACRYLATE COPOLYMERS;
   TISSUE; IMPLANTATION; PCL; REDIFFERENTIATION; ARCHITECTURE; BIOMATERIAL;
   FABRICATION
AB Two series of 3D scaffolds based on epsilon-caprolactone were synthesized. The pore size and architecture (spherical interconnected pores) was the same in all the scaffolds. In one of the series of scaffolds, made of pure epsilon-polycaprolactone, the volume fraction of pores varied between 60% and 85% with the main consequence of varying the interconnectivity between pores since the pore size was kept constant. The other scaffolds were prepared with copolymers made of a epsilon-caprolactone-based hydrophobous monomer and hydroxyethyl acrylate, as the hydrophilic component. Thus, the hydrophilicity and, presumably, the adhesion properties varied monotonously in the copolymer series while porosity was kept constant. A suspension of human chondrocytes in culture medium was injected in the 3D scaffolds and cultured in static conditions up to 28 days. SEM and immunofluorescence assays allowed characterizing cells and extracellular matrix inside the scaffolds after different culture times. To do that, cross sections of the scaffolds were observed by SEM and confocal microscopy. The quantity of cells inside the scaffolds decreases with a decrease of the volume fraction of pores, due to the lack of interconnectivity between the cavities. The scaffolds up to a 30% of hydrophilicity behave in a similar way than the hydrophobous; a further increase of the hydrophilicity rapidly decreases cell viability. In all the experiments production of collagen type I, type II, and aggrecan was found, and some cells were Ki-67 positive, showing that some cells are adhered to the pore walls and maintain their dedifferentiated phenotype even when cultured in three-dimensional conditions.
C1 [Soria, J. M.] Univ CEU Cardenal Herrera, Fac Ciencias Salud, Valencia 46113, Spain.
   [Perez Olmedilla, Marcos; Escobar Ivirico, J. L.; Gallego Ferrer, G.; Gomez Ribelles, J. L.] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia 46022, Spain.
   [Lebourg, M.; Gallego Ferrer, G.; Gomez Ribelles, J. L.] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valencia, Spain.
   [Gallego Ferrer, G.; Gomez Ribelles, J. L.] Prince Felipe Res Ctr, Regenerat Med Unit, Valencia 46013, Spain.
   [Garcia Giralt, N.] Autonomous Univ Barcelona, Hosp Mar, RETICEF, URFOA IMIM, E-08003 Barcelona, Spain.
   [Nebot, I.] Hosp Gen Univ Valencia, Valencia 46614, Spain.
RP Soria, JM (reprint author), Univ CEU Cardenal Herrera, Dept Fisiol Farmacol & Toxicol, Fac Ciencias Salud, Ave Seminario, Moncada 46313, Valencia, Spain.
EM jose.soria@uch.ceu.es
RI Escobar Ivirico, Jorge Luis/M-1947-2013; Escobar ivirico,
   Jorge/J-1203-2016; Escobar Ivirico, Jorge/G-9649-2012; Soria Lopez, Jose
   Miguel/M-5266-2017; Gomez Ribelles, Jose Luis/L-5629-2014;
   Gallego-Ferrer, Gloria/H-6690-2015; soria, jose/K-6722-2014
OI Escobar Ivirico, Jorge Luis/0000-0002-1077-2333; Escobar ivirico,
   Jorge/0000-0002-1077-2333; Soria Lopez, Jose Miguel/0000-0001-9144-5096;
   Gomez Ribelles, Jose Luis/0000-0001-9099-0885; Gallego-Ferrer,
   Gloria/0000-0002-2428-0903; soria, jose/0000-0001-9144-5096
FU Spanish Ministry of Science [MAT2007-66759-C03-01,
   MAT2007-66759-C03-02]; Programa de ayudas a la Investigacion cientifica
   Ramon Areces; Copernicus-Santander Universidad CEU- Cardenal Herrera
   [PRCEU-UCH/COP01/08]; Programa de ayudas a la Investigacion Universidad
   CEU-Cardenal Herrera [PRCEU-UCH16/09]; Instituto de Salud Carlos III;
   Conselleria de Sanidad de la Comunidad Valenciana; CIPF for the
   'Investigacion Basica y Traslacional en Medicina Regenerativa'
FX The support of the Spanish Ministry of Science through projects No.
   MAT2007-66759-C03-01 and MAT2007-66759-C03-02 (including the FEDER
   financial support) is acknowledged.; JMSL acknowledge funding through
   Programa de ayudas a la Investigacion cientifica Ramon Areces (2009) and
   funding through Copernicus-Santander (PRCEU-UCH/COP01/08) Universidad
   CEU- Cardenal Herrera and also Programa de ayudas a la Investigacion
   Universidad CEU-Cardenal Herrera (PRCEU-UCH16/09).; GGF and JLGR
   acknowledge funding in the framework of the collaboration agreement
   among the Instituto de Salud Carlos III, the Conselleria de Sanidad de
   la Comunidad Valenciana and the CIPF for the 'Investigacion Basica y
   Traslacional en Medicina Regenerativa'
CR Barlic A, 2008, J ORTHOP RES, V26, P847, DOI 10.1002/jor.20559
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   Bolgen N, 2009, J BIOMED MATER RES A, V91A, P60, DOI 10.1002/jbm.a.32193
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   Brodkin KR, 2004, BIOMATERIALS, V25, P5929, DOI 10.1016/j.biomaterials.2004.01.044
   Chua K H, 2005, Eur Cell Mater, V9, P58
   Martinez EC, 2007, J MATER SCI-MATER M, V18, P1627, DOI 10.1007/s10856-007-3038-1
   Martinez EC, 2008, TISSUE ENG PT A, V14, P1751, DOI 10.1089/ten.tea.2007.0270
   Ivirico JLE, 2007, J BIOMED MATER RES B, V83B, P266, DOI 10.1002/jbm.b.30792
   Freemont AJ, 2006, EUR J RADIOL, V57, P32, DOI 10.1016/j.ejrad.2005.08.008
   Gantenbein-Ritter B, 2008, TISSUE ENG PART C-ME, V14, P353, DOI 10.1089/ten.tec.2008.0313
   Garcia-Giralt N, 2008, J BIOMED MATER RES A, V85A, P1082, DOI 10.1002/jbm.a.31670
   Giannini S, 2008, AM J SPORT MED, V36, P873, DOI 10.1177/0363546507312644
   Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001
   Hutcheon GA, 1998, J MATER SCI-MATER M, V9, P815, DOI 10.1023/A:1008940027063
   Izquierdo R, 2008, J BIOMED MATER RES A, V85A, P25, DOI 10.1002/jbm.a.31396
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Kisiday JD, 2005, TISSUE ENG, V11, P141, DOI 10.1089/ten.2005.11.141
   Lebourg M, 2008, J MATER SCI-MATER M, V19, P2047, DOI 10.1007/s10856-007-3282-4
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Manfredini M, 2007, ACTA ORTHOP BELG, V73, P207
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Olmedilla MP, 2006, BIOMATERIALS, V27, P1003, DOI 10.1016/j.biomaterials.2005.07.030
   Rudert M, 2000, CELLS TISSUES ORGANS, V167, P95, DOI 10.1159/000016773
   Sarkar S, 2008, J BIOMAT SCI-POLYM E, V19, P1347, DOI 10.1163/156856208786052371
   Schagemann JC, 2010, J BIOMED MATER RES A, V93A, P454, DOI 10.1002/jbm.a.32521
   Schmal H, 2006, TISSUE ENG, V12, P741, DOI 10.1089/ten.2006.12.741
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wyre RM, 2000, BIOMATERIALS, V21, P335, DOI 10.1016/S0142-9612(99)00185-4
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
NR 35
TC 10
Z9 10
U1 2
U2 29
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD SEP
PY 2012
VL 27
IS 3
BP 299
EP 309
DI 10.1177/0885328211404263
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 993EP
UT WOS:000307838900006
PM 21586602
DA 2018-10-19
ER

PT J
AU Zhang, SC
   Liu, T
   Wang, YJ
AF Zhang, Shi-Chang
   Liu, Tao
   Wang, Ying-Jie
TI Porous and single-skinned polyethersulfone membranes support the growth
   of HepG2 cells: A potential biomaterial for bioartificial liver systems
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Polyethersulfone; PES; human hepatoblastoma cell line; membranes;
   liver-specific functions; bioartificial liver
ID BIOREACTOR; CULTURE; HEPATOCYTES; DIFFERENTIATION; MORPHOLOGY; MAINTAIN;
   SCAFFOLD; FAILURE; PLASMA; TRIAL
AB In this study, we evaluated a porous and single-layer skin polyethersulfone (PES) membrane as a material for use in hybrid bioartificial liver support systems. The PES membrane has been characterized as a single-layer skin structure, with a rough porous surface. Specifically, we studied the ability of the human hepatoblastoma cell lines (HepG2) to adhere, grow, and spread on the PES membrane. Furthermore, we examined albumin secretion, low-density lipoprotein uptake, and CYP450 activity of HepG2 cells that grew on the membrane. HepG2 cells readily adhered onto the outer surfaces of PES membranes. Over time, HepG2 cells proliferated actively, and confluent monolayer of cells covered the available surface area of the membrane, eventually forming cell clusters and three-dimensional aggregates. Furthermore, HepG2 cells grown on PES membranes maintained highly specific functions, including uptake capability, biosynthesis and biotransformation. These results indicate that PES membranes are potential substrates for the growth of human liver cells and may be useful in the construction of hollow fiber bioreactors. Porous and single-layer skin PES membranes and HepG2 cells may be potential biomaterials for the development of biohybrid liver devices.
C1 [Zhang, Shi-Chang; Liu, Tao; Wang, Ying-Jie] Third Mil Med Univ, Dept Infect Dis, Southwest Hosp, Chongqing 400038, Peoples R China.
RP Wang, YJ (reprint author), Third Mil Med Univ, Dept Infect Dis, Southwest Hosp, 30 Gaotanyan Rd, Chongqing 400038, Peoples R China.
EM yingjiewng@yahoo.com
RI May, Patrick/B-8615-2015
OI Liu, Tao/0000-0001-6187-3540
FU National Natural Science Foundation of China [30470458]
FX This study was supported by the National Natural Science Foundation of
   China (30470458). We are grateful to Xian-Guo Yu and Shu-Dong Sun, for
   their expert technical assistance in PES membrane preparation. We thank
   Suren Sooranna for editorial assistance.
CR Catapano G, 2001, BIOMATERIALS, V22, P659, DOI 10.1016/S0142-9612(00)00228-3
   Coward SM, 2009, ARTIF ORGANS, V33, P1117, DOI 10.1111/j.1525-1594.2009.00821.x
   De Bartolo L, 2005, BIOMATERIALS, V26, P4432, DOI 10.1016/j.biomaterials.2004.11.009
   De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o
   De Bartolo L, 2006, J NANOSCI NANOTECHNO, V6, P2344, DOI 10.1166/jnn.2006.514
   De Bartolo L, 2009, BIOMATERIALS, V30, P2531, DOI 10.1016/j.biomaterials.2009.01.011
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Demetriou AA, 2004, ANN SURG, V239, P660, DOI 10.1097/01.sla.0000124298.74199.e5
   Hoque ME, 2007, J BIOMAT SCI-POLYM E, V18, P45, DOI 10.1163/156856207779146088
   Kataoka K, 2005, BIOMATERIALS, V26, P2509, DOI 10.1016/j.biomaterials.2004.07.012
   Kinasiewicz A, 2008, ARTIF ORGANS, V32, P747, DOI 10.1111/j.1525-1594.2008.00600.x
   Krasteva N, 2002, BIOMATERIALS, V23, P2467, DOI 10.1016/S0142-9612(01)00381-7
   Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469
   Lu HF, 2005, TISSUE ENG, V11, P1667, DOI 10.1089/ten.2005.11.1667
   Mizumoto H, 2008, TISSUE ENG PART C-ME, V14, P167, DOI 10.1089/ten.tec.2007.0373
   Omasa T, 2005, BIOTECHNOL PROGR, V21, P161, DOI 10.1021/bp049757a
   Patzer JF, 2002, J AM COLL SURGEONS, V195, P299, DOI 10.1016/S1072-7515(02)01277-2
   Poyck PPC, 2007, INT J ARTIF ORGANS, V30, P183
   Schmelzer E, 2010, TISSUE ENG PT A, V16, P2007, DOI [10.1089/ten.tea.2009.0569, 10.1089/ten.TEA.2009.0569]
   Strain AJ, 2002, SCIENCE, V295, P1005, DOI 10.1126/science.1068660
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Van de Kerkhove MP, 2002, INT J ARTIF ORGANS, V25, P950
NR 23
TC 4
Z9 5
U1 2
U2 23
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD SEP
PY 2012
VL 27
IS 3
BP 359
EP 366
DI 10.1177/0885328211406299
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 993EP
UT WOS:000307838900011
PM 21750186
DA 2018-10-19
ER

PT J
AU Trombino, S
   Cassano, R
   Ferrarelli, T
   Isacchi, B
   Bilia, AR
   Picci, N
AF Trombino, Sonia
   Cassano, Roberta
   Ferrarelli, Teresa
   Isacchi, Benedetta
   Bilia, Anna Rita
   Picci, Nevio
TI Collagen alpha-tocopherulate for topical applications: Preparation,
   characterization, and antioxidant activity evaluation
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE solid phase synthesis; alpha-tocopherol protein conjugate; antioxidant
   activity
ID SCAFFOLDS
AB The aim of this work was to synthesize collagen alpha-tocopherulate for topical treatments. Collagen is a natural polymer largely applied to enhance wound repair, and alpha-tocopherol is a known antioxidant used for the treatment of various skin diseases. Linking the two through covalent bonds could improve alpha-tocopherol transport and metabolic stability, reduce the rate of degradation, and ensure a longer persistence than free antioxidant. The new biopolymer was prepared by a solid-phase synthesis employing a carboxypolystyrene resin. Its antioxidant activity in rat liver microsomal membranes was also evaluated. The obtained collagen-based biomaterial represents a new prodrug of alpha-tocopherol that could be used for various biomedical applications.
C1 [Trombino, Sonia; Cassano, Roberta; Ferrarelli, Teresa; Picci, Nevio] Univ Calabria, Dept Pharmaceut Sci, I-87036 Cosenza, Italy.
   [Isacchi, Benedetta; Bilia, Anna Rita] Univ Florence, Dept Pharmaceut Sci, I-50019 Florence, Italy.
RP Cassano, R (reprint author), Univ Calabria, Dept Pharmaceut Sci, I-87036 Cosenza, Italy.
EM roberta.cassano@unical.it
OI Bilia, Anna Rita/0000-0001-8772-1895; Picci, Nevio/0000-0003-1985-2724;
   Trombino, Sonia/0000-0001-9939-4457
FU Academic Funds; MIUR
FX This work was financially supported by Academic Funds and MIUR
   (Programma di Ricerca di Rilevante Interesse Nazionale 2008).
CR Albeiicio F., 2001, ORG PREP P INT, V33, P203
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cassano R., 2010, BIOMACROMOLECULES, V11, P1139
   Cassano R, 2009, CARBOHYD POLYM, V78, P639, DOI 10.1016/j.carbpol.2009.05.030
   Cassano R, 2009, EUR J PHARM BIOPHARM, V72, P232, DOI 10.1016/j.ejpb.2008.10.003
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Gruessner M., 2001, AM J SURG, V182, P502
   Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Pitarresi G, 2008, J BIOMED MATER RES A, V87A, P770, DOI 10.1002/jbm.a.31825
   Radhika M, 1997, J BIOMED MATER RES, V35, P497
   Sabatino G, 2002, LETT PEPT SCI, V9, P119, DOI 10.1007/BF02576873
   Sukla A., 1997, FREE RADICAL RES, V26, P93
   TATUM VL, 1990, LIPIDS, V25, P226, DOI 10.1007/BF02535752
   Thornton JF, 2005, PLAST RECONSTR SURG, V116, P677, DOI 10.1097/01.prs.0000175953.48172.88
   Timpl R, 1984, EXTRACELLULAR MATRIX, P159
   Trombino S, 2004, J AGR FOOD CHEM, V52, P2411, DOI 10.1021/jf0303924
   Vin F., 2002, WOUND CARE, V11, P335
   WHITE MJ, 1990, CLIN PLAST SURG, V17, P473
NR 21
TC 2
Z9 2
U1 0
U2 9
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD SEP
PY 2012
VL 20
IS 9
BP 939
EP 943
DI 10.1007/s13233-012-0129-8
PG 5
WC Polymer Science
SC Polymer Science
GA 002RB
UT WOS:000308549600007
DA 2018-10-19
ER

PT J
AU Wang, WC
   Wang, ZP
   Liu, Y
   Li, N
   Wang, W
   Gao, JP
AF Wang, Wenchao
   Wang, Zhipeng
   Liu, Yu
   Li, Nan
   Wang, Wei
   Gao, Jianping
TI Preparation of reduced graphene oxide/gelatin composite films with
   reinforced mechanical strength
SO MATERIALS RESEARCH BULLETIN
LA English
DT Article
DE Composites; Thin films; Mechanical properties
ID INTERCALATED GRAPHITE OXIDE; POLY(VINYL ALCOHOL); IN-VIVO; GELATIN;
   POLYMERIZATION; NANOCOMPOSITES; NANOPLATELETS; PARTICLES
AB Graphene oxide (GO) was reduced by chitosan/gelatin solution and added to gelatin (Gel) to fabricate reduced graphene oxide/gelatin (RGO/Gel) films by a solvent-casting method using genipin as crosslinking agent. The structure and properties of the films were characterized by scanning electron microscopy (SEM), X-ray powder diffraction (XRD), thermogravimetric analysis (TGA) and UV-vis spectroscopy. The addition of RGO increased the tensile strength of the RGO/Gel films in both dry and wet states, but decreased their elongation at break. The incorperation of RGO also decreased the swelling ability of the films in water. Cell cultures were carried out in order to test the cytotoxicity of the films. The cells grew and reproduced well on the RGO/Gel films, indicating that the addition of RGO has no negative effect on the compatibility of the gelatin. Therefore, the reduced graphene oxide/gelatin composite is a promising biomaterial with excellent mechanical properties and good cell compatibility. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Wang, Zhipeng; Wang, Wei; Gao, Jianping] Tianjin Univ, Sch Chem Engn, Tianjin 300072, Peoples R China.
   [Wang, Wenchao; Wang, Zhipeng; Liu, Yu; Li, Nan] Tianjin Univ, Sch Sci, Tianjin 300072, Peoples R China.
RP Gao, JP (reprint author), Tianjin Univ, Sch Chem Engn, Tianjin 300072, Peoples R China.
EM jianpingg@eyou.com
FU Tianjin Municipal Science and Technology Commission of P.R. China
   [09JCZDJC23300]; National Science Foundation of China [21074089]
FX This work was supported by Tianjin Municipal Science and Technology
   Commission of P.R. China (09JCZDJC23300) and National Science Foundation
   of China (No. 21074089).
CR Ai H, 2003, J CONTROL RELEASE, V86, P59, DOI 10.1016/S0168-3659(02)00322-X
   Bahadir O, 2003, EUR ARCH OTO-RHINO-L, V260, P19, DOI 10.1007/s00405-002-0494-6
   BAI H, 2011, CATALYSTS AFFECT GRO, V23, P1089, DOI DOI 10.1002/ADMA.201003753
   Becerril HA, 2008, ACS NANO, V2, P463, DOI 10.1021/nn700375n
   Bijan S., 2002, J SURG RES, V106, P99
   Cassagneau T, 1999, J PHYS CHEM B, V103, P1789, DOI 10.1021/jp984690t
   Cassagneau T, 1998, ADV MATER, V10, P877, DOI 10.1002/(SICI)1521-4095(199808)10:11<877::AID-ADMA877>3.0.CO;2-1
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chang WH, 2003, J BIOMAT SCI-POLYM E, V14, P481, DOI 10.1163/156856203766652084
   Chiellini E, 2001, BIOMACROMOLECULES, V2, P806, DOI 10.1021/bm015519h
   Chiellini E, 2001, POLYM DEGRAD STABIL, V73, P549, DOI 10.1016/S0141-3910(01)00132-X
   Dreyer DR, 2012, POLYM CHEM-UK, V3, P757, DOI 10.1039/c2py00545j
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Dreyer DR, 2011, MACROMOLECULES, V44, P7659, DOI 10.1021/ma201306x
   Dreyer DR, 2011, CHEM SCI, V2, P1233, DOI 10.1039/c1sc00035g
   Dreyer DR, 2010, ANGEW CHEM INT EDIT, V49, P9336, DOI 10.1002/anie.201003024
   Emo C., 2001, POLYM DEGRADATION ST, V73, P549
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Guo YQ, 2012, CARBON, V50, P2513, DOI 10.1016/j.carbon.2012.01.074
   Han DL, 2011, CARBOHYD POLYM, V83, P653, DOI 10.1016/j.carbpol.2010.08.038
   Higashika S, 1999, CARBON, V37, P354, DOI 10.1016/S0008-6223(99)90002-7
   Hirata M, 2004, CARBON, V42, P2929, DOI 10.1016/j.carbon.2004.07.003
   Huang YJ, 2010, CHEM MATER, V22, P4096, DOI 10.1021/cm100998e
   Kovtyukhova NI, 1999, CHEM MATER, V11, P771, DOI 10.1021/cm981085u
   Ku MS, 2010, INT J PHARMACEUT, V386, P30, DOI 10.1016/j.ijpharm.2009.10.050
   Kyotani T, 1997, CARBON, V35, P1185, DOI 10.1016/S0008-6223(97)84648-9
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lee SH, 2010, MACROMOL RAPID COMM, V31, P281, DOI 10.1002/marc.200900641
   Liang JJ, 2009, ADV FUNCT MATER, V19, P2297, DOI 10.1002/adfm.200801776
   Liu BS, 2004, J BIOMATER APPL, V19, P21, DOI 10.1177/0885328204042544
   Liu PG, 1999, CARBON, V37, P706, DOI 10.1016/S0008-6223(99)00037-8
   Liu PG, 1999, CARBON, V37, P2073, DOI 10.1016/S0008-6223(99)00219-5
   Liu S., 2010, AM OIL CHEM SOC, V87, P809
   Matsuda S, 2002, BIOMATERIALS, V23, P2901, DOI 10.1016/S0142-9612(01)00418-5
   Matsuo Y, 1998, CHEM MATER, V10, P2266, DOI 10.1021/cm980203a
   Matsuo Y, 1997, CARBON, V35, P113, DOI 10.1016/S0008-6223(96)00123-6
   Matsuo Y, 1999, CARBON, V37, P897, DOI 10.1016/S0008-6223(98)00226-7
   Morishige K, 2005, LANGMUIR, V21, P6277, DOI 10.1021/la050544k
   Park JS, 2011, ACS APPL MATER INTER, V3, P360, DOI 10.1021/am100977p
   Potts JR, 2011, POLYMER, V52, P5, DOI 10.1016/j.polymer.2010.11.042
   Puterman M, 2005, INT J PEDIATR OTORHI, V69, P57, DOI 10.1016/j.ijporl.2004.08.001
   Schonauer C, 2004, EUR SPINE J, V13, pS89, DOI 10.1007/s00586-004-0727-z
   Schreiner M, 2003, J FOOD ENG, V56, P237, DOI 10.1016/S0260-8774(02)00259-5
   SREEPRASAD TS, 2011, HAZARD MAT, V186, P921, DOI DOI 10.1016/J.JHAZMAT.2010.11.100
   Teresa J., 2011, ADSORPTION, V17, P5
   Wan CY, 2011, SOFT MATTER, V7, P6159, DOI 10.1039/c1sm05321c
   Wang XL, 2010, J MATER CHEM, V20, P9032, DOI 10.1039/c0jm01852j
   Wu JH, 2008, LANGMUIR, V24, P4800, DOI 10.1021/laa800095z
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Yang XJ, 2003, CHEM MATER, V15, P1228, DOI 10.1021/cm025697x
   Yang YF, 2009, LANGMUIR, V25, P11808, DOI 10.1021/la901441p
   Yin YJ, 1999, POLYM INT, V48, P429, DOI 10.1002/(SICI)1097-0126(199906)48:6<429::AID-PI160>3.3.CO;2-T
   Zhao X, 2010, MACROMOLECULES, V43, P9411, DOI 10.1021/ma101456y
NR 53
TC 21
Z9 21
U1 5
U2 126
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-5408
EI 1873-4227
J9 MATER RES BULL
JI Mater. Res. Bull.
PD SEP
PY 2012
VL 47
IS 9
BP 2245
EP 2251
DI 10.1016/j.materresbull.2012.05.060
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 010FZ
UT WOS:000309081400021
DA 2018-10-19
ER

PT J
AU Rahimi, S
   Mokhtari, H
   Shahi, S
   Kazemi, A
   Asgary, S
   Eghbal, MJ
   Mesgariabbasi, M
   Mohajeri, D
AF Rahimi, Saeed
   Mokhtari, Hadi
   Shahi, Shahriar
   Kazemi, Ali
   Asgary, Saeed
   Eghbal, Mohammad-Jafar
   Mesgariabbasi, Mehran
   Mohajeri, Daryoush
TI Osseous reaction to implantation of two endodontic cements: Mineral
   trioxide aggregate (MTA) and calcium enriched mixture (CEM)
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Endodontics; MTA; CEM; osseous reaction
ID END FILLING MATERIAL; MICROSCOPIC ANALYSIS; INFLAMMATORY CELLS;
   PERMANENT MOLARS; TISSUE-REACTIONS; SEALING ABILITY; BIOCOMPATIBILITY;
   PULPOTOMY; PHOSPHATE; DOGS
AB Aim: The aim of the present in vivo study was to determine bone tissue reaction to calcium enriched mixture (CEM) and mineral trioxide aggregate (MTA) using a rat femur model.
   Study Design: Sixty-three rats were selected and randomly divided into three groups of 21 each [experimental groups (n=15), control (n=6)]. Implantation cavities were prepared in each femoral bone and randomly filled with the biomaterials only in the experimental groups. The animals in three groups were sacrificed 1, 4, and 8 weeks postoperatively. Histologic evaluations comprising inflammation severity and new bone formation were blindly made on H&E-stained decalcified 6-mu m sections.
   Results: At 1, 4, and 8 weeks after implantation number of inflammatory cells had decreased in the CEM, MTA and control groups, respectively, with no statistically significant differences. Conversely, new bone formation had increased in all the experimental and control groups, without statistically significant differences.
   Conclusion: The results suggest that biocompatibility of MTA, as gold standard, and CEM cement as a new endodontic biomaterial are comparable.
C1 [Rahimi, Saeed; Mokhtari, Hadi; Shahi, Shahriar] Tabriz Univ Med Sci, Fac Dent, Dent & Periodontal Res Ctr, Dept Endodont, Tabriz 5166614713, Iran.
   [Kazemi, Ali] Shahed Univ Med Sci, Fac Dent, Dept Endodont, Tehran, Iran.
   [Asgary, Saeed; Eghbal, Mohammad-Jafar] Shahid Beheshti Univ MC, Dent Res Ctr, Iranian Ctr Endodont Res, Tehran, Iran.
   [Mesgariabbasi, Mehran] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.
   [Mohajeri, Daryoush] Islamic Azad Univ, Tabriz Branch, Dept Pathobiol, Tabriz, Iran.
RP Mokhtari, H (reprint author), Tabriz Univ Med Sci, Fac Dent, Dent & Periodontal Res Ctr, Dept Endodont, Golgasht St, Tabriz 5166614713, Iran.
EM mokhtari.z.h@gmail.com
RI Mesgari Abbasi, Mehran/D-3557-2017
OI Mesgari Abbasi, Mehran/0000-0003-0276-930X; Rahimi Darehchi,
   Saeed/0000-0003-0740-7906; shahi, shahriar/0000-0003-0249-0982
CR Asgary S, 2008, J BIOMED MATER RES A, V87A, P706, DOI 10.1002/jbm.a.31678
   Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   Asgary S, 2011, J ENDODONT, V37, P411, DOI 10.1016/j.joen.2010.11.015
   Asgary S, 2010, J ENDODONT, V36, P837, DOI 10.1016/j.joen.2010.03.005
   Asgary S, 2009, AUST ENDOD J, V35, P147, DOI 10.1111/j.1747-4477.2008.00137.x
   Asgary Saeed, 2008, J Oral Sci, V50, P469
   Asgary S, 2009, J ENDODONT, V35, P243, DOI 10.1016/j.joen.2008.10.026
   Cintra LTA, 2006, J ENDODONT, V32, P556, DOI 10.1016/j.joen.2005.07.007
   Danesh F, 2010, J ENDODONT, V36, P1036, DOI 10.1016/j.joen.2010.02.014
   DEGROOD ME, 1995, J ENDODONT, V21, P65, DOI 10.1016/S0099-2399(06)81097-6
   Eghbal MJ, 2009, AUST ENDOD J, V35, P4, DOI 10.1111/j.1747-4477.2009.00166.x
   Estrela C, 2000, Braz Dent J, V11, P3
   Funteas UR, 2003, AUST ENDOD J, V29, P43
   Koh ET, 1997, J BIOMED MATER RES, V37, P432, DOI 10.1002/(SICI)1097-4636(19971205)37:3<432::AID-JBM14>3.0.CO;2-D
   Lotfi M, 2009, J ENDODONT, V35, P703, DOI 10.1016/j.joen.2009.01.013
   Moretton TR, 2000, J BIOMED MATER RES, V52, P528, DOI 10.1002/1097-4636(20001205)52:3<528::AID-JBM11>3.0.CO;2-9
   Murray Peter E, 2007, Med Oral Patol Oral Cir Bucal, V12, pE258
   Noetzel J, 2006, CLIN ORAL INVEST, V10, P77, DOI 10.1007/s00784-005-0032-1
   Nosrat A, 2011, J ENDODONT, V37, P562, DOI 10.1016/j.joen.2011.01.011
   Panzarini SR, 2007, DENT TRAUMATOL, V23, P265, DOI 10.1111/j.1600-9657.2006.00456.x
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Rahimi Saeed, 2008, J Oral Sci, V50, P273
   Samiee M, 2010, CLIN ORAL INVEST, V14, P653, DOI 10.1007/s00784-009-0351-8
   Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41
   Shahi S, 2006, J ENDODONT, V32, P776, DOI 10.1016/j.joen.2006.01.014
   Shahi S, 2010, J ENDODONT, V36, P899, DOI 10.1016/j.joen.2010.01.001
   Tabarsi B, 2010, INT ENDOD J, V43, P565, DOI 10.1111/j.1365-2591.2010.01711.x
   TORABINEJAD M, 1993, J ENDODONT, V19, P591, DOI 10.1016/S0099-2399(06)80271-2
   Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010
   Sanchez AFY, 2008, MED ORAL PATOL ORAL, V13, pE180
NR 30
TC 14
Z9 16
U1 0
U2 9
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-6946
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD SEP
PY 2012
VL 17
IS 5
BP E907
EP E911
AR 18136
DI 10.4317/medoral.18136
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 008UH
UT WOS:000308981600029
PM 22549692
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Santos, HA
   Hirvonen, J
AF Santos, Helder A.
   Hirvonen, Jouni
TI Nanostructured porous silicon materials: potential candidates for
   improving drug delivery
SO NANOMEDICINE
LA English
DT Editorial Material
DE bioavailability; biocompatibility; biodistribution; biomaterial; drug
   release; micro- and nano-particle; nanocarrier; permeability; porous
   silicon; solubility
ID MESOPOROUS SILICON; MICROPARTICLES; NANOPARTICLES; BIODISTRIBUTION;
   PARTICLES; RELEASE; SYSTEMS
C1 [Santos, Helder A.; Hirvonen, Jouni] Univ Helsinki, Div Pharmaceut Technol, FI-00014 Helsinki, Finland.
RP Hirvonen, J (reprint author), Univ Helsinki, Div Pharmaceut Technol, FI-00014 Helsinki, Finland.
EM Jouni.hirvonen@helsinki.fi
RI Santos, Helder/B-5253-2009
OI Santos, Helder/0000-0001-7850-6309
CR Bimbo LM, 2012, NANOSCALE, V4, P3184, DOI 10.1039/c2nr30397c
   Bimbo LM, 2011, BIOMATERIALS, V32, P9089, DOI 10.1016/j.biomaterials.2011.08.011
   Bimbo LM, 2011, BIOMATERIALS, V32, P2625, DOI 10.1016/j.biomaterials.2010.12.011
   Bimbo LM, 2010, ACS NANO, V4, P3023, DOI 10.1021/nn901657w
   Cheng L, 2008, BRIT J OPHTHALMOL, V92, P705, DOI 10.1136/bjo.2007.133587
   Goh ASW, 2007, INT J RADIAT ONCOL, V67, P786, DOI 10.1016/j.ijrobp.2006.09.011
   Hoffman AS, 2008, J CONTROL RELEASE, V132, P153, DOI 10.1016/j.jconrel.2008.08.012
   Kaukonen AM, 2007, EUR J PHARM BIOPHARM, V66, P348, DOI 10.1016/j.ejpb.2006.11.021
   Kilpelainen M, 2009, J CONTROL RELEASE, V137, P166, DOI 10.1016/j.jconrel.2009.03.017
   Kilpelainen M, 2011, EUR J PHARM BIOPHARM, V77, P20, DOI 10.1016/j.ejpb.2010.10.004
   Kinnari P, 2011, INT J PHARMACEUT, V414, P148, DOI 10.1016/j.ijpharm.2011.05.021
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Salonen J, 2005, J CONTROL RELEASE, V108, P362, DOI 10.1016/j.jconrel.2005.08.017
   Salonen J, 2008, J PHARM SCI-US, V97, P632, DOI 10.1002/jps.20999
   Santos Helder A, 2011, Curr Drug Discov Technol, V8, P228
   Sarparanta M, 2012, MOL PHARMACEUT, V9, P654, DOI 10.1021/mp200611d
   Sarparanta MP, 2012, BIOMATERIALS, V33, P3353, DOI 10.1016/j.biomaterials.2012.01.029
   Tahvanainen M, 2012, INT J PHARMACEUT, V422, P125, DOI 10.1016/j.ijpharm.2011.10.040
   Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34
   Wang F, 2010, MOL PHARMACEUT, V7, P227, DOI 10.1021/mp900221e
   Wu J, 2009, ADV FUNCT MATER, V19, P733, DOI 10.1002/adfm.200800921
NR 21
TC 27
Z9 27
U1 1
U2 23
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD SEP
PY 2012
VL 7
IS 9
BP 1281
EP 1284
DI 10.2217/NNM.12.106
PG 4
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 009NI
UT WOS:000309032100002
PM 22994953
DA 2018-10-19
ER

PT J
AU Lapiodot, S
   Meirovitch, S
   Sharon, S
   Heyman, A
   Kaplan, DL
   Shoseyov, O
AF Lapiodot, Shahul
   Meirovitch, Sigal
   Sharon, Sigal
   Heyman, Arnon
   Kaplan, David L.
   Shoseyov, Oded
TI Clues for biomimetics from natural composite materials
SO NANOMEDICINE
LA English
DT Review
DE bio-inspired; cellulose; collagen; resilin; silk; SP1
ID SPIDER SILK; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; PROTEIN
   SCAFFOLD; TRANSGENIC PLANTS; STABLE PROTEIN; SHAPE MODULES; SQUID BEAKS;
   NANOCOMPOSITES; BIOMATERIALS
AB Bio-inspired material systems are derived from different living organisms such as plants, arthropods, mammals and marine organisms. These biomaterial systems from nature are always present in the form of composites, with molecular-scale interactions optimized to direct functional features. With interest in replacing synthetic materials with natural materials due to biocompatibility, sustainability and green chemistry issues, it is important to understand the molecular structure and chemistry of the raw component materials to also learn from their natural engineering, interfaces and interactions leading to durable and highly functional material architectures. This review will focus on applications of biomaterials in single material forms, as well as biomimetic composites inspired by natural organizational features. Examples of different natural composite systems will be described, followed by implementation of the principles underlying their composite organization into artificial bio-inspired systems for materials with new functional features for future medicine.
C1 [Lapiodot, Shahul; Meirovitch, Sigal; Sharon, Sigal; Heyman, Arnon; Shoseyov, Oded] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environ, IL-91905 Jerusalem, Israel.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Shoseyov, O (reprint author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environ, IL-91905 Jerusalem, Israel.
EM shoseyov@agri.huji.ac.il
FU NIH grant [EB002520]
FX Parts of the work discussed in this paper were funded by NIH grant No.
   EB002520. The authors have no other relevant affiliations or financial
   involvement with any organization or entity with a financial interest in
   or financial conflict with the subject matter or materials discussed in
   the manuscript apart from those disclosed.
CR Ardell DH, 2001, INSECT BIOCHEM MOLEC, V31, P965, DOI 10.1016/S0965-1748(01)00044-3
   Azami M, 2012, J BIOMED MATER RES A, V100A, P1347, DOI 10.1002/jbm.a.34074
   Bagnaninchi PO, 2007, J SPORTS MED, V41, pe10
   Berglund LA, 2010, MRS BULL, V35, P201, DOI 10.1557/mrs2010.652
   Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378
   Broomell CC, 2008, BIOMACROMOLECULES, V9, P1669, DOI 10.1021/bm800200a
   Brubaker CE, 2010, BIOMATERIALS, V31, P420, DOI 10.1016/j.biomaterials.2009.09.062
   Burrows M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-41
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Capadona J, 2010, SCIENCE, V319, P1370
   Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277
   Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w
   Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P17, DOI 10.1007/s00114-007-0288-1
   Dgany O, 2004, J BIOL CHEM, V279, P51516, DOI 10.1074/jbc.M409952200
   Durkin CA, 2009, EUKARYOT CELL, V8, P1038, DOI 10.1128/EC.00079-09
   Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   FAVIER V, 1995, POLYM ADVAN TECHNOL, V6, P351, DOI 10.1002/pat.1995.220060514
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Gautier C, 2008, COLLOID SURFACE B, V65, P140, DOI 10.1016/j.colsurfb.2008.03.005
   Heyman A, 2007, J BIOTECHNOL, V131, P433, DOI 10.1016/j.jbiotec.2007.07.940
   Heyman A, 2009, ANGEW CHEM INT EDIT, V48, P9290, DOI 10.1002/anie.200903075
   Heyman A, 2009, LANGMUIR, V25, P5226, DOI 10.1021/la804132z
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Hubbe M. A., 2008, BioResources, V3, P929
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   KOVOOR J, 1982, TISSUE CELL, V14, P519, DOI 10.1016/0040-8166(82)90044-1
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Levy I, 2002, CELLULOSE, V9, P91, DOI 10.1023/A:1015848701029
   Levy I, 2004, CURR PROTEIN PEPT SC, V5, P33, DOI 10.2174/1389203043486919
   Levy I, 2004, BIOMATERIALS, V25, P1841, DOI 10.1016/j.biomaterials.2003.08.041
   Lewandowski AT, 2008, BIOTECHNOL BIOENG, V99, P499, DOI 10.1002/bit.21580
   Li J, 2012, J BIOMAT SCI-POLYM E, DOI [10.1163/156856212X627351, DOI 10.1163/156856212X627351]
   Medalsy I, 2008, NANO LETT, V8, P473, DOI 10.1021/nl072455t
   Medalsy I, 2010, NAT NANOTECHNOL, V5, P451, DOI [10.1038/nnano.2010.62, 10.1038/NNANO.2010.62]
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117
   Miserez A, 2007, ACTA BIOMATER, V3, P139, DOI 10.1016/j.actbio.2006.09.004
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Naik RR, 2002, J NANOSCI NANOTECHNO, V2, P95, DOI 10.1166/jnn.2002.074
   Noishiki Y, 2002, J APPL POLYM SCI, V86, P3425, DOI 10.1002/app.11370
   Panseri S, 2012, J BIOMED MATER RES, V00A, P1
   Qin G, 2009, BIOMACROMOLECULES, V10, P887
   Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010
   RANBY BG, 1949, ACTA CHEM SCAND, V3, P649, DOI 10.3891/acta.chem.scand.03-0649
   Rengasamy RS, 2005, AUTEX RES J, V5, P30
   Rodrigues M.T, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1459, DOI 10.1002/TERM.1459]
   Rodrigues MT, 2012, J TISSUE ENG REGEN M, V6, pe24, DOI 10.1002/term.499
   Rusli R, 2010, BIOMACROMOLECULES, V11, P762, DOI 10.1021/bm1001203
   SAKURADA I, 1962, J POLYM SCI, V57, P651, DOI 10.1002/pol.1962.1205716551
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m
   Schacht K, 2011, BIOMACROMOLECULES, V12, P2488, DOI 10.1021/bm200154k
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179
   Scott JE, 1998, J ANAT, V192, P391, DOI 10.1046/j.1469-7580.1998.19230391.x
   SCOTT JE, 1992, FASEB J, V6, P2639
   Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t
   Seker UOS, 2008, BIOMACROMOLECULES, V10, P250
   Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05
   Siqueira G, 2010, POLYMERS-BASEL, V2, P728, DOI 10.3390/polym2040728
   Stein H, 2009, BIOMACROMOLECULES, V10, P2640, DOI 10.1021/bm900571b
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793
   Tang LM, 2010, ACS APPL MATER INTER, V2, P1073, DOI 10.1021/am900830h
   Teeri TT, 2007, TRENDS BIOTECHNOL, V25, P299, DOI 10.1016/j.tibtech.2007.05.002
   Velema J, 2006, ADV BIOCHEM ENG BIOT, V102, P187, DOI 10.1007/10_013
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Wang WX, 2006, BIOTECHNOL BIOENG, V95, P161, DOI 10.1002/bit.21010
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
   Yang JJ, 2005, TRANSGENIC RES, V14, P313, DOI 10.1007/s11248-005-0272-5
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
   Zakhem E, 2012, BIOMATERIALS, V33, P4810, DOI 10.1016/j.biomaterials.2012.03.051
NR 79
TC 17
Z9 17
U1 5
U2 115
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD SEP
PY 2012
VL 7
IS 9
BP 1409
EP 1423
DI 10.2217/NNM.12.107
PG 15
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 009NI
UT WOS:000309032100020
PM 22994958
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Chen, SF
   Lu, WF
   Wen, ZY
   Li, Q
   Chen, JH
AF Chen, Shui-Fang
   Lu, Wen-Fen
   Wen, Zhi-Yong
   Li, Qiang
   Chen, Jian-Hai
TI Preparation, characterization and anticancer activity of
   norcantharidin-loaded poly(ethylene glycol)-poly(caprolactone)
   amphiphilic block copolymer micelles
SO PHARMAZIE
LA English
DT Article
ID CONTROLLED DELIVERY; PLGA NANOPARTICLES; POLYMERIC MICELLE;
   DRUG-DELIVERY; PACLITAXEL; RELEASE; CELLS; FORMULATION; SYSTEM;
   SOLUBILIZATION
AB In this study, a novel amphiphilic block copolymer biomaterial - poly (ethylene glycol)-poly (caprolactone) (PEG-PCL), was used to entrap norcantharidin (NCTD), taking advantage of self-assembly theory. Dialysis and volatilization dialysis were used to prepare copolymer micelles. Drug-loaded micelles were compared with blank micelles in terms of their particle diameter, morphology and IR spectral characteristics. The results revealed that there was no significant difference in respect of morphology and IR spectrum, but particle size differed. Drug-loaded micelles had a smaller particle size than blank micelles. Three important factors influencing particle size, the drug loading content (LC) and the drug entrapment efficiency (EE) of the NCTD-loaded micelles, were studied. The results indicated that the method of preparation and the type of organic solvent had a significant influence on the size of the micelles. LC and EE were greatly affected by the ratio of NCTD to copolymer. In vitro release of NCTD from the conjugate micelles showed that its release rate depended on the pH of the phosphate buffer solution (PBS). The amount released was higher at lower pH than under neutral conditions. In vitro antitumor activity of the NCTD conjugate against human hepatoma (HepG2) cell line and human lung cancer (A549) cell line was evaluated by the MTT method. Micelles loaded with NCTD demonstrated greater and more satisfactory cell viability inhibition than the free drug. In vivo antitumor activity of drug-loaded micelles was investigated in mice bearing S180 mouse sarcoma. NCTD-loaded micelles displayed tumor inhibition effects, better than the free drug. As a new drug delivery system, copolymer micelles present many advantages including easy formulation, good water solubility, low toxicity and high treatment efficacy, and show great potential as carriers of hydrophobic drugs.
C1 [Chen, Shui-Fang; Lu, Wen-Fen; Wen, Zhi-Yong; Chen, Jian-Hai] So Med Univ, Nanfang Hosp, Dept Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.
   [Li, Qiang] So Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.
RP Chen, JH (reprint author), So Med Univ, Nanfang Hosp, Dept Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.
EM jianhaichen11@yahoo.com.cn
CR Blanco E, 2007, J CONTROL RELEASE, V122, P365, DOI 10.1016/j.jconrel.2007.04.014
   Cai SS, 2007, PHARM RES, V24, P2099, DOI 10.1007/s11095-007-9335-z
   Chen YN, 2003, BRIT J PHARMACOL, V140, P461, DOI 10.1038/sj.bjp.0705461
   Chen YJ, 2009, CHEM-BIOL INTERACT, V181, P440, DOI 10.1016/j.cbi.2009.07.004
   Di Tommaso C, 2010, EUR J PHARM SCI, V40, P38, DOI 10.1016/j.ejps.2010.02.006
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Dong YC, 2004, BIOMATERIALS, V25, P2843, DOI 10.1016/j.biomaterials.2003.09.055
   Fonseca C, 2002, J CONTROL RELEASE, V83, P273, DOI 10.1016/S0168-3659(02)00212-2
   Gao X, 2011, J BIOMED NANOTECHNOL, V7, P285, DOI 10.1166/jbn.2011.1280
   Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3
   Huh KM, 2008, J CONTROL RELEASE, V126, P122, DOI 10.1016/j.jconrel.2007.11.008
   KATAOKA K, 1993, J CONTROL RELEASE, V24, P119
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kim JH, 1999, POLYM ADVAN TECHNOL, V10, P647, DOI 10.1002/(SICI)1099-1581(199911)10:11<647::AID-PAT918>3.0.CO;2-Y
   Kim SC, 2001, J CONTROL RELEASE, V72, P191, DOI 10.1016/S0168-3659(01)00275-9
   Kok SH, 2003, ORAL ONCOL, V39, P19, DOI 10.1016/S1368-8375(01)00129-4
   Li RT, 2009, INT J PHARMACEUT, V379, P158, DOI 10.1016/j.ijpharm.2009.06.007
   Liu Jiong, 2006, Journal of Shanghai Jiaotong University, V40, P1343
   Lukyanov AN, 2002, PHARMACEUT RES, V19, P1424, DOI 10.1023/A:1020488012264
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Paul M, 1998, DRUG DEVELOP RES, V43, P98, DOI 10.1002/(SICI)1098-2299(199802)43:2<98::AID-DDR2>3.0.CO;2-K
   Sezgin Z, 2006, EUR J PHARM BIOPHARM, V64, P261, DOI 10.1016/j.ehpb.2006.06.003
   [汪俊 WANG Jun], 2009, [波谱学杂志, Chinese Journal of Magnetic Resonance], V26, P126
   Wang LX, 2006, INT J PHARM, V323, P161, DOI 10.1016/j.ijpharm.2006.05.060
   Wang Q, 2010, NANOMED-NANOTECHNOL, V6, P371, DOI 10.1016/j.nano.2009.07.006
   Wu Qiu-lan, 2007, Yaoxue Xuebao, V42, P440
   Xie Z, 2007, J CONTROL RELEASE, V117, P210, DOI 10.1016/j.jconrel.2006.11.014
   Yamagata M, 1998, BRIT J CANCER, V77, P1726, DOI 10.1038/bjc.1998.289
   Yang L, 2009, PHARM RES-DORD, V26, P2332, DOI 10.1007/s11095-009-9949-4
   Yang PY, 2011, TOXICOL IN VITRO, V25, P699, DOI 10.1016/j.tiv.2011.01.011
   Yang ZL, 2008, J BIOMED MATER RES A, V85A, P539, DOI 10.1002/jbm.a.31504
   Yokoyama M, 2004, J DRUG TARGET, V12, P373, DOI 10.1080/10611860412331285251
   Zhang C, 2004, COLLOID SURFACE B, V39, P69, DOI 10.1016/j.colsurfb.2004.09.002
   Zhang L, 2005, DRUG DELIV, V12, P289, DOI 10.1080/10717540500176829
   Zhang XF, 2005, BIOMATERIALS, V26, P2121, DOI 10.1016/j.biomaterials.2004.06.024
   Zhang ZP, 2006, BIOMATERIALS, V27, P262, DOI 10.1016/j.biomaterials.2005.05.104
NR 36
TC 8
Z9 9
U1 1
U2 39
PU GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH
PI ESCHBORN
PA PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY
SN 0031-7144
J9 PHARMAZIE
JI Pharmazie
PD SEP
PY 2012
VL 67
IS 9
BP 781
EP 788
DI 10.1691/ph.2012.1151
PG 8
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA 006WR
UT WOS:000308851000006
PM 23016451
DA 2018-10-19
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Raaen, S
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Raaen, Steiner
TI Characterization of Passive Film Formed on AISI 316L Stainless Steel
   after Magnetoelectropolishing in a Broad Range of Polarization
   Parameters
SO STEEL RESEARCH INTERNATIONAL
LA English
DT Article
DE AISI 316L stainless steel; corrosion potential; magnetoelectropolishing
   MEP; surface film composition; XP spectra
ID MAGNETIC-FIELD; SURFACE CHARACTERIZATION; BIOMATERIAL; CORROSION; XPS
AB The aim of the paper is to present the changes in the surface film composition on AISI 316L stainless steel (SS) after electropolishing (EP) and magnetoelectropolishing (MEP) in a broad range of the process conditions. The X-ray photoelectron spectroscopy surface analyses were performed to reveal the effect of MEP. The EP process has been performed under natural convection (in a stagnant electrolyte), much above the polarization plateau. A series of experiments were carried out on AISI 316L SS samples in accordance with the five-level composite rotary statistical plan with the variables being the magnetic field intensity B (mT), and the anodic current density i (A?dm-2). XP high resolution spectra have been obtained on AISI 316L SS surface concerning Fe 2p, Cr 2p, O 1s, S 2p, P 2p, and C 1s, respectively. The Cr:Fe ratio regarding both metallic M and compound X was also studied and calculated. At the end, the summary results of Cr/Fe?=?f(B, i) in relation to the corrosion potential, have been compared. The conclusions, concerning the selection of MEP process conditions, regarding the optimum Cr/Fe ratio and corrosion behavior, have been formulated. It was found the Cr:Fe ratio well correlates with the pitting corrosion potential. MEP process can modify not only the rate of dissolution to a determined extent, but also control the corrosion behavior and Cr:Fe ratio results.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Politech Koszalinska, Div Surface Electrochem, PL-75620 Koszalin, Poland.
   [Raaen, Steiner] NTNU Trondheim, Inst Phys, Trondheim, Norway.
RP Rokosz, K (reprint author), Politech Koszalinska, Div Surface Electrochem, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl
OI Raaen, Steinar/0000-0001-5565-0690
CR [Anonymous], 1990, MET HDB PROP SEL IR, V1, P841
   Bund A, 2003, ELECTROCHIM ACTA, V49, P147, DOI 10.1016/j.electacta.2003.04.009
   Bund A, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/2/024208
   Crist B.V., 2000, HDB MONOCHROMATIC XP
   Dettner P., 1988, ELECTROLYTIC CHEM PO
   Fahidy T. Z., 2002, MOD ASPECT ELECTROC, P333
   FUKASE Y, 1977, TETSU TO HAGANE, V63, P688
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2008, SURF COAT TECH, V202, P1668, DOI 10.1016/j.surfcoat.2007.07.067
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Hryniewicz T., 2005, MONOGRAPH POLITECHNI
   Hryniewicz T., 2007, SURFACE TREATMENT ME
   Hryniewicz T., STUDY ELECTROPOLISHI
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Hryniewicz T, 2009, MATERIALS, V2, P129, DOI 10.3390/ma2010129
   Khatak H. S., 2002, CORROSION AUSTENITIC
   Kukielka L., 2002, FUNDAMENTALS ENG STU
   Linhardt P, 2005, CORROS SCI, V47, P1599, DOI 10.1016/j.corsci.2004.09.002
   Okamoto G., 1978, PASSIVITY METALS, P646
   Peckner D., 1977, HDB STAINL STEELS
   Rokosz K, 2010, CORROSION, V66, DOI 10.5006/1.3360910
   Rokosz K., 2010, T VSB MECH SER TU OS, V56, P301
   Sedriks AJ., 1996, CORROSION STAINLESS
   Shibata T, 2007, CORROS SCI, V49, P20, DOI 10.1016/j.corscsi.2006.05.031
NR 27
TC 23
Z9 23
U1 1
U2 17
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1611-3683
J9 STEEL RES INT
JI Steel Res. Int.
PD SEP
PY 2012
VL 83
IS 9
BP 910
EP 918
DI 10.1002/srin.201200046
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 000QK
UT WOS:000308401700012
DA 2018-10-19
ER

PT J
AU Hulsmann, J
   Grun, K
   El Amouri, S
   Barth, M
   Hornung, K
   Holzfuss, C
   Lichtenberg, A
   Akhyari, P
AF Huelsmann, Joern
   Gruen, Katja
   El Amouri, Sonya
   Barth, Mareike
   Hornung, Katrin
   Holzfuss, Carlheinz
   Lichtenberg, Artur
   Akhyari, Payam
TI Transplantation material bovine pericardium: biomechanical and
   immunogenic characteristics after decellularization vs.
   glutaraldehyde-fixing
SO XENOTRANSPLANTATION
LA English
DT Article
DE alpha Gal; biomaterials; bovine pericardium; decellularization; elastic
   modulus
ID HEART-VALVES; MECHANICAL-PROPERTIES; TISSUE; RECELLULARIZATION;
   ALLOGRAFTS; DETERGENT; PROTEINS; LEAFLET; MATRIX; FRESH
AB Hulsmann J, Grun K, El Amouri S, Barth M, Hornung K, Holzfu beta C, Lichtenberg A, Akhyari P. Transplantation material bovine pericardium: biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing. Xenotransplantation 2012; 19: 286297. (c) 2012 John Wiley & Sons A/S. Abstract: Background: Today, bovine pericardium (BP) is extensively investigated as a biomaterial for the generation of various bioimplants. But despite the commercial distribution, and the development of methods either to remove (decellularization) or to mask (chemical cross-linking, for example by glutaraldehyde [GA] treatment) the xenogeneic antigen epitopes, yet questions around the immunogenic reactivity of BP remain. The aim of this study is the comparison of crucial tissue characteristics, that is, biomechanical properties, the presence of aGal epitopes, and residual DNA in acellular vs. GA-fixed BP. Methods: Bovine pericardium was either cross-linked with 0.6% GA or decellularized according to two common protocols using either sodium dodecyl sulfate (SDS) and desoxycholic acid (DCA) or trypsin and ethylenediaminetetraacetic acid (EDTA). The resulting extracellular matrix was prone to one-dimensional tensile testing. The tissue content for aGal was evaluated by immunoblotting, and residual DNA was determined by a commercial assay. Untreated BP served as control. Results: In contrast to previous reports, we found a pronounced decrease in the elastic modulus (E-Modulus) for common GA treatment and overall smaller values for the elastic moduli after decellularization (P < 0.05). In parallel, we observed an overall increased ultimate elongation of acellular and cross-linked BP, although ultimate stress values did not significantly differ. SDS/DCA decellularized BP revealed a dramatic reduction in the DNA content and an almost complete removal of aGal epitopes, whereas the trypsin/EDTA protocol retained a residual DNA content of almost 50% and with a great trail of aGal signal. GA-treated tissue had a remarkable content of DNA and aGal. Conclusions: Although chemically fixated BP is clinically still in wide use, for example, for biological heart valve engineering, our results suggest that an improved biomaterial preparation may be provided by appropriate decellularization. SDS/DCA decellularized BP shows similar biomechanical characteristics as GA treatment, paired with reduced potential immunogenic reactivity. Furthermore, decellularized BP holds the potential of cellular repopulation in vivo or in vitro, to enable an endogenous regenerative capacity in contrast to the toxic effects of GA fixing.
C1 [Huelsmann, Joern; El Amouri, Sonya; Barth, Mareike; Lichtenberg, Artur; Akhyari, Payam] Duesseldorf Univ Hosp, Dept Cardiovasc Surg, D-40225 Dusseldorf, Germany.
   [Huelsmann, Joern; Gruen, Katja; Hornung, Katrin; Lichtenberg, Artur; Akhyari, Payam] Univ Hosp Jena, Dept Thorac & Cardiac Surg, Jena, Germany.
   [Holzfuss, Carlheinz] Univ Appl Sci, Jena, Germany.
   [Barth, Mareike] German Canc Res Ctr, Helmholtz Grp Cell Biol, D-6900 Heidelberg, Germany.
RP Hulsmann, J (reprint author), Duesseldorf Univ Hosp, Dept Cardiovasc Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM joern.huelsmann@med.uni-duesseldorf.de
OI Akhyari, Payam/0000-0002-6452-8678
FU Research Commission of Duesseldorf University Hospital [28/09]
FX The authors thank Gisela Muller and Martina Stuff for their excellent
   technical assistance. The authors are grateful for the funding support
   of the Research Commission of Duesseldorf University Hospital (grant #
   28/09).
CR Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   Aupart MR, 2006, J HEART VALVE DIS, V15, P768
   Aupart MR, 2006, J HEART VALVE DIS, V15, P775
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Baraki H, 2009, BIOMATERIALS, V30, P6240, DOI 10.1016/j.biomaterials.2009.07.068
   Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015
   Cebotari S, 2011, CIRCULATION, V124, pS115, DOI 10.1161/CIRCULATIONAHA.110.012161
   Cigliano A, 2012, BIOCHEM RES INT, DOI 10.1155/2012/979351
   da Costa FDA, 2010, ANN THORAC SURG, V90, P1854, DOI 10.1016/j.athoracsur.2010.08.022
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Griffiths LG, 2008, BIOMATERIALS, V29, P3514, DOI 10.1016/j.biomaterials.2008.05.006
   Kalejs Martins, 2009, Interact Cardiovasc Thorac Surg, V8, P553, DOI 10.1510/icvts.2008.196220
   Kasimir M, 2006, TISSUE ENG, V11, P1274
   Kortsmit J, 2009, TISSUE ENG PART C-ME, V15, P707, DOI [10.1089/ten.tec.2008.0658, 10.1089/ten.TEC.2008.0658]
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Langdon SE, 1999, BIOMATERIALS, V20, P137, DOI 10.1016/S0142-9612(98)00142-2
   Li KW, 2010, ANN BIOMED ENG, V38, P2690, DOI 10.1007/s10439-010-0009-3
   Liao J, 2007, J BIOMECH ENG-T ASME, V129, P78, DOI 10.1115/1.2401186
   McGregor CGA, 2011, J THORAC CARDIOV SUR, V141, P269, DOI 10.1016/j.jtcvs.2010.08.064
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Mendoza-Novelo B, 2010, ACTA BIOMATER, V7, P1241
   Naso F, 2011, ACTA BIOMATER, V7, P1728, DOI 10.1016/j.actbio.2010.11.030
   Oswal D, 2007, J HEART VALVE DIS, V16, P165
   Paez JMG, 1999, J BIOMATER APPL, V13, P351, DOI 10.1177/088532829901300404
   Penrose R., 1955, P CAMBRIDGE PHILOS S, V51, P406, DOI DOI 10.1017/S0305004100030401
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Smuts AN, 2011, J MECH BEHAV BIOMED, V4, P85, DOI 10.1016/j.jmbbm.2010.09.009
   Stephens EH, 2008, ACTA BIOMATER, V4, P1148, DOI 10.1016/j.actbio.2008.03.014
   VESELY I, 1993, J BIOMECH, V26, P121, DOI 10.1016/0021-9290(93)90043-E
   Yang M, 2009, J BIOMED MATER RES B, V91B, P354, DOI 10.1002/jbm.b.31409
   ZIOUPOS P, 1992, MED BIOL ENG COMPUT, V30, P76, DOI 10.1007/BF02446197
NR 35
TC 35
Z9 37
U1 6
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0908-665X
EI 1399-3089
J9 XENOTRANSPLANTATION
JI Xenotransplantation
PD SEP-OCT
PY 2012
VL 19
IS 5
BP 286
EP 297
DI 10.1111/j.1399-3089.2012.00719.x
PG 12
WC Medicine, Research & Experimental; Transplantation
SC Research & Experimental Medicine; Transplantation
GA 008DE
UT WOS:000308936700003
PM 22978462
DA 2018-10-19
ER

PT J
AU Ma, ZG
   Zhao, N
   Xiong, CD
AF Ma, Zhigang
   Zhao, Na
   Xiong, Chengdong
TI Degradation and miscibility of poly(DL-lactic acid)/poly(glycolic acid)
   composite films: Effect of poly(DL-lactic-co-glycolic acid)
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE Polymers; composite materials; thin films; microstructure; compatibility
ID IN-VITRO DEGRADATION; FIBERS
AB The in vitro degradation behaviour of poly(glycolic acid) (PGA) and its composite films containing poly(DL-lactic acid) (PDLLA) and poly(DL-lactic-co-glycolic acid) (PDLGA) were investigated via mass loss, scanning electron microscopy (SEM) and differential scanning calorimetry (DSC). All the films were prepared by solution casting, using 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) as the solvent. Since the degradation rate of PDLLA is lower than that of PGA, those of the PDLLA/PGA composite films decreased. As a compatibilizer, PDLGA improved the compatibility and hydrolytic stability of PDLLA/PGA composite films. Changes in the composite films indicate that this kind of PGA-based composite biomaterial may be applicable to device design for clinical application in the future.
C1 [Ma, Zhigang; Zhao, Na] Huangshi Inst Technol, Sch Chem & Mat Engn, Huangshi 435003, Peoples R China.
   [Xiong, Chengdong] Chinese Acad Sci, Chengdu Organ Chem Co Ltd, Chengdu 610041, Peoples R China.
RP Zhao, N (reprint author), Huangshi Inst Technol, Sch Chem & Mat Engn, Huangshi 435003, Peoples R China.
EM zhaona014112034@163.com
FU Hubei Key Laboratory of Mine Environmental Pollution Control and
   Remediation
FX The authors would like to thank Hubei Key Laboratory of Mine
   Environmental Pollution Control and Remediation for support.
CR Choueka Jack, 1995, Journal of Biomedical Materials Research, V29, P1309, DOI 10.1002/jbm.820291102
   de Oca HM, 2006, POLYMER, V47, P7070, DOI 10.1016/j.polymer.2006.07.045
   Doi Y, 2004, BIOPOLYMERS, V4, P152
   Ye X, 2006, CARBOHYD POLYM, V64, P532, DOI 10.1016/j.carbpol.2005.11.005
   You Y, 2005, POLYM DEGRAD STABIL, V90, P441, DOI 10.1016/j.polydegradstab.2005.04.015
   Zong XH, 2003, BIOMACROMOLECULES, V4, P416, DOI 10.1021/bm025717o
NR 6
TC 4
Z9 6
U1 2
U2 28
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD SEP
PY 2012
VL 35
IS 4
BP 575
EP 578
DI 10.1007/s12034-012-0326-2
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 006JY
UT WOS:000308816700014
DA 2018-10-19
ER

PT J
AU Rios, CN
   Skoracki, RJ
   Mathur, AB
AF Rios, Carmen N.
   Skoracki, Roman J.
   Mathur, Anshu B.
TI GNAS1 and PHD2 Short-interfering RNA Support Bone Regeneration in Vitro
   and in an in Vivo Sheep Model
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; INDUCIBLE FACTOR-I; EXTRACELLULAR-MATRIX; TISSUE
   REGENERATION; CHITOSAN BLEND; SILK FIBROIN; SCAFFOLDS; PROTEIN
AB Our ability to guide cells in biomaterials for in vivo bone repair is limited and requires novel strategies. Short-interfering RNA (siRNA) allows the regulation of multiple cellular pathways. Core binding factor alpha 1 (Cbfa1) and hypoxia-inducible factor 1 (HIF-1) pathways can be modulated to direct bone formation via siRNA against guanine nucleotide-binding protein alpha-stimulating activity polypeptide 1 (siGNAS1) and prolyl hydroxylase domain-containing protein 2 (siPHD2), respectively.
   We determined whether the administration of siGNAS1 and siPHD2 in mesenchymal stem cells (MSCs) promotes osteogenic phenotype, the dose-dependent effects of siGNAS1 on MSC differentiation to osteogenic phenotype, and whether the two siRNAs promote bone formation in vivo.
   siRNAs were administered to MSCs at Day 0, and protein expression of bone-specific markers was assessed at Days 1, 2, and 4 (n = 3/group/time point). In an in vivo model using seven sheep, chambers containing silk fibroin-chitosan (SFCS) scaffolds with siRNA were implanted over the periosteum and harvested at Days 7, 21, 36, and 70 (n = 4/group/time point, except at Day 70 [n = 2]) to assess bone formation.
   siGNAS1 promoted collagen I and osteopontin expression, whereas siPHD2 had no effect in vitro. Dose-dependent effects of siGNAS1 on ALP expression were maximal at Day 1 for 10 mu g/mL and Day 4 for 100 mu g/mL. In vivo, by Day 70, mean bone volume increased compared to Day 7 for siGNAS1-SFCS (47.8 versus 1.8 mg/mL) and siPHD2-SFCS (61.3 versus 1.5 mg/mL).
   Both siPHD2 and siGNAS1 support bone regeneration in vivo, whereas only siGNAS1 regulates bone phenotype in MSCs in vitro.
   While the use of autologous tissue is limited for reconstructing critical-sized defects, the development of biomaterial-based approaches to promote bone formation may abrogate some of those limitations.
C1 [Skoracki, Roman J.; Mathur, Anshu B.] Univ Texas MD Anderson Canc Ctr, Tissue Regenerat & Mol Cell Engn Labs, Dept Plast Surg, Houston, TX 77030 USA.
   [Rios, Carmen N.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.
RP Mathur, AB (reprint author), Univ Texas MD Anderson Canc Ctr, Tissue Regenerat & Mol Cell Engn Labs, Dept Plast Surg, 1515 Holcombe Blvd,Unit 602, Houston, TX 77030 USA.
EM amathur@mdanderson.org
OI Mathur, Anshu/0000-0002-6689-5906
FU Musculoskeletal Transplant Foundation (Edison, NJ, USA)
FX One of the authors (ABM), or a member of her immediate family, has
   received or may receive funding, during the study period, from the
   Musculoskeletal Transplant Foundation (Edison, NJ, USA).
CR Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392
   Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]
   Cheema SK, 2007, WOUND REPAIR REGEN, V15, P286, DOI 10.1111/j.1524-475X.2007.00228.x
   Cheng MH, 2005, TISSUE ENG, V11, P214, DOI 10.1089/ten.2005.11.214
   Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368
   Dong SW, 2009, BIOSCI BIOTECH BIOCH, V73, P2226, DOI 10.1271/bbb.90329
   Gobin AS, 2006, TISSUE ENG, V12, P3383, DOI 10.1089/ten.2006.12.3383
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Kopf J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-37
   Lietman SA, 2005, CLIN ORTHOP RELAT R, P231, DOI 10.1097/01.blo.0000153279.90512.38
   Mazure NM, 2003, CURR PHARM DESIGN, V9, P531, DOI 10.2174/1381612033391469
   McKee MD, 1996, CONNECT TISSUE RES, V35, P197, DOI 10.3109/03008209609029192
   Miller MJ, 2000, SEMIN SURG ONCOL, V19, P294
   Palsson B.O., 2004, TISSUE ENG
   Ramasubramanian A, 2011, PHARM RES-DORDR, V28, P1328, DOI 10.1007/s11095-011-0406-9
   Rios CN, 2009, TISSUE ENG PT A, V15, P2717, DOI 10.1089/ten.TEA.2008.0360
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Yin JH, 2000, BIOCHEM BIOPH RES CO, V279, P30, DOI 10.1006/bbrc.2000.3896
NR 18
TC 19
Z9 20
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD SEP
PY 2012
VL 470
IS 9
BP 2541
EP 2553
DI 10.1007/s11999-012-2475-4
PG 13
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 987FK
UT WOS:000307402300023
PM 22833384
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Jaekel, DJ
   Day, JS
   Klein, GR
   Levine, H
   Parvizi, J
   Kurtz, SM
AF Jaekel, David J.
   Day, Judd S.
   Klein, Gregg R.
   Levine, Harlan
   Parvizi, Javad
   Kurtz, Steven M.
TI Do Dynamic Cement-on-Cement Knee Spacers Provide Better Function and
   Activity During Two-stage Exchange?
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID BONE-CEMENT; ARTICULATING SPACER; ARTHROPLASTY; INFECTION; REVISION; HIP
AB Implantation of an antibiotic bone cement spacer is used to treat infection of a TKA. Dynamic spacers fashioned with cement-on-cement articulating surfaces potentially facilitate patient mobility and reduce bone loss as compared with their static counterparts, while consisting of a biomaterial not traditionally used for load-bearing articulations. However, their direct impact on patient mobility and wear damage while implanted remains poorly understood.
   We characterized patient activity, surface damage, and porous structure of dynamic cement-on-cement spacers.
   We collected 22 dynamic and 14 static knee antibiotic cement spacers at revision surgeries at times ranging from 0.5 to 13 months from implantation. For these patients, we obtained demographic data and UCLA activity levels. We characterized surface damage using the Hood damage scoring method and used micro-CT analysis to observe the internal structure, cracking, and porosity of the cement.
   The average UCLA score was higher for patients with dynamic spacers than for patients with static spacers, with no differences in BMI or age. Burnishing was the only prevalent damage mode on all the bearing surfaces. Micro-CT analysis revealed the internal structure of the spacers was porous and highly inhomogeneous, including heterogeneous dispersion of radiopaque material and cavity defects. The average porosity was 8% (range, 1%-29%) and more than A1/2 of the spacers had pores greater than 1 mm in diameter.
   Our observations suggest dynamic, cement-on-cement spacers allow for increased patient activity without catastrophic failure. Despite the antibiotic loading and internal structural inhomogeneity, burnishing was the only prevalent damage mode that could be consistently classified with no evidence of fracture or delamination. The porous structure of the spacers varied highly across the surfaces without influencing the material failure.
C1 [Jaekel, David J.; Day, Judd S.; Kurtz, Steven M.] Drexel Univ, Implant Res Ctr, Sch Biomed Engn Sci & Heath Syst, Philadelphia, PA 19104 USA.
   [Jaekel, David J.; Day, Judd S.; Kurtz, Steven M.] Exponent Inc, Philadelphia, PA USA.
   [Klein, Gregg R.; Levine, Harlan] Hackensack Univ, Hartzband Ctr, Med Ctr, Hackensack, NJ USA.
   [Parvizi, Javad] Rothman Inst Jefferson, Philadelphia, PA USA.
RP Jaekel, DJ (reprint author), Drexel Univ, Implant Res Ctr, Sch Biomed Engn Sci & Heath Syst, 3401 Market St,Suite 300, Philadelphia, PA 19104 USA.
EM djj25@drexel.edu
FU Exponent, Inc
FX We thank Exponent, Inc, for support and resources in the analysis of
   materials. We also thank our interns Madeline Olsen and Genymphas Higgs
   for assistance with data processing and implant cleaning.
CR Agency for Healthcare Research and Quality, 2011, HEALTHC COST UT PROJ
   Bishop NE, 1996, J BONE JOINT SURG BR, V78B, P349
   Calton TF, 1997, CLIN ORTHOP RELAT R, P148
   Emerson RH, 2002, CLIN ORTHOP RELAT R, P132, DOI 10.1097/01.blo.0000030493.43495.2a
   Fehring TK, 2000, CLIN ORTHOP RELAT R, P9
   Fink B, 2011, CLIN ORTHOP RELAT R, V469, P1095, DOI 10.1007/s11999-010-1479-1
   Gooding CR, 2011, CLIN ORTHOP RELAT R, V469, P985, DOI 10.1007/s11999-010-1579-y
   Hellmann M, 2010, J ARTHROPLASTY, V25
   HOFMANN AA, 1995, CLIN ORTHOP RELAT R, P45
   HOOD RW, 1983, J BIOMED MATER RES, V17, P829, DOI 10.1002/jbm.820170510
   Jamsen E, 2009, ACTA ORTHOP, V80, P67, DOI 10.1080/17453670902805064
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   Kurtz SM, 2010, CLIN ORTHOP RELAT R, V468, P52, DOI 10.1007/s11999-009-1013-5
   Maheshwari AV, 2010, J ARTHROPLASTY, V25, P92, DOI 10.1016/j.arth.2010.04.017
   Park SJ, 2010, INT ORTHOP, V34, P1181, DOI 10.1007/s00264-009-0907-x
   Parvizi Javad, 2010, Orthopedics, V33, P659, DOI 10.3928/01477447-20100722-42
   Pitto RP, 2005, INT ORTHOP, V29, P305, DOI 10.1007/s00264-005-0670-6
   Pitto RP, 2004, INT ORTHOP, V28, P129, DOI 10.1007/s00264-004-0545-2
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   Van Thiel GS, 2011, CLIN ORTHOP RELAT R, V469, P994, DOI 10.1007/s11999-010-1644-6
   Villa T, 2007, KNEE, V14, P145, DOI 10.1016/j.knee.2006.11.010
   Yamamoto K, 2009, J ARTHROPLASTY, V24, P83, DOI 10.1016/j.arth.2004.06.032
NR 22
TC 12
Z9 12
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD SEP
PY 2012
VL 470
IS 9
BP 2599
EP 2604
DI 10.1007/s11999-012-2332-5
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 987FK
UT WOS:000307402300030
PM 22476896
OA Green Published
DA 2018-10-19
ER

PT J
AU Li, CC
   Hsiang, CY
   Lo, HY
   Pai, FT
   Wu, SL
   Ho, TY
AF Li, Chia-Cheng
   Hsiang, Chien-Yun
   Lo, Hsin-Yi
   Pai, Fu-Tzu
   Wu, Shih-Lu
   Ho, Tin-Yun
TI Genipin inhibits lipopolysaccharide-induced acute systemic inflammation
   in mice as evidenced by nuclear factor-kappa B bioluminescent
   imaging-guided transcriptomic analysis
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Genipin; Systemic inflammation; Nuclear factor-kappa B; Bioluminescent
   imaging; DNA microarray
ID HOST-BIOMATERIAL INTERACTION; ACTIVE INGREDIENTS; SIGNALING PATHWAY;
   HERBAL MEDICINE; TRANSGENIC MICE; ACTIVATION; GARDENIA; CELLS; GENE;
   HEPATITIS
AB Genipin is a natural blue colorant in food industry. Inflammation is correlated with human disorders, and nuclear factor-kappa B (NF-kappa B) is the critical molecule involved in inflammation. In this study, the anti-inflammatory effect of genipin on the lipopolysaccharide (LPS)-induced acute systemic inflammation in mice was evaluated by NF-kappa B bioluminescence-guided transcriptomic analysis. Transgenic mice carrying the NF-kappa B-driven luciferase genes were administered intraperitoneally with IFS and various amounts of genipin. Bioluminescent imaging showed that genipin significantly suppressed LPS-induced NF-kappa B-dependent luminescence in vivo. The suppression of LPS-induced acute inflammation by genipin was further evidenced by the reductions of cytokine levels in sera and organs. Microarray analysis of these organs showed that the transcripts of 79 genes were differentially expressed in both LPS and LPS/genipin groups, and one third of these genes belonged to chemokine ligand, chemokine receptor, and interferon (IFN)-induced protein genes. Moreover, network analysis showed that NF-kappa B played a critical role in the regulation of genipin-affected gene expression. In conclusion, we newly identified that genipin exhibited anti-inflammatory effects in a model of LPS-induced acute systemic inflammation via downregulation of chemokine ligand, chemokine receptor, and IFN-induced protein productions. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Li, Chia-Cheng; Lo, Hsin-Yi; Pai, Fu-Tzu; Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med, Taichung 40402, Taiwan.
   [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung 40402, Taiwan.
   [Wu, Shih-Lu] China Med Univ, Dept Biochem, Taichung 40402, Taiwan.
   [Ho, Tin-Yun] China Med Univ Hosp, Dept Nucl Med, Taichung 40447, Taiwan.
RP Ho, TY (reprint author), China Med Univ, Grad Inst Chinese Med, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.
EM cyhsiang@mail.cmu.edu.tw
RI Hsiang, Chien-Yun/O-3853-2015; Ho, Tin-Yun/O-3889-2015
FU National Science Council, Committee on Chinese Medicine and Pharmacy at
   Department of Health [CCMP100-RD-048, CCMP101-RD-103]; China Medical
   University [CMU100-S-16, CMU100-S-34, CMU100-TS-14]
FX This work was supported by grants from National Science Council,
   Committee on Chinese Medicine and Pharmacy at Department of Health
   (CCMP100-RD-048 and CCMP101-RD-103), and China Medical University
   (CMU100-S-16, CMU100-S-34, and CMU100-TS-14).
CR Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x
   Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510
   Balan V, 2006, ANTIVIR THER, V11, P901
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008
   Cheng HM, 2010, J ETHNOPHARMACOL, V132, P429, DOI 10.1016/j.jep.2010.08.022
   Ellis SL, 2010, J IMMUNOL, V185, P1864, DOI 10.4049/jimmunol.1000900
   FUJIKAWA S, 1987, J FERMENT BIOENG, V65, P419, DOI 10.1016/0385-6380(87)90138-5
   Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6
   He ML, 2006, CHROMATOGRAPHIA, V64, P713, DOI 10.1365/s10337-006-0099-0
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hseu YC, 2010, FOOD CHEM TOXICOL, V48, P2319, DOI 10.1016/j.fct.2010.05.066
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Hughes DP, 2003, CIRC RES, V92, P630, DOI 10.1161/01.RES.0000063422.38690.DC
   Jeon WK, 2011, ARCH BIOCHEM BIOPHYS, V512, P119, DOI 10.1016/j.abb.2011.05.016
   Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870
   Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011
   Koo HJ, 2004, EUR J PHARMACOL, V495, P201, DOI 10.1016/j.ejphar.2004.05.031
   Lee JH, 2009, FOOD CHEM TOXICOL, V47, P1127, DOI 10.1016/j.fct.2009.01.037
   MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010
   Mase A, 2010, J ETHNOPHARMACOL, V127, P742, DOI 10.1016/j.jep.2009.11.029
   MATHISON JC, 1979, J IMMUNOL, V123, P2133
   Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197
   Nam KN, 2010, INT IMMUNOPHARMACOL, V10, P493, DOI 10.1016/j.intimp.2010.01.011
   O'Sullivan JB, 2010, J NEUROIMMUNOL, V220, P34, DOI 10.1016/j.jneuroim.2009.12.007
   Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371
   Park KS, 2010, EVID-BASED COMPL ALT, V7, P41, DOI 10.1093/ecam/nem129
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336
   TSENG TH, 1995, CANCER LETT, V97, P61, DOI 10.1016/0304-3835(95)03964-X
   Wu SL, 2009, J PHARMACOL EXP THER, V330, P370, DOI 10.1124/jpet.109.152835
   Yamamoto M, 2000, GASTROENTEROLOGY, V118, P380, DOI 10.1016/S0016-5085(00)70220-4
   Yamauchi M, 2007, INT IMMUNOL, V19, P935, DOI 10.1093/intimm/dxm054
   Yamazaki M, 2008, EUR J PHARMACOL, V581, P255, DOI 10.1016/j.ejphar.2007.12.001
   Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834
   Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16
NR 36
TC 24
Z9 25
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD SEP
PY 2012
VL 50
IS 9
BP 2978
EP 2986
DI 10.1016/j.fct.2012.05.054
PG 9
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA 003PT
UT WOS:000308624500004
PM 22687549
DA 2018-10-19
ER

PT J
AU Kang, HW
   Cho, DW
AF Kang, Hyun-Wook
   Cho, Dong-Woo
TI Development of an Indirect Stereolithography Technology for Scaffold
   Fabrication with a Wide Range of Biomaterial Selectivity
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID SOLID FREEFORM FABRICATION; FREE-FORM FABRICATION; PLGA SCAFFOLDS;
   MICRO-STEREOLITHOGRAPHY; DYNAMIC MASK; MICROSTEREOLITHOGRAPHY;
   COMPOSITES; OSTEOBLAST; LASER; REGENERATION
AB Tissue engineering, which is the study of generating biological substitutes to restore or replace tissues or organs, has the potential to meet current needs for organ transplantation and medical interventions. Various approaches have been attempted to apply three-dimensional (3D) solid freeform fabrication technologies to tissue engineering for scaffold fabrication. Among these, the stereolithography (SL) technology not only has the highest resolution, but also offers quick fabrication. However, a lack of suitable biomaterials is a barrier to applying the SL technology to tissue engineering. In this study, an indirect SL method that combines the SL technology and a sacrificial molding process was developed to address this challenge. A sacrificial mold with an inverse porous shape was fabricated from an alkali-soluble photopolymer by the SL technology. A sacrificial molding process was then developed for scaffold construction using a variety of biomaterials. The results indicated a wide range of biomaterial selectivity and a high resolution. Achievable minimum pore and strut sizes were as large as 50 and 65 mm, respectively. This technology can also be used to fabricate three-dimensional organ shapes, and combined with traditional fabrication methods to construct a new type of scaffold with a dual-pore size. Cytotoxicity tests, as well as nuclear magnetic resonance and gel permeation chromatography analyses, showed that this technology has great potential for tissue engineering applications.
C1 [Cho, Dong-Woo] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang 790784, Gyungbuk, South Korea.
   [Cho, Dong-Woo] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, Gyungbuk, South Korea.
   [Kang, Hyun-Wook] Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
RP Cho, DW (reprint author), Pohang Univ Sci & Technol, Dept Mech Engn, San 31, Pohang 790784, Gyungbuk, South Korea.
EM dwcho@postech.ac.kr
FU National Research Foundation of Korea (NRF); Korea government (MEST)
   [2011-0000412]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MEST; no. 2011-0000412).
CR Bertsch A, 1997, MICROSYST TECHNOL, V3, P42, DOI 10.1007/s005420050053
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Engelhardt S, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/025003
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Hanson M, 2004, AM J ORTHOD DENTOFAC, V126, P65, DOI 10.1016/j.ajodo.2003.07.006
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jung JW, 2012, INT J PRECIS ENG MAN, V13, P445, DOI 10.1007/s12541-012-0057-8
   Kang HW, 2004, J MANUF SCI E-T ASME, V126, P766, DOI 10.1115/1.1811116
   Kang KS, 2011, EXP MOL MED, V43, P367, DOI 10.3858/emm.2011.43.6.040
   Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Kim JY, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/5/055027
   Kwon IK, 2005, BIOMATERIALS, V26, P1675, DOI 10.1016/j.biomaterials.2004.06.041
   Lee JW, 2007, MICROELECTRON ENG, V84, P1702, DOI 10.1016/j.mee.2007.01.267
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee M, 2005, BIOMATERIALS, V26, P4281, DOI 10.1016/j.biomaterials.2004.10.040
   Lee SJ, 2008, BIOMED MICRODEVICES, V10, P233, DOI 10.1007/s10544-007-9129-4
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Liska R, 2005, J APPL POLYM SCI, V97, P2286, DOI 10.1002/app.22025
   Malinauskas M, 2010, LITH J PHYS, V50, P75, DOI 10.3952/lithjphys.50121
   Maruo S, 2002, SENSOR ACTUAT A-PHYS, V100, P70, DOI 10.1016/S0924-4247(02)00043-2
   Melissinaki V, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045005
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Rothen-Weinhold A, 1999, EUR J PHARM BIOPHARM, V48, P113, DOI 10.1016/S0939-6411(99)00034-X
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Sachlos E, 2008, ACTA BIOMATER, V4, P1322, DOI 10.1016/j.actbio.2008.03.016
   Sanchez-Salcedo S, 2008, CHEM ENG J, V137, P62, DOI 10.1016/j.cej.2007.09.01
   Shim JH, 2010, J BIOMAT SCI-POLYM E, V21, P1069, DOI 10.1163/092050609X12457428919034
   Smith LL, 2007, INT J NANOMED, V2, P383
   Sun C, 2005, SENSOR ACTUAT A-PHYS, V121, P113, DOI 10.1016/j.sna.2004.12.011
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Taylor PM, 2006, BIOMATERIALS, V27, P2733, DOI 10.1016/j.biomaterials.2005.12.003
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Yang DY, 2007, INT J PRECIS ENG MAN, V8, P63
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 42
TC 29
Z9 29
U1 0
U2 26
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD SEP
PY 2012
VL 18
IS 9
BP 719
EP 729
DI 10.1089/ten.tec.2011.0621
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 000ET
UT WOS:000308370000008
PM 22443315
OA Green Published
DA 2018-10-19
ER

PT J
AU Wang, XY
   Li, SL
   Cao, T
   Fu, X
   Yu, GY
AF Wang, Xiaoying
   Li, Shenglin
   Cao, Tong
   Fu, Xin
   Yu, Guangyan
TI Evaluating biotoxicity with fibroblasts derived from human embryonic
   stem cells
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Human embryonic stem cell; Fibroblast; Biomaterial; Cytotoxicity;
   Genotoxicity
ID IN-VITRO; OXIDATIVE STRESS; HUMAN BLASTOCYSTS; SODIUM-FLUORIDE; FEEDER
   CELLS; CROSS-LINKS; DNA-DAMAGE; LINES; ASSAY; TOXICITY
AB To investigate the use of differentiated fibroblasts from human embryonic stem cells as a cellular model for cytotoxicity and genotoxicity screening. The EBf-H9 cells were derived from human embryonic stem cells (H9) via embryonic body (ES) and treated with Sodium fluoride (NaF) and Formaldehyde (FA). Proliferation, specific gene and protein expression and karyotype of cells were analyzed by MIT assay, RT-PCR, immunocytochemistry and karyotype analysis, respectively. Cytotoxicity was detected by MIT assay and flow cytometry, and genotoxicity was studied by micronucleus test (MNT), sister chromatid exchange (SCE) and comet assay. EBf-119s were spindle-shaped with a diploid karyotype. They expressed the fibroblast markers prolyl 4-hydroxylase beta and vimentin but did not express Oct-4 and Sox-2, and decreased expression of Nanog. The proliferation of EBf-H9 and murine L929 cells was inhibited by sodium fluoride (NaF) and formaldehyde (FA), and the cell cycle was arrested in different phases with the treatments. In genotoxicity assays with NaF and FA, positive responses were detected in human EBf-H9s comparable to those in the murine L929 cell line. EBf-H9 may be a suitable new cell source for toxicity research on biomaterials and other agents. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Wang, Xiaoying; Li, Shenglin] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing, Peoples R China.
   [Li, Shenglin] Peking Univ, Sch & Hosp Stomatol, Lab Oral & Maxillofacial Surg, Beijing, Peoples R China.
   [Cao, Tong; Fu, Xin] Natl Univ Singapore, Dept Oral & Maxillofacial Surg, Singapore 117548, Singapore.
   [Yu, Guangyan] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing, Peoples R China.
RP Li, SL (reprint author), Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing, Peoples R China.
EM kqshlli@bjmu.edu.cn
RI CAO, Tong/B-1008-2008
OI CAO, Tong/0000-0002-7994-9627
FU Ministry of Science and Technology of China (ISTCP) [2008DFB30090,
   2011DFA32190]
FX This study was supported by the Ministry of Science and Technology of
   China (ISTCP, 2008DFB30090; 2011DFA32190). We thank Dr. Ran Xiao and
   Yixiang Wang for their help.
CR Ames JM, 2009, J ENDODONT, V35, P225, DOI 10.1016/j.joen.2008.11.008
   Andorfer P., 2011, EAPP GATEKEEPER CROS
   Bedi RS, 2009, ACTA BIOMATER, V5, P3265, DOI 10.1016/j.actbio.2009.04.019
   Cao T, 2008, CLONING STEM CELLS, V10, P1, DOI 10.1089/clo.2007.0049
   Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330
   Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8
   Festag M, 2007, TOXICOL IN VITRO, V21, P1631, DOI 10.1016/j.tiv.2007.06.014
   Fu X, 2010, TISSUE ENG PART C-ME, V16, P719, DOI 10.1089/ten.tec.2009.0360
   Ghosh J, 2008, TOXICOL IN VITRO, V22, P1918, DOI 10.1016/j.tiv.2008.09.010
   Greenhough S, 2010, TOXICOLOGY, V278, P250, DOI 10.1016/j.tox.2010.07.012
   Guguen-Guillouzo C, 2010, TOXICOLOGY, V270, P3, DOI 10.1016/j.tox.2009.09.019
   Hand CM, 1998, J NEURO-ONCOL, V36, P1, DOI 10.1023/A:1005894723087
   Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442
   Hay R J, 1996, Hum Cell, V9, P143
   Hilliard C, 2007, MUTAT RES-FUND MOL M, V616, P103, DOI 10.1016/j.mrfmmm.2006.11.013
   Huang AH, 1996, J PATHOL, V180, P223, DOI 10.1002/(SICI)1096-9896(199610)180:2<223::AID-PATH635>3.0.CO;2-H
   Jakab MG, 2010, MUTAT RES-GEN TOX EN, V698, P11, DOI 10.1016/j.mrgentox.2010.02.015
   James M.P., 2010, MUTAGENESIS, V25, P531
   Kleinsasser NH, 2006, BIOMATERIALS, V27, P1762, DOI 10.1016/j.biomaterials.2005.09.023
   Konigs M, 2009, TOXICOLOGY, V258, P106, DOI 10.1016/j.tox.2009.01.012
   Mittal M, 2006, CHEM-BIOL INTERACT, V162, P128, DOI 10.1016/j.cbi.2006.05.018
   Mulac D, 2011, TOXICOLOGY, V282, P112, DOI 10.1016/j.tox.2011.01.019
   Phelps R M, 1996, J Cell Biochem Suppl, V24, P32
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Saxena S, 2008, MOL REPROD DEV, V75, P1523, DOI 10.1002/mrd.20895
   SCHMALZ G, 1994, J DENT, V22, pS6, DOI 10.1016/0300-5712(94)90032-9
   Schwengberg S, 2005, J DENT, V33, P49, DOI 10.1016/j.jdent.2004.08.001
   Shan KR, 2004, TOXICOLOGY, V200, P169, DOI 10.1016/j.tox.2004.03.013
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Skottman H, 2007, REGEN MED, V2, P265, DOI 10.2217/17460751.2.3.265
   Speit G, 2002, MUTAGENESIS, V17, P183, DOI 10.1093/mutage/17.3.183
   Speit G, 2000, MUTAGENESIS, V15, P85, DOI 10.1093/mutage/15.1.85
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Thonemann B, 2002, DENT MATER, V18, P318, DOI 10.1016/S0109-5641(01)00056-2
   Zhang LP, 2009, MUTAT RES-REV MUTAT, V681, P150, DOI 10.1016/j.mrrev.2008.07.002
   Zhang M, 2007, TOXICOLOGY, V236, P208, DOI 10.1016/j.tox.2007.04.007
NR 36
TC 3
Z9 8
U1 3
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD SEP
PY 2012
VL 26
IS 6
BP 1056
EP 1063
DI 10.1016/j.tiv.2012.04.002
PG 8
WC Toxicology
SC Toxicology
GA 986EM
UT WOS:000307323900037
PM 22525295
DA 2018-10-19
ER

PT J
AU Chun, J
   Bhak, G
   Lee, SG
   Lee, JH
   Lee, D
   Char, K
   Paik, SR
AF Chun, Jiyeong
   Bhak, Ghibom
   Lee, Sang-Gil
   Lee, Ji-Hye
   Lee, Daekyun
   Char, Kookheon
   Paik, Seung R.
TI kappa-Casein-Based Hierarchical Suprastructures and Their Use for
   Selective Temporal and Spatial Control over Neuronal Differentiation
SO BIOMACROMOLECULES
LA English
DT Article
ID AMYLOID FIBRIL FORMATION; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; IN-VIVO;
   A-BETA; PROTEIN; PEPTIDE; TISSUE; POLYMORPHISM; BIOMATERIAL
AB Functions are diversified by producing hierarchical structures from a single raw material. Biologically compatible milk protein of kappa-casein has been employed to fabricate higher-order suprastructures. In the presence of dithiothreitol and heat treatment, kappa-casein transforms into amyloid fibrils with distinctive morphology attributable to mechanism-based fibrillar polymorphism. As the fibrils elongate to yield high aspect ratio during high-temperature incubation, the resulting fibrils laterally associate into the liquid crystalline state by forming a two-dimensional fibrillar array. Following a desalting process, the fibrillar arrays turn into a three-dimensional matrix of hydrogel that could be selectively disintegrated by subsequent salt treatment. The hydrogel was demonstrated to be a matrix capable of exhibiting controlled release of bioactive substances like retinoic acid, which led to temporal and spatial control over the differentiation of neuronal cells. Therefore, the hierarchical suprastructure formation derived from the single protein of kappa-casein producing one-dimensional protein nanofibrils, a two-dimensional liquid crystalline state and a three-dimensional hydrogel could be widely appreciated in various areas of nanobiotechnology including drug delivery and tissue engineering.
C1 [Chun, Jiyeong; Bhak, Ghibom; Lee, Sang-Gil; Lee, Ji-Hye; Lee, Daekyun; Char, Kookheon; Paik, Seung R.] Seoul Natl Univ, Coll Engn, Inst Chem Proc, Sch Chem & Biol Engn, Seoul 151744, South Korea.
RP Paik, SR (reprint author), Seoul Natl Univ, Coll Engn, Inst Chem Proc, Sch Chem & Biol Engn, 599 Gwanak Ro, Seoul 151744, South Korea.
EM srpaik@snu.ac.kr
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science, and Technology [2010-0009809]; Korea Ministry of Education,
   Science and Technology (MEST) [2010-0018290]; WCU Program of Chemical
   Convergence for Energy and Environment [R31-10013]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science, and Technology (2010-0009809). K.C. acknowledges
   the financial support from the National Research Foundation of Korea
   (NRF) funded by the Korea Ministry of Education, Science and Technology
   (MEST; The Creative Research Initiative Program for "Intelligent Hybrids
   Research Center"; No. 2010-0018290) and The WCU Program of Chemical
   Convergence for Energy and Environment (No. R31-10013).
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106
   Bhak G, 2010, BIOMATERIALS, V31, P5986, DOI 10.1016/j.biomaterials.2010.03.080
   Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Corrigan AM, 2006, J AM CHEM SOC, V128, P14740, DOI 10.1021/ja064455l
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dobson CM, 2004, METHODS, V34, P4, DOI 10.1016/j.ymeth.2004.03.002
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Ecroyd H, 2008, J BIOL CHEM, V283, P9012, DOI 10.1074/jbc.M709928200
   Ecroyd H, 2010, BIOCHEM J, V429, P251, DOI 10.1042/BJ20091949
   Fandrich M, 2009, PRION, V3, P89
   Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006
   Fu XY, 2003, ADV MATER, V15, P902, DOI 10.1002/adma.200304624
   Gazit E, 2007, FEBS J, V274, P317, DOI 10.1111/j.1742-4658.2006.05605.x
   Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127
   Gras S.L., 2008, BIOMATERIALS, V29, P1553
   Groves ML, 1998, J PROTEIN CHEM, V17, P73, DOI 10.1023/A:1022518613574
   HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064
   Hamedi M, 2008, NANO LETT, V8, P1736, DOI 10.1021/nl0808233
   Hamley IW, 2010, MACROMOL BIOSCI, V10, P40, DOI 10.1002/mabi.200900217
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385
   Hennink WE, 2004, INT J PHARM, V277, P99, DOI 10.1016/j.ijpharm.2003.02.002
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f
   Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3
   Iconomidou VA, 2006, J STRUCT BIOL, V156, P480, DOI 10.1016/j.jsb.2006.08.011
   Junn E, 2002, NEUROSCI LETT, V320, P146, DOI 10.1016/S0304-3940(02)00016-2
   KLEGERIS A, 1994, BIOCHEM BIOPH RES CO, V199, P984, DOI 10.1006/bbrc.1994.1326
   Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007
   KREWSON CE, 1994, BIOTECHNOL BIOENG, V43, P555, DOI 10.1002/bit.260430704
   Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee JH, 2010, ACTA BIOMATER, V6, P4689, DOI 10.1016/j.actbio.2010.06.023
   Leonil J, 2008, J MOL BIOL, V381, P1267, DOI 10.1016/j.jmb.2008.06.064
   Licciardi M, 2010, INT J PHARMACEUT, V390, P183, DOI 10.1016/j.ijpharm.2010.02.002
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x
   Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   Pilkington SM, 2010, BIOTECHNOL PROGR, V26, P93, DOI 10.1002/btpr.309
   RASMUSSEN LK, 1992, EUR J BIOCHEM, V207, P215, DOI 10.1111/j.1432-1033.1992.tb17040.x
   Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4
   Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137
   Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201
   Talbot NJ, 2003, CURR BIOL, V13, pR696, DOI 10.1016/S0960-9822(03)00643-2
   Thorn DC, 2005, BIOCHEMISTRY-US, V44, P17027, DOI 10.1021/bi051352r
   Vetri V, 2005, BIOPHYS CHEM, V113, P83, DOI 10.1016/j.bpc.2004.07.042
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959
   Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108
   Wong IY, 2008, J AM CHEM SOC, V130, P7908, DOI 10.1021/ja7103284
   Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061
   Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y
   Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596
   Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k
NR 62
TC 5
Z9 5
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2012
VL 13
IS 9
BP 2731
EP 2738
DI 10.1021/bm300692k
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 002CO
UT WOS:000308508500014
PM 22849622
DA 2018-10-19
ER

PT J
AU Kumar, NSS
   Nazeer, RA
   Jaiganesh, R
AF Kumar, N. S. Sampath
   Nazeer, R. A.
   Jaiganesh, R.
TI Wound Healing Properties of Collagen from the Bone of Two Marine Fishes
SO INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS
LA English
DT Article
DE Collagen; Wound healing; Bone; Magalaspis cordyla; Otolithes ruber
ID ACID-SOLUBLE COLLAGEN; SILVER SULFADIAZINE; SKIN; SCALE; BIOMATERIAL;
   GROWTH; RATS
AB Type I collagen was extracted from the bone of two marine fishes; Magalaspis cordyla and Otolithes ruber and its efficacy in wound healing was studied. The yields of acid soluble (30.5 and 27.6%) and pepsin soluble (45.1 and 48.6%) collagen were respectively as per their dry weight basis. Extracted protein was characterized as type I collagen basing on SDS PAGE, UV-Vis, FTIR spectrometer and amino acid composition. The characterized collagen was cross-linked with glutaraldehyde and found to possess three dimensional pores and acted efficiently in healing the excision wounds made on Wistar rats. Bone is generally considered as waste and discarded in many processing plant. But, the current study proved that it has excellent medicinal importance and reveals a possible way to convert this waste into a medicinally important source.
C1 [Kumar, N. S. Sampath; Nazeer, R. A.; Jaiganesh, R.] SRM Univ, Sch Bioengn, Dept Biotechnol, Madras 603203, Tamil Nadu, India.
RP Nazeer, RA (reprint author), SRM Univ, Sch Bioengn, Dept Biotechnol, Madras 603203, Tamil Nadu, India.
EM nazeer.ra@ktr.srmuniv.ac.in
RI Nune, Satya Sampath Kumar/A-1734-2016
OI Nune, Satya Sampath Kumar/0000-0002-8577-2143
CR Bajpai PK, 1985, BIOCOMPATIBILITY TIS, P5
   Bama P., 2010, INT J PHARM PHARM SC, V2, P133
   Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020
   Foegeding E. A., 1996, FOOD CHEM, V3, P902
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   George J, 2008, J BIOMED MATER RES A, V87A, P1103, DOI 10.1002/jbm.a.32277
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   Jansson K, 2001, SCAND J PLAST RECONS, V35, P369
   Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042
   Kumar NSS, 2012, AMINO ACIDS, V42, P1641, DOI 10.1007/s00726-011-0858-6
   Kumar NSS, 2011, PEPTIDES, V32, P1496, DOI 10.1016/j.peptides.2011.05.020
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAZARUS GS, 1994, ARCH DERMATOL, V130, P489, DOI 10.1001/archderm.130.4.489
   Lee ARC, 2005, BIOMATERIALS, V26, P4670, DOI 10.1016/j.biomaterials.2004.11.041
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li H, 2004, FOOD CHEM, V84, P65, DOI 10.1016/S0308-8146(03)00167-5
   Liu H, 2007, FOOD CHEM, V101, P621, DOI 10.1016/j.foodchem.2006.01.059
   MCCAULEY RL, 1992, J SURG RES, V52, P276, DOI 10.1016/0022-4804(92)90086-F
   MEADE KR, 1990, BIOMATERIALS, V11, P176, DOI 10.1016/0142-9612(90)90151-F
   MORTON JJP, 1972, ARCH INT PHARMACOD T, V196, P117
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Nagai T, 2004, INT J FOOD SCI TECH, V39, P239, DOI 10.1111/j.1365-2621.2004.00777.x
   Nagai T, 2002, FOOD CHEM, V78, P173, DOI 10.1016/S0308-8146(01)00396-X
   Nagai T, 1999, J SCI FOOD AGR, V79, P855, DOI 10.1002/(SICI)1097-0010(19990501)79:6<855::AID-JSFA299>3.3.CO;2-E
   Nagai T, 2000, FOOD CHEM, V68, P277, DOI 10.1016/S0308-8146(99)00188-0
   Naqash SY, 2011, INT J FOOD SCI TECH, V46, P37, DOI 10.1111/j.1365-2621.2010.02443.x
   Nazeer RA, 2014, J FOOD SCI TECH MYS, V51, P750, DOI 10.1007/s13197-011-0539-1
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Nimni ME, 1988, COLLAGEN BIOCH, VI
   Ogawa M, 2004, FOOD CHEM, V88, P495, DOI 10.1016/j.foodchem.2004.02.006
   Paola LD, 2006, CURR DIABETES REV, V2, P431, DOI 10.2174/1573399810602040431
   Pasteris JD, 2008, ELEMENTS, V4, P97, DOI 10.2113/GSELEMENTS.4.2.97
   PIEZ KA, 1965, BIOCHEMISTRY-US, V4, P2590, DOI 10.1021/bi00888a007
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   RAMACHANDRAN GN, 1988, INT J PEPT PROT RES, V31, P1
   Rane MM, 2003, FITOTERAPIA, V74, P553, DOI 10.1016/S0367-326X(03)00118-7
   Schultz GS, 2003, WOUND REPAIR REGEN, V11, pS1, DOI 10.1046/j.1524-475X.11.s2.1.x
   Sidhu GS, 1999, WOUND REPAIR REGEN, V7, P362, DOI 10.1046/j.1524-475X.1999.00362.x
   Wang L, 2007, J FOOD SCI, V72, pE450, DOI 10.1111/j.1750-3841.2007.00478.x
   Wong D. W. S., 1989, MECH THEORY FOOD CHE
   Yan M, 2008, FOOD CHEM, V107, P1581, DOI 10.1016/j.foodchem.2007.10,027
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhang JJ, 2009, FOOD CHEM, V116, P318, DOI 10.1016/j.foodchem.2009.02.053
   Zhang M, 2009, FOOD CHEM, V115, P826, DOI 10.1016/j.foodchem.2009.01.006
NR 47
TC 12
Z9 14
U1 1
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1573-3149
EI 1573-3904
J9 INT J PEPT RES THER
JI Int. J. Pept. Res. Ther.
PD SEP
PY 2012
VL 18
IS 3
BP 185
EP 192
DI 10.1007/s10989-012-9291-2
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 002NF
UT WOS:000308538200002
DA 2018-10-19
ER

PT J
AU Khoda, AKMB
   Koc, B
AF Khoda, A. K. M. Bashirul
   Koc, Bahattin
TI Designing Controllable Porosity for Multifunctional Deformable Tissue
   Scaffolds
SO JOURNAL OF MEDICAL DEVICES-TRANSACTIONS OF THE ASME
LA English
DT Article
DE porosity; deformed tissue scaffolds; variational porosity
ID FABRICATION; DRESSINGS; POLYMER; BONE
AB Reconstructing or repairing a damaged tissue with porous scaffolds to restore the mechanical, biological, and chemical functions is one of the major tissue engineering and wound healing strategies. Recent developments in three-dimensional bioprinting techniques and improvements in the biomaterial properties have made fabrication of controlled and interconnected porous scaffold structures possible. Especially, for wound healing or soft tissue engineering, membranes/scaffolds made out of visco-elastic hydrogels, or other soft biomaterials with regular porous structures are commonly used. When the visco-elastic structures are applied onto a wound or damaged area, various forces might act upon these structures. The applied forces caused by bandage or occlusive dressings, contraction, and/or the self-weight could deform the fabricated scaffolds. As a result, the geometry and the designed porosity changes which eventually alters the desired choreographed functionality. To remedy this problem, a denser scaffold providing higher material concentration could be developed. However, denser scaffolds might have a negative impact on cell proliferation and also could block pathways for nutrient and waste transportation. In this work, a novel multifunctional visco-elastic scaffold modeling has been proposed to control the effective porosity of scaffolds. The designed scaffolds are optimized to provide spatial functionality and controlled material concentration under deformed conditions. The proposed methodology has been implemented and illustrative examples are provided in this paper. Effective porosity between the traditional and the proposed scaffold design have been compared by applying both models on the same free-form surface mimicking a wound. [DOI: 10.1115/1.4007009]
C1 [Koc, Bahattin] Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
   [Khoda, A. K. M. Bashirul] SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
RP Koc, B (reprint author), Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
EM akm32@buffalo.edu; bahattinkoc@sabanciuniv.edu
RI Koc, Bahattin/D-7277-2012
OI Koc, Bahattin/0000-0001-9073-8516
FU EU [PCIG09-GA-2011-294088]
FX This work is partially funded by EU FP7 Marie Curie Grant No.
   PCIG09-GA-2011-294088 awarded to Dr. Koc.
CR Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Eaglstein WH, 2001, DERMATOL SURG, V27, P175, DOI 10.1046/j.1524-4725.2001.00299.x
   Gomez C., 2007, THESIS DREXEL U PHIL
   Hadjizadeh A., 2009, J BIOMED MATER RES A, V93A, P1140
   Hong H, 2008, ASAIO J, V54, P627, DOI 10.1097/MAT.0b013e31818965d3
   Hong H, 2007, COMPOS PART B-ENG, V38, P311, DOI 10.1016/j.compositesb.2006.05.005
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khoda A., 2011, BIOFABRICATION, V3, P1
   Khoda AKMB, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002933
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Ng KW, 2005, J BIOMED MATER RES A, V75A, P425, DOI 10.1002/jbm.a.30454
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   Risbud MV, 2002, J MATER SCI LETT, V21, P1191, DOI 10.1023/A:1016564201212
   Saxena V, 2004, PLAST RECONSTR SURG, V114, P1086, DOI 10.1097/01.prs.0000135330.51408.97
   Six K, 2004, J PHARM SCI-US, V93, P124, DOI 10.1002/jps.10522
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
NR 22
TC 6
Z9 6
U1 0
U2 19
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1932-6181
J9 J MED DEVICES
JI J. Med. Devices
PD SEP
PY 2012
VL 6
IS 3
AR 031003
DI 10.1115/1.4007009
PG 12
WC Engineering, Biomedical
SC Engineering
GA 000TL
UT WOS:000308411500003
DA 2018-10-19
ER

PT J
AU Kucharska, M
   Bubak, G
   Rzodkiewicz, P
   Bojar, W
   Gruber, B
   Krzyszton-Russjan, J
   Marczewska, J
   Karwicka, E
   Koperski, L
   Ciach, T
AF Kucharska, M.
   Bubak, G.
   Rzodkiewicz, P.
   Bojar, W.
   Gruber, B.
   Krzyszton-Russjan, J.
   Marczewska, J.
   Karwicka, E.
   Koperski, L.
   Ciach, T.
TI In vivo evaluation of chitosan/TCP/alginate self-setting biomaterial for
   dental application
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Warsaw Univ Technol, Biomed Engn Lab, Fac Chem & Proc Engn, PL-00661 Warsaw, Poland.
   Med Univ Warsaw, Dept Pathol, Warsaw, Poland.
RI Bubak, Grzegorz/I-3808-2018
OI Bubak, Grzegorz/0000-0001-7938-4016
NR 0
TC 0
Z9 0
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 9
EP 10
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313000036
DA 2018-10-19
ER

PT J
AU Kirkpatrick, CJ
AF Kirkpatrick, C. J.
TI Keynote: Signals in biomaterial constructs to improve bone
   vascularization
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Kirkpatrick, C. J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, D-6500 Mainz, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 21
EP 21
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313000074
DA 2018-10-19
ER

PT J
AU Centola, M
   Abbruzzese, F
   Vadala, G
   Scotti, C
   Barbero, A
   Martin, I
   Trombetta, M
   Marsano, A
   Rainer, A
AF Centola, M.
   Abbruzzese, F.
   Vadala, G.
   Scotti, C.
   Barbero, A.
   Martin, I.
   Trombetta, M.
   Marsano, A.
   Rainer, A.
TI Biomaterial-based anti-angiogenic drug delivery system enhances the in
   vivo chondrogenesis of freshly seeded chondrocytes-based constructs
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 ICFS Univ Hosp Basel, Basel, Switzerland.
   CIR Univ Campus Biomed Rome, Rome, Italy.
RI Vadala, Gianluca/B-1538-2014
OI Vadala, Gianluca/0000-0001-7142-1660
NR 0
TC 0
Z9 0
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 54
EP 54
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313000194
DA 2018-10-19
ER

PT J
AU Rottmar, M
   Richter, M
   Maeder, X
   Grieder, K
   von Rechenberg, B
   Nuss, K
   Zimmermann, E
   Buser, S
   Blume, B
   Bruinink, A
AF Rottmar, M.
   Richter, M.
   Maeder, X.
   Grieder, K.
   von Rechenberg, B.
   Nuss, K.
   Zimmermann, E.
   Buser, S.
   Blume, B.
   Bruinink, A.
TI Revcel, a resorbable biomaterial as wound dressing
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Nolax AG, Empa Swiss Labs Mat Sci & Technol, CABMM Tierspital Zurich, Zurich, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 96
EP 97
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313000351
DA 2018-10-19
ER

PT J
AU Abtahi, B
AF Abtahi, B.
TI Novel biomaterial strategies for repairing musculoskeletal defect
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Abtahi, B.] Shahid Beheshti Univ Med Sci, Tehran, Iran.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 119
EP 119
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313001032
DA 2018-10-19
ER

PT J
AU Coronel, M
   Pedraza, E
   Stabler, C
AF Coronel, M.
   Pedraza, E.
   Stabler, C.
TI Novel oxygen generating biomaterial for enhancing cell survival under
   hypoxic conditions
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Coronel, M.; Pedraza, E.; Stabler, C.] Univ Miami, Coral Gables, FL 33124 USA.
NR 0
TC 0
Z9 0
U1 1
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 120
EP 121
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313001037
DA 2018-10-19
ER

PT J
AU Jain, D
   Ludlow, J
   Halberstadt, C
   Payne, R
   Guthrie, K
   Genheimer, C
   Spencer, T
   Rivera, E
   Garg, N
   Bertram, T
AF Jain, D.
   Ludlow, J.
   Halberstadt, C.
   Payne, R.
   Guthrie, K.
   Genheimer, C.
   Spencer, T.
   Rivera, E.
   Garg, N.
   Bertram, T.
TI Regenerating kidney tissue with a neo-kidney augment implant containing
   selected renal cells and natural biomaterial
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Jain, D.; Ludlow, J.; Halberstadt, C.; Payne, R.; Guthrie, K.; Genheimer, C.; Spencer, T.; Rivera, E.; Garg, N.; Bertram, T.] Tengion Inc, Winston Salem, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 127
EP 127
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313001062
DA 2018-10-19
ER

PT J
AU Porter, PJ
   Meenan, BJ
   Burke, GA
AF Porter, P. J.
   Meenan, B. J.
   Burke, G. A.
TI Retinal pigment epithelial cell viability and functionality on
   electrospun PLLA biomaterial scaffolds
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Porter, P. J.; Meenan, B. J.; Burke, G. A.] Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland.
NR 0
TC 0
Z9 0
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 141
EP 141
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313001116
DA 2018-10-19
ER

PT J
AU Nimeskern, L
   Martinez, H
   Pleumeekers, MM
   Klein, S
   Feldmann, EM
   Rotter, N
   van Osch, GJVM
   Gatenholm, P
   Muller, R
   Stok, KS
AF Nimeskern, L.
   Martinez, H.
   Pleumeekers, M. M.
   Klein, S.
   Feldmann, E. M.
   Rotter, N.
   van Osch, G. J. V. M.
   Gatenholm, P.
   Mueller, R.
   Stok, K. S.
TI Bacterial nano-cellulose is a promising mechanically tuneable
   biomaterial for regenerative tissue engineering of the outer ear
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.
   Chalmers, Gothenburg, Sweden.
   Erasmus MC, Rotterdam, Netherlands.
   Univ Ulm, Med Ctr, D-89069 Ulm, Germany.
RI Stok, Kathryn/A-4871-2011
OI Stok, Kathryn/0000-0002-0522-4180
NR 0
TC 0
Z9 0
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 152
EP 152
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313001157
DA 2018-10-19
ER

PT J
AU Goppelt, A
AF Goppelt, A.
TI Keynote: Fibrin - a biomaterial with a long history and a bright future
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 157
EP 157
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313001175
DA 2018-10-19
ER

PT J
AU Montzka, K
   Laufer, T
   Woltje, M
   Rheinnecker, M
   Heidenreich, A
AF Montzka, K.
   Laeufer, T.
   Woeltje, M.
   Rheinnecker, M.
   Heidenreich, A.
TI Silk - a novel biomaterial for the reconstruction of the urinary tract
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Rhein Westfal TH Aachen, Dept Urol, Aachen, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 180
EP 180
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313001265
DA 2018-10-19
ER

PT J
AU Wang, S
   Taraballi, F
   Sow, WT
   Ow, KSA
   Hartrianti, P
   Ng, KW
AF Wang, S.
   Taraballi, F.
   Sow, W. T.
   Ow, K. S. A.
   Hartrianti, P.
   Ng, K. W.
TI The potential of human hair keratins as a biomaterial for tissue
   engineering and regenerative medicine (TERM) applications
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Wang, S.; Taraballi, F.; Sow, W. T.; Ow, K. S. A.; Hartrianti, P.; Ng, K. W.] Nanyang Technol Univ, Singapore 639798, Singapore.
RI Ng, Kee Woei/B-7242-2008
OI Ng, Kee Woei/0000-0002-7276-3563
NR 0
TC 0
Z9 0
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 215
EP 215
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313001400
DA 2018-10-19
ER

PT J
AU Grotenhuis, N
   van der Toom, H
   Bayon, Y
   Lange, JF
   van Osch, G
   Bastiaansen-Jenniskens, YM
AF Grotenhuis, N.
   van der Toom, H.
   Bayon, Y.
   Lange, J. F.
   van Osch, G.
   Bastiaansen-Jenniskens, Y. M.
TI Inflammatory reaction of macrophages to a contaminated environment
   depends on the biomaterial
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Univ Rotterdam Hosp, Erasmus MC, Dept Otorhinolaryngol, Rotterdam, Netherlands.
   Univ Rotterdam Hosp, Erasmus MC, Dept Gen Surg, Rotterdam, Netherlands.
   Univ Rotterdam Hosp, Erasmus MC, Dept Orthopaed, Rotterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 218
EP 218
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313002005
DA 2018-10-19
ER

PT J
AU Pilmane, M
   Salms, G
   Salma, I
   Skagers, A
AF Pilmane, M.
   Salms, G.
   Salma, I.
   Skagers, A.
TI Characterization of biocompatibility after different biomaterial
   implantation in bone of experimental animals
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Riga Stradins Univ, Riga, Latvia.
   Riga Tech Univ, Riga, Latvia.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 222
EP 222
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313002021
DA 2018-10-19
ER

PT J
AU Chatzinikolaidou, M
   Simantirakis, E
   Terzaki, K
   Farsari, M
   Vamvakaki, M
   Mitraki, A
AF Chatzinikolaidou, M.
   Simantirakis, E.
   Terzaki, K.
   Farsari, M.
   Vamvakaki, M.
   Mitraki, A.
TI Designing functional self-assembling peptides as biomaterial-scaffolds
   for bone repair
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Univ Crete, Dept Mat Sci & Technol, Khania, Greece.
RI Terzaki, Konstantina/A-2389-2014; Vamvakaki, Maria/A-4443-2014;
   Chatzinikolaidou, Maria/H-1061-2014
OI Chatzinikolaidou, Maria/0000-0002-2749-2506
NR 0
TC 0
Z9 0
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 226
EP 226
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313002037
DA 2018-10-19
ER

PT J
AU Yang, TL
   Lin, L
   Young, TH
   Lee, HW
   Hsiao, YC
AF Yang, T. L.
   Lin, L.
   Young, T. H.
   Lee, H. W.
   Hsiao, Y. C.
TI Formation of tissue structure by engineering epithelial progenitor cells
   of glandular organs by biomaterial cultivation
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.
   Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei, Taiwan.
   Natl Taiwan Univ, Coll Engn, Taipei, Taiwan.
   Taipei City Hosp, Zhongxing Branch, Dept Ophthalmol, Taipei, Taiwan.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 244
EP 244
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313002104
DA 2018-10-19
ER

PT J
AU Young, KS
   Kyoung-Hwan, C
   Jick, KY
   Hyune, CB
   Ra, PS
   Byoung-Hyun, M
AF Young, K. Sun
   Kyoung-Hwan, C.
   Jick, K. Young
   Hyune, C. Byung
   Ra, P. So
   Byoung-Hyun, M.
TI Inhibitory effect of porcine cartilage-derived water-soluble biomaterial
   on angiogenesis
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
   Ajou Univ, Med Ctr, Cell Therapy Ctr, Suwon 441749, South Korea.
   Inha Univ, Coll Med, Div Biomed & Bioengn Sci, Inchon, South Korea.
   Ajou Univ, Dept Orthoped Surg, Sch Med, Suwon 441749, South Korea.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 304
EP 304
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313002322
DA 2018-10-19
ER

PT J
AU Malayeri, A
   Gabbott, C
   Reilly, G
   Ghassemieh, E
   Hatton, PV
   Claeyssens, F
AF Malayeri, A.
   Gabbott, C.
   Reilly, G.
   Ghassemieh, E.
   Hatton, P. V.
   Claeyssens, F.
TI Feasibility of 3D printing and stereolithography for fabrication of
   custom-shaped poly (lactic acid): hydroxyapatite composite biomaterial
   scaffolds
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Univ Sheffield, Sch Clin Dent, Ctr Biomat & Tissue Engn, Sheffield S10 2TN, S Yorkshire, England.
RI Claeyssens, Frederik/E-4781-2011
OI Claeyssens, Frederik/0000-0002-1030-939X
NR 0
TC 2
Z9 2
U1 1
U2 36
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 367
EP 367
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313003161
DA 2018-10-19
ER

PT J
AU Rnjak-Kovacina, J
   Wray, LS
   Mandal, BB
   Gil, ES
   Weiss, AS
   Kaplan, DL
AF Rnjak-Kovacina, J.
   Wray, L. S.
   Mandal, B. B.
   Gil, E. S.
   Weiss, A. S.
   Kaplan, D. L.
TI Versatile biomaterial scaffold platform for critically-sized tissue
   constructs
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Indian Inst Technol, Gauhati, India.
   Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
RI Rnjak-Kovacina, Jelena/B-8928-2014
NR 0
TC 0
Z9 0
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 387
EP 387
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313003231
DA 2018-10-19
ER

PT J
AU Inglin, R
   Brugger, L
   Notzli, S
   Candinas, D
   Eberli, D
AF Inglin, R.
   Bruegger, L.
   Noetzli, S.
   Candinas, D.
   Eberli, D.
TI Multi-layered hybrid biomaterial for the engineering of colon tissue
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 Univ Zurich Hosp, Lab Tissue Engn & Regenerat Med, Dept Urol, Zurich, Switzerland.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP
PY 2012
VL 6
SU 1
SI SI
BP 411
EP 411
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 999LG
UT WOS:000308313003313
DA 2018-10-19
ER

PT J
AU Guo, L
   Wang, W
   Chen, ZP
   Zhou, R
   Liu, Y
   Yuan, Z
AF Guo Lei
   Wang Wei
   Chen ZhiPing
   Zhou Rong
   Liu Yuan
   Yuan Zhi
TI Promotion of microvasculature formation in alginate composite hydrogels
   by an immobilized peptide GYIGSRG
SO SCIENCE CHINA-CHEMISTRY
LA English
DT Article
DE GYIGSRG; alginate composite hydrogel; angiogenesis; tissue engineering
ID TISSUE; ANGIOGENESIS; SURFACES; DELIVERY; MODEL; VEGF
AB The ability to create artificial thick tissues is a major tissue engineering problem, requiring the formation of a suitable vascular supply. In this work we examined the ability of inducing angiogenesis in a bioactive hydrogel. GYIGSRG (NH2-Gly-Tyr-Ile-Gly-Ser-Arg-Gly-COOH, GG) has been conjugated to sodium alginate (ALG) to synthesize a biological active biomaterial ALG-GG. The product was characterized by H-1 NMR, FT-IR and elemental analysis. A series of CaCO3/ALG-GG composite hydrogels were prepared by crosslinking ALG-GG with D-glucono-delta-lactone/calcium carbonate (GDL/CaCO3) in different molar ratios. The mechanical strength and swelling ratio of the composite hydrogels were studied. The results revealed that both of them can be regulated under different preparation conditions. Then, CaCO3/ALG-GG composite hydrogel was implanted in vivo to study the ability to induce angiogenesis. The results demonstrated that ALG-GG composited hydrogel can induce angiogenesis significantly compared with non-modified ALG group, and it may be valuable in the development of thick tissue engineering scaffold.
C1 [Guo Lei; Wang Wei; Chen ZhiPing; Zhou Rong; Liu Yuan; Yuan Zhi] Nankai Univ, Inst Polymer Chem, Minist Educ, Key Lab Funct Polymer Mat, Tianjin 300071, Peoples R China.
RP Wang, W (reprint author), Nankai Univ, Inst Polymer Chem, Minist Educ, Key Lab Funct Polymer Mat, Tianjin 300071, Peoples R China.
EM duruo@nankai.edu.cn; zhiy@nankai.edu.cn
FU National Basic Research Program of China (973 Project) [2011CB606202]
FX This work was financially supported by the National Basic Research
   Program of China (973 Project, 2011CB606202).
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Davidovich-Pinhas M, 2010, CARBOHYD POLYM, V79, P1020, DOI 10.1016/j.carbpol.2009.10.036
   DEE KC, 1994, MATER RES SOC SYMP P, V331, P115
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Jun HW, 2005, J BIOMED MATER RES B, V72B, P131, DOI 10.1002/jbm.b.30135
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Kong HJ, 2008, PHARM RES, V25, P1230, DOI 10.1007/s11095-007-9526-7
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Meinhart JG, 2005, TISSUE ENG, V11, P887, DOI 10.1089/ten.2005.11.887
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Monteiro G.A., 2009, TISSUE ENG PART A, V17, P1663
   Moya ML, 2010, BIOMATERIALS, V31, P2816, DOI 10.1016/j.biomaterials.2009.12.053
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Saik JE, 2011, BIOMACROMOLECULES, V12, P2715, DOI 10.1021/bm200492h
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shi HF, 2008, TISSUE ENG PT A, V14, P1775, DOI 10.1089/ten.tea.2007.0007
   Wang CY, 2008, CARBOHYD POLYM, V71, P476, DOI 10.1016/j.carbpol.2007.06.018
   Wang JX, 2009, CHINESE J ANAL CHEM, V37, P648
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   [赵名艳 Zhao Mingyan], 2010, [功能材料, Journal of Functional Materials], V41, P1353
NR 26
TC 4
Z9 4
U1 1
U2 32
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7291
J9 SCI CHINA CHEM
JI Sci. China-Chem.
PD SEP
PY 2012
VL 55
IS 9
BP 1781
EP 1787
DI 10.1007/s11426-012-4513-1
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 997UN
UT WOS:000308192400015
DA 2018-10-19
ER

PT J
AU Singh, VK
   Reddy, BR
AF Singh, Vinay Kumar
   Reddy, B. Ravindra
TI Synthesis and characterization of bioactive zirconia toughened alumina
   doped with HAp and fluoride compounds
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Sintering; Nanocomposites; Mechanical properties; Apatite; Biomedical
   applications
ID MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS; PHASE-STABILITY;
   COMPOSITE; CERAMICS; BIOCOMPATIBILITY; NANOCOMPOSITE; BIOMATERIAL;
   ZRO2-AL2O3; TOUGHNESS
AB Alumina zirconia nanostructured composites (ZrO2 addition by 20 wt%) were prepared using combined gelation precipitation process. A modified sol gel process has been developed to prepare nano structured spinel [MgAl2O4], Al2O3, ZrO2 and their composite materials. This process is useful in retaining tetragonal phase of zirconia at room temperature, which provides transformation toughening in the nano composites. Dried gels powders were calcined up to 1250 degrees C. Similarly, hydroxyapatite powders were produced by wet-chemical method and calcined at different temperatures. All the dried gel and calcined powders were characterized by using X-ray diffraction, DTA/TGA and SEM. Samples were prepared by uniaxial pressing the composites powders using ZTA, HAp, MgF2 and CaF2 in different ratio. Incorporation of CaF2 and MgF2 as a source for fluorine was also done to improve the sinterability of composites. The samples were sintered at 1400 degrees C for three hours. Densification and mechanical behaviour of sintered samples were observed. Bioactivities of all compositions were tested using SBF solution and then characterizing by FTIR. The main objective of work was to dope ZTA nano composites with HAp and fluoride compounds to obtain better sinterability at lower temperatures. Then evaluate the obtained ZTA based bioactive composite ceramics that have high mechanical strengths. This study verifies the bioactivities of HAp-added ZTA composites. (c) 2012 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Singh, Vinay Kumar; Reddy, B. Ravindra] Banaras Hindu Univ, Inst Technol, Dept Ceram Engn, Varanasi 221005, Uttar Pradesh, India.
RP Singh, VK (reprint author), Banaras Hindu Univ, Inst Technol, Dept Ceram Engn, Varanasi 221005, Uttar Pradesh, India.
EM vinaycer@gmail.com
CR Adolfsson E, 2000, J AM CERAM SOC, V83, P2798
   [Anonymous], 2003, BIOMATERIALS, V24, P667
   Antoni P., 2005, ENG MAT, V7, P11
   AYED FB, 2000, J EUR CERAM SOC, V20, P1069
   Blaker JJ, 2004, BIOMATERIALS, V25, P1319, DOI 10.1016/j.biomaterials.2003.08.007
   BRAUN LM, 1992, J AM CERAM SOC, V75, P3049, DOI 10.1111/j.1151-2916.1992.tb04385.x
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Choi JW, 1998, J AM CERAM SOC, V81, P1743
   Correa C., 2004, MAT RES, V7, P643
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   DUCHEYNE P, 1993, INTRO BIOCERAMICS, P281
   Duff E. J., 1980, ADV BIOMATER, V2, P465
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Gremillard L., 2007, 20 INT S CERM MED, P791
   Gu YW, 2005, BIOMATERIALS, V26, P713, DOI 10.1016/j.biomaterials.2004.03.019
   Heimann RB, 1997, J MATER SCI LETT, V16, P437, DOI 10.1023/A:1018591605388
   Hongbo G., 2010, ACTA BIOMATER, V6, P229
   INGRAM GS, 1980, CARIES RES, V14, P298, DOI 10.1159/000260467
   Kim DJ, 2000, J BIOMED MATER RES, V53, P438, DOI 10.1002/1097-4636(2000)53:4<438::AID-JBM19>3.0.CO;2-3
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kong YM, 2005, BIOMATERIALS, V26, P509, DOI 10.1016/j.biomaterials.2004.02.061
   Kong YM, 2002, J BIOMED MATER RES, V63, P714, DOI 10.1002/jbm.10392
   KRAJEWSKI A, 1990, J MATER SCI, V25, P3203, DOI 10.1007/BF00587675
   LEGEROS RZ, 1983, J DENT RES, V62, P138, DOI 10.1177/00220345830620021101
   Lenk R, 2005, CER ORTHO, P175, DOI 10.1007/3-7985-1540-9_27
   LI J, 1993, J MATER SCI-MATER M, V4, P50, DOI 10.1007/BF00122977
   Mobasherpour I, 2009, CERAM INT, V35, P1569, DOI 10.1016/j.ceramint.2008.08.017
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   Moussa H., 2000, J BIOMED MATER RES, V52, P422
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pyda W., 2001, COMPOSITES, V1-2, P133
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   Rajarao W., 1974, J DENT, V53, P1351
   Rapacz-Kmita A, 2006, J EUR CERAM SOC, V26, P1481, DOI 10.1016/j.jeurceramsoc.2005.01.059
   Razavi M, 2010, MATER CHARACT, V61, P1363, DOI 10.1016/j.matchar.2010.09.008
   Ruhle M., 1984, ADV CERAM, P14
   Shackelford J.F., 2001, MAT SCI ENG HDB, P461
   Silva VV, 2001, COMPOS SCI TECHNOL, V61, P301, DOI 10.1016/S0266-3538(00)00222-0
   Singh V.K., 2011, TECHN P NAT S CER EN, P204
   Singh V.K., 1996, P IND CER SOC, P197
   Singh V.K., 2008, INDOCERAM, V45, P34
   Singh V.K., 2006, ADV APPL CERAM, V22, P1
   Singh V.K., 1993, THESIS IT BHU
   Singh VK, 2008, TRANS INDIAN CERAM S, V66, P85
   SINGH VK, 1994, MATER LETT, V18, P201, DOI 10.1016/0167-577X(94)90231-3
   Singh VK, 1997, MATER LETT, V31, P281, DOI 10.1016/S0167-577X(96)00286-8
   Suchanek W, 1997, BIOMATERIALS, V18, P923, DOI 10.1016/S0142-9612(97)00019-7
   Tanaka K, 2003, J BIOMED MATER RES A, V67A, P200, DOI 10.1002/jbm.a.10006
   Thamaraiselvi TV, 2004, TRENDS BIOMATER ARTI, V19, P9
   Wang J, 2010, SURF COAT TECH, V204, P2576, DOI 10.1016/j.surfcoat.2010.01.042
   Yap AUJ, 2002, BIOMATERIALS, V23, P955, DOI 10.1016/S0142-9612(01)00208-3
   Yuan L.A., 2010, ACTA BIOMATER, V6, P4143
NR 53
TC 10
Z9 10
U1 1
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD SEP
PY 2012
VL 38
IS 7
BP 5333
EP 5340
DI 10.1016/j.ceramint.2012.03.039
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 982FD
UT WOS:000307027300002
DA 2018-10-19
ER

PT J
AU van der Hagen, SJ
   van der Meer, W
   Soeters, PB
   Baeten, CG
   van Gemert, WG
AF van der Hagen, S. J.
   van der Meer, W.
   Soeters, P. B.
   Baeten, C. G.
   van Gemert, W. G.
TI A prospective non-randomized two-centre study of patients with passive
   faecal incontinence after birth trauma and patients with soiling after
   anal surgery, treated by elastomer implants versus rectal irrigation
SO INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
LA English
DT Article
DE Passive faecal incontinence; Birth trauma; Anal surgery; Elastomer
   implants
ID INJECTABLE SILICONE BIOMATERIAL; SPHINCTER DYSFUNCTION; DYNAMIC
   GRACILOPLASTY; MANAGEMENT; INJECTION; PRESSURE; PTQ(TM)
AB This study is a prospective evaluation of patients with passive faecal incontinence and patients with soiling treated by elastomer implants and rectal irrigation.
   Patients with passive faecal incontinence after birth trauma resulting from a defect of the internal sphincter and patients with soiling after previous anal surgery were included. All patients underwent endo-anal ultrasound, magnetic resonance imaging, and anal manometry. The patients with passive faecal incontinence were initially treated by anal sphincter exercises and biofeedback therapy during half a year. The patients completed incontinence scores, a quality of life questionnaire, and a 2-week diary card.
   The elastomer group consisted of 30 males and 45 females with a mean age of 53 years (25-77). The rectal irrigation group consisted of 32 males and 43 females with a mean age of 50 years (25-74). At 6 months follow-up, 30 patients with soiling of the rectal irrigation group and only nine patients of the elastomer group were completely cured (p = 0.02). Only three patients with passive faecal incontinence were cured in the rectal irrigation group and none in the elastomer group. Three distal migrations of elastomer implants required removal at follow-up.
   After patients had performed anal sphincter exercises, no clear improvement of passive faecal incontinence was obtained by elastomer implants or rectal irrigation. However, rectal irrigation is far more effective than elastomer implants in patients with soiling.
C1 [van der Hagen, S. J.; Soeters, P. B.; Baeten, C. G.; van Gemert, W. G.] Univ Hosp Maastricht, Dept Surg, NL-9501 Stadskanaal, HE, Netherlands.
   [van der Hagen, S. J.; van der Meer, W.] NPBC, Assen, Netherlands.
   [van der Hagen, S. J.; van der Meer, W.] Refaja Hosp, Stadskanaal, Netherlands.
RP van der Hagen, SJ (reprint author), Univ Hosp Maastricht, Dept Surg, Boerhaavestr 1, NL-9501 Stadskanaal, HE, Netherlands.
EM s.vanderhagen@refaja.nl
CR Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Bharucha AE, 2005, GASTROENTEROLOGY, V129, P42, DOI 10.1053/j.gastro.2005.04.006
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   Deutekom M, 2005, COLORECTAL DIS, V7, P263, DOI 10.1111/j.1463-1318.2005.00772.x
   DUTHIE HL, 1965, GUT, V6, P64, DOI 10.1136/gut.6.1.64
   FELTBERSMA RJF, 1989, INT J COLORECTAL DIS, V4, P37, DOI 10.1007/BF01648548
   FRENCKNER B, 1975, GUT, V16, P482, DOI 10.1136/gut.16.6.482
   FRENCKNER B, 1975, GUT, V16, P638, DOI 10.1136/gut.16.8.638
   Geerdes BP, 1996, DIS COLON RECTUM, V39, P912, DOI 10.1007/BF02053991
   Gosselink MP, 2005, COLORECTAL DIS, V7, P65, DOI 10.1111/j.1463-1318.2004.00696.x
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   HOFFMANN BA, 1995, DIS COLON RECTUM, V38, P746, DOI 10.1007/BF02048034
   Johanson JF, 1996, AM J GASTROENTEROL, V91, P33
   KATZ C, 1987, J PEDIATR SURG, V22, P976, DOI 10.1016/S0022-3468(87)80605-X
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870
   Lightner Deborah J, 2002, Curr Opin Urol, V12, P333, DOI 10.1097/00042307-200207000-00012
   LODER PB, 1994, BRIT J SURG, V81, P946, DOI 10.1002/bjs.1800810707
   Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Oliveira LCC, 2009, SURG INNOV, V16, P155, DOI 10.1177/1553350609338374
   SHAFIK A, 1993, INT SURG, V78, P159
   Sielezneff I, 1999, BRIT J SURG, V86, P61
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   STARK LJ, 1990, J PEDIATR PSYCHOL, V15, P659, DOI 10.1093/jpepsy/15.5.659
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tod Angela Mary, 2007, Br J Nurs, V16, P858
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   van der Hagen SJ, 2007, BRIT J SURG, V94, P222, DOI 10.1002/bjs.5463
   van der Hagen SJ, 2011, TECH COLOPROCTOL, V15, P291, DOI 10.1007/s10151-011-0709-1
NR 36
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0179-1958
J9 INT J COLORECTAL DIS
JI Int. J. Colorectal Dis.
PD SEP
PY 2012
VL 27
IS 9
BP 1191
EP 1198
DI 10.1007/s00384-012-1468-9
PG 8
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 997RH
UT WOS:000308183300009
PM 22576903
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Jensen, CL
   Petersen, MM
   Schroder, HM
   Lund, B
AF Jensen, Claus L.
   Petersen, Michael M.
   Schroder, Henrik M.
   Lund, Bjarne
TI Bone mineral density changes of the proximal tibia after revision total
   knee arthroplasty. A randomised study with the use of porous tantalum
   metaphyseal cones
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Article
ID X-RAY ABSORPTIOMETRY; FOLLOW-UP; DUAL-PHOTON; REPLACEMENT; BIOMATERIAL;
   COMPONENTS; FEMUR
AB Forty patients were enrolled in a prospective randomised study using conventional method or "Trabecular Metal Cone" (TM Cone) (Zimmer inc., Warsaw, USA) for reconstruction of bone loss of the proximal tibia during revision total knee arthroplasty (rTKA). The aim was to evaluate changes in bone mineral density (BMD) at the proximal tibia.
   Thirty-six patients [median 67 years (range: 40-85 years)] received rTKA with NexGenA (R) (Zimmer Warsaw, USA) revision system. Knee SocietyA ' s Knee Scoring System and the Anderson Orthopaedic Research Institute (AORI) bone classification was used. Changes in BMD were measured by dual energy X-ray absorptiometry (DEXA).
   Knee and function score improved in both groups. No significant changes between the groups were found. Changes in BMD within the two groups were quite similar. Overall decreases in BMD of 0.1 - 5.4 % were found in both groups (ROI 1-6) postoperative to 12 months of follow-up, except that ROI 7 showed an increase in BMD (0.8 - 1.3 %). After 24 months of follow-up, an increase in BMD was found along the stem (ROI 2-5) of 1.9 - 6.3 % , with significant changes in the TM Cone Group (ROI 3, 4, 5) . No significant changes in BMD between the groups were found.
   The bone remodelling pattern was almost the same in the two groups after two years.
C1 [Jensen, Claus L.; Petersen, Michael M.; Schroder, Henrik M.; Lund, Bjarne] Univ Copenhagen, Rigshosp, Dept Orthopaed Surg U, DK-2100 Copenhagen O, Denmark.
RP Jensen, CL (reprint author), Univ Copenhagen, Rigshosp, Dept Orthopaed Surg U, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.
EM clindkaer@gmail.com
FU Maggie og Svend Fritzches Mindelegat, Zimmer, Nordic Medical Supply, and
   Hovedstadens Sygehusfaellesskab (H:S)
FX We thank laboratory technician Karen-Elisabeth Sonderlev for help with
   performing the DEXA measurements. The DEXA scanner was donated by The
   Velux Foundation of 1981. Financial support was received from Maggie og
   Svend Fritzches Mindelegat, Zimmer, Nordic Medical Supply, and
   Hovedstadens Sygehusfaellesskab (H:S).
CR Benjamin J, 2001, CLIN ORTHOP RELAT R, P62
   Berend KR, 2009, CLIN ORTHOP RELAT R, V467, P485, DOI 10.1007/s11999-008-0329-x
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006
   Engh GA, 1998, ORTHOP CLIN N AM, V29, P205, DOI 10.1016/S0030-5898(05)70319-9
   Engh GA, 2007, J BONE JOINT SURG AM, V89A, P2640, DOI 10.2106/JBJS.F00865
   FINSEN V, 1988, CALCIFIED TISSUE INT, V42, P1, DOI 10.1007/BF02555831
   Gehrchen PM, 2008, NORD ORT FED 54 C AM
   Gehrchen PM, 2000, HIP INT, V10, P204
   Hernandez-Vaquero D, 2008, INT ORTHOP, V32, P47, DOI 10.1007/s00264-006-0280-y
   INSALL JN, 1989, CLIN ORTHOP RELAT R, P13
   Jarvinen M, 1997, J BONE JOINT SURG AM, V79A, P263, DOI 10.2106/00004623-199702000-00017
   Li MG, 2000, J ORTHOPAED RES, V18, P40, DOI 10.1002/jor.1100180107
   MAZESS RB, 1988, ANN CHIR GYNAECOL FE, V77, P197
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   Peters CL, 2005, J ARTHROPLASTY, V20, P302, DOI 10.1016/j.arth.2004.08.010
   Petersen MM, 1996, CALCIFIED TISSUE INT, V59, P311, DOI 10.1007/s002239900131
   Petersen MM, 2005, J ARTHROPLASTY, V20, P516, DOI 10.1016/j.arth.2004.09.041
   Petersen MM, 1995, ACTA ORTHOP SCAND, V66, P513, DOI 10.3109/17453679509002305
   PETERSEN MM, 1995, J ARTHROPLASTY, V10, P7
   Robertsson O, 2001, ACTA ORTHOP SCAND, V72, P503, DOI 10.1080/000164701753532853
   Trevisan C, 1998, CALCIFIED TISSUE INT, V62, P359, DOI 10.1007/s002239900444
   Wilkinson JM, 2001, J BONE JOINT SURG BR, V83B, P283, DOI 10.1302/0301-620X.83B2.10562
NR 25
TC 12
Z9 13
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2695
EI 1432-5195
J9 INT ORTHOP
JI Int. Orthop.
PD SEP
PY 2012
VL 36
IS 9
BP 1857
EP 1863
DI 10.1007/s00264-012-1601-y
PG 7
WC Orthopedics
SC Orthopedics
GA 995FW
UT WOS:000307994300015
PM 22733440
OA Green Published
DA 2018-10-19
ER

PT J
AU Koller, U
   Nehrer, S
   Vavken, P
   Kapeller, B
   Windhager, R
   Chiari, C
AF Koller, Ulrich
   Nehrer, Stefan
   Vavken, Patrick
   Kapeller, Barbara
   Windhager, Reinhard
   Chiari, Catharina
TI Polyethylene terephthalate (PET) enhances chondrogenic differentiation
   of ovine meniscocytes in a hyaluronic acid/polycaprolactone scaffold in
   vitro
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Article
ID CARTILAGE REPAIR; BONE; MENISCECTOMY; MENISCUS; MATRIX; REGENERATION;
   POLYMERS; BEHAVIOR; DEFECTS; MODEL
AB The purpose of this study was to assess the effect of polyethylene terephthalate (PET) on proliferation, differentiation, and attachment of ovine meniscocytes seeded in a hyaluronic acid/polycaprolactone biomaterial (BF-1)
   BF-1 (30 % hyaluronic acid and 70 % polycaprolactone) cylinders with PET (CO-PET) or without PET, were seeded with 2x10(6) ovine meniscus cells. The specimens were harvested in triplets at 12 hours, seven, 14, 21 and 28 days. DNA content was measured to test proliferation, histological analysis for cell morphology, and biochemical assessment of glycosaminoglycan content and RT-PCR for type I and II collagen were used to assess differentiation, with immunohistochemistry as post-translational control. Attachment was evaluated by electronic microscopy at 28 days.
   DNA content was consistent and equal across groups, suggesting no effect of PET on cell proliferation. However, the BF-1 CO-PET showed a higher percentage of cells with spherical morphology which is typical for a chondrocytic phenotype. This biomaterial with PET also showed a higher type II collagen mRNA expression and an eightfold higher GAG-content than the material without PET. Small amounts of type I collagen mRNA expression were present on both materials at all time points. PCR results were confirmed by immunohistochemistry.
   Addition of PET to a hyaluronic acid/polycaprolactone biomaterial enhances a cartilaginous phenotype, increased type II collagen mRNA expression and a higher GAG production in ovine mensicocytes.
C1 [Koller, Ulrich; Windhager, Reinhard; Chiari, Catharina] Med Univ Vienna, Dept Orthopaed, A-1090 Vienna, Austria.
   [Nehrer, Stefan] Danube Univ Krems, Ctr Regenerat Med, A-3500 Krems, Austria.
   [Vavken, Patrick] Harvard Univ, Sch Med, Dept Orthoped Surg, Sports Med Res Lab,Childrens Hosp Boston, Boston, MA 02115 USA.
   [Vavken, Patrick] Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Boston, MA 02115 USA.
   [Kapeller, Barbara] Med Univ Vienna, Core Unit Biomed Res, A-1090 Vienna, Austria.
RP Koller, U (reprint author), Med Univ Vienna, Dept Orthopaed, Waehringer Gurtel 18-20, A-1090 Vienna, Austria.
EM Ulrich.Koller@meduniwien.ac.at
FU European Commission Fifth Framework Program [GRD1-2001-40401,
   G5RD-CT-2002-00703]
FX This research was supported by the European Commission Fifth Framework
   Program (Project title: Innovative materials and technologies for a
   bio-engineered meniscus substitute, Project No GRD1-2001-40401, Contract
   No G5RD-CT-2002-00703). The authors wish to thank Guenther Brand and
   Ruth Gruebl for their assistance with the preparation of the
   histological specimens.
CR Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305
   Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS244
   Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X
   Chiari C, 2006, OSTEOARTHR CARTILAGE, V14, P1056, DOI 10.1016/j.joca.2006.04.007
   Chiari C, 2008, TISSUE ENG PT A, V14, P1295, DOI [10.1089/ten.tea.2007.0341, 10.1089/tea.2007.0341]
   Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Inui A, 2010, INT ORTHOP, V34, P1327, DOI 10.1007/s00264-009-0917-8
   Ivkovic A, 2010, GENE THER, V17, P779, DOI 10.1038/gt.2010.16
   Ivkovic Alan, 2011, Front Biosci (Elite Ed), V3, P923
   KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003
   MOW V.C., 1992, KNEE MENISCUS BASIC
   Nakata K, 2001, CLIN ORTHOP RELAT R, pS208
   Nehrer S, 2006, EUR J RADIOL, V57, P3, DOI 10.1016/j.ejrad.2005.08.005
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Pecina M, 2007, INT ORTHOP, V31, P719, DOI 10.1007/s00264-007-0425-7
   Roos H, 1998, ARTHRITIS RHEUM, V41, P687, DOI 10.1002/1529-0131(199804)41:4<687::AID-ART16>3.0.CO;2-2
   Seedhom BB, 1975, ANN RHEUM DIS, V34, P118
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515
   Wyland DJ, 2002, J ORTHOP RES, V20, P996, DOI 10.1016/S0736-0266(02)00022-0
NR 24
TC 2
Z9 2
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2695
EI 1432-5195
J9 INT ORTHOP
JI Int. Orthop.
PD SEP
PY 2012
VL 36
IS 9
BP 1953
EP 1960
DI 10.1007/s00264-012-1534-5
PG 8
WC Orthopedics
SC Orthopedics
GA 995FW
UT WOS:000307994300029
PM 22476452
OA Green Published
DA 2018-10-19
ER

PT J
AU Zhou, Y
   Li, HY
   Lin, KL
   Zhai, WY
   Gu, WM
   Chang, J
AF Zhou, Yue
   Li, Hongying
   Lin, Kaili
   Zhai, Wanying
   Gu, Weiming
   Chang, Jiang
TI Effect of heat treatment on the properties of SiO2-CaO-MgO-P2O5
   bioactive glasses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; IN-VITRO; SCAFFOLDS; CALCIUM; OSTEOBLASTS;
   DIFFERENTIATION; MINERALIZATION; BIOCERAMICS; CERAMICS; BEHAVIOR
AB Since the invention of 45S5 Bioglass, researchers never stopped exploring new generation bioactive glass (BG) materials for wider applications in regenerative medicine, among which a novel SiO2-CaO-MgO-P2O5 bioactive glass (BG20) is an excellent candidate. However, apart from their biocompatibility and bioactivity, a porous structure is also a must for a tissue engineering scaffold in successfully fixing bone defect. The porosity is the outcome of the high temperature (500-1,000 A degrees C) treatment in the fabricating process of the bioglass scaffold. Under the high temperature, the amorphous glass material will become crystallized at certain percentage in the glass matrix, and possibly leading to consequent changes in the mechanical strength, biodegradability and bioactivity. To elucidate the effect of phase transition on the change of the properties of BG20, the experiments in this report were designed to fine-tuning the heat treating temperatures to fabricate a series of BG20 powders with different crystallization structures. X-ray diffraction revealed a positive correlation between the heating temperature and the crystallization, as well as the compressive strength of the materials. In vitro degradation and ion analysis by ICP-AES demonstrated a similar releasing behavior of different ions including Mg2+, Ca2+ and Si4+, which in common is the tendency of decreasing of the ion concentration along with the increasing of the treating temperature. Cell proliferation assay using both mouse fibroblasts (NIH3T3) and bone marrow stromal cells (BMSCs) showed little toxicity of the ionic extract of the BG20 powders at all the treating temperatures, while fibroblasts demonstrated a significant promoting in the percentage of proliferation. Furthermore, reverse-transcription and polymerase chain reaction analysis on two representative marker genes for early osteogenesis and endochondral ossification, respectively, type I collagen alpha 1 and Indian Hedge-hog, showed an interesting induction of both genes over their basal levels by the treatment of the ionic extract of BG20, implying its important capability in regulating the fate of differentiation of the BMSCs as a novel biomaterial in bone tissue engineering.
C1 [Zhou, Yue; Li, Hongying; Chang, Jiang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.
   [Zhou, Yue; Li, Hongying; Chang, Jiang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China.
   [Lin, Kaili; Zhai, Wanying; Gu, Weiming; Chang, Jiang] Chinese Acad Sci, State Key Lab High Performance Ceram & Superfine, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Chang, J (reprint author), Shanghai Jiao Tong Univ, Sch Biomed Engn, 1954 Huashan Rd, Shanghai 200030, Peoples R China.
EM jchang@mail.sic.ac.cn
FU Natural Science Foundation of China [30730034, 31070844];
   Multidisciplinary Research Foundation of Shanghai Jiao Tong University
   [YG2010MS84]; State Key laboratory of High Performance Ceramics and
   Superfine Microstructure [SKL2009 10SIC]
FX The authors acknowledge with appreciation the support of this research
   by the Natural Science Foundation of China (Grant Number 30730034,
   31070844), the Multidisciplinary Research Foundation of Shanghai Jiao
   Tong University (Grant Number YG2010MS84) and the State Key laboratory
   of High Performance Ceramics and Superfine Microstructure (grant number
   SKL2009 10SIC).
CR Abed E, 2007, CELL PROLIFERAT, V40, P849, DOI 10.1111/j.1365-2184.2007.00476.x
   Abed E, 2011, CALCIFIED TISSUE INT, V88, P246, DOI 10.1007/s00223-010-9455-z
   Bhakta S, 2010, J MATER SCI-MATER M, V21, P2979, DOI 10.1007/s10856-010-4145-y
   Bombonato-Prado KF, 2009, J BIOMED MATER RES A, V88A, P401, DOI 10.1002/jbm.a.31701
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chen Q, 2006, BIOMATERIALS, V27, P2412
   Chen QZ, 2007, ACTA BIOMATER, V3, P551, DOI 10.1016/j.actbio.2007.01.008
   Ding SJ, 2010, TISSUE ENG PT A, V16, P2343, DOI [10.1089/ten.tea.2009.0749, 10.1089/ten.TEA.2009.0749]
   Du RL, 2006, J BIOMATER APPL, V20, P341, DOI 10.1177/0885328206054535
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   Francis L, 2010, ACTA BIOMATER, V6, P2773, DOI 10.1016/j.actbio.2009.12.054
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hesaraki S, 2009, J MATER SCI-MATER M, V20, P2011, DOI 10.1007/s10856-009-3783-4
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Lefebvre L, 2008, ACTA BIOMATER, V4, P1894, DOI 10.1016/j.actbio.2008.05.019
   Lin TM, 2005, STEM CELLS DEV, V14, P92, DOI 10.1089/scd.2005.14.92
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   Nakano Y, 2004, BONE, V35, P1077, DOI 10.1016/j.bone.2004.07.009
   Radice S, 2007, J BIOMED MATER RES A, V82A, P436, DOI 10.1002/jbm.a.31162
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Varanasi VG, 2009, ACTA BIOMATER, V5, P3536, DOI 10.1016/j.actbio.2009.05.035
   Wolf Federica I., 1999, Frontiers in Bioscience, V4, pd607, DOI 10.2741/Wolf
   Wu CT, 2006, J BIOMED MATER RES B, V78B, P47, DOI 10.1002/jbm.b.30456
NR 35
TC 9
Z9 9
U1 2
U2 31
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2012
VL 23
IS 9
BP 2101
EP 2108
DI 10.1007/s10856-012-4699-y
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 998LY
UT WOS:000308242000007
PM 22699712
DA 2018-10-19
ER

PT J
AU Bohl, A
   Rohm, HW
   Ceschi, P
   Paasche, G
   Hahn, A
   Barcikowski, S
   Lenarz, T
   Stover, T
   Pau, HW
   Schmitz, KP
   Sternberg, K
AF Bohl, Anne
   Rohm, Henning W.
   Ceschi, Piera
   Paasche, Gerrit
   Hahn, Anne
   Barcikowski, Stephan
   Lenarz, Thomas
   Stoever, Timo
   Pau, Hans-Wilhelm
   Schmitz, Klaus-Peter
   Sternberg, Katrin
TI Development of a specially tailored local drug delivery system for the
   prevention of fibrosis after insertion of cochlear implants into the
   inner ear
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GUINEA-PIG COCHLEA; HEARING PRESERVATION; COATED ELECTRODE;
   DEXAMETHASONE; RELEASE; GLUCOCORTICOIDS; BIOMATERIAL; STENTS
AB A cochlear implant (CI)-associated local drug delivery system based on dexamethasone (DMS) was developed with the purpose to inhibit the growth of fibrotic tissue which influences the signal transmission from the CI to the neurons of the inner ear. For the realization of a targeted DMS delivery the following concepts were combined: modification of the silicone-based electrode carrier by incorporation of DMS and a DMS-containing polymeric coating chemically attached on the surface of the electrode carrier. It was demonstrated that the coated CI showed a high coating stability in a simulated implantation procedure. The in vitro drug release studies in a quasi-stationary model revealed a faster DMS release in the initial phase originating from the DMS-containing coatings and then a lower and sustained DMS release originating from the DMS-loaded silicone carrier. The performed in vitro biocompatibility study confirmed that the released DMS was non-toxic for cultured spiral ganglion cells.
C1 [Bohl, Anne; Rohm, Henning W.; Schmitz, Klaus-Peter; Sternberg, Katrin] Univ Rostock, Inst Biomed Engn, D-18119 Rostock, Germany.
   [Ceschi, Piera; Paasche, Gerrit; Lenarz, Thomas] Hannover Med Sch, Dept Otolaryngol, D-30625 Hannover, Germany.
   [Hahn, Anne; Barcikowski, Stephan] Laser Zentrum Hannover eV, D-30419 Hannover, Germany.
   [Stoever, Timo] Goethe Univ Frankfurt, Dept Otolaryngol, D-60590 Frankfurt, Germany.
   [Pau, Hans-Wilhelm] Univ Rostock, Dept Otorhinolaryngol Head & Neck Surg, D-18057 Rostock, Germany.
RP Sternberg, K (reprint author), Univ Rostock, Inst Biomed Engn, Friedrich Barnewitz Str 4, D-18119 Rostock, Germany.
EM katrin.sternberg@uni-rostock.de
RI Barcikowski, Stephan/I-4754-2012
OI Barcikowski, Stephan/0000-0002-9739-7272
FU Deutsche Forschungsgemeinschaft (DFG) [SFB Transregio 37, GZ: TRR 37];
   Bundesministerium fur Bildung und Forschung (BMBF) [FKZ: 03IS2081]
FX The authors would like to thank Peter Littwin, Martina Schroder and
   Andrea Rohde for their technical assistance as well as Thilo Storm and
   Katharina Wulf for their helpful notes and suggestions. Furthermore, the
   Tepha, Inc. (Lexington, MA, USA) and the Bayer MaterialScience AG
   (Leverkusen, Germany) are acknowledged for the supply of the polymeric
   biomaterials P(4HB) and PUR, respectively. This work was funded by the
   Deutsche Forschungsgemeinschaft (DFG) within SFB Transregio 37
   "Mikro-und Nanosysteme in der Medizin-Rekonstruktion biologischer
   Funktionen" (GZ: TRR 37) and the Bundesministerium fur Bildung und
   Forschung (BMBF) within REMEDIS "Hohere Lebensqualitat durch neuartige
   Mikroimplantate" (FKZ: 03IS2081).
CR Arnold W, 2005, AUDIOL NEURO-OTOL, V10, P53, DOI 10.1159/000082575
   Bird PA, 2011, OTOL NEUROTOL, V32, P933, DOI 10.1097/MAO.0b013e3182255933
   Borden RC, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000313506
   Braun S, 2011, ORL-J OTO-RHIN-LARYN, V73, P219, DOI 10.1159/000329791
   Dexamethason, 2009, Arzneistoff-Profile, Basisinformation uber arzneiliche Wirkstoffe, Patent No. 20080033520
   Dittrich B, 2009, BIOMATERIALIEN MUNCH, V10, P61
   Eastwood H, 2010, HEARING RES, V265, P25, DOI 10.1016/j.heares.2010.03.006
   Furze A, 2008, ACTA OTO-LARYNGOL, V128, P122, DOI 10.1080/00016480701390128
   Ghavi FF, 2010, J BIOMED MATER RES B, V94B, P388, DOI 10.1002/jbm.b.31666
   Hargunani CA, 2006, OTOL NEUROTOL, V27, P564, DOI 10.1097/00129492-200606000-00021
   Jolly C, 2010, ADV OTO-RHINO-LARYNG, V67, P28, DOI 10.1159/000262594
   Jolly C, 2008, DEXAMETHASON ARZNEIS, Patent No. US 2008/0033520 A1
   Kukreja N, 2008, PHARMACOL RES, V57, P171, DOI 10.1016/.i.phrs.2008.01.012
   Lanzer P, 2008, HERZ, V33, P334, DOI 10.1007/s00059-008-3080-x
   Maini S, 2009, AUDIOL NEURO-OTOL, V14, P402, DOI 10.1159/000241897
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   Mohammad F, 2012, COCHLEAR IMPLANTS IN, DOI [10.1179/17547628MY.0000000024, DOI 10.1179/17547628MY.0000000024]
   Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071
   Paasche G, 2003, OTOL NEUROTOL, V24, P222, DOI 10.1097/00129492-200303000-00016
   Paasche G, 2006, OTOL NEUROTOL, V27, P639, DOI 10.1097/01.mao.0000227662.88840.61
   Praetorius M, 2001, AUDIOL NEURO-OTOL, V6, P250, DOI 10.1159/000046130
   Radeloff A, 2009, LARYNGOSCOPE, V119, P959, DOI 10.1002/lary.20206
   Rajan GP, 2012, LARYNGOSCOPE, V122, P190, DOI 10.1002/lary.22142
   Salt AN, 2005, DRUG DISCOV TODAY, V10, P1299, DOI 10.1016/S1359-6446(05)03574-9
   Souter M, 2012, OTOL NEUROTOL, V33, P532, DOI 10.1097/MAO.0b013e31824bac44
   Sternberg K, 2007, J MATER SCI-MATER M, V18, P1423, DOI 10.1007/s10856-007-0148-8
   van de Water TR, 2010, ACTA OTO-LARYNGOL, V130, P308, DOI [10.3109/00016480903124655, 10.1080/00016480903124655]
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008
NR 29
TC 19
Z9 20
U1 0
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2012
VL 23
IS 9
BP 2151
EP 2162
DI 10.1007/s10856-012-4698-z
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 998LY
UT WOS:000308242000012
PM 22706626
DA 2018-10-19
ER

PT J
AU Chrzanowski, W
   Kondyurin, A
   Lee, JH
   Lord, MS
   Bilek, MMM
   Kim, HW
AF Chrzanowski, W.
   Kondyurin, A.
   Lee, Jae Ho
   Lord, Megan S.
   Bilek, M. M. M.
   Kim, Hae-Won
TI Biointerface: protein enhanced stem cells binding to implant surface
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NI-TI ALLOY; NICKEL-TITANIUM; MEDICAL APPLICATIONS; IN-VITRO; CORROSION
   BEHAVIOR; ION-IMPLANTATION; NITINOL SURFACES; STAINLESS-STEEL;
   BIOCOMPATIBILITY; BIOMATERIALS
AB The number of metallic implantable devices placed every year is estimated at 3.7 million. This number has been steadily increasing over last decades at a rate of around 8 %. In spite of the many successes of the devices the implantation of biomaterial into tissues almost universally leads to the development of an avascular sac, which consists of fibrous tissue around the device and walls off the implant from the body. This reaction can be detrimental to the function of implant, reduces its lifetime, and necessitates repeated surgery. Clearly, to reduce the number of revision surgeries and improve long-term implant function it is necessary to enhance device integration by modulating cell adhesion and function. In this paper we have demonstrated that it is possible to enhance stem cell attachment using engineered biointerfaces. To create this functional interface, samples were coated with polymer (as a precursor) and then ion implanted to create a reactive interface that aids the binding of biomolecules-fibronectin. Both AFM and XPS analyses confirmed the presence of protein layers on the samples. The amount of protein was significant greater for the ion implanted surfaces and was not disrupted upon washing with detergent, hence the formation of strong bonds with the interface was confirmed. While, for non ion implanted surfaces, a decrease of protein was observed after washing with detergent. Finally, the number of stem cells attached to the surface was enhanced for ion implanted surfaces. The studies presented confirm that the developed bionterface with immobilised fibronectin is an effective means to modulate stem cell attachment.
C1 [Chrzanowski, W.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.
   [Kondyurin, A.; Bilek, M. M. M.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.
   [Lee, Jae Ho; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 330715, South Korea.
   [Lord, Megan S.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   [Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330715, South Korea.
   [Kim, Hae-Won] Dankook Univ, WCU Nanobiomed Sci Res Ctr, Cheonan 330715, South Korea.
RP Chrzanowski, W (reprint author), Univ Sydney, Fac Pharm, Pharm & Bank Bldg A15, Sydney, NSW 2006, Australia.
EM wchrzanowski@sydney.edu.au
RI Kondyurin, Alexey/B-9580-2011; Lord, Megan/D-4673-2013
OI Kondyurin, Alexey/0000-0002-8837-9734; Lord, Megan/0000-0002-0506-9811;
   Bilek, Marcela/0000-0003-3363-2664
CR Abou Neel EA, 2009, J R SOC INTERFACE, V6, P435, DOI 10.1098/rsif.2008.0348
   Abou Neel EA, 2009, J BIOMED MATER RES B, V89B, P392, DOI 10.1002/jbm.b.31227
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   ANDREASEN GF, 1978, AM J ORTHOD DENTOFAC, V73, P141
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P773, DOI 10.1016/j.actbio.2008.02.009
   Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y
   Bilek Marcela M, 2010, Biophys Rev, V2, P55, DOI 10.1007/s12551-010-0028-1
   Bilek MMM, 2011, P NATL ACAD SCI USA, V108, P14405, DOI 10.1073/pnas.1103277108
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Chen YL, 1999, J COLLOID INTERF SCI, V214, P38
   Chrzanowski W, 2008, J MATER SCI-MATER M, V19, P1553, DOI 10.1007/s10856-008-3374-9
   Chrzanowski W, 2005, J MATER PROCESS TECH, V162, P163, DOI 10.1016/j.jmatprotec.2005.02.203
   Chrzanowski W, 2009, EUR CELL MAT S2, V18, P54
   Chrzanowski W, 2008, J R SOC INTERFACE, V5, P1009, DOI 10.1098/rsif.2007.1313
   Chrzanowski W, 2008, J BIOMATER APPL, V23, P51, DOI 10.1177/0885328207083728
   Chrzanowski W, 2010, ADV ENG MATER, V12, pB298, DOI 10.1002/adem.200980083
   Chrzanowski W, 2010, J BIOMED MATER RES A, V93A, P1596, DOI 10.1002/jbm.a.32646
   Chrzanowski W, 2010, MAT SCI ENG C-MATER, V30, P225, DOI 10.1016/j.msec.2009.10.003
   Chrzanowski W, 2008, ACTA BIOMATER, V4, P1969, DOI 10.1016/j.actbio.2008.05.010
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Es-Souni M, 2005, ANAL BIOANAL CHEM, V381, P557, DOI 10.1007/s00216-004-2888-3
   Hallab NJ, 2004, TISSUE ENG, V7, P16
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Kondyurin A, 2008, ACTA BIOMATER, V4, P1218, DOI 10.1016/j.actbio.2008.04.017
   Kondyurin A, 2008, ION BEAM TREATMENT OF POLYMERS: APPLICATION ASPECTS FROM MEDICINE TO SPACE, P205, DOI 10.1016/B978-008044692-9.50011-X
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu LY, 2008, J BIOMAT SCI-POLYM E, V19, P821, DOI 10.1163/156856208784522083
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Lu HT, 2005, MOL CELL BIOCHEM, V279, P45, DOI 10.1007/s11010-005-8215-2
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2004, BIOMATERIALS SCI INT, P465
   Ratner BD, 2007, POLYM INT, V56, P1183, DOI 10.1002/pi.2319
   Richards RG, 2008, EUR CELL MAT S2, V16, P9
   Richards RG, 2007, EUR CELL MAT S1, V14, P44
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001
   Roy RK, 2009, VACUUM, V83, P1179, DOI 10.1016/j.vacuum.2009.03.005
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1999, THESIS FM OULU
   Sachdeva R. C. L., 2001, ENCY MAT SCI TECHNOL, P6155, DOI DOI 10.1016/B0-08-043152-6/01093-7
   Schrader B., 2008, INFRARED RAMAN SPECT
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P3662, DOI 10.1016/j.biomaterials.2009.03.034
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P468, DOI 10.1016/j.biomaterials.2008.10.014
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Tan L, 2003, BIOMATERIALS, V24, P3931, DOI 10.1016/S0142-9612(03)00271-0
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
NR 53
TC 14
Z9 14
U1 1
U2 42
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2012
VL 23
IS 9
BP 2203
EP 2215
DI 10.1007/s10856-012-4687-2
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 998LY
UT WOS:000308242000016
PM 22714559
DA 2018-10-19
ER

PT J
AU Li, ZS
   Yang, XZ
   Guo, HF
   Yang, XC
   Sun, LL
   Dong, SW
AF Li, Zhensheng
   Yang, Xiaozhan
   Guo, Hongfeng
   Yang, Xiaochao
   Sun, Lili
   Dong, Shiwu
TI Hydroxyapatite additive influenced the bioactivity of bioactive
   nano-titania ceramics and new bone-forming capacity
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Hydroxyapatite; Nano-titania ceramics; Bioactivity
ID TI; BIOMATERIAL; ADHESION; IMPLANTS; APATITE
AB Bioceramics plays an important role in bone-substitutes. In this study, titania porous ceramics with excellent bioactivity were prepared using hydroxyapatite (HA, 10 vol.% contents) as a grain growth inhibitor. The pure TiO2 porous ceramics were also prepared as a control. After sintered at 1,000 degrees C with a pressureless sintering method, the particle size of the pure TiO2 and TiO2/HA (10 vol.%) porous ceramics were 450 and 310 nm, respectively. Each of the porous ceramics presented numerous pores, which were cross-connected. The size of the pores ranged from 100 to 300 mu m. There were also profuse micropores inside the pore wall and between the particles. A SBF soaking experiment demonstrated that the HA additive played an important role in promoting apatite formation. The cell proliferation demonstrated that osteoblasts on the TiO2/HA (10 vol.%) porous ceramics proliferated faster than that on the pure TiO2 ceramics. The histological sections and EDX assay results of the two porous ceramics also illustrated that TiO2/HA (10 vol.%) composite ceramics combined with Ca and P elements induced much better apatite formation than that of the pure TiO2 ceramics. These results indicated that titania ceramics combined with HA holds great promise for bone-substitutes.
C1 [Guo, Hongfeng; Dong, Shiwu] Third Mil Med Univ, Tissue Engn Res Ctr Chongqing, Dept Anat, Coll Basic Med Sci, Chongqing 400038, Peoples R China.
   [Li, Zhensheng; Sun, Lili] Third Mil Med Univ, Coll Biomed Engn & Med Imaging, Chongqing 400038, Peoples R China.
   Chongqing Univ Technol, Sch Optoelect Informat, Chongqing 400054, Peoples R China.
RP Dong, SW (reprint author), Third Mil Med Univ, Tissue Engn Res Ctr Chongqing, Dept Anat, Coll Basic Med Sci, Chongqing 400038, Peoples R China.
EM shiwudong@gmail.com
FU National Basic Research Program of China [2011CB964701]; National
   Natural Science Foundation of China [81000670]; key scientific and
   technological projects of Chongqing [2011 AC5025]
FX This work was supported by the National Basic Research Program of China
   (2011CB964701), National Natural Science Foundation of China (81000670),
   and the key scientific and technological projects of Chongqing (2011
   AC5025).
CR Aksakal B, 2007, J FAIL ANAL PREV, V4, P17
   Dimitrievska S, 2011, J BIOMED MATER RES A, V98A, P576, DOI 10.1002/jbm.a.32964
   Gordin DM, 2005, MATER LETT, V59, P2936, DOI 10.1016/j.matlet.2004.09.063
   Jensen H, 2005, APPL SURF SCI, V246, P239, DOI 10.1016/j.apsusc.2004.11.015
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Lee SH, 2006, J BIOMATER APPL, V20, P195, DOI 10.1177/0885328206050518
   Leonor IB, 2008, ACTA BIOMATER, V4, P1349, DOI 10.1016/j.actbio.2008.03.003
   Liu HN, 2011, MAT SCI ENG C-MATER, V31, P77, DOI 10.1016/j.msec.2010.07.013
   Michiko S, 2009, BIOMATERALS, V20, P6143
   Piveteau LD, 1999, J MATER SCI-MATER M, V10, P161, DOI 10.1023/A:1008985423644
   Schwartz AD, 2009, INT J ORAL MAXILLOF, V20, P238
   Seramak T, 2010, J BIOMECH, V43, pS55
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
NR 16
TC 5
Z9 5
U1 1
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD SEP
PY 2012
VL 14
IS 9
AR 1145
DI 10.1007/s11051-012-1145-5
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 998GP
UT WOS:000308225800069
DA 2018-10-19
ER

PT J
AU Re'em, T
   Witte, F
   Willbold, E
   Ruvinov, E
   Cohen, S
AF Re'em, Tali
   Witte, Frank
   Willbold, Elmar
   Ruvinov, Emil
   Cohen, Smadar
TI Simultaneous regeneration of articular cartilage and subchondral bone
   induced by spatially presented TGF-beta and BMP-4 in a bilayer affinity
   binding system
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Affinity-binding scaffold; Bilayer; TGF-beta 1; BMP-4; Subchondral
   defect
ID OSTEOCHONDRAL DEFECTS; ALGINATE BIOMATERIAL; SEQUENTIAL DELIVERY;
   IN-VIVO; REPAIR; CHONDROGENESIS; MODEL; SCAFFOLDS; GROWTH; CELLS
AB Subchondral defect repair is a multitask challenge requiring the simultaneous regeneration of cartilage and bone. Herein, we describe the features of a hydrogel system designed to simultaneously induce the endogenous regeneration of hyaline cartilage and subchondral bone. The system was constructed as two layers, spatially presenting the chondroinductive transforming growth factor-beta 1 (TGF-beta 1) in one layer and the osteoinductive bone morphogenetic protein-4 (BMP-4) in a second layer, via affinity binding to the matrix. Human mesenchymal stem cells seeded in the bilayer system differentiated into chondrocytes and osteoblasts in the respective layers, confirming the spatial presentation and prolonged activity of TGF-beta 1 and BMP-4. Administration of the bilayer system with affinity-bound TGF-beta 1 and BMP-4 (with no cells) into a subchondral defect in rabbits induced endogenous regeneration of articular cartilage and the subchondral bone underneath within 4 weeks. Cartilage extracellular matrix proteoglycans were found in the top layer, with no mineralization, whereas the layer underneath consisted of newly formed woven bone. The results indicate that stem cells migrating into the defect are able to sense the biological cues spatially presented in the hydrogel and respond by differentiation into the appropriate cell lineage. The strategy has a real translational potential for repairing osteochondral defects in humans as it is acellular and can be implanted via a minimally invasive method. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Re'em, Tali; Witte, Frank; Ruvinov, Emil; Cohen, Smadar] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
   [Witte, Frank; Willbold, Elmar] Hannover Med Sch, Lab Biomech & Biomat, D-30625 Hannover, Germany.
RP Cohen, S (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
EM scohen@bgu.ac.il
OI Witte, Frank/0000-0001-9154-6217
FU Azrieli Foundation
FX T.R. acknowledges a generous fellowship from the Azrieli Foundation. We
   thank Oren Levy for his excellent technical assistance with the Western
   blot analyses. This work was done in partial fulfillment of the
   requirements for a PhD degree (T.R.) at the Department of Biotechnology
   Engineering, Ben-Gurion University of the Negev, Israel. S.C. holds the
   Clair and Harold Oshry Professor Chair in Biotechnology.
CR Bessa PC, 2009, PROTEIN EXPRES PURIF, V63, P89, DOI 10.1016/j.pep.2008.09.014
   BILLS CE, 1971, J HOPKINS MED J, V128, P194
   Cordonnier T, 2011, TISSUE ENG PART C-ME, V17, P249, DOI [10.1089/ten.tec.2010.0387, 10.1089/ten.TEC.2010.0387]
   Crawford DC, 2009, AM J SPORT MED, V37, P1334, DOI 10.1177/0363546509333011
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Hu QY, 2004, EMBO REP, V5, P734, DOI 10.1038/sj.embor.7400184
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC
   Kozawa O, 2002, J CELL BIOCHEM, V84, P583, DOI 10.1002/jcb.10056
   Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041
   Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200
   Levy O, 2008, INT J BIOCHEM CELL B, V40, P2606, DOI 10.1016/j.biocel.2008.05.010
   Levy O, 2010, INT J BIOCHEM CELL B, V42, P1823, DOI 10.1016/j.biocel.2010.07.017
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   MIURA Y, 1994, CLIN ORTHOP RELAT R, P271
   Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404
   Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4
   Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62
   Qi HL, 2003, P NATL ACAD SCI USA, V100, P3305, DOI 10.1073/pnas.0532693100
   Re'em T, 2012, BIOMATERIALS, V33, P751, DOI 10.1016/j.biomaterials.2011.10.007
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
NR 35
TC 57
Z9 57
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2012
VL 8
IS 9
BP 3283
EP 3293
DI 10.1016/j.actbio.2012.05.014
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 990JD
UT WOS:000307625900010
PM 22617742
DA 2018-10-19
ER

PT J
AU Lee, PH
   Tsai, SH
   Kuo, L
   Hwang, CY
   Kuo, CY
   Yang, VC
   Chen, JK
AF Lee, Po-Han
   Tsai, Shu-Huai
   Kuo, Lih
   Hwang, Chih-Yung
   Kuo, Chan-Yen
   Yang, Vivian C.
   Chen, Jan-Kan
TI A prototype tissue engineered blood vessel using amniotic membrane as
   scaffold
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Amniotic membrane; Tissue engineering; Junctional molecules; Integrins;
   Blood vessel
ID ARTERIAL ENDOTHELIAL-CELLS; LIMBAL EPITHELIAL-CELLS; VASCULAR GRAFTS;
   SHEAR-STRESS; IN-VITRO; COLLAGEN; SYSTEM; FIBRIN; TRANSPLANTATION;
   RECONSTRUCTION
AB In this study, we used amniotic membrane (AM), a natural extracellular matrix, as a scaffold for the fabrication of tissue engineered blood vessels (TEBVs). The inner surface of the denuded glutaraldehyde cross-linked AM tube was endothelialized with porcine vascular endothelial cells (ECs) and subjected to a physiological (12 dyne cm(-2)) shear stress (SS) for 2 and 4 days. The results showed that after applying SS, an intact EC monolayer was maintained in the lumen surface of the TEBV. The ECs were aligned with their long axis parallel to the blood flow. The immunofluorescent microscopy showed that the intercellular junctional proteins, PECAM-1 and VE-cadherin, were surrounding the EC periphery and were better developed and more abundant in SS-treated TEBVs than the static controls. The Western blot indicated that the expressions of PECAM-1 and VE-cadherin were increased by 72 +/- 9% and 67 +/- 7%, respectively, after shear stress treatment. The distribution pattern of integrin beta 1 was mainly at the interface of ECs and AM in static TEBVs but it was extended to the cell-cell junctions after SS treatment. The SS promoted the expression of integrin alpha(v)beta(3) without altering its distribution in TEBV. The results suggest that glutaraldehyde cross-linked AM tube can potentially be used as a scaffold biomaterial for TEBV fabrication. Most importantly, the use of an AM tube shortened the TEBV fabrication. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lee, Po-Han; Tsai, Shu-Huai; Hwang, Chih-Yung; Kuo, Chan-Yen; Yang, Vivian C.] Tunghai Univ, Coll Sci, Dept Life Sci, Taichung 40704, Taiwan.
   [Kuo, Lih] Texas A&M Hlth Sci Ctr, Coll Med, Cardiovasc Res Inst, Dept Syst Biol & Translat Med, Temple, TX 76504 USA.
   [Chen, Jan-Kan] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan.
RP Yang, VC (reprint author), Tunghai Univ, Coll Sci, Dept Life Sci, Taichung 40704, Taiwan.
EM vcyang@thu.edu.tw; jkc508@mail.cgu.edu.tw
OI Tsai, Shu-Huai/0000-0002-5459-8672
FU National Science Council, Taiwan, Republic of China
   [NSC-96-2745-B-029-001-URD]
FX This research was supported by Grant NSC-96-2745-B-029-001-URD from the
   National Science Council, Taiwan, Republic of China.
CR Burman Sanghamitra, 2004, Cell and Tissue Banking, V5, P161, DOI 10.1023/B:CATB.0000046067.25057.0a
   Conklin BS, 2002, J SURG RES, V102, P13, DOI 10.1006/jsre.2001.6295
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Dahl SL, 2011, SCI TRANSL MED, V3
   Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013
   Heydarkhan-Hagvall S, 2006, TISSUE ENG, V12, P831
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hirai J, 1996, CELL TRANSPLANT, V5, P93, DOI 10.1016/0963-6897(95)02002-0
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kolluru GK, 2010, NITRIC OXIDE-BIOL CH, V22, P304, DOI 10.1016/j.niox.2010.02.004
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Laflamme K, 2005, CIRCULATION, V111, P459, DOI 10.1161/01.CIR.0000153850.53419.50
   Meinhart JG, 2005, TISSUE ENG, V11, P887, DOI 10.1089/ten.2005.11.887
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   OTT MJ, 1995, SURGERY, V117, P334, DOI 10.1016/S0039-6060(05)80210-7
   Rashid ST, 2008, FASEB J, V22, P2084, DOI 10.1096/fj.07-096586
   Reneman RS, 2008, MED BIOL ENG COMPUT, V46, P499, DOI 10.1007/s11517-008-0330-2
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Tosi GM, 2005, J CELL PHYSIOL, V202, P849, DOI 10.1002/jcp.20181
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tsai SH, 2007, BIOCHEM BIOPH RES CO, V357, P984, DOI 10.1016/j.bbrc.2007.04.047
   Vrana NE, 2010, J BIOMED MATER RES A, V94A, P1080, DOI 10.1002/jbm.a.32790
   Wang DY, 2003, INVEST OPHTH VIS SCI, V44, P4698, DOI 10.1167/iovs.03-0272
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Williams C, 2005, ANN BIOMED ENG, V33, P920, DOI 10.1007/s10439-005-3238-0
   Zhang WJ, 2007, J CELL MOL MED, V11, P945, DOI 10.1111/j.1582-4934.2007.00099.x
NR 33
TC 10
Z9 11
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2012
VL 8
IS 9
BP 3342
EP 3348
DI 10.1016/j.actbio.2012.05.012
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 990JD
UT WOS:000307625900016
PM 22609451
DA 2018-10-19
ER

PT J
AU Eimar, H
   Ghadimi, E
   Marelli, B
   Vali, H
   Nazhat, SN
   Amin, WM
   Torres, J
   Ciobanu, O
   Albuquerque, RF
   Tamimi, F
AF Eimar, Hazem
   Ghadimi, Elnaz
   Marelli, Benedetto
   Vali, Hojatollah
   Nazhat, Showan N.
   Amin, Wala M.
   Torres, Jesus
   Ciobanu, Ovidiu
   Albuquerque, Rubens F., Jr.
   Tamimi, Faleh
TI Regulation of enamel hardness by its crystallographic dimensions
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Enamel; Microhardness; Apatite; Nanocrystals
ID TRANSFORM INFRARED-SPECTROSCOPY; HUMAN DENTAL ENAMEL;
   MECHANICAL-PROPERTIES; GRAIN-SIZE; CALCIUM-PHOSPHATE; MINERAL-CONTENT;
   CRYSTALLITE SIZE; APATITE CRYSTALS; ELASTIC-MODULUS; EARLY DEPOSITS
AB Enamel is a composite biomaterial comprising a minor organic matrix (similar to 2%) and a hierarchically organized inorganic ultrastructure (similar to 96-98%). Surprisingly, to date there is no available information in the literature regarding the possible role of the enamel ultrastructure on the nanoscale level in tooth macroscopic properties. Understanding this relationship is of especial interest for restorative purposes in dentistry. Accordingly, this study was designed to investigate how enamel nanocrystals regulate its hardness. We performed microindentation analysis on 100 extracted human teeth. The tooth enamel hardness was quantified and correlated with changes in enamel chemical composition and crystallographic dimensions obtained from Fourier transform infrared spectroscopy and X-ray diffraction, respectively. Enamel hardness was not related to the variability in organic content, but was associated with the size of apatite crystals along the c-axis. This association followed the Hall-Petch model for polycrystalline materials, indicating that the optimal size of apatite nanocrystals (larger than the critical size) provides enamel with the greatest hardness, which enables teeth to survive the heavy wear over a human lifetime. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Eimar, Hazem; Ghadimi, Elnaz; Vali, Hojatollah; Albuquerque, Rubens F., Jr.; Tamimi, Faleh] McGill Univ, Fac Dent, Montreal, PQ H3A 0C7, Canada.
   [Marelli, Benedetto; Nazhat, Showan N.] McGill Univ, Dept Min & Mat Engn, Montreal, PQ H3A 2A7, Canada.
   [Amin, Wala M.] Univ Jordan, Fac Dent, Amman 11942, Jordan.
   [Torres, Jesus] Univ Rey Juan Carlos, Dept Hlth Sci 3, Alcorcon 28922, Spain.
   [Ciobanu, Ovidiu] McGill Univ, Ctr Continuing Educ, Montreal, PQ H3A 3R1, Canada.
RP Tamimi, F (reprint author), McGill Univ, Fac Dent, Montreal, PQ H3A 0C7, Canada.
EM faleh.tamimimarino@mcgill.ca
RI Ciobanu, Ovidiu/S-7297-2017; Albuquerque, Rubens/F-4979-2011; Vali,
   Hojatollah/F-3511-2012
OI Ciobanu, Ovidiu/0000-0002-6849-1710; Albuquerque,
   Rubens/0000-0003-2016-1752; Vali, Hojatollah/0000-0003-3464-9943;
   Marelli, Benedetto/0000-0001-5311-6961; TORRES GARCIA DENCHE,
   JESUS/0000-0002-8310-9209
FU "Fondation de l'Ordre des dentistes du Quebec" (FODQ); "Le Reseau de
   recherche en sante buccodentaire et osseuse" (RSBO); Faculty of
   Dentistry of McGill University; Natural Sciences and Engineering
   Research Council of Canada
FX The authors would like to acknowledge the "Fondation de l'Ordre des
   dentistes du Quebec" (FODQ), "Le Reseau de recherche en sante
   buccodentaire et osseuse" (RSBO), the Faculty of Dentistry of McGill
   University and Natural Sciences and Engineering Research Council of
   Canada (F.T) for their financial support. We also acknowledge Prof. E.
   Lopez Cabarcos for his valuable advices and constructive criticism.
CR Aichmayer B, 2005, J STRUCT BIOL, V151, P239, DOI 10.1016/j.jsb.2005.06.007
   Ang SF, 2010, BIOMATERIALS, V31, P1955, DOI 10.1016/j.biomaterials.2009.11.045
   Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   Aparicio S, 2002, CALCIFIED TISSUE INT, V70, P422, DOI 10.1007/s00223-001-1016-z
   Attin T, 2004, CARIES RES, V38, P62, DOI 10.1159/000073922
   Bachmann L, 2003, APPL SPECTROSC REV, V38, P1, DOI 10.1081/ASR-120017479
   BALDWIN WM, 1958, ACTA METALL MATER, V6, P139, DOI 10.1016/0001-6160(58)90136-6
   Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   Bartlett JD, 1996, GENE, V183, P123, DOI 10.1016/S0378-1119(96)00525-2
   Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204
   Bechtle S, 2010, BIOMATERIALS, V31, P375, DOI 10.1016/j.biomaterials.2009.09.050
   Bembey AK, 2005, MATER RES SOC SYMP P, V874, P125
   BESIC FC, 1975, J AM DENT ASSOC, V91, P594, DOI 10.14219/jada.archive.1975.0416
   Bohic S, 2000, BONE, V26, P341, DOI 10.1016/S8756-3282(99)00276-8
   Boivin G, 2008, BONE, V43, P532, DOI 10.1016/j.bone.2008.05.024
   Bres EF, 2002, J BIOMED MATER RES, V63, P433, DOI 10.1002/jbm.10254
   Buchalla W, 2008, CARIES RES, V42, P157, DOI 10.1159/000128559
   Cerny R, 1996, J BONE MINER RES, V11, P883
   CONRAD H, 1963, ACTA METALL MATER, V11, P75, DOI 10.1016/0001-6160(63)90134-2
   COTTRELL AH, 1958, T AM I MIN MET ENG, V212, P192
   Cui FZ, 2007, J TISSUE ENG REGEN M, V1, P185, DOI 10.1002/term.21
   DOI Y, 1984, J DENT RES, V63, P98, DOI 10.1177/00220345840630021801
   Eimar H, 2011, J DENT, V39, pE3, DOI 10.1016/j.jdent.2011.11.008
   ELLIOTT JC, 1985, CALCIFIED TISSUE INT, V37, P372, DOI 10.1007/BF02553704
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Fan YW, 2007, BIOMATERIALS, V28, P3034, DOI 10.1016/j.biomaterials.2007.02.016
   FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3
   GASPERSIC D, 1995, J ORAL PATHOL MED, V24, P153, DOI 10.1111/j.1600-0714.1995.tb01157.x
   Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h
   GROVE CA, 1972, J DENT RES, V51, P22, DOI 10.1177/00220345720510012201
   Gutiérrez-Salazar Maria del Pilar, 2003, Mat. Res., V6, P367, DOI 10.1590/S1516-14392003000300011
   Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3
   HAINES D J, 1968, Journal of Biomechanics, V1, P117, DOI 10.1016/0021-9290(68)90014-6
   HALL EO, 1951, P PHYS SOC LOND B, V64, P742, DOI 10.1088/0370-1301/64/9/302
   He W, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/015003
   Hong HL, 2006, J WUHAN UNIV TECHNOL, V21, P9
   Hu JCC, 2000, J DENT RES, V79, P70, DOI 10.1177/00220345000790011301
   Huang TTY, 2010, ACTA BIOMATER, V6, P4553, DOI 10.1016/j.actbio.2010.06.028
   Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323
   Kim HS, 1998, SCRIPTA MATER, V39, P1057, DOI 10.1016/S1359-6462(98)00257-7
   Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103
   Kinney JH, 1999, ARCH ORAL BIOL, V44, P813, DOI 10.1016/S0003-9969(99)00080-1
   Krebsbach PH, 1996, J BIOL CHEM, V271, P4431
   Lasch P, 2002, BIOPOLYMERS, V67, P335, DOI 10.1002/bip.10095
   LEGEROS RZ, 1991, CALCIUM PHOSPHATES O, P109
   LeGeros RZ, 1983, GERODONTOLOGY, V2, P1
   Leventouri T, 2009, INT J BIOMATER, DOI 10.1155/2009/698547
   LI JCM, 1970, METALL TRANS, V1, P1145, DOI 10.1007/BF02900225
   LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901
   Liu YY, 2007, J DENT, V35, P226, DOI 10.1016/j.jdent.2006.08.006
   Mabilleau G, 2010, ACTA BIOMATER, V6, P1555, DOI 10.1016/j.actbio.2009.10.035
   Maupome G, 1999, CARIES RES, V33, P140, DOI 10.1159/000016508
   Mendelsohn R, 2000, APPL SPECTROSC, V54, P1183, DOI 10.1366/0003702001950751
   NELSON DGA, 1982, AUST J CHEM, V35, P715, DOI 10.1071/CH9820715
   Newbrun E, 1960, AUST DENT J, V5, P210, DOI DOI 10.1111/J.1834-7819.1960.TB01939.X
   Ou-Yang H, 2001, J BONE MINER RES, V16, P893, DOI 10.1359/jbmr.2001.16.5.893
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Potocnik I, 2000, J ENDODONT, V26, P203, DOI 10.1097/00004770-200004000-00001
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   RYGE G, 1961, J DENT RES, V40, P1116, DOI 10.1177/00220345610400060401
   Saber-Samandari S, 2009, ACTA BIOMATER, V5, P2206, DOI 10.1016/j.actbio.2009.02.009
   Sakae T, 2006, J ORAL BIOSCI, V48, P85, DOI 10.2330/joralbiosci.48.85
   Sastry SS, 2001, CONF PROC INT SYMP C, P278, DOI 10.1109/ISCA.2001.937456
   Scherrer P., 1918, NACHR GES WISS GOTT, V2, p98 
   SHIMODA S, 1990, J DENT RES, V69, P1731, DOI 10.1177/00220345900690110501
   Simmer J.P., 2001, J DENT EDUC, V65, P896
   Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601
   Simmons LM, 2011, EUR J ORAL SCI, V119, P19, DOI 10.1111/j.1600-0722.2011.00909.x
   Sonju Clasen A B, 1997, Adv Dent Res, V11, P523
   Sprawson E, 1928, P R SOC LOND B-CONTA, V102, P419, DOI 10.1098/rspb.1928.0016
   Sriraman KR, 2007, MATER LETT, V61, P715, DOI 10.1016/j.matlet.2006.05.049
   SYDNEYZAX M, 1991, J DENT RES, V70, P913, DOI 10.1177/00220345910700051001
   Taube F, 2010, J DENT, V38, P72, DOI 10.1016/j.jdent.2009.09.006
   Ten Cate AR, 1999, ORAL HISTOLOGY DEV S
   TIPPER CF, 1953, J IRON STEEL I, V173, P280
   Tramini P, 2000, CARIES RES, V34, P233, DOI 10.1159/000016596
   Wang Jiwen, 2009, Biomaterials, V30, P6565, DOI 10.1016/j.biomaterials.2009.08.048
   WANG N, 1995, ACTA METALL MATER, V43, P519, DOI 10.1016/0956-7151(94)00253-E
   Westbrook JH, 1973, SCI HARDNESS TESTING
   White SN, 2000, J AM CERAM SOC, V83, P238, DOI 10.1111/j.1151-2916.2000.tb01181.x
   Xu HHK, 1998, J DENT RES, V77, P472, DOI 10.1177/00220345980770030601
   Xue J, 2008, J SYNCHROTRON RADIAT, V15, P235, DOI 10.1107/S0909049508003397
   Xue Jing, 2008, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V25, P65
   Zheng J, 2006, TRIBOL INT, V39, P266, DOI 10.1016/j.triboint.2004.09.004
NR 86
TC 24
Z9 24
U1 4
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2012
VL 8
IS 9
BP 3400
EP 3410
DI 10.1016/j.actbio.2012.06.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 990JD
UT WOS:000307625900022
PM 22684114
DA 2018-10-19
ER

PT J
AU Cui, XF
   Breitenkamp, K
   Lotz, M
   D'Lima, D
AF Cui, Xiaofeng
   Breitenkamp, Kurt
   Lotz, Martin
   D'Lima, Darryl
TI Synergistic action of fibroblast growth factor-2 and transforming growth
   factor-beta1 enhances bioprinted human neocartilage formation
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE inkjet printing; cartilage tissue engineering; chondrocyte; hydrogel;
   extracellular matrix; photoplymerization
ID HUMAN ARTICULAR CHONDROCYTES; POLY(ETHYLENE GLYCOL) HYDROGELS; HUMAN EAR
   CHONDROCYTES; SERUM-FREE MEDIUM; IN-VITRO; GENE-EXPRESSION; PDGF-BB;
   CELLS; EXPANSION; CARTILAGE
AB Bioprinting as a promising but unexplored approach for cartilage tissue engineering has the advantages of high throughput, digital control, and highly accurate placement of cells and biomaterial scaffold to the targeted 3D locations with simultaneous polymerization. This study tested feasibility of using bioprinting for cartilage engineering and examined the influence of cell density, growth, and differentiation factors. Human articular chondrocytes were printed at various densities, stimulated transiently with growth factors and subsequently with chondrogenic factors. Samples were cultured for up to 4 weeks to evaluate cell proliferation and viability, mechanical properties, mass swelling ratio, water content, gene expression, ECM production, DNA content, and histology. Bioprinted samples treated with FGF-2/TGF-beta 1 had the best chondrogenic properties among all groups apparently due to synergistic stimulation of cell proliferation and chondrogenic phenotype. ECM production per chondrocyte in low cell density was much higher than that in high cell seeding density. This finding was also verified by mechanical testing and histology. In conclusion, cell seeding density that is feasible for bioprinting also appears optimal for human neocartilage formation when combined with appropriate growth and differentiation factors. Biotechnol. Bioeng. 2012;109: 23572368. (c) 2012 Wiley Periodicals, Inc.
C1 [Cui, Xiaofeng; Lotz, Martin; D'Lima, Darryl] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.
   [Cui, Xiaofeng; D'Lima, Darryl] Scripps Clin, Shiley Ctr Orthopaed Res & Educ, La Jolla, CA 92037 USA.
   [Breitenkamp, Kurt] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.
   [Breitenkamp, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
RP D'Lima, D (reprint author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM ddlima@scripps.edu
RI Cui, Xiaofeng/A-7208-2012
OI Cui, Xiaofeng/0000-0003-2761-3934; D'Lima, Darryl/0000-0002-8707-1455
FU NIH [AG007996]; CIRM [TR1-01216]; STSI [UL1 RR025774]; NSF [1011796]
FX Contract grant sponsor: NIH; Contract grant number: AG007996; Contract
   grant sponsor: CIRM; Contract grant number: TR1-01216; Contract grant
   sponsor: STSI; Contract grant number: UL1 RR025774; Contract grant
   sponsor: NSF; Contract grant number: 1011796
CR BLANCO FJ, 1995, AM J PATHOL, V146, P75
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508
   Brandl A, 2010, J ORTHOP RES, V28, P354, DOI 10.1002/jor.21007
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   BUSKIRK WA, 1988, HEWLETT-PACKARD J, V39, P55
   Buxton AN, 2011, TISSUE ENG PT A, V17, P371, DOI [10.1089/ten.tea.2009.0839, 10.1089/ten.TEA.2009.0839]
   Chaudhary LR, 2000, J CELL BIOCHEM, V76, P354, DOI 10.1002/(SICI)1097-4644(20000301)76:3<354::AID-JCB2>3.0.CO;2-U
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.TEA.2011.0543, 10.1089/ten.tea.2011.0543]
   Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Grogan SP, 2006, TISSUE ENG, V12, P2141, DOI 10.1089/ten.2006.12.2141
   HARMON JP, 1988, HEWLETT-PACKARD J, V39, P62
   Hoenig E, 2011, TISSUE ENG PT A, V17, P1401, DOI [10.1089/ten.TEA.2010.0395, 10.1089/ten.tea.2010.0395]
   HURLEY MM, 1993, J BIOL CHEM, V268, P5588
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   MAIER R, 1993, J BIOL CHEM, V268, P21527
   Mandl EW, 2002, TISSUE ENG, V8, P573, DOI 10.1089/107632702760240490
   Mandl EW, 2004, MATRIX BIOL, V23, P231, DOI 10.1016/j.matbio.2004.06.004
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wilson WC, 2003, ANAT REC PART A, V272A, P491, DOI 10.1002/ar.a.10057
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
NR 31
TC 36
Z9 38
U1 1
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD SEP
PY 2012
VL 109
IS 9
BP 2357
EP 2368
DI 10.1002/bit.24488
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 978QE
UT WOS:000306759500020
PM 22508498
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mali, SA
AF Mali, S. A.
TI Nucleation of biocompatible nanostructured coatings via electrochemical
   process
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Electrochemical deposition; Austenitic stainless steel; Composite
   coatings; Hydroxyapatite; Chitosan; Collagen
ID HYDROXYAPATITE COATINGS; CALCIUM-PHOSPHATE; TITANIUM; DEPOSITION; BONE;
   COMPOSITES; REPAIR; METAL; FILMS
AB Hydroxyapatite (HA) has received significant attention and has been clinically applied in orthopaedics and dentistry because of excellent biocompatibility and osteoconductive properties. The combination of high mechanical strength of metals with osteoconductive properties of calcium phosphate makes HA coatings on austenitic stainless steel a promising biomaterial for treatment of bone defects. Hydroxyapatite coatings were obtained on austenitic stainless steels by electrochemical deposition. Electron microscopy observations suggested uniform spread of HA with vein type interconnected structure. The HA coatings were also codeposited with biocompatible chitosan and collagen. The mechanism of electrodeposition of HA based coatings is outlined.
C1 [Mali, S. A.] Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.
   [Mali, S. A.] Univ Louisiana Lafayette, Lafayette, LA USA.
RP Mali, SA (reprint author), Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.
EM samali@syr.edu
CR Borsari V, 2005, J BIOMED MATER RES B, V75B, P359, DOI 10.1002/jbm.b.30313
   COTELL CM, 1992, J APPL BIOMATER, V3, P87, DOI 10.1002/jab.770030204
   COVENTRY MB, 1992, CLIN ORTHOP RELAT R, P22
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   Eliaz N, 2005, SURF ENG, V21, P238, DOI 10.1179/174329405X50091
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   Farrugia CA, 1999, J PHARM PHARMACOL, V51, P643, DOI 10.1211/0022357991772925
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   Manara S, 2008, INORG CHIM ACTA, V361, P1634, DOI 10.1016/j.ica.2007.03.044
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   Misra RDK, 2009, ACTA BIOMATER, V5, P1455, DOI 10.1016/j.actbio.2008.12.017
   Misra R. D. K., 2009, ADY MAT, V26, P1280
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Ong JL, 2006, JOM-US, V58, P67, DOI 10.1007/s11837-006-0145-2
   PARK JB, 1987, BIOMATERIALS SCI ENG
   Redepenning J, 2003, J BIOMED MATER RES A, V66A, P411, DOI 10.1002/jbm.a.10571
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Thein-han WW, 2008, MAT SCI TECHNOL, V34, P1062
   Tomsia AP, 2005, ADV ENG MATER, V7, P999, DOI 10.1002/adem.200500143
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang J, 2004, J DENT RES, V83, P296, DOI 10.1177/154405910408300405
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   Willmann G, 1999, ADV ENG MATER, V1, P95
   Zhang QY, 2005, BIOMATERIALS, V26, P3853, DOI 10.1016/j.biomaterials.2004.09.057
   Zhang YY, 2006, T NONFERR METAL SOC, V16, P633, DOI 10.1016/S1003-6326(06)60112-X
   Zhitomirsky I, 2000, AM CERAM SOC BULL, V79, P57
NR 29
TC 1
Z9 1
U1 0
U2 20
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD SEP
PY 2012
VL 27
IS 4
BP 284
EP 288
DI 10.1179/1753555712Y.0000000020
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 988MX
UT WOS:000307496200003
DA 2018-10-19
ER

PT J
AU Rashad, MM
   Ibrahim, IA
AF Rashad, M. M.
   Ibrahim, I. A.
TI Structural, microstructure and magnetic properties of strontium
   hexaferrite particles synthesised by modified coprecipitation method
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Strontium hexaferrite; Synthesis; Crystal modifier; Microstructure;
   Magnetic properties
ID FERRITE COMPOSITE NANOPARTICLES; NANOCRYSTALLINE NICKEL FERRITE;
   SURFACE-ACTIVE AGENTS; DIELECTRIC-PROPERTIES; BARIUM HEXAFERRITE;
   BIOMATERIAL SYSTEM; BEHAVIOR; CO; CARRIER; SHELL
AB Strontium hexaferrite (SrFe12O19) particles were synthesised using the modified chemical coprecipitation method. The results indicated that a single strontium hexaferrite phase formed at low annealing temperature 800 degrees C in the presence of surfactant or by oxalic acid addition. Sonochemical assisted coprecipitation route improved the formation of well crystalline strontium hexaferrite phase with Fe3+/Sr2+ molar ratios of 9.23 and 8 annealed at 1000 degrees C for 2 h. The crystallite size of the produced powders increased with increasing annealing temperature. The crystallite size of the formed powders was in the range between 67 and 125 nm. The microstructures of the formed particles appeared as a hexagonal platelet-like structure. Moreover, the addition of surfactant exhibited a uniform homogeneous hexagonal platelet-like structure. The formed ultrafine pure SrFe12O19 powders have good magnetic saturations (44.6-73.6 emu g(-1)) and wide intrinsic coercivities (692-5612 Oe).
C1 [Rashad, M. M.; Ibrahim, I. A.] CMRDI, Cairo, Egypt.
RP Rashad, MM (reprint author), CMRDI, POB 87 Helwan, Cairo, Egypt.
EM rashad133@yahoo.com
RI Rashad, Mohamed/L-8421-2013
OI Rashad, Mohamed/0000-0002-7482-9693
FU Science and Technology Development Fund (STDF), Egypt [246]
FX This research was financially supported by the Science and Technology
   Development Fund (STDF), Egypt, under project ID no. 246.
CR Anis-ur-Rehman M, 2011, J ALLOY COMPD, V509, P435, DOI 10.1016/j.jallcom.2010.09.050
   Ashiq MN, 2011, J MAGN MAGN MATER, V323, P259, DOI 10.1016/j.jmmm.2010.08.054
   COCHARDT A, 1963, J APPL PHYS, V34, P1273, DOI 10.1063/1.1729468
   Hessien MM, 2008, J MAGN MAGN MATER, V320, P336, DOI 10.1016/j.jmmm.2007.06.009
   Hessien MM, 2007, J ANAL APPL PYROL, V78, P282, DOI 10.1016/j.jaap.2006.08.005
   Hessien MM, 2009, J ALLOY COMPD, V476, P373, DOI 10.1016/j.jallcom.2008.08.076
   Iqbal MJ, 2008, CHEM ENG J, V136, P383, DOI 10.1016/j.cej.2007.05.046
   Jean M, 2010, J ALLOY COMPD, V496, P306, DOI 10.1016/j.jallcom.2010.02.002
   Kale A, 2004, J MAGN MAGN MATER, V277, P350, DOI 10.1016/j.jmmm.2003.11.015
   Kojima H., 1982, N MAGNETO OPTICAL RE, V3, P305
   Mahmoud MHH, 2004, J COLLOID INTERF SCI, V270, P99, DOI 10.1016/j.jcis.2003.09.023
   Nathani H, 2005, MAT SCI ENG B-SOLID, V121, P126, DOI 10.1016/j.mseb.2005.03.016
   Nathani H, 2004, MAT SCI ENG B-SOLID, V111, P95, DOI 10.1016/j.mseb.2004.03.002
   Qiao L, 2010, CERAM INT, V36, P1423, DOI 10.1016/j.ceramint.2010.02.003
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rashad MM, 2008, J ALLOY COMPD, V453, P304, DOI 10.1016/j.jallcom.2006.11.080
   Rashad MM, 2011, J MAGN MAGN MATER, V323, P2158, DOI 10.1016/j.jmmm.2011.03.023
   Rashad MM, 2005, MATER CHEM PHYS, V94, P365, DOI 10.1016/j.matchemphys.2005.05.028
   Reddy KM, 2004, MATER RES BULL, V39, P1491, DOI [10.1016/j.materresbull.2004.04.022, 10.1016/j.materresbult.2004.04.022]
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Wang ZY, 2010, J MAGN MAGN MATER, V322, P2782, DOI 10.1016/j.jmmm.2010.04.027
   Yuan Q, 2008, ACTA BIOMATER, V4, P1024, DOI 10.1016/j.actbio.2008.02.002
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zi ZF, 2008, J MAGN MAGN MATER, V320, P2746, DOI 10.1016/j.jmmm.2008.06.009
NR 25
TC 13
Z9 13
U1 1
U2 16
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD SEP
PY 2012
VL 27
IS 4
BP 308
EP 314
DI 10.1179/1753555712Y.0000000013
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 988MX
UT WOS:000307496200008
DA 2018-10-19
ER

PT J
AU Anfuso, CD
   Motta, C
   Satriano, C
   Gennaro, S
   Marletta, G
   Giurdanella, G
   Alberghina, M
   Lupo, G
AF Anfuso, Carmelina Daniela
   Motta, Carla
   Satriano, Cristina
   Gennaro, Salvatore
   Marletta, Giovanni
   Giurdanella, Giovanni
   Alberghina, Mario
   Lupo, Gabriella
TI Microcapillary-like structures prompted by phospholipase A(2) activation
   in endothelial cells and pericytes co-cultures on a
   polyhydroxymethylsiloxane thin film
SO BIOCHIMIE
LA English
DT Article
DE PHMS thin films; Hydrophobicity; Biomaterial vascularization; EC/PC
   co-cultures; Phospholipases A(2)
ID SMOOTH-MUSCLE-CELLS; POLYMER SURFACES; VASCULAR GRAFTS; 3D COCULTURE;
   PROLIFERATION; ADHESION; PLASMA; TISSUE; VESSEL; GROWTH
AB A thin film of poly(hydroxymethylsiloxane) (PHMS) has been deposited on glass dishes and tested as artificial support material for vascularization from mixed cultures of endothelial cells (EC) and pericytes (PC). The EC/PC co-cultures adhered massively on PHMS, with the formation of net-like microcapillary structures. Such evidence was not found on control glass substrates in the same co-culture conditions neither on PHMS for EC and PC in monocultures.
   The physicochemical characterization of PHMS and control glass surface by time-of-flight secondary ion mass spectrometry, X-ray photoelectron spectroscopy, water contact angle and atomic force microscopy, pointed to the main role of the polymer hydrophobilicy to explain the observed cellular behavior.
   Moreover, enhanced intercellular cross-talk was evidenced by the up-regulation and activation of cytoplasmic and Ca2+-independent phospholipase A(2) (cPLA(2) and iPLA(2)) expression and cPLA(2) phosphorylation, leading to the cell proliferation and microcapillary formation on the PHMS surface, as evidenced by confocal microscopy analyses. Co-cultures, established with growth-arrested PCs by treatment with mitomycin C, showed an increase in EC proliferation on PHMS. AACOCF(3) or co-transfection with cPLA(2) and iPLA(2) siRNA reduced cell proliferation.
   The results highlight the major role played by EC/PC cross-talk as well as the hydrophobic character of the substrate surface, to promote microcapillary formation. Our findings suggest an attractive strategy for vascular tissue engineering and provide new details on the interplay of artificial substrates and capillary formation. (C) 2012 Elsevier Masson SAS. All rights reserved.
C1 [Anfuso, Carmelina Daniela; Motta, Carla; Alberghina, Mario; Lupo, Gabriella] Univ Catania, Dept Clin & Mol Biomed, I-95125 Catania, Italy.
   [Satriano, Cristina; Marletta, Giovanni] Univ Catania, Dept Chem Sci, I-95125 Catania, Italy.
   [Satriano, Cristina; Marletta, Giovanni] CSGI, I-95125 Catania, Italy.
   [Gennaro, Salvatore] FBK CMM, MiNALab, I-38123 Trento, Italy.
   [Giurdanella, Giovanni] Univ Catania, Fac Med, CIRES Lab, I-97100 Ragusa, Italy.
   [Giurdanella, Giovanni] Ragusa Univ Consortium, I-97100 Ragusa, Italy.
RP Lupo, G (reprint author), Univ Catania, Dept Clin & Mol Biomed, Viale Andrea Doria 5, I-95125 Catania, Italy.
EM csatriano@unict.it; lupogab@unict.it
RI Marletta, Giovanni/F-3154-2012; Satriano, Cristina/A-3976-2012
OI Marletta, Giovanni/0000-0002-6929-9499; Satriano,
   Cristina/0000-0001-5348-5863; LUPO, Gabriella/0000-0002-9291-6969;
   ANFUSO, Carmelina Daniela/0000-0001-7951-1812
FU MIUR-Italy; PRIN
FX This work was supported by grants from MIUR-Italy (60% 2008/9) and PRIN
   2009.
CR Anfuso CD, 2007, J LIPID RES, V48, P782, DOI 10.1194/jlr.M600489-JLR200
   Antoniotti S, 2003, J CELL PHYSIOL, V197, P370, DOI 10.1002/jcp.10359
   Assero G, 2004, MICROVASC RES, V68, P209, DOI 10.1016/j.mvr.2004.08.003
   Bhattacharya S, 2001, AM J PHYSIOL-LUNG C, V280, pL1049
   Bianchi F, 2007, J BIOMED MATER RES B, V81B, P462, DOI 10.1002/jbm.b.30685
   Cao L, 2011, J BIOMECH, V44, P2150, DOI 10.1016/j.jbiomech.2011.05.024
   Carnazza S, 2005, J COLLOID INTERF SCI, V289, P386, DOI 10.1016/j.jcis.2005.03.089
   Chiu JJ, 2004, J BIOMECH, V37, P531, DOI 10.1016/j.jbiomech.2003.08.012
   Daxecker H, 2002, CLIN CHIM ACTA, V325, P171, DOI 10.1016/S0009-8981(02)00244-9
   Dore-Duffy P, 2011, METHODS MOL BIOL, V686, P49, DOI 10.1007/978-1-60761-938-3_2
   Formosa F, 2008, MICROVASC RES, V75, P330, DOI 10.1016/j.mvr.2007.11.005
   Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015
   Giurdanella G, 2011, MICROVASC RES, V81, P1, DOI 10.1016/j.mvr.2010.11.005
   Grewal S, 2002, J CELL SCI, V115, P4533, DOI 10.1242/jcs.00148
   Hadjizadeh A, 2010, J TISSUE ENG REGEN M, V4, P524, DOI 10.1002/term.269
   Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6
   Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024
   Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044
   Kaji H, 2011, BBA-GEN SUBJECTS, V1810, P239, DOI 10.1016/j.bbagen.2010.07.002
   Koens MJW, 2010, ACTA BIOMATER, V6, P4666, DOI 10.1016/j.actbio.2010.06.038
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee S, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194115
   Lupo G, 2005, BBA-MOL CELL BIOL L, V1735, P135, DOI 10.1016/j.bbalip.2005.05.008
   Lupo G, 2001, BBA-MOL CELL BIOL L, V1531, P143, DOI 10.1016/S1388-1981(01)00102-0
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Parizek M, 2011, PHYSIOL RES, V60, P419
   Richards OC, 2010, ENDOCR REV, V31, P343, DOI 10.1210/er.2009-0035
   Saavedra G, 2006, J PHARMACOL EXP THER, V318, P1211, DOI 10.1124/jpet.106.105650
   Satriano C, 2003, J VAC SCI TECHNOL A, V21, P1145, DOI 10.1116/1.1575217
   Satriano C, 2002, LANGMUIR, V18, P9469, DOI 10.1021/la025800x
   Satriano C, 2010, LANGMUIR, V26, P5715, DOI 10.1021/la903826d
   Satriano C, 2008, SURF INTERFACE ANAL, V40, P649, DOI 10.1002/sia.2764
   Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27
   TOMASZ M, 1986, P NATL ACAD SCI USA, V83, P6702, DOI 10.1073/pnas.83.18.6702
   Uttayarat P, 2010, ACTA BIOMATER, V6, P4229, DOI 10.1016/j.actbio.2010.06.008
   van Oss CJ, 2002, J DISPER SCI TECHNOL, V23, P455, DOI 10.1081/DIS-120014013
   Wallace CS, 2010, AM J PHYSIOL-HEART C, V299, pH338, DOI 10.1152/ajpheart.01029.2009
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Zhou M, 2012, J BIOMED MATER RES B, V100B, P111, DOI 10.1002/jbm.b.31928
NR 41
TC 1
Z9 1
U1 0
U2 12
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
J9 BIOCHIMIE
JI Biochimie
PD SEP
PY 2012
VL 94
IS 9
BP 1860
EP 1870
DI 10.1016/j.biochi.2012.04.021
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 983AG
UT WOS:000307087900003
PM 22575274
DA 2018-10-19
ER

PT J
AU Hasanpour, A
   Niyaifar, M
   Mohammadpour, H
   Amighian, J
AF Hasanpour, A.
   Niyaifar, M.
   Mohammadpour, H.
   Amighian, J.
TI A novel non-thermal process of TiO2-shell coating on Fe3O4-core
   nanoparticles
SO JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS
LA English
DT Article
DE Sol-gel growth; Nanostructures; Magnetic properties; X-ray diffraction;
   Electron microscopy
ID PHOTOCATALYTIC TITANIUM-DIOXIDE; ANATASE TIO2; MAGNETITE NANOPARTICLES;
   THIN-FILMS; LIGHT; SHELL; CORE; BIOMATERIAL; SUSPENSIONS; PARTICLES
AB In this work magnetite (Fe3O4) nanoparticles coated with titanium dioxide (TiO2) were prepared by a novel non-thermal method. In this method, magnetite and pure TiO2 (anatase) nanoparticles were individually prepared by the sol-gel method. After modifying the surface of magnetite nanoparticles by sodium citrate, titanium dioxide was coated on them without using conjunction or heat treatment to obtain Fe3O4:TiO2 core-shell nanoparticles. XRD, EDX, SEM, TEM and VSM were used to investigate the structure, morphology and magnetic properties of the samples. The average crystallite size of the powders was measured by Scherrer's formula. The results obtained from different measurements confirm the formation of Fe3O4:TiO2 core-shell nanoparticles with a decrease in saturation magnetization. Hysteresis loops of the core-shell nanoparticles show no exchange bias effects, which confirms that there is no interaction or interdiffusion at the interface. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Hasanpour, A.; Niyaifar, M.; Mohammadpour, H.] Islamic Azad Univ, Dept Phys, Sci & Res Branch, Khouzestan, Iran.
   [Amighian, J.] Islamic Azad Univ, Dept Phys, Najafabad Branch, Esfahan, Iran.
   [Hasanpour, A.] PNU, Dept Phys, Tehran, Iran.
RP Hasanpour, A (reprint author), Islamic Azad Univ, Dept Phys, Sci & Res Branch, Khouzestan, Iran.
EM Hasanpour88@gmail.com
CR Addamo M, 2004, J PHYS CHEM B, V108, P3303, DOI 10.1021/jp0312924
   Augugliaro V, 2008, CHEM-EUR J, V14, P4640, DOI 10.1002/chem.200702044
   Banerjee S, 2006, CURR SCI INDIA, V90, P1378
   Beydoun D, 2002, MAT SCI ENG B-SOLID, V94, P71, DOI 10.1016/S0921-5107(02)00085-5
   BIRKEFELD LD, 1992, J AM CERAM SOC, V75, P2964, DOI 10.1111/j.1151-2916.1992.tb04372.x
   Chen WJ, 2008, SMALL, V4, P485, DOI 10.1002/smll.200701164
   Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016
   Christensen PA, 2003, APPL CATAL B-ENVIRON, V41, P371, DOI 10.1016/S0926-3373(02)00172-8
   Fu WY, 2005, MATER LETT, V59, P3530, DOI 10.1016/j.matlet.2005.06.071
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   HAN DH, 1994, J MAGN MAGN MATER, V136, P176, DOI 10.1016/0304-8853(94)90462-6
   He QH, 2008, OPT MATER, V31, P380, DOI 10.1016/j.optmat.2008.05.011
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Hong SS, 2003, SOL ENERG MAT SOL C, V80, P273, DOI 10.1016/j.solmat.2003.08.003
   Li Y, 2004, J SOLID STATE CHEM, V177, P1372, DOI 10.1016/j.jssc.2003.11.016
   Li Y, 2008, CHEM COMMUN, P564, DOI 10.1039/b716055k
   Lin CR, 2006, MATER LETT, V60, P447, DOI 10.1016/j.matlet.2005.09.009
   Lin JJ, 2007, J PHYS D APPL PHYS, V40, P2548, DOI 10.1088/0022-3727/40/8/020
   Luca D, 2003, J OPTOELECTRON ADV M, V5, P835
   Machida M, 2005, J AM CERAM SOC, V88, P95, DOI [10.1111/j.1551-2916.2004.00006.x, 10.1111/j.1551-2916.2004.0006.x]
   Murugan AV, 2006, MATER LETT, V60, P479, DOI 10.1016/j.matlet.2005.09.017
   NAYA S, 1965, ACTA CRYSTALLOGR, V19, P734, DOI 10.1107/S0365110X65004292
   OREGAN B, 1990, J PHYS CHEM-US, V94, P8720, DOI 10.1021/j100387a017
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Sekiya T, 2000, J LUMIN, V87-9, P1140, DOI 10.1016/S0022-2313(99)00570-0
   Shen X, 2010, J SOL-GEL SCI TECHN, V54, P340, DOI 10.1007/s10971-010-2201-1
   Shihon X., 2007, CHINESE J CHEM ENG, V13, P190
   Sounderyal N., 2008, RECENT PAT BIOMED EN, V1, P34
   Vega V, 2007, NANOSCALE RES LETT, V2, P355, DOI 10.1007/s11671-007-9073-5
   Xu J, 2007, J MAGN MAGN MATER, V309, P307, DOI 10.1016/j.jmmm.2006.07.037
   Xu SC, 2011, ADV MATER RES-SWITZ, V217-218, P216, DOI 10.4028/www.scientific.net/AMR.217-218.216
   Zeltner WA, 2005, ASHRAE TRAN, V111, P523
   Zhang WF, 2000, PHYS STATUS SOLIDI A, V179, P319, DOI 10.1002/1521-396X(200006)179:2<319::AID-PSSA319>3.0.CO;2-H
NR 33
TC 39
Z9 41
U1 2
U2 99
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3697
J9 J PHYS CHEM SOLIDS
JI J. Phys. Chem. Solids
PD SEP
PY 2012
VL 73
IS 9
BP 1066
EP 1070
DI 10.1016/j.jpcs.2012.04.003
PG 5
WC Chemistry, Multidisciplinary; Physics, Condensed Matter
SC Chemistry; Physics
GA 982IA
UT WOS:000307035200003
DA 2018-10-19
ER

PT J
AU Pinheiro, ALB
   Soares, LGP
   Cangussu, MCT
   Santos, NRS
   Barbosa, AFS
   Silveira, L
AF Pinheiro, Antonio L. B.
   Soares, Luiz G. P.
   Cangussu, Maria Cristina T.
   Santos, Nicole R. S.
   Barbosa, Artur Felipe S.
   Silveira Junior, Landulfo
TI Effects of LED phototherapy on bone defects grafted with MTA, bone
   morphogenetic proteins and guided bone regeneration: a Raman
   spectroscopic study
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Biomaterial; Bone repair; Light emitting diode; MTA
ID MINERAL TRIOXIDE AGGREGATE; INFRARED-LASER LIGHT; RODENT MODEL; IN-VIVO;
   DENTAL IMPLANTS; EMITTING-DIODES; BOVINE BONE; TGF-BETA; THERAPY; TISSUE
AB We studied peaks of calcium hydroxyapatite (CHA) and protein and lipid CH groups in defects grafted with mineral trioxide aggregate (MTA) treated or not with LED irradiation, bone morphogenetic proteins and guided bone regeneration. A total of 90 rats were divided into ten groups each of which was subdivided into three subgroups (evaluated at 15, 21 and 30 days after surgery). Defects were irradiated with LED light (wavelength 850 +/- 10 nm) at 48-h intervals for 15 days. Raman readings were taken at the surface of the defects. There were no statistically significant differences in the CHA peaks among the nonirradiated defects at any of the experimental time-points. On the other hand, there were significant differences between the defects filled with blood clot and the irradiated defects at all time-points (p < 0.001, p = 0.02, p < 0.001). There were significant differences between the mean peak CHA in nonirradiated defects at all the experimental time-points (p < 0.01). The mean peak of the defects filled with blood clot was significantly different from that of the defects filled with MTA (p < 0.001). There were significant differences between the defects filled with blood clot and the irradiated defects (p < 0.001). The results of this study using Raman spectral analysis indicate that infrared LED light irradiation improves the deposition of CHA in healing bone grafted or not with MTA.
C1 [Pinheiro, Antonio L. B.; Soares, Luiz G. P.; Santos, Nicole R. S.; Barbosa, Artur Felipe S.] Univ Fed Bahia, Ctr Biophoton, Sch Dent, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio L. B.; Silveira Junior, Landulfo] Univ Camilo Castelo Branco Nucleo Parque Tecnol S, Sao Jose Dos Campos, SP, Brazil.
   [Pinheiro, Antonio L. B.] Inst Nacl Ciencia & Tecnol Opt & Foton, Sao Carlos, SP, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Ctr Biophoton, Sch Dent, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Pinheiro, Antonio Luiz/A-1962-2008; Optica e fotonica, Inct/I-2419-2013;
   Barbosa, Artur/G-3839-2012; Silveira, Landulfo/I-2474-2012
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321; Silveira,
   Landulfo/0000-0002-6616-3334
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), a
   government research agency
FX We would like to thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for providing financial support for this
   project.; The authors received a grant from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), a government research
   agency, but have full control of all primary data and agree to allow the
   journal to review their data if requested.
CR Al-Watban F. A. H., 1997, Lasers in the Life Sciences, V7, P237
   Al-Watban FAH, 2003, J CLIN LASER MED SUR, V21, P249, DOI 10.1089/104454703322564451
   Barolet D, 2008, SEMIN CUTAN MED SURG, V27, P227, DOI 10.1016/j.sder.2008.08.003
   BYSTROM A, 1985, Endodontics and Dental Traumatology, V1, P170
   de Sousa APC, 2011, PHOTOMED LASER SURG, V29, P605, DOI 10.1089/pho.2010.2833
   Cho HS, 2008, J BIOMATER APPL, V22, P545, DOI 10.1177/0885328207080825
   COOK SD, 1994, CLIN ORTHOP RELAT R, P302
   Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011
   Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121
   Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1
   Evans GH, 1997, CURR OPIN PERIODONT, V4, P75
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Hunt TR, 1993, T ORTHOP RES SOC, V18, P489
   Ihsan FRM, 2005, PHOTOMED LASER SURG, V23, P289, DOI 10.1089/pho.2005.23.289
   Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001
   Kalfas I H, 2001, Neurosurg Focus, V10, pE1
   Kempen DHR, 2010, TISSUE ENG PART B-RE, V16, P551, DOI 10.1089/ten.teb.2010.0176
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Lanzafame RJ, 2002, LASER SURG MED, P12
   Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Muschler GF, 1990, SPINAL FUSION SCI TE, P9
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Nascimento Cássio do, 2007, Int. J. Morphol., V25, P839, DOI 10.4067/S0717-95022007000400025
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Park YJ, 2000, J BIOMED MATER RES, V51, P391, DOI 10.1002/1097-4636(20000905)51:3<391::AID-JBM13>3.0.CO;2-9
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   PROLO DJ, 1990, CLIN NEUR, V36, P135
   Recker RR, 1992, DISORDERS BONE MINER, P219
   Reddi AH, 2009, CYTOKINE GROWTH F R, V20, P341, DOI 10.1016/j.cytogfr.2009.10.015
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Rocha AM, 2009, PHOTOMED LASER SURG, V27, P303, DOI 10.1089/pho.2008.2277
   Safavi SM, 2008, LASER MED SCI, V23, P331, DOI 10.1007/s10103-007-0491-5
   Saygun I, 2008, LASER MED SCI, V23, P211, DOI 10.1007/s10103-007-0477-3
   Schwartz RS, 1999, J AM DENT ASSOC, V130, P967, DOI 10.14219/jada.archive.1999.0337
   Silva Junior N, 2002, J CLIN LASER MED SUR, V20, P83
   Smith KC, 2005, PHOTOMED LASER SURG, V23, P78, DOI 10.1089/pho.2005.23.78
   Tachiara R., 2002, LASERS SURG MED S, V14, P11
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   URIST MR, 1968, CLIN ORTHOP RELAT R, P59
   Vinck EM, 2003, LASER MED SCI, V18, P95, DOI 10.1007/s10103-003-0262-x
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Whelan HT, 2002, J CLIN LASER MED SUR, V20, P319, DOI 10.1089/104454702320901107
   Whelan HT, 2001, AIP CONF PROC, V552, P35
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
NR 64
TC 23
Z9 24
U1 1
U2 15
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
J9 LASER MED SCI
JI Lasers Med. Sci.
PD SEP
PY 2012
VL 27
IS 5
BP 903
EP 916
DI 10.1007/s10103-011-1010-2
PG 14
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA 987GZ
UT WOS:000307406500003
PM 22016039
DA 2018-10-19
ER

PT J
AU Pinheiro, ALB
   Soares, LGP
   Barbosa, AFS
   Ramalho, LMP
   dos Santos, JN
AF Pinheiro, Antonio L. B.
   Soares, Luiz G. P.
   Barbosa, Artur F. S.
   Ramalho, Luciana M. P.
   dos Santos, Jean N.
TI Does LED phototherapy influence the repair of bone defects grafted with
   MTA, bone morphogenetic proteins, and guided bone regeneration? A
   description of the repair process on rodents
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Biomaterial; Light emitting diode; Mineral trioxide aggregate
ID MINERAL TRIOXIDE AGGREGATE; EMITTING DIODE IRRADIATION; END FILLING
   MATERIALS; LASER PHOTOBIOMODULATION; TISSUE-REACTIONS; DIABETIC-RATS;
   IN-VIVO; LIGHT; MODEL; CEMENT
AB This work carried out a histological analysis on bone defects grafted (MTA) treated or not with LED, BMPs, and membrane (GBR). Benefits of their isolated or combined usage on bone repair were reported, but not their association. Ninety rats were divided into ten groups and each subdivided into three. Defects on G II and I were filled with the blood clot. G II was further LED irradiated. G III and IV were filled with MTA; G IV was further LED irradiated. In G V and VI, the defects were filled with MTA and covered with a membrane (GBR). G VI was further LED irradiated. In G VII and VIII, BMPs were added to the MTA and group VIII was further LED irradiated. In G IX and X, the MTA + BMP graft was covered with a membrane (GBR). G X was further LED irradiated. LED was applied over the defect at 48-h intervals and repeated for 15 days. Specimens were processed, cut, and stained with H&E and Sirius red and underwent histological analysis. The use of LED light alone dramatically reduced inflammation. However, its use on MTA associated with BMP and/or GBR increased the severity of the inflammatory reaction. Regarding bone reabsorption, the poorest result was seen when the LED light was associated with the MTA + BMP graft. In the groups Clot and MTA + GBR, no bone reabsorption was detectable. Increased collagen deposition was observed when the LED light was associated with the use of the MTA associated with BMP and/or GBR. Increased new bone formation was observed when the LED light was used alone or associated with the use of MTA + GBR, MTA + BMP, on association of MTA + BMP + GBR and when BMP was added to the MTA. Our results indicate that the use of LED light alone or in association with MTA, MTA + BMP, MTA + GBR, and MTA + BMP + GBR caused less inflammation, and an increase of both collagen deposition and bone deposition as seen on both histological and morphometric analysis.
C1 [Pinheiro, Antonio L. B.; Soares, Luiz G. P.; Barbosa, Artur F. S.; Ramalho, Luciana M. P.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio L. B.] Univ Camilo Castelo Branco, BR-12245230 Sao Jose Dos Campos, SP, Brazil.
   [Pinheiro, Antonio L. B.; Ramalho, Luciana M. P.; dos Santos, Jean N.] Natl Inst Opt & Photon, BR-13560970 Sao Carlos, SP, Brazil.
   [dos Santos, Jean N.] Univ Fed Bahia, Lab Surg Pathol, Sch Dent, BR-40110150 Salvador, BA, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br; luizguilherme_@hotmail.com; arturfelipes@gmail.com;
   lucianaramalho@uol.com.br; jeanpatol@gmail.com
RI RAMALHO, LUCIANA/R-8862-2016; Barbosa, Artur/G-3839-2012; Optica e
   fotonica, Inct/I-2419-2013; Pinheiro, Antonio Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq
FX We would like to thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq for providing financial support for this
   project.
CR Al-Rabeah E, 2006, J ENDODONT, V32, P872, DOI 10.1016/j.joen.2006.03.019
   Al-Watban FAH, 2006, PHOTOMED LASER SURG, V24, P10, DOI 10.1089/pho.2006.24.10
   Al-Watban FAH, 2003, J CLIN LASER MED SUR, V21, P249, DOI 10.1089/104454703322564451
   Barolet D, 2008, SEMIN CUTAN MED SURG, V27, P227, DOI 10.1016/j.sder.2008.08.003
   Bystrom A., 1995, ENDOD DENT TRAUMATOL, P170
   Camilleri J, 2006, INT ENDOD J, V39, P747, DOI 10.1111/j.1365-2591.2006.01135.x
   Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011
   Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Higuchi A, 2007, CYTOTECHNOLOGY, V54, P181, DOI 10.1007/s10616-007-9087-y
   Karu TI, 2003, BIOMEDICAL PHOTONICS
   Lanzafame RJ, 2002, LASER SURG MED, P12
   Lee YL, 2004, BIOMATERIALS, V25, P787, DOI 10.1016/S0142-9612(03)00591-X
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Moretton TR, 2000, J BIOMED MATER RES, V52, P528, DOI 10.1002/1097-4636(20001205)52:3<528::AID-JBM11>3.0.CO;2-9
   Morreton TR, 2000, J BIOMED MATER RES, V52, P528
   Perez AL, 2000, INT ENDOD J, V36, P564
   Perinpanayagam H, 2009, J CAN DENT ASSOC, V75, P369
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Regan JD, 2002, INT ENDOD J, V35, P840, DOI 10.1046/j.1365-2591.2002.00582.x
   Rox Anderson R, 2002, LASER SURG MED, V30
   Saidon J, 2003, ORAL SURG ORAL MED O, V95, P483, DOI 10.1067/moe.2003.20
   Sommer AP, 2001, J CLIN LASER MED SUR, V19, P29, DOI 10.1089/104454701750066910
   STAHL SS, 1990, J CLIN PERIODONTOL, V17, P191, DOI 10.1111/j.1600-051X.1990.tb01085.x
   Tachiara R., 2002, LASERS SURG MED S, V14, P11
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   TORABINEJAD M, 1995, J ENDODONT, V21, P569, DOI 10.1016/S0099-2399(06)80987-8
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Tronstad L, 1981, J Endod, V7, P17, DOI 10.1016/S0099-2399(81)80262-2
   Vinck EM, 2005, PHOTOMED LASER SURG, V23, P167, DOI 10.1089/pho.2005.23.167
   Weiss RA, 2005, DERMATOL SURG, V31, P1199
   Whelan HT, 2001, AIP CONF PROC, V552, P35
   Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758
NR 39
TC 23
Z9 24
U1 1
U2 11
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
J9 LASER MED SCI
JI Lasers Med. Sci.
PD SEP
PY 2012
VL 27
IS 5
BP 1013
EP 1024
DI 10.1007/s10103-011-1033-8
PG 12
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA 987GZ
UT WOS:000307406500017
PM 22170161
DA 2018-10-19
ER

PT J
AU Kim, YB
   Kim, G
AF Kim, Yong Bok
   Kim, GeunHyung
TI Functionally graded PCL/beta-TCP biocomposites in a multilayered
   structure for bone tissue regeneration
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID COMPOSITE SCAFFOLDS; IN-VITRO; CELLS; DEGRADATION; MORPHOLOGY; POROSITY
AB Functionally graded (FG) composites consisting of polycaprolactone (PCL) and beta-tricalcium phosphate (beta-TCP) particles were fabricated with a multilayered structure using a melt plotter with a two-heating-barrel system. Using this process, the concentration of beta-TCP particles varied in each layered strut. Scanning electron microscopy (SEM) and energy dispersive spectroscopy mapping of calcium on the fabricated scaffolds indicated that the beta-TCP particles were well distributed in each PCL strut, according to conceptual design. By incorporating beta-TCP, the FG-PCL/beta-TCP scaffolds had meaningful increases in water absorption (30 % increase) and showed good mechanical properties, although the mechanical properties are slightly low compared to pure PCL/beta-TCP composite. We performed biological assessments to evaluate the capability of these FG scaffolds to act as a biomaterial for bone tissue regeneration with osteoblast-like cells (MG63). SEM images of cell-seeded FG scaffolds showed that the concentrated alpha-TCP struts were affected as good cell attachment/proliferation sites. Additionally, calcium deposition on the FG scaffolds was higher than that of normal scaffolds after 14 days. In particular, we observed high levels of mineralization in the highly concentrated beta-TCP struts in the FG scaffolds. Based on these results, we believe that the FG scaffolds having various spatially designed structures with graded properties will be widely applicable for hard tissue engineering applications.
C1 [Kim, Yong Bok; Kim, GeunHyung] Chosun Univ, Dept Mech Engn, Bio Nanofluid Lab, Kwangju 501759, South Korea.
RP Kim, G (reprint author), Chosun Univ, Dept Mech Engn, Bio Nanofluid Lab, Kwangju 501759, South Korea.
EM gkim@chosun.ac.kr
CR Ang KC, 2007, J BIOMED MATER RES A, V80A, P655, DOI 10.1002/jbm.a.30996
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   BITTIGER H, 1970, ACTA CRYSTALL B-STRU, VB 26, P1923, DOI 10.1107/S0567740870005198
   Catledge SA, 2007, BIOMED MATER, V2, P142, DOI 10.1088/1748-6041/2/2/013
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cyster LA, 2005, BIOMATERIALS, V26, P697, DOI 10.1016/j.biomaterials.2004.03.017
   Gross KA, 2004, BIOMATERIALS, V25, P4955, DOI 10.1016/j.biomaterials.2004.01.046
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Kalita SJ, 2003, MAT SCI ENG C-BIO S, V23, P611, DOI 10.1016/S0928-4931(03)00052-3
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   McCullen SD, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035002
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mulhaupt R., 2003, EUR CELLS MAT S1, V6, P12
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Ozkan S, 2010, J BIOMED MATER RES A, V92A, P1007, DOI 10.1002/jbm.a.32425
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   ROOSA SM, 2009, J BIOMED MATER RES A, V92, P359
   Sudarmadji N, 2011, ACTA BIOMATER, V7, P530, DOI 10.1016/j.actbio.2010.09.024
   Takagishi Y, 2006, TISSUE ENG, V12, P927, DOI 10.1089/ten.2006.12.927
   UTRACKI LA, 1983, POLYM ENG SCI, V23, P602, DOI 10.1002/pen.760231103
   Yeo A, 2010, J BIOMED MATER RES A, V93A, P1358, DOI 10.1002/jbm.a.32633
   Yeo MG, 2012, CHEM MATER, V24, P903, DOI 10.1021/cm201119q
   Yeo M, 2011, BIOMACROMOLECULES, V12, P502, DOI 10.1021/bm1013052
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
NR 33
TC 6
Z9 6
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD SEP
PY 2012
VL 108
IS 4
BP 949
EP 959
DI 10.1007/s00339-012-7004-5
PG 11
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 986HN
UT WOS:000307332800026
DA 2018-10-19
ER

PT J
AU Silva, NA
   Cooke, MJ
   Tam, RY
   Sousa, N
   Salgado, AJ
   Reis, RL
   Shoichet, MS
AF Silva, Nuno A.
   Cooke, Michael J.
   Tam, Roger Y.
   Sousa, Nuno
   Salgado, Antonio J.
   Reis, Rui L.
   Shoichet, Molly S.
TI The effects of peptide modified gellan gum and olfactory ensheathing
   glia cells on neural stem/progenitor cell fate
SO BIOMATERIALS
LA English
DT Article
DE Gellan gum; Olfactory ensheathing glia cell; Neural stem/progenitor
   cell; Spinal cord injury; RGD; Diels-Alder click chemistry
ID SPINAL-CORD-INJURY; NERVE GROWTH-FACTOR; PROMOTE LOCOMOTOR RECOVERY;
   STEM-CELLS; DELAYED TRANSPLANTATION; EXTRACELLULAR-MATRIX; CORTICOSPINAL
   TRACT; DIFFERENTIATION; SCAFFOLDS; HYDROGEL
AB The regenerative capacity of injured adult central nervous system (CNS) tissue is very limited. Specifically, traumatic spinal cord injury (SCI) leads to permanent loss of motor and sensory functions below the site of injury, as well as other detrimental complications. A potential regenerative strategy is stem cell transplantation; however, cell survival is typically less than 1%. To improve cell survival, stem cells can be delivered in a biomaterial matrix that provides an environment conducive to survival after transplantation. One major challenge in this approach is to define the biomaterial and cell strategies in vitro. To this end, we investigated both peptide-modification of gellan gum and olfactory ensheathing glia (OEG) on neural stem/progenitor cell (NSPC) fate. To enhance cell adhesion, the gellan gum (GG) was modified using Diels-Alder click chemistry with a fibronectin-derived synthetic peptide (GRGDS). Amino acid analysis demonstrated that approximately 300 nmol of GRGDS was immobilized to each mg of GG. The GG-GRGDS had a profound effect on NSPC morphology and proliferation, distinct from that of NSPCs in GG alone, demonstrating the importance of GRGDS for cell-GG interaction. To further enhance NSPC survival and outgrowth, they were cultured with OEG. Here NSPCs interacted extensively with OEG, demonstrating significantly greater survival and proliferation relative to monocultures of NSPCs. These results suggest that this co-culture strategy of NSPCs with OEG may have therapeutic benefit for SCI repair. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Silva, Nuno A.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, Guimaraes, Portugal.
   [Silva, Nuno A.; Sousa, Nuno; Salgado, Antonio J.; Reis, Rui L.] ICVS 3Bs PT Govt Associated Lab, Braga, Portugal.
   [Silva, Nuno A.; Sousa, Nuno; Salgado, Antonio J.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.
   [Silva, Nuno A.; Cooke, Michael J.; Tam, Roger Y.; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
   [Silva, Nuno A.; Cooke, Michael J.; Tam, Roger Y.; Shoichet, Molly S.] Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Shoichet, Molly S.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.
RP Shoichet, MS (reprint author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St,Room 514, Toronto, ON M5S 3E1, Canada.
EM molly.shoichet@utoronto.ca
RI Sousa, Nuno/C-2782-2009; Salgado, Antonio/J-4129-2013; Silva,
   Nuno/K-4077-2012; Sousa, Nuno/N-9137-2017; Reis, Rui L./A-8938-2008;
   Group, 3Bs/E-4374-2012
OI Salgado, Antonio/0000-0003-3806-9823; Silva, Nuno/0000-0002-1061-1716;
   Sousa, Nuno/0000-0002-8755-5126; Reis, Rui L./0000-0002-4295-6129;
   Group, 3Bs/0000-0002-5195-3456; Tam, Roger/0000-0002-8441-6681
FU Canadian Institute of Health Research; Ontario Neurotrauma Foundation
   and Stem Cell Network; Ontario Ministry of Research and Innovation;
   Portuguese Foundation for Science and Technology
   [NAS-SFRH/BD/40684/2007, PTDC/SAU-BMA/114059/2009]
FX We are grateful to Dr Ying Fang Chen for the isolation and propagation
   of neural stem/progenitor cells, Dr Shawn Owen for assistance with
   chemical modification of gellan gum and to Rey Interior from Advanced
   Protein Technology Centre at Toronto's Hospital for Sick Children for
   amino acid analyses. We acknowledge funding from: the Canadian Institute
   of Health Research (MSS); the Ontario Neurotrauma Foundation and Stem
   Cell Network (MJC); the Ontario Ministry of Research and Innovation
   (post-doctoral fellowship to RYT); and the Portuguese Foundation for
   Science and Technology (doctoral fellowship to NAS-SFRH/BD/40684/2007;
   Science 2007 Program - Antonio J. Salgado; Grant No.
   PTDC/SAU-BMA/114059/2009).
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Arboleda D, 2011, CELL MOL NEUROBIOL, P1
   Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI [10.1227/01.NEU.0000280154.19237.36, 10.1227/01.NEU.0000311081.50648.4C]
   Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004
   Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010
   Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158
   Cao L, 2010, BRAIN RES, V1359, P56, DOI 10.1016/j.brainres.2010.08.063
   Casha S, 2008, MINOCYCLINE PERFUSIO
   CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Dobkin BH, 2006, NEUROREHAB NEURAL RE, V20, P5, DOI 10.1177/1545968305284675
   DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602
   Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657
   Fink H, 2011, J TISSUE ENG REGEN M, V5, P454, DOI 10.1002/term.334
   Gascon E, 2010, ADV EXP MED BIOL, V663, P127, DOI 10.1007/978-1-4419-1170-4_8
   Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006
   Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428
   Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002
   Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021744
   Kubasak MD, 2008, BRAIN, V131, P264, DOI 10.1093/brain/awm267
   Kubo W, 2003, INT J PHARM, V258, P55, DOI 10.1016/S0378-5173(03)00163-7
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000
   Li Y, 2003, J NEUROSCI, V23, P727
   Lima C, 2006, J SPINAL CORD MED, V29, P191, DOI 10.1080/10790268.2006.11753874
   Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Mackay-Sim A, 2000, PROG NEUROBIOL, V62, P527, DOI 10.1016/S0301-0082(00)00009-5
   McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986
   MOORHOUSE R, 1981, SOLUTION PROPERTIES, P111
   MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9
   Oliveira JT, 2010, J ORTHOP RES, V28, P1193, DOI 10.1002/jor.21114
   Pal R, 2010, CYTOTHERAPY, V12, P792, DOI 10.3109/14653249.2010.487899
   Ramon-Cueto A, 1998, BRAIN RES BULL, V46, P175, DOI 10.1016/S0361-9230(97)00463-2
   RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   SCHWARZ MA, 1990, CELL GROWTH DIFFER, V1, P313
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Silva-Correia J, 2011, J TISSUE ENG REGEN M, V5, pE97, DOI 10.1002/term.363
   Steinke A, 2008, HISTOCHEM CELL BIOL, V130, P339, DOI 10.1007/s00418-008-0441-8
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192
   Wellings DA, 1997, METHOD ENZYMOL, V289, P44
   WOODHALL E, 2001, MOL BRAIN RES, V88, P203
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zvibel I, 2002, CELL TRANSPLANT, V11, P621, DOI 10.3727/000000002783985404
NR 52
TC 49
Z9 49
U1 3
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2012
VL 33
IS 27
BP 6345
EP 6354
DI 10.1016/j.biomaterials.2012.05.050
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 983WA
UT WOS:000307148200005
PM 22698724
DA 2018-10-19
ER

PT J
AU Bryan, N
   Ashwin, H
   Smart, N
   Bayon, Y
   Scarborough, N
   Hunt, JA
AF Bryan, Nicholas
   Ashwin, Helen
   Smart, Neil
   Bayon, Yves
   Scarborough, Nelson
   Hunt, John A.
TI The innate oxygen dependant immune pathway as a sensitive parameter to
   predict the performance of biological graft materials
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Neutrophil; Reactive oxygen species; Chemiluminescence;
   Acute inflammation; In Vitro
ID MESHES IN-VITRO; REACTIVE OXYGEN; NEUTROPHIL ACTIVATION; ROS PRODUCTION;
   PHOLASIN; MACROPHAGES; LEUKOCYTES; CELLS; CHEMILUMINESCENCE; INDUCTION
AB Clinical performance of a biomaterial is decided early after implantation as leukocytes interrogate the graft throughout acute inflammation. High degrees of leukocyte activation lead to poor material/patient compliance, accelerated degeneration and graft rejection. A number reactive oxygen species (ROS) are released by leukocytes throughout their interaction with a material, which can be used as a sensitive measure of leukocyte activation. The aim of this study was to compare leukocyte activation by commercially available biologic surgical materials and define the extent manufacturing variables influence down-stream ROS response. Chemiluminescence assays were performed using modifications to a commercially available kit (Knight Scientific, UK). Whole blood was obtained from 4 healthy human adults at 7 day intervals for 4 weeks, combined with Adjuvant K. Pholasin (a highly sensitive ROS excitable photoprotein) and biomaterial, and incubated for 60 min with continuous chemiluminescent measurements. Leukocyte ROS inducers fMLP and PMA were added as controls. Xeno- and allogeneic dermal and small intestinal submucosal (SIS) derived biomaterials were produced commercially (Surgisis Biodesign (TM), Alloderm (R), Strattice (R) Firm & Pliable & Permacol (TM)) or fabricated in house to induce variations in decellularisation and cross-linking. Statistics were performed using Waller-Duncan post hoc ranking. Materials demonstrated significant differences in leukocyte activation as a function of decellularisation reagent and tissue origin. The data demonstrated SIS was significantly more pro-inflammatory than dermis. Additionally it was deduced that SDS during decellularisation induced pro-inflammatory changes to dermal materials. Furthermore, it was possible to conclude inter-patient variation in leukocyte response. The in vitro findings were validated in vivo which confirmed the chemiluminescence observations, highlighting the potential for translation of this technique as a routine component of pre-surgical evaluation to maximise foreign body compliance. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Bryan, Nicholas; Hunt, John A.] Univ Liverpool, Inst Ageing & Chron Dis, Clin Engn UKCTE, Liverpool L69 3GA, Merseyside, England.
   [Ashwin, Helen; Bayon, Yves] Covidien Sofradim Prod, F-01600 Trevoux, France.
   [Scarborough, Nelson] Covidien, Bedford, MA 01730 USA.
   [Smart, Neil] Royal Devon & Exeter Hosp, Exeter Hlth Sci Res Unit, Exeter EX2 5DW, Devon, England.
RP Bryan, N (reprint author), Univ Liverpool, Inst Ageing & Chron Dis, Clin Engn UKCTE, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.
EM n.bryan@liv.ac.uk
RI Hunt, John/G-6366-2012; Smart, Neil/F-8837-2014
OI Hunt, John/0000-0002-5168-4778; Smart, Neil/0000-0002-3043-8324; Ashwin,
   Helen/0000-0003-1029-0032
FU Covidien
FX The authors would like to acknowledge Covidien for funding this research
   and disclose no conflicts of interest.
CR Bryan N, 2009, BIOMATERIALS, V30, P180, DOI 10.1016/j.biomaterials.2008.09.003
   Butterfield TA, 2006, J ATHL TRAINING, V41, P457
   Cheung CY, 2008, ADV FUNCT MATER, V18, P3119, DOI 10.1002/adfm.200800566
   Crossley LJ, 2003, J LEUKOCYTE BIOL, V74, P583, DOI 10.1189/jlb.0103020
   Gavella M, 2010, BRAZ J MED BIOL RES, V43, P942, DOI 10.1590/S0100-879X2010001000004
   Glebska J, 2005, FREE RADICAL BIO MED, V38, P1014, DOI 10.1016/j.freeadbiomed.2004.12.028
   Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6
   GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P259, DOI 10.1042/bj1990259
   Kader KN, 2007, J BIOMED MATER RES B, V83B, P138, DOI 10.1002/jbm.b.30777
   Knight J, 1996, BRIT J RHEUMATOL S2, V35
   Knight J, 1997, IMMUNOL NEWS, V4, P26
   Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107
   Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0
   Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320
   Lieberman MM, 1996, CLIN DIAGN LAB IMMUN, V3, P654
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Malcarney HL, 2005, AM J SPORT MED, V33, P907, DOI 10.1177/0363546504271500
   Marin DP, 2011, INT IMMUNOPHARMACOL, V11, P103, DOI 10.1016/j.intimp.2010.10.013
   MULLER T, 1989, J BIOLUM CHEMILUM, V3, P105, DOI 10.1002/bio.1170030304
   Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367
   Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841
   Nathan C, 2006, NAT REV IMMUNOL, V6, P175
   Orenstein SB, 2010, HERNIA, V14, P401, DOI 10.1007/s10029-010-0634-7
   Orenstein S, 2010, J SURG RES, V158, P10, DOI 10.1016/j.jss.2009.05.033
   Orenstein SB, 2010, SURG ENDOSC, V24, P805, DOI 10.1007/s00464-009-0664-3
   Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028
   Potnis PA, 2011, J CARDIOVASC PHARM, V57, P712, DOI 10.1097/FJC.0b013e31821a4f1e
   Reichl S, 2001, FREE RADICAL RES, V35, P723, DOI 10.1080/10715760100301231
   Reichl S, 2000, FREE RADICAL BIO MED, V28, P1555, DOI 10.1016/S0891-5849(00)00268-9
   Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4
   Segel AW, 2005, ANNU REV IMMUNOL, V23, P197
   Segel GB, 2011, J LEUKOCYTE BIOL, V89, P1
   Shah BC, 2011, HERNIA, V15, P165, DOI 10.1007/s10029-010-0768-7
   Shallberger SP, 2008, VET SURG, V38, P515
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TSAN MF, 1980, INFLAMMATION, V4, P371, DOI 10.1007/BF00916048
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Walton JR, 2007, J BONE JOINT SURG AM, V89A, P786, DOI 10.2106/JBJS.F.00315
   Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067
   WOSSNER JF, 1991, FASEB J, V5, P2145
   Yoo SK, 2009, CURR BIOL, V19, pR553, DOI 10.1016/j.cub.2009.06.025
NR 41
TC 17
Z9 17
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2012
VL 33
IS 27
BP 6380
EP 6392
DI 10.1016/j.biomaterials.2012.05.058
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 983WA
UT WOS:000307148200009
PM 22738779
DA 2018-10-19
ER

PT J
AU Goodrich, JT
   Sandler, AL
   Tepper, O
AF Goodrich, James Tait
   Sandler, Adam L.
   Tepper, Oren
TI A review of reconstructive materials for use in craniofacial surgery
   bone fixation materials, bone substitutes, and distractors
SO CHILDS NERVOUS SYSTEM
LA English
DT Review
DE Craniosynostosis; Bioabsorbable fixation; Autologous/autogenous
   cranioplasty; Allograft cranioplasty; Skull defect; Custom-made
   implants; Biomaterial; Hydroxyapatite; Resorbable plates and screws;
   Methyl methacrylate; Bone cement; Calvarial bone grafts; Pediatric
   neurosurgery
ID LE-FORT-III; CALCIUM-PHOSPHATE CEMENT; HIGH-DENSITY POLYETHYLENE; LARGE
   SKULL DEFECTS; TERM-FOLLOW-UP; HYDROXYAPATITE CEMENT; SYNDROMIC
   CRANIOSYNOSTOSIS; CALVARIAL DEFECTS; CRANIAL DEFECTS; STEM-CELLS
AB Over the last 40 years, craniofacial surgery, in general, and surgery for craniosynostosis, in particular, has witnessed the introduction of a number of new materials for use in operations involving the cranial vault. Some of these materials have proven quite useful over time, while others have failed to meet their stated objectives. In this review, the more popular implant materials are analyzed, and their relative merits and drawbacks are discussed. Craniofacial surgery in the pediatric population has its own unique limitations, quite different from the adult population and those issues are reviewed as well.
C1 [Goodrich, James Tait; Sandler, Adam L.] Montefiore Med Ctr, Albert Einstein Coll Med, Leo Davidoff Dept Neurol Surg, Bronx, NY 10467 USA.
   [Tepper, Oren] Montefiore Med Ctr, Albert Einstein Coll Med, Div Plast & Reconstruct Surg, Bronx, NY 10467 USA.
RP Goodrich, JT (reprint author), Montefiore Med Ctr, Albert Einstein Coll Med, Leo Davidoff Dept Neurol Surg, Bronx, NY 10467 USA.
EM goodrich@aecom.yu.edu
CR Afifi AM, 2010, PLAST RECONSTR SURG, V126, P1300, DOI 10.1097/PRS.0b013e3181ead057
   Ahmad N, 2008, J CRANIOFAC SURG, V19, P855, DOI 10.1097/SCS.0b013e31816ae358
   Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Arnander C, 2006, J CRANIOFAC SURG, V17, P275, DOI 10.1097/00001665-200603000-00013
   Arnaud E, 1999, BIOMATERIALS, V20, P1909, DOI 10.1016/S0142-9612(99)00090-3
   Arnaud E, 2000, CHILD NERV SYST, V16, P659, DOI 10.1007/s003810000321
   Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158
   Bradley JP, 2006, PLAST RECONSTR SURG, V118, P1585, DOI 10.1097/01.prs.0000233010.15987.4d
   Brevi BC, 2010, J PEDIATR SURG, V45, pE17, DOI 10.1016/j.jpedsurg.2010.01.011
   Bruce JN, 2003, J NEUROSURG, V98, P1203, DOI 10.3171/jns.2003.98.6.1203
   Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091
   Chin M, 1997, PLAST RECONSTR SURG, V100, P819, DOI 10.1097/00006534-199709001-00001
   Cohen SR, 1999, PLAST RECONSTR SURG, V103, P1592, DOI 10.1097/00006534-199905060-00006
   Costantino PD, 2000, OTOLARYNG HEAD NECK, V123, P409, DOI 10.1067/mhn.2000.107679
   COULDWELL WT, 1994, J NEUROSURG, V81, P483, DOI 10.3171/jns.1994.81.3.0483
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   David L, 2005, J CRANIOFAC SURG, V16, P129, DOI 10.1097/00001665-200501000-00026
   Davis C, 2009, PLAST RECONSTR SURG, V123, P470, DOI 10.1097/PRS.0b013e3181954ce3
   De Bonis P, 2011, J NEUROTRAUM, V29, P1071
   Dean D, 1999, PLAST RECONSTR SURG, V104, P705, DOI 10.1097/00006534-199909030-00014
   Dujovny M, 1997, SURG NEUROL, V48, P294, DOI 10.1016/S0090-3019(97)00277-2
   Duke BJ, 1996, PEDIATR NEUROSURG, V25, P31, DOI 10.1159/000121093
   Durand JL, 1997, HIST CRANIOPLASTIES, P75
   Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01.01290.8E
   EPPLEY BL, 1995, PLAST RECONSTR SURG, V96, P316, DOI 10.1097/00006534-199508000-00009
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P116, DOI 10.1097/00001665-199703000-00010
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P850, DOI 10.1097/01.FRS.0000132856.69391.43
   Eufinger H, 1998, PLAST RECONSTR SURG, V102, P300, DOI 10.1097/00006534-199808000-00002
   Fearon JA, 2005, PLAST RECONSTR SURG, V115, P1524, DOI 10.1097/01.PRS.0000160270.08827.15
   FEARON JA, 1995, PLAST RECONSTR SURG, V95, P634, DOI 10.1097/00006534-199504000-00002
   Figueroa AA, 2004, PLAST RECONSTR SURG, V114, P1382, DOI 10.1097/01.PRS.0000138593.89303.1B
   Flores RL, 2009, PLAST RECONSTR SURG, V124, P590, DOI 10.1097/PRS.0b013e3181b0fba9
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Gilardino MS, 2009, PLAST RECONSTR SURG, V123, P983, DOI 10.1097/PRS.0b013e318199f6ad
   GOLDBERG DS, 1995, J CRANIOFAC SURG, V6, P301, DOI 10.1097/00001665-199507000-00008
   Gomez E, 2005, J ORAL MAXIL SURG, V63, P8, DOI 10.1016/j.jams.2004.09.008
   Gosain AF, 2002, PLAST RECONSTR SURG, V109, P619, DOI 10.1097/00006534-200202000-00032
   Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163
   Greenberg BM, 2005, ANN PLAS SURG, V55, P43, DOI 10.1097/01.sap.0000168157.10664.9c
   Hardt N, 1994, FORTSCHRITTE KIEFERU, V34, P47
   Heissler E, 1998, INT J ORAL MAX SURG, V27, P334, DOI 10.1016/S0901-5027(98)80060-X
   Herron Scott, 2003, Am J Orthop (Belle Mead NJ), V32, P581
   Ilizarov GA, 1954, COLLECTION SCI WORKS, P145
   Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236
   Jho DH, 2007, J NEUROSURG, V107, P440, DOI 10.3171/JNS-07/08/0440
   Kirschner RE, 2002, ANN PLAS SURG, V49, P33, DOI 10.1097/00000637-200207000-00005
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Kriegel RJ, 2007, ZBL NEUROCHIR, V68, P182, DOI 10.1055/s-2007-985857
   Kubler N, 1998, MUND KIEFER GESICHTS, V2, P32
   Kurpad SN, 2000, PEDIATR NEUROSURG, V33, P306, DOI 10.1159/000055976
   Kuttenberger JJ, 2001, J CRANIO MAXILL SURG, V29, P75, DOI 10.1054/jcms.2001.0197
   Lauritzen CGK, 2008, PLAST RECONSTR SURG, V121, P545, DOI 10.1097/01.prs.0000297638.76602.de
   LEE C, 1995, J CRANIO MAXILL SURG, V23, P133, DOI 10.1016/S1010-5182(05)80001-0
   Lee JA, 2003, ANN PLAS SURG, V50, P610, DOI 10.1097/01.SAP.0000069069.23266.35
   Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002
   Liu JK, 2004, NEUROSURG FOCUS, V16, P1, DOI DOI 10.3171/F0C.2004.16.4.3
   MALIS LI, 1989, NEUROSURGERY, V25, P351, DOI 10.1227/00006123-198909000-00005
   Maltese G, 2007, PLAST RECONSTR SURG, V119, P977, DOI 10.1097/01.prs.0000252276.46113.ee
   Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101
   Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055
   Matic D, 2002, PLAST RECONSTR SURG, V110, P1, DOI 10.1097/00006534-200207000-00001
   Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6
   McCarthy JG, 2001, PLAST RECONSTR SURG, V107, P1812, DOI 10.1097/00006534-200106000-00029
   MCCARTHY JG, 1992, PLAST RECONSTR SURG, V89, P1
   Miller L, 2005, ANN PLAS SURG, V55, P87, DOI 10.1097/01.sap.0000162510.05196.c6
   Mofid MM, 2001, PLAST RECONSTR SURG, V108, P1103, DOI 10.1097/00006534-200110000-00001
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   Munro IR, 1993, 5 INT C INT SOC CRAN
   Neovius E, 2010, J PLAST RECONSTR AES, V63, P1615, DOI 10.1016/j.bjps.2009.06.003
   Orringer JS, 1998, J CRANIOFAC SURG, V9, P40, DOI 10.1097/00001665-199801000-00009
   POCHON JP, 1991, EUR J PEDIATR SURG, V1, P199, DOI 10.1055/s-2008-1042487
   Poetker DM, 2004, OTOL NEUROTOL, V25, P604, DOI 10.1097/00129492-200407000-00031
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rachmiel A, 2006, PLAST RECONSTR SURG, V117, P2399, DOI 10.1097/01.prs.0000204798.50710.a7
   Rohner D, 2002, Mund Kiefer Gesichtschir, V6, P162
   Rubin JP, 1997, PLAST RECONSTR SURG, V100, P1336, DOI 10.1097/00006534-199710000-00043
   Sahoo N, 2010, J CRANIOFAC SURG, V21, P79, DOI 10.1097/SCS.0b013e3181c3ba58
   SAILER HF, 1994, J CRANIO MAXILL SURG, V22, P191, DOI 10.1016/S1010-5182(05)80557-8
   Salyer KE, 1997, PLAST RECONSTR SURG, V99, P1721, DOI 10.1097/00006534-199705000-00038
   Sanus GZ, 2008, J CRANIOFAC SURG, V19, P88, DOI 10.1097/scs.0b013e31815c93fe
   Schantz JT, 2003, EVALUATION CELLULAR, V9, P127
   Schantz JT, 2003, EVALUATION OSTEOGENE, V9, P113
   Sevin K, 2000, BRIT J ORAL MAX SURG, V38, P44, DOI 10.1054/bjom.1998.0038
   Shetye PR, 2010, PLAST RECONSTR SURG, V126, P973, DOI 10.1097/PRS.0b013e3181e60502
   SPECTOR M, 1976, J BIOMED MATER RES, V10, P595, DOI 10.1002/jbm.820100416
   Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014
   Steinbacher DM, 2011, PLAST RECONSTR SURG, V127, P792, DOI 10.1097/PRS.0b013e318200ab83
   Verheggen R, 2001, ACTA NEUROCHIR, V143, P919, DOI 10.1007/s007010170022
   Verret DJ, 2005, OTOLARYNG HEAD NECK, V133, P897, DOI 10.1016/j.otohns.2005.09.001
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Wong RK, 2011, J CRANIOFAC SURG, V22, P247, DOI 10.1097/SCS.0b013e3181f7b7db
   Yano H, 2006, PLAST RECONSTR SURG, V117, P193, DOI 10.1097/01.prs.0000194903.45939.b8
   Yu JC, 2004, PLAST RECONSTR SURG, V114, p1E, DOI 10.1097/01.PRS.0000128965.52013.95
   Zins JE, 2007, PLAST RECONSTR SURG, V120, P1332, DOI 10.1097/01.prs.0000279557.29134.cd
   Zins JE, 2008, PLAST RECONSTR SURG, V121, p271E, DOI 10.1097/PRS.0b013e31816a9fd1
NR 95
TC 29
Z9 30
U1 1
U2 31
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD SEP
PY 2012
VL 28
IS 9
BP 1577
EP 1588
DI 10.1007/s00381-012-1776-y
PG 12
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA 987IS
UT WOS:000307411000040
PM 22872276
DA 2018-10-19
ER

PT J
AU Cheng, Y
   Lin, HY
   Chen, ZL
   Megharaj, M
   Naidu, R
AF Cheng, Ying
   Lin, HongYan
   Chen, Zuliang
   Megharaj, Mallavarapu
   Naidu, Ravi
TI Biodegradation of crystal violet using Burkholderia vietnamiensis C09V
   immobilized on PVA-sodium alginate-kaolin gel beads
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Biodegradation; Crystal violet; Burkholderia vietnamiensis C09V;
   Immobilisation; Polyvinyl alcohol (PVA)
ID PSEUDOMONAS-PUTIDA; AQUEOUS-SOLUTIONS; MALACHITE-GREEN; AZO-DYE;
   DECOLORIZATION; DEGRADATION; ADSORPTION; REMOVAL; PHENOL; WASTE
AB The strain, Burkholderia vietnamiensis C09V was immobilized on PVA-alginate-kaolin gel beads as a biomaterial to improve the degradation of crystal violet from aqueous solution. The results show that 98.6% (30 mg L-1) crystal violet was removed from aqueous solution using immobilized cells on PVA-alginate-kaolin gel beads, while 94.0% crystal violet was removed by free cells after degradation at the pH 5 and 30 C for 30 h. Kinetics studies show that the pseudo-second-order kinetics well described the adsorption of crystal violet on the PVA-alginate-kaolin beads. Biodegradation of crystal violet on immobilized cells was fitted well by first-order reaction kinetics, indicating that CV was adsorbed onto kaolin and followed their degradation by immobilized cells onto the the PVA-alginate-kaolin beads. Characterization with SEM shows that cells attached well to the surface of PVA-alginate-kaolin beads, leading to improved crystal violet transfer from aqueous solution to immobilized cells. In addition, UV-vis show that the absorption peak at 588 nm was reduced by the degraded N-bond linkages, as well as the formation of degrading products were observed by Fourier transform infrared (FTIR). These results suggest that crystal violet was biodegraded to N,N-dimethylaminophenol and Michler's Ketone prior to these intermediates being further degraded. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Chen, Zuliang; Megharaj, Mallavarapu; Naidu, Ravi] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA 5095, Australia.
   [Cheng, Ying; Lin, HongYan; Chen, Zuliang] Fujian Normal Univ, Sch Environm Sci & Engn, Fuzhou 350007, Peoples R China.
   [Chen, Zuliang; Megharaj, Mallavarapu; Naidu, Ravi] Cooperat Res Ctr Contaminat Assessment & Remediat, Mawson Lakes, SA 5095, Australia.
RP Chen, ZL (reprint author), Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA 5095, Australia.
EM Zuliang.chen@unisa.edu.au
RI Mallavarapu, Megharaj/D-3408-2011
OI Mallavarapu, Megharaj/0000-0002-6230-518X
FU Fujian Provincial Development and Reform Commission; Fujian Normal
   University, P. R. China from "MinJiang Fellowship"
FX The authors sincerely thank Fujian Provincial Development and Reform
   Commission for providing the research funding and Fujian Normal
   University, P. R. China for the supporting from "MinJiang Fellowship".
CR Ahmad R, 2010, J ENVIRON MANAGE, V91, P1032, DOI 10.1016/j.jenvman.2009.12.016
   Akhtar K, 2009, BIORESOURCE TECHNOL, V100, P4551, DOI 10.1016/j.biortech.2009.03.073
   Al-Zuhair S, 2011, BIOCHEM ENG J, V56, P46, DOI 10.1016/j.bej.2011.05.005
   Asad S, 2007, BIORESOURCE TECHNOL, V98, P2082, DOI 10.1016/j.biortech.2006.08.020
   Ayed L, 2010, DESALINATION, V260, P137, DOI 10.1016/j.desal.2010.04.052
   Ayed L, 2009, WORLD J MICROB BIOT, V25, P705, DOI 10.1007/s11274-008-9941-x
   Chen CH, 2010, J HAZARD MATER, V177, P281, DOI 10.1016/j.jhazmat.2009.12.030
   Chen CH, 2008, CHEMOSPHERE, V72, P1712, DOI 10.1016/j.chemosphere.2008.04.069
   Chen CY, 2009, J HAZARD MATER, V172, P1439, DOI 10.1016/j.jhazmat.2009.08.009
   Chen JP, 2007, PROCESS BIOCHEM, V42, P934, DOI 10.1016/j.procbio.2007.03.001
   Chen XC, 2008, COLLOID SURFACE B, V61, P170, DOI 10.1016/j.colsurfb.2007.08.002
   Chen YM, 2007, J HAZARD MATER, V148, P660, DOI 10.1016/j.jhazmat.2007.03.030
   Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025
   Dominguez A, 2005, WORLD J MICROB BIOT, V21, P405, DOI 10.1007/s11274-004-1763-x
   El-Naas MH, 2009, J HAZARD MATER, V164, P720, DOI 10.1016/j.jhazmat.2008.08.059
   Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001
   Ha J, 2009, BIORESOURCE TECHNOL, V100, P1138, DOI 10.1016/j.biortech.2008.08.022
   Harris RG, 2001, COLLOID SURFACE A, V180, P131, DOI 10.1016/S0927-7757(00)00747-0
   Kulkarni M, 2007, J ENVIRON MANAGE, V85, P496, DOI 10.1016/j.jenvman.2007.06.009
   Nandi BK, 2009, APPL CLAY SCI, V42, P583, DOI 10.1016/j.clay.2008.03.015
   Nandi BK, 2009, J HAZARD MATER, V161, P387, DOI 10.1016/j.jhazmat.2008.03.110
   Nievas ML, 2006, BIORESOURCE TECHNOL, V97, P2280, DOI 10.1016/j.biortech.2005.10.042
   Noubactep C, 2009, J HAZARD MATER, V166, P79, DOI 10.1016/j.jhazmat.2008.11.001
   Rodriguez-Couto S., 2009, BIOTECHNOL ADV, V2009, P227
   Saltikov CW, 2003, APPL ENVIRON MICROB, V69, P2800, DOI 10.1128/AEM.69.5.2800-2809.2003
   Say R, 2001, BIORESOURCE TECHNOL, V76, P67, DOI 10.1016/S0960-8524(00)00071-7
   Steffan S, 2005, ENVIRON INT, V31, P201, DOI 10.1016/j.envint.2004.09.016
   Tao XQ, 2009, INT J ENV RES PUB HE, V6, P2470, DOI 10.3390/ijerph6092470
   Venkata M. S., 2007, ECOL ENG, V31, P242
   Wang J, 2009, WORLD J MICROB BIOT, V25, P875, DOI 10.1007/s11274-009-9962-0
   Wang X, 2007, APPL ENVIRON MICROB, V73, P6421, DOI 10.1128/AEM.01051-07
   Wu L, 2009, J ENVIRON SCI-CHINA, V21, P237, DOI 10.1016/S1001-0742(08)62257-3
   Zhang LS, 2007, J ENVIRON SCI-CHINA, V19, P1293, DOI 10.1016/S1001-0742(07)60211-3
NR 33
TC 35
Z9 41
U1 3
U2 50
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD SEP 1
PY 2012
VL 83
BP 108
EP 114
DI 10.1016/j.ecoenv.2012.06.017
PG 7
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 983OX
UT WOS:000307129700015
PM 22789742
DA 2018-10-19
ER

PT J
AU Hallmann, L
   Ulmer, P
   Reusser, E
   Hammerle, CHF
AF Hallmann, Lubica
   Ulmer, Peter
   Reusser, Eric
   Haemmerle, Christoph H. F.
TI Surface characterization of dental Y-TZP ceramic after air abrasion
   treatment
SO JOURNAL OF DENTISTRY
LA English
DT Article
DE Airborne particle abrasion; Dental zirconia; FESEM; XPS
ID YTTRIA-STABILIZED ZIRCONIA; FLEXURAL STRENGTH; OXIDE CERAMICS; BOND
   STRENGTHS; LUTING CEMENTS; HEAT-TREATMENT; RESIN BOND; IN-VITRO;
   TRANSFORMATION; BIOMATERIAL
AB Objective: The aim of this study was to characterize the surface of Y-TZP after abrasion with various airborne particles.
   Methods: The Y-TZP blanks were cut into 44 discs and sintered according to the manufacturer's instructions. The specimens were treated as follows: (a) control specimens, (b) abraded with 50 mm alumina, (c) abraded with 110 mm alumina, (d) abraded with 30 mu m silica-coated alumina, (e) abraded with 110 mm silica-coated alumina, (f) abraded with 110 mm alumina followed by 110 mu m silica-coated alumina particles. Airborne abrasion was performed at a pressure of 2.5 bar for 15 s/cm(2). The Y-TZP was characterized using X-ray photoelectron spectroscopy (XPS), field emission scanning electron microscopy (FESEM) and X-ray diffraction analysis (XRD).
   Results: Surface morphology of Y-TZP ceramic was changed after the airborne abrasion process compared to the control specimens. The grain boundaries disappeared and part of the airborne particles are embedded and/or rested on the ceramic surfaces. The elemental composition of the Y-TZP surface after the airborne abrasion process depended on the type and size of these particles. The concentration of Si resulted higher after the airborne abrasion process with 110 mu m alumina followed by 110 mu m silica-coated alumina particles in comparison to the specimens abraded with 110 mu m silica-coated alumina particles. The ratio of elements normalized by yttrium for these specimens was: [Zr]/[Y]/[Al]/[Si] = 15.2/1.0/26.0/73.6, respectively.
   Conclusion: The change of grain topography occurred during each impact process. Silica nano-particles covered not only loosely the abraded ceramic surface after abrasion process, but the release of kinetic energy in form of thermal energy resulted in melting of the ceramic surface and in the formation of zirconium silicate. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Hallmann, Lubica; Haemmerle, Christoph H. F.] Univ Zurich, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Ctr Dent Med, CH-8032 Zurich, Switzerland.
   [Ulmer, Peter; Reusser, Eric] ETH, Inst Geochem & Petrol, Zurich, Switzerland.
RP Hallmann, L (reprint author), Univ Zurich, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Ctr Dent Med, Plattenstr 11, CH-8032 Zurich, Switzerland.
EM lubica.hallmann@zzm.uzh.ch; peter.ulmer@erdw.ethz.ch;
   eric.reusser@erdw.ethz.ch; christoph.hammerle@zzm.uzh.ch
RI Ulmer, Peter/G-4694-2018
OI Ulmer, Peter/0000-0001-9131-0669
CR Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1
   BARR TL, 1991, J VAC SCI TECHNOL A, V9, P1793, DOI 10.1116/1.577464
   Blatz Markus B, 2003, J Esthet Restor Dent, V15, P362, DOI 10.1111/j.1708-8240.2003.tb00309.x
   Blatz MB, 2003, J PROSTHET DENT, V89, P268, DOI 10.1067/mpr.2003.50
   Boch P, 2007, CERAMIC MATERIALS: PROCESSES, PROPERTIES AND APPLICATIONS, P1, DOI 10.1002/9780470612415
   Castain J., 1992, HDB XRAY PHOTOELECTR
   Casucci A, 2009, J DENT, V37, P891, DOI 10.1016/j.jdent.2009.06.013
   Cavalcanti AN, 2009, OPER DENT, V34, P268
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Curtis AR, 2006, J DENT, V34, P195, DOI 10.1016/j.jdent.2005.06.006
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Derand P, 2000, INT J PROSTHODONT, V13, P131
   Everson P, 2012, J DENT, V40, P347, DOI 10.1016/j.jdent.2011.12.011
   Faro AC, 2003, PHYS CHEM CHEM PHYS, V5, P1932, DOI 10.1039/b300899a
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guazzato M, 2004, BIOMATERIALS, V25, P2153, DOI 10.1016/j.biomaterials.2003.08.056
   Guittet MJ, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125117
   Harris AF, 1999, INT J ADHES ADHES, V19, P445, DOI 10.1016/S0143-7496(98)00061-X
   Heikkinen TT, 2007, ACTA ODONTOL SCAND, V65, P241, DOI 10.1080/00016350701459753
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Holmberg K, 2000, CERAM INT, V26, P787, DOI 10.1016/S0272-8842(00)00015-8
   HOWARD CJ, 1988, ACTA CRYSTALLOGR B, V44, P116, DOI 10.1107/S0108768187010279
   Kern M, 2009, J ADHES SCI TECHNOL, V23, P1097, DOI 10.1163/156856109X432721
   Kim MJ, 2011, J DENT, V39, P795, DOI 10.1016/j.jdent.2011.08.012
   Kisi E. H., 1998, Key Engineering Materials, V153-154, P1
   Kitayama S, 2010, DENT MATER, V26, P426, DOI 10.1016/j.dental.2009.11.159
   Koshizaki N, 1998, THIN SOLID FILMS, V325, P130, DOI 10.1016/S0040-6090(98)00512-4
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Koutayas SO, 2009, INT J ESTHET DENT, V4, P348
   Lohbauer U, 2008, J BIOMED MATER RES B, V87B, P461, DOI 10.1002/jbm.b.31126
   Lorente MC, 2010, DENT MATER, V26, P1035, DOI 10.1016/j.dental.2010.06.005
   Lung CYK, 2010, APPL SURF SCI, V257, P1228, DOI 10.1016/j.apsusc.2010.08.029
   MAJUMDAR D, 1991, J APPL PHYS, V70, P988, DOI 10.1063/1.349611
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Messerschmidt U, 1997, MAT SCI ENG A-STRUCT, V233, P61, DOI 10.1016/S0921-5093(97)00050-6
   Momber A, 2008, BLASTING CLEANING TE
   Osorio E, 2010, J DENT, V38, P118, DOI 10.1016/j.jdent.2009.09.010
   Phark JH, 2009, J PROSTHET DENT, V101, P29, DOI 10.1016/S0022-3913(08)60286-3
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pittayachawan P, 2009, J BIOMED MATER RES B, V88B, P366, DOI 10.1002/jbm.b.31064
   Rayner GB, 2003, J VAC SCI TECHNOL B, V21, P1783, DOI 10.1116/1.1593646
   Richerson D. W., 2006, MODERN CERAMICS ENG
   Sato H, 2008, DENT MATER J, V27, P408, DOI 10.4012/dmj.27.408
   Schelling PK, 2001, J AM CERAM SOC, V84, P1609
   Shigeyasu A, 2000, J ADHES SCI TECHNOL, V14, P27
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   Wang SJ, 2003, APPL PHYS LETT, V82, P2047, DOI 10.1063/1.1565182
   Wang SJ, 2002, APPL PHYS LETT, V80, P2541, DOI 10.1063/1.1467970
   Xible AA, 2006, J PROSTHET DENT, V95, P224, DOI 10.1016/j.prosdent.2005.12.010
   Yang B, 2010, DENT MATER, V26, P44, DOI 10.1016/j.dental.2009.08.008
   Zhang Y, 2004, J BIOMED MATER RES B, V71B, P381, DOI 10.1002/jbm.b.30097
NR 54
TC 18
Z9 22
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0300-5712
J9 J DENT
JI J. Dent.
PD SEP
PY 2012
VL 40
IS 9
BP 723
EP 735
DI 10.1016/j.jdent.2012.05.003
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 981MZ
UT WOS:000306973800004
PM 22608990
DA 2018-10-19
ER

PT J
AU Desai, N
   Suryanarayana, A
   Calabro, A
AF Desai, N.
   Suryanarayana, A.
   Calabro, A.
TI NOVEL BIOMATERIAL FOR THREE DIMENSIONAL CULTURE OF MOUSE PRE-ANTRAL
   FOLLICLES
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
C1 [Desai, N.; Suryanarayana, A.] Cleveland Clin, Womens Hlth Inst, Obstet & Gynecol, Beachwood, OH USA.
   [Calabro, A.] Cleveland Clin, Biomed Engn, Cleveland, OH 44106 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2012
VL 98
IS 3
SU S
MA P-158
BP S158
EP S158
DI 10.1016/j.fertnstert.2012.07.582
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA V45UY
UT WOS:000209842700526
DA 2018-10-19
ER

PT J
AU Babu, PJ
   Saranya, S
   Sharma, P
   Tamuli, R
   Bora, U
AF Babu, Punuri Jayasekhar
   Saranya, Sibyala
   Sharma, Pragya
   Tamuli, Ranjan
   Bora, Utpal
TI Gold nanoparticles: sonocatalytic synthesis using ethanolic extract of
   Andrographis paniculata and functionalization with polycaprolactone-
   gelatin composites
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Article
DE sonocatalasis; Andrographis paniculata; functionalization; crystal
   growth; biomaterial; PCL-GL composite
AB Gold nanoparticles (AuNPs) were synthesized by sonication using ethanolic leaf extract of Andrographis paniculata. We investigated the optimum parameters for AuNP synthesis and functionalization with polycaprolactone- gelatin (PCL-GL) composites. The AuNPs were characterized with various biophysical techniques such as TEM, XRD, FT-IR and EDX spectroscopy. TEM images showed that nanoparticles were spherical in shape with a size range from 5 to 75 nm. EDX analysis revealed the presence of molecular oxygen and carbon on the surface of AuNPs. The synthesized AuNPs were tested for their effect on HeLa (human cervical cancer) and MCF7 (human breast cancer) cell lines and found to be nontoxic and biocompatible, which are potential carriers for hydrophobic drugs.
C1 [Babu, Punuri Jayasekhar; Bora, Utpal] Indian Inst Technol Guwahati, Dept Biotechnol, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
   [Babu, Punuri Jayasekhar; Saranya, Sibyala; Sharma, Pragya; Tamuli, Ranjan; Bora, Utpal] Indian Inst Technol Guwahati, Ctr Environm, Biotech Hub, Gauhati 781039, Assam, India.
   [Saranya, Sibyala] DRW Coll, Dept Biotechnol, Sps Nellore 524101, Andhra Pradesh, India.
RP Bora, U (reprint author), Indian Inst Technol Guwahati, Dept Biotechnol, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
EM ubora@iitg.ernet.in
FU Department of Biotechnology, Government of India; MHRD
FX We thank the Department of Biotechnology, Government of India, for
   funding this work (Project title "Establishment of Institutional Biotech
   hubs" (IBT hubs) by DBT). PJB thanks MHRD for providing research
   fellowship and PS thanks DBT Biotech Hub for the post doctoral trainee
   ship. SS thanks Dr. Utpal Bora for providing guidance for her M.Sc
   project work.
CR Ahmad M, 1993, INT C US TRAD MED OT
   Babu PJ, 2011, FRONT MATER SCI, V5, P379, DOI 10.1007/s11706-011-0153-1
   Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013
   CHANG RS, 1988, ANTIVIR RES, V9, P163
   Dua VK, 2004, J ETHNOPHARMACOL, V95, P247, DOI 10.1016/j.jep.2004.07.008
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016
   Giljohann DA, 2010, ANGEW CHEM INT EDIT, V49, P3280, DOI 10.1002/anie.200904359
   Hiremath JG, 2011, ASIAN J PHARM, V5, DOI 10.4103/0973-8398.80058
   Jarukamjorn K, 2008, J HEALTH SCI, V54, P370, DOI 10.1248/jhs.54.370
   Kannan P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/8/085602
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Kirtikar KR, 1975, INDIAN MED PLANTS, V3, P1884
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   Lee KB, 2004, NANO LETT, V4, P1869, DOI 10.1021/nl049002y
   LEWIS LN, 1993, CHEM REV, V93, P2693, DOI 10.1021/cr00024a006
   Madav S., 1996, Fitoterapia, V67, P452
   Madikizela B., 2013, INT J GREEN NANOTECH, V2013, P1
   Maisonhaute E, 2002, ULTRASON SONOCHEM, V9, P297, DOI 10.1016/S1350-4177(02)00089-5
   Mason TJ, 2011, ULTRASON SONOCHEM, V18, P226, DOI 10.1016/j.ultsonch.2010.05.008
   Mody VV, 2010, J PHARM BIOALLIED SC, V2, P282, DOI 10.4103/0975-7406.72127
   Mohammadi MS, 2010, ACTA BIOMATER, V6, P3157, DOI 10.1016/j.actbio.2010.03.002
   Nagahama H, 2009, CARBOHYD POLYM, V76, P255, DOI 10.1016/j.carbpol.2008.10.015
   Narayanan KB, 2011, ADV COLLOID INTERFAC, V169, P59, DOI 10.1016/j.cis.2011.08.004
   NAZIMUDEEN S K, 1978, Indian Journal of Pharmaceutical Sciences, V40, P132
   Nune SK, 2009, J MATER CHEM, V19, P2912, DOI 10.1039/b822015h
   PURI A, 1993, J NAT PROD, V56, P995, DOI 10.1021/np50097a002
   Sahoo R, 2011, EUR J SCI RES, V48, P527
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152
   Sheeja K, 2008, IMMUNOPHARM IMMUNOT, V30, P181, DOI [10.1080/08923970701692916, 10.1080/08923970701692916 ]
   Singha PK, 2003, FITOTERAPIA, V74, P692, DOI 10.1016/s0367-326X(03)00159-X
   SIRIPONG P, 1992, J SCI SOC THAILAND, V18, P187
   Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   Thisoda P, 2006, EUR J PHARMACOL, V553, P39, DOI 10.1016/j.ejphar.2006.09.052
   Uboldi C, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-18
   Yang L, 2009, CANCER LETT, V276, P180, DOI 10.1016/j.canlet.2008.11.015
NR 38
TC 6
Z9 6
U1 1
U2 5
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD SEP
PY 2012
VL 6
IS 3
BP 236
EP 249
DI 10.1007/s11706-012-0175-3
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA V32FC
UT WOS:000208936100005
DA 2018-10-19
ER

PT J
AU Johannes, M
   Schneider, J
AF Johannes, M.
   Schneider, J.
TI Processing of Nanostructured Zirconia Composite Ceramics with High Aging
   Resistance
SO JOURNAL OF CERAMIC SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Zirconia; Y-TZP; ATZ; ceramic composite; nanostructured ceramics;
   low-temperature degradation; stirred media mill
ID PARTIALLY-STABILIZED ZIRCONIA; STIRRED MEDIA MILLS; TETRAGONAL ZIRCONIA;
   FRACTURE-TOUGHNESS; Y-TZP; TRANSFORMATION BEHAVIOR; HIGH-STRENGTH;
   DEGRADATION; NANOCOMPOSITES; BIOMATERIAL
AB Dense-sintered ceramic bodies of 3Y-TZP and ATZ (90 % ZrO2-10 %Al2O3) composite ceramic were prepared from commercial powders by means of slip casting, sintering and hot isostatic pressing. The powders were processed in an optimized milling procedure. The properties of the milled particles were determined with diffusive light scattering, Rietveld refinement, BET and SEM. The enhanced sintering activity allows a decrease in the sintering temperature by more than 100 K. After hot isostatic pressing, samples with a grain size of similar or equal to 150 nm were obtained. These nanostructured ceramics are not affected by low-temperature degradation in hydrothermal atmosphere at 134 degrees C. No significant difference in fracture toughness between coarse-grained Y-TZP and nanostructured ceramics was observed. The bending strength of nanostructured Y-TZP is slightly reduced compared with coarse-grained Y-TZP. The prepared ATZ ceramic exhibits a bending strength of about 1700 MPa and a Weibull parameter of 14.
C1 [Johannes, M.; Schneider, J.] Fraunhofer Inst Ceram Technol & Syst, Dept Oxide & Polymer Ceram Components, D-07629 Hermsdorf, Germany.
RP Schneider, J (reprint author), Fraunhofer Inst Ceram Technol & Syst, Dept Oxide & Polymer Ceram Components, Michael Faraday Str 1, D-07629 Hermsdorf, Germany.
EM jens.schneider@ikts.fraunhofer.de
FU German Federal Ministry of Economics and Technology (BMWi) [MF090111]
FX The authors are grateful to the German Federal Ministry of Economics and
   Technology (BMWi) for its financial support of the "Struktodent"
   Project, reference number MF090111.
CR ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x
   Basu B, 2004, MAT SCI ENG A-STRUCT, V366, P338, DOI 10.1016/j.msea.2003.08.063
   BECHER PF, 1992, J AM CERAM SOC, V75, P493, DOI 10.1111/j.1151-2916.1992.tb07832.x
   Binner J, 2008, J EUR CERAM SOC, V28, P973, DOI 10.1016/j.jeurceramsoc.2007.09.002
   Binner J, 2011, INT J APPL CERAM TEC, V8, P766, DOI 10.1111/j.1744-7402.2010.02503.x
   Bravo-Leon A, 2002, ACTA MATER, V50, P4555, DOI 10.1016/S1359-6454(02)00283-5
   Cales B, 2000, CLIN ORTHOP RELAT R, P94
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Claussen N., 1984, SCI TECHNOLOGY ZIRCO, V12
   Fischer H, 2008, DENT MATER, V24, P618, DOI 10.1016/j.dental.2007.06.021
   Gadow R, 2010, ADV ENG MATER, V12, P1220, DOI 10.1002/adem.201000181
   Guo X, 2004, CHEM MATER, V16, P3988, DOI 10.1021/cm040167h
   Houivet D, 2011, ADV ENG MATER, V13, P609, DOI 10.1002/adem.201000356
   Kbler J, 1999, 37 VAMAS EMP DBEND
   Kern F, 2012, J CERAM SCI TECHNOL, V3, P1, DOI 10.4416/JCST2011-00036
   Kern F, 2011, J CERAM SCI TECHNOL, V2, P147, DOI 10.4416/JCST2011-00020
   Kosmac T., 2008, GLOB ROADM CER INT C, V2, P1
   KRELL A, 1995, J AM CERAM SOC, V78, P1417, DOI 10.1111/j.1151-2916.1995.tb08508.x
   KRELL A, 1994, J AM CERAM SOC, V77, P600, DOI 10.1111/j.1151-2916.1994.tb07036.x
   Krell A, 2009, J EUR CERAM SOC, V29, P207, DOI 10.1016/j.jeurceramsoc.2008.03.025
   LANGE FF, 1982, J MATER SCI, V17, P240, DOI 10.1007/BF00809059
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   Matsui K, 2003, J AM CERAM SOC, V86, P1401, DOI 10.1111/j.1151-2916.2003.tb03483.x
   Mende S, 2004, J MATER SCI, V39, P5223, DOI 10.1023/B:JMSC.0000039214.12131.58
   NIIHARA K, 1983, J MATER SCI LETT, V2, P221, DOI 10.1007/BF00725625
   Paul A, 2011, J AM CERAM SOC, V94, P2146, DOI 10.1111/j.1551-2916.2010.04341.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Quinn GD, 2007, J AM CERAM SOC, V90, P673, DOI 10.1111/j.1551-2916.2006.01482.x
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Schneider J, 2008, J AM CERAM SOC, V91, P3613, DOI 10.1111/j.1551-2916.2008.02700.x
   Schubert H, 2005, J EUR CERAM SOC, V25, P1597, DOI 10.1016/j.jeurceramsoc.2004.03.025
   Sida D, 2002, KEY ENG MAT, V218-2, P581, DOI 10.4028/www.scientific.net/KEM.218-220.581
   Stenger F, 2005, POWDER TECHNOL, V156, P103, DOI 10.1016/j.powtec.2005.04.005
   Suarez G, 2010, J NANOSCI NANOTECHNO, V10, P6634, DOI 10.1166/jnn.2010.2645
   Suarez G, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/2/025004
   TILLER FM, 1991, J AM CERAM SOC, V74, P210, DOI 10.1111/j.1151-2916.1991.tb07319.x
   Trunec M, 2007, J AM CERAM SOC, V90, P2735, DOI 10.1111/j.1551-2916.2007.01781.x
   Vasylkiv O, 2003, J AM CERAM SOC, V86, P299, DOI 10.1111/j.1151-2916.2003.tb00015.x
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
   Yashima M, 1996, SOLID STATE IONICS, V86-8, P1131, DOI 10.1016/0167-2738(96)00386-4
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
   Zheng J., 1997, THESIS COLUMBIA U
NR 46
TC 4
Z9 4
U1 1
U2 6
PU GOLLER VERLAG GMBH
PI BADEN BADEN
PA ASCHMATTSTRASSE 8, D-76532 BADEN BADEN, GERMANY
SN 2190-9385
J9 J CERAM SCI TECHNOL
JI J. Ceram. Sci. Technol.
PD SEP
PY 2012
VL 3
IS 3
BP 151
EP 158
DI 10.4416/JCST2012-00015
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA V36FU
UT WOS:000209199300006
DA 2018-10-19
ER

PT J
AU Dhollander, AAM
   Sanchez, VRG
   Almqvist, KF
   Verdonk, R
   Verbruggen, G
   Verdonk, PCM
AF Dhollander, Aad A. M.
   Guevara Sanchez, Victor R.
   Almqvist, Karl F.
   Verdonk, Rene
   Verbruggen, Gust
   Verdonk, Peter C. M.
TI The Use of Scaffolds in the Treatment of Osteochondral Lesions in the
   Knee: Current Concepts and Future Trends
SO JOURNAL OF KNEE SURGERY
LA English
DT Article
DE cartilage; scaffolds; repair; knee
ID ARTICULAR-CARTILAGE DEFECTS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   MESENCHYMAL STEM-CELLS; BONE-MATRIX GELATIN; COMPOSITE MULTILAYERED
   BIOMATERIAL; ALLOGRAFT CHONDROCYTES; POLY(ETHYLENE GLYCOL);
   MORPHOGENETIC PROTEIN; EXTRACELLULAR-MATRIX; CLINICAL-APPLICATION
AB Long after the first reports on human autologous chondrocyte implantation (ACI) by Brittberg in 1994, the development of a so-called optimal technology for osteochondral tissue regeneration is still one of the most challenging issues in knee surgery. Although the short-and intermediate-term results of ACI appear to be favorable, resources are being directed toward scaffold research to improve the technology. Scaffolds used for osteochondral repair may be either cell or noncell-based before its implantation in the knee. The characteristics that make scaffolds optimal for clinical use are that they be biocompatible, biodegradable, permeable, reproducible, mechanically stable, noncytotoxic, and capable of serving as a temporary support for the cells while allowing for eventual replacement by matrix components synthesized by the implanted cells. There is a growing interest in noncell and last-minute cell seeding technologies since they allow for a one-step surgery eliminating the morbidity and necessity of a previous chondral biopsy. Although clinical and histological results from many, already clinically available scaffolds seem to be promising, improvements throughout these technologies and the developments of new ones are still necessary to obtain a more efficient biological response as well as to improve the implant's stability. Moreover, as the understanding of interactions between articular cartilage and subchondral bone continues to evolve, increased attention should be directed at treatment options for the entire osteochondral unit, rather than focusing on the articular surface only.
C1 [Dhollander, Aad A. M.; Almqvist, Karl F.; Verdonk, Rene; Verdonk, Peter C. M.] Ghent Univ Hosp, Dept Orthopaed Surg & Traumatol, B-9000 Ghent, Belgium.
   [Dhollander, Aad A. M.; Verbruggen, Gust] Ghent Univ Hosp, Dept Rheumatol, Lab Connect Tissue Biol, B-9000 Ghent, Belgium.
   [Guevara Sanchez, Victor R.] Inst Nacl Rehabil, Mexico City, DF, Mexico.
   [Verdonk, Peter C. M.] Stedelijk Ziekenhuis Roeselare, Dept Orthopaed Surg, Roeselare, Belgium.
RP Verdonk, PCM (reprint author), Ghent Univ Hosp, Dept Orthopaed Surg & Traumatol, De Pintelaan 185, B-9000 Ghent, Belgium.
EM pverdonk@yahoo.com
CR Ahmed TAE, 2011, TISSUE ENG PT A, V17, P323, DOI [10.1089/ten.tea.2009.0773, 10.1089/ten.TEA.2009.0773]
   Almqvist KF, 2009, AM J SPORT MED, V37, P1920, DOI 10.1177/0363546509335463
   Almqvist KF, 2001, OSTEOARTHR CARTILAGE, V9, P341, DOI 10.1053/joca.2000.0394
   Almqvist KF, 2001, ANN RHEUM DIS, V60, P781, DOI 10.1136/ard.60.8.781
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Barker TH, 2001, J BIOMED MATER RES, V56, P529, DOI 10.1002/1097-4636(20010915)56:4<529::AID-JBM1124>3.0.CO;2-2
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Cascio BM, 2008, OPER TECHN SPORT MED, V16, P221, DOI 10.1053/j.otsm.2009.01.001
   Cerynik DL, 2009, KNEE SURG SPORT TR A, V17, P1135, DOI 10.1007/s00167-009-0765-5
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Chen GP, 2004, TISSUE ENG, V10, P323, DOI 10.1089/107632704323061681
   Choi NY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-103
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   DAHLBERG L, 1991, J ORTHOPAED RES, V9, P11, DOI 10.1002/jor.1100090103
   Davidson PA, 2007, ARTHR ASS N AM M DEN
   Dhollander AAM, 2010, EUR J RADIOL, V75, P72, DOI 10.1016/j.ejrad.2009.03.056
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Erggelet C, 2010, ARCH ORTHOP TRAUM SU, V130, P957, DOI 10.1007/s00402-009-0957-y
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Furthmayr H, 1976, Int Rev Connect Tissue Res, V7, P61
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Hegewald AA, 2004, TISSUE CELL, V36, P431, DOI 10.1016/j.tice.2004.07.003
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   HOMMINGA GN, 1993, ACTA ORTHOP SCAND, V64, P441, DOI 10.3109/17453679308993663
   HU XB, 1993, CLIN ORTHOP RELAT R, P360
   Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2
   Iwata H, 2002, CLIN ORTHOP RELAT R, P99
   Kasemkijwattana Channarong, 2011, Journal of the Medical Association of Thailand, V94, P395
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   Kerker JT, 2008, SPORTS MED ARTHROSC, V16, P208, DOI 10.1097/JSA.0b013e31818cdbaa
   KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301, DOI 10.2106/00004623-199173090-00004
   Knecht S, 2007, J BIOMED MATER RES B, V83B, P50, DOI 10.1002/jbm.b.30765
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2008, SPORTS MED ARTHROSC, V16, P221, DOI 10.1097/JSA.0b013e31818cdbc5
   Kreuz PC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2638
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   McCormick F, 2008, SPORTS MED ARTHROSC, V16, P217, DOI 10.1097/JSA.0b013e31818e0e4a
   MCNICKLE AG, 2008, SPORTS MED ARTHROSC, V16, P196, DOI DOI 10.1097/JSA.0B013E31818CDB82
   Minas T, 1998, Am J Orthop (Belle Mead NJ), V27, P739
   MIZUTANI H, 1982, CLIN ORTHOP RELAT R, P213
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   NOGAMI H, 1978, CLIN ORTHOP RELAT R, P238
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   OCHI M, 1998, CONTROVERSIES ORTHOP, P549
   Patrascu JM, 2010, J BONE JOINT SURG BR, V92B, P1160, DOI 10.1302/0301-620X.92B8.24341
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   PONTZ B, 1970, EUR J BIOCHEM, V16, P50, DOI 10.1111/j.1432-1033.1970.tb01051.x
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Safran MR, 2008, J AM ACAD ORTHOP SUR, V16, P306, DOI 10.5435/00124635-200806000-00002
   Saithna AA, 2008, BRIT ORTH ASS C LIV
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Steadman JR, 1997, OPER TECH ORTHOP, V7, P300, DOI DOI 10.1016/S1048-6666(97)80033-X
   Steinwachs MR, 2008, INJURY, V39, pS26, DOI 10.1016/j.injury.2008.01.042
   Stella JA, 2010, ACTA BIOMATER, V6, P2365, DOI 10.1016/j.actbio.2010.01.001
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Tohyama H, 2009, J ORTHOP SCI, V14, P579, DOI 10.1007/s00776-009-1384-1
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   Verdonk PCM, 2005, OSTEOARTHR CARTILAGE, V13, P548, DOI 10.1016/j.joca.2005.01.010
   Visna P, 2004, ACTA CHIR BELG, V104, P709, DOI 10.1080/00015458.2004.11679648
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Yang B, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045003
   Zantop T, 2009, ARTHROSCOPY, V25, P1354, DOI 10.1016/j.arthro.2009.04.077
   Zelle S, 2007, ARTHROSCOPY, V23, P1073, DOI 10.1016/j.arthro.2007.05.015
NR 80
TC 12
Z9 14
U1 1
U2 10
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 1538-8506
EI 1938-2480
J9 J KNEE SURG
JI J. Knee Surg.
PD SEP
PY 2012
VL 25
IS 3
BP 179
EP 186
DI 10.1055/s-0032-1322596
PG 8
WC Orthopedics
SC Orthopedics
GA AW9KH
UT WOS:000346575500002
PM 23057136
DA 2018-10-19
ER

PT J
AU Petersen, LK
   Chavez-Santoscoy, AV
   Narasimhan, B
AF Petersen, Latrisha K.
   Chavez-Santoscoy, Ana V.
   Narasimhan, Balaji
TI Combinatorial Synthesis of and High-throughput Protein Release from
   Polymer Film and Nanoparticle Libraries
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 67; combinatorial; high-throughput; polymer
   synthesis; polyanhydrides; nanoparticle fabrication; release kinetics;
   protein delivery
AB Polyanhydrides are a class of biomaterials with excellent biocompatibility and drug delivery capabilities. While they have been studied extensively with conventional one-sample-at-a-time synthesis techniques, a more recent high-throughput approach has been developed enabling the synthesis and testing of large libraries of polyanhydrides(1). This will facilitate more efficient optimization and design process of these biomaterials for drug and vaccine delivery applications. The method in this work describes the combinatorial synthesis of biodegradable polyanhydride film and nanoparticle libraries and the high-throughput detection of protein release from these libraries. In this robotically operated method (Figure 1), linear actuators and syringe pumps are controlled by LabVIEW, which enables a hands-free automated protocol, eliminating user error. Furthermore, this method enables the rapid fabrication of micro-scale polymer libraries, reducing the batch size while resulting in the creation of multivariant polymer systems. This combinatorial approach to polymer synthesis facilitates the synthesis of up to 15 different polymers in an equivalent amount of time it would take to synthesize one polymer conventionally. In addition, the combinatorial polymer library can be fabricated into blank or protein-loaded geometries including films or nanoparticles upon dissolution of the polymer library in a solvent and precipitation into a non-solvent (for nanoparticles) or by vacuum drying (for films). Upon loading a fluorochrome-conjugated protein into the polymer libraries, protein release kinetics can be assessed at high-throughput using a fluorescence-based detection method (Figures 2 and 3) as described previously(1). This combinatorial platform has been validated with conventional methods(2) and the polyanhydride film and nanoparticle libraries have been characterized with H-1 NMR and FTIR. The libraries have been screened for protein release kinetics, stability and antigenicity; in vitro cellular toxicity, cytokine production, surface marker expression, adhesion, proliferation and differentiation; and in vivo biodistribution and mucoadhesion(1-11). The combinatorial method developed herein enables high-throughput polymer synthesis and fabrication of protein-loaded nanoparticle and film libraries, which can, in turn, be screened in vitro and in vivo for optimization of biomaterial performance.
C1 [Petersen, Latrisha K.; Chavez-Santoscoy, Ana V.; Narasimhan, Balaji] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
RP Narasimhan, B (reprint author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
EM nbalaji@iastate.edu
RI Narasimhan, Balaji/A-5487-2008
OI Narasimhan, Balaji/0000-0002-7955-5353
FU ONR-MURI Award [NN00014-06-1-1176]; U.S. Army Medical Research and
   Materiel Command [W81XWH-10-1-0806]; National Science Foundation [EEC
   0552584, 0851519]
FX The authors acknowledge the ONR-MURI Award (NN00014-06-1-1176) and the
   U.S. Army Medical Research and Materiel Command (Grant No.
   W81XWH-10-1-0806) for financial support. This material is based upon
   work supported by the National Science Foundation under Grant No. EEC
   0552584 and 0851519.
CR Adler AF, 2009, COMB CHEM HIGH T SCR, V12, P634, DOI 10.2174/138620709788923764
   Carrillo-Conde B, 2010, ACTA BIOMATER, V6, P3110, DOI 10.1016/j.actbio.2010.01.040
   Determan AS, 2006, BIOMATERIALS, V27, P3312, DOI 10.1016/j.biomaterials.2006.01.054
   Determan AS, 2004, J CONTROL RELEASE, V100, P97, DOI 10.1016/j.jconrel.2004.08.006
   Petersen LK, 2010, ACTA BIOMATER, V6, P3873, DOI 10.1016/j.actbio.2010.04.004
   Petersen LK, 2010, J COMB CHEM, V12, P51, DOI 10.1021/cc900116c
   Petersen L. K., 2012, ADV HEALTHCARE UNPUB
   Petersen LK, 2008, EXPERT OPIN DRUG DEL, V5, P837, DOI [10.1517/17425240802291652, 10.1517/17425247.5.8.837 ]
   Petersen LK, 2011, TISSUE ENG PT A, V17, P2533, DOI [10.1089/ten.tea.2011.0095, 10.1089/ten.TEA.2011.0095]
   Petersen LK, 2011, BIOMATERIALS, V32, P6815, DOI 10.1016/j.biomaterials.2011.05.063
   Petersen LK, 2009, BIOMATERIALS, V30, P5131, DOI 10.1016/j.biomaterials.2009.05.069
   Thorstenson JB, 2009, J COMB CHEM, V11, P820, DOI 10.1021/cc900039k
   Torres MP, 2007, BIOMATERIALS, V28, P108, DOI 10.1016/j.biomaterials.2006.08.047
   Torres MP, 2006, J BIOMED MATER RES A, V76A, P102, DOI 10.1002/jbm.a.30510
   Vogel BM, 2005, J COMB CHEM, V7, P921, DOI 10.1021/cc050077p
   Xue L., 2011, ACS COMB SCI, V13, P50
NR 16
TC 0
Z9 0
U1 0
U2 2
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD SEP
PY 2012
IS 67
AR UNSP e3882
DI 10.3791/3882
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36QH
UT WOS:000209225500011
PM 22987047
OA Green Published
DA 2018-10-19
ER

PT J
AU Almeida, RS
   Rodriguez, GN
   Lima, LL
   Bavaresco, VP
   Zavaglia, CAC
   d'Avila, MA
AF Almeida, Rosemeire S.
   Rodriguez, Geraldine N.
   Lima, Loneta L.
   Bavaresco, Vanessa P.
   Zavaglia, Cecilia A. C.
   d'Avila, Marcos A.
TI Preparation and Characterization of PVA Hidrogels Nanofibers
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 11th Brazilian Polymer Conference
CY OCT 16-20, 2011
CL Campos do Jordao, BRAZIL
DE characterization; electrospinning; hydrogel; Poly(vinyl alcohol) (PVA);
   scaffolds
AB Poly(vinyl alcohol) (PVA) is a biomaterial that has interesting features for applications in soft tissue replacement due to its similarities in the mechanical properties of such tissues. This paper describes the preparation and characterization of PVA fibers obtained by electrospinning and crosslinked with potassium persulfate as thermoinitiator. These PVA fibers were characterized by Scanning Electron Microscopy (SEM) and Optical Microscopy (OM) to analyze the morphology of the spun samples. Finally, Fourier Transform Infrared Spectroscopy (FTIR) and differential scanning calorimetry (DSC) were performed and the results showed that the biomaterial was partially cross-linked, which indicates a potential use for dermal regeneration applications. The morphology of the fibers indicated that structural changes occurred in the biomaterial after thermal crosslinking.
C1 [Almeida, Rosemeire S.; Rodriguez, Geraldine N.; d'Avila, Marcos A.] Univ Estadual Campinas, Sch Mech Engn, BR-13083860 Unicamp, Brazil.
   [Lima, Loneta L.; Zavaglia, Cecilia A. C.] Univ Estadual Campinas, Sch Mech Engn, LABIOMEC, Natl Inst S&T Biofabricat INCT Biofabris, BR-13083860 Unicamp, Brazil.
   [Bavaresco, Vanessa P.] Univ Estadual Campinas, CTC, Natl Inst S&T Biofabricat INCT Biofabris, BR-13083860 Unicamp, Brazil.
RP Almeida, RS (reprint author), Univ Estadual Campinas, Sch Mech Engn, Mendeleyev 200, BR-13083860 Unicamp, Brazil.
EM rmalmeida.rs@hotmail.com
CR Bartolo PJ, 2011, STEREOLITHOGRAPHY: MATERIALS, PROCESSES AND APPLICATIONS, P1
   Cooly J. F., 1902, U.S. Patent, Patent No. [692,691, 692691]
   Kang YO, 2009, J BIOMED MATER RES B, P568
   Kishida A, 2002, HYDROGELS BIOMEDICAL
   Liu X, 2010, J BIOMED MATER RES A, V94A, P499, DOI 10.1002/jbm.a.32718
   Morton W. J., 1902, U.S. Patent, Patent No. [705,631, 705631]
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Tang C, 2010, MACROMOLECULES, V43, P630, DOI 10.1021/ma902269p
   Yang EL, 2008, MATER LETT, V62, P3555, DOI [10.1016/j.matlet.2008.03.049, 10.1016/i.matlet.2008.03.049]
   Yang JH, 2011, J APPL POLYM SCI, V120, P2337, DOI 10.1002/app.33435
NR 10
TC 2
Z9 2
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD SEP
PY 2012
VL 319
IS 1
SI SI
BP 136
EP 142
DI 10.1002/masy.201100172
PG 7
WC Polymer Science
SC Polymer Science
GA V32IX
UT WOS:000208946000018
DA 2018-10-19
ER

PT J
AU Schlie, S
   Gruene, M
   Dittmar, H
   Chichkov, BN
AF Schlie, Sabrina
   Gruene, Martin
   Dittmar, Hagen
   Chichkov, Boris N.
TI Dynamics of Cell Attachment: Adhesion Time and Force
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID PROTEIN ADSORPTION; INTEGRIN BINDING; SURFACES; KINETICS; MODEL;
   INTERFACES; AFM
AB Due to its biological significance, cell adhesion to biomaterial surfaces or scaffolds is the key step in biomedical applications. Here, we describe two sensitive and facile methods that quantify the kinetic and mechanic properties of the entire cell attachment process characterized by two parameters: Adhesion Time T-Ad and Adhesion Force F-Ad. We demonstrate that both methods can be applied to any adherent cell type (e. g., stem or cancer cells), tissue-engineered substrate, and culture condition in a fast, effective, and reproducible manner. Additional investigations about the role of the extracellular matrix and the formation of focal contacts help in acquiring further interpretations of these parameters from biological and mechanical points of view.
C1 [Schlie, Sabrina; Gruene, Martin; Dittmar, Hagen; Chichkov, Boris N.] Laser Zentrum Hannover eV, Dept Nanotechnol, D-30419 Hannover, Germany.
RP Schlie, S (reprint author), Laser Zentrum Hannover eV, Dept Nanotechnol, Hollerithallee 8, D-30419 Hannover, Germany.
EM s.schlie@lzh.de
RI Chichkov, Boris/M-4112-2015
OI Chichkov, Boris/0000-0002-8129-7373
FU European Graduate College "Interference and Quantum Applications;
   Cluster of Excellence Rebirth "From Regenerative Biology to
   Reconstructive Therapy''; BMBF
FX The authors would like to thank Prof. Dr. H. Kuster, head of the
   Institute of Biophysics (Leibniz University of Hannover, Germany), for
   granting the use of a microplate reader and a fluorescence microscope.
   Thanks are also due to E. Fadeeva for preparing silicone elastomer and
   A. Koroleva for preparing PEG samples (Laser Zentrum Hannover e. V.,
   Germany). M. Pflaum (Medical High School of Hannover, Germany) and A.
   Deiwick (Laser Zentrum Hannover e. V., Germany) provided human
   adipose-derived stem cells, and A. Deiwick, further mesenchymal stem
   cells. Dr. S. Schlie was partly supported by the European Graduate
   College "Interference and Quantum Applications.'' The work was further
   supported by Cluster of Excellence Rebirth "From Regenerative Biology to
   Reconstructive Therapy'' and the BMBF project REMEDIS.
CR Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   BONGRAND P, 1982, PROG SURF SCI, V12, P217, DOI 10.1016/0079-6816(82)90007-7
   Brooks PC, 1996, EUR J CANCER, V32A, P2423, DOI 10.1016/S0959-8049(96)00381-4
   Chaudhuri O, 2009, NAT METHODS, V6, P383, DOI [10.1038/NMETH.1320, 10.1038/nmeth.1320]
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895
   Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   EVANS E, 1995, BIOPHYS J, V68, P2580, DOI 10.1016/S0006-3495(95)80441-8
   Fang F, 2001, BIOPHYS J, V80, P2568, DOI 10.1016/S0006-3495(01)76228-5
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Fereol S, 2009, BIOPHYS J, V96, P2009, DOI 10.1016/j.bpj.2008.10.072
   Ferreira OD, 2010, APPL SURF SCI, V257, P48, DOI 10.1016/j.apsusc.2010.06.031
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gruene M, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/015005
   Gruene M, 2011, TISSUE ENG PART C-ME, V17, P79, DOI [10.1089/ten.tec.2010.0359, 10.1089/ten.TEC.2010.0359]
   HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8
   Kim H, 2002, APPL SURF SCI, V188, P493, DOI 10.1016/S0169-4332(01)00978-3
   Koo LY, 2002, J CELL SCI, V115, P1423
   MCCLAY DR, 1981, P NATL ACAD SCI-BIOL, V78, P4975, DOI 10.1073/pnas.78.8.4975
   Nicolas A, 2006, BIOPHYS J, V91, P61, DOI 10.1529/biophysj.105.077115
   Parise LV, 2000, SEMIN CANCER BIOL, V10, P407, DOI 10.1006/scbi.2000.0337
   Ryes C.D., 2003, INC J BIOMED MAT R A, V67A, P328
   Talbot J, 2000, COLLOID SURFACE A, V165, P287, DOI 10.1016/S0927-7757(99)00409-4
   XIA Z, 1993, BIOPHYS J, V65, P1073, DOI 10.1016/S0006-3495(93)81178-0
NR 29
TC 8
Z9 8
U1 0
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD SEP
PY 2012
VL 18
IS 9
BP 688
EP 696
DI 10.1089/ten.tec.2011.0635
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 000ET
UT WOS:000308370000005
PM 22429453
DA 2018-10-19
ER

PT J
AU Henslee, AM
   Gwak, DH
   Mikos, AG
   Kasper, FK
AF Henslee, Allan M.
   Gwak, Dong-Ho
   Mikos, Antonios G.
   Kasper, F. Kurtis
TI Development of a biodegradable bone cement for craniofacial applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; poly(propylene fumarate); injectable
   biomaterial; in situ crosslinkable
ID POLY(PROPYLENE FUMARATE)-BASED NETWORKS; IN-VIVO DEGRADATION;
   MORPHOGENETIC PROTEIN-2; TRICALCIUM PHOSPHATE; COMPOSITE SCAFFOLDS;
   INJECTABILITY; POLYMETHYLMETHACRYLATE; REGENERATION; TEMPERATURE;
   MORBIDITY
AB This study investigated the formulation of a two-component biodegradable bone cement comprising the unsaturated linear polyester macromer poly(propylene fumarate) (PPF) and crosslinked PPF microparticles for use in craniofacial bone repair applications. A full factorial design was employed to evaluate the effects of formulation parameters such as particle weight percentage, particle size, and accelerator concentration on the setting and mechanical properties of crosslinked composites. It was found that the addition of crosslinked microparticles to PPF macromer significantly reduced the temperature rise upon crosslinking from 100.3 degrees C +/- 21.6 degrees C to 102.7 degrees C +/- 49.3 degrees C for formulations without microparticles to 28.0 degrees C +/- 2.0 degrees C to 65.3 degrees C +/- 17.5 degrees C for formulations with microparticles. The main effects of increasing the particle weight percentage from 25 to 50% were to significantly increase the compressive modulus by 37.7 +/- 16.3 MPa, increase the compressive strength by 2.2 +/- 0.5 MPa, decrease the maximum temperature by 9.5 degrees C +/- 3.7 degrees C, and increase the setting time by 0.7 +/- 0.3 min. Additionally, the main effects of increasing the particle size range from 0150 mu m to 150300 mu m were to significantly increase the compressive modulus by 31.2 +/- 16.3 MPa and the compressive strength by 1.3 +/- 0.5 MPa. However, the particle size range did not have a significant effect on the maximum temperature and setting time. Overall, the composites tested in this study were found to have properties suitable for further consideration in craniofacial bone repair applications. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 22522259, 2012.
C1 [Henslee, Allan M.; Mikos, Antonios G.; Kasper, F. Kurtis] Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
   [Gwak, Dong-Ho] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA.
RP Kasper, FK (reprint author), Rice Univ, Dept Bioengn, MS 142,6100 Main St, Houston, TX 77005 USA.
EM kasper@rice.edu
FU DARPA [W922NF-09-1-0044]; NIH [R01-DE017441]; Armed Forces Institute of
   Regenerative Medicine [W81XWH-08-2-0032]
FX Contract grant sponsor: DARPA; contract grant number: W922NF-09-1-0044;
   Contract grant sponsor: NIH; contract grant number: R01-DE017441;
   Contract grant sponsor: The Armed Forces Institute of Regenerative
   Medicine; contract grant number: W81XWH-08-2-0032
CR Abdo RCC, 2011, J APPL ORAL SCI, V19, P426, DOI 10.1590/S1678-77572011000400021
   ASTM, 2008, F451 ASTM, pF451
   Becker ST, 2011, J ORAL MAXIL SURG, V69, P48, DOI 10.1016/j.joms.2010.05.061
   Bruens ML, 2003, J CRANIOFAC SURG, V14, P63, DOI 10.1097/00001665-200301000-00011
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   Costello BJ, 2010, ORAL MAXIL SURG CLIN, V22, P33, DOI 10.1016/j.coms.2009.10.009
   DiMaio FR, 2002, ORTHOPEDICS, V25, P1399
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Gbureck U, 2004, BIOMATERIALS, V25, P2187, DOI 10.1016/j.biomaterials.2003.08.066
   HAAS SS, 1975, J BONE JOINT SURG AM, VA 57, P380, DOI 10.2106/00004623-197557030-00017
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Henslee AM, 2011, ACTA BIOMATER, V7, P3627, DOI 10.1016/j.actbio.2011.06.043
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Jack V, 2008, P I MECH ENG H, V222, P19, DOI 10.1243/09544119JEIM312
   Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236
   Kasper FK, 2009, NAT PROTOC, V4, P518, DOI 10.1038/nprot.2009.24
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   Kim C, 2007, J SPINAL DISORD TECH, V20, P604, DOI 10.1097/BSD.0b013e318040ad73
   Kim K, 2009, BIOMACROMOLECULES, V10, P1810, DOI 10.1021/bm900240k
   Langdown AJ, 2006, J ARTHROPLASTY, V21, P381, DOI 10.1016/j.arth.2005.03.032
   Mistry AS, 2010, J BIOMED MATER RES A, V92A, P451, DOI 10.1002/jbm.a.32371
   Nicole R, 2005, EUR ARCH OTO-RHINO-L, V262, P539, DOI 10.1007/s00405-004-0866-1
   Nocini PF, 2003, MINERVA STOMATOL, V52, P448
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   RECKLING FW, 1977, J BONE JOINT SURG AM, V59, P80, DOI 10.2106/00004623-197759010-00014
   Scheller EL, 2009, J ORAL REHABIL, V36, P368, DOI 10.1111/j.1365-2842.2009.01939.x
   Shi M, 2010, BIOMATERIALS, V31, P4146, DOI 10.1016/j.biomaterials.2010.01.112
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Timmer MD, 2003, BIOMACROMOLECULES, V4, P1026, DOI 10.1021/bm0300150
   Timmer MD, 2003, J BIOMED MATER RES A, V66A, P811, DOI 10.1002/jbm.a.10011
   Timmer MD, 2003, BIOMATERIALS, V24, P571, DOI 10.1016/S0142-9612(02)00368-X
   Vlad MD, 2008, SPINE, V33, P2290, DOI 10.1097/BRS.0b013e31817eccab
NR 36
TC 18
Z9 18
U1 1
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2012
VL 100A
IS 9
BP 2252
EP 2259
DI 10.1002/jbm.a.34157
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 980VJ
UT WOS:000306922000006
PM 22499285
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ebrahimi, M
   Pripatnanont, P
   Monmaturapoj, N
   Suttapreyasri, S
AF Ebrahimi, Mehdi
   Pripatnanont, Prisana
   Monmaturapoj, Naruporn
   Suttapreyasri, Srisurang
TI Fabrication and characterization of novel nano
   hydroxyapatite/beta-tricalcium phosphate scaffolds in three different
   composition ratios
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biphasic calcium phosphate; nanoceramics; scaffolds; collagen
ID MECHANICAL-PROPERTIES; CERAMICS; BONE; COLLAGEN; BIOCERAMICS;
   OSTEOBLASTS; EXPRESSION; MEDICINE; POROSITY; POWDERS
AB The biphasic calcium phosphate (BCP) concept was introduced to overcome disadvantages of single phase biomaterials. Different composition ratios of BCP bioceramics have been studied, yet controversies regarding the effects of ratio on biomaterial behavior still exist. In this study, BCP scaffolds were prepared from nano hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP) that were synthesized via a solid state reaction. Three different composition ratios of pure BCP and collagen-based BCP scaffolds (%HA/%beta-TCP; 30/70, 40/60, and 50/50) were produced using a polymeric sponge method. Physical and mechanical properties of all materials and scaffolds were investigated. SEM showed overall distribution of both macropores (80200 mu m) and micropores (0.52 mu m) with high interconnected porosities. Total porosity of pure BCP (90% +/- 3%) was found to be higher than collagen-based BCP (85% +/- 2%). It was observed that following sintering process, dimensional shrinkage of large scaffolds (39% +/- 4%) was lower than small ones (42% +/- 5%) and scaffolds with high HA ratios (50%) experienced higher dimensional changes than those with higher beta-TCP (70%) ratios (45% +/- 3% and 36% +/- 1%, respectively). Compressive strength of both groups was less than 0.1 MPa and collagen coating had almost no influence on mechanical behavior. Further studies may improve the physical properties of these scaffolds and investigate their exact biological behaviors. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 22602268, 2012.
C1 [Ebrahimi, Mehdi; Pripatnanont, Prisana; Suttapreyasri, Srisurang] Prince Songkla Univ, Dept Oral & Maxillofacial Surg, Fac Dent, Hat Yai 90112, Songkhla, Thailand.
   [Monmaturapoj, Naruporn] Natl Met & Mat Technol Ctr, Pathum Thani 12120, Thailand.
RP Ebrahimi, M (reprint author), Prince Songkla Univ, Dept Oral & Maxillofacial Surg, Fac Dent, Hat Yai 90112, Songkhla, Thailand.
EM dr.mahdi05@gmail.com
RI Pripatnanont, Prisana/K-4879-2012
FU Graduate School, Prince of Songkla University (Hatyai, Thailand)
FX Contract grant sponsor: Graduate School, Prince of Songkla University
   (Hatyai, Thailand)
CR Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Brodie JC, 2006, J MATER SCI-MATER M, V17, P43, DOI 10.1007/s10856-006-6328-0
   Daculsi G, 2006, ENCY BIOMATERIALS BI, P1
   Daculsi G, 2008, HDB BIOCERAMICS THEI, P395
   Dorozhkin Sergey V, 2009, Journal of Biomimetrics, Biomaterials, and Tissue Engineering, V3, P59, DOI 10.4028/www.scientific.net/JBBTE.3.59
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   John A, 2003, J BIOMATER APPL, V18, P63, DOI 10.1177/088532803032826
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keaveny T., 1993, MECH PROPERTIES CORT, P285
   Kim HW, 2007, TISSUE ENG, V13, P965, DOI 10.1089/ten.2006.0299
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mostafa NY, 2005, MATER CHEM PHYS, V94, P333, DOI 10.1016/j.matchemphys.2005.05.011
   Rouvillain JL, 2009, KNEE, V16, P392, DOI 10.1016/j.knee.2008.12.015
   Shiota T, 2008, J CERAM SOC JPN, V116, P1002, DOI 10.2109/jcersj2.116.1002
   Suh H, 2001, ARTIF ORGANS, V25, P4
   Suzuki T, 1997, J BIOMED MATER RES, V34, P507, DOI 10.1002/(SICI)1097-4636(19970315)34:4<507::AID-JBM11>3.3.CO;2-P
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Takeuchi Y, 1996, J BIOL CHEM, V271, P3938
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Wang CY, 2004, BIOMATERIALS, V25, P2949, DOI 10.1016/j.biomaterials.2003.09.088
   Yang XH, 1998, J MATER CHEM, V8, P2233, DOI 10.1039/a802067a
   Zhang FM, 2008, J EUR CERAM SOC, V28, P539, DOI 10.1016/j.jeurceramsoc.2007.07.012
NR 28
TC 28
Z9 29
U1 0
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2012
VL 100A
IS 9
BP 2260
EP 2268
DI 10.1002/jbm.a.34160
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 980VJ
UT WOS:000306922000007
PM 22499354
DA 2018-10-19
ER

PT J
AU de Mel, A
   Chaloupka, K
   Malam, Y
   Darbyshire, A
   Cousins, B
   Seifalian, AM
AF de Mel, Achala
   Chaloupka, Karla
   Malam, Yogeshkumar
   Darbyshire, Arnold
   Cousins, Brian
   Seifalian, Alexander M.
TI A silver nanocomposite biomaterial for blood-contacting implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cardiovascular implants; platelets; thrombosis; antiplatelet; silver
   nanoparticles; nanocomposite polymer; antibacterial
ID AORTIC GRAFT INFECTION; ESCHERICHIA-COLI; IN-VITRO; ANTIBACTERIAL
   PROPERTIES; STAPHYLOCOCCUS-AUREUS; ANTIPLATELET AGENTS; COATED
   POLYESTER; VASCULAR-SURGERY; NANOPARTICLES; RESISTANCE
AB Cardiovascular implants must resist infection and thrombosis. A nanocomposite polymeric material [polyhedral-oligomeric-silsesquioxane-poly(carbonate-urea)urethane; POSS-PCU] demonstrates ideal properties for cardiovascular applications. Silver nanoparticles or nanosilver (NS) are recognized for efficient antibacterial properties. This study aims to determine the influence of NS integrated POSS-PCU on thrombogenicity. Silver nitrate was reduced with dimethylformamide and stabilized by the inclusion of fumed silica nanoparticles to prevent aggregation of NS and were incorporated into POSS-PCU to form a range of POSS-PCU-NS concentrations (by weight); 0.20% (NS16), 0.40% (NS32), 0.75% (NS64), and 1.50% (NS128). Surface wettability was determined with sessile-drop water contact angles. Platelets were introduced onto test samples and Alamar Blue (AB), mitochondrial-activity assay, quantified the degree of platelet adhesion whilst platelet-factor-4 (PF4) ELISA quantified the degree of platelet activation. Thromboelastography (TEG) determined the profiles of whole blood kinetics while hemolysis assay demonstrated the degree of blood compatibility. Increasing levels of NS induced greater hydrophilicity. A concentration dependant decrease in platelet adhesion and activation was observed with AB and PF4 readings, respectively. TEG demonstrated that the antithrombogenic properties of POSS-PCU were retained with POSS-PCU-NS16, and enhanced with POSS-PCU-NS32, but was reduced with POSS-PCU-NS64 and POSS-PCU-NS128. POSS-PCU-NS64 and POSS-PCU-NS128 demonstrated a hemolytic tendency, but no hemolysis was observed with POSS-PCU-NS16 and POSS-PCU-NS32. Overall, POSS-PCU-NS32 rendered potent antithrombogenic properties. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 23482357, 2012.
C1 [de Mel, Achala; Chaloupka, Karla; Malam, Yogeshkumar; Darbyshire, Arnold; Cousins, Brian; Seifalian, Alexander M.] UCL, UCL Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
   [Chaloupka, Karla] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland.
   [Seifalian, Alexander M.] Royal Free Hampstead NHS Trust Hosp, Dept Surg, London, England.
RP Seifalian, AM (reprint author), UCL, UCL Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
EM a.seifalian@ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
FU EPSRC
FX Contract grant sponsor: EPSRC
CR Alghamdi AA, 2007, J CARDIAC SURG, V22, P247, DOI 10.1111/j.1540-8191.2007.00402.x
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Banbury MK, 2006, J AM COLL SURGEONS, V202, P131, DOI 10.1016/j.jamcollsurg.2005.08.028
   Belch JJF, 2010, J VASC SURG, V52, P825, DOI 10.1016/j.jvs.2010.04.027
   Berardelli P, 2009, SCIENCENOW
   Bhattacharya V, 2000, BLOOD, V95, P581
   Blasco-Colmenares E, 2009, ARCH INTERN MED, V169, P788, DOI 10.1001/archinternmed.2009.42
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Chiesa R, 2002, ACTA CHIR BELG, V102, P238
   Chou CW, 2008, J BIOMED MATER RES A, V84A, P785, DOI 10.1002/jbm.a.31387
   Cuttle L, 2007, BURNS, V33, P701, DOI 10.1016/j.burns.2007.02.012
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Galiano K, 2008, NEUROL RES, V30, P285, DOI 10.1179/016164107X229902
   Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496
   Goeau-Brissonniere OA, 2002, J VASC SURG, V35, P1260, DOI 10.1067/mva.2002.121980
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   He T, 2010, J BIOMED MATER RES A, V95A, P454, DOI 10.1002/jbm.a.32872
   Inoue Y, 2010, J BIOMED MATER RES A, V92A, P1171, DOI 10.1002/jbm.a.32456
   Johnson Willard C, 2004, Vascular, V12, P362, DOI 10.2310/6670.2004.00043
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Keefer LK, 2003, NAT MATER, V2, P357, DOI 10.1038/nmat913
   Kehrel BE, 2004, TRANSFUS MED HEMOTH, V31, P379, DOI 10.1159/000082482
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kidane AG, 2006, J BIOMED MATER RES A, V79A, P606, DOI 10.1002/jbm.a.30817
   Kieffer E, 2004, J VASC SURG, V39, P1009, DOI 10.1016/j.jvs.2003.12.040
   Kong H, 2008, BIOMACROMOLECULES, V9, P2677, DOI 10.1021/bm800574x
   Koshiko S, 2002, J VASC SURG, V35, P779, DOI 10.1067/mva.2002.121850
   Lehnhardt FJ, 2002, EUR J VASC ENDOVASC, V23, P127, DOI 10.1053/ejvs.2001.1571
   Loizidou M, 2010, BRIT J SURG, V97, P463, DOI 10.1002/bjs.7074
   Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z
   Martinez-Gutierrez F, 2011, NANOMEDICINE, V8, P1
   Nasim A, 2001, EUR J VASC ENDOVASC, V22, P211, DOI 10.1053/ejvs.2001.1429
   Perry DJ, 2010, BRIT J HAEMATOL, V150, P501, DOI 10.1111/j.1365-2141.2010.08223.x
   Prechel MM, 2010, THROMB RES, V125, pE143, DOI 10.1016/j.thromres.2009.10.021
   Saleem BR, 2010, AM J SURG, V200, P47, DOI 10.1016/j.amjsurg.2009.05.018
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   Sarkar S, 2009, J BIOMECH, V42, P722, DOI 10.1016/j.jbiomech.2009.01.003
   Schmacht Dale, 2005, Vasc Endovascular Surg, V39, P411, DOI 10.1177/153857440503900505
   Schneider F, 2008, ANN VASC SURG, V22, P815, DOI 10.1016/j.avsg.2008.06.011
   Seeger JM, 2000, J VASC SURG, V32, P451, DOI 10.1067/mva.2000.109471
   Seifalian AM, 2001, J BIOMED MATER RES, V55, P637, DOI 10.1002/1097-4636(20010615)55:4<637::AID-JBM1058>3.0.CO;2-Z
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
   Shrivastava S, 2009, ACS NANO, V3, P1357, DOI 10.1021/nn900277t
   SHUMAN MA, 1980, J CLIN INVEST, V65, P307, DOI 10.1172/JCI109673
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Stevens KNJ, 2009, BIOMATERIALS, V30, P3682, DOI 10.1016/j.biomaterials.2009.03.054
   Thachil J, 2008, BRIT J SURG, V95, P1437, DOI 10.1002/bjs.6381
   Thachil J, 2010, EUR J INTERN MED, V21, P79, DOI 10.1016/j.ejim.2009.11.007
   Topel I, 2010, ANGIOLOGY, V61, P423, DOI 10.1177/0003319709360029
   Travan A, 2009, BIOMACROMOLECULES, V10, P1429, DOI 10.1021/bm900039x
   Vieira EP, 2009, LANGMUIR, V25, P9879, DOI 10.1021/la9009948
   Vittorino E, 2012, J COLLOID INTERF SCI, V368, P191, DOI 10.1016/j.jcis.2011.09.084
   von Hundelshausen P, 2007, CIRC RES, V100, P27, DOI 10.1161/01.RES.0000252802.25497.b7
   Voronkov M. G., 2001, PHARM CHEM J, V35, P252
   Xing ZC, 2010, BIOMACROMOLECULES, V11, P1248, DOI 10.1021/bm1000372
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005
   Yang Z, 2010, J R SOC INTERFACE, V7, pS411, DOI 10.1098/rsif.2010.0158.focus
   Zan XJ, 2010, BIOMACROMOLECULES, V11, P1082, DOI 10.1021/bm100048q
NR 66
TC 30
Z9 30
U1 2
U2 49
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2012
VL 100A
IS 9
BP 2348
EP 2357
DI 10.1002/jbm.a.34177
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 980VJ
UT WOS:000306922000017
PM 22528182
DA 2018-10-19
ER

PT J
AU Boccafoschi, F
   Fusaro, L
   Mosca, C
   Bosetti, M
   Chevallier, P
   Mantovani, D
   Cannas, M
AF Boccafoschi, F.
   Fusaro, L.
   Mosca, C.
   Bosetti, M.
   Chevallier, P.
   Mantovani, D.
   Cannas, M.
TI The biological response of poly(L-lactide) films modified by different
   biomolecules: Role of the coating strategy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PLLA; laminin; fibronectin; RGD; SIKVAV
ID SURFACE MODIFICATION; CELL-ADHESION; MATRIX METALLOPROTEINASES;
   FIBRONECTIN; PEPTIDE; LAMININ; RGD; ATTACHMENT; ACID); ANGIOGENESIS
AB The interactions between the surface of synthetic scaffolds and cells play an important role in tissue engineering applications. To improve these interactions, two strategies are generally followed: surface coating with large proteins and surface grafting with small peptides. The proteins and peptides more often used and derived from the extracellular matrix, are fibronectin, laminin, and their active peptides, RGD and SIKVAV, respectively. The aim of this work was to compare the effects of coating and grafting of poly(L-lactide) (PLLA) films on MRC5 fibroblast cells. Grafting reactions were verified by X-ray photoelectron spectroscopy. Cell adhesion and proliferation on coated and grafted PLLA surfaces were measured by cell counting. Vinculin localization and distribution were performed on cell cultured on PLLA samples using a fluorescence microscopy technique. Finally, western blot was performed to compare signals of cell adhesion proteins, such as vinculin, Rac1, and RhoA, as well as cell proliferation, such as PCNA. These tests showed similar results for fibronectin and laminin coated PLLA, while RGD grafting is more effective compared with SIKVAV grafting. Considering the overall view of these results, although coating and grafting can both be regarded as effective methods for surface modification to enhance cell adhesion and proliferation on a biomaterial, RGD grafted PLLA show better cell adhesion and proliferation than coated PLLA, while SIKVAV grafted PLLA show similar adhesion but worse proliferation. These data verified different biological effects depending on the surface modification method used. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 23732381, 2012.
C1 [Boccafoschi, F.; Fusaro, L.; Mosca, C.; Cannas, M.] Univ Piemonte Orientale, Human Anat Lab, Dept Hlth Sci, I-28100 Novara, Italy.
   [Bosetti, M.] Univ Piemonte Orientale, Dipartimento Sci Farmaco, I-28100 Novara, Italy.
   [Chevallier, P.; Mantovani, D.] Univ Laval, Lab Biomat & Bioengn, Dept Min Met Mat Engn, Quebec City, PQ G1V 0A6, Canada.
   [Chevallier, P.; Mantovani, D.] Univ Hosp Res Ctr, Quebec City, PQ G1V 0A6, Canada.
RP Boccafoschi, F (reprint author), Univ Piemonte Orientale, Human Anat Lab, Dept Hlth Sci, I-28100 Novara, Italy.
EM francesca.boccafoschi@med.unipmn.it
OI Bosetti, Michela/0000-0002-3682-8702; Mantovani,
   Diego/0000-0001-9672-895X; Boccafoschi, Francesca/0000-0002-6734-5447
CR Boateng SY, 2005, AM J PHYSIOL-CELL PH, V288, pC30, DOI 10.1152/ajpcell.00199.2004
   Boxus T, 1998, BIOORGAN MED CHEM, V6, P1577, DOI 10.1016/S0968-0896(98)00083-2
   Campbell S, 2003, ENDOCRINOLOGY, V144, P1486, DOI 10.1210/en.2002-220903
   CORCORAN ML, 1995, J BIOL CHEM, V270, P10365, DOI 10.1074/jbc.270.18.10365
   Cronin EM, 2004, J BIOMED MATER RES A, V69A, P373, DOI 10.1002/jbm.a.30009
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   Geiger B, 2011, COLD SPRING HARB PER, V3, P1, DOI [10.1101/cshperspect.a005033, DOI 10.1101/CSHPERSPECT.A005033]
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hindie M, 2011, ACTA BIOMATER, V7, P387, DOI 10.1016/j.actbio.2010.08.001
   Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Jung HJ, 2005, MACROMOL RES, V13, P446, DOI 10.1007/BF03218479
   Katoh K, 1998, J THROMB THROMBOLYS, V5, P129, DOI 10.1023/A:1008878012268
   KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633
   KIBBEY MC, 1994, J CELL PHYSIOL, V160, P185, DOI 10.1002/jcp.1041600121
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   Lin X, 2006, BBA-GEN SUBJECTS, V1760, P1403, DOI 10.1016/j.bbagen.2006.05.010
   Malinda KM, 1999, FASEB J, V13, P53
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SCHNAPER HW, 1993, KIDNEY INT, V43, P20, DOI 10.1038/ki.1993.5
   Szymczak P, 2010, ACTA NEUROBIOL EXP, V70, P325
   Teraoka F, 2006, DENT MATER J, V25, P560, DOI 10.4012/dmj.25.560
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935
   Wang B, 2011, J MECH BEHAV BIOMED, V4, P600, DOI 10.1016/j.jmbbm.2011.01.008
   Xu H, 2011, TISSUE ENG PT A, V17, P865, DOI [10.1089/ten.tea.2010.0129, 10.1089/ten.TEA.2010.0129]
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
   YAMAGUCHI M, 2004, J ARTIF ORGANS, V7, P187
   Yang XZ, 2009, BIOMACROMOLECULES, V10, P2213, DOI 10.1021/bm900390k
NR 37
TC 12
Z9 14
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2012
VL 100A
IS 9
BP 2373
EP 2381
DI 10.1002/jbm.a.34180
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 980VJ
UT WOS:000306922000020
PM 22528472
DA 2018-10-19
ER

PT J
AU Baskin, JZ
   Vasanji, A
   McMasters, J
   Soenjaya, Y
   Barbu, AM
   Eppell, SJ
AF Baskin, Jonathan Z.
   Vasanji, Amit
   McMasters, James
   Soenjaya, Yohannes
   Barbu, Anca M.
   Eppell, Steven J.
TI Nanophase bone substitute in vivo response to subcutaneous implantation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone substitute; mineralized collagen; histological response;
   morphology; porosity
ID HYDROXYAPATITE/COLLAGEN HAP/COL COMPOSITE; POROUS SCAFFOLDS; BIOACTIVE
   GLASS; TRAUMA SURGERY; COLLAGEN; BIOMATERIAL; PARTICLES; MATRIX; VITRO;
   RATS
AB A collagen-apatite composite designed as a load-bearing bone substitute implant is used to characterize the relationship between implant morphology and in vivo behavior. This nanophase bone substitute (NBS) is studied morphologically using a nondestructive imaging technique and biologically using the rodent subcutaneous model. Porosity and pore interconnectivity are correlated with histological outcomes showing cellular invasion occurs with average pore sizes below 100 mu m. Crosslinking with D-ribose is shown to affect cellular infiltration in a dose-response manner. These data suggest that collagen-apatite bone substitutes can support cellular infiltration with pore size significantly smaller than 100 mu m, an encouraging result regarding development of the NBS into a platform of biomaterials with enhanced mechanical properties. The data also indicate that increasing crosslinking density decreases cellular infiltration of NBS. Thus, modulating mechanical properties of the material by altering crosslink density is likely to produce decreased biological response within the material. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 24622473, 2012.
C1 [Baskin, Jonathan Z.; Barbu, Anca M.; Eppell, Steven J.] Case Western Reserve Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA.
   [Baskin, Jonathan Z.] Louis Stokes Cleveland VA Med Ctr, Dept Otolaryngol Head & Neck Surg, Cleveland, OH USA.
   [Baskin, Jonathan Z.; McMasters, James; Soenjaya, Yohannes; Eppell, Steven J.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Vasanji, Amit] ImageIQ Inc, Cleveland, OH USA.
RP Baskin, JZ (reprint author), Case Western Reserve Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA.
EM jonathan.baskin2@va.gov; steven.eppell@case.edu
OI Eppell, Steven/0000-0002-0302-1910
FU US Army SBIR Phase II [946.02-ARM-2S/CWRU]; Coulter Foundation; The Ohio
   Board of Regents; Veterans Administration pilot grant
FX Contract grant sponsor: US Army SBIR Phase II; contract grant number:
   946.02-ARM-2S/CWRU; Contract grant sponsors: Coulter Foundation, The
   Ohio Board of Regents, Veterans Administration pilot grant
CR Abed A, 2008, TISSUE ENG PT A, V14, P519, DOI 10.1089/tea.2007.0134
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   BAI PM, 1992, CONNECT TISSUE RES, V28, P1, DOI 10.3109/03008209209014224
   Bertoldi C, 2008, BIOMATERIALS, V29, P1817, DOI 10.1016/j.biomaterials.2007.12.034
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Eppell SJ, 2007, BIOMATERIALS IMPLATS
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304
   Govindaraj S, 1999, Facial Plast Surg, V15, P73, DOI 10.1055/s-2008-1064302
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Hench LL., 2000, BIOMIMETIC PROCESSIN, P404
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hunter SA, 2005, J ORTHOP RES, V23, P555, DOI 10.1016/j.orthres.2004.09.004
   Ilharreborde B, 2008, J PEDIATR ORTHOPED, V28, P347, DOI 10.1097/BPO.0b013e318168d1d4
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2005, BIO-MED MATER ENG, V15, P29
   Itoh S, 2004, CELL TRANSPLANT, V13, P451, DOI 10.3727/000000004783983774
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   KAMINSKI EJ, 1977, J BIOMED MATER RES, V11, P871, DOI 10.1002/jbm.820110607
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   KAWAGUCHI H, 1993, CELL MATER, V3, P337
   Kenichi S, 2005, USA Patent, Patent No. [6,887,272, 6887272]
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   LIEBER RL, 1990, J ORTHOPAED RES, V8, P304, DOI 10.1002/jor.1100080221
   Lieber RL, 1994, ORTHOPAEDIC BASIS SC, P631
   Lohmann H, 2007, ARCH ORTHOP TRAUM SU, V127, P345, DOI 10.1007/s00402-006-0277-4
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Oyane A, 2003, J BIOMED MATER RES A, V64A, P339, DOI 10.1002/jbm.a.10426
   Pham QP, 2009, J BIOMED MATER RES A, V88A, P295, DOI 10.1002/jbm.a.31875
   Rahm MD, 2009, SPINE J, V9, P434
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   TANAKA S, 1988, J BIOL CHEM, V263, P17650
   Tcacencu I, 2008, J MATER SCI-MATER M, V19, P2015, DOI 10.1007/s10856-007-3284-2
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Tommila M, 2008, ACTA BIOMATER, V4, P354, DOI 10.1016/j.actbio.2007.07.005
   Tong W., 2001, SYNTHESIS NANOMETER
   Webb C L, 1988, ASAIO Trans, V34, P851
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
NR 45
TC 7
Z9 7
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2012
VL 100A
IS 9
BP 2462
EP 2473
DI 10.1002/jbm.a.34175
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 980VJ
UT WOS:000306922000029
PM 22573370
DA 2018-10-19
ER

PT J
AU Zhang, W
   Wu, CW
   Zhang, CZ
   Chen, Z
AF Zhang, Wei
   Wu, Chengwei
   Zhang, Chenzhao
   Chen, Zhen
TI Numerical Study of the Mechanical Response of Turtle Shell
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE biomaterial; turtle shell; mechanical response; static and dynamic loads
ID HUMAN-BODY; EVOLUTION
AB The turtle shell is an amazing structure optimized through the long-term evolution by nature. This paper reports the mechanical response of the shell (Red-ear turtle) to static and dynamic loads, respectively. It is found that the turtle shell under a compressive load yields the maximum vertical displacement at the rear end, but the vertical displacement at the front end is only half of that at the rear end. The maximum horizontal displacement of the shell also occurs at the rear end. It is believed that such a deformation pattern is helpful for protecting the turtle's internal organs and its head. The principal stress directions in the inside surface of the shell under a compressive load are almost the same as those of the biofiber distribution in the inside surface, which results in the strong bending resistance of the turtle shell.
C1 [Zhang, Wei; Wu, Chengwei; Zhang, Chenzhao; Chen, Zhen] Dalian Univ Technol, Fac Vehicle Engn & Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China.
   [Chen, Zhen] Univ Missouri, Dept Civil & Environm Engn, Columbia, MO 65211 USA.
   [Zhang, Wei] Dalian Univ Technol, Sch Mat Sci & Engn, Dalian 116024, Peoples R China.
RP Wu, CW (reprint author), Dalian Univ Technol, Fac Vehicle Engn & Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China.
EM cwwu@dlut.edu.cn; chenzh@missouri.edu
OI Chen, Zhen/0000-0002-9231-8395
FU National Natural Science Foundation of China [10972050, 90816025]
FX This work was supported by the National Natural Science Foundation of
   China (No. 10972050 and No. 90816025).
CR BURKE AC, 1991, AM ZOOL, V31, P616
   Carr A, 1952, HDB TURTLES TURTLES
   Cebra-Thomas J, 2005, J EXP ZOOL PART B, V304B, P558, DOI 10.1002/jez.b.21059
   Choi SB, 2007, J SOUND VIB, V303, P391, DOI 10.1016/j.jsv.2007.01.027
   Dai SL, 1996, MECH ENG, V18, P19
   Domokos G., 2007, P ROYAL SOC B, V275, P11
   GAUNT AS, 1969, J MORPHOL, V128, P195, DOI 10.1002/jmor.1051280205
   Jackson DC, 2000, NEWS PHYSIOL SCI, V15, P181
   Kitazaki S, 1998, J BIOMECH, V31, P143
   Krauss S, 2009, ADV MATER, V21, P407, DOI 10.1002/adma.200801256
   Lee M.S.Y., 1996, NATURE, V379, P811
   Rhee H, 2009, MAT SCI ENG C-MATER, V29, P2333, DOI 10.1016/j.msec.2009.06.002
   Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1
   Rivera Angela R. V., 2004, Journal of Morphology, V260, P322
   Xu YD, 1995, ACTA MAT COMPOSITAE, V12, P53
   Yu ZS, 2000, AUTOMOBILE DESIGN TH
   Zhang W, 2012, THEOR APPL MECH LETT, V2, DOI 10.1063/2.1201409
   [周佑君 ZHOU Youjun], 2006, [机械设计, Journal of Machine Design], V23, P37
NR 18
TC 7
Z9 7
U1 1
U2 23
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD SEP
PY 2012
VL 9
IS 3
BP 330
EP 335
DI 10.1016/S1672-6529(11)60129-7
PG 6
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 983UN
UT WOS:000307144300008
DA 2018-10-19
ER

PT J
AU Cadman, J
   Zhou, SW
   Chen, YH
   Li, Q
AF Cadman, Joseph
   Zhou, Shiwei
   Chen, Yuhang
   Li, Qing
TI Cuttlebone: Characterisation, Application and Development of Biomimetic
   Materials
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE cuttlebone; characterisation; biomimetic; homogenisation
ID ARAGONITIC CUTTLEFISH BONES; RIGID BIOLOGICAL-SYSTEMS; HYDROXYAPATITE
   SCAFFOLDS; ORGANIC MATRIX; SILVER NANOPARTICLES; COMPOSITE-MATERIALS;
   SEPIA CEPHALOPODA; DESIGN; MICROSTRUCTURE; MINERALIZATION
AB Cuttlebone signifies a special class of ultra-lightweight cellular natural material possessing unique chemical, mechanical and structural properties, which have drawn considerable attention in the literature. The aim of this paper is to better understand the mechanical and biological roles of cuttlebone. First, the existing literature concerning the characterisation and potential applications inspired by this remarkable biomaterial is critiqued. Second, the finite element-based homogenisation method is used to verify that morphological variations within individual cuttlebone samples have minimal impact on the effective mechanical properties. This finding agrees with existing literature, which suggests that cuttlebone strength is dictated by the cuttlefish habitation depth. Subsequently, this homogenisation approach is further developed to characterise the effective mechanical bulk modulus and biofluidic permeability that cuttlebone provides, thereby quantifying its mechanical and transporting functionalities to inspire bionic design of structures and materials for more extensive applications. Finally, a brief rationale for the need to design a biomimetic material inspired by the cuttlebone microstructure is provided, based on the preceding investigation.
C1 [Cadman, Joseph; Li, Qing] Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia.
   [Zhou, Shiwei] RMIT Univ, Sch Civil Environm & Chem Engn, Innovat Struct Grp, Melbourne, Vic 3001, Australia.
   [Chen, Yuhang] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.
RP Li, Q (reprint author), Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia.
EM Qing.Li@Sydney.edu.au
RI Li, Qing/B-3422-2009; Chen, Yuhang/C-8602-2014
OI Li, Qing/0000-0002-7930-2145; 
FU Australian Research Council (ARC); Sydney University
FX The support from Australian Research Council (ARC) is great
   acknowledged. The first author also appreciates the Sydney University
   Postgraduate Award during his PhD study.
CR BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2
   Bensoussan A, 1978, ASYMPTOTIC ANAL PERI
   BIRCHALL JD, 1983, J MATER SCI, V18, P2081, DOI 10.1007/BF00555001
   Boletzky S. v., 1983, P31
   Cadman J., 2012, MAT SCI ENG C
   Cadman J, 2009, 8 WORLD C STRUCT MUL
   Cadman J, 2010, ADV MATER RES-SWITZ, V123-125, P295, DOI 10.4028/www.scientific.net/AMR.123-125.295
   Cadman J, 2010, MATER SCI FORUM, V654-656, P2229, DOI 10.4028/www.scientific.net/MSF.654-656.2229
   Cadman J, 2010, ACTA MECH SINICA-PRC, V26, P27, DOI 10.1007/s10409-009-0310-2
   Chen YH, 2009, INT J MOD PHYS B, V23, P1345, DOI 10.1142/S0217979209060920
   Culverwell E, 2008, CHEM COMMUN, P1055, DOI 10.1039/b715368f
   de Kruijf N, 2007, INT J SOLIDS STRUCT, V44, P7092, DOI 10.1016/j.ijsolstr.2007.03.028
   DENTON EJ, 1961, J MAR BIOL ASSOC UK, V41, P351, DOI 10.1017/S0025315400023961
   Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646
   Jasso-Gastinel CF, 2009, MACROMOL SYMP, V283-84, P159, DOI 10.1002/masy.200950921
   Garcia-Enriquez S, 2010, J BIOMAT SCI-POLYM E, V21, P113, DOI 10.1163/156856209X410265
   Gibiansky LV, 2000, J MECH PHYS SOLIDS, V48, P461, DOI 10.1016/S0022-5096(99)00043-5
   Gower David, 1996, Biomimetics, V4, P37
   Gutowska MA, 2010, MAR BIOL, V157, P1653, DOI 10.1007/s00227-010-1438-0
   HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Ivankovic H, 2010, J MATER SCI-MATER M, V21, P2711, DOI 10.1007/s10856-010-4115-4
   Ivankovic H, 2009, J MATER SCI-MATER M, V20, P1039, DOI 10.1007/s10856-008-3674-0
   JACKSON AP, 1990, J MATER SCI, V25, P3173, DOI 10.1007/BF00587670
   Jia XP, 2008, COLLOID SURFACE A, V330, P234, DOI 10.1016/j.colsurfa.2008.08.016
   Jia XP, 2009, COLLOID SURFACE B, V68, P231, DOI 10.1016/j.colsurfb.2008.10.017
   Jung Y, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056319
   Kannan S, 2007, ACTA BIOMATER, V3, P243, DOI 10.1016/j.actbio.2006.09.006
   Kasioptas A, 2010, J CRYST GROWTH, V312, P2431, DOI 10.1016/j.jcrysgro.2010.05.014
   Lee SJ, 2007, J CERAM PROCESS RES, V8, P427
   Lee SJ, 2007, MATER LETT, V61, P1279, DOI 10.1016/j.matlet.2006.07.008
   Liang Y, 2008, MAT SCI ENG A-STRUCT, V483-84, P309, DOI 10.1016/j.msea.2006.09.156
   Liu CZ, 2007, MATER SCI TECH-LOND, V23, P379, DOI 10.1179/174328407X177027
   Mayer G, 2006, MAT SCI ENG C-BIO S, V26, P1261, DOI 10.1016/j.msec.2005.08.031
   Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994
   Mayer G, 2002, EXP MECH, V42, P395, DOI 10.1007/BF02412144
   MILTON GW, 1988, J MECH PHYS SOLIDS, V36, P597, DOI 10.1016/0022-5096(88)90001-4
   Ogasawara W, 2000, CHEM MATER, V12, P2835, DOI 10.1021/cm0004376
   Poompradub S, 2008, EUR POLYM J, V44, P4157, DOI 10.1016/j.eurpolymj.2008.09.015
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Rocha JHG, 2006, J BIOMED MATER RES A, V77A, P160, DOI 10.1002/jbm.a.30566
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Rocha JHG, 2005, J MATER CHEM, V15, P5007, DOI 10.1039/b510122k
   Sherrard KM, 2000, BIOL BULL, V198, P404, DOI 10.2307/1542696
   Song YS, 2006, CARBON, V44, P710, DOI 10.1016/j.carbon.2005.09.034
   Torquato S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.266601
   Vincent JFV, 2001, HDB ELASTIC PROPERTI, P213
   Vogel S, 2006, J BIOSCIENCES, V31, P309, DOI 10.1007/BF02704103
   WARD PD, 1984, J MAR BIOL ASSOC UK, V64, P955, DOI 10.1017/S0025315400047366
   Xu GL, 2009, BIOSENS BIOELECTRON, V25, P362, DOI 10.1016/j.bios.2009.07.014
   Yildirim OS, 2007, CAN J ANAL SCI SPECT, V52, P270
   Zaremba CM, 1998, CHEM MATER, V10, P3813, DOI 10.1021/cm970785g
   Zhou SW, 2008, J MATER SCI, V43, P5157, DOI 10.1007/s10853-008-2722-y
   Zhou SW, 2008, J MATER RES, V23, P798, DOI [10.1557/JMR.2008.0I01, 10.1557/JMR.2008.0101]
   Zhou SW, 2008, J COMPUTATI IN PRESS
NR 55
TC 17
Z9 18
U1 4
U2 88
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD SEP
PY 2012
VL 9
IS 3
BP 367
EP 376
DI 10.1016/S1672-6529(11)60132-7
PG 10
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 983UN
UT WOS:000307144300013
DA 2018-10-19
ER

PT J
AU Chawla, K
   Yu, TB
   Stutts, L
   Yen, M
   Guan, ZB
AF Chawla, Kanika
   Yu, Ting-bin
   Stutts, Lisa
   Yen, Max
   Guan, Zhibin
TI Modulation of chondrocyte behavior through tailoring functional
   synthetic saccharide-peptide hydrogels
SO BIOMATERIALS
LA English
DT Article
DE Tissue engineering; Chondrocyte; Cartilage; Sacchride-peptide; Amino
   acid; Functional group
ID ARTICULAR-CARTILAGE; MICHAEL ADDITION; EXTRACELLULAR MATRICES;
   CHONDROITIN SULFATE; GLYCOL) HYDROGELS; GLOBULAR-PROTEINS; CALCIUM
   ALGINATE; IN-VITRO; TISSUE; REPAIR
AB Tailoring three-dimensional (3D) biomaterial environments to provide specific cues in order to modulate function of encapsulated cells could potentially eliminate the need for addition of exogenous cues in cartilage tissue engineering. We recently developed saccharide-peptide copolymer hydrogels for cell culture and tissue engineering applications. In this study, we aim to tailor our saccharide-peptide hydrogel for encapsulating and culturing chondrocytes in 3D and examine the effects of changing single amino acid moieties differing in hydrophobicity/hydrophilicity (valine (V), cysteine (C), tyrosine (Y)) on modulation of chondrocyte function. Encapsulated chondrocytes remained viable over 21 days in vitro. Glycosaminoglycan and collagen content was significantly higher in Y-functionalized hydrogels compared to V-functionalized hydrogels. Extensive matrix accumulation and concomitant increase in mechanical properties was evident over time, particularly with the presence of Y amino acid. After 21 days in vitro, Y-functionalized hydrogels attained a modulus of 193 +/- 46 kPa, compared to 44 +/- 21 kPa for V-functionalized hydrogels. Remarkably, mechanical and biochemical properties of chondrocyte-laden hydrogels were modulated by change in a single amino acid moiety. This unique property, combined with the versatility and biocompatibility, makes our saccharide-peptide hydrogels promising candidates for further investigation of combinatorial effects of multiple functional groups on controlling chondrocyte and other cellular function and behavior. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Chawla, Kanika; Yu, Ting-bin; Stutts, Lisa; Yen, Max; Guan, Zhibin] Univ Calif Irvine, Dept Chem, Irvine, CA 92606 USA.
RP Guan, ZB (reprint author), Univ Calif Irvine, Dept Chem, Irvine, CA 92606 USA.
EM zguan@uci.edu
FU NIH [R01 EB006797]
FX This work was supported by a grant from the NIH (R01 EB006797). We thank
   Dr. Pratibha Vora at Histoserv, Inc., for assistance with sample
   preparation and paraffin embedding and sectioning.
CR AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Betts M. J., 2003, BIOINFORMATICS GENET
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Bugbee William D, 2002, J Knee Surg, V15, P191
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Chawla K, 2006, J ORTHOP RES, V24, P1499, DOI 10.1002/jor.20116
   Chawla K, 2007, TISSUE ENG, V13, P1525, DOI 10.1089/ten.2007.0044
   Chawla K, 2011, BIOMACROMOLECULES, V12, P560, DOI 10.1021/bm100980w
   Choi BG, 2011, SOFT MATTER, V7, P456, DOI 10.1039/c0sm00611d
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Coates E, 2012, J TISSUE ENG REGEN M, V6, P179, DOI 10.1002/term.411
   CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6
   Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erickson IE, 2008, TISSUE ENG PART A, P14
   Ivirico JLE, 2007, J BIOMED MATER RES B, V83B, P266, DOI 10.1002/jbm.b.30792
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GOLDBERG VM, 1994, ORTHOPEDICS, V17, P819
   Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001
   Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742
   Herzner H, 2000, CHEM REV, V100, P4495, DOI 10.1021/cr990308c
   Hiemstra C, 2007, MACROMOLECULES, V40, P1165, DOI 10.1021/ma062468d
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Hu BH, 2009, BIOMACROMOLECULES, V10, P2194, DOI 10.1021/bm900366e
   Hutcheon GA, 2001, BIOMATERIALS, V22, P667, DOI 10.1016/S0142-9612(00)00229-5
   JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0
   Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024
   Jin R, 2010, TISSUE ENG A
   Ke Y, 2010, J BIOMAT SCI-POLYM E, V21, P1589, DOI 10.1163/092050609X12520505439788
   Kim PD, 2009, BIOMATERIALS, V30, P3854, DOI 10.1016/j.biomaterials.2009.04.013
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lane JG, 2004, AM J SPORT MED, V32, P1440, DOI 10.1177/0363546504263945
   Liao SW, 2009, J AM CHEM SOC, V131, P17638, DOI 10.1021/ja907097t
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   Masuda K, 2006, OSTEOARTHR CARTILAGE, V14, P384, DOI 10.1016/j.joca.2005.10.006
   Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794
   Metzke M, 2005, ANGEW CHEM INT EDIT, V44, P6529, DOI 10.1002/anie.200501944
   Miller RE, 2011, CLIN ORTHOP RELAT R, V469, P2716, DOI 10.1007/s11999-011-1891-1
   Mow V.C., 1991, BASIC ORTHOPAEDIC BI, P143
   Olmedilla MP, 2006, BIOMATERIALS, V27, P1003, DOI 10.1016/j.biomaterials.2005.07.030
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Park JS, 2007, J CONTROL RELEASE, V124, P51, DOI 10.1016/j.jconrel.2007,08.030
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Ramachandran GN, 1967, CHEM COLLAGEN
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714
   SCOTT JE, 1965, HISTOCHEMISTRY, V5, P221, DOI 10.1007/BF00306130
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Steadman JR, 1997, OPER TECH ORTHOP, V7, P300, DOI DOI 10.1016/S1048-6666(97)80033-X
   Strehin I, 2010, BIOMATERIALS, V31, P2788, DOI 10.1016/j.biomaterials.2009.12.033
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Villanueva I, 2010, MATRIX BIOL, V29, P51, DOI 10.1016/j.matbio.2009.08.004
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030
NR 71
TC 15
Z9 15
U1 3
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2012
VL 33
IS 26
BP 6052
EP 6060
DI 10.1016/j.biomaterials.2012.04.058
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 978DI
UT WOS:000306720400007
PM 22672831
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mukherjee, R
   Chaudhury, K
   Das, S
   Sengupta, S
   Biswas, P
AF Mukherjee, Rashmi
   Chaudhury, Koel
   Das, Soumen
   Sengupta, Subhrangshu
   Biswas, Partha
TI Posterior capsular opacification and intraocular lens surface
   micro-roughness characteristics: An atomic force microscopy study
SO MICRON
LA English
DT Review
DE Posterior capsule opacification; Intraocular lens; Atomic force
   microscope; Surface roughness characteristics
ID DESIGN
AB Objective: Surface roughness parameters of various intraocular lenses (IOLs) biomaterials using atomic force microscopy (AFM) are compared. Variation, if any, in the micro-roughness properties of different IOLs made up of the same biomaterial is also explored. Retrospective analysis of posterior capsular pacification (PCO) incidence has been followed up for a period of four years post IOL implantation to evaluate the correlation of PCO formation with surface roughness of IOLs.
   Design: Experimental materials study.
   Materials and participants: Surface characteristics of 20 different IOL models were assessed using AFM. These IOL models were made up of PMMA or HEMA or acrylic hydrophobic or acrylic hydrophilic or silicone. Retrospective analysis of PCO incidence in 3629 eyes of 2656 patients implanted with the same IOL models was performed.
   Methods: Topological characteristics of 20 different IOLs made up of 5 different biomaterials including (i) PMMA, (ii) HEMA, (iii) acrylic hydrophobic, (iv) acrylic hydrophilic and (v) silicone were evaluated using AFM in the tapping mode. Images were acquired with a resolution of 256 x 256 data points per scan at a scan rate of 0.5 Hz per line and a scan size of 10 x 10 mu m. Rate of PCO formation in 3629 eyes of 2656 patients implanted with the five different IOL biomaterials was retrospectively analyzed.
   Results: AFM images of IOL optic surfaces showed a collection of pores, grooves, ridges and surface irregularities. Surface roughness parameters of the IOL optics were significantly different on comparing lenses of different materials. Acrylic hydrophobic IOLs had minimum surface roughness while acrylic hydrophilic IOLs showed the highest surface roughness. Different IOL models of the same biomaterial showed varied topological roughness characteristics. Retrospective analyses of PCO formation rate after IOL implantation was carried out, which revealed that rate of PCO incidence, was directly proportional to the increase in surface micro-roughness of IOLs.
   Conclusions: AFM is a powerful technique for the topological characterization of IOLs. Acrylic hydrophobic IOLs showed minimum surface roughness properties as well as minimum PCO incidence over a period of four years post implantation. It is, therefore, tempting to consider acrylic hydrophobic IOLs over other IOL biomaterials as the ideal biocompatible material for lowering PCO incidence. These results suggest an urgent need for manufacturers to optimize the various steps involved in the fabrication of IOLs. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Mukherjee, Rashmi; Chaudhury, Koel] Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.
   [Das, Soumen] Univ Cent Florida, Nanosci & Technol Ctr, Orlando, FL 32816 USA.
   [Sengupta, Subhrangshu; Biswas, Partha] BB Eye Fdn, Kolkata, W Bengal, India.
RP Chaudhury, K (reprint author), Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.
EM koel@smst.iitkgp.ernet.in
OI Chaudhury, Koel/0000-0002-9390-1179; Chaudhury, Koel/0000-0001-8739-5110
CR Chaudhury K., 2010, MICROSCOPY SCI TECHN, P560
   Cheng JW, 2007, AM J OPHTHALMOL, V143, P428, DOI 10.1016/j.ajo.2006.11.045
   Dogru M, 2000, J CATARACT REFR SURG, V26, P571, DOI 10.1016/S0886-3350(99)00342-9
   Escobar-Gomez M, 2003, J CATARACT REFR SURG, V29, P164, DOI 10.1016/S0886-3350(02)01435-9
   Findl O, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003738.pub2
   Guryca Vilem, 2007, Cont Lens Anterior Eye, V30, P215, DOI 10.1016/j.clae.2007.02.010
   Hayashi K, 2004, BRIT J OPHTHALMOL, V88, P182, DOI 10.1136/bjo.2003.023580
   Hollick EJ, 1998, BRIT J OPHTHALMOL, V82, P1182, DOI 10.1136/bjo.82.10.1182
   Klebe S, 2006, CLIN EXP OPTOM, V89, P386, DOI 10.1111/j.1444-0938.2006.00072.x
   Kurosaka D, 2002, OPHTHALMIC RES, V34, P29, DOI 10.1159/000048322
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Lombardo M, 2006, J CATARACT REFR SURG, V32, P1378, DOI 10.1016/j.jcrs.2006.02.068
   Lombardo M, 2010, J CATARACT REFR SURG, V36, P1573, DOI 10.1016/j.jcrs.2010.06.031
   Lombardo M, 2009, J CATARACT REFR SURG, V35, P1266, DOI 10.1016/j.jcrs.2009.02.029
   Moreno-Montanes J, 2005, INVEST OPHTH VIS SCI, V46, P3999, DOI 10.1167/iovs.04-1531
   Murril CA, 1995, CAPSULOTOMY OPTOMCLI, V4, P69
   Nishi O, 2004, J CATARACT REFR SURG, V30, P2170, DOI 10.1016/j.jcrs.2004.05.022
   Saika S, 2004, PROG RETIN EYE RES, V23, P283, DOI 10.1016/j.preteyeres.2004.02.004
   SELLMAN TR, 1988, J CATARACT REFR SURG, V14, P68, DOI 10.1016/S0886-3350(88)80067-1
   Shah A.R., 2007, EYE, V22, P889
   Tanaka T, 2005, J CATARACT REFR SURG, V31, P1648, DOI 10.1016/j.jcrs.2004.11.050
   Tehrani M, 2004, OPHTHALMOLOGICA, V218, P57, DOI 10.1159/000074568
   Van Tenten Y., 2000, B SOC BELG OPHTHALM, P61
   Waddell KM, 2004, BRIT J OPHTHALMOL, V88, P734, DOI 10.1136/bjo.2003.031187
   Wejde G, 2003, J CATARACT REFR SURG, V29, P1556, DOI 10.1016/S0886-3350(03)00342-0
NR 25
TC 13
Z9 14
U1 1
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD SEP
PY 2012
VL 43
IS 9
BP 937
EP 947
DI 10.1016/j.micron.2012.03.015
PG 11
WC Microscopy
SC Microscopy
GA 958TG
UT WOS:000305263000003
PM 22522120
DA 2018-10-19
ER

PT J
AU Anyango, JO
   Duneas, N
   Taylor, JRN
   Taylor, J
AF Anyango, Joseph O.
   Duneas, Nicolaas
   Taylor, John R. N.
   Taylort, Janet
TI Physicochemical Modification of Kafirin Microparticles and Their Ability
   To Bind Bone Morphogenetic Protein-2 (BMP-2), for Application as a
   Biomaterial
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE kafirin; microparticle; cross-linking; binding; BMP-2
ID SECONDARY STRUCTURE; FUNCTIONAL-PROPERTIES; CONTROLLED-RELEASE; COLLAGEN
   SPONGES; DELIVERY-SYSTEMS; WATER STABILITY; CROSS-LINKING; MAIZE ZEIN;
   SORGHUM; DIGESTIBILITY
AB Vacuolated spherical kafirin microparticles with a mean diameter of 5 mu m can be formed from an acidic solution with water addition. Three-dimensional scaffolds for hard tissue repair require large structures with a high degree of interconnected porosity. Cross linking the formed kafirin microparticles using wet heat or glutaraldehyde treatment resulted in larger structures (approximately 20 mu m), which, while similar in size and external morphology, were apparently formed by further assisted assembly by two significantly different mechanisms. Heat treatment, which increased the vacuole size, involved kafirin polymerization by disulfide bonding with the microparticles being formed from round, coalesced nanostructures, as shown by atomic force microscopy (AFM). Kafirin polymerization, of glutaraldehyde-treated microparticles was not by disulfide bonding, and the nanostructures, as revealed by AFM, were spindle shaped. Both treatments enhanced BMP-2 binding to the microparticles, probably due to their increased size. Thus, these. Modified kafirin microparticles have potential as natural, nonanimal protein bioactive scaffolds.
C1 [Anyango, Joseph O.; Taylor, John R. N.; Taylort, Janet] Univ Pretoria, Inst Food Nutr & Well Being, ZA-0028 Hatfield, South Africa.
   [Anyango, Joseph O.; Taylor, John R. N.; Taylort, Janet] Univ Pretoria, Dept Food Sci, ZA-0028 Hatfield, South Africa.
   [Duneas, Nicolaas] Aids Biol, Pretoria, South Africa.
RP Taylor, J (reprint author), Univ Pretoria, Inst Food Nutr & Well Being, Private Bag X20, ZA-0028 Hatfield, South Africa.
EM janet.taylor@up.ac.za
OI Taylor, John/0000-0002-9714-2093; Taylor, Janet/0000-0001-7148-5437
FU University of Pretoria
FX J.A. is grateful for the provision of a University of Pretoria
   Postgraduate Research Support Bursary.
CR [Anonymous], 2000, APPR METH AACC
   Anyango JO, 2011, J AGR FOOD CHEM, V59, P12674, DOI 10.1021/jf203273y
   Belton PS, 2006, J CEREAL SCI, V44, P272, DOI 10.1016/j.jcs.2006.05.004
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Byaruhanga YB, 2006, J AGR FOOD CHEM, V54, P4198, DOI 10.1021/jf052942z
   Caillard R, 2009, FOOD RES INT, V42, P98, DOI 10.1016/j.foodres.2008.10.004
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Csonka FA, 1926, J AM CHEM SOC, V48, P763, DOI 10.1021/ja01414a035
   Duodu KG, 2003, J CEREAL SCI, V38, P117, DOI 10.1016/S0733-5210(03)00016-X
   El Nour N. A., 1998, J CEREAL SCI, V28, P197
   Emmambux N. M., 2009, J AGR FOOD CHEM, V57, P1045, DOI DOI 10.1021/JF802672E
   Erickson DP, 2012, TRENDS FOOD SCI TECH, V24, P74, DOI 10.1016/j.tifs.2011.10.008
   Ezeogu LI, 2005, J CEREAL SCI, V42, P33, DOI 10.1016/j.jcs.2005.02.002
   Farris S, 2010, J AGR FOOD CHEM, V58, P998, DOI 10.1021/jf9031603
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Gao CL, 2005, J AGR FOOD CHEM, V53, P306, DOI 10.1021/jf0492666
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006
   Guo YC, 2005, J CEREAL SCI, V41, P277, DOI 10.1016/j.jcs.2004.12.005
   HAMAKER BR, 1986, J AGR FOOD CHEM, V34, P647, DOI 10.1021/jf00070a014
   Higberger J., 1939, J AM CHEM SOC, V61, P2302
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009
   Krebs MRH, 2007, BIOPHYS J, V92, P1336, DOI 10.1529/biophysj.106.094342
   Lehtinen KEJ, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.205402
   Migneault I., 2004, BIOTECHNIQUES, V37, P790
   Mizutani Y, 2003, J AGR FOOD CHEM, V51, P229, DOI 10.1021/jf0205007
   Muthuselvi L, 2006, COLLOID SURFACE B, V51, P39, DOI [10.1016/j.colsurfb.2006.05.012, 10.1016/colsurfb.2006.05.012]
   Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7
   Panchapakesan C, 2012, J CEREAL SCI, V55, P174, DOI 10.1016/j.jcs.2011.11.004
   Parris N, 2005, J AGR FOOD CHEM, V53, P4788, DOI 10.1021/jf040492p
   Patel A, 2010, SOFT MATTER, V6, P6192, DOI 10.1039/c0sm00800a
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320
   Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0
   Reddy N, 2011, TRENDS BIOTECHNOL, V29, P490, DOI 10.1016/j.tibtech.2011.05.003
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Schrier JA, 1999, PHARM DEV TECHNOL, V4, P611, DOI 10.1081/PDT-100101400
   SHAKESHEFF KM, 1994, SURF SCI, V304, pL393, DOI 10.1016/0039-6028(94)90739-0
   Soliman EA, 2009, J AGR FOOD CHEM, V57, P2529, DOI 10.1021/jf8032599
   Taylor J, 2002, INT J FOOD SCI TECH, V37, P129, DOI 10.1046/j.1365-2621.2002.00549.x
   Taylor J., 2009, J CEREAL SCI, V50, P90
   Taylor J, 2009, J AGR FOOD CHEM, V57, P7523, DOI 10.1021/jf901592q
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang Y, 2012, LANGMUIR, V28, P2429, DOI 10.1021/la204204j
   Wang Y, 2010, LANGMUIR, V26, P12897, DOI 10.1021/la101688v
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
   Xiao D, 2011, J AGR FOOD CHEM, V59, P7393, DOI 10.1021/jf200774v
   Xu HL, 2011, J MATER CHEM, V21, P18227, DOI 10.1039/c1jm11163a
   Xu WJ, 2008, POLYM INT, V57, P1110, DOI 10.1002/pi.2450
   Yao C, 2007, J APPL POLYM SCI, V103, P380, DOI 10.1002/app.24619
   Zhang WN, 2009, J AGR FOOD CHEM, V57, P9181, DOI 10.1021/jf902045u
NR 55
TC 8
Z9 8
U1 2
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD AUG 29
PY 2012
VL 60
IS 34
BP 8419
EP 8426
DI 10.1021/jf302533e
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 995VT
UT WOS:000308042800022
PM 22867133
DA 2018-10-19
ER

PT J
AU Li, YN
   Wang, GZ
   Tian, J
   Liu, HF
   Yang, HP
   Yi, YZ
   Wang, JH
   Shi, XF
   Jiang, F
   Yao, B
   Zhang, ZF
AF Li, Yinu
   Wang, Guozeng
   Tian, Jian
   Liu, Huifen
   Yang, Huipeng
   Yi, Yongzhu
   Wang, Jinhui
   Shi, Xiaofeng
   Jiang, Feng
   Yao, Bin
   Zhang, Zhifang
TI Transcriptome Analysis of the Silkworm (Bombyx mori) by High-Throughput
   RNA Sequencing
SO PLOS ONE
LA English
DT Article
ID EST DATABASE; MICROARRAY ANALYSIS; GENE; GENOME; EXPRESSION; REVEALS;
   SEQ; CONSTRUCTION; PLATFORM; ISOFORM
AB The domestic silkworm, Bombyx mori, is a model insect with important economic value for silk production that also acts as a bioreactor for biomaterial production. The functional complexity of the silkworm transcriptome has not yet been fully elucidated, although genomic sequencing and other tools have been widely used in its study. We explored the transcriptome of silkworm at different developmental stages using high-throughput paired-end RNA sequencing. A total of about 3.3 gigabases (Gb) of sequence was obtained, representing about a 7-fold coverage of the B. mori genome. From the reads that were mapped to the genome sequence; 23,461 transcripts were obtained, 5,428 of them were novel. Of the 14,623 predicted protein-coding genes in the silkworm genome database, 11,884 of them were found to be expressed in the silkworm transcriptome, giving a coverage of 81.3%. A total of 13,195 new exons were detected, of which, 5,911 were found in the annotated genes in the Silkworm Genome Database (SilkDB). An analysis of alternative splicing in the transcriptome revealed that 3,247 genes had undergone alternative splicing. To help with the data analysis, a transcriptome database that integrates our transcriptome data with the silkworm genome data was constructed and is publicly available at http://124.17.27.136/gbrowse2/. To our knowledge, this is the first study to elucidate the silkworm transcriptome using high-throughput RNA sequencing technology. Our data indicate that the transcriptome of silkworm is much more complex than previously anticipated. This work provides tools and resources for the identification of new functional elements and paves the way for future functional genomics studies.
C1 [Li, Yinu; Wang, Guozeng; Tian, Jian; Liu, Huifen; Yang, Huipeng; Yi, Yongzhu; Wang, Jinhui; Shi, Xiaofeng; Jiang, Feng; Zhang, Zhifang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.
   [Wang, Guozeng; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Beijing 100193, Peoples R China.
RP Li, YN (reprint author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.
EM yaobin@mail.caas.net.cn; zhifangzhang@yahoo.com
FU National Basic Research Program [2012CB114602]; National Natural
   Sciences Foundation of China [31070139]
FX This work was supported by the National Basic Research Program (No.
   2012CB114602, http://www.973.gov.cn/English/Index.aspx) and the National
   Natural Sciences Foundation of China (No. 31070139,
   http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abdel-Banat BMA, 2002, J BIOL CHEM, V277, P30524, DOI 10.1074/jbc.M112422200
   Chen J, 2006, J BIOTECHNOL, V123, P236, DOI 10.1016/j.jbiotec.2005.11.015
   DREVET JR, 1995, J MOL BIOL, V246, P43, DOI 10.1006/jmbi.1994.0064
   Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801
   Funaguma S, 2007, INSECT BIOCHEM MOLEC, V37, P147, DOI 10.1016/j.ibmb.2006.11.001
   Gan LP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.11401
   Gopalapillai R, 2006, J LIPID RES, V47, P1005, DOI 10.1194/jlr.M500462-JLR200
   Li XH, 2011, MOL BIOL REP, V38, P3897, DOI 10.1007/s11033-010-0505-4
   Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002273
   Liu HF, 2011, MOL BIOL REP, V38, P2793, DOI 10.1007/s11033-010-0424-4
   Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638
   Malko DB, 2006, GENOME RES, V16, P505, DOI 10.1101/gr.4236606
   Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6
   Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100
   Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13
   Nagaoka S, 2011, ARCH INSECT BIOCHEM, V76, P97, DOI 10.1002/arch.20407
   Niu BL, 2005, ACTA BIOCH BIOPH SIN, V37, P728, DOI 10.1111/j.1745-7270.2005.00106.x
   Ote M, 2004, INSECT BIOCHEM MOLEC, V34, P775, DOI 10.1016/j.ibmb.2004.04.002
   Qian Y, 2011, SILK, V04, P57
   Shimomura M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-486
   Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256
   Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620
   Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI 10.1016/j.ibmb.2008.11.004
   Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210
   Xia QY, 2001, INSECT BIOCHEM MOLEC, V32, P9, DOI 10.1016/S0965-1748(01)00074-1
   Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626
   Zha XF, 2005, INSECT MOL BIOL, V14, P113, DOI 10.1111/j.1365-2583.2004.00536.x
   Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109
   Zhang Y, 2007, GENOMICS, V90, P372, DOI 10.1016/j.ygeno.2007.05.005
NR 33
TC 12
Z9 13
U1 2
U2 31
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 23
PY 2012
VL 7
IS 8
AR e43713
DI 10.1371/journal.pone.0043713
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 998GE
UT WOS:000308224700023
PM 22928022
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Seet, WT
   Maarof, M
   Anuar, KK
   Chua, KH
   Irfan, AWA
   Ng, MH
   Aminuddin, BS
   Ruszymah, BHI
AF Seet, Wan Tai
   Maarof, Manira
   Anuar, Khairoji Khairul
   Chua, Kien-Hui
   Irfan, Abdul Wahab Ahmad
   Ng, Min Hwei
   Aminuddin, Bin Saim
   Ruszymah, Bt Hj Idrus
TI Shelf-Life Evaluation of Bilayered Human Skin Equivalent, MyDerm (TM)
SO PLOS ONE
LA English
DT Article
ID DIABETIC FOOT ULCERS; CLINICAL-EVALUATION; RANDOMIZED-TRIAL; ARTIFICIAL
   SKIN; IN-VITRO; SUBSTITUTES; FIBROBLASTS; EPITHELIA; APLIGRAF; EFFICACY
AB Skin plays an important role in defense against infection and other harmful biological agents. Due to its fragile structure, skin can be easily damaged by heat, chemicals, traumatic injuries and diseases. An autologous bilayered human skin equivalent, MyDerm (TM), was engineered to provide a living skin substitute to treat critical skin loss. However, one of the disadvantages of living skin substitute is its short shelf-life, hence limiting its distribution worldwide. The aim of this study was to evaluate the shelf-life of MyDerm (TM) through assessment of cell morphology, cell viability, population doubling time and functional gene expression levels before transplantation. Skin samples were digested with 0.6% Collagenase Type I followed by epithelial cells dissociation with TrypLE Select. Dermal fibroblasts and keratinocytes were culture-expanded to obtain sufficient cells for MyDerm (TM) construction. MyDerm (TM) was constructed with plasma-fibrin as temporary biomaterial and evaluated at 0, 24, 48 and 72 hours after storage at 4 degrees C for its shelf-life determination. The morphology of skin cells derived from MyDerm (TM) remained unchanged across storage times. Cells harvested from MyDerm (TM) after storage appeared in good viability (90.5%+/- 2.7% to 94.9%+/- 1.6%) and had short population doubling time (58.4 +/- 8.7 to 76.9 +/- 19 hours). The modest drop in cell viability and increased in population doubling time at longer storage duration did not demonstrate a significant difference. Gene expression for CK10, CK14 and COL III were also comparable between different storage times. In conclusion, MyDerm (TM) can be stored in basal medium at 4 degrees C for at least 72 hours before transplantation without compromising its functionality.
C1 [Seet, Wan Tai; Maarof, Manira; Anuar, Khairoji Khairul; Chua, Kien-Hui; Irfan, Abdul Wahab Ahmad; Ng, Min Hwei; Aminuddin, Bin Saim; Ruszymah, Bt Hj Idrus] Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Kuala Lumpur, Malaysia.
   [Chua, Kien-Hui; Ruszymah, Bt Hj Idrus] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.
   [Aminuddin, Bin Saim] Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Selangor, Malaysia.
RP Seet, WT (reprint author), Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Kuala Lumpur, Malaysia.
EM ruszyidrus@gmail.com
FU Malaysian Technology Development Corporation (MTDC)
   [UKM-MTDC-BF-0001-2008]; Universiti Kebangsaan Malaysia
FX This study is made possible by a grant from Malaysian Technology
   Development Corporation (MTDC), grant number UKM-MTDC-BF-0001-2008,
   Universiti Kebangsaan Malaysia (http://www.mtdc.com.my/). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Bar-Meir E, 2006, ISRAEL MED ASSOC J, V8, P188
   BERNSTAM L I, 1990, Journal of Dermatological Science, V1, P173, DOI 10.1016/0923-1811(90)90129-2
   Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018
   Dinh TL, 2006, PLAST RECONSTR SURG, V117, p152S, DOI 10.1097/01.prs.0000222534.79915.d3
   Edmonds M, 2009, INT J LOW EXTR WOUND, V8, P11, DOI 10.1177/1534734609331597
   Furukawa K, 1998, CYTOTECHNOLOGY, V26, P153, DOI 10.1023/A:1007934216507
   HANSBROUGH JF, 1992, SURGERY, V111, P438
   HANSBROUGH JF, 1994, SURGERY, V115, P633
   HARRIGER M D, 1992, Journal of Burn Care and Rehabilitation, V13, P187, DOI 10.1097/00004630-199203000-00002
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Kumar RJ, 2004, ANZ J SURG, V74, P622, DOI 10.1111/j.1445-1433.2004.03106.x
   LEVINE JF, 1985, J CELL BIOL, V100, P1415, DOI 10.1083/jcb.100.5.1415
   Lewis M. P., 2006, PHARM TECHNOLOGY EUR, P50
   MacNeil S, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70087-7
   Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701
   Mast B.A., 1992, WOUND HEALING BIOCH, V13, P344
   Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022
   Mazlyzam AL, 2008, ARCH MED RES, V39, P743, DOI 10.1016/j.arcmed.2008.09.001
   Moiemen NS, 2006, PLAST RECONSTR SURG, V117, p160S, DOI 10.1097/01.prs.0000222609.40461.68
   MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7
   PURKIS PE, 1990, J CELL SCI, V97, P39
   Schon M, 1996, BRIT J DERMATOL, V135, P696
   Schurr MJ, 2009, J TRAUMA, V66, P866, DOI 10.1097/TA.0b013e31819849d6
   Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1
   TAVIS MJ, 1980, BURNS, V7, P123, DOI 10.1016/0305-4179(80)90038-8
   THIVOLET J, 1986, TRANSPLANTATION, V42, P274, DOI 10.1097/00007890-198609000-00010
   Tilden E, 2010, FACTS ORGAN DONATION
   Wainwright David, 1996, Journal of Burn Care and Rehabilitation, V17, P124, DOI 10.1097/00004630-199603000-00006
   Wang C., 2011, AFRICAN J BIOTECHNOL, V10, P2524
   Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 33
TC 23
Z9 23
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 23
PY 2012
VL 7
IS 8
AR e40978
DI 10.1371/journal.pone.0040978
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 998GE
UT WOS:000308224700001
PM 22927903
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Baumann, L
   Prokoph, S
   Gabriel, C
   Freudenberg, U
   Werner, C
   Beck-Sickinger, AG
AF Baumann, Lars
   Prokoph, Silvana
   Gabriel, Christian
   Freudenberg, Uwe
   Werner, Carsten
   Beck-Sickinger, Annette G.
TI A novel, biased-like SDF-1 derivative acts synergistically with
   starPEG-based heparin hydrogels and improves eEPC migration in vitro
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE SDF-1 alpha; Heparin; Hydrogel; Biomaterial; Endothelial progenitor
   cells; Cardiac regeneration
ID CELL-DERIVED FACTOR-1-ALPHA; ENDOTHELIAL PROGENITOR CELLS; ACUTE
   MYOCARDIAL-INFARCTION; HEMATOPOIETIC STEM-CELLS; SDF-1-INDUCED
   MIGRATION; HEART-FAILURE; PEPTIDASE-IV; CATHEPSIN-G; AMI TRIAL; CXCR4
AB The CXC chemokine stromal cell-derived factor-1 alpha (SDF-1 alpha, CXCL12) has been proven to recruit CXCR4 positive stem and progenitor cells of different sources to defected heart sites, with significant clinical benefits. However, the rapid proteolytic inactivation by inflammation-related proteases, inaccurate drug delivery or inappropriate local concentrations belong to the largest disadvantages for feasible application. Herein, we present a switchable, biased-like SDF-1 alpha variant, AAV-[S4V]-SDF-1 alpha, whose distinct activity is coupled to the inflammation-associated presence of dipeptidylpeptidase-4 (DPP-4), which cleaves an alanine-alanine dipeptide from the precursor. We decorated starPEG-heparin hydrogels with our novel SDF-1 alpha variant and tested them for immobilization efficiency, time-dependent protein release as well as mobilization of early endothelial progenitor cells (eEPCs) in vitro. We found higher migration rates compared to conventional SDF-1 alpha. In summary, we provide a conceptual work on cooperative effects of enzymatically activatable SDF-1 alpha and starPEG-heparin hydrogels. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Baumann, Lars; Gabriel, Christian; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany.
   [Prokoph, Silvana; Freudenberg, Uwe; Werner, Carsten] Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res Dresden, Dresden, Germany.
   [Prokoph, Silvana; Freudenberg, Uwe; Werner, Carsten] Tech Univ Dresden, CRTD, Dresden, Germany.
RP Beck-Sickinger, AG (reprint author), Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Bruderstr 43, D-04103 Leipzig, Germany.
EM beck-sickinger@uni-leipzig.de
RI Baumann, Lars/H-7991-2015; Werner, Carsten/F-8127-2010; Umlauf,
   Ursula/D-3356-2014
OI Werner, Carsten/0000-0003-0189-3448; Gabriel,
   Christian/0000-0003-2043-9320
CR Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Ballard VLT, 2007, CIRC RES, V100, P1116, DOI 10.1161/01.RES.0000261964.19115.e5
   Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460
   Baumann L, 2010, BIOPOLYMERS, V94, P771, DOI 10.1002/bip.21465
   Bellmann-Sickert K, 2011, CHEMMEDCHEM, V6, P193, DOI 10.1002/cmdc.201000403
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479
   Chwalek K, 2011, BIOMATERIALS, V32, P9649, DOI 10.1016/j.biomaterials.2011.08.078
   De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423
   Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6
   Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   George JC, 2010, TRANSL RES, V155, P10, DOI 10.1016/j.trsl.2009.06.009
   Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451
   Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009
   Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09
   Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110
   Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354
   McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353
   Peterson JT, 2000, CARDIOVASC RES, V46, P307, DOI 10.1016/S0008-6363(00)00029-8
   Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024
   Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039
   Proost P, 1998, FEBS LETT, V432, P73, DOI 10.1016/S0014-5793(98)00830-8
   Rao RM, 2004, J EXP MED, V200, P713, DOI 10.1084/jem.20040499
   Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200
   Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200
   Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703
   Sasaki T, 2007, PEDIATR INT, V49, P966, DOI 10.1111/j.1442-200X.2007.02491.x
   Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992
   Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014
   Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388
   Schuh A, 2008, BASIC RES CARDIOL, V103, P69, DOI 10.1007/s00395-007-0685-9
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651
   Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0
   Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200
   Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tsurkan MV, 2010, MACROMOL RAPID COMM, V31, P1529, DOI 10.1002/marc.201000155
   Tsurkan MV, 2010, CHEM COMMUN, V46, P1141, DOI 10.1039/b921616b
   Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200
   Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505
   Wang YN, 2011, BIOMATERIALS, V32, P4903, DOI 10.1016/j.biomaterials.2011.03.027
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
   Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f
   Zieris A, 2011, J CONTROL RELEASE, V156, P28, DOI 10.1016/j.jconrel.2011.06.042
   Zieris A, 2010, J MATER SCI-MATER M, V21, P915, DOI 10.1007/s10856-009-3913-z
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
NR 53
TC 41
Z9 42
U1 3
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 20
PY 2012
VL 162
IS 1
BP 68
EP 75
DI 10.1016/j.jconrel.2012.04.049
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 992IP
UT WOS:000307769200008
PM 22634073
DA 2018-10-19
ER

EF